PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Benoit-Bird, KJ; Battaile, BC; Heppell, SA; Hoover, B; Irons, D; Jones, N; Kuletz, KJ; Nordstrom, CA; Paredes, R; Suryan, RM; Waluk, CM; Trites, AW				Benoit-Bird, Kelly J.; Battaile, Brian C.; Heppell, Scott A.; Hoover, Brian; Irons, David; Jones, Nathan; Kuletz, Kathy J.; Nordstrom, Chad A.; Paredes, Rosana; Suryan, Robert M.; Waluk, Chad M.; Trites, Andrew W.			Prey Patch Patterns Predict Habitat Use by Top Marine Predators with Diverse Foraging Strategies	PLOS ONE			English	Article							SEALS CALLORHINUS-URSINUS; PRIBILOF ISLANDS; SPATIAL SCALE; FUR SEALS; ANTARCTIC KRILL; BERING-SEA; SEABIRDS; DENSITY; MODELS; FOOD	Spatial coherence between predators and prey has rarely been observed in pelagic marine ecosystems. We used measures of the environment, prey abundance, prey quality, and prey distribution to explain the observed distributions of three co-occurring predator species breeding on islands in the southeastern Bering Sea: black-legged kittiwakes (Rissa tridactyla), thick-billed murres (Uria lomvia), and northern fur seals (Callorhinus ursinus). Predictions of statistical models were tested using movement patterns obtained from satellite-tracked individual animals. With the most commonly used measures to quantify prey distributions - areal biomass, density, and numerical abundance - we were unable to find a spatial relationship between predators and their prey. We instead found that habitat use by all three predators was predicted most strongly by prey patch characteristics such as depth and local density within spatial aggregations. Additional prey patch characteristics and physical habitat also contributed significantly to characterizing predator patterns. Our results indicate that the small-scale prey patch characteristics are critical to how predators perceive the quality of their food supply and the mechanisms they use to exploit it, regardless of time of day, sampling year, or source colony. The three focal predator species had different constraints and employed different foraging strategies - a shallow diver that makes trips of moderate distance (kittiwakes), a deep diver that makes trip of short distances (murres), and a deep diver that makes extensive trips (fur seals). However, all three were similarly linked by patchiness of prey rather than by the distribution of overall biomass. This supports the hypothesis that patchiness may be critical for understanding predator-prey relationships in pelagic marine systems more generally.	[Benoit-Bird, Kelly J.; Waluk, Chad M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Heppell, Scott A.; Paredes, Rosana; Suryan, Robert M.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Battaile, Brian C.; Nordstrom, Chad A.; Trites, Andrew W.] Univ British Columbia, Marine Mammal Res Unit, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Battaile, Brian C.; Nordstrom, Chad A.; Trites, Andrew W.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Hoover, Brian; Jones, Nathan] Univ Calif, Moss Landing Marine Labs, Moss Landing, CA USA; [Irons, David; Kuletz, Kathy J.] US Fish & Wildlife Serv, Anchorage, AK USA	Oregon State University; Oregon State University; University of British Columbia; University of British Columbia; Moss Landing Marine Laboratories; United States Department of the Interior; US Fish & Wildlife Service	Benoit-Bird, KJ (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	kbenoit@coas.oregonstate.edu	Trites, Andrew/K-5648-2012	Hoover, Brian/0000-0003-1603-6932; Trites, Andrew/0000-0003-0342-5322	North Pacific Research Board	North Pacific Research Board	Funding was provided by the North Pacific Research Board as part of the Bering Sea Project [http://bsierp.nprb.org/]. The funders facilitated indersciplinary partnerships as part of the program but had no role in the specifics of the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; Antonelis GA, 1997, J ZOOL, V242, P435, DOI 10.1111/j.1469-7998.1997.tb03847.x; BARANGE M, 1994, S AFR J MARINE SCI, V14, P333; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P66; Belsey DA, 1980, REGRESSION DIAGNOSTI; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benoit-Bird KJ, 2010, CONT SHELF RES, V30, P17, DOI 10.1016/j.csr.2009.08.001; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Benoit-Bird KJ, 2009, MAR ECOL PROG SER; Beyer JE, 1995, ICES COUNC M COP DEN; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Brierley AS, 1996, MAR ECOL PROG SER, V138, P51, DOI 10.3354/meps138051; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; CROLL DA, 1992, ECOLOGY, V73, P344, DOI 10.2307/1938746; De Robertis A, 2010, CAN J FISH AQUAT SCI, V67, P1459, DOI 10.1139/F10-075; Decker MB, 1996, MAR ECOL PROG SER, V139, P1, DOI 10.3354/meps139001; DIEKMANN O, 1988, EXP APPL ACAROL, V5, P319, DOI 10.1007/BF02366100; Diner N, 2001, AQUAT LIVING RESOUR, V14, P211, DOI 10.1016/S0990-7440(01)01121-4; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; FOOTE KG, 1988, J ACOUST SOC AM, V83, P9, DOI 10.1121/1.396190; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Gaston A.J., 1998, AUKS ALCIDAE; GODIN JGJ, 1984, ANIM BEHAV, V32, P120, DOI 10.1016/S0003-3472(84)80330-9; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; Goss C, 1997, MAR ECOL PROG SER, V154, P41, DOI 10.3354/meps154041; GOSSCUSTARD JD, 1977, J APPL ECOL, V14, P681, DOI 10.2307/2402803; Greco NM, 1999, EXP APPL ACAROL, V23, P567, DOI 10.1023/A:1006125103981; Greene C. H., 1994, OCEANOGRAPHY, V7, P4; GREENE CH, 1991, NATURE, V349, P110, DOI 10.1038/349110a0; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hammond JI, 2007, ECOLOGY, V88, P1525, DOI 10.1890/06-1236; Hatch SA, 2009, BIRDS N AM; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Hickey JJ, 1977, ENV ASSESSMENT ALASK, V2, P96; Hines AH, 1997, J EXP MAR BIOL ECOL, V216, P191, DOI 10.1016/S0022-0981(97)00096-8; Hunt G.L.J., 1990, STUD AVIAN BIOL, V14, P7; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Krebs J.R., 1978, P23; LASKER R, 1975, FISH B-NOAA, V73, P453; Leising AW, 2001, MAR ECOL PROG SER, V216, P167, DOI 10.3354/meps216167; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Logerwell EA, 1998, ECOGRAPHY, V21, P212, DOI 10.1111/j.1600-0587.1998.tb00674.x; LOUGHLIN TR, 1989, ARCTIC, V42, P368; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MacLennan D.N., 1992, SPRINGER SCI BUS MED; Mason DM, 1996, ENVIRON BIOL FISH, V45, P283, DOI 10.1007/BF00003098; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McIntosh NE, 2011, THESIS OREGON STATE; Milne BT, 1989, LANDSCAPE ECOL, V2, P102; Mizobata K, 2008, DEEP-SEA RES PT II, V55, P1717, DOI 10.1016/j.dsr2.2008.03.002; Morgan RA, 1997, ECOLOGY, V78, P1087, DOI 10.1890/0012-9658(1997)078[1087:TEOSSO]2.0.CO;2; MUOTKA T, 1994, CAN J FISH AQUAT SCI, V51, P2210, DOI 10.1139/f94-223; Nordstrom CA, DEEP SEA RES 2, DOI [10.1016/j.dsr1012.2012.1007.1010, DOI 10.1016/J.DSR1012.2012.1007.1010]; Orians G.H., 1979, P155; Paredes R, 2012, MAR ECOL PR IN PRESS; Piatt J.F., 1990, Studies in Avian Biology, P36; Renner HM, 2012, DEEP SEA RES 2; ROSE GA, 1990, ECOLOGY, V71, P33, DOI 10.2307/1940245; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Sigler MF, 2012, DEEP SEA RES 2; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Steele J. H., 1978, NATO C SERIES, V3, P470; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; TISELIUS P, 1993, B MAR SCI, V53, P247; Traynor JJ, 1996, ICES J MAR SCI, V53, P253, DOI 10.1006/jmsc.1996.0031; Veit RR, 1999, ARDEA, V87, P41; Whitman L, 2010, THESIS OREGON STATE; Wiese FK, 2012, DEEP SEA RES 2; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zeppelin TK, 2006, J ZOOL, V270, P565, DOI 10.1111/j.1469-7998.2006.00122.x; ZHANG ZQ, 1993, OECOLOGIA, V96, P24, DOI 10.1007/BF00318026	87	135	136	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53348	10.1371/journal.pone.0053348	http://dx.doi.org/10.1371/journal.pone.0053348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301063	Green Published, gold			2022-12-27	WOS:000313480000051
J	Bortoletto, M; Mattingley, JB; Cunnington, R				Bortoletto, Marta; Mattingley, Jason B.; Cunnington, Ross			Effects of Context on Visuomotor Interference Depends on the Perspective of Observed Actions	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; AUTOMATIC IMITATION; MOTOR FACILITATION; SELF; ATTENTION; REPRESENTATIONS; SPECIFICITY; PERCEPTION; MECHANISMS; MOVEMENTS	Visuomotor interference occurs when the execution of an action is facilitated by the concurrent observation of the same action and hindered by the concurrent observation of a different action. There is evidence that visuomotor interference can be modulated top-down by higher cognitive functions, depending on whether own performed actions or observed actions are selectively attended. Here, we studied whether these effects of cognitive context on visuomotor interference are also dependent on the point-of-view of the observed action. We employed a delayed go/no-go task known to induce visuomotor interference. Static images of hand gestures in either egocentric or allocentric perspective were presented as "go'' stimuli after participants were pre-cued to prepare either a matching (congruent) or non-matching (incongruent) action. Participants performed this task in two different cognitive contexts: In one, they focused on the visual image of the hand gesture shown as the go stimulus (image context), whereas in the other they focused on the hand gesture they performed (action context). We analyzed reaction times to initiate the prepared action upon presentation of the gesture image and found evidence of visuomotor interference in both contexts and for both perspectives. Strikingly, results show that the effect of cognitive context on visuomotor interference also depends on the perspective of observed actions. When focusing on own-actions, visuomotor interference was significantly less for gesture images in allocentric perspective than in egocentric perspective; when focusing on observed actions, visuomotor interference was present regardless of the perspective of the gesture image. Overall these data suggest that visuomotor interference may be modulated by higher cognitive processes, so that when we are specifically attending to our own actions, images depicting others' actions (allocentric perspective) have much less interference on our own actions.	[Bortoletto, Marta] IRCCS San Giovanni di Dio Fatebenefratelli, Cognit Neurosci Unit, Brescia, Italy; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	IRCCS Fatebenefratelli; University of Queensland; University of Queensland	Bortoletto, M (corresponding author), IRCCS San Giovanni di Dio Fatebenefratelli, Cognit Neurosci Unit, Brescia, Italy.	marta.bortoletto@cognitiveneuroscience.it	Bortoletto, Marta/A-9403-2012; Mattingley, Jason/J-1537-2014	Bortoletto, Marta/0000-0002-8489-8043; Mattingley, Jason/0000-0003-0929-9216; Cunnington, Ross/0000-0002-7423-4809	Australian Research Council [DP110103285]	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (DP110103285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Bortoletto M, 2011, NEUROPSYCHOLOGIA, V49, P2097, DOI 10.1016/j.neuropsychologia.2011.04.004; Bruzzo A, 2008, NEUROSCI LETT, V441, P61, DOI 10.1016/j.neulet.2008.06.020; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Cattaneo L, 2010, SOCIAL COGNITIVE AFF; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Halasz V, 2012, BRAIN SCI, V2, P130, DOI 10.3390/brainsci2020130; Hesse MD, 2009, J COGNITIVE NEUROSCI, V21, P776, DOI 10.1162/jocn.2009.21058; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Longo MR, 2008, J EXP PSYCHOL HUMAN, V34, P489, DOI 10.1037/0096-1523.34.2.489; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; Mulder T, 2007, J NEURAL TRANSM, V114, P1265, DOI 10.1007/s00702-007-0763-z; Oberman LM, 2007, SOC COGN AFFECT NEUR, V2, P62, DOI 10.1093/scan/nsl022; Obhi SS, 2011, J NEUROSCI, V31, P14531, DOI 10.1523/JNEUROSCI.3186-11.2011; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Ogawa K, 2011, NEUROIMAGE, V56, P728, DOI 10.1016/j.neuroimage.2010.10.043; Oosterhof NN, 2012, J COGNITIVE NEUROSCI, V24, P975, DOI 10.1162/jocn_a_00195; Perry A, 2011, NEUROIMAGE, V58, P895, DOI 10.1016/j.neuroimage.2011.06.060; Pomeroy VM, 2005, NEUROREHAB NEURAL RE, V19, P4, DOI 10.1177/1545968304274351; Press C, 2008, BRAIN COGNITION, V67, P44, DOI 10.1016/j.bandc.2007.11.001; Press C, 2010, J COGNITIVE NEUROSCI, V22, P2198, DOI 10.1162/jocn.2009.21409; Prinz W., 2005, PERSPECT IMITATION N, V1, P141; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Watanabe R, 2011, NEUROSCI LETT, V503, P100, DOI 10.1016/j.neulet.2011.08.016; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	53	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53248	10.1371/journal.pone.0053248	http://dx.doi.org/10.1371/journal.pone.0053248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301050	Green Submitted, gold, Green Published			2022-12-27	WOS:000313480000043
J	Frangoulidis, D; Splettstoesser, WD; Landt, O; Dehnhardt, J; Henning, K; Hilbert, A; Bauer, T; Antwerpen, M; Meyer, H; Walter, MC; Knobloch, JKM				Frangoulidis, Dimitrios; Splettstoesser, Wolf D.; Landt, Olfert; Dehnhardt, Jasmin; Henning, Klaus; Hilbert, Angela; Bauer, Tilman; Antwerpen, Markus; Meyer, Hermann; Walter, Mathias C.; Knobloch, Johannes K. -M.			Microevolution of the Chromosomal Region of Acute Disease Antigen A (adaA) in the Query (Q) Fever Agent Coxiella burnetii	PLOS ONE			English	Article							PLASMID BASED DIFFERENTIATION; MOLECULAR CHARACTERIZATION; ENDOCARDITIS; SEQUENCE; IDENTIFICATION; DIVERSITY; EVOLUTION; SAMPLES; FRANCE; GENE	The acute disease antigen A (adaA) gene is believed to be associated with Coxiella burnetii strains causing acute Q fever. The detailed analysis of the adaA genomic region of 23 human- and 86 animal-derived C. burnetii isolates presented in this study reveals a much more polymorphic appearance and distribution of the adaA gene, resulting in a classification of C. burnetii strains of better differentiation than previously anticipated. Three different genomic variants of the adaA gene were identified which could be detected in isolates from acute and chronic patients, rendering the association of adaA positive strains with acute Q fever disease disputable. In addition, all adaA positive strains in humans and animals showed the occurrence of the QpH1 plasmid. All adaA positive isolates of acute human patients except one showed a distinct SNP variation at position 431, also predominant in sheep strains, which correlates well with the observation that sheep are a major source of human infection. Furthermore, the phylogenetic analysis of the adaA gene revealed three deletion events and supported the hypothesis that strain Dugway 5J108-111 might be the ancestor of all known C. burnetii strains. Based on our findings, we could confirm the QpDV group and we were able to define a new genotypic cluster. The adaA gene polymorphisms shown here improve molecular typing of Q fever, and give new insights into microevolutionary adaption processes in C. burnetii.	[Frangoulidis, Dimitrios; Splettstoesser, Wolf D.; Antwerpen, Markus; Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany; [Landt, Olfert; Dehnhardt, Jasmin] TIB MOLBIOL GmbH, Berlin, Germany; [Henning, Klaus; Hilbert, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Wusterhausen, Germany; [Walter, Mathias C.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Walter, Mathias C.] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Knobloch, Johannes K. -M.] Med Univ Lubeck, Inst Med Microbiol & Hyg, D-23538 Lubeck, Germany	Bundeswehr Institute of Microbiology (IMB); Friedrich Loeffler Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Lubeck	Frangoulidis, D (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	DimitriosFrangoulidis@Bundeswehr.org	Walter, Mathias/AGP-4944-2022; Walter, Mathias/B-8837-2013; Knobloch, Johannes K./D-6456-2011	Walter, Mathias/0000-0003-3012-2626; Walter, Mathias/0000-0003-3012-2626; Knobloch, Johannes K./0000-0002-2591-6387; Antwerpen, Markus/0000-0003-4013-8808; Frangoulidis, Dimitrios/0000-0002-2864-3820	German Ministry of Education and Research (BMBF) [01KI0731, 01KI1001]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Ministry of Education and Research (BMBF) under contract No. 01KI0731 and 01KI1001 (http://www.gesundheitsforschung-bmbf.de/de/1721.php#zoonosen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AlHajjar S, 1997, PEDIATR INFECT DIS J, V16, P911, DOI 10.1097/00006454-199709000-00020; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bena G, 1998, MOL PHYLOGENET EVOL, V9, P552, DOI 10.1006/mpev.1998.0493; Cao W, 2003, CANCER DETECT PREV, V27, P397, DOI 10.1016/S0361-090X(03)00103-X; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Fernandes I, 2009, CLIN MICROBIOL INFEC, V15, P163, DOI 10.1111/j.1469-0691.2008.02209.x; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Frangoulidis D, 2012, FEMS IMMUNOL MED MIC, V64, P134, DOI 10.1111/j.1574-695X.2011.00900.x; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hatchette TF, 2001, CLIN INFECT DIS, V33, P1347, DOI 10.1086/323031; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; HOOVER TA, 1992, J BACTERIOL, V174, P5540, DOI 10.1128/JB.174.17.5540-5548.1992; Jado I, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-91; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; MALLAVIA LP, 1991, EUR J EPIDEMIOL, V7, P213, DOI 10.1007/BF00145669; Massung RF, 2012, ADV EXP MED BIOL, V984, P381, DOI 10.1007/978-94-007-4315-1_19; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; RAOULT D, 1987, J INFECT DIS, V155, P570, DOI 10.1093/infdis/155.3.570; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SAMUEL JE, 1985, INFECT IMMUN, V49, P775, DOI 10.1128/IAI.49.3.775-779.1985; SAMUEL JE, 1983, INFECT IMMUN, V41, P488, DOI 10.1128/IAI.41.2.488-493.1983; SAVINELLI EA, 1990, ANN NY ACAD SCI, V590, P523, DOI 10.1111/j.1749-6632.1990.tb42262.x; SAWYER LA, 1987, REV INFECT DIS, V9, P935; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Seshadri R, 2006, EMBL GENBANK D UNPUB; STEIN A, 1993, MICROB PATHOGENESIS, V15, P177, DOI 10.1006/mpat.1993.1068; Stein A, 1998, CLIN INFECT DIS, V27, P592, DOI 10.1086/514698; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THIELE D, 1994, EUR J EPIDEMIOL, V10, P427, DOI 10.1007/BF01719667; To H, 1998, MICROBIOL IMMUNOL, V42, P81, DOI 10.1111/j.1348-0421.1998.tb02255.x; Tomaso H, 2005, MOL CELL PROBE, V19, P9, DOI 10.1016/j.mcp.2004.08.001; VALKOVA D, 1995, FEMS MICROBIOL LETT, V125, P275, DOI 10.1111/j.1574-6968.1995.tb07368.x; Willems H, 1998, J BACTERIOL, V180, P3816, DOI 10.1128/JB.180.15.3816-3822.1998; WILLEMS H, 1993, EUR J EPIDEMIOL, V9, P411, DOI 10.1007/BF00157399; Zhang GQ, 2005, INFECT IMMUN, V73, P1561, DOI 10.1128/IAI.73.3.1561-1567.2005	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53440	10.1371/journal.pone.0053440	http://dx.doi.org/10.1371/journal.pone.0053440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301072	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000058
J	Gutschow, MV; Hughey, JJ; Ruggero, NA; Bajar, BT; Valle, SD; Covert, MW				Gutschow, Miriam V.; Hughey, Jacob J.; Ruggero, Nicholas A.; Bajar, Bryce T.; Valle, Sean D.; Covert, Markus W.			Single-Cell and Population NF-kappa B Dynamic Responses Depend on Lipopolysaccharide Preparation	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIVATION; LPS; OSCILLATIONS; TRANSCRIPTION; DETERMINES; SIGNAL; TLR4; MICE	Background: Lipopolysaccharide (LPS), found in the outer membrane of gram-negative bacteria, elicits a strong response from the transcription factor family Nuclear factor (NF)-kappa B via Toll-like receptor (TLR) 4. The cellular response to lipopolysaccharide varies depending on the source and preparation of the ligand, however. Our goal was to compare single-cell NF-kappa B dynamics across multiple sources and concentrations of LPS. Methodology/Principal Findings: Using live-cell fluorescence microscopy, we determined the NF-kappa B activation dynamics of hundreds of single cells expressing a p65-dsRed fusion protein. We used computational image analysis to measure the nuclear localization of the fusion protein in the cells over time. The concentration range spanned up to nine orders of magnitude for three E. coli LPS preparations. We find that the LPS preparations induce markedly different responses, even accounting for potency differences. We also find that the ability of soluble TNF receptor to affect NF-kappa B dynamics varies strikingly across the three preparations. Conclusions/Significance: Our work strongly suggests that the cellular response to LPS is highly sensitive to the source and preparation of the ligand. We therefore caution that conclusions drawn from experiments using one preparation may not be applicable to LPS in general.	[Gutschow, Miriam V.; Hughey, Jacob J.; Bajar, Bryce T.; Valle, Sean D.; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ruggero, Nicholas A.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mcovert@stanford.edu		Hughey, Jacob/0000-0002-1558-6089; Bajar, Bryce/0000-0002-0169-0870; Covert, Markus/0000-0002-5993-8912	NCI Pathway Independence Award [K99/R00 CA125994]; National Institutes of Health (NIH) Director's Pioneer Award [DP1OD006413]; Bio-X; ARCS Graduate Student Fellowship; National Science Foundation Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [K99CA125994, R00CA125994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI104305] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	NCI Pathway Independence Award; National Institutes of Health (NIH) Director's Pioneer Award; Bio-X; ARCS Graduate Student Fellowship; National Science Foundation Graduate Student Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors were supported by an NCI Pathway Independence Award (K99/R00 CA125994) and a National Institutes of Health (NIH) Director's Pioneer Award (DP1OD006413) to MWC; a Bio-X and an ARCS Graduate Student Fellowship to JJH; and an National Science Foundation Graduate Student Fellowship to NAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lee TK, 2010, CURR OPIN GENET DEV, V20, P677, DOI 10.1016/j.gde.2010.08.005; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Lipniacki T, 2007, CARDIOVASC TOXICOL, V7, P215, DOI 10.1007/s12012-007-9003-x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson G, 2002, J CELL SCI, V115, P1137; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sillitoe K, 2007, BIOCHEM SOC T, V35, P263, DOI 10.1042/BST0350263; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145	24	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53222	10.1371/journal.pone.0053222	http://dx.doi.org/10.1371/journal.pone.0053222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301045	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000040
J	Erritty, P; Wydell, TN				Erritty, Philip; Wydell, Taeko N.			Are Lay People Good at Recognising the Symptoms of Schizophrenia?	PLOS ONE			English	Article							MENTAL-HEALTH LITERACY; HELP-SEEKING; 1ST-EPISODE PSYCHOSIS; UNTREATED PSYCHOSIS; PRODROMAL SYMPTOMS; PATHWAYS; DURATION; CARE; BELIEFS; ILLNESS	Aim: The aim of this study was to explore the general public's perception of schizophrenia symptoms and the need to seek-help for symptoms. The recognition (or 'labelling') of schizophrenia symptoms, help-seeking behaviours and public awareness of schizophrenia have been suggested as potentially important factors relating to untreated psychosis. Method: Participants were asked to rate to what extent they believe vignettes describing classic symptoms (positive and negative) of schizophrenia indicate mental illness. They were also asked if the individuals depicted in the vignettes required help or treatment and asked to suggest what kind of help or treatment. Results: Only three positive symptoms (i.e., Hallucinatory behaviour, Unusual thought content and Suspiciousness) of schizophrenia were reasonably well perceived (above 70%) as indicating mental illness more than the other positive or negative symptoms. Even when the participants recognised that the symptoms indicated mental illness, not everyone recommended professional help. Conclusion: There may be a need to improve public awareness of schizophrenia and psychosis symptoms, particularly regarding an awareness of the importance of early intervention for psychosis.	[Erritty, Philip; Wydell, Taeko N.] Brunel Univ, Uxbridge UB8 3PH, Middx, England	Brunel University	Wydell, TN (corresponding author), Brunel Univ, Uxbridge UB8 3PH, Middx, England.	taeko.wydell@brunel.ac.uk		Wydell, Taeko/0000-0001-9675-164X				Addington J, 2002, ACTA PSYCHIAT SCAND, V106, P358, DOI 10.1034/j.1600-0447.2002.02004.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Brekke JS, 2001, PSYCHIATR SERV, V52, P1358, DOI 10.1176/appi.ps.52.10.1358; CASTLE DJ, 1994, BRIT J PSYCHIAT, V165, P101, DOI 10.1192/bjp.165.1.101; Chiang J.C.S., 2005, HONG KONG J PSYCHIAT, V15, P18; Choi JS, 2009, J KOREAN MED SCI, V24, P1083, DOI 10.3346/jkms.2009.24.6.1083; Dell'Osso B, 2010, CNS SPECTRUMS, V15, P238, DOI 10.1017/S1092852900000079; Etheridge K, 2004, J Psychiatr Ment Health Nurs, V11, P125, DOI 10.1111/j.1365-2850.2003.00673.x; Gourzis P, 2002, SCHIZOPHRENIA BULL, V28, P415, DOI 10.1093/oxfordjournals.schbul.a006950; Joa I, 2008, SCHIZOPHRENIA BULL, V34, P466, DOI 10.1093/schbul/sbm095; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Klosterkotter J, 2000, FORTSCHR NEUROL PSYC, V68, pS13; KOHN D, 2004, PSYCHIATRIE, V72, P635, DOI DOI 10.1055/S-2004-818418; Krstev H, 2004, SOC PSYCH PSYCH EPID, V39, P711, DOI 10.1007/s00127-004-0798-5; Lauber C, 2003, EUR ARCH PSY CLIN N, V253, P248, DOI 10.1007/s00406-003-0439-0; Lieberman JA, 2000, AM J PSYCHIAT, V157, P1727, DOI 10.1176/appi.ajp.157.11.1727; Lincoln C, 1998, BRIT J PSYCHIAT, V172, P21, DOI 10.1192/S0007125000297614; Luty J, 2006, PSYCHIATR BULL, V30, P435, DOI 10.1192/pb.30.11.435; Marshall M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004718.pub2; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; MASON P, 1995, BRIT J PSYCHIAT, V167, P596, DOI 10.1192/bjp.167.5.596; MCEVOY JP, 1993, AM J PSYCHIAT, V150, P1649; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Morgan C, 2005, BRIT J PSYCHIAT, V186, P290, DOI 10.1192/bjp.186.4.290; Murray RM, 2005, SRF INTERVIEWS R MUR; O'Callaghan E, 2010, SOC PSYCH PSYCH EPID, V45, P381, DOI 10.1007/s00127-009-0081-x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Perkins DO, 1999, SCHIZOPHR RES, V36, P52; Pote HL, 2002, ETHNIC HEALTH, V7, P7, DOI 10.1080/13557850220146966; ROGLER LH, 1993, AM J PSYCHIAT, V150, P554; Schennach-Wolff R, 2011, EUROPEAN NEUROP 0119; Singh SP, 2006, SCHIZOPHR RES, V81, P75, DOI 10.1016/j.schres.2005.09.018; Stone L, 2008, INT J SOC PSYCHIATR, V54, P242, DOI 10.1177/0020764008089616; Yung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654	36	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52913	10.1371/journal.pone.0052913	http://dx.doi.org/10.1371/journal.pone.0052913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301001	Green Published, gold			2022-12-27	WOS:000313320900044
J	Klenovics, KS; Boor, P; Somoza, V; Celec, P; Fogliano, V; Sebekova, K				Klenovics, Kristina Simon; Boor, Peter; Somoza, Veronika; Celec, Peter; Fogliano, Vincenzo; Sebekova, Katarina			Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; NONDIABETIC SUBJECTS; GLUCOSE-METABOLISM; SOLUBLE RECEPTOR; RISK-FACTORS; HUMAN HEALTH; HUMAN-MILK; BREAST; RAGE; AGES	Introduction: Infant formula-feeding is associated with reduced insulin sensitivity. In rodents and healthy humans, advanced glycation end product (AGE)-rich diets exert diabetogenic effects. In comparison with human breast-milk, infant formulas contain high amounts of AGEs. We assessed the role of AGEs in infant-formula-consumption-associated insulin resistance. Methods: Total plasma levels of N-epsilon-(carboxymethyl)lysine (CML), AGEs-associated fluorescence (lambda(ex) = 370 nm/lambda(em) = 445 nm), soluble adhesion molecules, markers of micro-binflammation (hsCRP), oxidative stress (malondialdehyde, 8-isoprostanes) and leptinemia were determined, and correlated with insulin sensitivity in a cross-sectional study in 166 healthy term infants aged 3-to-14 months, subdivided according to feeding regimen (breast-milk- vs. infant formula-fed) and age (3-to-6-month-olds, 7-to-10-month-olds, and 11-to-14-month-old infants). Effects of the consumption of low- vs. high-CML-containing formulas were assessed. 36 infants aged 5.8 +/- 0.3 months were followed-up 7.5 +/- 0.3 months later. Results: Cross-sectional study: 3-to-6-month-olds and 7-to-10-month-old formula-fed infants presented higher total plasma CML levels and AGEs-associated fluorescence (p<0.01, both), while only the 3-to-6-month-olds displayed lower insulin sensitivity (p<0.01) than their breast-milk-fed counterparts. 3-to-6-month-olds fed low-CML-containing formulas presented lower total plasma CML levels (p<0.01), but similar insulin sensitivity compared to those on high-CML-containing formulas. Markers of oxidative stress and inflammation, levels of leptin and adhesion molecules did not differ significantly between the groups. Follow-up study: at initial investigation, the breast-milk-consuming infants displayed lower total plasma CML levels (p<0.01) and AGEs-associated fluorescence (p<0.05), but higher insulin sensitivity (p<0.05) than the formulas-consuming infants. At follow-up, the groups did not differ significantly in either determined parameter. Conclusions: In healthy term infants, high dietary load with CML does not play a pathophysiological role in the induction of infant formula-associated insulin resistance. Whether a high load of AGEs in early childhood affects postnatal programming remains to be elucidated.	[Klenovics, Kristina Simon; Sebekova, Katarina] Slovak Med Univ, Fac Med, Dept Clin & Expt Pharmacotherapy, Bratislava, Slovakia; [Klenovics, Kristina Simon] Comenius Univ, Inst Physiol, Fac Med, Bratislava, Slovakia; [Boor, Peter; Celec, Peter; Sebekova, Katarina] Comenius Univ, Inst Mol BioMed, Fac Med, Bratislava, Slovakia; [Boor, Peter] Rhein Westfal TH Aachen, Div Nephrol, Aachen, Germany; [Boor, Peter] Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany; [Somoza, Veronika] German Res Ctr Food Chem, Garching, Germany; [Somoza, Veronika] Univ Vienna, Dept Nutr & Physiol Chem, Vienna, Austria; [Fogliano, Vincenzo] Univ Naples Federico II, Dept Food Sci, Naples, Italy	Comenius University Bratislava; Slovak Medical University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; RWTH Aachen University; RWTH Aachen University; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; University of Vienna; University of Naples Federico II	Sebekova, K (corresponding author), Slovak Med Univ, Fac Med, Dept Clin & Expt Pharmacotherapy, Bratislava, Slovakia.	kata.sebekova@gmail.com	fogliano, vincenzo/W-6885-2019; Fogliano, Vincenzo/M-8166-2019; Celec, Peter/I-7103-2012; Boor, Peter/C-7707-2011; Somoza, Veronika/D-4141-2013; Sebekova, Katarina/GSD-7056-2022; fogliano, vincenzo/A-1419-2009; Sebekova, Katarina/H-4906-2016	fogliano, vincenzo/0000-0001-8786-9355; Celec, Peter/0000-0001-5883-3580; Boor, Peter/0000-0001-9921-4284; Somoza, Veronika/0000-0003-2456-9245; Sebekova, Katarina/0000-0002-9641-9265; fogliano, vincenzo/0000-0001-8786-9355; Sebekova, Katarina/0000-0002-9641-9265; Mericq, Veronica/0000-0003-2287-0181	EC of EU [COLL-CT-2005-516415]; Slovak Research and Development Agency [VMSP-II-0027-09]	EC of EU; Slovak Research and Development Agency(Slovak Research and Development Agency)	This study was supported by the grant from 6th FP of EC of EU (ICARE, No. COLL-CT-2005-516415), and from Slovak Research and Development Agency (No. VMSP-II-0027-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2003, DIABETES, V52, P1004, DOI 10.2337/diabetes.52.4.1004; Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; Basta G, 2006, J CLIN ENDOCR METAB, V91, P4628, DOI 10.1210/jc.2005-2559; Bergmann R, 2001, NAHRUNG, V45, P182, DOI 10.1002/1521-3803(20010601)45:3&lt;182::AID-FOOD182&gt;3.0.CO;2-Q; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Birlouez-Aragon I, 2004, FOOD CHEM, V87, P253, DOI 10.1016/j.foodchem.2003.11.019; Birlouez-Aragon I, 2010, AM J CLIN NUTR, V91, P1220, DOI 10.3945/ajcn.2009.28737; Boor P, 2010, CLIN CHIM ACTA, V411, P1034, DOI 10.1016/j.cca.2010.03.033; Buetler TM, 2008, MOL NUTR FOOD RES, V52, P370, DOI 10.1002/mnfr.200700101; Buetler TM, 2011, MOL NUTR FOOD RES, V55, P291, DOI 10.1002/mnfr.201000140; Bulk-Bunschoten AMW, 2002, PAEDIATR PERINAT EP, V16, P361, DOI 10.1046/j.1365-3016.2002.00440.x; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Das UN, 2002, PROSTAG LEUKOTR ESS, V67, P1, DOI 10.1054/plef.2002.0374; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Delatour T, 2009, J CHROMATOGR A, V1216, P2371, DOI 10.1016/j.chroma.2009.01.011; Erkekoglu P, 2010, NUTR RES REV, V23, P323, DOI 10.1017/S0954422410000211; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Felton JS, 2007, MUTAT RES-FUND MOL M, V616, P90, DOI 10.1016/j.mrfmmm.2006.11.010; Fohgelberg P, 2005, FOOD CHEM TOXICOL, V43, P951, DOI 10.1016/j.fct.2005.02.001; GINSBURG BE, 1984, ACTA PAEDIATR SCAND, V73, P213, DOI 10.1111/j.1651-2227.1984.tb09931.x; Gupta M, 2010, INDIAN J PEDIATR, V77, P509, DOI 10.1007/s12098-010-0065-6; Havel PJ, 1998, AM J CLIN NUTR, V67, P355, DOI 10.1093/ajcn/67.3.355; Heird WC, 2007, J NUTR, V137, p499S, DOI 10.1093/jn/137.2.499S; Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284; JENNESS R, 1979, SEMIN PERINATOL, V3, P225; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Klenovicsova K, 2011, CLIN CHIM ACTA, V412, P1842, DOI 10.1016/j.cca.2011.06.019; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Leung AKC, 2005, J NATL MED ASSOC, V97, P1010; Li HY, 2009, CLIN CHIM ACTA, V404, P149, DOI 10.1016/j.cca.2009.03.041; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Lonnerdal B, 2000, AM J CLIN NUTR, V72, P484; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Madsen AL, 2010, DIABETIC MED, V27, P1350, DOI 10.1111/j.1464-5491.2010.03134.x; Meltretter J, 2008, ANN NY ACAD SCI, V1126, P134, DOI 10.1196/annals.1433.022; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Mericq V, 2010, DIABETES CARE, V33, P2232, DOI 10.2337/dc10-1058; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Miyata T, 2000, KIDNEY INT, V58, pS120, DOI 10.1046/j.1523-1755.2000.07615.x; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Pischetsrieder M, 2012, AMINO ACIDS, V42, P1111, DOI 10.1007/s00726-010-0775-0; Puddu A, 2010, BIOCHEM BIOPH RES CO, V395, P122, DOI 10.1016/j.bbrc.2010.03.152; Savino F, 2009, CLIN ENDOCRINOL, V71, P757, DOI 10.1111/j.1365-2265.2009.03585.x; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Sebekova K, 2001, EUR J NUTR, V40, P275, DOI 10.1007/s394-001-8356-3; Sebekova K, 2008, ANN NY ACAD SCI, V1126, P177, DOI 10.1196/annals.1433.049; Sebekova K, 2007, MOL NUTR FOOD RES, V51, P1079, DOI 10.1002/mnfr.200700035; Shu TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018782; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara Helen, 2007, Curr Diab Rep, V7, P235, DOI 10.1007/s11892-007-0037-z; WONG SHY, 1987, CLIN CHEM, V33, P214; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342	70	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53056	10.1371/journal.pone.0053056	http://dx.doi.org/10.1371/journal.pone.0053056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301020	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900056
J	Ucero, AC; Berzal, S; Ocana-Salceda, C; Sancho, M; Orzaez, M; Messeguer, A; Ruiz-Ortega, M; Egido, J; Vicent, MJ; Ortiz, A; Ramos, AM				Ucero, Alvaro C.; Berzal, Sergio; Ocana-Salceda, Carlos; Sancho, Monica; Orzaez, Mar; Messeguer, Angel; Ruiz-Ortega, Marta; Egido, Jesus; Vicent, Maria J.; Ortiz, Alberto; Ramos, Adrian M.			A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATING FACTOR-1 APAF-1; ACUTE KIDNEY INJURY; CYTOCHROME-C; APOPTOSIS; INHIBITORS; EXPRESSION; RECRUITMENT; COMPLEX; ALPHA	The polyglutamic acid/peptoid 1 (QM56) nanoconjugate inhibits apoptosis by interfering with Apaf-1 binding to procaspase-9. We now describe anti-inflammatory properties of QM56 in mouse kidney and renal cell models. In cultured murine tubular cells, QM56 inhibited the inflammatory response to Tweak, a non-apoptotic stimulus. Tweak induced MCP-1 and Rantes synthesis through JAK2 kinase and NF-kappa B activation. Similar to JAK2 kinase inhibitors, QM56 inhibited Tweak-induced NF-kappa B transcriptional activity and chemokine expression, despite failing to inhibit NF-kappa B-p65 nuclear translocation and NF-kappa B DNA binding. QM56 prevented JAK2 activation and NF-kappa B-p65(Ser536) phosphorylation. The anti-inflammatory effect and JAK2 inhibition by QM56 were observed in Apaf-1(-/-) cells. In murine acute kidney injury, QM56 decreased tubular cell apoptosis and kidney inflammation as measured by down-modulations of MCP-1 and Rantes mRNA expression, immune cell infiltration and activation of the JAK2-dependent inflammatory pathway. In conclusion, QM56 has an anti-inflammatory activity which is independent from its role as inhibitor of Apaf-1 and apoptosis and may have potential therapeutic relevance.	[Ucero, Alvaro C.; Berzal, Sergio; Ocana-Salceda, Carlos; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto; Ramos, Adrian M.] IIS FJD, Lab Nephrol & Vasc Pathol, Madrid, Spain; [Sancho, Monica; Orzaez, Mar; Vicent, Maria J.] Ctr Invest Principe Felipe, Dept Med Chem, Valencia, Spain; [Messeguer, Angel] Inst Quim Avancada Catalunya, Dept Chem & Biomol Nanotechnol, Barcelona, Spain; [Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Egido, Jesus; Ortiz, Alberto] FRIAT, Madrid, Spain	Fundacion Jimenez Diaz; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Madrid	Ramos, AM (corresponding author), IIS FJD, Lab Nephrol & Vasc Pathol, Madrid, Spain.	amramos@fjd.es	Orzaez, Mar/B-4992-2014; Ruiz-Ortega, Marta/D-3584-2012; Ucero, Alvaro Conrado/AGQ-2114-2022; Ortega, Marta Ruiz/AAN-2136-2020; Ramos, Adrián Mario/W-6860-2018; Ucero, Alvaro C/C-8437-2013; ortiz, alberto/Y-7582-2018; Vicent, Maria J./O-3664-2019; Medina, Mónica Sancho/L-4660-2014; Vicent, Maria J. J/A-9690-2014; ruiz-ortega, marta/D-3584-2012	Orzaez, Mar/0000-0003-3231-5835; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ucero, Alvaro Conrado/0000-0002-5575-0808; Ortega, Marta Ruiz/0000-0002-1495-6535; Ucero, Alvaro C/0000-0002-5575-0808; ortiz, alberto/0000-0002-9805-9523; Vicent, Maria J./0000-0001-7771-3373; Medina, Mónica Sancho/0000-0003-3707-062X; Vicent, Maria J. J/0000-0001-7771-3373; Messeguer, Angel/0000-0002-8358-9425; ruiz-ortega, marta/0000-0002-1403-2690; Ocana-Salceda, Carlos/0000-0002-3949-0014	Instituto de Salud Carlos III [PI07/0020, CP08/1083, PS09/00447, ISCIII-RETICS REDINREN RD 06/0016]; Sociedad Espanola de Nefrologia; Fundacion Conchita Rabago; Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III; Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO [0283/2006]; FIS (Programa Miguel Servet)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Espanola de Nefrologia; Fundacion Conchita Rabago; Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III; Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO; FIS (Programa Miguel Servet)	This work was supported by grants from the Instituto de Salud Carlos III (www.isciii.es), FIS: PI07/0020, CP08/1083, PS09/00447 and ISCIII-RETICS REDINREN RD 06/0016; Sociedad Espanola de Nefrologia (www.senefro.org). Alvaro Ucero, Sergio Berzal and Carlos Ocana supported by Fundacion Conchita Rabago (www.fundacionconchitarabago.net), Alberto Ortiz by the Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III and the Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO 0283/2006 www.madrid.org/lainentralgo) and Adrian Ramos, by FIS (Programa Miguel Servet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fritzenwanger M, 2006, CYTOKINE, V33, P46, DOI 10.1016/j.cyto.2005.11.016; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Goncalves S, 2010, CURR MED CHEM, V17, P974, DOI 10.2174/092986710790820642; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Neria F, 2009, KIDNEY INT, V75, P227, DOI 10.1038/ki.2008.487; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sattler M, 2009, CANCER CELL, V16, P365, DOI 10.1016/j.ccr.2009.10.009; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Strassheim D, 2009, J IMMUNOL, V183, P6981, DOI 10.4049/jimmunol.0901045; Tanimoto A, 2008, J BIOL CHEM, V283, P4643, DOI 10.1074/jbc.M708853200; Grande MT, 2008, CURR MED CHEM, V15, P2054, DOI 10.2174/092986708785132889; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Wang S, 2010, LUPUS, V19, P1171, DOI 10.1177/0961203310367660; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	44	28	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51992	10.1371/journal.pone.0051992	http://dx.doi.org/10.1371/journal.pone.0051992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300960	Green Published, gold			2022-12-27	WOS:000313320900016
J	Caballero, JM; Garzon, A; Gonzalez-Cintado, L; Kowalczyk, W; Torres, IJ; Calderita, G; Rodriguez, M; Gondar, V; Bernal, JJ; Ardavin, C; Andreu, D; Zurcher, T; von Kobbe, C				Martin Caballero, Juan; Garzon, Ana; Gonzalez-Cintado, Leticia; Kowalczyk, Wioleta; Jimenez Torres, Ignacio; Calderita, Gloria; Rodriguez, Margarita; Gondar, Virginia; Jose Bernal, Juan; Ardavin, Carlos; Andreu, David; Zuercher, Thomas; von Kobbe, Cayetano			Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7-Dependent Tumors	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; DENDRITIC CELLS; CERVICAL-CANCER; DNA VACCINES; CTL EPITOPES; E7; VACCINATION; PROTECTION; COMBINATION; IMMUNITY	Cervical cancer is caused by persistent high-risk human papillomavirus (HR-HPV) infection and represents the second most frequent gynecological malignancy in the world. The HPV-16 type accounts for up to 55% of all cervical cancers. The HPV-16 oncoproteins E6 and E7 are necessary for induction and maintenance of malignant transformation and represent tumor-specific antigens for targeted cytotoxic T lymphocyte-mediated immunotherapy. Therapeutic cancer vaccines have become a challenging area of oncology research in recent decades. Among current cancer immunotherapy strategies, virus-like particle (VLP)-based vaccines have emerged as a potent and safe approach. We generated a vaccine (VLP-E7) incorporating a long C-terminal fragment of HPV-16 E7 protein into the infectious bursal disease virus VLP and tested its therapeutic potential in HLA-A2 humanized transgenic mice grafted with TC1/A2 tumor cells. We performed a series of tumor challenge experiments demonstrating a strong immune response against already-formed tumors (complete eradication). Remarkably, therapeutic efficacy was obtained with a single dose without adjuvant and against two injections of tumor cells, indicating a potent and long-lasting immune response.	[Martin Caballero, Juan] Barcelona Biomed Res Pk, Lab Anim Unit, Barcelona, Spain; [Garzon, Ana; Jimenez Torres, Ignacio; Calderita, Gloria; Rodriguez, Margarita; Gondar, Virginia; Jose Bernal, Juan; Zuercher, Thomas; von Kobbe, Cayetano] Chimera Pharma SLU, Canc Vaccines Unit, R&D Dept, Madrid, Spain; [Gonzalez-Cintado, Leticia; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Pompeu Fabra University	von Kobbe, C (corresponding author), Chimera Pharma SLU, Canc Vaccines Unit, R&D Dept, Madrid, Spain.	cvonkobbe@cbm.uam.es	Kowalczyk, Wioleta/F-5904-2014; bernal, juan jose/AAA-6474-2020; Andreu, David/I-4359-2014	Andreu, David/0000-0002-6317-6666; Kowalczyk, Wioleta/0000-0001-5180-594X; bernal, juan jose/0000-0001-6825-4590; von Kobbe, Cayetano/0000-0003-3895-3790	Instituto Marileno de Desarrollo [PIE/473/2009, PIE/506/2008]; Comunidad Autonoma de Madrid [25/2008]; Ministerio de Educacion [CIT-010000-2008-18]; Ministerio de Industria, Turismo y Comercio [FIT-010000-2007-68]; Ministerio de Ciencia e Innovacion (PROFIT) [CIT-010000-2007-34]; Consorci Parc de Recerca Biomedica de Barcelona	Instituto Marileno de Desarrollo; Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion; Ministerio de Industria, Turismo y Comercio(Spanish Government); Ministerio de Ciencia e Innovacion (PROFIT); Consorci Parc de Recerca Biomedica de Barcelona	This work was supported in part by grants PIE/473/2009 and PIE/506/2008 from Instituto Marileno de Desarrollo, 25/2008 from Comunidad Autonoma de Madrid, CIT-010000-2008-18 from Ministerio de Educacion, FIT-010000-2007-68 from Ministerio de Industria, Turismo y Comercio, and CIT-010000-2007-34 from Ministerio de Ciencia e Innovacion (PROFIT). Additional support was provided by Consorci Parc de Recerca Biomedica de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman JA, 2007, VACCINE, V25, P3437, DOI 10.1016/j.vaccine.2006.12.045; Cid-Arregui Angel, 2009, Open Virol J, V3, P67, DOI 10.2174/1874357900903010067; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Daftarian PM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-26; Delgui L, 2009, VIROLOGY, V386, P360, DOI 10.1016/j.virol.2008.12.036; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Dybing JK, 1998, AVIAN DIS, V42, P80, DOI 10.2307/1592579; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Haigh O, 2010, CANCER GENE THER, V17, P708, DOI 10.1038/cgt.2010.27; Herbert Jennifer, 2008, J Am Osteopath Assoc, V108, P65; Hirohashi Y, 2009, CANCER SCI, V100, P798, DOI 10.1111/j.1349-7006.2009.01137.x; Hoory T, 2008, J FORMOS MED ASSOC, V107, P198, DOI 10.1016/S0929-6646(08)60138-2; Hung CF, 2007, EXP MOL MED, V39, P679, DOI 10.1038/emm.2007.74; International Agency for Research on Cancer (IARC), 2005, IARC HANDBOOKS OF CA, V10; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Keller SA, 2009, J IMMUNOL, V182, P6261, DOI 10.4049/jimmunol.0804035; Khatri M, 2007, CYTOGENET GENOME RES, V117, P388, DOI 10.1159/000103202; Kowalczyk W, 2011, J PEPT SCI, V17, P247, DOI 10.1002/psc.1310; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Ma B, 2010, CURR CANCER THER REV, V6, P81, DOI 10.2174/157339410791202583; Peng S, 2006, GENE THER, V13, P257, DOI 10.1038/sj.gt.3302646; Peng SW, 1998, VIROLOGY, V240, P147, DOI 10.1006/viro.1997.8912; Qin Y, 2007, GYNECOL ONCOL, V104, P199, DOI 10.1016/j.ygyno.2006.07.044; RESSING ME, 1995, J IMMUNOL, V154, P5934; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Schreiber TH, 2010, SEMIN IMMUNOL, V22, P105, DOI 10.1016/j.smim.2010.02.001; Sheng WY, 2011, PHARM RES-DORDR, V28, P200, DOI 10.1007/s11095-010-0258-8; Smith KA, 2009, CLIN CANCER RES, V15, P6167, DOI 10.1158/1078-0432.CCR-09-0645; Toubaji A, 2007, VACCINE, V25, P5882, DOI 10.1016/j.vaccine.2007.05.040; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vergati M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/596432; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Yamaguchi T, 1996, ARCH VIROL, V141, P1493, DOI 10.1007/BF01718250; Zhou LQ, 2010, HUM GENE THER, V21, P109, DOI 10.1089/hum.2009.139	37	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52976	10.1371/journal.pone.0052976	http://dx.doi.org/10.1371/journal.pone.0052976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300838	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600042
J	Mesnil, C; Sabatel, CM; Marichal, T; Toussaint, M; Cataldo, D; Drion, PV; Lekeux, P; Bureau, F; Desmet, CJ				Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Cataldo, Didier; Drion, Pierre-Vincent; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.			Resident CD11b(+)Ly6C(-) Lung Dendritic Cells Are Responsible for Allergic Airway Sensitization to House Dust Mite in Mice	PLOS ONE			English	Article							TH2 RESPONSES; T-CELLS; GM-CSF; IMMUNE-RESPONSES; IN-VIVO; INFLAMMATION; ANTIGEN; ASTHMA; DIFFERENTIATION; HOMEOSTASIS	Conventional dendritic cells (DCs) are considered to be the prime initiators of airway allergy. Yet, it remains unclear whether specific DC subsets are preferentially involved in allergic airway sensitization. Here, we systematically assessed the respective pro-allergic potential of individually sorted lung DC subsets isolated from house dust mite antigen (HDM)-treated donor mice, following transfer to naive recipients. Transfer of lung CD11c(+)CD11b(+) DCs, but not CD11c(+)CD11b(-)CD103(+) DCs, was sufficient to prime airway allergy. The CD11c(+)CD11b(+) DC subpopulation was composed of CD11c(+)CD11b(+)Ly6C(+) inflammatory monocyte-derived cells, whose numbers increase in the lungs following HDM exposure, and of CD11c(+)CD11b(+)Ly6C(-) DCs, which remain stable. Counterintuitively, only CD11c(+)CD11b(+)Ly6C(-) DCs, and not CD11c(+)CD11b(+)Ly6C(+) DCs, were able to convey antigen to the lymph nodes and induce adaptive T cell responses and subsequent airway allergy. Our results thus support that lung resident non-inflammatory CD11c(+)CD11b(+)Ly6C(-) DCs are the essential inducers of allergic airway sensitization to the common aeroallergen HDM in mice.	[Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Lab Cellular & Mol Immunol, GIGA Res, Liege, Belgium; [Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Fac Vet Med, Liege, Belgium; [Cataldo, Didier] Univ Liege, Lab Tumours & Dev Biol, GIGA Res, Liege, Belgium; [Drion, Pierre-Vincent] Univ Liege, Lab Preclin & Biomed Sci, Univ Hosp Ctr, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Bureau, F (corresponding author), Univ Liege, Lab Cellular & Mol Immunol, GIGA Res, Liege, Belgium.	fabrice.bureau@ulg.ac.be; christophe.desmet@ulg.ac.be	Cataldo, Didier/GPG-3453-2022	Cataldo, Didier/0000-0002-3079-7941	"Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium); "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE); Belgian State (Belgian Science Policy)	"Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium)(Fonds de la Recherche Scientifique - FNRS); "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE)(Belgian Federal Science Policy Office); Belgian State (Belgian Science Policy)(Belgian Federal Science Policy Office)	The Laboratory of Cellular and Molecular Immunology is supported by grants of the "Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium), the "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium), and the Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE) initiated by the Belgian State (Belgian Science Policy). C. M., C. S. and T. M. are research fellows, and C.J.D. is a post-doctoral researcher of the FRS-FNRS. M. T. is a research fellow of the "Fonds de la Formation a la Recherche dans l'Industrie et l'Agriculture" (FRIA; Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Ortiz-Stern A, 2011, MUCOSAL IMMUNOL, V4, P343, DOI 10.1038/mi.2010.73; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Plantinga M, 2010, EUR J IMMUNOL, V40, P2112, DOI 10.1002/eji.201040562; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	40	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53242	10.1371/journal.pone.0053242	http://dx.doi.org/10.1371/journal.pone.0053242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300898	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600073
J	Fujiwara, K; Ohuchida, K; Mizumoto, K; Shindo, K; Eguchi, D; Kozono, S; Ikenaga, N; Ohtsuka, T; Takahata, S; Aishima, S; Tanaka, M				Fujiwara, Kenji; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Shindo, Koji; Eguchi, Daiki; Kozono, Shingo; Ikenaga, Naoki; Ohtsuka, Takao; Takahata, Shunichi; Aishima, Shinichi; Tanaka, Masao			CD271(+) Subpopulation of Pancreatic Stellate Cells Correlates with Prognosis of Pancreatic Cancer and Is Regulated by Interaction with Cancer Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; STROMAL FIBROBLASTS; STIMULATING PROLIFERATION; MATRIX SYNTHESIS; TUMOR-STROMA; IDENTIFICATION; EXPRESSION; FIBROSIS; ENHANCE	Pancreatic stellate cells (PSCs) play a crucial role in the aggressive behavior of pancreatic cancer. Although heterogeneity of PSCs has been identified, the functional differences remain unclear. We characterized CD271(+) PSCs in human pancreatic cancer. Immunohistochemistry for CD271 was performed for 31 normal pancreatic tissues and 105 pancreatic ductal adenocarcinomas (PDACs). We performed flow cytometry and quantitative RT-PCR, and assessed CD271 expression in PSCs isolated from pancreatic tissues and the changes in CD271 expression in PSCs cocultured with cancer cells. We also investigated the pattern of CD271 expression in a SCID mouse xenograft model. In the immunohistochemical analyses, the CD271-high staining rates in pancreatic stroma in normal pancreatic tissues and PDACs were 2/31 (6.5%) and 29/105 (27.6%), respectively (p = 0.0069). In PDACs, CD271(+) stromal cells were frequently observed on the edge rather than the center of the tumors. Stromal CD271 high expression was associated with a good prognosis (p = 0.0040). Flow cytometric analyses demonstrated CD271-positive rates in PSCs were 0-2.1%. Quantitative RT-PCR analyses revealed that CD271 mRNA expression was increased in PSCs after coculture with pancreatic cancer cells. However, the level of CD271 mRNA expression subsequently decreased after the transient increase. Furthermore, CD271 mRNA expression was decreased in PSCs migrating toward pancreatic cancer cells through Matrigel. In the xenograft model, CD271(+) PSCs were present at tumor margins/periphery and were absent in the tumor core. In conclusion, CD271 was expressed in PSCs around pancreatic tumors, but not in the center of the tumors, and expression decreased after long coculture with pancreatic cancer cells or after movement toward pancreatic cancer cells. These findings suggest that CD271(+) PSCs appear at the early stage of pancreatic carcinogenesis and that CD271 expression is significantly correlated with a better prognosis in patients with PDAC.	[Fujiwara, Kenji; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Shindo, Koji; Eguchi, Daiki; Kozono, Shingo; Ikenaga, Naoki; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Adv Med Initiat, Fukuoka 812, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan; [Shindo, Koji; Aishima, Shinichi] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Ohuchida, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382; Ohuchida, Kenoki/0000-0003-4792-1168	JSPS KAKENHI [24-1237, 23390327, 24659613, 23659654, 24390319, 22591524, 23-11109, 23659655, 24390318]; Grants-in-Aid for Scientific Research [24791430] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 24-1237, 23390327, 24659613, 23659654, 24390319, 22591524, 23-11109, 23659655, 24390318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Cook KL, 2010, CANCER RES, V70, P8319, DOI 10.1158/0008-5472.CAN-10-1136; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Haas SL, 2009, GROWTH FACTORS, V27, P289, DOI 10.1080/08977190903132273; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Polisetty N, 2008, MOL VIS, V14, P431; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Strakova Z, 2008, CELL TISSUE RES, V332, P479, DOI 10.1007/s00441-008-0604-x; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang W, 2009, EJSO-EUR J SURG ONC, V35, P826, DOI 10.1016/j.ejso.2008.10.013	28	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52682	10.1371/journal.pone.0052682	http://dx.doi.org/10.1371/journal.pone.0052682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300742	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100073
J	Almeida, ARM; Arroz-Madeira, S; Fonseca-Pereira, D; Ribeiro, H; Lasrado, R; Pachnis, V; Veiga-Fernandes, H				Martins Almeida, Afonso Rocha; Arroz-Madeira, Silvia; Fonseca-Pereira, Diogo; Ribeiro, Helder; Lasrado, Reena; Pachnis, Vassilis; Veiga-Fernandes, Henrique			RET/GFR alpha Signals Are Dispensable for Thymic T Cell Development In Vivo	PLOS ONE			English	Article							MEDULLARY-THYROID CANCER; C-RET PROTOONCOGENE; KINASE RECEPTOR RET; NEUROTROPHIC FACTOR; TYROSINE KINASE; NERVOUS-SYSTEM; GDNF FAMILY; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; MICE LACKING	Identification of thymocyte regulators is a central issue in T cell biology. Interestingly, growing evidence indicates that common key molecules control neuronal and immune cell functions. The neurotrophic factor receptor RET mediates critical functions in foetal hematopoietic subsets, thus raising the possibility that RET-related molecules may also control T cell development. We show that Ret, Gfra1 and Gfra2 are abundantly expressed by foetal and adult immature DN thymocytes. Despite the developmentally regulated expression of these genes, analysis of foetal thymi from Gfra1, Gfra2 or Ret deficient embryos revealed that these molecules are dispensable for foetal T cell development. Furthermore, analysis of RET gain of function and Ret conditional knockout mice showed that RET is also unnecessary for adult thymopoiesis. Finally, competitive thymic reconstitution assays indicated that Ret deficient thymocytes maintained their differentiation fitness even in stringent developmental conditions. Thus, our data demonstrate that RET/GFR alpha signals are dispensable for thymic T cell development in vivo, indicating that pharmacological targeting of RET signalling in tumours is not likely to result in T cell production failure.	[Martins Almeida, Afonso Rocha; Arroz-Madeira, Silvia; Fonseca-Pereira, Diogo; Ribeiro, Helder; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Lasrado, Reena; Pachnis, Vassilis] Natl Inst Med Res, Div Mol Neurobiol, MRC, London NW7 1AA, England	Universidade de Lisboa; MRC National Institute for Medical Research	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	jhfernandes@fm.ul.pt	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/D-9857-2013; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Fonseca-Pereira, Diogo/0000-0002-7400-9804; Ribeiro, Helder/0000-0002-7090-9274; Almeida, Afonso/0000-0002-4292-8558; Pachnis, Vassilis/0000-0001-9733-7686; Veiga-Fernandes, Henrique/0000-0001-6216-1836	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/44426/2008, SFRH/BD/44960/2008, PTDC/SAU-MII/104931/2008]; European Molecular Biology Organization [1648]; European Research Council [207057]; Medical Research Council [G0800973, MC_U117537087] Funding Source: researchfish; MRC [G0800973, MC_U117537087] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ARMA and DF-P were supported by scholarships from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/44426/2008 and SFRH/BD/44960/2008). Work in this article was funded by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-MII/104931/2008), Portugal; European Molecular Biology Organization (Project 1648) and European Research Council (Project 207057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Anderson G, 2008, J IMMUNOL, V181, P7435, DOI 10.4049/jimmunol.181.11.7435; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carlomagno F, 1998, ENDOCRINOLOGY, V139, P3613, DOI 10.1210/en.139.8.3613; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Gattei V, 1997, BLOOD, V89, P2925; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Houvras Y, 2012, J CLIN ONCOL, V30, P200, DOI 10.1200/JCO.2011.38.7639; Kondo S, 2003, EUR J IMMUNOL, V33, P2233, DOI 10.1002/eji.200323458; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakayama S, 1999, BRIT J HAEMATOL, V105, P50, DOI 10.1046/j.1365-2141.1999.01311.x; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52949	10.1371/journal.pone.0052949	http://dx.doi.org/10.1371/journal.pone.0052949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300832	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100104
J	Schmidt, CS; Bultmann, S; Meilinger, D; Zacher, B; Tresch, A; Maier, KC; Peter, C; Martin, DE; Leonhardt, H; Spada, F				Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Peter, Christian; Martin, Dietmar E.; Leonhardt, Heinrich; Spada, Fabio			Global DNA Hypomethylation Prevents Consolidation of Differentiation Programs and Allows Reversion to the Embryonic Stem Cell State	PLOS ONE			English	Article							SELF-RENEWAL; MAMMALIAN DEVELOPMENT; METHYLATION PATTERNS; GENE-REGULATION; ES CELLS; MOUSE; PLURIPOTENCY; METHYLTRANSFERASE; MAINTENANCE; TRANSCRIPTION	DNA methylation patterns change dynamically during mammalian development and lineage specification, yet scarce information is available about how DNA methylation affects gene expression profiles upon differentiation. Here we determine genome-wide transcription profiles during undirected differentiation of severely hypomethylated (Dnmt1(-/-)) embryonic stem cells (ESCs) as well as ESCs completely devoid of DNA methylation (Dnmt1(-/-); Dnmt3a(-/-); Dnmt3b(-/-) or TKO) and assay their potential to transit in and out of the ESC state. We find that the expression of only few genes mainly associated with germ line function and the X chromosome is affected in undifferentiated TKO ESCs. Upon initial differentiation as embryoid bodies (EBs) wild type, Dnmt1(-/-) and TKO cells downregulate pluripotency associated genes and upregulate lineage specific genes, but their transcription profiles progressively diverge upon prolonged EB culture. While Oct4 protein levels are completely and homogeneously suppressed, transcription of Oct4 and Nanog is not completely silenced even at late stages in both Dnmt1(-/-) and TKO EBs. Despite late wild type and Dnmt1(-/-) EBs showing a much higher degree of concordant expression, after EB dissociation and replating under pluripotency promoting conditions both Dnmt1(-/-) and TKO cells, but not wild type cells rapidly revert to expression profiles typical of undifferentiated ESCs. Thus, while DNA methylation seems not to be critical for initial activation of differentiation programs, it is crucial for permanent restriction of developmental fate during differentiation.	[Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Leonhardt, Heinrich; Spada, Fabio] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Martin, Dietmar E.] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany; [Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Martin, Dietmar E.; Leonhardt, Heinrich; Spada, Fabio] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Tresch, Achim] Univ Cologne, Inst Genet, Inst Bot, Cologne, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Dept Computat Biol, Cologne, Germany; [Peter, Christian] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Munich; University of Munich; University of Munich; University of Cologne; Max Planck Society; University of Oxford	Spada, F (corresponding author), Univ Munich, Dept Chem, Munich, Germany.	Fabio.Spada@cup.uni-muenchen.de	Spada, Fabio/J-4354-2013; Bultmann, Sebastian/AAC-7729-2020; Leonhardt, Heinrich/B-2791-2014	Spada, Fabio/0000-0002-7148-9013; 	Deutsche Forschungsgemeinschaft [SPP1356, SFB TR5, SFB 646]; International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School Life Science Munich (LSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School Life Science Munich (LSM)	This work was supported by grants from the Deutsche Forschungsgemeinschaft to HL (SPP1356, SFB TR5, SFB 646; www.dfg.de) and AT (SFB 646; www.dfg.de). CSS gratefully acknowledges the support by the International Doctorate Program NanoBioTechnology (IDK-NBT; www.cens.de/doctorate-program) and the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, www.imprs-ls.de). SB was supported by the Graduate School Life Science Munich (LSM, www.lsm.bio.lmu.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Hata K, 2002, DEVELOPMENT, V129, P1983; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isagawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026052; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Leeb M, 2012, CHROMOSOMA, V121, P251, DOI 10.1007/s00412-012-0365-x; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2012, EPIGENETICS, P7; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	79	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52629	10.1371/journal.pone.0052629	http://dx.doi.org/10.1371/journal.pone.0052629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300728	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100069
J	Okiro, EA; Ngama, M; Bett, A; Nokes, DJ				Okiro, Emelda A.; Ngama, Mwanajuma; Bett, Ann; Nokes, D. James			The Incidence and Clinical Burden of Respiratory Syncytial Virus Disease Identified through Hospital Outpatient Presentations in Kenyan Children	PLOS ONE			English	Article							KILIFI DISTRICT; YOUNG-CHILDREN; INFECTION; EPIDEMIOLOGY; INFANTS; PNEUMONIA; TRACT; DURATION; VACCINES; BIRTH	Background: There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods: We studied a systematic sample of children aged,5 years presenting to a rural district hospital in Kenya with acute respiratory infection (ARI) between May 2002 and April 2004. We collected clinical data and screened nasal wash samples for RSV antigen by immunofluorescence. We used a linked demographic surveillance system to estimate disease incidence. Results: Among 2143 children tested, 166 (8%) were RSV positive (6% among children with upper respiratory tract infection and 12% among children with lower respiratory tract infection (LRTI). RSV was more likely in LRTI than URTI (p<0.001). 51% of RSV cases were aged 1 year or over. RSV cases represented 3.4% of hospital outpatient presentations. Relative to RSV negative cases, RSV positive cases were more likely to have crackles (RR = 1.63; 95% CI 1.34-1.97), nasal flaring (RR = 2.66; 95% CI 1.40-5.04), in-drawing (RR = 2.24; 95% CI 1.47-3.40), fast breathing for age (RR = 1.34; 95% CI 1.03-1.75) and fever (RR = 1.54; 95% CI 1.33-1.80). The estimated incidence of RSV-ARI and RSV-LRTI, per 100,000 child years, among those aged,5 years was 767 and 283, respectively. Conclusion: The burden of childhood RSV-associated URTI and LRTI presenting to outpatients in this setting is considerable. The clinical features of cases associated with an RSV infection were more severe than cases without an RSV diagnosis.	[Okiro, Emelda A.] KEMRI Wellcome Trust Collaborat Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya; [Okiro, Emelda A.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Ngama, Mwanajuma; Bett, Ann; Nokes, D. James] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Nokes, D. James] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Oxford; Kenya Medical Research Institute; University of Warwick	Okiro, EA (corresponding author), KEMRI Wellcome Trust Collaborat Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya.	eokiro@nairobi.kemri-wellcome.org		Okiro, Emelda/0000-0001-9543-8360	Wellcome Trust [061584]; Wellcome Trust under their Research Training Fellowship programme [086166]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust under their Research Training Fellowship programme(Wellcome Trust)	Financial support was provided by the Wellcome Trust(061584). EAO is supported by the Wellcome Trust under their Research Training Fellowship programme (#086166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Central Bureau of Statistics Ministry of finance and planning, 2002, KEN 1999 POP HOUS CE; Collins PL, 2007, RESP SYNCYTIAL VIRUS, P233; Fisher RG, 1997, PEDIATRICS, V99, pE71, DOI 10.1542/peds.99.2.e7; Freymuth F, 1997, CLIN DIAGN VIROL, V8, P31, DOI 10.1016/S0928-0197(97)00060-3; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Government of Kenya, 2002, DEV MOPAN, P1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Moura FEA, 2003, MEM I OSWALDO CRUZ, V98, P739, DOI 10.1590/S0074-02762003000600005; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Okiro EA, 2007, TRANSMISSION DYNAMIC; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Okiro EA, 2008, J CLIN MICROBIOL, V46, P1659, DOI 10.1128/JCM.02190-07; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2009, LANCET, V374, P854, DOI 10.1016/S0140-6736(09)61608-1; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1998, PEDIATR INFECT DIS J, V17, P224, DOI 10.1097/00006454-199803000-00010; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52520	10.1371/journal.pone.0052520	http://dx.doi.org/10.1371/journal.pone.0052520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300695	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800099
J	Shodai, A; Ido, A; Fujiwara, N; Ayaki, T; Morimura, T; Oono, M; Uchida, T; Takahashi, R; Ito, H; Urushitani, M				Shodai, Akemi; Ido, Akemi; Fujiwara, Noriko; Ayaki, Takashi; Morimura, Toshifumi; Oono, Miki; Uchida, Tsukasa; Takahashi, Ryosuke; Ito, Hidefumi; Urushitani, Makoto			Conserved Acidic Amino Acid Residues in a Second RNA Recognition Motif Regulate Assembly and Function of TDP-43	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; CYTOPLASMIC INCLUSIONS; MUTATIONS; AGGREGATION; ALS; FRAGMENT; NUCLEAR; SOD1	Accumulating evidence suggests that pathogenic TAR DNA-binding protein (TDP)-43 fragments contain a partial RNA-recognition motif domain 2 (RRM2) in amyotrophic lateral sclerosis (ALS)/frontotemporal lobar degeneration. However, the molecular basis for how this domain links to the conformation and function of TDP-43 is unclear. Previous crystal analyses have documented that the RRM2-DNA complex dimerizes under acidic and high salt conditions, mediated by the intermolecular hydrogen bonds of Glu246-Ile249 and Asp247-Asp247. The aims of this study were to investigate the roles of Glu246 and Asp247 in the molecular assembly of RRM2 under physiological conditions, and to evaluate their potential use as markers for TDP-43 misfolding due to the aberrantly exposed dimer interface. Unexpectedly, gel filtration analyses showed that, regardless of DNA interaction, the RRM2 domain remained as a stable monomer in phosphate-buffered saline. Studies using substitution mutants revealed that Glu246 and, especially, Asp247 played a crucial role in preserving the functional RRM2 monomers. Substitution to glycine at Glu246 or Asp247 induced the formation of fibrillar oligomers of RRM2 accompanied by the loss of DNA-binding affinity, which also affected the conformation and the RNA splicing function of full-length TDP-43. A novel monoclonal antibody against peptides containing Asp247 was found to react with TDP-43 inclusions of ALS patients and mislocalized cytosolic TDP-43 in cultured cells, but not with nuclear wild-type TDP-43. Our findings indicate that Glu246 and Asp247 play pivotal roles in the proper conformation and function of TDP-43. In particular, Asp247 should be studied as a molecular target with an aberrant conformation related to TDP-43 proteinopathy.	[Shodai, Akemi; Ido, Akemi; Morimura, Toshifumi; Oono, Miki; Uchida, Tsukasa; Urushitani, Makoto] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Fujiwara, Noriko] Hyogo Coll Med, Dept Biochem, Hyogo, Japan; [Ayaki, Takashi; Oono, Miki; Uchida, Tsukasa; Takahashi, Ryosuke; Ito, Hidefumi] Kyoto Univ, Dept Neurol, Kyoto, Japan; [Ito, Hidefumi] Wakayama Med Univ, Grad Sch Med, Dept Neurol, Wakayama, Japan	Shiga University of Medical Science; Hyogo College of Medicine; Kyoto University; Wakayama Medical University	Urushitani, M (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan.	uru@belle.shiga-med.ac.jp		Urushitani, Makoto/0000-0003-2773-9836	KEKENHI from the Ministry of Education, Culture, Sports, Science & Technology (MEXT) [23300131, 22659171, 23111002]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [22-4]; Grants-in-Aid for Scientific Research [23580417, 23300131] Funding Source: KAKEN	KEKENHI from the Ministry of Education, Culture, Sports, Science & Technology (MEXT); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by KEKENHI 23300131 for Scientific Research (B), 22659171 for Challenging Exploratory Research, and a Grant-in Aid 23111002 for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science & Technology (MEXT), a Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan, and an Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of NCNP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu C-H, 2012, NATURE; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52776	10.1371/journal.pone.0052776	http://dx.doi.org/10.1371/journal.pone.0052776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300771	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800145
J	Bandyopadhyay, U; Cotney, J; Nagy, M; Oh, S; Leng, J; Mahajan, M; Mane, S; Fenton, WA; Noonan, JP; Horwich, AL				Bandyopadhyay, Urmi; Cotney, Justin; Nagy, Maria; Oh, Sunghee; Leng, Jing; Mahajan, Milind; Mane, Shrikant; Fenton, Wayne A.; Noonan, James P.; Horwich, Arthur L.			RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; G-ASSOCIATED KINASE; SUPEROXIDE-DISMUTASE; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT; GENE-EXPRESSION; KNOCKOUT MICE; FAMILIAL ALS; MUTATIONS; TDP-43	Mechanisms involved with degeneration of motor neurons in amyotrophic lateral sclerosis (ALS; Lou Gehrig's Disease) are poorly understood, but genetically inherited forms, comprising similar to 10% of the cases, are potentially informative. Recent observations that several inherited forms of ALS involve the RNA binding proteins TDP43 and FUS raise the question as to whether RNA metabolism is generally disturbed in ALS. Here we conduct whole transcriptome profiling of motor neurons from a mouse strain, transgenic for a mutant human SOD1 (G85R SOD1-YFP), that develops symptoms of ALS and paralyzes at 5-6 months of age. Motor neuron cell bodies were laser microdissected from spinal cords at 3 months of age, a time when animals were presymptomatic but showed aggregation of the mutant protein in many lower motor neuron cell bodies and manifested extensive neuromuscular junction morphologic disturbance in their lower extremities. We observed only a small number of transcripts with altered expression levels or splicing in the G85R transgenic compared to age-matched animals of a wild-type SOD1 transgenic strain. Our results indicate that a major disturbance of polyadenylated RNA metabolism does not occur in motor neurons of mutant SOD1 mice, suggesting that the toxicity of the mutant protein lies at the level of translational or post-translational effects.	[Bandyopadhyay, Urmi; Cotney, Justin; Nagy, Maria; Oh, Sunghee; Leng, Jing; Mahajan, Milind; Mane, Shrikant; Fenton, Wayne A.; Noonan, James P.; Horwich, Arthur L.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bandyopadhyay, Urmi; Nagy, Maria; Horwich, Arthur L.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Noonan, James P.; Horwich, Arthur L.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Leng, Jing; Noonan, James P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	arthur.horwich@yale.edu	Noonan, James/ABF-1320-2021; Bandyopadhyay, Urmi/A-3944-2015; Cotney, Justin L/ABE-8500-2021	Bandyopadhyay, Urmi/0000-0003-3438-8923; Cotney, Justin L/0000-0001-8230-2157	Howard Hughes Medical Institute; NIH [GM094780]; Andersen Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andersen Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (A.L.H.), NIH GM094780 (J.P.N.), and an Andersen Foundation Fellowship (J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Farr GW, 2011, PROTEIN SCI, V20, P1692, DOI 10.1002/pro.700; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hedlund E, 2010, BRAIN, V133, P2313, DOI 10.1093/brain/awq167; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2006, NEUROSCI RES, V54, P11, DOI 10.1016/j.neures.2005.09.006; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107	37	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53575	10.1371/journal.pone.0053575	http://dx.doi.org/10.1371/journal.pone.0053575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301088	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000067
J	Coxon, GD; Craig, D; Corrales, RM; Vialla, E; Gannoun-Zaki, L; Kremer, L				Coxon, Geoffrey D.; Craig, Derek; Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent			Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MYCOLIC ACIDS; MULTIDRUG-RESISTANT; DRUG-TREATMENT; ETHIONAMIDE; ACTIVATION; CYCLOPROPANATION; PHOSPHORYLATION; IMMUNOCOMPETENT; BIOSYNTHESIS	Defining the pharmacological target(s) of currently used drugs and developing new analogues with greater potency are both important aspects of the search for agents that are effective against drug-sensitive and drug-resistant Mycobacterium tuberculosis. Thiacetazone (TAC) is an anti-tubercular drug that was formerly used in conjunction with isoniazid, but removed from the antitubercular chemotherapeutic arsenal due to toxic side effects. However, several recent studies have linked the mechanisms of action of TAC to mycolic acid metabolism and TAC-derived analogues have shown increased potency against M. tuberculosis. To obtain new insights into the molecular mechanisms of TAC resistance, we isolated and analyzed 10 mutants of M. tuberculosis that were highly resistant to TAC. One strain was found to be mutated in the methyltransferase MmaA4 at Gly101, consistent with its lack of oxygenated mycolic acids. All remaining strains harbored missense mutations in either HadA (at Cys61) or HadC (at Val85, Lys157 or Thr123), which are components of the beta-hydroxyacyl-ACP dehydratase complex that participates in the mycolic acid elongation step. Separately, a library of 31 new TAC analogues was synthesized and evaluated against M. tuberculosis. Two of these compounds, 15 and 16, exhibited minimal inhibitory concentrations 10-fold lower than the parental molecule, and inhibited mycolic acid biosynthesis in a dose-dependent manner. Moreover, overexpression of HadAB HadBC or HadABC in M. tuberculosis led to high level resistance to these compounds, demonstrating that their mode of action is similar to that of TAC. In summary, this study uncovered new mutations associated with TAC resistance and also demonstrated that simple structural optimization of the TAC scaffold was possible and may lead to a new generation of TAC-derived drug candidates for the potential treatment of tuberculosis as mycolic acid inhibitors.	[Coxon, Geoffrey D.; Craig, Derek] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France; [Corrales, Rosa Milagros; Vialla, Emilie; Gannoun-Zaki, Laila; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, Montpellier, France; [Kremer, Laurent] DIMNP, INSERM, Montpellier, France	University of Strathclyde; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Coxon, GD (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	geoff.coxon@strath.ac.uk; laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Gannoun, Laila/0000-0002-9644-1083	InfectioPole Sud	InfectioPole Sud	This work was supported by the InfectioPole Sud (to RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belardinelli JM, 2012, MOL MICROBIOL, V86, P568, DOI 10.1111/mmi.12005; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; FEGAN D, 1994, T ROY SOC TROP MED H, V88, P714, DOI 10.1016/0035-9203(94)90246-1; FEGAN D, 1995, LANCET, V345, P63; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Kremer L, 2002, EXPERT OPIN INV DRUG, V11, P1033; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Shahab FM, 2010, XENOBIOTICA, V40, P225, DOI 10.3109/00498250903461411; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	40	50	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53162	10.1371/journal.pone.0053162	http://dx.doi.org/10.1371/journal.pone.0053162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301038	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000313480000036
J	Liu, JX; Cheng, X; Guo, ZR; Wang, ZH; Li, D; Kang, FB; Li, HJ; Li, BS; Cao, ZC; Nassal, M; Sun, DX				Liu, Jinxia; Cheng, Xin; Guo, Zhengrong; Wang, Zihua; Li, Dong; Kang, Fubiao; Li, Haijun; Li, Baosheng; Cao, Zhichen; Nassal, Michael; Sun, Dianxing			Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis	PLOS ONE			English	Article							HEPATOMA-CELL LINES; LARGE SURFACE-ANTIGEN; CLOSED CIRCULAR DNA; GENE DELIVERY; TRANSCRIPTIONAL ACTIVATOR; PREGENOME ENCAPSIDATION; TUPAIA HEPATOCYTES; FIBROSIS; INFECTION; COLLAGEN	Background: Liver cirrhosis is a potentially life-threatening disease caused by progressive displacement of functional hepatocytes by fibrous tissue. The underlying fibrosis is often driven by chronic infection with hepatitis B virus (HBV). Matrix metalloproteinases including MMP-8 are crucial for excess collagen degradation. In a rat model of liver cirrhosis, MMP-8 delivery by an adenovirus (Ad) vector achieved significant amelioration of fibrosis but application of Ad vectors in humans is subject to various issues, including a lack of intrinsic liver specificity. Methods: HBV is highly liver-specific and its principal suitability as liver-specific gene transfer vector is established. HBV vectors have a limited insertion capacity and are replication-defective. Conversely, in an HBV infected cell vector replication may be rescued in trans by the resident virus, allowing conditional vector amplification and spreading. Capitalizing on a resident pathogen to help in its elimination and/or in treating its pathogenic consequences would provide a novel strategy. However, resident HBV may also reduce susceptibility to HBV vector superinfection. Thus a size-compatible truncated MMP-8 (tMMP8) gene was cloned into an HBV vector which was then used to generate a chimeric Ad-HBV shuttle vector that is not subject to superinfection exclusion. Rats with thioacetamide-induced liver cirrhosis were injected with the chimera to evaluate therapeutic efficacy. Results: Our data demonstrate that infectious HBV vector particles can be obtained via trans-complementation by wild-type virus, and that the tMMP8 HBV vector can efficiently be shuttled by an Ad vector into cirrhotic rat livers. There it exerted a comparable beneficial effect on fibrosis and hepatocyte proliferation markers as a conventional full-length MMP-8Ad vector. Conclusions: Though the rat cirrhosis model does not allow assessing in vivo HBV vector amplification these results advocate the further development of Ad-HBV vectors for liver-specific gene therapy, including and perhaps particularly for HBV-related disease.	Bethune Int Peace Hosp, Liver Dis Diag & Treatment Ctr PLA, Shijiazhuang, Peoples R China; [Cao, Zhichen] Hebei Med Univ, Affiliated Hosp 3, Dept Tradit Chinese Med & Liver Dis, Shijiazhuang, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Freiburg, Germany	Hebei Medical University; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; sundianxing@hotmail.com	Nassal, Michael/U-4529-2019; Wang, Zhiquan/HHS-6768-2022	Nassal, Michael/0000-0003-2204-9158; 	National Natural Science Foundation of China [30872255, 30571667]; Wang Baoen Liver Fibrosis Foundation [20070001]; Chinese Foundation for Hepatitis Prevention and Control	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wang Baoen Liver Fibrosis Foundation; Chinese Foundation for Hepatitis Prevention and Control	This work was supported by National Natural Science Foundation of China (grant numbers: 30872255; 30571667, URL of the funder's website, http://isisn.nsfc.gov.cn/egrantweb/) and Chinese Foundation for Hepatitis Prevention and Control, Wang Baoen Liver Fibrosis Foundation (grant number: 20070001, URL of funder's website, http://www.wbelff.org/keti.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Bruck R, 2007, J GASTROEN HEPATOL, V22, P2189, DOI 10.1111/j.1440-1746.2006.04777.x; Dandri M, 2005, J HEPATOL, V42, P54, DOI 10.1016/j.jhep.2004.09.021; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Ganem D, 1999, P NATL ACAD SCI USA, V96, P11696, DOI 10.1073/pnas.96.21.11696; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goyal N, 2009, CLIN RADIOL, V64, P1056, DOI 10.1016/j.crad.2009.05.010; GRESSNER AM, 1991, EUR J CLIN CHEM CLIN, V29, P293; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guo HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043270; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; HILDT E, 1995, ONCOGENE, V11, P2055; Hildt E, 1998, RECENT RES CANCER, V154, P315; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7; Iredale JP, 2004, GASTROENTEROLOGY, V126, P1199, DOI 10.1053/j.gastro.2004.01.060; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Li D, 2011, J BIOCHEM, V150, P371, DOI 10.1093/jb/mvr086; Liu Jin-Xia, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P316; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; MONTFORT I, 1978, AM J PATHOL, V92, P411; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Ni SH, 2005, HUM GENE THER, V16, P664, DOI 10.1089/hum.2005.16.664; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Oren R, 1996, HEPATOLOGY, V24, P419; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; PEREZTAMAYO R, 1987, EXP MOL PATHOL, V47, P300, DOI 10.1016/0014-4800(87)90015-3; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; RANEY AK, 1990, J VIROL, V64, P2360, DOI 10.1128/JVI.64.5.2360-2368.1990; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; ROJKIND M, 1974, ANAL BIOCHEM, V57, P1, DOI 10.1016/0003-2697(74)90043-8; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; SCHALLER H, 1991, CURR TOP MICROBIOL, V168, P21; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452; Siller-Lopez F, 2004, GASTROENTEROLOGY, V126, P1122, DOI 10.1053/j.gastro.2003.12.045; Siller-Lopez F, 2000, J HEPATOL, V33, P758, DOI 10.1016/S0168-8278(00)80307-4; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Untergasser A, 2004, HUM GENE THER, V15, P203, DOI 10.1089/104303404772680001; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Walters KA, 2004, J VIROL, V78, P7925, DOI 10.1128/JVI.78.15.7925-7937.2004; Wang TaiLing, 1998, Chinese Journal of Hepatology, V6, P195; Zoulim F, 2009, LIVER INT, V29, P108, DOI 10.1111/j.1478-3231.2008.01939.x	65	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53392	10.1371/journal.pone.0053392	http://dx.doi.org/10.1371/journal.pone.0053392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301066	gold, Green Published			2022-12-27	WOS:000313480000053
J	Louvanto, K; Rautava, J; Willberg, J; Wideman, L; Syrjanen, K; Grenman, S; Syrjanen, S				Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Kari; Grenman, Seija; Syrjanen, Stina			Genotype-Specific Incidence and Clearance of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HPV INFECTIONS; RISK-FACTORS; BLOT HYBRIDIZATION; NATURAL-HISTORY; PREGNANT-WOMEN; PREVALENCE; DNA; SEROLOGY; HEAD	Background: There are no previous longitudinal studies on genotype-specific natural history of human papillomavirus (HPV) infections in oral mucosa of women. Methods: In the Finnish Family HPV Study, 329 pregnant women were enrolled and followed up. HPV-genotyping of oral scrapings was performed with nested PCR and Multimetrix (R) test (Progen, Heidelberg, Germany). Incidence and clearance times and rates for each HPV-genotype identified in oral mucosa were determined. Predictors for incident and cleared HPV infections for species 7/9 genotypes were analyzed using Poisson regression model. Results: Altogether, 115 baseline HPV-negative women acquired incident oral HPV infection, and 79 women cleared their infection. HPV16 and multiple HPVs most frequently caused incident infections (65% and 12%) in 13.3 and 17.1 months respectively, followed by HPV58, HPV18 and HPV6 (close to 5% each) in 11-24 months. HPV58, HPV18 and HPV66 were the most common to clear. HPV6 and HPV11 had the shortest clearance times, 4.6 months and 2.5 months, and the highest clearance rates, 225.5/1000 wmr and 400/1000 wmr, respectively. The protective factors for incident oral HPV-species 7/9 infections were 1) new pregnancy during follow-up and 2) having the same sexual partner during FU. Increased clearance was related with older age and a history of atopic reactions, whereas previous sexually transmitted disease and new pregnancy were associated with decreased clearance. Conclusions: HPV16 was the most frequent genotype to cause an incident oral HPV-infection. Low risk HPV genotypes cleared from oral mucosa more quickly than high risk HPV genotypes. Pregnancy affected the outcome of oral HPV infection.	[Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol, Turku, Finland; [Louvanto, Karolina; Rautava, Jaana; Willberg, Jaana; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Med Res Lab, Turku, Finland; [Louvanto, Karolina; Grenman, Seija] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynecol, Turku, Finland; [Syrjanen, Kari] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Syrjanen, Kari] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil	University of Turku; University of Turku; University of Turku; University of Turku; Hospital de Cancer de Barretos	Rautava, J (corresponding author), Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol, Turku, Finland.	jaana.rautava@utu.fi	Louvanto, Karolina/GXG-3296-2022	Louvanto, Karolina/0000-0002-1172-363X; Syrjanen, Kari/0000-0001-7180-7491; Syrjanen, Stina/0000-0003-0738-5698	Academy of Finland [116438/2006, 130204/2008]; Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	This work was supported by the Academy of Finland (#116438/2006, #130204/2008), Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, and the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in the study design and data analysis, decision to publish, or preparation of the manuscript.	Anttila M, 1999, GYNECOL ONCOL, V72, P337, DOI 10.1006/gyno.1998.5264; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fife KH, 1999, AM J OBSTET GYNECOL, V180, P1110, DOI 10.1016/S0002-9378(99)70602-2; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hernandez-Giron C, 2005, SEX TRANSM DIS, V32, P613, DOI 10.1097/01.olq.0000179888.47309.db; KELLOKOSKI J, 1992, ORAL MICROBIOL IMMUN, V7, P19, DOI 10.1111/j.1399-302X.1992.tb00014.x; KELLOKOSKI JK, 1992, J ORAL PATHOL MED, V21, P459, DOI 10.1111/j.1600-0714.1992.tb00975.x; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Louvanto K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-179; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montgomery SM, 2002, BRIT J CANCER, V87, P989, DOI 10.1038/sj.bjc.6600585; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Nobbenhuis MAE, 2002, BRIT J CANCER, V87, P75, DOI 10.1038/sj.bjc.6600367; Paaso AE, 2011, J GEN VIROL, V92, P2034, DOI 10.1099/vir.0.032011-0; Rautava J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042171; Rintala M, 2006, J CLIN VIROL, V35, P89, DOI 10.1016/j.jcv.2005.05.012; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005; Safaeian M, 2008, CANCER EPIDEM BIOMAR, V17, P1300, DOI 10.1158/1055-9965.EPI-07-2678; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Sarkola ME, 2009, GYNECOL OBSTET INVES, V67, P208, DOI 10.1159/000209204; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Smith EM, 2007, PEDIATR INFECT DIS J, V26, P836, DOI 10.1097/INF.0b013e318124a4ae; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; Syrjanen S., 2000, PAPILLOMAVIRUS INFEC; Syrjanen S, 2009, J GEN VIROL, V90, P1515, DOI 10.1099/vir.0.007823-0; Tenti P, 1997, J INFECT DIS, V176, P277, DOI 10.1086/517266; Terai M, 1999, ORAL MICROBIOL IMMUN, V14, P201, DOI 10.1034/j.1399-302X.1999.140401.x; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; WILLIAMS H, 1993, ARCH DERMATOL, V129, P717, DOI 10.1001/archderm.129.6.717; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	43	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53413	10.1371/journal.pone.0053413	http://dx.doi.org/10.1371/journal.pone.0053413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301068	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000055
J	Shintani, N; Siebenrock, KA; Hunziker, EB				Shintani, Nahoko; Siebenrock, Klaus A.; Hunziker, Ernst B.			TGF-beta 1 Enhances the BMP-2-Induced Chondrogenesis of Bovine Synovial Explants and Arrests Downstream Differentiation at an Early Stage of Hypertrophy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; FIBROBLAST GROWTH FACTOR-2; ARTICULAR-CARTILAGE REPAIR; MUSCLE-DERIVED CELLS; STROMAL CELLS; X COLLAGEN; ADIPOSE-TISSUE; IN-VITRO; MORPHOGENETIC PROTEIN-2	Background: Synovial explants furnish an in-situ population of mesenchymal stem cells for the repair of articular cartilage. Although bone morphogenetic protein 2 (BMP-2) induces the chondrogenesis of bovine synovial explants, the cartilage formed is neither homogeneously distributed nor of an exclusively hyaline type. Furthermore, the downstream differentiation of chondrocytes proceeds to the stage of terminal hypertrophy, which is inextricably coupled with undesired matrix mineralization. With a view to optimizing BMP-2-induced chondrogenesis, the modulating influences of fibroblast growth factor 2 (FGF-2) and transforming growth factor beta 1 (TGF-beta 1) were investigated. Methodology/Principal Findings: Explants of bovine calf metacarpal synovium were exposed to BMP-2 (200 ng/ml) for 4 (or 6) weeks. FGF-2 (10 ng/ml) or TGF-beta 1 (10 ng/ml) was introduced at the onset of incubation and was present either during the first week of culturing alone or throughout its entire course. FGF-2 enhanced the BMP-2-induced increase in metachromatic staining for glycosaminoglycans (GAGs) only when it was present during the first week of culturing alone. TGF-beta 1 enhanced not only the BMP-2- induced increase in metachromasia (to a greater degree than FGF-2), but also the biochemically-assayed accumulation of GAGs, when it was present throughout the entire culturing period; in addition, it arrested the downstream differentiation of cells at an early stage of hypertrophy. These findings were corroborated by an analysis of the gene- and protein-expression levels of key cartilaginous markers and by an estimation of individual cell volume. Conclusions/Significance: TGF-beta 1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants, improves the hyaline-like properties of the neocartilage, and arrests the downstream differentiation of cells at an early stage of hypertrophy. With the prospect of engineering a mature, truly articular type of cartilage in the context of clinical repair, our findings will be of importance in fine-tuning the stimulation protocol for the optimal chondrogenic differentiation of synovial explants.	[Hunziker, Ernst B.] Univ Bern, Dept Orthopaed Surg, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland; Univ Bern, Dept Clin Res, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland	University of Bern; University of Bern	Hunziker, EB (corresponding author), Univ Bern, Dept Orthopaed Surg, Ctr Regenerat Med Skeletal Tissues, Bern, Switzerland.	ernst.hunziker@dkf.unibe.ch	Hunziker, Ernst B/GYA-1015-2022	Siebenrock, Klaus Arno/0000-0003-3627-4313; Shintani, Nahoko/0000-0002-5722-5134	National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) [5 R01 AR052766]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052766] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIH), USA (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), grant number: 5 R01 AR052766, www.niams.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; BALLOCK RT, 1993, DEV BIOL, V158, P414, DOI 10.1006/dbio.1993.1200; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Berg E, 1999, Orthop Nurs, V18, P55; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; EGGLI PS, 1988, ANAT REC, V222, P217, DOI 10.1002/ar.1092220302; ELFORD PR, 1992, CYTOKINE, V4, P232, DOI 10.1016/1043-4666(92)90061-U; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fowler MR, 2002, ARCH PATHOL LAB MED, V126, P727; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; Gualtieri G, 1978, Chir Ital, V30, P642; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D; Hellingman CA, 2010, TISSUE ENG PT A, V16, P545, DOI [10.1089/ten.tea.2008.0551, 10.1089/ten.TEA.2008.0551]; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; HUNZIKER EB, 1983, J HISTOCHEM CYTOCHEM, V31, P717, DOI 10.1177/31.6.6341460; KATO Y, 1988, P NATL ACAD SCI USA, V85, P9552, DOI 10.1073/pnas.85.24.9552; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368; Kim JH, 2011, TISSUE ENG PT A, V17, P991, DOI [10.1089/ten.tea.2010.0277, 10.1089/ten.TEA.2010.0277]; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; KIRSCH T, 1991, FEBS LETT, V294, P149, DOI 10.1016/0014-5793(91)81363-D; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Lammi PE, 2002, BONE, V31, P690, DOI 10.1016/S8756-3282(02)00904-3; Lee S, 2009, TISSUE ENG PT A, V15, P3401, DOI [10.1089/ten.tea.2008.0466, 10.1089/ten.TEA.2008.0466]; Li GH, 2009, TISSUE ENG PT A, V15, P2123, DOI 10.1089/ten.tea.2008.0214; Manek NJ, 2003, ARTHRITIS RHEUM-US, V48, P1024, DOI 10.1002/art.10884; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442; MAURICE H, 1988, J BONE JOINT SURG BR, V70, P807, DOI 10.1302/0301-620X.70B5.3192585; Miyamoto C, 2007, J ORTHOP SCI, V12, P555, DOI 10.1007/s00776-007-1176-4; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H; Noth U, 2002, J ORTHOP RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006; Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Roth R D, 1993, Clin Podiatr Med Surg, V10, P137; Rui YF, 2010, CHINESE MED J-PEKING, V123, P3040, DOI 10.3760/cma.j.issn.0366-6999.2010.21.017; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sheehan D, 1980, THEORY PRACTICE HIST, Vsecond, P226; Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412; Shen BJ, 2009, TISSUE ENG PT A, V15, P1311, DOI 10.1089/ten.tea.2008.0132; Shintani N, 2011, Eur Cell Mater, V22, P302; Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701; Shintani N, 2007, J ORTHOP RES, V25, P813, DOI 10.1002/jor.20345; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Stevens MM, 2004, J ORTHOP RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021; STOCKWELL RA, 1979, BIOL CARTILAGE CELLS; Theoret CL, 1996, VET SURG, V25, P142, DOI 10.1111/j.1532-950X.1996.tb01390.x; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; van der Kraan PM, 2001, OSTEOARTHR CARTILAGE, V9, P92, DOI 10.1053/joca.2000.0364; WARDALE RJ, 1993, J CELL SCI, V105, P975; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	85	43	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53086	10.1371/journal.pone.0053086	http://dx.doi.org/10.1371/journal.pone.0053086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301025	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000030
J	Kim, S; Dubrovska, A; Salamone, RJ; Walker, JR; Grandinetti, KB; Bonamy, GMC; Orth, AP; Elliott, J; Porta, DG; Garcia-Echeverria, C; Reddy, VA				Kim, Sungeun; Dubrovska, Anna; Salamone, Richard J.; Walker, John R.; Grandinetti, Kathryn B.; Bonamy, Ghislain M. C.; Orth, Anthony P.; Elliott, Jimmy; Porta, Diana Graus; Garcia-Echeverria, Carlos; Reddy, Venkateshwar A.			FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; GROWTH-FACTOR RECEPTOR-2; TYROSINE KINASE INHIBITOR; MAMMARY-GLAND DEVELOPMENT; GENOME-WIDE ASSOCIATION; ACUTE MYELOID-LEUKEMIA; ADULT HUMAN BREAST; MOUSE MODEL; HEMATOPOIETIC PROGENITORS; MULTIPLE-MYELOMA	Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiating cells) and eliminating TICs may offer a new strategy to develop successful anti-cancer therapies. As molecular mechanisms underlying the maintenance of the TIC pool are poorly understood, the development of TIC-specific therapeutics remains a major challenge. We first identified and characterized TICs and non-TICs isolated from a mouse breast cancer model. TICs displayed increased tumorigenic potential, self-renewal, heterogeneous differentiation, and bipotency. Gene expression analysis and immunostaining of TICs and non-TICs revealed that FGFR2 was preferentially expressed in TICs. Loss of FGFR2 impaired self-renewal of TICs, thus resulting in marked decreases in the TIC population and tumorigenic potential. Restoration of FGFR2 rescued the defects in TIC pool maintenance, bipotency, and breast tumor growth driven by FGFR2 knockdown. In addition, pharmacological inhibition of FGFR2 kinase activity led to a decrease in the TIC population which resulted in suppression of breast tumor growth. Moreover, human breast TICs isolated from patient tumor samples were found enriched in a FGFR2+ population that was sufficient to initiate tumor growth. Our data suggest that FGFR2 is essential in sustaining the breast TIC pool through promotion of self-renewal and maintenance of bipotent TICs, and raise the possibility of FGFR2 inhibition as a strategy for anti-cancer therapy by eradicating breast TICs.	[Kim, Sungeun; Salamone, Richard J.; Walker, John R.; Grandinetti, Kathryn B.; Bonamy, Ghislain M. C.; Orth, Anthony P.; Elliott, Jimmy; Reddy, Venkateshwar A.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Dubrovska, Anna] Scripps Res Inst, La Jolla, CA 92037 USA; [Porta, Diana Graus; Garcia-Echeverria, Carlos] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland	Novartis; Scripps Research Institute; Novartis	Kim, S (corresponding author), Amgen Inc, San Francisco, CA USA.	sungeunk@amgen.com; venkateshwar.reddy@sanofi.com	Dubrovska, Anna/AAE-8514-2019	Dubrovska, Anna/0000-0002-3375-1500; Bonamy, Ghislain/0000-0002-2826-5225	Genomics Institute of the Novartis Research Foundation	Genomics Institute of the Novartis Research Foundation	This work was supported by Genomics Institute of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNANE J, 1991, ONCOGENE, V6, P659; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chase A, 2007, BLOOD, V110, P3729, DOI 10.1182/blood-2007-02-074286; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iseki S, 1999, DEVELOPMENT, V126, P5611; Jang JH, 2001, CANCER RES, V61, P3541; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Moffa AB, 2004, MOL CANCER RES, V2, P643; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pedchenko VK, 2000, MOL REPROD DEV, V56, P441, DOI 10.1002/1098-2795(200008)56:4&lt;441::AID-MRD1&gt;3.0.CO;2-C; PIERCE GB, 1974, AM J PATHOL, V77, P103; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Turner N, 2010, ONCOGENE; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Xin XH, 2006, CLIN CANCER RES, V12, P4908, DOI 10.1158/1078-0432.CCR-06-0957; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	66	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51671	10.1371/journal.pone.0051671	http://dx.doi.org/10.1371/journal.pone.0051671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300950	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900008
J	Maltha, J; Gillet, P; Heutmekers, M; Bottieau, E; Van Gompel, A; Jacobs, J				Maltha, Jessica; Gillet, Philippe; Heutmekers, Marloes; Bottieau, Emmanuel; Van Gompel, Alfons; Jacobs, Jan			Self-Diagnosis of Malaria by Travelers and Expatriates: Assessment of Malaria Rapid Diagnostic Tests Available on the Internet	PLOS ONE			English	Article							ACCURACY; QUALITY; PLDH	Introduction: In the past malaria rapid diagnostic tests (RDTs) for self-diagnosis by travelers were considered suboptimal due to poor performance. Nowadays RDTs for self-diagnosis are marketed and available through the internet. The present study assessed RDT products marketed for self-diagnosis for diagnostic accuracy and quality of labeling, content and instructions for use (IFU). Methods: Diagnostic accuracy of eight RDT products was assessed with a panel of stored whole blood samples comprising the four Plasmodium species (n = 90) as well as Plasmodium negative samples (n = 10). IFUs were assessed for quality of description of procedure and interpretation and for lay-out and readability level. Errors in packaging and content were recorded. Results: Two products gave false-positive test lines in 70% and 80% of Plasmodium negative samples, precluding their use. Of the remaining products, 4/6 had good to excellent sensitivity for the diagnosis of Plasmodium falciparum (98.2%-100.0%) and Plasmodium vivax (93.3%-100.0%). Sensitivity for Plasmodium ovale and Plasmodium malariae diagnosis was poor (6.7%-80.0%). All but one product yielded false-positive test lines after reading beyond the recommended reading time. Problems with labeling (not specifying target antigens (n = 3), and content (desiccant with no humidity indicator (n = 6)) were observed. IFUs had major shortcomings in description of test procedure and interpretation, poor readability and layout and user-unfriendly typography. Strategic issues (e.g. the need for repeat testing and reasons for false-negative tests) were not addressed in any of the IFUs. Conclusion: Diagnostic accuracy of RDTs for self-diagnosis was variable, with only 4/8 RDT products being reliable for the diagnosis of P. falciparum and P. vivax, and none for P. ovale and P. malariae. RDTs for self-diagnosis need improvements in IFUs (content and user-friendliness), labeling and content before they can be considered for self-diagnosis by the traveler.	[Maltha, Jessica; Gillet, Philippe; Heutmekers, Marloes; Bottieau, Emmanuel; Van Gompel, Alfons; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica] Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium	Institute of Tropical Medicine (ITM)	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jmaltha@itg.be	Heutmekers, Marloes/P-6140-2015; Jacobs, Jan/GRX-7316-2022	Heutmekers, Marloes/0000-0003-0880-409X; gillet, philippe/0000-0001-5878-6446	Steunfonds Marguerite-Marie Delacroix	Steunfonds Marguerite-Marie Delacroix	J.M. holds a grant of the 'Steunfonds Marguerite-Marie Delacroix.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Causer LM, 2004, CLIN INFECT DIS, V39, P1583, DOI 10.1086/425311; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; European Commission, 1998, EUR STAND IN VITR DI; Funk M, 1999, T ROY SOC TROP MED H, V93, P268, DOI 10.1016/S0035-9203(99)90018-4; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-215; Grobusch MP, 2002, EUR J CLIN MICROBIOL, V21, P818, DOI 10.1007/s10096-002-0831-0; Hopkins H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-30; Jelinek T, 1999, LANCET, V354, P1609, DOI 10.1016/S0140-6736(99)01969-8; Magill Alan J, 2006, Curr Infect Dis Rep, V8, P35, DOI 10.1007/s11908-006-0033-5; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Maltha J, 2011, EUR J PEDIATR, V170, P821, DOI 10.1007/s00431-011-1451-4; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-198; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Miller RS, 2001, BRIT J HAEMATOL, V113, P558, DOI 10.1046/j.1365-2141.2001.02782.x; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Mueller I, 2007, J CLIN MICROBIOL, V45, P627, DOI 10.1128/JCM.00816-06; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Roukens AH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-128; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; Schlagenhauf P, 2012, EXPERT REV ANTI-INFE, V10, P537, DOI [10.1586/ERI.12.42, 10.1586/eri.12.42]; Trachsler M, 1999, TROP MED INT HEALTH, V4, P442, DOI 10.1046/j.1365-3156.1999.00419.x; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Dijk DPJ, 2010, EUR J CLIN MICROBIOL, V29, P577, DOI 10.1007/s10096-010-0898-y; Wallace LS, 2009, J WOMENS HEALTH, V18, P363, DOI 10.1089/jwh.2008.0985; Whitty CJM, 2000, AM J TROP MED HYG, V63, P295, DOI 10.4269/ajtmh.2000.63.295; World Health Organization, 2003, M 20 23 JAN 2003 MAN; World Health Organization, 2012, INT TRAV HLTH	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53102	10.1371/journal.pone.0053102	http://dx.doi.org/10.1371/journal.pone.0053102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301027	Green Published, gold			2022-12-27	WOS:000313320900060
J	Terahara, K; Ishige, M; Ikeno, S; Mitsuki, Y; Okada, S; Kobayashi, K; Tsunetsugu-Yokota, Y				Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Mitsuki, Yu-ya; Okada, Seiji; Kobayashi, Kazuo; Tsunetsugu-Yokota, Yasuko			Expansion of Activated Memory CD4(+) T Cells Affects Infectivity of CCR5-Tropic HIV-1 in Humanized NOD/SCID/JAK3(null) Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD CD34(+) CELLS; DENDRITIC CELLS; IMMUNE-SYSTEM; HOMEOSTATIC PROLIFERATION; TRANSMISSION; MATURE; NAIVE; RECONSTITUTION; PATHOGENESIS	Humanized mice reconstituted with human hematopoietic cells have been developed as an experimental animal model for human immunodeficiency virus type 1 (HIV-1) infection. Myeloablative irradiation is usually performed to augment the engraftment of donor hematopoietic stem cells (HSCs) in recipient mice; however, some mouse strains are susceptible to irradiation, making longitudinal analysis difficult. We previously attempted to construct humanized NOD/SCID/JAK3(null) (hNOJ) mice, which were not irradiated prior to human HSC transplantation. We found that, over time, many of the reconstituted CD4(+) T cells expanded with an activated effector memory phenotype. Therefore, the present study used hNOJ mice that were irradiated (hNOJ (IR+)) or not (hNOJ (IR-)) prior to human HSC transplantation to examine whether the development and cellularity of the reconstituted CD4(+) T cells were influenced by the degree of chimerism, and whether they affected HIV-1 infectivity. Indeed, hNOJ (IR+) mice showed a greater degree of chimerism than hNOJ (IR-) mice. However, the conversion of CD4(+) T cells to an activated effector memory phenotype, with a high percentage of cells showing Ki-67 expression, occurred in both hNOJ (IR+) and hNOJ (IR-) mice, probably as a result of lymphopenia-induced homeostatic expansion. Furthermore, when hNOJ (IR+) and hNOJ (IR-) mice, which were selected as naive- and memory CD4(+) T cell subset-rich groups, respectively, were infected with CCR5-tropic HIV-1 in vivo, virus replication (as assessed by the plasma viral load) was delayed; however, the titer subsequently reached a 1-log higher level in memory-rich hNOJ (IR-) mice than in naive-rich hNOJ (IR+) mice, indicating that virus infectivity in hNOJ mice was affected by the different status of the reconstituted CD4(+) T cells. Therefore, the hNOJ mouse model should be used selectively, i.e., according to the specific experimental objectives, to gain an appropriate understanding of HIV-1 infection/pathogenesis.	[Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Mitsuki, Yu-ya; Kobayashi, Kazuo; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Ishige, Masayuki; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan; [Ikeno, Shota] Kitasato Univ, Kitasato Inst Life Sci, Lab Viral Infect 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Kumamoto University; Kitasato University	Tsunetsugu-Yokota, Y (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	yyokota@nih.go.jp	Okada, Seiji/F-5785-2013	Terahara, Kazutaka/0000-0001-9876-4356	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [23790453] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (K. T.), and the Ministry of Health, Labour and Welfare of Japan (K.T. and Y.T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020169; Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; David SA, 2001, AIDS RES HUM RETROV, V17, P59, DOI 10.1089/088922201750056799; Goldstein Harris, 2008, AIDS Res Ther, V5, P3, DOI 10.1186/1742-6405-5-3; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Kemp K, 2001, J INTERF CYTOK RES, V21, P503, DOI 10.1089/10799900152434376; Langeveld M, 2006, EUR J CLIN INVEST, V36, P250, DOI 10.1111/j.1365-2362.2006.01626.x; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Liu CX, 2010, BLOOD, V116, P5518, DOI 10.1182/blood-2009-12-260810; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Okada R, 2008, INT IMMUNOL, V20, P1189, DOI 10.1093/intimm/dxn075; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Onoe T, 2010, J IMMUNOL, V184, P6756, DOI 10.4049/jimmunol.0901711; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Picker LJ, 2005, NAT IMMUNOL, V6, P430, DOI 10.1038/ni0505-430; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Saito A, 2011, MICROBES INFECT, V13, P58, DOI 10.1016/j.micinf.2010.10.001; Sato K, 2011, EXP BIOL MED MAYWOOD; Sato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042776; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013109; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shacklett BL, 2008, PLOS MED, V5, P16, DOI 10.1371/journal.pmed.0050013; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; Terahara K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00280; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tsunetsugu-Yokota Y, 1997, VIROLOGY, V239, P259, DOI 10.1006/viro.1997.8895; Tsunetsugu-Yokota Y., 2008, AIDS VACCINES HIV RE, P117; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	62	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53495	10.1371/journal.pone.0053495	http://dx.doi.org/10.1371/journal.pone.0053495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301078	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900080
J	Jenkinson, WE; Nakamura, K; White, AJ; Jenkinson, EJ; Anderson, G				Jenkinson, William E.; Nakamura, Kyoko; White, Andrea J.; Jenkinson, Eric J.; Anderson, Graham			Normal T Cell Selection Occurs in CD205-Deficient Thymic Microenvironments	PLOS ONE			English	Article							CORTICAL EPITHELIAL-CELLS; DENDRITIC CELLS; POSITIVE SELECTION; IN-VIVO; ANTIGEN PRESENTATION; RECEPTOR DEC-205; SELF-TOLERANCE; BETA-CHAIN; THYMOCYTES; EXPRESSION	The thymus imparts a developmental imprint upon T cells, screening beneficial and self-tolerant T cell receptor (TCR) specificities. Cortical thymic epithelial cells (CTEC) present self-peptide self-MHC complexes to thymocytes, positively selecting those with functional TCRs. Importantly, CTEC generate diverse self-peptides through highly specific peptide processing. The array of peptides utilized for positive selection appears to play a key role in shaping TCR repertoire and influencing T cell functionality. Whilst self-peptide diversity influences T cell development, the precise source of proteins generating such self-peptide arrays remains unknown, the abundance of apoptotic thymocytes failing thymic selection may provide such a pool of self-proteins. In relation to this notion, whilst it has been previously demonstrated that CTEC expression of the endocytic receptor CD205 facilitates binding and uptake of apoptotic thymocytes, the possible role of CD205 during intrathymic T cell development has not been studied. Here, we directly address the role of CD205 in normal thymocyte development and selection. Through analysis of both polyclonal and monoclonal transgenic TCR T-cell development in the context of CD205 deficiency, we demonstrate that CD205 does not play an overt role in T cell development or selection.	[Jenkinson, William E.; Nakamura, Kyoko; White, Andrea J.; Jenkinson, Eric J.; Anderson, Graham] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England	University of Birmingham	Jenkinson, WE (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England.	w.e.jenkinson@bham.ac.uk; g.anderson@bham.ac.uk	Nakamura, Kyoko/B-4184-2013	anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372	MRC; Medical Research Council [G1000213, G0401620, G1001055] Funding Source: researchfish; MRC [G1001055, G1000213, G0401620] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an MRC New Investigator Award to WEJ, an MRC Program Grant to GA and EJ and core facilities of the MRC Centre for Immune Regulation, University of Birmingham, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Fiorini E, 2008, J IMMUNOL, V181, P8199, DOI 10.4049/jimmunol.181.12.8199; Fukui Y, 1998, J EXP MED, V188, P897, DOI 10.1084/jem.188.5.897; Gaszewska-Mastalarz A, 2000, J IMMUNOL, V165, P6099, DOI 10.4049/jimmunol.165.11.6099; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nitta T, 2011, CURR OPIN IMMUNOL, V23, P190, DOI 10.1016/j.coi.2010.12.002; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Small M, 2003, INT IMMUNOL, V15, P197, DOI 10.1093/intimm/dxg024; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; VANVLIET E, 1984, EUR J IMMUNOL, V14, P524, DOI 10.1002/eji.1830140608; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53416	10.1371/journal.pone.0053416	http://dx.doi.org/10.1371/journal.pone.0053416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300927	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600098
J	Lee, LA; Yu, JF; Lo, YL; Chen, YS; Wang, DL; Cho, CM; Ni, YL; Chen, NH; Fang, TJ; Huang, CG; Li, HY				Lee, Li-Ang; Yu, Jen-Fang; Lo, Yu-Lun; Chen, Yen-Sheng; Wang, Ding-Li; Cho, Chih-Ming; Ni, Yung-Lun; Chen, Ning-Hung; Fang, Tuan-Jen; Huang, Chung-Guei; Li, Hsueh-Yu			Energy Types of Snoring Sounds in Patients with Obstructive Sleep Apnea Syndrome: A Preliminary Observation	PLOS ONE			English	Article							OUTCOMES SURVEY; HYPOPNEA INDEX; SEVERITY; VALIDATION; SNORERS; ANATOMY; SIGNALS; SITE	Background: Annoying snore is the principle symptom and problem in obstructive sleep apnea syndrome (OSAS). However, investigation has been hampered by the complex snoring sound analyses. Objective: This study was aimed to investigate the energy types of the full-night snoring sounds in patients with OSAS. Patients and Method: Twenty male OSAS patients underwent snoring sound recording throughout 6 hours of in-lab overnight polysomnogragphy. Snoring sounds were processed and analyzed by a new sound analytic program, named as Snore Map (R). We transformed the 6-hour snoring sound power spectra into the energy spectrum and classified it as snore map type 1 (monosyllabic low-frequency snore), type 2 (duplex low-& mid-frequency snore), type 3 (duplex low-& high-frequency snore), and type 4 (triplex low-, mid-, & high-frequency snore). The interrator and test-retest reliabilities of snore map typing were assessed. The snore map types and their associations among demographic data, subjective snoring questionnaires, and polysomnographic parameters were explored. Results: The interrator reliability of snore map typing were almost perfect (kappa = 0.87) and the test-retest reliability was high (r = 0.71). The snore map type was proportional to the body mass index (r = 0.63, P = 0.003) and neck circumference (r = 0.52, P = 0.018). Snore map types were unrelated to subjective snoring questionnaire scores (All P > 0.05). After adjustment for body mass index and neck circumference, snore map type 3-4 was significantly associated with severity of OSAS (r = 0.52, P = 0.026). Conclusions: Snore map typing of a full-night energy spectrum is feasible and reliable. The presence of a higher snore map type is a warning sign of severe OSAS and indicated priority OSAS management. Future studies are warranted to evaluate whether snore map type can be used to discriminate OSAS from primary snoring and whether it is affected by OSAS management.	[Lee, Li-Ang; Fang, Tuan-Jen; Li, Hsueh-Yu] Chang Gung Univ, Dept Otolaryngol, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Yu, Jen-Fang; Chen, Yen-Sheng; Wang, Ding-Li; Cho, Chih-Ming] Chang Gung Univ, Grad Inst Med Mechatron, Taiouan Interdisciplinary Otolaryngol Lab, Tao Yuan, Taiwan; [Lo, Yu-Lun; Ni, Yung-Lun; Chen, Ning-Hung] Chang Gung Univ, Dept Thorac Med, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Huang, Chung-Guei] Chang Gung Univ, Dept Pathol, Chang Gung Mem Hosp, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Li, HY (corresponding author), Chang Gung Univ, Dept Otolaryngol, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan.	hyli38@adm.cgmh.org.tw	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; Fang, TuanJen/0000-0002-7805-3458; YU, JEN-FANG/0000-0002-3202-8433	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG390301, CMRPG390302]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG390301 and CMRPG390302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2002, CLIN OTOLARYNGOL, V27, P162, DOI 10.1046/j.1365-2273.2002.00554.x; Fiz JA, 2010, LARYNGOSCOPE, V120, P854, DOI 10.1002/lary.20815; Beck R, 1995, EUR RESPIR J, V8, P2120, DOI 10.1183/09031936.95.08122120; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; Cathcart RA, 2010, CLIN OTOLARYNGOL, V35, P198, DOI 10.1111/j.1749-4486.2010.02127.x; Chen NH, 2002, QUAL LIFE RES, V11, P601, DOI 10.1023/A:1016337008763; Chuang Li-Pang, 2008, Chang Gung Med J, V31, P175; Douglas SA, 2006, OTOLARYNG HEAD NECK, V134, P56, DOI 10.1016/j.otohns.2005.09.006; Emoto T., 2011, Journal of Medical Engineering & Technology, V35, P425, DOI 10.3109/03091902.2011.626838; Friedman M, 2004, LARYNGOSCOPE, V114, P454, DOI 10.1097/00005537-200403000-00013; Gliklich RE, 2002, ARCH OTOLARYNGOL, V128, P819, DOI 10.1001/archotol.128.7.819; Hoffstein V, 1996, SLEEP, V19, P783; Iber C., 2007, AASM MANUAL SCORING; Jury E., 1961, P IRE, V49, P1947; Li HY, 2008, LARYNGOSCOPE, V118, P354, DOI 10.1097/MLG.0b013e318158f73f; Li HY, 2006, SLEEP, V29, P1537, DOI 10.1093/sleep/29.12.1537; Lim PVH, 1999, J LARYNGOL OTOL, V113, P336, DOI 10.1017/S0022215100143919; Mesquita J, 2012, MED BIOL ENG COMPUT, V50, P373, DOI 10.1007/s11517-012-0885-9; Michael H, 2008, EUR ARCH OTO-RHINO-L, V265, P105, DOI 10.1007/s00405-007-0408-8; Miyazaki S, 1998, ACTA OTO-LARYNGOL, P47; PEREZPADILLA JR, 1993, AM REV RESPIR DIS, V147, P635, DOI 10.1164/ajrccm/147.3.635; Sola-Soler J, 2003, P ANN INT IEEE EMBS, V25, P2527, DOI 10.1109/IEMBS.2003.1280430; WHITE JES, 1994, CLIN OTOLARYNGOL, V19, P218, DOI 10.1111/j.1365-2273.1994.tb01218.x; Wilson K, 1999, CHEST, V115, P762, DOI 10.1378/chest.115.3.762; Xu HJ, 2010, ACTA OTO-LARYNGOL, V130, P1175, DOI 10.3109/00016481003694774; Yu JF, 2012, J MECH, V28, P91, DOI 10.1017/jmech.2012.9	26	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53481	10.1371/journal.pone.0053481	http://dx.doi.org/10.1371/journal.pone.0053481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300931	Green Published, gold			2022-12-27	WOS:000313872600102
J	Xu, MJ; Ai, L; Fu, JH; Nisbet, AJ; Liu, QY; Chen, MX; Zhou, DH; Zhu, XQ				Xu, Min-Jun; Ai, Lin; Fu, Jing-Hua; Nisbet, Alasdair J.; Liu, Qing-You; Chen, Mu-Xin; Zhou, Dong-Hui; Zhu, Xing-Quan			Comparative Characterization of MicroRNAs from the Liver Flukes Fasciola gigantica and F-hepatica	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; HUMAN HEALTH; IDENTIFICATION; PCR; EXPRESSION	MicroRNAs (miRNAs) are key regulators of gene expression at the post-transcription level. The present study specifically explored and compared the miRNA expression profiles of F. gigantica and F. hepatica using an integrated sequencing and bioinformatics platform and quantitative real-time PCR. Nineteen and 16 miRNA candidates were identified from F. gigantica and F. hepatica, respectively. The two parasites shared 11 miRNAs, with 8 also showing similarity to miRNAs of Schistosoma japonicum. Another 8 miRNAs were identified as F. gigantica-specific and 5 as F. hepatica-specific, most of which were novel. Predicted target analysis with 11465 mRNA and EST sequences of F. hepatica and F. gigantica revealed that all of the miRNAs had more than one target, ranging from 2 to 398 with an average of 51 targets. Some functions of the predicted targets were only found in F. gigantica, such as "transcription regulator'', while some others were only found in F. hepatica, such as "reproduction'' and "response to stimulus'', indicating the different metabolism and gene regulation patterns of the two parasites. The present study represents the first global comparative characterization of miRNA expression profiles of F. gigantica and F. hepatica, which has provided novel valuable resources for a better understanding of the two zoonotic trematodes.	[Xu, Min-Jun; Ai, Lin; Fu, Jing-Hua; Zhou, Dong-Hui; Zhu, Xing-Quan] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Ai, Lin; Chen, Mu-Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Fu, Jing-Hua] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Nisbet, Alasdair J.] Moredun Res Inst, Div Parasitol, Penicuik, Midlothian, Scotland; [Liu, Qing-You] Guangxi Univ, Anim Reprod Inst, Guangxi Key Lab Subtrop Bioresource Conservat & U, Nanning, Guangxi Zhuang, Peoples R China; [Zhu, Xing-Quan] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; South China Agricultural University; Moredun Research Institute; Guangxi University; Heilongjiang Bayi Agricultural University	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com		Nisbet, Alasdair/0000-0002-4965-5396	National S & T Major Program [2012ZX10004220]; China Postdoctoral Science Foundation [201104363, 20090460064]; Shanghai Postdoctoral Sustentation Fund [KT-1203]; Program for Outstanding Scientists in Agricultural Research; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2010KFKT009, SKLVEB2011KFKT004, SKLVEB2011KFKT010]	National S & T Major Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund; Program for Outstanding Scientists in Agricultural Research; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences	Project support was provided by the National S & T Major Program (Grant No. 2012ZX10004220), the China Postdoctoral Science Foundation (Grant Nos. 201104363 and 20090460064), Shanghai Postdoctoral Sustentation Fund (Grant No. KT-1203), the Program for Outstanding Scientists in Agricultural Research, and the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant Nos. SKLVEB2010KFKT009, SKLVEB2011KFKT004 and SKLVEB2011KFKT010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2010, ANN TROP MED PARASIT, V104, P65, DOI 10.1179/136485910X12607012373713; Ai L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-101; Ali H, 2008, PARASITOL RES, V102, P1021, DOI 10.1007/s00436-007-0870-7; Ali NM, 2012, PARASITOL RES, V110, P1649, DOI 10.1007/s00436-011-2678-8; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Boray J. C., 1969, Adv. Parasitol., V7, P95, DOI 10.1016/S0065-308X(08)60435-2; Charlier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043216; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126; Fried B, 2010, PARASITOL RES, V106, P1263, DOI 10.1007/s00436-010-1807-0; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Howell A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-196; Huang LM, 2012, CARCINOGENESIS, V33, P94, DOI [10.1093/carcin/bgq230, 10.1093/carcin/bgr228]; Huang WY, 2004, VET PARASITOL, V120, P75, DOI 10.1016/j.vetpar.2003.12.006; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotfy WM, 2008, AM J TROP MED HYG, V79, P248, DOI 10.4269/ajtmh.2008.79.248; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; McGonigle S, 1997, PARASITOLOGY, V115, P101, DOI 10.1017/S0031182097001170; Piedrafita D, 2010, PARASITE IMMUNOL, V32, P572, DOI 10.1111/j.1365-3024.2010.01223.x; Rokni MB, 2008, ANN TROP MED PARASIT, V102, P283, DOI 10.1179/136485908X300805; Wang CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047001; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003	30	28	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53387	10.1371/journal.pone.0053387	http://dx.doi.org/10.1371/journal.pone.0053387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300925	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600096
J	Zhang, YX; Barry, JG; Moore, DR; Amitay, S				Zhang, Yu-Xuan; Barry, Johanna G.; Moore, David R.; Amitay, Sygal			A New Test of Attention in Listening (TAIL) Predicts Auditory Performance	PLOS ONE			English	Article							SELECTIVE ATTENTION; WORKING-MEMORY; HUMAN BRAIN; SYSTEM; DISCRIMINATION; INHIBITION; INTERFERENCE; MODULATION; JUDGMENTS; CORTEX	Attention modulates auditory perception, but there are currently no simple tests that specifically quantify this modulation. To fill the gap, we developed a new, easy-to-use test of attention in listening (TAIL) based on reaction time. On each trial, two clearly audible tones were presented sequentially, either at the same or different ears. The frequency of the tones was also either the same or different (by at least two critical bands). When the task required same/different frequency judgments, presentation at the same ear significantly speeded responses and reduced errors. A same/different ear (location) judgment was likewise facilitated by keeping tone frequency constant. Perception was thus influenced by involuntary orienting of attention along the task-irrelevant dimension. When information in the two stimulus dimensions were congruent (same-frequency same-ear, or different-frequency different-ear), response was faster and more accurate than when they were incongruent (same-frequency different-ear, or different-frequency same-ear), suggesting the involvement of executive control to resolve conflicts. In total, the TAIL yielded five independent outcome measures: (1) baseline reaction time, indicating information processing efficiency, (2) involuntary orienting of attention to frequency and (3) location, and (4) conflict resolution for frequency and (5) location. Processing efficiency and conflict resolution accounted for up to 45% of individual variances in the low-and high-threshold variants of three psychoacoustic tasks assessing temporal and spectral processing. Involuntary orientation of attention to the irrelevant dimension did not correlate with perceptual performance on these tasks. Given that TAIL measures are unlikely to be limited by perceptual sensitivity, we suggest that the correlations reflect modulation of perceptual performance by attention. The TAIL thus has the power to identify and separate contributions of different components of attention to auditory perception.	[Zhang, Yu-Xuan; Barry, Johanna G.; Moore, David R.; Amitay, Sygal] MRC, Inst Hearing Res, Nottingham, England; [Zhang, Yu-Xuan] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, YX (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	yuxuan.zhang@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435; Barry, Johanna/0000-0002-3733-8721	Medical Research Council (MRC), United Kingdom; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council (MRC), United Kingdom, through intramural funding to the MRC Institute of Hearing Research. All authors were MRC employees at the time the research was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Armony J.L., 2010, OXFORD HDB AUDITORY, VVol. 2, P479, DOI [10.1093/oxfordhb/9780199233281.013.0019, DOI 10.1093/OXFORDHB/9780199233281.013.0019]; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barry J. G., 2010, JOVE-J VIS EXP, V44, P2139, DOI [10.3791/2139, DOI 10.3791/2139]; Botvinick M, 2004, COGNITIVE NEUROSCIEN; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brancucci A, 1999, NEUROPSYCHOLOGIA, V37, P1445, DOI 10.1016/S0028-3932(99)00065-2; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cherry EC, 1952, AM SCI, V40, P640; Cohen J. D., 2004, COGNITIVE NEUROSCIEN, P71; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fossella J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1255; Houston DM, 2012, J AM ACAD AUDIOL, V23, P446, DOI 10.3766/jaaa.23.6.7; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leigh-Paffenroth ED, 2011, J AM ACAD AUDIOL, V22, P393, DOI 10.3766/jaaa.22.7.2; Lupianez J, 1997, PERCEPT PSYCHOPHYS, V59, P1241, DOI 10.3758/BF03214211; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Martin-Arevalo E, 2013, Q J EXP PSYCHOL, V66, P347, DOI 10.1080/17470218.2012.711844; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McKinnon MC, 1997, CAN J EXP PSYCHOL, V51, P171, DOI 10.1037/1196-1961.51.2.171; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mondor TA, 1998, PERCEPT PSYCHOPHYS, V60, P296, DOI 10.3758/BF03206038; Moore B., 2003, INTRO PSYCHOL HEARIN; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Moore DR, 2012, INT J AUDIO IN PRESS; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; PENDSE SG, 1977, PERCEPT MOTOR SKILL, V44, P923, DOI 10.2466/pms.1977.44.3.923; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Posner M., 1975, INFORM PROCESSING CO; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Roberts KL, 2006, J INT NEUROPSYCH SOC, V12, P485, DOI 10.1017/S1355617706060620; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; Schneider BA, 2010, SPRINGER HANDB AUDIT, V34, P167, DOI 10.1007/978-1-4419-0993-0_7; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Dijk P, 2003, HEARING RES, V181, P8, DOI 10.1016/S0378-5955(03)00130-8; Vernon P. A., 1987, SPEED INFORM PROCESS; Weinberger N. M., 2010, AUDITORY BRAIN, P441; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53502	10.1371/journal.pone.0053502	http://dx.doi.org/10.1371/journal.pone.0053502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300934	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872600104
J	Novoa, A; Gonzalez, L; Moravcova, L; Pysek, P				Novoa, Ana; Gonzalez, Luis; Moravcova, Lenka; Pysek, Petr			Effects of Soil Characteristics, Allelopathy and Frugivory on Establishment of the Invasive Plant Carpobrotus edulis and a Co-Occuring Native, Malcolmia littorea	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SPECIES INVASIVENESS; BIOLOGICAL INVASION; SPP. AIZOACEAE; ALIEN PLANTS; GERMINATION; LITTER; IMPACT; COMMUNITIES; CALIFORNIA	Background: The species Carpobrotus edulis, native to South Africa, is one of the major plant invaders of Mediterranean coastal ecosystems around the world. Invasion by C. edulis exerts a great impact on coastal habitats. The low number of native species in invaded communities points to the possible existence of mechanisms suppressing their germination. In this study we assessed whether soil factors, endozoochory, competition and allelopathic effects of the invader affect its own early establishment and that of the native species Malcolmia littorea. We used laboratory solutions representing different chemical composition and moisture of the soil, herbivore feeding assays to simulate seed scarification and rainwater solutions to account for the effect of differently aged C. edulis litter. Principal Findings: We show that unlike that of the native species, germination and early growth of C. edulis was not constrained by low moisture. The establishment of C. edulis, in terms of germination and early growth, was increased by scarification of seeds following passage through the European rabbit intestines; the rabbits therefore may have potential implications for plant establishment. There was no competition between C. edulis and M. littorea. The litter of the invasive C. edulis, which remains on the soil surface for several years, releases allelopathic substances that suppress the native plant germination process and early root growth. Conclusions: The invasive species exhibits features that likely make it a better colonizer of sand dunes than the co-occurring native species. Allelopathic effects, ability to establish in drier microsites and efficient scarification by rabbits are among the mechanisms allowing C. edulis to invade. The results help to explain the failure of removal projects that have been carried out in order to restore dunes invaded by C. edulis, and the long-lasting effects of C. edulis litter need to be taken into account in future restoration projects.	[Novoa, Ana; Gonzalez, Luis] Univ Vigo, Dept Bioloxia Vexetal & Ciencia Solo, Vigo 36310, Spain; [Novoa, Ana; Moravcova, Lenka; Pysek, Petr] Acad Sci Czech Republ, Dept Invas Ecol, Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	Universidade de Vigo; Czech Academy of Sciences; Charles University Prague	Novoa, A (corresponding author), Univ Vigo, Dept Bioloxia Vexetal & Ciencia Solo, Vigo 36310, Spain.	ananovoa@uvigo.es	Moravcová, Lenka/H-1613-2014; González, Luís/M-2582-2019; Novoa, Ana/F-9034-2016; Pysek, Petr/B-1957-2012; González, Luís/F-6408-2010	González, Luís/0000-0001-8091-9364; Novoa, Ana/0000-0001-7092-3917; González, Luís/0000-0001-8091-9364	Ministry of Education of Spain; Academy of Sciences of the Czech Republic [GA206/09/0563, RVO 67985939]; Praemium Academiae award from the Academy of Sciences of the Czech Republic	Ministry of Education of Spain(Spanish Government); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Praemium Academiae award from the Academy of Sciences of the Czech Republic	AN was supported by the "grant to encourage mobility of visiting professors and students under institutional strategies of doctoral training in universities and consolidation of doctoral programs with mention to Excellence" of the Ministry of Education of Spain. PP and LM were supported by grant no. GA206/09/0563 and long-term research development project no. RVO 67985939 (both from the Academy of Sciences of the Czech Republic). PP was also supported by institutional resources of the Ministry of Education, Youth and Sports of the Czech Republic, and acknowledges support by the Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ME, 1995, PORTRAIT INVADER; Allen SE, 1989, CHEM ANAL ECOLOGICAL; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 1992, OFFICIAL J EUROPEAN, P7; Balestri E, 2004, J COASTAL RES, V20, P761, DOI 10.2112/1551-5036(2004)20[761:GAEECO]2.0.CO;2; Bartomeus I, 2008, ANN BOT-LONDON, V102, P417, DOI 10.1093/aob/mcn109; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bourgeois K, 2005, ECOSCIENCE, V12, P248, DOI 10.2980/i1195-6860-12-2-248.1; Bradbeer J.W., 1998, SEED DORMANCY GERMIN, Vfirst; Bubel N., 1988, NEW SEED STARTERS HD; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Carranza ML, 2011, PRESLIA, V83, P529; Castroviejo S, 1991, N E BR FLORA IBERICA, V2, P84; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cervan Carmona Maria, 1997, Donana Acta Vertebrata, V24, P143; Chiapusio G, 1997, J CHEM ECOL, V23, P2445, DOI 10.1023/B:JOEC.0000006658.27633.15; Cogoni A, 2011, NOVA HEDWIGIA, V92, P159, DOI 10.1127/0029-5035/2011/0092-0159; Conser C, 2009, BIOL INVASIONS, V11, P349, DOI 10.1007/s10530-008-9252-z; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; D'Antonio CM, 2006, GLOBAL INVASIVE SPEC; DANTONIO CM, 1991, AM J BOT, V78, P885, DOI 10.2307/2445167; DANTONIO CM, 1990, J APPL ECOL, V27, P693, DOI 10.2307/2404312; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; de la Pena E, 2010, BIOL INVASIONS, V12, P3637, DOI 10.1007/s10530-010-9756-1; Del Vecchio S, J NATURE CO IN PRESS; Dias LS, 2001, J CHEM ECOL, V27, P411, DOI 10.1023/A:1005644808956; Diaz Gonzalez TE, 2005, ESPECIES PROTEGIDAS, P1; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gallagher KG, 1997, AM J BOT, V84, P905, DOI 10.2307/2446280; Gioria M, 2012, PRESLIA, V84, P327; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hejda M, 2009, GLOBAL ECOL BIOGEOGR, V18, P372, DOI 10.1111/j.1466-8238.2009.00445.x; HESP PA, 1991, J ARID ENVIRON, V21, P165, DOI 10.1016/S0140-1963(18)30681-5; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Hulme P, 2004, ECOLOGIA INSULAR ASO, P359; Hussain MI, 2008, ALLELOPATHY J, V22, P101; Khurana E, 2004, J TROP ECOL, V20, P385, DOI 10.1017/S026646740400135X; Lorenzo P, 2010, AUST J BOT, V58, P546, DOI 10.1071/BT10094; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchante E, 2009, BIOL INVASIONS, V11, P813, DOI 10.1007/s10530-008-9295-1; Marques C, 2001, MAMMALIA, V65, P437, DOI 10.1515/mamm.2001.65.4.437; Martina JP, 2012, ENVIRON EXP BOT, V82, P43, DOI 10.1016/j.envexpbot.2012.03.010; Maun MA, 2009, BIOL COASTAL SAND DU; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Moravcova L., 2011, NeoBiota, P31, DOI 10.3897/neobiota.9.1266; Moravcova L, 2010, PRESLIA, V82, P365; Okay Y, 2011, AFR J BIOTECHNOL, V10, P1545; Phillips ML, 2010, PRESLIA, V82, P465; Pignatti, 1982, FLORA ITALY; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodgers JC, 2003, DIVERS DISTRIB, V9, P385, DOI 10.1046/j.1472-4642.2003.00036.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; SENECA ED, 1972, ECOLOGY, V53, P465, DOI 10.2307/1934234; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Suehs CM, 2004, HEREDITY, V92, P31, DOI 10.1038/sj.hdy.6800374; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Traveset A, 2008, BIOL INVASIONS, V10, P847, DOI 10.1007/s10530-008-9245-y; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Tutin TG, 1993, FLORA EUROPAEA, V1; Viard-Cretat F, 2010, PRESLIA, V82, P483; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vila M, 1998, ECOLOGY, V79, P1053, DOI 10.1890/0012-9658(1998)079[1053:FCASDO]2.0.CO;2; Violle C, 2006, J ECOL, V94, P196, DOI 10.1111/j.1365-2745.2005.01061.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; Wardle DA, 1996, J CHEM ECOL, V22, P933, DOI 10.1007/BF02029946; Weber E, 1999, CAN J BOT, V77, P1411, DOI 10.1139/cjb-77-10-1411; Weber E., 2003, INVASIVE PLANT SPECI; Wisura W., 1993, CONTRIB BOLUS HERB, V15, P76; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	81	49	50	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53166	10.1371/journal.pone.0053166	http://dx.doi.org/10.1371/journal.pone.0053166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300885	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500114
J	Beckmann, S; Quack, T; Dissous, C; Cailliau, K; Lang, G; Grevelding, CG				Beckmann, Svenja; Quack, Thomas; Dissous, Colette; Cailliau, Katia; Lang, Gabriele; Grevelding, Christoph G.			Discovery of Platyhelminth-Specific alpha/beta-Integrin Families and Evidence for Their Role in Reproduction in Schistosoma mansoni	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MALE-FEMALE INTERACTION; MOLECULAR EVOLUTION; BETA-2 INTEGRINS; SRC; SYK; ACTIVATION; GENOME; ADHESION; BINDING	In all metazoa, the response of cells to molecular stimuli from their environment represents a fundamental principle of regulatory processes controlling cell growth and differentiation. Among the membrane-linked receptors mediating extracellular communication processes are integrin receptors. Besides managing adhesion to the extracellular matrix or to other cells, they arrange information flow into the cells by activating intracellular signaling pathways often acting synergistically through cooperation with growth factor receptors. Although a wealth of information exists on integrins in different model organisms, there is a big gap of knowledge for platyhelminths. Here we report on the in silico detection and reconstruction of alpha and beta integrins from free-living and parasitic platyhelminths, which according to structural and phylogenetic analyses form specific clades separate from each other and from further metazoan integrins. As representative orthologs of parasitic platyhelminths we have cloned one beta-integrin (Sm beta-Int1) and four alpha-integrins (Sm alpha-Int1 - Sm alpha-Int4) from Schistosoma mansoni; they were characterized by molecular and biochemical analyses. Evidence is provided that Sm beta-Int1 interacts and co-localizes in the reproductive organs with known schistosome cellular tyrosine kinases (CTKs), of which the Syk kinase SmTK4 appeared to be the strongest interaction partner as shown by yeast two-hybrid analyses and coimmunoprecipitation experiments. By a novel RNAi approach with adult schistosomes in vitro we demonstrate for the first time multinucleated oocytes in treated females, indicating a decisive role Sm beta-Int1 during oogenesis as phenotypically analyzed by confocal laser scanning microscopy (CLSM). Our findings provide a first comprehensive overview about platyhelminth integrins, of which the parasite group exhibits unique features allowing a clear distinction from the free-living groups. Furthermore, we shed first lights on the functions of integrins in a trematode model parasite, revealing the complexity of molecular processes involved in its reproductive biology, which may be representative for other platyhelminths.	[Beckmann, Svenja; Quack, Thomas; Lang, Gabriele; Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, Giessen, Germany; [Dissous, Colette] Univ Lille, CIIL, Inserm U1019, Lille, France; [Cailliau, Katia] Univ Lille 1, Lab Regulat Signaux Div, Lille, France	Justus Liebig University Giessen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Grevelding, CG (corresponding author), Univ Giessen, Inst Parasitol, Giessen, Germany.	Christoph.Grevelding@vetmed.uni-giessen.de		Cailliau, Katia/0000-0001-7993-8437; Dissous, Colette/0000-0002-5003-8205; cailliau, katia/0000-0003-1772-1034	Deutsche Forschungsgemeinschaft [GR1549/8-2]; Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2	This work was supported by the Deutsche Forschungsgemeinschaft, Grant GR1549/8-2, and by the Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Beckmann S, 2010, INT J PARASITOL, V40, P521, DOI 10.1016/j.ijpara.2010.01.007; Beckmann S, 2010, PARASITOLOGY, V139, P651; Beckmann S, 2011, J BIOL CHEM, V286, P42325, DOI 10.1074/jbc.M110.210336; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; ERASMUS DA, 1973, PARASITOLOGY, V67, P165, DOI 10.1017/S0031182000046394; Ewan R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-31; FINKEN M, 1994, MOL BIOCHEM PARASIT, V64, P135, DOI 10.1016/0166-6851(94)90141-4; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006; GREVELDING CG, 1995, MOL BIOCHEM PARASIT, V71, P269, DOI 10.1016/0166-6851(94)00058-U; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Knobloch J, 2002, GENE, V294, P87, DOI 10.1016/S0378-1119(02)00760-6; Knobloch J, 2002, DEV GROWTH DIFFER, V44, P559; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Leutner S, 2011, AN ACAD BRAS CIENC, V83, P637, DOI 10.1590/S0001-37652011000200023; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MUSIAL J, 1990, CIRCULATION, V82, P261, DOI 10.1161/01.CIR.82.1.261; Ndegwa D, 2007, EXP PARASITOL, V117, P284, DOI 10.1016/j.exppara.2007.07.012; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Oliveira KC, 2011, AN ACAD BRAS CIENC, V83, P673, DOI 10.1590/S0001-37652011000200026; Piccardoni P, 2004, BIOCHEM J, V380, P57, DOI 10.1042/BJ20040151; POPIEL I, 1986, J CHEM ECOL, V12, P1745, DOI 10.1007/BF01022380; Quack T, 2006, BERL MUNCH TIERARZTL, V119, P365; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; SATO M, 1990, J CELL BIOL, V111, P1713, DOI 10.1083/jcb.111.4.1713; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wimmer W, 1999, EUR J BIOCHEM, V260, P156, DOI 10.1046/j.1432-1327.1999.00146.x; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	78	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52519	10.1371/journal.pone.0052519	http://dx.doi.org/10.1371/journal.pone.0052519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300694	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100059
J	Edwards, DB				Edwards, Darryl B.			Immune Investment Is Explained by Sexual Selection and Pace-of-Life, but Not Longevity in Parrots (Psittaciformes)	PLOS ONE			English	Article							TRADE-OFFS; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL IMMUNOLOGY; NATURAL-POPULATIONS; MOLECULAR PHYLOGENY; MATING SYSTEMS; DISEASE RISK; EVOLUTION; PARASITES; HISTORY	Investment in current reproduction should come at the expense of traits promoting future reproduction, such as immunity and longevity. To date, comparative studies of pace-of-life traits have provided some support for this, with slower paced species having greater immune function. Another means of investment in current reproduction is through secondary sexual characters (SSC). Investment in SSC's is considered costly, both in terms of immunity and longevity, with greater costs being borne by species with more elaborate traits. Yet within species, females prefer more ornate males and those males are typically immunologically superior. Because of this, predictions about the relationship between immunity and SSC's across species are not clear. If traits are costly, brighter species should have reduced immune function, but the opposite is true if SSC's arise from selection for more immunocompetent individuals. My approach was to investigate immune investment in relation to SSC's, pace-of-life and longevity while considering potentially confounding ecological factors. To do so I assessed leukocyte counts from in a novel group, the Psittaciformes. Investment in SSC's best explained investment in immunity: species with brighter plumage had higher leukocyte counts and those with a greater degree of sexual dichromatism had fewer. Ecological variables and pace-of-life models tended to be poor predictors of immune investment. However, shorter incubation periods were associated with lower leukocyte counts supporting the notion that species with a fast pace-of-life invest less in immunity. These results suggest that investment in reproduction in terms of fast pace-of-life and sexual dichromatism results in reduced immunity; however, investment in plumage colour per se does not impose a cost on immunity across species.	Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	Laurentian University	Edwards, DB (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	db_edwards@laurentian.ca			Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship	Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship. The NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2009, P ROY SOC B-BIOL SCI, V276, P3979, DOI 10.1098/rspb.2009.1296; Alderton D, 2000, ULTIMATE ENCY CAGED; Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Astuti D, 2006, ZOOL SCI, V23, P191, DOI 10.2108/zsj.23.191; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Catoni C, 2008, FUNCT ECOL, V22, P649, DOI 10.1111/j.1365-2435.2008.01400.x; CHRISTIDIS L, 1991, CONDOR, V93, P302, DOI 10.2307/1368946; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Del Hoyo, 1997, HDB BIRDS WORLD SAND; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE, DOI [10.1093/acprof:oso/9780199208784.001.0001, DOI 10.1093/ACPR0F:0S0/9780199208784.001.0001]; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forshaw J. M., 1973, PARROTS WORLD; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; HOLMES DJ, 1995, AM ZOOL, V35, P307; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Juniper T, 1998, PARROTS GUIDE PARROT; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Low R, 1998, ENCY LORIES; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Masello JF, 2008, J AVIAN BIOL, V39, P653, DOI 10.1111/j.1600-048X.2008.04417.x; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P2267, DOI 10.1098/rspb.2006.3590; Mayr G, 2010, EMU, V110, P348, DOI 10.1071/MU10035; McGraw KJ, 2005, BIOL LETTERS, V1, P38, DOI 10.1098/rsbl.2004.0269; McNaught MK, 2002, J EVOLUTION BIOL, V15, P505, DOI 10.1046/j.1420-9101.2002.00431.x; Moller AP, 1997, P ROY SOC B-BIOL SCI, V264, P561, DOI 10.1098/rspb.1997.0080; Moller AP, 1998, J EVOLUTION BIOL, V11, P703, DOI 10.1007/s000360050114; Moller AP, 2001, AM NAT, V158, P136, DOI 10.1086/321308; Moller AP, 1998, OIKOS, V82, P265, DOI 10.2307/3546966; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Moller AP, 1999, Q REV BIOL, V74, P3, DOI 10.1086/392949; Monaghan P, 2001, TRENDS GENET, V17, P568, DOI 10.1016/S0168-9525(01)02415-5; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morelli R, 2003, DRUG EXP CLIN RES, V29, P95; Munshi-South J, 2006, AUK, V123, P108, DOI 10.1642/0004-8038(2006)123[0108:DILSIP]2.0.CO;2; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Nunn CL, 2002, EVOLUTION, V56, P177; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palacios MG, 2006, OECOLOGIA, V146, P505, DOI 10.1007/s00442-005-0220-3; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peach WJ, 2001, OIKOS, V93, P235, DOI 10.1034/j.1600-0706.2001.930207.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pini E, 2004, DRUG EXP CLIN RES, V30, P203; PROMISLOW D, 1994, EVOLUTION, V48, P2045, DOI 10.1111/j.1558-5646.1994.tb02232.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; R Core Team, 2018, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; READ AF, 1989, NATURE, V339, P618, DOI 10.1038/339618a0; READ AF, 1987, NATURE, V328, P68, DOI 10.1038/328068a0; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricklefs RE, 2000, J AVIAN BIOL, V31, P103, DOI 10.1034/j.1600-048X.2000.210201.x; Roitt I, 1993, IMMUNOLOGY; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Schweizer M, 2010, MOL PHYLOGENET EVOL, V54, P984, DOI 10.1016/j.ympev.2009.08.021; SCOTT DK, 1990, BEHAV ECOL SOCIOBIOL, V26, P261, DOI 10.1007/BF00178319; Semple S, 2002, P ROY SOC B-BIOL SCI, V269, P1031, DOI 10.1098/rspb.2001.1950; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Stearns S.C., 1992, pi; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Valkiunas G, 2004, AVIAN MALARIA PARASI; WATVE MG, 1995, P NATL ACAD SCI USA, V92, P8945, DOI 10.1073/pnas.92.19.8945; Watve MG, 1997, J THEOR BIOL, V184, P167, DOI 10.1006/jtbi.1996.0267; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	92	3	3	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53066	10.1371/journal.pone.0053066	http://dx.doi.org/10.1371/journal.pone.0053066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300862	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100115
J	Ndungu, FM; Mwacharo, J; Kimani, D; Kai, O; Moris, P; Jongert, E; Vekemans, J; Olotu, A; Bejon, P				Ndungu, Francis M.; Mwacharo, Jedidah; Kimani, Domtila; Kai, Oscar; Moris, Philippe; Jongert, Erik; Vekemans, Johan; Olotu, Ally; Bejon, Philip			A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; VACCINIA VIRUS ANKARA; AFRICAN CHILDREN; ADJUVANT SYSTEMS; IMMUNE-RESPONSE; DOUBLE-BLIND; EFFICACY; TRIAL; PROTECTION; INDUCTION	The candidate malaria vaccine RTS,S/AS01(E) provides significant but partial protection from clinical malaria. On in vitro circumsporozoite protein (CSP) peptide stimulation and intra-cellular cytokine staining of whole blood taken from 407 5-17 month-old children in a phase IIb trial of RTS,S/AS01(E), we identified significantly increased frequencies of two CSP-specific CD4+ T cells phenotypes among RTS,S/AS01(E) vaccinees (IFN gamma IL2+TNF- and IFN gamma IL2+TNF+ CD4+ T cells), and increased frequency of IFN gamma-IL2-TNF+ CD4+ T cells after natural exposure. All these T cells phenotypes were individually associated with reductions in the risk of clinical malaria, but IFN gamma-IL2-TNF+ CD4+ T cells independently predicted reduced risk of clinical malaria on multi-variable analysis (HR = 0.29, 95% confidence intervals 0.15-0.54, p<0.0005). Furthermore, there was a strongly significant synergistic interaction between CSP-specific IFN gamma-IL2-TNF+ CD4+ T cells and anti-CSP antibodies in determining protection against clinical malaria (p = 0.002). Vaccination strategies that combine potent cellular and antibody responses may enhance protection against malaria.	[Ndungu, Francis M.; Mwacharo, Jedidah; Kimani, Domtila; Kai, Oscar; Olotu, Ally; Bejon, Philip] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Ndungu, Francis M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Moris, Philippe; Jongert, Erik; Vekemans, Johan] GlaxoSmithKline Biol, Wavre, Belgium; [Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	Kenya Medical Research Institute; University of Oxford; GlaxoSmithKline; University of Oxford	Ndungu, FM (corresponding author), Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya.	fndungu@kilifi.kemri-wellcome.org	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030	PATH Malaria Vaccine Initiative (MVI); European and Developing Countries Clinical Trials Partnership (EDCTP); Biomedical Research Centre in Oxford; MRC - UK; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	PATH Malaria Vaccine Initiative (MVI); European and Developing Countries Clinical Trials Partnership (EDCTP); Biomedical Research Centre in Oxford; MRC - UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project has been funded by PATH Malaria Vaccine Initiative (MVI). Francis Ndungu is a post-doctoral fellow under the Malaria Vectored Vaccines Consortium (MVVC), funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). Philip Bejon is supported by the Biomedical Research Centre in Oxford, and the MRC - UK. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MVI had no other role in data collection or analysis, and the decision to publish was covered by a pre-study agreement.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Ansong D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018891; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Depinay N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017464; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-168; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Horowitz A, 2012, J IMMUNOL, V188, P5054, DOI 10.4049/jimmunol.1102710; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; TAPCHAISRI P, 1983, AM J TROP MED HYG, V32, P1203, DOI 10.4269/ajtmh.1983.32.1203; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Wang RB, 1996, J IMMUNOL, V157, P4061; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	38	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52870	10.1371/journal.pone.0052870	http://dx.doi.org/10.1371/journal.pone.0052870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300801	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100088
J	Sahana, N; Kaur, H; Basavaraj; Tena, F; Jain, RK; Palukaitis, P; Canto, T; Praveen, S				Sahana, Nandita; Kaur, Harpreet; Basavaraj; Tena, Fatima; Jain, Rakesh Kumar; Palukaitis, Peter; Canto, Tomas; Praveen, Shelly			Inhibition of the Host Proteasome Facilitates Papaya Ringspot Virus Accumulation and Proteosomal Catalytic Activity Is Modulated by Viral Factor HcPro	PLOS ONE			English	Article							HELPER COMPONENT-PROTEINASE; LONG-DISTANCE MOVEMENT; SMALL RNA-BINDING; 20S PROTEASOME; HC-PRO; TAT PROTEIN; SUPPRESSOR; POTYVIRUS; GENE; DEGRADATION	The ubiquitin/26S proteasome system plays an essential role not only in maintaining protein turnover, but also in regulating many other plant responses, including plant-pathogen interactions. Previous studies highlighted different roles of the 20S proteasome in plant defense during virus infection, either indirectly through viral suppressor-mediated degradation of Argonaute proteins, affecting the RNA interference pathway, or directly through modulation of the proteolytic and RNase activity of the 20S proteasome, a component of the 20S proteasome, by viral proteins, affecting the levels of viral proteins and RNAs. Here we show that MG132, a cell permeable proteasomal inhibitor, caused an increase in papaya ringspot virus (PRSV) accumulation in its natural host papaya (Carica papaya). We also show that the PRSV HcPro interacts with the papaya homologue of the Arabidopsis PAA (alpha 1 subunit of the 20S proteasome), but not with the papaya homologue of Arabidopsis PAE (alpha 5 subunit of the 20S proteasome), associated with the RNase activity, although the two 20S proteasome subunits interacted with each other. Mutated forms of PRSV HcPro showed that the conserved KITC54 motif in the N-terminal domain of HcPro was necessary for its binding to PAA. Co-agroinfiltration assays demonstrated that HcPro expression mimicked the action of MG132, and facilitated the accumulation of bothtotal ubiquitinated proteins and viral/non-viral exogenous RNA in Nicotiana benthamiana leaves. These effects were not observed by using an HcPro mutant (KITS54), which impaired the HcPro - PAA interaction. Thus, the PRSV HcPro interacts with a proteasomal subunit, inhibiting the action of the 20S proteasome, suggesting that HcPro might be crucial for modulating its catalytic activities in support of virus accumulation.	[Tena, Fatima; Canto, Tomas] CSIC, Ctr Invest Biol, Madrid, Spain; [Sahana, Nandita] Indian Agr Res Inst, Div Biochem, New Delhi 110012, India; [Kaur, Harpreet; Basavaraj; Jain, Rakesh Kumar; Praveen, Shelly] Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India; [Palukaitis, Peter] Seoul Womens Univ, Dept Hort Sci, Seoul, South Korea	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Seoul Women's University	Canto, T (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	tomas.canto@cib.csic.es; shellypraveen@iari.res.in	Praveen, Shelly/D-3691-2014	Praveen, Shelly/0000-0002-6330-4592; sahana, nandita/0000-0003-4959-173X	Department of Science and Technology, Govt. of India [DST/INT/SPAIN/P-9/2009]; Ministerio de Ciencia e Innovacion, Govt. of Spain [ACI/2009-0855]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [MOEHRD-KRF-2012-0007187]; Indian Agricultural Research Institute, New Delhi;  [PJ007450]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Ministerio de Ciencia e Innovacion, Govt. of Spain; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); 	This work was supported in part by grants from Department of Science and Technology, Govt. of India to SP (Grant DST/INT/SPAIN/P-9/2009), from Ministerio de Ciencia e Innovacion, Govt. of Spain (Grant ACI/2009-0855) to TC, and from a Research Professorship Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MOEHRD-KRF-2012-0007187) and Agenda grants (PJ007450) of RDA to PP. The authors are also thankful to Indian Agricultural Research Institute, New Delhi, for providing fellowship to NS and B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; ATREYA CD, 1993, P NATL ACAD SCI USA, V90, P11919, DOI 10.1073/pnas.90.24.11919; Ballut L, 2005, J GEN VIROL, V86, P2595, DOI 10.1099/vir.0.81107-0; Ballut L, 2003, BBA-PROTEINS PROTEOM, V1645, P30, DOI 10.1016/S1570-9639(02)00500-9; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Blanc S, 1998, J GEN VIROL, V79, P3119, DOI 10.1099/0022-1317-79-12-3119; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Dhanam S., 2011, Archives of Phytopathology and Plant Protection, V44, P925, DOI 10.1080/03235400903395393; Dielen AS, 2011, MOL PLANT PATHOL, V12, P137, DOI 10.1111/j.1364-3703.2010.00654.x; Gautier-Bert K, 2003, MOL BIOL REP, V30, P1, DOI 10.1023/A:1022261925117; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; GOVIER DA, 1977, VIROLOGY, V78, P306, DOI 10.1016/0042-6822(77)90101-5; GRZIWA A, 1991, FEBS LETT, V290, P186, DOI 10.1016/0014-5793(91)81256-8; Guo DY, 1999, J GEN VIROL, V80, P1127, DOI 10.1099/0022-1317-80-5-1127; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; HUET H, 1994, J GEN VIROL, V75, P1407, DOI 10.1099/0022-1317-75-6-1407; Jin YS, 2007, J VIROL, V81, P12881, DOI 10.1128/JVI.00913-07; Kasschau KD, 1997, VIROLOGY, V228, P251, DOI 10.1006/viro.1996.8368; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Mangrauthia SK, 2008, J PLANT BIOCHEM BIOT, V17, P201, DOI 10.1007/BF03263287; Mangrauthia SK, 2010, MOL BIOTECHNOL, V44, P22, DOI 10.1007/s12033-009-9205-5; Mangrauthia SK, 2009, VIRUS GENES, V38, P429, DOI 10.1007/s11262-009-0336-3; Marx J, 2002, SCIENCE, V297, P1792, DOI 10.1126/science.297.5588.1792; Parameswari B, 2007, ARCH VIROL, V152, P843, DOI 10.1007/s00705-006-0890-0; Plisson C, 2003, J BIOL CHEM, V278, P23753, DOI 10.1074/jbc.M302512200; Qiu QS, 2007, PLANT PHYSIOL, V144, P468, DOI 10.1104/pp.106.095182; Rakitina DV, 2006, FEBS LETT, V580, P5077, DOI 10.1016/j.febslet.2006.08.032; Reichel C, 2000, J VIROL, V74, P3330, DOI 10.1128/JVI.74.7.3330-3337.2000; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; THORNBURY DW, 1985, VIROLOGY, V144, P260, DOI 10.1016/0042-6822(85)90322-8; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Urcuqui-Inchima S, 1999, VIROLOGY, V258, P95, DOI 10.1006/viro.1999.9725; Varrelmann M, 2007, J GEN VIROL, V88, P1005, DOI 10.1099/vir.0.82200-0; Wang RY, 1999, PHYTOPATHOLOGY, V89, P564, DOI 10.1094/PHYTO.1999.89.7.564; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053	47	40	41	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52546	10.1371/journal.pone.0052546	http://dx.doi.org/10.1371/journal.pone.0052546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300704	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100062
J	Ng, SK; Tessa, RMT; Wang, Y; Ng, D; Goh, LT; Bardor, M; Victor, VTW; Lam, KP				Say Kong Ng; Tessa Rui Min Tan; Wang, Yang; Daniel Ng; Goh, Lin-Tang; Bardor, Muriel; Victor Vai Tak Wong; Kong Peng Lam			Production of Functional Soluble Dectin-1 Glycoprotein Using an IRES-Linked Destabilized-Dihydrofolate Reductase Expression Vector	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; MAMMALIAN-CELL LINES; CHO-CELLS; PNEUMOCYSTIS-CARINII; RECOMBINANT PROTEINS; BICISTRONIC VECTOR; STABLE EXPRESSION; TYROSINE KINASE; RECOGNITION; SEQUENCE	Dectin-1 (CLEC7A) is a C-type lectin receptor that binds to beta-glucans found in fungal cell walls to act as a major pattern recognition receptor (PRR). Since beta-glucans epitope is not present in human cells, we are of the opinion that Dectin-1 can have therapeutic functions against fungal infections. We thus set out to produce a soluble extracellular domain of murine Dectin-1 (called sDectin-1) in sufficient titers to facilitate such studies in mouse models. Since sDectin-1 has previously been shown to be glycosylated, we chose to produce this protein using Chinese Hamster Ovary (CHO) cells, a mammalian host cell line suitable for the high-titer production of recombinant glycoproteins. To ensure a high titer production of sDectin-1 and minimize the effects of gene fragmentation, we constructed a mammalian expression vector with a PEST-destabilized dhfr amplifiable marker downstream of an attenuated IRES element, which was in turn downstream of the sDectin-1 gene and a CMV IE promoter. Stably transfected and MTX-amplified cell pools were generated using this vector, and maximum sDectin-1 titers of 246 mg/l and 598 mg/l were obtained in shake flask batch culture and bioreactor fed-batch culture respectively. The purified recombinant sDectin-1 was shown to be glycosylated. Protein functionality was also demonstrated by its ability to bind to zymosan particles and to the cell wall of Saccharomyces cerevisiae. We describe for the first time the use of an attenuated IRES-linked PEST-destabilized dhfr amplifiable marker for the production of recombinant proteins with stably amplified cell pools. With our process, we reached the highest reported titer for producing recombinant proteins smaller than 50 kDa in cell pools. sDectin-1 protein produced is glycosylated and functional. This vector design can thus be used efficiently for the high-titer production of functional recombinant proteins.	[Say Kong Ng; Tessa Rui Min Tan; Wang, Yang; Daniel Ng; Goh, Lin-Tang; Bardor, Muriel; Victor Vai Tak Wong; Kong Peng Lam] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Say Kong Ng] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Ng, SK (corresponding author), Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore.	ng_say_kong@bti.a-star.edu.sg	victor, victor/Q-4843-2019	Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TL, 2003, BIOTECHNOL PROGR, V19, P1433, DOI 10.1021/bp034056j; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; AUCOUTURIER P, 1992, BIOCHEM J, V285, P149, DOI 10.1042/bj2850149; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Campbell M, 2010, MOL BIOTECHNOL, V45, P199, DOI 10.1007/s12033-010-9266-5; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Goulart HR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/405872; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; HOFFMAN MA, 1995, J VIROL, V69, P4399, DOI 10.1128/JVI.69.7.4399-4406.1995; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jiang Z, 2008, BIOTECHNOL BIOENG, V100, P189, DOI 10.1002/bit.21726; Kato Y, 2006, BIOL PHARM BULL, V29, P1580, DOI 10.1248/bpb.29.1580; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Lu SB, 2005, PROCESS BIOCHEM, V40, P1917, DOI 10.1016/j.procbio.2004.07.004; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; MILBRANDT JD, 1981, P NATL ACAD SCI-BIOL, V78, P6043, DOI 10.1073/pnas.78.10.6043; Ng SK, 2007, METAB ENG, V9, P304, DOI 10.1016/j.ymben.2007.01.001; Ng SK, 2010, BIOTECHNOL PROGR, V26, P11, DOI 10.1002/btpr.281; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Plantinga TS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2933; Rajendra Y, 2012, BIOTECHNOL LETT, V34, P619, DOI 10.1007/s10529-011-0809-z; Rees S, 1996, BIOTECHNIQUES, V20, P102; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Schatz SM, 2003, BIOTECHNOL BIOENG, V84, P433, DOI 10.1002/bit.10793; Schilling J, 1982, GENE AMPLIFICATION, P149; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Ujita M, 2009, BIOSCI BIOTECH BIOCH, V73, P237, DOI 10.1271/bbb.80503; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Viriyakosol S, 2005, INFECT IMMUN, V73, P1553, DOI 10.1128/IAI.73.3.1553-1560.2005; Westwood AD, 2010, BIOTECHNOL PROGR, V26, P1558, DOI 10.1002/btpr.491; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Ye JX, 2010, BIOTECHNOL PROGR, V26, P1431, DOI 10.1002/btpr.469; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Yung CW, 2009, LAB CHIP, V9, P1171, DOI 10.1039/b816986a; Zhang Z, 2011, J BIOSCI BIOENG, V111, P1, DOI 10.1016/j.jbiosc.2010.08.012; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	61	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52785	10.1371/journal.pone.0052785	http://dx.doi.org/10.1371/journal.pone.0052785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300776	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800147
J	Schramm, RD; Li, S; Harris, BS; Rounds, RP; Burgess, RW; Ytreberg, FM; Fuerst, PG				Schramm, R. Dee; Li, Shuai; Harris, Belinda S.; Rounds, Ryan P.; Burgess, Robert W.; Ytreberg, F. Marty; Fuerst, Peter G.			A Novel Mouse Dscam Mutation Inhibits Localization and Shedding of DSCAM	PLOS ONE			English	Article							DENDRITIC SELF-AVOIDANCE; NETRIN RECEPTOR; NEUROMUSCULAR-JUNCTION; MOLECULAR DIVERSITY; REQUIRE DSCAM; RETINA; DROSOPHILA; CONNECTIONS; SPECIFICITY; LAMINATION	The differential adhesion hypothesis of development states that patterning of organisms, organs and tissues is mediated in large part by expression of cell adhesion molecules. The cues provided by cell adhesion molecules are also hypothesized to facilitate specific connectivity within the nervous system. In this study we characterize a novel mouse mutation in the gene Dscam (Down Syndrome Cell Adhesion Molecule). Vertebrate DSCAM is required for normal development of the central nervous system and has been best characterized in the visual system. In the visual system DSCAM is required for regulation of cell number, mosaic formation, laminar specificity, and refinement of retinal-tectal projections. We have identified a novel mutation in Dscam that results in a single amino acid substitution, R1018P, in the extracellular domain of the DSCAM protein. Mice homozygous for the R1018P mutation develop a subset of defects observed in Dscam null mice. In vitro analysis identified defects in DSCAM R1018P localization to filopodia. We also find that wild type DSCAM protein is constitutively cleaved and shed from transfected cells. This secretion is inhibited by the R1018P mutation. We also characterized a novel splice isoform of Dscam and identified defects in lamination of type 2 and type 6 cone bipolar cells in Dscam mutant mice. The identification and characterization of partial loss of function mutations in genes such as Dscam will be helpful in predicting signs and symptoms that may be observed in human patients with partial loss of DSCAM function.	[Schramm, R. Dee; Li, Shuai; Rounds, Ryan P.; Fuerst, Peter G.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Harris, Belinda S.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Fuerst, Peter G.] Univ Idaho, WWAMI Med Educ Program, Univ Washington, Moscow, ID 83843 USA	Idaho; University of Idaho; Jackson Laboratory; Idaho; University of Idaho; Idaho; University of Idaho	Fuerst, PG (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	Fuerst@uidaho.edu		Li, Shuai/0000-0001-5889-3655; Burgess, Robert/0000-0002-9229-3407	National Eye Institute [EY020857, EY018605]; National Center for Research Resources [RR01183, CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018605, R01EY020857] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Eye Institute EY020857 to Peter G. Fuerst; National Eye Institute EY018605 to Robert W. Burgess; and National Center for Research Resources RR01183 and CA34196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blank M, 2011, J NEUROSCI, V31, P5764, DOI 10.1523/JNEUROSCI.6015-10.2011; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2007, DEV BIOL, V303, P165, DOI 10.1016/j.ydbio.2006.11.033; Fuerst PG, 2012, DEV BIOL, V361, P326, DOI 10.1016/j.ydbio.2011.10.028; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Fuerst PG, 2009, CURR OPIN NEUROBIOL, V19, P389, DOI 10.1016/j.conb.2009.07.013; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Keeley PW, 2011, J COMP NEUROL; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Matthews BJ, 2011, CURR BIOL, V21, P1480, DOI 10.1016/j.cub.2011.07.040; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Qin FH X.-R., RIKEN STRUCTUR UNPUB; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Xiao T, 2011, CELL, V146, P164, DOI 10.1016/j.cell.2011.06.016; Xu YL, 2011, PROTEIN CELL, V2, P647, DOI 10.1007/s13238-011-1072-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52652	10.1371/journal.pone.0052652	http://dx.doi.org/10.1371/journal.pone.0052652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300735	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800121
J	Goebl, W; Palmer, C				Goebl, Werner; Palmer, Caroline			Temporal Control and Hand Movement Efficiency in Skilled Music Performance	PLOS ONE			English	Article							FINGER MOVEMENTS; PIANO; ACCURACY; FEEDBACK; MODEL	Skilled piano performance requires considerable movement control to accomplish the high levels of timing and force precision common among professional musicians, who acquire piano technique over decades of practice. Finger movement efficiency in particular is an important factor when pianists perform at very fast tempi. We document the finger movement kinematics of highly skilled pianists as they performed a five-finger melody at very fast tempi. A three-dimensional motion-capture system tracked the movements of finger joints, the hand, and the forearm of twelve pianists who performed on a digital piano at successively faster tempi (7-16 tones/s) until they decided to stop. Joint angle trajectories computed for all adjacent finger phalanges, the hand, and the forearm (wrist angle) indicated that the metacarpophalangeal joint contributed most to the vertical fingertip motion while the proximal and distal interphalangeal joints moved slightly opposite to the movement goal (finger extension). An efficiency measure of the combined finger joint angles corresponded to the temporal accuracy and precision of the pianists' performances: Pianists with more efficient keystroke movements showed higher precision in timing and force measures. Keystroke efficiency and individual joint contributions remained stable across tempo conditions. Individual differences among pianists supported the view that keystroke efficiency is required for successful fast performance.	[Goebl, Werner] Univ Mus & Performing Arts Vienna, Inst Mus Acoust, Vienna, Austria; [Palmer, Caroline] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Palmer, C (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	caroline.palmer@mcgill.ca		Goebl, Werner/0000-0002-1722-0718; Palmer, Caroline/0000-0003-4816-8067	Austrian Science Fund [FWF J 2526, P 23248]; NSERC Grant [298173]; Canada Research Chair	Austrian Science Fund(Austrian Science Fund (FWF)); NSERC Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by the Austrian Science Fund (FWF J 2526 and P 23248 to the first author) and by NSERC Grant 298173 and a Canada Research Chair to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp R, 1997, CLASSICAL PIANO  MAR; Beauchamp R, 2003, CURVED FINGERS TENSI; Bernstein NA, 1930, P PIAN METH SECT STA, P5; Della Bella S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015029; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Furuya S, 2008, NEUROSCIENCE, V156, P390, DOI 10.1016/j.neuroscience.2008.07.028; Furuya S, 2011, FRONT HUM NEUROSCI, V5, P1; Furuya S, 2012, J NEUROPHYSIOL, V108, P2060, DOI 10.1152/jn.00378.2012; Furuya S, 2011, J NEUROPHYSIOL, V106, P2849, DOI 10.1152/jn.00378.2011; Gat J, 1988, TECHNIQUE PIANO PLAY; Gerig Reginald R., 1974, FAMOUS PIANISTS THEI; Goebl W., 2009, P INT S PERF SCI 200, P65; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hildebrandt Dieter, 1988, PIANOFORTE SOCIAL HI; Huron D, 2001, MUSIC PERCEPT, V19, P1, DOI 10.1525/mp.2001.19.1.1; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Kay BA, 2003, MOTOR CONTROL, V7, P1; Kopiez Reinhard, 2004, MUSIKALISCHE VIRTUOS, P205; Leijnse JNAL, 1997, J BIOMECH, V30, P1107, DOI 10.1016/S0021-9290(97)00091-2; Lhevinne, 1972, BASIC PRINCIPLES PIA; Loehr JD, 2009, J MOTOR BEHAV, V41, P128, DOI 10.3200/JMBR.41.2.128-136; Mark T., 2003, WHAT EVERY PIANIST N; Neuhaus H., 1973, ART PIANO PLAYING; Ortmann O, 1962, PHYSL MECH PIANO TEC; Ortmann Otto, 1929, PHYSL MECH PIANO TEC; Palmer C, 2009, MUSIC PERCEPT, V26, P439, DOI 10.1525/MP.2009.26.5.439; Parncutt R., 2002, SCI PSYCHOL MUSIC PE, P285, DOI DOI 10.1093/ACPR0F:0S0/9780195138108.001.0001; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Slobounov S, 2002, BRAIN RES, V954, P212, DOI 10.1016/S0006-8993(02)03288-2; TUBIANA R, 1988, MED PROBL PERFORM AR, V3, P83; TUBIANA R, 1988, MED PROBL PERFORM AR, V3, P123; Watson AHD, 2006, J ANAT, V208, P527, DOI 10.1111/j.1469-7580.2006.00545.x; Watson AHD, 2009, BIOL MUSICAL PERFORM; Wolters K, 1985, HDB KLAVIERLITERATUR	37	56	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e50901	10.1371/journal.pone.0050901	http://dx.doi.org/10.1371/journal.pone.0050901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23300946	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000002
J	Lech, PJ; Tobin, GJ; Bushnell, R; Gutschenritter, E; Pham, LD; Nace, R; Verhoeyen, E; Cosset, FL; Muller, CP; Russell, SJ; Nara, PL				Lech, Patrycja J.; Tobin, Gregory J.; Bushnell, Ruth; Gutschenritter, Emily; Pham, Linh D.; Nace, Rebecca; Verhoeyen, Els; Cosset, Francois-Loic; Muller, Claude P.; Russell, Stephen J.; Nara, Peter L.			Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies	PLOS ONE			English	Article							CURRENT WILD-TYPE; CELLULAR RECEPTOR; IMMUNE-RESPONSES; VACCINE FAILURE; CD46; SITES; GLYCOSYLATION; ATTACHMENT; STRAINS; RESCUE	The measles virus (MV) is serologically monotypic. Life-long immunity is conferred by a single attack of measles or following vaccination with the MV vaccine. This is contrary to viruses such as influenza, which readily develop resistance to the immune system and recur. A better understanding of factors that restrain MV to one serotype may allow us to predict if MV will remain monotypic in the future and influence the design of novel MV vaccines and therapeutics. MV hemagglutinin (H) glycoprotein, binds to cellular receptors and subsequently triggers the fusion (F) glycoprotein to fuse the virus into the cell. H is also the major target for neutralizing antibodies. To explore if MV remains monotypic due to a lack of plasticity of the H glycoprotein, we used the technology of Immune Dampening to generate viruses with rationally designed N-linked glycosylation sites and mutations in different epitopes and screened for viruses that escaped monoclonal antibodies (mAbs). We then combined rationally designed mutations with naturally selected mutations to generate a virus resistant to a cocktail of neutralizing mAbs targeting four different epitopes simultaneously. Two epitopes were protected by engineered N-linked glycosylations and two epitopes acquired escape mutations via two consecutive rounds of artificial selection in the presence of mAbs. Three of these epitopes were targeted by mAbs known to interfere with receptor binding. Results demonstrate that, within the epitopes analyzed, H can tolerate mutations in different residues and additional N-linked glycosylations to escape mAbs. Understanding the degree of change that H can tolerate is important as we follow its evolution in a host whose immunity is vaccine induced by genotype A strains instead of multiple genetically distinct wild-type MVs.	[Lech, Patrycja J.; Gutschenritter, Emily; Pham, Linh D.; Nace, Rebecca; Russell, Stephen J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Tobin, Gregory J.; Bushnell, Ruth; Nara, Peter L.] Biol Mimet Inc, Frederick, MD USA; [Verhoeyen, Els; Cosset, Francois-Loic] INSERM, EVIR Team, Human Virol Lab, U758, Lyon, France; [Verhoeyen, Els; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Verhoeyen, Els; Cosset, Francois-Loic] Univ Lyon, UCB Lyon1, Lyon, France; [Muller, Claude P.] WHO Collaborating Ctr Reference & Res Measles Inf, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg; [Muller, Claude P.] Dept Immunol, Luxembourg, Luxembourg; [Nara, Peter L.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Mayo Clinic; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Luxembourg Institute of Health; Iowa State University	Lech, PJ (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	Lech.patrycja@mayo.edu	Verhoeyen, Els/AAW-4853-2021; Verhoeyen, Els/H-6360-2016; Dr. Peter L. Nara, M.Sc./I-7432-2019; Cosset, François-Loïc/M-5862-2019	Verhoeyen, Els/0000-0001-9224-5491; Cosset, François-Loïc/0000-0001-8842-3726; Tobin, Gregory/0000-0002-8396-0466; Russell, Stephen/0000-0002-0799-6432	Mayo Clinic, NIH/NCI [R01 CA129966]; Richard M. Schulze Family Foundation; BMI; NATIONAL CANCER INSTITUTE [R01CA129966] Funding Source: NIH RePORTER	Mayo Clinic, NIH/NCI; Richard M. Schulze Family Foundation; BMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from Mayo Clinic, NIH/NCI (R01 CA129966), and the Richard M. Schulze Family Foundation. The funders for the design and constructions of the mutant measles viruses used in the study were done so using BMI R&D funds. The co-authors Dr. Peter L. Nara and Greg Tobin are employed by BMI and were involved in part in the study design, some data collection, decision to publish and preparation of the manuscript.; There are no financial, personal, or professional interest that could be construed to have influenced the paper. There were no identified intellectual property developed in the course of the funded work by BMI. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials. Gregory J. Tobin, Peter L. Nara, and Ruth V. Bushnell are employees of Biological Mimetics, Inc. BMI does not currently have any products or patents in development related to the materials produced in this study. BMI confirms its adherence to all PLOS ONE policies on sharing data and materials.	Bankamp B, 2011, J INFECT DIS, V204, pS533, DOI 10.1093/infdis/jir097; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; de Swart RL, 2009, J GEN VIROL, V90, P2982, DOI 10.1099/vir.0.014944-0; de Swart RL, 2005, J VIROL, V79, P11547, DOI 10.1128/JVI.79.17.11547-11551.2005; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; EDMONSON MB, 1990, JAMA-J AM MED ASSOC, V263, P2467, DOI 10.1001/jama.263.18.2467; Erlenhofer C, 2002, J GEN VIROL, V83, P1431, DOI 10.1099/0022-1317-83-6-1431; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Gans HA, 2004, J INFECT DIS, V190, P83, DOI 10.1086/421032; Gans HA, 2004, VIRAL IMMUNOL, V17, P298, DOI 10.1089/0882824041310522; Garrity RR, 1997, J IMMUNOL, V159, P279; GIRAUDON P, 1985, VIROLOGY, V144, P46, DOI 10.1016/0042-6822(85)90303-4; GIRAUDON P, 1981, J GEN VIROL, V54, P325, DOI 10.1099/0022-1317-54-2-325; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; GRIFFIN DE, 2007, FIELDS VIROLOGY; Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00247; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Hashiguchi Takao, 2008, Virus (Nagoya), V58, P1; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; HU AH, 1994, J GEN VIROL, V75, P1043, DOI 10.1099/0022-1317-75-5-1043; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Klingele M, 2000, J MED VIROL, V62, P91, DOI 10.1002/1096-9071(200009)62:1&lt;91::AID-JMV14&gt;3.0.CO;2-B; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Lancz G., 1992, NEUTRALIZATION; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Manchester M, 2000, VIROLOGY, V274, P5, DOI 10.1006/viro.2000.0469; Manchester M, 2000, J VIROL, V74, P3967, DOI 10.1128/JVI.74.9.3967-3974.2000; MARKOWITZ LE, 1990, PEDIATR CLIN N AM, V37, P603; MATHIAS RG, 1989, AM J PUBLIC HEALTH, V79, P475, DOI 10.2105/AJPH.79.4.475; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; Mossong J, 1999, AM J EPIDEMIOL, V150, P1238, DOI 10.1093/oxfordjournals.aje.a009951; Msaouel P, 2009, PROSTATE, V69, P82, DOI 10.1002/pros.20857; Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Nakamura T, 2004, NAT BIOTECHNOL, V22, P331, DOI 10.1038/nbt942; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Nicacio CD, 2002, J VIROL, V76, P251, DOI 10.1128/JVI.76.1.251-258.2002; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Pabst HF, 1999, VACCINE, V17, P1910, DOI 10.1016/S0264-410X(98)00472-1; Pham L, 2009, J GENE MED, V11, P197, DOI 10.1002/jgm.1289; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; RICHARDSON CD, 1983, VIROLOGY, V131, P518, DOI 10.1016/0042-6822(83)90517-2; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Santiago C, 2002, J BIOL CHEM, V277, P32294, DOI 10.1074/jbc.M202973200; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0; Schierup MH, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-52; Schrag SJ, 1999, J VIROL, V73, P51, DOI 10.1128/JVI.73.1.51-54.1999; SHESHBERADARAN H, 1986, VIROLOGY, V152, P58, DOI 10.1016/0042-6822(86)90371-5; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; WARD BJ, 1995, J INFECT DIS, V172, P1591, DOI 10.1093/infdis/172.6.1591; Whittle H, 1999, PEDIATR INFECT DIS J, V18, P53, DOI 10.1097/00006454-199901000-00013; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; World Health Organization, 2012, MEASL FACT SHEET 286; XIANG JZ, 1983, REV INFECT DIS, V5, P506; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	80	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52306	10.1371/journal.pone.0052306	http://dx.doi.org/10.1371/journal.pone.0052306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300970	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000008
J	Loi, S; Michiels, S; Baselga, J; Bartlett, JMS; Singhal, SK; Sabine, VS; Sims, AH; Sahmoud, T; Dixon, JM; Piccart, MJ; Sotiriou, C				Loi, Sherene; Michiels, Stefan; Baselga, Jose; Bartlett, John M. S.; Singhal, Sandeep K.; Sabine, Vicky S.; Sims, Andrew H.; Sahmoud, Tarek; Dixon, J. Michael; Piccart, Martine J.; Sotiriou, Christos			PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer	PLOS ONE			English	Article							ENDOCRINE THERAPY; EXPRESSION; CELLS; PI3K; SENSITIVITY; APOPTOSIS; MODELS; MTOR; AKT	The phosphatidylinositol 39 kinase (PI3K) pathway is commonly activated in breast cancer and aberrations such as PI3K mutations are common. Recent exciting clinical trial results in advanced estrogen receptor-positive (ER) breast cancer support mTOR activation is a major means of estrogen-independent tumor growth. Hence the means to identify a responsive breast cancer population that would most benefit from these compounds in the adjuvant or earlier stage setting is of high interest. Here we study PIK3CA genotype as well as a previously reported PI3K/mTOR-pathway gene signature (PIK3CA-GS) and their ability to estimate the level of PI3K pathway activation in two clinical trials of newly diagnosed ER-positive breast cancer patients- a total of 81 patients- one of which was randomized between letrozole and placebo vs letrozole and everolimus. The main objectives were to correlate the baseline PIK3CA genotype and GS with the relative change from baseline to day 15 in Ki67 (which has been shown to be prognostic in breast cancer) and phosphorylated S6 (S240) immunohistochemistry (a substrate of mTOR). In the randomized dataset, the PIK3CA-GS could identify those patients with the largest relative decreases in Ki67 to letrozole/everolimus (R = -0.43, p = 0.008) compared with letrozole/ placebo (R = 0.07, p = 0.58; interaction test p = 0.02). In a second dataset of pre-surgical everolimus alone, the PIK3CA-GS was not significantly correlated with relative change in Ki67 (R = -0.11, p = 0.37) but with relative change in phosphorlyated S6 (S240) (R = -0.46, p = 0.028). PIK3CA genotype was not significantly associated with any endpoint in either datasets. Our results suggest that the PIK3CA-GS has potential to identify those ER-positive BCs who may benefit from the addition of everolimus to letrozole. Further evaluation of the PIK3CA-GS as a predictive biomarker is warranted as it may facilitate better selection of responsive patient populations for mTOR inhibition in combination with letrozole.	[Loi, Sherene; Michiels, Stefan; Singhal, Sandeep K.; Sotiriou, Christos] Inst Jules Bordet, Breast Canc Translat Res Lab BCTL, B-1000 Brussels, Belgium; [Baselga, Jose] Massachusetts Gen Hosp, Ctr Canc, Div Hematol & Oncol, Boston, MA USA; [Bartlett, John M. S.; Sabine, Vicky S.] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland; [Bartlett, John M. S.] Ontario Inst Canc Res, Toronto, ON, Canada; [Sims, Andrew H.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Breast Unit, Edinburgh, Midlothian, Scotland; [Sahmoud, Tarek] Novartis Pharmaceut, E Hanover, NJ USA; [Dixon, J. Michael] Univ Edinburgh, Western Gen Hosp, Appl Bioinformat Canc Grp, Canc Res Ctr,Inst Genet & Mol Med,Edinburgh Break, Edinburgh, Midlothian, Scotland; [Piccart, Martine J.] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium	Institut Jules Bordet; Harvard University; Massachusetts General Hospital; University of Edinburgh; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Edinburgh; Novartis; University of Edinburgh; Institut Jules Bordet	Loi, S (corresponding author), Inst Jules Bordet, Breast Canc Translat Res Lab BCTL, B-1000 Brussels, Belgium.	sherene.loi@bordet.be	Michiels, Stefan/L-1516-2013; Loi, Sherene/H-1979-2016; Sims, Andrew/E-4819-2012	Michiels, Stefan/0000-0002-6963-2968; Loi, Sherene/0000-0001-6137-9171; Sims, Andrew/0000-0001-9082-3665	JC Fonds Heuson, Belgium; Estee Lauder Breast Cancer Research Foundation, NY	JC Fonds Heuson, Belgium; Estee Lauder Breast Cancer Research Foundation, NY	SL and CS are supported by the JC Fonds Heuson, Belgium and the Estee Lauder Breast Cancer Research Foundation, NY. The authors acknowledge the Edinburgh Cancer Medicine Centre and Cancer Research UK for tissue banking support for dataset B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Pharma did not provide any financial support for research reported in this manuscript.	Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Chow LWC, 2006, BREAST CANC RES T S1, P6091; Cizkova M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3113; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dowsett M, 2006, CLIN CANCER RES, V12, p1024S, DOI 10.1158/1078-0432.CCR-05-2127; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2010, BREAST CANCER RES TR, V119, P379, DOI 10.1007/s10549-009-0575-y; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Macaskill EJ, 2010, BREAST CANC RES TREA; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Sabine VS, 2010, BREAST CANCER RES TR, V122, P419, DOI 10.1007/s10549-010-0928-6; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025	23	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53292	10.1371/journal.pone.0053292	http://dx.doi.org/10.1371/journal.pone.0053292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301057	Green Published, gold			2022-12-27	WOS:000313320900073
J	Ma, HL; Qin, L; Dong, C; Zhong, RJ; Sato, Y				Ma, Hanlu; Qin, Ling; Dong, Chao; Zhong, Renjia; Sato, Yu			Comparison of Neural Responses to Cat Meows and Human Vowels in the Anterior and Posterior Auditory Field of Awake Cats	PLOS ONE			English	Article							NATURAL SOUNDS; CONSPECIFIC VOCALIZATIONS; FUNCTIONAL SPECIALIZATION; MODULATORY INFLUENCES; NEURONAL RESPONSES; CORTEX; REPRESENTATION; DISCRIMINATION; COMPLEX; STIMULI	For humans and animals, the ability to discriminate speech and conspecific vocalizations is an important physiological assignment of the auditory system. To reveal the underlying neural mechanism, many electrophysiological studies have investigated the neural responses of the auditory cortex to conspecific vocalizations in monkeys. The data suggest that vocalizations may be hierarchically processed along an anterior/ventral stream from the primary auditory cortex (A1) to the ventral prefrontal cortex. To date, the organization of vocalization processing has not been well investigated in the auditory cortex of other mammals. In this study, we examined the spike activities of single neurons in two early auditory cortical regions with different anteroposterior locations: anterior auditory field (AAF) and posterior auditory field (PAF) in awake cats, as the animals were passively listening to forward and backward conspecific calls (meows) and human vowels. We found that the neural response patterns in PAF were more complex and had longer latency than those in AAF. The selectivity for different vocalizations based on the mean firing rate was low in both AAF and PAF, and not significantly different between them; however, more vocalization information was transmitted when the temporal response profiles were considered, and the maximum transmitted information by PAF neurons was higher than that by AAF neurons. Discrimination accuracy based on the activities of an ensemble of PAF neurons was also better than that of AAF neurons. Our results suggest that AAF and PAF are similar with regard to which vocalizations they represent but differ in the way they represent these vocalizations, and there may be a complex processing stream between them.	[Ma, Hanlu; Qin, Ling; Dong, Chao; Zhong, Renjia; Sato, Yu] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Physiol, Chuo, Yamanashi, Japan; [Qin, Ling; Zhong, Renjia] China Med Univ, Dept Physiol, Shenyang, Peoples R China	University of Yamanashi; China Medical University	Qin, L (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Physiol, Chuo, Yamanashi, Japan.	qinling@yamanashi.ac.jp			Strategic Research Program for Brain Sciences from the Japan Ministry of Education, Culture, Sports, Science and Technology [08038015, 23700377]; National Nature Science Foundation of China [30970979, 31171057]	Strategic Research Program for Brain Sciences from the Japan Ministry of Education, Culture, Sports, Science and Technology; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Strategic Research Program for Brain Sciences 08038015 and No. 23700377 from the Japan Ministry of Education, Culture, Sports, Science and Technology (YS and LQ), and the National Nature Science Foundation of China under Grant No. 30970979 and 31171057 (LQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Carrasco A, 2011, J NEUROPHYSIOL, V106, P1166, DOI 10.1152/jn.00940.2010; Carrasco A, 2010, J NEUROSCI, V30, P1476, DOI 10.1523/JNEUROSCI.5708-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P8350, DOI 10.1523/JNEUROSCI.6001-08.2009; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cohen YE, 2004, J NEUROSCI, V24, P11307, DOI 10.1523/JNEUROSCI.3935-04.2004; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Di Lorenzo PM, 2003, J NEUROPHYSIOL, V90, P1418, DOI 10.1152/jn.00177.2003; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025895; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; ETTLINGER G, 1990, CORTEX, V26, P319, DOI 10.1016/S0010-9452(13)80084-6; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P144, DOI 10.1152/jn.00807.2006; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kikuchi Y, 2010, J NEUROSCI, V30, P13021, DOI 10.1523/JNEUROSCI.2267-10.2010; Kusmierek P, 2012, J NEUROPHYSIOL, V107, P1123, DOI 10.1152/jn.00793.2011; Kusmierek P, 2009, J NEUROPHYSIOL, V102, P1606, DOI 10.1152/jn.00167.2009; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Lee CC, 2011, HEARING RES, V274, P85, DOI 10.1016/j.heares.2010.05.008; Lee CC, 2011, NAT NEUROSCI, V14, P108, DOI 10.1038/nn.2713; Liu YC, 2010, BEHAV BRAIN RES, V215, P28, DOI 10.1016/j.bbr.2010.06.013; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; Mishkin M, 1982, ANAL VISUAL BEHAV, P486; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Pelleg-Toiba R., 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P257; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Qin L, 2008, J NEUROPHYSIOL, V100, P1622, DOI 10.1152/jn.90364.2008; Qin L, 2008, J NEUROPHYSIOL, V99, P2305, DOI 10.1152/jn.01125.2007; Qin L, 2007, J NEUROPHYSIOL, V97, P3421, DOI 10.1152/jn.00184.2007; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Recanzone GH, 2011, HEARING RES, V271, P115, DOI 10.1016/j.heares.2010.03.084; Recanzone GH, 2008, J NEUROSCI, V28, P13184, DOI 10.1523/JNEUROSCI.3619-08.2008; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Rotman Y, 2001, HEARING RES, V152, P110, DOI 10.1016/S0378-5955(00)00243-4; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Suta D, 2008, PHYSIOL RES, V57, pS149, DOI 10.33549/physiolres.931608; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Wallace MN, 2005, HEARING RES, V204, P115, DOI 10.1016/j.heares.2005.01.007; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Winer JA, 2007, HEARING RES, V229, P3, DOI 10.1016/j.heares.2007.01.017	67	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52942	10.1371/journal.pone.0052942	http://dx.doi.org/10.1371/journal.pone.0052942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301004	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900047
J	Parfitt, GJ; Xie, YL; Reid, KM; Dervillez, X; Brown, DJ; Jester, JV				Parfitt, Geraint J.; Xie, Yilu; Reid, Korey M.; Dervillez, Xavier; Brown, Donald J.; Jester, James V.			A Novel Immunofluorescent Computed Tomography (ICT) Method to Localise and Quantify Multiple Antigens in Large Tissue Volumes at High Resolution	PLOS ONE			English	Article							CORNEAL COLLAGEN ORGANIZATION; 2ND-HARMONIC GENERATION; STED MICROSCOPY; MEIBOMIAN GLAND; ANTIBODY; METHACRYLATE; SECTIONS; RECONSTRUCTION; DYSFUNCTION; ZONE	Current immunofluorescence protocols are limited as they do not provide reliable antibody staining within large tissue volumes (mm(3)) and cannot localise and quantify multiple antigens or cell populations in the same tissue at high resolution. To address this limitation, we have developed an approach to three-dimensionally visualise large tissue volumes (mm(3)) at high resolution (< 1 mu m) and with multiple antigen labelling, for volumetric and quantitative analysis. This is made possible through computer reconstruction of serial sectioned and sequentially immunostained butyl-methyl methacrylate (BMMA) embedded tissue. Using this novel immunofluorescent computed tomography (ICT) approach, we have three-dimensionally reconstructed part of the murine lower eyelid that contains the meibomian gland and localised cell nuclei (DAPI), Ki67 and cytokeratin 1 (CK1), as well as performing non-linear optical (NLO) microscopy imaging of collagen, to assess cell density, cell proliferation, gland keratinisation and gland volume respectively. Antigenicity was maintained after four iterative stains on the same tissue, suggesting that there is no defined limit to the number of antigens that can be immunostained for reconstruction, as long as the sections remain intact and the previous antibody has been successfully eluted. BMMA resin embedding also preserved fluorescence of transgenic proteins. We propose that ICT may provide valuable high resolution, three-dimensional biological maps of multiple biomolecules within a single tissue or organ to better characterise and quantify tissue structure and function.	[Parfitt, Geraint J.; Xie, Yilu; Reid, Korey M.; Dervillez, Xavier; Brown, Donald J.; Jester, James V.] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA	University of California System; University of California Irvine	Jester, JV (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA.	JJester@uci.edu	Dervillez, Xavier/AAB-4798-2020; Parfitt, Geraint/J-2778-2018	Parfitt, Geraint/0000-0002-8704-7906; Jester, James/0000-0002-9246-0981	NEI (National Eye Institute) [EY021510]; Discovery Eye Foundation; Skirball Program in Molecular Ophthalmology and Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY019719, R01EY021510] Funding Source: NIH RePORTER	NEI (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Discovery Eye Foundation; Skirball Program in Molecular Ophthalmology and Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by NEI EY021510 (National Eye Institute), Discovery Eye Foundation, and the Skirball Program in Molecular Ophthalmology and Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASKIN TI, 1992, PLANTA, V187, P405, DOI 10.1007/BF00195665; Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; BRORSON SH, 1994, MICRON, V25, P453, DOI 10.1016/0968-4328(94)00035-2; Brown DJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717540; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; Coons AH, 1942, J IMMUNOL, V45, P159; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jester BE, 2011, ANAT REC, V294, P185, DOI 10.1002/ar.21305; Jester JV, 2010, EYE CONTACT LENS, V36, P260, DOI 10.1097/ICL.0b013e3181ee8992; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu SH, 2007, ARCH OPHTHALMOL-CHIC, V125, P523, DOI 10.1001/archopht.125.4.523; Meagher CK, 2005, EXP EYE RES, V80, P545, DOI 10.1016/j.exer.2004.11.005; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mueller M, 2000, AM J PATHOL, V157, P1829, DOI 10.1016/S0002-9440(10)64822-5; Nien CJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P462, DOI 10.1001/archophthalmol.2011.69; Nien CJ, 2009, EXP EYE RES, V89, P1021, DOI 10.1016/j.exer.2009.08.013; Oberti D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00050; Palmer JH, 2001, CYTOBIOS, V104, P145; Pan F, 2008, DEV NEUROBIOL, V68, P771, DOI 10.1002/dneu.20630; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Riau A, 2008, CURR EYE RES, V33, P912, DOI 10.1080/02713680802485147; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Warren KC, 1998, J HISTOCHEM CYTOCHEM, V46, P149, DOI 10.1177/002215549804600203; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Winkler M, 2011, INVEST OPHTH VIS SCI, V52, P8818, DOI 10.1167/iovs.11-8070; Winkler M, 2010, BRAIN RES BULL, V81, P339, DOI 10.1016/j.brainresbull.2009.06.001	36	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53245	10.1371/journal.pone.0053245	http://dx.doi.org/10.1371/journal.pone.0053245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300899	Green Published, gold			2022-12-27	WOS:000313872600074
J	Watanabe, Y; Tatebe, H; Taguchi, K; Endo, Y; Tokuda, T; Mizuno, T; Nakagawa, M; Tanaka, M				Watanabe, Yoshihisa; Tatebe, Harutsugu; Taguchi, Katsutoshi; Endo, Yasuhisa; Tokuda, Takahiko; Mizuno, Toshiki; Nakagawa, Masanori; Tanaka, Masaki			p62/SQSTM1-Dependent Autophagy of Lewy Body-Like alpha-Synuclein Inclusions	PLOS ONE			English	Article							PARKINSONS-DISEASE; DEGRADATION; PROTEINS; PATHWAY; MACROAUTOPHAGY; MITOCHONDRIA; MECHANISMS; CLEARANCE; MODELS; P62	alpha-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson's disease. Although alpha-synuclein accumulation is caused by inhibition of proteasome and autophagy-lysosome, the degradation of alpha-synuclein inclusions is still unknown. Formation of Lewy body-like inclusions can be replicated in cultured cells by introducing alpha-synuclein fibrils generated in vitro. We used this cell culture model to investigate the autophagy of alpha-synuclein inclusions and impaired mitochondria. The intracellular alpha-synuclein inclusions immediately underwent phosphorylation and ubiquitination. Simultaneously they were encircled by an adaptor protein p62/SQSTM1 and directed to the autophagy-lysosome pathway in HEK293 cell line. Most phospho-alpha-synuclein-positive inclusions were degraded in 24 h, however, lysosomal dysfunction with bafilomycin A1 significantly affected their clearance. Moreover, inhibition of autophagy by Atg-5 siRNA treatment reduced the incorporation of alpha-synuclein inclusions into LC3-positive autophagosomes. Knockdown experiments demonstrated the requirement of p62 for alpha-synuclein autophagy. These results demonstrate that alpha-synuclein inclusions are preferred targets for p62-dependent autophagy. Next, we investigated the autophagic clearance of impaired mitochondria in alpha-synuclein inclusion-containing cells. Impaired mitochondria were almost completely eliminated after mitochondrial uncoupling even in the presence of alpha-synuclein inclusions, suggesting that mitochondrial clearance is not prevented by alpha-synuclein inclusions in HEK293 cells.	[Watanabe, Yoshihisa; Taguchi, Katsutoshi; Tanaka, Masaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan; [Tatebe, Harutsugu; Tokuda, Takahiko; Mizuno, Toshiki; Nakagawa, Masanori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamikyo Ku, Kyoto, Japan; [Endo, Yasuhisa] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Institute of Technology	Tanaka, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan.	mtanaka@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020		Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591272, 23591252, 22591595, 21500329]; NICHD, National Institutes of Health; Grants-in-Aid for Scientific Research [23591252] Funding Source: KAKEN	Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan to M.N., and from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, to Y.W. (No. 24591272), T. T. (No. 23591252), T. M. (No. 22591595), and M. T. (No. 21500329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The anti-LAMP-1 antibody, developed by J. Thomas August and James E. K. Hildreth, was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of NICHD, National Institutes of Health, and maintained by the Department of Biology, University of Iowa.	Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsui H, 2010, J NEUROCHEM, V115, P1150, DOI 10.1111/j.1471-4159.2010.07012.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Olanow CW, 2011, MOVEMENT DISORD, V26, P1056, DOI 10.1002/mds.23767; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Tanji K, 2011, NEUROBIOL DIS, V43, P690, DOI 10.1016/j.nbd.2011.05.022; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yamaguchi T, 2008, J NEUROSCI RES, V86, P610, DOI 10.1002/jnr.21517; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	37	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52868	10.1371/journal.pone.0052868	http://dx.doi.org/10.1371/journal.pone.0052868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300799	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600032
J	Candelario, J; Tavakoli, H; Chachisvilis, M				Candelario, Jose; Tavakoli, Hesam; Chachisvilis, Mirianas			PTH1 Receptor Is Involved in Mediating Cellular Response to Long-Chain Polyunsaturated Fatty Acids	PLOS ONE			English	Article							PARATHYROID-HORMONE RECEPTOR; BONE-MINERAL DENSITY; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; SUPPLEMENTATION; DIFFERENTIATION; MECHANISMS; MOUSE; OMEGA-3-FATTY-ACIDS; PROLIFERATION	The molecular pathways by which long chain polyunsaturated fatty acids (LCPUFA) influence skeletal health remain elusive. Both LCPUFA and parathyroid hormone type 1 receptor (PTH1R) are known to be involved in bone metabolism while any direct link between the two is yet to be established. Here we report that LCPUFA are capable of direct, PTH1R dependent activation of extracellular ligand-regulated kinases (ERK). From a wide range of fatty acids studied, varying in chain length, saturation, and position of double bonds, eicosapentaenoic (EPA) and docosahexaenoic fatty acids (DHA) caused the highest ERK phosphorylation. Moreover, EPA potentiated the effect of parathyroid hormone (PTH(1-34)) in a superagonistic manner. EPA or DHA dependent ERK phosphorylation was inhibited by the PTH1R antagonist and by knockdown of PTH1R. Inhibition of PTH1R downstream signaling molecules, protein kinases A (PKA) and C (PKC), reduced EPA and DHA dependent ERK phosphorylation indicating that fatty acids predominantly activate G-protein pathway and not the beta-arrestin pathway. Using picosecond time-resolved fluorescence microscopy and a genetically engineered PTH1R sensor (PTH-CC), we detected conformational responses to EPA similar to those caused by PTH(1-34). PTH1R antagonist blocked the EPA induced conformational response of the PTH-CC. Competitive binding studies using fluorescence anisotropy technique showed that EPA and DHA competitively bind to and alter the affinity of PTH1 receptor to PTH(1-34) leading to a superagonistic response. Finally, we showed that EPA stimulates protein kinase B (Akt) phosphorylation in a PTH1R-dependent manner and affects the osteoblast survival pathway, by inhibiting glucocorticoid-induced cell death. Our findings demonstrate for the first time that LCPUFAs, EPA and DHA, can activate PTH1R receptor at nanomolar concentrations and consequently provide a putative molecular mechanism for the action of fatty acids in bone.	[Candelario, Jose; Tavakoli, Hesam; Chachisvilis, Mirianas] La Jolla Bioengn Inst, San Diego, CA USA	La Jolla Bioengineering Institute	Chachisvilis, M (corresponding author), La Jolla Bioengn Inst, San Diego, CA USA.	mirianas@ljbi.org		Tavakoli, Hesam/0000-0003-3787-007X	NIH [HL86943, HL86943-S1]; NSF [MCB 0721396]; TeraGrid [TG-MCB090202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); TeraGrid; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL86943 and HL86943-S1, NSF grant MCB 0721396, and TeraGrid resources (TG-MCB090202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; ANDERSON WB, 1977, ARCH BIOCHEM BIOPHYS, V180, P374, DOI 10.1016/0003-9861(77)90051-0; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bonnet N, 2011, J NUTR BIOCHEM, V22, P665, DOI 10.1016/j.jnutbio.2010.05.006; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Coetzee M, 2007, PROSTAG LEUKOTR ESS, V76, P35, DOI 10.1016/j.plefa.2006.10.001; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; Fernandes G, 2008, FRONT BIOSCI-LANDMRK, V13, P4015, DOI 10.2741/2989; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; HOAK JC, 1970, NATURE, V228, P1330, DOI 10.1038/2281330a0; Hogstrom M, 2007, AM J CLIN NUTR, V85, P803; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Juppner H, 2001, ENDOCRINOLOGY, P969; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; KRUGER MC, 1995, NUTR RES, V15, P211, DOI 10.1016/0271-5317(95)92587-A; Kruger MC, 1998, AGING-CLIN EXP RES, V10, P385, DOI 10.1007/BF03339885; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li Y, 2010, BRIT J NUTR, V104, P674, DOI 10.1017/S0007114510001133; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; McCarthy ID, 1997, CLIN ORTHOP RELAT R, P24; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; NUTT RF, 1990, ENDOCRINOLOGY, V127, P491, DOI 10.1210/endo-127-1-491; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; OTTO JC, 1994, J BIOL CHEM, V269, P19868; OWEN M, 1976, J PHYSIOL-LONDON, V257, P293, DOI 10.1113/jphysiol.1976.sp011369; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; ROBINSON DR, 1993, J LIPID RES, V34, P1423; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rossignol M, 2002, INT J TECHNOL ASSESS, V18, P597; Saito J, 1997, ATHEROSCLEROSIS, V131, P219, DOI 10.1016/S0021-9150(97)00048-8; SAKAGUCHI K, 1994, PROSTAG LEUKOTR ESS, V50, P81, DOI 10.1016/0952-3278(94)90151-1; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Schlemmer CK, 1999, PROSTAG LEUKOTR ESS, V61, P381, DOI 10.1054/plef.1999.0116; Shichikawa K, 1981, Ryumachi, V21 Suppl, P35; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Sneddon WB, 2007, AM J PHYSIOL-RENAL, V292, pF1028, DOI 10.1152/ajprenal.00288.2006; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Strewler GJ, 2000, NEW ENGL J MED, V342, P177, DOI 10.1056/NEJM200001203420306; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; van Kan GA, 2008, J NUTR HEALTH AGING, V12, P355, DOI 10.1007/BF02982667; VANMETER AR, 1994, MECH AGEING DEV, V75, P95, DOI 10.1016/0047-6374(94)90079-5; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Watkins BA, 2001, PROG LIPID RES, V40, P125, DOI 10.1016/S0163-7827(00)00016-3; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weiss LA, 2005, AM J CLIN NUTR, V81, P934, DOI 10.1093/ajcn/81.4.934; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008; Zwart SR, 2010, J BONE MINER RES, V25, P1049, DOI 10.1359/jbmr.091041	72	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52583	10.1371/journal.pone.0052583	http://dx.doi.org/10.1371/journal.pone.0052583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300710	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100065
J	Keller, KK; Thomsen, JS; Stengaard-Pedersen, K; Dagnaes-Hansen, F; Nyengaard, JR; Hauge, EM				Keller, Kresten Krarup; Thomsen, Jesper Skovhus; Stengaard-Pedersen, Kristian; Dagnaes-Hansen, Frederik; Nyengaard, Jens Randel; Hauge, Ellen-Margrethe			Bone Formation and Resorption Are Both Increased in Experimental Autoimmune Arthritis	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ARBITRARY PARTICLES; NUMBER; CELLS; SIZE; OSTEOPROTEGERIN; REGULATOR; CYTOKINE	Introduction: Arthritic bone loss in the joints of patients with rheumatoid arthritis is the result of a combination of osteoclastic bone resorption and osteoblastic bone formation. This process is not completely understood, and especially the importance of local inflammation needs further investigation. We evaluated how bone formation and bone resorption are altered in experimental autoimmune arthritis. Methods: Twenty-one female SKG mice were randomized to either an arthritis group or a control group. Tetracycline was used to identify mineralizing surfaces. After six weeks the right hind paws were embedded undecalcified in methylmethacrylate. The paws were cut exhaustively according to the principles of vertical sectioning and systematic sampling. 3D design-based methods were used to estimate the total number of osteoclasts, mineralizing surfaces, eroded surfaces, and osteoclast-covered bone surfaces. In addition the presence of adjacent inflammation was ascertained. Results: The total number of osteoclasts, mineralizing surfaces, eroded surfaces, and osteoclast covered surfaces were elevated in arthritic paws compared to normal paws. Mineralizing surfaces were elevated adjacent to as well as not adjacent to inflammation in arthritic mice compared to normal mice. In arthritic mice, eroded surfaces and osteoclast covered surfaces were larger on bone surfaces adjacent to inflammation than on bone surfaces without adjacent inflammation. However, we found no difference between mineralizing surfaces at bone surfaces with or without inflammation in arthritic mice. Conclusions: Inflammation induced an increase in resorptive bone surfaces as well as formative bone surfaces. The bone formative response may be more general, since formative bone surfaces were also increased when not associated with inflammation. Thus, the bone loss may be the result of a substantial local bone resorption, which cannot be compensated by the increased local bone formation. These findings may be valuable for the development of new osteoblast targeting drugs in RA.	[Keller, Kresten Krarup; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Thomsen, Jesper Skovhus; Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Nyengaard, Jens Randel] Aarhus Univ Hosp, Stereol & Electron Microscopy Lab, Ctr Stochast Geometry & Adv Bioimaging, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Keller, KK (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	kresten@ana.au.dk	Keller, Kresten Krarup/S-2067-2019	Keller, Kresten Krarup/0000-0003-2474-3389; Thomsen, Jesper Skovhus/0000-0001-9386-6679; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Danish Rheumatism Association; A. P. Moller Foundation for the Advancement of Medical Science; Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant; Hede Nielsens Family Foundation; Aase and Ejnar Danielsens Foundation; Villum Foundation	Danish Rheumatism Association; A. P. Moller Foundation for the Advancement of Medical Science; Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant; Hede Nielsens Family Foundation; Aase and Ejnar Danielsens Foundation; Villum Foundation(Villum Fonden)	This work was supported by grants from the Danish Rheumatism Association, The A. P. Moller Foundation for the Advancement of Medical Science, the Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant, the Hede Nielsens Family Foundation, and Aase and Ejnar Danielsens Foundation. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Ferguson SJ, 1999, MED ENG PHYS, V21, P111, DOI 10.1016/S1350-4533(99)00032-6; Gortz B, 2004, J BONE MINER RES, V19, P990, DOI 10.1359/JBMR.040205; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hyde DM, 2007, TOXICOL PATHOL, V35, P41, DOI 10.1080/01926230601059977; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jimi E, 1999, J IMMUNOL, V163, P434; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Keller KK, 2011, CLIN EXP RHEUMATOL, V29, P536; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; McQueen FM, 2003, ARTHRITIS RHEUM, V48, P1814, DOI 10.1002/art.11162; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P1126, DOI 10.1007/BF00401056; Rau R, 2006, CLIN EXP RHEUMATOL, V24, pS41; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; Romas E, 2000, ARTHRITIS RHEUM, V43, P821, DOI 10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53034	10.1371/journal.pone.0053034	http://dx.doi.org/10.1371/journal.pone.0053034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300855	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100111
J	Qin, J; He, XJ; Wang, D; Qi, P; Guo, L; Huang, SH; Cai, X; Li, HP; Wang, R				Qin, Jie; He, Xijing; Wang, Dong; Qi, Peng; Guo, Lei; Huang, Sihua; Cai, Xuan; Li, Haopeng; Wang, Rui			Artificial Cervical Vertebra and Intervertebral Complex Replacement through the Anterior Approach in Animal Model: A Biomechanical and In Vivo Evaluation of a Successful Goat Model	PLOS ONE			English	Article							TOTAL DISC REPLACEMENT; SPINE; FUSION; BONE; ADJACENT; ANATOMY; KINEMATICS; DISKECTOMY; SCREWS	This was an in vitro and in vivo study to develop a novel artificial cervical vertebra and intervertebral complex (ACVC) joint in a goat model to provide a new method for treating degenerative disc disease in the cervical spine. The objectives of this study were to test the safety, validity, and effectiveness of ACVC by goat model and to provide preclinical data for a clinical trial in humans in future. We designed the ACVC based on the radiological and anatomical data on goat and human cervical spines, established an animal model by implanting the ACVC into goat cervical spines in vitro prior to in vivo implantation through the anterior approach, and evaluated clinical, radiological, biomechanical parameters after implantation. The X-ray radiological data revealed similarities between goat and human intervertebral angles at the levels of C2-3, C3-4, and C4-5, and between goat and human lordosis angles at the levels of C3-4 and C4-5. In the in vivo implantation, the goats successfully endured the entire experimental procedure and recovered well after the surgery. The radiological results showed that there was no dislocation of the ACVC and that the ACVC successfully restored the intervertebral disc height after the surgery. The biomechanical data showed that there was no significant difference in range of motion (ROM) or neural zone (NZ) between the control group and the ACVC group in flexion-extension and lateral bending before or after the fatigue test. The ROM and NZ of the ACVC group were greater than those of the control group for rotation. In conclusion, the goat provides an excellent animal model for the biomechanical study of the cervical spine. The ACVC is able to provide instant stability after surgery and to preserve normal motion in the cervical spine.	[Qin, Jie; He, Xijing; Wang, Dong; Qi, Peng; Guo, Lei; Huang, Sihua; Cai, Xuan; Li, Haopeng; Wang, Rui] Xi An Jiao Tong Univ, Dept Orthoped, Hosp 2, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	He, XJ (corresponding author), Xi An Jiao Tong Univ, Dept Orthoped, Hosp 2, Xian 710049, Shaanxi Provinc, Peoples R China.	xijing_h@vip.tom.com	He, Xijing/AAE-7424-2021; Li, Hao/GPS-9834-2022	He, Xijing/0000-0002-0465-5376; 	"13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province [2011KTCL03-17]; China Scholarship Council; Ministry of Education of China	"13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province; China Scholarship Council(China Scholarship Council); Ministry of Education of China(Ministry of Education, China)	This study was sponsored by "13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province (Program title: Study of design and application of artificial cervical vertebra and intervertebral complex (ACVC). Program number: 2011KTCL03-17. http://www.sninfo.gov.cn/). No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript. Jie Qin was supported in part by a fellowship from the China Scholarship Council (http://www.csc.edu.cn/) and a fellowship of academic talent of doctorial candidates from Ministry of Education of China (http://www.moe.edu.cn/). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231; Auerbach JD, 2008, SPINE J, V8, P711, DOI 10.1016/j.spinee.2007.06.018; Auerbach JD, 2007, SPINE, V32, P527, DOI 10.1097/01.brs.0000256915.90236.17; Cakir B, 2009, SPINE, V34, P1287, DOI 10.1097/BRS.0b013e3181a136ab; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e; Galbusera F, 2008, MED ENG PHYS, V30, P1127, DOI 10.1016/j.medengphy.2008.02.002; Gore DR, 1998, SPINE, V23, P2047, DOI 10.1097/00007632-199810010-00002; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348; Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5; Lu B, 2009, SPINE, V34, P1893, DOI 10.1097/BRS.0b013e3181ae25dc; Lu B, 2009, EUR SPINE J, V18, P109, DOI 10.1007/s00586-008-0835-2; Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x; Pait TG, 1996, NEUROSURGERY, V39, P769, DOI 10.1097/00006123-199610000-00026; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; PANJABI MM, 1991, SPINE, V16, P861, DOI 10.1097/00007632-199108000-00001; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Rocca M, 1998, INT J ARTIF ORGANS, V21, P553, DOI 10.1177/039139889802100911; SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023; TOMINAGA T, 1995, SPINE, V20, P131, DOI 10.1097/00007632-199501150-00001; van der Donk S, 2001, COMPARATIVE MED, V51, P336; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; ZDEBLICK TA, 1992, SPINE, V17, pS418, DOI 10.1097/00007632-199210001-00013; Zhang J, 2006, SPINE, V31, P2195, DOI 10.1097/01.brs.0000232798.97075.73; Zhu QG, 2007, SPINE, V32, P55, DOI 10.1097/01.brs.0000250983.91339.9f	28	19	21	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52910	10.1371/journal.pone.0052910	http://dx.doi.org/10.1371/journal.pone.0052910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300816	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100096
J	Francois, A; Grauso, M; Demondion, E; Bozzolan, F; Debernard, S; Lucas, P				Francois, Adrien; Grauso, Marta; Demondion, Elodie; Bozzolan, Francoise; Debernard, Stephane; Lucas, Philippe			Bestrophin-Encoded Ca2+-Activated Cl- Channels Underlie a Current with Properties Similar to the Native Current in the Moth Spodoptera littoralis Olfactory Receptor Neurons	PLOS ONE			English	Article							ACTIVATED CHLORIDE CONDUCTANCE; FUNCTIONAL-PROPERTIES; MOUSE BESTROPHIN-2; RT-PCR; CALCIUM; FAMILY; DROSOPHILA; PROTEIN; GENE; CA2+	Responses of insect olfactory receptor neurons (ORNs) involve an entry of Ca2+ through olfactory heterodimeric receptor complexes. In moths, the termination of ORN responses was found to strongly depend on the external Ca2+ concentration through the activation of unknown Ca2+-dependent Cl- channels. We thus investigated the molecular identity of these Cl- channels. There is compelling evidence that bestrophins form Cl- channels when expressed in heterologous systems. Here we provide evidence that antennae of the moth Spodoptera littoralis express three transcripts encoding proteins with hallmarks of bestrophins. One of these transcripts, SlitBest1b, is expressed in ORNs. The heterologous expression of SlitBest1b protein in CHO-K1 cells yielded a Ca2+-activated Cl- current that shares electrophysiological properties with the native Ca2+-activated Cl- current of ORNs. Both currents are anionic, present similar dependence on the intracellular Ca2+ concentration, partly inactivate over time, have the same anion permeability sequence, the same sequence of inhibitory efficiency of blockers, the same almost linear I-V relationships and finally both currents do not depend on the cell volume. Therefore, our data suggest that SlitBest1b is a good candidate for being a molecular component of the olfactory Ca2+-activated Cl- channel and is likely to constitute part of the insect olfactory transduction pathway. A different function (e. g. regulation of other proteins, maintenance of the anionic homeostasis in the sensillar lymph) and a different role (e. g. involvement in the olfactory system development) cannot be excluded however.	[Francois, Adrien; Grauso, Marta; Demondion, Elodie; Lucas, Philippe] INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France; [Francois, Adrien; Bozzolan, Francoise; Debernard, Stephane] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Lucas, P (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France.	philippe.lucas@versailles.inra.fr	Lucas, Philippe/I-6020-2016	Grauso, Marta/0000-0003-0413-9950; Lucas, Philippe/0000-0003-2166-8248	state program "Investissements d'avenir'' [ANR-10-BINF-05]	state program "Investissements d'avenir''(French National Research Agency (ANR))	This work was funded by the state program "Investissements d'avenir'' managed by ANR (grant ANR-10-BINF-05 "Pherotaxis''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audinat E, 1996, NEUROCHEM INT, V28, P119, DOI 10.1016/0197-0186(95)00075-5; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; BAKER TC, 1987, PHYSIOL ENTOMOL, V12, P263, DOI 10.1111/j.1365-3032.1987.tb00751.x; Barro-Soria R, 2009, PFLUGERS ARCH; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Britton FC, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P233; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jacquin-Joly E., 2005, CURR TOP NEUROCHEM, V4, P75; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling KE, 1997, EXS, V84, P343; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keil T.A., 1984, P477; Kleene SJ, 2002, CURR TOP MEMBR, V53, P119, DOI 10.1016/S1063-5823(02)53031-3; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Klimmeck D, 2009, J COMP NEUROL, V515, P585, DOI 10.1002/cne.22075; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Lucas P, 1997, CELL TISSUE RES, V289, P375, DOI 10.1007/s004410050884; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Matchkov VV, 2008, CIRC RES, V103, P864, DOI 10.1161/CIRCRESAHA.108.178517; Milenkovic VM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-72; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nakagawa-Inoue A, 1998, ZOOL SCI, V15, P661, DOI 10.2108/zsj.15.661; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; O'Driscoll KE, 2008, AM J PHYSIOL-CELL PH, V295, pC1610, DOI 10.1152/ajpcell.00461.2008; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Pezier A, 2010, J NEUROSCI, V30, P6323, DOI 10.1523/JNEUROSCI.0261-10.2010; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2010, J CARDIOVASC PHARM, V55, P110, DOI 10.1097/FJC.0b013e3181c87c85; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WILLIS MA, 1984, PHYSIOL ENTOMOL, V9, P341, DOI 10.1111/j.1365-3032.1984.tb00715.x; Yang C, 2010, J GEN PHYSIOL, V135, P3, DOI 10.1085/jgp.200910265; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583	70	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52691	10.1371/journal.pone.0052691	http://dx.doi.org/10.1371/journal.pone.0052691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300744	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800127
J	Hansen, U; Allen, JM; White, R; Moscibrocki, C; Bruckner, P; Bateman, JF; Fitzgerald, J				Hansen, Uwe; Allen, Justin M.; White, Rachel; Moscibrocki, Cathleen; Bruckner, Peter; Bateman, John F.; Fitzgerald, Jamie			WARP Interacts with Collagen VI-Containing Microfibrils in the Pericellular Matrix of Human Chondrocytes	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; BEADED MICROFIBRILS; BASEMENT-MEMBRANES; ALPHA-2(VI) CHAINS; GLOBULAR DOMAINS; TERMINAL REGION; PROTEIN WARP; CARTILAGE; FIBRILS; PROTEOGLYCAN	Collagen VI and WARP are extracellular structural macromolecules present in cartilage and associated with BM suprastructures in non-skeletal tissues. We have previously shown that in WARP-deficient mice, collagen VI is specifically reduced in regions of the peripheral nerve ECM where WARP is expressed, suggesting that both macromolecules are part of the same suprastructure. The object of this study was to conduct a detailed analysis of WARP-collagen VI interactions in vitro in cartilage, a tissue rich in WARP and collagen VI. Immunohistochemical analysis of mouse and human articular cartilage showed that WARP and collagen VI co-localize in the pericellular matrix of superficial zone articular chondrocytes. EM analysis on extracts of human articular cartilage showed that WARP associates closely with collagen VI-containing suprastructures. Additional evidence of an interaction is provided by immunogold EM and immunoblot analysis showing that WARP was present in collagen VI-containing networks isolated from cartilage. Further characterization were done by solid phase binding studies and reconstitution experiments using purified recombinant WARP and isolated collagen VI. Collagen VI binds to WARP with an apparent K-d of approximately 22 nM and the binding site(s) for WARP resides within the triple helical domain since WARP binds to both intact collagen VI tetramers and pepsinized collagen VI. Together, these data confirm and extend our previous findings by demonstrating that WARP and collagen VI form high affinity associations in vivo in cartilage. We conclude that WARP is ideally placed to function as an adapter protein in the cartilage pericellular matrix.	[Hansen, Uwe; Bruckner, Peter] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Allen, Justin M.; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Justin M.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [White, Rachel; Moscibrocki, Cathleen; Fitzgerald, Jamie] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA	University of Munster; Murdoch Children's Research Institute; University of Melbourne; Oregon Health & Science University	Fitzgerald, J (corresponding author), Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA.	fitzgerj@ohsu.edu	Bruckner, Peter/F-4817-2019	Bruckner, Peter/0000-0002-5566-5611; Bateman, John/0000-0001-8542-0730	National Health and Medical Research grant [284524]; National Institutes of Health [R01AR055957]; Deutsche Forschungsgemeinschaft Grant [SFB, A2]; Victorian Government's Operational Infrastructure Support Program; National Center for Research Resources [S10-RR023432]; Arthritis Research Campaign Travel Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055957] Funding Source: NIH RePORTER	National Health and Medical Research grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Victorian Government's Operational Infrastructure Support Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arthritis Research Campaign Travel Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Health and Medical Research grant 284524 (to JF and JB), an Arthritis Research Campaign Travel Award (to RW) and by the National Institutes of Health (to JF, R01AR055957), the Deutsche Forschungsgemeinschaft Grant SFB, A2 (to PB), the Victorian Government's Operational Infrastructure Support Program and by the National Center for Research Resources (S10-RR023432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Allen JM, 2009, J BIOL CHEM, V284, P12020, DOI 10.1074/jbc.M806968200; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Niiyama T, 2002, ACTA NEUROPATHOL, V104, P67, DOI 10.1007/s00401-002-0522-z; POOLE CA, 1988, J CELL SCI, V90, P635; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Wilusz RE, 2012, J R SOC INTERFACE; Wilusz RE, 2012, MATRIX BIOL	29	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52793	10.1371/journal.pone.0052793	http://dx.doi.org/10.1371/journal.pone.0052793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300779	Green Published, gold			2022-12-27	WOS:000313618800148
J	Jellyman, JK; Martin-Gronert, MS; Cripps, RL; Giussani, DA; Ozanne, SE; Shen, QWW; Du, M; Fowden, AL; Forhead, AJ				Jellyman, Juanita K.; Martin-Gronert, Malgorzata S.; Cripps, Roselle L.; Giussani, Dino A.; Ozanne, Susan E.; Shen, Qingwu W.; Du, Min; Fowden, Abigail L.; Forhead, Alison J.			Effects of Cortisol and Dexamethasone on Insulin Signalling Pathways in Skeletal Muscle of the Ovine Fetus during Late Gestation	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; ANTENATAL CORTICOSTEROIDS; DEVELOPMENTAL CONTROL; MAMMALIAN TARGET; FETAL; GROWTH; SHEEP; GLUCOCORTICOIDS; EXPRESSION; RESTRICTION	Before birth, glucocorticoids retard growth, although the extent to which this is mediated by changes in insulin signalling pathways in the skeletal muscle of the fetus is unknown. The current study determined the effects of endogenous and synthetic glucocorticoid exposure on insulin signalling proteins in skeletal muscle of fetal sheep during late gestation. Experimental manipulation of fetal plasma glucocorticoid concentration was achieved by fetal cortisol infusion and maternal dexamethasone treatment. Cortisol infusion significantly increased muscle protein levels of Akt2 and phosphorylated Akt at Ser473, and decreased protein levels of phosphorylated forms of mTOR at Ser2448 and S6K at Thr389. Muscle GLUT4 protein expression was significantly higher in fetuses whose mothers were treated with dexamethasone compared to those treated with saline. There were no significant effects of glucocorticoid exposure on muscle protein abundance of IR-beta, IGF-1R, PKC zeta, Akt1, calpastatin or muscle glycogen content. The present study demonstrated that components of the insulin signalling pathway in skeletal muscle of the ovine fetus are influenced differentially by naturally occurring and synthetic glucocorticoids. These findings may provide a mechanism by which elevated concentrations of endogenous glucocorticoids retard fetal growth.	[Jellyman, Juanita K.; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Martin-Gronert, Malgorzata S.; Cripps, Roselle L.; Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Shen, Qingwu W.; Du, Min] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA	University of Cambridge; University of Cambridge; University of Wyoming	Forhead, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ajf1005@cam.ac.uk	Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X; Forhead, Alison/0000-0003-2125-4811; Ozanne, Susan/0000-0001-8753-5144; Jellyman, Juanita/0000-0002-8455-7652; Giussani, Dino/0000-0002-1308-1204	Biotechnology and Biological Sciences Research Council; Tommy's the Baby Charity, UK; Biotechnology and Biological Sciences Research Council [BB/E002668/1, S18103, BB/I011773/1] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; BBSRC [BB/E002668/1, BB/I011773/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommy's the Baby Charity, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council and Tommy's the Baby Charity, UK. SEO is a British Heart Foundation Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1256, DOI 10.1152/ajpregu.2001.281.4.R1256; Blanco CL, 2010, ENDOCRINOLOGY, V151, P1990, DOI 10.1210/en.2009-0777; Brown LD, 2009, AM J PHYSIOL-ENDOC M, V296, pE56, DOI 10.1152/ajpendo.90310.2008; Challis JRG, 2001, MOL CELL ENDOCRINOL, V185, P135, DOI 10.1016/S0303-7207(01)00624-4; Coderre L, 1996, AM J PHYSIOL-ENDOC M, V271, pE643, DOI 10.1152/ajpendo.1996.271.4.E643; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; Ewart HS, 1998, FEBS LETT, V425, P178; Forhead AJ, 2008, J PHYSIOL-LONDON, V586, P2393, DOI 10.1113/jphysiol.2007.149237; Forhead AJ, 2007, ENDOCRINOLOGY, V148, P800, DOI 10.1210/en.2006-1194; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Fowden AL, 1996, J ENDOCRINOL, V151, P97, DOI 10.1677/joe.0.1510097; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; Gray S, 2006, J ENDOCRINOL, V189, P219, DOI 10.1677/joe.1.06589; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Jellyman JK, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.012; Kelly BA, 2012, PEDIATRICS, V129, pE1282, DOI 10.1542/peds.2011-3175; LI J, 1993, ENDOCRINOLOGY, V132, P2083, DOI 10.1210/en.132.5.2083; Li J, 2002, J PHYSIOL-LONDON, V541, P581, DOI 10.1113/jphysiol.2002.016402; MOLINA RD, 1993, PEDIATR RES, V34, P654, DOI 10.1203/00006450-199311000-00018; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROBINSON PM, 1983, Q J EXP PHYSIOL CMS, V68, P15, DOI 10.1113/expphysiol.1983.sp002697; Royal College of Obstetricians and Gynaecologists, 2010, GREEN TOP GUID; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shen WH, 2003, AM J PHYSIOL-ENDOC M, V284, pE748, DOI 10.1152/ajpendo.00399.2002; Sloboda DM, 2005, AM J PHYSIOL-ENDOC M, V289, pE721, DOI 10.1152/ajpendo.00040.2005; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wu M, 2010, J CELL PHYSL, V226, P29; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	43	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52363	10.1371/journal.pone.0052363	http://dx.doi.org/10.1371/journal.pone.0052363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300651	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800072
J	Keyes, LR; Hargett, D; Soland, M; Bego, MG; Rossetto, CC; Almeida-Porada, G; St Jeor, S				Keyes, Lisa R.; Hargett, Danna; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen			HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14(+) Cells	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; HEMATOPOIETIC PROGENITOR CELLS; GENE-EXPRESSION; IN-VITRO; MODEL; MONOCYTES; TRANSCRIPT; DAXX	Human cytomegalovirus (HCMV) is a member of the Herpesviridae family that infects individuals throughout the world. Following an initial lytic stage, HCMV can persist in the individual for life in a non-active (or latent) form. During latency, the virus resides within cells of the myeloid lineage. The mechanisms controlling HCMV latency are not completely understood. A latency associated transcript, UL81-82ast, encoding the protein LUNA (Latency Unique Natural Antigen) was identified from latently infected donors in vivo. To address the role of the UL81-82ast protein product LUNA, in the context of the viral genome, we developed a recombinant HCMV bacterial artificial chromosome (BAC) that does not express LUNA. This construct, LUNA knockout FIX virus (FIX-Delta LUNA), was used to evaluate LUNA's role in HCMV latency. The FIX-Delta LUNA virus was able to lytically infect Human Fibroblast (HF) cells, showing that LUNA is not required to establish a lytic infection. Interestingly, we observed significantly higher viral copy numbers in HF cells infected with FIX-Delta LUNA when compared to FIX-WT virus. Furthermore, FIX-WT and FIX- Delta LUNA genomic DNA and transcription of UL81-82ast persisted over time in primary monocytes. In contrast, the levels of UL138 transcript expression in FIX-Delta LUNA infected HF and CD14(+) cells was 100 and 1000 fold lower (respectively) when compared to the levels observed for FIX-WT infection. Moreover, FIX-Delta LUNA virus failed to reactivate from infected CD14(+) cells following differentiation. This lack of viral reactivation was accompanied by a lack of lytic gene expression, increase in viral copy numbers, and lack of the production of infectious units following differentiation of the cells. Our study suggests that the LUNA protein is involved in regulating HCMV reactivation, and that in the absence of LUNA, HCMV may not be able to enter a proper latent state and therefore cannot be rescued from the established persistent infection in CD14(+) cells.	[Keyes, Lisa R.; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen] Univ Nevada, Dept Microbiol, Reno, NV 89557 USA; [Keyes, Lisa R.; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen] Univ Nevada, Grad Program Cell & Mol Biol, Reno, NV 89557 USA; [Hargett, Danna] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Princeton University	St Jeor, S (corresponding author), Univ Nevada, Dept Microbiol, Reno, NV 89557 USA.	stjeor@gmail.com		soland, Melisa/0000-0001-8217-9734; Rossetto, Cyprian/0000-0002-4415-0196; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	NIH [HL63470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063470] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by NIH grant HL63470. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Bego M, 2005, J VIROL, V79, P11022, DOI 10.1128/JVI.79.17.11022-11034.2005; Bego MG, 2006, EXP HEMATOL, V34, P555, DOI 10.1016/j.exphem.2005.11.012; Bego MG, 2011, ARCH VIROL, V156, P1847, DOI 10.1007/s00705-011-1027-7; Bego MG, 2011, ARCH VIROL; Beisser PS, 2001, J VIROL, V75, P5949, DOI 10.1128/JVI.75.13.5949-5957.2001; Cheung AKL, 2009, BLOOD, V114, P4128, DOI 10.1182/blood-2008-12-197111; CHUA CC, 1981, J GEN VIROL, V56, P1, DOI 10.1099/0022-1317-56-1-1; Goodrum F, 2004, BLOOD, V104, P687, DOI 10.1182/blood-2003-12-4344; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; GREFTE A, 1994, J GEN VIROL, V75, P1989, DOI 10.1099/0022-1317-75-8-1989; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Hwang JW, 2007, VIROLOGY, V367, P334, DOI 10.1016/j.virol.2007.05.037; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Kondo K, 1995, SCAND J INFECT DIS, P63; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; LaMarca HL, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-8; Landini MP, 2000, BIOL BLOOD MARROW TR, V6, P100, DOI 10.1016/S1083-8791(00)70072-3; MACIEJEWSKI JP, 1992, BLOOD, V80, P170; Maciejewski JP, 1999, LEUKEMIA LYMPHOMA, V33, P1; Patrone M, 2005, J VIROL, V79, P8361, DOI 10.1128/JVI.79.13.8361-8373.2005; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; Reeves MB, 2010, J GEN VIROL, V91, P599, DOI 10.1099/vir.0.015602-0; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Saffert RT, 2010, J VIROL, V84, P5594, DOI 10.1128/JVI.00348-10; Slobedman B, 2010, FUTURE MICROBIOL, V5, P883, DOI 10.2217/FMB.10.58; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Sorg G, 1998, J GEN VIROL, V79, P3039, DOI 10.1099/0022-1317-79-12-3039; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhuravskaya T, 1997, BLOOD, V90, P2482, DOI 10.1182/blood.V90.6.2482.2482_2482_2491	39	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52827	10.1371/journal.pone.0052827	http://dx.doi.org/10.1371/journal.pone.0052827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300789	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800154
J	Mercer, SE; Cheng, CH; Atkinson, DL; Krcmery, J; Guzman, CE; Kent, DT; Zukor, K; Marx, KA; Odelberg, SJ; Simon, HG				Mercer, Sarah E.; Cheng, Chia-Ho; Atkinson, Donald L.; Krcmery, Jennifer; Guzman, Claudia E.; Kent, David T.; Zukor, Katherine; Marx, Kenneth A.; Odelberg, Shannon J.; Simon, Hans-Georg			Multi-Tissue Microarray Analysis Identifies a Molecular Signature of Regeneration	PLOS ONE			English	Article							AMPHIBIAN LIMB REGENERATION; FIBROBLAST-GROWTH-FACTOR; ZEBRAFISH HEART REGENERATION; SPINAL-CORD REGENERATION; DIGIT TIP REGENERATION; LARGE GENE LISTS; INTERMEDIATE-FILAMENTS; LENS REGENERATION; NEWT LIMB; FIN REGENERATION	The inability to functionally repair tissues that are lost as a consequence of disease or injury remains a significant challenge for regenerative medicine. The molecular and cellular processes involved in complete restoration of tissue architecture and function are expected to be complex and remain largely unknown. Unlike humans, certain salamanders can completely regenerate injured tissues and lost appendages without scar formation. A parsimonious hypothesis would predict that all of these regenerative activities are regulated, at least in part, by a common set of genes. To test this hypothesis and identify genes that might control conserved regenerative processes, we performed a comprehensive microarray analysis of the early regenerative response in five regeneration-competent tissues from the newt Notophthalmus viridescens. Consistent with this hypothesis, we established a molecular signature for regeneration that consists of common genes or gene family members that exhibit dynamic differential regulation during regeneration in multiple tissue types. These genes include members of the matrix metalloproteinase family and its regulators, extracellular matrix components, genes involved in controlling cytoskeleton dynamics, and a variety of immune response factors. Gene Ontology term enrichment analysis validated and supported their functional activities in conserved regenerative processes. Surprisingly, dendrogram clustering and RadViz classification also revealed that each regenerative tissue had its own unique temporal expression profile, pointing to an inherent tissue-specific regenerative gene program. These new findings demand a reconsideration of how we conceptualize regenerative processes and how we devise new strategies for regenerative medicine.	[Mercer, Sarah E.; Krcmery, Jennifer; Guzman, Claudia E.; Simon, Hans-Georg] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Mercer, Sarah E.; Krcmery, Jennifer; Guzman, Claudia E.; Simon, Hans-Georg] Childrens Mem Res Ctr, Chicago, IL USA; [Cheng, Chia-Ho; Marx, Kenneth A.] Univ Massachusetts Lowell, Dept Chem, Lowell, MA USA; [Atkinson, Donald L.; Kent, David T.; Zukor, Katherine; Odelberg, Shannon J.] Univ Utah, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84112 USA	Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Lowell; Utah System of Higher Education; University of Utah	Simon, HG (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	hgsimon@northwestern.edu			DARPA; Restorative Injury Repair [BAA04-12]; Chicago Community Trust; Craig H. Neilsen Foundation; American Heart Association [11PRE5570021]; National Institutes of Health (NIH) [T-32 GM008061-27]; NIH [5T32 HL07576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Restorative Injury Repair; Chicago Community Trust; Craig H. Neilsen Foundation; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DARPA, Restorative Injury Repair BAA04-12 Addendum B (H.-G. Simon and S. Odelberg), Searle Funds at the Chicago Community Trust (H.-G. Simon), the Craig H. Neilsen Foundation (S. Odelberg), American Heart Association predoctoral fellowship 11PRE5570021 (S. Mercer), National Institutes of Health (NIH) Cellular and Molecular Basis of Disease training program T-32 GM008061-27 (S. Mercer), and NIH Cardiology Fellowship Training Grant 5T32 HL07576 (D. Kent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHEMIN M, 1994, INT J DEV BIOL, V38, P641; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bicknell KA, 2004, BIOCHEM J, V382, P411, DOI 10.1042/BJ20031481; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calve S, 2012, FASEB J; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Cameron DA, 2005, MOL VIS, V11, P775; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; CHERNOFF EAG, 1995, DEV GROWTH DIFFER, V37, P133; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; COMERA C, 1995, BRIT J PHARMACOL, V115, P1043, DOI 10.1111/j.1476-5381.1995.tb15916.x; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIS BM, 1990, EXP NEUROL, V108, P198, DOI 10.1016/0014-4886(90)90124-B; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; DelRioTsonis K, 1997, P NATL ACAD SCI USA, V94, P13701, DOI 10.1073/pnas.94.25.13701; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; Ferretti P, 2004, CURR NEUROVASC RES, V1, P215, DOI 10.2174/1567202043362397; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084952102000903; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grow M, 2006, DEV DYNAM, V235, P2667, DOI 10.1002/dvdy.20897; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Han MJ, 2001, DEV DYNAM, V220, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1085>3.0.CO;2-8; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Hoffman P, 1997, VISUALIZATION '97 - PROCEEDINGS, P437, DOI 10.1109/VISUAL.1997.663916; Holten-Andersen MN, 2004, EUR J CANCER, V40, P2159, DOI 10.1016/j.ejca.2004.06.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imokawa Y, 2004, PHILOS T R SOC B, V359, P765, DOI 10.1098/rstb.2004.1467; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; KIRCHHEIMER JC, 1987, THROMB RES, V48, P291, DOI 10.1016/0049-3848(87)90441-5; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Liu NK, 2007, J NEUROPATH EXP NEUR, V66, P932, DOI 10.1097/nen.0b013e3181567d59; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Marx KA, 2003, J CHEM INF COMP SCI, V43, P1652, DOI 10.1021/ci034050+; Marx KA, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P131; McCarthy JF, 2004, ANN NY ACAD SCI, V1020, P239, DOI 10.1196/annals.1310.020; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; Murciano C, 2002, DEV BIOL, V252, P214, DOI 10.1006/dbio.2002.0848; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012058; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip JG, 1998, REGUL PEPTIDES, V73, P133, DOI 10.1016/S0167-0115(97)01077-X; Pizette S, 2001, DEVELOPMENT, V128, P4463; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; POULIN ML, 1993, DEVELOPMENT, V119, P353; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; RAMAEKERS FCS, 1983, P NATL ACAD SCI-BIOL, V80, P2618, DOI 10.1073/pnas.80.9.2618; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shimazaki Y, 2001, DEV COMP IMMUNOL, V25, P467, DOI 10.1016/S0145-305X(01)00007-6; SIMON HG, 1993, DEVELOPMENT, V117, P1397; SIMON HG, 1995, DEV DYNAM, V202, P1, DOI 10.1002/aja.1002020102; Simon HG, 2002, CELL MOL LIFE SCI, V59, P1264, DOI 10.1007/s00018-002-8505-8; Simon HG, 1996, GENE, V172, P175, DOI 10.1016/0378-1119(96)00015-7; Singh BN, 2010, J CARDIOVASC TRANSL; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Stevenson TJ, 2006, DEV DYNAM, V235, P606, DOI 10.1002/dvdy.20654; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Tanaka EM, 1999, CURR BIOL, V9, P792, DOI 10.1016/S0960-9822(99)80362-5; Tazaki A, 2005, DEV DYNAM, V233, P1394, DOI 10.1002/dvdy.20472; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; TSONIS PA, 1982, DEV GROWTH DIFFER, V24, P183; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Tsonis PA, 2008, CURR STEM CELL RES T, V3, P53, DOI 10.2174/157488808783489408; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walder S, 2003, DEV GENES EVOL, V213, P625, DOI 10.1007/s00427-003-0364-2; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang F, 2000, DEV BIOL, V225, P381, DOI 10.1006/dbio.2000.9843; ZILAKOS NP, 1992, CANCER RES, V52, P4858; Zukor KA, 2010, DEV DYNAM, V239, P3048, DOI 10.1002/dvdy.22441	129	29	29	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52375	10.1371/journal.pone.0052375	http://dx.doi.org/10.1371/journal.pone.0052375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300656	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800076
J	Miller, HD; Clark, BW; Hinton, DE; Whitehead, A; Martin, S; Kwok, KW; Kullman, SW				Miller, Hilary D.; Clark, Bryan W.; Hinton, David E.; Whitehead, Andrew; Martin, Stan; Kwok, Kevin W.; Kullman, Seth W.			Anchoring Ethinylestradiol Induced Gene Expression Changes with Testicular Morphology and Reproductive Function in the Medaka	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; FROG RANA-ESCULENTA; MALE GERM-CELLS; ORYZIAS-LATIPES; ESTROGEN-RECEPTOR; C-MYC; GONADAL DEVELOPMENT; FERTILIZATION SUCCESS	Environmental estrogens are ubiquitous in the environment and can cause detrimental effects on male reproduction. In fish, a multitude of effects from environmental estrogens have been observed including altered courting behavior and fertility, sex reversal, and gonadal histopathology. However, few studies in fish assess the impacts of estrogenic exposure on a physiological endpoint, such as reproduction, as well as the associated morphologic response and underlying global gene expression changes. This study assessed the implications of a 14 day sub-chronic exposure of ethinylestradiol (EE2; 1.0 or 10.0 mu g/L EE2) on male medaka fertility, testicular histology and testicular gene expression. The findings demonstrate that a 14 day exposure to EE2 induced impaired male reproductive capacity and time- and dose-dependent alterations in testicular morphology and gene expression. The average fertilization rate/day following the exposure for control, 1.0 and 10.0 mu g/L EE2 was 91.3% (+/- 4.4), 62.8% (+/- 8.3) and 28.8% (+/- 5.8), respectively. The testicular morphologic alterations included increased germ cell apoptosis, decreased germinal epithelium and thickening of the interstitium. These changes were highly associated with testicular gene expression changes using a medaka-specific microarray. A pathway analysis of the differentially expressed genes emphasized genes and pathways associated with apoptosis, cell cycle and proliferation, collagen production/extracellular matrix organization, hormone signaling, male reproduction and protein ubiquitination among others. These findings highlight the importance of anchoring global gonadal gene expression changes with morphology and ultimately with tissue/organ function.	[Miller, Hilary D.; Clark, Bryan W.] Duke Univ, Nicholas Sch Environm, Integrated Toxicol & Environm Hlth Program, Durham, NC 27708 USA; [Whitehead, Andrew] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Martin, Stan] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Kullman, Seth W.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	Duke University; University of California System; University of California Davis; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kullman, SW (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	swkullma@ncsu.edu	Whitehead, Andrew/G-2122-2012	Kullmam, Seth/0000-0002-6029-2266; Kwok, Kevin Wing Hin/0000-0003-3264-134X	National Institute of Environmental Health Sciences (NIEHS) [T3207031, P42ES010356]; Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS) [NIEHS P30ES03828]; National Institutes of Health (NIH) National Center for Research Resources (NCRR) [NCRR 1R01RR018583]; NIH National Cancer Institute (NCI) [NCI R21CA106084-01A1]; Water Environment Research Foundation (WERF) [01-HHE-22-T]; North Carolina Biotechnology Center [ARG0030]; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE [R21CA106084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, P30ES003828] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS); National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Water Environment Research Foundation (WERF); North Carolina Biotechnology Center; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in-part by National Institute of Environmental Health Sciences Institutional Training Grant funded Duke University Integrated Toxicology and Environmental Health Program (NIEHS T3207031), Duke University Superfund Basic Research Program (NIEHS P42ES010356), and Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS P30ES03828), National Institutes of Health (NIH) National Center for Research Resources (NCRR 1R01RR018583) and NIH National Cancer Institute (NCI R21CA106084-01A1), Water Environment Research Foundation (WERF) (01-HHE-22-T), and North Carolina Biotechnology Center (ARG0030), as well as Fred and Alice Stanback. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Y, 1999, ENVIRON TOXICOL CHEM, V18, P1791, DOI 10.1002/etc.5620180827; Almog T, 2008, MOL CELL ENDOCRINOL, V282, P39, DOI 10.1016/j.mce.2007.11.011; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Aoki J, 2010, SCI TOTAL ENVIRON, V408, P660, DOI 10.1016/j.scitotenv.2009.08.009; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; Balch GC, 2004, ENVIRON TOXICOL CHEM, V23, P782, DOI 10.1897/02-539; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bouskine A, 2008, ENDOCRINOLOGY, V149, P565, DOI 10.1210/en.2007-1318; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Carreau S, 2010, PHILOS T R SOC B, V365, P1517, DOI 10.1098/rstb.2009.0235; Chieffi P, 2002, MOL REPROD DEV, V61, P218, DOI 10.1002/mrd.1151; CHIEFFI P, 1995, GEN COMP ENDOCR, V99, P127, DOI 10.1006/gcen.1995.1093; Chieffi P, 2000, J ENDOCRINOL, V167, P77, DOI 10.1677/joe.0.1670077; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Dolci S, 2001, J BIOL CHEM, V276, P40225, DOI 10.1074/jbc.M105143200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ewen K, 2010, BIOL REPROD, V83, P1005, DOI 10.1095/biolreprod.110.086801; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Foran CM, 2002, TOXICOL SCI, V68, P389, DOI 10.1093/toxsci/68.2.389; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; GRIER HJ, 1981, AM ZOOL, V21, P345; GRIER HJ, 1976, CELL TISSUE RES, V168, P419, DOI 10.1007/BF00215993; Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/reprod/122.6.857; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Harshbarger JC, 2000, MAR ENVIRON RES, V50, P247, DOI 10.1016/S0141-1136(00)00055-6; Hashimoto S, 2009, ARCH ENVIRON CON TOX, V56, P253, DOI 10.1007/s00244-008-9183-9; Hinck JE, 2009, AQUAT TOXICOL, V95, P60, DOI 10.1016/j.aquatox.2009.08.001; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Islinger M, 2003, AQUAT TOXICOL, V62, P85, DOI 10.1016/S0166-445X(02)00049-8; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Johnson R., 2009, OECD GUIDANCE DCUMEN; Kang IJ, 2002, CHEMOSPHERE, V47, P71, DOI 10.1016/S0045-6535(01)00205-3; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kieffer E, 2010, M S-MED SCI, V26, P848, DOI 10.1051/medsci/20102610848; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kirchen R. V, 1976, JAPANESE MEDAKA ITS; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Koulish S, 2002, J MORPHOL, V254, P292, DOI 10.1002/jmor.10037; Kuch HM, 2000, FRESEN J ANAL CHEM, V366, P392, DOI 10.1007/s002160050080; Kullman SW, 2003, ENV SCI, V10, P223; Lange A, 2009, ENVIRON SCI TECHNOL, V43, P1219, DOI 10.1021/es802661p; Lange A, 2011, ENVIRON SCI TECHNOL, V45, P1673, DOI 10.1021/es103232q; Larsson DGJ, 1999, AQUAT TOXICOL, V45, P91, DOI 10.1016/S0166-445X(98)00112-X; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Levens D, 2002, P NATL ACAD SCI USA, V99, P5757, DOI 10.1073/pnas.102173199; Lo Nostro FL, 2004, TISSUE CELL, V36, P221, DOI 10.1016/j.tice.2004.03.001; LOIR M, 1995, MICROSC RES TECHNIQ, V32, P533, DOI 10.1002/jemt.1070320606; Lu CX, 2005, PEDIATR RES, V57, p70R, DOI 10.1203/01.PDR.0000159573.55187.CA; Luconi M, 2002, J STEROID BIOCHEM, V80, P369, DOI 10.1016/S0960-0760(02)00041-9; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Matsui Y, 1998, APMIS, V106, P142, DOI 10.1111/j.1699-0463.1998.tb01329.x; McCabe ERB, 2007, MOL CELL ENDOCRINOL, V265, P179, DOI 10.1016/j.mce.2006.12.017; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; Niakan KK, 2005, MOL GENET METAB, V86, P70, DOI 10.1016/j.ymgme.2005.07.019; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Palace VP, 2006, ENVIRON TOXICOL CHEM, V25, P1114, DOI 10.1897/04-557R1.1; Parenti LR, 2004, INTEGR COMP BIOL, V44, P333, DOI 10.1093/icb/44.5.333; Parrott JL, 2005, ENVIRON TOXICOL, V20, P131, DOI 10.1002/tox.20087; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI 10.1897/1551-5028(2002)021&lt;1692:EOEOTR&gt;2.0.CO;2; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Stabile V, 2006, REPRODUCTION, V132, P477, DOI 10.1530/rep.1.01107; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; TABAK HH, 1981, DEV IND MICROBIOL, V22, P497; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Tilton SC, 2005, ENVIRON TOXICOL CHEM, V24, P352, DOI 10.1897/04-016R.1; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; Van der Ven LTM, 2003, ENVIRON TOXICOL CHEM, V22, P908, DOI [10.1897/1551-5028(2003)022&lt;0908:HAATFT&gt;2.0.CO;2, 10.1002/etc.5620220431]; Vicini E, 2006, J CELL PHYSIOL, V206, P238, DOI 10.1002/jcp.20454; Vigano L, 2001, SCI TOTAL ENVIRON, V269, P189, DOI 10.1016/S0048-9697(00)00821-4; Volz DC, 2006, TOXICOL SCI, V89, P524, DOI 10.1093/toxsci/kfj033; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Weber LP, 2004, ENVIRON TOXICOL CHEM, V23, P792, DOI 10.1897/02-570; Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xu H, 2008, AQUAT TOXICOL, V88, P1, DOI 10.1016/j.aquatox.2008.01.020; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	92	22	24	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52479	10.1371/journal.pone.0052479	http://dx.doi.org/10.1371/journal.pone.0052479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300682	gold, Green Published			2022-12-27	WOS:000313618800094
J	Rodrigues, PH; Reyes, L; Chadda, AS; Belanger, M; Wallet, SM; Akin, D; Dunn, W; Progulske-Fox, A				Rodrigues, Paulo H.; Reyes, Leticia; Chadda, Amandeep S.; Belanger, Myriam; Wallet, Shannon M.; Akin, Debra; Dunn, William, Jr.; Progulske-Fox, Ann			Porphyromonas gingivalis Strain Specific Interactions with Human Coronary Artery Endothelial Cells: A Comparative Study	PLOS ONE			English	Article							FIMBRIA-DEPENDENT ACTIVATION; ABDOMINAL AORTIC-ANEURYSMS; POLYMERASE-CHAIN-REACTION; EPITHELIAL-CELLS; CHRONIC PERIODONTITIS; CARDIOVASCULAR-DISEASE; ATHEROSCLEROTIC PLAQUE; IMMUNE-RESPONSE; FIMA GENOTYPES; INVASION	Both epidemiologic and experimental findings suggest that infection with Porphyromonas gingivalis exacerbates progression of atherosclerosis. As P. gingivalis exhibits significant strain variation, it is reasonable that different strains possess different capabilities and/or mechanisms by which they promote atherosclerosis. Using P. gingivalis strains that have been previously evaluated in the ApoE null atherosclerosis model, we assessed the ability of W83, A7436, 381, and 33277 to adhere, invade, and persist in human coronary artery endothelial (HCAE) cells. W83 and 381 displayed an equivalent ability to adhere to HCAE cells, which was significantly greater than both A7436 and 33277 (P<0.01). W83, 381, and 33277 were more invasive than A7436 (P<0.0001). However, only W83 and A7436 were able to remain viable up to 48 hours in HCAE cell cultures, whereas 381 was cleared by 48 hours and 33277 was cleared by 24 hours. These differences in persistence were in part due to strain specific differences in intracellular trafficking. Both W83 and 381 trafficked through the autophagic pathway, but not A7436 or 33277. Internalized 381 was the only strain that was dependent upon the autophagic pathway for its survival. Finally, we assessed the efficacy of these strains to activate HCAE cells as defined by production of IL-6, IL-8, IL-12p40, MCP-1, RANTES, TNF-alpha, and soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin). Only moderate inflammation was observed in cells infected with either W83 or A7436, whereas cells infected with 381 exhibited the most profound inflammation, followed by cells infected with 33277. These results demonstrate that virulence mechanisms among different P. gingivalis strains are varied and that pathogenic mechanisms identified for one strain are not necessarily applicable to other strains.	[Rodrigues, Paulo H.; Reyes, Leticia; Chadda, Amandeep S.; Belanger, Myriam; Wallet, Shannon M.; Progulske-Fox, Ann] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Rodrigues, Paulo H.; Reyes, Leticia; Chadda, Amandeep S.; Belanger, Myriam; Wallet, Shannon M.; Progulske-Fox, Ann] Univ Florida, Ctr Mol Microbiol, Gainesville, FL USA; [Akin, Debra; Dunn, William, Jr.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA; [Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Reyes, L (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	lreyes@ufl.edu	Reyes, Leticia/H-7338-2019; Rodrigues, Paulo/O-2689-2017	Rodrigues, Paulo/0000-0002-4646-6805	National Institutes of Heath [5R01DE013545-10]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013545] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by the National Institutes of Heath, grant number 5R01DE013545-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Amano A, 2000, J DENT RES, V79, P1664, DOI 10.1177/00220345000790090501; Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Amar S, 2009, J IMMUNOL, V182, P1584, DOI 10.4049/jimmunol.182.3.1584; Aoyama N, 2012, J PERIODONTAL RES, V47, P463, DOI 10.1111/j.1600-0765.2011.01454.x; Aoyama N, 2011, J PERIODONTAL RES, V46, P176, DOI 10.1111/j.1600-0765.2010.01326.x; Belanger M, 2007, CURR PROTOC MICROBIO; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Brodala N, 2005, ARTERIOSCL THROM VAS, V25, P1446, DOI 10.1161/01.ATV.0000167525.69400.9c; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; Carrion J, 2012, J IMMUNOL, V189, P3178, DOI 10.4049/jimmunol.1201053; Chen T, 2004, MICROB PATHOGENESIS, V36, P205, DOI 10.1016/j.micpath.2003.12.001; Chou HH, 2005, INFECT IMMUN, V73, P5367, DOI 10.1128/IAI.73.9.5367-5378.2005; Delbosc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018679; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Fukasawa A, 2011, IMMUNOPHARMACOL IMMU; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hokamura K, 2010, J PERIODONTAL RES, V45, P337, DOI 10.1111/j.1600-0765.2009.01242.x; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Inaba H, 2009, FEBS LETT, V583, P128, DOI 10.1016/j.febslet.2008.11.036; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Khlgatian M, 2002, INFECT IMMUN, V70, P257, DOI 10.1128/IAI.70.1.257-267.2002; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Mahendra Jaideep, 2010, Indian J Dent Res, V21, P248, DOI 10.4103/0970-9290.66649; Castillo DM, 2011, J CLIN PERIODONTOL, V38, P418, DOI 10.1111/j.1600-051X.2011.01717.x; Marcelino SL, 2010, ANAEROBE, V16, P629, DOI 10.1016/j.anaerobe.2010.08.007; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Nakagawa I, 2002, INFECT IMMUN, V70, P277, DOI 10.1128/IAI.70.1.277-285.2002; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; Nakano K, 2011, ORAL DIS, V17, P370, DOI 10.1111/j.1601-0825.2010.01759.x; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Padilla C, 2006, J PERIODONTAL RES, V41, P350, DOI 10.1111/j.1600-0765.2006.00882.x; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Pereira RB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-80; Pollreisz A, 2010, J PERIODONTAL RES, V45, P239, DOI 10.1111/j.1600-0765.2009.01225.x; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; Progulske-Fox A, 1999, J PERIODONTAL RES, V34, P393, DOI 10.1111/j.1600-0765.1999.tb02272.x; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Rodrigues PH, 2005, INFECT IMMUN, V73, P6169, DOI 10.1128/IAI.73.9.6169-6173.2005; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Singh A, 2011, INFECT IMMUN, V79, P4533, DOI 10.1128/IAI.05016-11; Song H, 2005, INFECT IMMUN, V73, P7267, DOI 10.1128/IAI.73.11.7267-7273.2005; Takahashi Y, 2006, CELL MICROBIOL, V8, P738, DOI 10.1111/j.1462-5822.2005.00661.x; Takeuchi Hiroki, 2011, Commun Integr Biol, V4, P587, DOI 10.4161/cib.4.5.16549; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Vita JA, 2002, CIRCULATION, V106, P164, DOI 10.1161/01.CIR.0000023452.26135.34; Wada K, 2010, J PHARMACOL SCI, V113, P115, DOI 10.1254/jphs.09R22FM; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; Yamatake K, 2007, INFECT IMMUN, V75, P2090, DOI 10.1128/IAI.01013-06; Yuan L, 2008, MICROBIOL-SGM, V154, P1161, DOI 10.1099/mic.0.2007/015131-0; Yumoto H, 2005, INFECT IMMUN, V73, P8050, DOI 10.1128/IAI.73.12.8050-8059.2005; Zaremba M, 2007, J PERIODONTOL, V78, P322, DOI 10.1902/jop.2006.060081; Zhang Yan-lin, 2010, Zhonghua Yi Xue Za Zhi, V90, P2792	74	43	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52606	10.1371/journal.pone.0052606	http://dx.doi.org/10.1371/journal.pone.0052606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300720	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800111
J	Grimes, ML; Lee, WJ; Van der Maaten, L; Shannon, P				Grimes, Mark L.; Lee, Wan-Jui; Van der Maaten, Laurens; Shannon, Paul			Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways	PLOS ONE			English	Article							SRC FAMILY KINASES; LUNG-CANCER; NETWORKS; RECEPTOR; GENE; CYTOSCAPE; BIOINFORMATICS; VISUALIZATION; COMBINATION; SOFTWARE	The interpretation of biological data sets is essential for generating hypotheses that guide research, yet modern methods of global analysis challenge our ability to discern meaningful patterns and then convey results in a way that can be easily appreciated. Proteomic data is especially challenging because mass spectrometry detectors often miss peptides in complex samples, resulting in sparsely populated data sets. Using the R programming language and techniques from the field of pattern recognition, we have devised methods to resolve and evaluate clusters of proteins related by their pattern of expression in different samples in proteomic data sets. We examined tyrosine phosphoproteomic data from lung cancer samples. We calculated dissimilarities between the proteins based on Pearson or Spearman correlations and on Euclidean distances, whilst dealing with large amounts of missing data. The dissimilarities were then used as feature vectors in clustering and visualization algorithms. The quality of the clusterings and visualizations were evaluated internally based on the primary data and externally based on gene ontology and protein interaction networks. The results show that t-distributed stochastic neighbor embedding (t-SNE) followed by minimum spanning tree methods groups sparse proteomic data into meaningful clusters more effectively than other methods such as k-means and classical multidimensional scaling. Furthermore, our results show that using a combination of Spearman correlation and Euclidean distance as a dissimilarity representation increases the resolution of clusters. Our analyses show that many clusters contain one or more tyrosine kinases and include known effectors as well as proteins with no known interactions. Visualizing these clusters as networks elucidated previously unknown tyrosine kinase signal transduction pathways that drive cancer. Our approach can be applied to other data types, and can be easily adopted because open source software packages are employed.	[Grimes, Mark L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lee, Wan-Jui; Van der Maaten, Laurens] Delft Univ Technol, Pattern Recognit & Bioinformat Grp, Cd Delft, Netherlands; [Shannon, Paul] Fred Hutchison Canc Res Inst, Seattle, WA USA	University of Montana System; University of Montana; Delft University of Technology; Fred Hutchinson Cancer Center	Grimes, ML (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	Mark.Grimes@mso.umt.edu			National Institutes of Health (NIH) [NS070746-01, NS061303-01]; COBRE NCRR [P20 RR015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070746, R15NS061303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG was supported by National Institutes of Health (NIH) NS070746-01, NS061303-01, and COBRE NCRR grant P20 RR015583. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044982; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belani CP, 2012, CANCER TREAT REV, V38, P173, DOI 10.1016/j.ctrv.2011.05.009; Bennetzen MV, 2012, J PROTEOME RES, V11, P3480, DOI 10.1021/pr300016e; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bot JJ, 2011, BIOINFORMATICS, V27, P2451, DOI 10.1093/bioinformatics/btr388; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Celton M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-15; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Clery D, 2011, SCIENCE, V333, P173, DOI 10.1126/science.333.6039.173; Cuesta-Albertos JA, 1997, ANN STAT, V25, P553; Duin RPW, 2012, PATTERN RECOGN LETT, V33, P826, DOI 10.1016/j.patrec.2011.04.019; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Engholm-Keller K, 2012, J PROTEOMICS, V75, P5749, DOI 10.1016/j.jprot.2012.08.007; Gabow H. N., 1977, SIAM Journal on Computing, V6, P139, DOI 10.1137/0206011; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Gilmore JM, 2012, ANAL BIOANAL CHEM, V402, P711, DOI 10.1007/s00216-011-5466-5; Goh WWB, 2012, PROTEOMICS, V12, P550, DOI 10.1002/pmic.201100321; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Ibba A., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3360, DOI 10.1109/ICPR.2010.820; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jianu R, 2010, IEEE T VIS COMPUT GR, V16, P609, DOI 10.1109/TVCG.2009.106; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; Lopez Elena, 2011, J Clin Bioinforma, V1, P26, DOI 10.1186/2043-9113-1-26; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Naegle KM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002119; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pekalska E, 2006, PATTERN RECOGN, V39, P189, DOI 10.1016/j.patcog.2005.06.012; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Salakhutdinov R., 2007, P 24 INT C MACHINE L, P791, DOI 10.1145/1273496.1273596; Sasaki H, 2012, ONCOL LETT, V4, P33, DOI 10.3892/ol.2012.684; SCHAAB C, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.014068; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Srebro N., 2003, P 20 INT C MACHINE L, P720; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tufte ER, 2001, GRAPHICS PR, P1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Wu XD, 2012, CANCER TREAT REV, V38, P580, DOI 10.1016/j.ctrv.2012.02.013; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	64	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52884	10.1371/journal.pone.0052884	http://dx.doi.org/10.1371/journal.pone.0052884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300999	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000020
J	Guensch, DP; Fischer, K; Flewitt, JA; Friedrich, MG				Guensch, Dominik P.; Fischer, Kady; Flewitt, Jacqueline A.; Friedrich, Matthias G.			Impact of Intermittent Apnea on Myocardial Tissue Oxygenation-A Study Using Oxygenation-Sensitive Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							CORONARY BLOOD-FLOW; ARTERY-DISEASE INSIGHTS; SIGNAL RESPONSE; CARBON-DIOXIDE; 3 TESLA; HYPERCAPNIA; PERFUSION; MODEL; STATE; HYPOXIA	Background: Carbon dioxide (CO2) is a recognized vasodilator of myocardial blood vessels that leads to changes in myocardial oxygenation through the recruitment of the coronary flow reserve. Yet, it is unknown whether changes of carbon dioxide induced by breathing maneuvers can be used to modify coronary blood flow and thus myocardial oxygenation. Oxygenation-sensitive cardiovascular magnetic resonance (CMR) using the blood oxygen level-dependent (BOLD) effect allows for non-invasive monitoring of changes of myocardial tissue oxygenation. We hypothesized that mild hypercapnia induced by long breath-holds leads to changes in myocardial oxygenation that can be detected by oxygenation-sensitive CMR. Methods and Results: In nine anaesthetized and ventilated pigs, 60s breath-holds were induced. Left ventricular myocardial and blood pool oxygenation changes, as monitored by oxygenation-sensitive CMR using a T2*-weighted steady-state-free-precession (SSFP) sequence at 1.5T, were compared to changes of blood gas levels obtained immediately prior to and after the breath-hold. Long breath-holds resulted in an increase of paCO(2), accompanied by a decrease of paO(2) and pH. There was a significant decrease of blood pressure, while heart rate did not change. A decrease in the left ventricular blood pool oxygenation was observed, which was similar to drop in SaO(2). Oxygenation in the myocardial tissue however, was maintained throughout the period. Changes in myocardial oxygenation were strongly correlated with the change in paCO(2) during the breath-hold (r = 0.90, p = 0.010). Conclusion: Despite a drop in blood oxygen levels, myocardial oxygenation is maintained throughout long breath-holds and is linearly correlated with the parallel increase of arterial CO2, a known coronary vasodilator. Breathing maneuvers in combination with oxygenation-sensitive CMR may be useful as a diagnostic test for coronary artery function.	[Guensch, Dominik P.; Fischer, Kady; Flewitt, Jacqueline A.; Friedrich, Matthias G.] Univ Calgary, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci & Radiol, Calgary, AB, Canada; [Fischer, Kady; Friedrich, Matthias G.] Univ Montreal, CMR Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Universite de Montreal	Friedrich, MG (corresponding author), Univ Calgary, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci & Radiol, Calgary, AB, Canada.	mgwfriedrich@gmail.com	Friedrich, Matthias/H-8474-2015	Friedrich, Matthias/0000-0003-1204-5647; Gunsch, Dominik/0000-0003-4127-4086; Fischer, Kady/0000-0002-7765-4550	The Husky Energy Inc.	The Husky Energy Inc.	The Husky Energy Inc., as part of the Husky Energy Program for the Early Detection of Cardiovascular Disease, sponsored this investigation, yet did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2004, J APPL PHYSIOL, V97, P149, DOI 10.1152/japplphysiol.01385.2003; ALELLA A, 1955, AM J PHYSIOL, V183, P570, DOI 10.1152/ajplegacy.1955.183.3.570; Arellano R, 1999, CRIT CARE MED, V27, P2729, DOI 10.1097/00003246-199912000-00021; Arnold JR, 2012, J AM COLL CARDIOL, V59, P1954, DOI 10.1016/j.jacc.2012.01.055; ATALAY MK, 1995, MAGNET RESON MED, V34, P623, DOI 10.1002/mrm.1910340420; Bauer WR, 1999, PHYS REV LETT, V83, P4215, DOI 10.1103/PhysRevLett.83.4215; Bauer WR, 1999, MAGN RESON MED, V42, P1004, DOI 10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M; Beaudin AE, 2011, AM J PHYSL HEART CIR; BROTEN TP, 1991, CIRC RES, V68, P531, DOI 10.1161/01.RES.68.2.531; CASE RB, 1976, CIRC RES, V39, P558, DOI 10.1161/01.RES.39.4.558; Dharmakumar R, 2006, MAGN RESON MED, V55, P1372, DOI 10.1002/mrm.20911; ELIADES D, 1986, CARDIOVASC RES, V20, P127, DOI 10.1093/cvr/20.2.127; Fieno DS, 2004, CIRCULATION, V110, P1284, DOI 10.1161/01.CIR.0000140673.13057.34; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Hsu YY, 2010, J MAGN RESON IMAGING, V31, P78, DOI 10.1002/jmri.22015; Kannurpatti SS, 2002, MAGN RESON MED, V47, P864, DOI 10.1002/mrm.10131; Karamitsos TD, 2010, CIRC-CARDIOVASC IMAG, V3, P32, DOI 10.1161/CIRCIMAGING.109.860148; KASSAB GS, 1994, AM J PHYSIOL-HEART C, V267, pH2100, DOI 10.1152/ajpheart.1994.267.6.H2100; KELMAN GR, 1966, J APPL PHYSIOL, V21, P1375, DOI 10.1152/jappl.1966.21.4.1375; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KOEHLER RC, 1980, AM J PHYSIOL, V239, pH545, DOI 10.1152/ajpheart.1980.239.4.H545; KUO L, 1995, AM J PHYSIOL-HEART C, V269, pH541, DOI 10.1152/ajpheart.1995.269.2.H541; Li DB, 1996, MAGNET RESON MED, V36, P16, DOI 10.1002/mrm.1910360105; MANKA R, 2010, J CARDIOVASC MAGN R, V12, DOI DOI 10.1186/1532-429X-12-54; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Rioja E, 2010, AM J VET RES, V71, P24, DOI 10.2460/ajvr.71.1.24; ROTHE CF, 1985, AM J PHYSIOL, V249, P1061; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Shea SM, 2005, RADIOLOGY, V236, P503, DOI 10.1148/radiol.2362040149; VARJAVAND N, 2000, MAGN RESON MED, DOI DOI 10.1002/MRM.20911; Vohringer M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-20; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5	33	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53282	10.1371/journal.pone.0053282	http://dx.doi.org/10.1371/journal.pone.0053282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301055	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000046
J	Hamilton, ST; Scott, G; Naing, Z; Iwasenko, J; Hall, B; Graf, N; Arbuckle, S; Craig, ME; Rawlinson, WD				Hamilton, Stuart T.; Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Hall, Beverley; Graf, Nicole; Arbuckle, Susan; Craig, Maria E.; Rawlinson, William D.			Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy Outcomes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; TERM PLACENTAE; IN-VITRO; INFECTION; EXPRESSION; INDUCTION; TRANSMISSION; PROTEIN-1; APOPTOSIS	Human cytomegalovirus (CMV) infection of the developing fetus can result in adverse pregnancy outcomes including death in utero. Fetal injury results from direct viral cytopathic damage to the CMV-infected fetus, although evidence suggests CMV placental infection may indirectly cause injury to the fetus, possibly via immune dysregulation with placental dysfunction. This study investigated the effects of CMV infection on expression of the chemokine MCP-1 (CCL2) and cytokine TNF-alpha in placentae from naturally infected stillborn babies, and compared these changes with those found in placental villous explant histocultures acutely infected with CMV ex vivo. Tissue cytokine protein levels were assessed using quantitative immunohistochemistry. CMV-infected placentae from stillborn babies had significantly elevated MCP-1 and TNF-alpha levels compared with uninfected placentae (p = 0.001 and p = 0.007), which was not observed in placentae infected with other microorganisms (p = 0.62 and p = 0.71) (n = 7 per group). Modelling acute clinical infection using ex vivo placental explant histocultures showed infection with CMV laboratory strain AD169 (0.2 pfu/ml) caused significantly elevated expression of MCP-1 and TNF-alpha compared with uninfected explants (p = 0.0003 and p<0.0001) (n = 25 per group). Explant infection with wild-type Merlin at a tenfold lower multiplicity of infection (0.02 pfu/ml), caused a significant positive correlation between increased explant infection and upregulation of MCP-1 and TNF-alpha expression (p = 0.0001 and p = 0.017). Cytokine dysregulation has been associated with adverse outcomes of pregnancy, and can negatively affect placental development and function. These novel findings demonstrate CMV infection modulates the placental immune environment in vivo and in a multicellular ex vivo model, suggesting CMV-induced cytokine modulation as a potential initiator and/or exacerbator of placental and fetal injury.	[Hamilton, Stuart T.; Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Hall, Beverley; Craig, Maria E.; Rawlinson, William D.] Prince Wales Hosp, Div Virol, SEALS Microbiol, Sydney, NSW, Australia; [Hamilton, Stuart T.; Scott, Gillian; Rawlinson, William D.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Graf, Nicole; Arbuckle, Susan] Childrens Hosp Westmead, Dept Histopathol, Sydney, NSW, Australia; [Craig, Maria E.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Craig, Maria E.] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney	Rawlinson, WD (corresponding author), Prince Wales Hosp, Div Virol, SEALS Microbiol, Sydney, NSW, Australia.	w.rawlinson@unsw.edu.au		Rawlinson, William/0000-0003-0988-7827; Craig, Maria E/0000-0001-6004-576X; Hamilton, Stuart/0000-0002-2170-4889	Stillbirth Foundation Australia	Stillbirth Foundation Australia	This work was supported by charitable grants from the Stillbirth Foundation Australia, www.stillbirthfoundation.org.au. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Briana DD, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65032; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P159, DOI 10.1080/713605644; Chan G, 2006, J PATHOL, V210, P111, DOI 10.1002/path.2025; Chan G, 2004, BIOL REPROD, V71, P797, DOI 10.1095/biolreprod.104.028118; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Esplin MS, 2005, PLACENTA, V26, P661, DOI 10.1016/j.placenta.2004.09.012; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026; Garcia-Lloret MI, 2000, J LEUKOCYTE BIOL, V68, P903; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; GENDRON RL, 1990, J REPROD FERTIL, V90, P395, DOI 10.1530/jrf.0.0900395; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P253, DOI 10.1007/s00795-003-0223-2; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325; Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x; Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Lopez H, 2011, PLACENTA, V32, P522, DOI 10.1016/j.placenta.2011.04.016; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06; Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210; McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004; Nigro G, 2011, CURR OPIN OBSTET GYN, V23, P123, DOI 10.1097/GCO.0b013e328342f1f6; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Scott GM, 2012, J INFECT DIS, V205, P1305, DOI 10.1093/infdis/jis186; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Steinborn A, 1998, OBSTET GYNECOL, V91, P329, DOI 10.1016/S0029-7844(97)00680-7; Tabata T, 2012, AM J PATHOL; Toder V, 2003, J ASSIST REPROD GEN, V20, P73, DOI 10.1023/A:1021740108284; Trincado DE, 2005, J INFECT DIS, V192, P650, DOI 10.1086/431999; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; VINCE G, 1992, CLIN EXP IMMUNOL, V88, P174; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004	51	58	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52899	10.1371/journal.pone.0052899	http://dx.doi.org/10.1371/journal.pone.0052899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300810	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872600034
J	Kazi, JU; Ronnstrand, L				Kazi, Julhash U.; Roennstrand, Lars			Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling	PLOS ONE			English	Article							CBL-DEPENDENT MANNER; C-CBL; NEGATIVE REGULATOR; FAMILY KINASES; LEUKEMIA; EXPRESSION; AUTOPHOSPHORYLATION; SUBTYPES; SYK; AML	Fms-like tyrosine kinase 3 (Flt3) is an important growth factor receptor in hematopoiesis. Gain-of-function mutations of the receptor contribute to the transformation of acute myeloid leukemia (AML). Src-like adaptor protein (SLAP) is an interaction partner of the E3 ubiquitin ligase Cbl that can regulate receptor tyrosine kinases-mediated signal transduction. In this study, we analyzed the role of SLAP in signal transduction downstream of the type III receptor tyrosine kinase Flt3. The results show that upon ligand stimulation SLAP stably associates with Flt3 through multiple phosphotyrosine residues in Flt3. SLAP constitutively interacts with oncogenic Flt3-ITD and co-localizes with Flt3 near the cell membrane. This association initiates Cbl-dependent receptor ubiquitination and degradation. Depletion of SLAP expression by shRNA in Flt3-transfected Ba/F3 cells resulted in a weaker activation of FL-induced PI3K-Akt and MAPK signaling. Meta-analysis of microarray data from patient samples suggests that SLAP mRNA is differentially expressed in different cancers and its expression was significantly increased in patients carrying the Flt3-ITD mutation. Thus, our data suggest a novel role of SLAP in different cancers and in modulation of receptor tyrosine kinase signaling apart from its conventional role in regulation of receptor stability.	[Kazi, Julhash U.; Roennstrand, Lars] Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Kazi, Julhash U./D-9190-2011	Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Cancer Society; Swedish Children's Cancer Organization; Swedish Research Council; ALF governmental clinical grant; Wenner Foundation; Gren Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Organization; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF governmental clinical grant; Wenner Foundation; Gren Foundation	This research was funded by the Swedish Cancer Society, the Swedish Children's Cancer Organization, the Swedish Research Council, and an ALF governmental clinical grant. J.U. Kazi was supported by Wenner-Gren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asyali MH, 2005, BIOINFORMATICS, V21, P644, DOI 10.1093/bioinformatics/bti036; Dragone LL, 2006, P NATL ACAD SCI USA, V103, P18202, DOI 10.1073/pnas.0608965103; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Hiragun T, 2006, J IMMUNOL, V177, P2047, DOI 10.4049/jimmunol.177.4.2047; Kazi JU, 2012, J BIOL CHEM, V287, P36509, DOI 10.1074/jbc.M112.376111; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Liontos LM, 2011, J IMMUNOL, V186, P1923, DOI 10.4049/jimmunol.0903292; Marasca R, 2006, LEUKEMIA, V20, P103, DOI 10.1038/sj.leu.2404000; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Roche S, 1998, CURR BIOL, V8, P975, DOI 10.1016/S0960-9822(98)70400-2; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Sirvent A, 2008, ONCOGENE, V27, P3494, DOI 10.1038/sj.onc.1211011; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Tang J, 1999, P NATL ACAD SCI USA, V96, P9775, DOI 10.1073/pnas.96.17.9775; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421	28	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53509	10.1371/journal.pone.0053509	http://dx.doi.org/10.1371/journal.pone.0053509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300935	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600105
J	Koutsoudakis, G; Perez-del-Pulgar, S; Gonzalez, P; Crespo, G; Navasa, M; Forns, X				Koutsoudakis, George; Perez-del-Pulgar, Sofia; Gonzalez, Patricia; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier			A Gaussia Luciferase Cell-Based System to Assess the Infection of Cell Culture- and Serum-Derived Hepatitis C Virus	PLOS ONE			English	Article							B TYPE-I; REPLICATION; EPIDEMIOLOGY; RECEPTOR	Robust replication of hepatitis C virus (HCV) in cell culture occurs only with the JFH-1 (genotype 2a) recombinant genome. The aim of this study was to develop a system for HCV infection quantification analysis and apply it for the selection of patient sera that may contain cell culture infectious viruses, particularly of the most clinically important genotype 1. Initially, a hepatoma cell line (designated Huh-7.5/EG(4A/4B)GLuc) was generated that stably expressed the enhanced green fluorescent protein (EGFP) fused in-frame to the secreted Gaussia luciferase via a recognition sequence of the viral NS3/4A protease. Upon HCV infection, NS3/4A cleaved at its signal and the Gaussia was secreted to the culture medium, thus facilitating the infection quantification. The Huh-7.5/EG(4A/4B)GLuc cell line provided a rapid and highly sensitive quantification of HCV infection in cell culture using JFH-1-derived viruses. Furthermore, the Huh-7.5/EG(4A/4B)GLuc cells were also shown to be a suitable host for the discovery of anti-HCV inhibitors by using known compounds that target distinct stages of the HCV life cycle; the Z-factor of this assay ranged from 0.72 to 0.75. Additionally, eighty-six sera derived from HCV genotype 1b infected liver transplant recipients were screened for their in vitro infection and replication potential. Approximately 12% of the sera contained in vitro replication-competent viruses, as deduced by the Gaussia signal, real time quantitative PCR, immunofluorescence and capsid protein secretion. We conclude that the Huh-7.5/EG(4A/4B)GLuc cell line is an excellent system not only for the screening of in vitro replication-competent serum-derived viruses, but also for the subsequent cloning of recombinant isolates. Additionally, it can be utilized for high-throughput screening of antiviral compounds.	[Koutsoudakis, George; Perez-del-Pulgar, Sofia; Gonzalez, Patricia; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Koutsoudakis, G (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	gkoutsou@clinic.ub.es	Navasa, Miquel/G-7958-2016	Navasa, Miquel/0000-0002-3130-9604; Forns, Xavier/0000-0002-8188-1764; Perez-del-Pulgar, Sofia/0000-0002-9890-300X; Crespo, Gonzalo/0000-0002-1178-4897	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad [PI11/01907]; Fondo Europeo de Desarrollo Regional (FEDER); Union Europea; Una manera de hacer Europa; Roche Organ Transplantation Research Foundation (ROTRF) [CI: 442035057]	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Union Europea; Una manera de hacer Europa; Roche Organ Transplantation Research Foundation (ROTRF)	X. Forns received a grant from Instituto de Salud Carlos III, Ministerio de Economia y Competitividad (PI11/01907), co-funded by Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa; and from the Roche Organ Transplantation Research Foundation (ROTRF, CI: 442035057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dragun J, 2011, AM J TRANSPLANT, V11, P767, DOI 10.1111/j.1600-6143.2011.03440.x; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kato N, 2000, CURR TOP MICROBIOL, V242, P261; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JC, 2005, ASSAY DRUG DEV TECHN, V3, P385, DOI 10.1089/adt.2005.3.385; Lee JW, 2003, CHEM COMMUN, P1852, DOI 10.1039/b303960a; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pan KL, 2009, ANTIMICROB AGENTS CH, V53, P4825, DOI 10.1128/AAC.00601-09; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	40	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53254	10.1371/journal.pone.0053254	http://dx.doi.org/10.1371/journal.pone.0053254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300900	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600075
J	Leung, L; Andrews-Zwilling, Y; Yoon, SY; Jain, S; Ring, K; Dai, J; Wang, MM; Tong, L; Walker, D; Huang, YD				Leung, Laura; Andrews-Zwilling, Yaisa; Yoon, Seo Yeon; Jain, Sachi; Ring, Karen; Dai, Jessica; Wang, Max Mu; Tong, Leslie; Walker, David; Huang, Yadong			Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; MESSENGER-RIBONUCLEIC-ACID; ALZHEIMERS-DISEASE; DENTATE GYRUS; TARGETED REPLACEMENT; ULTRASTRUCTURAL EVIDENCE; STEREOLOGICAL METHODS; REDUCED INHIBITION; ANDROGEN RECEPTORS	Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease (AD). ApoE4 has sex-dependent effects, whereby the risk of developing AD is higher in apoE4-expressing females than males. However, the mechanism underlying the sex difference, in relation to apoE4, is unknown. Previous findings indicate that apoE4 causes age-dependent impairments of hilar GABAergic interneurons in female mice, leading to learning and memory deficits. Here, we investigate whether the detrimental effects of apoE4 on hilar GABAergic interneurons are sex-dependent using apoE knock-in (KI) mice across different ages. We found that in female apoE-KI mice, there was an age-dependent depletion of hilar GABAergic interneurons, whereby GAD67- or somatostatin-positive-but not NPY-or parvalbumin-positive-interneuron loss was exacerbated by apoE4. Loss of these neuronal populations was correlated with the severity of spatial learning deficits at 16 months of age in female apoE4-KI mice; however, this effect was not observed in female apoE3-KI mice. In contrast, we found an increase in the numbers of hilar GABAergic interneurons with advancing age in male apoE-KI mice, regardless of apoE genotype. Moreover, male apoE-KI mice showed a consistent ratio of hilar inhibitory GABAergic interneurons to excitatory mossy cells approximating 1.5 that is independent of apoE genotype and age, whereas female apoE-KI mice exhibited an age-dependent decrease in this ratio, which was exacerbated by apoE4. Interestingly, there are no apoE genotype effects on GABAergic interneurons in the CA1 and CA3 subregions of the hippocampus as well as the entorhinal and auditory cortexes. These findings suggest that the sex-dependent effects of apoE4 on developing AD is in part attributable to inherent sex-based differences in the numbers of hilar GABAergic interneurons, which is further modulated by apoE genotype.	[Leung, Laura; Andrews-Zwilling, Yaisa; Yoon, Seo Yeon; Jain, Sachi; Ring, Karen; Dai, Jessica; Wang, Max Mu; Tong, Leslie; Walker, David; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Walker, David; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Leung, Laura; Andrews-Zwilling, Yaisa; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Jain, Sachi; Ring, Karen; Tong, Leslie; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu		Wang, Max/0000-0002-2810-8561	J. David Gladstone Institutes; National Institutes of Health [P01 AG022074, P30 NS065780, C06RR18928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes, National Institutes of Health grants P01 AG022074, P30 NS065780, and C06RR18928, and a gift from the S.D. Bechtel Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo S, 2008, LETT DRUG DES DISCOV, V5, P271, DOI 10.2174/157018008784619898; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; BAREGGI SR, 1982, ARCH NEUROL-CHICAGO, V39, P709, DOI 10.1001/archneur.1982.00510230035010; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; BEATTY WW, 1979, HORM BEHAV, V12, P112, DOI 10.1016/0018-506X(79)90017-5; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; CASTELLANO C, 1993, BEHAV NEURAL BIOL, V60, P123, DOI 10.1016/0163-1047(93)90215-4; CLANCY AN, 1992, LIFE SCI, V50, P409, DOI 10.1016/0024-3205(92)90375-Y; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Collinson N, 2002, J NEUROSCI, V22, P5572; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Fillit H, 1997, MATURITAS, V26, P159, DOI 10.1016/S0378-5122(97)01101-8; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Fukuda T, 1998, J COMP NEUROL, V395, P177, DOI 10.1002/(SICI)1096-9861(19980601)395:2<177::AID-CNE3>3.0.CO;2-#; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gill DA, 2010, BRAIN RES, V1331, P114, DOI 10.1016/j.brainres.2010.03.054; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; Grouselle D, 1998, NEUROSCI LETT, V255, P21, DOI 10.1016/S0304-3940(98)00698-3; Hajszan T, 2007, PROG BRAIN RES, V163, P399, DOI 10.1016/S0079-6123(07)63023-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1987, NEUROSCI LETT, V73, P192, DOI 10.1016/0304-3940(87)90016-4; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476; Hilke S, 2009, NEUROPEPTIDES, V43, P327, DOI 10.1016/j.npep.2009.04.005; Hu JH, 2004, NEUROREPORT, V15, P9, DOI 10.1097/00001756-200401190-00003; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Hunter JM, 2012, BRAIN RES, V1467, P120, DOI 10.1016/j.brainres.2012.05.048; Jinno S, 2009, HIPPOCAMPUS, V19, P1130, DOI 10.1002/hipo.20576; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Lloyd K G, 1986, Adv Neurol, V44, P1033; LOY R, 1988, DEV BRAIN RES, V39, P245, DOI 10.1016/0165-3806(88)90028-4; Luine, 1997, Stress, V2, P21; McAbee MD, 1998, ENDOCRINOLOGY, V139, P1738, DOI 10.1210/en.139.4.1738; McEwen BS, 1997, ACTA PAEDIATR, V86, P41; MCKINNEY TD, 1972, J MAMMAL, V53, P391, DOI 10.2307/1379187; Medina AE, 2001, PHARMACOL BIOCHEM BE, V68, P591, DOI 10.1016/S0091-3057(01)00466-X; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Milner TA, 2001, J COMP NEUROL, V429, P355; Mortensen EL, 2001, NEUROLOGY, V57, P89, DOI 10.1212/WNL.57.1.89; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Naftolin F, 1975, Adv Biosci, V15, P105; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Payami H, 1996, NEUROLOGY, V46, P126, DOI 10.1212/WNL.46.1.126; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pfankuch T, 2005, BRAIN RES, V1053, P88, DOI 10.1016/j.brainres.2005.06.028; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Seidl R, 2001, N-S ARCH PHARMACOL, V363, P139, DOI 10.1007/s002100000346; Shi J, 2012, ACTA BIOCH BIOPHYS S; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; Stoffel-Wagner B, 1998, BIOCHEM BIOPH RES CO, V244, P768, DOI 10.1006/bbrc.1998.8337; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tabori NE, 2005, NEUROSCIENCE, V130, P151, DOI 10.1016/j.neuroscience.2004.08.048; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Tokita K, 2005, EUR J PHARMACOL, V527, P111, DOI 10.1016/j.ejphar.2005.10.022; Vas CJ, 2001, INT PSYCHOGERIATR, V13, P439, DOI 10.1017/S1041610201007852; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Vepsalainen S, 2007, J NEUROL, V254, P1504, DOI 10.1007/s00415-007-0539-2; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Wang WZ, 2000, NEUROEPIDEMIOLOGY, V19, P194, DOI 10.1159/000026255; WEILAND NG, 1992, ENDOCRINOLOGY, V131, P2697, DOI 10.1210/en.131.6.2697; Weiland NG, 1997, J COMP NEUROL, V388, P603, DOI 10.1002/(SICI)1096-9861(19971201)388:4<603::AID-CNE8>3.0.CO;2-6; West M J, 2001, Folia Morphol (Warsz), V60, P11; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Xue SF, 2009, NEUROSCI LETT, V465, P181, DOI 10.1016/j.neulet.2009.09.002; Zappone CA, 2004, J NEUROSCI, V24, P853, DOI 10.1523/JNEUROSCI.1619-03.2004; ZIMMER R, 1984, ARCH NEUROL-CHICAGO, V41, P602, DOI 10.1001/archneur.1984.04210080010005	94	61	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53569	10.1371/journal.pone.0053569	http://dx.doi.org/10.1371/journal.pone.0053569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300939	Green Published, gold			2022-12-27	WOS:000313872600109
J	Tsai, YC; Hung, CC; Kuo, MC; Tsai, JC; Yeh, SM; Hwang, SJ; Chiu, YW; Kuo, HT; Chang, JM; Chen, HC				Tsai, Yi-Chun; Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Yeh, Shih-Meng; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun			Association of hsCRP, White Blood Cell Count and Ferritin with Renal Outcome in Chronic Kidney Disease Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACUTE-PHASE PROTEINS; CARDIOVASCULAR-DISEASE; SERUM FERRITIN; ALL-CAUSE; INFLAMMATION; DIALYSIS; MORTALITY; PROGRESSION; MARKERS	Inflammation is a pathogenic factor in renal injury, but whether inflammation is related to renal outcome in chronic kidney disease (CKD) patients is little known. We thus assess the association of inflammation and renal outcome in an advanced CKD cohort. This study analyzed the association between inflammatory markers, such as C-reactive protein (hsCRP), white blood cell (WBC) count and ferritin, renal replacement therapy (RRT) and rapid renal progression (estimated GFR slope<-6 ml/min/1.73 m(2)/y) in 3303 patients with stage 3-5 CKD. In all subjects, the mean hsCRP, WBC count, and ferritin levels were 1.2 (0.4, 5.4) mg/L, 7.2 +/- 2.3x10(3) cells/mu L, and 200 (107,349) ng/mL, respectively. During a mean 3.2-year follow-up, there were 1080 (32.7%) subjects commencing RRT, and 841(25.5%) subjects presenting rapid renal progression. Both hsCRP and ferritin were associated with increased risk for RRT with the adjusted HR (tertile 3 versus tertile 1:1.17 (1.01-1.36) and 1.20 (1.03-1.40), respectively). Both hsCRP and ferritin were associated with increased odds for rapid renal progression with the adjusted OR (tertile 3 versus tertile 1:1.40 (1.13-1.77) and 1.32 (1.06-1.67), respectively). hsCRP and ferritin stratified by albumin were also associated with RRT and rapid renal progression. Instead, WBC count was not associated with renal outcome. In conclusion, elevated levels of hsCRP and ferritin are risk factors associated with RRT and rapid renal progression in advanced CKD patients.	[Tsai, Yi-Chun; Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Yeh, Shih-Meng; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Chang, JM (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan.	jemich@kmu.edu.tw		Kuo, Hung-Tien/0000-0002-9931-4354				Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Ates K, 2005, PERITON DIALYSIS INT, V25, P256; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; Boos CJ, 2006, CURR PHARM DESIGN, V12, P1623, DOI 10.2174/138161206776843313; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Erlinger TP, 2003, AM J KIDNEY DIS, V42, P256, DOI 10.1016/S0272-6386(03)00650-4; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Fox ER, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-1; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Johnson DW, 2005, KIDNEY INT, V67, P738, DOI 10.1111/j.1523-1755.2005.67135.x; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P141, DOI 10.1093/ndt/gfg493; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V37, P564, DOI 10.1053/ajkd.2001.22433; Kalender B, 2002, INT J CLIN PRACT, V56, P505; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim Y, 2012, INT UROL NEPHROL, DOI [10.1007/j.int urol nephrol.2012.04.015, DOI 10.1007/J.INTUROLNEPHROL.2012.04.015]; Koeda Y, 2011, INT HEART J, V52, P180, DOI 10.1536/ihj.52.180; Kovesdy CP, 2009, CLIN J AM SOC NEPHRO, V4, P435, DOI 10.2215/CJN.03980808; Kovesdy CP, 2009, AM J CLIN NUTR, V90, P407, DOI 10.3945/ajcn.2008.27390; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Navarro JF, 2006, AM J NEPHROL, V26, P562, DOI 10.1159/000098004; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rijkin DE, 2009, AM J KIDNEY DIS, V53, P572, DOI 10.1053/j.ajkd.2009.01.001; ROGERS JT, 1990, J BIOL CHEM, V265, P14572; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Streja E, 2011, AM J KIDNEY DIS, V57, P883, DOI 10.1053/j.ajkd.2010.10.050; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Tatli MM, 2000, PEDIATR INT, V42, P289, DOI 10.1046/j.1442-200x.2000.01217.x; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wang AYM, 2003, J AM SOC NEPHROL, V14, P1871, DOI 10.1097/01.ASN.0000070071.57901.B3; Wanner C, 2002, KIDNEY INT, V61, pS99, DOI 10.1046/j.1523-1755.61.s80.18.x; Westhuyzen J, 2000, ANN CLIN LAB SCI, V30, P133; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417	48	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52775	10.1371/journal.pone.0052775	http://dx.doi.org/10.1371/journal.pone.0052775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300770	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600025
J	Wu, ZJ; Lou, YQ; Jin, W; Liu, Y; Lu, L; Lu, GP				Wu, Zhijun; Lou, Yuqing; Jin, Wei; Liu, Yan; Lu, Lin; Lu, Guoping			The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPAR gamma 2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-Analysis	PLOS ONE			English	Article							ACC/AHA 2007 GUIDELINES; MYOCARDIAL-INFARCTION; PPAR-GAMMA; HEART-DISEASE; INSULIN-RESISTANCE; P12A POLYMORPHISM; MANAGEMENT; VARIANT; BIAS	Background: Contradictory results have been reported regarding the association between Pro12Ala polymorphism of PPAR gamma 2 and coronary artery disease (CAD). We sought to estimate the inconsistent results by performing a comprehensive meta-analysis. Methods: Studies in English or Chinese publications were identified by screening MEDLINE, Embase, CNKI, Wanfang and CBM. 22 studies including 8948 cases and 14427 controls were selected. A random-effects model was applied to combine the divergent outcomes of the individual studies, while addressing between-study heterogeneity and publication bias. Results: The Pro12Ala polymorphism of control population followed Hardy-Weinberg equilibrium for all studies (P>0.05). Overall, a marginal increased risk of CAD under the recessive genetic model (AlaAla vs ProAla+ProPro: P = 0.04, OR = 1.31, 95% CI 1.01-1.69, P-heterogeneity = 0.67, I-2=0%) and the homozygote comparison (AlaAla vs ProPro: P = 0.04, OR = 1.30, 95%CI 1.01-1.68, P-heterogeneity = 0.68, I-2 = 0%) was observed. In the subgroup analysis by ethnicity, carriers of AlaAla homozygotes had a significant increased risk for CAD among Caucasians (AlaAla vs ProAla+ProPro: P = 0.01, OR = 1.45, 95% CI 1.08-1.96, P-heterogeneity = 0.48, I-2 = 0%; AlaAla vs ProPro: P = 0.02, OR = 1.44, 95% CI 1.07-1.93, P-heterogeneity = 0.46, I-2 = 0%). After dividing into population source, the CAD risk magnitude of hospital-based studies was distinctly strengthened under the recessive model (P = 0.03, OR = 1.85,95% CI 1.07-3.19, P-heterogeneity = 0.87, I-2 = 0%) and the homozygote comparison (P = 0.03, OR = 1.83, 95% CI 1.06-3.16, P-heterogeneity = 0.88, I-2 = 0%). There was no observable publication bias as reflected by funnel plot and Egger's linear regression test (t = -0.12, P = 0.91). Conclusion:: Our results demonstrated that the PPAR gamma 2 Pro12Ala polymorphism might be risk-conferring locus for the progression of CAD among Caucasians, but not among Asians.	[Wu, Zhijun; Jin, Wei; Liu, Yan; Lu, Lin; Lu, Guoping] Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Lou, Yuqing] Shanghai Jiao Tong Univ, Dept Pulm, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, GP (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	gplu52@yahoo.com.cn	wu, zhi/GXH-3041-2022		Shanghai Excellent Young Teachers Training Fund of Colleges and Universities [jdy09097]; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine [11XJ21001]	Shanghai Excellent Young Teachers Training Fund of Colleges and Universities; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the Shanghai Excellent Young Teachers Training Fund of Colleges and Universities (jdy09097) and the Science and Technology Fund of Shanghai Jiao Tong University School of Medicine (11XJ21001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shali KZ, 2004, STROKE, V35, P2036, DOI 10.1161/01.STR.0000138784.68159.a5; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; AshokKumar M, 2010, ARCH MED RES, V41, P19, DOI 10.1016/j.arcmed.2010.01.005; Aydogan HY, 2012, GENET TEST MOL BIOMA, V16, P134, DOI 10.1089/gtmb.2011.0077; Bluher M, 2002, EUR J ENDOCRINOL, V146, P545, DOI 10.1530/eje.0.1460545; CASTELLI WP, 1981, LANCET, V2, P109, DOI 10.1016/S0140-6736(81)90297-X; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Dallongeville J, 2009, PPAR RES, V2009, DOI 10.1155/2009/543746; Doney ASF, 2004, ARTERIOSCL THROM VAS, V24, P2403, DOI 10.1161/01.ATV.0000147897.57527.e4; Dragojevic J, 2008, BIOCHEM MEDICA, V18, P342; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelisti L, 2009, ATHEROSCLEROSIS, V205, P186, DOI 10.1016/j.atherosclerosis.2008.11.009; Fisman EZ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-38; Fullerton SM, 2010, HUM GENET, V127, P563, DOI 10.1007/s00439-010-0800-0; Galgani A, 2010, DIS MARKERS, V29, P259, DOI [10.1155/2010/501730, 10.3233/DMA-2010-0756]; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho JS, 2012, DIABETES RES CLIN PR; Huang W, 2011, FASEB J, V25, P3979, DOI 10.1096/fj.11-188607; Iwata E, 2003, DIABETES RES CLIN PR, V62, P55, DOI 10.1016/S0168-8227(03)00161-X; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Kabagambe EK, 2001, AM J EPIDEMIOL, V154, P1126, DOI 10.1093/aje/154.12.1126; Kurnaz O, 2011, IN VIVO, V25, P539; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Li L, 2006, CLIN CARDIOL, V29, P300, DOI 10.1002/clc.4960290706; Ma RC, 2011, DIABETES, V60, pA557; Meirhaeghe A, 2004, MOL GENET METAB, V83, P93, DOI 10.1016/j.ymgme.2004.08.014; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Michalik L, 2011, PROSTAG LEUKOTR ESS, V85, P235, DOI 10.1016/j.plefa.2011.04.016; Namvaran F, 2011, EUR J PHARMACOL, V671, P1, DOI 10.1016/j.ejphar.2011.09.158; Nassar BA, 2006, CLIN BIOCHEM, V39, P109, DOI 10.1016/j.clinbiochem.2005.10.002; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pischon T, 2005, ARTERIOSCL THROM VAS, V25, P1654, DOI 10.1161/01.ATV.0000171993.78135.7e; Qu AJ, 2012, ARTERIOSCL THROM VAS, V32, P65, DOI 10.1161/ATVBAHA.111.239137; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rhee EJ, 2007, CIRC J, V71, P338, DOI 10.1253/circj.71.338; Ridker PM, 2003, ARTERIOSCL THROM VAS, V23, P859, DOI 10.1161/01.ATV.0000068680.19521.34; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruiz-Narvaez EA, 2007, AM J CLIN NUTR, V86, P1238, DOI 10.1093/ajcn/86.4.1238; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Temelkova-Kurktschiev T, 2004, J CLIN ENDOCR METAB, V89, P4238, DOI 10.1210/jc.2003-032120; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Tonjes A, 2007, CURR OPIN CLIN NUTR, V10, P410, DOI 10.1097/MCO.0b013e3281e389d9; Vogel U, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-52; Vos HL, 2000, BLOOD, V96, p62B; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Wang LP, 2012, GENET MOL RES, V11, P2929, DOI 10.4238/2012.May.18.13; Wang NP, 2011, CIRC J, V75, P528, DOI 10.1253/circj.CJ-11-0060; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798; Yilmaz-Aydogan H, 2011, IN VIVO, V25, P513; Yilmaz-Aydogan H, 2011, MOL CELL BIOCHEM, V358, P355, DOI 10.1007/s11010-011-0987-y; Zafarmand MH, 2008, VASC HEALTH RISK MAN, V4, P427; Zee RYL, 2006, J THROMB HAEMOST, V4, P341, DOI 10.1111/j.1538-7836.2006.01754.x; Zhang HB, 2012, AEROSP SCI TECHNOL, V18, P35, DOI 10.1016/j.ast.2011.04.003	65	28	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53105	10.1371/journal.pone.0053105	http://dx.doi.org/10.1371/journal.pone.0053105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300871	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600059
J	Bhat, KH; Ahmed, A; Kumar, S; Sharma, P; Mukhopadhyay, S				Bhat, Khalid Hussain; Ahmed, Asma; Kumar, Santosh; Sharma, Pawan; Mukhopadhyay, Sangita			Role of PPE18 Protein in Intracellular Survival and Pathogenicity of Mycobacterium tuberculosis in Mice	PLOS ONE			English	Article							GRANULOMA-FORMATION; INFECTIOUS-DISEASE; HUMAN MACROPHAGES; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; IL-10; VIRULENCE; APOPTOSIS; CYTOKINES	Background: Ever since its discovery the mycobacterial proline-proline-glutamic acid (PPE) family of proteins has generated a huge amount of interest. Understanding the role of these proteins in the pathogenesis of Mycobacterium tuberculosis (Mtb) is important. We have demonstrated earlier that the PPE18 protein of Mtb induces IL-10 production in macrophages with subsequent downregulation of pro-inflammatory cytokines like IL-12 and TNF-alpha and favors a T-helper (Th) 2-type of immune response. Methodology/Principal Findings: Using a ppe18 genetic knock-out Mtb strain, we have now carried out infection studies in mice to understand the role of PPE18 in Mtb virulence. The studies reveal that lack of PPE18 leads to attenuation of Mtb in vivo. Mice infected with the ppe18 deleted strain have reduced infection burden in lung, liver and spleen and have better survival rates compared to mice infected with the wild-type Mtb strain. Conclusions/Significance: Taken together our data suggest that PPE18 could be a crucial virulence factor for intracellular survival of Mtb.	[Bhat, Khalid Hussain; Ahmed, Asma; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, Andhra Pradesh, India; [Kumar, Santosh; Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Sharma, Pawan] NE Reg Biotechnol Programme Management Cell NER B, New Delhi, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, Andhra Pradesh, India.	sangita@cdfd.org.in	Sharma, Pawan/F-7806-2010	Sharma, Pawan/0000-0002-2525-5451; Bhat, Dr. Khalid Hussain/0000-0002-0952-7496; Mukhopadhyay, Sangita/0000-0002-5511-3315; Ahmed, Asma/0000-0001-7735-1202	Department of Biotechnology (DBT), Government of India [BT/PR/7890/MED/14/1171/2006, BT/01/COE/07/02]; DBT; Council of Scientific and Industrial Research (CSIR), India; DBT Research Associateship in Biotechnology and Life Sciences from Department of Biotechnology (DBT), Government of India; National Institutes of Health-NIAID	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT Research Associateship in Biotechnology and Life Sciences from Department of Biotechnology (DBT), Government of India; National Institutes of Health-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants (BT/PR/7890/MED/14/1171/2006 and BT/01/COE/07/02) from Department of Biotechnology (DBT), Government of India and a core grant to Centre for DNA Fingerprinting and Diagnostics (CDFD), India by DBT. This work was also supported by research fellowship to KHB from the Council of Scientific and Industrial Research (CSIR), India and by DBT Research Associateship in Biotechnology and Life Sciences to AA from the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the gift of mutant strain (JHU ID 1440, MT1234) and the WT strain (CDC1551) of M. tuberculosis from Dr. Karen Dobos of the Colorado State University, Ft. Collins, CO through the National Institutes of Health-NIAID Contract entitled "Tuberculosis Vaccine Testing & Research Materials". We thank Dr. J. Gowrishankar, CDFD, India and Prof. V.S. Chauhan, ICGEB, India for kind help and support. The animal infection studies and determination of CFU counts were carried out at the Department of Biotechnology (DBT), Govt. of India-funded National Facility for Tuberculosis Research at ICGEB, New Delhi.	Abdul-Majid KB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-151; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Baliko Z, 1998, FEMS IMMUNOL MED MIC, V22, P199, DOI 10.1016/S0928-8244(98)00089-3; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; FALCONE V, 1994, FEMS IMMUNOL MED MIC, V8, P225, DOI 10.1111/j.1574-695X.1994.tb00447.x; Feng CG, 2002, INFECT IMMUN, V70, P6672, DOI 10.1128/IAI.70.12.6672-6679.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Goldstone RM, 2009, INFECT IMMUN, V77, P4654, DOI 10.1128/IAI.01495-08; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Karls RK, 2006, MICROBIOL-SGM, V152, P1591, DOI 10.1099/mic.0.28591-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Li W, 2012, VACCINE, V30, P3223, DOI 10.1016/j.vaccine.2012.02.014; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Mukhopadhyay S, 2012, FEMS MICROBIOL REV, V36, P463, DOI 10.1111/j.1574-6976.2011.00302.x; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Rook G, 2001, TRENDS IMMUNOL, V22, P481, DOI 10.1016/S1471-4906(01)01980-9; Rook GAW, 2001, EUR RESPIR J, V17, P537, DOI 10.1183/09031936.01.17305370; Rosas-Taraco AG, 2009, AM J RESP CELL MOL, V41, P136, DOI 10.1165/rcmb.2008-0363OC; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Senaldi G, 1996, J IMMUNOL, V157, P5022; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Wilsher M. L., 1999, Tubercle and Lung Disease, V79, P371, DOI 10.1054/tuld.1999.0223	81	37	40	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52601	10.1371/journal.pone.0052601	http://dx.doi.org/10.1371/journal.pone.0052601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300718	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500038
J	Glas, J; Seiderer, J; Czamara, D; Pasciuto, G; Diegelmann, J; Wetzke, M; Olszak, T; Wolf, C; Muller-Myhsok, B; Balschun, T; Achkar, JP; Kamboh, MI; Franke, A; Duerr, RH; Brand, S				Glas, Juergen; Seiderer, Julia; Czamara, Darina; Pasciuto, Giulia; Diegelmann, Julia; Wetzke, Martin; Olszak, Torsten; Wolf, Christiane; Mueller-Myhsok, Bertram; Balschun, Tobias; Achkar, Jean-Paul; Kamboh, M. Ilyas; Franke, Andre; Duerr, Richard H.; Brand, Stephan			PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-kappa B and XBP1 Binding Sites	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; CELL-DIFFERENTIATION; FRAMESHIFT MUTATION; GERMAN POPULATION; RECEPTOR SUBTYPE; SULFONIC-ACID; GENETIC RISK	Background: Genome-wide association studies identified a PTGER4 expression-modulating region on chromosome 5p13.1 as Crohn's disease (CD) susceptibility region. The study aim was to test this association in a large cohort of patients with inflammatory bowel disease (IBD) and to elucidate genotypic and phenotypic interactions with other IBD genes. Methodology/Principal Findings: A total of 7073 patients and controls were genotyped: 844 CD and 471 patients with ulcerative colitis and 1488 controls were analyzed for the single nucleotide polymorphisms (SNPs) rs4495224 and rs7720838 on chromosome 5p13.1. The study included two replication cohorts of North American (CD: n = 684; controls: n = 1440) and of German origin (CD: n = 1098; controls: n = 1048). Genotype-phenotype, epistasis and transcription factor binding analyses were performed. In the discovery cohort, an association of rs4495224 (p = 4.10x10(-5); 0.76 [0.67-0.87]) and of rs7720838 (p = 6.91x10(-4); 0.81 [0.71-0.91]) with susceptibility to CD was demonstrated. These associations were confirmed in both replication cohorts. In silico analysis predicted rs4495224 and rs7720838 as essential parts of binding sites for the transcription factors NF-kappa B and XBP1 with higher binding scores for carriers of the CD risk alleles, providing an explanation of how these SNPs might contribute to increased PTGER4 expression. There was no association of the PTGER4 SNPs with IBD phenotypes. Epistasis detected between 5p13.1 and ATG16L1 for CD susceptibility in the discovery cohort (p = 5.99x10(-7) for rs7720838 and rs2241880) could not be replicated in both replication cohorts arguing against a major role of this gene-gene interaction in the susceptibility to CD. Conclusions/Significance: We confirmed 5p13.1 as a major CD susceptibility locus and demonstrate by in silico analysis rs4495224 and rs7720838 as part of binding sites for NF-kappa B and XBP1. Further functional studies are necessary to confirm the results of our in silico analysis and to analyze if changes in PTGER4 expression modulate CD susceptibility.	[Glas, Juergen; Seiderer, Julia; Pasciuto, Giulia; Diegelmann, Julia; Olszak, Torsten; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Czamara, Darina; Wolf, Christiane; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-8000 Munich, Germany; [Wetzke, Martin] Hannover Med Sch, Ctr Pediat, D-3000 Hannover, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med, Boston, MA 02115 USA; [Balschun, Tobias; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Achkar, Jean-Paul] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Achkar, Jean-Paul] Cleveland Clin, Dept Gastroenterol & Hepatol, Inst Digest Dis, Cleveland, OH 44106 USA; [Kamboh, M. Ilyas; Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA	University of Munich; University of Munich; RWTH Aachen University; Max Planck Society; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	Stephan.Brand@med.uni-muenchen.de	Franke, Andre/B-2151-2010; Wetzke, Martin/HDM-2614-2022; Duerr, Richard H/B-4188-2009	Franke, Andre/0000-0003-1530-5811; Duerr, Richard H/0000-0001-6586-3905; Kamboh, M. Ilyas/0000-0002-3453-1438	Deutsche Forschungsgemeinschaft [BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Demling Grant from DCCV e.V.; Excellence Initiative of the Ludwig-Maximilians-University Munich; University of Munich (FoFoLe) [422]; Robert-Bosch-Foundation; Else-Kroner-Fresenius-Stiftung; Broad Medical Foundation [IBD-0126R2]; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'; National Institutes of Health (NIH)/NIDDK [DK062420]; NIH [AG030653, HL092397, AG041718, DK068112]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068112, U01DK062420, R01DK076025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030653, R01AG041718] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Demling Grant from DCCV e.V.; Excellence Initiative of the Ludwig-Maximilians-University Munich; University of Munich (FoFoLe); Robert-Bosch-Foundation; Else-Kroner-Fresenius-Stiftung; Broad Medical Foundation; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); National Institutes of Health (NIH)/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SB was supported by grants from Deutsche Forschungsgemeinschaft (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), by the Ludwig-Demling Grant 2007 from DCCV e.V. and by a grant from the Excellence Initiative of the Ludwig-Maximilians-University Munich (Investment Funds 2008). JS and JD were supported by grants from the University of Munich (FoFoLe Nr. 422; Habilitationsstipendium to JS and Promotionsstipendium to JD); JS also was supported by the Robert-Bosch-Foundation and the Else-Kroner-Fresenius-Stiftung. JG was supported by a grant from the Broad Medical Foundation (IBD-0126R2). TB and AF were supported by the German Ministry of Education and Research through the National Genome Research Network and infrastructure support through the Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'. RHD is supported by National Institutes of Health (NIH)/NIDDK grant DK062420. MIK was supported by NIH grants AG030653, HL092397 and AG041718. JPA was supported by NIH grant DK068112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chen Q, 2010, BRIT J PHARMACOL, V160, P292, DOI 10.1111/j.1476-5381.2010.00647.x; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clark P, 2008, J PHARMACOL EXP THER, V325, P425, DOI 10.1124/jpet.107.134510; Cox DG, 2005, WORLD J GASTROENTERO, V11, P6003, DOI 10.3748/wjg.v11.i38.6003; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Gookin JL, 2003, AM J PHYSIOL-GASTR L, V285, pG967, DOI 10.1152/ajpgi.00532.2002; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Morteau Olivier, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P473; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nitta M, 2002, SCAND J IMMUNOL, V56, P66, DOI 10.1046/j.1365-3083.2002.01096.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okamoto T, 2012, J PHARMACOL EXP THER, V341, P340, DOI 10.1124/jpet.111.190447; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Thalmaier D, 2006, ALIMENT PHARM THERAP, V24, P1105, DOI 10.1111/j.1365-2036.2006.03093.x; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	57	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52873	10.1371/journal.pone.0052873	http://dx.doi.org/10.1371/journal.pone.0052873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300802	Green Published, gold			2022-12-27	WOS:000312829100089
J	Huby, AC; Kavvadas, P; Alfieri, C; Abed, A; Toubas, J; Rastaldi, MP; Dussaule, JC; Chatziantoniou, C; Chadjichristos, CE				Huby, Anne-Cecile; Kavvadas, Panagiotis; Alfieri, Carlo; Abed, Ahmed; Toubas, Julie; Rastaldi, Maria-Pia; Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.			The RenTg Mice: A Powerful Tool to Study Renin-Dependent Chronic Kidney Disease	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; NITRIC-OXIDE SYNTHESIS; KAPPA-B ACTIVATION; ANGIOTENSIN-II; TRANSGENIC MICE; ADHESION MOLECULE-1; RENAL FIBROSIS; TGF-BETA; COLLAGEN; INJURY	Background: Several studies have shown that activation of the renin-angiotensin system may lead to hypertension, a major risk factor for the development of chronic kidney disease (CKD). The existing hypertension-induced CDK mouse models are quite fast and consequently away from the human pathology. Thus, there is an urgent need for a mouse model that can be used to delineate the pathogenic process leading to progressive renal disease. The objective of this study was dual: to investigate whether mice overexpressing renin could mimic the kinetics and the physiopathological characteristics of hypertension-induced renal disease and to identify cellular and/or molecular events characterizing the different steps of the progression of CKD. Methodology/Principal Findings: We used a novel transgenic strain, the RenTg mice harboring a genetically clamped renin transgene. At 3 months, heterozygous mice are hypertensive and slightly albuminuric. The expression of adhesion markers such as vascular cell adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 are increased in the renal vasculature indicating initiation of endothelial dysfunction. At 5 months, perivascular and periglomerular infiltrations of macrophages are observed. These early renal vascular events are followed at 8 months by leukocyte invasion, decreased expression of nephrin, increased expression of KIM-1, a typical protein of tubular cell stress, and of several pro-fibrotic agents of the TGFb family. At 12 months, mice display characteristic structural alterations of hypertensive renal disease such as glomerular ischemia, glomerulo- and nephroangio-sclerosis, mesangial expansion and tubular dilation. Conclusions/Significance: The RenTg strain develops CKD progressively. In this model, endothelial dysfunction is an early event preceding the structural and fibrotic alterations which ultimately lead to the development of CKD. This model can provide new insights into the mechanisms of chronic renal failure and help to identify new targets for arresting and/or reversing the development of the disease.	[Huby, Anne-Cecile; Kavvadas, Panagiotis; Alfieri, Carlo; Abed, Ahmed; Toubas, Julie; Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.] Tenon Hosp, Inst Natl Sante & Rech Med Joint Res Unit S 702, Paris, France; [Rastaldi, Maria-Pia] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Rastaldi, Maria-Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Dussaule, Jean-Claude] Hosp St Antoine, AP HP, Dept Physiol, Paris, France; [Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.] Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; IRCCS Ca Granda Ospedale Maggiore Policlinico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Chatziantoniou, C (corresponding author), Tenon Hosp, Inst Natl Sante & Rech Med Joint Res Unit S 702, Batiment Rech, Paris, France.	christos.chatziantoniou@upmc.fr	Chadjichristos, Christos E/J-4871-2016; Chatziantoniou, Christos/L-2501-2016; Alfieri, Carlo/Q-8959-2016	Chadjichristos, Christos E/0000-0001-6657-7900; Alfieri, Carlo/0000-0003-3860-5219	European Union [PIEF-GA-2008-221415]; European Renal Association; European Dialysis and Transplant Association [ERALTF25-2007]; Institut National de la Sante et de la Recherche Medicale; University Pierre et Marie Curie; ERA-EDTA; University of Milano	European Union(European Commission); European Renal Association; European Dialysis and Transplant Association; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre et Marie Curie; ERA-EDTA; University of Milano	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the European Union (PIEF-GA-2008-221415 to CEC and JCD), the European Renal Association and European Dialysis and Transplant Association (ERALTF25-2007 to CEC), the Institut National de la Sante et de la Recherche Medicale (CC) and the University Pierre et Marie Curie (CC and JCD). ACH, AA and JT are doctoral fellows of the French Ministry of National Education (Ecole Doctorale de Physiologie & Physiopathologie, ED 394). PK and CA were financially supported by fellowships from ERA-EDTA and the University of Milano, respectively.	Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; DIAMOND JR, 1990, AM J PATHOL, V137, P1323; Dirks J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P695; Dussaule JC, 2007, CELL DEATH DIFFER, V14, P1343, DOI 10.1038/sj.cdd.4402143; Eliahou H, 2001, AM J NEPHROL, V21, P78, DOI 10.1159/000046225; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Macconi D, 2010, HISTOL HISTOPATHOL, V25, P655, DOI 10.14670/HH-25.655; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; NavarroCid J, 1996, AM J HYPERTENS, V9, P1077, DOI 10.1016/0895-7061(96)00195-1; Pastore L, 1999, CIRCULATION, V100, P1646, DOI 10.1161/01.CIR.100.15.1646; Placier S, 2006, NEPHROL DIAL TRANSPL, V21, P881, DOI 10.1093/ndt/gfk004; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Sata M, 2010, J MED INVESTIG, V57, P12, DOI 10.2152/jmi.57.12; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Ying L, 2003, HYPERTENSION, V42, P937, DOI 10.1161/01.HYP.0000099240.89890.94; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	25	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52362	10.1371/journal.pone.0052362	http://dx.doi.org/10.1371/journal.pone.0052362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300650	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800071
J	Irvine, L; Falconer, DW; Jones, C; Ricketts, IW; Williams, B; Crombie, IK				Irvine, Linda; Falconer, Donald W.; Jones, Claire; Ricketts, Ian W.; Williams, Brian; Crombie, Iain K.			Can Text Messages Reach the Parts Other Process Measures Cannot Reach: An Evaluation of a Behavior Change Intervention Delivered by Mobile Phone?	PLOS ONE			English	Article							HEALTH; IMPACT; CARE	Background: Process evaluation is essential in developing, piloting and evaluating complex interventions. This often involves observation of intervention delivery and interviews with study participants. Mobile telephone interventions involve no face to face contact, making conventional process evaluation difficult. This study assesses the utility of novel techniques for process evaluation involving no face to face contact. Methods: Text messages were delivered to 34 disadvantaged men as part of a feasibility study of a brief alcohol intervention. Process evaluation focused on delivery of the text messages and responses received from study participants. The computerized delivery system captured data on receipt of the messages. The text messages, delivered over 28 days, included nine which asked questions. Responses to these questions served as one technique for process evaluation by ascertaining the nature of engagement with the study and with steps on the causal chain to behavior change. Results: A total of 646 SMS text messages were sent to participants. Of these, 613 messages (95%) were recorded as delivered to participants' telephones. 88% of participants responded to messages that asked questions. There was little attenuation in responses to the questions across the intervention period. Content analysis of the responses revealed that participants engaged with text messages, thought deeply about their content and provided carefully considered personal responses to the questions. Conclusions: Socially disadvantaged men, a hard to reach population, engaged in a meaningful way over a sustained period with an interactive intervention delivered by text message. The novel process measures used in the study are unobtrusive, low cost and collect real-time data on all participants. They assessed the fidelity of delivery of the intervention and monitored retention in the study. They measured levels of engagement and identified participants' reactions to components of the intervention. These methods provide a valuable addition to conventional process evaluation techniques.	[Irvine, Linda; Falconer, Donald W.; Crombie, Iain K.] Univ Dundee, Ctr Biomed Sci & Publ Hlth, Dundee, Scotland; [Jones, Claire; Ricketts, Ian W.] Univ Dundee, Sch Comp, Dundee, Scotland; [Williams, Brian] Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland	University of Dundee; University of Dundee; University of Stirling	Irvine, L (corresponding author), Univ Dundee, Ctr Biomed Sci & Publ Hlth, Dundee, Scotland.	m.a.j.irvine@dundee.ac.uk	Williams, Brian/G-5736-2012; Williams, Brian/AAS-3714-2021	Williams, Brian/0000-0003-0000-4354; Williams, Brian/0000-0003-0000-4354; Irvine, Linda/0000-0002-8527-876X	National Institute for Health Research Public Health Research (NIHR PHR) [09/3001/09]; National Institute for Health Research [09/3001/09] Funding Source: researchfish; Chief Scientist Office [NMAHP2] Funding Source: researchfish	National Institute for Health Research Public Health Research (NIHR PHR); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The study was funded by the National Institute for Health Research Public Health Research (NIHR PHR) programme http://www.phr.nihr.ac.uk/(project number 09/3001/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health.	Audit Scotland, 2007, OV SCOTL HLTH NHS PE; Baranowski T, 2000, HEALTH EDUC BEHAV, V27, P157, DOI 10.1177/109019810002700202; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; BMA Board of Science, 2008, ALC MIS TACKL UK EP; Cohn AM, 2011, ALCOHOL CLIN EXP RES, V35, P2209, DOI 10.1111/j.1530-0277.2011.01571.x; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Conner M, 2005, PREDICTING HLTH BEHA; Cooper M.L., 1992, PSYCHOL ASSESS J CON, V4, P123, DOI DOI 10.1037/1040-3590.4.2.123; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Faulkner X, 2005, INTERACT COMPUT, V17, P167, DOI 10.1016/j.intcom.2004.11.002; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Graff FS, 2009, AM J ADDICTION, V18, P277, DOI 10.1080/10550490902925540; Heather N, 2008, ADDICT RES THEORY, V16, P421, DOI 10.1080/16066350801900321; ICT Data and Statistics Division Telecommunication Development Bureau, 2011, WORLD 2011 ICT FACTS; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Linnan L., 2002, PROCESS EVALUATION P, P1; Linnan L.S.A., 2002, PROCESS EVALUATION P, V1e; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Prochaska J. O., 2008, HLTH BEHAV HLTH ED T, P97; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Schneider M, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.118; Scottish Government, 2004, SCOTTISH INDEX MULTI; Spagnolli A, 2007, BRIT J SOC PSYCHOL, V46, P343, DOI 10.1348/014466606X120482; Toroyan T, 2004, CHILD CARE HLTH DEV, V30, P691, DOI 10.1111/j.1365-2214.2004.00481.x; Tsang MM, 2004, INT J ELECTRON COMM, V8, P65, DOI 10.1080/10864415.2004.11044301; Voigt-Radloff S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000094; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]	33	39	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52621	10.1371/journal.pone.0052621	http://dx.doi.org/10.1371/journal.pone.0052621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300726	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800116
J	Kim, E; Sun, L; Gabel, CV; Fang-Yen, C				Kim, Eric; Sun, Lin; Gabel, Christopher V.; Fang-Yen, Christopher			Long-Term Imaging of Caenorhabditis elegans Using Nanoparticle-Mediated Immobilization	PLOS ONE			English	Article							DYNAMIC-RANGE; SENSITIVITY; NEURONS; CA2+	One advantage of the nematode Caenorhabditis elegans as a model organism is its suitability for in vivo optical microscopy. Imaging C. elegans often requires animals to be immobilized to avoid movement-related artifacts. Immobilization has been performed by application of anesthetics or by introducing physical constraints using glue or specialized microfluidic devices. Here we present a method for immobilizing C. elegans using polystyrene nanoparticles and agarose pads. Our technique is technically simple, does not expose the worm to toxic substances, and allows recovery of animals. We evaluate the method and show that the polystyrene beads increase friction between the worm and agarose pad. We use our method to quantify calcium transients and long-term regrowth in single neurons following axotomy by a femtosecond laser.	[Kim, Eric; Fang-Yen, Christopher] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Sun, Lin; Gabel, Christopher V.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Pennsylvania; Boston University	Fang-Yen, C (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	fangyen@seas.upenn.edu	Fang-Yen, Christopher/AAY-9017-2020	Fang-Yen, Christopher/0000-0002-4568-3218; Gabel, Christopher/0000-0002-2763-3938	Penn Undergraduate Research Mentorship program; Massachusetts Life Science Center New Investigator Matching Grant	Penn Undergraduate Research Mentorship program; Massachusetts Life Science Center New Investigator Matching Grant	EK was partly supported by the Penn Undergraduate Research Mentorship program. CVG was partly supported by the Massachusetts Life Science Center New Investigator Matching Grant. (http://www.masslifesciences.com/grants/invest.html) No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; Chokshi TV, 2009, LAB CHIP, V9, P151, DOI 10.1039/b807345g; Chu GKT, 2001, NEUROSCIENCE, V102, P945, DOI 10.1016/S0306-4522(00)00514-5; Fang-Yen C, 2011, METHODS CELL BIOL; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gabel CV, 2008, CONTEMP PHYS, V49, P391, DOI 10.1080/00107510802628263; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hart A. C., 2006, WORMBOOK; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Keane J, 2003, GENETICS, V164, P153; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Shaham S., 2006, WORMBOOK; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001	22	184	188	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53419	10.1371/journal.pone.0053419	http://dx.doi.org/10.1371/journal.pone.0053419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301069	Green Published, gold			2022-12-27	WOS:000313480000056
J	Kriangkum, J; Warkinton, A; Belch, AR; Pilarski, LM				Kriangkum, Jitra; Warkinton, Amanda; Belch, Andrew R.; Pilarski, Linda M.			Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-Mrna Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes	PLOS ONE			English	Article							WALDENSTROMS MACROGLOBULINEMIA; SILENT MUTATIONS; BREAST-CANCER; MSH2 MISSENSE; G-RUNS; GENE; VARIANTS; EXON; PROTEIN; SITE	Aberrant pre-mRNA splice variants of hyaluronan synthase 1 (HAS1) have been identified in malignant cells from cancer patients. Bioinformatic analysis suggests that intronic sequence changes can underlie aberrant splicing. Deletions and mutations were introduced into HAS1 minigene constructs to identify regions that can influence aberrant intronic splicing, comparing the splicing pattern in transfectants with that in multiple myeloma (MM) patients. Introduced genetic variations in introns 3 and 4 of HAS1 as shown here can promote aberrant splicing of the type detected in malignant cells from MM patients. HAS1Vd is a novel intronic splice variant first identified here. HAS1Vb, an intronic splice variant previously identified in patients, skips exon 4 and utilizes the same intron 4 alternative 3'splice site as HAS1Vd. For transfected constructs with unaltered introns 3 and 4, HAS1Vd transcripts are readily detectable, frequently to the exclusion of HAS1Vb. In contrast, in MM patients, HAS1Vb is more frequent than HAS1Vd. In the HAS1 minigene, combining deletion in intron 4 with mutations in intron 3 leads to a shift from HAS1Vd expression to HAS1Vb expression. The upregulation of aberrant splicing, exemplified here by the expression of HAS1Vb, is shown here to be influenced by multiple genetic changes in intronic sequences. For HAS1Vb, this includes enhanced exon 4 skipping and increased usage of alternative 3' splice sites. Thus, the combination of introduced mutations in HAS1 intron3 with introduced deletions in HAS1 intron 4 promoted a shift to an aberrant splicing pattern previously shown to be clinically significant. Most MM patients harbor genetic variations in intron 4, and as shown here, nearly half harbor recurrent mutations in HAS1 intron 3. Our work suggests that aberrant intronic HAS1 splicing in MM patients may rely on intronic HAS1 deletions and mutations that are frequent in MM patients but absent from healthy donors.	[Kriangkum, Jitra; Warkinton, Amanda; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada	University of Alberta	Kriangkum, J (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada.	jitra@ualberta.ca; lpilarsk@ualberta.ca			Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is funded by Alberta Cancer Foundation and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Adamia S, 2005, CLIN LYMPHOMA, V5, P253, DOI 10.3816/CLM.2005.n.010; Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Adamia S, 2003, SEMIN ONCOL, V30, P165, DOI 10.1053/sonc.2003.50042; Adamia S, 2009, CLIN LYMPHOMA MYELOM, V9, P30, DOI 10.3816/CLM.2009.n.006; Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Bechtel Jason M, 2008, BMC Res Notes, V1, P4, DOI 10.1186/1756-0500-1-4; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Colgin L M, 1999, Hum Mutat, V14, P92, DOI 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU24>3.0.CO;2-#; Durocher F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-230; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Moon SD, 2005, J CLIN ENDOCR METAB, V90, P878, DOI 10.1210/jc.2004-0991; NUSSINOV R, 1987, BIOCHIM BIOPHYS ACTA, V910, P261, DOI 10.1016/0167-4781(87)90119-9; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pagenstecher C, 2006, HUM GENET, V119, P9, DOI 10.1007/s00439-005-0107-8; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53469	10.1371/journal.pone.0053469	http://dx.doi.org/10.1371/journal.pone.0053469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301075	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000059
J	Lopacinska, JM; Emneus, J; Dufva, M				Lopacinska, Joanna M.; Emneus, Jenny; Dufva, Martin			Poly(Dimethylsiloxane) (PDMS) Affects Gene Expression in PC12 Cells Differentiating into Neuronal-Like Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHEOCHROMOCYTOMA CELLS; CULTURE MODELS; BIOCOMPATIBILITY; MICROARRAY; RECEPTORS; OUTGROWTH; DISEASES; ASSAYS; LEVEL	Introduction: Microfluidics systems usually consist of materials like PMMA - poly(methyl methacrylate) and PDMS - poly(dimethylsiloxane) and not polystyrene (PS), which is usually used for cell culture. Cellular and molecular responses in cells grown on PS are well characterized due to decades of accumulated research. In contrast, the experience base is limited for materials used in microfludics chip fabrication. Methods: The effect of different materials (PS, PMMA and perforated PMMA with a piece of PDMS underneath) on the growth and differentiation of PC12 (adrenal phaeochromocytoma) cells into neuronal-like cells was investigated using cell viability, cell cycle distribution, morphology, and gene expression analysis. Results/Conclusions: After differentiation, the morphology, viability and cell cycle distribution of PC12 cells grown on PS, PMMA with and without PDMS underneath was the same. By contrast, 41 genes showed different expression for PC12 cells differentiating on PMMA as compared to on PS. In contrast, 677 genes showed different expression on PMMA with PDMS underneath as compared with PC12 cells on PS. The differentially expressed genes are involved in neuronal cell development and function. However, there were also many markers for neuronal cell development and functions that were expressed similarly in cells differentiating on PS, PMMA and PMMA with PDMS underneath. In conclusion, it was shown that PMMA has a minor impact and PDMS a major impact on gene expression in PC12 cells.	[Lopacinska, Joanna M.; Emneus, Jenny; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, Kongens Lyngby, Denmark	Technical University of Denmark	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Kongens Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Emneus, Jenny/A-5763-2012; Dufva, Martin/V-9469-2019; Lopacinska-Jørgensen, Joanna/AGO-3187-2022; Dufva, Martin/D-1873-2012	Emneus, Jenny/0000-0002-8061-201X; Lopacinska-Jørgensen, Joanna/0000-0001-7803-425X; Dufva, Martin/0000-0001-5449-0189	EU [NMP4-SL-2008-214706, CP-FP 214566-2]	EU(European Commission)	The authors would like to acknowledge two EU funded FP7 projects: NMP4-SL-2008-214706 Excell and CP-FP 214566-2 NanoScale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Bontoux N, 2008, LAB CHIP, V8, P443, DOI 10.1039/b716543a; Bournat JC, 2001, MOL BRAIN RES, V90, P149, DOI 10.1016/S0169-328X(01)00097-3; Carvalho B, 2010, ANAL NIMBLEGEN EXPRE; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; CHEN TK, 1994, ANAL CHEM, V66, P3031, DOI 10.1021/ac00091a007; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DIMAGGIO DA, 1994, ENDOCRINOLOGY, V134, P719, DOI 10.1210/en.134.2.719; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Gao YD, 2011, BIOMED MICRODEVICES, V13, P539, DOI 10.1007/s10544-011-9523-9; Gentelmen R, 2005, BIOINFORMATICS COMPU; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING PW, 1981, J NEUROSCI, V1, P368; Hardy J, 2001, J ALZHEIMERS DIS, V3, P109, DOI 10.3233/JAD-2001-3115; Heiskanen A, 2010, NATO SCI PEACE SEC A, P399, DOI 10.1007/978-90-481-9029-4_19; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeon JS, 2011, BIOMED MICRODEVICES, V13, P325, DOI 10.1007/s10544-010-9496-0; Kartalov EP, 2006, J NANOSCI NANOTECHNO, V6, P2265, DOI 10.1166/jnn.2006.504; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Koike T, 2006, NEUROSCI LETT, V410, P212, DOI 10.1016/j.neulet.2006.10.008; Leclerc E, 2004, BIOTECHNOL PROGR, V20, P750, DOI 10.1021/bp0300568; Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002; Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Millet LJ, 2007, LAB CHIP, V7, P987, DOI 10.1039/b705266a; Ni M, 2009, INT J MOL SCI, V10, P5411, DOI 10.3390/ijms10125411; Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca; Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804; Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b; Rajakumar PA, 1998, REGUL PEPTIDES, V73, P123, DOI 10.1016/S0167-0115(97)01072-0; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Sabourin D, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/035021; Sabourin D, 2010, P 14 INT C MIN SYST, P1433; Sabourin D, 2012, J LAB AUTOM; Sabourin D, 2010, MICROFLUID NANOFLUID, V9, P87, DOI 10.1007/s10404-009-0520-8; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Skafte-Pedersen P, 2012, BIOMED MICRODEVICES, V14, P385, DOI 10.1007/s10544-011-9615-6; Skafte-Pedersen P, 2009, LAB CHIP, V9, P3003, DOI 10.1039/b906156h; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stangegaard M, 2005, THESIS TU DENMARK KO; Stangegaard M, 2006, LAB CHIP, V6, P1045, DOI 10.1039/b603379b; Stangegaard M, 2006, MOL BIOSYST, V2, P421, DOI 10.1039/b608239d; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Urdiales JL, 1998, J NEUROSCI, V18, P6767; van Midwoud PM, 2012, ANAL CHEM, V84, P3938, DOI 10.1021/ac300771z; vanGrunsven LA, 1996, ONCOGENE, V12, P855; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Yuan H, 2010, SPINAL CORD, V48, P850, DOI 10.1038/sc.2010.47	56	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53107	10.1371/journal.pone.0053107	http://dx.doi.org/10.1371/journal.pone.0053107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301028	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000031
J	Ng, EKO; Li, RFN; Shin, VY; Jin, HC; Leung, CPH; Ma, ESK; Pang, R; Chua, D; Chu, KM; Law, WL; Law, SYK; Poon, RTP; Kwong, A				Ng, Enders K. O.; Li, Rufina; Shin, Vivian Y.; Jin, Hong Chuan; Leung, Candy P. H.; Ma, Edmond S. K.; Pang, Roberta; Chua, Daniel; Chu, Kent-Man; Law, W. L.; Law, Simon Y. K.; Poon, Ronnie T. P.; Kwong, Ava			Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CELL LUNG-CANCER; TUMOR-SUPPRESSOR; EXPRESSION; SERUM; PROLIFERATION; PROGNOSIS; LEUKEMIA; MIR-16	Background: We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection. Methodology/Principal Findings: TaqMan-based miRNA profiling was performed in tumor, adjacent non-tumor, corresponding plasma from breast cancer patients, and plasma from matched healthy controls. All putative markers identified were verified in a training set of breast cancer patients. Selected markers were validated in a case-control cohort of 170 breast cancer patients, 100 controls, and 95 other types of cancers and then blindly validated in an independent set of 70 breast cancer patients and 50 healthy controls. Profiling results showed 8 miRNAs were concordantly up-regulated and 1 miRNA was concordantly down-regulated in both plasma and tumor tissue of breast cancer patients. Of the 8 up-regulated miRNAs, only 3 were significantly elevated (p<0.0001) before surgery and reduced after surgery in the training set. Results from the validation cohort showed that a combination of miR-145 and miR-451 was the best biomarker (p<0.0001) in discriminating breast cancer from healthy controls and all other types of cancers. In the blind validation, these plasma markers yielded Receiver Operating Characteristic (ROC) curve area of 0.931. The positive predictive value was 88% and the negative predictive value was 92%. Altered levels of these miRNAs in plasma have been detected not only in advanced stages but also early stages of tumors. The positive predictive value for ductal carcinoma in situ (DCIS) cases was 96%. Conclusions: These results suggested that these circulating miRNAs could be a potential specific biomarker for breast cancer screening.	[Ng, Enders K. O.; Li, Rufina; Shin, Vivian Y.; Leung, Candy P. H.; Pang, Roberta; Chu, Kent-Man; Law, W. L.; Law, Simon Y. K.; Poon, Ronnie T. P.; Kwong, Ava] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Chua, Daniel] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ng, Enders K. O.; Ma, Edmond S. K.; Kwong, Ava] Hong Kong Sanat & Hosp, Dept Mol Pathol, Hong Kong, Hong Kong, Peoples R China; [Jin, Hong Chuan] Zhejiang Univ, Sch Med, Sir Runrun Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; University of Hong Kong; Zhejiang University	Ng, EKO (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	ngko@hku.hk; akwong@asiabreastregistry.com	Jin, Hongchuan/C-3686-2009; Ma, Shiu Kwan Edmond/AAZ-7637-2021; Kwong, Ava/D-8005-2013; Law, Simon/C-4324-2009; Ng, Enders/T-3881-2019; Ng, Enders K.O./F-2787-2010	Ma, Shiu Kwan Edmond/0000-0002-1259-2205; Kwong, Ava/0000-0002-6968-9489; Law, Simon/0000-0002-6518-5806; Ng, Enders/0000-0002-6955-0030; Ng, Enders K.O./0000-0002-6955-0030; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097; Shin, Vivian Yvonne/0000-0003-1282-7593; Ng, Enders Kai-on/0000-0002-5293-3529	Hong Kong Hereditary Breast Cancer Family Registry	Hong Kong Hereditary Breast Cancer Family Registry	The authors sincerely thank Hong Kong Hereditary Breast Cancer Family Registry for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank to Hong Kong Hereditary Breast Cancer Family Registry for their support. We also like to thank Dr Dacita Suen, Dr Catherine Choi and Ms. Wong Ling for helping in patient recruitment.	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duffy MJ, 1999, ANN CLIN BIOCHEM, V36, P579, DOI 10.1177/000456329903600503; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kaddar T, 2009, LEUKEMIA RES, V33, P1217, DOI 10.1016/j.leukres.2008.12.015; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2010, GUT, V59, P1004, DOI 10.1136/gut.2010.208082; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	36	199	211	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53141	10.1371/journal.pone.0053141	http://dx.doi.org/10.1371/journal.pone.0053141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301032	Green Published, gold			2022-12-27	WOS:000313480000032
J	Rolland, AD; Lardenois, A; Goupil, AS; Lareyre, JJ; Houlgatte, R; Chalmel, F; Le Gac, F				Rolland, Antoine D.; Lardenois, Aurelie; Goupil, Anne-Sophie; Lareyre, Jean-Jacques; Houlgatte, Remi; Chalmel, Frederic; Le Gac, Florence			Profiling of Androgen Response in Rainbow Trout Pubertal Testis: Relevance to Male Gonad Development and Spermatogenesis	PLOS ONE			English	Article							CATFISH CLARIAS-GARIEPINUS; EEL ANGUILLA-JAPONICA; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; JAPANESE EEL; HYPOPHYSECTOMIZED RAT; HORMONAL-REGULATION; SERTOLI-CELLS; SEX STEROIDS; COHO SALMON	The capacity of testicular somatic cells to promote and sustain germ cell differentiation is largely regulated by sexual steroids and notably androgens. In fish species the importance of androgens is emphasized by their ability to induce sex reversal of the developing fries and to trigger spermatogenesis. Here we studied the influence of androgens on testicular gene expression in trout testis using microarrays. Following treatment of immature males with physiological doses of testosterone or 11-ketotestosterone, 418 genes that exhibit changes in expression were identified. Interestingly, the activity of testosterone appeared stronger than that of 11-ketotestosterone. Expression profiles of responsive genes throughout testis development and in isolated germ cells confirmed androgens to mainly affect gene expression in somatic cells. Furthermore, specific clusters of genes that exhibit regulation coincidently with changes in the natural circulating levels of androgens during the reproductive cycle were highlighted, reinforcing the physiological significance of these data. Among somatic genes, a phylogenetic footprinting study identified putative androgen response elements within the proximal promoter regions of 42 potential direct androgen target genes. Finally, androgens were also found to alter the germ line towards meiotic expression profiles, supporting the hypothesis of a role for the somatic responsive genes in driving germ cell fate. This study significantly increases our understanding of molecular pathways regulated by androgens in vertebrates. The highly cyclic testicular development in trout together with functions associated with regulated genes reveal potential mechanisms for androgen actions in tubule formation, steroid production, germ cell development and sperm secretion.	[Rolland, Antoine D.; Goupil, Anne-Sophie; Lareyre, Jean-Jacques; Le Gac, Florence] Biogenouest, INRA, LPGP UR1037, SFR Biosit, Rennes, France; [Lardenois, Aurelie; Chalmel, Frederic] Univ Rennes 1, INSERM, U1085, IRSET, Rennes, France; [Houlgatte, Remi] Inst Thorax IRT UN, INSERM, UMR1087, Nantes, France; [Houlgatte, Remi] Univ Nantes, Nantes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Le Gac, F (corresponding author), Biogenouest, INRA, LPGP UR1037, SFR Biosit, Campus Beaulieu, Rennes, France.	legac@rennes.inra.fr	Lardenois, Aurélie/AAA-8961-2020; ROLLAND, Antoine D/B-2611-2012; Houlgatte, Remi/P-3020-2017; Chalmel, Frédéric/AAM-1079-2021; Rolland, Antoine/A-6263-2011; Chalmel, Frédéric/L-5360-2018; Chalmel, Frederic/M-1297-2016	ROLLAND, Antoine D/0000-0002-9758-4406; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; 	AGENAE program; INRA-CIPA-OFIMER European community IFOP grant; French National Research Agency [ANR-06-GANI-014]; European Community's Seventh Framework Programme (FP7), project LIFECYCLE [222719]; SIGENAE informatics team	AGENAE program; INRA-CIPA-OFIMER European community IFOP grant; French National Research Agency(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7), project LIFECYCLE; SIGENAE informatics team	This work was supported by the AGENAE program (www.agenae.fr), INRA-CIPA-OFIMER European community IFOP grant. This research received funding from the French National Research Agency (ANR-06-GANI-014 "Spermgen") and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no222719, project LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the SIGENAE informatics team for their support, the PEIMA experimental fish farming facilities for the experimental animals and the INRA-Rennes/BIOSIT functional genomic platform for advice.	Adams IR, 2002, DEVELOPMENT, V129, P1155; ADLER AJ, 1991, MOL ENDOCRINOL, V5, P1587, DOI 10.1210/mend-5-11-1587; Alavi SMH, 2006, CELL BIOL INT, V30, P1, DOI 10.1016/j.cellbi.2005.06.004; Amer MA, 2001, BIOL REPROD, V65, P1057, DOI 10.1095/biolreprod65.4.1057; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Cavaco JEB, 1998, AM J PHYSIOL-REG I, V275, pR1793, DOI 10.1152/ajpregu.1998.275.6.R1793; Cavaco JEB, 2001, BIOL REPROD, V65, P1807, DOI 10.1095/biolreprod65.6.1807; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; COCHRAN RC, 1992, J EXP ZOOL, V261, P143, DOI 10.1002/jez.1402610205; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; DECLERCQ L, 1977, IN VITRO CELL DEV B, V13, P85; Dickey JT, 1998, J MOL ENDOCRINOL, V21, P291, DOI 10.1677/jme.0.0210291; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; El Shennawy A, 1998, J ANDROL, V19, P320; ELKINGTON JS, 1974, AUST J BIOL SCI, V27, P47, DOI 10.1071/BI9740047; FITZPATRICK MS, 1994, GEN COMP ENDOCR, V95, P399, DOI 10.1006/gcen.1994.1139; FOSTIER A, 1982, GEN COMP ENDOCR, V46, P428, DOI 10.1016/0016-6480(82)90096-X; Galas JE, 2009, ANN NY ACAD SCI, V1163, P398, DOI 10.1111/j.1749-6632.2008.03663.x; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Gomez JM, 1998, BIOL REPROD, V58, P483, DOI 10.1095/biolreprod58.2.483; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khan IA, 1999, BIOL REPROD, V61, P834, DOI 10.1095/biolreprod61.3.834; KOBAYASHI M, 1991, ZOOL SCI, V8, P389; Lareyre JJ, 2000, BIOL REPROD, V63, P1881, DOI 10.1095/biolreprod63.6.1881; Leal MC, 2009, GEN COMP ENDOCR, V162, P134, DOI 10.1016/j.ygcen.2009.03.003; Loir M, 1999, MOL REPROD DEV, V53, P422, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;422::AID-MRD8&gt;3.0.CO;2-V; MARSHALL WS, 1993, GEN COMP ENDOCR, V90, P232, DOI 10.1006/gcen.1993.1078; MATHER JP, 1990, ENDOCRINOLOGY, V127, P3206, DOI 10.1210/endo-127-6-3206; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; MIURA T, 1995, FISHERIES SCI, V61, P434, DOI 10.2331/fishsci.61.434; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 2002, DEVELOPMENT, V129, P2689; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rolland AD, 2008, ADV EXP MED BIOL, V636, P16, DOI 10.1007/978-0-387-09597-4_2; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2001, COMP BIOCHEM PHYS B, V129, P407, DOI 10.1016/S1096-4959(01)00339-6; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takeo J, 1999, J BIOL CHEM, V274, P5674, DOI 10.1074/jbc.274.9.5674; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Woods M, 2009, MOL CELL ENDOCRINOL, V303, P57, DOI 10.1016/j.mce.2008.12.014; Wu Y, 2007, ENDOCRINOLOGY, V148, P2984, DOI 10.1210/en.2006-1653; Zhou Q, 2002, J ANDROL, V23, P870	60	32	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53302	10.1371/journal.pone.0053302	http://dx.doi.org/10.1371/journal.pone.0053302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301058	gold, Green Published			2022-12-27	WOS:000313480000048
J	Zeng, Q; Dong, SY; Wu, LX; Li, H; Sun, ZJ; Li, JB; Jiang, HX; Chen, ZH; Wang, QB; Chen, WW				Zeng, Qiang; Dong, Sheng-Yong; Wu, Liu-Xin; Li, Hong; Sun, Zhi-Jian; Li, Jing-Bo; Jiang, Hong-Xia; Chen, Zhi-Heng; Wang, Qi-Bin; Chen, Wei-Wei			Variable Food-Specific IgG Antibody Levels in Healthy and Symptomatic Chinese Adults	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; IMMUNOGLOBULIN-G; GENE POLYMORPHISMS; MILK PROTEIN; DOUBLE-BLIND; ALLERGY; PREVALENCE; PEANUT; ELIMINATION; RESPONSES	Background: The presence of food-specific IgG antibodies in human serum may be useful for diagnosis of adverse food reactions. However, the clinical utility of tesing for such antibodies remains very controversial. The aim of this study was to evaluate the serum levels and population distribution of food-specific IgGs and their association with chronic symptoms in a large-scale Chinese population. Methodology/Principal Findings: A total of 21305 adult participants from different regions of China had 14 type of food-specific serum IgG antibodies that were measured by enzyme-linked immunosorbent assay. Amongthese, 5,394 participants were randomly chosen to complete follow-up questionnaire surveys on their dietary characteristics and chronic symptoms. The concentrations of food-specific IgGs against 14 foods ranged from a median (interquartile range) of 7.3 (3.8, 12.6) U/mL of pork-specfic IgG to 42.3 (28.8, 60.2) U/mL of crab-specific IgG. The concentration of food-specific IgGs was closely related to gender; after adjustment for region and age, women had higher concentrations of food-specific IgGs against all of the 14 foods except chicken (regression coefficient (95% CI): 0.01 (-0.003, 0.023); P = 0.129) and corn (0.002 (-0.013, 0.016); P = 0.825). Similar results were also found in the relationship of geographic region to the food-specific IgG concentrations for the 14 foods. Chronic symptoms were negatively associated with the concentrations of a few food-specific IgGs, and were positively associated with the concentrations of other food-specific IgGs. Conclusions: The levels of food-specific IgGs were variable both in healthy and in symptomatic Chinese adults. These findings raise awareness that demographic factors, the type of food and specific chronic symptoms should be considered before food elimination treatment based on IgG testing in patients with chronic symptoms is used in clinical practice.	[Zeng, Qiang; Dong, Sheng-Yong] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Wu, Liu-Xin] PLA AF Inst Aviat Med, Lab 2, Beijing, Peoples R China; [Li, Hong] Fujian Prov Hosp, Hlth Management Ctr, Fuzhou, Fujian, Peoples R China; [Sun, Zhi-Jian] Shandong Prov Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Li, Jing-Bo] Third Mil Med Univ, Southwest Hosp, Hlth Management Ctr, Chongqing, Peoples R China; [Jiang, Hong-Xia] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Chen, Zhi-Heng] Cent S Univ, Xiangya Hosp 3, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Wang, Qi-Bin] Shandong Elect Power Ctr Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Chen, Wei-Wei] 302 Hosp PLA, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fujian Provincial Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Army Medical University; Central South University; Central South University; Fifth Medical Center of Chinese PLA General Hospital	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@hotmail.com; cww302@126.com		Dong, Sheng-Yong/0000-0002-8395-4269	State Science and Technology Support Program [2012BAI37B04]	State Science and Technology Support Program	This study was supported by the State Science and Technology Support Program (No. 2012BAI37B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens B, 2010, ALLERGY, V65, P1554, DOI 10.1111/j.1398-9995.2010.02429.x; Alberto EJC, 2008, PEDIAT ALLERG IMM-UK, V19, P716, DOI 10.1111/j.1399-3038.2007.00709.x; Alpay K, 2010, CEPHALALGIA, V30, P829, DOI 10.1177/0333102410361404; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Antico A, 2011, INT ARCH ALLERGY IMM, V155, P52, DOI 10.1159/000318736; Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Babu BNH, 2008, CLIN EXP ALLERGY, V38, P1795, DOI 10.1111/j.1365-2222.2008.03076.x; Battais F, 2003, CLIN EXP ALLERGY, V33, P962, DOI 10.1046/j.1365-2222.2003.01592.x; Carvalho RVB, 2010, DIGEST DIS SCI, V55, P60, DOI 10.1007/s10620-008-0698-8; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Chen Y, 2003, J CLIN EPIDEMIOL, V56, P180, DOI 10.1016/S0895-4356(02)00593-0; CROWE SE, 1992, GASTROENTEROLOGY, V103, P1075, DOI 10.1016/0016-5085(92)90047-3; Dreskin SC, 2010, CLIN IMMUNOL, V137, P366, DOI 10.1016/j.clim.2010.08.009; Harduar-Morano L, 2011, J ALLERGY CLIN IMMUN, V128, P594, DOI 10.1016/j.jaci.2011.04.049; Hochwallner H, 2011, ALLERGY, V66, P1201, DOI 10.1111/j.1398-9995.2011.02635.x; Hong XM, 2011, J ALLERGY CLIN IMMUN, V128, P374, DOI 10.1016/j.jaci.2011.05.007; HOST A, 1992, ALLERGY, V47, P218, DOI 10.1111/j.1398-9995.1992.tb00654.x; Hunter JO, 2005, GUT, V54, P1203; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kanagawa Y, 2009, PEDIATR ALLERGY IMMU, V20, P347, DOI 10.1111/j.1399-3038.2008.00791.x; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Penard-Morand C, 2005, ALLERGY, V60, P1165, DOI 10.1111/j.1398-9995.2005.00860.x; Poulos LM, 2007, J ALLERGY CLIN IMMUN, V120, P878, DOI 10.1016/j.jaci.2007.07.040; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; Scott-Taylor TH, 2010, PEDIAT ALLERG IMM-UK, V21, P935, DOI 10.1111/j.1399-3038.2010.01025.x; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Stapel SO, 2008, ALLERGY, V63, P793, DOI 10.1111/j.1398-9995.2008.01705.x; Tay SS, 2007, CLIN EXP ALLERGY, V37, P1512, DOI 10.1111/j.1365-2222.2007.02802.x; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zar S, 2005, AM J GASTROENTEROL, V100, P1550, DOI 10.1111/j.1572-0241.2005.41348.x; Zuberbier T, 2004, ALLERGY, V59, P338, DOI 10.1046/j.1398-9995.2003.00403.x; Zuo XL, 2007, CLIN EXP ALLERGY, V37, P823, DOI 10.1111/j.1365-2222.2007.02727.x	38	22	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53612	10.1371/journal.pone.0053612	http://dx.doi.org/10.1371/journal.pone.0053612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301096	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000072
J	Camens, AB; Carey, SP				Camens, Aaron Bruce; Carey, Stephen Paul			Contemporaneous Trace and Body Fossils from a Late Pleistocene Lakebed in Victoria, Australia, Allow Assessment of Bias in the Fossil Record	PLOS ONE			English	Article							SOUTH EAST REGION; VERTEBRATE SITES; FOOTPRINTS; ICHNOFACIES	The co-occurrence of vertebrate trace and body fossils within a single geological formation is rare and the probability of these parallel records being contemporaneous (i.e. on or near the same bedding plane) is extremely low. We report here a late Pleistocene locality from the Victorian Volcanic Plains in south-eastern Australia in which demonstrably contemporaneous, but independently accumulated vertebrate trace and body fossils occur. Bite marks from a variety of taxa are also present on the bones. This site provides a unique opportunity to examine the biases of these divergent fossil records (skeletal, footprints and bite marks) that sampled a single fauna. The skeletal record produced the most complete fauna, with the footprint record indicating a markedly different faunal composition with less diversity and the feeding traces suggesting the presence, amongst others, of a predator not represented by either the skeletal or footprint records. We found that the large extinct marsupial predator Thylacoleo was the only taxon apparently represented by all three records, suggesting that the behavioral characteristics of large carnivores may increase the likelihood of their presence being detected within a fossil fauna. In contrast, Diprotodon (the largest-ever marsupial) was represented only by trace fossils at this site and was absent from the site's skeletal record, despite its being a common and easily detected presence in late Pleistocene skeletal fossil faunas elsewhere in Australia. Small mammals absent from the footprint record for the site were represented by skeletal fossils and bite marks on bones.	[Camens, Aaron Bruce] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Carey, Stephen Paul] Univ Ballarat, Ctr Environm Management, Sch Sci Informat Technol & Engn, Ballarat, Vic 3353, Australia	Flinders University South Australia; Federation University Australia	Camens, AB (corresponding author), Flinders Univ S Australia, Bedford Pk, SA 5042, Australia.	aaron.b.camens@gmail.com		Carey, Stephen/0000-0002-5075-560X	Corangamite Catchment Management Authority; Heritage Australia	Corangamite Catchment Management Authority; Heritage Australia	The fieldwork for this study was partially funded by the Corangamite Catchment Management Authority and Heritage Australia (www.ccma.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous farming family of the Victorian Volcanic Plains who have protected the trackways site for decades; regional staff of Parks Victoria; David Pickering of Museum Victoria and his crew of volunteers, and students, staff and friends of the University of Ballarat who helped lay out the grid and excavate the skeletal fossils; and Matt Gibson, formerly of the University of Ballarat, who prepared the map of the locality. We thank Rodney Berrell, Erich Fitzgerald, Dave Pickering, Gavin Prideaux, Karen Roberts and Rod Wells for assistance in identifying and counting specimens. Trevor Worthy made helpful comments on the draft manuscript. Aspects of this study were funded by the Corangamite Catchment Management Authority and Heritage Australia.	Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ANDREWS P, 1979, BIOL J LINN SOC, V11, P177, DOI 10.1111/j.1095-8312.1979.tb00034.x; Aramayo SA, 2009, ICHNOS, V16, P25, DOI 10.1080/10420940802470714; Armstrong K.N., 2008, MAMMALS AUSTR, P470; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Camens A, 2009, J VERTEBR PALEONTOL, V29, P863, DOI 10.1671/039.029.0316; Camp C.L., 1956, MEM U CALIF, V13, P255; Carey SP, 2011, QUATERNARY SCI REV, V30, P591, DOI 10.1016/j.quascirev.2010.11.021; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Coe M., 1980, P55; COHEN AS, 1993, PALEOBIOLOGY, V19, P433; De Vis CW, 1883, P LINNEAN SOC NEW S, V8, P187; De Vis CW, 1899, P ROYAL SOC VICTORIA, V12, P107; Demathieu G. R., 1990, DINOSAUR TRACKS TRAC, P201; Errey K, 1978, ARTEFACT, V3, P101; Guiler, 1977, BIOL MARSUPIALS, P155; Hamer JMM, 2010, SEDIMENT GEOL, V228, P319, DOI 10.1016/j.sedgeo.2010.06.002; Harris Jerald D., 1998, Modern Geology, V23, P291; Hebert BL, 2004, CAN J EARTH SCI, V41, P247, DOI 10.1139/E03-096; Hope J, 1984, VERTEBRATE ZOOGEOGRA, P75; Krapovickas V, 2009, PALAEOGEOGR PALAEOCL, V284, P129, DOI 10.1016/j.palaeo.2009.09.015; LAPORTE LF, 1980, J SEDIMENT PETROL, V50, P1337; LOCKLEY M G, 1986, Palaios, V1, P37, DOI 10.2307/3514457; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley M.G., 2000, DINOSAUR TRACKS OTHE; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley MG, 1998, NATURE, V396, P429, DOI 10.1038/24783; Marshall LG, 1974, MEMOIRS NATL MUSEUM, V13, P63; MATSUKAWA M, 1995, PALAIOS, V10, P3, DOI 10.2307/3515004; McCrea R. T., 2003, ALB PAL SOC 7 ANN S, P41; McIlroy D, 2008, PALAEOGEOGR PALAEOCL, V270, P332, DOI 10.1016/j.palaeo.2008.07.016; McNeil P, 2005, QUATERNARY SCI REV, V24, P1253, DOI 10.1016/j.quascirev.2004.08.019; McNeil PE, 2004, ARCHAEOLOGY EDGE NEW, P79; Nakano Y, 2001, J AFRICAN STUDIES, V59, P101; Pemberton D., 1990, SOCIAL ORG BEHAV TAS; PICKFORD M, 1984, AFR STUDY MONOGR S, V2, P67; Price GJ, 2006, AUST J EARTH SCI, V53, P947, DOI 10.1080/08120090600880842; Reed EH, 2009, T ROY SOC SOUTH AUST, V133, P30, DOI 10.1080/03721426.2009.10887108; Reed EH, 2000, T ROY SOC SOUTH AUST, V124, P61; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Rylaarsdam JR, 2006, CAN J EARTH SCI, V43, P631, DOI 10.1139/E06-014; SOBBE I H, 1990, Memoirs of the Queensland Museum, V28, P299; Stander PE, 1997, J ZOOL, V242, P329; Thulborn T., 1990, DINOSAUR TRACKS; Tsujikawa Hiroshi, 2005, African Study Monographs Supplementary Issue, V32, P51; VandenBerg AHM, 2009, GEOLOGICAL SURVEY VI, V129, P112; WEST RM, 1983, CURR SCI INDIA, V52, P12; Western D., 1980, P41; Wroe S, 2004, P ROY SOC B-BIOL SCI, V271, pS34, DOI 10.1098/rsbl.2003.0095; Wroe S, 2003, PALEOBIOLOGY, V29, P403, DOI 10.1666/0094-8373(2003)029<0403:AAMFPB>2.0.CO;2; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906	52	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52957	10.1371/journal.pone.0052957	http://dx.doi.org/10.1371/journal.pone.0052957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301008	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900050
J	Elmazar, MM; El-Abhar, HS; Schaalan, MF; Farag, NA				Elmazar, Mohamed M.; El-Abhar, Hanan S.; Schaalan, Mona F.; Farag, Nahla A.			Phytol/Phytanic Acid and Insulin Resistance: Potential Role of Phytanic Acid Proven by Docking Simulation and Modulation of Biochemical Alterations	PLOS ONE			English	Article							ACTIVATED RECEPTOR PPAR; PLASMA-CONCENTRATIONS; PIOGLITAZONE; ADIPONECTIN; PHYTOL; ALPHA; SENSITIVITY; DIET; GAMMA; METABOLISM	Since activation of PPAR gamma is the main target for the antidiabetic effect of TZDs, especially when it heterodimerizes with RXR, we aimed to test the potential antidiabetic effect of phytol (250 mg/ kg), the natural precursor of phytanic acid, a RXR ligand and/or pioglitazone (5 mg/kg) to diabetic insulin-resistant rats. Regarding the molecular docking simulation on PPAR gamma, phytanic acid, rather than phytol, showed a binding mode that mimics the crystal orientation of rosiglitazone and pioglitazone, forming H bonds with the same amino acids (S289, H 323, H 449 and Y 473), and the least energy level, which emphasizes their importance for PPAR gamma molecular recognition, activation, hence antidiabetic activity. In addition, docking on the RXR alpha/PPAR gamma heterodimer, revealed that phytanic acid has higher binding affinity and lesser energy score on RXR alpha, compared to the original ligand, retinoic acid. Phytanic acid binds by 3H bonds and shares retinoic acid in arginine (R 316). These results were further supported biochemically, where oral phytol and/or pioglitazone (5 mg/ kg) improved significantly glucose homeostasis, lipid panel, raised serum adiponectin level and lowered TNF- a, reaching in most cases the effect of the 10 mg/ kg pioglitazone. The study concluded that the insulin sensitizing/ anti- diabetic effect of phytol is mediated by partly from activation of nuclear receptors and heterodimerization of RXR with PPAR gamma by phytanic acid.	[Elmazar, Mohamed M.] British Univ Cairo BUE, Cairo, Egypt; [El-Abhar, Hanan S.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Schaalan, Mona F.] Misr Int Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Farag, Nahla A.] Misr Int Univ, Fac Pharm, Dept Pharmaceut Med Chem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology; Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology	El-Abhar, HS (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanabhar@yahoo.com	Farag, Nahla/AAJ-6846-2020; El-Abhar, Hanan/L-2289-2019; Elmazar, M M/D-9325-2013	Farag, Nahla/0000-0003-0978-7973; El-Abhar, Hanan/0000-0001-8819-9891; Schaalan, Mona/0000-0002-8569-689X; Elmazar, M M/0000-0002-5076-9817				Allen NE, 2008, BRIT J NUTR, V99, P653, DOI 10.1017/S000711450782407X; Anderson A, 1999, J MOL GRAPH MODEL, V17, P180, DOI 10.1016/S1093-3263(99)00029-7; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Ding SY, 2005, ACTA PHARMACOL SIN, V26, P575, DOI 10.1111/j.1745-7254.2005.00090.x; Elmazar MMA, 2004, ARCH TOXICOL, V78, P660, DOI 10.1007/s00204-004-0586-8; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gloerich J, 2007, J LIPID RES, V48, P77, DOI 10.1194/jlr.M600050-JLR200; Gloerich J, 2005, J LIPID RES, V46, P716, DOI 10.1194/jlr.M400337-JLR200; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HANSEN RP, 1966, NATURE, V210, P841, DOI 10.1038/210841a0; Hashimoto T, 2006, J NUTR, V136, P882, DOI 10.1093/jn/136.4.882; Heim M, 2002, FASEB J, V16, P718, DOI 10.1096/fj.01-0816fje; HOFMANN C, 1991, ENDOCRINOLOGY, V129, P1915, DOI 10.1210/endo-129-4-1915; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Koch SSC, 1999, J MED CHEM, V42, P742, DOI 10.1021/jm980621r; LEVY J, 1984, DIABETES, V33, P901, DOI 10.2337/diabetes.33.9.901; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarty MF, 2005, MED HYPOTHESES, V64, P399, DOI 10.1016/j.mehy.2004.03.034; McCarty MF, 2001, MED HYPOTHESES, V56, P217, DOI 10.1054/mehy.2000.1153; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Murcko M. A., 1997, PRACTICAL APPL COMPU, P355; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Sakamoto J, 2000, BIOCHEM BIOPH RES CO, V278, P704, DOI 10.1006/bbrc.2000.3868; Schaalan M, 2009, J DIABETES COMPLICAT, V23, P199, DOI 10.1016/j.jdiacomp.2008.02.003; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van den Brink DM, 2005, J BIOL CHEM, V280, P26838, DOI 10.1074/jbc.M501861200; VANDENBRANDEN C, 1986, PEDIATR RES, V20, P411, DOI 10.1203/00006450-198605000-00007; Vijay SK, 2009, ACTA DIABETOL, V46, P27, DOI 10.1007/s00592-008-0054-7; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	47	70	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e45638	10.1371/journal.pone.0045638	http://dx.doi.org/10.1371/journal.pone.0045638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300941	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900001
J	Reigada, R				Reigada, Ramon			Atomistic Study of Lipid Membranes Containing Chloroform: Looking for a Lipid-Mediated Mechanism of Anesthesia	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LATERAL PRESSURE PROFILES; GENERAL-ANESTHETICS; FATTY-ACIDS; CHOLESTEROL; BILAYER; CHANNEL; CONFORMATION; PROTEINS; ALCOHOLS	The molecular mechanism of general anesthesia is still a controversial issue. Direct effect by linking of anesthetics to proteins and indirect action on the lipid membrane properties are the two hypotheses in conflict. Atomistic simulations of different lipid membranes subjected to the effect of small volatile organohalogen compounds are used to explore plausible lipid-mediated mechanisms. Simulations of homogeneous membranes reveal that electrostatic potential and lateral pressure transversal profiles are affected differently by chloroform (anesthetic) and carbon tetrachloride (non-anesthetic). Simulations of structured membranes that combine ordered and disordered regions show that chloroform molecules accumulate preferentially in highly disordered lipid domains, suggesting that the combination of both lateral and transversal partitioning of chloroform in the cell membrane could be responsible of its anesthetic action.	[Reigada, Ramon] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain; [Reigada, Ramon] Univ Barcelona, Inst Quim Teor & Computac IQTCUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Reigada, R (corresponding author), Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain.	reigada@ub.edu		Reigada, Ramon/0000-0003-2177-7014	Secretaria de Estado de Investigacion y Desarrollo [BFU2010-21847-C02-02]; Departament d'Universitats, Recerca i Sistemes de la Informacio [2009-SGR-1055]	Secretaria de Estado de Investigacion y Desarrollo; Departament d'Universitats, Recerca i Sistemes de la Informacio	Financial support is provided by Secretaria de Estado de Investigacion y Desarrollo through project BFU2010-21847-C02-02 and by Departament d'Universitats, Recerca i Sistemes de la Informacio through project 2009-SGR-1055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Bachar M, 2004, J PHYS CHEM B, V108, P7170, DOI 10.1021/jp036981u; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bondarenko V, 2008, BIOPHYS J, V94, P1681, DOI 10.1529/biophysj.107.116772; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1997, NAT MED, V3, P377, DOI 10.1038/nm0497-377; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gurtovenko AA, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148885; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Hu MY, 2012, BIOPHYS J, V102, P1403, DOI 10.1016/j.bpj.2012.02.013; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; Koubi L, 2001, BIOPHYS J, V81, P3339, DOI 10.1016/S0006-3495(01)75967-X; LIEB WR, 1982, BIOCHIM BIOPHYS ACTA, V688, P388, DOI 10.1016/0005-2736(82)90350-9; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123; Martinez-Seara H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011162; Martinez-Seara H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976443; MILLER KW, 1989, P NATL ACAD SCI USA, V86, P1084, DOI 10.1073/pnas.86.3.1084; MILLER KW, 1976, NATURE, V263, P253, DOI 10.1038/263253a0; Nishizawa M, 2008, BIOPHYS J, V95, P1729, DOI 10.1529/biophysj.108.130658; Ollila OHS, 2007, J STRUCT BIOL, V159, P311, DOI 10.1016/j.jsb.2007.01.012; Ollila OHS, 2010, RSC BIOMOL SCI, P26, DOI 10.1039/9781849732154-00026; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pandit SA, 2004, BIOPHYS J, V87, P1092, DOI 10.1529/biophysj.104.041939; PANG KYY, 1978, BIOCHIM BIOPHYS ACTA, V511, P1, DOI 10.1016/0005-2736(78)90060-3; Patra M, 2005, EUR BIOPHYS J BIOPHY, V35, P79, DOI 10.1007/s00249-005-0011-0; Reigada R, 2011, J PHYS CHEM B, V115, P2527, DOI 10.1021/jp110699h; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tang P, 2002, P NATL ACAD SCI USA, V99, P16035, DOI 10.1073/pnas.252522299; Turkyilmaz S, 2010, LANGMUIR, V26, P5309, DOI 10.1021/la100712y; Turkyilmaz S, 2009, J AM CHEM SOC, V131, P5068, DOI 10.1021/ja9011468; Ueda I, 1998, BIOPHYS J, V75, P1052, DOI 10.1016/S0006-3495(98)77594-0; Ueda Issaku, 2001, Keio Journal of Medicine, V50, P20; Watts P, 2004, 58 WHO IPCS; Xu Y, 1997, BBA-BIOMEMBRANES, V1323, P154, DOI 10.1016/S0005-2736(96)00184-8	49	19	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52631	10.1371/journal.pone.0052631	http://dx.doi.org/10.1371/journal.pone.0052631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300982	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900034
J	Schon, C; Hoffmann, NA; Ochs, SM; Burgold, S; Filser, S; Steinbach, S; Seeliger, MW; Arzberger, T; Goedert, M; Kretzschmar, HA; Schmidt, B; Herms, J				Schoen, Christian; Hoffmann, Nadine A.; Ochs, Simon M.; Burgold, Steffen; Filser, Severin; Steinbach, Sonja; Seeliger, Mathias W.; Arzberger, Thomas; Goedert, Michel; Kretzschmar, Hans A.; Schmidt, Boris; Herms, Jochen			Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice	PLOS ONE			English	Article							AMYLOID DEPOSITION; MOUSE MODEL; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PROTEIN; ABNORMALITIES; DEGENERATION; MUTATIONS; PATHOLOGY; PRECEDES	Tauopathies are widespread neurodegenerative disorders characterised by the intracellular accumulation of hyperphosphorylated tau. Especially in Alzheimer's disease, pathological alterations in the retina are discussed as potential biomarkers to improve early diagnosis of the disease. Using mice expressing human mutant P301S tau, we demonstrate for the first time a straightforward optical approach for the in vivo detection of fibrillar tau in the retina. Longitudinal examinations of individual animals revealed the fate of single cells containing fibrillar tau and the progression of tau pathology over several months. This technique is most suitable to monitor therapeutic interventions aimed at reducing the accumulation of fibrillar tau. In order to evaluate if this approach can be translated to human diagnosis, we tried to detect fibrillar protein aggregates in the post-mortem retinas of patients that had suffered from Alzheimer's disease or Progressive Supranuclear Palsy. Even though we could detect hyperphosphorylated tau, we did not observe any fibrillar tau or Ass aggregates. In contradiction to previous studies, our observations do not support the notion that Ab or tau in the retina are of diagnostic value in Alzheimer's disease.	[Schoen, Christian; Hoffmann, Nadine A.; Ochs, Simon M.; Burgold, Steffen; Filser, Severin; Steinbach, Sonja; Herms, Jochen] DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany; [Schoen, Christian; Hoffmann, Nadine A.; Burgold, Steffen; Arzberger, Thomas; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol, Munich, Germany; [Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, Darmstadt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; MRC Laboratory Molecular Biology; Technical University of Darmstadt	Herms, J (corresponding author), DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany.	Jochen.Herms@med.uni-muenchen.de	Schmidt, Boris/D-3293-2009; Herms, Jochen/D-3518-2011; Schmidt, Boris/M-7886-2019	Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392	German Federal Ministry for Education and Research (BMBF) [13N10636]; UK Medical Research Council [U105184291]; Medical Research Council [MC_U105184291] Funding Source: researchfish; MRC [MC_U105184291] Funding Source: UKRI	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the German Federal Ministry for Education and Research (BMBF - 13N10636)( http://www.bmbf.de) and the UK Medical Research Council (U105184291) (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Bolander A, 2012, J MED CHEM; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bull ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034724; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Leger F, 2011, J NEUROPATH EXP NEUR, V70, P63, DOI 10.1097/NEN.0b013e31820376cc; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Maurage CA, 2003, ANN NEUROL, V54, P542, DOI 10.1002/ana.10730; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021405; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Walsh MK, 2008, J NEUROSCI METH, V169, P214, DOI 10.1016/j.jneumeth.2007.11.029; Wostyn P, 2009, BRIT J OPHTHALMOL, V93, P1557, DOI 10.1136/bjo.2008.148064; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x	46	116	119	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53547	10.1371/journal.pone.0053547	http://dx.doi.org/10.1371/journal.pone.0053547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300938	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600108
J	Tahvanainen, P; Alpermann, TJ; Figueroa, RI; John, U; Hakanen, P; Nagai, S; Blomster, J; Kremp, A				Tahvanainen, Pia; Alpermann, Tilman J.; Figueroa, Rosa Isabel; John, Uwe; Hakanen, Paivi; Nagai, Satoshi; Blomster, Jaanika; Kremp, Anke			Patterns of Post-Glacial Genetic Differentiation in Marginal Populations of a Marine Microalga	PLOS ONE			English	Article							ALEXANDRIUM-OSTENFELDII DINOPHYCEAE; FUCUS-VESICULOSUS; COMPUTER-PROGRAM; ZOSTERA-MARINA; RIBOSOMAL DNA; DIVERSITY; DINOFLAGELLATE; ATLANTIC; AFLP; LIFE	This study investigates the genetic structure of an eukaryotic microorganism, the toxic dinoflagellate Alexandrium ostenfeldii, from the Baltic Sea, a geologically young and ecologically marginal brackish water estuary which is predicted to support evolution of distinct, genetically impoverished lineages of marine macroorganisms. Analyses of the internal transcribed spacer (ITS) sequences and Amplified Fragment Length Polymorphism (AFLP) of 84 A. ostenfeldii isolates from five different Baltic locations and multiple external sites revealed that Baltic A. ostenfeldii is phylogenetically differentiated from other lineages of the species and micro-geographically fragmented within the Baltic Sea. Significant genetic differentiation (FST) between northern and southern locations was correlated to geographical distance. However, instead of discrete genetic units or continuous genetic differentiation, the analysis of population structure suggests a complex and partially hierarchic pattern of genetic differentiation. The observed pattern suggests that initial colonization was followed by local differentiation and varying degrees of dispersal, most likely depending on local habitat conditions and prevailing current systems separating the Baltic Sea populations. Local subpopulations generally exhibited low levels of overall gene diversity. Association analysis suggests predominately asexual reproduction most likely accompanied by frequency shifts of clonal lineages during planktonic growth. Our results indicate that the general pattern of genetic differentiation and reduced genetic diversity of Baltic populations found in large organisms also applies to microscopic eukaryotic organisms.	[Tahvanainen, Pia; Hakanen, Paivi; Kremp, Anke] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Tahvanainen, Pia; Blomster, Jaanika] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Alpermann, Tilman J.] LOEWE Biodivers & Climate Res Ctr, Frankfurt, Germany; [Alpermann, Tilman J.] Senckenberg Res Inst, Frankfurt, Germany; [Alpermann, Tilman J.] Natl Museum, Frankfurt, Germany; [Figueroa, Rosa Isabel] Lund Univ, Lund, Sweden; [Figueroa, Rosa Isabel] Inst Espanol Oceanog, Vigo, Spain; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Nagai, Satoshi] Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan	Finnish Environment Institute; University of Helsinki; Senckenberg Gesellschaft fur Naturforschung (SGN); Lund University; Spanish Institute of Oceanography; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Japan Fisheries Research & Education Agency (FRA)	Tahvanainen, P (corresponding author), Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland.	pia.tahvanainen@helsinki.fi	john, uwe/S-3009-2016; Kremp, Anke/I-8139-2013; Figueroa, Rosa Isabel/M-7598-2015	john, uwe/0000-0002-1297-4086; Figueroa, Rosa Isabel/0000-0001-9944-7993; Blomster, Jaanika/0000-0003-1347-7919	Academy of Finland [128833]; Maj and Thor Nessling foundation; Walter ja Andree de Nottbeck foundation; Hesse's Ministry of Higher Education, Research, and the Arts; Alfred Wegener Institute	Academy of Finland(Academy of Finland); Maj and Thor Nessling foundation; Walter ja Andree de Nottbeck foundation; Hesse's Ministry of Higher Education, Research, and the Arts; Alfred Wegener Institute	This paper was supported by grants from the Academy of Finland (# 128833), the Maj and Thor Nessling as well as the Walter ja Andree de Nottbeck foundations. Additional financial support was obtained by the research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; and the PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADACHI M, 1994, J PHYCOL, V30, P857, DOI 10.1111/j.0022-3646.1994.00857.x; Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Bolch CJS, 1999, J PHYCOL, V35, P339, DOI 10.1046/j.1529-8817.1999.3520339.x; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Brosnahan ML, 2010, DEEP-SEA RES PT II, V57, P175, DOI 10.1016/j.dsr2.2009.09.005; Casali Sandro, 2011, P1; Cembella AD, 2001, J PLANKTON RES, V23, P1413, DOI 10.1093/plankt/23.12.1413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Elken Jueri, 2008, P379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Figueroa RI, 2008, PROTIST, V159, P563, DOI 10.1016/j.protis.2008.05.003; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu HF, 2011, J SYST EVOL, V49, P606, DOI 10.1111/j.1759-6831.2011.00160.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakanen P, 2012, HARMFUL ALGAE, V15, P91, DOI 10.1016/j.hal.2011.12.002; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Haubold B, 1998, GENETICS, V150, P1341; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Figueroa RI, 2010, DEEP-SEA RES PT II, V57, P190, DOI 10.1016/j.dsr2.2009.09.016; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, J PHYCOL, V47, P990, DOI 10.1111/j.1529-8817.2011.01032.x; John U, 2004, PROTIST, V155, P169, DOI 10.1078/143446104774199574; John U, 2003, MOL BIOL EVOL, V20, P1015, DOI 10.1093/molbev/msg105; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kremp A, 2006, J PHYCOL, V42, P400, DOI 10.1111/j.1529-8817.2006.00205.x; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kremp A, 2009, HARMFUL ALGAE, V8, P318, DOI 10.1016/j.hal.2008.07.004; Laamanen MJ, 2002, APPL ENVIRON MICROB, V68, P5296, DOI 10.1128/AEM.68.11.5296-5303.2002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Logares R, 2007, MICROB ECOL, V53, P549, DOI 10.1007/s00248-006-9088-y; Logares R, 2009, PROTIST, V160, P301, DOI 10.1016/j.protis.2008.10.004; MOESTRUP O, 1988, OPHELIA, V28, P195, DOI 10.1080/00785326.1988.10430813; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Olsson J, 2011, J FISH BIOL, V79, P122, DOI 10.1111/j.1095-8649.2011.02998.x; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rambaut A., 2007, TRACER V1 4; Reusch TBH, 1999, MAR ECOL PROG SER, V183, P301, DOI 10.3354/meps183301; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Tatarenkov A, 2007, J PHYCOL, V43, P675, DOI 10.1111/j.1529-8817.2007.00369.x; ten Lohuis MR, 1998, J PHYCOL, V34, P152; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Xu J, 2010, MICROBIAL POPULATION GENETICS, P1; Xu J., 2005, EVOL GENET, P87	75	45	45	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53602	10.1371/journal.pone.0053602	http://dx.doi.org/10.1371/journal.pone.0053602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300940	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600110
J	Cetinkol, OP; Smith-Moritz, AM; Cheng, G; Lao, J; George, A; Hong, KL; Henry, R; Simmons, BA; Heazlewood, JL; Holmes, BM				Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Cheng, Gang; Lao, Jeemeng; George, Anthe; Hong, Kunlun; Henry, Robert; Simmons, Blake A.; Heazlewood, Joshua L.; Holmes, Bradley M.			Structural and Chemical Characterization of Hardwood from Tree Species with Applications as Bioenergy Feedstocks	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; ENZYMATIC-HYDROLYSIS; CELL-WALL; LIGNIN MODIFICATION; PULP PRODUCTION; OPPOSITE WOOD; CELLULOSE; BIOMASS; NMR; SPECTROSCOPY	Eucalypt species are a group of flowering trees widely used in pulp production for paper manufacture. For several decades, the wood pulp industry has focused research and development efforts on improving yields, growth rates and pulp quality through breeding and the genetic improvement of key tree species. Recently, this focus has shifted from the production of high quality pulps to the investigation of the use of eucalypts as feedstocks for biofuel production. Here the structure and chemical composition of the heartwood and sapwood of Eucalyptus dunnii, E. globulus, E. pillularis, E. urophylla, an E. urophylla-E. grandis cross, Corymbia citriodora ssp. variegata, and Acacia mangium were compared using nuclear magnetic resonance spectroscopy (NMR), X-ray diffraction (XRD) and biochemical composition analysis. Some trends relating to these compositions were also identified by Fourier transform near infrared (FT-NIR) spectroscopy. These results will serve as a foundation for a more comprehensive database of wood properties that will help develop criteria for the selection of tree species for use as biorefinery feedstocks.	[Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Cheng, Gang; Lao, Jeemeng; George, Anthe; Simmons, Blake A.; Heazlewood, Joshua L.; Holmes, Bradley M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Lao, Jeemeng; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cheng, Gang; George, Anthe; Simmons, Blake A.; Holmes, Bradley M.] Sandia Natl Labs, Joint BioEnergy Inst, Livermore, CA USA; [Hong, Kunlun] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Henry, Robert; Simmons, Blake A.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Queensland	Heazlewood, JL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA.	jlheazlewood@lbl.gov	Heazlewood, Joshua L/A-2554-2008; Cetinkol, Ozgul Persil/AAZ-6526-2020; Hong, Kunlun/E-9787-2015; Simmons, Blake/N-6022-2016; Henry, Robert J/B-5824-2008	Heazlewood, Joshua L/0000-0002-2080-3826; Hong, Kunlun/0000-0002-2852-5111; Simmons, Blake/0000-0002-1332-1810; Henry, Robert J/0000-0002-4060-0292; PERSIL CETINKOL, OZGUL/0000-0002-6632-6981; Lao, Jeemeng/0000-0002-6576-1260	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Basic Energy Sciences, United States Department of Energy	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE))	This work was part of the Department of Energy (DOE) Joint BioEnergy Institute (http://www.jbei.org) supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the United States Department of Energy. The XRD experiments were conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo MG, 2010, MADERAS-CIENC TECNOL, V12, P241, DOI 10.4067/S0718-221X2010000300008; Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; Alves EF, 2010, CARBOHYD POLYM, V82, P1097, DOI 10.1016/j.carbpol.2010.06.038; Antal MJ, 1996, ENERG FUEL, V10, P652, DOI 10.1021/ef9501859; BORRALHO NMG, 1993, CAN J FOREST RES, V23, P648, DOI 10.1139/x93-085; Bunzel M, 2006, J AGR FOOD CHEM, V54, P8352, DOI 10.1021/jf061525z; Cao Y, 2004, J MOL STRUCT, V693, P87, DOI 10.1016/j.molstruc.2004.02.017; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z; Coates JP, 1996, APPL SPECTROSC REV, V31, P179, DOI 10.1080/05704929608000568; Del Lungo A., 2006, 38 FAO UN; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Evtuguin DV, 2003, CARBOHYD RES, V338, P597, DOI 10.1016/S0008-6215(02)00529-3; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Garrote G, 2003, BIORESOURCE TECHNOL, V88, P61, DOI 10.1016/S0960-8524(02)00256-0; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hames B, 2003, APPL BIOCHEM BIOTECH, V105, P14; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Ibarra D, 2007, HOLZFORSCHUNG, V61, P634, DOI 10.1515/HF.2007.096; Ibarra D, 2007, J AGR FOOD CHEM, V55, P3477, DOI 10.1021/jf063728t; Inoue H, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-2; Kaida R, 2009, J WOOD SCI, V55, P381, DOI 10.1007/s10086-009-1038-0; Kim H, 2008, BIOENERG RES, V1, P56, DOI 10.1007/s12155-008-9004-z; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; KUMAR M, 1992, BIOMASS BIOENERG, V3, P411, DOI 10.1016/0961-9534(92)90037-Q; Lisboa SA, 2007, HOLZFORSCHUNG, V61, P478, DOI 10.1515/HF.2007.110; MAEKAWA E, 1989, J WOOD CHEM TECHNOL, V9, P549, DOI 10.1080/02773818908050315; Magalhaes W., 2011, BMC P, V5, P116, DOI [10.1186/1753-6561-5-S7-P116, DOI 10.1186/1753-6561-5-S7-P116]; Munoz C, 2011, J IND MICROBIOL BIOT, V38, P1861, DOI 10.1007/s10295-011-0975-y; Norgate T, 2009, ISIJ INT, V49, P587, DOI 10.2355/isijinternational.49.587; NORRIS KH, 1984, CEREAL CHEM, V61, P158; Piketty MG, 2009, BIOMASS BIOENERG, V33, P180, DOI 10.1016/j.biombioe.2008.06.002; Pinto PC, 2005, J AGR FOOD CHEM, V53, P7856, DOI 10.1021/jf058081b; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Raymond C. A., 2001, Forest Genetics, V8, P213; Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096; Rencoret J, 2009, HOLZFORSCHUNG, V63, P691, DOI 10.1515/HF.2009.070; Romani A, 2011, BIORESOURCE TECHNOL, V102, P5896, DOI 10.1016/j.biortech.2011.02.070; Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/BFS.11.136, 10.4155/bfs.11.136]; Sierra R, 2008, CHEM ENG PROG, V104, pS10; Sluiter A, 2008, TECHNICAL REPORT; Smith-Moritz AM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-26; SUEHARA KI, 2004, ADV BIOCHEM ENG BIOT, V90, P173; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Wada M, 2003, POLYM J, V35, P155, DOI 10.1295/polymj.35.155; Watson C, 1977, ANAL CHEM, V49, P835; Watt DK, 1999, CARBOHYD POLYM, V39, P165, DOI 10.1016/S0144-8617(99)00002-8; WETZEL DL, 1983, ANAL CHEM, V55, P1165, DOI 10.1021/ac00262a001; Willfor S, 2005, WOOD SCI TECHNOL, V39, P601, DOI 10.1007/s00226-005-0039-4; Wyman CE, 1999, ANNU REV ENERG ENV, V24, P189, DOI 10.1146/annurev.energy.24.1.189; Yelle DJ, 2008, MAGN RESON CHEM, V46, P508, DOI 10.1002/mrc.2201; Yu Q, 2010, BIORESOURCE TECHNOL, V101, P4895, DOI 10.1016/j.biortech.2009.11.051	55	25	25	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52820	10.1371/journal.pone.0052820	http://dx.doi.org/10.1371/journal.pone.0052820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300786	Green Published, gold			2022-12-27	WOS:000313051500066
J	Liebler, SS; Feldner, A; Adam, MG; Korff, T; Augustin, HG; Fischer, A				Liebler, Sven S.; Feldner, Anja; Adam, M. Gordian; Korff, Thomas; Augustin, Hellmut G.; Fischer, Andreas			No Evidence for a Functional Role of Bi-Directional Notch Signaling during Angiogenesis	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; LIGAND DELTA1; VASCULAR MORPHOGENESIS; SPROUTING ANGIOGENESIS; PRIMARY NEUROGENESIS; CYTOPLASMIC DOMAIN; GAMMA-SECRETASE; ADAM PROTEASES; BINDING; REGION	The Delta-Notch pathway is a signal exchanger between adjacent cells to regulate numerous differentiation steps during embryonic development. Blood vessel formation by sprouting angiogenesis requires high expression of the Notch ligand DLL4 in the leading tip cell, while Notch receptors in the trailing stalk cells are activated by DLL4 to achieve strong Notch signaling activity. Upon ligand binding, Notch receptors are cleaved by ADAM proteases and gamma-secretase. This releases the intracellular Notch domain that acts as a transcription factor. There is evidence that also Notch ligands (DLL1, DLL4, JAG1, JAG2) are processed upon receptor binding to influence transcription in the ligand-expressing cell. Thus, the existence of bi-directional Delta-Notch signaling has been proposed. We report here that the Notch ligands DLL1 and JAG1 are processed in endothelial cells in a gamma-secretase-dependent manner and that the intracellular ligand domains accumulate in the cell nucleus. Overexpression of JAG1 intracellular domain (ICD) as well as DLL1-ICD, DLL4-ICD and NOTCH1-ICD inhibited endothelial proliferation. Whereas NOTCH1-ICD strongly repressed endothelial migration and sprouting angiogenesis, JAG1-ICD, DLL1-ICD and DLL4-ICD had no significant effects. Consistently, global gene expression patterns were only marginally affected by the processed Notch ligands. In addition to its effects as a transcription factor, NOTCH1-ICD promotes cell adhesion to the extracellular matrix in a transcription-independent manner. However, JAG1-ICD, DLL1-ICD and DLL4-ICD did not influence endothelial cell adhesion. In summary, reverse signaling of Notch ligands appears to be dispensable for angiogenesis in cellular systems.	[Liebler, Sven S.; Feldner, Anja; Adam, M. Gordian; Fischer, Andreas] DKFZ ZMBH Alliance, German Canc Res Ctr Heidelberg, Heidelberg, Germany; [Liebler, Sven S.; Adam, M. Gordian; Augustin, Hellmut G.; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis CBTM, D-6800 Mannheim, Germany; [Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis A190, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, A (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr Heidelberg, Heidelberg, Germany.	a.fischer@dkfz.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242	Deutsche Forschungsgemeinschaft [DFG-SFB/TR23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft DFG-SFB/TR23 to T.K., H.G.A., and A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Carey MF, 2009, COLD SPRING HARB PRO, V2009; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kiyota T, 2004, MECH DEVELOP, V121, P573, DOI 10.1016/j.mod.2004.03.034; Klueg KM, 1998, MOL BIOL CELL, V9, P1709, DOI 10.1091/mbc.9.7.1709; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Meloty-Kapella L, 2012, DEV CELL; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfister S, 2003, J MOL BIOL, V333, P229, DOI 10.1016/j.jmb.2003.08.043; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Popovic M, 2007, FEBS J, V274, P5325, DOI 10.1111/j.1742-4658.2007.06053.x; Popovic M, 2006, PROTEIN EXPRES PURIF, V47, P398, DOI 10.1016/j.pep.2005.11.027; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	36	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53074	10.1371/journal.pone.0053074	http://dx.doi.org/10.1371/journal.pone.0053074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300864	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500106
J	Kientz, B; Ducret, A; Luke, S; Vukusic, P; Mignot, T; Rosenfeld, E				Kientz, Betty; Ducret, Adrien; Luke, Stephen; Vukusic, Peter; Mignot, Tam; Rosenfeld, Eric			Glitter-Like Iridescence within the Bacteroidetes Especially Cellulophaga spp.: Optical Properties and Correlation with Gliding Motility	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SP NOV.; FLAVOBACTERIUM-JOHNSONIAE; STRUCTURAL COLORS; BACTERIA; MECHANISMS; RECLASSIFICATION; IRIDOPHORES; SURFACES; LYTICA	Iridescence results from structures that generate color. Iridescence of bacterial colonies has recently been described and illustrated. The glitter-like iridescence class, created especially for a few strains of Cellulophaga lytica, exhibits an intense iridescence under direct illumination. Such color appearance effects were previously associated with other bacteria from the Bacteroidetes phylum, but without clear elucidation and illustration. To this end, we compared various bacterial strains to which the iridescent trait was attributed. All Cellulophaga species and additional Bacteroidetes strains from marine and terrestrial environments were investigated. A selection of bacteria, mostly marine in origin, were found to be iridescent. Although a common pattern of reflected wavelengths was recorded for the species investigated, optical spectroscopy and physical measurements revealed a range of different glitter-like iridescence intensity and color profiles. Importantly, gliding motility was found to be a common feature of all iridescent colonies. Dynamic analyses of "glitter" formation at the edges of C. lytica colonies showed that iridescence was correlated with layer superposition. Both gliding motility, and unknown cell-to-cell communication processes, may be required for the establishment, in time and space, of the necessary periodic structures responsible for the iridescent appearance of Bacteroidetes.	[Kientz, Betty; Rosenfeld, Eric] Univ La Rochelle, UMR Littoral Environm & Soc 7266, CNRS, La Rochelle, France; [Ducret, Adrien; Mignot, Tam] Univ Aix Marseille, UMR 7283, CNRS, Lab Chim Bacterienne,Inst Microbiol Mediterranee, Marseille, France; [Luke, Stephen; Vukusic, Peter] Univ Exeter, Sch Phys, Exeter, Devon, England	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Exeter	Rosenfeld, E (corresponding author), Univ La Rochelle, UMR Littoral Environm & Soc 7266, CNRS, La Rochelle, France.	eric.rosenfeld@univ-lr.fr		Mignot, Tam/0000-0003-4338-9063; ERIC, ROSENFELD/0000-0003-1196-5265	AFOSR [FA9550-10-1-0020]; Ministere de la recherche et de l'enseignement superieur; CNRS [AIR75515]; Biotechnology and Biological Sciences Research Council [BB/E000177/1, JF16983] Funding Source: researchfish; BBSRC [BB/E000177/1] Funding Source: UKRI	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ministere de la recherche et de l'enseignement superieur; CNRS(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	PV acknowledges the support of AFOSR grant FA9550-10-1-0020. BK was a PhD student with a grant from the Ministere de la recherche et de l'enseignement superieur. ER acknowledges the support of CNRS grant AIR75515 ("Bacteridescence" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2011, STAND GENOMIC SCI, V4, P72, DOI 10.4056/sigs.1543845; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J-F, 2006, PROKARYOTES HDB BIOL, V7, P455, DOI [DOI 10.1007/0-387-30747-8_16, DOI 10.1007/0-387-30747-8]; Bowman JP, 2000, INT J SYST EVOL MICR, V50, P1861, DOI 10.1099/00207713-50-5-1861; Bowman JP, 2011, BERGEYS MANUAL SYSTE, V4, P176; Braun TF, 2005, J BACTERIOL, V187, P6943, DOI 10.1128/JB.187.20.6943-6952.2005; DOBSON SJ, 1991, ARCH MICROBIOL, V156, P56, DOI 10.1007/BF00418188; Doucet SM, 2006, J EXP BIOL, V209, P380, DOI 10.1242/jeb.01988; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; ENGBOEK HC, 1950, ACTA PATHOL MIC SC, V27, P388; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Greenewalt CH, 1960, P AM PHILOS SOC, V104, P249, DOI DOI 10.1364/JOSA.50; Guillot M, 1941, CR HEBD ACAD SCI, P1100; Jensen PR, 1996, MAR BIOL, V126, P1, DOI 10.1007/BF00571371; Johansen JE, 1999, INT J SYST BACTERIOL, V49, P1231, DOI 10.1099/00207713-49-3-1231; Kahng HY, 2009, INT J SYST EVOL MICR, V59, P654, DOI 10.1099/ijs.0.003210-0; Kientz B, 2012, FEMS MICROBIOL LETT, V333, P101, DOI 10.1111/j.1574-6968.2012.02614.x; Kientz B, 2012, APPL ENVIRON MICROB, V78, P2092, DOI 10.1128/AEM.07339-11; KOBELT F, 1992, J COMP PHYSIOL B, V162, P314; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; LEWIN RA, 1969, J GEN MICROBIOL, V58, P145, DOI 10.1099/00221287-58-2-145; Lewin RA, 1969, MICROBIOLOGY, V58, P189; LYTHGOE JN, 1989, J EXP BIOL, V141, P313; McBride MJ, 2004, J MOL MICROB BIOTECH, V7, P63, DOI 10.1159/000077870; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Meadows MG, 2009, J R SOC INTERFACE, V6, pS107, DOI 10.1098/rsif.2009.0013.focus; Nedashkovskaya OI, 2004, INT J SYST EVOL MICR, V54, P609, DOI 10.1099/ijs.0.02737-0; NOGRADY G, 1964, Rev Can Biol, V23, P367; Noyes J, 2008, J MATER RES, V23, P3229, DOI 10.1557/JMR.2008.0381; Park S, 2012, INT J SYST EVOL MICR, V62, P1354, DOI 10.1099/ijs.0.033340-0; Pati A, 2011, STAND GENOMIC SCI, V4, P221, DOI 10.4056/sigs.1774329; Pijper A, 1923, S AFR MED REC, V17, P243; Pijper A, 1918, MED J S AFRICA, V14, P211; Ponder E, 1934, J EXP BIOL, V11, P54; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Reichenbach H, 1981, PROKARYOTES, V1, P356; Reichenbach H, 1989, BERGEYS MANUAL SYSTE, V3, P2015; Rhodes RG, 2011, J BACTERIOL, V193, P2418, DOI 10.1128/JB.00117-11; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; STANIER RY, 1947, J BACTERIOL, V53, P297, DOI 10.1128/JB.53.3.297-315.1947; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P85, DOI 10.1099/ijs.0.02857-0; VANDERMEULEN HJ, 1974, A VAN LEEUW J MICROB, V40, P329, DOI 10.1007/BF00399345; VOZNYAKOVSKAYA Y M, 1969, Mikrobiologiya, V38, P135; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Vukusic P, 2001, NATURE, V410, P36, DOI 10.1038/35065161; WEEKS OWEN B., 1955, JOUR BACT, V69, P649; Welch V, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041916; WILLIAMS RC, 1958, BIOCHIM BIOPHYS ACTA, V28, P464, DOI 10.1016/0006-3002(58)90507-9; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P2051, DOI 10.1099/ijs.0.63777-0	52	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52900	10.1371/journal.pone.0052900	http://dx.doi.org/10.1371/journal.pone.0052900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300811	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100092
J	Eiro, N; Pidal, I; Fernandez-Garcia, B; Junquera, S; Lamelas, ML; del Casar, JM; Gonzalez, LO; Lopez-Muniz, A; Vizoso, FJ				Eiro, Noemi; Pidal, Ivan; Fernandez-Garcia, Belen; Junquera, Sara; Lamelas, Maria L.; del Casar, Jose M.; Gonzalez, Luis O.; Lopez-Muniz, Alfonso; Vizoso, Francisco J.			Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast Cancer	PLOS ONE			English	Article							MONONUCLEAR INFLAMMATORY CELLS; ANTIGEN-PRESENTING CELLS; MATRIX METALLOPROTEINASES; B-CELLS; CLINICAL-VALUE; T-CELLS; MACROPHAGES; INHIBITORS; EXPRESSION; ANGIOGENESIS	Tumors are infiltrated by macrophages, T and B-lymphocytes, which may favor tumor development by promoting angiogenesis, growth and invasion. The aim of this study was to investigate the clinical relevance of the relative amount of macrophages (CD68(+)), T-cells (CD3(+)) and B-cells (CD20(+)) at the invasive front of breast carcinomas, and the expression of matrix metalloproteases (MMPs) and their inhibitors (TIMPs) either at the invasive front or at the tumor center. We performed an immunohistochemical study counting CD3, CD20 and CD68 positive cells at the invasive front, in 102 breast carcinomas. Also, tissue sections were stained with MMP-2, -9, -11, -14 and TIMP-2 antibodies, and immunoreactivity location, percentage of reactive area and intensity were determined at the invasive front and at the tumor center. The results showed that an increased CD68 count and CD68/(CD3+CD20) ratio were directly associated with both MMP-11 and TIMP-2 expression by mononuclear inflammatory cells at the tumor center (p = 0.041 and p = 0.025 for CD68 count and p = 0.001 and p = 0.045 for ratio, respectively for MMP-11 and TIMP-2). In addition, a high CD68/(CD3+CD20) ratio (>0.05) was directly associated with a higher probability of shortened relapse-free survival. Multivariate analysis revealed that CD68/(CD3+CD20) ratio was an independent factor associated with distant relapse- free survival (RR: 2.54, CI: (1.23-5.24), p<0.01). Therefore, CD68/(CD3+ CD20) ratio at the invasive front could be used as an important prognostic marker.	[Eiro, Noemi; Pidal, Ivan; Fernandez-Garcia, Belen; Junquera, Sara; Lamelas, Maria L.; del Casar, Jose M.; Gonzalez, Luis O.; Vizoso, Francisco J.] Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain; [Lamelas, Maria L.] Fdn Hosp Jove, Serv Ginecol, Gijon, Asturias, Spain; [del Casar, Jose M.; Vizoso, Francisco J.] Fdn Hosp Jove, Serv Cirugia Gen, Gijon, Asturias, Spain; [Gonzalez, Luis O.] Fdn Hosp Jove, Serv Anat Patol, Gijon, Asturias, Spain; [Lopez-Muniz, Alfonso] Univ Oviedo, Dept Morfol & Biol Celular, Fac Med, E-33006 Oviedo, Asturias, Spain	University of Oviedo	Vizoso, FJ (corresponding author), Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain.	investigacion@hospitaldejove.com	; Eiro, Noemi/C-9510-2018	Fernandez-Garcia, Belen/0000-0002-9950-2494; Eiro, Noemi/0000-0001-5840-4807	Fondo de Inversion Sanitaria-Instituto Carlos III [FIS-PI07/0306, FIS-PI10/02106]; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia [FICYT IB08-170]; Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU)	Fondo de Inversion Sanitaria-Instituto Carlos III; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia(Principality of Asturias); Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU)	This work was supported by grants from Fondo de Inversion Sanitaria-Instituto Carlos III (FIS-PI07/0306, FIS-PI10/02106), from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT IB08-170), and Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel D, 2005, CANCER RES, V65, P2018, DOI 10.1158/0008-5472.CAN-04-3444; Del Casar J, 2009, BREAST CANCER RES TR, V116, P39, DOI 10.1007/s10549-009-0351-z; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eiro N, 2012, PLOS ONE IN PRESS; Eiro N, 2012, EUR J CANC IN PRESS; Ellis I.O., 2006, HISTOLOGIC GRADE BRE, P225; Giatromanolaki A, 2004, APMIS, V112, P431, DOI 10.1111/j.1600-0463.2004.apm11207-0804.x; Gonzalez LO, 2007, BRIT J CANCER, V97, P957, DOI 10.1038/sj.bjc.6603963; Gonzalez LO, 2010, HISTOPATHOLOGY, V57, P862, DOI 10.1111/j.1365-2559.2010.03723.x; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Griffiths L, 2000, GENE THER, V7, P255, DOI 10.1038/sj.gt.3301058; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; JOHNSON JP, 1989, IMMUNOL TODAY, V10, pS35; KELLY PMA, 1988, BRIT J CANCER, V57, P174, DOI 10.1038/bjc.1988.36; Lapointe R, 2003, CANCER RES, V63, P2836; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Lin Elaine Y, 2004, Novartis Found Symp, V256, P158; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Lofdahl B, 2012, ACTA ONCOL; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; NAUKKARINEN A, 1990, J PATHOL, V160, P217, DOI 10.1002/path.1711600307; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Volodko N, 1998, BREAST, V7, P99, DOI 10.1016/S0960-9776(98)90065-0	46	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52796	10.1371/journal.pone.0052796	http://dx.doi.org/10.1371/journal.pone.0052796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300781	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800149
J	Farid, WO; Lawrence, AJ; Krstew, EV; Tait, RJ; Hulse, GK; Dunlop, SA				Farid, Waleed O.; Lawrence, Andrew J.; Krstew, Elena V.; Tait, Robert J.; Hulse, Gary K.; Dunlop, Sarah A.			Maternally Administered Sustained-Release Naltrexone in Rats Affects Offspring Neurochemistry and Behaviour in Adulthood	PLOS ONE			English	Article							ENDOGENOUS OPIOID SYSTEMS; LOW-DOSE NALTREXONE; MESSENGER-RNA EXPRESSION; LONG-LASTING CHANGES; BLOOD NALTREXONE; ETHANOL-CONSUMPTION; INCREASED VULNERABILITY; ANTAGONIST NALTREXONE; MAINTENANCE TREATMENT; ALCOHOL DEPENDENCE	Naltrexone is not recommended during pregnancy. However, sustained-release naltrexone implant use in humans has resulted in cases of inadvertent foetal exposure. Here, we used clinically relevant dosing to examine the effects of maternally administered sustained-release naltrexone on the rat brain by examining offspring at birth and in adulthood. Maternal treatment (naltrexone or placebo implant) started before conception and ceased during gestation, birth or weaning. Morphometry was assessed in offspring at birth and adulthood. Adult offspring were evaluated for differences in locomotor behaviour (basal and morphine-induced, 10 mg/kg, s.c.) and opioid neurochemistry, propensity to self-administer morphine and cue-induced drug-seeking after abstinence. Blood analysis confirmed offspring exposure to naltrexone during gestation, birth and weaning. Naltrexone exposure increased litter size and reduced offspring birth-weight but did not alter brain morphometry. Compared to placebo, basal motor activity of naltrexone- exposed adult offspring was lower, yet they showed enhanced development of psychomotor sensitization to morphine. Developmental naltrexone exposure was associated with resistance to morphine-induced down-regulation of striatal preproenkephalin mRNA expression in adulthood. Adult offspring also exhibited greater operant responding for morphine and, in addition, cue-induced drug-seeking was enhanced. Collectively, these data show pronounced effects of developmental naltrexone exposure, some of which persist into adulthood, highlighting the need for follow up of humans that were exposed to naltrexone in utero.	[Farid, Waleed O.; Dunlop, Sarah A.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Dunlop, Sarah A.] Western Australian Inst Med Res, Perth, WA, Australia; [Farid, Waleed O.; Tait, Robert J.; Hulse, Gary K.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Unit Res & Educ Drugs & Alcohol, Perth, WA 6009, Australia; [Lawrence, Andrew J.; Krstew, Elena V.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [Lawrence, Andrew J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Tait, Robert J.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Australian National University	Dunlop, SA (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	sarah.dunlop@uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Tait, Robert/B-8693-2009	Dunlop, Sarah/0000-0002-1306-3962; Tait, Robert/0000-0003-0648-3093	Australian Children's Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC [APP1002347, PRF1020737]; Woodside Neurotrauma Award	Australian Children's Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Woodside Neurotrauma Award	The research was supported by the Australian Children's Trust and a Woodside Neurotrauma Award. AJL is supported by the Victorian Government's Operational Infrastructure Support Program. SAD (Grant number: APP1002347) and AJL (Grant number: PRF1020737) are NHMRC Principal Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal YP, 2005, MED HYPOTHESES, V64, P721, DOI 10.1016/j.mehy.2004.09.024; Arnold JM, 1997, PHARMACOL BIOCHEM BE, V57, P441, DOI 10.1016/S0091-3057(96)00445-5; BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Bertolotti M, 1997, J HEPATOL, V27, P505, DOI 10.1016/S0168-8278(97)80355-8; BHARGAVA HN, 1993, PHARMACOLOGY, V46, P66, DOI 10.1159/000139030; Bickel WK, 2000, PSYCHOPHARMACOLOGY, V153, P44, DOI 10.1007/s002130000589; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; Bugge CJL, 1996, DETERMINATION NALTRE; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Carroll ME, 2001, EXP CLIN PSYCHOPHARM, V9, P307, DOI 10.1037//1064-1297.9.3.307; CARROLL ME, 1981, PSYCHOPHARMACOLOGY, V74, P197, DOI 10.1007/BF00427092; Caswell A, 2005, MIMS BIMONTHLY; Chen F, 2004, J PHARMACOL EXP THER, V310, P1020, DOI 10.1124/jpet.104.068692; Chen F, 2000, J PHARMACOL EXP THER, V293, P159; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowen MS, 1999, ALCOHOL CLIN EXP RES, V23, P1008, DOI 10.1097/00000374-199906000-00007; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; Cree BAC, 2010, ANN NEUROL, V68, P145, DOI 10.1002/ana.22006; DAMATO FR, 1988, DEV PSYCHOBIOL, V21, P283, DOI 10.1002/dev.420210309; Dannon PN, 2005, J CLIN PSYCHOPHARM, V25, P593, DOI 10.1097/01.jcp.0000186867.90289.ed; Darlington RB, 1999, J COMP NEUROL, V411, P359; DELAVEGA CD, 1995, PHARMACOL BIOCHEM BE, V50, P277, DOI 10.1016/0091-3057(94)00314-9; DIRESTA GR, 1991, J NEUROSCI METH, V39, P245, DOI 10.1016/0165-0270(91)90103-7; Djouma E, 2002, J PHARMACOL EXP THER, V302, P551, DOI 10.1124/jpet.102.035915; Farid WO, 2009, J BIOMED MATER RES A, V91A, P964, DOI 10.1002/jbm.a.32283; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FRANK P, 1991, J PHARMACOL METHOD, V26, P233, DOI 10.1016/0160-5402(91)90047-9; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Georges F, 1999, EUR J NEUROSCI, V11, P481, DOI 10.1046/j.1460-9568.1999.00462.x; Gironi M, 2008, MULT SCLER J, V14, P1076, DOI 10.1177/1352458508095828; Grasing K, 2003, PSYCHOPHARMACOLOGY, V168, P387, DOI 10.1007/s00213-003-1442-x; GROTA LJ, 1973, ANIM BEHAV, V21, P78, DOI 10.1016/S0003-3472(73)80042-9; HARRY GJ, 1979, PHARMACOL BIOCHEM BE, V11, P19; HAUSER KF, 1989, J COMP NEUROL, V281, P13, DOI 10.1002/cne.902810103; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Hulse G, 2002, AUST NZ J OBSTET GYN, V42, P569, DOI 10.1111/j.0004-8666.2002.548_14.x; Hulse GK, 2004, INT J GYNECOL OBSTET, V85, P170, DOI 10.1016/j.ijgo.2003.10.001; Hulse GK, 2004, ADDICT BIOL, V9, P67, DOI 10.1080/13556210410001674112; Hulse GK, 2004, ADDICT BIOL, V9, P59, DOI 10.1080/13556210410001674103; Hulse GK, 2003, AUST NZ J OBSTET GYN, V43, P386, DOI 10.1046/j.0004-8666.2003.00121.x; Hulse GK, 2002, AUST NZ J OBSTET GYN, V42, P93; Hulse GK, 2001, AUST NZ J OBSTET GYN, V41, P424, DOI 10.1111/j.1479-828X.2001.tb01322.x; JACOBSON B, 1990, BRIT MED J, V301, P1067, DOI 10.1136/bmj.301.6760.1067; Johansson BA, 2006, ADDICTION, V101, P491, DOI 10.1111/j.1360-0443.2006.01369.x; Kalinichev M, 2004, PSYCHOPHARMACOLOGY, V177, P61, DOI 10.1007/s00213-004-1990-8; Kalinichev M, 2003, NEUROPSYCHOPHARMACOL, V28, P317, DOI 10.1038/sj.npp.1300068; Kalinichev M, 2002, NEUROPSYCHOPHARMACOL, V27, P518; Kim SW, 2001, BIOL PSYCHIAT, V49, P914, DOI 10.1016/S0006-3223(01)01079-4; Kim SW, 1998, J CLIN PSYCHIAT, V59, P159; Kirchmayer U, 2002, ADDICTION, V97, P1241, DOI 10.1046/j.1360-0443.2002.00217.x; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kranzler HR, 2004, ALCOHOL CLIN EXP RES, V28, P1051, DOI 10.1097/01.ALC.0000130804.08397.29; Lahti T, 2010, PSYCHOPHARMACOL BULL, V43, P35; LANG WJ, 1977, PHARMACOL BIOCHEM BE, V7, P65, DOI 10.1016/0091-3057(77)90012-0; Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959; Lee SC, 2000, PHARMACOL BIOCHEM BE, V66, P347, DOI 10.1016/S0091-3057(00)00170-2; Lesscher HMB, 2003, EUR J NEUROSCI, V17, P1006, DOI 10.1046/j.1460-9568.2003.02502.x; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Liu YD, 2006, DRUG DEV IND PHARM, V32, P85, DOI 10.1080/03639040500388466; LUDDEN TM, 1976, J PHARM SCI, V65, P712, DOI 10.1002/jps.2600650521; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; McLaughlin PJ, 1997, PHARMACOL BIOCHEM BE, V58, P1075, DOI 10.1016/S0091-3057(97)00307-9; McLaughlin PJ, 1997, PHYSIOL BEHAV, V62, P501, DOI 10.1016/S0031-9384(97)00007-3; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; MEYER MC, 1984, J CLIN PSYCHIAT, V45, P15; MEYERSON BJ, 1988, PHARMACOL BIOCHEM BE, V31, P63, DOI 10.1016/0091-3057(88)90312-7; MISRA AL, 1976, DRUG METAB DISPOS, V4, P276; Narita M, 2006, NEUROSCI LETT, V402, P249, DOI 10.1016/j.neulet.2006.04.014; Ngo HTT, 2008, PROG NEURO-PSYCHOPH, V32, P23, DOI 10.1016/j.pnpbp.2007.06.007; NOWOSIELSKISLE.BJA, 1974, ACTA MORPHOL NEER SC, V12, P299; Nyberg K, 2000, EPIDEMIOLOGY, V11, P715, DOI 10.1097/00001648-200011000-00018; NYBERG K, 1992, BRIT J ADDICT, V87, P1669; O'Brien CP, 2011, AM J ADDICTION, V20, P106, DOI 10.1111/j.1521-0391.2010.00107.x; Olive MF, 1998, J PHARMACOL EXP THER, V285, P1310; Owoeye O, 2011, ROM J MORPHOL EMBRYO, V52, P81; PAUL L, 1978, NEUROPHARMACOLOGY, V17, P655, DOI 10.1016/0028-3908(78)90163-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plodkowski RA, 2009, EXPERT OPIN PHARMACO, V10, P1069, DOI [10.1517/14656560902775750 , 10.1517/14656560902775750]; Riley MA, 2006, NEUROPHARMACOLOGY, V51, P295, DOI 10.1016/j.neuropharm.2006.03.022; Roberts D.C.S., 1992, ANIMAL MODELS DRUG A, P233, DOI [10.1385/0-89603-217-5:233, DOI 10.1385/0-89603-217-5:233]; ROBINSON SR, 1990, BRAIN BEHAV EVOLUT, V36, P177, DOI 10.1159/000115306; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 1998, NEUROSCI BIOBEHAV R, V22, P347, DOI 10.1016/S0149-7634(97)00020-1; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Shabat-Simon M, 2008, J NEUROSCI, V28, P8406, DOI 10.1523/JNEUROSCI.1958-08.2008; SINGER G, 1978, PHARMACOL BIOCHEM BE, V9, P387, DOI 10.1016/0091-3057(78)90302-7; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; TEMPEL A, 1992, ANN NY ACAD SCI, V654, P529, DOI 10.1111/j.1749-6632.1992.tb26021.x; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WALL ME, 1984, DRUG METAB DISPOS, V12, P677; WALL ME, 1981, DRUG METAB DISPOS, V9, P369; Wang HF, 2008, BIORESOURCES, V3, P3; Wassum KM, 2009, NEUROSCIENCE, V163, P770, DOI 10.1016/j.neuroscience.2009.06.071; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WILLIG F, 1987, NEUROBIOL AGING, V8, P393, DOI 10.1016/0197-4580(87)90033-9; Witkamp RF, 2011, PHARM RES-DORDR, V28, P1792, DOI 10.1007/s11095-010-0341-1; YOBURN BC, 1988, LIFE SCI, V43, P1319, DOI 10.1016/0024-3205(88)90587-5; YOBURN BC, 1985, LIFE SCI, V36, P2325, DOI 10.1016/0024-3205(85)90322-4; YOBURN BC, 1986, J PHARMACOL EXP THER, V237, P126; ZAGON IS, 1987, BRAIN RES, V412, P68, DOI 10.1016/0006-8993(87)91440-5; ZAGON IS, 1986, J NEUROSCI, V6, P1424; ZAGON IS, 1985, PHYSIOL BEHAV, V34, P507, DOI 10.1016/0031-9384(85)90041-1; ZAGON IS, 1985, PHARMACOL BIOCHEM BE, V22, P441, DOI 10.1016/0091-3057(85)90046-2; ZAGON IS, 1986, DEV BRAIN RES, V28, P233, DOI 10.1016/0165-3806(86)90025-8; ZAGON IS, 1983, LIFE SCI, V33, P2449, DOI 10.1016/0024-3205(83)90639-2; Zagon IS, 1997, LIFE SCI, V61, P1261, DOI 10.1016/S0024-3205(97)00671-1; Zagon IS, 1999, BRAIN RES, V839, P313, DOI 10.1016/S0006-8993(99)01753-9; Zagon IS, 1997, LIFE SCI, V62, P221, DOI 10.1016/S0024-3205(97)01090-4; ZAGON IS, 1984, LIFE SCI, V35, P2057, DOI 10.1016/0024-3205(84)90563-0; Zagon IS, 1998, PHARMACOL BIOCHEM BE, V59, P201, DOI 10.1016/S0091-3057(97)00419-X	112	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52812	10.1371/journal.pone.0052812	http://dx.doi.org/10.1371/journal.pone.0052812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300784	Green Published, gold			2022-12-27	WOS:000313618800151
J	Ligasova, A; Strunin, D; Liboska, R; Rosenberg, I; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Liboska, Radek; Rosenberg, Ivan; Koberna, Karel			Atomic Scissors: A New Method of Tracking the 5-Bromo-2 '-Deoxyuridine-Labeled DNA In Situ	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; REPLICATION SITES; STRAND SCISSION; DAMAGE; ION; COPPER(II); ASCORBATE; CLUSTERS	A new method of the light microscopy detection of BrdU-labeled DNA in situ is described. It is based on the oxidative attack at the deoxyribose moiety by copper(I) in the presence of oxygen, which leads to the abstraction of hydrogen atom from deoxyribose culminating in the elimination of the nucleobase, scission of the nucleic-acid strand and formation of frequent gaps. The gaps allow the reaction of the antibodies with the commonly used markers of replication (e.g. 5-bromo-2'-deoxyuridine), which are otherwise masked. The method developed makes it possible to detect nuclear and mitochondrial DNA replication efficiently. In most cases, it does not inhibit effective protein detections and in addition enables simultaneous localization of newly-synthesized RNA. The alternative presently-used methods result in protein denaturation and/or extensive DNA cleavage followed by the DNA-bound proteins peeling off.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Acad Sci Czech Republic, Inst Biophys, Dept Mol Cytol & Cytometry, CS-61265 Brno, Czech Republic; [Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Acad Sci Czech Republic, Inst Mol Genet, Dept RNA Biol, Prague, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Oligonucleotide Grp, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Ligasova, A (corresponding author), Acad Sci Czech Republic, Inst Biophys, Dept Mol Cytol & Cytometry, Kralovopolska 135, CS-61265 Brno, Czech Republic.	ligasova@gmail.com	Ligasová, Anna/P-5460-2015; Liboska, Radek/I-5715-2014; Rosenberg, Ivan/G-5602-2014; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Czech Science Foundation [204/09/0973, P302/12/G157]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514, AV0Z50040702]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work has been supported by the Czech Science Foundation [204/09/0973, P302/12/G157] and the Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514 and AV0Z50040702]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Drouin R, 1996, FREE RADICAL BIO MED, V21, P261, DOI 10.1016/0891-5849(96)00037-8; Haines KM, J VIS EXP; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JOHNSON GRA, 1988, J CHEM SOC FARAD T 1, V84, P501, DOI 10.1039/f19888400501; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; MASARWA M, 1988, J AM CHEM SOC, V110, P4293, DOI 10.1021/ja00221a031; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; REED CJ, 1989, BIOCHEM BIOPH RES CO, V162, P1111, DOI 10.1016/0006-291X(89)90788-2; RUSH JD, 1988, J AM CHEM SOC, V110, P4957, DOI 10.1021/ja00223a013; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SAWYER DT, 1993, J AM CHEM SOC, V115, P5817, DOI 10.1021/ja00066a057; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; STOEWE R, 1987, FREE RADICAL BIO MED, V3, P97, DOI 10.1016/S0891-5849(87)80003-5; Tkatchenko AV, 2006, BIOTECHNIQUES, V40, P29, DOI 10.2144/000112094; YAMAMOTO K, 1989, J BIOL CHEM, V264, P15435; YAMAZAKI I, 1991, J AM CHEM SOC, V113, P7588, DOI 10.1021/ja00020a021	31	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52584	10.1371/journal.pone.0052584	http://dx.doi.org/10.1371/journal.pone.0052584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300711	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800107
J	Titmarsh, DM; Hudson, JE; Hidalgo, A; Elefanty, AG; Stanley, EG; Wolvetang, EJ; Cooper-White, JJ				Titmarsh, Drew M.; Hudson, James E.; Hidalgo, Alejandro; Elefanty, Andrew G.; Stanley, Edouard G.; Wolvetang, Ernst J.; Cooper-White, Justin J.			Microbioreactor Arrays for Full Factorial Screening of Exogenous and Paracrine Factors in Human Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							WNT; MOUSE; GENE; EMBRYOGENESIS; OPTIMIZATION; INDUCTION; CANCER; LINES; AXIS	Timed exposure of pluripotent stem cell cultures to exogenous molecules is widely used to drive differentiation towards desired cell lineages. However, screening differentiation conditions in conventional static cultures can become impractical in large parameter spaces, and is intrinsically limited by poor spatiotemporal control of the microenvironment that also makes it impossible to determine whether exogenous factors act directly or through paracrine-dependent mechanisms. We detail here the development of a continuous flow microbioreactor array platform that combines full-factorial multiplexing of input factors with progressive accumulation of paracrine factors through serially-connected culture chambers, and further, the use of this system to explore the combinatorial parameter space of both exogenous and paracrine factors involved in human embryonic stem cell (hESC) differentiation to a MIXL1-GFP(+) primitive streak-like population. We show that well known inducers of primitive streak (BMP, Activin and Wnt signals) do not simply act directly on hESC to induce MIXL1 expression, but that this requires accumulation of surplus, endogenous factors; and, that conditioned medium or FGF-2 supplementation is able to offset this. Our approach further reveals the presence of a paracrine, negative feedback loop to the MIXL1-GFP(+) population, which can be overcome with GSK-3 beta inhibitors (BIO or CHIR99021), implicating secreted Wnt inhibitory signals such as DKKs and sFRPs as candidate effectors. Importantly, modulating paracrine effects identified in microbioreactor arrays by supplementing FGF-2 and CHIR in conventional static culture vessels resulted in improved differentiation outcomes. We therefore demonstrate that this microbioreactor array platform uniquely enables the identification and decoding of complex soluble factor signalling hierarchies, and that this not only challenges prevailing strategies for extrinsic control of hESC differentiation, but also is translatable to conventional culture systems.	[Titmarsh, Drew M.; Hudson, James E.; Hidalgo, Alejandro; Wolvetang, Ernst J.; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia	University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; University of Queensland	Cooper-White, JJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	j.cooperwhite@uq.edu.au	Hudson, James/AAE-1605-2019; Titmarsh, Drew M/F-9546-2011; Hudson, James E/O-1775-2013; Elefanty, Andrew G/A-6066-2008; Wolvetang, Ernst J/J-7602-2013; Stanley, Ed G/A-2985-2013; Wolvetang, Ernst jurgen/D-6644-2017	Titmarsh, Drew M/0000-0001-8379-6136; Hudson, James E/0000-0003-0832-9356; Stanley, Ed G/0000-0002-6389-3665; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Cooper-White, Justin/0000-0002-1920-8229; Elefanty, Andrew/0000-0001-6448-8314; Hidalgo, Alejandro/0000-0002-8395-7179	Australian Stem Cell Centre	Australian Stem Cell Centre	The Australian Stem Cell Centre (www.stemcellcentre.edu.au) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Box GEP, 1978, STAT EXPT INTRO DESI, pxviii; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Moledina F, 2012, P NATL ACAD SCI US; Monahan J, 2001, ANAL CHEM, V73, P3193, DOI 10.1021/ac001426z; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Przybyla L, 2012, ANNU REV ANAL CHEM, V5, P293, DOI 10.1146/annurev-anchem-062011-143122; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sachlos E, 2008, BIOMATERIALS, V29, P4471, DOI 10.1016/j.biomaterials.2008.08.012; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Titmarsh DM, 2012, BIOTECHNOL IN PRESS; Titmarsh D, 2011, BIOTECHNOL BIOENG, V108, P2894, DOI 10.1002/bit.23260; Titmarsh D, 2009, BIOTECHNOL BIOENG, V104, P1240, DOI 10.1002/bit.22504; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	34	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52405	10.1371/journal.pone.0052405	http://dx.doi.org/10.1371/journal.pone.0052405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300662	Green Published, gold			2022-12-27	WOS:000313618800081
J	Baysal, O; Lai, D; Xu, HH; Siragusa, M; Caliskan, M; Carimi, F; da Silva, JAT; Tor, M				Baysal, Omur; Lai, Duo; Xu, Han-Hong; Siragusa, Mirko; Caliskan, Mikail; Carimi, Francesco; da Silva, Jaime A. Teixeira; Toer, Mahmut			A Proteomic Approach Provides New Insights into the Control of Soil-Borne Plant Pathogens by Bacillus Species	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; FUSARIC ACID; LIPOPEPTIDE; BIOCONTROL; GROWTH; ANTIBIOTICS; PROTEINS; SUBTILIS; DISEASE	Beneficial microorganisms (also known as biopesticides) are considered to be one of the most promising methods for more rational and safe crop management practices. We used Bacillus strains EU07, QST713 and FZB24, and investigated their inhibitory effect on Fusarium. Bacterial cell cultures, cell-free supernatants and volatiles displayed varying degrees of suppressive effect. Proteomic analysis of secreted proteins from EU07 and FZB24 revealed the presence of lytic enzymes, cellulases, proteases, 1,4-beta-glucanase and hydrolases, all of which contribute to degradation of the pathogen cell wall. Further proteomic investigations showed that proteins involved in metabolism, protein folding, protein degradation, translation, recognition and signal transduction cascade play an important role in the control of Fusarium oxysporum. Our findings provide new knowledge on the mechanism of action of Bacillus species and insight into biocontrol mechanisms.	[Baysal, Omur] Mugla Sitki Kocman Univ, Fac Life Sci, Dept Mol Biol & Genet, Mugla, Turkey; [Lai, Duo; Xu, Han-Hong] S China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Siragusa, Mirko; Carimi, Francesco] CNR, Inst Plant Genet, Res Div Palermo, Palermo, Italy; [Caliskan, Mikail] Turkish Minist Food Agr & Livestock, Cent Res Inst Field Crops, Ankara, Turkey; [da Silva, Jaime A. Teixeira] Kagawa Univ, Fac Agr, Miki, Ikenobe 76107, Japan; [da Silva, Jaime A. Teixeira] Kagawa Univ, Grad Sch Agr, Miki, Ikenobe 76107, Japan; [Toer, Mahmut] Univ Worcester, NPARU, Henwick Grove, Worcester, England	Mugla Sitki Kocman University; South China Agricultural University; Consiglio Nazionale delle Ricerche (CNR); Gida Tarim Ve Hayvancilik Bakanligi; Ministry of Food, Agriculture & Livestock - Turkey; Kagawa University; Kagawa University; University of Worcester	Baysal, O (corresponding author), Mugla Sitki Kocman Univ, Fac Life Sci, Dept Mol Biol & Genet, Mugla, Turkey.	omurbaysal@mu.edu.tr; hhxu@scau.edu.cn	Biology and Genetics / Molecular Microbiology and Genetics, Ömür Baysal Ph.D. Professor on Molecular/C-8869-2013; Carimi, Francesco/E-2954-2016; Baysal, Ömür/AAC-8891-2022; Tor, Mahmut/AAF-6449-2020; Carimi, Francesco/GYU-0312-2022; Tor, Mahmut/AAU-4624-2020	Carimi, Francesco/0000-0002-7700-9527; Baysal, Ömür/0000-0001-5104-0983; Tor, Mahmut/0000-0002-4416-5048; Xu, Han-Hong/0000-0001-7841-2396; Teixeira da Silva, Jaime A./0000-0003-3299-2772	The Leverhulme Trust	The Leverhulme Trust(Leverhulme Trust)	The authors acknowledge Dr. Kunhua Hu (Protemics Research Center, SUN Yat-sen University, China) and Dr. QS Yang (BGI-Shenzhen, China) for their technical support. Work in Mahmut Tor's laboratory is supported by The Leverhulme Trust.	Ahn IP, 2002, MOL CELLS, V13, P302; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Amani H, 2010, APPL BIOCHEM BIOTECH, V162, P510, DOI 10.1007/s12010-009-8889-0; Bacon CW, 2004, CAN J BOT, V82, P878, DOI [10.1139/b04-067, 10.1139/B04-067]; Bacon CW, 2002, BIOL CONTROL, V23, P274, DOI 10.1006/bcon.2001.1016; Baysal O, 2009, PHYSIOL MOL PLANT P, V74, P68, DOI 10.1016/j.pmpp.2009.09.008; Baysal O, 2008, PHYSIOL MOL PLANT P, V73, P25, DOI 10.1016/j.pmpp.2008.11.002; Bent AF, 1999, ADV AGRON, V66, P251, DOI 10.1016/S0065-2113(08)60429-0; Bland JM, 1996, J ORG CHEM, V61, P5663, DOI 10.1021/jo960452n; Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bouizgarne B, 2006, MOL PLANT MICROBE IN, V19, P550, DOI 10.1094/MPMI-19-0550; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; EEA, 2005, 10 EEA; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Godsey MH, 2007, PROTEIN SCI, V16, P1285, DOI 10.1110/ps.062674007; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Han SH, 2006, MOL PLANT MICROBE IN, V19, P924, DOI 10.1094/MPMI-19-0924; Ivanova I, 1998, INT J FOOD MICROBIOL, V42, P147, DOI 10.1016/S0168-1605(98)00067-1; JARVIS WR, 1983, PLANT DIS, V67, P38, DOI 10.1094/PD-67-38; Katan T, 1999, PLANT PATHOL, V48, P541, DOI 10.1046/j.1365-3059.1999.00362.x; Kim PI, 2004, J APPL MICROBIOL, V97, P942, DOI 10.1111/j.1365-2672.2004.02356.x; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Munimbazi C, 1998, J APPL MICROBIOL, V84, P959, DOI 10.1046/j.1365-2672.1998.00431.x; Pacwa-Plociniczak M, 2011, INT J MOL SCI, V12, P633, DOI 10.3390/ijms12010633; Pare PW, 2005, PHOTOSYNTH RES, V85, P149, DOI 10.1007/s11120-005-1001-x; Ravishankar KV, 2011, ACTA HORTIC, V897, P363; Rohlf F.J., 1994, NTSYS NUMERICAL TAXO; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Saleem M, 2007, J IND MICROBIOL BIOT, V34, P635, DOI 10.1007/s10295-007-0240-6; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; THIMON L, 1995, FEMS MICROBIOL LETT, V128, P101, DOI 10.1111/j.1574-6968.1995.tb07507.x; Todorov SD, 2005, FOOD TECHNOL BIOTECH, V43, P165; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Van Loon LC, 2004, ECOL STU AN, V170, P177; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wang YQ, 2010, PESTIC BIOCHEM PHYS, V98, P224, DOI 10.1016/j.pestbp.2010.06.011; Zhao J., 2006, Floriculture, ornamental and plant biotechnology, P344; Zuber Peter, 1993, P897	46	55	59	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53182	10.1371/journal.pone.0053182	http://dx.doi.org/10.1371/journal.pone.0053182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301041	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000038
J	Lin, JZ; Sieglaff, DH; Yuan, CS; Su, J; Arumanayagam, AS; Firouzbakht, S; Pompa, JJC; Reynolds, FD; Zhou, XB; Cvoro, A; Webb, P				Lin, Jean Z.; Sieglaff, Douglas H.; Yuan, Chaoshen; Su, Jing; Arumanayagam, AnithaChristy S.; Firouzbakht, Sharareh; Cantu Pompa, Jaime J.; Reynolds, Frances Denoto; Zhou, Xiabo; Cvoro, Aleksandra; Webb, Paul			Gene Specific Actions of Thyroid Hormone Receptor Subtypes	PLOS ONE			English	Article							TR-ALPHA; ROLES; ISOFORMS; SYSTEM; LIGAND; BETA	There are two homologous thyroid hormone (TH) receptors (TRs alpha and beta), which are members of the nuclear hormone receptor (NR) family. While TRs regulate different processes in vivo and other highly related NRs regulate distinct gene sets, initial studies of TR action revealed near complete overlaps in their actions at the level of individual genes. Here, we assessed the extent that TR alpha and TR beta differ in target gene regulation by comparing effects of equal levels of stably expressed exogenous TRs +/- T-3 in two cell backgrounds (HepG2 and HeLa). We find that hundreds of genes respond to T-3 or to unliganded TRs in both cell types, but were not able to detect verifiable examples of completely TR subtype-specific gene regulation. TR actions are, however, far from identical and we detect TR subtype-specific effects on global T-3 response kinetics in HepG2 cells and many examples of TR subtype specificity at the level of individual genes, including effects on magnitude of response to TR +/- T-3, TR regulation patterns and T-3 dose response. Cycloheximide (CHX) treatment confirms that at least some differential effects involve verifiable direct TR target genes. TR subtype/gene-specific effects emerge in the context of widespread variation in target gene response and we suggest that gene-selective effects on mechanism of TR action highlight differences in TR subtype function that emerge in the environment of specific genes. We propose that differential TR actions could influence physiologic and pharmacologic responses to THs and selective TR modulators (STRMs).	[Lin, Jean Z.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA; [Yuan, Chaoshen; Reynolds, Frances Denoto] Univ Calif San Francisco, Med Ctr, Ctr Diabet, San Francisco, CA USA; [Su, Jing; Zhou, Xiabo; Webb, Paul] Methodist Hosp, Res Inst, Dept Radiol, Houston, TX 77030 USA; [Cantu Pompa, Jaime J.] Tec Monterrey Sch Med & Hlth Sci, Dept Res & Innovat, Monterrey, Mexico	University of Houston System; University of Houston; University of California System; University of California San Francisco; The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey	Webb, P (corresponding author), Methodist Hosp, Res Inst, Dept Radiol, 6535 Fannin, Houston, TX 77030 USA.	pwebb@tmhs.org	Pompa, Jaime Javier Cantu/H-8389-2017; Arumanayagam, Anithachristy/S-5750-2018	Pompa, Jaime Javier Cantu/0000-0003-3601-6138; Su, Jing/0000-0003-4917-6173				Bassett JHD, 2009, J MOL ENDOCRINOL, V42, P269, DOI 10.1677/JME-08-0142; Baxter J D, 1979, Recent Prog Horm Res, V35, P97; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochukova E, 2012, NEW ENGL J MED, V366, P243, DOI 10.1056/NEJMoa1110296; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiamolera MI, 2012, MOL ENDOCRINOL, V26, P926, DOI 10.1210/me.2011-1290; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flamant F., 2012, BIOCHIM BIOPHYS ACTA; Fondell JD, 2012, BIOCH BIOPHYS ACTA; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Fozzatti L, 2011, MOL ENDOCRINOL, V25, P908, DOI 10.1210/me.2010-0474; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Glass CK, 2000, GENE DEV, V14, P121; Hipp D. R, SQLITE; Hollenberg AN, 2012, BIOCH BIOPHYS ACTA; Lonard DM, 2009, PROG MOL BIOL TRANSL, V87, P117, DOI 10.1016/S1877-1173(09)87004-X; Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Team RDC, 2009, R LANG ENV STAT COMP; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002; Weiss R E, 2000, Rev Endocr Metab Disord, V1, P97, DOI 10.1023/A:1010072605757; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325	32	26	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52407	10.1371/journal.pone.0052407	http://dx.doi.org/10.1371/journal.pone.0052407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300972	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000009
J	Liu, GX; Li, YQ; Huang, XR; Wei, LH; Chen, HY; Shi, YJ; Heuchel, RL; Lan, HY				Liu, Guan-Xian; Li, You-Qi; Huang, Xiao R.; Wei, Lihua; Chen, Hai-Yong; Shi, Yong-Jun; Heuchel, Rainer L.; Lan, Hui Y.			Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-beta/Smad3-NF center dot kappa B-Dependent Mechanisms in Mice	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; COLLAGEN EXPRESSION; LATENT TGF-BETA-1; GENE-EXPRESSION; KIDNEY; RECEPTOR; SP1; NEPHROPATHY; PATHWAY; SPECIFICITY	Smad7 is an inhibitory Smad and plays a protective role in obstructive and diabetic kidney disease. However, the role and mechanisms of Smad7 in hypertensive nephropathy remains unexplored. Thus, the aim of this study was to investigate the role and regulatory mechanisms of Smad7 in ANG II-induced hypertensive nephropathy. Smad7 gene knockout (KO) and wild-type (WT) mice received a subcutaneous infusion of ANG II or control saline for 4 weeks via osmotic mini-pumps. ANG II infusion produced equivalent hypertension in Smad7 KO and WT mice; however, Smad7 KO mice exhibited more severe renal functional injury as shown by increased proteinuria and reduced renal function (both p < 0.05) when compared with Smad7 WT mice. Enhanced renal injury in Smad7 KO mice was associated with more progressive renal fibrosis with elevated TGF-beta/Smad3 signalling. Smad7 KO mice also showed more profound renal inflammation including increased macrophage infiltration, enhanced IL-1 beta and TNF-alpha expression, and a marked activation of NF-kappa B signaling (all p < 0.01). Further studies revealed that enhanced ANG II-mediated renal inflammation and fibrosis in Smad7 KO mice were also associated with upregulation of Sp1 but downregulation of miR-29b expression. Taken together, the present study revealed that enhanced Sp1-TGF-beta 1/Smad3-NF-kappa B signaling and loss of miR-29 may be mechanisms by which deletion of Smad7 promotes ANG II-mediated renal fibrosis and inflammation. Thus, Smad7 may play a protective role in ANG II-induced hypertensive kidney disease.	[Liu, Guan-Xian; Li, You-Qi; Shi, Yong-Jun] Cent Municipal Hosp Huizhou, Dept Nephrol, Huizhou, Guangdong, Peoples R China; [Huang, Xiao R.; Wei, Lihua; Chen, Hai-Yong; Lan, Hui Y.] CUHK Res Inst, Shenzhen, Guangdong, Peoples R China; [Huang, Xiao R.; Heuchel, Rainer L.; Lan, Hui Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao R.; Heuchel, Rainer L.; Lan, Hui Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; Karolinska Inst, CLINTEC, Stockholm, Sweden	Chinese University of Hong Kong; Chinese University of Hong Kong; Karolinska Institutet	Liu, GX (corresponding author), Cent Municipal Hosp Huizhou, Dept Nephrol, Huizhou, Guangdong, Peoples R China.	liyouqi0330@163.com; hylan@cuhk.edu.hk	CHEN, Hai-Yong/K-5853-2019; Heuchel, Rainer/P-7875-2019; CHEN, Hai-Yong/B-1424-2013; Chen, Haiyong/G-6787-2014; Lan, Hui Yao/C-9734-2015	CHEN, Hai-Yong/0000-0002-4889-2752; Heuchel, Rainer/0000-0002-2782-585X; CHEN, Hai-Yong/0000-0002-4706-9596; Chen, Haiyong/0000-0002-4889-2752; Lan, Hui Yao/0000-0003-4283-9755	Major State Basic Research Development Program of China (973) [2012CB517700]; The Shenzhen Basic Research Program (SZSITC) [JC201104220290A]; Research Grant Council of Hong Kong [RGC GRF 469110, N_CUHK404/10, CUHK5/CRF/09]; Focused Investment Scheme B from the Chinese University of Hong Kong [1902061]	Major State Basic Research Development Program of China (973)(National Basic Research Program of China); The Shenzhen Basic Research Program (SZSITC); Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Focused Investment Scheme B from the Chinese University of Hong Kong	This work was supported by grants from Major State Basic Research Development Program of China (973, No. 2012CB517700); The Shenzhen Basic Research Program (SZSITC, JC201104220290A), the Research Grant Council of Hong Kong (RGC GRF 469110, N_CUHK404/10, CUHK5/CRF/09); and the Focused Investment Scheme B (1902061) from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Hart PD, 2010, EXPERT OPIN PHARMACO, V11, P2675, DOI 10.1517/14656566.2010.485612; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang XR, 2008, AM J PHYSIOL-RENAL, V295, pF118, DOI 10.1152/ajprenal.00021.2008; Huang XR, 2008, J AM SOC NEPHROL, V19, P233, DOI 10.1681/ASN.2007040484; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Ka SM, 2007, J AM SOC NEPHROL, V18, P1777, DOI 10.1681/ASN.2006080901; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kopp JB, 1996, LAB INVEST, V74, P991; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liu FY, 2007, AM J NEPHROL, V27, P176, DOI 10.1159/000100518; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Luna C, 2011, INVEST OPHTH VIS SCI, V52, P3567, DOI 10.1167/iovs.10-6448; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Remuzzi G, 2005, KIDNEY INT, V68, P57; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yang YZ, 2010, DIABETES, V59, pA590; Zhao X, 2001, BBA-GENE STRUCT EXPR, V1522, P195, DOI 10.1016/S0167-4781(01)00341-4; Zhuo JL, 2011, PEPTIDES, V32, P1551, DOI 10.1016/j.peptides.2011.05.012	46	78	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53573	10.1371/journal.pone.0053573	http://dx.doi.org/10.1371/journal.pone.0053573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301086	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000066
J	Zhao, Y; Xing, B; Dang, YH; Qu, CL; Zhu, F; Yan, CX				Zhao, Yan; Xing, Bo; Dang, Yong-hui; Qu, Chao-ling; Zhu, Feng; Yan, Chun-xia			Microinjection of Valproic Acid into the Ventrolateral Orbital Cortex Enhances Stress-Related Memory Formation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; GYRUS GRANULE NEURONS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; DENTATE GYRUS; EPIGENETIC MECHANISMS; HISTONE MODIFICATIONS; PSYCHOLOGICAL STRESS; DOPAMINE-RECEPTORS; CONDITIONED FEAR	There is collecting evidence suggesting that the process of chromatin remodeling such as changes in histone acetylation contribute to the formation of stress-related memory. Recently, the ventrolateral orbital cortex (VLO), a major subdivision of orbitofrontal cortex (OFC), was shown to be involved in antidepressant-like actions through epigenetic mechanisms. Here, we further investigated the effects of the histone deacetylase inhibitor (HDACi) valproic acid (VPA) on stress-related memory formation and the underlying molecular mechanisms by using the traditional two-day forced swimming test (FST). The results showed that VPA significantly increased the immobility time on day 2 when infused into the VLO before the initial forced swim stress on day 1. The learned immobility response to the stress was associated with increased phosphorylation of extracellular signal-regulated kinase (ERK) in VLO and hippocampus on the first day. The levels of phosphorylated ERK (phospho-ERK) in VLO and hippocampus were significantly decreased when retested 24 h later. The pretreatment with intra-VLO VPA infusion further reduced the activation of ERK on day 2 and day 7 compared with the saline controls. Moreover, the VPA infusion pretreatment also induced a significantly decreased BDNF level in the VLO on day 2, whereas no change was detected in the hippocampus. These findings suggest that VPA enhance the memories of emotionally stressful events and the ERK activity is implicated in stimulating adaptive and mnemonic processes in case the event would recur.	[Zhao, Yan; Dang, Yong-hui; Zhu, Feng; Yan, Chun-xia] Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Forens Med,Key Lab Environm & Genes Related, Xian 710049, Shaanxi, Peoples R China; [Xing, Bo] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Qu, Chao-ling] Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Physiol & Pathophysiol,Key Lab Environm & Ge, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Dang, YH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Forens Med,Key Lab Environm & Genes Related, Xian 710049, Shaanxi, Peoples R China.	psydyh@mail.xjtu.edu.cn; yanchx@mail.xjtu.edu.cn	Qu, Chaoling/J-5841-2013		National Science Foundation of China [NSFC 81171262, NSFC 81172903]; scientific and technological research and development projects in Shaanxi Province [2011K15-01-03, 2012K16-03-02]; scientific research project of Shaanxi Provincial Health Department [2012E4]; Fundamental Research Funds for the Central Universities in China [2011JDHZ59]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological research and development projects in Shaanxi Province; scientific research project of Shaanxi Provincial Health Department; Fundamental Research Funds for the Central Universities in China	This work was supported by the National Science Foundation of China (NSFC 81171262 for Yong-hui Dang and NSFC 81172903 for Chun-xia Yan), the scientific and technological research and development projects in Shaanxi Province (2011K15-01-03 and 2012K16-03-02), the scientific research project of Shaanxi Provincial Health Department (2012E4) and the Fundamental Research Funds for the Central Universities in China (2011JDHZ59). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betensky JD, 2008, PSYCHIAT RES, V160, P38, DOI 10.1016/j.psychres.2007.06.001; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Bohn I, 2003, CEREB CORTEX, V13, P968, DOI 10.1093/cercor/13.9.968; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Calzavara MB, 2009, SCHIZOPHRENIA BULL, V35, P748, DOI 10.1093/schbul/sbn006; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chen YC, 2012, NEUROSCI LETT, V506, P327, DOI 10.1016/j.neulet.2011.11.038; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P79, DOI 10.1016/0166-4328(94)90010-8; Dang YH, 2010, NEUROSCIENCE, V169, P1872, DOI 10.1016/j.neuroscience.2010.06.050; Dang YH, 2011, EUR J PHARMACOL, V657, P97, DOI 10.1016/j.ejphar.2011.01.064; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Foley AG, 2004, NEUROBIOL AGING, V25, P539, DOI 10.1016/j.neurobiolaging.2003.07.006; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Lin HL, 2012, BRAIN RES, V1447, P119, DOI 10.1016/j.brainres.2012.01.053; Loring DW, 2004, NEUROLOGY, V62, P872, DOI 10.1212/01.WNL.0000115653.82763.07; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; Michaelis M, 2006, CELL DEATH DIFFER, V13, P446, DOI 10.1038/sj.cdd.4401759; Nemeroff CB, 2009, HDB STRESS SCI BIOL; Padovan CM, 2004, PHARMACOL BIOCHEM BE, V77, P15, DOI 10.1016/j.pbb.2003.09.015; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Whittle N, 2013, NEUROPHARMACOLOGY, V64, P414, DOI 10.1016/j.neuropharm.2012.06.001; Xing B, 2011, BRAIN RES BULL, V85, P153, DOI 10.1016/j.brainresbull.2011.03.007; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011	40	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52698	10.1371/journal.pone.0052698	http://dx.doi.org/10.1371/journal.pone.0052698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23300985	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000013
J	Albouy, G; Fogel, S; Pottiez, H; Nguyen, VA; Ray, L; Lungu, O; Carrier, J; Robertson, E; Doyon, J				Albouy, Genevieve; Fogel, Stuart; Pottiez, Hugo; Vo An Nguyen; Ray, Laura; Lungu, Ovidiu; Carrier, Julie; Robertson, Edwin; Doyon, Julien			Daytime Sleep Enhances Consolidation of the Spatial but Not Motoric Representation of Motor Sequence Memory	PLOS ONE			English	Article							EFFECTOR-SPECIFIC REPRESENTATIONS; TIME-COURSE; INTERMANUAL TRANSFER; BASAL GANGLIA; IMPLICIT; ACQUISITION; MECHANISMS; SPINDLES; DISSOCIATION; PERFORMANCE	Motor sequence learning is known to rely on more than a single process. As the skill develops with practice, two different representations of the sequence are formed: a goal representation built under spatial allocentric coordinates and a movement representation mediated through egocentric motor coordinates. This study aimed to explore the influence of daytime sleep (nap) on consolidation of these two representations. Through the manipulation of an explicit finger sequence learning task and a transfer protocol, we show that both allocentric (spatial) and egocentric (motor) representations of the sequence can be isolated after initial training. Our results also demonstrate that nap favors the emergence of offline gains in performance for the allocentric, but not the egocentric representation, even after accounting for fatigue effects. Furthermore, sleep-dependent gains in performance observed for the allocentric representation are correlated with spindle density during non-rapid eye movement (NREM) sleep of the post-training nap. In contrast, performance on the egocentric representation is only maintained, but not improved, regardless of the sleep/wake condition. These results suggest that motor sequence memory acquisition and consolidation involve distinct mechanisms that rely on sleep (and specifically, spindle) or simple passage of time, depending respectively on whether the sequence is performed under allocentric or egocentric coordinates.	[Albouy, Genevieve; Fogel, Stuart; Pottiez, Hugo; Vo An Nguyen; Ray, Laura; Lungu, Ovidiu; Carrier, Julie; Doyon, Julien] CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Albouy, Genevieve; Fogel, Stuart; Carrier, Julie; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Donald Berman Maimonides Geriatr Ctr, Dept Res, Montreal, PQ, Canada; [Carrier, Julie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Robertson, Edwin] Harvard Univ, Sch Med, Harvard Ctr Noninvas Brain Stimulat, Boston, MA USA; [Robertson, Edwin] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Doyon, J (corresponding author), CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada.	julien.doyon@umontreal.ca	Fogel, Stuart/F-7179-2017; ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019	Fogel, Stuart/0000-0002-3227-5370; ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Lungu, Ovidiu/0000-0001-6608-5818; Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health and Research (CIHR); Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE); postdoctoral grant from the Fyssen Foundation; CIHR postdoctoral grant	Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE); postdoctoral grant from the Fyssen Foundation; CIHR postdoctoral grant(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health and Research (CIHR) as well as the Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE). GA was first supported by a postdoctoral grant from the Fyssen Foundation and is now supported through a CIHR postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Bapi RS, 2006, NEUROIMAGE, V32, P714, DOI 10.1016/j.neuroimage.2006.04.205; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Barakat M, 2012, HUM BRAIN M IN PRESS; Bischoff-Grethe A, 2004, J COGNITIVE NEUROSCI, V16, P127, DOI 10.1162/089892904322755610; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; ELLIS BW, 1981, SLEEP, V4, P93, DOI 10.1093/sleep/4.1.93; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, SLEEP SPINDLES UNPUB; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gheysen F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00137; Grafton ST, 1998, J NEUROSCI, V18, P9420; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Hallgato E, 2012, CORTEX; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; Keisler A, 2007, LEARN MEMORY, V14, P669, DOI 10.1101/lm.751807; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Leclercq Y, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/598206; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Morin A, 2008, SLEEP, V31, P1149; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer C, 2000, PSYCHOL SCI, V11, P63, DOI 10.1111/1467-9280.00216; Perez MA, 2007, CURR BIOL, V17, P1896, DOI 10.1016/j.cub.2007.09.058; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Press DZ, 2005, BRAIN RES COGN BRAIN; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Romei V, 2009, CORTEX, V45, P1058, DOI 10.1016/j.cortex.2009.01.003; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Shea CH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00052; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Verwey WB, 2005, PSYCHOL RES-PSYCH FO, V69, P242, DOI 10.1007/s00426-004-0181-x; Verwey WB, 2004, PSYCHOL RES-PSYCH FO, V68, P64, DOI 10.1007/s00426-003-0144-7; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062	64	81	81	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52805	10.1371/journal.pone.0052805	http://dx.doi.org/10.1371/journal.pone.0052805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300993	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900040
J	Battistella, G; Fornari, E; Thomas, A; Mall, JF; Chtioui, H; Appenzeller, M; Annoni, JM; Favrat, B; Maeder, P; Giroud, C				Battistella, Giovanni; Fornari, Eleonora; Thomas, Aurelien; Mall, Jean-Frederic; Chtioui, Haithem; Appenzeller, Monique; Annoni, Jean-Marie; Favrat, Bernard; Maeder, Philippe; Giroud, Christian			Weed or Wheel! fMRI, Behavioural, and Toxicological Investigations of How Cannabis Smoking Affects Skills Necessary for Driving	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MEDIAL PREFRONTAL CORTEX; INTRINSIC CONNECTIVITY NETWORKS; ANTERIOR CINGULATE CORTEX; DEFAULT-MODE; MOTOR CONTROL; WHOLE-BLOOD; DELTA-9-TETRAHYDROCANNABINOL THC; FUNCTIONAL CONNECTIVITY; MARIJUANA SMOKING	Marijuana is the most widely used illicit drug, however its effects on cognitive functions underling safe driving remain mostly unexplored. Our goal was to evaluate the impact of cannabis on the driving ability of occasional smokers, by investigating changes in the brain network involved in a tracking task. The subject characteristics, the percentage of Delta(9)-Tetrahydrocannabinol in the joint, and the inhaled dose were in accordance with real-life conditions. Thirty-one male volunteers were enrolled in this study that includes clinical and toxicological aspects together with functional magnetic resonance imaging of the brain and measurements of psychomotor skills. The fMRI paradigm was based on a visuo-motor tracking task, alternating active tracking blocks with passive tracking viewing and rest condition. We show that cannabis smoking, even at low Delta(9)-Tetrahydrocannabinol blood concentrations, decreases psychomotor skills and alters the activity of the brain networks involved in cognition. The relative decrease of Blood Oxygen Level Dependent response (BOLD) after cannabis smoking in the anterior insula, dorsomedial thalamus, and striatum compared to placebo smoking suggests an alteration of the network involved in saliency detection. In addition, the decrease of BOLD response in the right superior parietal cortex and in the dorsolateral prefrontal cortex indicates the involvement of the Control Executive network known to operate once the saliencies are identified. Furthermore, cannabis increases activity in the rostral anterior cingulate cortex and ventromedial prefrontal cortices, suggesting an increase in self-oriented mental activity. Subjects are more attracted by intrapersonal stimuli ("self'') and fail to attend to task performance, leading to an insufficient allocation of task-oriented resources and to sub-optimal performance. These effects correlate with the subjective feeling of confusion rather than with the blood level of Delta(9)-Tetrahydrocannabinol. These findings bolster the zero-tolerance policy adopted in several countries that prohibits the presence of any amount of drugs in blood while driving.	[Battistella, Giovanni; Fornari, Eleonora; Maeder, Philippe] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Battistella, Giovanni; Fornari, Eleonora; Maeder, Philippe] Univ Lausanne, Lausanne, Switzerland; [Fornari, Eleonora] Ctr Hosp Univ Vaudois CHUV Unit, CIBM Ctr Imagerie Biomed, Lausanne, Switzerland; [Thomas, Aurelien] CURML Univ Ctr Legal Med, UTCF Forens Toxicol & Chem Unit, Geneva, Switzerland; [Mall, Jean-Frederic] CHU Vaudois, SUPAA, Dept Psychiat, Lausanne, Switzerland; [Chtioui, Haithem; Appenzeller, Monique] CHU Vaudois, Dept Clin Pharmacol & Toxicol, Lausanne, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Dept Med, Neurol Unit, CH-1700 Fribourg, Switzerland; [Favrat, Bernard] CURML Univ Ctr Legal Med, UMPT Unit Psychol & Traff Med, Lausanne, Switzerland; [Favrat, Bernard] CURML Univ Ctr Legal Med, UMPT Unit Psychol & Traff Med, Geneva, Switzerland; [Giroud, Christian] CURML Univ Ctr Legal Med, UTCF Forens Toxicol & Chem Unit, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg	Maeder, P (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.	Philippe.Maeder@chuv.ch		Favrat, Bernard/0000-0001-6920-099X; Thomas, Aurelien/0000-0001-6790-2285	Swiss National Scientific Research Foundation [SNF 320030_127507/1]; Faculty of Biology and Medicine of the University of Lausanne (multidisciplinary project FBM); Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards and Jeantet Foundations	Swiss National Scientific Research Foundation; Faculty of Biology and Medicine of the University of Lausanne (multidisciplinary project FBM); Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards and Jeantet Foundations	This project was supported by the Swiss National Scientific Research Foundation (grant SNF 320030_127507/1) and the Faculty of Biology and Medicine of the University of Lausanne (multidisciplinary project FBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG), and the Leenaards and Jeantet Foundations. We thank Prof. Patrice Mangin, Dr. Christian Staub, Dr. Marc Augsburger of the University Center of Forensic Medicine Lausanne-Geneva, Prof. Thierry Buclin, and the staff of the division of Clinical Pharmacology and Toxicology at CHUV. We also acknowledge Mrs Estelle Lauer, CURML Geneva, for her technical assistance and Ms. Dasha Polzik (University of Chicago) for her assistance in preparing the manuscript.	Allen RW, 1981, DETECTING HUMAN OPER, P611; Asbridge M, 2005, TRAFFIC INJ PREV, V5, P241; Asbridge Mark, 2005, Traffic Inj Prev, V6, P197, DOI 10.1080/15389580590931716; Atlas LY, 2012, J NEUROSCI, V32, P8053, DOI 10.1523/JNEUROSCI.0383-12.2012; BOBON D, 1986, BRIT J PSYCHIAT, V148, P467, DOI 10.1192/bjp.148.4.467; Brown GG, 2004, J CLIN EXP NEUROPSYC, V26, P356, DOI 10.1080/13803390490510086; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; BURNS M, 1980, EUR J CLIN PHARMACOL, V17, P259, DOI 10.1007/BF00625799; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Calhoun VD, 2004, NEUROPSYCHOPHARMACOL, V29, P2097, DOI 10.1038/sj.npp.1300543; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Cattaneo L, 2012, CEREBELLUM, V11, P264, DOI 10.1007/s12311-011-0307-9; Chang L, 2006, BRAIN, V129, P1096, DOI 10.1093/brain/awl064; Chang L, 2007, NEUROSCIENTIST, V13, P422, DOI 10.1177/1073858406296601; Copersino ML, 2009, EXP CLIN PSYCHOPHARM, V17, P337, DOI 10.1037/a0017260; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Duverneuil-Mayer C, 2011, ANN TOXICOL ANAL, V23, P193; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gallea C, 2008, BEHAV BRAIN RES, V193, P117, DOI 10.1016/j.bbr.2008.05.014; Giroud C, 2001, FORENSIC SCI INT, V123, P159, DOI 10.1016/S0379-0738(01)00538-2; Gonzalez R, 2007, NEUROPSYCHOL REV, V17, P347, DOI 10.1007/s11065-007-9036-8; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grotenhermen F, 2007, ADDICTION, V102, P1910, DOI 10.1111/j.1360-0443.2007.02009.x; Gruber SA, 2005, COGNITIVE BRAIN RES, V23, P107, DOI 10.1016/j.cogbrainres.2005.02.016; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HABER SN, 1995, J NEUROSCI, V15, P4851; Hamzei F, 2002, EXP BRAIN RES, V146, P273, DOI 10.1007/s00221-002-1139-0; Harder S, 1997, INT J CLIN PHARM TH, V35, P155; Harding IH, 2012, NEUROPSYCHOPHARMACOL, V37, P1923, DOI 10.1038/npp.2012.39; Hart CL, 2001, NEUROPSYCHOPHARMACOL, V25, P757, DOI 10.1016/S0893-133X(01)00273-1; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; HUESTIS MA, 1992, J ANAL TOXICOL, V16, P276, DOI 10.1093/jat/16.5.276; Hunault C, 2008, PSYCHOPHARMACOLOGY, V201, P171, DOI 10.1007/s00213-008-1260-2; Hunault CC, 2009, PSYCHOPHARMACOLOGY, V204, P85, DOI 10.1007/s00213-008-1440-0; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Legleye S, 2011, DRUG ALCOHOL DEPEN, V113, P229, DOI 10.1016/j.drugalcdep.2010.08.011; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Lindquist MA, 2007, NEUROIMAGE, V35, P1125, DOI 10.1016/j.neuroimage.2007.01.004; Lindquist MA, 2007, HUM BRAIN MAPP, V28, P764, DOI 10.1002/hbm.20310; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; MATHEW RJ, 1992, J CEREBR BLOOD F MET, V12, P750, DOI 10.1038/jcbfm.1992.106; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; MATHEW RJ, 1993, LIFE SCI, V52, P757, DOI 10.1016/0024-3205(93)90239-Y; MATHEW RJ, 1989, ACTA PSYCHIAT SCAND, V79, P118, DOI 10.1111/j.1600-0447.1989.tb08579.x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Movig KLL, 2004, ACCIDENT ANAL PREV, V36, P631, DOI 10.1016/S0001-4575(03)00084-8; Muggleton NG, 2011, J NEUROPHYSIOL, V105, P2891, DOI 10.1152/jn.01149.2009; Nordstrom BR, 2006, NEUROPSYCHOPHARMACOL, V31, P2798, DOI 10.1038/sj.npp.1301210; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramaekers JG, 2006, DRUG ALCOHOL DEPEN, V85, P114, DOI 10.1016/j.drugalcdep.2006.03.015; Ramaekers JG, 2009, J PSYCHOPHARMACOL, V23, P266, DOI 10.1177/0269881108092393; Ramaekers JG, 2003, J CLIN PSYCHIAT, V64, P20, DOI 10.4088/JCP.v64n0106; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2800, DOI 10.1038/sj.npp.1301211; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Robinson LF, 2010, NEUROIMAGE, V49, P1581, DOI 10.1016/j.neuroimage.2009.08.061; Roiser JP, 2010, NEUROIMAGE, V50, P657, DOI 10.1016/j.neuroimage.2009.11.075; Sacco R.G., 2010, INT J PSYCHOL STUDIE, V2, P26, DOI DOI 10.1037/H0077714; Schwope DM, 2011, CLIN CHEM, V57, P1406, DOI 10.1373/clinchem.2011.171777; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Senna MC, 2010, FORENSIC SCI INT, V198, P11, DOI 10.1016/j.forsciint.2010.02.014; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Steentoft A, 2010, TRAFFIC INJ PREV, V11, P329, DOI 10.1080/15389581003792783; Thomas A, 2007, J PHARMACEUT BIOMED, V45, P495, DOI 10.1016/j.jpba.2007.08.019; Toennes SW, 2005, FORENSIC SCI INT, V152, P149, DOI 10.1016/j.forsciint.2004.08.002; Van der Kooy F, 2009, INHAL TOXICOL, V21, P87, DOI [10.1080/08958370802187296, 10.1080/08958370802187296 ]; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Walsh JM, 2008, ADDICTION, V103, P1258, DOI 10.1111/j.1360-0443.2008.02277.x; Walsh J Michael, 2004, Traffic Inj Prev, V5, P241; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Wingen M, 2005, J CLIN PSYCHIAT, V66, P436, DOI 10.4088/JCP.v66n0405	87	49	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52545	10.1371/journal.pone.0052545	http://dx.doi.org/10.1371/journal.pone.0052545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300977	Green Published, gold			2022-12-27	WOS:000313320900029
J	Moll, K; Roces, F; Federle, W				Moll, Karin; Roces, Flavio; Federle, Walter			How Load-Carrying Ants Avoid Falling Over: Mechanical Stability during Foraging in Atta vollenweideri Grass-Cutting Ants	PLOS ONE			English	Article							LEAF-CUTTER ANTS; SIZE DETERMINATION; STEPPING PATTERNS; TISSUE TRANSPORT; LOCOMOTION; DISTANCE; FORMICIDAE; STRATEGIES; CEPHALOTES; SELECTION	Background: Foraging workers of grass-cutting ants (Atta vollenweideri) regularly carry grass fragments larger than their Fragment length has been shown to influence the ants' running speed and thereby the colony's food intake rate. We investigated whether and how grass-cutting ants maintain stability when carrying fragments of two different lengths but identical mass. Principal Findings: Ants carried all fragments in an upright, backwards-tilted position, but held long fragments more vertically than short ones. All carrying ants used an alternating tripod gait, where mechanical stability was increased by overlapping stance phases of consecutive steps. The overlap was greatest for ants carrying long fragments, resulting in more legs contacting the ground simultaneously. For all ants, the projection of the total centre of mass (ant and fragment) was often outside the supporting tripod, i.e. the three feet that would be in stance for a non-overlapping tripod gait. Stability was only achieved through additional legs in ground contact. Tripod stability (quantified as the minimum distance of the centre of mass to the edge of the supporting tripod) was significantly smaller for ants with long fragments. Here, tripod stability was lowest at the beginning of each step, when the center of mass was near the posterior margin of the supporting tripod. By contrast, tripod stability was lowest at the end of each step for ants carrying short fragments. Consistently, ants with long fragments mainly fell backwards, whereas ants carrying short fragments mainly fell forwards or to the side. Assuming that transporting ants adjust neither the fragment angle nor the gait, they would be less stable and more likely to fall over. Conclusions: In grass-cutting ants, the need to maintain static stability when carrying long grass fragments has led to multiple kinematic adjustments at the expense of a reduced material transport rate.	[Moll, Karin; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Moll, Karin] Univ Freiburg, Univ Coll Freiburg, D-79106 Freiburg, Germany; [Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, D-97070 Wurzburg, Germany	University of Cambridge; University of Freiburg; University of Wurzburg	Moll, K (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	moll.karin.home@gmail.com	Federle, Walter/K-8263-2014	Federle, Walter/0000-0002-6375-3005; Roces, Flavio/0000-0001-9258-3079	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D526129/1]; German Academic Exchange Service (DAAD); Cambridge European Trust; Balfour Fund of the Department of Zoology (University of Cambridge); German Research Foundation (DFG) [Sonderforschungsbereich SFB 554]; Biotechnology and Biological Sciences Research Council [BB/E004156/1] Funding Source: researchfish; BBSRC [BB/E004156/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Cambridge European Trust; Balfour Fund of the Department of Zoology (University of Cambridge)(University of Cambridge); German Research Foundation (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by a Dissertation Grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/D526129/1, http://www.bbsrc.ac.uk/), by the German Academic Exchange Service (DAAD, http://www.daad.de/en/), by the Cambridge European Trust, by the Balfour Fund of the Department of Zoology (University of Cambridge, http://www.zoo.cam.ac.uk/), and by the German Research Foundation (DFG, Sonderforschungsbereich SFB 554, http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; BALDERRAMA NM, 1992, J COMP PHYSIOL B, V162, P440, DOI 10.1007/BF00258967; Bollazzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017667; Burd M, 2001, ECOL ENTOMOL, V26, P551, DOI 10.1046/j.1365-2311.2001.00334.x; Cartmill M, 1985, FUNCTIONAL VERTEBRAT; Dussutour A, 2009, ANIM COGN, V12, P21, DOI 10.1007/s10071-008-0165-0; FOWLER HG, 1979, ECOL ENTOMOL, V4, P239, DOI 10.1111/j.1365-2311.1979.tb00581.x; FULL RJ, 1991, J EXP BIOL, V156, P215; GRAHAM D, 1981, J EXP BIOL, V92, P229; Gunther M, 2012, J THEOR BIOL, V293, P82, DOI 10.1016/j.jtbi.2011.10.011; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Heran H, 1962, VERHANDLUNGEN DTSCH, P346; Holt NC, 2012, J EXP BIOL, V215, P2545, DOI 10.1242/jeb.057695; HUBBELL SP, 1980, BIOTROPICA, V12, P210, DOI 10.2307/2387973; HUGHES GM, 1952, J EXP BIOL, V29, P267; JONKMAN JCM, 1979, Z ANGEW ENTOMOL, V88, P27; JONKMAN JCM, 1976, Z ANGEW ENTOMOL, V81, P140; Lewis OT, 2008, BEHAV ECOL, V19, P805, DOI 10.1093/beheco/arn032; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Lutz FE, 1929, AM MUS NOVIT, V388, P1, DOI DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Moll K, 2012, J EXP BIOL, V215, P161, DOI 10.1242/jeb.063594; Moll K, 2010, J COMP PHYSIOL A, V196, P471, DOI 10.1007/s00359-010-0535-3; RISSING SW, 1982, ENVIRON ENTOMOL, V11, P905, DOI 10.1093/ee/11.4.905; ROBINSON SW, 1982, Z ANGEW ENTOMOL, V93, P42; ROCES F, 1993, BEHAV ECOL SOCIOBIOL, V33, P183, DOI 10.1007/BF00216599; ROCES F, 1995, NATURE, V373, P392, DOI 10.1038/373392a0; ROCES F, 1990, ANIM BEHAV, V40, P1181, DOI 10.1016/S0003-3472(05)80185-X; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; Roschard J, 2002, THESIS U WURZBURG; Roschard J, 2011, PSYCHE, V2011; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; TING LH, 1994, J EXP BIOL, V197, P251; Torres-Contreras H, 2004, INSECT SOC, V51, P265, DOI 10.1007/s00040-004-0737-1; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; Wetterer JK, 1990, BEHAV ECOL, V1, P95, DOI 10.1093/beheco/1.2.95; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P119; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P95	40	23	23	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52816	10.1371/journal.pone.0052816	http://dx.doi.org/10.1371/journal.pone.0052816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300994	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900041
J	Ramirez-Garcia, A; Arteta, B; Abad-Diaz-de-Cerio, A; Pellon, A; Antoran, A; Marquez, J; Rementeria, A; Hernando, FL				Ramirez-Garcia, Andoni; Arteta, Beatriz; Abad-Diaz-de-Cerio, Ana; Pellon, Aize; Antoran, Aitziber; Marquez, Joana; Rementeria, Aitor; Hernando, Fernando L.			Candida albicans Increases Tumor Cell Adhesion to Endothelial Cells In Vitro: Intraspecific Differences and Importance of the Mannose Receptor	PLOS ONE			English	Article							HEPATIC MELANOMA METASTASIS; CYTOKINE PRODUCTION; PROINFLAMMATORY RESPONSE; SINUSOIDAL ENDOTHELIUM; FILAMENTOUS FORMS; EXPRESSION; INFECTION; INTERLEUKIN-18; IDENTIFICATION; INFLAMMATION	The dimorphic fungus Candida albicans is able to trigger a cytokine-mediated pro-inflammatory response that increases tumor cell adhesion to hepatic endothelium and metastasis. To check the intraspecific differences in this effect, we used an in vitro murine model of hepatic response against C. albicans, which made clear that tumor cells adhered more to endothelium incubated with blastoconidia, both live and killed, than germ tubes. This finding was related to the higher carbohydrate/protein ratio found in blastoconidia. In fact, destruction of mannose ligand residues on the cell surface by metaperiodate treatment significantly reduced tumor cell adhesion induced. Moreover, we also noticed that the effect of clinical strains was greater than that of the reference one. This finding could not be explained by the carbohydrate/protein data, but to explain these differences between strains, we analyzed the expression level of ten genes (ADH1, APE3, IDH2, ENO1, FBA1, ILV5, PDI1, PGK1, QCR2 and TUF1) that code for the proteins identified previously in a mannoprotein-enriched pro-metastatic fraction of C. albicans. The results corroborated that their expression was higher in clinical strains than the reference one. To confirm the importance of the mannoprotein fraction, we also demonstrate that blocking the mannose receptor decreases the effect of C. albicans and its mannoproteins, inhibiting IL-18 synthesis and tumor cell adhesion increase by around 60%. These findings could be the first step towards a new treatment for solid organ cancers based on the role of the mannose receptor in C. albicans-induced tumor progression and metastasis.	[Ramirez-Garcia, Andoni; Abad-Diaz-de-Cerio, Ana; Pellon, Aize; Antoran, Aitziber; Rementeria, Aitor; Hernando, Fernando L.] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Leioa, Spain; [Ramirez-Garcia, Andoni] Univ Basque Country UPV EHU, Fac Pharm, Dept Immunol Microbiol & Parasitol, Vitoria, Spain; [Arteta, Beatriz; Marquez, Joana] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Cell Biol & Histol, Leioa, Spain	University of Basque Country; University of Basque Country; University of Basque Country	Ramirez-Garcia, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Leioa, Spain.	andoni.ramirez@ehu.es	Pellon, Aize/I-2870-2015; Arteta, Beatriz/I-4161-2019; Pellon, Aize/K-6083-2019; Ramirez-Garcia, Andoni/I-1697-2015; Antoran, Aitziber/AAA-4435-2019; Hernando, Fernando/I-2763-2015; Arteta, Beatriz/N-4353-2015; Rementeria, Aitor/B-3936-2008; ABAD DIAZ DE CERIO, ANA/Z-1039-2018	Pellon, Aize/0000-0003-0415-6566; Arteta, Beatriz/0000-0003-3253-3162; Pellon, Aize/0000-0003-0415-6566; Ramirez-Garcia, Andoni/0000-0003-2696-162X; Antoran, Aitziber/0000-0003-2594-8220; Hernando, Fernando/0000-0002-7151-9083; Rementeria, Aitor/0000-0003-0478-1038; ABAD DIAZ DE CERIO, ANA/0000-0001-6022-1751; MARQUEZ CLAVIJO, JOANA/0000-0002-6429-615X	SAIOTEK [S-PE09UN41, S-PE11UN070]; Basque Government [IT343/10]; University of the Basque Country [UE 03/04, UE 08/14]; UFI Grant from the University of the Basque Country UPV/EHU [UFI11/25]; Government of the Basque Country	SAIOTEK; Basque Government(Basque Government); University of the Basque Country; UFI Grant from the University of the Basque Country UPV/EHU; Government of the Basque Country	This work was supported by two SAIOTEK grants (S-PE09UN41 and S-PE11UN070) and a consolidated research group IT343/10 of Basque Government, two grants from the University of the Basque Country (UE 03/04 and UE 08/14) and a UFI Grant (UFI11/25) from the University of the Basque Country UPV/EHU. Andoni Ramirez-Garcia was supported by a fellowship from the Government of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632; Bendel CM, 2003, CRIT CARE MED, V31, P501, DOI 10.1097/01.CCM.0000049954.48239.A1; Blackwell TS, 1997, J IMMUNOL, V158, P5934; Cannom RRM, 2002, J INFECT DIS, V186, P389, DOI 10.1086/341660; Carrascal MT, 2003, CANCER RES, V63, P491; CHUNG CW, 1954, J BIOL CHEM, V208, P395; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Filler SG, 1996, INFECT IMMUN, V64, P2609, DOI 10.1128/IAI.64.7.2609-2617.1996; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Gil ML, 2006, FEMS IMMUNOL MED MIC, V46, P1, DOI 10.1111/j.1574-695X.2005.00018.x; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Hernando FL, 2007, INT MICROBIOL, V10, P103, DOI 10.2436/20.1501.01.15; HERNANDO FL, 1993, J MED VET MYCOL, V31, P227; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Orozco AS, 2000, INFECT IMMUN, V68, P1134, DOI 10.1128/IAI.68.3.1134-1141.2000; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Ramirez-Garcia A, 2011, APPL MICROBIOL BIOT, V92, P133, DOI 10.1007/s00253-011-3540-8; Rodriguez-Cuesta J, 2010, CLIN EXP METASTAS, V27, P35, DOI 10.1007/s10585-009-9300-9; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; SAWYER RT, 1976, INFECT IMMUN, V14, P1348, DOI 10.1128/IAI.14.6.1348-1355.1976; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Villar CC, 2005, INFECT IMMUN, V73, P4588, DOI 10.1128/IAI.73.8.4588-4595.2005	30	17	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53584	10.1371/journal.pone.0053584	http://dx.doi.org/10.1371/journal.pone.0053584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301091	Green Published, gold			2022-12-27	WOS:000313320900085
J	Tan, JZ; Hare, B				Tan, Jingzhi; Hare, Brian			Bonobos Share with Strangers	PLOS ONE			English	Article							BEHAVIORAL-EXPERIMENTS; SOCIAL RELATIONSHIPS; CHIMPANZEES HELP; FOOD; COOPERATION; EVOLUTION; PREFERENCES; NONHUMAN; PRIMATE; RECIPROCITY	Humans are thought to possess a unique proclivity to share with others - including strangers. This puzzling phenomenon has led many to suggest that sharing with strangers originates from human-unique language, social norms, warfare and/or cooperative breeding. However, bonobos, our closest living relative, are highly tolerant and, in the wild, are capable of having affiliative interactions with strangers. In four experiments, we therefore examined whether bonobos will voluntarily donate food to strangers. We show that bonobos will forego their own food for the benefit of interacting with a stranger. Their prosociality is in part driven by unselfish motivation, because bonobos will even help strangers acquire out-of-reach food when no desirable social interaction is possible. However, this prosociality has its limitations because bonobos will not donate food in their possession when a social interaction is not possible. These results indicate that other-regarding preferences toward strangers are not uniquely human. Moreover, language, social norms, warfare and cooperative breeding are unnecessary for the evolution of xenophilic sharing. Instead, we propose that prosociality toward strangers initially evolves due to selection for social tolerance, allowing the expansion of individual social networks. Human social norms and language may subsequently extend this ape-like social preference to the most costly contexts.	[Tan, Jingzhi; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University	Tan, JZ (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA.	jingzhi.tan@duke.edu			ERC [233297, NSF-BCS-27552, NSF-BCS-25172]	ERC(European Research Council (ERC)European Commission)	This work was supported by the ERC #233297 (http://erc.europa.eu/) and NSF-BCS-27552; NSF-BCS-25172 (http://www.nsf.gov/div/index.jsp?div=BCS) to Brian Hare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Brent L., 2001, CARE MANAGEMENT CAPT; Bullinger AE, ANIMAL BEHA IN PRESS; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Cheney DL, 2011, P NATL ACAD SCI USA, V108, P10902, DOI 10.1073/pnas.1100291108; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Crofoot MC, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P171, DOI 10.1007/978-3-642-02725-3_8; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Engh AL, 2006, P ROY SOC B-BIOL SCI, V273, P707, DOI 10.1098/rspb.2005.3378; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Feistner A.T.C., 1989, P21; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Ganem G, 2004, PHYSIOL BEHAV, V82, P555, DOI 10.1016/j.physbeh.2004.05.002; Gold Kenneth C., 2001, P90; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Hare B, 2007, CURR DIR PSYCHOL SCI, V16, P60, DOI 10.1111/j.1467-8721.2007.00476.x; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann E, 2011, DEVELOPMENTAL SCI, V14, P1393, DOI 10.1111/j.1467-7687.2011.01082.x; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hohmann G, 2001, PRIMATES, V42, P91, DOI 10.1007/BF02640692; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; House BR, 2012, EVOL HUM BEHAV, V33, P291, DOI 10.1016/j.evolhumbehav.2011.10.007; IDANI G, 1991, FOLIA PRIMATOL, V57, P83, DOI 10.1159/000156568; Jaeggi AV, 2011, BEHAV ECOL SOCIOBIOL, V65, P2125, DOI 10.1007/s00265-011-1221-3; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; Rosati AG, 2012, ANIM BEHAV, V84, P869, DOI 10.1016/j.anbehav.2012.07.010; Seabright P, 2004, CO STRANGERS; Seres M, 2001, ZOO BIOL, V20, P501, DOI 10.1002/zoo.10003; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; Stumpf R, 2011, PRIMATES PERSPECTIVE, P340; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tomasello M, 2009, WHY WE COOPERATE, P1; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Vaish A, 2012, SO NEUROSCI SER, P131; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wobber V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017147; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Woods V, 2011, PRIMATES, V52, P111, DOI 10.1007/s10329-010-0229-z; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; Yamamoto S, 2012, P NATL ACAD SCI USA; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416	68	156	159	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51922	10.1371/journal.pone.0051922	http://dx.doi.org/10.1371/journal.pone.0051922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300956	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900012
J	Wang, ML; Wang, JP; Wang, TP; Li, J; Hui, L; Ha, XQ				Wang, Meiliang; Wang, Jiuping; Wang, Tianping; Li, Jing; Hui, Ling; Ha, Xiaoqin			Thrombocytopenia as a Predictor of Severe Acute Kidney Injury in Patients with Hantaan Virus Infections	PLOS ONE			English	Article							PUUMALA HANTAVIRUS INFECTION; CONGO HEMORRHAGIC-FEVER; RENAL SYNDROME; DISEASE SEVERITY; DENGUE SEVERITY; NICARAGUA; DIAGNOSIS; FATALITY; FAILURE; PROTEIN	Background: Hematological abnormalities often occur several days before kidney injury in patients with hemorrhagic fever with renal syndrome (HFRS). We aimed to investigate the prevalence and prognostic value of the early hematological markers in patients with HFRS caused by Hantaan virus (HTNV) infection. Methods: In a retrospective cohort study, we analyzed the case records of 112 patients with acute HTNV infection and evaluated the hematological markers for early prediction and risk stratification of HFRS patients with acute kidney injury (AKI). Results: Of 112 patients analyzed, 66 (59%) developed severe AKI, defined as either receipt of acute dialysis or increased serum creatinine >= 354 mu mol/L. The prognostic accuracy of hematological markers, as quantified by the area under the receiver-operating-characteristic curve (AUC), was highest with the nadir platelet count (AUC, 0.89; 95% CI, 0.83-0.95), as compared with the admission platelet count (AUC, 0.84; 95% CI, 0.77-0.92), and the admission and peak leukocyte counts. The nadir platelet count correlated moderately with the levels of peak blood urea nitrogen (r = -0.616) and serum creatinine (r = -0.589), the length of hospital stay (r = -0.599), and the number of dialysis sessions that each patient received during hospital stay (r = -0.625). By multivariate analysis, decreased nadir platelet count remained independently associated with the development of severe AKI (odds ratio, 27.57; 95% CI, 6.96-109.16; P<0.0001). Conclusions: Thrombocytopenia, rather than leukocytosis, is independently associated with subsequent severe AKI among patients with acute HTNV infection.	[Wang, Meiliang; Hui, Ling; Ha, Xiaoqin] Lanzhou Gen Hosp, Ctr Med Expt, Lanzhou Mil Command, Lanzhou, Gansu, Peoples R China; [Wang, Jiuping; Wang, Tianping; Li, Jing] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi, Peoples R China; [Hui, Ling; Ha, Xiaoqin] Gansu Key Lab Stem Cell & Gene Therapy, Lanzhou, Gansu, Peoples R China	Air Force Military Medical University	Wang, ML (corresponding author), Lanzhou Gen Hosp, Ctr Med Expt, Lanzhou Mil Command, Lanzhou, Gansu, Peoples R China.	mlwang_2003@yahoo.com						Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Denecke B, 2010, MAYO CLIN PROC, V85, P1016, DOI 10.4065/mcp.2009.0040; Evika MA, 2008, INT J INFECT DIS, V12, P374, DOI [10.1016/j.ijid.2007.09.010, 10.1016/j.ijid.2007.09.01]; Fisgin NT, 2009, TROP DOCT, V39, P158, DOI 10.1258/td.2008.080092; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Kim YO, 2003, J KOREAN MED SCI, V18, P696, DOI 10.3346/jkms.2003.18.5.696; Kim YK, 2007, J INFECTION, V54, P381, DOI 10.1016/j.jinf.2006.07.006; Klein SL, 2011, CLIN INFECT DIS, V52, P1414, DOI 10.1093/cid/cir232; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Onguru P, 2010, J CLIN LAB ANAL, V24, P163, DOI 10.1002/jcla.20383; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Pozner RG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000847; Rasche FM, 2004, EMERG INFECT DIS, V10, P1420, DOI 10.3201/eid1008.031069; Sane J, 2012, ANN MED, V44, P468, DOI 10.3109/07853890.2011.573500; Sundberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021134; Takala A, 2000, J INFECT DIS, V181, P1964, DOI 10.1086/315522; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Wang ML, 2009, J INFECT DIS, V199, P188, DOI 10.1086/595834	21	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53236	10.1371/journal.pone.0053236	http://dx.doi.org/10.1371/journal.pone.0053236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301047	Green Submitted, gold, Green Published			2022-12-27	WOS:000313320900070
J	Figueroa-Romero, C; Hur, J; Bender, DE; Delaney, CE; Cataldo, MD; Smith, AL; Yung, R; Ruden, DM; Callaghan, BC; Feldman, EL				Figueroa-Romero, Claudia; Hur, Junguk; Bender, Diane E.; Delaney, Colin E.; Cataldo, Michael D.; Smith, Andrea L.; Yung, Raymond; Ruden, Douglas M.; Callaghan, Brian C.; Feldman, Eva L.			Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; DNA METHYLATION; SUPEROXIDE-DISMUTASE; GENECHIP DATA; MOUSE MODEL; 5-HYDROXYMETHYLCYTOSINE; PATHWAYS; TRANSCRIPTION; MECHANISM; SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a terminal disease involving the progressive degeneration of motor neurons within the motor cortex, brainstem and spinal cord. Most cases are sporadic (sALS) with unknown causes suggesting that the etiology of sALS may not be limited to the genotype of patients, but may be influenced by exposure to environmental factors. Alterations in epigenetic modifications are likely to play a role in disease onset and progression in ALS, as aberrant epigenetic patterns may be acquired throughout life. The aim of this study was to identify epigenetic marks associated with sALS. We hypothesize that epigenetic modifications may alter the expression of pathogenesis-related genes leading to the onset and progression of sALS. Using ELISA assays, we observed alterations in global methylation (5 mC) and hydroxymethylation (5 HmC) in postmortem sALS spinal cord but not in whole blood. Loci-specific differentially methylated and expressed genes in sALS spinal cord were identified by genome-wide 5mC and expression profiling using high-throughput microarrays. Concordant direction, hyper- or hypo-5mC with parallel changes in gene expression (under-or over-expression), was observed in 112 genes highly associated with biological functions related to immune and inflammation response. Furthermore, literature-based analysis identified potential associations among the epigenes. Integration of methylomics and transcriptomics data successfully revealed methylation changes in sALS spinal cord. This study represents an initial identification of epigenetic regulatory mechanisms in sALS which may improve our understanding of sALS pathogenesis for the identification of biomarkers and new therapeutic targets.	[Figueroa-Romero, Claudia; Hur, Junguk; Bender, Diane E.; Cataldo, Michael D.; Smith, Andrea L.; Callaghan, Brian C.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Delaney, Colin E.; Yung, Raymond] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ruden, Douglas M.] Wayne State Univ, Inst Environm Hlth Sci, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA; [Feldman, Eva L.] Univ Michigan, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu	Hur, Junguk/J-6229-2019; Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Hur, Junguk/0000-0002-0736-2149; Ruden, Douglas/0000-0002-0070-437X; Figueroa-Romero, Claudia/0000-0001-7546-4190; Delaney, Colin E/0000-0001-6880-6973; Bender, Diane/0000-0002-8311-4390; Feldman, Eva/0000-0002-9162-2694	University of Michigan A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; National Institutes of Health (NIH) [R01-ES012933, AG020628, AG028268, ES017885]; National Institutes of Health (NIH) Michigan Institute for Clinical & Health Research [UL1RR024986]; American Diabetes Association; Juvenile Diabetes Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021983, R01ES012933, P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028268, R56AG020628, R01AG020628] Funding Source: NIH RePORTER	University of Michigan A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) Michigan Institute for Clinical & Health Research; American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the University of Michigan A. Alfred Taubman Medical Research Institute (http://www.taubmaninstitute.org); the Program for Neurology Research and Discovery (to E. L. F.); the National Institutes of Health (NIH) (R01-ES012933 to D. M. R.; AG020628, AG028268, and ES017885 to R.Y.; the Michigan Institute for Clinical & Health Research (UL1RR024986)); the American Diabetes Association Junior Faculty Award to B. C. C.; and the Juvenile Diabetes Research Foundation Postdoctoral Fellowship to J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, NEUROL CLIN, V29, P689, DOI 10.1016/j.ncl.2011.06.001; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Calvo A, 2010, CNS NEUROL DISORD-DR, V9, P325, DOI 10.2174/187152710791292657; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Connolly R, 2012, J MAMMARY GLAND BIOL; Coppede F, 2011, THESCIENTIFICWORLDJO, V11, P1679, DOI 10.1100/2011/853474; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Crispi S, 2004, FEBS LETT, V562, P27, DOI 10.1016/S0014-5793(04)00166-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Deforges S, 2009, J PHYSIOL-LONDON, V587, P3561, DOI 10.1113/jphysiol.2009.169748; Eklow C, 2008, ANN RHEUM DIS, V67, P1742, DOI 10.1136/ard.2007.076976; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Hashioka S, 2009, NEUROBIOL AGING, V30, P1924, DOI 10.1016/j.neurobiolaging.2008.02.019; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur J, 2011, BRAIN, V134, P3222, DOI 10.1093/brain/awr228; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Illumina I, 2008, GENOMESTUDIO GEN EXP, P97; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Irier HA, 2012, DNA CELL BIOL, V31, pS42, DOI 10.1089/dna.2011.1565; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishigaki S, 2002, FEBS LETT, V531, P354, DOI 10.1016/S0014-5793(02)03546-9; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kim JH, 2011, INT J ONCOL, V39, P955, DOI 10.3892/ijo.2011.1075; Kirby J, 2011, BRAIN, V134, P506, DOI 10.1093/brain/awq345; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lee YM, 2011, J CELL BIOCHEM, V112, P394, DOI 10.1002/jcb.22969; Lokk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039813; Makrantonaki E, 2007, EXP GERONTOL, V42, P879, DOI 10.1016/j.exger.2007.07.002; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Miah SMS, 2008, J IMMUNOL, V180, P2922; Morahan JM, 2007, TOXICOL LETT, V168, P83, DOI 10.1016/j.toxlet.2006.11.003; Morahan JM, 2009, AMYOTROPH LATERAL SC, V10, P418, DOI 10.3109/17482960802635397; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Oates N, 2007, AMYOTROPH LATERAL SC, V8, P83, DOI 10.1080/17482960601149160; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Qureshi IA, 2011, CURR NEUROL NEUROSCI, V11, P464, DOI 10.1007/s11910-011-0210-2; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Siddique T, 2011, Acta Myol, V30, P117; SMITH SA, 1994, J NEUROL SCI, V124, P84, DOI 10.1016/0022-510X(94)90188-0; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; Valente T, 2012, NEUROBIOL AGING, V33, P2186, DOI 10.1016/j.neurobiolaging.2011.09.019; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van Blitterswijk M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.004; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; van den Hove DLA, 2012, CURR ALZHEIMER RES, V9, P545; Wang Q, 2011, NEUROSCI BULL, V27, P15, DOI 10.1007/s12264-011-1042-4; Wang XS, 2006, AMYOTROPH LATERAL SC, V7, P201, DOI 10.1080/17482960600947689; WERDELIN L, 1990, ACTA NEUROL SCAND, V82, P132; Xu J, 2009, J NEUROSCI, V29, P2022, DOI 10.1523/JNEUROSCI.2621-08.2009; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zheng S, 2002, DEV BRAIN RES, V136, P101, DOI 10.1016/S0165-3806(02)00348-6	92	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52672	10.1371/journal.pone.0052672	http://dx.doi.org/10.1371/journal.pone.0052672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300739	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800124
J	Formoso, G; Taraborrelli, M; Guagnano, MT; D'Adamo, M; Di Pietro, N; Tartaro, A; Consoli, A				Formoso, Gloria; Taraborrelli, Merilda; Guagnano, Maria T.; D'Adamo, Monica; Di Pietro, Natalia; Tartaro, Armando; Consoli, Agostino			Magnetic Resonance Imaging Determined Visceral Fat Reduction Associates with Enhanced IL-10 Plasma Levels in Calorie Restricted Obese Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; WEIGHT-LOSS; GLUCOSE-INTOLERANCE; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; INFLAMMATION; INTERLEUKIN-10; MARKERS; HUMANS	Background: Obesity is characterized by a low grade chronic inflammation state. Indeed circulating pro-inflammatory cytokines, such as TNF-alpha and IL-6, are elevated in obese subjects, while anti-inflammatory cytokines, such as IL-10, appear to be reduced. Cytokines profile improves after weight loss, but how visceral or subcutaneous fat loss respectively affect pro- or anti-inflammatory cytokines plasma levels has not been precisely assessed. Therefore in the present study we correlated changes in circulating cytokine profile with quantitative changes in visceral and subcutaneous adipose tissue depots measured by an ad hoc Magnetic Resonance Imaging (MRI) protocol before and after weight loss. Materials and Methods: In 14 obese subjects, MRI determination of visceral and subcutaneous fat and plasma glucose, insulin, TNF-alpha IL-6, and IL-10 measurements were performed before and after a caloric restriction induced weight loss of at least 5% of the original body weight. Results: Weight loss improved insulin sensitivity (QUICKI Index: 0.35 +/- 0.03 vs 0.37 +/- 0.04; P<0.05), increased IL-10 (3.4 +/- 1.9 vs 4.6 +/- 1.0 pg/mL; P<0.03), and reduced TNF-alpha and IL-6 plasma levels (2.5 +/- 1.3 vs 1.6 +/- 1.5 pg/mL, P<0.0015, 2.3 +/- 0.4 vs 1.6 +/- 0.6 pg/mL, P<0.02 respectively). A significant correlation was observed between the amount of visceral fat loss and the percentage reduction in both TNF-alpha (r = 0.56, p<0.05) and IL-6 (r = 0.19 p<0.05) plasma levels. In a multiple regression analysis, the amount of visceral fat loss independently correlated with the increase in IL-10 plasma levels. Conclusion: The reduction in visceral adipose tissue is the main driver of the improved inflammatory profile induced by weight loss.	[Formoso, Gloria; Taraborrelli, Merilda; Guagnano, Maria T.; Consoli, Agostino] Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy; [Formoso, Gloria; Consoli, Agostino] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Formoso, Gloria; Di Pietro, Natalia; Consoli, Agostino] Univ G DAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Formoso, Gloria; Di Pietro, Natalia; Tartaro, Armando; Consoli, Agostino] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Formoso, Gloria; Di Pietro, Natalia; Consoli, Agostino] Univ G dAnnunzio, CeSI, Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Consoli, A (corresponding author), Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy.	consoli@unich.it	Di Pietro, Natalia/K-1604-2016; tartaro, armando at/K-2184-2016; D'Adamo, Monica/AAL-4676-2020; Consoli, Agostino/J-8027-2018; Guagnano, Maria Teresa/AAT-1701-2021	Di Pietro, Natalia/0000-0001-9720-2116; tartaro, armando at/0000-0003-0095-2792; D'Adamo, Monica/0000-0002-1673-1591; Consoli, Agostino/0000-0002-1885-451X; 	Government Italian Research Grant [2009FATXW3]	Government Italian Research Grant	A Government Italian Research Grant, Protocol #2009FATXW3, supported the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busetto L, 2000, INT J OBESITY, V24, P60, DOI 10.1038/sj.ijo.0801086; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fisher G, 2012, OBESITY, V20, P715, DOI 10.1038/oby.2011.85; Fisman EZ, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-11; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Organization WH, 1997, WHONUTNCD981; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zhang HR, 2011, ARTERIOSCL THROM VAS, V31, P2063, DOI 10.1161/ATVBAHA.111.225870	26	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52774	10.1371/journal.pone.0052774	http://dx.doi.org/10.1371/journal.pone.0052774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300769	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800144
J	Hinterwirth, AJ; Medina, B; Lockey, J; Otten, D; Voldman, J; Lang, JH; Hildebrand, JG; Daniel, TL				Hinterwirth, Armin J.; Medina, Billie; Lockey, Jacob; Otten, David; Voldman, Joel; Lang, Jeffrey H.; Hildebrand, John G.; Daniel, Thomas L.			Wireless Stimulation of Antennal Muscles in Freely Flying Hawkmoths Leads to Flight Path Changes	PLOS ONE			English	Article							URTICAE L-LEPIDOPTERA; STABILIZATION; MOTHS	Insect antennae are sensory organs involved in a variety of behaviors, sensing many different stimulus modalities. As mechanosensors, they are crucial for flight control in the hawkmoth Manduca sexta. One of their roles is to mediate compensatory reflexes of the abdomen in response to rotations of the body in the pitch axis. Abdominal motions, in turn, are a component of the steering mechanism for flying insects. Using a radio controlled, programmable, miniature stimulator, we show that ultra-low-current electrical stimulation of antennal muscles in freely-flying hawkmoths leads to repeatable, transient changes in the animals' pitch angle, as well as less predictable changes in flight speed and flight altitude. We postulate that by deflecting the antennae we indirectly stimulate mechanoreceptors at the base, which drive compensatory reflexes leading to changes in pitch attitude.	[Hinterwirth, Armin J.; Medina, Billie; Lockey, Jacob; Daniel, Thomas L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Otten, David; Voldman, Joel; Lang, Jeffrey H.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ USA	University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); University of Arizona	Hinterwirth, AJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ahinterw@uw.edu			Defense Advanced Research Projects Agency (DARPA); University of Washington (UW) Komen Endowed Chair	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Washington (UW) Komen Endowed Chair	This work was supported by a Defense Advanced Research Projects Agency (DARPA) grant to JV, JGH and TLD, and funds from the University of Washington (UW) Komen Endowed Chair to TLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GEWECKE M, 1970, NATURE, V225, P1263, DOI 10.1038/2251263a0; GEWECKE M, 1981, J COMP PHYSIOL, V145, P249, DOI 10.1007/BF00605037; GEWECKE M, 1974, NATURE, V249, P584, DOI 10.1038/249584a0; Gewecke M, 1967, J COMP PHYSL A; Gullan PA, 2014, INSECTS OUTLINE ENTO; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heran H, 1959, J COMP PHYSIOL A, V42, P103; Hinterwirth AJ, 2010, J COMP PHYSIOL A, V196, P947, DOI 10.1007/s00359-010-0578-5; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767; Krishnan A, 2012, J EXP BIOL, V215, P3096, DOI 10.1242/jeb.071704; NIEHAUS M, 1981, J COMP PHYSIOL, V145, P257, DOI 10.1007/BF00605038; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Sun M, 2007, J EXP BIOL, V210, P2714, DOI 10.1242/jeb.004507; Taylor GK, 2003, J EXP BIOL, V206, P2803, DOI 10.1242/jeb.00501; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8	16	29	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52725	10.1371/journal.pone.0052725	http://dx.doi.org/10.1371/journal.pone.0052725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300751	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800131
J	Melchior, M; Chastang, JF; Falissard, B; Galera, C; Tremblay, RE; Cote, SM; Boivin, M				Melchior, Maria; Chastang, Jean-Francois; Falissard, Bruno; Galera, Cedric; Tremblay, Richard E.; Cote, Sylvana M.; Boivin, Michel			Food Insecurity and Children's Mental Health: A Prospective Birth Cohort Study	PLOS ONE			English	Article							HYPERACTIVITY-INATTENTION SYMPTOMS; RISK-FACTORS; BEHAVIOR; CHILDHOOD; DEPRESSION; OVERWEIGHT; INCOME; INSUFFICIENCY; HUNGER; SECURITY	Food insecurity (which can be defined as inadequate access to sufficient, safe, and nutritious food that meets individuals' dietary needs) is concurrently associated with children's psychological difficulties. However, the predictive role of food insecurity with regard to specific types of children's mental health symptoms has not previously been studied. We used data from the Longitudinal Study of Child Development in Quebec, LSCDQ, a representative birth cohort study of children born in the Quebec region, in Canada, in 1997-1998 (n = 2120). Family food insecurity was ascertained when children were 11/2 and 41/2 years old. Children's mental health symptoms were assessed longitudinally using validated measures of behaviour at ages 41/2, 5, 6 and 8 years. Symptom trajectory groups were estimated to identify children with persistently high levels of depression/anxiety (21.0%), aggression (26.2%), and hyperactivity/inattention (6.0%). The prevalence of food insecurity in the study was 5.9%. In sex-adjusted analyses, children from food-insecure families were disproportionately likely to experience persistent symptoms of depression/anxiety (OR: 1.79, 95% CI 1.15-2.79) and hyperactivity/inattention (OR: 3.06, 95% CI 1.68-5.55). After controlling for immigrant status, family structure, maternal age at child's birth, family income, maternal and paternal education, prenatal tobacco exposure, maternal and paternal depression and negative parenting, only persistent hyperactivity/inattention remained associated with food insecurity (fully adjusted OR: 2.65, 95% CI 1.16-6.06). Family food insecurity predicts high levels of children's mental health symptoms, particularly hyperactivity/inattention. Addressing food insecurity and associated problems in families could help reduce the burden of mental health problems in children and reduce social inequalities in development.	[Melchior, Maria; Chastang, Jean-Francois] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France; [Melchior, Maria; Chastang, Jean-Francois] Univ Versailles St Quentin, UMRS 1018, Versailles, France; [Falissard, Bruno; Tremblay, Richard E.; Cote, Sylvana M.] Univ Paris 11, INSERM, U669, F-75679 Paris, France; [Falissard, Bruno; Tremblay, Richard E.; Cote, Sylvana M.] Univ Paris 05, F-75679 Paris, France; [Galera, Cedric] Univ Bordeaux 2, Hop Charles Perrens, Serv Pedopsychiat Univ, F-33076 Bordeaux, France; [Tremblay, Richard E.; Cote, Sylvana M.] Univ Montreal, Int Lab Child & Adolescent Mental Hlth, Res Grp Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Boivin, Michel] Univ Laval, Quebec City, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal; University College Dublin; Laval University	Melchior, M (corresponding author), INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France.	maria.melchior@inserm.fr	Côté, Sylvana M./T-4600-2019; Boivin, Michel/J-3652-2013; Melchior, Maria/E-3992-2017; Galera, Cedric/T-4896-2019; CHASTANG, Jean-FrançoiS/J-9412-2015; Tremblay, Richard E./O-1360-2014; Cote, Silvana Maria/O-1356-2014	Côté, Sylvana M./0000-0001-7944-0647; Boivin, Michel/0000-0001-8621-9844; GALERA, CEDRIC/0000-0003-0549-9608	Quebec's Ministry of Health and Social Services; Quebec Fund for Research on Society and Culture (Fonds quebecois de la recherche sur la societe et la culture); Quebec Fund for Research on Nature and Technology (Fonds quebecois de la recherche sur la nature et la technologie); Health Research Fund of Quebec (Fonds de recherche en sante du Quebec); Quebec's Ministry of Research, Science, and Technology; Canadian Institutes of Health Research; Social Sciences and Humanities Research Council of Canada; Human Resources Development Canada; Health Canada; Lucie and Andre Chagnon Foundation; National Science Foundation; University of Montreal; Laval University; McGill University; French National Research Agency; Canada Research Chair program	Quebec's Ministry of Health and Social Services; Quebec Fund for Research on Society and Culture (Fonds quebecois de la recherche sur la societe et la culture); Quebec Fund for Research on Nature and Technology (Fonds quebecois de la recherche sur la nature et la technologie); Health Research Fund of Quebec (Fonds de recherche en sante du Quebec); Quebec's Ministry of Research, Science, and Technology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Human Resources Development Canada; Health Canada; Lucie and Andre Chagnon Foundation; National Science Foundation(National Science Foundation (NSF)); University of Montreal; Laval University; McGill University; French National Research Agency(French National Research Agency (ANR)); Canada Research Chair program(Canada Research Chairs)	This study was supported by grants from Quebec's Ministry of Health and Social Services, the Quebec Fund for Research on Society and Culture (Fonds quebecois de la recherche sur la societe et la culture), the Quebec Fund for Research on Nature and Technology (Fonds quebecois de la recherche sur la nature et la technologie), the Health Research Fund of Quebec (Fonds de recherche en sante du Quebec), Quebec's Ministry of Research, Science, and Technology, the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council of Canada, Human Resources Development Canada, Health Canada, the Lucie and Andre Chagnon Foundation, the National Science Foundation, the University of Montreal, Laval University, and McGill University. The funders supported the design and conduct of the study; collection, management, and analysis of the data, but had no influence on the preparation, review, or approval of the manuscript. MM is the recipient of a Young Researcher Award from the French National Research Agency. MB is supported by the Canada Research Chair program. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; Alaimo K, 2001, PEDIATRICS, V108, P44; Ashiabi GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000940; Ashiabi GS, 2008, CHILD DEV PERSPECT, V2, P71, DOI 10.1111/j.1750-8606.2008.00049.x; Baumann BL, 2004, J EMOT BEHAV DISORD, V12, P90, DOI 10.1177/10634266040120020301; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Belsky DW, 2010, AM J EPIDEMIOL, V172, P809, DOI 10.1093/aje/kwq201; Boivin M, 2005, J CHILD PSYCHOL PSYC, V46, P612, DOI 10.1111/j.1469-7610.2004.00375.x; BOYLE MH, 1993, CAN J PSYCHIAT, V38, P397, DOI 10.1177/070674379303800605; Bronte-Tinkew J, 2007, J NUTR, V137, P2160, DOI 10.1093/jn/137.9.2160; Broughton MA, 2006, CAN J PUBLIC HEALTH, V97, P214, DOI 10.1007/BF03405588; Casey P, 2004, PEDIATRICS, V113, P298, DOI 10.1542/peds.113.2.298; Casey PH, 2001, ARCH PEDIAT ADOL MED, V155, P508, DOI 10.1001/archpedi.155.4.508; Che J, 2001, Health Rep, V12, P11; Cicchetti D, 1998, AM PSYCHOL, V53, P221, DOI 10.1037/0003-066X.53.2.221; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2009, J CHILD PSYCHOL PSYC, V50, P1201, DOI 10.1111/j.1469-7610.2009.02099.x; Dubois L, 2006, SOC SCI MED, V63, P1503, DOI 10.1016/j.socscimed.2006.04.002; Dubois L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-199; Evenson KR, 2002, PUBLIC HEALTH REP, V117, P358, DOI 10.1016/S0033-3549(04)50172-3; Galera C, 2009, PSYCHOL MED, V39, P1895, DOI 10.1017/S0033291709005510; Galera C, 2012, BR J PSYCHI IN PRESS; Galera C, 2008, DRUG ALCOHOL DEPEN, V94, P30, DOI 10.1016/j.drugalcdep.2007.09.022; Galera C, 2011, ARCH GEN PSYCHIAT, V68, P1267, DOI 10.1001/archgenpsychiatry.2011.138; Health consequences of poverty for children, HLTH CONS POV CHILDR; Huijbregts SCJ, 2008, DEV PSYCHOPATHOL, V20, P437, DOI 10.1017/S0954579408000217; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; Kleinman RE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e3; Martin-Fernandez J, 2011, B EPIDEMIOL HEBD, V49-50, P515; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Melchior M, 2009, PEDIATRICS, V124, pE564, DOI 10.1542/peds.2009-0583; Millichap J Gordon, 2012, Pediatrics, V129, P330, DOI 10.1542/peds.2011-2199; Molcho M, 2007, PUBLIC HEALTH NUTR, V10, P364, DOI 10.1017/S1368980007226072; Murphy JM, 1998, ARCH PEDIAT ADOL MED, V152, P899; Murphy JM, 1998, J AM ACAD CHILD PSY, V37, P163, DOI 10.1097/00004583-199802000-00008; Nagin DS, 2010, J QUANT CRIMINOL, V26, P445, DOI 10.1007/s10940-010-9113-7; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Pilgrim A, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.125476; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rose D, 2006, PEDIATRICS, V117, P464, DOI 10.1542/peds.2005-0582; Rose D, 1999, J NUTR, V129, p517S, DOI 10.1093/jn/129.2.517S; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Statistics Canada, 1995, OV SURV INSTR 1994 1; Thomas Achenbach, 1991, MANUAL CHILD BEHAV C; TREMBLAY RE, 1987, INT J BEHAV DEV, V10, P467, DOI 10.1177/016502548701000406; United Nations Food and Agriculture Organization, 2003, TRAD REF FOOD SEC; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239; Zaslow M, 2009, MATERN CHILD HLTH J, V13, P66, DOI 10.1007/s10995-008-0329-1	51	130	131	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52615	10.1371/journal.pone.0052615	http://dx.doi.org/10.1371/journal.pone.0052615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300723	Green Published, gold			2022-12-27	WOS:000313618800113
J	Wu, J; Liu, DJ; Xie, Q; Wang, JY				Wu, Jing; Liu, Duojian; Xie, Qing; Wang, Jingyu			Biological Fractionation of Lead Isotopes in Sprague-Dawley Rats Lead Poisoned via the Respiratory Tract	PLOS ONE			English	Article							EXPOSURE; TOXICITY; CHILDREN; RATIOS; BLOOD; REDUCTION; POLLUTION; CADMIUM; ZINC	Objectives: It was considered that lead isotope ratios did not change during physical, chemical, or biological processes. Thus, lead isotope ratios have been used as fingerprints to identify possible lead sources. However, recent evidence has shown that the lead isotope ratios among different biological samples in human are not always identical from its lead origins in vitro. An animal experiment was conducted to explore the biological fractionation of lead isotopes in biological systems. Methods: 24 male Sprague-Dawley (SD) rats were divided into groups that received acute lead exposure (0, 0.02, 0.2, or 2 mg/kg body weight of lead acetate) via the respiratory route every day for 5 days. Biological samples (i.e., blood, urine, and feces) were collected for comparison with the lead acetate (test substance) and the low-lead animal feed (diet) administered to the rats. The lead isotope ratios were determined by inductively coupled plasma mass spectrometry (ICP-MS). Results: There are significant differences (p<0.05) in lead isotope ratios between blood, urine, and feces. Moreover, a nonlinear relationship between the blood lead concentration and the blood lead isotope ratios was observed. There is also a threshold effect to the fractionation function. Only the blood isotope ratio of Pb-204/Pb-206 matches the test substance well. As for feces, when Pb-204/Pb-206 ratio is considered, there is no significant difference between feces-test substance pairs in medium and high dose group. Conclusions: The biological fractionation of lead isotopes in SD rats was observed. Moreover, there might be a threshold for the biological fractionation of lead isotopes which is depending on whole blood lead level. It is considered to be more reliable that we compared the isotope ratios of potential lead hazards with both blood and feces lead fingerprints especially for Pb-204/Pb-206 ratio under high-dose exposure.	[Wu, Jing; Liu, Duojian; Xie, Qing; Wang, Jingyu] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Xie, Qing; Wang, Jingyu] Peking Univ, Ctr Med & Hlth Anal, Beijing 100871, Peoples R China; [Wu, Jing] Hebei Univ Technol, Sch Chem Engn & Technol, Tianjin, Peoples R China	Peking University; Peking University; Hebei University of Technology	Wang, JY (corresponding author), Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China.	wjy@bjmu.edu.cn			Natural Science Foundation of China [30972434]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Natural Science Foundation of China (No. 30972434, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton H, 2000, MICROCHEM J, V67, P21, DOI 10.1016/S0026-265X(00)00089-8; BERMAN E, 1966, CLIN PEDIATR, V5, P287, DOI 10.1177/000992286600500508; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Budge SM, 2011, J EXP BIOL, V214, P3790, DOI 10.1242/jeb.057596; Cheng HF, 2010, ENVIRON POLLUT, V158, P1134, DOI 10.1016/j.envpol.2009.12.028; Chiaradia M, 2000, ATMOS ENVIRON, V34, P959, DOI 10.1016/S1352-2310(99)00213-7; Cloquet C, 2008, ANAL BIOANAL CHEM, V390, P451, DOI 10.1007/s00216-007-1635-y; Cui JF, 2011, ARCHAEOMETRY, V53, P205, DOI 10.1111/j.1475-4754.2010.00548.x; Glorennec P, 2006, ENVIRON RES, V100, P150, DOI 10.1016/j.envres.2005.03.007; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; Gwiazda RH, 2000, ENVIRON HEALTH PERSP, V108, P1091, DOI 10.2307/3434964; Hoefs J., 2009, STABLE ISOTOPE GEOCH, P1, DOI [DOI 10.1007/978-3-540-70708-0, 10.1007/978-3-540-70708-0]; Jouvin D, 2012, ENVIRON SCI TECHNOL, V46, P2652, DOI 10.1021/es202587m; Landrigan PJ, 2000, PUBLIC HEALTH REP, V115, P530, DOI 10.1093/phr/115.6.530; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu J, 2007, CHINESE J FOOD HYGIE, V19, P297; Liu Jingxiu, 2009, Wei Sheng Yan Jiu, V38, P375; Morton-Bermea O, 2011, CHEM ERDE-GEOCHEM, V71, P189, DOI 10.1016/j.chemer.2011.03.003; NEATHERY MW, 1975, J DAIRY SCI, V58, P1767, DOI 10.3168/jds.S0022-0302(75)84785-0; Patel MM, 2008, INT J CIRCUMPOL HEAL, V67, P261, DOI 10.3402/ijch.v67i2-3.18283; PIOMELLI S, 1982, P NATL ACAD SCI-BIOL, V79, P3335, DOI 10.1073/pnas.79.10.3335; RADER JI, 1981, ENVIRON HEALTH PERSP, V42, P187, DOI 10.2307/3429208; Rankin CW, 2005, ENVIRON HEALTH PERSP, V113, P1344, DOI 10.1289/ehp.8009; Reitsema LJ, 2011, AM J PHYS ANTHROPOL, V145, P495, DOI 10.1002/ajpa.21513; SCHWARTZ J, 1990, AM J PUBLIC HEALTH, V80, P165, DOI 10.2105/AJPH.80.2.165; Shiel AE, 2010, SCI TOTAL ENVIRON, V408, P2357, DOI 10.1016/j.scitotenv.2010.02.016; SINGH B, 1994, BIOL TRACE ELEM RES, V40, P21, DOI 10.1007/BF02916817; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; STURGES WT, 1987, NATURE, V329, P144, DOI 10.1038/329144a0; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Wu J, 2011, The enrichment and separation of trace lead in complex matrix, Patent No. 201110001498; Wu J, 2012, SPECTROSC SPECT ANAL, V32, P765, DOI 10.3964/j.issn.1000-0593(2012)03-0765-05	35	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52462	10.1371/journal.pone.0052462	http://dx.doi.org/10.1371/journal.pone.0052462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300678	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800092
J	Xia, CH; Chang, B; DeRosa, AM; Cheng, C; White, TW; Gong, XH				Xia, Chun-hong; Chang, Bo; DeRosa, Adam M.; Cheng, Catherine; White, Thomas W.; Gong, Xiaohua			Cataracts and Microphthalmia Caused by a Gja8 Mutation in Extracellular Loop 2	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; LENS DEVELOPMENT; ALPHA(3) CONNEXIN; DOMINANT CATARACTS; POINT MUTATION; MOUSE MODELS; MICE; CATARACTOGENESIS; PROTEIN; CX50	The mouse semi-dominant Nm2249 mutation displays variable cataracts in heterozygous mice and smaller lenses with severe cataracts in homozygous mice. This mutation is caused by a Gja8(R205G) point mutation in the second extracellular loop of the Cx50 (or alpha 8 connexin) protein. Immunohistological data reveal that Cx50-R205G mutant proteins and endogenous wild-type Cx46 (or alpha 3 connexin) proteins form diffuse tiny spots rather than typical punctate signals of normal gap junctions in the lens. The level of phosphorylated Cx46 proteins is decreased in Gja8(R205G/R205G) mutant lenses. Genetic analysis reveals that the Cx50-R205G mutation needs the presence of wild-type Cx46 to disrupt lens peripheral fibers and epithelial cells. Electrophysiological data in Xenopus oocytes reveal that Cx50-R205G mutant proteins block channel function of gap junctions composed of wild-type Cx50, but only affect the gating of wild-type Cx46 channels. Both genetic and electrophysiological results suggest that Cx50-R205G mutant proteins alone are unable to form functional channels. These findings imply that the Gja8(R205G) mutation differentially impairs the functions of Cx50 and Cx46 to cause cataracts, small lenses and microphthalmia. The Gja8(R205G) mutation occurs at the same conserved residue as the human GJA8(R198W) mutation. This work provides molecular insights to understand the cataract and microphthalmia/microcornea phenotype caused by Gja8 mutations in mice and humans.	[Xia, Chun-hong; Cheng, Catherine; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Xia, Chun-hong; Cheng, Catherine; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [DeRosa, Adam M.; White, Thomas W.] SUNY Stony Brook, Stony Brook, NY 11794 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Jackson Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gong, XH (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	xgong@berkeley.edu	White, Thomas/GPG-4026-2022; White, Thomas W./R-3605-2019	White, Thomas/0000-0002-3285-7434; Chang, Bo/0000-0001-8259-7290	National Institutes of Health [EY13849, EY13163, EY019943]; NATIONAL EYE INSTITUTE [R01EY013849, R01EY013163, R01EY019943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (EY13849 to XG and EY13163 to TW, and EY019943 to BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chang B, 2002, HUM MOL GENET, V11, P507, DOI 10.1093/hmg/11.5.507; Cheng C, 2008, EXP EYE RES, V86, P966, DOI 10.1016/j.exer.2008.03.015; DeRosa AM, 2007, J CELL SCI, V120, P4107, DOI 10.1242/jcs.012237; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hu SS, 2010, MOL VIS, V16, P1585; Huang Guo-Ying, 2011, J Cardiovasc Dis Res, V2, P206, DOI 10.4103/0975-3583.89804; JIANG JX, 1993, INVEST OPHTH VIS SCI, V34, P3558; Jiang JX, 1996, P NATL ACAD SCI USA, V93, P1287, DOI 10.1073/pnas.93.3.1287; Kar R, 2012, ARCH BIOCH BIOPHYSIC; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z; Magnotti LM, 2011, GLIA, V59, P26, DOI 10.1002/glia.21073; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Rong P, 2002, DEVELOPMENT, V129, P167; RUNGE PE, 1992, INVEST OPHTH VIS SCI, V33, P3202; Schutz M, 2011, HUM MOL GENET, V20, P28, DOI 10.1093/hmg/ddq429; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shiels A, 2010, MOL VIS, V16, P2007; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Xia CH, 2006, DEVELOPMENT, V133, P2033, DOI 10.1242/dev.02361; Xia CH, 2006, EXP EYE RES, V83, P688, DOI 10.1016/j.exer.2006.03.013; Xia CH, 2006, J CELL SCI, V119, P2138, DOI 10.1242/jcs.02940	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52894	10.1371/journal.pone.0052894	http://dx.doi.org/10.1371/journal.pone.0052894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300808	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800160
J	Miwa, S; Nishida, H; Tanzawa, Y; Takata, M; Takeuchi, A; Yamamoto, N; Shirai, T; Hayashi, K; Kimura, H; Igarashi, K; Mizukoshi, E; Nakamoto, Y; Kaneko, S; Tsuchiya, H				Miwa, Shinji; Nishida, Hideji; Tanzawa, Yoshikazu; Takata, Munetomo; Takeuchi, Akihiko; Yamamoto, Norio; Shirai, Toshiharu; Hayashi, Katsuhiro; Kimura, Hiroaki; Igarashi, Kentaro; Mizukoshi, Eishiro; Nakamoto, Yasunari; Kaneko, Shuichi; Tsuchiya, Hiroyuki			TNF-alpha and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors	PLOS ONE			English	Article							CANCER; THERAPY; LYMPHOCYTES; MELANOMA; IMMUNITY; BLOOD; OSTEOSARCOMA; VACCINATION; ANTICANCER; ACTIVATION	Background: Dendritic cells (DCs) play a pivotal role in the immune system. There are many reports concerning DC-based immunotherapy. The differentiation and maturation of DCs is a critical part of DC-based immunotherapy. We investigated the differentiation and maturation of DCs in response to various stimuli. Methods: Thirty-one patients with malignant bone and soft tissue tumors were enrolled in this study. All the patients had metastatic tumors and/or recurrent tumors. Peripheral blood mononuclear cells (PBMCs) were suspended in media containing interleukin-4 (IL-4) and granulocyte-macrophage colony stimulating factor (GM-CSF). These cells were then treated with or without 1) tumor lysate (TL), 2) TL + TNF-alpha, 3) OK-432. The generated DCs were mixed and injected in the inguinal or axillary region. Treatment courses were performed every week and repeated 6 times. A portion of the cells were analyzed by flow cytometry to determine the degree of differentiation and maturation of the DCs. Serum IFN-gamma and serum IL-12 were measured in order to determine the immune response following the DC-based immunotherapy. Results: Approximately 50% of PBMCs differentiated into DCs. Maturation of the lysate-pulsed DCs was slightly increased. Maturation of the TL/TNF-alpha-pulsed DCs was increased, commensurate with OK-432-pulsed DCs. Serum IFN-gamma and serum IL-12 showed significant elevation at one and three months after DC-based immunotherapy. Conclusions: Although TL-pulsed DCs exhibit tumor specific immunity, TL-pulsed cells showed low levels of maturation. Conversely, the TL/TNF-alpha-pulsed DCs showed remarkable maturation. The combination of IL-4/GM-CSF/TL/TNF-alpha resulted in the greatest differentiation and maturation for DC-based immunotherapy for patients with bone and soft tissue tumors.	[Miwa, Shinji; Nishida, Hideji; Tanzawa, Yoshikazu; Takata, Munetomo; Takeuchi, Akihiko; Yamamoto, Norio; Shirai, Toshiharu; Hayashi, Katsuhiro; Kimura, Hiroaki; Igarashi, Kentaro; Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan; [Mizukoshi, Eishiro; Nakamoto, Yasunari; Kaneko, Shuichi] Kanazawa Univ, Sch Med, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 920, Japan	Kanazawa University; Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan.	tsuchi@med.kanazawa-u.ac.jp	Miwa, Shinji/AAI-9309-2020; Takeuchi, Akihiko/AAJ-1563-2020; Hayashi, K/C-4685-2015	Miwa, Shinji/0000-0002-5962-8287; Takeuchi, Akihiko/0000-0002-4071-5620; Hayashi, K/0000-0001-8665-2154; Igarashi, Kentaro/0000-0003-2278-1736	Grants-in-Aid for Scientific Research [23791630] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agarwal A, 2010, IMMUNOPHARM IMMUNOT, V32, P348, DOI 10.3109/08923970903300151; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15; Crittenden MR, 2005, IMMUNOLOGY, V114, P11, DOI 10.1111/j.1365-2567.2004.02001.x; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Gregoire M, 2003, VACCINE, V21, P791, DOI 10.1016/S0264-410X(02)00600-X; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hovden AO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-2; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Joyama S, 2006, CLIN ORTHOP RELAT R, P318, DOI 10.1097/01.blo.0000229347.02834.5e; Kawano M, 2010, CLIN ORTHOP RELAT R, V468, P1373, DOI 10.1007/s11999-010-1302-z; Ladanyi A, 2007, CANCER IMMUNOL IMMUN, V56, P1459, DOI 10.1007/s00262-007-0286-3; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Matsumoto M, 2001, INT IMMUNOPHARMACOL, V1, P1559, DOI 10.1016/S1567-5769(01)00071-6; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Moretti S, 2001, MELANOMA RES, V11, P395, DOI 10.1097/00008390-200108000-00010; Nakamoto Y, 2007, CLIN EXP IMMUNOL, V147, P296, DOI 10.1111/j.1365-2249.2006.03290.x; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Okada H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-67; OKAMOTO H, 1967, JPN J MICROBIOL, V11, P323, DOI 10.1111/j.1348-0421.1967.tb00350.x; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Reddy A, 1997, BLOOD, V90, P3640, DOI 10.1182/blood.V90.9.3640; Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tsuboi K, 2004, CANCER LETT, V205, P207, DOI 10.1016/j.canlet.2003.10.010; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wertel I, 2008, CYTOM PART B-CLIN CY, V74B, P251, DOI 10.1002/cyto.b.20410	38	12	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52926	10.1371/journal.pone.0052926	http://dx.doi.org/10.1371/journal.pone.0052926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300824	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800108
J	Elbroch, LM; Wittmer, HU				Elbroch, L. Mark; Wittmer, Heiko U.			Nuisance Ecology: Do Scavenging Condors Exact Foraging Costs on Pumas in Patagonia?	PLOS ONE			English	Article							DOGS LYCAON-PICTUS; PREDATION RISK; HOME-RANGE; PREY; KLEPTOPARASITISM; FEAR; LANDSCAPES; SURVIVAL; SYSTEMS; ENERGY	Predation risk describes the energetic cost an animal suffers when making a trade off between maximizing energy intake and minimizing threats to its survival. We tested whether Andean condors (Vultur gryphus) influenced the foraging behaviors of a top predator in Patagonia, the puma (Puma concolor), in ways comparable to direct risks of predation for prey to address three questions: 1) Do condors exact a foraging cost on pumas?; 2) If so, do pumas exhibit behaviors indicative of these risks?; and 3) Do pumas display predictable behaviors associated with prey species foraging in risky environments? Using GPS location data, we located 433 kill sites of 9 pumas and quantified their kill rates. Based upon time pumas spent at a carcass, we quantified handling time. Pumas abandoned > 10% of edible meat at 133 of 266 large carcasses after a single night, and did so most often in open grasslands where their carcasses were easily detected by condors. Our data suggested that condors exacted foraging costs on pumas by significantly decreasing puma handling times at carcasses, and that pumas increased their kill rates by 50% relative to those reported for North America to compensate for these losses. Finally, we determined that the relative risks of detection and associated harassment by condors, rather than prey densities, explained puma "giving up times'' (GUTs) across structurally variable risk classes in the study area, and that, like many prey species, pumas disproportionately hunted in high-risk, high-resource reward areas.	[Elbroch, L. Mark; Wittmer, Heiko U.] Univ Calif Davis, Davis, CA 95616 USA; [Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of California System; University of California Davis; Victoria University Wellington	Elbroch, LM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	lmelbroch@ucdavis.edu	Wittmer, Heiko U/D-4172-2015	Wittmer, Heiko U/0000-0002-8861-188X	National Science Foundation (USA) Graduate Fellowship; National Geographic Society Explorer Grant; Felidae Conservation Fund; Conservacion Patagonica; Oregon Zoo Future for Wildlife Program; Pacific Rim Research Program; University of California, Davis; Hemispheric Institute on the Americas; The American Society of Mammalogists Grants in Aid of Research Program; Stockton Sportsman's Club	National Science Foundation (USA) Graduate Fellowship; National Geographic Society Explorer Grant; Felidae Conservation Fund; Conservacion Patagonica; Oregon Zoo Future for Wildlife Program; Pacific Rim Research Program; University of California, Davis(University of California System); Hemispheric Institute on the Americas; The American Society of Mammalogists Grants in Aid of Research Program; Stockton Sportsman's Club(Mukai Science and Technology Foundation)	Funding for this research was generously provided through a National Science Foundation (USA) Graduate Fellowship, National Geographic Society Explorer Grant, Felidae Conservation Fund, Conservacion Patagonica, Oregon Zoo Future for Wildlife Program, Pacific Rim Research Program, University of California, Davis, the Hemispheric Institute on the Americas, The American Society of Mammalogists Grants in Aid of Research Program, the Stockton Sportsman's Club, Charles and Elizabeth Gorst, Fred Vanderbeck, Nancy Birtwell and Carole Bell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 1984, MAMMALIAN SPECIES, V219; Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Bellati J, 1990, P 14 VERT PEST C U C, P163; Birdlife International, 2008, IUCN 2011 IUCN RED L; Broom M, 2003, BEHAV ECOL, V14, P23, DOI 10.1093/beheco/14.1.23; Brown Joel S., 2007, P437; BROWN JS, 1994, AUST J ZOOL, V42, P435, DOI 10.1071/ZO9940435; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; Caro T., 1994, CHEETAHS SERENGETI P; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elbroch L. M., 2012, ORYX IN PRESS; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Elbroch LM, 2013, J MAMMAL IN PRESS, V94; Elbroch M, 2011, CONSERV BIOL, V25, P1195, DOI 10.1111/j.1523-1739.2011.01740.x; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; Evans JW, 2009, J WILDLIFE MANAGE, V73, P426, DOI 10.2193/2007-514; Flueck Werner T., 2005, Mastozool. neotrop., V12, P245; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; Houston D.C., 1994, HDB BIRDS WORLD, V2; Iriarte A., 2008, MAMMIFEROS CHILE; Kaczensky P, 2005, WILDLIFE BIOL, V11, P101, DOI 10.2981/0909-6396(2005)11[101:EORCCS]2.0.CO;2; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McLellan BN, 2010, ECOLOGY, V91, P286, DOI 10.1890/09-0286.1; Mukherjee S, 2009, OECOLOGIA, V159, P661, DOI 10.1007/s00442-008-1243-3; Murphy Kerry, 2010, P118; Putnam R., 1988, NATURAL HIST DEER; Raedeke KJ, 1979, THESIS U WASHINGTON; Ruth TK, 2011, J WILDLIFE MANAGE, V75, P1381, DOI 10.1002/jwmg.190; Ruth Toni K., 2010, P163; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Steel R., 1997, PRINCIPLES PROCEDURE; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Todd, 1996, NATURAL HIST WATERFO; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Walker Susan, 2010, P91; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	58	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53595	10.1371/journal.pone.0053595	http://dx.doi.org/10.1371/journal.pone.0053595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301093	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000070
J	Lin, SW; Ghosh, A; Porras, C; Markt, SC; Rodriguez, AC; Schiffman, M; Wacholder, S; Kemp, TJ; Pinto, LA; Gonzalez, P; Wentzensen, N; Esser, MT; Matys, K; Meuree, A; Quint, W; van Doorn, LJ; Herrero, R; Hildesheim, A; Safaeian, M				Lin, Shih-Wen; Ghosh, Arpita; Porras, Carolina; Markt, Sarah C.; Cecilia Rodriguez, Ana; Schiffman, Mark; Wacholder, Sholom; Kemp, Troy J.; Pinto, Ligia A.; Gonzalez, Paula; Wentzensen, Nicolas; Esser, Mark T.; Matys, Katie; Meuree, Ariane; Quint, Wim; van Doorn, Leen-Jan; Herrero, Rolando; Hildesheim, Allan; Safaeian, Mahboobeh		Costa Rican Vaccine Trial Grp	HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; VIRUS-LIKE PARTICLES; NEUTRALIZING EPITOPES; YOUNG-WOMEN; VACCINE; ANTIBODIES; GUANACASTE	Background: Several serological assays have been developed to detect antibodies elicited against infections with oncogenic human papillomavirus (HPV) type 16. The association between antibody levels measured by various assays and subsequent HPV infection risk may differ. We compared HPV16-specific antibody levels previously measured by a virus-like particle (VLP)-based direct enzyme-linked immunoassay (ELISA) with levels measured by additional assays and evaluated the protection against HPV16 infection conferred at different levels of the assays. Methodology/Principal Findings: Replicate enrollment serum aliquots from 388 unvaccinated women in the control arm of the Costa Rica HPV vaccine trial were measured for HPV16 seropositivity using three serological assays: a VLP-based direct ELISA; a VLP-based competitive Luminex immunoassay (cLIA); and a secreted alkaline phosphatase protein neutralization assay (SEAP-NA). We assessed the association of assay seropositivity and risk of subsequent HPV16 infection over four years of follow-up by calculating sampling-adjusted odds ratios (OR) and HPV16 seropositivity based on standard cutoff from the cLIA was significantly associated with protection from subsequent HPV16 infection (OR = 0.48, CI = 0.27-0.86, compared with seronegatives). Compared with seronegatives, the highest seropositive tertile antibody levels from the direct ELISA (OR = 0.53, CI = 0.28-0.90) as well as the SEAP-NA (OR = 0.20, CI = 0.06, 0.64) were also significantly associated with protection from HPV16 infection. Conclusions/Significance: Enrollment HPV16 seropositivity by any of the three serological assays evaluated was associated with protection from subsequent infection, although cutoffs for immune protection were different. We defined the assays and seropositivity levels after natural infection that better measure and translate to protective immunity.	[Lin, Shih-Wen; Ghosh, Arpita; Schiffman, Mark; Wacholder, Sholom; Wentzensen, Nicolas; Hildesheim, Allan; Safaeian, Mahboobeh] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Porras, Carolina; Cecilia Rodriguez, Ana; Gonzalez, Paula] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, Guanacaste, Costa Rica; [Markt, Sarah C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kemp, Troy J.; Pinto, Ligia A.] NCI, HPV Immunol Lab, SAIC Frederick Inc, Frederick, MD 21701 USA; [Esser, Mark T.] Medimmune Inc, Gaithersburg, MD 20878 USA; [Matys, Katie] PPD Vaccines & Biol Ctr Excellence, Wayne, PA USA; [Meuree, Ariane] GlaxoSmithKline Biol, Rixensart, Belgium; [Quint, Wim; van Doorn, Leen-Jan] DDL Diagnost Lab, Voorburg, Netherlands; [Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, F-69372 Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; AstraZeneca; Medimmune; GlaxoSmithKline; DDL Diagnostic Laboratory; World Health Organization; International Agency for Research on Cancer (IARC)	Lin, SW (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	lins4@mail.nih.gov	Markt, Sarah/O-7554-2019; Wentzensen, Nicolas/AAG-8522-2019; Hildesheim, Allan/B-9760-2015; Schiffman, Mark/B-9766-2015; Rodríguez, Ana/GQR-0554-2022	Markt, Sarah/0000-0003-2873-0358; Hildesheim, Allan/0000-0003-0257-2363; Ghosh, Arpita/0000-0003-0036-4376	Costa Rica HPV Vaccine Trial; NCI [N01-CP-11005]; National Institutes of Health Office of Research on Women's Health; National Institutes of Health (NIH) [R25 CA098566]; Ministry of Health of Costa Rica; NATIONAL CANCER INSTITUTE [R25CA098566, ZIACP010216] Funding Source: NIH RePORTER	Costa Rica HPV Vaccine Trial; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health of Costa Rica; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Costa Rica HPV Vaccine Trial, a long-standing collaboration between investigators in Costa Rica and the US National Cancer Institute (NCI) at the National Institutes of Health (NIH). The trial is sponsored and funded by the NCI (contract N01-CP-11005), with funding support from the National Institutes of Health Office of Research on Women's Health. SCM is supported in part by the National Institutes of Health research training grant (NIH, R25 CA098566). The NCI and Costa Rica investigators are responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation of the article. The NCI and Costa Rica investigators make final editorial decisions on this and subsequent publications; GSK has the right to review and comment.; This study was conducted with the support from the Ministry of Health of Costa Rica. Vaccine was provided for the trial by GlaxoSmithKline Biologicals (GSK), under a Clinical Trials Agreement with the NCI. GSK also provided support for aspects of the trial associated with regulatory submission needs of the company under FDA BB-IND 7920. One or more of the authors are employed by a commercial company. These include: Mark T. Esser, MedImmune; Katie Matys, PPD Vaccines and Biologics Center of Excellence; Ariane Meuree, GlaxoSmithKline Biologicals; Wim Quint, DDL Diagnostic Laboratory; and Leen-Jan van Doorn, DDL Diagnostic Laboratory. No other financial disclosures were reported. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2008, CERV CANC INC MORT W; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Coseo SE, 2011, SEX TRANSM DIS, V38, P976, DOI 10.1097/OLQ.0b013e31822545c0; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Frazer Ian H, 2010, Gynecol Oncol, V118, pS8, DOI 10.1016/j.ygyno.2010.04.003; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Safaeian M, 2012, CANC EPIDEMIOL BIOMA; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Schiffman M, 2009, SEX TRANSM DIS, V36, P675, DOI 10.1097/OLQ.0b013e3181bce102; SHOPE RICHARD E., 1937, JOUR EXP MED, V65, P219, DOI 10.1084/jem.65.2.219; Smith JF, 2008, HUM VACCINES, V4, P134, DOI 10.4161/hv.4.2.5261; Stanley MA, 2006, REV MED VIROL, V16, P139, DOI 10.1002/rmv.498; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; WIDEROFF L, 1995, J INFECT DIS, V172, P1425, DOI 10.1093/infdis/172.6.1425	23	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53067	10.1371/journal.pone.0053067	http://dx.doi.org/10.1371/journal.pone.0053067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301022	Green Submitted, gold, Green Published			2022-12-27	WOS:000313320900058
J	Moncunill, G; Aponte, JJ; Nhabomba, AJ; Dobano, C				Moncunill, Gemma; Aponte, John J.; Nhabomba, Augusto J.; Dobano, Carlota			Performance of Multiplex Commercial Kits to Quantify Cytokine and Chemokine Responses in Culture Supernatants from Plasmodium falciparum Stimulations	PLOS ONE			English	Article							BEAD ARRAY; MALARIA; ASSAYS; INFECTION; SEVERITY	Background: Cytokines and chemokines are relevant biomarkers of pathology and immunity to infectious diseases such as malaria. Several commercially available kits based on quantitative suspension array technologies allow the profiling of multiple cytokines and chemokines in small volumes of sample. However, kits are being continuously improved and information on their performance is lacking. Methodology/Principal Findings: Different cytokine/chemokine kits, two flow cytometry-based (eBioscience (R) FlowCytomix (TM) and BD (R) Cytometric Bead Array Human Enhanced Sensitivity) and four Luminex (R)-based (Invitrogen (TM) Human Cytokine 25-Plex Panel, Invitrogen (TM) Human Cytokine Magnetic 30-Plex Panel, Bio-Rad (R) Bio-Plex Pro (TM) Human Cytokine Plex Assay and Millipore (TM) MILLIPLEX (R) MAP Plex Kit) were compared. Samples tested were supernatants of peripheral blood mononuclear cells of malaria-exposed children stimulated with Plasmodium falciparum parasite lysates. Number of responses in range that could be detected was determined and reproducibility of duplicates was evaluated by the Bland-Altman test. Luminex (R) kits performed better than flow cytometry kits in number of responses in range and reproducibility. Luminex (R) kits were more reproducible when magnetic beads were used. However, within each methodology overall performance depended on the analyte tested in each kit. Within the Luminex (R) kits, the Invitrogen (TM) with polystyrene beads had the poorer performance, whereas Invitrogen (TM) with magnetic beads had the higher percentage of cytokines/chemokines with both readings in range (40%), followed by Bio-Rad (R) with magnetic beads (35%). Regarding reproducibility, the Millipore (TM) kit had the highest percentage (60%) of cytokines/chemokines with acceptable limits of agreement (<30%), followed by the Invitrogen (TM) with magnetic beads (40%) that had tighter limits of agreement. Conclusions/Significance: Currently available kits for cytokine and chemokine quantification differ in reproducibility and concentration range of accurate detection. Luminex (R)-based kits with magnetic beads perform the best. Data highlights the importance of testing different kits before each study to choose the most appropriate, depending on the priority of the cytokines assessed.	[Moncunill, Gemma; Aponte, John J.; Dobano, Carlota] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain; [Nhabomba, Augusto J.; Dobano, Carlota] Ctr Invest Saude Manhica, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica	Moncunill, G (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain.	gemma.moncunill@cresib.cat	Dobaño, Carlota/N-4119-2014; Moncunill, Gemma/B-7989-2011	Dobaño, Carlota/0000-0002-6751-4060; Moncunill, Gemma/0000-0001-5105-9836	Ministerio de Economia y Competitividad [SAF2008-00743, SAF2005-25642-E, RYC-2008-02631]; Instituto de Salud Carlos III [PI11/00423, A107190024, CD10/00156]; EU FP6 (AgeMal grant) [LSHP-CT-2005-18902]; Spanish Agency for International Cooperation and Development (AECID)	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU FP6 (AgeMal grant); Spanish Agency for International Cooperation and Development (AECID)(Spanish Government)	The study received financial support from the Ministerio de Economia y Competitividad (SAF2008-00743, SAF2005-25642-E, and salary support RYC-2008-02631 to C.D.) the Instituto de Salud Carlos III (PI11/00423, A107190024, and salary support CD10/00156 to G.M.) and the EU FP6 (AgeMal grant LSHP-CT-2005-18902). The Centro de Investigacao em Saude de Manhica receives core support from the Spanish Agency for International Cooperation and Development (AECID). Manufacturers did not participate in the conception and design of the work, the analysis and interpretation of data or the writing up of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Berthoud TK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-115; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carstensen B., 2012, METHCOMP FUNCTIONS A; Defawe OD, 2012, J IMMUNOL METHODS, V382, P117, DOI 10.1016/j.jim.2012.05.011; Development Core Team, 2005, R LANG ENV STAT COMP; Dobano C, 2009, HUM VACCINES, V5, P562, DOI 10.4161/hv.5.8.8313; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Jost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025060; Kellar KL, 2001, CYTOMETRY, V45, P27, DOI 10.1002/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I; Khan IH, 2009, CYTOM PART B-CLIN CY, V76B, P159, DOI 10.1002/cyto.b.20452; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Nechansky A, 2008, BIOMARK INSIGHTS, V3, P227; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Richens JL, 2010, J BIOMOL SCREEN, V15, P562, DOI 10.1177/1087057110362099; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Siawaya JFD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002535; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Young SH, 2008, J IMMUNOL METHODS, V331, P59, DOI 10.1016/j.jim.2007.11.004	23	46	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52587	10.1371/journal.pone.0052587	http://dx.doi.org/10.1371/journal.pone.0052587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300981	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900033
J	Abrahams, KA; Cox, JAG; Spivey, VL; Loman, NJ; Pallen, MJ; Constantinidou, C; Fernandez, R; Alemparte, C; Remuinan, MJ; Barros, D; Ballell, L; Besra, GS				Abrahams, Katherine A.; Cox, Jonathan A. G.; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Fernandez, Raquel; Alemparte, Carlos; Remuinan, Modesto J.; Barros, David; Ballell, Lluis; Besra, Gurdyal S.			Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; DRUG-RESISTANT TUBERCULOSIS; ANTITUBERCULAR DRUG; RESPIRATORY-CHAIN; QUINOL OXIDATION; ATP HOMEOSTASIS; DISCOVERY; MUCIDIN; LIBRARY; GENES	Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. Through the use of high throughput whole cell screening of an extensive compound library a number of imidazo[1,2-a]pyridine (IP) compounds were obtained as potent lead molecules active against M. tuberculosis and Mycobacterium bovis BCG. The IP inhibitors (1-4) demonstrated minimum inhibitory concentrations (MICs) in the range of 0.03 to 5 mu M against a panel of M. tuberculosis strains. M. bovis BCG spontaneous resistant mutants were generated against IP 1, 3, and 4 at 56 MIC and subsequent whole genome sequencing identified a single nucleotide polymorphism (937)ACC>(937)GCC (T313A) in qcrB, which encodes the b subunit of the electron transport ubiquinol cytochrome C reductase. This mutation also conferred cross-resistance against IP 1, 3 and 4 demonstrating a common target. Gene dosage experiments confirmed M. bovis BCG QcrB as the target where over-expression in M. bovis BCG led to an increase in MIC from 0.5 to >8 mu M for IP 3. An acute murine model of TB infection established bacteriostatic activity of the IP series, which await further detailed characterization.	[Abrahams, Katherine A.; Cox, Jonathan A. G.; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Fernandez, Raquel; Alemparte, Carlos; Remuinan, Modesto J.; Barros, David; Ballell, Lluis] GlaxoSmithKline, Dis Dev World, Madrid, Spain	University of Birmingham; GlaxoSmithKline	Ballell, L (corresponding author), GlaxoSmithKline, Dis Dev World, Madrid, Spain.	Lluis.p.ballell@gsk.com; g.besra@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Abrahams, Katherine/0000-0002-0769-3423; Alemparte, Carlos/0000-0001-5521-8304; Besra, Gurdyal/0000-0002-5605-0395; Rowlands, Vicky/0000-0002-1352-938X; Cox, Jonathan/0000-0001-5208-4056; Ballell, Lluis/0000-0002-3029-1860	Royal Society Wolfson Research Merit Award; European Union's 7th Framework Programme [261378]; Biotechnology and Biological Sciences Research Council [1112080] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); European Union's 7th Framework Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GSB acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick and a Royal Society Wolfson Research Merit Award. The research leading to these results has received funding from the European Union's 7th Framework Programme (FP7-2007-2013) under grant agreement no 261378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAFLOUS A, 2004, LETT DRUG DES DISCOV, V1, P35; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CLOUGH JM, 1993, NAT PROD REP, V10, P565, DOI 10.1039/np9931000565; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; DALDAL F, 1989, EMBO J, V8, P3951, DOI 10.1002/j.1460-2075.1989.tb08578.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Kasimogullari BO, 2004, MOLECULES, V9, P894, DOI 10.3390/91000894; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kraiczy P, 1996, EUR J BIOCHEM, V235, P54, DOI 10.1111/j.1432-1033.1996.00054.x; KUCERA I, 1988, BIOCHEM J, V252, P905, DOI 10.1042/bj2520905; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lee RE, 2003, J COMB CHEM, V5, P172, DOI 10.1021/cc020071p; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Matteelli A, 2010, FUTURE MICROBIOL, V5, P849, DOI [10.2217/fmb.10.50, 10.2217/FMB.10.50]; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Sacksteder KA, 2012, FUTURE MICROBIOL, V7, P823, DOI [10.2217/FMB.12.56, 10.2217/fmb.12.56]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Scherman MS, 2012, BIOORGAN MED CHEM, V20, P3255, DOI 10.1016/j.bmc.2012.03.058; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; SUBIK J, 1974, BIOCHEM BIOPH RES CO, V57, P17, DOI 10.1016/S0006-291X(74)80351-7; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; TOKITO MK, 1993, MOL MICROBIOL, V9, P965, DOI 10.1111/j.1365-2958.1993.tb01226.x; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; VONJAGOW G, 1986, BIOCHEMISTRY-US, V25, P775, DOI 10.1021/bi00352a006; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP	51	148	152	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52951	10.1371/journal.pone.0052951	http://dx.doi.org/10.1371/journal.pone.0052951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300833	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000313872600041
J	Krug, U; Koschmieder, A; Schwammbach, D; Gerss, J; Tidow, N; Steffen, B; Bug, G; Brandts, CH; Schaich, M; Rollig, C; Thiede, C; Noppeney, R; Stelljes, M; Buchner, T; Koschmieder, S; Duhrsen, U; Serve, H; Ehninger, G; Berdel, WE; Muller-Tidow, C				Krug, Utz; Koschmieder, Anja; Schwammbach, Daniela; Gerss, Joachim; Tidow, Nicola; Steffen, Bjoern; Bug, Gesine; Brandts, Christian H.; Schaich, Markus; Roellig, Christoph; Thiede, Christian; Noppeney, Richard; Stelljes, Matthias; Buechner, Thomas; Koschmieder, Steffen; Duehrsen, Ulrich; Serve, Hubert; Ehninger, Gerhard; Berdel, Wolfgang E.; Mueller-Tidow, Carsten			Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia - A Randomised SAL Pilot Study	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; RISK MYELODYSPLASTIC SYNDROMES; CONVENTIONAL CARE REGIMENS; PROGNOSTIC IMPACT; DNMT3A MUTATIONS; IDH2 MUTATIONS; TET2; 5-AZACYTIDINE; RECOMMENDATIONS; INDUCTION	Introduction: Older patients with acute myeloid leukemia (AML) experience short survival despite intensive chemotherapy. Azacitidine has promising activity in patients with low proliferating AML. The aim of this dose-finding part of this trial was to evaluate feasibility and safety of azacitidine combined with a cytarabine-and daunorubicin-based chemotherapy in older patients with AML. Trial Design: Prospective, randomised, open, phase II trial with parallel group design and fixed sample size. Patients and Methods: Patients aged 61 years or older, with untreated acute myeloid leukemia with a leukocyte count of <20,000/mu l at the time of study entry and adequate organ function were eligible. Patients were randomised to receive azacitidine either 37.5 (dose level 1) or 75 mg/sqm (dose level 2) for five days before each cycle of induction (7+3 cytarabine plus daunorubicine) and consolidation (intermediate-dose cytarabine) therapy. Dose-limiting toxicity was the primary endpoint. Results: Six patients each were randomised into each dose level and evaluable for analysis. No dose-limiting toxicity occurred in either dose level. Nine serious adverse events occurred in five patients (three in the 37.5 mg, two in the 75 mg arm) with two fatal outcomes. Two patients at the 37.5 mg/sqm dose level and four patients at the 75 mg/sqm level achieved a complete remission after induction therapy. Median overall survival was 266 days and median event-free survival 215 days after a median follow up of 616 days. Conclusions: The combination of azacitidine 75 mg/sqm with standard induction therapy is feasible in older patients with AML and was selected as an investigational arm in the randomised controlled part of this phase-II study, which is currently halted due to an increased cardiac toxicity observed in the experimental arm.	[Krug, Utz; Koschmieder, Anja; Schwammbach, Daniela; Tidow, Nicola; Stelljes, Matthias; Buechner, Thomas; Koschmieder, Steffen; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Hosp, Dept Med A, Munster, Germany; [Gerss, Joachim] Univ Hosp, Inst Biostat & Clin Res, Munster, Germany; [Steffen, Bjoern; Bug, Gesine; Brandts, Christian H.; Serve, Hubert] Goethe Univ Frankfurt, Dept Med, D-60054 Frankfurt, Germany; [Schaich, Markus; Roellig, Christoph; Thiede, Christian; Ehninger, Gerhard] Tech Univ Dresden, Dept Med 1, D-01062 Dresden, Germany; [Noppeney, Richard; Duehrsen, Ulrich] Univ Hosp, Dept Hematol, Essen, Germany	University of Munster; University of Munster; Goethe University Frankfurt; Technische Universitat Dresden; University of Duisburg Essen	Muller-Tidow, C (corresponding author), Univ Hosp, Dept Med A, Munster, Germany.	muellerc@uni-muenster.de	Bug, Gesine/H-8827-2013; Gerß, Joachim WO/B-5702-2013; Thiede, Christian/AAS-7595-2020; Müller-Tidow, Carsten/O-7207-2018	Thiede, Christian/0000-0003-1241-2048; Müller-Tidow, Carsten/0000-0002-7166-5232; Brandts, Christian H./0000-0003-1732-2535; Serve, Hubert/0000-0001-8472-5516; Koschmieder, Steffen/0000-0002-1011-8171	Celgene Inc.; Amgen Inc.	Celgene Inc.(Bristol-Myers SquibbCelgene Corporation); Amgen Inc.(Amgen)	This trial receives financial support from Celgene Inc. (http://www.celgene.com) and Amgen Inc. (http://www.amgen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAMIS VI, 1989, CANCER CHEMOTH PHARM, V24, P203; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; Cros E, 2004, LEUKEMIA LYMPHOMA, V45, P1123, DOI 10.1080/1042819032000159861; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Estey EH, 2006, SEMIN HEMATOL, V43, P89, DOI 10.1053/j.seminhematol.2006.01.002; Fenaux P, 2010, BRIT J HAEMATOL, V149, P244, DOI 10.1111/j.1365-2141.2010.08082.x; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Itzykson R, 2011, LEUKEMIA, V25, P1147, DOI 10.1038/leu.2011.71; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; KONG XB, 1991, MOL PHARMACOL, V39, P250; Krug Utz, 2007, V176, P243; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; NEIL GL, 1976, CANCER RES, V36, P1114; Scandura JM, 2011, BLOOD, V118, P1472, DOI 10.1182/blood-2010-11-320093; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Thol F, 2010, BLOOD, V116, P614, DOI 10.1182/blood-2010-03-272146; Traina F, 2011, ASH ANN M, V118, pA461; Wagner K, 2010, J CLIN ONCOL, V28, P2356, DOI 10.1200/JCO.2009.27.6899; Walker AR, 2011, ASH ANN M, V118, pA944	30	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52695	10.1371/journal.pone.0052695	http://dx.doi.org/10.1371/journal.pone.0052695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300745	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600022
J	Agarwal, G; Jhanwar, S; Priya, P; Singh, VK; Saxena, MS; Parida, SK; Garg, R; Tyagi, AK; Jain, M				Agarwal, Gaurav; Jhanwar, Shalu; Priya, Pushp; Singh, Vikash K.; Saxena, Maneesha S.; Parida, Swarup K.; Garg, Rohini; Tyagi, Akhilesh K.; Jain, Mukesh			Comparative Analysis of Kabuli Chickpea Transcriptome with Desi and Wild Chickpea Provides a Rich Resource for Development of Functional Markers	PLOS ONE			English	Article							CICER-ARIETINUM L.; NUCLEOTIDE POLYMORPHISM DISCOVERY; ALLELE-SPECIFIC PCR; GENE DISCOVERY; RESPONSIVE TRANSCRIPTOME; MICROSATELLITE MARKERS; STRESS TOLERANCE; PRIMER DESIGN; GENOME; MAP	Chickpea (Cicer arietinum L.) is an important crop legume plant with high nutritional value. The transcriptomes of desi and wild chickpea have already been sequenced. In this study, we sequenced the transcriptome of kabuli chickpea, C. arietinum (genotype ICCV2), having higher commercial value, using GS-FLX Roche 454 and Illumina technologies. The assemblies of both Roche 454 and Illumina datasets were optimized using various assembly programs and parameters. The final optimized hybrid assembly generated 43,389 transcripts with an average length of 1065 bp and N50 length of 1653 bp representing 46.2 Mb of kabuli chickpea transcriptome. We identified a total of 5409 simple sequence repeats (SSRs) in these transcript sequences. Among these, at least 130 and 493 SSRs were polymorphic with desi (ICC4958) and wild (PI489777) chickpea, respectively. In addition, a total of 1986 and 37,954 single nucleotide polymorphisms (SNPs) were predicted in kabuli/desi and kabuli/wild genotypes, respectively. The SNP frequency was 0.043 SNP per kb for kabuli/desi and 0.821 SNP per kb for kabuli/wild, reflecting very low genetic diversity in chickpea. Further, SSRs and SNPs present in tissue-specific and transcription factor encoding transcripts have been identified. The experimental validation of a selected set of polymorphic SSRs and SNPs exhibited high intra-specific polymorphism potential between desi and kabuli chickpea, suggesting their utility in large-scale genotyping applications. The kabuli chickpea gene index assembled, and SSRs and SNPs identified in this study will serve as useful genomic resource for genetic improvement of chickpea.	[Agarwal, Gaurav; Jhanwar, Shalu; Priya, Pushp; Singh, Vikash K.; Saxena, Maneesha S.; Parida, Swarup K.; Garg, Rohini; Tyagi, Akhilesh K.; Jain, Mukesh] NIPGR, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), NIPGR, Funct & Appl Genom Lab, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021; Jhanwar, Shalu/J-7746-2015	Jain, Mukesh/0000-0002-7622-1083; Jhanwar, Shalu/0000-0001-7576-7298	Department of Biotechnology, Government of India [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009 from 2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Barker GLA, 2009, PLANT BIOTECHNOL J, V7, P318, DOI 10.1111/j.1467-7652.2009.00412.x; Bharadwaj C, 2011, J GENET, V90, pE94, DOI 10.1007/s12041-011-0114-6; Bharadwaj C., 2010, J AGR SCI, V81, P116; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Choudhary S, 2012, THEOR APPL GENET, V124, P1449, DOI 10.1007/s00122-012-1800-3; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Galasso I, 1996, GENOME, V39, P258, DOI 10.1139/g96-035; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Gaur R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-117; Gujaria N, 2011, THEOR APPL GENET, V122, P1577, DOI 10.1007/s00122-011-1556-1; Haseneyer G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-5; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jain M, 2011, CURR SCI INDIA, V101, P1435; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Jiang ZH, 2008, GENETICS, V180, P639, DOI 10.1534/genetics.108.090860; Kielbasa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003210; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; KUMAR J, 1985, CROP SCI, V25, P576, DOI 10.2135/cropsci1985.0011183X002500030047x; Labdi M, 1996, EUPHYTICA, V88, P181, DOI 10.1007/BF00023889; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Maheri-Sis N, 2008, AFR J BIOTECHNOL, V7, P2946; Mantri NL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-303; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Metzgar D, 2000, GENOME RES, V10, P72; Molina C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-31; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Mondini L, 2012, OMICS, V16, P178, DOI 10.1089/omi.2011.0081; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-140; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Radhika P, 2007, THEOR APPL GENET, V115, P209, DOI 10.1007/s00122-007-0556-7; Sethy NK, 2006, THEOR APPL GENET, V112, P1416, DOI 10.1007/s00122-006-0243-0; Shukla RK, 2009, FEBS J, V276, P5252, DOI 10.1111/j.1742-4658.2009.07219.x; Singh R, 2008, BIOTECHNOL GENET ENG, V25, P267, DOI 10.5661/bger-25-267; Thacker PA, 2002, J SCI FOOD AGR, V82, P1312, DOI 10.1002/jsfa.1174; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; UDUPA SM, 1993, J PLANT BIOCHEM BIOT, V2, P83, DOI 10.1007/BF03262930; Upadhyaya HD, 2011, J GENET, V90, P479, DOI 10.1007/s12041-011-0099-1; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young ET, 2000, GENETICS, V154, P1053; Zatloukalova P, 2011, CHROMOSOME RES, V19, P729, DOI 10.1007/s10577-011-9235-2	57	90	91	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52443	10.1371/journal.pone.0052443	http://dx.doi.org/10.1371/journal.pone.0052443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300670	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100049
J	Guo, EE; He, QY; Liu, SM; Tian, L; Sheng, ZT; Peng, Q; Guan, JM; Shi, MA; Li, K; Gilbert, LI; Wang, J; Cao, Y; Li, S				Guo, Enen; He, Qianyu; Liu, Shumin; Tian, Ling; Sheng, Zhentao; Peng, Qin; Guan, Jingmin; Shi, Mingan; Li, Kang; Gilbert, Lawrence I.; Wang, Jian; Cao, Yang; Li, Sheng			MET Is Required for the Maximal Action of 20-Hydroxyecdysone during Bombyx Metamorphosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BHLH-PAS FAMILY; JUVENILE-HORMONE RECEPTOR; FTZ-F1 NUCLEAR RECEPTOR; DROSOPHILA FAT-BODY; METHOPRENE-TOLERANT; ECDYSONE RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATORS; SILKWORM	Little is known about how the putative juvenile hormone (JH) receptor, the bHLH-PAS transcription factor MET, is involved in 20-hydroxyecdysone (20E; the molting hormone) action. Here we report that two MET proteins found in the silkworm, Bombyx mori, participate in 20E signal transduction. Met is 20E responsive and its expression peaks during molting and pupation, when the 20E titer is high. As found with results from RNAi knockdown of EcR-USP (the ecdysone receptor genes), RNAi knockdown of Met at the early wandering stage disrupts the 20E-triggered transcriptional cascade, preventing tissue remodeling (including autophagy, apoptosis and destruction of larval tissues and generation of adult structures) and causing lethality during the larval-pupal transition. MET physically interacts with EcR-USP. Moreover, MET, EcR-USP and the 20E-response element (EcRE) form a protein-DNA complex, implying that MET might modulate 20E-induced gene transcription by interacting with EcR-USP. In conclusion, the 20E induction of MET is required for the maximal action of 20E during Bombyx metamorphosis.	[Guo, Enen; Li, Kang; Cao, Yang] S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Guo, Enen; He, Qianyu; Liu, Shumin; Tian, Ling; Sheng, Zhentao; Peng, Qin; Guan, Jingmin; Shi, Mingan; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland College Park	Cao, Y (corresponding author), S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou, Guangdong, Peoples R China.	caoyang@scau.edu.cn; shengli@sippe.ac.cn	sheng, Zhentao Sheng/E-8962-2017		973 program [2012CB114605, 2012CB114602]; National Science Foundation of China [31125025, 31101670]; Science and Technology Commission of Shanghai Municipality [10JC1416700]	973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the 973 program (2012CB114605), the National Science Foundation of China (31125025) and the Science and Technology Commission of Shanghai Municipality (10JC1416700) to S. Li (corresponding author), the National Science Foundation of China (31101670) to LT, and the 973 program (2012CB114602) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Chan HM, 2001, J CELL SCI, V114, P2363; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Imamura M, 2003, GENETICS, V165, P1329; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Khurad AM, 2009, IN VITRO CELL DEV-AN, V45, P414, DOI 10.1007/s11626-009-9197-2; Kimura S, 2008, BIOCHEM BIOPH RES CO, V371, P889, DOI 10.1016/j.bbrc.2008.05.003; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu Y, 2010, J INSECT PHYSIOL, V56, P1436, DOI 10.1016/j.jinsphys.2010.02.011; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou S, 2010, INSECT MOL BIOL, V19, P727, DOI 10.1111/j.1365-2583.2010.01026.x; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	48	37	43	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53256	10.1371/journal.pone.0053256	http://dx.doi.org/10.1371/journal.pone.0053256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300902	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100130
J	Horvat, N; Koder, M; Kos, M				Horvat, Nejc; Koder, Marko; Kos, Mitja			Using the Simulated Patient Methodology to Assess Paracetamol-Related Counselling for Headache	PLOS ONE			English	Article							COMMUNITY PHARMACIES; IMPLEMENTATION; ANALGESICS; MEDICINES; BEHAVIOR; QUALITY; CARE	Objectives: Firstly, to assess paracetamol-related counselling. Secondly, to evaluate the patient's approach as a determinant of counselling and to test the acceptability of the simulated patient method in Slovenian pharmacies. Methods: The simulated patient methodology was used in 17 community pharmacies. Three scenarios related to self-medication for headaches were developed and used in all participating pharmacies. Two scenarios were direct product requests: scenario 1: a patient with an uncomplicated short-term headache; scenario 2: a patient with a severe, long-duration headache who takes paracetamol for too long and concurrently drinks alcohol. Scenario 3 was a symptom-based request: a patient asking for medicine for a headache. Pharmacy visits were audio recorded and scored according to predetermined criteria arranged in two categories: counselling content and manner of counselling. The acceptability of the methodology used was evaluated by surveying the participating pharmacists. Results: The symptom-based request was scored significantly better (a mean 2.17 out of a possible 4 points) than the direct product requests (means of 1.64 and 0.67 out of a possible 4 points for scenario 1 and 2, respectively). The most common information provided was dosage and adverse effects. Only the symptom-based request stimulated spontaneous counselling. No statistically significant differences in the duration of the consultation between the scenarios were found. There were also no significant differences in the quality of counselling between the Masters of Pharmacy and Pharmacy Technicians. The acceptability of the SP method was not as high as in other countries. Conclusion: The assessment of paracetamol-related counselling demonstrates room for practice improvement.	[Horvat, Nejc; Koder, Marko; Kos, Mitja] Univ Ljubljana, Fac Pharm, Chair Social Pharm, Ljubljana, Slovenia	University of Ljubljana	Kos, M (corresponding author), Univ Ljubljana, Fac Pharm, Chair Social Pharm, Ljubljana, Slovenia.	mitja.kos@ffa.uni-lj.si	Kos, Mitja/C-7440-2019; Horvat, Nejc/I-4746-2012	Kos, Mitja/0000-0002-6801-6450; Horvat, Nejc/0000-0001-8460-276X	University of Ljubljana - Faculty of Pharmacy	University of Ljubljana - Faculty of Pharmacy	No separate funding was obtained for this study. The authors are researchers at the University of Ljubljana - Faculty of Pharmacy, which has contributed to financing the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alte D, 2007, ANN PHARMACOTHER, V41, P1023, DOI 10.1345/aph.1H565; Benrimoj SI, 2008, PHARM WORLD SCI, V30, P147, DOI 10.1007/s11096-007-9162-7; Berger K, 2005, J CLIN PHARM THER, V30, P45, DOI 10.1111/j.1365-2710.2004.00611.x; Brvar M, 2008, ZDR VESTN, V77, P39; Cufar A, 2006, FARM VESTN, V57, P55; Dargan PI, 2002, DRUG SAFETY, V25, P625, DOI 10.2165/00002018-200225090-00002; Deschamps M, 2003, CAN PHARM J, V136, P42; French DP, 2008, PHARM WORLD SCI, V30, P79, DOI 10.1007/s11096-007-9146-7; IBM SPSS Inc, 2008, IBM SPSS STAT VERS 1; Kaniecki R, 2003, JAMA-J AM MED ASSOC, V289, P1430, DOI 10.1001/jama.289.11.1430; Kelly FS, 2009, ANN PHARMACOTHER, V43, P1877, DOI 10.1345/aph.1L121; Lowe N K, 1999, Nurse Pract, V24, P34; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Mlinaric A, 2007, FARMAKON, V26, P1; Moynihan R, 2002, BRIT MED J, V325, P678, DOI 10.1136/bmj.325.7366.678; O'Rourke M, 2002, IRISH J MED SCI, V171, P148, DOI 10.1007/BF03170503; Orizio G, 2010, PHARMACOEPIDEM DR S, V19, P970, DOI 10.1002/pds.2007; ORTIZ M, 1989, J SOC ADMIN PHARM, V6, P39; Puspitasari HP, 2009, RES SOC ADMIN PHARM, V5, P197, DOI 10.1016/j.sapharm.2008.08.006; Puumalainen I, 2005, THESIS U KUOPIO KUOP; Puumalainen II, 2005, INT J PHARM PRACT, V13, P149, DOI 10.1211/0022357056307; QSR International Pty Ltd, 2008, NVIVO QUAL DAT AN SO; Roumie CL, 2004, DRUG AGING, V21, P485, DOI 10.2165/00002512-200421080-00001; Schommer JC, 1997, PHARM RES-DORDR, V14, P145, DOI 10.1023/A:1012084207399; Sheen CL, 2002, QJM-INT J MED, V95, P609, DOI 10.1093/qjmed/95.9.609; Trsinar M, 2007, FARM VESTN, V58, P45; Tully MP, 2011, PATIENT EDUC COUNS, V83, P3, DOI 10.1016/j.pec.2010.04.029; van Mil JWF, 2004, PHARM WORLD SCI, V26, P303; Watson MC, 2009, FAM PRACT, V26, P532, DOI 10.1093/fampra/cmp061; Watson MC, 2004, PHARM WORLD SCI, V26, P32, DOI 10.1023/B:PHAR.0000013467.61875.ce; Werner JB, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7206136	31	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52510	10.1371/journal.pone.0052510	http://dx.doi.org/10.1371/journal.pone.0052510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300691	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100058
J	Nguyen, TM; Ravindra, D; Kwong, B; Waheed, S; Ferguson, R; Tarlton, N; Wu, V; Sequeira, CS; Bremer, M; Abramson, T				Nguyen, Tuan M.; Ravindra, Dipti; Kwong, Brian; Waheed, Sana; Ferguson, Ryan; Tarlton, Nicole; Wu, Victoria; Sequeira, Christopher S.; Bremer, Martina; Abramson, Tzvia			Differential Expression of Alpha 4 Integrins on Effector Memory T Helper Cells during Bordetella Infections. Delayed Responses in Bordetella pertussis	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; ADENYLATE-CYCLASE TOXIN; ISLET-ACTIVATING PROTEIN; DENDRITIC CELLS; CHEMOKINE RECEPTORS; LUNG; LYMPHOCYTES; MOLECULES; PULMONARY; IMMUNITY	Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, a respiratory disease that is reemerging worldwide. Mechanisms of selective lymphocyte trafficking to the airways are likely to be critical in the immune response to this pathogen. We compared murine infection by B. pertussis, B. parapertussis, and a pertussis toxin-deleted B. pertussis mutant (Bp Delta PTX) to test the hypothesis that effector memory T-helper cells (emTh) display an altered pattern of trafficking receptor expression in B. pertussis infection due to a defect in imprinting. Increased cell recruitment to the lungs at 5 days post infection (p.i.) with B. parapertussis, and to a lesser extent with Bp Delta PTX, coincided with an increased frequency of circulating emTh cells expressing the mucosal-associated trafficking receptors alpha 4 beta 7 and alpha 4 beta 1 while a reduced population of these cells was observed in B. pertussis infection. These cells were highly evident in the blood and lungs in B. pertussis infection only at 25 days p.i. when B. parapertussis and BpDPTX infections were resolved. Although at 5 days p.i., an equally high percentage of lung dendritic cells (DCs) from all infections expressed maturation markers, this expression persisted only in B. pertussis infection at 25 days p.i. Furthermore, at 5 days p.i with B. pertussis, lung DCs migration to draining lymph nodes may be compromised as evidenced by decreased frequency of CCR7(+) DCs, inhibited CCR7-mediated in vitro migration, and fewer DCs in lung draining lymph nodes. Lastly, a reduced frequency of allogeneic CD4(+) cells expressing alpha 4 beta 1 was detected following co-culture with lung DCs from B. pertussis-infected mice, suggesting a defect in DC imprinting in comparison to the other infection groups. The findings in this study suggest that B. pertussis may interfere with imprinting of lung-associated trafficking receptors on T lymphocytes leading to extended survival in the host and a prolonged course of disease.	[Nguyen, Tuan M.; Ravindra, Dipti; Kwong, Brian; Waheed, Sana; Ferguson, Ryan; Tarlton, Nicole; Wu, Victoria; Sequeira, Christopher S.; Abramson, Tzvia] San Jose State Univ, Dept Biol, San Jose, CA 95192 USA; [Bremer, Martina] San Jose State Univ, Dept Math, San Jose, CA 95192 USA	California State University System; San Jose State University; California State University System; San Jose State University	Abramson, T (corresponding author), San Jose State Univ, Dept Biol, San Jose, CA 95192 USA.	tzvia.abramson@sjsu.edu	Nguyen, Tony Minh/AAH-1121-2019	Nguyen, Tony Minh/0000-0003-4879-3962	CSU startup 538 funds; National Institutes of Health (NIH) [SC3 GM100854-01]; NIH [AI047822, AI072618, DK084647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072618, R21AI047822, R37AI047822, R01AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM100854] Funding Source: NIH RePORTER	CSU startup 538 funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CSU startup 538 funds and National Institutes of Health (NIH) grant SC3 GM100854-01 awarded to Dr. Tzvia Abramson, and in part by NIH grants AI047822, AI072618, and DK084647 awarded to Dr. Eugene Butcher (Stanford University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitorabi MA, 1996, J IMMUNOL, V156, P3111; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Anis MM, 2008, INFECT IMMUN, V76, P671, DOI 10.1128/IAI.01079-07; ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Bergfors E, 1999, Int J Infect Dis, V3, P140, DOI 10.1016/S1201-9712(99)90035-8; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Garcia A, 1996, J CLIN MICROBIOL, V34, P182; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kang SG, 2011, MUCOSAL IMMUNOL, V4, P66, DOI 10.1038/mi.2010.42; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; MUNOZ JJ, 1981, INFECT IMMUN, V33, P820, DOI 10.1128/IAI.33.3.820-826.1981; NENCIONI L, 1991, INFECT IMMUN, V59, P4732, DOI 10.1128/IAI.59.12.4732-4734.1991; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; PICKER LJ, 1990, AM J PATHOL, V136, P1053; PICKER LJ, 1994, EUR J IMMUNOL, V24, P1269, DOI 10.1002/eji.1830240605; PITTMAN M, 1980, J INFECT DIS, V142, P56, DOI 10.1093/infdis/142.1.56; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693; Schneider OD, 2009, J IMMUNOL, V182, P5730, DOI 10.4049/jimmunol.0803114; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Thatte J, 2003, BLOOD, V101, P4916, DOI 10.1182/blood-2002-10-3159; UI M, 1988, ADV SEC MESS PHOSPH, V21, P39; Vaya A, 2012, CLIN HEMORHEOL MICRO, V51, P51, DOI 10.3233/CH-2011-1508; Verma A, 2008, J BACTERIOL, V190, P7285, DOI 10.1128/JB.01106-08; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Wolber FM, 1998, J IMMUNOL, V161, P4396; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	60	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52903	10.1371/journal.pone.0052903	http://dx.doi.org/10.1371/journal.pone.0052903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300813	Green Published, gold			2022-12-27	WOS:000312829100094
J	Tseng, CH				Tseng, Chin-Hsiao			Thyroid Cancer Risk Is Not Increased in Diabetic Patients	PLOS ONE			English	Article							METABOLIC SYNDROME; POOLED ANALYSIS; UNITED-STATES; INSULIN; TAIWAN; POPULATION; EXPRESSION; COHORT; CELLS	Objective: This study evaluated thyroid cancer risk with regards to diabetes status and diabetes duration, and with the use of anti-diabetic drugs including sulfonylurea, metformin, insulin, acarbose, pioglitazone and rosiglitazone, by using a population-based reimbursement database in Taiwan. Methods: A random sample of 1,000,000 subjects covered by the National Health Insurance was recruited. After excluding patients with type 1 diabetes, 999730 subjects (495673 men and 504057 women) were recruited into the analyses. Logistic regression estimated the odds ratios (OR) and their 95% confidence intervals (Cl) for independent variables including age, sex, diabetes status/duration, anti-diabetic drugs, other medications, comorbidities, living regions, occupation and examinations that might potentially lead to the diagnosis of thyroid cancer in various models. Results: The diabetic patients had a significantly higher probability of receiving potential detection examinations (6.38% vs. 5.83%, P<0.0001). After multivariable-adjustment, the OR (95% Cl) for diabetes status was 0.816 (0.652-1.021); and for diabetes duration <1 year, 1-3 years, 3-5 years and >= 5 years vs. non-diabetes was 0.071 (0.010-0.507), 0.450 (0.250-0.813), 0.374 (0.203-0.689) and 1.159 (0.914-1.470), respectively. Among the anti-diabetic agents, only sulfonylurea was significantly associated with thyroid cancer, OR (95% Cl): 1.882 (1.202-2.947). The OR (95% Cl) for insulin, metformin, acarbose, pioglitazone and rosiglitazone was 1.701 (0.860-3.364), 0.696 (0.419-1.155), 0.581 (0.202-1.674), 0.522 (0.069-3.926) and 0.669 (0.230-1.948), respectively. Furthermore, patients with benign thyroid disease or other cancer, living in Kao-Ping/Eastern regions, or receiving potential detection examinations might have a significantly higher risk; and male sex, hypertension, dyslipidemia, chronic obstructive pulmonary disease, vascular complications or use of statin, aspirin or non-steroidal anti-inflammatory drugs might be associated with a significantly lower risk. Conclusions: There is a lack an overall association between diabetes and thyroid cancer, but patients with diabetes duration <5 years have a significantly lower risk. Sulfonylurea may increase the risk of thyroid cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123				Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Aschebrook-Kilfoy B, 2011, THYROID, V21, P957, DOI 10.1089/thy.2010.0396; Bureau of Health Promotion, 2010, CANC REG ANN REP 200; Cappelli C, 2012, OBES SURG, V22, P460, DOI 10.1007/s11695-011-0410-5; Chen GG, 2008, CURR CANCER DRUG TAR, V8, P367, DOI 10.2174/156800908785133150; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chiou WK, 2011, ASIAN PAC J CANCER P, V12, P1577; Cho NL, 2010, THYROID, V20, P615, DOI 10.1089/thy.2009.0415; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Farasat T, 2011, PAK J ZOOL, V43, P379; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guney E, 1999, TURKISH J ENDOCRINOL, V4, P173; Hegedus L, 2008, CLIN ENDOCRINOL, V68, P2, DOI 10.1111/j.1365-2265.2007.02983.x; HERSHMAN JM, 1968, ENDOCRINOLOGY, V83, P74, DOI 10.1210/endo-83-1-74; HU RM, 1994, MOL CELL ENDOCRINOL, V103, P65; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kadiyala R, 2010, INT J CLIN PRACT, V64, P1130, DOI 10.1111/j.1742-1241.2010.02376.x; Kim HK, 2013, CLIN ENDOCRINOL, V78, P472, DOI 10.1111/cen.12027; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P1615, DOI 10.1007/s10552-012-0039-2; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P463, DOI 10.1007/s10552-012-9896-y; McNally RJQ, 2012, EUR J EPIDEMIOL, V27, P615, DOI 10.1007/s10654-012-9710-x; NIKKILA EA, 1960, ACTA ENDOCRINOL-COP, V33, P623; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Roche LM, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/850105; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; Shih SR, 2012, EXP DIABETES RES, DOI 10.1155/2012/578285; Tarcin O, 2012, METAB SYNDR RELAT D, V10, P137, DOI 10.1089/met.2011.0098; Tseng CH, 2012, EUR J ENDOCRINOL, V167, P409, DOI 10.1530/EJE-12-0369; Wang CY, 2012, ENDOCR J, V59, P911, DOI 10.1507/endocrj.EJ12-0076; Zhan YS, 2010, MED ONCOL, V27, P177, DOI 10.1007/s12032-009-9189-9	31	76	78	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53096	10.1371/journal.pone.0053096	http://dx.doi.org/10.1371/journal.pone.0053096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300866	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100117
J	You, QS; Wu, LJ; Duan, JL; Luo, YX; Liu, LJ; Li, X; Gao, Q; Wang, W; Xu, L; Jonas, JB; Guo, XH				You, Qi Sheng; Wu, Li Juan; Duan, Jia Li; Luo, Yan Xia; Liu, Li Juan; Li, Xia; Gao, Qi; Wang, Wei; Xu, Liang; Jonas, Jost B.; Guo, Xiu Hua			Factors Associated with Myopia in School Children in China: The Beijing Childhood Eye Study	PLOS ONE			English	Article							RISK-FACTORS; REFRACTIVE ERRORS; OUTDOOR ACTIVITY; ADULT CHINESE; OCULAR PARAMETERS; PARENTAL MYOPIA; FOLLOW-UP; SINGAPORE; WORK; PREVALENCE	Purpose: To assess factors associated with myopia in school children in rural and urban parts of Greater Beijing. Methods: The Beijing Pedriatic Eye Study was a population-based cross-sectional study, in which one school of each level (primary, junior high, senior high) was randomly selected from nine randomly selected districts out of 18 districts of Greater Beijing. The children underwent non-cylcoplegic refractometry and their parents an interview. Results: Of 16,771 eligible students, 15,066 (89.8%) children (7,769 (51.6%) girls) participated, with 8,860 (58.8%) participants living in the rural region. Mean age was 13.2 +/- 3.4 years (range: 7-18 years). In multivariate analysis, prevalence of myopia (defined as <=-1.00 diopters) was associated with higher age (Odds ratio(OR): 1.37; 95% confidence interval(CI): 1.35,1.39), female gender (OR: 1.35; 95% CI: 1.25,1.47), key school type (OR: 0.77; 95% CI: 0.70,0.85), higher family income (OR: 1.04; 95% CI: 1.01,1.07), parental myopia (OR: 1.46; 95% CI: 1.40,1.53), dim reading illumination (OR: 0.93; 95% CI: 0.88,0.98), longer daily studying duration (OR: 1.10; 95% CI: 1.06,1.15), shorter duration of watching television (or computer) (OR: 0.93; 95% CI: 0.89,0.97), higher self-reported protein intake (OR: 0.94; 95% CI: 0.90,0.99), feeling well about life and status (OR: 0.93; 95% CI: 0.89,0.98), and feeling tired or dizzy (OR: 0.94; 95% CI: 0.91,0.97). Prevalence of high myopia (defined as <=-6.00 diopters) was associated with higher age (OR: 1.43; 95% CI: 1.38, 1.48), key school type (OR: 0.61; 95% CI: 0.49,0.74), family income (OR: 1.07; 95% CI: 1.02,1.13), parental myopia (OR: 1.65; 95% CI: 1.54,1.76), dim reading illumination (OR: 0.86; 95% CI: 0.77,0.96), less rest during studying (OR: 1.18; 95% CI: 1.10,1.27), feeling well about life and studying (OR: 0.88; 95% CI: 0.81,0.96) and feeling dizzy or tired (OR: 0.93; 95% CI: 0.87,0.99). Prevalence of high myopia (defined as <=-8.00 diopters) was significantly associated with higher age (OR: 1.39; 95% CI: 1.31,1.48;), key school type (OR: 0.61; 95% CI: 0.42,0.88) and parental myopia (OR: 1.87; 95% CI: 1.66,2.12). Conclusions: Myopia in school children in Greater Beijing was associated with higher age, female gender, school type, parental myopia, higher socioeconomic background, dim reading illumination, longer daily studying duration, less rest during study, shorter duration of watching television (or computer), higher self-reported protein intake, feeling well about life and status, and feeling tired and dizzy.	[You, Qi Sheng; Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Beijing Key Lab Epidemiol, Beijing, Peoples R China; [Duan, Jia Li] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Joondalup, Australia; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Edith Cowan University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com; jost.jonas@umm.de; guoxiuh@ccmu.edu.cn	Gao, Qi/N-8721-2019; You, Qisheng/AAG-7153-2020; liu, li/HGC-0900-2022; You, Qisheng/A-3619-2014	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Gao, Qi/0000-0002-5370-5536; wang, wei/0000-0002-1430-1360	Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]; Natural Science Fund of China [30972550]; Beijing Nova Program [2010B032]	Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Supported by the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); the program of Natural Science Fund of China (Serial Number: 30972550), and the Beijing Nova Program (No. 2010B032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Dong F, 2011, MOL VIS, V17, P2824; French AN, 2012, INVEST OPHTHALMOL VI; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P3858, DOI 10.1167/iovs.07-1451; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P2520, DOI 10.1167/iovs.06-0716; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Khader Y. S., 2006, Eastern Mediterranean Health Journal, V12, P434; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim LS, 2010, OPHTHALMOLOGY, V117, P993, DOI 10.1016/j.ophtha.2009.10.003; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Loman J, 2002, OPHTHALMOLOGY, V109, P1032, DOI 10.1016/S0161-6420(02)01012-6; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P1230, DOI 10.1136/bjo.2006.093450; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Sharma A, 2010, AM J OPHTHALMOL, V149, P347, DOI 10.1016/j.ajo.2009.08.015; Williams C, 2008, BRIT J OPHTHALMOL, V92, P1117, DOI 10.1136/bjo.2007.128256; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2011, ACTA OPHTHALMOL, V89, P442, DOI 10.1111/j.1755-3768.2009.01734.x; Zhang MZ, 2010, INVEST OPHTH VIS SCI, V51, P4969, DOI 10.1167/iovs.10-5424; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	42	72	83	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52668	10.1371/journal.pone.0052668	http://dx.doi.org/10.1371/journal.pone.0052668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300738	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100071
J	Gao, XG; Liu, D; Fan, YY; Li, XZ; Xue, HT; Ma, YY; Zhou, YF; Tai, GH				Gao, Xiaoge; Liu, Dan; Fan, Yuying; Li, Xinzhi; Xue, Huiting; Ma, Yingyun; Zhou, Yifa; Tai, Guihua			The Two Endocytic Pathways Mediated by the Carbohydrate Recognition Domain and Regulated by the Collagen-like Domain of Galectin-3 in Vascular Endothelial Cells	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; EXTRACELLULAR FUNCTIONS; CIRCULATING GALECTIN-3; HOMOTYPIC AGGREGATION; ANGIOGENESIS; METASTASIS; INHIBITION; ACTIVATION; SECRETION; CLEAVAGE	Galectin-3 plays an important role in endothelial morphogenesis and angiogenesis. We investigated the endocytosis of galectin-3 in human vascular endothelial cells and showed that galectin-3 could associate with and internalized into the cells in a carbohydrate-dependent manner. Our work also revealed that galectin-3 was transported to the early/recycling endosomes and then partitioned into two routes - recycling back to the plasma membrane or targeting to the late endosomes/lysosomes. Various N- and C-terminal truncated forms of galectin-3 were constructed and compared with the full-length protein. These comparisons showed that the carbohydrate-recognition domain of galectin-3 was required for galectin-3 binding and endocytosis. The N- terminal half of the protein, which comprises the N- terminal leader domain and the collagen-like internal repeating domain, could not mediate binding and endocytosis alone. The collagen-like domain, although it was largely irrelevant to galectin-3 trafficking to the early/recycling endosomes, was required for targeting galectin-3 to the late endosomes/lysosomes. In contrast, the leader domain was irrelevant to both binding and intracellular trafficking. The data presented in this study correlate well with different cellular behaviors induced by the full-length and the truncated galectin-3 and provide an alternative way of understanding its angiogenic mechanisms.	[Gao, Xiaoge; Liu, Dan; Fan, Yuying; Li, Xinzhi; Xue, Huiting; Ma, Yingyun; Zhou, Yifa; Tai, Guihua] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China	Northeast Normal University - China	Tai, GH (corresponding author), NE Normal Univ, Sch Life Sci, Changchun, Peoples R China.	taigh477@nenu.edu.cn			National Natural Science Foundation of China [81173605, 30670478]; Fundamental Research Funds for the Central Universities [11SSXT154, 12SSXM005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Nos: 81173605 & 30670478; http://www.nsfc.gov.cn/Portal0/default152.htm) and the Fundamental Research Funds for the Central Universities (11SSXT154 & 12SSXM005; http://www.nenu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Glinsky VV, 2003, CANCER RES, V63, P3805; Gong HC, 1999, CANCER RES, V59, P6239; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; LEVI G, 1981, J BIOL CHEM, V256, P5735; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233; Mirandola L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021811; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rapoport EM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P393, DOI 10.1134/S0006297908040032; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Yang E, 2007, BIOCHEM BIOPH RES CO, V363, P336, DOI 10.1016/j.bbrc.2007.08.179; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096; Zhu WQ, 2001, CANCER RES, V61, P1869	39	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52430	10.1371/journal.pone.0052430	http://dx.doi.org/10.1371/journal.pone.0052430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300668	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800085
J	Karp, NA; Melvin, D; Mott, RF				Karp, Natasha A.; Melvin, David; Mott, Richard F.		Sanger Mouse Genetics Project	Robust and Sensitive Analysis of Mouse Knockout Phenotypes	PLOS ONE			English	Article							EXPERIMENTAL-DESIGN; REFERENCE VALUES; COMPLEX TRAITS; GENOME-WIDE; GENE; ASSOCIATION; ENVIRONMENT; BEHAVIOR; QUALITY; MODEL	A significant challenge of in-vivo studies is the identification of phenotypes with a method that is robust and reliable. The challenge arises from practical issues that lead to experimental designs which are not ideal. Breeding issues, particularly in the presence of fertility or fecundity problems, frequently lead to data being collected in multiple batches. This problem is acute in high throughput phenotyping programs. In addition, in a high throughput environment operational issues lead to controls not being measured on the same day as knockouts. We highlight how application of traditional methods, such as a Student's t-Test or a 2-way ANOVA, in these situations give flawed results and should not be used. We explore the use of mixed models using worked examples from Sanger Mouse Genome Project focusing on Dual-Energy X-Ray Absorptiometry data for the analysis of mouse knockout data and compare to a reference range approach. We show that mixed model analysis is more sensitive and less prone to artefacts allowing the discovery of subtle quantitative phenotypes essential for correlating a gene's function to human disease. We demonstrate how a mixed model approach has the additional advantage of being able to include covariates, such as body weight, to separate effect of genotype from these covariates. This is a particular issue in knockout studies, where body weight is a common phenotype and will enhance the precision of assigning phenotypes and the subsequent selection of lines for secondary phenotyping. The use of mixed models with in-vivo studies has value not only in improving the quality and sensitivity of the data analysis but also ethically as a method suitable for small batches which reduces the breeding burden of a colony. This will reduce the use of animals, increase throughput, and decrease cost whilst improving the quality and depth of knowledge gained.	[Karp, Natasha A.; Melvin, David; Sanger Mouse Genetics Project] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England; [Mott, Richard F.] Wellcome Trust Ctr Human Genet, Oxford, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics	Karp, NA (corresponding author), Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England.	nk3@sanger.ac.uk		Mott, Richard/0000-0002-1022-9330; Karp, Natasha/0000-0002-8404-2907	Wellcome Trust [WT098051]; National Institutes of Health [1 U54 HG006370-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Wellcome Trust (grant number WT098051) and the National Institutes of Health (grant number 1 U54 HG006370-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Chen CK, 2012, HUM MUTAT, V33, P858, DOI 10.1002/humu.22051; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley M.J., 2007, R BOOK; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; Goncalves P, 2005, STAT MODELLING CARDI; Hu Donglei, 2008, V448, P31, DOI 10.1007/978-1-59745-205-2_3; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kafkafi N, 2005, P NATL ACAD SCI USA, V102, P4619, DOI 10.1073/pnas.0409554102; Karp NA, 2012, LAB ANIM IN PRESS; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Mansergh FC, 2007, PHYSIOL GENOMICS, V32, P64, DOI 10.1152/physiolgenomics.00151.2007; Meyer CW, 2007, NATURWISSENSCHAFTEN, V94, P401, DOI 10.1007/s00114-006-0203-1; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pinkert CA., 2002, TRANSGENIC ANIMAL TE; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Richter S, 2010, CHLOE, V41, P7; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Sabrautzki S, 2012, MAMM GENOME; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; SOLBERG HE, 1983, J CLIN CHEM CLIN BIO, V21, P749; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; West B. T., 2007, LINEAR MIXED MODELS; Wurbel H., 2007, NC3RS, V9, P1, DOI DOI 10.1016/S1353-8020(08)70759-4; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	37	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52410	10.1371/journal.pone.0052410	http://dx.doi.org/10.1371/journal.pone.0052410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300663	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800082
J	Yang, SZ; Wen, X; Jin, HJ; Wu, QB				Yang, Sizhong; Wen, Xi; Jin, Huijun; Wu, Qingbai			Pyrosequencing Investigation into the Bacterial Community in Permafrost Soils along the China-Russia Crude Oil Pipeline (CRCOP)	PLOS ONE			English	Article							MICROBIAL DIVERSITY; TUNDRA SOILS; BIOREMEDIATION; DEGRADATION; HYDROCARBONS; PENTACHLOROPHENOL; BIODEGRADATION; WETLANDS; REMOVAL; ECOLOGY	The China-Russia Crude Oil Pipeline (CRCOP) goes through 441 km permafrost soils in northeastern China. The bioremediation in case of oil spills is a major concern. So far, little is known about the indigenous bacteria inhabiting in the permafrost soils along the pipeline. A pilot 454 pyrosequencing analysis on the communities from four selected sites which possess high environment risk along the CRCOP is herein presented. The results reveal an immense bacterial diversity than previously anticipated. A total of 14448 OTUs with 84834 reads are identified, which could be assigned into 39 different phyla, and 223 families or 386 genera. Only five phyla sustain a mean OTU abundance more than 5% in all the samples, but they altogether account for 85.08% of total reads. Proteobacteria accounts for 41.65% of the total OTUs or 45% of the reads across all samples, and its proportion generally increases with soil depth, but OTUs numerically decline. Among Proteobacteria, the abundance of Beta-, Alpha-, Delta- and Gamma- subdivisions average to 38.7% (2331 OTUs), 37.5% (2257 OTUs), 10.35% (616 OTUs), and 6.21% (374 OTUs), respectively. Acidobacteria (esp. Acidobacteriaceae), Actinobacteria (esp. Intrasporangiaceae), Bacteroidetes (esp. Sphingobacteria and Flavobacteria) and Chloroflexi (esp. Anaerolineaceae) are also very common, accounting for 8.56% (1237 OTUs), 7.86% (1136 OTUs); 7.35% (1063 OTUs) and 8.27% (1195 OTUs) of total libraries, respectively. The ordination analysis indicates that bacteria communities in the upper active layer cluster together (similar), while bacterial consortia from the lower active layer and permafrost table scatter (less similar). The abundance of Rhodococcus (12 OTUs), Pseudomonas (71 OTUs) and Sphingomonas (87 OTUs) is even less (<0.01%). This effort to profile the background diversity may set the first stage for better evaluating the bacterial dynamics in response to accidental oil spills.	[Yang, Sizhong; Jin, Huijun; Wu, Qingbai] Chinese Acad Sci, State Key Lab Frozen Soil Engn SKLFSE, Cold & Arid Reg Environm & Engn Res Inst CAREERI, Lanzhou, Peoples R China; [Wen, Xi] NW Univ Nationalities, Coll Elect Engn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Yang, SZ (corresponding author), Chinese Acad Sci, State Key Lab Frozen Soil Engn SKLFSE, Cold & Arid Reg Environm & Engn Res Inst CAREERI, Lanzhou, Peoples R China.	yangsz@lzb.ac.cn		Yang, Sizhong/0000-0001-8417-593X	National Natural Science Foundation of China (NSFC) [20091044]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (NSFC) (Grant No. 20091044) (http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeckersberg F, 1998, ARCH MICROBIOL, V170, P361, DOI 10.1007/s002030050654; Aislabie J, 2001, POLAR BIOL, V24, P308, DOI 10.1007/s003000000210; Al Ming-qiang, 2010, Yingyong Shengtai Xuebao, V21, P1014; [Anonymous], BIOREMEDIATION PETRO; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Chakraborty R, 2004, APPL MICROBIOL BIOT, V64, P437, DOI 10.1007/s00253-003-1526-x; Chen H., 2012, VENNDIAGRAM GENERATE; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Det Norske Veritas (DNV), 2003, RUSS PIP OIL SPILL S; Gerdes B, 2005, FEMS MICROBIOL ECOL, V53, P129, DOI 10.1016/j.femsec.2004.11.010; Gilichinsky David, 2008, P83, DOI 10.1007/978-3-540-74335-4_6; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He ZG, 2003, PETROL SCI TECHNOL, V21, P201, DOI 10.1081/LFT-120016942; Huang LC, 2007, BIOMED ENVIRON SCI, V20, P414; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jin HJ, 2007, PERMAFROST PERIGLAC, V18, P245, DOI 10.1002/ppp.589; Jin HJ, 2010, COLD REG SCI TECHNOL, V64, P213, DOI 10.1016/j.coldregions.2009.12.003; Kolde R., 2013, PHEATMAP PRETTY HEAT; Li G, 2000, WATER RES, V34, P3845, DOI 10.1016/S0043-1354(00)00134-2; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li PJ, 2002, ENVIRON ENG SCI, V19, P277, DOI 10.1089/10928750260418926; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Liu YJ, 2009, ANAEROBE, V15, P214, DOI 10.1016/j.anaerobe.2009.03.007; Lo KV, 1998, ENVIRON TECHNOL, V19, P91, DOI 10.1080/09593331908616659; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Mohn WW, 2001, APPL MICROBIOL BIOT, V57, P242; Niu H.G., 1995, SWAMPS CHINA, P143; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Rike A. G., 2001, Polar Record, V37, P239; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Saul DJ, 2005, FEMS MICROBIOL ECOL, V53, P141, DOI 10.1016/j.femsec.2004.11.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Snape Ian, 2003, Polar Record, V39, P291, DOI 10.1017/S003224740300322X; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spormann AM, 2000, BIODEGRADATION, V11, P85, DOI 10.1023/A:1011122631799; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Tyagi M, 2011, BIODEGRADATION, V22, P231, DOI 10.1007/s10532-010-9394-4; Vishnivetskaya TA, 2006, ASTROBIOLOGY, V6, P400, DOI 10.1089/ast.2006.6.400; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang J, 2007, PETROL SCI, V4, P68, DOI 10.1007/s12182-007-0012-y; Jun W, 2008, WORLD J MICROB BIOT, V24, P1981, DOI 10.1007/s11274-008-9694-6; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/w11-004, 10.1139/W11-004]; Williams Peter A., 2008, P99; XUN LY, 1992, J BACTERIOL, V174, P2898, DOI 10.1128/JB.174.9.2898-2902.1992; Yang SZ, 2010, COLD REG SCI TECHNOL, V64, P271, DOI 10.1016/j.coldregions.2009.11.004; Ye SH, 2006, APPL MICROBIOL BIOT, V71, P543, DOI 10.1007/s00253-005-0165-9; Yu SL, 2011, J ENVIRON SCI, V23, P1533, DOI 10.1016/S1001-0742(10)60585-2; Zhang F, 2010, APPL MICROBIOL BIOT, V88, P1413, DOI 10.1007/s00253-010-2841-7; Zheng CG, 2011, BIORESOURCE TECHNOL, V102, P9155, DOI 10.1016/j.biortech.2011.06.074	52	27	35	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52730	10.1371/journal.pone.0052730	http://dx.doi.org/10.1371/journal.pone.0052730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300754	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800134
J	Li, JC; Li, XD; Li, Y; Yang, H; Wang, LJ; Qin, YR; Liu, HB; Fu, L; Guan, XY				Li, Jiangchao; Li, Xiaodong; Li, Yan; Yang, Hong; Wang, Lijing; Qin, Yanru; Liu, Haibo; Fu, Li; Guan, Xin-Yuan			Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization	PLOS ONE			English	Article							LUNG-CANCER; SIGNAL AMPLIFICATION; EXPRESSION; MICRORNAS; ESTABLISHMENT; SURVIVAL	MicroRNAs (miRNAs) play important roles in the regulation of genes associated with cancer development and progression. By the more deeply characterization of miRNAs' effect in cancer development, it requires a useful tool to investigate expression and distribution of a miRNA in cancer cells and tissues. To fulfill this application demand, we developed a miRNA in situ hybridization (MISH) approach using the 2'-Fluoro modified miRNA probe in combination with enzyme-labeled fluorescence (ELF) signal amplification approach. MISH was used to study expression of miR-375 in esophageal squamous cell carcinoma (ESCC) cell lines and tissues using a tissue microarray (TMA) containing 300 cases. The results showed that our MISH approach is a practical way to detect expression and distribution of a tested miRNA in both cultured cells and archive tissue sections. MISH results also showed that miR-375 was frequently downregulated in ESCCs, which was significantly associated with advanced clinical stage (p = 0.003) tumor metastasis (p = 0.04) and poor outcome (p = 0.04) of ESCC. Moreover, the accuracy of MISH results could be confirmed by QRT-PCR. Our results demonstrated that MISH is a useful and reliable tool to study miRNA expression in solid tumors. Downregulation of miR-375 can be used as a biomarker to predict the outcome of ESCC.	[Li, Jiangchao; Li, Yan; Liu, Haibo; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiangchao; Wang, Lijing] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China; [Li, Xiaodong; Yang, Hong] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Yanru] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China; [Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University; Sun Yat Sen University; Zhengzhou University; University of Hong Kong	Guan, XY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Li, Jiangchao/AAF-4515-2021; /A-3639-2009; Guan, Xin-Yuan/A-3639-2009	Fu, Li/0000-0003-2643-6278; Li, Jiangchao/0000-0002-0947-7580; /0000-0003-1874-9805; Guan, Xin-Yuan/0000-0002-4485-6017	National Natural Science Foundation of China [30971606, 81172338, 81000863]; Sun Yat-Sen University "Hundred Talents Program'' [85000-3171311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University "Hundred Talents Program''	This work was supported by grants from the National Natural Science Foundation of China (30971606 and 81172338), the Sun Yat-Sen University "Hundred Talents Program'' (85000-3171311) and the National Natural Science Foundation of China (81000863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Fu L, 2011, DIS ESOPHAGUS; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu YC, 2000, CANCER GENET CYTOGEN, V118, P112, DOI 10.1016/S0165-4608(99)00193-4; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Li JC, 2012, MOL MED REP, V5, P114, DOI 10.3892/mmr.2011.613; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Paragas VB, 1997, J HISTOCHEM CYTOCHEM, V45, P345, DOI 10.1177/002215549704500302; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999	17	53	57	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53582	10.1371/journal.pone.0053582	http://dx.doi.org/10.1371/journal.pone.0053582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301089	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000068
J	Rueda, A; Fernandez-Velasco, M; Benitah, JP; Gomez, AM				Rueda, Angelica; Fernandez-Velasco, Maria; Benitah, Jean-Pierre; Gomez, Ana Maria			Abnormal Ca2+ Spark/STOC Coupling in Cerebral Artery Smooth Muscle Cells of Obese Type 2 Diabetic Mice	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL MESENTERIC-ARTERIES; RYANODINE RECEPTORS; OXIDATIVE STRESS; DOWN-REGULATION; CALCIUM SPARKS; RETICULUM CA2+; DYSFUNCTION; RELEASE; STROKE	Diabetes is a major risk factor for stroke. However, the molecular mechanisms involved in cerebral artery dysfunction found in the diabetic patients are not completely elucidated. In cerebral artery smooth muscle cells (CASMCs), spontaneous and local increases of intracellular Ca2+ due to the opening of ryanodine receptors (Ca2+ sparks) activate large conductance Ca2+-activated K+ (BK) channels that generate spontaneous transient outward currents (STOCs). STOCs have a key participation in the control of vascular myogenic tone and blood pressure. Our goal was to investigate whether alterations in Ca2+ spark and STOC activities, measured by confocal microscopy and patch-clamp technique, respectively, occur in isolated CASMCs of an experimental model of type-2 diabetes (db/db mouse). We found that mean Ca2+ spark amplitude, duration, size and rate-of-rise were significantly smaller in Fluo-3 loaded db/db compared to control CASMCs, with a subsequent decrease in the total amount of Ca2+ released through Ca2+ sparks in db/db CASMCs, though Ca2+ spark frequency remained. Interestingly, the frequency of large-amplitude Ca2+ sparks was also significantly reduced in db/db cells. In addition, the frequency and amplitude of STOCs were markedly reduced at all voltages tested (from -50 to 0 mV) in db/db CASMCs. The latter correlates with decreased BK channel beta 1/alpha subunit ratio found in db/db vascular tissues. Taken together, Ca2+ spark alterations lead to inappropriate BK channels activation in CASMCs of db/db mice and this condition is aggravated by the decrease in the BK beta 1 subunit/alpha subunit ratio which underlies the significant reduction of Ca2+ spark/STOC coupling in CASMCs of diabetic animals.	[Rueda, Angelica] Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico; [Rueda, Angelica; Fernandez-Velasco, Maria] Univ Montpellier 2, Univ Montpellier 1, U637, INSERM, Montpellier, France; [Fernandez-Velasco, Maria] Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Benitah, Jean-Pierre; Gomez, Ana Maria] Univ Paris 11, INSERM, U769, IFR141, Chatenay Malabry, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Hospital Universitario La Paz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rueda, A (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico.	arueda@cinvestav.mx; ana-maria.gomez@inserm.fr	Gomez, Ana M./B-5376-2013; Rueda, Angelica/G-4055-2012; velasco, maria fernandez/AAO-5062-2021; Benitah, Jean-Pierre/L-6060-2018; Rueda, Angelica/A-1394-2009; Rueda, Angelica/AAW-4621-2020	Gomez, Ana M./0000-0003-0009-2884; Rueda, Angelica/0000-0001-8749-8494; Benitah, Jean-Pierre/0000-0002-9866-9081; Rueda, Angelica/0000-0001-8749-8494	Conacyt [80960]; ICyTDF [331/2010]; Agence National de la Recherche [Geno-09-HyperEpac, Geno-09-Carythm]; Region Ile de France [CODDIM: COD100256]; European Union (CONTICA) [018802]; FRM (Fondation pour la Recherche medicale)	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyTDF; Agence National de la Recherche(French National Research Agency (ANR)); Region Ile de France(Region Ile-de-France); European Union (CONTICA); FRM (Fondation pour la Recherche medicale)(Fondation pour la Recherche Medicale)	This work was funded by Conacyt (No. 80960), ICyTDF No.331/2010), Agence National de la Recherche (Geno-09-HyperEpac and Geno-09-Carythm), Region Ile de France (CODDIM: COD100256), European Union (2005 No018802, CONTICA) and FRM (Fondation pour la Recherche medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Asfandiyarova Nailya, 2006, Diab Vasc Dis Res, V3, P57, DOI 10.3132/dvdr.2006.009; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Bagi Z, 2003, AM J PHYSIOL-HEART C, V285, pH1404, DOI 10.1152/ajpheart.00235.2003; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; Didion SP, 2007, AM J PHYSIOL-HEART C, V292, pH1579, DOI 10.1152/ajpheart.00939.2006; Didion SP, 2005, STROKE, V36, P342, DOI 10.1161/01.STR.0000152952.42730.92; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Erdei N, 2007, AM J PHYSIOL-HEART C, V292, pH649, DOI 10.1152/ajpheart.00596.2006; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Essin K, 2007, J PHYSIOL-LONDON, V584, P205, DOI 10.1113/jphysiol.2007.138982; Gollasch M, 2000, Z KARDIOL, V89, P15; Gollasch M, 1998, CIRC RES, V83, P1104, DOI 10.1161/01.RES.83.11.1104; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Gomez-Viquez L, 2003, BIOPHYS J, V85, P370, DOI 10.1016/S0006-3495(03)74481-6; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Janghorbani M, 2007, DIABETES CARE, V30, P1730, DOI 10.2337/dc06-2363; JORGENSEN HS, 1994, STROKE, V25, P1977, DOI 10.1161/01.STR.25.10.1977; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Liao Y, 2008, DIABETES-METAB RES, V21, P554; Lu T, 2008, BIOPHYS J, V95, P5165, DOI 10.1529/biophysj.108.138339; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; McGahon Mary K, 2007, Channels (Austin), V1, P141; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; Miike T, 2008, N-S ARCH PHARMACOL, V377, P401, DOI 10.1007/s00210-008-0261-3; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Pannirselvam M, 2002, BRIT J PHARMACOL, V136, P255, DOI 10.1038/sj.bjp.0704683; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Piercy V, 1998, PHARMACOLOGY, V56, P267, DOI 10.1159/000028208; Rueda A, 2002, CELL CALCIUM, V31, P161, DOI 10.1054/ceca.2002.0270; Rueda A, 2006, J PHYSIOL-LONDON, V576, P887, DOI 10.1113/jphysiol.2006.113951; Shen JX, 2004, BIOPHYS J, V86, P182, DOI 10.1016/S0006-3495(04)74095-3; Su J, 2008, ARTERIOSCL THROM VAS, V28, P1432, DOI 10.1161/ATVBAHA.108.167205; Tureyen K, 2010, J NEUROCHEM; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Wang Y, 2010, CURR NEUROVASC RES, V7, P75, DOI 10.2174/156720210791184925; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349	48	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53321	10.1371/journal.pone.0053321	http://dx.doi.org/10.1371/journal.pone.0053321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301060	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000049
J	Volz, MS; Suarez-Contreras, V; Mendonca, ME; Pinheiro, FS; Merabet, LB; Fregni, F				Volz, Magdalena Sarah; Suarez-Contreras, Vanessa; Mendonca, Mariana E.; Pinheiro, Fernando Santos; Merabet, Lotfi B.; Fregni, Felipe			Effects of Sensory Behavioral Tasks on Pain Threshold and Cortical Excitability	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; ELECTRICAL NERVE-STIMULATION; PRIMARY SOMATOSENSORY CORTEX; MOTOR CORTEX; NEUROPATHIC PAIN; MACAQUE MONKEY; MEDIAL PAIN; SYSTEM; PLASTICITY	Background/Objective: Transcutaneous electrical stimulation has been proven to modulate nervous system activity, leading to changes in pain perception, via the peripheral sensory system, in a bottom up approach. We tested whether different sensory behavioral tasks induce significant effects in pain processing and whether these changes correlate with cortical plasticity. Methodology/Principal Findings: This randomized parallel designed experiment included forty healthy right-handed males. Three different somatosensory tasks, including learning tasks with and without visual feedback and simple somatosensory input, were tested on pressure pain threshold and motor cortex excitability using transcranial magnetic stimulation (TMS). Sensory tasks induced hand-specific pain modulation effects. They increased pain thresholds of the left hand ( which was the target to the sensory tasks) and decreased them in the right hand. TMS showed that somatosensory input decreased cortical excitability, as indexed by reduced MEP amplitudes and increased SICI. Although somatosensory tasks similarly altered pain thresholds and cortical excitability, there was no significant correlation between these variables and only the visual feedback task showed significant somatosensory learning. Conclusions/Significance: Lack of correlation between cortical excitability and pain thresholds and lack of differential effects across tasks, but significant changes in pain thresholds suggest that analgesic effects of somatosensory tasks are not primarily associated with motor cortical neural mechanisms, thus, suggesting that subcortical neural circuits and/or spinal cord are involved with the observed effects. Identifying the neural mechanisms of somatosensory stimulation on pain may open novel possibilities for combining different targeted therapies for pain control.	[Volz, Magdalena Sarah; Suarez-Contreras, Vanessa; Mendonca, Mariana E.; Pinheiro, Fernando Santos; Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat,Dept Phys Med & Rehabil, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Volz, Magdalena Sarah] Charite Univ Med Berlin, Charite Ctr Neurol Neurosurg & Psychiat, Berlin, Germany; [Merabet, Lotfi B.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Fregni, F (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat,Dept Phys Med & Rehabil, Boston, MA 02115 USA.	fregni.felipe@mgh.harvard.edu	Merabet, Lotfi B./V-2735-2017; merabet, lotfi/AAU-8259-2020	Merabet, Lotfi B./0000-0002-8094-9536; merabet, lotfi/0000-0002-8094-9536; Pruss, Magdalena Sarah/0000-0002-4522-7482; Fregni, Felipe/0000-0001-9359-8643	National Institutes of Health (NIH) grant [R21 DK081773-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081773] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health (NIH) grant (R21 DK081773-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Chesterton LS, 2002, PAIN, V99, P253, DOI 10.1016/S0304-3959(02)00118-5; DARIANSMITH C, 1993, J COMP NEUROL, V335, P200, DOI 10.1002/cne.903350205; DARIANSMITH C, 1993, J COMP NEUROL, V335, P173, DOI 10.1002/cne.903350204; Dietrich C, 2011, NEUROSCI LETT; Dionne JK, 2010, HUM BRAIN MAPP, V31, P14, DOI 10.1002/hbm.20841; Fischer AA, 1987, CLIN J PAIN, V2, P207; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Freitas C, 2011, FRONT AGING NEUROSCI, V3, DOI [10.3389/fnagi.2011.00005, 10.3389/fnagi.2011.00006]; Heed T, 2011, J EXP PSYCHOL HUM PE; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Johnson MI, 2011, EXPERT REV NEUROTHER, V11, P735, DOI [10.1586/ern.11.48, 10.1586/ERN.11.48]; Knudsen L, 2011, J PAIN, V12, P451, DOI 10.1016/j.jpain.2010.10.008; Lane JW, 2010, J NEUROSCI METH, V185, P221, DOI 10.1016/j.jneumeth.2009.09.025; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lefaucheur JP, 2008, CLIN NEUROPHYSIOL, V119, P2179, DOI 10.1016/j.clinph.2008.07.007; Lefaucheur JP, 2008, BRAIN STIMUL, V1, P337, DOI 10.1016/j.brs.2008.07.003; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Mulvey MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007264.pub2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reed JL, 2011, J NEUROSCI, V31, P3589, DOI 10.1523/JNEUROSCI.4310-10.2011; REEVES JL, 1986, PAIN, V24, P313, DOI 10.1016/0304-3959(86)90117-X; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sewards TV, 2002, BRAIN RES BULL, V58, P243, DOI 10.1016/S0361-9230(02)00783-9; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; van Vliet PM, 2006, MANUAL THER, V11, P208, DOI 10.1016/j.math.2006.03.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Volz MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034273; Wang L, 2006, CLIN NEUROPHYSIOL, V117, P1075, DOI 10.1016/j.clinph.2006.01.007; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14	42	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52968	10.1371/journal.pone.0052968	http://dx.doi.org/10.1371/journal.pone.0052968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301010	gold, Green Submitted, Green Published			2022-12-27	WOS:000313480000022
J	Dukic, VM; Lauderdale, DS; Wilder, J; Daum, RS; David, MZ				Dukic, Vanja M.; Lauderdale, Diane S.; Wilder, Jocelyn; Daum, Robert S.; David, Michael Z.			Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; CHANGING EPIDEMIOLOGY; SKIN; TRENDS; EMERGENCE; SYSTEM	Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methicillin-resistant strains of S. aureus (MRSA) that emerged in the 1960s presented a relatively limited public health threat until the 1990s, when novel community-associated (CA-) MRSA strains began circulating. CA-MRSA infections are now common, resulting in serious and sometimes fatal infections in otherwise healthy people. Although some have suggested that there is an epidemic of CA-MRSA in the U.S., the origins, extent, and geographic variability of CA-MRSA infections are not known. We present a meta-analysis of published studies that included trend data from a single site or region, and derive summary epidemic curves of CA-MRSA spread over time. Our analysis reveals a dramatic increase in infections over the past two decades, with CA-MRSA strains now endemic at unprecedented levels in many US regions. This increase has not been geographically homogeneous, and appears to have occurred earlier in children than adults.	[Dukic, Vanja M.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Lauderdale, Diane S.; Wilder, Jocelyn; David, Michael Z.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Daum, Robert S.; David, Michael Z.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [David, Michael Z.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Colorado System; University of Colorado Boulder; University of Chicago; University of Chicago; University of Chicago	David, MZ (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	mdavid@medicine.bsd.uchicago.edu	Dukic, Vanja/AAI-1494-2020; David, Michael Z./X-6737-2019	Dukic, Vanja/0000-0002-0348-0834; David, Michael Z./0000-0002-1926-7800	NIH - National Institute of General Medical Sciences grant [U01GM087729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087729] Funding Source: NIH RePORTER	NIH - National Institute of General Medical Sciences grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the NIH - National Institute of General Medical Sciences grant U01GM087729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton N.F., 2003, ESSENTIAL MATH BIOL; Buckingham SC, 2004, PEDIATR INFECT DIS J, V23, P619, DOI 10.1097/01.inf.0000131981.67342.c4; Casey JA, 2012, EPIDEMIOL I IN PRESS; Chen AE, 2006, PEDIATR EMERG CARE, V22, P717, DOI 10.1097/01.pec.0000236832.23947.a0; Clancy MJ, 2005, SOUTH MED J, V98, P1069, DOI 10.1097/01.smj.0000184800.83171.f7; Como-Sabetti K, 2009, PUBLIC HEALTH REP, V124, P427, DOI 10.1177/003335490912400312; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Fergie J, 2008, PEDIATR INFECT DIS J, V27, P67, DOI 10.1097/INF.0b013e31816087a7; Fergie JE, 2001, PEDIATR INFECT DIS J, V20, P860, DOI 10.1097/00006454-200109000-00007; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hota B, 2007, ARCH INTERN MED, V167, P1026, DOI 10.1001/archinte.167.10.1026; Hussain FM, 2000, PEDIATR INFECT DIS J, V19, P1163, DOI 10.1097/00006454-200012000-00009; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Jungk J, 2007, PEDIATR INFECT DIS J, V26, P339, DOI 10.1097/01.inf.0000257452.58182.e1; Kairam N, 2011, J EMERG MED, V41, P460, DOI 10.1016/j.jemermed.2009.05.015; Kallen AJ, 2000, INFECT CONT HOSP EP, V21, P223, DOI 10.1086/501750; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kennedy LA, 2010, INFECT CONT HOSP EP, V31, P983, DOI 10.1086/655837; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McMullen KM, 2009, AM J INFECT CONTROL, V37, P454, DOI 10.1016/j.ajic.2008.09.015; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Ray GT, 2012, J CLIN MICROBIOL, V50, P1950, DOI 10.1128/JCM.00134-12; Rossini CJ, 2011, J PEDIATR SURG, V46, P1089, DOI 10.1016/j.jpedsurg.2011.03.036; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Schramm GE, 2007, INFECT CONT HOSP EP, V28, P95, DOI 10.1086/509856; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Szczesiul JM, 2007, PEDIATR INFECT DIS J, V26, P852, DOI 10.1097/INF.0b013e318124aa5c; Tracy LA, 2011, EMERG INFECT DIS, V17, P441, DOI 10.3201/eid1703.100502; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877	38	92	97	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52722	10.1371/journal.pone.0052722	http://dx.doi.org/10.1371/journal.pone.0052722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300988	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900036
J	Lu, YN; Bhushan, S; Tchatalbachev, S; Marconi, M; Bergmann, M; Weidner, W; Chakraborty, T; Meinhardt, A				Lu, Yongning; Bhushan, Sudhanshu; Tchatalbachev, Svetlin; Marconi, Marcelo; Bergmann, Martin; Weidner, Wolfgang; Chakraborty, Trinad; Meinhardt, Andreas			Necrosis Is the Dominant Cell Death Pathway in Uropathogenic Escherichia coli Elicited Epididymo-Orchitis and Is Responsible for Damage of Rat Testis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; TOLL-LIKE RECEPTORS; REPRODUCTIVE-TRACT; MALE-INFERTILITY; MALE-FERTILITY; INFLAMMATION; HMGB1; APOPTOSIS; MEN; ACTIVATION	Male infertility is a frequent medical condition, compromising approximately one in twenty men, with infections of the reproductive tract constituting a major etiological factor. Bacterial epididymo-orchitis results in acute inflammation most often caused by ascending canalicular infections from the urethra via the continuous male excurrent ductal system. Uropathogenic Escherichia coli (UPEC) represent a relevant pathogen in urogenital tract infections. To explore how bacteria can cause damage and cell loss and thus impair fertility, an in vivo epididymo-orchitis model was employed in rats by injecting UPEC strain CFT073 into the vas deference in close proximity to the epididymis. Seven days post infection bacteria were found predominantly in the testicular interstitial space. UPEC infection resulted in severe impairment of spermatogenesis by germ cell loss, damage of testicular somatic cells, a decrease in sperm numbers and a significant increase in TUNEL (+) cells. Activation of caspase-8 (extrinsic apoptotic pathway), caspase-3/-6 (intrinsic apoptotic pathway), caspase-1 (pyroptosis pathway) and the presence of 180 bp DNA fragments, all of which serve as indicators of the classical apoptotic pathway, were not observed in infected testis. Notably, electron microscopical examination revealed degenerative features of Sertoli cells (SC) in UPEC infected testis. Furthermore, the passive release of high mobility group protein B1 (HMGB1), as an indication of necrosis, was observed in vivo in infected testis. Thus, necrosis appears to be the dominant cell death pathway in UPEC infected testis. Substantial necrotic changes seen in Sertoli cells will contribute to impaired spermatogenesis by loss of function in supporting the dependent germ cells.	[Lu, Yongning; Bhushan, Sudhanshu; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35390 Giessen, Germany; [Tchatalbachev, Svetlin; Chakraborty, Trinad] Univ Giessen, Dept Med Microbiol, D-35390 Giessen, Germany; [Marconi, Marcelo; Weidner, Wolfgang] Univ Giessen, Clin & Policlin Urol Pediat Urol & Androl, D-35390 Giessen, Germany; [Bergmann, Martin] Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35390 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	chakraborty, trinad/D-1812-2014		Deutsche Forschungsgemeinschaft [KFO 181/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 181/2) to AM and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bryniarski K, 2004, AM J REPROD IMMUNOL, V52, P27, DOI 10.1111/j.1600-0897.2004.00178.x; CHAPIN RE, 1983, EXP MOL PATHOL, V38, P149, DOI 10.1016/0014-4800(83)90082-5; Chassin C, 2008, J AM SOC NEPHROL, V19, P2364, DOI 10.1681/ASN.2007121273; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen M, 2004, J INFECT DIS, V190, P127, DOI 10.1086/421243; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Girling JE, 2007, IMMUNOL CELL BIOL, V85, P481, DOI 10.1038/sj.icb.7100086; Hedger MP, 2011, J REPROD IMMUNOL, V88, P130, DOI 10.1016/j.jri.2011.01.010; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Huyghe S, 2006, ENDOCRINOLOGY, V147, P2228, DOI 10.1210/en.2005-1571; Johnson JR, 2005, CLIN INFECT DIS, V40, P813, DOI 10.1086/428048; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Krieger JN, 2011, UROLOGY, V77, P1420, DOI 10.1016/j.urology.2010.12.059; Lamkanfi M, CELL HOST MICROBE, V8, P44; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Lipsky BA, 1999, AM J MED, V106, P327, DOI 10.1016/S0002-9343(99)00017-0; Ludwig M, 2002, BJU INT, V90, P933, DOI 10.1046/j.1464-410X.2002.03029.x; MERINO G, 1995, ARCH ANDROLOGY, V35, P43, DOI 10.3109/01485019508987852; Metukuri MR, 2010, INFLAMMATION, V33, P235, DOI 10.1007/s10753-009-9177-4; Nieschlag E, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P1, DOI 10.1007/978-3-540-78355-8; Palladino MA, 2007, BIOL REPROD, V76, P958, DOI 10.1095/biolreprod.106.059410; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perry SW, 1997, BIOTECHNIQUES, V22, P1102, DOI 10.2144/97226st01; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; Schuppe HC, 2008, BIOL MALE GERM CELLS; Wu C-X, 2011, J SURG RES; Wu CX, 2012, J SURG RES, V175, P88, DOI 10.1016/j.jss.2011.02.026; Zetterstrom CK, 2006, HUM REPROD, V21, P2801, DOI 10.1093/humrep/del256	38	40	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52919	10.1371/journal.pone.0052919	http://dx.doi.org/10.1371/journal.pone.0052919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301002	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900045
J	Martinez-Argudo, I; Veenendaal, AKJ; Liu, X; Roehrich, AD; Ronessen, MC; Franzoni, G; van Rietschoten, KN; Morimoto, YV; Saijo-Hamano, Y; Avison, MB; Studholme, DJ; Namba, K; Minamino, T; Blocker, AJ				Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Morimoto, Yusuke V.; Saijo-Hamano, Yumiko; Avison, Matthew B.; Studholme, David J.; Namba, Keiichi; Minamino, Tohru; Blocker, Ariel J.			Isolation of Salmonella Mutants Resistant to the Inhibitory Effect of Salicylidene acylhydrazides on Flagella-Mediated Motility	PLOS ONE			English	Article							III SECRETION SYSTEM; SMALL-MOLECULE INHIBITORS; TERMINAL CYTOPLASMIC DOMAIN; PROTEIN EXPORT APPARATUS; VIRULENCE FACTORS; ESCHERICHIA-COLI; BACTERIAL VIRULENCE; GENETIC-ANALYSIS; ATP SYNTHASE; FLII	Salicylidene acylhydrazides identified as inhibitors of virulence-mediating type III secretion systems (T3SSs) potentially target their inner membrane export apparatus. They also lead to inhibition of flagellar T3SS-mediated swimming motility in Salmonella enterica serovar. Typhimurium. We show that INP0404 and INP0405 act by reducing the number of flagella/cell. These molecules still inhibit motility of a Salmonella Delta fliH-fliI-fliJ/flhB((P28T)) strain, which lacks three soluble components of the flagellar T3S apparatus, suggesting that they are not the target of this drug family. We implemented a genetic screen to search for the inhibitors' molecular target(s) using motility assays in the Delta fliH-fliI/flhB((P28T)) background. Both mutants identified were more motile than the background strain in the absence of the drugs, although HM18 was considerably more so. HM18 was more motile than its parent strain in the presence of both drugs while DI15 was only insensitive to INP0405. HM18 was hypermotile due to hyperflagellation, whereas DI15 was not hyperflagellated. HM18 was also resistant to a growth defect induced by high concentrations of the drugs. Whole-genome resequencing of HM18 indicated two alterations within protein coding regions, including one within atpB, which encodes the inner membrane a-subunit of the FOF1-ATP synthase. Reverse genetics indicated that the alteration in atpB was responsible for all of HM18' s phenotypes. Genome sequencing of DI15 uncovered a single A562P mutation within a gene encoding the flagellar inner membrane protein FlhA, the direct role of which in mediating drug insensitivity could not be confirmed. We discuss the implications of these findings in terms of T3SS export apparatus function and drug target identification.	[Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Avison, Matthew B.; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Avison, Matthew B.; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Veenendaal, Andreas K. J.; Blocker, Ariel J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Morimoto, Yusuke V.; Saijo-Hamano, Yumiko; Namba, Keiichi; Minamino, Tohru] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Studholme, David J.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Minamino, Tohru] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	University of Bristol; University of Bristol; University of Oxford; Osaka University; University of Exeter; Japan Science & Technology Agency (JST)	Blocker, AJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	ariel.blocker@bristol.ac.uk	Morimoto, Yusuke V./M-4022-2015; Blocker, Ariel/Q-6617-2016; Studholme, David/H-6790-2019; Namba, Keiichi/A-9406-2016; Martinez, Isabel/R-4803-2019; Franzoni, Giulia/AAY-1088-2020	Morimoto, Yusuke V./0000-0003-1573-8967; Studholme, David/0000-0002-3010-6637; Martinez, Isabel/0000-0001-5067-1791; Franzoni, Giulia/0000-0003-0987-3863; Avison, Matthew/0000-0003-1454-8440	Wellcome Trust [088266, 088231]; E.C. Marie Curie postdoctoral fellowship [MEIF-CT-2005-023694]; EMBO short-term fellowship [244-2007]; University of Bristol Centenary Postgraduate Studentship; MRC [G0701243, MR-J002097-1]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22570161, 23121516, 21227006]; Takeda Science Foundation; MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [G0701243, MR/J002097/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); E.C. Marie Curie postdoctoral fellowship; EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); University of Bristol Centenary Postgraduate Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	IMA and XL were supported by Wellcome Trust Project Grant 088266 to IMA and AJB. AKJV was funded by an E.C. Marie Curie postdoctoral fellowship (MEIF-CT-2005-023694) and an EMBO short-term fellowship (244-2007). XL was supported additionally by Wellcome Trust Project Grant 088231 to AJB and KN. DR was supported by a University of Bristol Centenary Postgraduate Studentship. This work was also supported in part by MRC project grants G0701243 and MR-J002097-1 to AJB and AJB and KN, respectively, and by Grants-in-Aid for Scientific Research (22570161 and 23121516 to TM, and 21227006 to KN) and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Takeda Science Foundation (to TM). YVM is a Research Fellow of the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Erhardt M, 2010, MOL MICROBIOL, V75, P376, DOI 10.1111/j.1365-2958.2009.06973.x; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Grier MC, 2010, BIOORG MED CHEM LETT, V20, P3380, DOI 10.1016/j.bmcl.2010.04.014; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Iwatsuki M, 2008, J ANTIBIOT, V61, P230, DOI 10.1038/ja.2008.33; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Kimura K, 2011, J ANTIBIOT, V64, P197, DOI 10.1038/ja.2010.155; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; KUTSUKAKE K, 1985, MOL GEN GENET, V199, P406, DOI 10.1007/BF00330750; Layton AN, 2010, FEMS MICROBIOL LETT, V302, P114, DOI 10.1111/j.1574-6968.2009.01847.x; Le Gall S, 2009, VET MICROBIOL, V137, P306, DOI 10.1016/j.vetmic.2009.01.023; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linington RG, 2006, J NAT PROD, V69, P173, DOI 10.1021/np050192h; Linington RG, 2002, ORG LETT, V4, P4089, DOI 10.1021/ol0268337; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Noda S, 2006, J BACTERIOL, V188, P6869, DOI 10.1128/JB.00452-06; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pan N, 2007, ADV EXP MED BIOL, V603, P367; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Wang D, 2011, J BIOL CHEM; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	69	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52179	10.1371/journal.pone.0052179	http://dx.doi.org/10.1371/journal.pone.0052179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300965	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900021
J	Schaefer, M; Konczak, F; Heinze, HJ; Rotte, M				Schaefer, Michael; Konczak, Franziska; Heinze, Hans-Jochen; Rotte, Michael			Referral of Touch and Ownership between the Hands and the Role of the Somatosensory Cortices	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; CORTEX; REPRESENTATION; REORGANIZATION; ACTIVATION; SENSATIONS; ILLUSION	Recent studies have shown that the feeling of body ownership can be fooled by simple visuo-tactile manipulations. Perceptual illusions have been reported in which participants sense phantom touch seen on a rubber hand (rubber hand illusion). While previous studies used homologous limbs for those experiments, we here examined an illusion where people feel phantom touch on a left rubber hand when they see it brushed simultaneously with brushes applied to their right hand. Thus, we investigated a referral of touch from the right to the left hand (across the body midline). Since it is known from animal studies that tactile illusions may alter early sensory processing, we expected a modulation of the primary somatosensory cortex (SI) corresponding to this illusion. Neuromagnetic source imaging of the functional topographic organization in SI showed a shift in left SI, associated with the strength of the referral of touch. Hence, we argue that SI seems to be closely associated with this perceptual illusion. The results suggest that the transfer of tactile information across the body midline could be mediated by neurons with bilateral tactile receptive fields (most likely BA2).	[Schaefer, Michael; Konczak, Franziska; Heinze, Hans-Jochen; Rotte, Michael] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany	Otto von Guericke University	Schaefer, M (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.	mischa@neuro2.med.uni-magdeburg.de			Deutsche Forschungsgemeinschaft [Scha105/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MS was supported by the Deutsche Forschungsgemeinschaft (Scha105/4-1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Braun C, 2002, NEUROIMAGE, V17, P1451, DOI 10.1006/nimg.2002.1277; Braun C, 2000, J NEUROSCI, V20, P446, DOI 10.1523/JNEUROSCI.20-01-00446.2000; Braun C, 2001, BRAIN, V124, P2259, DOI 10.1093/brain/124.11.2259; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Ebisch SJ, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI DOI 10.1162/J0CN.2008.20111; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Flor H, 2000, NEUROREPORT, V11, P1407, DOI 10.1097/00001756-200005150-00011; GALLEN CC, 1994, ELECTROEN CLIN NEURO, V90, P145, DOI 10.1016/0013-4694(94)90006-X; Grusser SM, 2004, EXP BRAIN RES, V154, P97, DOI 10.1007/s00221-003-1649-4; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Schaefer M, 2006, NEUROIMAGE, V29, P67, DOI 10.1016/j.neuroimage.2005.07.001; Schaefer M, 2004, BRAIN TOPOGR, V17, P47, DOI 10.1023/B:BRAT.0000047336.15770.86; Tastevin J, 1937, ENCEPHALE, V1, P57; YUMIYA H, 1984, EXP BRAIN RES, V53, P259	30	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52768	10.1371/journal.pone.0052768	http://dx.doi.org/10.1371/journal.pone.0052768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300992	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900039
J	Bin, Y; Ye, WH; Muller-Landau, HC; Wu, LF; Lian, JY; Cao, HL				Bin, Yue; Ye, Wanhui; Muller-Landau, Helene C.; Wu, Linfang; Lian, Juyu; Cao, Honglin			Unimodal Tree Size Distributions Possibly Result from Relatively Strong Conservatism in Intermediate Size Classes	PLOS ONE			English	Article							RAIN-FOREST TREES; SUBTROPICAL FOREST; METABOLIC ECOLOGY; TROPICAL FORESTS; POPULATION-LEVEL; SHADE TOLERANCE; GROWTH; MORTALITY; COMMUNITY; PLOT	Tree size distributions have long been of interest to ecologists and foresters because they reflect fundamental demographic processes. Previous studies have assumed that size distributions are often associated with population trends or with the degree of shade tolerance. We tested these associations for 31 tree species in a 20 ha plot in a Dinghushan south subtropical forest in China. These species varied widely in growth form and shade-tolerance. We used 2005 and 2010 census data from that plot. We found that 23 species had reversed J shaped size distributions, and eight species had unimodal size distributions in 2005. On average, modal species had lower recruitment rates than reversed J species, while showing no significant difference in mortality rates, per capita population growth rates or shade-tolerance. We compared the observed size distributions with the equilibrium distributions projected from observed size-dependent growth and mortality. We found that observed distributions generally had the same shape as predicted equilibrium distributions in both unimodal and reversed J species, but there were statistically significant, important quantitative differences between observed and projected equilibrium size distributions in most species, suggesting that these populations are not at equilibrium and that this forest is changing over time. Almost all modal species had U-shaped size-dependent mortality and/or growth functions, with turning points of both mortality and growth at intermediate size classes close to the peak in the size distribution. These results show that modal size distributions do not necessarily indicate either population decline or shade-intolerance. Instead, the modal species in our study were characterized by a life history strategy of relatively strong conservatism in an intermediate size class, leading to very low growth and mortality in that size class, and thus to a peak in the size distribution at intermediate sizes.	[Bin, Yue; Ye, Wanhui; Wu, Linfang; Lian, Juyu; Cao, Honglin] Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Muller-Landau, Helene C.] Smithsonian Trop Res Inst, Panama City, Panama	Chinese Academy of Sciences; South China Botanical Garden, CAS; Smithsonian Institution; Smithsonian Tropical Research Institute	Lian, JY (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	lianjy@scbg.ac.cn		Muller-Landau, Helene C./0000-0002-3526-9021	Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-EW-Z]; National Natural Science Foundation of China [31100312, 31011120470]; Chinese Forest Biodiversity Monitoring Network; US National Science Foundation [DEB-1046113]; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Forest Biodiversity Monitoring Network; US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-EW-Z), the National Natural Science Foundation of China (31100312) and Chinese Forest Biodiversity Monitoring Network. This manuscript is a product of the 2011 analytical workshop of the Center for Tropical Forest Science (CTFS) in Changbaishan, China, jointly funded by the US National Science Foundation (DEB-1046113) and the National Natural Science Foundation of China (31011120470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Y, 2012, EUR J FOREST RES, V131, P453, DOI 10.1007/s10342-011-0519-z; Caswell, 2000, MATRIX POPULATION MO; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; CONDIT R, 1993, FOREST ECOL MANAG, V62, P123, DOI 10.1016/0378-1127(93)90046-P; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Deb P, 2008, FOREST ECOL MANAG, V255, P3995, DOI 10.1016/j.foreco.2008.03.046; Doak DF, 1999, ECOLOGY, V80, P1537, DOI 10.2307/176545; Franklin J, 2003, NEW ZEAL J BOT, V41, P669, DOI 10.1080/0028825X.2003.9512877; George AK, 2005, RIVER RES APPL, V21, P271, DOI 10.1002/rra.846; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kohira M, 2003, FOREST ECOL MANAG, V174, P423, DOI 10.1016/S0378-1127(02)00076-2; KOHYAMA T, 1992, FUNCT ECOL, V6, P206, DOI 10.2307/2389756; KOHYAMA T, 1991, ANN BOT-LONDON, V68, P173, DOI 10.1093/oxfordjournals.aob.a088236; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; KOHYAMA T, 1994, J PLANT RES, V107, P107, DOI 10.1007/BF02344537; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; LEAK WB, 1975, ECOLOGY, V56, P1451, DOI 10.2307/1934714; Lin J, 2001, CAN J FOREST RES, V31, P345, DOI 10.1139/cjfr-31-2-345; McCarthy JW, 2006, SILVA FENN, V40, P209, DOI 10.14214/sf.339; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; North M, 2004, FOREST SCI, V50, P299; Peng S., 1998, ACTA PHYTOECOLOGICA, V22, P245; Poorter L, 1996, FOREST ECOL MANAG, V84, P61, DOI 10.1016/0378-1127(96)03736-X; Primack RB., 1995, PRIMER CONSERVATION; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; Wei P., 1998, CHINESE BIODIVERSITY, V6, P116; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005	38	23	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52596	10.1371/journal.pone.0052596	http://dx.doi.org/10.1371/journal.pone.0052596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300714	Green Published, gold			2022-12-27	WOS:000313872600020
J	Braun, N; Alscher, MD; Fritz, P; Latus, J; Edenhofer, I; Reimold, F; Alper, SL; Kimmel, M; Biegger, D; Lindenmeyer, M; Cohen, CD; Wuthrich, RP; Segerer, S				Braun, Niko; Alscher, M. Dominik; Fritz, Peter; Latus, Joerg; Edenhofer, Ilka; Reimold, Fabian; Alper, Seth L.; Kimmel, Martin; Biegger, Dagmar; Lindenmeyer, Maja; Cohen, Clemens D.; Wuethrich, Rudolf P.; Segerer, Stephan			The Spectrum of Podoplanin Expression in Encapsulating Peritoneal Sclerosis	PLOS ONE			English	Article							CELLS; INFLAMMATION	Encapsulating peritoneal sclerosis (EPS) is a life threatening complication of peritoneal dialysis (PD). Podoplanin is a glycoprotein expressed by mesothelial cells, lymphatic endothelial cells, and myofibroblasts in peritoneal biopsies from patients with EPS. To evaluate podoplanin as a marker of EPS we measured podoplanin mRNA and described the morphological patterns of podoplanin-positive cells in EPS. Included were 20 peritoneal biopsies from patients with the diagnosis of EPS (n = 5), patients on PD without signs of EPS (n = 5), and control patients (uremic patients not on PD, n = 5, non-uremic patients n = 5). EPS patient biopsies revealed significantly elevated levels of podoplanin mRNA (p < 0.05). In 24 peritoneal biopsies from patients with EPS, podoplanin and smooth muscle actin (SMA) were localized by immunohistochemistry. Four patterns of podoplanin distribution were distinguishable. The most common pattern (8 of 24) consisted of organized, longitudinal layers of podoplanin-positive cells and vessels in the fibrotic zone ("organized'' pattern). 7 of 24 biopsies demonstrated a diffuse distribution of podoplanin-positive cells, accompanied by occasional, dense clusters of podoplanin-positive cells. Five biopsies exhibited a mixed pattern, with some diffuse areas and some organized areas ("mixed"). These contained cuboidal podoplanin-positive cells within SMA-negative epithelial structures embedded in extracellular matrix. Less frequently observed was the complete absence of, or only focal accumulations of podoplanin-positive fibroblasts outside of lymphatic vessels (podoplanin "low'', 4 of 24 biopsies). Patients in this group exhibited a lower index of systemic inflammation and a longer symptomatic period than in EPS patients with biopsies of the "mixed" type (p < 0.05). In summary we confirm the increased expression of podoplanin in EPS, and distinguish EPS biopsies according to different podoplanin expression patterns which are associated with clinical parameters. Podoplanin might serve as a useful adjunct to the morphological workup of peritoneal biopsies.	[Braun, Niko; Alscher, M. Dominik; Latus, Joerg; Reimold, Fabian; Kimmel, Martin] Robert Bosch Krankenhaus, Dept Internal Med, Div Gen Internal Med & Nephrol, Stuttgart, Germany; [Alscher, M. Dominik; Fritz, Peter] Inst Digital Med, Stuttgart, Germany; [Fritz, Peter] Robert Bosch Krankenhaus, Div Pathol, Dept Diagnost Med, Stuttgart, Germany; [Edenhofer, Ilka; Lindenmeyer, Maja; Cohen, Clemens D.; Wuethrich, Rudolf P.; Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Edenhofer, Ilka; Segerer, Stephan] Univ Zurich, Inst Anat, Zurich, Switzerland; [Reimold, Fabian; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Nephrol,Dept Med, Boston, MA 02215 USA; [Biegger, Dagmar] Univ Tubingen, Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Lindenmeyer, Maja; Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich, Switzerland	Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus; University of Zurich; University Zurich Hospital; University of Zurich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eberhard Karls University of Tubingen; University of Zurich	Segerer, S (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	Stephan.segerer@usz.ch	Kimmel, Martin/AAM-2514-2021	Segerer, Stephan/0000-0002-1936-9719; Latus, Joerg/0000-0003-0584-4870; Alscher, Mark Dominik/0000-0002-9658-1211; Lindenmeyer, Maja/0000-0003-4162-9107	Baxter; Swiss National Science Foundation [SNF 32003B_129710]; Robert-Bosch Foundation; SNF [32-122439/1]; Harvard Digestive Diseases Center [DK34854]	Baxter; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Robert-Bosch Foundation; SNF; Harvard Digestive Diseases Center	SS is supported by a grant by Baxter and a grant by the Swiss National Science Foundation (SNF 32003B_129710); NB by the Robert-Bosch Foundation and a grant by Baxter, FR by the Robert-Bosch Foundation; CDC by SNF (32-122439/1); SLA by the Harvard Digestive Diseases Center (DK34854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher DM, 2007, AM J KIDNEY DIS, V49, P452, DOI 10.1053/j.ajkd.2006.11.040; Augustine T, 2009, NEPHRON CLIN PRACT, V111, pC149, DOI 10.1159/000191214; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown MC, 2009, CLIN J AM SOC NEPHRO; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Garosi G, 2001, J NEPHROL, V14, pS30; Heller F, 2007, AM J PATHOL, V170, P457, DOI 10.2353/ajpath.2007.060554; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Hou TZ, 2010, FEBS LETT, V584, P3955, DOI 10.1016/j.febslet.2010.07.053; Kalof AN, 2009, ADV ANAT PATHOL, V16, P62, DOI 10.1097/PAP.0b013e3181915e94; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Raica M, 2008, ANTICANCER RES, V28, P2997; Vlijm A, 2009, PERITON DIALYSIS INT, V29, P517; Yaginuma T, 2012, PERIT DIAL INT	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53382	10.1371/journal.pone.0053382	http://dx.doi.org/10.1371/journal.pone.0053382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300922	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000313872600093
J	Dai, LB; Zhou, SH; Ruan, LX; Zheng, ZJ				Dai, Li-Bo; Zhou, Shui-Hong; Ruan, Ling-Xiang; Zheng, Zhou-Jun			Correlation of Computed Tomography with Pathological Features in Angiomatous Nasal Polyps	PLOS ONE			English	Article							ANGIOFIBROMA; VARIANT; MRI; CT	Background: Angiomatous nasal polyps (ANPs), also known as angiectatic polyps, have rarely been reported in the literature. ANPs are characterized by extensive vascular proliferation and ectasia. ANPs can grow rapidly and exhibit aggressive clinical behavior that could simulate malignancy preoperatively, and they are easily confused with other diseases. In the present study, we analyzed the correlation between the computed tomography (CT) findings of nasal angiomatous polyps and their pathological features. Methods: We evaluated CT findings and pathological features of 31 surgically proven ANPs. Results: The study population included 16 males and 15 females aged between 27 and 81 years (mean age, 53.5 years). On CT, the masses were heterogeneous; they had a soft tissue density and filled the maxillary and/or nasal cavities. Calcifications were found in 2 of the 31 cases. The lesions showed a clear boundary (15/31). The low-density shading on CT was related to the inflammatory, necrotic, and cystic changes, and the high-density shading on CT was related to hemorrhagic areas of the mass. On contrast-enhanced CT, the center of the lesions was non-enhanced with peripheral intensification due to occlusion or compression of feeder vessels of the polyp center, and the inflammatory cells and neovascularization around the edge of the mass. The most common site of maxillary wall erosion was the medial wall (21/31), followed by the posterior lateral wall (3/31), upper wall (2/31), and septum (3/31). Of these, the nasal cavity and/or maxillary sinus were enlarged in 28 cases. These findings were associated with the chronic progress of nasal angiomatous changes. Conclusions: CT of ANPs may demonstrate benign bone changes associated with the lesions and may also reflect the fact that ANPs do not invade peripheral soft tissue. CT demonstrated these lesions consistently and provided information useful for surgical planning.	[Dai, Li-Bo; Zhou, Shui-Hong] Zhejiang Univ, Dept Otolaryngol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ruan, Ling-Xiang] Zhejiang Univ, Dept Radiol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Zhou-Jun] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, SH (corresponding author), Zhejiang Univ, Dept Otolaryngol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zhouyunzhoush@163.com						BATSAKIS JG, 1992, ANN OTO RHINOL LARYN, V101, P623, DOI 10.1177/000348949210100716; Ceylan A, 2007, B-ENT, V3, P145; De Vuysere S, 2001, EUR RADIOL, V11, P55, DOI 10.1007/s003300000565; Iwata N, 2002, AURIS NASUS LARYNX, V29, P335, DOI 10.1016/S0385-8146(02)00028-7; Lee DK, 2007, AM J NEURORADIOL, V28, P618; Lloyd G, 2000, J LARYNGOL OTOL, V114, P727; Mafee MF, 2006, CLIN REV ALLERG IMMU, V30, P165, DOI 10.1385/CRIAI:30:3:165; Onerci M, 2006, RHINOLOGY, V44, P39; Rudralingam M, 2002, BRIT J ORAL MAX SURG, V40, P504, DOI 10.1016/S0266-4356(02)00225-5; Ryan WR, 2011, LARYNGOSCOPE, V121, P674, DOI 10.1002/lary.21394; Sheahan P, 2005, EUR ARCH OTO-RHINO-L, V262, P225, DOI 10.1007/s00405-004-0779-z; SOM PM, 1982, RADIOLOGY, V144, P329, DOI 10.1148/radiology.144.2.6283593; Wang YZ, 2012, AM J NEURORADIOL, V33, P767, DOI 10.3174/ajnr.A2856; Yfantis HG, 2000, ARCH PATHOL LAB MED, V124, P406	14	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53306	10.1371/journal.pone.0053306	http://dx.doi.org/10.1371/journal.pone.0053306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300910	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600082
J	Evans, J; Hannan, NJ; Hincks, C; Rombauts, LJF; Salamonsen, LA				Evans, Jemma; Hannan, Natalie J.; Hincks, Cassandra; Rombauts, Luk J. F.; Salamonsen, Lois A.			Defective Soil for a Fertile Seed? Altered Endometrial Development Is Detrimental to Pregnancy Success	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; IN-VITRO FERTILIZATION; LOW-INTENSITY IVF; HUMAN CHORIONIC-GONADOTROPIN; OVARIAN STIMULATION; EMBRYO IMPLANTATION; OOCYTE RETRIEVAL; LUTEAL-PHASE; REPRODUCTIVE-BIOLOGY; PROGESTERONE RISE	Background: Synchronous development of the endometrium (to achieve a receptive state) and of the embryo is essential for successful implantation and ongoing pregnancy. Endometrial receptivity exists only for a finite time in a menstrual cycle and the endometrium is refractory to embryo implantation outside of this window. Administration of hormones to stimulate multifollicular development within the ovary, integral to the majority of assisted reproduction (ART) protocols, dramatically alters the hormonal milieu to which the endometrium is exposed versus normal menstrual cycles. Endometrial maturation may be profoundly affected by this altered endocrine environment. Aim: Compare endometrial histology in fertile women, fertile women undergoing hormonal stimulation for oocyte donation and infertile women undergoing fresh embryo transfers in an ART cycle with further comparisons between women who did or did not become pregnant. Examine the presence of leukocytes and markers of endometrial maturation. Methods: Endometrial histology was examined by hematoxylin and eosin staining with a semi quantitative scoring method developed to compare histological appearance of tissues. The presence of leukocytes and developmental markers was examined by immunohistochemistry and scored. Results: Endometrial histology was dramatically altered upon stimulation for ART. However, those women who became pregnant presented with significantly less alterations in histological endometrial maturation. Numbers and activation status of leukocyte populations were also altered within the endometria stimulated for ART, with neutrophils undergoing degranulation, usually observed only pre-menstrually. Conclusion: We propose that such developmental changes render the endometrium hostile to the embryo and that modifications to ART protocols should be considered to take account of the requirement for endometrial receptivity and hence increase pregnancy rates.	[Evans, Jemma; Hannan, Natalie J.; Hincks, Cassandra; Salamonsen, Lois A.] Univ Melbourne, Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Hannan, Natalie J.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Rombauts, Luk J. F.] Monash Univ, Melbourne, Vic 3004, Australia; [Rombauts, Luk J. F.] Monash IVF, Melbourne, Vic, Australia	Prince Henry's Institute of Medical Research; University of Melbourne; University of Melbourne; Monash University	Evans, J (corresponding author), Univ Melbourne, Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	jemma.evans@princehenrys.org	Salamonsen, Lois/J-9822-2019	evans, jemma/0000-0002-3300-8127; Salamonsen, Lois/0000-0003-0558-7325; Rombauts, Luk/0000-0003-2656-2792; Hannan, Natalie/0000-0001-8446-2250	Monash IVF; National Health and Medical Research Council (NHMRC) (Australia) [494802]; Victorian Government's Operational Infrastructure Support Program; NHMRC Postdoctoral Training Fellowship [628927]; NHMRC Fellowship [388901]	Monash IVF; National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Postdoctoral Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Monash IVF and National Health and Medical Research Council (NHMRC) (Australia): Project/Program Grant #494802 and by the Victorian Government's Operational Infrastructure Support Program. NJH was supported by NHMRC Postdoctoral Training Fellowship #628927, and LAS by NHMRC Fellowship #388901. Monash IVF partially funded this research and Luk JF Rombauts is a minority shareholder and company board member of Monash IVF. Luk JF Rombauts conducted human tissue collections and aided manuscript editing.	Boomsma CM, 2009, REPROD BIOMED ONLINE, V18, P85, DOI 10.1016/S1472-6483(10)60429-4; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; [CDC Prevention CfDCa], 2011, ASS REPR TECHN; Coutifaris C, 2004, FERTIL STERIL, V82, P1264, DOI 10.1016/j.fertnstert.2004.03.069; Deligdisch L, 2000, MODERN PATHOLOGY, V13, P10; DeLoia JA, 2002, FERTIL STERIL, V77, P548, DOI 10.1016/S0015-0282(01)03062-X; Devoto L, 1997, HUM REPROD, V12, P708, DOI 10.1093/humrep/12.4.708; Devroey P, 2004, TRENDS ENDOCRIN MET, V15, P84, DOI 10.1016/j.tem.2004.01.009; Fatemi HM, 2011, CURR PHARM BIOTECHNO; Fatemi HM, 2010, FERTIL STERIL, V94, P2054, DOI 10.1016/j.fertnstert.2009.11.036; Gleicher N, 2012, REPROD BIOMED ONLINE, V24, P396, DOI 10.1016/j.rbmo.2011.12.011; Gleicher N, 2011, REPROD BIOMED ONLINE, V23, P274, DOI 10.1016/j.rbmo.2011.05.018; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2011, EXPERT REV CLIN IMMU, V7, P789, DOI [10.1586/ECI.11.65, 10.1586/eci.11.65]; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Kolibianakis E, 2002, FERTIL STERIL, V78, P1025, DOI 10.1016/S0015-0282(02)03323-X; Kolibianakis Efstratios M, 2002, Reprod Biomed Online, V5 Suppl 1, P26; Kolibianakis EM, 2003, FERTIL STERIL, V80, P464, DOI 10.1016/S0015-0282(03)00663-0; Kolibianakis EM, 2005, HUM REPROD, V20, P2453, DOI 10.1093/humrep/dei069; Kolibianakis EM, 2011, CURR PHARM BIOTECHNO; Lessey BA, 2011, FERTIL STERIL, V96, P522, DOI 10.1016/j.fertnstert.2011.07.1095; Lukassen HGM, 2004, MOL HUM REPROD, V10, P513, DOI 10.1093/molehr/gah067; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; Murray MJ, 2004, FERTIL STERIL, V81, P1333, DOI 10.1016/j.fertnstert.2003.11.030; Navot D., 1991, ANN NY ACAD SCI, V622, P212, DOI 10.1111/j.1749-6632.1991.tb37864.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Paiva P, 2011, HUM REPROD, V26, P1153, DOI 10.1093/humrep/der027; Papanikolaou EG, 2005, HUM REPROD, V20, P1541, DOI 10.1093/humrep/deh793; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Pollard JW, 2008, J CLIN INVEST, V118, P3832, DOI 10.1172/JCI37733; Rackow BW, 2008, FERTIL STERIL, V89, P1234, DOI [10.1016/j.fertnstert.2007.04.060, 10.1016/j.fertnstert.2007.12.030]; Reshkin SJ, 1997, INT J ONCOL, V11, P603; Robertson SA, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.01039.x; Robker RL, 2011, J REPROD IMMUNOL, V88, P142, DOI 10.1016/j.jri.2011.01.008; Russell P, 2011, J REPROD IMMUNOL, V91, P90, DOI 10.1016/j.jri.2011.03.013; Salamonsen LA, 2000, HUM REPROD UPDATE, V6, P16, DOI 10.1093/humupd/6.1.16; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Scherjon S, 2011, PLACENTA, V32, pS291, DOI 10.1016/j.placenta.2011.03.014; Schulke L, 2008, HUM REPROD, V23, P1574, DOI 10.1093/humrep/den030; Seow KM, 2010, GYNECOL OBSTET INVES, V70, P64, DOI 10.1159/000290062; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; SIMS JA, 1994, HUM REPROD, V9, P235, DOI 10.1093/oxfordjournals.humrep.a138488; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Tavaniotou A, 2001, ANN NY ACAD SCI, V943, P55, DOI 10.1111/j.1749-6632.2001.tb03790.x; Ubaldi F, 1997, FERTIL STERIL, V67, P521, DOI 10.1016/S0015-0282(97)80080-5; URBANCSEK J, 1990, HUM REPROD, V5, P675, DOI 10.1093/oxfordjournals.humrep.a137166; van der Gaast MH, 2008, REPROD BIOMED ONLINE, V17, P553, DOI 10.1016/S1472-6483(10)60244-1; Van Vaerenbergh I, 2009, HUM REPROD, V24, P1085, DOI 10.1093/humrep/den501; Verberg MFG, 2009, HUM REPROD UPDATE, V15, P13, DOI 10.1093/humupd/dmn056; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wynn RM, 1989, BIOL UTERUS, P289; Zhang J, 2012, REPROD BIOMED ONLINE, V24, P254, DOI 10.1016/j.rbmo.2011.11.009	59	47	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53098	10.1371/journal.pone.0053098	http://dx.doi.org/10.1371/journal.pone.0053098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300868	gold, Green Published			2022-12-27	WOS:000313872600056
J	Orsomando, G; Cialabrini, L; Amici, A; Mazzola, F; Ruggieri, S; Conforti, L; Janeckova, L; Coleman, MP; Magni, G				Orsomando, Giuseppe; Cialabrini, Lucia; Amici, Adolfo; Mazzola, Francesca; Ruggieri, Silverio; Conforti, Laura; Janeckova, Lucie; Coleman, Michael P.; Magni, Giulio			Simultaneous Single-Sample Determination of NMNAT Isozyme Activities in Mouse Tissues	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; WALLERIAN DEGENERATION; NAD BIOSYNTHESIS; SUBCELLULAR COMPARTMENTATION; NMN/NAMN ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; AXON DEGENERATION; EXPRESSION; ENZYME; METABOLISM	A novel assay procedure has been developed to allow simultaneous activity discrimination in crude tissue extracts of the three known mammalian nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1) isozymes. These enzymes catalyse the same key reaction for NAD biosynthesis in different cellular compartments. The present method has been optimized for NMNAT isozymes derived from Mus musculus, a species often used as a model for NAD-biosynthesis-related physiology and disorders, such as peripheral neuropathies. Suitable assay conditions were initially assessed by exploiting the metal-ion dependence of each isozyme recombinantly expressed in bacteria, and further tested after mixing them in vitro. The variable contributions of the three individual isozymes to total NAD synthesis in the complex mixture was calculated by measuring reaction rates under three selected assay conditions, generating three linear simultaneous equations that can be solved by a substitution matrix calculation. Final assay validation was achieved in a tissue extract by comparing the activity and expression levels of individual isozymes, considering their distinctive catalytic efficiencies. Furthermore, considering the key role played by NMNAT activity in preserving axon integrity and physiological function, this assay procedure was applied to both liver and brain extracts from wild-type and Wallerian degeneration slow (Wld(S)) mouse. Wld(S) is a spontaneous mutation causing overexpression of NMNAT1 as a fusion protein, which protects injured axons through a gain-of-function. The results validate our method as a reliable determination of the contributions of the three isozymes to cellular NAD synthesis in different organelles and tissues, and in mutant animals such as Wld(S).	[Orsomando, Giuseppe; Cialabrini, Lucia; Amici, Adolfo; Mazzola, Francesca] Polytech Univ Marche, Dept Clin Sci DISCO, Biochem Sect, Ancona, Italy; [Ruggieri, Silverio] Polytech Univ Marche, Dept Agr Food & Environm Sci D3A, Ancona, Italy; [Conforti, Laura] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham, England; [Janeckova, Lucie; Coleman, Michael P.] Babraham Inst, Cambridge, England; [Magni, Giulio] Univ Camerino, Sch Biol & Biotechnol, I-62032 Camerino, MC, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Camerino	Orsomando, G (corresponding author), Polytech Univ Marche, Dept Clin Sci DISCO, Biochem Sect, Ancona, Italy.	g.orsomando@univpm.it; giulio.magni@unicam.it	Amici, Adolfo/C-5342-2012; Orsomando, Giuseppe/L-2120-2015; Mazzola, Francesca/ADC-1197-2022	Amici, Adolfo/0000-0002-1081-7749; Orsomando, Giuseppe/0000-0001-6640-097X; Mazzola, Francesca/0000-0001-9140-012X	Ricerca Scientifica di Ateneo - RSA; Medical Research Council [G10000702]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C200] Funding Source: researchfish	Ricerca Scientifica di Ateneo - RSA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by "Ricerca Scientifica di Ateneo - RSA 2009-2010'' (GO, AA and SR), the Medical Research Council grant G10000702 (MPC and GM), and a Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant (LC, MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Brunetti L, 2010, PROTEIN SCI, V19, P2440, DOI 10.1002/pro.526; Chen L, 2008, CURR MED CHEM, V15, P650; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 2005, J NEUROL SCI, V233, P133, DOI 10.1016/j.jns.2005.03.028; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hasmann M, 2003, CANCER RES, V63, P7436; HUGHES KT, 1983, J BACTERIOL, V155, P213, DOI 10.1128/JB.155.1.213-221.1983; Imai S, 2009, BBA-GEN SUBJECTS, V1790, P997, DOI 10.1016/j.bbagen.2009.03.005; Jayaram HN, 2011, CURR MED CHEM, V18, P1962; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; KORNBERG A, 1948, J BIOL CHEM, V176, P1475; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raches DW, 2011, MED CHEM, V7, P718; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Trench WF, 1972, MULTIVARIABLE CALCUL, P82; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang J, 2009, CELL ADHES MIGR, V3, P77, DOI 10.4161/cam.3.1.7483; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	44	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53271	10.1371/journal.pone.0053271	http://dx.doi.org/10.1371/journal.pone.0053271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300904	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600077
J	Tedeschi, G; Mazloumian, A; Gallegati, M; Helbing, D				Tedeschi, Gabriele; Mazloumian, Amin; Gallegati, Mauro; Helbing, Dirk			Bankruptcy Cascades in Interbank Markets	PLOS ONE			English	Article							SYSTEMIC RISK; BUSINESS FLUCTUATIONS; BANK RUNS; FIRM; IMPERFECTIONS; INFORMATION; PSYCHOLOGY; CONTAGION; SURVIVAL; DYNAMICS	We study a credit network and, in particular, an interbank system with an agent-based model. To understand the relationship between business cycles and cascades of bankruptcies, we model a three-sector economy with goods, credit and interbank market. In the interbank market, the participating banks share the risk of bad debits, which may potentially spread a bank's liquidity problems through the network of banks. Our agent-based model sheds light on the correlation between bankruptcy cascades and the endogenous economic cycle of booms and recessions. It also demonstrates the serious trade-off between, on the one hand, reducing risks of individual banks by sharing them and, on the other hand, creating systemic risks through credit-related interlinkages of banks. As a result of our study, the dynamics underlying the meltdown of financial markets in 2008 becomes much better understandable.	[Tedeschi, Gabriele; Gallegati, Mauro] Univ Politecn Marche, Dept Econ, Ancona, Italy; [Mazloumian, Amin; Helbing, Dirk] ETH, Dept Humanities & Social Sci, Zurich, Switzerland	Marche Polytechnic University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tedeschi, G (corresponding author), Univ Politecn Marche, Dept Econ, Ancona, Italy.	g.tedeschi@univpm.it	GALLEGATI, MAURO/A-4091-2016	Tedeschi, Gabriele/0000-0003-2638-7373				Allen F, 2000, ECON J, V110, P236, DOI 10.1111/1468-0297.00499; Angelini P, 1996, J BANK FINANC, V20, P853, DOI 10.1016/0378-4266(95)00029-1; [Anonymous], 2001, FRB RICHMOND EC Q; [Anonymous], 2002, ASSET PRICES FINANCI; AUDRETSCH DB, 1991, REV ECON STAT, V73, P441, DOI 10.2307/2109568; Audretsch DB, 1995, INT J IND ORGAN, V13, P441, DOI 10.1016/0167-7187(95)00499-8; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Bartelsman E, 2005, IND CORP CHANGE, V14, P365, DOI 10.1093/icc/dth057; Bartram SM, 2007, J FINANC ECON, V86, P835, DOI 10.1016/j.jfineco.2006.10.001; Battiston S, 2012, J EC DYNAMI IN PRESS; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Berger AN, 2004, J FINANC INTERMED, V13, P458, DOI 10.1016/j.jfi.2004.06.006; Bhattacharya Sudipto, 2011, MINSKYS FINANCIAL IN; Borio C., 2001, PROCYCLICALITY FINAN; Boss M, 2004, QUANTITATIVE FINANCE; Brunnermeier MK, 2009, J ECON PERSPECT, V23, P77, DOI 10.1257/jep.23.1.77; Caccioli F, 2011, 110944 SANT FE I; Calomiris CW, 1996, J MONEY CREDIT BANK, V28, P766, DOI 10.2307/2077920; Castiglionesi F, 2007, 2007100 TILB U CTR E; Caves R., 1998, J ECON LIT, V36, P1974; Chinazzi M, 2012, POSTMORTEM EXAMINATI, DOI DOI 10.2139/SSRN.1995499; Cocco JF, 2009, J FINANC INTERMED, V18, P24, DOI 10.1016/j.jfi.2008.06.003; Cont R., 2007, LONG MEMORY EC, P289, DOI [10.1007/978-3-540-34625-8_10, DOI 10.1007/978-3-540-34625-8_10]; COWEN T, 1989, J MONEY CREDIT BANK, V21, P221, DOI 10.2307/1992370; Delli Gatti D, J EC BEHAV IN PRESS; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; DIXIT A, 1989, J POLIT ECON, V97, P620, DOI 10.1086/261619; Donaldson R. G., 1992, J FINANC INTERMED, V2, P59, DOI DOI 10.1016/1042-9573(92)90020-E; Edison HJ, 2000, ECON J, V110, P309, DOI 10.1111/1468-0297.00503; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Furth Douglas L., 2001, SECURED LENDER   SEP, P31; Gabaix X, 2006, Q J ECON, V121, P461, DOI 10.1162/qjec.2006.121.2.461; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Gatti DD, 2005, J ECON BEHAV ORGAN, V56, P489, DOI 10.1016/j.jebo.2003.10.012; Gatti DD, 2007, MACROECON DYN, V11, P62, DOI 10.1017/S136510050706018X; GREENWALD B, 1984, AM ECON REV, V74, P194; GREENWALD BC, 1990, AM ECON REV, V80, P160; GREENWALD BC, 1993, Q J ECON, V108, P77, DOI 10.2307/2118496; Hale G, 2011, 17356 NAT BUR EC RES; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HOPENHAYN HA, 1992, ECONOMETRICA, V60, P1127, DOI 10.2307/2951541; Horvath E, 2002, STUDIES PROCYCLICAL; Humphrey D, 1986, TECHNOLOGY REGULATIO, P97; Ijiri Y, 1977, SKEW DISTRIBUTIONS S; Iori G, 2006, J ECON BEHAV ORGAN, V61, P525, DOI 10.1016/j.jebo.2004.07.018; JACKLIN CJ, 1988, J POLIT ECON, V96, P568, DOI 10.1086/261552; Janicki H., 2006, FRB RICHMOND EC Q, V92, P291; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kaushik R, 2012, ARXIV12050976V1; Kiyotaki N, 1997, J POLIT ECON, V105, P211, DOI 10.1086/262072; Kyle AS, 2001, J FINANC, V56, P1401, DOI 10.1111/0022-1082.00373; Lorenz J, 2008, NETWORKS HETEROGENEO, V3; Minoiu C., 2011, IMF WORKING PAPERS, P1; Morris S., 2004, Review of Finance, V8, P1, DOI 10.1023/B:EUFI.0000022155.98681.25; Morris S, 2008, BROOKINGS PAP ECO AC, P229; Pareto, 1897, COURS EC POLITIQUE; Pushkin DO, 2004, PHYSICA A, V336, P571, DOI 10.1016/j.physa.2003.12.056; Schiavo S, 2010, QUANT FINANC, V10, P389, DOI 10.1080/14697680902882420; SHLEIFER A, 1992, J FINANC, V47, P1343, DOI 10.2307/2328943; Simon H. A., 1957, MODELS MAN; SIMON HA, 1979, AM ECON REV, V69, P493; Sornette D, 2011, NATURE, V471, P166, DOI 10.1038/471166a; Stanca L., 1999, IND CORP CHANGE, V8, P551; Summer M, 2002, WORKING PAPERS AUSTR; Thurner S, 2003, QUANT FINANC, V3, P306, DOI 10.1088/1469-7688/3/4/307; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Upper C, 2002, DISCUSSION PAPER SER; Zipf, 1949, HUMAN BEHAV PRINCIPL	70	47	48	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52749	10.1371/journal.pone.0052749	http://dx.doi.org/10.1371/journal.pone.0052749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300760	Green Published, gold			2022-12-27	WOS:000313872600024
J	Blouin, Y; Hauck, Y; Soler, C; Fabre, M; Vong, R; Dehan, C; Cazajous, G; Massoure, PL; Kraemer, P; Jenkins, A; Garnotel, E; Pourcel, C; Vergnaud, G				Blouin, Yann; Hauck, Yolande; Soler, Charles; Fabre, Michel; Vong, Rithy; Dehan, Celine; Cazajous, Geraldine; Massoure, Pierre-Laurent; Kraemer, Philippe; Jenkins, Akinbowale; Garnotel, Eric; Pourcel, Christine; Vergnaud, Gilles			Significance of the Identification in the Horn of Africa of an Exceptionally Deep Branching Mycobacterium tuberculosis Clade	PLOS ONE			English	Article							LARGE SEQUENCE POLYMORPHISMS; DRUG SUSCEPTIBILITY PATTERN; GENETIC DIVERSITY; VARIABLE-NUMBER; POPULATION-STRUCTURE; COMPLEX; STRAINS; GENOME; DNA; EVOLUTION	Molecular and phylogeographic studies have led to the definition within the Mycobacterium tuberculosis complex (MTBC) of a number of geotypes and ecotypes showing a preferential geographic location or host preference. The MTBC is thought to have emerged in Africa, most likely the Horn of Africa, and to have spread worldwide with human migrations. Under this assumption, there is a possibility that unknown deep branching lineages are present in this region. We genotyped by spoligotyping and multiple locus variable number of tandem repeats (VNTR) analysis (MLVA) 435 MTBC isolates recovered from patients. Four hundred and eleven isolates were collected in the Republic of Djibouti over a 12 year period, with the other 24 isolates originating from neighbouring countries. All major M. tuberculosis lineages were identified, with only two M. africanum and one M. bovis isolates. Upon comparison with typing data of worldwide origin we observed that several isolates showed clustering characteristics compatible with new deep branching. Whole genome sequencing (WGS) of seven isolates and comparison with available WGS data from 38 genomes distributed in the different lineages confirms the identification of ancestral nodes for several clades and most importantly of one new lineage, here referred to as lineage 7. Investigation of specific deletions confirms the novelty of this lineage, and analysis of its precise phylogenetic position indicates that the other three superlineages constituting the MTBC emerged independently but within a relatively short timeframe from the Horn of Africa. The availability of such strains compared to the predominant lineages and sharing very ancient ancestry will open new avenues for identifying some of the genetic factors responsible for the success of the modern lineages. Additional deep branching lineages may be readily and efficiently identified by large-scale MLVA screening of isolates from sub-Saharan African countries followed by WGS analysis of a few selected isolates.	[Blouin, Yann; Hauck, Yolande; Pourcel, Christine; Vergnaud, Gilles] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Blouin, Yann; Hauck, Yolande; Pourcel, Christine; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Soler, Charles; Fabre, Michel; Vong, Rithy] Hop Instruct Armees Percy, Lab Biol Clin, Clamart, France; [Dehan, Celine; Cazajous, Geraldine] Hop Mil Bouffard, Djibouti, Djibouti; [Massoure, Pierre-Laurent; Kraemer, Philippe; Garnotel, Eric] Hop Instruct Armees Alphonse Laveran, Marseille, France; [Jenkins, Akinbowale] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Pretoria	Vergnaud, G (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	gilles.vergnaud@u-psud.fr	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Jenkins, Akinbowale/0000-0001-8107-3321	CNRS; Paris-Sud University; french military health services; french Direction Generale de l'Armement (DGA)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Paris-Sud University; french military health services; french Direction Generale de l'Armement (DGA)	The study was funded by CNRS, Paris-Sud University, the french military health services, and the french Direction Generale de l'Armement (DGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Asiimwe BB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-101; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Deshayes C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-78; Eldholm V, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-76; Eldin GSS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-219; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Ferdinand Severine, 2005, Infection Genetics and Evolution, V5, P340, DOI 10.1016/j.meegid.2004.10.002; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Godreuil S, 2009, CLIN MICROBIOL INFEC; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KAPUR V, 1994, J INFECT DIS, V170, P1348, DOI 10.1093/infdis/170.5.1348; Kibiki GS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-51; Koeck JL, 2010, CLIN MICROBIOL INFEC; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Ledru S, 1996, TUBERCLE LUNG DIS, V77, P429, DOI 10.1016/S0962-8479(96)90116-1; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Mays S, 2001, AM J PHYS ANTHROPOL, V114, P298, DOI 10.1002/ajpa.1042; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mulenga C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-177; Namouchi A, 2012, GENOME RES; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; Rothschild BM, 2001, CLIN INFECT DIS, V33, P305, DOI 10.1086/321886; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2011, INFECT GENET EVOL; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stavrum R, 2009, J CLIN MICROBIOL, V47, P1848, DOI 10.1128/JCM.02167-08; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taylor GM, 1999, MICROBIOL-UK, V145, P899, DOI 10.1099/13500872-145-4-899; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Veyrier FJ, 2011, TRENDS MICROBIOL, V19, P156, DOI 10.1016/j.tim.2010.12.008; Viana-Niero C, 2001, J CLIN MICROBIOL, V39, P57, DOI 10.1128/JCM.39.1.57-65.2001; Viegas SO, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-195; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038; Wilbur AK, 2009, J ARCHAEOL SCI, V36, P1990, DOI 10.1016/j.jas.2009.05.020; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003; Zumarraga M, 1999, MICROBIOL-SGM, V145, P893, DOI 10.1099/13500872-145-4-893	71	69	71	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52841	10.1371/journal.pone.0052841	http://dx.doi.org/10.1371/journal.pone.0052841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300794	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100085
J	Fitzpatrick, KE; Sellers, S; Spark, P; Kurinczuk, JJ; Brocklehurst, P; Knight, M				Fitzpatrick, Kathryn E.; Sellers, Susan; Spark, Patsy; Kurinczuk, Jennifer J.; Brocklehurst, Peter; Knight, Marian			Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study	PLOS ONE			English	Article							PREVIA-ACCRETA; PATHOLOGY; PREGNANCY; MORBIDITY	Background: Placenta accreta/increta/percreta is associated with major pregnancy complications and is thought to be becoming more common. The aims of this study were to estimate the incidence of placenta accreta/increta/percreta in the UK and to investigate and quantify the associated risk factors. Methods: A national case-control study using the UK Obstetric Surveillance System was undertaken, including 134 women diagnosed with placenta accreta/increta/percreta between May 2010 and April 2011 and 256 control women. Results: The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall; 577 per 10,000 in women with both a previous caesarean delivery and placenta praevia. Women who had a previous caesarean delivery (adjusted odds ratio (aOR) 14.41, 95%CI 5.63-36.85), other previous uterine surgery (aOR 3.40, 95%CI 1.30-8.91), an IVF pregnancy (aOR 32.13, 95%CI 2.03-509.23) and placenta praevia diagnosed antepartum (aOR 65.02, 95%CI 16.58-254.96) had raised odds of having placenta accreta/increta/percreta. There was also a raised odds of placenta accreta/increta/ percreta associated with older maternal age in women without a previous caesarean delivery (aOR 1.30, 95%CI 1.13-1.50 for every one year increase in age). Conclusions: Women with both a prior caesarean delivery and placenta praevia have a high incidence of placenta accreta/increta/percreta. There is a need to maintain a high index of suspicion of abnormal placental invasion in such women and preparations for delivery should be made accordingly.	[Fitzpatrick, Kathryn E.; Spark, Patsy; Kurinczuk, Jennifer J.; Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Sellers, Susan] Univ Hosp Bristol NHS Trust, Bristol, Avon, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London, England	University of Oxford; University of London; University College London	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.	kate.fitzpatrick@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575	National Institute for Health Research (NIHR) [RP-PG-0608-10038]; National Institute for Health Research [RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the "Beyond maternal death: Improving the quality of maternity care through national studies of "near-miss" maternal morbidity" programme (Programme Grant RP-PG-0608-10038). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Serehi A, 2008, J ULTRAS MED, V27, P1623, DOI 10.7863/jum.2008.27.11.1623; CLARK SL, 1985, OBSTET GYNECOL, V66, P89; Cook J, 2012, BJOG INT J OBSTET GY; Esh-Broder E, 2011, BJOG-INT J OBSTET GY, V118, P1084, DOI 10.1111/j.1471-0528.2011.02976.x; Garmi G, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/873929; General Register Office for Scotland, 2011, VIT EV REF TABL 2010; Gielchinsky Y, 2002, PLACENTA, V23, P210, DOI 10.1053/plac.2001.0764; Guise JM, 2010, VAGINAL BIRTH CESARE, P1; Hung TH, 1999, OBSTET GYNECOL, V93, P545, DOI 10.1016/S0029-7844(98)00460-8; Jacques SM, 1996, INT J GYNECOL PATHOL, V15, P28, DOI 10.1097/00004347-199601000-00005; JAMES WH, 1995, HUM REPROD, V10, P1403, DOI 10.1093/HUMREP/10.6.1403; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; Northern Ireland Statistics and Research Agency, 2011, REG GEN ANN REP 2010; Office for National Statistics, 2007, BRIT STAT REV REG GE; Office for National Statistics (ONS), 2021, BIRTH SUMM TABL ENGL; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; RCOG Clinical Effectiveness Support Unit, 2001, NAT SENT CAES SECT A; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Usta IM, 2005, AM J OBSTET GYNECOL, V193, P1045, DOI 10.1016/j.ajog.2005.06.037; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074; Zaki ZMS, 1998, ACTA OBSTET GYN SCAN, V77, P391, DOI 10.1034/j.1600-0412.1998.00015.x	25	216	231	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52893	10.1371/journal.pone.0052893	http://dx.doi.org/10.1371/journal.pone.0052893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300807	Green Published, gold			2022-12-27	WOS:000312829100091
J	Kuban-Jankowska, A; Tuszynski, JA; Winter, P; Gorska, M; Knap, N; Wozniak, M				Kuban-Jankowska, Alicja; Tuszynski, Jack A.; Winter, Philip; Gorska, Magdalena; Knap, Narcyz; Wozniak, Michal			Activation of Hydrogen Peroxide to Peroxytetradecanoic Acid Is Responsible for Potent Inhibition of Protein Tyrosine Phosphatase CD45	PLOS ONE			English	Article								Hydrogen peroxide induces oxidation and consequently inactivation of many protein tyrosine phosphatases. It was found that hydrogen peroxide, in the presence of carboxylic acids, was efficiently activated to form even more potent oxidant - peroxy acid. We have found that peroxytetradecanoic acid decreases the enzymatic activity of CD45 phosphatase significantly more than hydrogen peroxide. Our molecular docking computational analysis suggests that peroxytetradecanoic acid has a higher binding affinity to the catalytic center of CD45 than hydrogen peroxide.	[Kuban-Jankowska, Alicja; Gorska, Magdalena; Knap, Narcyz; Wozniak, Michal] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland; [Tuszynski, Jack A.; Winter, Philip] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Wozniak, Michal] Fac Gdynia, Coll Hlth Beauty Care & Educ Poznan, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk; University of Alberta	Kuban-Jankowska, A (corresponding author), Med Univ Gdansk, Dept Med Chem, Gdansk, Poland.	alicjakuban@gumed.edu.pl; mwozniak@gumed.edu.pl	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; gorska-ponikowska, magdalena/0000-0002-7366-8429; Wozniak, Michal/0000-0001-7083-6792; Knap, Narcyz/0000-0002-6162-3987	Polish National Science Center [N N401 029537]; NSERC (Canada); Allard Foundation; Canadian Breast Cancer Foundation	Polish National Science Center; NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Allard Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by Grant No. N N401 029537 from the Polish National Science Center. JAT acknowledges support from NSERC (Canada), the Allard Foundation, and the Canadian Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernhardt P, 2005, ANGEW CHEM INT EDIT, V44, P2742, DOI 10.1002/anie.200463006; Bhattacharya S, 2008, BIOORG MED CHEM LETT, V18, P5856, DOI 10.1016/j.bmcl.2008.06.029; BJORKLING F, 1992, TETRAHEDRON, V48, P4587, DOI 10.1016/S0040-4020(01)81232-1; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; de Dios I, 2006, J PATHOL, V210, P234, DOI 10.1002/path.2037; De Dios I, 2005, FEBS LETT, V579, P6355, DOI 10.1016/j.febslet.2005.10.017; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Klenk H., 2000, ULLMANNS ENCY IND CH, DOI [DOI 10.1002/14356007.A19_199, 10.1002/14356007.a19_199]; Kuban-Jankowska A, 2011, BIOCHEM BIOPH RES CO, V415, P270, DOI 10.1016/j.bbrc.2011.10.033; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; PARKER WE, 1955, J AM CHEM SOC, V77, P4037, DOI 10.1021/ja01620a023; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Rubio M, 2005, J MOL STRUC-THEOCHEM, V726, P261, DOI 10.1016/j.theochem.2005.02.076; Soulsby M, 2009, PHYSIOLOGY, V24, P281, DOI 10.1152/physiol.00017.2009; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52495	10.1371/journal.pone.0052495	http://dx.doi.org/10.1371/journal.pone.0052495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300686	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100054
J	Malisi, C; Schumann, M; Toussaint, NC; Kageyama, J; Kohlbacher, O; Hocker, B				Malisi, Christoph; Schumann, Marcel; Toussaint, Nora C.; Kageyama, Jorge; Kohlbacher, Oliver; Hoecker, Birte			Binding Pocket Optimization by Computational Protein Design	PLOS ONE			English	Article							LIGAND-BINDING; DOCKING; ALGORITHMS; PREDICTION; ACCURACY; REDESIGN; PROGRAMS; DATABASE	Engineering specific interactions between proteins and small molecules is extremely useful for biological studies, as these interactions are essential for molecular recognition. Furthermore, many biotechnological applications are made possible by such an engineering approach, ranging from biosensors to the design of custom enzyme catalysts. Here, we present a novel method for the computational design of protein-small ligand binding named POCKETOPTIMIZER. The program can be used to modify protein binding pocket residues to improve or establish binding of a small molecule. It is a modular pipeline based on a number of customizable molecular modeling tools to predict mutations that alter the affinity of a target protein to its ligand. At its heart it uses a receptor-ligand scoring function to estimate the binding free energy between protein and ligand. We compiled a benchmark set that we used to systematically assess the performance of our method. It consists of proteins for which mutational variants with different binding affinities for their ligands and experimentally determined structures exist. Within this test set POCKETOPTIMIZER correctly predicts the mutant with the higher affinity in about 69% of the cases. A detailed analysis of the results reveals that the strengths of POCKETOPTIMIZER lie in the correct introduction of stabilizing hydrogen bonds to the ligand, as well as in the improved geometric complemetarity between ligand and binding pocket. Apart from the novel method for binding pocket design we also introduce a much needed benchmark data set for the comparison of affinities of mutant binding pockets, and that we use to asses programs for in silico design of ligand binding.	[Malisi, Christoph; Kageyama, Jorge; Hoecker, Birte] Max Planck Inst Dev Biol, Tubingen, Germany; [Schumann, Marcel; Toussaint, Nora C.; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, Quantitat Biol Ctr, Tubingen, Germany; [Schumann, Marcel; Toussaint, Nora C.; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hocker, B (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	birte.hoecker@tuebingen.mpg.de	Kohlbacher, Oliver/B-7310-2008; Kohlbacher, Oliver/AAF-3297-2021	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Schumann, Marcel/0000-0002-9473-0156; Hocker, Birte/0000-0002-8250-9462; Toussaint, Nora/0000-0001-7911-7647	Deutsche Forschungsgemeinschaft [HO 4022/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 4022/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Benson DE, 2000, P NATL ACAD SCI USA, V97, P6292, DOI 10.1073/pnas.97.12.6292; Boas FE, 2008, J MOL BIOL, V380, P415, DOI 10.1016/j.jmb.2008.04.001; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; Frey KM, 2010, P NATL ACAD SCI USA, V107, P13707, DOI 10.1073/pnas.1002162107; Georgiev I, 2008, BIOINFORMATICS, V24, pI196, DOI 10.1093/bioinformatics/btn169; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hildebrandt A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-531; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; Morin A, 2011, PROTEIN ENG DES SEL, V24, P503, DOI 10.1093/protein/gzr006; Morin A, 2011, TRENDS BIOTECHNOL, V29, P159, DOI 10.1016/j.tibtech.2011.01.002; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Murphy PM, 2009, P NATL ACAD SCI US, V0, P00; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Schumann M, 2012, CADDSUITE 1 0; Shetty RP, 2003, PROTEIN ENG, V16, P963, DOI 10.1093/protein/gzg143; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vallee-Belisle A, 2010, CURR OPIN STRUC BIOL, V20, P518, DOI 10.1016/j.sbi.2010.05.001; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Weiss Y., 2008, P UAI, P503; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zavodszky MI, 2009, J MOL RECOGNIT, V22, P280, DOI 10.1002/jmr.942	46	29	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52505	10.1371/journal.pone.0052505	http://dx.doi.org/10.1371/journal.pone.0052505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300688	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100056
J	Mencacci, A; Leli, C; Cardaccia, A; Meucci, M; Moretti, A; D'Alo, F; Farinelli, S; Pagliochini, R; Barcaccia, M; Bistoni, F				Mencacci, Antonella; Leli, Christian; Cardaccia, Angela; Meucci, Marta; Moretti, Amedeo; D'Alo, Francesco; Farinelli, Senia; Pagliochini, Rita; Barcaccia, Mariella; Bistoni, Francesco			Procalcitonin Predicts Real-Time PCR Results in Blood Samples from Patients with Suspected Sepsis	PLOS ONE			English	Article							LIGHTCYCLER SEPTIFAST; STREAM INFECTION; RAPID DETECTION; DIAGNOSIS; MANAGEMENT; BACTERIAL; BACTEREMIA; CONTAMINATION; BIOMARKERS; PATHOGENS	Background: Early diagnosis and rapid bacterial identification are of primary importance for outcome of septic patients. SeptiFast (R) (SF) real-time PCR assay is of potential utility in the etiological diagnosis of sepsis, but it cannot replace blood culture (BC) for routine use in clinical laboratory. Procalcitonin (PCT) is a marker of sepsis and can predict bacteremia in septic patients. The aim of the present study was to investigate whether PCT serum levels could predict SF results, and could help screening febrile patients in which a SF assay can improve the etiological diagnosis of sepsis. Methods: From 1009 febrile patients with suspected sepsis, 1009 samples for BC, SF real-time PCR, and PCT determination were obtained simultaneously, and results were compared and statistically analysed. Receiver operating characteristic (ROC) curves were generated to determine the area under the curve and to identify which cut-off of PCT value produced the best sensitivity to detect SF results. Results: Mean PCT values of sera drawn simultaneously with samples SF positive (35.42 +/- 61.03 ng/ml) or BC positive (23.14 +/- 51.56 ng/ml) for a pathogen were statistically higher than those drawn simultaneously with SF negative (0.84 +/- 1.67 ng/ml) or BC negative (2.79 +/- 16.64 ng/ml) samples (p<0.0001). For SF, ROC analysis showed an area under the curve of 0.927 (95% confidence interval: 0.899-0.955, p<0.0001). The PCT cut-off value of 0.37 ng/ml showed a negative predictive value of 99%, reducing the number of SF assays of 53.9%, still identifying the 96.4% of the pathogens. Conclusion: PCT can be used in febrile patients with suspected sepsis to predict SF positive or negative results. A cut-off value of 0.37 ng/ml can be considered for optimal sensitivity, so that, in the routine laboratory activity, SF assay should not be used for diagnosis of sepsis in an unselected patient population with a PCT value <0.37 ng/ml.	[Mencacci, Antonella; Leli, Christian; Cardaccia, Angela; Meucci, Marta; Moretti, Amedeo; D'Alo, Francesco; Farinelli, Senia; Pagliochini, Rita; Barcaccia, Mariella; Bistoni, Francesco] Univ Perugia, Microbiol Sect, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Perugia	Mencacci, A (corresponding author), Univ Perugia, Microbiol Sect, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	mencacci@unipg.it	Leli, Christian/AAP-9337-2020	Leli, Christian/0000-0002-8689-7028; MENCACCI, ANTONELLA/0000-0001-9221-6172				Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bravo D, 2011, INT J INFECT DIS, V15, pE326, DOI 10.1016/j.ijid.2011.01.003; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Emonet S, 2011, EXPERT REV ANTI-INFE, V9, P707, DOI [10.1586/eri.11.84, 10.1586/ERI.11.84]; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hausfater P, 2010, CLIN CHEM LAB MED, V48, P501, DOI 10.1515/CCLM.2010.091; Kim MH, 2011, YONSEI MED J, V52, P276, DOI 10.3349/ymj.2011.52.2.276; Knudsen JB, 2010, AM J MED, V123, P1121, DOI 10.1016/j.amjmed.2010.07.018; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mencacci A, 2012, J MED MICROBIOL, V61, P881, DOI 10.1099/jmm.0.040113-0; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Muller B, 2001, SWISS MED WKLY, V131, P595; Obara H, 2011, J INFECT CHEMOTHER, V17, P327, DOI 10.1007/s10156-010-0168-z; Pasqualini L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; PLORDE JJ, 1985, J CLIN MICROBIOL, V22, P292, DOI 10.1128/JCM.22.2.292-295.1985; Riedel S, 2012, DIAGN MICR INFEC DIS, V73, P221, DOI 10.1016/j.diagmicrobio.2012.05.002; Sakr Y, 2008, INFECTION, V36, P396, DOI 10.1007/s15010-008-7374-Y; Schuetz P, 2007, INFECTION, V35, P352, DOI 10.1007/s15010-007-7065-0; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; Tromp M, 2012, J INFECTION, V65, P292, DOI 10.1016/j.jinf.2012.06.004; Vincent JL, 2008, LANGENBECK ARCH SURG, V393, P817, DOI 10.1007/s00423-008-0343-1; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003	35	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53279	10.1371/journal.pone.0053279	http://dx.doi.org/10.1371/journal.pone.0053279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300907	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100132
J	Brulle, L; Vandamme, M; Ries, D; Martel, E; Robert, E; Lerondel, S; Trichet, V; Richard, S; Pouvesle, JM; Le Pape, A				Brulle, Laura; Vandamme, Marc; Ries, Delphine; Martel, Eric; Robert, Eric; Lerondel, Stephanie; Trichet, Valerie; Richard, Serge; Pouvesle, Jean-Michel; Le Pape, Alain			Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model	PLOS ONE			English	Article							GROWTH-INHIBITION; CANCER; CELLS; RADIOSENSITIZATION; TOMOGRAPHY; EXPRESSION; HYPOXIA; TUMORS	Pancreatic tumors are the gastrointestinal cancer with the worst prognosis in humans and with a survival rate of 5% at 5 years. Nowadays, no chemotherapy has demonstrated efficacy in terms of survival for this cancer. Previous study focused on the development of a new therapy by non thermal plasma showed significant effects on tumor growth for colorectal carcinoma and glioblastoma. To allow targeted treatment, a fibered plasma (Plasma Gun) was developed and its evaluation was performed on an orthotopic mouse model of human pancreatic carcinoma using a MIA PaCa2-luc bioluminescent cell line. The aim of this study was to characterize this pancreatic carcinoma model and to determine the effects of Plasma Gun alone or in combination with gemcitabine. During a 36 days period, quantitative BLI could be used to follow the tumor progression and we demonstrated that plasma gun induced an inhibition of MIA PaCa2-luc cells proliferation in vitro and in vivo and that this effect could be improved by association with gemcitabine possibly thanks to its radiosensitizing properties.	[Brulle, Laura; Vandamme, Marc; Lerondel, Stephanie; Le Pape, Alain] UPS44 CNRS, Ctr Imagerie Petit Anim CIPA TAAM, Orleans, France; [Brulle, Laura; Martel, Eric; Richard, Serge] Ctr Rech Biol CERB, Baugy, France; [Vandamme, Marc; Ries, Delphine; Robert, Eric; Pouvesle, Jean-Michel] Univ Orleans, GREMI UMR CNRS 7344, Orleans, France; [Le Pape, Alain] Univ Tours, INSERM UMR1100 EA6305, CEPR, Tours, France; [Trichet, Valerie] Univ Nantes, Fac Med, INSERM, UMR957, Nantes, France; [Vandamme, Marc] GERMITEC SAS, Clichy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Brulle, L (corresponding author), UPS44 CNRS, Ctr Imagerie Petit Anim CIPA TAAM, Orleans, France.	laura.brulle@cnrs-orleans.fr	Trichet, Valérie/L-1553-2015; POUVESLE, Jean-Michel/L-2087-2018; robert, eric/E-7992-2019	Trichet, Valérie/0000-0003-4183-9032; POUVESLE, Jean-Michel/0000-0002-3236-0102; robert, eric/0000-0002-7894-7080	Region Centre (APR "PlasMed''); Germitec; Conseil Regional du Centre; CNRS; French 'Agence Nationale de la Recherche' [ANR 2010 BLAN 0930 01]	Region Centre (APR "PlasMed'')(Region Centre-Val de Loire); Germitec; Conseil Regional du Centre(Region Centre-Val de Loire); CNRS(Centre National de la Recherche Scientifique (CNRS)); French 'Agence Nationale de la Recherche'(French National Research Agency (ANR))	This work is supported by the Region Centre (APR "PlasMed''), Germitec, Conseil Regional du Centre, CNRS and also by French 'Agence Nationale de la Recherche' (program ANR 2010 BLAN 0930 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bornmann C, 2008, CANCER CHEMOTH PHARM, V61, P395, DOI 10.1007/s00280-007-0482-z; Bouvet M, 2009, MINERVA CHIR, V64, P521; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Buchs NC, 2011, J GASTROEN HEPATOL, V26, P657, DOI 10.1111/j.1440-1746.2010.06525.x; Cardillo TM, 2002, INT J CANCER, V97, P386, DOI 10.1002/ijc.1613; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Hessenius C, 2000, EUR J NUCL MED, V27, P1684, DOI 10.1007/s002590000325; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, APPL PHYS LETT, V96; Kim CH, 2010, J BIOTECHNOL; Kim JY, 2011, SMALL, V7, P2291, DOI 10.1002/smll.201100456; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Latz D, 1998, INT J RADIAT ONCOL, V41, P875, DOI 10.1016/S0360-3016(98)00105-9; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; Mees G, 2009, EUR J NUCL MED MOL I, V36, P1674, DOI 10.1007/s00259-009-1195-9; Milas L, 1999, CANCER RES, V59, P107; Okano K, 2011, WORLD J GASTROENTERO, V17, P231, DOI 10.3748/wjg.v17.i2.231; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Robert E, 2009, PLASMA PROCESS POLYM, V6, P795, DOI 10.1002/ppap.200900078; Rousseau J, 2010, CANCER GENE THER, V17, P387, DOI 10.1038/cgt.2009.89; Saif MW, 2011, J PANCREAS, V12, P306; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Vandamme M, 2011, PLASMA MED, V1, P27, DOI DOI 10.1615/PlasmaMed.v1.i1.30; Vandamme M, 2011, INT J CANC; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Varvarigou A, 2004, CANCER BIOTHER RADIO, V19, P219, DOI 10.1089/108497804323072002; Wescott MP, 2008, CANCER PREV RES, V1, P503, DOI 10.1158/1940-6207.CAPR-08-0195; Wilson KD, 2009, METHODS MOL BIOL, V574, P87, DOI 10.1007/978-1-60327-321-3_8; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; Yip-Schneider MT, 2001, J PHARMACOL EXP THER, V298, P976; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118; Zagon IS, 2005, CANCER CHEMOTH PHARM, V56, P510, DOI 10.1007/s00280-005-1028-x; Zhao H, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-15	44	176	179	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52653	10.1371/journal.pone.0052653	http://dx.doi.org/10.1371/journal.pone.0052653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300736	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800122
J	Gardill, BR; Vogl, MR; Lin, HY; Hammond, GL; Muller, YA				Gardill, Bernd R.; Vogl, Michael R.; Lin, Hai-Yan; Hammond, Geoffrey L.; Muller, Yves A.			Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences	PLOS ONE			English	Article							SERPIN CONFORMATIONAL-CHANGE; CORTISOL-BINDING; MECHANISM; VARIANT; SERUM; MUTATIONS; OVALBUMIN; TRANSPORT; SITE	Corticosteroid-binding globulin (CBG) transports glucocorticoids and progesterone in the blood and thereby modulates the tissue availability of these hormones. As a member of the serine protease inhibitor (SERPIN) family, CBG displays a reactive center loop (RCL) that is targeted by proteinases. Cleavage of the RCL is thought to trigger a SERPIN-typical stressed-to-relaxed (S-to-R) transition that leads to marked structural rearrangements and a reduced steroid-binding affinity. To characterize structure-function relationships in CBG we studied various conformational states of E. coli-produced rat and human CBG. In the 2.5 angstrom crystal structure of human CBG in complex with progesterone, the RCL is cleaved at a novel site that differs from the known human neutrophil elastase recognition site. Although the cleaved RCL segment is five residues longer than anticipated, it becomes an integral part of beta-sheet A as a result of the S-to-R transition. The atomic interactions observed between progesterone and CBG explain the lower affinity of progesterone in comparison to corticosteroids. Surprisingly, CD measurements in combination with thermal unfolding experiments show that rat CBG fails to undergo an S-to-R transition upon proteolytic cleavage of the RCL hinting that the S-to-R transition observed in human CBG is not a prerequisite for CBG function in rat. This observation cautions against drawing general conclusions about molecular mechanisms by comparing and merging structural data from different species.	[Gardill, Bernd R.; Vogl, Michael R.; Muller, Yves A.] Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, D-91054 Erlangen, Germany; [Lin, Hai-Yan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Hammond, Geoffrey L.] Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of Erlangen Nuremberg; Chinese Academy of Sciences; Institute of Zoology, CAS; Child & Family Research Institute; University of British Columbia	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, D-91054 Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016	Muller, Yves A/0000-0003-0519-8928; Hammond, Geoffrey/0000-0002-4639-7336	DFG [MU 1477/5]; BIGSS; BMBF [05-ES3XBA/5]	DFG(German Research Foundation (DFG)); BIGSS; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the DFG (MU 1477/5) and BIGSS. Synchrotron data collection was supported by a grant from the BMBF (05-ES3XBA/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier J, 1998, CRIT CARE MED, V26, P452, DOI 10.1097/00003246-199803000-00014; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; Delano WL., 2002, PYMOL MOL GRAPHICS S; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin HY, 2012, J CLIN ENDOCR METAB, V97, pE678, DOI 10.1210/jc.2011-3141; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LOMAS DA, 1995, J BIOL CHEM, V270, P5282, DOI 10.1074/jbc.270.10.5282; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICKELSON KE, 1981, BIOCHEMISTRY-US, V20, P6211, DOI 10.1021/bi00524a047; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2010, J CLIN ENDOCR METAB, V95, pE142, DOI 10.1210/jc.2010-0746; PUGEAT M, 1989, CLIN CHEM, V35, P1675; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumer-Bayraktar Z, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009100; Torpy DJ, 2012, J CLIN ENDOCR METAB, V97, pE151, DOI 10.1210/jc.2011-2022; Torpy DJ, 2001, J CLIN ENDOCR METAB, V86, P3692, DOI 10.1210/jc.86.8.3692; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; VANBAELEN H, 1982, J BIOL CHEM, V257, P3397; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; ZOUAGHI H, 1985, EUR J CLIN INVEST, V15, P365, DOI 10.1111/j.1365-2362.1985.tb00286.x	50	39	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52759	10.1371/journal.pone.0052759	http://dx.doi.org/10.1371/journal.pone.0052759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300763	Green Published, gold			2022-12-27	WOS:000313618800139
J	Jones, JJ; Settle, JE; Bond, RM; Fariss, CJ; Marlow, C; Fowler, JH				Jones, Jason J.; Settle, Jaime E.; Bond, Robert M.; Fariss, Christopher J.; Marlow, Cameron; Fowler, James H.			Inferring Tie Strength from Online Directed Behavior	PLOS ONE			English	Article								Some social connections are stronger than others. People have not only friends, but also best friends. Social scientists have long recognized this characteristic of social connections and researchers frequently use the term tie strength to refer to this concept. We used online interaction data (specifically, Facebook interactions) to successfully identify real-world strong ties. Ground truth was established by asking users themselves to name their closest friends in real life. We found the frequency of online interaction was diagnostic of strong ties, and interaction frequency was much more useful diagnostically than were attributes of the user or the user's friends. More private communications (messages) were not necessarily more informative than public communications (comments, wall posts, and other interactions).	[Jones, Jason J.; Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA; [Jones, Jason J.; Settle, Jaime E.; Bond, Robert M.; Fariss, Christopher J.; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Marlow, Cameron] Facebook Inc, Data Sci, Menlo Pk, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Facebook Inc	Jones, JJ (corresponding author), Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA.	jasonj@ucsd.edu	Fariss, Christopher/A-2244-2010; Fariss, Christopher/AAN-9494-2020; Jones, Jason J/I-3350-2012; Fariss, Christopher J/AAG-9477-2021; Fowler, James H/C-2750-2008; Bond, Robert Meade/A-1561-2014	Jones, Jason J/0000-0002-4140-0268; Fariss, Christopher J/0000-0001-9837-186X; Fowler, James H/0000-0001-7795-1638; 	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation, Science of Generosity Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation, Science of Generosity Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the James S. McDonnell Foundation and the University of Notre Dame and the John Templeton Foundation as part of the Science of Generosity Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatarjav EA, 2010, IEEE CCNC 2010; Baym NK, 2009, INFORM COMMUN SOC, V12, P408, DOI 10.1080/13691180802635430; Boase J, 2006, STRENGTH INTERNET TI; Christakis N.A., 2009, CONNECTED SURPRISING; Gilbert E, 2009, CHI 2009 APR 4 9 200; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Haythornthwaite C., 2005, Information Communication & Society, V8, P125, DOI 10.1080/13691180500146185; Kahanda I, 2009, P 3 INT ICWSM C; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Xiang R, 2010, WWW2010 APR 26 30 20; Zhang H, 2010, ISI 2010 MAY 23 26 2	14	108	111	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52168	10.1371/journal.pone.0052168	http://dx.doi.org/10.1371/journal.pone.0052168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300964	Green Published, gold			2022-12-27	WOS:000313320900020
J	Price, ME; Pound, N; Dunn, J; Hopkins, S; Kang, JS				Price, Michael E.; Pound, Nicholas; Dunn, James; Hopkins, Sian; Kang, Jinsheng			Body Shape Preferences: Associations with Rater Body Shape and Sociosexuality	PLOS ONE			English	Article							FEMALE PHYSICAL ATTRACTIVENESS; PREDICTS WOMENS PREFERENCES; WAIST-HIP RATIO; SEXUAL-DIMORPHISM; EVOLUTIONARY PSYCHOLOGY; VISUAL-PERCEPTION; MATE CHOICE; MALE FACES; STRATEGIES; CONTEXT	There is accumulating evidence of condition-dependent mate choice in many species, that is, individual preferences varying in strength according to the condition of the chooser. In humans, for example, people with more attractive faces/bodies, and who are higher in sociosexuality, exhibit stronger preferences for attractive traits in opposite-sex faces/bodies. However, previous studies have tended to use only relatively simple, isolated measures of rater attractiveness. Here we use 3D body scanning technology to examine associations between strength of rater preferences for attractive traits in opposite-sex bodies, and raters' body shape, self-perceived attractiveness, and sociosexuality. For 118 raters and 80 stimuli models, we used a 3D scanner to extract body measurements associated with attractiveness (male waist-chest ratio [WCR], female waist-hip ratio [WHR], and volume-height index [VHI] in both sexes) and also measured rater self-perceived attractiveness and sociosexuality. As expected, WHR and VHI were important predictors of female body attractiveness, while WCR and VHI were important predictors of male body attractiveness. Results indicated that male rater sociosexuality scores were positively associated with strength of preference for attractive (low) VHI and attractive (low) WHR in female bodies. Moreover, male rater self-perceived attractiveness was positively associated with strength of preference for low VHI in female bodies. The only evidence of condition-dependent preferences in females was a positive association between attractive VHI in female raters and preferences for attractive (low) WCR in male bodies. No other significant associations were observed in either sex between aspects of rater body shape and strength of preferences for attractive opposite-sex body traits. These results suggest that among male raters, rater self-perceived attractiveness and sociosexuality are important predictors of preference strength for attractive opposite-sex body shapes, and that rater body traits -with the exception of VHI in female raters-may not be good predictors of these preferences in either sex.	[Price, Michael E.; Pound, Nicholas; Dunn, James; Hopkins, Sian] Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Kang, Jinsheng] Brunel Univ, Sch Engn & Design, Uxbridge UB8 3PH, Middx, England	Brunel University; Brunel University	Price, ME (corresponding author), Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England.	michael.price@brunel.ac.uk	Pound, Nicholas/B-5453-2008	Pound, Nicholas/0000-0003-2170-9943; Kang, Jinsheng/0000-0002-0050-1062; Price, Michael/0000-0002-2572-4326	Brunel University School of Social Sciences	Brunel University School of Social Sciences	Funding was provided by the Brunel University School of Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; BURLEY N, 1983, ETHOL SOCIOBIOL, V4, P191, DOI 10.1016/0162-3095(83)90009-2; Burriss RP, 2011, PERS INDIV DIFFER, V50, P542, DOI 10.1016/j.paid.2010.11.022; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buunk BP, 2005, PERS INDIV DIFFER, V39, P379, DOI 10.1016/j.paid.2005.01.020; Cicchetti DV, 1981, AM J MENTAL DEFICIEN, V86; Confer JC, 2010, EVOL HUM BEHAV, V31, P348, DOI 10.1016/j.evolhumbehav.2010.04.002; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; Darwin C., 1871, P423; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Fan JT, 2007, PERCEPT MOTOR SKILL, V105, P117, DOI 10.2466/PMS.105.1.117-132; Fan JT, 2005, P ROY SOC B-BIOL SCI, V272, P219, DOI 10.1098/rspb.2004.2922; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; Fawcett TW, 2003, BEHAV ECOL, V14, P771, DOI 10.1093/beheco/arg075; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Fink B, 2002, CURR DIR PSYCHOL SCI, V11, P154, DOI 10.1111/1467-8721.00190; Furnham A, 2006, PERS INDIV DIFFER, V41, P443, DOI 10.1016/j.paid.2006.02.007; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; HORVATH T, 1979, SOC BEHAV PERSONAL, V7, P145, DOI 10.2224/sbp.1979.7.2.145; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jones BC, 2005, EVOL HUM BEHAV, V26, P451, DOI 10.1016/j.evolhumbehav.2005.05.001; KALICK SM, 1986, J PERS SOC PSYCHOL, V51, P673, DOI 10.1037/0022-3514.51.4.673; Lassek WD, 2008, EVOL HUM BEHAV, V29, P26, DOI 10.1016/j.evolhumbehav.2007.07.005; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lee L, 2008, PSYCHOL SCI, V19, P669, DOI 10.1111/j.1467-9280.2008.02141.x; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2008, EVOL HUM BEHAV, V29, P140, DOI 10.1016/j.evolhumbehav.2007.11.007; Little AC, 2011, BEHAV ECOL, V22, P862, DOI 10.1093/beheco/arr061; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Norman P. Li, 2007, [心理学报, Acta Psychologica Sinica], V39, P528; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; POMIANKOWSKI A, 1987, J THEOR BIOL, V128, P195, DOI 10.1016/S0022-5193(87)80169-8; Provost MP, 2006, ARCH SEX BEHAV, V35, P305, DOI 10.1007/s10508-006-9029-3; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Riebel Katharina, 2010, Communicative & Integrative Biology, V3, P271; Sacco DF, 2009, PERS INDIV DIFFER, V47, P777, DOI 10.1016/j.paid.2009.06.021; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; Smith FG, 2009, PERS INDIV DIFFER, V47, P476, DOI 10.1016/j.paid.2009.04.022; Swami V, 2007, J SOC PSYCHOL, V147, P15, DOI 10.3200/SOCP.147.1.15-26; Swami V, 2008, PERS INDIV DIFFER, V44, P98, DOI 10.1016/j.paid.2007.07.017; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; TC2 - Textile/Clothing Technology Corporation, 2010, 3D BOD SCANN SPEC; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; Waynforth D, 2005, EVOL HUM BEHAV, V26, P409, DOI 10.1016/j.evolhumbehav.2005.03.003; Welling LLM, 2008, HORM BEHAV, V54, P703, DOI 10.1016/j.yhbeh.2008.07.012	64	23	24	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52532	10.1371/journal.pone.0052532	http://dx.doi.org/10.1371/journal.pone.0052532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300976	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900028
J	Alves, GS; O'Dwyer, L; Jurcoane, A; Oertel-Knochel, V; Knochel, C; Prvulovic, D; Sudo, F; Alves, CE; Valente, L; Moreira, D; Fusser, F; Karakaya, T; Pantel, J; Engelhardt, E; Laks, J				Alves, Gilberto Sousa; O'Dwyer, Laurence; Jurcoane, Alina; Oertel-Knoechel, Viola; Knoechel, Christian; Prvulovic, David; Sudo, Felipe; Alves, Carlos Eduardo; Valente, Letice; Moreira, Denise; Fusser, Fabian; Karakaya, Tarik; Pantel, Johannes; Engelhardt, Eliasz; Laks, Jerson			Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients	PLOS ONE			English	Article							RAT SPINAL-CORD; SPATIAL STATISTICS; CORPUS-CALLOSUM; TENSOR TRACTOGRAPHY; UNCINATE FASCICULUS; WALLERIAN DEGENERATION; VOXELWISE ANALYSIS; AXONAL DAMAGE; BRAIN IMAGES; DISEASE	Alzheimers disease (AD) represents the most prevalent neurodegenerative disorder that causes cognitive decline in old age. In its early stages, AD is associated with microstructural abnormalities in white matter (WM). In the current study, multiple indices of diffusion tensor imaging (DTI) and brain volumetric measurements were employed to comprehensively investigate the landscape of AD pathology. The sample comprised 58 individuals including cognitively normal subjects (controls), amnestic mild cognitive impairment (MCI) and AD patients. Relative to controls, both MCI and AD subjects showed widespread changes of anisotropic fraction (FA) in the corpus callosum, cingulate and uncinate fasciculus. Mean diffusivity and radial changes were also observed in AD patients in comparison with controls. After controlling for the gray matter atrophy the number of regions of significantly lower FA in AD patients relative to controls was decreased; nonetheless, unique areas of microstructural damage remained, e. g., the corpus callosum and uncinate fasciculus. Despite sample size limitations, the current results suggest that a combination of secondary and primary degeneration occurrs in MCI and AD, although the secondary degeneration appears to have a more critical role during the stages of disease involving dementia.	[Alves, Gilberto Sousa; Sudo, Felipe; Alves, Carlos Eduardo; Valente, Letice; Engelhardt, Eliasz; Laks, Jerson] Univ Fed Rio de Janeiro, Inst Psychiat, Alzheimers Dis Ctr, BR-21941 Rio De Janeiro, Brazil; [Engelhardt, Eliasz] Univ Fed Rio de Janeiro, Inst Neurol, Cognit & Behav Neurol Unit, BR-21941 Rio De Janeiro, Brazil; [Moreira, Denise] Univ Fed Rio de Janeiro, Procardiaco Hosp, Inst Neurol Deolindo Couto, Serv Radiol, BR-21941 Rio De Janeiro, Brazil; [Alves, Gilberto Sousa; O'Dwyer, Laurence; Oertel-Knoechel, Viola; Knoechel, Christian; Prvulovic, David; Fusser, Fabian; Karakaya, Tarik] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany; [Moreira, Denise] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany; [Pantel, Johannes] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Alves, GS (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Alzheimers Dis Ctr, BR-21941 Rio De Janeiro, Brazil.	gsalves123@hotmail.com	Sudo, Felipe Kenji/P-3090-2016; Alves, Gilberto S./J-9515-2012; Pantel, Johannes/ABC-6341-2020; Jurcoane, Alina/E-7982-2010	Sudo, Felipe Kenji/0000-0003-4738-1368; Alves, Gilberto S./0000-0002-0463-6183; Jurcoane, Alina/0000-0001-5571-9635	Fundacao Universitaria Jose Bonifacio [11112-4]; Brazilian National Council of Research (CNPq); CNPq in exchange cooperation program [290012/2009-0]; Deutscher Akademischer Austauschdienst (DAAD)	Fundacao Universitaria Jose Bonifacio; Brazilian National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq in exchange cooperation program(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Fundacao Universitaria Jose Bonifacio (Nr. 11112-4). Dr. Jerson Laks received funding as a researcher 2 from the Brazilian National Council of Research (CNPq). Dr. Gilberto Sousa Alves was also supported from the CNPq in exchange cooperation program (Nr. 290012/2009-0) with the Deutscher Akademischer Austauschdienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Berlow YA, 2010, INT J GERIATR PSYCH, V25, P780, DOI 10.1002/gps.2418; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Chavez S, 2009, MAGN RESON MED, V62, P510, DOI 10.1002/mrm.22019; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Cole M, 1964, ARCH NEUROL-CHICAGO, V11, DOI [10.1001/archneur.1964.00460240114017, DOI 10.1001/ARCHNEUR.1964.00460240114017]; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frisoni GB, 2007, NAT CLIN PRACT NEURO, V3, P620, DOI 10.1038/ncpneuro0638; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Moreira IDH, 2009, CAD SAUDE PUBLICA, V25, P1774, DOI 10.1590/S0102-311X2009000800013; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Ito S, 2008, CURR MED IMAGING REV, V4, P226, DOI 10.2174/157340508786404116; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; O'Dwyer L, 2011, PLOS ONE, V6, DOI [10.1371/journal.-pone.0021745, DOI 10.1371/JOURNAL.-PONE.0021745]; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reisberg B, 1999, EUR ARCH PSY CLIN N, V249, P28; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shim YS, 2008, CLIN NEUROL NEUROSUR, V110, P552, DOI 10.1016/j.clineuro.2008.02.021; Shu N, 2011, J ALZHEIMERS DIS, V26, P275, DOI 10.3233/JAD-2011-0024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weintraub S., 1978, BOSTON NAMING TEST E; Xie S, 2005, NEUROREPORT, V16, P1275, DOI 10.1097/01.wnr.0000174061.41897.ee; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zarei M, 2009, STROKE, V40, P773, DOI 10.1161/STROKEAHA.108.530832; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	91	52	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52859	10.1371/journal.pone.0052859	http://dx.doi.org/10.1371/journal.pone.0052859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300797	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600030
J	Luhken, G; Fleck, K; Pauciullo, A; Huisinga, M; Erhardt, G				Luehken, Gesine; Fleck, Katharina; Pauciullo, Alfredo; Huisinga, Maike; Erhardt, Georg			Familiar Hypopigmentation Syndrome in Sheep Associated with Homozygous Deletion of the Entire Endothelin Type-B Receptor Gene	PLOS ONE			English	Article							WHITE FOAL SYNDROME; OVERO SPOTTED HORSES; HIRSCHSPRUNG-DISEASE; WAARDENBURG-SYNDROME; LETHAL WHITE; INTERSTITIAL DELETION; INTESTINAL AGANGLIONOSIS; RIVER BUFFALO; FRAGILE SITES; 13Q DELETION	In humans, rodents and horses, pigmentary anomalies in combination with other disorders, notably intestinal aganglionosis, are associated with variants of the endothelin type-B receptor gene (EDNRB). In an inbred Cameroon sheep flock, five white lambs with light blue eyes were sired from the same ram and died within a few hours up to a few days after birth, some of them with signs of intestinal obstruction. The aim of this study was to investigate if the observed hypopigmentation and a possible lethal condition were associated with a molecular change at the ovine EDNRB locus, and to check if such a genetic alteration also occurs in other Cameroon sheep flocks. Sequence analysis revealed a deletion of about 110 kb on sheep chromosome 10, comprising the entire EDNRB gene, on both chromosomes in the two available hypopigmented lambs and on a single chromosome in the two dams and three other unaffected relatives. This micro-chromosomal deletion was also confirmed by quantitative real-time PCR and by fluorescence in situ hybridization. Genotyping of a total of 127 Cameroon sheep in 7 other flocks by duplex PCR did not identify additional carriers of the deletion. Although both hypopigmented lambs available for post-mortem examination had a considerably dilated cecum and remaining meconium, histopathological examination of intestinal samples showed morphologically normal ganglion cells in appropriate number and distribution. This is to our knowledge the first description of an ENDRB gene deletion and associated clinical signs in a mammalian species different from humans and rodents. In humans and rats it is postulated that the variable presence and severity of intestinal aganglionosis and other features in individuals with EDNRB deletion is due to a variable genetic background and multiple gene interactions. Therefore the here analyzed sheep are a valuable animal model to test these hypotheses in another species.	[Luehken, Gesine; Fleck, Katharina; Pauciullo, Alfredo; Erhardt, Georg] Univ Giessen, Dept Anim Breeding & Genet, D-35390 Giessen, Germany; [Huisinga, Maike] Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Luhken, G (corresponding author), Univ Giessen, Dept Anim Breeding & Genet, D-35390 Giessen, Germany.	Gesine.Luehken@agrar.uni-giessen.de	Pauciullo, Alfredo/AAF-7713-2020	Pauciullo, Alfredo/0000-0002-3140-9373				Ali A, 2008, J GENET, V87, P219, DOI 10.1007/s12041-008-0035-1; ARAI H, 1993, J BIOL CHEM, V268, P3463; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; Bonnet JP, 1996, EUR J PEDIATR SURG, V6, P245, DOI 10.1055/s-2008-1066521; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Hilbe M, 2005, J COMP PATHOL, V132, P223, DOI 10.1016/j.jcpa.2004.07.002; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Huisinga M, 2008, VET PATHOL, V45, P63, DOI 10.1354/vp.45-1-63; HULTGREN BD, 1982, J AM VET MED ASSOC, V180, P289; Iannuzzi L, 2001, CYTOGENET CELL GENET, V94, P43, DOI 10.1159/000048781; Iannuzzi L, 2008, J APPL GENET, V49, P357, DOI 10.1007/BF03195634; Jimenez A, 2007, J VET MED A, V54, P103, DOI 10.1111/j.1439-0442.2007.00871.x; Karaki H, 1996, BIOCHEM BIOPH RES CO, V222, P139, DOI 10.1006/bbrc.1996.0711; Kutzbach B, 2007, J AAPOS, V11, P513, DOI 10.1016/j.jaapos.2007.04.012; LAMONT MA, 1989, J MED GENET, V26, P100, DOI 10.1136/jmg.26.2.100; MCCABE L, 1990, AM J MED GENET, V36, P336, DOI 10.1002/ajmg.1320360319; McCallion AS, 2001, PIGM CELL RES, V14, P161, DOI 10.1034/j.1600-0749.2001.140305.x; Meier-Ruge WA, 2004, EUR J PEDIATR SURG, V14, P392, DOI 10.1055/s-2004-830354; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; MONTGOMERY GW, 1990, NEW ZEAL J AGR RES, V33, P437, DOI 10.1080/00288233.1990.10428440; Nicodemo D, 2008, CYTOGENET GENOME RES, V120, P178, DOI 10.1159/000118760; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Santschi EM, 1998, MAMM GENOME, V9, P306, DOI 10.1007/s003359900754; Schlapfer J, 1997, MAMM GENOME, V8, P380, DOI 10.1007/s003359900447; SCHNEIDER JE, 1978, J EQUINE MED SURG, V2, P479; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Shanske A, 2001, AM J MED GENET, V102, P231, DOI 10.1002/ajmg.1451; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; TROMMERSHAUSENSMITH A, 1977, THERIOGENOLOGY, V8, P303, DOI 10.1016/0093-691X(77)90237-0; Tuysuz B, 2009, AM J MED GENET A, V149A, P2290, DOI 10.1002/ajmg.a.33031; VANCAMP G, 1995, J MED GENET, V32, P531, DOI 10.1136/jmg.32.7.531; VONDERFECHT SL, 1983, VET PATHOL, V20, P65, DOI 10.1177/030098588302000107; Weigel BJ, 1998, AM J MED GENET, V77, P285, DOI 10.1002/(SICI)1096-8628(19980526)77:4<285::AID-AJMG7>3.0.CO;2-M; Yang GC, 1998, HUM MOL GENET, V7, P1047, DOI 10.1093/hmg/7.6.1047	39	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53020	10.1371/journal.pone.0053020	http://dx.doi.org/10.1371/journal.pone.0053020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300849	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600047
J	Vegfors, J; Petersson, S; Kovacs, A; Polyak, K; Enerback, C				Vegfors, Jenny; Petersson, Stina; Kovacs, Aniko; Polyak, Kornelia; Enerback, Charlotta			The Expression of Psoriasin (S100A7) and CD24 Is Linked and Related to the Differentiation of Mammary Epithelial Cells	PLOS ONE			English	Article							CARCINOMA IN-SITU; HUMAN BREAST-CARCINOMA; DUCTAL CARCINOMA; CANCER DEVELOPMENT; CALGRANULIN-B; PROGRESSION; GROWTH; PROTEINS; RECEPTOR; CULTURE	Psoriasin (S100A7), a member of the S100 family of calcium-binding proteins, is highly expressed in high-grade ductal carcinoma in situ (DCIS) and in the benign hyperproliferative skin disorder psoriasis. The gene that encodes psoriasin and many other S100 genes are located within a gene cluster on chromosome region 1q21, known as the epidermal differentiation complex. This cluster contains genes for several differentiation markers that play important roles in the terminal differentiation of the epidermis. The purpose of the present study was to evaluate the role of psoriasin in the differentiation process of mammary epithelial cells. Normal mammary epithelial cells (MCF10A) cultured in confluence and suspension, conditions known to induce psoriasin expression, demonstrated a shift towards a more differentiated phenotype indicated by an increase in the expression of the luminal differentiation markers CD24 and MUC1 and the reduced expression of the breast stem cell marker CD44. The expression of psoriasin and MUC1 was most pronounced in the CD24(+)-enriched fraction of confluent MCF10A cells. The shift towards a more differentiated phenotype was abolished upon the downregulation of psoriasin using short hairpin RNA (shRNA) and small interfering RNA (siRNA). Using specific inhibitors, we showed that psoriasin and CD24 expression was regulated by reactive oxygen species (ROS) and the nuclear factor (NF)-kappa B signaling pathways. While immunohistochemical analyses of DCIS showed heterogeneity, the expression of psoriasin and CD24 showed a similar staining pattern. Our findings suggest that the expression of psoriasin is linked to the luminal differentiation marker CD24 in mammary epithelial cells. Psoriasin demonstrated an essential role in the shift towards a more differentiated CD24(+) phenotype, supporting the hypothesis that psoriasin plays a role in the differentiation of luminal mammary epithelial cells.	[Vegfors, Jenny; Petersson, Stina; Enerback, Charlotta] Linkoping Univ, Ingrid Asp Psoriasis Res Ctr, Dept Clin & Expt Med, Linkoping, Sweden; [Kovacs, Aniko] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Linkoping University; Sahlgrenska University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Enerback, C (corresponding author), Linkoping Univ, Ingrid Asp Psoriasis Res Ctr, Dept Clin & Expt Med, Linkoping, Sweden.	charlotta.enerback@liu.se			Ingrid Asp Foundation; Swedish Cancer Society; Swedish Psoriasis Association; Welander Foundation	Ingrid Asp Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Psoriasis Association; Welander Foundation	This study was supported by grants from the Ingrid Asp Foundation, the Swedish Cancer Society, the Swedish Psoriasis Association and the Welander Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; BORGLUM AD, 1995, HUM GENET, V96, P592; Cabezon T, 2009, MOL ONCOL; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Carlsson H, 2005, INT J ONCOL, V27, P1473; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; Fogel M, 1999, CANCER LETT, V143, P87, DOI 10.1016/S0304-3835(99)00195-0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Lee JH, 2009, ONCOL REP, V22, P1149, DOI 10.3892/or_00000548; Leygue E, 1996, CANCER RES, V56, P4606; Martinsson H, 2005, EXP DERMATOL, V14, P161, DOI 10.1111/j.0906-6705.2005.00239.x; Martinsson H, 2004, EXP DERMATO IN PRESS; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Petersson S, 2011, BREAST CANCER RES TR, V125, P13, DOI 10.1007/s10549-010-0820-4; Petersson S, 2010, BREAST CANC RES TREA; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Porter D, 2003, MOL CANCER RES, V1, P362; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Shubbar E, 2011, BREAST CANC RES TREA; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53119	10.1371/journal.pone.0053119	http://dx.doi.org/10.1371/journal.pone.0053119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300877	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100122
J	Villa-Galaviz, E; Boege, K; del-Val, E				Villa-Galaviz, Edith; Boege, Karina; del-Val, Ek			Resilience in Plant-Herbivore Networks during Secondary Succession	PLOS ONE			English	Article							TROPICAL FOREST; COMMUNITIES; NESTEDNESS; DIVERSITY; HABITAT; ASSEMBLAGES; RICHNESS; UPLAND	Extensive land-use change in the tropics has produced a mosaic of successional forests within an agricultural and cattle-pasture matrix. Post-disturbance biodiversity assessments have found that regeneration speed depends upon propagule availability and the intensity and duration of disturbance. However, reestablishment of species interactions is still poorly understood and this limits our understanding of the anthropogenic impacts upon ecosystem resilience. This is the first investigation that evaluates plant-herbivore interaction networks during secondary succession. In particular we investigated succession in a Mexican tropical dry forest using data of caterpillar associations with plants during 2007-2010. Plant-herbivore networks showed high resilience. We found no differences in most network descriptors between secondary and mature forest and only recently abandoned fields were found to be different. No significant nestedness or modularity network structure was found. Plant-herbivore network properties appear to quickly reestablish after perturbation, despite differences in species richness and composition. This study provides some valuable guidelines for the implement of restoration efforts that can enhance ecological processes such as the interaction between plants and their herbivores.	[Villa-Galaviz, Edith; del-Val, Ek] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Boege, Karina] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	del-Val, E (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	ekdelval@oikos.unam.mx	Paré, Karina Boege/AAP-9596-2021; Villa-Galaviz, Edith/ABB-9896-2020; del val, Ek/AAB-8343-2019	del-val, ek/0000-0003-3862-1024; Villa-Galaviz, Edith/0000-0002-2783-7877	Conacyt;  [PAPIIT-UNAM- IN208610]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This study was supported by PAPIIT-UNAM- IN208610 and PAPIIT-UNAM- IN208610, EVG received a grant from Conacyt for graduate studies and acknowledges the academic support provided by the Posgrado en Ciencias Biologicas-UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Chazdon Robin L., 2011, P195; Crawley M. J, 2002, STAT COMPUTING INTRO; Avila-Cabadilla LD, 2009, FOREST ECOL MANAG, V258, P986, DOI 10.1016/j.foreco.2008.12.011; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Dormann C.F., 2008, R NEWS, V8, P8; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; FAO, 2020, GLOBAL FOREST RESOUR; Godinez MC, 2011, PLANTAS UTILES POTEN; Guariguata MR, 2002, ECOLOGIA CONSERVACIO, P591; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; Kitching RL, 2000, J APPL ECOL, V37, P284, DOI 10.1046/j.1365-2664.2000.00490.x; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lebrija-Trejos E, 2008, PERSPECT PLANT ECOL, V12, P267; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lopez-Carretero A, 2010, COMPOSICION DIVERSID; LOTT EJ, 1987, BIOTROPICA, V19, P228, DOI 10.2307/2388340; Martinez-Garza C, 2003, J APPL ECOL, V40, P423, DOI 10.1046/j.1365-2664.2003.00819.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Newman M. E. J., 2004, PHYS REV, V69; Noguera F, 2002, HIST NATURAL CHAMELA; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Nylin S, 1999, HERBIVORES PLANTS PR, P175; Passmore HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040803; Pescador-Rubio A, 2002, HIST NATURAL CHAMELA, P183; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; R Core Team, 2021, R LANGUAGE ENV STAT; Sanchez-Azofeifa GA, 2009, FOREST ECOL MANAG, V258, P907, DOI 10.1016/j.foreco.2008.10.030; Sanchez-Azofeifa GA, 2005, CONSERV BIOL, V19, P285, DOI 10.1111/j.1523-1739.2005.s01_1.x; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; WRIGHT SJ, 1992, TRENDS ECOL EVOL, V7, P260, DOI 10.1016/0169-5347(92)90171-7	49	46	46	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53009	10.1371/journal.pone.0053009	http://dx.doi.org/10.1371/journal.pone.0053009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300846	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100107
J	Contreras, V; Urien, C; Jouneau, L; Bourge, M; Bouet-Cararo, C; Bonneau, M; Zientara, S; Klonjkowski, B; Schwartz-Cornil, I				Contreras, Vanessa; Urien, Celine; Jouneau, Luc; Bourge, Mickael; Bouet-Cararo, Coraline; Bonneau, Michel; Zientara, Stephan; Klonjkowski, Bernard; Schwartz-Cornil, Isabelle			Canine Recombinant Adenovirus Vector Induces an Immunogenicity-Related Gene Expression Profile in Skin-Migrated CD11b(+)-Type DCs	PLOS ONE			English	Article							LYMPH DENDRITIC CELLS; RECEPTOR PATHWAY; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; TYPE-35 VECTORS; IN-VITRO; VACCINE; EFFICACY; SUBSETS; VIRUS	Gene expression profiling of the blood cell response induced early after vaccination has previously been demonstrated to predict the immunogenicity of vaccines. In this study, we evaluated whether the analysis of the gene expression profile of skin-migrated dendritic cells (DCs) could be informative for the in vitro prediction of immunogenicity of vaccine, using canine adenovirus serotype 2 (CAV2) as vaccine vector. CAV2 has been shown to induce immunity to transgenes in several species including sheep and is an interesting alternative to human adenovirus-based vectors, based on the safety records of the parental strain in dogs and the lack of pre-existing immunity in non-host species. Skin-migrated DCs were collected from pseudo-afferent lymph in sheep. Both the CD11b(+)-type and CD103(+)-type skin-migrated DCs were transduced by CAV2. An analysis of the global gene response to CAV2 in the two skin DC subsets showed that the gene response in CD11b+-type DCs was far higher and broader than in the CD103(+)-type DCs. A newly released integrative analytic tool from Ingenuity systems revealed that the CAV2-modulated genes in the CD11b(+)-type DCs clustered in several activated immunogenicity-related functions, such as immune response, immune cell trafficking and inflammation. Thus gene profiling in skin-migrated DC in vitro indicates that the CD11b(+) DC type is more responsive to CAV2 than the CD103(+) DC type, and provides valuable information to help in evaluating and possibly improving viral vector vaccine effectiveness.	[Bonneau, Michel; Schwartz-Cornil, Isabelle] INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France; [Bourge, Mickael] CNRS, IMAGIF, Gif Sur Yvette, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] INRA, UMR Virol, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Univ Paris Est, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Ecole Natl Vet Alfort, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Agence Natl Securite Sanit Alimentat Environm & T, Maisons Alfort, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Schwartz-Cornil, I (corresponding author), INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr	Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021; Jouneau, Luc/AAC-4711-2020; schwartz-cornil, isabelle/D-8547-2011; Klonjkowski, Bernard/N-7785-2019	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503; Bourge, Mickael/0000-0002-4111-6208; Klonjkowski, Bernard/0000-0003-3372-0656; Contreras, Vanessa/0000-0003-4072-9819	Agence Nationale pour la Recherche [ANR 06 GANI 015-03, ANR 09 BLAN 0073]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale pour la Recherche (VacGenDC ANR 06 GANI 015-03; PhylogenDC, ANR 09 BLAN 0073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WC, 2009, J GEN VIROL, V90, P1600, DOI 10.1099/vir.0.008342-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bouet-Cararo C, 2011, VACCINE, V29, P1304, DOI 10.1016/j.vaccine.2010.11.068; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Buschow SI, 2010, IMMUNITY, V32, P149, DOI 10.1016/j.immuni.2010.02.006; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Combadiere B, 2008, COMP IMMUNOL MICROB, V31, P293, DOI 10.1016/j.cimid.2007.07.015; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Cubillos-Zapata C, 2011, J VIROL, V85, P9385, DOI 10.1128/JVI.05127-11; de Gruijl TD, 2006, J IMMUNOL, V177, P2208, DOI 10.4049/jimmunol.177.4.2208; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Hangalapura BN, 2011, VACCINE, V29, P2313, DOI 10.1016/j.vaccine.2011.01.022; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Henning P, 2011, EUR J IMMUNOL, V41, P2185, DOI 10.1002/eji.201041009; Hu RL, 2007, VACCINE, V25, P5301, DOI 10.1016/j.vaccine.2007.05.024; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; Keriel A, 2006, J VIROL, V80, P1487, DOI 10.1128/JVI.80.3.1487-1496.2006; Kremer EJ, 2004, J GENE MED, V6, pS139, DOI 10.1002/jgm.497; Kushwah R, 2011, IMMUNOLOGY, V133, P409, DOI 10.1111/j.1365-2567.2011.03457.x; Lindsay RWB, 2010, J IMMUNOL, V185, P1513, DOI 10.4049/jimmunol.1000338; Liu Y, 2008, VACCINE, V26, P5368, DOI 10.1016/j.vaccine.2008.08.001; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016320; Miller G, 2003, CANCER IMMUNOL IMMUN, V52, P347, DOI 10.1007/s00262-003-0379-6; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nalubarnba KS, 2007, VET IMMUNOL IMMUNOP, V118, P252, DOI 10.1016/j.vetimm.2007.05.018; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Perreau M, 2006, MOL BIOTECHNOL, V34, P247, DOI 10.1385/MB:34:2:247; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Schwartz-Cornil I, 2006, NAT PROTOC, V1, P874, DOI 10.1038/nprot.2006.147; Smyth GK, 2004, STAT APPL GENETICS M; Soudais C, 2000, J VIROL, V74, P10639, DOI 10.1128/JVI.74.22.10639-10649.2000; Top S, 2011, J VIROL, V85, P12982, DOI 10.1128/JVI.00128-11; Verhaagh S, 2006, J GEN VIROL, V87, P255, DOI 10.1099/vir.0.81293-0; Yuan ZG, 2009, VACCINE, V27, P5247, DOI 10.1016/j.vaccine.2009.06.062; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52513	10.1371/journal.pone.0052513	http://dx.doi.org/10.1371/journal.pone.0052513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300693	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800098
J	Fleischman, D; Berdahl, JP; Zaydlarova, J; Stinnett, S; Fautsch, MP; Allingham, RR				Fleischman, David; Berdahl, John P.; Zaydlarova, Jana; Stinnett, Sandra; Fautsch, Michael P.; Allingham, R. Rand			Cerebrospinal Fluid Pressure Decreases with Older Age	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; OCULAR HYPERTENSION; CHOROID-PLEXUS; CSF PRESSURE; RISK-FACTORS; PREVALENCE; POPULATION	Purpose: Clinical studies implicate low cerebrospinal fluid pressure (CSFP) or a high translaminar pressure difference in the pathogenesis of primary open angle glaucoma (POAG) and normal tension glaucoma (NTG). This study was performed to examine the effect of age, sex, race and body mass index (BMI) on CSFP. Methods: Electronic medical records from all patients who had a lumbar puncture (LP) performed at the Mayo Clinic from 1996-2009 were reviewed. Information including age, sex, race, height and weight, ocular and medical diagnoses, intraocular pressure (IOP) and LP opening pressure was obtained. Patients using medications or with medical diagnoses known to affect CSFP, and those who underwent neurosurgical procedures or where more than one LP was performed were excluded from analysis. Results: Electronic medical records of 33,922 patients with a history of having an LP during a 13-year period (1996-2009) were extracted. Of these, 12,118 patients met all entry criteria. Relative to mean CSFP at age group 20-49 (mean 11.5 +/- 2.8 mmHg), mean CSFP declined steadily after age 50, with percent reduction of 2.5% for the 50-54 age group (mean 11.2 +/- 2.7 mmHg, p<0.002) to 26.9% for the 90-95 group (mean 8.4 +/- 2.4 mmHg, p<0.001). Females had lower CSFP than males throughout all age groups. BMI was positively and independently associated with CSFP within all age groups. Conclusion: There is a sustained and significant reduction of CSFP with age that begins in the 6th decade. CSFP is consistently lower in females. BMI is positively and independently associated with CSFP in all age groups. The age where CSFP begins to decline coincides with the age where the prevalence of POAG increases. These data support the hypothesis that reduced CSFP may be a risk factor for POAG and may provide an explanation for the mechanism that underlies the age-related increase in the prevalence of POAG and NTG.	[Fleischman, David] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA; [Berdahl, John P.] Univ S Dakota, Med Ctr, Sioux Falls, SD USA; [Zaydlarova, Jana; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Stinnett, Sandra; Allingham, R. Rand] Duke Univ, Ctr Eye, Durham, NC 27706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of South Dakota; Mayo Clinic; Duke University	Allingham, RR (corresponding author), Duke Univ, Ctr Eye, Durham, NC 27706 USA.	rand.allingham@duke.edu		Stinnett, Sandra/0000-0001-7192-0195	National Institutes of Health [EY 15736, EY 07065]; Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY; Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE [R01EY015736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health research grants EY 15736 (MPF), EY 07065 (MPF); Mayo Foundation, Rochester, MN (MPF); and Research to Prevent Blindness, New York, NY (MPF is a recipient of a Lew R. Wasserman Merit Award and the Department of Ophthalmology, Mayo Clinic; Department of Ophthalmology, University of North Carolina Hospitals, and Duke University Eye Center are recipients of unrestricted grants). The funding agencies had no role in the design or conduct of this research.	Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; [Anonymous], 1995, PHYS STAT US INT ANT; Anton A, 2004, J GLAUCOMA, V13, P371; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; FARACI FM, 1990, AM J PHYSIOL, V258, pR94, DOI 10.1152/ajpregu.1990.258.1.R94; Fishman RA, 1992, CEREBROSPINAL FLUID, P71; Fleischman D, 2011, OPHTHALMOLOGY, V118, P1225, DOI 10.1016/j.ophtha.2011.01.025; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Francis BA, 2011, INVEST OPHTH VIS SCI, V52, P6257, DOI 10.1167/iovs.09-5126; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Frolkis VV, 1999, ARCH GERONTOL GERIAT, V29, P193; GILLAND O, 1974, J NEUROSURG, V40, P587, DOI 10.3171/jns.1974.40.5.0587; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Herndon LW, 2004, ARCH OPHTHALMOL-CHIC, V122, P17, DOI 10.1001/archopht.122.1.17; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Karahalios DG, 1996, NEUROLOGY, V46, P198, DOI 10.1212/WNL.46.1.198; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Malm J, 2011, NEUROLOGY, V76, P903, DOI 10.1212/WNL.0b013e31820f2dd0; Masserman JH, 1935, ARCH NEURO PSYCHIATR, V34, P564, DOI 10.1001/archneurpsyc.1935.02250210085006; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; McComb J, 1990, PATHOPHYSIOLOGY BLOO, P421; McComb JG., 1984, HYDROCEPHALUS, P83; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Nagra G, 2007, NEUROPATH APPL NEURO, V33, P684, DOI 10.1111/j.1365-2990.2007.00857.x; Nizankowska Maria Hanna, 2004, Klin Oczna, V106, P147; Nizankowska MH, 2005, OPHTHAL EPIDEMIOL, V12, P363, DOI 10.1080/09286580500212904; Papaiconomou C, 2004, CHILD NERV SYST, V20, P29, DOI 10.1007/s00381-003-0840-z; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Saenz-Frances F, 2011, INVEST OPHTH VIS SCI, V52, P3683, DOI 10.1167/iovs.10-6660; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Sugerman HJ, 1997, NEUROLOGY, V49, P507, DOI 10.1212/WNL.49.2.507; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wu RY, 2011, INVEST OPHTH VIS SCI, V52, P1320, DOI 10.1167/iovs.10-6038; Yoshida M, 2001, J CLIN EPIDEMIOL, V54, P1151, DOI 10.1016/S0895-4356(01)00388-2; Zakharov A, 2004, MICROVASC RES, V67, P96, DOI 10.1016/j.mvr.2003.08.004	64	89	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52664	10.1371/journal.pone.0052664	http://dx.doi.org/10.1371/journal.pone.0052664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300737	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800123
J	Ge, SQ; Wipfler, B; Pohl, H; Hua, Y; Slipinski, A; Yang, XK; Beutel, RG				Ge, Si-Qin; Wipfler, Benjamin; Pohl, Hans; Hua, Yi; Slipinski, Adam; Yang, Xing-Ke; Beutel, Rolf Georg			The First Complete 3D Reconstruction of a Spanish Fly Primary Larva (Lytta vesicatoria, Meloidae, Coleoptera)	PLOS ONE			English	Article							BLISTER BEETLE GENUS; INSTAR LARVAE; PHYLOGENETIC IMPLICATIONS; SYSTEMATIC POSITION; HEAD MORPHOLOGY; WORLD GENERA; MINIATURIZATION; TENEBRIONOIDEA; KEY; CYANEOLYTTA	The first detailed anatomical study of a primary larva of Meloidae is presented. Thereby techniques such as three-dimensional reconstructions, microtome sections, SEM (scanning electronic microscopy) and CLSM (confocal laser scanning microscopy) are applied. The structural features are discussed in the context of phylogeny, but also possible correlations with parasitism, phoresy and miniaturisation. The triungulin first instar larva is likely an apomorphy of Meloidae excl. Eleticinae and linked with a specialisation on acridoid eggs or larvae and provisions of bees. The campodeid body shape of Lytta and Meloinae is a groundplan feature of Meloidae, whereas a navicular body is an autapomorphy of the generally phoretic larvae of Nemognathinae. Head structures of Lytta and features of the postcephalic body are largely plesiomorphic. The musculature of the head is only moderately simplified while the one of the postcephalic body is well developed. Its thorax is largely characterised by plesiomorphies. The characteristics of the legs suggest phoretic habits, even though this does not apply to larvae of Lytta. It is conceivable that a phoretic behaviour is secondarily lost, together with some but not all morphological modifications related to it. Derived features of the abdomen of Meloidae are the complete loss of the fixed urogomphi (also missing in Rhipiphoridae and other related groups) and the presence of one or two conspicuous caudal bristles. Only few features of Lytta are shared with the parasitic larvae of Rhipiphoridae and Strepsiptera. These characteristics, which are possibly linked with specialised life habits, have obviously evolved independently. Miniaturisation effects are minimal in the larvae of Lytta.	[Ge, Si-Qin; Wipfler, Benjamin; Hua, Yi; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ge, Si-Qin; Wipfler, Benjamin; Pohl, Hans; Beutel, Rolf Georg] Univ Jena, Entomol Grp, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum, Jena, Germany; [Slipinski, Adam] Australian Natl Insect Collect, CSIRO Ecosyst Sci, Canberra, ACT, Australia	Chinese Academy of Sciences; Institute of Zoology, CAS; Friedrich Schiller University of Jena; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yang, XK (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn	Pohl, Hans/M-6873-2019; Slipinski, Stanislaw Adam/B-4293-2009; Wipfler, Benjamin/M-2926-2015; Slipinski, Adam/AAZ-2485-2020	Slipinski, Adam/0000-0002-1216-8068; Pohl, Hans/0000-0002-7090-6612; Beutel, Rolf Georg/0000-0002-0433-7626	National Science Foundation of China [31010103913, 30970390]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX3-IOZ-1004]; National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy) [NSFC-J0630964/J0109, J0930004]; DFG [BE1789/61]; Chinese Academy of Sciences Fellowship for Young International Scientist [2011Y2SB05]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy); DFG(German Research Foundation (DFG)); Chinese Academy of Sciences Fellowship for Young International Scientist	The project partly supported by grants from the National Science Foundation of China (Grant Nos. 31010103913 and 30970390), the Knowledge Innovation Program of Chinese Academy of Sciences (No. KSCX3-IOZ-1004), the National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0630964/J0109, J0930004). BW is supported by the DFG (grant number BE1789/61) and the Chinese Academy of Sciences Fellowship for Young International Scientist (grant number 2011Y2SB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi, 1994, EOS, V69, P45; Beutel R. G., 1999, Tijdschrift voor Entomologie, V142, P9; Beutel R.G., 1994, Koleopterologische Rundschau, V64, P103; Beutel RG, 1998, ZOOMORPHOLOGY, V118, P103, DOI 10.1007/s004350050061; Beutel RG, 2005, EUR J ENTOMOL, V102, P241, DOI 10.14411/eje.2005.037; BEUTEL RG, 1993, SYST ENTOMOL, V18, P127, DOI 10.1111/j.1365-3113.1993.tb00658.x; Beutel RG, 2002, SYST ENTOMOL, V27, P169, DOI 10.1046/j.1365-3113.2002.00172.x; Beutel RG, 2002, EUR J ENTOMOL, V99, P53, DOI 10.14411/eje.2002.011; Beutel RG, 1995, J ZOOL SYST EVOL RES, V33, P145; Beutel RG, 2001, EUR J ENTOMOL, V98, P219, DOI 10.14411/eje.2001.039; Beutel RG, 2000, INVERTEBR TAXON, V14, P825, DOI 10.1071/IT00030; BOLOGNA M A, 1992, Tropical Zoology, V5, P55; Bologna MA, 2003, ANN SOC ENTOMOL FR, V39, P139, DOI 10.1080/00379271.2003.10697369; Bologna MA, 2002, J NAT HIST, V36, P2013, DOI 10.1080/00222930110062318; Bologna MA, 2001, AFR ENTOMOL, V9, P105; Bologna MA, 1998, TROP ZOOL, V11, P19, DOI 10.1080/03946975.1998.10539352; Bologna MA, 1995, B ZOOL, V62, P383, DOI 10.1080/11250009509356093; Bologna MA, 2001, SYST ENTOMOL, V26, P33, DOI 10.1046/j.1365-3113.2001.00132.x; Bologna MA, 2010, HDB ZOOLOGY, V2, P681; Bologna MA, 2008, CONTRIB ZOOL, V77, P227, DOI 10.1163/18759866-07704003; Bouchard P, 2005, ANN ZOOL, V55, P499; Crowson RA, 1981, BIOL COLEOPTERA; Di Giulio A, 2003, TROP ZOOL, V16, P165, DOI 10.1080/03946975.2003.10531193; DYBAS H S, 1976, Fieldiana Zoology, V70, P29; Grebennikov VV, 2002, ARTHROPOD STRUCT DEV, V31, P157, DOI 10.1016/S1467-8039(02)00022-1; Josting E. A., 1942, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V67, P381; KINZELBACH R K, 1971, Zoologica (Stuttgart), V41, P1; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; Niehuis O, 2012, CURRENT BIOL; PINTO J D, 1970, P222; Pinto JD, 1999, J NAT HIST, V33, P569, DOI 10.1080/002229399300254; Pinto JD, 1996, SYST ENTOMOL, V21, P63, DOI 10.1111/j.1365-3113.1996.tb00599.x; Pohl H, 2010, MICROSC RES TECHNIQ, V73, P1073, DOI 10.1002/jemt.20835; Pohl Hans, 2000, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V10, P1; Polilov AA, 2010, ARTHROPOD STRUCT DEV, V39, P52, DOI 10.1016/j.asd.2009.08.005; Polilov AA, 2009, ARTHROPOD STRUCT DEV, V38, P247, DOI 10.1016/j.asd.2008.11.003; Selander R.B., 1991, Insecta Mundi, V5, P65; SELANDER RB, 1987, DEUT ENTOMOL Z, V34, P341; SELANDER RB, 1982, J KANSAS ENTOMOL SOC, V55, P427; SELANDER RB, 1987, J KANSAS ENTOMOL SOC, V60, P288; SELANDER RICHARD B., 1960, ILLINOIS BIOL MONOGR, V28, P1; Tagwireyi D, 2000, TOXICON, V38, P1865, DOI 10.1016/S0041-0101(00)00093-3; Turco F, 2006, DEUT ENTOMOL Z, V53, P213, DOI 10.1002/mmnd.200600017; von Keler S., 1963, ENTOMOLOGISCHES WORT; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; YOUNG DK, 1991, CAN J ZOOL, V69, P2234, DOI 10.1139/z91-312	46	14	17	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52511	10.1371/journal.pone.0052511	http://dx.doi.org/10.1371/journal.pone.0052511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300692	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800097
J	Li, QY; Jiang, Y; Wei, W; Yang, HW; Liu, JL				Li, Qiuyun; Jiang, Yi; Wei, Wei; Yang, Huawei; Liu, Jianlun			Clinical Efficacy of Including Capecitabine in Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-II TRIAL; DOCETAXEL	Background: Capecitabine has proven effective as a chemotherapy for metastatic breast cancer. Though several Phase II/III studies of capecitabine as neoadjuvant chemotherapy have been conducted, the results still remain inconsistent. Therefore, we performed a meta-analysis to obtain more precise understanding of the role of capecitabine in neoadjuvant chemotherapy for breast cancer patients. Methods: The electronic database PubMed and online abstracts from ASCO and SABCS were searched to identify randomized clinical trials comparing neoadjuvant chemotherapy with or without capecitabine in early/operable breast cancer patients without distant metastasis. Risk ratios were used to estimate the association between capecitabine in neoadjuvant chemotherapy and various efficacy outcomes. Fixed- or random-effect models were adopted to pool data in RevMan 5.1. Results: Five studies were included in the meta-analysis. Neoadjuvant use of capecitabine with anthracycline and/or taxane based therapy was not associated with significant improvement in clinical outcomes including: pathologic complete response in breast (pCR; RR = 1.10, 95% CI 0.87-1.40, p = 0.43), pCR in breast tumor and nodes (tnpCR RR = 0.99, 95% CI 0.83-1.18, p = 0.90), overall response rate (ORR; RR = 1.00, 95% CI 0.94-1.07, p = 0.93), or breast-conserving surgery (BCS; RR = 0.98, 95% CI 0.93-1.04, p = 0.49). Conclusions: Neoadjuvant treatment of breast cancer involving capecitabine did not significantly improve pCR, tnpCR, BCS or ORR. Thus adding capecitabine to neoadjuvant chemotherapy regimes is unlikely to improve outcomes in breast cancer patients without distant metastasis. Further research is required to establish the condition that capecitabine may be useful in breast cancer neoadjuvant chemotherapy.	[Li, Qiuyun; Jiang, Yi; Wei, Wei; Yang, Huawei; Liu, Jianlun] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Nanning, Peoples R China	Guangxi Medical University	Liu, JL (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Nanning, Peoples R China.	jianlunliu@hotmail.com						Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Blum JL, 2001, ONCOLOGIST, V6, P56, DOI 10.1634/theoncologist.6-1-56; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Greil R, 2009, EJSO-EUR J SURG ONC, V35, P1048, DOI 10.1016/j.ejso.2009.01.014; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jinno H, 2010, ANN ONCOL, V21, P1262, DOI 10.1093/annonc/mdp428; Koukourakis GV, 2008, MOLECULES, V13, P1897, DOI 10.3390/molecules13081897; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Lebowitz PF, 2004, CLIN CANCER RES, V10, P6764, DOI 10.1158/1078-0432.CCR-04-0976; Lee KS, 2008, BREAST CANCER RES TR, V109, P481, DOI 10.1007/s10549-007-9672-y; Lu YS, 2011, CANCER CHEMOTH PHARM, V67, P1257, DOI 10.1007/s00280-010-1401-2; Lybaert W, 2005, EJC S, V105; O'Shaughnessy J, 2002, Eur J Cancer, V38 Suppl 2, P10, DOI 10.1016/S0959-8049(01)00416-6; Manga GP, 2010, BREAST CANCER-TOKYO, V17, P205, DOI 10.1007/s12282-009-0136-6; Perez-Manga G, 2005, EJC SUPPL, V3, P133; Reichardt P, 2003, ANN ONCOL, V14, P1227, DOI 10.1093/annonc/mdg346; Sawada N, 1998, CLIN CANCER RES, V4, P1013; Steger GG, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.530; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Villman K, 2007, EUR J CANCER, V43, P1153, DOI 10.1016/j.ejca.2007.02.002; von Minckwitz G, 2010, J CLIN ONCOL, V28, P2015, DOI 10.1200/JCO.2009.23.8303; Zambetti M, 2012, BREAST CANCER RES TR, V132, P843, DOI 10.1007/s10549-011-1660-6	25	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53403	10.1371/journal.pone.0053403	http://dx.doi.org/10.1371/journal.pone.0053403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301067	gold, Green Submitted, Green Published			2022-12-27	WOS:000313480000054
J	Lopez-Acosta, JF; Moreno-Amador, JL; Jimenez-Palomares, M; Diaz-Marrero, AR; Cueto, M; Perdomo, G; Cozar-Castellano, I				Francisco Lopez-Acosta, Jose; Luis Moreno-Amador, Jose; Jimenez-Palomares, Margarita; Diaz-Marrero, Ana R.; Cueto, Mercedes; Perdomo, German; Cozar-Castellano, Irene			Epoxypukalide Induces Proliferation and Protects against Cytokine-Mediated Apoptosis in Primary Cultures of Pancreatic beta-Cells	PLOS ONE			English	Article							CYCLIN D2; REPLICATION; MOLECULE; GROWTH; INFLAMMATION; EXPRESSION; EXPANSION; HUMANS; MICE; MASS	There is an urgency to find new treatments for the devastating epidemic of diabetes. Pancreatic beta-cells viability and function are impaired in the two most common forms of diabetes, type 1 and type 2. Regeneration of pancreatic beta-cells has been proposed as a potential therapy for diabetes. In a preliminary study, we screened a collection of marine products for beta-cell proliferation. One unique compound (epoxypukalide) showed capability to induce beta-cell replication in the cell line INS1 832/13 and in primary rat cell cultures. Epoxypukalide was used to study beta-cell proliferation by [H-3] thymidine incorporation and BrdU incorporation followed by BrdU/insulin staining in primary cultures of rat islets. AKT and ERK1/2 signalling pathways were analyzed. Cell cycle activators, cyclin D2 and cyclin E, were detected by western-blot. Apoptosis was studied by TUNEL and cleaved caspase 3. beta-cell function was measured by glucose-stimulated insulin secretion. Epoxypukalide induced 2.5-fold increase in beta-cell proliferation; this effect was mediated by activation of ERK1/2 signalling pathway and upregulation of the cell cycle activators, cyclin D2 and cyclin E. Interestingly, epoxypukalide showed protection from basal (40% lower versus control) and cytokine-induced apoptosis (80% lower versus control). Finally, epoxypukalide did not impair beta-cell function when measured by glucose-stimulated insulin secretion. In conclusion, epoxypukalide induces beta-cell proliferation and protects against basal and cytokine-mediated beta-cell death in primary cultures of rat islets. These findings may be translated into new treatments for diabetes.	[Francisco Lopez-Acosta, Jose; Cozar-Castellano, Irene] Univ Valladolid, IBGM, Valladolid, Spain; [Francisco Lopez-Acosta, Jose; Luis Moreno-Amador, Jose; Jimenez-Palomares, Margarita; Perdomo, German; Cozar-Castellano, Irene] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Diaz-Marrero, Ana R.; Cueto, Mercedes] CSIC, Inst Prod Nat & Agrobiol, Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Cozar-Castellano, I (corresponding author), Univ Valladolid, IBGM, Valladolid, Spain.	cozarirene@gmail.com	Perdomo, German/K-6703-2014; Jimenez-Palomares, Margarita/ABG-8855-2020; Cozar-Castellano, Irene/B-5625-2015; Cueto, MERCEDES/L-3185-2014; Marrero, Ana R. Díaz/L-2899-2014	Perdomo, German/0000-0002-2301-0012; Cozar-Castellano, Irene/0000-0002-6065-5362; Cueto, MERCEDES/0000-0002-9112-6877; Marrero, Ana R. Díaz/0000-0002-8886-7519; Jimenez-Palomares, Margarita/0000-0002-3051-194X; Moreno Amador, Jose Luis/0000-0002-8028-2735	ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain [PS09/00671, CP08/00094]; Europe-FP7 Marie Curie grant [IRG-247835]; Servicio Andaluz de Salud [PI-0256/2009]	ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain; Europe-FP7 Marie Curie grant; Servicio Andaluz de Salud	This work was supported by ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain (PS09/00671 and CP08/00094), Europe-FP7 Marie Curie grant (IRG-247835) and Servicio Andaluz de Salud (PI-0256/2009) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorta E, 2007, TETRAHEDRON, V63, P9057, DOI 10.1016/j.tet.2007.06.080; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Grote D, 2008, CHEM BIODIVERS, V5, P2449, DOI 10.1002/cbdv.200890210; Guthalu Kondegowda Nagesha, 2010, Diabetes, V59, P3131, DOI 10.2337/db09-1796; KSEBATI MB, 1984, J NAT PROD, V47, P1009, DOI 10.1021/np50036a018; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Salpeter SJ, 2011, ENDOCRINOLOGY, V152, P2589, DOI 10.1210/en.2010-1372; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	23	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52862	10.1371/journal.pone.0052862	http://dx.doi.org/10.1371/journal.pone.0052862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300997	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900042
J	Le Coadic, M; Froquet, R; Lima, WC; Dias, M; Marchetti, A; Cosson, P				Le Coadic, Marion; Froquet, Romain; Lima, Wanessa C.; Dias, Marco; Marchetti, Anna; Cosson, Pierre			Phg1/TM9 Proteins Control Intracellular Killing of Bacteria by Determining Cellular Levels of the Kil1 Sulfotransferase in Dictyostelium	PLOS ONE			English	Article							MODEL HOST; ADHESION; DISCOIDEUM; PHAGOCYTOSIS	Dictyostelium discoideum has largely been used to study phagocytosis and intracellular killing of bacteria. Previous studies have shown that Phg1A, Kil1 and Kil2 proteins are necessary for efficient intracellular killing of Klebsiella bacteria. Here we show that in phg1a KO cells, cellular levels of lysosomal glycosidases and lysozyme are decreased, and lysosomal pH is increased. Surprisingly, overexpression of Kil1 restores efficient killing in phg1a KO cells without correcting these lysosomal anomalies. Conversely, kil1 KO cells are defective for killing, but their enzymatic content and lysosomal pH are indistinguishable from WT cells. The killing defect of phg1a KO cells can be accounted for by the observation that in these cells the stability and the cellular amount of Kil1 are markedly reduced. Since Kil1 is the only sulfotransferase characterized in Dictyostelium, an (unidentified) sulfated factor, defective in both phg1a and kil1 KO cells, may play a key role in intracellular killing of Klebsiella bacteria. In addition, Phg1B plays a redundant role with Phg1A in controlling cellular amounts of Kil1 and intracellular killing. Finally, cellular levels of Kil1 are unaffected in kil2 KO cells, and Kil1 overexpression does not correct the killing defect of kil2 KO cells, suggesting that Kil2 plays a distinct role in intracellular killing.	[Le Coadic, Marion; Froquet, Romain; Lima, Wanessa C.; Dias, Marco; Marchetti, Anna; Cosson, Pierre] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland	University of Geneva	Cosson, P (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland.	Pierre.Cosson@unige.ch		Le Coadic, Marion/0000-0003-4725-9610	Swiss National Science Foundation [31003A-135789]; Doerenkamp-Zbinden foundation; FENRIV foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Doerenkamp-Zbinden foundation; FENRIV foundation	This work was supported by grants from the Swiss National Science Foundation (31003A-135789 to P.C.) and from the Doerenkamp-Zbinden and the FENRIV foundations (E. Naef Fondation pour la recherche in vitro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Benghezal M, 2003, MOL BIOL CELL, V14, P2890, DOI 10.1091/mbc.E02-11-0724; Bergeret E, 2008, J CELL SCI, V121, P3325, DOI 10.1242/jcs.030163; Bozzaro S, 2011, CURR DRUG TARGETS, V12, P942, DOI 10.2174/138945011795677782; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Froquet R, 2008, J BIOL CHEM, V283, P6764, DOI 10.1074/jbc.M704484200; Froquet R, 2012, MOL BIOL CELL, V23, P679, DOI 10.1091/mbc.E11-04-0338; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Gopaldass N, 2012, TRAFFIC, V13, P120, DOI 10.1111/j.1600-0854.2011.01296.x; JACOBS T, 1995, EUR J BIOCHEM, V231, P831, DOI 10.1111/j.1432-1033.1995.0831d.x; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lozupone F, 2009, EMBO REP, V10, P1348, DOI 10.1038/embor.2009.236; Marchetti Anna, 2009, BMC Res Notes, V2, P7, DOI 10.1186/1756-0500-2-7; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; Muller I, 2005, J BIOL CHEM, V280, P10435, DOI 10.1074/jbc.M411445200; Nakimbugwe D, 2006, FEMS MICROBIOL LETT, V259, P41, DOI 10.1111/j.1574-6968.2006.00240.x	17	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53259	10.1371/journal.pone.0053259	http://dx.doi.org/10.1371/journal.pone.0053259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301051	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900071
J	Mannava, P; Geibel, S; King'ola, N; Temmerman, M; Luchters, S				Mannava, Priya; Geibel, Scott; King'ola, Nzioki; Temmerman, Marleen; Luchters, Stanley			Male Sex Workers Who Sell Sex to Men Also Engage in Anal Intercourse with Women: Evidence from Mombasa, Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; RISK-FACTORS; TRANSMISSION; EPIDEMIOLOGY; METAANALYSIS; BEHAVIOR; ALCOHOL; CONTEXT	Objective: To investigate self-report of heterosexual anal intercourse among male sex workers who sell sex to men, and to identify the socio-demographic characteristics associated with practice of the behavior. Design: Two cross-sectional surveys of male sex workers who sell sex to men in Mombasa, Kenya. Methods: Male sex workers selling sex to men were invited to participate in surveys undertaken in 2006 and 2008. A structured questionnaire administered by trained interviewers was used to collect information on socio-demographic characteristics, sexual behaviors, HIV and STI knowledge, and health service usage. Data were analyzed through descriptive and inferential statistics. Bivariate logistic regression, after controlling for year of survey, was used to identify socio-demographic characteristics associated with heterosexual anal intercourse. Results: From a sample of 867 male sex workers, 297 men had sex with a woman during the previous 30 days - of whom 45% did so with a female client and 86% with a non-paying female partner. Within these groups, 66% and 43% of male sex workers had anal intercourse with a female client and non-paying partner respectively. Factors associated with reporting recent heterosexual anal intercourse in bivariate logistic regression after controlling for year of survey participation were being Muslim, ever or currently married, living with wife only, living with a female partner only, living with more than one sexual partner, self-identifying as basha/king/bisexual, having one's own children, and lower education. Conclusions: We found unexpectedly high levels of self-reported anal sex with women by male sex workers, including selling sex to female clients as well as with their own partners. Further investigation among women in Mombasa is needed to understand heterosexual anal sex practices, and how HIV programming may respond.	[Mannava, Priya; Luchters, Stanley] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Geibel, Scott] Populat Council, Nairobi, Kenya; [King'ola, Nzioki; Temmerman, Marleen] Int Ctr Reprod Hlth, Mombasa, Kenya; [Temmerman, Marleen; Luchters, Stanley] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Luchters, Stanley] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia; [Luchters, Stanley] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	Burnet Institute; Ghent University; Monash University; University of Witwatersrand	Geibel, S (corresponding author), Populat Council, Nairobi, Kenya.	sgeibel@popcouncil.org		Luchters, Stanley/0000-0001-5235-5629; Geibel, Scott/0000-0001-9969-8776	President's Emergency Plan for AIDS Relief through the Office of HIV/AIDS, Bureau of Global Health, US Agency for International Development (USAID), through the Population Council's Horizons Program [HRN-A-00-97-00012-00]	President's Emergency Plan for AIDS Relief through the Office of HIV/AIDS, Bureau of Global Health, US Agency for International Development (USAID), through the Population Council's Horizons Program(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the President's Emergency Plan for AIDS Relief through the Office of HIV/AIDS, Bureau of Global Health, US Agency for International Development (USAID), through the Population Council's Horizons Program cooperative agreement of Award No. HRN-A-00-97-00012-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID.	Akande A, 1993, EARLY CHILD DEV CARE, V88, P73; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, SEX TRANSM INFECT, V85, P408, DOI 10.1136/sti.2009.037499; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brody S, 2003, INT J STD AIDS, V14, P431, DOI 10.1258/095646203322025704; DARROW WW, 1987, AM J PUBLIC HEALTH, V77, P479, DOI 10.2105/AJPH.77.4.479; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Geibel S, 2007, AIDS, V21, P1349, DOI 10.1097/QAD.0b013e328017f843; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalichman SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-807; Lane T, 2006, AIDS, V20, P123, DOI 10.1097/01.aids.0000198083.55078.02; LAZZARIN A, 1991, ARCH INTERN MED, V151, P2411, DOI 10.1001/archinte.151.12.2411; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Morar NS, 1998, S AFR MED J, V88, P470; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Onyango-Ouma W, 2005, UNDERSTANDING HIV ST; PADIAN N, 1987, JAMA-J AM MED ASSOC, V258, P788, DOI 10.1001/jama.258.6.788; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; Sallah E D, 1999, Sante, V9, P101; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; SEIDLIN M, 1993, AIDS, V7, P1247, DOI 10.1097/00002030-199309000-00015; Smith A, 2010, 17 C RETR OPP INF SA; Veldhuijzen NJ, 2011, SEX HEALTH, V8, P251, DOI 10.1071/SH10047; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	28	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52547	10.1371/journal.pone.0052547	http://dx.doi.org/10.1371/journal.pone.0052547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300978	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900030
J	Adamcic, U; Yurkiewich, A; Coomber, BL				Adamcic, Una; Yurkiewich, Alexander; Coomber, Brenda L.			Differential Expression of Tie2 Receptor and VEGFR2 by Endothelial Clones Derived from Isolated Bovine Mononuclear Cells	PLOS ONE			English	Article							BONE-MARROW CELLS; PROGENITOR CELLS; THERAPEUTIC NEOVASCULARIZATION; TIP CELLS; PHENOTYPIC HETEROGENEITY; IN-VITRO; TRANSPLANTATION; ANGIOGENESIS; MECHANISMS; ISCHEMIA	The purpose of these experiments was to evaluate the expression of endothelial markers, such as Tie2 and VEGFR2 in endothelial cells derived from blood mononuclear endothelial progenitor cells. Bovine mononuclear cells were isolated using separation by centrifugation and were grown in endothelial specific media supplemented with growth factors. Isolation of the whole cell population of mononuclear cells (MNC) from bovine peripheral blood gave rise to progenitor-like cells (CD45(-)) that, although morphologically similar, have different phenotypes revealed by expression of endothelial specific markers Tie2 and VEGFR2. Plating of MNCs on collagen and fibronectin gave rise to more colonies than non-coated dishes. Occasional colonies from MNC isolations had a mural cell phenotype, negative for Tie2 and VEGFR2 but positive for smooth muscle actin and PDGFR beta. Although cells expressing high levels of VEGFR2 and low levels of Tie2, and vice versa were both able to form cords on Matrigel, cells with higher expression of Tie2 migrate faster in a scratch assay than ones with lower expression of Tie2. When these different clones of cells were introduced in mice through tail vein injections, they retained an ability to home to angiogenesis occurring in a subcutaneous Matrigel plug, regardless of their Tie2/VEGFR2 receptor expression patterns, but cells with high VEGFR2/low Tie2 were more likely to be CD31 positive. Therefore, we suggest that active sites of angiogenesis (such as wounds, tumors, etc.) can attract a variety of endothelial cell precursors that may differentially express Tie2 and VEGFR2 receptors, and thus affect our interpretation of EPCs as biomarkers or therapies for vascular disease.	[Adamcic, Una; Yurkiewich, Alexander; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Coomber, BL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	bcoomber@uoguelph.ca			Canadian Institutes of Health Research [81213]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by an Operating Grant (MOP # 81213) to BLC from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; COOMBER BL, 1995, J CELL BIOCHEM, V58, P199, DOI 10.1002/jcb.240580209; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Deshpande H, 2011, VASC CELL, V3, P16; Fathers KE, 2005, AM J PATHOL, V167, P1753, DOI 10.1016/S0002-9440(10)61256-4; Gehling UM, 2007, BLOOD, V110, P1073, DOI 10.1182/blood-2007-03-081638; Gerhardt H, 2005, EXP SUPPL, V94, P3; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P45, DOI 10.1160/TH06-04-0185; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hsu JY, 2009, BIODRUGS, V23, P289, DOI 10.2165/11317600-000000000-00000; Ii M, 2010, METHODS MOL BIOL, V660, P9, DOI 10.1007/978-1-60761-705-1_2; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kuczynski EA, 2011, CANCER-AM CANCER SOC, V117, P5601, DOI 10.1002/cncr.26247; Kuczynski EA, 2011, ONCOLOGY-BASEL, V81, P126, DOI 10.1159/000332849; Lyon CA, 2010, J VASC SURG, V52, P1301, DOI 10.1016/j.jvs.2010.05.096; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mross K, 2011, CLIN MED INSIGHTS ON, V5, P213; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Smadja DM, 2007, CELL BIOL TOXICOL, V23, P223, DOI 10.1007/s10565-007-0177-6; Takahashi M, 2009, CURR PHARM DESIGN, V15, P2778, DOI 10.2174/138161209788923813; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Weber A, 2004, EUR J CARDIO-THORAC, V26, P137, DOI 10.1016/j.ejcts.2004.03.024; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	49	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53385	10.1371/journal.pone.0053385	http://dx.doi.org/10.1371/journal.pone.0053385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300924	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600095
J	Amorosi, CA; Myskova, H; Monti, MR; Argarana, CE; Morita, M; Kemp, S; de Kremer, RD; Dvorakova, L; de Ramirez, AMO				Anabel Amorosi, Cyntia; Myskova, Helena; Roxana Monti, Mariela; Enrique Argarana, Carlos; Morita, Masashi; Kemp, Stephan; Dodelson de Kremer, Raquel; Dvorakova, Lenka; Oller de Ramirez, Ana Maria			X-Linked Adrenoleukodystrophy: Molecular and Functional Analysis of the ABCD1 Gene in Argentinean Patients	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SKIN FIBROBLASTS; PROTEIN; PLASMA; MUTATIONS; OXIDATION; SEQUENCE; PMP70; ALDP	X-linked adrenoleukodystrophy (X-ALD) is an inherited metabolic disease associated with mutations in the ABCD1 gene that encodes an ATP-binding cassette transporter protein, ALDP. The disease is characterized by increased concentrations of very long-chain fatty acids (VLCFAs) in plasma and in adrenal, testicular and nervous tissues, due to a defect in peroxisomal VLCFA beta-oxidation. In the present study, we analyzed 10 male patients and 17 female carriers from 10 unrelated pedigrees with X-ALD from Argentina. By sequencing the ABCD1 we detected 9 different mutations, 8 of which were novel. These new mutations were verified by a combination of methods that included both functional (western blot and peroxisomal VLCFA beta-oxidation) and bioinformatics analysis. The spectrum of novel mutations consists of 3 frameshift (p.Ser284fs*16, p.Glu380Argfs*21 and p.Thr254Argfs*82); a deletion (p.Ser572_Asp575del); a splicing mutation (c.1081+5G>C) and 3 missense mutations (p.Ala341Asp, p.His420Pro and p.Tyr547Cys). In one patient 2 changes were found: a known missense (p.His669Arg) and an unpublished amino acid substitution (p.Ala19Ser). In vitro studies suggest that p.Ala19Ser is a polymorphism. Moreover, we identified two novel intronic polymorphisms and two amino acid polymorphisms. In conclusion, this study extends the spectrum of mutation in X-ALD and facilitates the identification of heterozygous females.	[Anabel Amorosi, Cyntia; Dodelson de Kremer, Raquel; Oller de Ramirez, Ana Maria] Univ Nacl Cordoba, Fac Med, Hosp Ninos, Ctr Estudio Metabolopatias Congenitas CEMECO,Cate, RA-5000 Cordoba, Argentina; [Myskova, Helena; Dvorakova, Lenka] First Fac Med, Inst Inherited Metab Disorders, Prague, Czech Republic; [Myskova, Helena; Dvorakova, Lenka] Gen Fac Hosp, Prague, Czech Republic; [Roxana Monti, Mariela; Enrique Argarana, Carlos] Natl Univ Cordoba, Sch Chem, Dept Biol Chem, CIQUIBIC, Cordoba, Argentina; [Morita, Masashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 930, Japan; [Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Pediatr,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands	National University of Cordoba; Charles University Prague; General University Hospital Prague; National University of Cordoba; University of Toyama; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Amorosi, CA (corresponding author), Univ Nacl Cordoba, Fac Med, Hosp Ninos, Ctr Estudio Metabolopatias Congenitas CEMECO,Cate, RA-5000 Cordoba, Argentina.	cytiam@hotmail.com	Kemp, Stephan/A-3935-2008; Dvorakova, Lenka/F-5011-2017	Kemp, Stephan/0000-0003-2023-064X; Dvorakova, Lenka/0000-0002-1620-3211	Fundacion Florencio Fiorini; Universidad Nacional de Cordoba (SECyT-UNC); Grant for Secretaria de Ciencia y Tecnologia;  [1116 PREST. BID 2437/OC-AR];  [VZ MSM CR 0021620806];  [PRVOUK-P24/LF1/3];  [RVO-VFN64165/2012]	Fundacion Florencio Fiorini; Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Grant for Secretaria de Ciencia y Tecnologia; ; ; ; 	This research was supported by a Grant for PICT 2010-FONCYT No1116 PREST. BID 2437/OC-AR, Fundacion Florencio Fiorini, Grant for Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SECyT-UNC), Grant support: VZ MSM CR 0021620806, PRVOUK-P24/LF1/3, RVO-VFN64165/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi CA, 2010, HUM GENET, V127, P463; Aveldano MI, 1996, CLIN CHEM, V42, P454; Bezman L, 1998, AM J MED GENET, V76, P415, DOI 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Dvorakova L, 2001, HUM MUTAT, V18, P52, DOI 10.1002/humu.1149; Echeverri PO, 2005, ACTA NEUROL COLOMB, V21, P299; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 2000, CELL BIOCHEM BIOPHYS, V32, P131, DOI 10.1385/CBB:32:1-3:131; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; Moser HW, 1991, MEASUREMENT SATURATE, P177; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pereira FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034195; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; SARDE CO, 1994, MAMM GENOME, V5, P810, DOI 10.1007/BF00292021; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; Soardi FC, 2010, ARQ BRAS ENDOCRINOL, V54, P738, DOI 10.1590/S0004-27302010000800013; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takahashi N, 2007, J NEUROCHEM, V101, P1632, DOI 10.1111/j.1471-4159.2007.04457.x; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Vargas CR, 2004, BBA-MOL BASIS DIS, V1688, P26, DOI 10.1016/j.bbadis.2003.10.004; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	33	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52635	10.1371/journal.pone.0052635	http://dx.doi.org/10.1371/journal.pone.0052635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300730	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600021
J	Hua, XD; Yang, JF; Wang, LM; Fang, QK; Zhang, GP; Liu, FQ				Hua, Xiude; Yang, Jifei; Wang, Limin; Fang, Qingkui; Zhang, Gaiping; Liu, Fengquan			Development of an Enzyme Linked Immunosorbent Assay and an Immunochromatographic Assay for Detection of Organophosphorus Pesticides in Different Agricultural Products	PLOS ONE			English	Article							RAPID DETECTION; MONOCLONAL-ANTIBODIES; LIQUID-CHROMATOGRAPHY; CHLORPYRIFOS-METHYL; GAS-CHROMATOGRAPHY; HAPTEN HETEROLOGY; IMMUNOASSAY; PARATHION; WATER; MICROEXTRACTION	Objective: Organophosphorus (OP) pesticides are considered hazardous substances because of their high toxicity to nontarget species and their persistence in the environment and agricultural products. Therefore, it is important to develop a rapid, sensitive, and economical method for detecting OP pesticides and their residues in food and the environment. Methods: A broad, selective monoclonal antibody (MAb) for organophosphorus pesticides was produced. Based on the MAb, an enzyme linked immunosorbent assay (ELISA) and an immunochromatography assay (ICA) for detecting OP pesticides in different agricultural products were developed using a binding inhibition format on microtiter plates and a membrane strip, respectively. Results: Under the optimized conditions, the IC50 values of the ELISA ranged from 3.7 to 162.2 ng mL(-1) for the 8 OP pesticides. The matrix interferences of Apple, Chinese cabbage, and greengrocery were removed by 40-fold dilution, the recoveries from spiked samples ranged from 79.1% to 118.1%. The IC50 values of ICA for the 8 OP pesticides ranged from 11.8 to 470.4 ng mL(-1). The matrix interference was removed from the Chinese cabbage and Apple samples with 5-fold dilution, and the interference was removed from the greengrocery samples with 20-fold dilution. The recoveries from the spiked samples ranged between 70.6 and 131.9%. The established ELISA and ICA were specific selectivity for the 8 OP pesticides. Conclusions: The established ELISA is a sensitive screening method for the detection of OP pesticides, but the ELISA detection method depends on a laboratory platform and requires a relative long assay time and several steps operation. The established ICA is very useful as a screening method for the quantitative, semi-quantitative or qualitative detection of OP pesticides in agricultural products, and it has advantages over ELISA methods with regard to factors such as the testing procedure, testing time, and matrix interferences, among others.	[Hua, Xiude; Wang, Limin; Fang, Qingkui; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Hua, Xiude; Wang, Limin; Fang, Qingkui; Liu, Fengquan] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Yang, Jifei; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Nanjing Agricultural University; Henan Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com			National High Technology Research and Development Program of China [2012AA101401-1]; Key Projects in the National Science & Technology Pillar Program [2009BADB9B03]; China Agriculture Research System [nycytx-29]; Natural Science Foundation of Jiangsu Province [BK2010445]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Projects in the National Science & Technology Pillar Program; China Agriculture Research System; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National High Technology Research and Development Program of China (2012AA101401-1), the Key Projects in the National Science & Technology Pillar Program (2009BADB9B03), the earmarked fund for the China Agriculture Research System (nycytx-29) and the Natural Science Foundation of Jiangsu Province (BK2010445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandler J, 2000, IVD TECHNOL, V6, P37, DOI DOI 10.1111/jfd.13302; Farran A, 1996, J CHROMATOGR A, V737, P109, DOI 10.1016/0021-9673(96)00145-8; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gandhi S, 2009, BIOSENS BIOELECTRON, V25, P502, DOI 10.1016/j.bios.2009.07.018; Gas F, 2010, BIOSENS BIOELECTRON, V25, P1235, DOI 10.1016/j.bios.2009.09.033; Gui WJ, 2008, ANAL BIOCHEM, V377, P202, DOI 10.1016/j.ab.2008.03.013; Gui WJ, 2009, ANAL BIOCHEM, V393, P88, DOI 10.1016/j.ab.2009.06.014; Hua XD, 2010, BIOSENS BIOELECTRON, V26, P189, DOI 10.1016/j.bios.2010.06.005; Jang MS, 2002, B KOR CHEM SOC, V23, P1116; Johnson JC, 1998, J AGR FOOD CHEM, V46, P3116, DOI 10.1021/jf970191y; Kim MJ, 2003, ANAL CHIM ACTA, V493, P47, DOI 10.1016/S0003-2670(03)00793-1; Kim YJ, 2003, ANAL CHIM ACTA, V494, P29, DOI 10.1016/j.aca.2003.07.003; Kim YJ, 2007, ANAL CHIM ACTA, V591, P183, DOI 10.1016/j.aca.2007.03.072; Kim YA, 2011, ANAL CHIM ACTA, V693, P106, DOI 10.1016/j.aca.2011.03.011; Kolosova AY, 2004, ANAL CHIM ACTA, V511, P323, DOI 10.1016/j.aca.2004.01.047; Krotzky AJ, 1995, PURE APPL CHEM, V67, P2065, DOI 10.1351/pac199567122065; LANGONE JJ, 1982, METHOD ENZYMOL, V84, P628; Li DW, 2009, BIOSENS BIOELECTRON, V24, P2277, DOI 10.1016/j.bios.2008.11.004; Liu Y, 2009, MICROCHEM J, V93, P36, DOI 10.1016/j.microc.2009.04.004; Liu YH, 2007, ANAL CHIM ACTA, V591, P173, DOI 10.1016/j.aca.2007.03.071; Morozova VS, 2005, J ANAL CHEM+, V60, P202, DOI 10.1007/s10809-005-0075-0; NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0; Padron-Sanz C, 2005, J CHROMATOGR A, V1078, P13, DOI 10.1016/j.chroma.2005.05.005; Pastor-Navarro N, 2007, TALANTA, V71, P923, DOI 10.1016/j.talanta.2006.05.073; Piao YZ, 2009, J AGR FOOD CHEM, V57, P10004, DOI 10.1021/jf901998y; Qian GL, 2009, FOOD CHEM, V117, P364, DOI 10.1016/j.foodchem.2009.03.097; Reder S, 2003, BIOSENS BIOELECTRON, V19, P447, DOI 10.1016/S0956-5663(03)00202-1; Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07; Roex EWM, 2003, AQUAT TOXICOL, V64, P451, DOI 10.1016/S0166-445X(03)00100-0; ROTH J, 1983, TECHNIQUES IMMUNOCYT, V2, P217; Sun JW, 2010, ANAL CHIM ACTA, V666, P76, DOI 10.1016/j.aca.2010.03.051; Wang CM, 2010, J AGR FOOD CHEM, V58, P5658, DOI 10.1021/jf904575k; Wang CM, 2009, FOOD CHEM, V115, P365, DOI 10.1016/j.foodchem.2008.11.091; Xiao Q, 2006, TALANTA, V69, P848, DOI 10.1016/j.talanta.2005.11.024; Xu Y, 2010, FOOD CHEM, V119, P834, DOI 10.1016/j.foodchem.2009.08.049; Xu ZL, 2009, ANAL CHIM ACTA, V647, P90, DOI 10.1016/j.aca.2009.05.025; Yao ZW, 2001, TALANTA, V55, P807, DOI 10.1016/S0039-9140(01)00504-5; Zhang GP, 2006, J IMMUNOL METHODS, V312, P27, DOI 10.1016/j.jim.2006.02.017; Zhang Q, 2007, ANAL CHIM ACTA, V596, P303, DOI 10.1016/j.aca.2007.06.009; Zhou P, 2004, J AGR FOOD CHEM, V52, P4355, DOI 10.1021/jf0499121; Zhou Y, 2009, BIOSENS BIOELECTRON, V24, P2744, DOI 10.1016/j.bios.2009.01.034; Zhu J, 2008, ENVIRON POLLUT, V156, P136, DOI 10.1016/j.envpol.2007.12.020	42	31	33	2	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53099	10.1371/journal.pone.0053099	http://dx.doi.org/10.1371/journal.pone.0053099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300869	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600057
J	Morgan, RML; Hernandez-Ramirez, LC; Trivellin, G; Zhou, LH; Roe, SM; Korbonits, M; Prodromou, C				Morgan, Rhodri M. L.; Hernandez-Ramirez, Laura C.; Trivellin, Giampaolo; Zhou, Lihong; Roe, S. Mark; Korbonits, Marta; Prodromou, Chrisostomos			Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal alpha-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition	PLOS ONE			English	Article							ARYL-HYDROCARBON-RECEPTOR; CELL-CYCLE ARREST; AH RECEPTOR; EVOLUTIONARY CONSERVATION; ATPASE ACTIVITY; NUCLEIC-ACIDS; BREAST-CANCER; HSP90; GENE; ESTROGEN	Mutations of the aryl hydrocarbon receptor interacting protein (AIP) have been associated with familial isolated pituitary adenomas predisposing to young-onset acromegaly and gigantism. The precise tumorigenic mechanism is not well understood as AIP interacts with a large number of independent proteins as well as three chaperone systems, HSP90, HSP70 and TOMM20. We have determined the structure of the TPR domain of AIP at high resolution, which has allowed a detailed analysis of how disease-associated mutations impact on the structural integrity of the TPR domain. A subset of C-terminal alpha-7 helix (C alpha-7h) mutations, R304* (nonsense mutation), R304Q, Q307* and R325Q, a known site for AhR and PDE4A5 client-protein interaction, occur beyond those that interact with the conserved MEEVD and EDDVE sequences of HSP90 and TOMM20. These C-terminal AIP mutations appear to only disrupt client-protein binding to the C alpha-7h, while chaperone binding remains unaffected, suggesting that failure of client-protein interaction with the C alpha-7h is sufficient to predispose to pituitary adenoma. We have also identified a molecular switch in the AIP TPR-domain that allows recognition of both the conserved HSP90 motif, MEEVD, and the equivalent sequence (EDDVE) of TOMM20.	[Morgan, Rhodri M. L.; Zhou, Lihong; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Hernandez-Ramirez, Laura C.; Trivellin, Giampaolo; Korbonits, Marta] Queen Mary Univ London, Dept Endocrinol, Barts & London Sch Med, London, England	University of Sussex; University of London; Queen Mary University London	Prodromou, C (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	chris.prodromou@sussex.ac.uk	Trivellin, Giampaolo/J-6583-2016; Prodromou, Chrisostomos/ABA-9133-2021; Hernández-Ramírez, Laura C./F-7983-2017	Trivellin, Giampaolo/0000-0003-2384-4153; Prodromou, Chrisostomos/0000-0003-4320-1147; Hernández-Ramírez, Laura C./0000-0002-6599-6406; Korbonits, Marta/0000-0002-4101-9432; Roe, Mark/0000-0002-7371-9855	Diamond Light Source; Wellcome Trust [095605/Z11/Z]; National Council of Science and Technology of Mexico; Barts and The London Charity	Diamond Light Source; Wellcome Trust(Wellcome TrustEuropean Commission); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Barts and The London Charity	The authors acknowledge support from the Diamond Light Source and the Wellcome Trust senior investigator award (LHP), 095605/Z11/Z. LCH-R is supported by the National Council of Science and Technology of Mexico and by the Barts and The London Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025201; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chahal HS, 2011, NEW ENGL J MED, V364, P43, DOI 10.1056/NEJMoa1008020; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cook C, 2012, J ALZHEIMERS DIS JAD; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Oliveira SK, 2007, J BIOL CHEM, V282, P13656, DOI 10.1074/jbc.M610942200; de Oliveira SK, 2009, BIOCHEM PHARMACOL, V77, P723, DOI 10.1016/j.bcp.2008.08.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Hollingshead BD, 2004, J BIOL CHEM, V279, P45652, DOI 10.1074/jbc.M407840200; Huang GM, 2005, MOL PHARMACOL, V67, P88, DOI 10.1124/mol.104.002410; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Jackson SE, 2012, HSP90 STRUCTURE FUNC; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Linnert M, 2012, BIOMOL NMR ASSIGN, V6, P209, DOI 10.1007/s12104-012-9359-0; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Muller P., 2012, ONCOGENE; Ozfirat Z, 2010, MOL CELL ENDOCRINOL, V326, P71, DOI 10.1016/j.mce.2010.05.001; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Persson I, 1999, CANCER CAUSE CONTROL, V10, P253, DOI 10.1023/A:1008909128110; Pocar P, 2005, REPRODUCTION, V129, P379, DOI 10.1530/rep.1.00294; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Safe S, 2000, J MAMMARY GLAND BIOL, V5, P295, DOI 10.1023/A:1009550912337; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Zeng Q, 2008, J PATHOL, V214, P425, DOI 10.1002/path.2297; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	58	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53339	10.1371/journal.pone.0053339	http://dx.doi.org/10.1371/journal.pone.0053339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300914	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000313872600085
J	Oka, O; Waters, LC; Strong, SL; Dosanjh, NS; Veverka, V; Muskett, FW; Renshaw, PS; Klempnauer, KH; Carr, MD				Oka, Ojore; Waters, Lorna C.; Strong, Sarah L.; Dosanjh, Nuvjeevan S.; Veverka, Vaclav; Muskett, Frederick W.; Renshaw, Philip S.; Klempnauer, Karl-Heinz; Carr, Mark D.			Interaction of the Transactivation Domain of B-Myb with the TAZ2 Domain of the Coactivator p300: Molecular Features and Properties of the Complex	PLOS ONE			English	Article							HUMAN HSP70 PROMOTER; N-TERMINAL DOMAIN; STRUCTURAL BASIS; TRANSCRIPTION FACTOR; SECONDARY STRUCTURE; CHEMICAL-SHIFT; CYCLIN D1; UNSTRUCTURED PROTEINS; UNFOLDED PROTEINS; ACTIVATION DOMAIN	The transcription factor B-Myb is a key regulator of the cell cycle in vertebrates, with activation of transcription involving the recognition of specific DNA target sites and the recruitment of functional partner proteins, including the coactivators p300 and CBP. Here we report the results of detailed studies of the interaction between the transactivation domain of B-Myb (B-Myb TAD) and the TAZ2 domain of p300. The B-Myb TAD was characterized using circular dichroism, fluorescence and NMR spectroscopy, which revealed that the isolated domain exists as a random coil polypeptide. Pull-down and spectroscopic experiments clearly showed that the B-Myb TAD binds to p300 TAZ2 to form a moderately tight (K-d, similar to 1.0-10 mu M) complex, which results in at least partial folding of the B-Myb TAD. Significant changes in NMR spectra of p300 TAZ2 suggest that the B-Myb TAD binds to a relatively large patch on the surface of the domain (similar to 1200 angstrom(2)). The apparent B-Myb TAD binding site on p300 TAZ2 shows striking similarity to the surface of CBP TAZ2 involved in binding to the transactivation domain of the transcription factor signal transducer and activator of transcription 1 (STAT1), which suggests that the structure of the B-Myb TAD-p300 TAZ2 complex may share many features with that reported for STAT1 TAD-p300 TAZ2.	[Oka, Ojore; Waters, Lorna C.; Strong, Sarah L.; Dosanjh, Nuvjeevan S.; Veverka, Vaclav; Muskett, Frederick W.; Renshaw, Philip S.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Leicester; University of Munster	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 7RH, Leics, England.	lw83@le.ac.uk; mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Oka, Ojore/H-4456-2013; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	Wellcome Trust [083629/Z/07/Z]; UCB Celltech Ltd; UK Biotechnology and Biological Sciences Research Council; University of Leicester	Wellcome Trust(Wellcome TrustEuropean Commission); UCB Celltech Ltd(UCB Pharma SA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leicester	The work reported here was funded by equipment and project grants from the Wellcome Trust (083629/Z/07/Z: http://www.wellcome.ac.uk/). Vaclav Veverka is supported by a collaborative grant from UCB Celltech Ltd (http://www.ucb.com/) and Nuvjeevan Dosanjh was supported by a Ph.D studentship from UK Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx). Ojore Oka was awarded a Ph.D scholarship by the University of Leicester (www.le.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bartusel T, 2005, GENE, V351, P171, DOI 10.1016/j.gene.2005.03.035; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; FOOS G, 1993, ONCOGENE, V8, P1775; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Garner E., 1998, GEN INF SER WORKSH G, V9, P201; Goodman RH, 2000, GENE DEV, V14, P1553; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; He J, 2011, NUCLEIC ACIDS RES, V39, P4464, DOI 10.1093/nar/gkr030; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; IYER KS, 1973, J BIOL CHEM, V248, P707; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; LEE MS, 1992, J BIOMOL NMR, V2, P307, DOI 10.1007/BF01874810; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Miller M, 2009, ACTA CRYSTALLOGR D, V65, P1301, DOI 10.1107/S0907444909040153; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; NAKAGOSHI H, 1993, J BIOL CHEM, V268, P14161; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; O'Connor MJ, 1999, J VIROL, V73, P3574; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Sala A, 1999, ONCOGENE, V18, P1333, DOI 10.1038/sj.onc.1202421; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Sala A, 1999, J CELL PHYSIOL, V179, P245; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Toribio F, 1996, J CHROMATOGR B, V684, P77, DOI 10.1016/0378-4347(95)00504-8; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; WATSON RJ, 1993, NUCLEIC ACIDS RES, V21, P267, DOI 10.1093/nar/21.2.267; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52906	10.1371/journal.pone.0052906	http://dx.doi.org/10.1371/journal.pone.0052906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300815	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600035
J	Reid, CN; Stevenson, M; Abogunrin, F; Ruddock, MW; Emmert-Streib, F; Lamont, JV; Williamson, KE				Reid, Cherith N.; Stevenson, Michael; Abogunrin, Funso; Ruddock, Mark W.; Emmert-Streib, Frank; Lamont, John V.; Williamson, Kate E.			Standardization of Diagnostic Biomarker Concentrations in Urine: The Hematuria Caveat	PLOS ONE			English	Article							BLADDER-CANCER; CREATININE; PROTEOMICS; PROTEINS; VALIDATION; DISCOVERY; ACCURACY; MARKERS	Sensitive and specific urinary biomarkers can improve patient outcomes in many diseases through informing early diagnosis. Unfortunately, to date, the accuracy and translation of diagnostic urinary biomarkers into clinical practice has been disappointing. We believe this may be due to inappropriate standardization of diagnostic urinary biomarkers. Our objective was therefore to characterize the effects of standardizing urinary levels of IL-6, IL-8, and VEGF using the commonly applied standards namely urinary creatinine, osmolarity and protein. First, we report results based on the biomarker levels measured in 120 hematuric patients, 80 with pathologically confirmed bladder cancer, 27 with confounding pathologies and 13 in whom no underlying cause for their hematuria was identified, designated "no diagnosis''. Protein levels were related to final diagnostic categories (p = 0.022, ANOVA). Osmolarity (mean = 529 mOsm; median = 528 mOsm) was normally distributed, while creatinine (mean = 10163 mu mol/l, median = 9350 mu mol/l) and protein (0.3297, 0.1155 mg/ml) distributions were not. When we compared AUROCs for IL-6, IL-8 and VEGF levels, we found that protein standardized levels consistently resulted in the lowest AUROCs. The latter suggests that protein standardization attenuates the "true'' differences in biomarker levels across controls and bladder cancer samples. Second, in 72 hematuric patients; 48 bladder cancer and 24 controls, in whom urine samples had been collected on recruitment and at follow-up (median = 11 (1 to 20 months)), we demonstrate that protein levels were approximately 24% lower at follow-up (Bland Altman plots). There was an association between differences in individual biomarkers and differences in protein levels over time, particularly in control patients. Collectively, our findings identify caveats intrinsic to the common practice of protein standardization in biomarker discovery studies conducted on urine, particularly in patients with hematuria.	[Reid, Cherith N.; Ruddock, Mark W.; Lamont, John V.] Randox Labs, Crumlin, North Ireland; [Stevenson, Michael] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland; [Abogunrin, Funso; Emmert-Streib, Frank; Williamson, Kate E.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Randox Laboratories; Queens University Belfast; Queens University Belfast	Williamson, KE (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	k.williamson@qub.ac.uk	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020; Abogunrin, Funso/L-5108-2015	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; Abogunrin, Funso/0000-0002-5931-6072	Randox Laboratories Ltd.	Randox Laboratories Ltd.	Randox Laboratories undertook laboratory analyses on anonymised patient samples. Randox played no role in data analyses which were undertaken by MS, FES and KW (Queen's University Belfast). Randox employees contributed to the preparation of the manuscript but were not involved in the decision to publish which was taken by Queen's University Belfast. The funders, Randox Laboratories Ltd., played no role in the design of the case control study and were not involved in collection of patient data and samples.	Abogunrin F, 2011, CANCER, V18, P2641; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Bazari H., 2007, CECIL MED; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Chen YT, 2010, J PROTEOME RES, V9, P5803, DOI 10.1021/pr100576x; Eissa Sanaa, 2007, Cancer Biomarkers, V3, P275; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Garde AH, 2004, ANN OCCUP HYG, V48, P171, DOI 10.1093/annhyg/meh019; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Henry T.J., 1974, CLIN CHEM, V2nd; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Julian BA, 2009, PROTEOM CLIN APPL, V3, P1029, DOI 10.1002/prca.200800243; Kashif W, 2003, CLEV CLIN J MED, V70, P535, DOI 10.3949/ccjm.70.6.535; Lee JW, 2009, BIOANALYSIS, V1, P1461, DOI 10.4155/BIO.09.130; Leibovici D, 2005, J CLIN ONCOL, V23, P5746, DOI 10.1200/JCO.2005.01.598; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Margel D, 2011, EUR UROL, V59, P113, DOI 10.1016/j.eururo.2010.10.008; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; Pesic I, 2011, J PROTEOMICS, V74, P1994, DOI 10.1016/j.jprot.2011.05.020; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Sanchez-Carbayo M, 2000, UROLOGY, V55, P526, DOI 10.1016/S0090-4295(99)00557-9; Seegmiller JC, 2009, CLIN CHEM, V55, P1991, DOI 10.1373/clinchem.2009.129833; Sertic J, 2007, CLIN CHEM LAB MED, V45, P1347, DOI 10.1515/CCLM.2007.321; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Svatek RS, 2006, CANCER-AM CANCER SOC, V106, P1701, DOI 10.1002/cncr.21795; Urquidi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037797	33	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53354	10.1371/journal.pone.0053354	http://dx.doi.org/10.1371/journal.pone.0053354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300915	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600086
J	Uno, Y; Nishida, C; Tarui, H; Ishishita, S; Takagi, C; Nishimura, O; Ishijima, J; Ota, H; Kosaka, A; Matsubara, K; Murakami, Y; Kuratani, S; Ueno, N; Agata, K; Matsuda, Y				Uno, Yoshinobu; Nishida, Chizuko; Tarui, Hiroshi; Ishishita, Satoshi; Takagi, Chiyo; Nishimura, Osamu; Ishijima, Junko; Ota, Hidetoshi; Kosaka, Ayumi; Matsubara, Kazumi; Murakami, Yasunori; Kuratani, Shigeru; Ueno, Naoto; Agata, Kiyokazu; Matsuda, Yoichi			Inference of the Protokaryotypes of Amniotes and Tetrapods and the Evolutionary Processes of Microchromosomes from Comparative Gene Mapping	PLOS ONE			English	Article							SEX-CHROMOSOMES; GENOME ANALYSIS; BIRD; INSIGHTS; REVEALS; TURTLE; ORIGIN; DIFFERENTIATION; RECONSTRUCTION; SALAMANDER	Comparative genome analysis of non-avian reptiles and amphibians provides important clues about the process of genome evolution in tetrapods. However, there is still only limited information available on the genome structures of these organisms. Consequently, the protokaryotypes of amniotes and tetrapods and the evolutionary processes of microchromosomes in tetrapods remain poorly understood. We constructed chromosome maps of functional genes for the Chinese soft-shelled turtle (Pelodiscus sinensis), the Siamese crocodile (Crocodylus siamensis), and the Western clawed frog (Xenopus tropicalis) and compared them with genome and/or chromosome maps of other tetrapod species (salamander, lizard, snake, chicken, and human). This is the first report on the protokaryotypes of amniotes and tetrapods and the evolutionary processes of microchromosomes inferred from comparative genomic analysis of vertebrates, which cover all major non-avian reptilian taxa (Squamata, Crocodilia, Testudines). The eight largest macrochromosomes of the turtle and chicken were equivalent, and 11 linkage groups had also remained intact in the crocodile. Linkage groups of the chicken macrochromosomes were also highly conserved in X. tropicalis, two squamates, and the salamander, but not in human. Chicken microchromosomal linkages were conserved in the squamates, which have fewer microchromosomes than chicken, and also in Xenopus and the salamander, which both lack microchromosomes; in the latter, the chicken microchromosomal segments have been integrated into macrochromosomes. Our present findings open up the possibility that the ancestral amniotes and tetrapods had at least 10 large genetic linkage groups and many microchromosomes, which corresponded to the chicken macro-and microchromosomes, respectively. The turtle and chicken might retain the microchromosomes of the amniote protokaryotype almost intact. The decrease in number and/or disappearance of microchromosomes by repeated chromosomal fusions probably occurred independently in the amphibian, squamate, crocodilian, and mammalian lineages.	[Uno, Yoshinobu; Ishishita, Satoshi; Matsuda, Yoichi] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nishida, Chizuko; Ishijima, Junko; Kosaka, Ayumi; Matsubara, Kazumi] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido, Japan; [Tarui, Hiroshi; Nishimura, Osamu] RIKEN Ctr Dev Biol, Genome Resource & Anal Subunit, Kobe, Hyogo, Japan; [Takagi, Chiyo; Ueno, Naoto] Natl Inst Basic Biol, Div Morphogenesis, Okazaki, Aichi 444, Japan; [Nishimura, Osamu; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Nishimura, Osamu] Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Kyoto, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Kobe, Hyogo 6500044, Japan; [Ota, Hidetoshi] Univ Hyogo, Museum Nat & Human Act, Kobe, Hyogo 6500044, Japan; [Murakami, Yasunori; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo, Japan; [Ueno, Naoto] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	Nagoya University; Hokkaido University; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; Kyoto University; University of Hyogo; University of Hyogo; RIKEN; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Matsuda, Y (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	yoimatsu@agr.nagoya-u.ac.jp	Ueno, Naoto/B-3307-2015; Kuratani, Shigeru/J-4146-2014; Nishimura, Osamu/AAC-1236-2020	Kuratani, Shigeru/0000-0001-9717-7221; Nishimura, Osamu/0000-0003-1969-2580; Matsubara, Kazumi/0000-0002-6680-1084; Ueno, Naoto/0000-0002-8375-2317; Uno, Yoshinobu/0000-0001-9609-1186; Agata, Kiyokazu/0000-0002-5195-2576	Ministry of Education, Culture, Sports, Science and Technology in Japan [23113004, 22370081]; Kyoto University Global COE Program [A06]; Grants-in-Aid for Scientific Research [24770226] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (no. 23113004) and Grant-in-Aid for Scientific Research (no. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology in Japan, and the Kyoto University Global COE Program (A06) for Evolution and Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Arai R, 2011, FISH KARYOTYPES CHEC, P26; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Castoe TA, 2011, STAND GENOMIC SCI, V4, P257, DOI 10.4056/sigs.1664145; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Kawagoshi T, 2008, CHROMOSOME RES, V16, P1119, DOI 10.1007/s10577-008-1263-1; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kuraku S, 2006, CHROMOSOME RES, V14, P187, DOI 10.1007/s10577-006-1035-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; Morescalchi A., 1973, P233; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Rock J, 1996, CYTOGENET CELL GENET, V73, P187, DOI 10.1159/000134336; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Signorino G., 2005, CHROMOREP REPTILE CH; Smith JJ, 2007, GENETICS, V177, P607, DOI 10.1534/genetics.107.072033; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2005, GENETICS, V171, P1161, DOI 10.1534/genetics.105.046433; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Uno Y, 2008, CHROMOSOME RES, V16, P999, DOI 10.1007/s10577-008-1257-z; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang F, 2003, P NATL ACAD SCI USA, V100, P1062, DOI 10.1073/pnas.0335540100	49	69	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53027	10.1371/journal.pone.0053027	http://dx.doi.org/10.1371/journal.pone.0053027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300852	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600050
J	Semlali, A; Witoled, C; Alanazi, M; Rouabhia, M				Semlali, Abdelhabib; Witoled, Chmielewski; Alanazi, Mohammed; Rouabhia, Mahmoud			Whole Cigarette Smoke Increased the Expression of TLRs, HBDs, and Proinflammory Cytokines by Human Gingival Epithelial Cells through Different Signaling Pathways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; BETA-CAROTENE; ORAL-CANCER; INFLAMMATION; ACTIVATION; RECEPTORS; MOLECULES	The gingival epithelium is becoming known as a regulator of the oral innate immune responses to a variety of insults such as bacteria and chemicals, including those chemicals found in cigarette smoke. We investigated the effects of whole cigarette smoke on cell-surface-expressed Toll-like receptors (TLR)-2, -4 and -6, human beta-defensin (HBD) and proinflammatory cytokine expression and production in primary human gingival epithelial cells. Whole cigarette smoke was shown to increase TLR2, TLR4 and TLR6 expression. Cigarette smoke led to ERK1/2, p38 and JNK phosphorylation in conjunction with nuclear factor-kappa B (NF kappa B) translocation into the nucleus. TLR expression following cigarette smoke exposure was down regulated by the use of ERK1/2, p38, JNK MAP kinases, and NF kappa B inhibitors, suggesting the involvement of these signaling pathways in the cellular response against cigarette smoke. Cigarette smoke also promoted HBD2, HBD3, IL-1 beta, and IL-6 expression through the ERK1/2 and NF kappa B pathways. Interestingly, the modulation of TLR, HBD, and cytokine expression was maintained long after the gingival epithelial cells were exposed to smoke. By promoting TLR, HBDs, and proinflammatory cytokine expression and production, cigarette smoke may contribute to innate immunity dysregulation, which may have a negative effect on human health.	[Semlali, Abdelhabib; Witoled, Chmielewski; Rouabhia, Mahmoud] Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Semlali, Abdelhabib; Alanazi, Mohammed] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia	Laval University; King Saud University	Rouabhia, M (corresponding author), Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.	mahmoud.rouabhia@fmd.ulaval.ca	Semlali, Abdelhabib/AAP-7043-2020	Semlali, Abdelhabib/0000-0002-1643-0377; Rouabhia, Mahmoud/0000-0003-2205-8281	Natural Sciences and Engineering Research Council of Canada (NSERC); "Fonds Emile-Beaulieu", Laval University Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds Emile-Beaulieu", Laval University Foundation	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Program (MR), and "Fonds Emile-Beaulieu", Laval University Foundation (MR and WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balansky R, 2012, ARCH TOXICOL, V86, P509, DOI 10.1007/s00204-011-0765-3; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BLUHM AL, 1971, NATURE, V229, P500, DOI 10.1038/229500a0; BROWN GP, 1989, AM J PHYSIOL, V256, pC260, DOI 10.1152/ajpcell.1989.256.2.C260; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen L, 2010, EUR RESPIR J, V36, P638, DOI 10.1183/09031936.00029409; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; De Nardo D, 2009, J IMMUNOL, V183, P8110, DOI 10.4049/jimmunol.0901031; Decanis N, 2009, CYTOKINE, V45, P132, DOI 10.1016/j.cyto.2008.11.011; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Eckmann L, 2006, CURR OPIN GASTROEN, V22, P95, DOI 10.1097/01.mog.0000208458.38772.2a; Fooladi Abbas Ali Imani, 2011, Inflammation & Allergy Drug Targets, V10, P198; Gao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009351; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Gorr SU, 2012, FRONT ORAL BIOL, V15, P84, DOI 10.1159/000329673; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Herfs M, 2012, AM J RESP CELL MOL B; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Janardhanam SB, 2011, ARCH ORAL BIOL; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kashiwagi Y, 2011, ARCH ORAL BIOL; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khorram O, 2010, FERTIL STERIL, V93, P257, DOI 10.1016/j.fertnstert.2008.09.074; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SY, 2006, AM J PHYSIOL-LUNG C, V291, pL84, DOI 10.1152/ajplung.00388.2005; Lee WK, 2007, AM J RHINOL, V21, P658, DOI 10.2500/ajr.2007.21.3094; Li Q, 2010, TRANSL RES, V156, P326, DOI 10.1016/j.trsl.2010.09.001; Lim DM, 2009, AM J PHYSIOL-GASTR L, V297, pG1172, DOI 10.1152/ajpgi.00065.2009; Liu XD, 2007, BIOCHEM BIOPH RES CO, V353, P121, DOI 10.1016/j.bbrc.2006.11.147; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Malemud CJ, 2007, CURR OPIN PHARMACOL, V7, P339, DOI 10.1016/j.coph.2006.11.012; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Muscat JE, 2011, CANCER-AM CANCER SOC, V117, P5377, DOI 10.1002/cncr.26235; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Nagler R, 2010, BBA-MOL BASIS DIS, V1802, P454, DOI 10.1016/j.bbadis.2010.01.008; Nihon-Yanagi Y, 2012, CANCER IMMUNOL IMMUN, V61, P71, DOI 10.1007/s00262-011-1085-4; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Palozza P, 2004, CARCINOGENESIS, V25, P1315, DOI 10.1093/carcin/bgh142; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pelaia G, 2004, J CELL BIOCHEM, V93, P142, DOI 10.1002/jcb.20124; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Proctor I, 2012, J CLIN PATHOL, V65, P129, DOI 10.1136/jclinpath-2011-200299; Profita M, 2011, LIFE SCI, V89, P36, DOI 10.1016/j.lfs.2011.04.025; Proia NK, 2006, CANCER EPIDEM BIOMAR, V15, P1061, DOI 10.1158/1055-9965.EPI-05-0983; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Rouabhia M, 2011, MED MYCOL, V49, P458, DOI 10.3109/13693786.2010.535031; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Semlali A, 2011, J PERIODONTAL RES, V46, P533, DOI 10.1111/j.1600-0765.2011.01370.x; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Shibata Y, 2008, RESPIROLOGY, V13, P1061, DOI 10.1111/j.1440-1843.2008.01362.x; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh RK, 2012, MICROBIOL RES; Starrett W, 2011, J IMMUNOTOXICOL, V8, P150, DOI 10.3109/1547691X.2011.558529; Taybos G, 2003, AM J MED SCI, V326, P179, DOI 10.1097/00000441-200310000-00005; Tsoumakidou M, 2011, CURR DRUG TARGETS, V12, P450, DOI 10.2174/138945011794751546; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201; Witschi H, 2005, TOXICOL SCI, V84, P81, DOI 10.1093/toxsci/kfi043; Yu HM, 2011, BASIC CLIN PHARMACOL, V109, P63, DOI 10.1111/j.1742-7843.2011.00686.x	73	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52614	10.1371/journal.pone.0052614	http://dx.doi.org/10.1371/journal.pone.0052614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300722	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500040
J	Cha, S; Yu, H; Kim, JY				Cha, Seongwon; Yu, Hyunjoo; Kim, Jong Yeol			Bone Mineral Density-Associated Polymorphisms Are Associated with Obesity-Related Traits in Korean Adults in a Sex-Dependent Manner	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; AORTIC CALCIFICATION; RISK-FACTOR; OSTEOPOROSIS; FRACTURE; MEN; PROGRESSION; PHENOTYPES; MENOPAUSE	Obesity and osteoporosis share common physiological factors, including the presence of atherosclerosis, a risk factor for cardiometabolic disease, as well as a common progenitor that differentiates into both adipocytes and osteoblasts. Among the 23 polymorphisms associated with bone mineral density (BMD) in recent genome-wide association studies (GWASs), an Osterix polymorphism has been identified and associated with childhood obesity in girls. Therefore, we focused on elucidating polymorphisms associated with adulthood obesity in a sex-dependent manner among the previously published BMD-associated polymorphisms from GWASs. We performed 2 screenings of 18 BMD-associated polymorphisms for obesity-related traits in 2,362 adults aged > 20 years. We excluded 13 polymorphisms showing deviations from Hardy-Weinberg equilibrium or no association with obesity-related traits (body mass index, waist circumference (WC), and waist-to-hip ratio). Among 5 selected polymorphisms (rs9594738 of RANKL, rs17066364 of NUFIP1, rs7227401 of OSBPL1A, and rs1856057 and rs2982573 of ESR1) analyzed, 2 polymorphisms (rs9594738 and rs17066364) were associated with obesity-related traits. We found sex-dependent associations such that the 4 polymorphisms (excluding rs9594738 of RANKL) were associated with abdominal traits such as WC and waist-to-hip ratio only in men. In addition, when the combined genetic risk score (GRS) for WC increase was calculated with 4 SNPs (rs9594738, rs17066364, rs7227401, and rs1856057) exhibiting similar trends for both sexes, the magnitude of the GRS effect for the WC increase was larger in men than in women (effect size = 0.856 cm, P = 0.0000452 for men; effect size = 0.598 cm, P = 0.00228 for women). In summary, we found 4 polymorphisms, previously related to osteoporosis, to be associated to obesity-related traits in a sex-dependent manner in Korean adults, particularly in men.	[Cha, Seongwon; Yu, Hyunjoo] KIOM, Constitut Med & Diag Res Grp, Div Med Res, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Cha, S (corresponding author), KIOM, Constitut Med & Diag Res Grp, Div Med Res, Taejon, South Korea.	scha@kiom.re.kr	Yeol, Kim Jong/AAP-5998-2020; Cha, Seongwon/A-2377-2012	Cha, Seongwon/0000-0001-9012-8718	Korea Science and Engineering Foundation (KOSEF) grant; Korea government (MEST) [20120009001, 2006-2005173]	Korea Science and Engineering Foundation (KOSEF) grant(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 20120009001 (2006-2005173)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CG, 2000, OSTEOPOROSIS INT, V11, P714, DOI 10.1007/s001980070071; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blum M, 2003, CALCIFIED TISSUE INT, V73, P27, DOI 10.1007/s00223-002-1019-4; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Farhat GN, 2007, OSTEOPOROSIS INT, V18, P999, DOI 10.1007/s00198-007-0338-8; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Gerber Y, 2011, AM J MED, V124, P418, DOI 10.1016/j.amjmed.2010.11.029; Gu JM, 2009, ACTA PHARMACOL SIN, V30, P1634, DOI 10.1038/aps.2009.169; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027312; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Imamov O, 2005, BIOL REPROD, V73, P866, DOI 10.1095/biolreprod.105.043497; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Jeong S, 2011, J BIOTECHNOL, V154, P321, DOI 10.1016/j.jbiotec.2011.05.017; Jorgensen L, 2001, STROKE, V32, P47, DOI 10.1161/01.STR.32.1.47; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim BY, 2012, J ALTERN COMPLEM MED, V18, P262, DOI 10.1089/acm.2010.0764; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim KC, 2010, YONSEI MED J, V51, P857, DOI 10.3349/ymj.2010.51.6.857; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210/jc.86.5.1884; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Premaor MO, 2011, J CLIN ENDOCR METAB, V96, P2414, DOI 10.1210/jc.2011-0076; Raspa M, 2010, AJIDD-AM J INTELLECT, V115, P482, DOI 10.1352/1944-7558-115.6.482; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; von der Recke P, 1999, AM J MED, V106, P273, DOI 10.1016/S0002-9343(99)00028-5; Xie H, 2011, CARDIOVASC RES, V92, P296, DOI 10.1093/cvr/cvr200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zhao JH, 2011, OBESITY, V19, P1311, DOI 10.1038/oby.2010.324; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	48	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53013	10.1371/journal.pone.0053013	http://dx.doi.org/10.1371/journal.pone.0053013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300848	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100109
J	D'Angelo, A; De Angelis, A; Avallone, B; Piscopo, I; Tammaro, R; Studer, M; Franco, B				D'Angelo, Anna; De Angelis, Amalia; Avallone, Bice; Piscopo, Immacolata; Tammaro, Roberta; Studer, Michele; Franco, Brunella			Ofd1 Controls Dorso-Ventral Patterning and Axoneme Elongation during Embryonic Brain Development	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; PRIMARY CILIA FORMATION; DEVELOPING NEOCORTEX; GENE-EXPRESSION; TELENCEPHALON DEVELOPMENT; TRANSCRIPTION FACTORS; DORSAL TELENCEPHALON; POSTMITOTIC NEURONS; MOUSE TELENCEPHALON; REPRESSOR FUNCTIONS	Oral-facial-digital type I syndrome (OFDI) is a human X-linked dominant-male-lethal developmental disorder caused by mutations in the OFD1 gene. Similar to other inherited disorders associated to ciliary dysfunction OFD type I patients display neurological abnormalities. We characterized the neuronal phenotype that results from Ofd1 inactivation in early phases of mouse embryonic development and at post-natal stages. We determined that Ofd1 plays a crucial role in forebrain development, and in particular, in the control of dorso-ventral patterning and early corticogenesis. We observed abnormal activation of Sonic hedgehog (Shh), a major pathway modulating brain development. Ultrastructural studies demonstrated that early Ofd1 inactivation results in the absence of ciliary axonemes despite the presence of mature basal bodies that are correctly orientated and docked. Ofd1 inducible-mediated inactivation at birth does not affect ciliogenesis in the cortex, suggesting a developmental stage-dependent role for a basal body protein in ciliogenesis. Moreover, we showed defects in cytoskeletal organization and apical-basal polarity in Ofd1 mutant embryos, most likely due to lack of ciliary axonemes. Thus, the present study identifies Ofd1 as a developmental disease gene that is critical for forebrain development and ciliogenesis in embryonic life, and indicates that Ofd1 functions after docking and before elaboration of the axoneme in vivo.	[D'Angelo, Anna; De Angelis, Amalia; Piscopo, Immacolata; Tammaro, Roberta; Studer, Michele; Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Avallone, Bice] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Franco, Brunella] Univ Naples Federico II, Dept Pediat, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II	Franco, B (corresponding author), Telethon Inst Genet & Med TIGEM, Via Pietro Castellino 111, Naples, Italy.	franco@tigem.it	Avallone, Bice/ABB-3425-2020; Studer, Michele/P-4580-2016; FRANCO, Brunella/S-2882-2018	Avallone, Bice/0000-0002-5355-1557; Studer, Michele/0000-0001-7105-2957; FRANCO, Brunella/0000-0001-5588-4569	Fondazione Telethon; European Community [201804, 241955]	Fondazione Telethon(Fondazione TelethonEuropean Commission); European Community(European Commission)	This work was supported by Fondazione Telethon (http://www.telethon.it/en) and the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreements 201804 and 241955. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Besse L, 2011, DEVELOPMENT, V138, P2079, DOI 10.1242/dev.059808; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Blotta S, 2009, BLOOD, V114, P3276, DOI 10.1182/blood-2009-04-219436; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BULFONE A, 1993, J NEUROSCI, V13, P3155; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Fode C, 2000, GENE DEV, V14, P67; Fotaki V, 2006, J NEUROSCI, V26, P9282, DOI 10.1523/JNEUROSCI.2673-06.2006; Fotaki V, 2010, DEV DYNAM, V239, P284, DOI 10.1002/dvdy.22137; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Grove EA, 1998, DEVELOPMENT, V125, P2315; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Howard PW, 2010, TRANSGENIC RES, V19, P121, DOI 10.1007/s11248-009-9292-x; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hunkapiller J, 2011, STEM CELLS DEV, V20, P831, DOI 10.1089/scd.2010.0362; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Juric-Sekhar G, 2012, ACTA NEUROPATHOL, V123, P695, DOI 10.1007/s00401-012-0951-2; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Prattichizzo C, 2008, HUM MUTAT, V29, P1237, DOI 10.1002/humu.20792; Qin J, 2011, P NATL ACAD SCI US; Richardson M, 1999, MAMM GENOME, V10, P923, DOI 10.1007/s003359901115; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Ruat M, 2012, DIFFERENTIATION, V83, pS97, DOI 10.1016/j.diff.2011.11.011; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Sussel L, 1999, DEVELOPMENT, V126, P3359; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Vogel TW, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12222; Waclaw RR, 2004, DEVELOPMENT, V131, P4013, DOI 10.1242/dev.01272; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Willaredt MA, 2012, MECH DEV; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Winterbottom EF, 2010, DEVELOPMENT, V137, P2623, DOI 10.1242/dev.047159	93	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52937	10.1371/journal.pone.0052937	http://dx.doi.org/10.1371/journal.pone.0052937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300826	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100101
J	Hertzog, M; Monteiro, P; Le Dez, G; Chavrier, P				Hertzog, Maud; Monteiro, Pedro; Le Dez, Gaelle; Chavrier, Philippe			Exo70 Subunit of the Exocyst Complex Is Involved in Adhesion-Dependent Trafficking of Caveolin-1	PLOS ONE			English	Article							PLASMA-MEMBRANE; CELL-MIGRATION; DOMAINS; PROTEIN; INTERNALIZATION; INTEGRINS; INTERACTS; DYNAMICS; RAC	Caveolae are specialized domains of the plasma membrane, which play key roles in signaling, endocytosis and mechanosensing. Using total internal reflection fluorescent microscopy (TIRF-M), we observe that the exocyst subunit Exo70 forms punctuate structures at the plasma membrane and partially localizes with caveolin-1, the main component of caveolae. Upon cell detachment, we found that Exo70 accumulates with caveolin-1-positive vesicular structures. Upon cell re-adhesion, caveolin-1 traffics back to the plasma membrane in a multistep process involving microtubules and actin cytoskeleton. In addition, silencing of Exo70 redirects caveolin-1 to focal adhesions identified by markers such as alpha 5 integrin or vinculin. Based on these findings, we conclude that Exo70 is involved in caveolin-1 recycling to the plasma membrane during re-adhesion of the cells to the substratum.	[Hertzog, Maud; Monteiro, Pedro; Le Dez, Gaelle; Chavrier, Philippe] Inst Curie, CNRS, UMR144, Res Ctr, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Hertzog, M (corresponding author), Univ Toulouse 3, CNRS, LMGM, UMR 5100, F-31062 Toulouse, France.	maud.hertzog@ibcg.biotoul.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X; Le Dez, Gaelle/0000-0002-9247-9666; Monteiro, Pedro/0000-0002-1690-0252	Association pour la Recherche sur le Cancer [SL220100601356]; Agence Nationale pour la Recherche [ANR-08-BLAN-0111]; Institut Curie; Centre National de la Recherche Scientifique (National Center for Scientific Research, France)	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut Curie; Centre National de la Recherche Scientifique (National Center for Scientific Research, France)	Support was provided to PC by Association pour la Recherche sur le Cancer.(grant #SL220100601356) and Agence Nationale pour la Recherche (grant #ANR-08-BLAN-0111). Core funding for this work was provided by Institut Curie and Centre National de la Recherche Scientifique (National Center for Scientific Research, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hertzog M, 2011, BIOCHEM J, V433, P403, DOI 10.1042/BJ20101214; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mundy DI, 2012, MOL BIOL CELL, V23, P864, DOI 10.1091/mbc.E11-07-0598; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	28	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52627	10.1371/journal.pone.0052627	http://dx.doi.org/10.1371/journal.pone.0052627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300727	Green Submitted, gold, Green Published			2022-12-27	WOS:000312829100068
J	Kelly, DJ; Robertson, A; Murphy, D; Fitzsimons, T; Costello, E; Gormley, E; Corner, LAL; Marples, NM				Kelly, David J.; Robertson, Andrew; Murphy, Denise; Fitzsimons, Tara; Costello, Eamon; Gormley, Eamonn; Corner, Leigh A. L.; Marples, Nicola M.			Trophic Enrichment Factors for Blood Serum in the European Badger (Meles meles)	PLOS ONE			English	Article							MULTIPLE STABLE ISOTOPES; OTTERS ENHYDRA-LUTRIS; BOVINE TUBERCULOSIS; STOMACH CONTENTS; MIXING MODELS; DIET; NITROGEN; CARBON; FRACTIONATION; ECOLOGY	Ecologists undertaking stable isotopic analyses of animal diets require trophic enrichment factors (TEFs) for the specific animal tissues that they are studying. Such basic data are available for a small number of species, so values from trophically or phylogenetically similar species are often substituted for missing values. By feeding a controlled diet to captive European badgers (Meles meles) we determined TEFs for carbon and nitrogen in blood serum. TEFs for nitrogen and carbon in blood serum were +3.0 +/- 0.4 parts per thousand and +0.4 +/- 0.1 parts per thousand respectively. The TEFs for serum in badgers are notably different from those published for the red fox (Vulpes vulpes). There is currently no data for TEFs in the serum of other mustelid species. Our data show that species sharing similar niches (red fox) do not provide adequate proxy values for TEFs of badgers. Our findings emphasise the importance of having species-specific data when undertaking trophic studies using stable isotope analysis.	[Kelly, David J.; Marples, Nicola M.] Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland; [Robertson, Andrew] Univ Exeter, Ctr Ecol & Conservat, Tremough, Cornwall, England; [Murphy, Denise; Fitzsimons, Tara; Gormley, Eamonn; Corner, Leigh A. L.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Costello, Eamon] Dept Agr Food & Marine, Cent Vet Res Lab, Celbridge, Kildare, Ireland	Trinity College Dublin; University of Exeter; University College Dublin	Kelly, DJ (corresponding author), Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland.	djkelly@tcd.ie	Gormley, Eamonn/AAU-6678-2020; Kelly, David/AAE-8278-2019; Marples, Nicola/D-8753-2014; Robertson, Andrew/A-4944-2016	Gormley, Eamonn/0000-0003-3900-0393; Robertson, Andrew/0000-0003-3720-6670; Kelly, David/0000-0002-5880-4162; Marples, Nicola/0000-0003-4693-2607	Irish Department of Agriculture, Fisheries and Food; FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis)	Irish Department of Agriculture, Fisheries and Food; FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis)	DJK was supported by a grant from the Irish Department of Agriculture, Fisheries and Food. The contributions of EG, LALC and DM were funded by FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker BH, 2007, CONDOR, V109, P451, DOI 10.1650/0010-5422(2007)109[451:DSINAC]2.0.CO;2; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Ben-David M, 1996, THESIS U ALASKA FAIR; Bodey TW, 2010, J APPL ECOL, V47, P114, DOI 10.1111/j.1365-2664.2009.01739.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Chang SSR., 2004, HDB STABLE ISOTOPE A; Christie KS, 2008, CAN J ZOOL, V86, P1317, DOI 10.1139/Z08-110; Cleary GP, 2011, MAMM BIOL, V76, P470, DOI 10.1016/j.mambio.2010.10.012; Cleary GP, 2009, MAMM BIOL, V74, P438, DOI 10.1016/j.mambio.2009.07.003; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Criss RE, 2008, REV MINERAL GEOCHEM, V68, P15, DOI 10.2138/rmg.2008.68.3; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Dalerum Fredrik, 2009, Current Zoology, V55, P188; Del Cerro I, 2010, ZOOL SCR, V39, P415, DOI 10.1111/j.1463-6409.2010.00436.x; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Flindt R, 2006, AMAZING NUMBERS BIOL; Gormley E, 2003, J APPL MICROBIOL, V94, p80S; Goszczynski J, 2000, J ZOOL, V250, P495, DOI 10.1111/j.1469-7998.2000.tb00792.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hinwood BG, 1997, TXB SCI HLTH PROFESS; Kaneko Y, 2006, J ZOOL, V270, P78, DOI 10.1111/j.1469-7998.2006.00063.x; KRUUK H, 1979, J APPL ECOL, V16, P453, DOI 10.2307/2402521; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; KRUUK H, 1983, Z SAUGETIERKD, V48, P45; Kruuk H., 1989, SOCIAL BADGER; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Lake JL, 2007, ENVIRON TOXICOL CHEM, V26, P2611, DOI 10.1897/06-607.1; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; LUPS P, 1987, MAMMALIA, V51, P559, DOI 10.1515/mamm.1987.51.4.559; MacDonald DW, 2005, CANIDS FOXES WOLVES, P129; Mathews F, 2009, ADV PARASIT, V68, P185, DOI 10.1016/S0065-308X(08)00608-8; McNett K, 2010, INSECT SOC, V57, P67, DOI 10.1007/s00040-009-0051-z; Meckstroth AM, 2007, J WILDLIFE MANAGE, V71, P2387, DOI 10.2193/2005-527; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; MIZUTANI H, 1992, ECOLOGY, V73, P1391, DOI 10.2307/1940684; Muldowney J, 2003, PEDOBIOLOGIA, V47, P913, DOI 10.1016/S0031-4056(04)70289-9; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; NEAL E, 1988, J ZOOL, V215, P367, DOI 10.1111/j.1469-7998.1988.tb04904.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Roper T, 2010, BADGER; Rosalino LM, 2005, MAMM BIOL, V70, P12, DOI 10.1078/1616-5047-00172; Rosalino LM, 2009, MAMMAL REV, V39, P67, DOI 10.1111/j.1365-2907.2008.00134.x; Rosalino LM, 2006, EUR J WILDLIFE RES, V52, P202, DOI 10.1007/s10344-006-0033-7; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Seminoff JA, 2009, J EXP MAR BIOL ECOL, V381, P33, DOI 10.1016/j.jembe.2009.08.018; Szpak P, 2012, J ARCHAEOL SCI, V39, P1553, DOI 10.1016/j.jas.2011.12.006; Tibbets TM, 2006, INTEGR COMP BIOL, V46, pE141; Todd SK, 2010, MAR MAMMAL SCI, V26, P176, DOI 10.1111/j.1748-7692.2009.00345.x; VACHA J, 1981, COMP BIOCHEM PHYS A, V69, P357, DOI 10.1016/0300-9629(81)92990-X; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Ward AI, 2006, ANIM SCI, V82, P767, DOI 10.1017/ASC2006102; White PCL, 2008, TRENDS MICROBIOL, V16, P420, DOI 10.1016/j.tim.2008.06.005	63	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53071	10.1371/journal.pone.0053071	http://dx.doi.org/10.1371/journal.pone.0053071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300863	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100116
J	Krause, G; Kreuchwig, A; Kleinau, G				Krause, Gerd; Kreuchwig, Annika; Kleinau, Gunnar			Extended and Structurally Supported Insights into Extracellular Hormone Binding, Signal Transduction and Organization of the Thyrotropin Receptor	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LEUCINE-RICH REPEATS; CHORIONIC-GONADOTROPIN RECEPTOR; SITE-DIRECTED MUTAGENESIS; HUMAN TSH RECEPTOR; HINGE REGION; CONSTITUTIVE ACTIVITY; LIGAND-BINDING; NEGATIVE COOPERATIVITY; GLYCOPROTEIN HORMONES	The hormone thyrotropin (TSH) and its receptor (TSHR) are crucial for the growth and function of the thyroid gland. The TSHR is evolutionary linked with the receptors of follitropin (FSHR) and lutropin/choriogonadotropin (LHR) and their sequences and structures are similar. The extracellular region of TSHR contains more than 350 amino acids and binds hormone and antibodies. Several important questions related to functions and mechanisms of TSHR are still not comprehensively understood. One major reason for these open questions is the lack of any structural information about the extracellular segment of TSHR that connects the N-terminal leucine-rich repeat domain (LRRD) with the transmembrane helix (TMH) 1, the hinge region. It has been shown experimentally that this segment is important for fine tuning of signaling and ligand interactions. A new crystal structure containing most of the extracellular hFSHR region in complex with hFSH has recently been published. Now, we have applied these new structural insights to the homologous TSHR and have generated a structural model of the TSHR LRRD/hinge-region/TSH complex. This structural model is combined and evaluated with experimental data including hormone binding (bTSH, hTSH, thyrostimulin), super-agonistic effects, antibody interactions and signaling regulation. These studies and consideration of significant and non-significant amino acids have led to a new description of mechanisms at the TSHR, including ligand-induced displacements of specific hinge region fragments. This event triggers conformational changes at a convergent center of the LRRD and the hinge region, activating an "intramolecular agonistic unit" close to the transmembrane domain.	[Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Krause, Gerd; Kreuchwig, Annika] Leibniz Inst Mol Pharmacol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Kleinau, G (corresponding author), Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	Gunnar.Kleinau@charite.de	Kleinau, Gunnar/GPX-6330-2022		Deutsche Forschungsgemeinschaft [KL2334/2-2, KR1273/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, projects KL2334/2-2 and KR1273/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Alvarez E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-90; Angelova K, 2010, J BIOL CHEM, V285, P34813, DOI 10.1074/jbc.M110.148221; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; BOLONKIN D, 1975, J BIOL CHEM, V250, P6516; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chen CR, 2012, ENDOCRINOLOGY, V153, P5058, DOI 10.1210/en.2012-1376; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2003, ENDOCRINOLOGY, V144, P3821, DOI 10.1210/en.2003-0430; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Galet C, 2005, MOL ENDOCRINOL, V19, P1263, DOI 10.1210/me.2004-0410; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Hai MTV, 2009, J CELL MOL MED, V13, P2253, DOI 10.1111/j.1582-4934.2008.00422.x; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Ho SC, 2005, MOL CELL ENDOCRINOL, V245, P158, DOI 10.1016/j.mce.2005.11.008; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jaquette J, 2002, MOL CELL ENDOCRINOL, V194, P211, DOI 10.1016/S0303-7207(02)00220-4; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Kreuchwig A, 2011, MOL ENDOCRINOL, V25, P707, DOI 10.1210/me.2010-0510; Miguel RN, 2004, THYROID, V14, P991, DOI 10.1089/thy.2004.14.991; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Mueller S, 2011, ENDOCRINOLOGY, V152, P3268, DOI 10.1210/en.2011-0153; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nishihara E, 2012, J ENDOCRINOL INVEST, V35, P49, DOI 10.3275/7738; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Sellami A, 2011, GEN COMP ENDOCR, V170, P582, DOI 10.1016/j.ygcen.2010.11.015; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Szkudlinski MW, 1996, TRENDS ENDOCRIN MET, V7, P277, DOI 10.1016/S1043-2760(96)00129-4; TATE RL, 1975, J BIOL CHEM, V250, P6509; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	81	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52920	10.1371/journal.pone.0052920	http://dx.doi.org/10.1371/journal.pone.0052920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300822	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100099
J	Phillips, BL; Puschendorf, R; VanDerWal, J; Alford, RA				Phillips, Ben L.; Puschendorf, Robert; VanDerWal, Jeremy; Alford, Ross A.			There Is No Evidence for a Temporal Link between Pathogen Arrival and Frog Extinctions in North-Eastern Australia	PLOS ONE			English	Article							AMPHIBIAN EXTINCTIONS; EPIDEMIC DISEASE; FUNGAL PATHOGEN; POPULATION; DECLINES; MORTALITY; GENOTYPES; DYNAMICS; CLIMATE	Pathogen spread can cause population declines and even species extinctions. Nonetheless, in the absence of tailored monitoring schemes, documenting pathogen spread can be difficult. In the case of worldwide amphibian declines the best present understanding is that the chytrid fungus Batrachochytrium dendrobatidis (Bd) has recently spread, causing amphibian declines and extinction in the process. However, good evidence demonstrating pathogen arrival followed by amphibian decline is rare, and analysis of putative evidence is often inadequate. Here we attempt to examine the relationship between Bd arrival and amphibian decline across north-eastern Australia, using sites where a wave-like pattern of amphibian decline was first noticed and at which intensive research has since been conducted. We develop an analytical framework that allows rigorous estimation of pathogen arrival date, which can then be used to test for a correlation between the time of pathogen arrival and amphibian decline across sites. Our results show that, with the current dataset, the earliest possible arrival date of Bd in north-eastern Australia is completely unresolved; Bd could have arrived immediately before sampling commenced or may have arrived thousands of years earlier, the present data simply cannot say. The currently available data are thus insufficient to assess the link between timing of pathogen arrival and population decline in this part of the world. This data insufficiency is surprising given that there have been decades of research on chytridiomycosis in Australia and that there is a general belief that the link between Bd arrival and population decline is well resolved in this region. The lack of data on Bd arrival currently acts as a major impediment to determining the role of environmental factors in driving the global amphibian declines, and should be a major focus of future research.	[Phillips, Ben L.; Puschendorf, Robert; VanDerWal, Jeremy; Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	James Cook University	Phillips, BL (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	ben.phillips1@jcu.edu.au	Phillips, Ben/C-7957-2009; Puschendorf, Robert/B-6280-2011; Alford, Ross A/H-1577-2011; VanDerWal, Jeremy/C-7457-2009	Phillips, Ben/0000-0003-2580-2336; Puschendorf, Robert/0000-0002-8105-171X; Alford, Ross A/0000-0002-3010-6768; 	Australian Research Council; Centre for Tropical Biodiversity and Climate Change	Australian Research Council(Australian Research Council); Centre for Tropical Biodiversity and Climate Change	BLP and RP thank the Australian Research Council for support through its fellowships program. JV was supported by The Centre for Tropical Biodiversity and Climate Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A.A., 2002, CONSERVATION MED ECO; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Collins J.P., 2009, EXTINCTION OUR TIMES; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; GINSBERG JR, 1995, P ROY SOC B-BIOL SCI, V262, P221, DOI 10.1098/rspb.1995.0199; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P1, DOI 10.1111/j.1442-9993.2007.01812.x; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; MCDONALD KR, 1999, DECLINES DISAPPEARAN; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; PLOWRIGHT W, 1962, ANN NY ACAD SCI, V101, P548, DOI 10.1111/j.1749-6632.1962.tb18896.x; Plowright W., 1982, Symposia of the Zoological Society of London, V50, P1; Plummer R, 2011, RJAGS BAYESIAN GRAPH; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; R Core Team, 2020, R LANG ENV STAT COMP; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860	37	7	7	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52502	10.1371/journal.pone.0052502	http://dx.doi.org/10.1371/journal.pone.0052502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300687	gold, Green Published, Green Accepted			2022-12-27	WOS:000312829100055
J	Jung, KW; Park, S; Shin, A; Oh, CM; Kong, HJ; Jun, JK; Won, YJ				Jung, Kyu-Won; Park, Sohee; Shin, Aesun; Oh, Chang-Mo; Kong, Hyun-Joo; Jun, Jae Kwan; Won, Young-Joo			Do Female Cancer Patients Display Better Survival Rates Compared with Males? Analysis of the Korean National Registry Data, 2005-2009	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; BLADDER-CANCER; RACIAL-DIFFERENCES; PROGNOSTIC-FACTORS; LIFE EXPECTANCY; SEX-DIFFERENCES; LUNG-CANCER; GENDER; AGE; MORTALITY	Background: Sex differences have been reported in the prognosis of certain cancers. In this study, we investigated whether Korean females display better survival rates compared with male patients for solid tumor sites. Methods: We analyzed data from the Korean National Cancer Incidence Database from 599,288 adult patients diagnosed with solid cancers between 2005 and 2009. Patients were followed until December 2010. We applied a relative excess risk (RER) model adjusting for year of follow-up, age at diagnosis, and stage at diagnosis. Results: For all solid cancer sites combined, women displayed an 11% lower risk of death compared to men (RER 0.89; 95% CI 0.88-0.90) after adjusting for year of follow-up, age, stage, and case mix. Women showed significantly lower RERs for the following sites: head/neck, esophagus, small intestine, liver, nasal cavities, lung, bone/cartilages, melanoma of skin, soft tissue, brain and CNS, and thyroid. In contrast, women displayed a poorer prognosis than did men for colorectal, laryngeal, kidney and bladder cancer. However, the survival gaps between men and women narrowed by increase in age; female patients over 75 years of age displayed a 3% higher RER of death compared with males in this age group. Conclusions: Female cancer patients display an improved survival for the majority of solid tumor sites, even after adjustment for age and stage. Age at diagnosis was the major contributor to the women's survival advantage.	[Jung, Kyu-Won; Shin, Aesun; Oh, Chang-Mo; Kong, Hyun-Joo; Won, Young-Joo] Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Shin, Aesun] Natl Canc Ctr, Mol Epidemiol Branch, Res Inst, Goyang, South Korea; [Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Canc Early Detect Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Jung, KW (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea.	ara@ncc.re.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center [NCC-1010160]	National Cancer Center	This work was supported by the National Cancer Center Grant (NCC-1010160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; Beisland C, 2002, SCAND J UROL NEPHROL, V36, P414, DOI 10.1080/003655902762467558; Chatkin Jose M, 2004, Gend Med, V1, P41, DOI 10.1016/S1550-8579(04)80009-3; Condon JR, 2005, MED J AUSTRALIA, V182, P277, DOI 10.5694/j.1326-5377.2005.tb06700.x; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Curado M, 2010, IARC SCI PUBLICATION, VIX; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Donington JS, 2006, CLIN LUNG CANCER, V8, P22, DOI 10.3816/CLC.2006.n.029; Janssen-Heijnen MLG, 2005, CRIT REV ONCOL HEMAT, V55, P231, DOI 10.1016/j.critrevonc.2005.04.008; Jee SH, 2003, HEALTH AND WELFARE P, P16; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008; Mungan NA, 2000, UROLOGY, V55, P876, DOI 10.1016/S0090-4295(00)00523-9; Oberaigner W, 2011, EUR J PUBLIC HEALTH, V21, P387, DOI 10.1093/eurpub/ckq099; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Schubbe S, 2012, CHEM MATER, V24, P914, DOI 10.1021/cm2018532; Scosyrev E, 2009, CANCER-AM CANCER SOC, V115, P68, DOI 10.1002/cncr.23986; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Stafford HS, 2008, J UROLOGY, V179, P1704, DOI 10.1016/j.juro.2008.01.027; Suissa S, 1999, AM J EPIDEMIOL, V150, P279; Villano JL, 2011, BRIT J CANCER, V105, P1414, DOI 10.1038/bjc.2011.357; WHO, 1992, MANUAL OF THE INTERN; Woldrich JM, 2008, J UROLOGY, V179, P1709, DOI 10.1016/j.juro.2008.01.024; Wolters U, 1996, EUR J SURG ONCOL, V22, P592, DOI 10.1016/S0748-7983(96)92320-3; World Health Organization, 2000, INTERNATIONAL CLASSI; Young JL, 2001, NIH PUB	33	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52457	10.1371/journal.pone.0052457	http://dx.doi.org/10.1371/journal.pone.0052457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300677	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800091
J	Naim, F; Nakasugi, K; Crowhurst, RN; Hilario, E; Zwart, AB; Hellens, RP; Taylor, JM; Waterhouse, PM; Wood, CC				Naim, Fatima; Nakasugi, Kenlee; Crowhurst, Ross N.; Hilario, Elena; Zwart, Alexander B.; Hellens, Roger P.; Taylor, Jennifer M.; Waterhouse, Peter M.; Wood, Craig C.			Advanced Engineering of Lipid Metabolism in Nicotiana benthamiana Using a Draft Genome and the V2 Viral Silencing-Suppressor Protein	PLOS ONE			English	Article							RNA; EFFICIENT; PLANTS; SGS3; P19	The transient leaf assay in Nicotiana benthamiana is widely used in plant sciences, with one application being the rapid assembly of complex multigene pathways that produce new fatty acid profiles. This rapid and facile assay would be further improved if it were possible to simultaneously overexpress transgenes while accurately silencing endogenes. Here, we report a draft genome resource for N. benthamiana spanning over 75% of the 3.1 Gb haploid genome. This resource revealed a two-member NbFAD2 family, NbFAD2.1 and NbFAD2.2, and quantitative RT-PCR (qRT-PCR) confirmed their expression in leaves. FAD2 activities were silenced using hairpin RNAi as monitored by qRT-PCR and biochemical assays. Silencing of endogenous FAD2 activities was combined with overexpression of transgenes via the use of the alternative viral silencing-suppressor protein, V2, from Tomato yellow leaf curl virus. We show that V2 permits maximal overexpression of transgenes but, crucially, also allows hairpin RNAi to operate unimpeded. To illustrate the efficacy of the V2-based leaf assay system, endogenous lipids were shunted from the desaturation of 18: 1 to elongation reactions beginning with 18: 1 as substrate. These V2-based leaf assays produced similar to 50% more elongated fatty acid products than p19-based assays. Analyses of small RNA populations generated from hairpin RNAi against NbFAD2 confirm that the siRNA population is dominated by 21 and 22 nt species derived from the hairpin. Collectively, these new tools expand the range of uses and possibilities for metabolic engineering in transient leaf assays.	[Naim, Fatima; Taylor, Jennifer M.; Waterhouse, Peter M.; Wood, Craig C.] Commonwealth Sci & Ind Res Org, Plant Ind, Canberra, ACT, Australia; [Crowhurst, Ross N.; Hilario, Elena; Hellens, Roger P.] New Zealand Inst Plant & Food Res Ltd, Breeding & Genom, Auckland, New Zealand; [Zwart, Alexander B.] Commonwealth Sci & Ind Res Org, Math Informat & Stat, Canberra, ACT, Australia; [Waterhouse, Peter M.] Univ Sydney, Sch Biol Sci, Sch Mol Biosci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); New Zealand Institute for Plant & Food Research Ltd; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Wood, CC (corresponding author), Commonwealth Sci & Ind Res Org, Plant Ind, Canberra, ACT, Australia.	Craig.Wood@csiro.au	Crowhurst, Ross N/N-8892-2017; Wood, Craig C/B-5792-2009; Taylor, Jennifer M/A-1686-2010; Hilario, Elena/ABB-8574-2021; Zwart, Alexander B/A-4822-2009	Crowhurst, Ross N/0000-0003-0608-2134; Taylor, Jennifer M/0000-0003-4231-0181; Hilario, Elena/0000-0001-8124-8881; Zwart, Alexander B/0000-0002-9158-3795; , Pepe/0000-0002-8794-9985; Waterhouse, Peter/0000-0002-2812-3753; Naim, Fatima/0000-0001-8451-1104; Hellens, Roger/0000-0003-2094-0887	CSIRO OCE PhD Scholarship; CSIRO; University of Sydney; New Zealand Institute for Plant and Food Research; ARC Federation [FF0776510]	CSIRO OCE PhD Scholarship; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Sydney(University of Sydney); New Zealand Institute for Plant and Food Research; ARC Federation(Australian Research Council)	FN is a CSIRO OCE PhD Scholarship recipient. This work was funded collaboratively by CSIRO, University of Sydney and The New Zealand Institute for Plant and Food Research. PMW is funded by the ARC Federation Fellowship FF0776510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baulcombe DC, 2004, TRENDS BIOCHEM SCI, V29, P279, DOI 10.1016/j.tibs.2004.04.007; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bombarely A, 2012, MOL PLANT MICROBE IN; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Coutu C, 2007, TRANSGENIC RES, V16, P771, DOI 10.1007/s11248-007-9066-2; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Fusaro AF, 2012, VIROLOGY, V426, P178, DOI 10.1016/j.virol.2012.01.026; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hilario E, 2004, ANTON LEEUW INT J G, V86, P51, DOI 10.1023/B:ANTO.0000024910.57117.16; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440, DOI 10.21273/HORTSCI.27.5.440; Mikkelsen MD, 2010, MOL PLANT, V3, P751, DOI 10.1093/mp/ssq020; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Petrie JR, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-8; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2011, PLOS PATHOGENS, V7; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zrachya A, 2007, VIROLOGY, V358, P159, DOI 10.1016/j.virol.2006.08.016	33	61	66	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52717	10.1371/journal.pone.0052717	http://dx.doi.org/10.1371/journal.pone.0052717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300750	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800130
J	Ozawa, T; Piao, XH; Kobayashi, E; Zhou, Y; Sakurai, H; Andoh, T; Jin, AS; Kishi, H; Muraguchi, A				Ozawa, Tatsuhiko; Piao, Xiuhong; Kobayashi, Eiji; Zhou, Yue; Sakurai, Hiroaki; Andoh, Tsugunobu; Jin, Aishun; Kishi, Hiroyuki; Muraguchi, Atsushi			A Novel Rabbit Immunospot Array Assay on a Chip Allows for the Rapid Generation of Rabbit Monoclonal Antibodies with High Affinity	PLOS ONE			English	Article							SINGLE-CELL; B-CELLS; MOUSE HYBRIDOMAS; SECRETING CELLS; ANTIGEN; GROWTH; TAK1; TAB1; HETEROHYBRIDOMAS; PHOSPHORYLATION	Antigen-specific rabbit monoclonal antibodies (RaMoAbs) are useful due to their high specificity and high affinity, and the establishment of a comprehensive and rapid RaMoAb generation system has been highly anticipated. Here, we present a novel system using immunospot array assay on a chip (ISAAC) technology in which we detect and retrieve antigen-specific antibody-secreting cells from the peripheral blood lymphocytes of antigen-immunized rabbits and produce antigen-specific RaMoAbs with 10(-12) M affinity within a time period of only 7 days. We have used this system to efficiently generate RaMoAbs that are specific to a phosphorylated signal-transducing molecule. Our system provides a new method for the comprehensive and rapid production of RaMoAbs, which may contribute to laboratory research and clinical applications.	[Ozawa, Tatsuhiko; Piao, Xiuhong; Kobayashi, Eiji; Jin, Aishun; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan; [Zhou, Yue; Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 930, Japan; [Andoh, Tsugunobu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 930, Japan; [Jin, Aishun] Harbin Med Univ, Coll Basic Med Sci, Dept Immunol, Harbin, Peoples R China	University of Toyama; University of Toyama; University of Toyama; Harbin Medical University	Kishi, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan.	immkishi@med.u-toyama.ac.jp	Sakurai, Hiroaki/AAE-4294-2019	Ozawa, Tatsuhiko/0000-0002-3112-452X; Kobayashi, Eiji/0000-0002-7303-2797; Zhou, Yue/0000-0002-1335-5703; Sakurai, Hiroaki/0000-0003-0657-9570	Vivalis; Vivalis (Nantes, France.)	Vivalis; Vivalis (Nantes, France.)	Vivalis; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AM was supported by a research fund from Vivalis (Nantes, France.) The ISAAC method is covered by patents that have been exclusively licensed to Vivalis (Nantes, France.) Patent details: Pub. No.: WO/2009/017226, International Application No.: PCT/JP2008/063874, Title: CELL SCREENING METHOD; HK is one of Scientific Advisory Board Members of Vivalis. Microwell array chips are now provided to us by Vivalis. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams GP, 2001, CANCER RES, V61, P4750; Bao YP, 2006, ANAL CHEM, V78, P2055, DOI 10.1021/ac051798d; BYSTRYN JC, 1982, HYBRIDOMA, V1, P465, DOI 10.1089/hyb.1.1982.1.465; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Djavadi-Ohaniance L., 1996, ANTIBODY ENG PRACTIC, P77; Feng LF, 2011, AM J TRANSL RES, V3, P269; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Huang ZD, 2006, APPL IMMUNOHISTO M M, V14, P229, DOI 10.1097/01.pai.0000157906.38495.31; Jin A, 2011, NAT PROTOC, V6, P668, DOI 10.1038/nprot.2011.322; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kinoshita K, 2009, CYTOM PART A, V75A, P682, DOI 10.1002/cyto.a.20758; Krause R M, 1970, Adv Immunol, V12, P1, DOI 10.1016/S0065-2776(08)60167-4; KUO MC, 1985, MOL IMMUNOL, V22, P351; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; NORRBY E, 1987, P NATL ACAD SCI USA, V84, P6572, DOI 10.1073/pnas.84.18.6572; Ozawa T, 2006, BIOTECHNIQUES, V40, P469, DOI 10.2144/000112123; Ozawa T, 2009, LAB CHIP, V9, P158, DOI 10.1039/b810438g; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; RAMAN C, 1994, J IMMUNOL, V152, P3935; RAYBOULD TJG, 1988, SCIENCE, V240, P1788, DOI 10.1126/science.3289119; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHAR IN PRESS; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Tajiri K, 2007, CYTOM PART A, V71A, P961, DOI 10.1002/cyto.a.20471; Tao GZ, 2006, EXP CELL RES, V312, P411, DOI 10.1016/j.yexcr.2005.11.010; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; VERBANAC KM, 1993, TRANSPLANT P, V25, P837; VERBANAC KM, 1993, HYBRIDOMA, V12, P285, DOI 10.1089/hyb.1993.12.285; WELLER A, 1987, DEVELOPMENT, V100, P351; Winstead CR, 1999, J IMMUNOL, V162, P6602; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009072; Zhu W, 2009, THERAPEUTIC MONOCLON; Zhu Z, 2003, LEUKEMIA, V17, P604, DOI 10.1038/sj.leu.2402831	41	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52383	10.1371/journal.pone.0052383	http://dx.doi.org/10.1371/journal.pone.0052383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300658	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800077
J	Chen, B; Tao, ZX; Zhao, YM; Chen, HW; Yong, YH; Liu, X; Wang, H; Wu, ZZ; Yang, ZJ; Yuan, L				Chen, Bo; Tao, Zhengxian; Zhao, Yingming; Chen, Hongwu; Yong, Yonghong; Liu, Xiang; Wang, Hua; Wu, Zuze; Yang, Zhijian; Yuan, Li			Catheter-Based Intramyocardial Delivery (NavX) of Adenovirus Achieves Safe and Accurate Gene Transfer in Pigs	PLOS ONE			English	Article							HEPATOCYTE-GROWTH-FACTOR; MYOCARDIAL-ISCHEMIA; TRANSENDOCARDIAL DELIVERY; ADENOASSOCIATED VIRUS; HEART FUNCTION; ANGIOGENESIS; THERAPY; CARDIOMYOPATHY; IMPROVEMENT; TACHYCARDIA	Background: Hepatocyte growth factor (HGF) is one of the major angiogenic factors being studied for the treatment of ischemic heart diseases. Our previous study demonstrated adenovirus-HGF was effective in myocardial ischemia models. The first clinical safety study showed a positive effect in patients with severe and diffused triple coronary disease. Methods: 12 Pigs were randomized (1:1) to receive HGF, which was administered as five injections into the infarcted myocardium, or saline (control group). The injections were guided by EnSite NavX left ventricular electroanatomical mapping. Results: The catheter-based injections caused no pericardial effusion, malignant arrhythmia or death. During mapping and injection, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, serum creatinine and creatine kinase-MB levels have no significant increase as compared to those before and after the injection in HGF group(P>0.05). HGF group has high HGF expression with Western blot, less myocardial infarct sizes by electroanatomical mapping (HGF group versus after saline group, 5.28 +/- 0.55 cm(2) versus 9.06 +/- 1.06 cm(2), P<0.01), better cardiac function with Gated-Single Photon Emission Computed Tomography compared with those in saline group. Histological, strongly increased lectin-positive microvessels and microvessel density were found in the myocardial ischemic regions in HGF group. Conclusion: Intramyocardial injection guided by NavX system provides a method of feasible and safe percutaneous gene transfer to myocardial infarct regions.	[Chen, Bo; Tao, Zhengxian; Zhao, Yingming; Chen, Hongwu; Yong, Yonghong; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Liu, Xiang] MicroPort Med Shanghai Co Ltd, Dev Technol Dept, Shanghai, Peoples R China; [Wang, Hua; Wu, Zuze] Acad Mil Med Sci, Beijing Inst Radiat Med China, Dept Expt Hematol, Beijing, Peoples R China; [Yuan, Li] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Academy of Military Medical Sciences - China; Nanjing Medical University	Yang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@yahoo.com.cn; Yuanli@njmu.edu.cn			National Nature Science Foundation of China [30971254]; Supporting Program of Science and Technology of Jiangsu [BE2009686]; Innovative Project of Clamber Scholar of Jiangsu [BK2010021]; Chinese National Basic Research and Development Grants '973' [2008CB517303]; National Mega-Project of Science Research of China [2009ZX09301-002]; Chinese High-Tech Grant'863' [2007AA021007]; Priority Acadamic Program Development of Jiangsu Higher Education Institutions	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Program of Science and Technology of Jiangsu; Innovative Project of Clamber Scholar of Jiangsu; Chinese National Basic Research and Development Grants '973'(National Basic Research Program of China); National Mega-Project of Science Research of China; Chinese High-Tech Grant'863'; Priority Acadamic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by grants from National Nature Science Foundation of China (30971254), Supporting Program of Science and Technology of Jiangsu (Social Development, BE2009686), the Innovative Project of Clamber Scholar of Jiangsu (BK2010021), Chinese National Basic Research and Development Grants '973' (2008CB517303), the National Mega-Project of Science Research of China (No.2009ZX09301-002) and Chinese High-Tech Grant'863'(2007AA021007), and a Project Funded by the Priority Acadamic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Azuma J, 2006, GENE THER, V13, P1206, DOI 10.1038/sj.gt.3302740; Bish LT, 2008, MOL THER, V16, P1953, DOI 10.1038/mt.2008.202; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Casella M, 2009, HEART RHYTHM, V6, P1598, DOI 10.1016/j.hrthm.2009.07.040; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chaanine AH, 2010, SEMIN THORAC CARDIOV, V22, P127, DOI 10.1053/j.semtcvs.2010.09.009; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Gao GP, 2011, HUM GENE THER, V22, P979, DOI 10.1089/hum.2011.042; Kaspar BK, 2005, J GENE MED, V7, P316, DOI 10.1002/jgm.665; Katz MG, 2010, HUM GENE THER, V21, P371, DOI 10.1089/hum.2009.164; Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024; Kornowski R, 2000, J AM COLL CARDIOL, V35, P1031, DOI 10.1016/S0735-1097(99)00642-7; Kornowski R, 1999, CATHETER CARDIO INTE, V48, P447, DOI 10.1002/(SICI)1522-726X(199912)48:4<447::AID-CCD23>3.0.CO;2-Y; Kovoor P, 1998, CIRCULATION, V98, P1534, DOI 10.1161/01.CIR.98.15.1534; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Poornima IG, 2004, J AM COLL CARDIOL, V43, P194, DOI 10.1016/j.jacc.2003.09.029; Reithmann C, 2009, J CARDIOVASC ELECTR, V20, P841, DOI 10.1111/j.1540-8167.2009.01467.x; Taniyama Y, 2000, CIRCULATION, V102, P246, DOI 10.1161/01.CIR.102.2.246; Tao ZX, 2010, J BIOMED RES, V24, P198, DOI 10.1016/S1674-8301(10)60029-2; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Tung R, 2011, HEART RHYTHM, V8, P439, DOI 10.1016/j.hrthm.2010.10.044; Vale PR, 2001, CIRCULATION, V103, P2138; Ventura R, 2004, J CARDIOVASC ELECTR, V15, P1157, DOI 10.1046/j.1540-8167.2004.04064.x; Wang W, 2006, ACTA PHARMACOL SIN, V27, P555, DOI 10.1111/j.1745-7254.2006.00306.x; Yang ZJ, 2010, MOL BIOL REP, V37, P2075, DOI 10.1007/s11033-009-9665-5; Yang ZJ, 2009, MOL BIOL REP, V36, P1323, DOI 10.1007/s11033-008-9315-3; Yuan B, 2008, IN VIVO, V22, P629; Yuan B, 2008, SCI CHINA SER C, V51, P537, DOI 10.1007/s11427-008-0073-1; ZhiJian Y, 2007, SCI CHINA SER C, V50, P748, DOI 10.1007/s11427-007-0102-5	34	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53007	10.1371/journal.pone.0053007	http://dx.doi.org/10.1371/journal.pone.0053007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301013	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000025
J	Snider, AJ; Ruiz, P; Obeid, LM; Oates, JC				Snider, Ashley J.; Ruiz, Phillip; Obeid, Lina M.; Oates, Jim C.			Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis	PLOS ONE			English	Article							RENAL THROMBOXANE PRODUCTION; MRL/LPR MICE; ERYTHEMATOSUS; SURVIVAL; FTY720; SPHINGOSINE-1-PHOSPHATE; DISEASE; CYCLOOXYGENASE-2; INFLAMMATION; ASSOCIATION	Sphingosine-1-phosphate (S1P), a potent bioactive lipid, is emerging as a central mediator in inflammation and immune responses. We have previously implicated S1P and its synthetic enzyme sphingosine kinase (SK) in inflammatory and autoimmune disorders, including inflammatory bowel disease and rheumatoid arthritis. Generation of S1P requires phosphorylation of sphingosine by SK, of which there are two isoforms. Numerous studies have implicated SK1 in immune cell trafficking, inflammation and autoimmune disorders. In this study, we set out to determine the role of SK and S1P in lupus nephritis (LN). To this end, we examined S1P and dihydro-S1P (dh-S1P) levels in serum and kidney tissues from a mouse model of LN. Interestingly dh-S1P was significantly elevated in serum and kidney tissue from LN mice, which is more readily phosphorylated by SK2. Therefore, we employed the use of the specific SK2 inhibitor, ABC294640 in our murine model of LN. Treatment with ABC294640 did not improve vascular or interstitial pathology associated with LN. However, mice treated with the SK2 inhibitor did demonstrate decreases in glomerular pathology and accumulation of B and T cells in the spleen these were not statistically different from lpr mice treated with vehicle. LN mice treated with ABC294640 did not have improved urine thromboxane levels or urine proteinuria measurements. Both S1P and dh-S1P levels in circulation were significantly reduced with ABC294640 treatment; however, dh-S1P was actually elevated in kidneys from LN mice treated with ABC294640. Together these data demonstrate a role for SKs in LN; however, they suggest that inhibition of SK1 or perhaps both SK isoforms would better prevent elevations in S1P and dh-S1P and potentially better protect against LN.	[Snider, Ashley J.; Obeid, Lina M.; Oates, Jim C.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Snider, Ashley J.; Obeid, Lina M.; Oates, Jim C.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Pathol, Div Immunopathol, Miami, FL 33136 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Mol & Cellular Biol & Pathobiol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Miami; Medical University of South Carolina	Oates, JC (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA.	oatesjc@musc.edu		obeid, lina/0000-0002-0734-0847; Oates, Jim/0000-0002-5426-1359	Alliance for Lupus Research; Veterans Affairs Merit Award; Career Development Award; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	Alliance for Lupus Research; Veterans Affairs Merit Award(US Department of Veterans Affairs); Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Alliance for Lupus Research (JCO), Veterans Affairs Merit Award (LMO) and Career Development Award (AJS). Lipid analyses provided by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V53, P460, DOI 10.1016/0090-1229(89)90008-1; Han TS, 2006, LUPUS, V15, P71, DOI 10.1191/0961203306lu2264oa; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; KELLEY VE, 1986, J CLIN INVEST, V77, P252, DOI 10.1172/JCI112284; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Oates JC, 2007, ARTHRITIS RHEUM, V56, P3738, DOI 10.1002/art.22955; Oates JC, 1997, CLIN IMMUNOL IMMUNOP, V83, P86, DOI 10.1006/clin.1997.4332; Okazaki H, 2002, J RHEUMATOL, V29, P707; Sekine H, 2006, J IMMUNOL, V177, P7423, DOI 10.4049/jimmunol.177.10.7423; Smith CD, 2007, SPHINGOSINE KINASE I; SPURNEY RF, 1991, PROSTAG OTH LIPID M, V42, P15, DOI 10.1016/0090-6980(91)90090-3; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tomasoni S, 1998, J AM SOC NEPHROL, V9, P1202; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; Wenderfer SE, 2008, KIDNEY INT, V74, P1319, DOI 10.1038/ki.2008.396; Xin C, 2007, BRIT J PHARMACOL, V150, P943, DOI 10.1038/sj.bjp.0707171; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zhang XK, 2004, J IMMUNOL, V173, P6481, DOI 10.4049/jimmunol.173.10.6481; Zoja C, 2001, KIDNEY INT, V60, P653, DOI 10.1046/j.1523-1755.2001.060002653.x	30	31	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53521	10.1371/journal.pone.0053521	http://dx.doi.org/10.1371/journal.pone.0053521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301082	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000063
J	Hasson, D; Theorell, T; Bergquist, J; Canlon, B				Hasson, Dan; Theorell, Tores; Bergquist, Jonas; Canlon, Barbara			Acute Stress Induces Hyperacusis in Women with High Levels of Emotional Exhaustion	PLOS ONE			English	Article							COLD-PRESSOR TEST; SUBJECTIVE HEALTH COMPLAINTS; CHRONIC-FATIGUE-SYNDROME; HEARING-LOSS; GLUCOCORTICOID-RECEPTORS; CLINICAL CONDITIONS; BLOOD-PRESSURE; PREVALENCE; NOISE; PAIN	Background: Hearing problems is one of the top ten public health disorders in the general population and there is a well-established relationship between stress and hearing problems. The aim of the present study was to explore if an acute stress will increase auditory sensitivity (hyperacusis) in individuals with high levels of emotional exhaustion (EE). Methods: Hyperacusis was assessed using uncomfortable loudness levels (ULL) in 348 individuals (140 men; 208 women; age 23-71 years). Multivariate analyses (ordered logistic regression), were used to calculate odds ratios, including interacting or confounding effects of age, gender, ear wax and hearing loss (PTA). Two-way ANCOVAs were used to assess possible differences in mean ULLs between EE groups pre- and post-acute stress task (a combination of cold pressor, emotional Stroop and Social stress/video recording). Results: There were no baseline differences in mean ULLs between the three EE groups (one-way ANOVA). However, after the acute stress exposure there were significant differences in ULL means between the EE-groups in women. Post-hoc analyses showed that the differences in mean ULLs were between those with high vs. low EE (range 5.5-6.5 dB). Similar results were found for frequencies 0.5 and 1 kHz. The results demonstrate that women with high EE-levels display hyperacusis after an acute stress task. The odds of having hyperacusis were 2.5 (2 kHz, right ear; left ns) and 2.2 (4 kHz, right ear; left ns) times higher among those with high EE compared to those with low levels. All these results are adjusted for age, hearing loss and ear wax. Conclusion: Women with high levels of emotional exhaustion become more sensitive to sound after an acute stress task. This novel finding highlights the importance of including emotional exhaustion in the diagnosis and treatment of hearing problems.	[Hasson, Dan; Canlon, Barbara] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hasson, Dan; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Karolinska Institutet; Stockholm University; Uppsala University	Hasson, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	dan.hasson@ki.se	Hasson, Dan/T-9262-2019; Bergquist, Jonas/C-5894-2015	Canlon, Barbara/0000-0002-4377-5266; Bergquist, Jonas/0000-0002-4597-041X; Theorell, Tores/0000-0003-1956-7931	Swedish Research Council [2008-4122, K2010-62X-09476-20-3, 621-2011-4423]; Swedish Council for Working Life and Social Research; Stiftelsen Tysta Skolan; AFA Forsakring; Bliwastiftelsen; Karolinska Institutet Funds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stiftelsen Tysta Skolan; AFA Forsakring; Bliwastiftelsen; Karolinska Institutet Funds	The authors express deepest gratitude for the kind and invaluable financial support from the following funding bodies that made this study and analyses possible: The Swedish Research Council (project numbers: 2008-4122 (TT), K2010-62X-09476-20-3 (BC), 621-2011-4423 (JB)), The Swedish Council for Working Life and Social Research (BC, DH), Stiftelsen Tysta Skolan (BC, DH), AFA Forsakring (DH) and Bliwastiftelsen (DH), and Karolinska Institutet Funds (BC, DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare they received funding from The Swedish Research Council, AFA Forsakring, The Swedish Council for Working Life and Social Research, Stiftelsen Tysta Skolan, Bliwastiftelsen and Karolinska Institutet Funds. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aaron LA, 2003, BEST PRACT RES CL RH, V17, P563, DOI 10.1016/S1521-6942(03)00033-0; Aaron LA, 2001, J GEN INTERN MED, V16, P24, DOI 10.1046/j.1525-1497.2001.03419.x; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Ciccone DS, 2003, PSYCHOSOM MED, V65, P268, DOI 10.1097/01.PSY.0000033125.08272.A9; Clauw DJ, 2002, AM J IND MED, V41, P370, DOI 10.1002/ajim.10068; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; De Nicola AF, 2009, EXP GERONTOL, V44, P34, DOI 10.1016/j.exger.2008.03.005; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; EASTWOOD MR, 1985, BRIT J PSYCHIAT, V147, P552, DOI 10.1192/bjp.147.5.552; Eriksen HR, 2004, J PSYCHOSOM RES, V56, P445, DOI 10.1016/S0022-3999(03)00629-9; Fasano ML, 1996, CLIN AUTON RES, V6, P249, DOI 10.1007/BF02556295; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; HAGERMAN B, 1995, SCAND AUDIOL, V24, P71, DOI 10.3109/01050399509042213; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Hallberg UE, 2004, EUR J PSYCHOL ASSESS, V20, P320, DOI 10.1027/1015-5759.20.4.320; Hannula S, 2011, J AM ACAD AUDIOL, V22, P550, DOI 10.3766/jaaa.22.8.7; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Hebert S, 2012, PSYCHOTHER IN PRESS; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hines EA, 1936, AM HEART J, V11, P1, DOI 10.1016/S0002-8703(36)90370-8; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Lawrence H P, 2001, Spec Care Dentist, V21, P129, DOI 10.1111/j.1754-4505.2001.tb00242.x; LINDQVIST M, 1993, CLIN SCI, V85, P401, DOI 10.1042/cs0850401; Lusk SL, 2002, ARCH ENVIRON HEALTH, V57, P273, DOI 10.1080/00039890209601410; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maslach C., 1996, MASLACH BURNOUT INVE; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 2002, METABOLISM, V51, P2, DOI 10.1053/meta.2002.33183; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 2000, PROG BRAIN RES, V122, P25; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Tahera Y, 2006, NEUROREPORT, V17, P879, DOI 10.1097/01.wnr.0000220131.24468.e7; Ursin H, 2001, ANN NY ACAD SCI, V933, P119; Velasco M, 1997, Am J Ther, V4, P34, DOI 10.1097/00045391-199701000-00008; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	48	34	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52945	10.1371/journal.pone.0052945	http://dx.doi.org/10.1371/journal.pone.0052945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301005	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900048
J	Ornelas, IM; Silva, TM; Fragel-Madeira, L; Ventura, ALM				Ornelas, Isis Moraes; Silva, Thayane Martins; Fragel-Madeira, Lucianne; Marques Ventura, Ana Lucia			Inhibition of PI3K/Akt Pathway Impairs G2/M Transition of Cell Cycle in Late Developing Progenitors of the Avian Embryo Retina	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ATP-INDUCED PROLIFERATION; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; HISTONE H3; DEPENDENT PHOSPHORYLATION; MESSENGER-RNA; MITOSIS	PI3K/Akt is an important pathway implicated in the proliferation and survival of cells in the CNS. Here we investigated the participation of the PI3K/Akt signal pathway in cell cycle of developing retinal progenitors. Immunofluorescence assays performed in cultures of chick embryo retinal cells and intact tissues revealed the presence of phosphorylated Akt and 4E-BP1 in cells with typical mitotic profiles. Blockade of PI3K activity with the chemical inhibitor LY 294002 (LY) in retinal explants blocked the progression of proliferating cells through G2/M transition, indicated by an expressive increase in the number of cells labeled for phosphorylated histone H3 in the ventricular margin of the retina. No significant level of cell death could be detected at this region. Retinal explants treated with LY for 24 h also showed a significant decrease in the expression of phospho-Akt, phospho-GSK-3 and the hyperphosphorylated form of 4E-BP1. Although no change in the expression of cyclin B1 was detected, a significant decrease in CDK1 expression was noticed after 24 h of LY treatment both in retinal explants and monolayer cultures. Our results suggest that PI3K/Akt is an active pathway during proliferation of retinal progenitors and its activity appears to be required for proper CDK1 expression levels and mitosis progression of these cells.	[Ornelas, Isis Moraes; Silva, Thayane Martins; Fragel-Madeira, Lucianne; Marques Ventura, Ana Lucia] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Neurosci Program, Rio De Janeiro, Brazil	Universidade Federal Fluminense	Ventura, ALM (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Neurosci Program, Rio De Janeiro, Brazil.	almv@vm.uff.br	Fragel-Madeira, Lucianne/I-2208-2016; Fragel-Madeira, Lucianne/V-1665-2019	Fragel-Madeira, Lucianne/0000-0001-6747-2828	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF); CAPES	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Pro-Reitoria de Pesquisa e Inovacao (PROPPi-UFF). Isis M. Ornelas is the recipient of a post-doctoral fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2000, PROG RETIN EYE RES, V19, P529, DOI 10.1016/S1350-9462(00)00008-2; Andersen CB, 1998, J BIOL CHEM, V273, P18705, DOI 10.1074/jbc.273.30.18705; Barton KM, 2008, DEV DYNAM, V237, P672, DOI 10.1002/dvdy.21449; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Boutros R, 2008, CELL CYCLE, V7, P401, DOI 10.4161/cc.7.3.5295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Nunes PHC, 2007, INT J DEV NEUROSCI, V25, P499, DOI 10.1016/j.ijdevneu.2007.09.007; Choi Kangduk, 2010, Korean Journal of Internal Medicine, V25, P119, DOI 10.3904/kjim.2010.25.2.119; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Espanel X, 1997, INT J DEV BIOL, V41, P469; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; Franca GR, 2007, INT J DEV NEUROSCI, V25, P283, DOI 10.1016/j.ijdevneu.2007.05.006; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kobayashi N, 2003, BLOOD, V102, P3186, DOI 10.1182/blood-2003-02-0567; Li YC, 2012, LIFE SCI, V90, P962, DOI 10.1016/j.lfs.2012.04.044; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Portugal LCL, 2009, NEUROSCI LETT, V466, P35, DOI 10.1016/j.neulet.2009.09.046; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; LIU XJ, 1995, MOL CELL BIOL, V15, P3563; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Ornelas IM, 2010, INT J DEV NEUROSCI, V28, P503, DOI 10.1016/j.ijdevneu.2010.06.001; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pearson R, 2002, J NEUROSCI, V22, P7569; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Pimentel B, 2002, DEV BIOL, V247, P295, DOI 10.1006/dbio.2002.0703; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rehen SK, 2002, BRAIN RES, V947, P78, DOI 10.1016/S0006-8993(02)02909-8; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Sadler KC, 1998, DEV BIOL, V197, P25, DOI 10.1006/dbio.1998.8869; Sanches G, 2002, INT J DEV NEUROSCI, V20, P21, DOI 10.1016/S0736-5748(02)00004-7; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimada M, 2003, J ENDOCRINOL, V179, P25, DOI 10.1677/joe.0.1790025; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Sholl-Franco A, 2010, INT J DEV NEUROSCI, V28, P63, DOI 10.1016/j.ijdevneu.2009.09.004; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9	60	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53517	10.1371/journal.pone.0053517	http://dx.doi.org/10.1371/journal.pone.0053517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301080	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900082
J	Yu, PC; Sewell, MA; Matson, PG; Rivest, EB; Kapsenberg, L; Hofmann, GE				Yu, Pauline C.; Sewell, Mary A.; Matson, Paul G.; Rivest, Emily B.; Kapsenberg, Lydia; Hofmann, Gretchen E.			Growth Attenuation with Developmental Schedule Progression in Embryos and Early Larvae of Sterechinus neumayeri Raised under Elevated CO2	PLOS ONE			English	Article							REDUCED SEAWATER PH; OCEAN ACIDIFICATION; CLIMATE-CHANGE; ECHINODERM LARVAE; HATCHING ENZYME; MCMURDO SOUND; IMPACT; PLASTICITY; INVERTEBRATES; ECHINOIDEA	The Southern Ocean, a region that will be an ocean acidification hotspot in the near future, is home to a uniquely adapted fauna that includes a diversity of lightly-calcified invertebrates. We exposed the larvae of the echinoid Sterechinus neumayeri to environmental levels of CO2 in McMurdo Sound (control: 410 mu atm, Omega = 1.35) and mildly elevated pCO(2) levels, both near the level of the aragonite saturation horizon (510 matm pCO(2), Omega = 1.12), and to under-saturating conditions (730 matm, Omega = 0.82). Early embryological development was normal under these conditions with the exception of the hatching process, which was slightly delayed. Appearance of the initial calcium carbonate (CaCO3) spicule nuclei among the primary mesenchyme cells of the gastrulae was synchronous between control and elevated pCO(2) treatments. However, by prism (7 days after the initial appearance of the spicule nucleus), elongating arm rod spicules were already significantly shorter in the highest CO2 treatment. Unfed larvae in the 730 matm pCO(2) treatment remained significantly smaller than unfed control larvae at days 15-30, and larvae in the 510 mu atm treatment were significantly smaller at day 20. At day 30, the arm lengths were more differentiated between 730 mu atm and control CO2 treatments than were body lengths as components of total length. Arm length is the most plastic morphological aspect of the echinopluteus, and appears to exhibit the greatest response to high pCO(2)/low pH/low carbonate, even in the absence of food. Thus, while the effects of elevated pCO(2) representative of near future climate scenarios are proportionally minor on these early developmental stages, the longer term effects on these long-lived invertebrates is still unknown.	[Yu, Pauline C.; Matson, Paul G.; Rivest, Emily B.; Kapsenberg, Lydia; Hofmann, Gretchen E.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Sewell, Mary A.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of California System; University of California Santa Barbara; University of Auckland	Yu, PC (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	pauline.yu@lifesci.ucsb.edu	Sewell, Mary A/C-9017-2009; Matson, Paul/AAB-9767-2019	Sewell, Mary A/0000-0002-1595-7951; Matson, Paul/0000-0003-2105-7308; Kapsenberg, Lydia/0000-0002-7361-9061	U.S. Office of Polar Programs, Antarctic Division (NSF) [ANT-0944201]; U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP) [1019340]; NSF Graduate Student Research Fellowships; Royal Society of New Zealand Marsden Fund; Directorate For Geosciences [0944201] Funding Source: National Science Foundation	U.S. Office of Polar Programs, Antarctic Division (NSF); U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP)(National Science Foundation (NSF)); NSF Graduate Student Research Fellowships; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by the U.S. Office of Polar Programs, Antarctic Division (NSF grant ANT-0944201 to GEH) (http:/www.nsf.gov). PCY was supported by a U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP Award 1019340); EBR and LK were supported by NSF Graduate Student Research Fellowships. MS was supported by the Royal Society of New Zealand Marsden Fund (http://www.royalsociety.org.nz/programmes/funds/marsden/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1603; Adomako-Ankomah A, 2011, DEV BIOL, V353, P81, DOI 10.1016/j.ydbio.2011.02.021; Anderson D, 2010, J EXP MAR BIOL ECOL, V384, P68, DOI 10.1016/j.jembe.2009.12.005; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Armstrong AF, 2012, AM NAT IN PRESS; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; BOSCH I, 1987, BIOL BULL, V173, P126, DOI 10.2307/1541867; BOUGIS P, 1967, HELGOLAND WISS MEER, V15, P59, DOI 10.1007/BF01618609; BREY T, 1991, POLAR BIOL, V11, P227; Brey T, 1995, MAR BIOL, V124, P279, DOI 10.1007/BF00347132; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Catarino AI, 2012, POLAR BIOL, V35, P455, DOI 10.1007/s00300-011-1074-2; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clarke A, 2007, PHILOS T R SOC B, V362, P5, DOI 10.1098/rstb.2006.1943; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Ericson JA, 2012, POLAR BIOL, V35, P1027, DOI 10.1007/s00300-011-1150-7; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; Hammond LM, 2012, J EXP BIOL, V215, P2445, DOI 10.1242/jeb.058008; Hammond LM, 2010, PHYSL RESPONSE ENV V; HART MW, 1994, BIOL BULL, V186, P291, DOI 10.2307/1542275; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Horstadius S, 1939, BIOL REV CAMB PHILOS, V14, P132, DOI 10.1111/j.1469-185X.1939.tb00929.x; Jimmy RA, 2003, AQUACULTURE, V220, P261, DOI 10.1016/S0044-8486(02)00193-X; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lamare M, 2010, 9 INT LARV BIOL S WE; Lebrato M, 2010, ECOL MONOGR, V80, P441, DOI 10.1890/09-0553.1; Leong PKK, 1999, J EXP BIOL, V202, P2051; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; Marsh AG, 1999, J EXP BIOL, V202, P2041; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Matson PG, 2011, ANTARCT SCI, V23, P607, DOI 10.1017/S0954102011000551; Matson PG, 2012, BIOL B IN PRESS; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McEdward LR, 1996, AM ZOOL, V36, P169; McNeil B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044597; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Miner BG, 2007, J EXP MAR BIOL ECOL, V343, P158, DOI 10.1016/j.jembe.2006.11.001; Miner BG, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P221; Morgan Steven G., 1995, P279; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pace DA, 2007, BIOL BULL-US, V212, P115, DOI 10.2307/25066589; Padilla-Gamino J, 2012, 10 INT LARV BIOL S B; PEARSE JS, 1991, AM ZOOL, V31, P65; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peled-Kamar M, 2002, EXP CELL RES, V272, P56, DOI 10.1006/excr.2001.5398; Place SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034068; Portner HO, 2010, GUIDE BEST PRACTICES; Reitzel AM, 2004, J PLANKTON RES, V26, P901, DOI 10.1093/plankt/fbh077; RIVKIN RB, 1991, AM ZOOL, V31, P5; Robbins L., 2010, US GEOLOGICAL SURVEY, P1, DOI DOI 10.3133/OFR20101280; ROE JL, 1990, J BIOL CHEM, V265, P8704; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Sabine CL, 2012, CARBON DIOXIDE HYDRO; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Sewell MA, 2011, 6 N AM ECH C AN WA; Sewell MA, 2011, GLOBAL CHANGE BIOL, V17, P734, DOI 10.1111/j.1365-2486.2010.02288.x; SHILLING FM, 1995, AM ZOOL, V35, P399; Shingleton AW, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P43; Smith CR, 2012, P ROY SOC B-BIOL SCI, V279, P1017, DOI 10.1098/rspb.2011.1496; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Sweet H, 2004, METHOD CELL BIOL, V74, P243; TAKEUCHI K, 1979, EUR J BIOCHEM, V100, P257, DOI 10.1111/j.1432-1033.1979.tb02056.x; Thatje S, 2008, POLAR BIOL, V31, P1143, DOI 10.1007/s00300-008-0457-5; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WOLPERT L, 1992, DEVELOPMENT, P7; Wray GA, 2004, METHOD CELL BIOL, V74, P75; Yoshikawa-Inoue H, 2005, TELLUS B, V57, P58, DOI 10.1111/j.1600-0889.2005.00130.x; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016	89	34	34	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52448	10.1371/journal.pone.0052448	http://dx.doi.org/10.1371/journal.pone.0052448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300974	gold, Green Submitted, Green Published			2022-12-27	WOS:000313320900026
J	Bertke, AS; Apakupakul, K; Ma, A; Imai, Y; Gussow, AM; Wang, KN; Cohen, JI; Bloom, DC; Margolis, TP				Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Gussow, Anne M.; Wang, Kening; Cohen, Jeffrey I.; Bloom, David C.; Margolis, Todd P.			LAT Region Factors Mediating Differential Neuronal Tropism of HSV-1 and HSV-2 Do Not Act in Trans	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; LATENCY-ASSOCIATED TRANSCRIPT; PRIMARY SENSORY NEURONS; IMMUNOHISTOCHEMICAL ANALYSIS; PRODUCTIVE INFECTION; VIRAL REPLICATION; GENE-EXPRESSION; TYPE-1; REACTIVATION; INTRON	After HSV infection, some trigeminal ganglion neurons support productive cycle gene expression, while in other neurons the virus establishes a latent infection. We previously demonstrated that HSV-1 and HSV-2 preferentially establish latent infection in A5+ and KH10+ sensory neurons, respectively, and that exchanging the latency-associated transcript (LAT) between HSV-1 and HSV-2 also exchanges the neuronal preference. Since many viral genes besides the LAT are functionally interchangeable between HSV-1 and HSV-2, we co-infected HSV-1 and HSV-2, both in vivo and in vitro, to determine if transacting viral factors regulate whether HSV infection follows a productive or latent pattern of gene expression in sensory neurons. The pattern of HSV-1 and HSV-2 latent infection in trigeminal neurons was no different following co-infection than with either virus alone, consistent with the hypothesis that a trans-acting viral factor is not responsible for the different patterns of latent infection of HSV-1 and HSV-2 in A5+ and KH10+ neurons. Since exchanging the LAT regions between the viruses also exchanges neuronal preferences, we infected transgenic mice that constitutively express 2.8 kb of the LAT region with the heterologous viral serotype. Endogenous expression of LAT did not alter the pattern of latent infection after inoculation with the heterologous serotype virus, demonstrating that the LAT region does not act in trans to direct preferential establishment of latency of HSV-1 and HSV-2. Using HSV1-RFP and HSV2-GFP in adult trigeminal ganglion neurons in vitro, we determined that HSV-1 and HSV-2 do not exert trans-acting effects during acute infection to regulate neuron specificity. Although some neurons were productively infected with both HSV-1 and HSV-2, no A5+ or KH10+ neurons were productively infected with both viruses. Thus, trans-acting viral factors do not regulate preferential permissiveness of A5+ and KH10+ neurons for productive HSV infection and preferential establishment of latent infection.	[Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Margolis, Todd P.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Margolis, Todd P.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Gussow, Anne M.; Bloom, David C.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Wang, Kening; Cohen, Jeffrey I.] NIAID, Med Virol Sect, Infect Dis Lab, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margolis, TP (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	todd.margolis@ucsf.edu		Bertke, Andrea/0000-0002-8941-8010	That Man May See (San Francisco, CA); National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [AI048633]; NICHD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000058, R01AI048633] Funding Source: NIH RePORTER	That Man May See (San Francisco, CA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by That Man May See (San Francisco, CA), and the intramural research program of the National Institute of Allergy and Infectious Diseases and National Institutes of Health (NIH) grant AI048633. Monoclonal antibodies FE-A5 developed by B. Fenderson and KH10 developed by T. M. Jessell and J. Dodd were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa, IA 52242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; FAREED MU, 1994, J VIROL, V68, P8071, DOI 10.1128/JVI.68.12.8071-8081.1994; Garber DA, 1997, J VIROL, V71, P5885, DOI 10.1128/JVI.71.8.5885-5893.1997; Gussow AM, 2006, J VIROL, V80, P9414, DOI 10.1128/JVI.00530-06; Imai Y, 2009, J VIROL, V83, P7873, DOI 10.1128/JVI.00043-09; Jarman RG, 2002, VIROLOGY, V292, P59, DOI 10.1006/viro.2001.1265; Mador N, 1998, J VIROL, V72, P5067, DOI 10.1128/JVI.72.6.5067-5075.1998; Margolis TP, 2007, J VIROL, V81, P1872, DOI 10.1128/JVI.02110-06; MARGOLIS TP, 1992, INVEST OPHTH VIS SCI, V33, P259; Ng AK, 2004, J VIROL, V78, P12097, DOI 10.1128/JVI.78.22.12097-12106.2004; Shen WW, 2009, J VIROL, V83, P9131, DOI 10.1128/JVI.00871-09; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Tang S, 2011, J VIROL, V85, P4501, DOI 10.1128/JVI.01997-10; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang KN, 2001, J VIROL, V75, P8166, DOI 10.1128/JVI.75.17.8166-8172.2001; Yang L, 2000, J VIROL, V74, P209, DOI 10.1128/JVI.74.1.209-217.2000	21	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53281	10.1371/journal.pone.0053281	http://dx.doi.org/10.1371/journal.pone.0053281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300908	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600080
J	Casalta, JP; Thuny, F; Fournier, PE; Lepidi, H; Habib, G; Grisoli, D; Raoult, D				Casalta, Jean-Paul; Thuny, Franck; Fournier, Pierre-Edouard; Lepidi, Hubert; Habib, Gilbert; Grisoli, Dominique; Raoult, Didier			DNA Persistence and Relapses Questions on the Treatment Strategies of Enterococcus Infections of Prosthetic Valves	PLOS ONE			English	Article							TERM-FOLLOW-UP; BIOPROSTHESIS DYSFUNCTION; DIAGNOSTIC METHODS; ENDOCARDITIS; GUIDELINES; RISK; PCR; REOPERATION; REINFECTION; BACTERIA	We used amplification of the 16S rRNA gene followed by sequencing to evaluate the persistence of bacterial DNA in explanted heart valve tissue as part of the routine work of a clinical microbiology laboratory, and we analyzed the role of this persistence in the relapses observed in our center. We enrolled 286 patients treated for infective endocarditis (IE) who had valve replacement surgery and were diagnosed according to the modified Duke's criteria described by Li et al. from a total of 579 IE cases treated in our center. The patients were grouped based on the infecting bacteria, and we considered the 4 most common bacterial genus associated with IE separately (144 were caused by Streptococcus spp., 52 by Enterococcus spp., 58 by Staphylococcus aureus and 32 by coagulase-negative Staphylococcus). Based on our cohort, the risk of relapse in patients with enterococcal prosthetic valve infections treated with antibiotics alone was 11%. Bacterial DNA is cleared over time, but this might be a very slow process, especially with Enterococcus spp. Based on a comprehensive review of the literature performed on Medline, most reports still advise combined treatment with penicillin and an aminoglycoside for as long as 4-6 weeks, but there has been no consensus for the treatment of enterococcal infection of prostheses in IE patients.	[Casalta, Jean-Paul; Fournier, Pierre-Edouard; Lepidi, Hubert; Raoult, Didier] Aix Marseille Univ, URMITE, UMR CNRS 7278, Fac Med,IRD 198,INSERM 1095, Marseille, France; [Thuny, Franck; Habib, Gilbert] Hop Enfants La Timone, Serv Cardiol, Marseille, France; [Grisoli, Dominique] Hop Enfants La Timone, Serv Chirurg Cardiaque, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Raoult, D (corresponding author), Aix Marseille Univ, URMITE, UMR CNRS 7278, Fac Med,IRD 198,INSERM 1095, Marseille, France.	didier.raoult@gmail.com	Thuny, Franck/GSD-2668-2022; Thuny, Franck/ABB-2408-2021; Thuny, Franck/ABC-7157-2020; RAOULT, Didier/A-8434-2008; Fournier, Pierre-Edouard/AAC-6155-2021	Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885				Casalta JP, 2009, ANTIBIOTIQUES, V11, P81, DOI 10.1016/j.antib.2009.01.004; Cenciarini-Borde C, 2009, FUTURE MICROBIOL, V4, P45, DOI 10.2217/17460913.4.1.45; Chu VH, 2005, CLIN INFECT DIS, V41, P406, DOI 10.1086/431590; Fournier, 1999, Curr Infect Dis Rep, V1, P136, DOI 10.1007/s11908-996-0020-x; Fournier PE, 1996, AM J MED, V100, P629, DOI 10.1016/S0002-9343(96)00040-X; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Habib G, 2005, HEART, V91, P954, DOI 10.1136/hrt.2004.046177; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Ho Hee-Hwa, 2010, Asian Cardiovasc Thorac Ann, V18, P430, DOI 10.1177/0218492310379457; Houpikian P, 2002, INFECT DIS CLIN N AM, V16, P377, DOI 10.1016/S0891-5520(01)00010-1; HUNTER TH, 1947, AM J MED, V2, P436, DOI 10.1016/0002-9343(47)90088-0; Jaussaud N, 2012, J HEART VALVE DIS, V21, P56; Jaussaud N, 2009, J HEART VALVE DIS, V18, P256; Jovanovic M, 2010, J HEART VALVE DIS, V19, P540; Lang S, 2004, J INFECTION, V48, P269, DOI 10.1016/S0163-4453(03)00102-6; Lepidi H, 2002, INFECT DIS CLIN N AM, V16, P339, DOI 10.1016/S0891-5520(02)00005-3; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mandell GL, 2000, ENTEROCOCCUS SPECIES, V2, P2147; Mansur AJ, 2001, AM HEART J, V141, P78, DOI 10.1067/mhj.2001.111952; MOELLERING RC, 1991, J ANTIMICROB CHEMOTH, V28, P1, DOI 10.1093/jac/28.1.1; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Olaison L, 2002, CLIN INFECT DIS, V34, P159, DOI 10.1086/338233; Potron A, 2010, J MED MICROBIOL, V59, P1524, DOI 10.1099/jmm.0.024380-0; Rovery C, 2005, J CLIN MICROBIOL, V43, P163, DOI 10.1128/JCM.43.1.163-167.2005; Talarmin JP, 2011, J CLIN MICROBIOL, V49, P1182, DOI 10.1128/JCM.02049-10; TORNOS MP, 1992, ANN INTERN MED, V117, P567, DOI 10.7326/0003-4819-117-7-567; Truninger K, 1999, HEART, V82, P714, DOI 10.1136/hrt.82.6.714; VERHEUL HA, 1993, AM J CARDIOL, V72, P682, DOI 10.1016/0002-9149(93)90885-G; Voldstedlund M, 2008, APMIS, V116, P190, DOI 10.1111/j.1600-0463.2008.00942.x; Vollmer T, 2010, EUR HEART J, V31, P1105, DOI 10.1093/eurheartj/ehp600; YU VL, 1994, ANN THORAC SURG, V58, P1073, DOI 10.1016/0003-4975(94)90458-8	32	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53335	10.1371/journal.pone.0053335	http://dx.doi.org/10.1371/journal.pone.0053335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300913	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600084
J	Manabe, Y; Miyatake, S; Takagi, M; Nakamura, M; Okeda, A; Nakano, T; Hirshman, MF; Goodyear, LJ; Fujii, NL				Manabe, Yasuko; Miyatake, Shouta; Takagi, Mayumi; Nakamura, Mio; Okeda, Ai; Nakano, Taemi; Hirshman, Michael F.; Goodyear, Laurie J.; Fujii, Nobuharu L.			Characterization of an Acute Muscle Contraction Model Using Cultured C2C12 Myotubes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; EXERCISE; STIMULATION; EXPRESSION; INSULIN; AKT	A cultured C2C12 myotube contraction system was examined for application as a model for acute contraction-induced phenotypes of skeletal muscle. C2C12 myotubes seeded into 4-well rectangular plates were placed in a contraction system equipped with a carbon electrode at each end. The myotubes were stimulated with electric pulses of 50 V at 1 Hz for 3 ms at 997-ms intervals. Approximately 80% of the myotubes were observed to contract microscopically, and the contractions lasted for at least 3 h with electrical stimulation. Calcium ion (Ca2+) transient evoked by the electric pulses was detected fluorescently with Fluo-8. Phosphorylation of protein kinase B/Akt (Akt), 5' AMP-activated protein kinase (AMPK), p38 mitogen-activated protein kinase (p38), and c-Jun NH2-terminal kinase (JNK)1/2, which are intracellular signaling proteins typically activated in exercised/contracted skeletal muscle, was observed in the electrically stimulated C2C12 myotubes. The contractions induced by the electric pulses increased glucose uptake and depleted glycogen in the C2C12 myotubes. C2C12 myotubes that differentiated after exogenous gene transfection by a lipofection or an electroporation method retained their normal contractile ability by electrical stimulation. These findings show that our C2C12 cell contraction system reproduces the muscle phenotypes that arise in vivo (exercise), in situ (hindlimb muscles in an anesthetized animal), and in vitro (dissected muscle tissues in incubation buffer) by acute muscle contraction, demonstrating that the system is applicable for the analysis of intracellular events evoked by acute muscle contraction.	[Manabe, Yasuko; Miyatake, Shouta; Takagi, Mayumi; Nakamura, Mio; Okeda, Ai; Nakano, Taemi; Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo 158, Japan; [Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Tokyo Metropolitan University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Fujii, NL (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo 158, Japan.	fujiin@tmu.ac.jp	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033	Japan Society for the Promotion of Science Kakenhi [21240063]; Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy [LS102]; National Institutes of Health [AR45670, AR42238];  [21700657]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR042238, R01AR042238, R01AR045670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Grant-in-Aid for Young Scientists B 21700657 (to Y.M.), the Japan Society for the Promotion of Science Kakenhi 21240063 (to N.L.F.), Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy LS102 (to N.L.F.), and National Institutes of Health Grants AR45670 and AR42238 (to L.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; De Deyne PG, 2000, AM J PHYSIOL-CELL PH, V279, pC1801, DOI 10.1152/ajpcell.2000.279.6.C1801; Deshmukh AS, 2008, INT J OBESITY, V32, pS18, DOI 10.1038/ijo.2008.118; Fujii N, 2004, P NUTR SOC, V63, P205, DOI 10.1079/PNS2004340; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Fujita H, 2011, BIOMED MICRODEVICES, V13, P123, DOI 10.1007/s10544-010-9477-3; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Ho RC, 2004, AM J PHYSIOL-REG I, V286, pR342, DOI 10.1152/ajpregu.00563.2003; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; Ito Y, 2006, PFLUG ARCH EUR J PHY, V451, P803, DOI 10.1007/s00424-005-1512-5; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Nagamine K, 2010, BIOTECHNOL BIOENG, V105, P1161, DOI 10.1002/bit.22636; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; PRICE TB, 1994, MED SCI SPORT EXER, V26, P983; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Wilson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011042; Wojtaszewski JFP, 2002, J APPL PHYSIOL, V93, P384, DOI 10.1152/japplphysiol.00043.2002	21	71	74	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52592	10.1371/journal.pone.0052592	http://dx.doi.org/10.1371/journal.pone.0052592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300713	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600019
J	Irla, M; Guerri, L; Guenot, J; Serge, A; Lantz, O; Liston, A; Imhof, BA; Palmer, E; Reith, W				Irla, Magali; Guerri, Lucia; Guenot, Jeanne; Serge, Arnauld; Lantz, Olivier; Liston, Adrian; Imhof, Beat A.; Palmer, Ed; Reith, Walter			Antigen Recognition by Autoreactive CD4(+) Thymocytes Drives Homeostasis of the Thymic Medulla	PLOS ONE			English	Article							T-CELL RECEPTOR; EPITHELIAL-CELLS; CENTRAL TOLERANCE; NEGATIVE SELECTION; POSITIVE SELECTION; GENE-EXPRESSION; PROMOTER-IV; IN-VIVO; MICE; SELF	The thymic medulla is dedicated for purging the T-cell receptor (TCR) repertoire of self-reactive specificities. Medullary thymic epithelial cells (mTECs) play a pivotal role in this process because they express numerous peripheral tissue-restricted self-antigens. Although it is well known that medulla formation depends on the development of single-positive (SP) thymocytes, the mechanisms underlying this requirement are incompletely understood. We demonstrate here that conventional SP CD4(+) thymocytes bearing autoreactive TCRs drive a homeostatic process that fine-tunes medullary plasticity in adult mice by governing the expansion and patterning of the medulla. This process exhibits strict dependence on TCR-reactivity with self-antigens expressed by mTECs, as well as engagement of the CD28-CD80/CD86 costimulatory axis. These interactions induce the expression of lymphotoxin alpha in autoreactive CD4(+) thymocytes and RANK in mTECs. Lymphotoxin in turn drives mTEC development in synergy with RANKL and CD40L. Our results show that Ag-dependent interactions between autoreactive CD4(+) thymocytes and mTECs fine-tune homeostasis of the medulla by completing the signaling axes implicated in mTEC expansion and medullary organization.	[Irla, Magali; Guenot, Jeanne; Serge, Arnauld; Imhof, Beat A.; Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Guerri, Lucia; Lantz, Olivier] Inst Curie, Dept Biol Tumeurs, Paris, France; [Guerri, Lucia; Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Liston, Adrian] VIB, Autoimmune Genet Lab, Louvain, Belgium; [Liston, Adrian] Katholieke Univ Leuven, Louvain, Belgium; [Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	University of Geneva; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Basel	Irla, M (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France.	Magali.Irla@unige.ch; Walter.Reith@unige.ch	Liston, Adrian/G-8606-2013; Sergé, Arnauld/N-4828-2019; Serge, Arnauld/AAP-1525-2020; IRLA, Magali/AAH-7941-2019; Guerri, Lucia/AAZ-4011-2020	Liston, Adrian/0000-0002-6272-4085; Sergé, Arnauld/0000-0003-4271-3706; Serge, Arnauld/0000-0002-1280-6277; IRLA, Magali/0000-0001-8803-9708; Guerri, Lucia/0000-0002-0878-0529; Lantz, olivier/0000-0003-3161-7719	Swiss National Science Foundation [PZ00P3-131945, 31003A-127255]; Jules Thorn foundation; Association de la Recherche sur le Cancer; ANR; Ligue Contre le Cancer; Inserm; Institut Curie	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Jules Thorn foundation; Association de la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	MI was supported by grants from the Swiss National Science Foundation (PZ00P3-131945, www.snf.ch) and the Jules Thorn foundation (www.julesthorntrust.org.uk). Work in the laboratory of WR was supported by the Swiss National Science Foundation (grant 31003A-127255, www.snf.ch). LG was supported by fellowships from the Association de la Recherche sur le Cancer (www.arc-cancer.net) and the ANR (www.agence-nationale-recherche.fr). The laboratory of OL was funded by the Ligue Contre le Cancer (www.liguecancer.ch/fr), Inserm (www.inserm.fr) and Institut Curie (curie.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Heikenwalder M, 2008, AM J PATHOL, V172, P1555, DOI 10.2353/ajpath.2008.070572; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2011, TRENDS IMMUNOL, V32, P188, DOI 10.1016/j.it.2011.03.002; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mouri Y, 2011, J IMMUNOL; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Zhu MZ, 2008, IMMUNITY, V29, P386, DOI 10.1016/j.immuni.2008.09.001; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	47	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52591	10.1371/journal.pone.0052591	http://dx.doi.org/10.1371/journal.pone.0052591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300712	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100066
J	McRae, BH; Hall, SA; Beier, P; Theobald, DM				McRae, Brad H.; Hall, Sonia A.; Beier, Paul; Theobald, David M.			Where to Restore Ecological Connectivity? Detecting Barriers and Quantifying Restoration Benefits	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; GENE FLOW; CONSERVATION; BIODIVERSITY; MANAGEMENT; PATTERNS; MATTERS; MODEL	Landscape connectivity is crucial for many ecological processes, including dispersal, gene flow, demographic rescue, and movement in response to climate change. As a result, governmental and non-governmental organizations are focusing efforts to map and conserve areas that facilitate movement to maintain population connectivity and promote climate adaptation. In contrast, little focus has been placed on identifying barriers-landscape features which impede movement between ecologically important areas-where restoration could most improve connectivity. Yet knowing where barriers most strongly reduce connectivity can complement traditional analyses aimed at mapping best movement routes. We introduce a novel method to detect important barriers and provide example applications. Our method uses GIS neighborhood analyses in conjunction with effective distance analyses to detect barriers that, if removed, would significantly improve connectivity. Applicable in least-cost, circuit-theoretic, and simulation modeling frameworks, the method detects both complete (impermeable) barriers and those that impede but do not completely block movement. Barrier mapping complements corridor mapping by broadening the range of connectivity conservation alternatives available to practitioners. The method can help practitioners move beyond maintaining currently important areas to restoring and enhancing connectivity through active barrier removal. It can inform decisions on trade-offs between restoration and protection; for example, purchasing an intact corridor may be substantially more costly than restoring a barrier that blocks an alternative corridor. And it extends the concept of centrality to barriers, highlighting areas that most diminish connectivity across broad networks. Identifying which modeled barriers have the greatest impact can also help prioritize error checking of land cover data and collection of field data to improve connectivity maps. Barrier detection provides a different way to view the landscape, broadening thinking about connectivity and fragmentation while increasing conservation options.	[McRae, Brad H.] Nature Conservancy, N Amer Reg, Seattle, WA USA; [Hall, Sonia A.] Nature Conservancy, Washington Chapter, Wenatchee, WA USA; [Beier, Paul] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Beier, Paul] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Theobald, David M.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA	Nature Conservancy; Northern Arizona University; Northern Arizona University; United States Department of the Interior	McRae, BH (corresponding author), Nature Conservancy, N Amer Reg, Seattle, WA USA.	bmcrae@tnc.org	Beier, Paul/K-9294-2013	Beier, Paul/0000-0002-4297-4343; Hall, Sonia A/0000-0002-3442-814X	North Pacific Landscape Conservation Cooperative [13170BG105]; Great Northern Landscape Conservation Cooperative [60181AG501]	North Pacific Landscape Conservation Cooperative; Great Northern Landscape Conservation Cooperative	This project was funded by the North Pacific Landscape Conservation Cooperative (www.fws.gov/nplcc; grant #13170BG105) and the Great Northern Landscape Conservation Cooperative (greatnorthernlcc.org; grant #60181AG501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Baldwin Robert F., 2012, Ecological Restoration, V30, P274, DOI 10.3368/er.30.4.274; Baldwin RF, 2010, LANDSCAPE-SCALE CONSERVATION PLANNING, P349, DOI 10.1007/978-90-481-9575-6_16; Ball I., 2000, MARXAN V1 8 2 MARINE; Beier P, 2008, ARIZONA MISSING LINK; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Blaauw D, 2005, ELECT DESIGN AUTOMAT; Breckheimer I, 2012, CONNECT LANDSCAPE CO; Breckheimer I, 2012, THESIS U N CAROLINA; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Cabeza M, 2003, ECOL LETT, V6, P665, DOI 10.1046/j.1461-0248.2003.00475.x; Carroll C., 2010, CONNECTIVITY ANAL TO; Carroll C, 2012, CONSERV BIOL, V26, P78, DOI 10.1111/j.1523-1739.2011.01753.x; Chardon JP, 2003, LANDSCAPE ECOL, V18, P561, DOI 10.1023/A:1026062530600; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Doyle PG., 1984, RANDOM WALKS ELECT N, Vvol 22; Estrada E, 2008, ECOL APPL, V18, P1810, DOI 10.1890/07-1419.1; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; Grimm V., 2005, INDIVIDUAL BASED MOD; Hall SA, 2012, FUTURE WORK CONCLUSI; Hargrove WW, 2005, LANDSCAPE ECOL, V20, P361, DOI 10.1007/s10980-004-3162-y; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; KNAAPEN JP, 1992, LANDSCAPE URBAN PLAN, V23, P1, DOI 10.1016/0169-2046(92)90060-D; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Lethbridge MR, 2010, ENVIRON MODELL SOFTW, V25, P737, DOI 10.1016/j.envsoft.2009.11.013; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McBride MF, 2010, ECOL MODEL, V221, P2243, DOI 10.1016/j.ecolmodel.2010.04.012; McRae B.H., 2012, BARRIER MAPPER CONNE; McRae B. H., 2009, CIRCUITSCAPE CONNECT; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2011, CONSERV LETT, V4, P383, DOI 10.1111/j.1755-263X.2011.00190.x; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Possingham H. P., 2006, PRINCIPLES CONSERVAT, V3rd, P507, DOI DOI 10.1023/A:1006601319528; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; *S COAST WILDL, 2008, S COAST MISS LINK WI; Schumaker N, 2011, HEXSIM; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Singleton PH, 2002, US FOR SERV R P PNW, P1; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Spencer W.D., 2010, CALIFORNIA ESSENTIAL; Stinson DW., 2004, WASHINGTON STATE REC; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Theobald DM, 2012, CONSERV LETT, V5, P123, DOI 10.1111/j.1755-263X.2011.00218.x; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Tracey JA, 2006, CONNECTIVITY CONSERV, P343; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Washington Wildlife Habitat Connectivity Working Group, 2012, WASH CONN LANDSC PRO; Washington Wildlife Habitat Connectivity Working Group (WHCWG), 2010, WASH CONN LANDSC PRO; Westphal MI, 2007, LANDSCAPE URBAN PLAN, V81, P56, DOI 10.1016/j.landurbplan.2006.10.015; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	71	143	174	7	258	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52604	10.1371/journal.pone.0052604	http://dx.doi.org/10.1371/journal.pone.0052604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300719	Green Published, gold			2022-12-27	WOS:000312829100067
J	Williams, C; Rauch, MF; Michaud, M; Robinson, R; Xu, H; Madri, J; Lavik, E				Williams, Cicely; Rauch, Millicent Ford; Michaud, Michael; Robinson, Rebecca; Xu, Hao; Madri, Joseph; Lavik, Erin			Short Term Interactions with Long Term Consequences: Modulation of Chimeric Vessels by Neural Progenitors	PLOS ONE			English	Article							OUTGROWTH ENDOTHELIAL-CELLS; HUMAN PERIPHERAL-BLOOD; SPINAL-CORD-INJURY; NETWORKS IN-VIVO; GROWTH-FACTOR; GENE-THERAPY; STEM-CELLS; VASCULAR NETWORKS; NEUROTROPHIC FACTOR; ANGIOGENESIS	Vessels are a critical and necessary component of most tissues, and there has been substantial research investigating vessel formation and stabilization. Several groups have investigated coculturing endothelial cells with a second cell type to promote formation and stabilization of vessels. Some have noted that long-term vessels derived from implanted cocultures are often chimeric consisting of both host and donor cells. The questions arise as to whether the coculture cell might impact the chimeric nature of the microvessels and can modulate the density of donor cells over time. If long-term engineered microvessels are primarily of host origin, any impairment of the host's angiogenic ability has significant implications for the long-term success of the implant. If one can modulate the host versus donor response, one may be able to overcome a host's angiogenic impairment. Furthermore, if one can modulate the donor contribution, one may be able to engineer microvascular networks to deliver molecules a patient lacks systemically for long times. To investigate the impact of the cocultured cell on the host versus donor contributions of endothelial cells in engineered microvascular networks, we varied the ratio of the neural progenitors to endothelial cells in subcutaneously implanted poly(ethylene glycol)/poly-L-lysine hydrogels. We found that the coculture of neural progenitors with endothelial cells led to the formation of chimeric host-donor vessels, and the ratio of neural progenitors has a significant impact on the long term residence of donor endothelial cells in engineered microvascular networks in vivo even though the neural progenitors are only present transiently in the system. We attribute this to the short term paracrine signaling between the two cell types. This suggests that one can modulate the host versus donor contributions using short-term paracrine signaling which has broad implications for the application of engineered microvascular networks and cellular therapy more broadly.	[Lavik, Erin] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Williams, Cicely] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Rauch, Millicent Ford; Robinson, Rebecca] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Michaud, Michael; Madri, Joseph] Yale Univ, Dept Pathol, New Haven, CT USA; [Xu, Hao] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Case Western Reserve University; Yale University; Yale University; Yale University; Washington University (WUSTL)	Lavik, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	erin.lavik@case.edu		Michaud, Michael/0000-0001-7332-4987; Lavik, Erin/0000-0002-0644-744X	NIH MSTP Training Grant [5T32GM07205]; NIH Neuroengineering Training Grant [T90-DK070068]; NIH Director's New Innovator Award [DP2OD007338]; NIH [PO1-NS00344738, RO1-HL51018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007338] Funding Source: NIH RePORTER	NIH MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroengineering Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by generous gifts from Richard and Gail Siegal and Carol Sirot. CAW acknowledges NIH MSTP Training Grant 5T32GM07205. MFR and RR acknowledge NIH Neuroengineering Training Grant T90-DK070068. This work was also funded by an NIH Director's New Innovator Award, DP2OD007338 to EL and NIH PO1-NS00344738 and RO1-HL51018 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chamberlain MD, 2011, TISSUE ENG A; Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI [10.1089/ten.tea.2010.0293, 10.1089/ten.TEA.2010.0293]; Cheng G, 2011, BLOOD; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Debatin KM, 2008, GENE THER, V15, P780, DOI 10.1038/gt.2008.36; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Dellian M, 1996, AM J PATHOL, V149, P59; Dudek AZ, 2007, BRIT J CANCER, V97, P513, DOI 10.1038/sj.bjc.6603883; Dudek AZ, 2010, TRANSL RES, V156, P136, DOI 10.1016/j.trsl.2010.07.003; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GOLDEN MA, 1991, J CLIN INVEST, V87, P406, DOI 10.1172/JCI115011; Gosain A, 2006, J SURG RES, V135, P218, DOI 10.1016/j.jss.2006.04.006; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Kolbe M, 2011, TISSUE ENG A; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; Laschke MW, 2009, TISSUE ENG PART B-RE, V15, P455, DOI 10.1089/ten.TEB.2009.0252; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Milbauer LC, 2009, TRANSL RES, V153, P179, DOI 10.1016/j.trsl.2008.12.009; Mondrinos MJ, 2008, TISSUE ENG PT A, V14, P361, DOI 10.1089/tea.2007.0041; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pap-Szekeres J, 2005, DIS ESOPHAGUS, V18, P274, DOI 10.1111/j.1442-2050.2005.00483.x; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134; PILI R, 1994, JNCI-J NATL CANCER I, V86, P1303, DOI 10.1093/jnci/86.17.1303; Pinter E, 1999, AM J PATHOL, V154, P1367, DOI 10.1016/S0002-9440(10)65391-6; Potter MJ, 2006, PLAST RECONSTR SURG, V117, P1876, DOI 10.1097/01.prs.0000218843.86011.f8; Rauch MF, 2008, J BIOMAT SCI-POLYM E, V19, P1469, DOI 10.1163/156856208786140409; Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x; Reed MJ, 2000, J CELL BIOCHEM, V77, P116, DOI 10.1002/(SICI)1097-4644(20000401)77:1<116::AID-JCB12>3.3.CO;2-Z; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Somani A, 2007, TRANSL RES, V150, P30, DOI 10.1016/j.trsl.2007.02.002; Squinto S P, 1994, In Vivo, V8, P771; Swift ME, 1999, LAB INVEST, V79, P1479; Thiele J, 2004, TRANSPLANTATION, V77, P1902, DOI 10.1097/01.TP.0000127591.34203.8E; Thiele J, 2004, HISTOL HISTOPATHOL, V19, P201, DOI 10.14670/HH-19.201; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	72	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53208	10.1371/journal.pone.0053208	http://dx.doi.org/10.1371/journal.pone.0053208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300890	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100127
J	El Harchi, A; Melgari, D; Zhang, YH; Zhang, HG; Hancox, JC				El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Zhang, Henggui; Hancox, Jules C.			Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K+ Channel	PLOS ONE			English	Article							POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; DOFETILIDE BLOCK; CLASS-I; MUTATION; INHIBITION; RECTIFIER; DISOPYRAMIDE; DEPENDENCE; QUINIDINE	Background: The familial Short QT Syndrome (SQTS) is associated with an increased risk of cardiac arrhythmia and sudden death. Gain-of-function mutations in the hERG K+ channel protein have been linked to variant 1 of the SQTS. A hERG channel pore (T618I) mutation has recently been identified in families with heritable SQTS. This study aimed to determine effects of the T618I-hERG mutation on (i) hERG current (I-hERG) elicited by ventricular action potentials; (ii) the sensitivity of I-hERG to inhibition by four clinically used antiarrhythmic drugs. Methods: Electrophysiological recordings of I-hERG were made at 37 degrees C from HEK 293 cells expressing wild-type (WT) or T618I hERG. Whole-cell patch clamp recording was performed using both conventional voltage clamp and ventricular action potential (AP) clamp methods. Results: Under conventional voltage-clamp, WT I-hERG peaked at 0-+10 mV, whilst for T618I I-hERG maximal current was rightward shifted to similar to +40 mV. Voltage-dependent activation and inactivation of T618I I-hERG were positively shifted (respectively by +15 and similar to +25 mV) compared to WT I-hERG. The I-hERG 'window' was increased for T618I compared to WT hERG. Under ventricular AP clamp, maximal repolarising WT I-hERG occurred at similar to -30 mV, whilst for T618I hERG peak I-hERG occurred earlier during AP repolarisation, at similar to +5 mV. Under conventional voltage clamp, half-maximal inhibitory concentrations (IC50) for inhibition of I-hERG tails by quinidine, disopyramide, D-sotalol and flecainide for T618I hERG ranged between 1.4 and 3.2 fold that for WT hERG. Under action potential voltage clamp, T618I IC(50)s ranged from 1.2 to 2.0 fold the corresponding IC50 values for WT hERG. Conclusions: The T618I mutation produces a more modest effect on repolarising I-hERG than reported previously for the N588K-hERG variant 1 SQTS mutation. All drugs studied here appear substantially to retain their ability to inhibit I-hERG in the setting of the SQTS-linked T618I mutation.	[El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Hancox, Jules C.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Hancox, Jules C.] Univ Bristol, Cardiovasc Res Labs, Bristol, Avon, England; [Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England	University of Bristol; University of Bristol; University of Manchester	Hancox, JC (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	Jules.hancox@bristol.ac.uk	Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011; Hancox, Jules C./Z-1550-2019	EL HARCHI, Aziza/0000-0003-3329-6234	British Heart Foundation [PG/10/96, FS/11/59, PG/10/17]; British Heart Foundation [PG/10/017/28239, PG/10/96/28661, FS/11/59/28938] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The authors thank the British Heart Foundation for funding (AEH: PG/10/96; DM: FS/11/59; YZ: PG/10/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002313; Breindahl T, 2000, J CHROMATOGR B, V746, P249, DOI 10.1016/S0378-4347(00)00343-1; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Du CY, 2010, J CARDIOVASC ELECTR, V21, P1160, DOI 10.1111/j.1540-8167.2010.01772.x; El Harchi A, 2009, J MOL CELL CARDIOL, V137, P83; El Harchi A, 2012, J MOL CELL CARDIOL, V52, P185, DOI 10.1016/j.yjmcc.2011.09.021; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gaita F, 2004, J AM COLL CARDIOL, V43, P1494, DOI 10.1016/j.jacc.2004.02.034; Giustetto C, 2006, EUR HEART J, V27, P2440, DOI 10.1093/eurheartj/ehl185; Giustetto C, 2011, J AM COLL CARDIOL, V58, P587, DOI 10.1016/j.jacc.2011.03.038; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; Kirsch Glenn E., 2004, Journal of Pharmacological and Toxicological Methods, V50, P93, DOI 10.1016/j.vascn.2004.06.003; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Levi AJ, 1996, PFLUG ARCH EUR J PHY, V432, P930, DOI 10.1007/s004240050217; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Maury P, 2008, ARCH CARDIOVASC DIS, V101, P779, DOI 10.1016/j.acvd.2008.08.009; McPate MJ, 2008, BRIT J PHARMACOL, V155, P957, DOI 10.1038/bjp.2008.325; McPate MJ, 2009, J PHYSIOL PHARMACOL, V60, P23; McPate MJ, 2006, J MOL CELL CARDIOL, V41, P563, DOI 10.1016/j.yjmcc.2006.05.021; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Milnes JT, 2010, J PHARMACOL TOX MET, V61, P178, DOI 10.1016/j.vascn.2010.02.007; Modell SM, 2006, GENET MED, V8, P143, DOI 10.1097/01.gim.0000204468.85308.86; Numaguchi H, 2000, CIRC RES, V87, P1012, DOI 10.1161/01.RES.87.11.1012; Paul AA, 2002, BRIT J PHARMACOL, V136, P717, DOI 10.1038/sj.bjp.0704784; Paul AA, 2001, BIOCHEM BIOPH RES CO, V280, P1243, DOI 10.1006/bbrc.2001.4269; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1995, POTASSIUM CHANNELS N, P151; Schimpf R, 2005, CARDIOVASC RES, V67, P357, DOI 10.1016/j.cardiores.2005.03.026; Schimpf R, 2003, J CARDIOVASC ELECTR, V14, P1273, DOI 10.1046/j.1540-8167.2003.03278.x; Schimpf R, 2007, J CARDIOVASC ELECTR, V18, P1157, DOI 10.1111/j.1540-8167.2007.00925.x; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Sun YX, 2011, J MOL CELL CARDIOL, V50, P433, DOI 10.1016/j.yjmcc.2010.11.017; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viskin S, 2007, EUROPACE, V9, P1105, DOI 10.1093/europace/eum181; Weerapura M, 2002, PFLUG ARCH EUR J PHY, V443, P520, DOI 10.1007/s004240100720; Weirich J, 1998, BASIC RES CARDIOL, V93, P125; Witchel HJ, 2000, CLIN EXP PHARMACOL P, V27, P753, DOI 10.1046/j.1440-1681.2000.03337.x; Wolpert C, 2005, J CARDIOVASC ELECTR, V16, P54, DOI 10.1046/j.1540-8167.2005.04470.x; Yao Jian-An, 2005, Journal of Pharmacological and Toxicological Methods, V52, P146, DOI 10.1016/j.vascn.2005.04.008; ZEMA MJ, 1984, THER DRUG MONIT, V6, P192, DOI 10.1097/00007691-198406000-00011; Zhang YH, 2011, BBA-BIOMEMBRANES, V1808, P2477, DOI 10.1016/j.bbamem.2011.07.001; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52451	10.1371/journal.pone.0052451	http://dx.doi.org/10.1371/journal.pone.0052451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300672	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800088
J	Hua, K; Schindler, MK; McQuail, JA; Forbes, ME; Riddle, DR				Hua, Kun; Schindler, Matthew K.; McQuail, Joseph A.; Forbes, M. Elizabeth; Riddle, David R.			Regionally Distinct Responses of Microglia and Glial Progenitor Cells to Whole Brain Irradiation in Adult and Aging Rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; WHITE-MATTER; SPINAL-CORD; STEM-CELL; RADIATION; RADIOTHERAPY; AGE; INJURY	Radiation therapy has proven efficacy for treating brain tumors and metastases. Higher doses and larger treatment fields increase the probability of eliminating neoplasms and preventing reoccurrence, but dose and field are limited by damage to normal tissues. Normal tissue injury is greatest during development and in populations of proliferating cells but also occurs in adults and older individuals and in non-proliferative cell populations. To better understand radiation-induced normal tissue injury and how it may be affected by aging, we exposed young adult, middle-aged, and old rats to 10 Gy of whole brain irradiation and assessed in gray- and white matter the responses of microglia, the primary cellular mediators of radiation-induced neuroinflammation, and oligodendrocyte precursor cells, the largest population of proliferating cells in the adult brain. We found that aging and/or irradiation caused only a few microglia to transition to the classically ``activated'' phenotype, e. g., enlarged cell body, few processes, and markers of phagocytosis, that is seen following more damaging neural insults. Microglial changes in response to aging and irradiation were relatively modest and three markers of reactivity - morphology, proliferation, and expression of the lysosomal marker CD68- were regulated largely independently within individual cells. Proliferation of oligodendrocyte precursors did not appear to be altered during normal aging but increased following irradiation. The impacts of irradiation and aging on both microglia and oligodendrocyte precursors were heterogeneous between white-and gray matter and among regions of gray matter, indicating that there are regional regulators of the neural response to brain irradiation. By several measures, the CA3 region of the hippocampus appeared to be differentially sensitive to effects of aging and irradiation. The changes assessed here likely contribute to injury following inflammatory challenges like brain irradiation and represent important end-points for analysis in studies of therapeutic strategies to protect patients from neural dysfunction.	[Hua, Kun; Forbes, M. Elizabeth; Riddle, David R.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [McQuail, Joseph A.; Riddle, David R.] Wake Forest Sch Med, Program Neurosci, Winston Salem, NC USA; [Schindler, Matthew K.] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA	Wake Forest University; Wake Forest University; University of Pennsylvania	Riddle, DR (corresponding author), Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA.	driddle@wakehealth.edu	Schindler, Matthew/ABG-6790-2020	Schindler, Matthew/0000-0003-0157-5669; McQuail, Joseph/0000-0003-4431-8582; Forbes, Elizabeth/0000-0003-3300-5476	National Institutes of Health [AG11370, CA133483]; NATIONAL CANCER INSTITUTE [R01CA133483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG11370 and CA133483 (DRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2011, CANCER RES, V71, P4834, DOI 10.1158/0008-5472.CAN-11-0027; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Atkinson SL, 2005, INT J RADIAT ONCOL, V62, P535, DOI 10.1016/j.ijrobp.2005.01.061; Barani IJ, 2007, INT J RADIAT ONCOL, V68, P324, DOI 10.1016/j.ijrobp.2007.01.033; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bodles AM, 2004, TRENDS NEUROSCI, V27, P621, DOI 10.1016/j.tins.2004.07.011; Brandes AA, 2000, EUR J CANCER, V36, P447, DOI 10.1016/S0959-8049(99)00322-6; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Byrne TN, 2005, CURR OPIN NEUROL, V18, P662, DOI 10.1097/01.wco.0000191511.52745.99; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Conner KR, 2010, RADIAT RES, V173, P49, DOI 10.1667/RR1821.1; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Fox Sherry W, 2006, Clin J Oncol Nurs, V10, P169, DOI 10.1188/06.CJON.169-176; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gutierrez AN, 2007, INT J RADIAT ONCOL, V69, P589, DOI 10.1016/j.ijrobp.2007.05.038; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayakawa K, 1997, Radiat Med, V15, P405; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kanaan NM, 2008, GLIA, V56, P1199, DOI 10.1002/glia.20690; Kempermann G, 1998, J NEUROSCI, V18, P3206; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; LEE PWH, 1989, J NEUROL NEUROSUR PS, V52, P488, DOI 10.1136/jnnp.52.4.488; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; Li YQ, 1996, CANCER RES, V56, P5417; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Maher FO, 2004, NEUROBIOL AGING, V25, P795, DOI 10.1016/j.neurobiolaging.2003.08.007; Marsh JC, 2010, INT J RADIAT ONCOL, V78, P946, DOI 10.1016/j.ijrobp.2009.12.012; Miller KR, 2007, NEURON GLIA BIOL, V3, P245, DOI 10.1017/S1740925X08000136; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakagawa M, 1996, INT J RADIAT ONCOL, V36, P113, DOI 10.1016/S0360-3016(96)00239-8; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Peiffer AM, 2010, BRAIN RES, V1351, P23, DOI 10.1016/j.brainres.2010.06.049; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Ramanan S, 2009, INT J RADIAT ONCOL, V75, P870, DOI 10.1016/j.ijrobp.2009.06.059; Reinacher PC, 1999, EXP NEUROL, V160, P117, DOI 10.1006/exnr.1999.7177; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Sasaki R, 2000, NEUROSCI LETT, V279, P57, DOI 10.1016/S0304-3940(99)00910-6; Schindler MK, 2008, INT J RADIAT ONCOL, V70, P826, DOI 10.1016/j.ijrobp.2007.10.054; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Shi L, 2009, J NEUROL SCI, V285, P178, DOI 10.1016/j.jns.2009.06.031; Siegal T, 1996, INT J RADIAT ONCOL, V36, P649, DOI 10.1016/S0360-3016(96)00357-4; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Swennen MHJ, 2004, J NEURO-ONCOL, V66, P333, DOI 10.1023/B:NEON.0000014518.16481.7e; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; Wen P.Y., 2001, CANC PRINCIPLES PRAC, P2655; Wu KL, 2010, INT J RADIAT ONCOL, V76, P220, DOI 10.1016/j.ijrobp.2009.08.017; Xu YZ, 2010, BRAIN BEHAV IMMUN, V24, P138, DOI 10.1016/j.bbi.2009.09.006; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	78	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52728	10.1371/journal.pone.0052728	http://dx.doi.org/10.1371/journal.pone.0052728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300752	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800132
J	Tomoda, A; Polcari, A; Anderson, CM; Teicher, MH				Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.			Reduced Visual Cortex Gray Matter Volume and Thickness in Young Adults Who Witnessed Domestic Violence during Childhood	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; CEREBRAL-BLOOD-FLOW; HIPPOCAMPAL VOLUME; CORPUS-CALLOSUM; MALTREATED CHILDREN; SENSITIVE PERIODS; HURTFUL WORDS; VERBAL ABUSE	Exposure to interparental violence is associated with negative outcomes, such as depression, post-traumatic stress disorder and reduced cognitive abilities. However, little is known about the potential effects of witnessing domestic violence during childhood on gray matter volume (GMV) or cortical thickness. High-resolution 3.0 T volumetric scans (Siemens Trio Scanner) were obtained on 52 subjects (18-25 years) including 22 (6 males/16 females) with a history of visually witnessing episodes of domestic violence, and 30 (8 males/22 females) unexposed control subjects, with neither a current nor past DSM-IV Axis I or II disorder. Potential confounding effects of age, gender, level of parental verbal aggression, parental education, financial stress, full scale IQ, and total GMV, or average thickness were modeled using voxel based morphometry and FreeSurfer. Witnessing domestic violence subjects had a 6.1% GMV reduction in the right lingual gyrus (BA18) (P = 0.029, False Discovery Rate corrected peak level). Thickness in this region was also reduced, as was thickness in V2 bilaterally and left occipital pole. Theses regions were maximally sensitive to exposure to witnessing domestic violence between 11-13 years of age. Regional reductions in GMV and thickness were observed in both susceptible and resilient witnessing domestic violence subjects. Results in subjects witnessing domestic violence were similar to previously reported results in subjects with childhood sexual abuse, as the primary region affected was visual cortex. Brain regions that process and convey the adverse sensory input of the abuse may be specifically modified by this experience, particularly in subjects exposed to a single type of maltreatment. Exposure to multiple types of maltreatment is more commonly associated with morphological alterations in corticolimbic regions. These findings fit with preclinical studies showing that visual cortex is a highly plastic structure.	[Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.] McLean Hosp, Dev Biopsychiat Res Program, Belmont, MA 02178 USA; [Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Polcari, Ann] Northeastern Univ, Sch Nursing, Boston, MA 02115 USA; [Anderson, Carl M.] McLean Hosp, Brain Imaging Ctr, Belmont, MA 02178 USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Fukui; Northeastern University; Harvard University; McLean Hospital	Tomoda, A (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	atomoda@u-fukui.ac.jp	Teicher, Martin H/P-3906-2017	Teicher, Martin H/0000-0002-6036-0177	United States of America National Institute of Mental Health [MH-066222, MH-091391]; National Institute of Drug Abuse [DA-016934, DA-017846]; Japan-United States Brain Research Cooperation Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091391, R01MH066222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017846, R01DA016934] Funding Source: NIH RePORTER	United States of America National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Japan-United States Brain Research Cooperation Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by RO1 awards from the United States of America National Institute of Mental Health (MH-066222, MH-091391) http://www.nimh.nih.gov/index.shtml and National Institute of Drug Abuse (DA-016934, DA-017846) http://www.drugabuse.gov/to MHT, and Grant-in-Aid for Scientific Research to AT from Japan-United States Brain Research Cooperation Program http://www.nips.ac.jp/jusnou/eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Casiano H, 2009, J NERV MENT DIS, V197, P856, DOI 10.1097/NMD.0b013e3181be9c55; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Fantuzzo J, 1997, J AM ACAD CHILD PSY, V36, P116, DOI 10.1097/00004583-199701000-00025; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; First M. B., 1997, STRUCTURED CLIN INTE; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gold, 1980, INTRO BIVARIATE MULT, DOI DOI 10.2307/2287559; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Hamby S, 2010, CHILD ABUSE NEGLECT, V34, P734, DOI 10.1016/j.chiabu.2010.03.001; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HERMAN JL, 1989, TRAUMATIC ANTECEDENT; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Joo EY, 2008, SLEEP, V31, P868, DOI 10.1093/sleep/31.6.868; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; KELLNER R, 1987, J CLIN PSYCHIAT, V48, P268; Kiyosawa M, 1996, GRAEF ARCH CLIN EXP, V234, P110, DOI 10.1007/BF00695250; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Luthra R, 2009, J INTERPERS VIOLENCE, V24, P1919, DOI 10.1177/0886260508325494; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; McCrory EJ, 2011, CURR BIOL, V21, pR947, DOI 10.1016/j.cub.2011.10.015; McDonald R, 2006, J FAM PSYCHOL, V20, P137, DOI 10.1037/0893-3200.20.1.137; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Nicodimos Semret, 2009, East Afr J Public Health, V6, P184; R Core Team, 2021, R LANGUAGE ENV STAT; Richert KA, 2006, DEPRESS ANXIETY, V23, P17, DOI 10.1002/da.20131; Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa; Russo R, 2003, STAT BEHAV SCI INTRO, P192; Salminen-Vaparanta N, 2012, NEUROPSYCHOLOGIA, V50, P1621, DOI 10.1016/j.neuropsychologia.2012.03.015; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Silva RR, 2000, AM J PSYCHIAT, V157, P1229, DOI 10.1176/appi.ajp.157.8.1229; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Teicher MH, 2010, AM J PSYCHIAT, V167, P1464, DOI 10.1176/appi.ajp.2010.10010030; Teicher MH, 2004, BIOL PSYCHIAT, V56, P80, DOI 10.1016/j.biopsych.2004.03.016; TEICHER MH, 1993, J NEUROPSYCH CLIN N, V5, P301; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; van Harmelen AL, 2012, SOC COGN AFFECT NEUR; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	71	85	87	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52528	10.1371/journal.pone.0052528	http://dx.doi.org/10.1371/journal.pone.0052528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300699	Green Published, gold			2022-12-27	WOS:000313618800101
J	Claverie-Martin, F; Garcia-Nieto, V; Loris, C; Ariceta, G; Nadal, I; Espinosa, L; Fernandez-Maseda, A; Anton-Gamero, M; Avila, A; Madrid, A; Gonzalez-Acosta, H; Cordoba-Lanus, E; Santos, F; Gil-Calvo, M; Espino, M; Garcia-Martinez, E; Sanchez, A; Muley, R				Claverie-Martin, Felix; Garcia-Nieto, Victor; Loris, Cesar; Ariceta, Gema; Nadal, Inmaculada; Espinosa, Laura; Fernandez-Maseda, Angeles; Anton-Gamero, Montserrat; Avila, Africa; Madrid, Alvaro; Gonzalez-Acosta, Hilaria; Cordoba-Lanus, Elizabeth; Santos, Fernando; Gil-Calvo, Marta; Espino, Mar; Garcia-Martinez, Elena; Sanchez, Ana; Muley, Rafael		RenalTube Grp	Claudin-19 Mutations and Clinical Phenotype in Spanish Patients with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis	PLOS ONE			English	Article							THICK ASCENDING LIMB; CLDN19 MUTATIONS; TIGHT JUNCTIONS; DISEASE; GENE; MAGNESIUM; GENOTYPE; FHHNC; SUBSTITUTIONS; PARACELLIN-1	Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is an autosomal recessive tubular disorder characterized by excessive renal magnesium and calcium excretion and chronic kidney failure. This rare disease is caused by mutations in the CLDN16 and CLDN19 genes. These genes encode the tight junction proteins claudin-16 and claudin-19, respectively, which regulate the paracellular ion reabsortion in the kidney. Patients with mutations in the CLDN19 gene also present severe visual impairment. Our goals in this study were to examine the clinical characteristics of a large cohort of Spanish patients with this disorder and to identify the disease causing mutations. We included a total of 31 patients belonging to 27 unrelated families and studied renal and ocular manifestations. We then analyzed by direct DNA sequencing the coding regions of CLDN16 and CLDN19 genes in these patients. Bioinformatic tools were used to predict the consequences of mutations. Clinical evaluation showed ocular defects in 87% of patients, including mainly myopia, nystagmus and macular colobomata. Twenty two percent of patients underwent renal transplantation and impaired renal function was observed in another 61% of patients. Results of the genetic analysis revealed CLDN19 mutations in all patients confirming the clinical diagnosis. The majority of patients exhibited the previously described p.G20D mutation. Haplotype analysis using three microsatellite markers showed a founder effect for this recurrent mutation in our cohort. We also identified four new pathogenic mutations in CLDN19, p.G122R, p.I41T, p.G75C and p.G75S. A strategy based on microsequencing was designed to facilitate the genetic diagnosis of this disease. Our data indicate that patients with CLDN19 mutations have a high risk of progression to chronic renal disease.	[Claverie-Martin, Felix; Gonzalez-Acosta, Hilaria; Cordoba-Lanus, Elizabeth] Hosp Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain; [Loris, Cesar] Hosp Infantil Miguel Servet, Zaragoza, Spain; [Ariceta, Gema] Hosp Cruces, Baracaldo, Spain; [Nadal, Inmaculada] Hosp Virgen Camino, Pamplona, Spain; [Espinosa, Laura] Hosp La Paz, Madrid, Spain; [Fernandez-Maseda, Angeles] Hosp Virgen Salud, Toledo, Spain; [Anton-Gamero, Montserrat; Garcia-Martinez, Elena] Hosp Reina Sofia, Cordoba, Spain; [Avila, Africa] Complejo Hosp Jaen, Jaen, Spain; [Madrid, Alvaro] Hosp Valle De Hebron, Barcelona, Spain; [Santos, Fernando] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain; [Gil-Calvo, Marta] Hosp Clin, Santiago De Compostela, Spain; [Espino, Mar] Hosp Fdn Alcorcon, Madrid, Spain; [Sanchez, Ana] Hosp Univ Virgen Rocio, Seville, Spain; [Muley, Rafael] Hosp 12 Octubre, E-28041 Madrid, Spain	Miguel Servet University Hospital; Hospital Universitario Cruces; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; Complejo Hospitalario de Toledo; Hospital Universitario Reina Sofia - Cordoba; Complejo Hospitalario de Jaen; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; University of Oviedo; Complexo Hospitalario Universitario de Santiago de Compostela; Alcorcon Foundation University Hospital; Virgen del Rocio University Hospital; Hospital Universitario 12 de Octubre	Claverie-Martin, F (corresponding author), Hosp Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain.	fclamar@gobiernodecanarias.org	ANTON-GAMERO, MONTSERRAT/AAV-3686-2021; Córdoba-Lanús, Elizabeth/B-8573-2014; Madariaga, Leire/B-5220-2019; Ramos-Trujillo, Elena/B-7843-2014; Anton-Gamero, Montserrat/M-8534-2017	ANTON-GAMERO, MONTSERRAT/0000-0002-8515-4900; Madariaga, Leire/0000-0002-4032-9842; Claverie-Martin, Felix/0000-0003-2468-3267; Madrid, Alvaro/0000-0002-5942-8488; Cordoba-Lanus, Elizabeth/0000-0001-5534-8280; Castano, Luis/0000-0003-0437-9401; Perez de Nanclares, Gustavo/0000-0002-1692-8976	Fondo de Investigacion Sanitaria (FIS) [PI09/91009, PI11/00342]; European Regional Development Fund; Fundacion Canaria de Investigacion y Salud FUNCIS [PI24/07]; Sociedad Canaria de Pediatria de Tenerife; FIS [PI09/90758, PI09/90888]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Fundacion Canaria de Investigacion y Salud FUNCIS; Sociedad Canaria de Pediatria de Tenerife; FIS(Instituto de Salud Carlos III)	This work was supported by research grants from Fondo de Investigacion Sanitaria (FIS, PI09/91009 and PI11/00342, cofinanced by the European Regional Development Fund) and Fundacion Canaria de Investigacion y Salud FUNCIS (PI24/07) to FCM, and by a fellowship from the Sociedad Canaria de Pediatria de Tenerife. FS and GA acknowledge funding from FIS (grants PI09/90758 and PI09/90888, respectively). The funding from FIS was granted as coordinated proyect Renaltube. No additional external funding was received for this study. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Anton-Gamero M, 2008, J AM SOC NEPHROL, V19, P597; Benigno V, 2000, NEPHROL DIAL TRANSPL, V15, P605, DOI 10.1093/ndt/15.5.605; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Claverie-Martin F, 2009, PEDIATR NEPHROL, V24, P1793; Faguer S, 2011, CLIN J AM SOC NEPHRO, V6, P355, DOI 10.2215/CJN.02870310; Godron A, 2012, CLIN J AM SOC NEPHRO, V7, P801, DOI 10.2215/CJN.12841211; Gunzel D, 2009, PFLUG ARCH EUR J PHY, V458, P77, DOI 10.1007/s00424-008-0589-z; Hampson G, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-12; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; Kang JH, 2005, PEDIATR NEPHROL, V20, P1490, DOI 10.1007/s00467-005-1969-7; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Konrad M, 2008, J AM SOC NEPHROL, V19, P171, DOI 10.1681/ASN.2007060709; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Loris Pablo C, 2004, An Pediatr (Barc), V61, P502; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Naeem M, 2011, AM J NEPHROL, V34, P241, DOI 10.1159/000330854; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; RODRIGUEZSORIANO J, 1987, PEDIATR NEPHROL, V1, P465, DOI 10.1007/BF00849255; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Tajima T, 2003, PEDIATR NEPHROL, V18, P1280, DOI 10.1007/s00467-003-1304-0; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872; Weber S, 2000, EUR J HUM GENET, V8, P414, DOI 10.1038/sj.ejhg.5200475	35	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53151	10.1371/journal.pone.0053151	http://dx.doi.org/10.1371/journal.pone.0053151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301036	gold, Green Submitted, Green Published			2022-12-27	WOS:000313480000034
J	Wang, JM; Du, J; Wu, ZQ; Jin, Q				Wang, Jianmin; Du, Jiang; Wu, Zhiqiang; Jin, Qi			Quinacrine Impairs Enterovirus 71 RNA Replication by Preventing Binding of Polypyrimidine-Tract Binding Protein with Internal Ribosome Entry Sites	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS VIRUS-RNA; CAP-INDEPENDENT TRANSLATION; REPUBLIC-OF-CHINA; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; WESTERN-AUSTRALIA; PICORNAVIRUS RNA; POLIOVIRUS RNA; IN-VITRO; INITIATION	Since the 1980s, epidemics of enterovirus 71 (EV71) and other enteroviruses have occurred in Asian countries and regions, causing a wide range of human diseases. No effective therapy is available for the treatment of these infections. Internal ribosome entry sites (IRESs) are indispensable for the initiation of translation in enteroviruses. Several cellular factors, as well as the ribosome, are recruited to the conserved IRES during this process. Quinacrine intercalates into the RNA architecture and inhibits RNA transcription and protein synthesis, and a recent study showed that quinacrine inhibited encephalomyocarditis virus and poliovirus IRES-mediated translation in vitro without disrupting internal cellular IRES. Here, we report that quinacrine was highly active against EV71, protecting cells from EV71 infection. Replication of viral RNA, expression of viral capsid protein, and production of virus were all strongly inhibited by quinacrine. Interaction of the polypyrimidine tract-binding protein (PTB) with the conserved IRES was prevented by quinacrine. Coxsackieviruses and echovirus were also inhibited by quinacrine in cultured cells. These results indicate that quinacrine may serve as a potential protective agent for use in the treatment of patients with chronic enterovirus infection.	[Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Basic Research Program from the Ministry of Science and Technology of China [2011CB504902, 2005CB522905]	National Basic Research Program from the Ministry of Science and Technology of China	The work was supported by the National Basic Research Program (grant no. 2011CB504902 and no. 2005CB522905) (http://www.973.gov.cn/AreaAppl.aspx) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; BASNUEVO J G, 1950, Rev Kuba Med Trop Parasitol, V6, P121; BASNUEVO J G, 1952, Rev Kuba Med Trop Parasitol, V8, P67; BORMAN A, 1993, J GEN VIROL, V74, P1775, DOI 10.1099/0022-1317-74-9-1775; BROWN EA, 1991, J VIROL, V65, P5828, DOI 10.1128/JVI.65.11.5828-5838.1991; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Craig ME, 1999, J PAEDIATR CHILD H, V35, P107, DOI 10.1046/j.1440-1754.1999.t01-1-00348.x; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Friedman J, 2007, CLIN CANCER RES, V13, P6568, DOI 10.1158/1078-0432.CCR-07-1591; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gasparian AV, 2010, J VIROL, V84, P9390, DOI 10.1128/JVI.02569-09; Gorbachev AV, 2007, EUR J IMMUNOL, V37, P2257, DOI 10.1002/eji.200636708; Gosert R, 2000, MOL CELL BIOL, V20, P1583, DOI 10.1128/MCB.20.5.1583-1595.2000; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hellen CUT, 1995, CURR TOP MICROBIOL, V203, P31; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Honda M, 1996, RNA, V2, P955; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; JONSSON F, 1953, Sven Lakartidn, V50, P239; Kaminski A, 1995, RNA, V1, P924; Kobayashi Yuka, 2003, Rinsho Shinkeigaku, V43, P403; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Malina A, 2005, FEBS LETT, V579, P79, DOI 10.1016/j.febslet.2004.06.103; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; OBRIEN RL, 1966, P NATL ACAD SCI USA, V55, P1511, DOI 10.1073/pnas.55.6.1511; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRITCHAR.NJ, 1966, NATURE, V212, P1360, DOI 10.1038/2121360a0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Toubi E, 2006, SCAND J IMMUNOL, V63, P299, DOI 10.1111/j.1365-3083.2006.01737.x; WALLACE DJ, 1989, SEMIN ARTHRITIS RHEU, V18, P282, DOI 10.1016/0049-0172(89)90050-4; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; WHITEHOU.MW, 1965, BIOCHEM PHARMACOL, V14, P1173, DOI 10.1016/0006-2952(65)90295-9; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zipper J, 1980, Int J Gynaecol Obstet, V18, P275	53	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52954	10.1371/journal.pone.0052954	http://dx.doi.org/10.1371/journal.pone.0052954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301007	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000021
J	Mullen, MP; Hanrahan, JP; Howard, DJ; Powell, R				Mullen, Michael P.; Hanrahan, James P.; Howard, Dawn J.; Powell, Richard			Investigation of Prolific Sheep from UK and Ireland for Evidence on Origin of the Mutations in BMP15 (FecX(G), FecX(B)) and GDF9 (FecG(H)) in Belclare and Cambridge Sheep	PLOS ONE			English	Article							INCREASED OVULATION RATE; BOOROOLA FECB; X-CHROMOSOME; GENE; STERILITY; DELETION	This paper concerns the likely origin of three mutations with large effects on ovulation rate identified in the Belclare and Cambridge sheep breeds; two in the BMP15 gene (FecX(G) and FecX(B)) and the third (FecG(H)) in GDF9. All three mutations segregate in Belclare sheep while one, FecX(B), has not been found in the Cambridge. Both Belclare and Cambridge breeds are relatively recently developed composites that have common ancestry through the use of genetic material from the Finnish Landrace and Lleyn breeds. The development of both composites also involved major contributions from exceptionally prolific ewes screened from flocks in Ireland (Belclare) and Britain (Cambridge) during the 1960s. The objective of the current study was to establish the likely origin of the mutations (FecX(G), FecX(B) and FecG(H)) through analysis of DNA from Finnish Landrace and Lleyn sheep, and Galway and Texel breeds which contributed to the development of the Belclare breed. Ewes with exceptionally high prolificacy (hyper-prolific ewes) in current flocks on Irish farms were identified to simulate the screening of ewes from Irish flocks in the 1960s. DNA was obtained from: prolific ewes in extant flocks of Lleyn sheep (n = 44) on the Lleyn peninsula in Wales; hyper-prolific ewes (n = 41); prolific Galway (n = 41) ewes; Finnish Landrace (n = 124) and Texel (n = 19) ewes. The FecX(G) mutation was identified in Lleyn but not in Finnish Landrace, Galway or Texel sheep; FecX(B) was only found among the hyper-prolific ewes. The FecG(H) mutation was identified in the sample of Lleyn sheep. It was concluded from these findings that the Lleyn breed was the most likely source of the FecX(G) and FecG(H) mutations in Belclare and Cambridge sheep and that the FecX(B) mutation came from the High Fertility line that was developed using prolific ewes selected from commercial flocks in Ireland in the 1960's and subsequently used in the genesis of the Belclare.	[Mullen, Michael P.; Powell, Richard] Natl Univ Ireland, Dept Microbiol, Galway, Ireland; [Mullen, Michael P.; Hanrahan, James P.; Howard, Dawn J.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Athenry, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Teagasc	Mullen, MP (corresponding author), Natl Univ Ireland, Dept Microbiol, Galway, Ireland.	michael.mullen@teagasc.ie		Howard, Dawn J/0000-0002-7573-5859	Teagasc Walsh Fellowship Scheme; Genesis Faraday SPARK award (Lleyn survey); Science Foundation Ireland [07/SRC/B1156]	Teagasc Walsh Fellowship Scheme; Genesis Faraday SPARK award (Lleyn survey); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Financial support through the Teagasc Walsh Fellowship Scheme, Genesis Faraday SPARK award (Lleyn survey) and Science Foundation Ireland (07/SRC/B1156) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bodin L, 1998, P WORLD C GEN APPL L, V27, P11; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; BRADFORD GE, 1986, J ANIM SCI, V63, P418, DOI 10.2527/jas1986.632418x; Chu Ming-Xing, 2005, Acta Genetica Sinica, V32, P38; Davis G. H., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P175; Davis GH, 2002, BIOL REPROD, V66, P1869, DOI 10.1095/biolreprod66.6.1869; Davis GH, 2006, ANIM REPROD SCI, V92, P87, DOI 10.1016/j.anireprosci.2005.06.001; DAVIS GH, 1982, NEW ZEAL J AGR RES, V25, P525, DOI 10.1080/00288233.1982.10425216; Davis GH, 2001, BIOL REPROD, V64, P216, DOI 10.1095/biolreprod64.1.216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Hanrahan J. P., 1984, Proceedings of the 2nd World Congress on Sheep and Beef Cattle Breeding, 16-19 April 1984, Pretoria, South Africa., P483; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; HANRAHAN JP, 1985, ANIM PROD, V40, P529; Hanrahan JP, 1990, RES REPORT, P139; Hanrahan JP, 1976, LLEYN SHEEP, P168; Hanrahan JP, 1975, P 29 ANN M EUR ASS A; Hanrahan JP, 2009, BSAS ADV ANIM BIOSCI, V1, P42; Hanrahan JP, 2007, P BRIT SOC AN SCI AN; Jonmundsson J. V., 1985, Genetics of reproduction in sheep., P159; Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514; Lecerf F, 2002, P 7 WORLD C GEN APP, P753; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; Monteagudo LV, 2009, ANIM REPROD SCI, V110, P139, DOI 10.1016/j.anireprosci.2008.01.005; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; Mullen MP, 2011, BSAS ADV ANIM BIOSCI, V2, P212; Mullen MP, 2003, P AGR RES FOR TULL I; Nicol L, 2009, REPRODUCTION, V138, P921, DOI 10.1530/REP-09-0193; Owen John B., 1976, SHEEP PRODUCTION; Piper L. R., 1982, The Booroola Merino. Proceedings of a workshop held at Armidale, N.S.W. 24 August 1980, P9; RADOMSKA MJ, 1988, J AGR SCI FINLAND, V60, P597; Silva BDM, 2011, ANIM GENET, V42, P89, DOI 10.1111/j.1365-2052.2010.02078.x; Timon V, 1963, GENETIC IMPROVEMENT, P78; Vaughan EK, 1997, VET REC, V140, P100, DOI 10.1136/vr.140.4.100; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225	37	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53172	10.1371/journal.pone.0053172	http://dx.doi.org/10.1371/journal.pone.0053172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301039	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900066
J	Du, YH; Yan, L; Wang, J; Zhan, WZ; Song, K; Han, X; Li, X; Cao, JM; Liu, HR				Du, Yunhui; Yan, Li; Wang, Jin; Zhan, Wenzhang; Song, Kai; Han, Xue; Li, Xiao; Cao, Jimin; Liu, Huirong			beta(1)-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the beta(1)-AR/cAMP/PKA and p38 MAPK Pathways	PLOS ONE			English	Article							PROTEIN-KINASE-A; DILATED CARDIOMYOPATHY; CARDIAC BETA(1)-ADRENOCEPTORS; BETA-1-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTORS; SERUM AUTOANTIBODIES; EXPRESSION; ANTIBODIES; AUTOIMMUNITY; PHOSPHORYLATION	Background: Autoantibodies against the second extracellular loop of the beta(1)-adrenergic receptor (beta(1)-AA) not only contribute to increased susceptibility to heart failure, but also play a causative role in myocardial remodeling through their sympathomimetic-like effects that are induced upon binding to the beta(1)-adrenergic receptor. However, their role in the function of T lymphocytes has never been previously investigated. Our present study was designed to determine whether beta(1)-AA isolated from the sera of dilated cardiomyopathy (DCM) patients caused the proliferation of T cells and the secretion of cytokines. Methods: Blood samples were collected from 95 DCM patients as well as 95 healthy subjects, and beta(1)-AA was detected using ELISA. The CD3(+)T lymphocytes were selected separately through flow cytometry and the effect of beta(1)-AA on T lymphocyte proliferation was examined by CCK-8 kits and CFSE assay. Western blotting was used to analyze the expressions of phospho-VASP and phospho-p38 MAPK. Results: beta(1)-AA enhanced the proliferation of T lymphocytes. This effect could be blocked by the selective beta(1)-adrenergic receptor antagonist metoprolol, PKA inhibitor H89, and p38 MAPK inhibitor SB203580. Furthermore, the expression of the phosphorylated forms of phospho-VASP and phospho-p38 MAPK were markedly increased in the presence of beta(1)-AA. beta(1)-AA also inhibited the secretion of interferon-gamma (IFN-gamma) while promoting an increase in interleukin-4 (IL-4) levels. Conclusions: These results demonstrate that beta(1)-AA isolated from DCM patients binds to beta(1)-AR on the surface of T cells, causing changes in T-cell proliferation and secretion through the beta(1)-AR/cAMP/PKA and p38 MAPK pathways.	[Du, Yunhui; Han, Xue; Li, Xiao; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Du, Yunhui] Shandong Univ, Dept Marine Bioengn, Marine Coll, Weihai, Shandong, Peoples R China; [Yan, Li; Cao, Jimin] Peking Union Med Coll, Inst Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100021, Peoples R China; [Wang, Jin] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Zhan, Wenzhang] Tonghua Min Grp CO LTD, Gen Hosp, Dept Internal Med, Baishan, Jilin, Peoples R China; [Song, Kai] Changzhi Med Coll, Peace Hosp, Dept Internal Med, Changzhi, Shanxi, Peoples R China; [Liu, Huirong] Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shanxi Medical University; Changzhi Medical College; Capital Medical University	Liu, HR (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	liuhr2000@126.com			National Natural Science Foundation of China [81070263]; General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China [KZ201110025023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81070263) and the General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (Grant No. KZ201110025023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; Bonney KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014571; Caforio ALP, 1997, HEART, V77, P62, DOI 10.1136/hrt.77.1.62; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; CHIALE PA, 1995, J AM COLL CARDIOL, V26, P864, DOI 10.1016/0735-1097(95)00262-2; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Dobreva ZG, 2009, IMMUNOPHARM IMMUNOT, V31, P195, DOI 10.1080/08923970802626276; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748; Ganapathy V, 2000, INT IMMUNOL, V12, P851, DOI 10.1093/intimm/12.6.851; Hsu SC, 2003, BLOOD, V101, P970, DOI 10.1182/blood-2002-03-0744; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Jahns R, 2006, INT J CARDIOL, V112, P7, DOI 10.1016/j.ijcard.2006.05.008; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lindberg E, 2010, CELL IMMUNOL, V263, P224, DOI 10.1016/j.cellimm.2010.04.003; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V119, P235, DOI 10.1016/j.jaci.2006.09.019; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; Magnusson Y, 1996, INT J CARDIOL, V54, P137, DOI 10.1016/0167-5273(96)02590-9; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Miao GB, 2006, EUR J CLIN INVEST, V36, P614, DOI 10.1111/j.1365-2362.2006.01705.x; Nagatomo Y, 2009, J CARD FAIL, V15, P224, DOI 10.1016/j.cardfail.2008.10.027; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Ramgolam VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014450; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Robinet A, 2005, CARDIOVASC RES, V66, P530, DOI 10.1016/j.cardiores.2005.02.010; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Tutor AS, 2007, CARDIOVASC RES, V76, P51, DOI 10.1016/j.cardiores.2007.05.022; Wallukat G, 1999, AM J CARDIOL, V83, p75H; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; WALLUKAT G, 1987, BIOMED BIOCHIM ACTA, V46, pS634; Yu XY, 2007, CLIN PHARMACOL THER, V81, P654, DOI 10.1038/sj.clpt.6100154; Zhang W G, 1996, Blood Press Suppl, V3, P45; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	40	24	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52911	10.1371/journal.pone.0052911	http://dx.doi.org/10.1371/journal.pone.0052911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300817	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600036
J	Raudies, F; Neumann, H				Raudies, Florian; Neumann, Heiko			A Bio-Inspired, Motion-Based Analysis of Crowd Behavior Attributes Relevance to Motion Transparency, Velocity Gradients, and Motion Patterns	PLOS ONE			English	Article							OPTIC FLOW STIMULI; MST NEURONS; AREA MT; MODEL; SELECTIVITY; PERCEPTION; ATTENTION; FEATURES; SIGNALS	The analysis of motion crowds is concerned with the detection of potential hazards for individuals of the crowd. Existing methods analyze the statistics of pixel motion to classify non-dangerous or dangerous behavior, to detect outlier motions, or to estimate the mean throughput of people for an image region. We suggest a biologically inspired model for the analysis of motion crowds that extracts motion features indicative for potential dangers in crowd behavior. Our model consists of stages for motion detection, integration, and pattern detection that model functions of the primate primary visual cortex area (V1), the middle temporal area (MT), and the medial superior temporal area (MST), respectively. This model allows for the processing of motion transparency, the appearance of multiple motions in the same visual region, in addition to processing opaque motion. We suggest that motion transparency helps to identify "danger zones" in motion crowds. For instance, motion transparency occurs in small exit passages during evacuation. However, motion transparency occurs also for non-dangerous crowd behavior when people move in opposite directions organized into separate lanes. Our analysis suggests: The combination of motion transparency and a slow motion speed can be used for labeling of candidate regions that contain dangerous behavior. In addition, locally detected decelerations or negative speed gradients of motions are a precursor of danger in crowd behavior as are globally detected motion patterns that show a contraction toward a single point. In sum, motion transparency, image speeds, motion patterns, and speed gradients extracted from visual motion in videos are important features to describe the behavioral state of a motion crowd.	[Raudies, Florian] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA; [Raudies, Florian; Neumann, Heiko] Boston Univ, Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany	Boston University; Boston University; Ulm University	Raudies, F (corresponding author), Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA.	fraudies@bu.edu			Office of Naval Research [ONR N00014-11-1-0535]; German Research Foundation (DFG) [SFB/TRR 62]	Office of Naval Research(Office of Naval Research); German Research Foundation (DFG)(German Research Foundation (DFG))	FR is supported in part by the Office of Naval Research (ONR N00014-11-1-0535) and HN in part by the Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Ali S, 2008, P EUR C COMP VIS ECC; Ali S., 2007, P IEEE C COMP VIS PA, DOI [10.1109/CVPR.2007.382977, DOI 10.1109/CVPR.2007.382977]; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Andrade EL, 2006, P IEEE INT C PATT RE; Angelucci A, 2002, J NEUROSCI, V22, P8633; Batty M, 1997, NATURE, V388, P19, DOI 10.1038/40266; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Bayerl P, 2007, BIOSYSTEMS, V89, P208, DOI 10.1016/j.biosystems.2006.04.018; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Braddick O, 2001, MOTION VISION, P85; Braddick OJ, 2002, VISION RES, V42, P1237, DOI 10.1016/S0042-6989(02)00018-4; Burr D, 2006, VISION RES, V46, P932, DOI 10.1016/j.visres.2005.09.025; Cao T, 2009, P IEEE INT C ROB BIO; Cohen CJ, 2008, 2008 IEEE CONFERENCE ON TECHNOLOGIES FOR HOMELAND SECURITY, VOLS 1 AND 2, P559, DOI 10.1109/THS.2008.4534514; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Duffy CJ, 1997, J NEUROSCI, V17, P2839; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Durant S, 2006, BIOL LETTERS, V2, P101, DOI 10.1098/rsbl.2005.0379; ENDRES D., 2011, 4 INT C IM CRIM DET, P1; Felisberti FM, 2005, VISION RES, V45, P2587, DOI 10.1016/j.visres.2005.03.004; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HEEGER DJ, 1987, INT J COMPUT VISION, V1, P279, DOI 10.1007/BF00133568; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2010, ENCY COMPLEXITY SYST, P6476, DOI DOI 10.1007/978-0-387-30440-3_382; HENDERSON LF, 1974, TRANSPORT RES, V8, P509, DOI 10.1016/0041-1647(74)90027-6; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ihaddadene N, 2008, P IEEE INT C PATT RE; Jiang F, 2009, P IEEE INT C IM PROC; Johansson A, 2008, ADV COMPLEX SYST, V11, P497, DOI 10.1142/S0219525908001854; Krausz B, 2012, COMPUT VIS IMAGE UND, V116, P307, DOI 10.1016/j.cviu.2011.08.006; Lucas Bruce, 1981, P 7 INT JOINT C ART, V81; Mechler F, 2002, J NEUROSCI, V22, P6129; Mehran R, 2011, VIDEOS NORMAL ABNORM; Mehran R, 2009, P IEEE INT C COMP VI; Mehran R, 2010, LECT NOTES COMPUT SC, V6313, P439; Moussaid M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002442; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Narain R, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618468; Nyquist H, 2002, P IEEE, V90, P280, DOI 10.1109/5.989875; Papenberg N, 2006, INT J COMPUT VISION, V67, P141, DOI 10.1007/s11263-005-3960-y; POLUS A, 1983, J TRANSP ENG-ASCE, V109, P46, DOI 10.1061/(ASCE)0733-947X(1983)109:1(46); QIAN N, 1994, J NEUROSCI, V14, P7381; Raudies F, 2012, DEV APPL BIOL INSPIR; Raudies F, VELOCITY GRADIENTS O; Raudies F, 2011, NEURAL COMPUT, V23, P2868, DOI 10.1162/NECO_a_00193; Raudies F, 2010, NEURAL NETWORKS, V23, P160, DOI 10.1016/j.neunet.2009.10.005; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Rodriguez M, 2009, IEEE I CONF COMP VIS, P1389, DOI 10.1109/ICCV.2009.5459301; Siebel NT, 2004, P ECCV 2004 WORKSH A, P103; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Stafstrom CE, 2000, J NEUROPHYSIOL, V2, P254; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; Xiong T, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/10/108901; Yu H, 2011, P IEEE 4 INT C IM SI; Zach C, 2007, LECT NOTES COMPUT SC, V4713, P214, DOI 10.1007/978-3-540-74936-3_22; Zanker JM, 2005, SPATIAL VISION, V18, P431, DOI 10.1163/1568568054389615; Zhan BB, 2008, MACH VISION APPL, V19, P345, DOI 10.1007/s00138-008-0132-4	67	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53456	10.1371/journal.pone.0053456	http://dx.doi.org/10.1371/journal.pone.0053456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300930	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600101
J	Mudrak, OS; Nazarov, IB; Jones, EL; Zalensky, AO				Mudrak, Olga S.; Nazarov, Igor B.; Jones, Estella L.; Zalensky, Andrei O.			Positioning of Chromosomes in Human Spermatozoa Is Determined by Ordered Centromere Arrangement	PLOS ONE			English	Article							HUMAN SPERM NUCLEUS; GENOME ORGANIZATION; NONHOMOLOGOUS CENTROMERES; SEX-CHROMOSOMES; EARLY G1; CHROMATIN; ARCHITECTURE; MOUSE; DNA; MITOSIS	The intranuclear positioning of chromosomes (CHRs) is a well-documented fact; however, mechanisms directing such ordering remain unclear. Unlike somatic cells, human spermatozoa contain distinct spatial markers and have asymmetric nuclei which make them a unique model for localizing CHR territories and matching peri-centromere domains. In this study, we established statistically preferential longitudinal and lateral positioning for eight CHRs. Both parameters demonstrated a correlation with the CHR gene densities but not with their sizes. Intranuclear non-random positioning of the CHRs was found to be driven by a specific linear order of centromeres physically interconnected in continuous arrays. In diploid spermatozoa, linear order of peri-centromeres was identical in two genome sets and essentially matched the arrangement established for haploid cells. We propose that the non-random longitudinal order of CHRs in human spermatozoa is generated during meiotic stages of spermatogenesis. The specific arrangement of sperm CHRs may serve as an epigenetic basis for differential transcription/replication and direct spatial CHR organization during early embryogenesis.	[Mudrak, Olga S.; Nazarov, Igor B.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Mudrak, Olga S.; Nazarov, Igor B.; Jones, Estella L.; Zalensky, Andrei O.] Eastern Virginia Med Sch, Jones Inst Reprod Med, Norfolk, VA 23501 USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Eastern Virginia Medical School	Mudrak, OS (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	olgamudrak2010@gmail.com	Nazarov, Igor/AAE-9319-2021	Nazarov, Igor/0000-0003-4525-6694	National Institutes of Health [HD-042748]; Jones Foundation; Russian Foundation for Basic Research [12-04-01489-a]; MCB RAS Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jones Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); MCB RAS Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant HD-042748, the Jones Foundation grant to A.O.Z., the Russian Foundation for Basic Research grant # 12-04-01489-a and the grant from MCB RAS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bardhan A, 2010, MOL BIOL CELL, V21, P1799, DOI 10.1091/mbc.E09-05-0392; Bickmore WA, 2003, CURR BIOL, V13, pR357, DOI 10.1016/S0960-9822(03)00276-8; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bojanowski K, 1998, J CELL BIOCHEM, V69, P127, DOI 10.1002/(SICI)1097-4644(19980501)69:2<127::AID-JCB4>3.0.CO;2-U; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2004, BIOL CELL, V96, P555, DOI 10.1016/j.biolcel.2004.07.002; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dozortsev D, 2000, FERTIL STERIL, V73, P366, DOI 10.1016/S0015-0282(99)00491-4; Egozcue S, 2002, HUM REPROD, V17, P5, DOI 10.1093/humrep/17.1.5; Elcock LS, 2010, BIOCHEM SOC T, V38, P263, DOI 10.1042/BST0380263; Essers J, 2005, MOL BIOL CELL, V16, P769, DOI 10.1091/mbc.e04-10-0876; Finch KA, 2008, HUM REPROD, V23, P1263, DOI 10.1093/humrep/den112; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Greaves IK, 2003, CHROMOSOME RES, V11, P503, DOI 10.1023/A:1024982929452; Gurevitch M, 2001, MOL REPROD DEV, V60, P507, DOI 10.1002/mrd.1116; HAAF T, 1990, EXP CELL RES, V187, P157, DOI 10.1016/0014-4827(90)90130-3; HAAF T, 1995, EXP CELL RES, V219, P604, DOI 10.1006/excr.1995.1270; Hartl TA, 2008, PLOS GENET, V4; Hazzouri M, 2000, MOL REPROD DEV, V55, P307, DOI 10.1002/(SICI)1098-2795(200003)55:3<307::AID-MRD9>3.0.CO;2-P; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; KORF BR, 1977, CYTOGENET CELL GENET, V19, P335, DOI 10.1159/000130827; Lanctot C, 2007, EXP CELL RES, V313, P1449, DOI 10.1016/j.yexcr.2007.01.027; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114; Manvelyan M, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-25; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Sbracia M, 2002, HUM REPROD, V17, P320, DOI 10.1093/humrep/17.2.320; Sengupta K, 2008, CHROMOSOMA, V117, P499, DOI 10.1007/s00412-008-0171-7; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Stewart MN, 2008, TRENDS GENET, V24, P564, DOI 10.1016/j.tig.2008.08.006; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Verschure PJ, 2004, BIOL CELL, V96, P569, DOI 10.1016/j.biolcel.2004.07.001; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Ward WS, 1996, CRIT REV EUKAR GENE, V6, P139, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.30; Weierich C, 2003, CHROMOSOME RES, V11, P485, DOI 10.1023/A:1025016828544; Wiland E, 2008, CHROMOSOME RES, V16, P291, DOI 10.1007/s10577-007-1194-2; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zalensky A, 2007, BIOCHEM SOC T, V35, P609, DOI 10.1042/BST0350609; ZALENSKY AO, 1995, CHROMOSOMA, V103, P577; ZALENSKY AO, 1993, CHROMOSOMA, V102, P509, DOI 10.1007/BF00368344	54	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52944	10.1371/journal.pone.0052944	http://dx.doi.org/10.1371/journal.pone.0052944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300830	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100102
J	Takano, M; Hikishima, K; Fujiyoshi, K; Shibata, S; Yasuda, A; Konomi, T; Hayashi, A; Baba, H; Honke, K; Toyama, Y; Okano, H; Nakamura, M				Takano, Morito; Hikishima, Keigo; Fujiyoshi, Kanehiro; Shibata, Shinsuke; Yasuda, Akimasa; Konomi, Tsunehiko; Hayashi, Akiko; Baba, Hiroko; Honke, Koichi; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			MRI Characterization of Paranodal Junction Failure and Related Spinal Cord Changes in Mice	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; PERIPHERAL NERVOUS-SYSTEM; MOUSE-BRAIN; IN-VIVO; SULFATIDE; MYELIN; DEGENERATION; AXON; GALACTOCEREBROSIDE; SULFOGLYCOLIPIDS	The paranodal junction is a specialized axon-glia contact zone that is important for normal neuronal activity and behavioral locomotor function in the central nervous system (CNS). Histological examination has been the only method for detecting pathological paranodal junction conditions. Recently, diffusion tensor MRI (DTI) has been used to detect microstructural changes in various CNS diseases. This study was conducted to determine whether MRI and DTI could detect structural changes in the paranodal junctions of the spinal cord in cerebroside sulfotransferase knock-out (CST-KO) mice. Here, we showed that high-resolution MRI and DTI characteristics can reflect paranodal junction failure in CST-KO mice. We found significantly lower T1 times and significantly higher T2 times in the spinal cord MRIs of CST-KO mice as compared to wildtype (WT) mice. Spinal cord DTI showed significantly lower axial diffusivity and significantly higher radial diffusivity in CST-KO mice as compared to WT mice. In contrast, the histological differences in the paranodal junctions of WT and CST-KO mice were so subtle that electron microscopy or immunohistological analyses were necessary to detect them. We also measured gait disturbance in the CST-KO mice, and determined the conduction latency by electrophysiology. These findings demonstrate the potential of using MRI and DTI to evaluate white matter disorders that involve paranodal junction failure.	[Takano, Morito; Yasuda, Akimasa; Konomi, Tsunehiko; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takano, Morito; Hikishima, Keigo; Shibata, Shinsuke; Konomi, Tsunehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Fujiyoshi, Kanehiro] Natl Hosp Org, Murayama Med Ctr, Tokyo, Japan; [Hayashi, Akiko; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, Tokyo, Japan; [Honke, Koichi] Kochi Univ, Dept Biochem, Sch Med, Nanko Ku, Kochi 780, Japan	Keio University; Keio University; Tokyo University of Pharmacy & Life Sciences; Kochi University	Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	masa@a8.keio.jp	Toyama, Yoshiaki/K-5743-2013; Konomi, Tsunehiko/AAY-6082-2020; Nakamura, Masaya/K-4111-2013; Konomi, Tsunehiko/ABB-1765-2020; Okano, Hideyuki/I-7584-2019; Hikishima, Keigo/AAP-9586-2020; Shibata, Shinsuke/AAM-6620-2020; Hikishima, Keigo/L-1202-2013	Konomi, Tsunehiko/0000-0001-6704-7573; Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); General Insurance Association of Japan; JST-CIRM Collaborative Research Program; Strategic Research Program for Brain Sciences; Leading Project for Realization of Regenerative Medicine; MEXT; Funding Program for World-leading Innovative R&D on Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); General Insurance Association of Japan; JST-CIRM Collaborative Research Program; Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); by a grant from the General Insurance Association of Japan, by the JST-CIRM Collaborative Research Program, to YO and MN; by a grant from the Strategic Research Program for Brain Sciences and the Leading Project for Realization of Regenerative Medicine, support for the Core Institutes for iPS cell research from MEXT and the Funding Program for World-leading Innovative R&D on Science and Technology to HO, and by a Grant-in-aid for the Global COE program from MEXT to the Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bonny JM, 2004, NEUROBIOL DIS, V15, P474, DOI 10.1016/j.nbd.2003.11.026; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Bosshard SC, 2010, PAIN, V151, P655, DOI 10.1016/j.pain.2010.08.025; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cowin GJ, 2011, NEUROIMAGE, V58, P69, DOI 10.1016/j.neuroimage.2011.06.003; Dyakin VV, 2010, NEUROIMAGE, V51, P1098, DOI 10.1016/j.neuroimage.2010.03.013; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; Eckhardt M, 2007, J NEUROSCI, V27, P9009, DOI 10.1523/JNEUROSCI.2329-07.2007; Ellingson BM, 2010, MAGN RESON IMAGING, V28, P1353, DOI 10.1016/j.mri.2010.06.006; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Hassen WB, 2009, NEUROIMAGE, V46, P1, DOI 10.1016/j.neuroimage.2009.01.022; Honke K, 2004, GLYCOCONJUGATE J, V21, P59, DOI 10.1023/B:GLYC.0000043749.06556.3d; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogura H, 2001, BEHAV BRAIN RES, V122, P215, DOI 10.1016/S0166-4328(01)00187-5; Patay Z, 2005, EUR RADIOL, V15, P2284, DOI 10.1007/s00330-005-2846-2; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; UZMAN BG, 1957, J BIOPHYS BIOCHEM CY, V3, P589, DOI 10.1083/jcb.3.4.589; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767	34	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52904	10.1371/journal.pone.0052904	http://dx.doi.org/10.1371/journal.pone.0052904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300814	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100095
J	Bepari, AK; Sano, H; Tamamaki, N; Nambu, A; Tanaka, KF; Takebayashi, H				Bepari, Asim K.; Sano, Hiromi; Tamamaki, Nobuaki; Nambu, Atsushi; Tanaka, Kenji F.; Takebayashi, Hirohide			Identification of Optogenetically Activated Striatal Medium Spiny Neurons by Npas4 Expression	PLOS ONE			English	Article							BASAL GANGLIA; C-FOS; GENE-EXPRESSION; MOTOR CORTEX; RAT STRIATUM; ORGANIZATION; STIMULATION; CONNECTIONS; PLASTICITY; INDUCTION	Optogenetics is a powerful neuromodulatory tool with many unique advantages to explore functions of neuronal circuits in physiology and diseases. Yet, interpretation of cellular and behavioral responses following in vivo optogenetic manipulation of brain activities in experimental animals often necessitates identification of photoactivated neurons with high spatial resolution. Although tracing expression of immediate early genes (IEGs) provides a convenient approach, neuronal activation is not always followed by specific induction of widely used neuronal activity markers like c-fos, Egr1 and Arc. In this study we performed unilateral optogenetic stimulation of the striatum in freely moving transgenic mice that expressed a channelrhodopsin-2 (ChR2) variant ChR2(C128S) in striatal medium spiny neurons (MSNs). We found that in vivo blue light stimulation significantly altered electrophysiological activity of striatal neurons and animal behaviors. To identify photoactivated neurons we then analyzed IEG expression patterns using in situ hybridization. Upon light illumination an induction of c-fos was not apparent whereas another neuronal IEG Npas4 was robustly induced in MSNs ipsilaterally. Our results demonstrate that tracing Npas4 mRNA expression following in vivo optogenetic modulation can be an effective tool for reliable and sensitive identification of activated MSNs in the mouse striatum.	[Bepari, Asim K.; Tamamaki, Nobuaki] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto, Japan; [Bepari, Asim K.; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Sano, Hiromi; Nambu, Atsushi] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 444, Japan; [Nambu, Atsushi] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi, Japan; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Takebayashi, Hirohide] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Kumamoto University; Niigata University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Keio University; Japan Science & Technology Agency (JST)	Tanaka, KF (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	kftanaka@a8.jp; takebaya@med.niigata-u.ac.jp	Bepari, Asim/D-4001-2013; Bepari, Asim Kumar/ABC-1166-2021; Bepari, Asim Kumar/GQI-3155-2022; Takebayashi, Hirohide/AAO-1693-2020	Bepari, Asim/0000-0001-5656-1833; Bepari, Asim Kumar/0000-0001-5656-1833; Bepari, Asim Kumar/0000-0001-5656-1833; Tanaka, Kenji/0000-0003-2511-0057; Nambu, Atsushi/0000-0003-2153-5445	JST PRESTO; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT [23680042, 24111551, 20700353, 23700479]; Takeda Science Foundation; Japanese Government (Monbukagakusho: MEXT) Scholarship	JST PRESTO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Government (Monbukagakusho: MEXT) Scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from JST PRESTO, the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to HT), a Grant-in-Aid for Young Scientists (A) from MEXT [23680042](to KFT), a Grant-in-Aid for Scientific Research on Innovative Areas "Brain Environment'' from MEXT [24111551](to KFT), Grants-in-Aid for Young Scientists (B) from MEXT [20700353, 23700479](to HS) and a grant from Takeda Science Foundation (to KFT and AN). AKB is a recipient of the Japanese Government (Monbukagakusho: MEXT) Scholarship. A part of this study is the result of the "Highly creative animal model development for brain sciences'' carried out under the Strategic Research Program for Brain Sciences by the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Gross NB, 2009, NEUROSCIENCE, V161, P1114, DOI 10.1016/j.neuroscience.2009.04.023; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; LaHoste GJ, 1996, BRAIN RES, V728, P97; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Mena-Segovia J, 2003, BRAIN RES, V986, P30, DOI 10.1016/S0006-8993(03)03167-6; Nakano K, 2000, J NEUROL, V247, P1; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; PISA M, 1988, BEHAV BRAIN RES, V27, P21, DOI 10.1016/0166-4328(88)90106-4; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Sano H, 2007, J NEUROSCI, V27, P6948, DOI 10.1523/JNEUROSCI.0514-07.2007; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Sullivan AM, 1996, NEUROREPORT, V8, P211, DOI 10.1097/00001756-199612200-00043; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Usui N, 2012, DEVELOPMENT, V139, P1125, DOI 10.1242/dev.069997; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x	48	23	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52783	10.1371/journal.pone.0052783	http://dx.doi.org/10.1371/journal.pone.0052783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300775	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800146
J	Boehme, L; Thompson, D; Fedak, M; Bowen, D; Hammill, MO; Stenson, GB				Boehme, Lars; Thompson, Dave; Fedak, Mike; Bowen, Don; Hammill, Mike O.; Stenson, Garry B.			How Many Seals Were There? The Global Shelf Loss during the Last Glacial Maximum and Its Effect on the Size and Distribution of Grey Seal Populations	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; GRAY SEALS; MAMMOTH STEPPE; CLIMATE-CHANGE; PHOCA-HISPIDA; NORTH-SEA; MOVEMENT; BEHAVIOR; HABITAT; PALEOECOLOGY	Predicting how marine mammal populations respond to habitat changes will be essential for developing conservation management strategies in the 21st century. Responses to previous environmental change may be informative in the development of predictive models. Here we describe the likely effects of the last ice age on grey seal population size and distribution. We use satellite telemetry data to define grey seal foraging habitat in terms of the temperature and depth ranges exploited by the contemporary populations. We estimate the available extent of such habitat in the North Atlantic at present (between 1.42.10(6) km(2) and 2.07.10(6) km(2)) and at the last glacial maximum (between 4.74.10(4) km(2) and 2.11.10(5) km(2)); taking account of glacial and seasonal sea-ice coverage, estimated reductions of sea-level (123 m) and sea surface temperature hind-casts. Most of the extensive continental shelf waters (North Sea, Baltic Sea and Scotian Shelf), currently supporting >95% of grey seals, were unavailable during the last glacial maximum. A combination of lower sea-level and extensive ice-sheets, massively increased seasonal sea-ice coverage and southerly extent of cold water would have pushed grey seals into areas with no significant shelf waters. The habitat during the last glacial maximum might have been as small as 3% of today's extent and grey seal populations may have fallen to similarly low numbers. An alternative scenario involving a major change to a pelagic or bathy-pelagic foraging niche cannot be discounted. However, hooded seals currently dominate that niche and may have excluded grey seals from such habitat. If as seems likely, the grey seal population fell to very low levels it would have remained low for several thousand years before expanding into current habitats over the past 12,000 years or so.	[Boehme, Lars; Thompson, Dave; Fedak, Mike] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Bowen, Don] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Hammill, Mike O.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Dept Fisheries & Oceans, Mont Joli, PQ G5H 3Z4, Canada; [Stenson, Garry B.] Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF, Canada	University of St Andrews; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Boehme, L (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	lb284@st-andrews.ac.uk	Fedak, Michael A/B-3987-2009; Boehme, Lars/B-6567-2009	Fedak, Michael A/0000-0002-9569-1128; Boehme, Lars/0000-0003-3513-6816; Thompson, David/0000-0003-1546-2876	Natural Environment Research Council, UK; Atlantic seal research program, Department of Fisheries and Oceans, Canada; NSERCD Discovery grants, Canada; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Atlantic seal research program, Department of Fisheries and Oceans, Canada; NSERCD Discovery grants, Canada; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The tagging studies were funded by the Natural Environment Research Council, UK; the Atlantic seal research program, Department of Fisheries and Oceans, Canada and NSERCD Discovery grants, Canada. This work also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Amante C., 2009, NGDC24 NOAA NESDIS, P19, DOI DOI 10.7289/V5C8276M.AVAILABLE0NLINEAT:HTTPS://WWW.NGDC.N0AA.G0V/MGG/GL0BAL/RELIEF/ET0P01/D0CS/ET0P01.PDF; [Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; [Anonymous], 2006, NATL ICE CTR ARCTIC; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Bigg GR, 2008, P ROY SOC B-BIOL SCI, V275, P163, DOI 10.1098/rspb.2007.1153; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bowen W. Don, 2010, P283; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2011, MAR ECOL PROG SER, V431, P267, DOI 10.3354/meps09134; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Collecte Localisation Satellites, 2016, ARG US MAN WORLDW TR; Darwin C, 1859, ORIGIN SPECIES MEANS; Duck C.D., 2007, NAMMCO Scientific Publications, V6, P69; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Freitas C, 2008, ECOL MODEL, V217, P19, DOI 10.1016/j.ecolmodel.2008.05.014; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Gerondeau M, 2007, J MAR BIOL ASSOC UK, V87, P365, DOI 10.1017/S0025315407054586; Grist JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048204; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; Hanebuth TJJ, 2009, GLOBAL PLANET CHANGE, V66, P76, DOI 10.1016/j.gloplacha.2008.03.011; Harding KC, 1999, AMBIO, V28, P619; Harington CR, 2008, ECOL APPL, V18, pS23, DOI 10.1890/06-0624.1; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; HAUG T, 1994, BIOL CONSERV, V70, P59, DOI 10.1016/0006-3207(94)90299-2; Hauksson Erlingur, 2007, NAMMCO Scientific Publications, V6, P85; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jahnke RA, 2010, GLOB CHANGE IGBP SER, P597, DOI 10.1007/978-3-540-92735-8_16; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; Mansfield AW, 1965, GREY SEAL HALICHOERU; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Meland MY, 2005, QUATERNARY SCI REV, V24, P835, DOI 10.1016/j.quascirev.2004.05.011; Members CP, 1981, SEASONAL RECONSTRUCT; Mikkelsen Bjarni, 2007, NAMMCO Scientific Publications, V6, P79; Moore SE, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P137; Nilssen Kjell Tormod, 2007, NAMMCO Scientific Publications, V6, P23; OSPAR Commission, 2000, ASS CLIM CHANG MIT A; Overpeck JT, 2005, EOS, V86; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pflaumann U, 2003, PALEOCEANOGRAPHY, V18; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Rivals F, 2010, PALAEOGEOGR PALAEOCL, V286, P42, DOI 10.1016/j.palaeo.2009.12.002; Rosvig-Asvid A, 2010, SEALS GREENLAND ILIN; Row LW, 1995, NGDC KEY GEOPHYS REC; SARNTHEIN M, 2003, PALEOCEANOGRAPHY, V18; SCOS, 2011, SCI ADV MATT REL MAN; SMRU Instrumentation Group, 2012, ARG GPS ARG SRDL TAG, P4; Stirling I., 1983, Special Publication American Society of Mammalogists, P489; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; THOMPSON D, 1993, J EXP BIOL, V174, P139; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Vibe C., 1967, Meddelelser om Gronland, V170, P1; Vie J-C, 2009, WILDLIFE CHANGING WO; Vincent C, 2005, BIOL CONSERV, V126, P62, DOI 10.1016/j.biocon.2005.04.022; Vincent C, 2003, MARQUAGE ELECTRONIQUE ET SUIVI TELEMETRIQUE DES GRANDS VERTEBRES MARINS MIGRATEURS, P101; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Waters JM, 2008, DIVERS DISTRIB, V14, P692, DOI 10.1111/j.1472-4642.2008.00481.x; Winton M, 2006, GEOPHYS RES LETT, V33; Wood SA, 2011, CAN J ZOOL, V89, P490, DOI 10.1139/Z11-012; Wood Stephanie A., 2007, NAMMCO Scientific Publications, V6, P117	75	10	10	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e53000	10.1371/journal.pone.0053000	http://dx.doi.org/10.1371/journal.pone.0053000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300843	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800166
J	Chen, YJ; Chang, SC; Tsao, KC; Shih, SR; Yang, SL; Lin, TY; Huang, YC				Chen, Yi-Jen; Chang, Shih-Cheng; Tsao, Kuo-Chien; Shih, Shin-Ru; Yang, Shu-Li; Lin, Tzou-Yien; Huang, Yhu-Chering			Comparative Genomic Analysis of Coxsackievirus A6 Strains of Different Clinical Disease Entities	PLOS ONE			English	Article							MOUTH-DISEASE; ENTEROVIRUS SEROTYPES; HAND; FOOT; OUTBREAK; ONYCHOMADESIS; A10; CIRCULATION; PROTEOLYSIS; INFECTIONS	Background: Studies regarding coxsackievirus A6 (CVA6) infection were limited. In Taiwan, outbreaks of CVA6 occurred in 2009 and 2010, respectively, but the clinical manifestations were markedly different. We conducted a study to compare the clinical features and genomic sequence between the two years. Methodology/Principal Findings: In 2009 and 2010, 205 patients with coxsackievirus A6 (CVA6) infection were treated at Chang Gung Memorial Hospital. Detailed clinical features were obtained from 126 inpatients, 62 in 2009 and 64 in 2010. Between the inpatients in 2009 and 2010, no statistically significant difference was noted in terms of demographics, length of hospital stay and laboratory data. Significantly more patients in 2009 presented with herpangina (82%) while more patients in 2010 presented with hand-foot-mouth disease (HFMD; 67%) and skin rash beyond the typical sites for HFMD. Complete genomic sequences were determined and compared for three isolates from patients with herpangina in 2009 and three isolates from patients with HFMD in 2010. The complete sequences showed that 2009 and 2010 CVA6 isolates were indistinguishable by partial VP1 genes, but there were 5 unique nucleotide changes in 39 UTR, and 23 out of 2201 (1%) amino acids were different. 2010 viruses underwent the largest number of amino acid changes in 3CD protein, which is the precursor of both 3C protease and 3D polymerase. Conclusions: Since 2008 in Finland, outbreaks of HFMD due to CVA6 were noted internationally. CVA6 of different genetic background may cause different clinical manifestations such as herpangina and HFMD.	[Chen, Yi-Jen; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan; [Chang, Shih-Cheng; Tsao, Kuo-Chien; Shih, Shin-Ru; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tsao, Kuo-Chien; Yang, Shu-Li] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan.	ychuang@cgmh.org.tw	Shih, Shin-Ru/M-9711-2016	Shih, Shin-Ru/0000-0003-4874-401X	Chang Gung Memorial Hospital [CMRPG 470132, CMRPG320019, CMRPG371663, CLRPG3B0041]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the grants from Chang Gung Memorial Hospital. (CMRPG 470132, CMRPG320019, CMRPG371663 and CLRPG3B0041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Goldstein EJC, 2010, MANDELL DOUGLAS BENN, V7th, P3035; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HELLEN CUT, 1991, J VIROL, V65, P4226, DOI 10.1128/JVI.65.8.4226-4231.1991; Kok CC, 2009, INT J BIOCHEM CELL B, V41, P498, DOI 10.1016/j.biocel.2008.03.019; Lin TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Davia JL, 2011, PEDIATR DERMATOL, V28, P1, DOI 10.1111/j.1525-1470.2010.01161.x; Maqbool A., 2011, NELSON TXB PEDIAT; McIntyre Mary G., 2012, Morbidity and Mortality Weekly Report, V61, P213; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mirmomeni MH, 1997, J VIROL, V71, P2363, DOI 10.1128/JVI.71.3.2363-2370.1997; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wu Z, 2010, INT J INFECT DIS, V14, pE340, DOI 10.1016/j.ijid.2010.02.377; Yamashita T, 2005, JPN J INFECT DIS, V58, P390	30	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52432	10.1371/journal.pone.0052432	http://dx.doi.org/10.1371/journal.pone.0052432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300669	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800086
J	Dyer, GA; Matthews, R; Meyfroidt, P				Dyer, George A.; Matthews, Robin; Meyfroidt, Patrick			Is There an Ideal REDD plus Program? An Analysis of Policy Trade-Offs at the Local Level	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES HELP; ECOSYSTEM SERVICES; DESIGNING PAYMENTS; DEFORESTATION; EMISSIONS; POVERTY; LESSONS; FORESTS; ISSUES	We use economy-wide simulation methods to analyze the outcome of a simple REDD+ program in a mixed subsistence/commercial-agriculture economy. Alternative scenarios help trace REDD+'s causal chain, revealing how trade-offs between the program's public and private costs and benefits determine its effectiveness, efficiency and equity (the 3Es). Scenarios reveal a complex relationship between the 3Es not evident in more aggregate analyses. Setting aside land as a carbon sink always influences the productivity of agriculture and its supply of non-market goods and services; but the overall returns to land and labor-which ultimately determine the opportunity cost of enrollment, the price of carbon and the distribution of gains and losses-depend on local conditions. In the study area, market-oriented landowners could enroll 30% of local land into a cost-effective program, but local subsistence demands would raise their opportunity costs as REDD+ unfurls, increasing the marginal cost of carbon. A combination of rent and wage changes would create net costs for most private stakeholders, including program participants. Increasing carbon prices undermines the program's efficiency without solving its inequities; expanding the program reduces inefficiencies but increases private costs with only minor improvements in equity. A program that prevents job losses could be the best option, but its efficiency compared to direct compensation could depend on program scale. Overall, neither the cost nor the 3Es of alternative REDD+ programs can be assessed without accounting for local demand for subsistence goods and services. In the context of Mexico's tropical highlands, a moderate-sized REDD+ program could at best have no net impact on rural households. REDD+ mechanisms should avoid general formulas by giving local authorities the necessary flexibility to address the trade-offs involved. National programs themselves should remain flexible enough to adjust for spatially and temporally changing contexts.	[Dyer, George A.; Matthews, Robin] Craigiebuckler, James Hutton Inst, Aberdeen, Scotland; [Meyfroidt, Patrick] FRS FNRS, Louvain, Belgium; [Meyfroidt, Patrick] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate, Earth & Life Inst, B-1348 Louvain, Belgium	James Hutton Institute; Fonds de la Recherche Scientifique - FNRS; Universite Catholique Louvain	Dyer, GA (corresponding author), Craigiebuckler, James Hutton Inst, Aberdeen, Scotland.	georgie.dyer@gmail.com	Matthews, Robin B/E-7975-2013; Meyfroidt, Patrick/G-7768-2012	Meyfroidt, Patrick/0000-0002-1047-9794	European Union [226310]	European Union(European Commission)	Financial support for this work was provided by the European Union under the REDD-ALERT (Reducing Emissions from Deforestation and Degradation from Alternative Land Uses in Rainforests of the Tropics) project, Grant Agreement number 226310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A., 2009, REALISING REDD NATL; Alix-Garcia J., LAND EC IN PRESS; ANGELSEN A., 2008, MOVING AHEAD REDD IS, P11, DOI [10.17528/cifor/002601, DOI 10.17528/CIFOR/002601]; Appendini K, 2010, GRANDES PROBLEMAS ME; Bell RG, 2011, MORE MEETS EYE SOCIA; Bond I M, 2009, NATURAL RESOURCE ISS, V16; Bulte EH, 2008, ENVIRON DEV ECON, V13, P245, DOI 10.1017/S1355770X08004348; Busch J, 2012, P NATL ACAD SCI USA, V109, P1062, DOI 10.1073/pnas.1109034109; Busch J, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044006; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chomitz KM, 2007, ENVIRON DEV ECON, V10, P293; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; Dyer G, 2005, VALUING CROP BIODIVE; Dyer G, 2008, 1774958V1MET1014 IDB; Dyer GA, 2006, AM J AGR ECON, V88, P279, DOI 10.1111/j.1467-8276.2006.00858.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Groom B, 2010, ENVIRON DEV ECON, V15, P219, DOI 10.1017/S1355770X09990167; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jagger P, 2010, 56 CIFOR; Key N, 2000, AM J AGR ECON, V82, P245, DOI 10.1111/0002-9092.00022; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Matthews R, 2011, CARBON MANAG, V2, P517, DOI 10.4155/CMT.11.52; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Sadoulet E, 2001, WORLD DEV, V29, P1043, DOI 10.1016/S0305-750X(01)00018-3; Seymour F., 2009, REALISING REDD NATL; Singh I., 1986, Agricultural household models. Extensions, applications, and policy, P17; Sloan S, 2012, GLOBAL ENVIRON CHANG, V22, P440, DOI 10.1016/j.gloenvcha.2012.02.001; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Southgate D, 2010, ENVIRON DEV ECON, V15, P21, DOI 10.1017/S1355770X09005361; Springate-Baginski O, 2010, REDD FOREST GOVERNAN; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; Taylor JE, 1999, J POLICY MODEL, V21, P453, DOI 10.1016/S0161-8938(97)00069-0; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Zilberman D, 2008, ENVIRON DEV ECON, V13, P255, DOI 10.1017/S1355770X08004294	40	11	11	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52478	10.1371/journal.pone.0052478	http://dx.doi.org/10.1371/journal.pone.0052478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300681	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800093
J	Haden, V; Niles, MT; Lubell, M; Perlman, J; Jackson, LE				Haden, Van R.; Niles, Meredith T.; Lubell, Mark; Perlman, Joshua; Jackson, Louise E.			Global and Local Concerns: What Attitudes and Beliefs Motivate Farmers to Mitigate and Adapt to Climate Change?	PLOS ONE			English	Article							MEDIATION ANALYSIS; RISK PERCEPTION; POLICY; STRATEGIES; PSYCHOLOGY; EXPERIENCE; RESPONSES; OPTIONS; BARON	In response to agriculture's vulnerability and contribution to climate change, many governments are developing initiatives that promote the adoption of mitigation and adaptation practices among farmers. Since most climate policies affecting agriculture rely on voluntary efforts by individual farmers, success requires a sound understanding of the factors that motivate farmers to change practices. Recent evidence suggests that past experience with the effects of climate change and the psychological distance associated with people's concern for global and local impacts can influence environmental behavior. Here we surveyed farmers in a representative rural county in California's Central Valley to examine how their intention to adopt mitigation and adaptation practices is influenced by previous climate experiences and their global and local concerns about climate change. Perceived changes in water availability had significant effects on farmers' intention to adopt mitigation and adaptation strategies, which were mediated through global and local concerns respectively. This suggests that mitigation is largely motivated by psychologically distant concerns and beliefs about climate change, while adaptation is driven by psychologically proximate concerns for local impacts. This match between attitudes and behaviors according to the psychological distance at which they are cognitively construed indicates that policy and outreach initiatives may benefit by framing climate impacts and behavioral goals concordantly; either in a global context for mitigation or a local context for adaptation.	[Haden, Van R.] Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA; [Niles, Meredith T.; Lubell, Mark; Perlman, Joshua] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haden, V (corresponding author), Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA.	vrhaden@ucdavis.edu; mtniles@ucdavis.edu		Niles, Meredith/0000-0002-8323-1351; Lubell, Mark/0000-0001-5757-7116	California Energy Commission [CEC-500-2012-032]	California Energy Commission	The source of funding for this study was the California Energy Commission (grant # CEC-500-2012-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Antle JM, 2010, APPL ECON PERSPECT P, V32, P386, DOI 10.1093/aepp/ppq015; Bryan E, 2009, ENVIRON SCI POLICY, V12, P413, DOI 10.1016/j.envsci.2008.11.002; California Air Resources Board, 2008, CLIMATE CHANGE SCOPI; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005; Haden VR, 2012, J ENVIRON PLANNING M; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Jackson LE, 2011, CLIMATIC CHANGE, V109, P407, DOI 10.1007/s10584-011-0306-3; Kerr S., 2008, FARM POLICY J, V4, P19; Krosnick JA, 2006, CLIMATIC CHANGE, V77, P7, DOI 10.1007/s10584-006-9068-8; Leary N, 2006, INTERNATIONAL START, P1; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Loewenstein G., 1992, CHOICE TIME; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lubell M, 2007, POLIT BEHAV, V29, P391, DOI 10.1007/s11109-006-9025-2; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Metz ORDB, 2007, CLIMATE CHANGE 2007; Niemeier D, 2009, CALIF AGR, V63, P96, DOI 10.3733/ca.v063n02p96; Niles MT, 2012, POLICY STUD J, V40, P41, DOI 10.1111/j.1541-0072.2012.00445.x; Ostrom E, 2010, ENVIRON CONSERV, V37, P451, DOI 10.1017/S0376892910000834; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rabinovich A, 2009, J ENVIRON PSYCHOL, V29, P391, DOI 10.1016/j.jenvp.2009.09.004; Reganold JP, 2011, SCIENCE, V332, P670, DOI 10.1126/science.1202462; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Sanna LJ, 2010, J EXP SOC PSYCHOL, V46, P1126, DOI 10.1016/j.jesp.2010.05.018; Sanna LJ, 2009, PSYCHOL SCI, V20, P1319, DOI 10.1111/j.1467-9280.2009.02458.x; Smith P, 2007, CLIMATE CHANGE 2007; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Valdivia C, 2010, ANN ASSOC AM GEOGR, V100, P818, DOI 10.1080/00045608.2010.500198; Victor DG, 2005, SCIENCE, V309, P1820, DOI 10.1126/science.1113180; Weber E. U., 1997, PSYCHOL PERSPECTIVES, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	40	145	148	3	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52882	10.1371/journal.pone.0052882	http://dx.doi.org/10.1371/journal.pone.0052882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300805	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800158
J	Kotecki, N; Penel, N; Adenis, A; Ferte, C; Clisant, S				Kotecki, Nuria; Penel, Nicolas; Adenis, Antoine; Ferte, Charles; Clisant, Stephanie			Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials	PLOS ONE			English	Article							RESPONSE EVALUATION; CRITERIA; RECIST; DESIGN	Background: The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging. Purpose: In this study, we intend to analyze the value of the PD based on clinical judgment and the risk of overestimating the occurrence of PD by clinical judgment. Methods: We have conducted a single-centre retrospective study to analyse the diagnostic accuracy of this clinical judgment compared to planned imaging including all patients enrolled in our institution in phase II trials investigating systemic treatments for advanced solid tumours between January 2008 and November 2010. Results: The positive predictive value (PPV) and the specificity of clinical judgment of PD was very high (>90%). Conclusions: According to this study, the clinical judgment of PD is highly predictive of radiological PD as assessed, for example, by RECIST. Physicians do not overestimate PD occurence. Clinical judgment of PD could be taken into account in the definition of PD.	[Kotecki, Nuria; Penel, Nicolas; Adenis, Antoine; Ferte, Charles; Clisant, Stephanie] Ctr Oscar Lambret, F-59020 Lille, France; [Penel, Nicolas] Lille Nord De France Univ, EA 2694, Lille, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Penel, N (corresponding author), Ctr Oscar Lambret, F-59020 Lille, France.	n-penel@o-lambret.fr	adenis, antoine/N-1536-2014	adenis, antoine/0000-0003-0585-5078; PENEL, Nicolas/0000-0001-5243-1548				Cousin S, 2012, CURR OPIN ONCOL, V24, P338, DOI 10.1097/CCO.0b013e3283528b73; Dodd LE, 2008, J CLIN ONCOL, V26, P3791, DOI 10.1200/JCO.2008.16.1711; Dudeck O, 2011, ANN ONCOL, V22, P1828, DOI 10.1093/annonc/mdq696; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Mick R, 2000, CONTROL CLIN TRIALS, V21, P343, DOI 10.1016/S0197-2456(00)00058-1; Penel N, 2011, ANN ONCOL, V22, P1266, DOI 10.1093/annonc/mdq608; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	7	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52638	10.1371/journal.pone.0052638	http://dx.doi.org/10.1371/journal.pone.0052638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300731	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800118
J	Mueller, EE; Brunner, SM; Mayr, JA; Stanger, O; Sperl, W; Kofler, B				Mueller, Edith E.; Brunner, Susanne M.; Mayr, Johannes A.; Stanger, Olaf; Sperl, Wolfgang; Kofler, Barbara			Functional Differences between Mitochondrial Haplogroup T and Haplogroup H in HEK293 Cybrid Cells	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA VARIATION; MACULAR DEGENERATION; POPULATION-GENETICS; MTDNA HAPLOGROUPS; ENERGY-METABOLISM; ALZHEIMER-DISEASE; INCREASED RISK; COMPLEX I; MUTATIONS	Background: Epidemiological case-control studies have revealed associations between mitochondrial haplogroups and the onset and/or progression of various multifactorial diseases. For instance, mitochondrial haplogroup T was previously shown to be associated with vascular diseases, including coronary artery disease and diabetic retinopathy. In contrast, haplogroup H, the most frequent haplogroup in Europe, is often found to be more prevalent in healthy control subjects than in patient study groups. However, justifications for the assumption that haplogroups are functionally distinct are rare. Therefore, we attempted to compare differences in mitochondrial function between haplogroup H and T cybrids. Methodology/Principal Findings: Mitochondrial haplogroup H and T cybrids were generated by fusion of HEK293 cells devoid of mitochondrial DNA with isolated thrombocytes of individuals with the respective haplogroups. These cybrid cells were analyzed for oxidative phosphorylation (OXPHOS) enzyme activities, mitochondrial DNA ( mtDNA) copy number, growth rate and susceptibility to reactive oxygen species (ROS). We observed that haplogroup T cybrids have higher survival rate when challenged with hydrogen peroxide, indicating a higher capability to cope with oxidative stress. Conclusions/Significance: The results of this study show that functional differences exist between HEK293 cybrid cells which differ in mitochondrial genomic background.	[Mueller, Edith E.; Brunner, Susanne M.; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria; [Stanger, Olaf] Paracelsus Med Univ, Dept Cardiac Surg, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University	Kofler, B (corresponding author), Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria.	b.kofler@salk.at		Mayr, Johannes/0000-0001-6970-336X; Kofler, Barbara/0000-0002-1198-4776; Brunner, Susanne Maria/0000-0002-9623-1115	Paracelsus Medical University Salzburg [R-10/05/020-MUE]; Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	Paracelsus Medical University Salzburg; Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	The study was supported by a grant from the Paracelsus Medical University Salzburg (R-10/05/020-MUE)(www.pmu.ac.at) and by the "Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg" (www.mito-center.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; [Anonymous], 2011, MITOMAP HUM MIT GEN; AQUADRO CF, 1983, GENETICS, V103, P287; Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2; Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243; Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Castro MG, 2007, MITOCHONDRION, V7, P354, DOI 10.1016/j.mito.2007.06.002; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; Ebenesersdottir SS, 2011, AM J PHYS ANTHROPOL, V144, P92, DOI 10.1002/ajpa.21419; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HORAI S, 1990, AM J HUM GENET, V46, P828; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Malyarchuk BA, 1999, ANN HUM GENET, V63, P489, DOI 10.1017/S0003480099007794; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Mueller EE, 2012, BIOCHEM BIOPH RES CO, V417, P1052, DOI 10.1016/j.bbrc.2011.12.093; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Stenico M, 1996, AM J HUM GENET, V59, P1363; Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33; STONEKING M, 1991, AM J HUM GENET, V48, P370; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740; Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wojtczak L, 1996, ACTA BIOCHIM POL, V43, P361	60	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52367	10.1371/journal.pone.0052367	http://dx.doi.org/10.1371/journal.pone.0052367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300652	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800073
J	Sartori, M; Reggiani, M; Farina, D; Lloyd, DG				Sartori, Massimo; Reggiani, Monica; Farina, Dario; Lloyd, David G.			EMG-Driven Forward-Dynamic Estimation of Muscle Force and Joint Moment about Multiple Degrees of Freedom in the Human Lower Extremity	PLOS ONE			English	Article							HUMAN KNEE; MUSCULOSKELETAL MODELS; BICEPS-BRACHII; TASKS; GAIT; OPTIMIZATION; SIMULATIONS; ACTIVATION; STRATEGIES; SUPPORT	This work examined if currently available electromyography (EMG) driven models, that are calibrated to satisfy joint moments about one single degree of freedom (DOF), could provide the same musculotendon unit (MTU) force solution, when driven by the same input data, but calibrated about a different DOF. We then developed a novel and comprehensive EMG-driven model of the human lower extremity that used EMG signals from 16 muscle groups to drive 34 MTUs and satisfy the resulting joint moments simultaneously produced about four DOFs during different motor tasks. This also led to the development of a calibration procedure that allowed identifying a set of subject-specific parameters that ensured physiological behavior for the 34 MTUs. Results showed that currently available single-DOF models did not provide the same unique MTU force solution for the same input data. On the other hand, the MTU force solution predicted by our proposed multi-DOF model satisfied joint moments about multiple DOFs without loss of accuracy compared to single-DOF models corresponding to each of the four DOFs. The predicted MTU force solution was (1) a function of experimentally measured EMGs, (2) the result of physiological MTU excitation, (3) reflected different MTU contraction strategies associated to different motor tasks, (4) coordinated a greater number of MTUs with respect to currently available single-DOF models, and (5) was not specific to an individual DOF dynamics. Therefore, our proposed methodology has the potential of producing a more dynamically consistent and generalizable MTU force solution than was possible using single-DOF EMG-driven models. This will help better address the important scientific questions previously approached using single-DOF EMG-driven modeling. Furthermore, it might have applications in the development of human-machine interfaces for assistive devices.	[Sartori, Massimo; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Sartori, Massimo] CNR, Inst Biomed Engn, Padua, Italy; [Reggiani, Monica] Univ Padua, Dept Management & Engn, Vicenza, Italy; [Lloyd, David G.] Griffith Univ, Griffith Hlth Inst, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia	University of Gottingen; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Griffith University; Menzies Health Institute Queensland	Sartori, M (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany.	massimo.srt@gmail.com	Lloyd, David Gavin/AAH-6066-2020; Reggiani, Monica/AAC-4776-2022; Farina, Dario/AAB-2648-2019; sartori, massimo/N-1220-2016	Lloyd, David Gavin/0000-0002-0824-9682; Reggiani, Monica/0000-0002-5029-1892; sartori, massimo/0000-0003-0930-6535	National Institutes of Health in the USA [R01 EB009351-01A2]; National Health and Medical Research Council in Australia [628850, 334151]; Western Australian Medical and Health Research Infrastructure Council; European Research Council Advanced Grant DEMOVE; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009351] Funding Source: NIH RePORTER	National Institutes of Health in the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia); Western Australian Medical and Health Research Infrastructure Council; European Research Council Advanced Grant DEMOVE; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by the National Institutes of Health in the USA [R01 EB009351-01A2]; the National Health and Medical Research Council in Australia [628850 and 334151]; the Western Australian Medical and Health Research Infrastructure Council; and the European Research Council Advanced Grant DEMOVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Barrett RS, 2007, SIMUL MODEL PRACT TH, V15, P1146, DOI 10.1016/j.simpat.2007.07.005; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Besier TF, 2009, J BIOMECH, V42, P898, DOI 10.1016/j.jbiomech.2009.01.032; Blemker SS, 2007, J MAGN RESON IMAGING, V25, P441, DOI 10.1002/jmri.20805; BOBET J, 1990, J BIOMECH, V23, P1275, DOI 10.1016/0021-9290(90)90386-H; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; BUCHANAN TS, 1995, NEUROSCI LETT, V194, P61, DOI 10.1016/0304-3940(95)11727-E; Buchanan TS, 1997, J ORTHOPAED RES, V15, P11, DOI 10.1002/jor.1100150103; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Cheng EJ, 2008, J NEURAL ENG, V5, P232, DOI 10.1088/1741-2560/5/2/014; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Farina D, 2012, REV BIOMEDI IN PRESS; Fleischer C, 2008, IEEE T ROBOT, V24, P872, DOI 10.1109/TRO.2008.926860; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Kahle W, 2002, COLOR ATLAS TXB HUMA, V3; Ko J, 2009, AUTON ROBOT, V27, P75, DOI 10.1007/s10514-009-9119-x; Lanovaz J L, 2001, Equine Vet J Suppl, P27; Lloyd D.G., 2008, HDB BIOMECHANICS HUM, P3; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Lloyd DG, 1996, J BIOMECH ENG-T ASME, V118, P367, DOI 10.1115/1.2796019; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Manal K, 2012, MULTIBODY SYST DYN, V28, P169, DOI 10.1007/s11044-011-9285-4; Martelli S, 2011, J BIOMECH, V44, P1716, DOI 10.1016/j.jbiomech.2011.03.039; Menegaldo LL, 2012, MULTIBODY SYST DYN, V28, P21, DOI 10.1007/s11044-011-9273-8; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; Pfeifer S, 2011, INT C REHAB ROBOT, DOI 10.1109/ICORR.2011.5975474; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Rao G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001383; Sartori M, 2012, CONVERGING CLIN ENG, P427; Sartori M, 2012, IEEE T BIO-MED ENG, V59, P2642, DOI 10.1109/TBME.2012.2208746; Sartori M, 2012, J BIOMECH, V45, P595, DOI 10.1016/j.jbiomech.2011.10.040; Shao Q, 2008, J BIOMECH, V41, P3097, DOI 10.1016/j.jbiomech.2008.07.015; Shao Q, 2011, ANN BIOMED ENG, V39, P110, DOI 10.1007/s10439-010-0131-2; Shao Q, 2009, COMPUT BIOL MED, V39, P1083, DOI 10.1016/j.compbiomed.2009.09.002; TAX AAM, 1990, EXP BRAIN RES, V79, P138, DOI 10.1007/BF00228882; TAX AAM, 1990, EXP BRAIN RES, V81, P567, DOI 10.1007/BF02423505; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Winby CR, 2008, J BIOMECH, V41, P1682, DOI 10.1016/j.jbiomech.2008.03.008; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Winter D.A., 2004, BIOMECHANICS MOTOR C, V4, DOI [10.1002/9780470549148, DOI 10.1002/9780470549148]; Yamaguchi G, 1990, MULTIPLE MUSCLE SYST; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	47	172	179	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52618	10.1371/journal.pone.0052618	http://dx.doi.org/10.1371/journal.pone.0052618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300725	Green Published, gold			2022-12-27	WOS:000313618800115
J	Badin, RA; Spinnewyn, B; Gaillard, MC; Jan, C; Malgorn, C; Van Camp, N; Dolle, F; Guillermier, M; Boulet, S; Bertrand, A; Savasta, M; Auguet, M; Brouillet, E; Chabrier, PE; Hantraye, P				Badin, Romina Aron; Spinnewyn, Brigitte; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Dolle, Frederic; Guillermier, Martine; Boulet, Sabrina; Bertrand, Anne; Savasta, Marc; Auguet, Michel; Brouillet, Emmanuel; Chabrier, Pierre-Etienne; Hantraye, Philippe			IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; MOTOR COMPLICATIONS; DOPAMINERGIC-NEURONS; MESSENGER-RNA; DOUBLE-BLIND; DISEASE; MODEL; AMANTADINE; MONKEYS; MECHANISMS	The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem in the long-term treatment of Parkinson's disease. This study aimed at evaluating the effect of IRC-082451 (base of BN82451), a novel multitargeting hybrid molecule, on L-DOPA-induced dyskinesias (LIDs) and hypolocomotor activity in a non-human primate model of PD. IRC-082451 displays multiple properties: it inhibits neuronal excitotoxicity (sodium channel blocker), oxidative stress (antioxidant) and neuroinflammation (cyclooxygenase inhibitor) and is endowed with mitochondrial protective properties. Animals received daily MPTP injections until stably parkinsonian. A daily treatment with increasing doses of L-DOPA was administered to parkinsonian primates until the appearance of dyskinesias. Then, different treatment regimens and doses of IRC-082451 were tested and compared to the benchmark molecule amantadine. Primates were regularly filmed and videos were analyzed with specialized software. A novel approach combining the analysis of dyskinesias and locomotor activity was used to determine efficacy. This analysis yielded the quantification of the total distance travelled and the incidence of dyskinesias in 7 different body parts. A dose-dependent efficacy of IRC-082451 against dyskinesias was observed. The 5 mg/kg dose was best at attenuating the severity of fully established LIDs. Its effect was significantly different from that of amantadine since it increased spontaneous locomotor activity while reducing LIDs. This dose was effective both acutely and in a 5-day sub-chronic treatment. Moreover, positron emission tomography scans using radiolabelled dopamine demonstrated that there was no direct interference between treatment with IRC-082451 and dopamine metabolism in the brain. Finally, post-mortem analysis indicated that this reduction in dyskinesias was associated with changes in cFOS, FosB and ARC mRNA expression levels in the putamen. The data demonstrates the antidyskinetic efficacy of IRC-082451 in a primate model of PD with motor complications and opens the way to the clinical application of this treatment for the management of LIDs.	[Badin, Romina Aron; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Guillermier, Martine; Brouillet, Emmanuel; Hantraye, Philippe] Commissariat Energie Atom, Mol Imaging Res Ctr, Fontenay Aux Roses, France; [Badin, Romina Aron; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Guillermier, Martine; Brouillet, Emmanuel; Hantraye, Philippe] Commissariat Energie Atom, URA CEA CNRS 2210, Fontenay Aux Roses, France; [Spinnewyn, Brigitte; Auguet, Michel; Chabrier, Pierre-Etienne] IPSEN Innovat, Les Ulis, France; [Dolle, Frederic] Commissariat Energie Atom, Inst Imagerie BioMed, Serv Hosp Frederic Joliot, Orsay, France; [Boulet, Sabrina; Bertrand, Anne; Savasta, Marc] INSERM, Grenoble Inst, Neurosci Team 1, U836, Grenoble, France; [Boulet, Sabrina; Savasta, Marc] Univ Grenoble 1, Grenoble, France; [Savasta, Marc] Ctr Hosp Univ, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Ipsen; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Badin, RA (corresponding author), Commissariat Energie Atom, Mol Imaging Res Ctr, Fontenay Aux Roses, France.	romina.aron-badin@cea.fr	Van Camp, Nadja/H-5141-2017; Brouillet, Emmanuel/B-4784-2014; Savasta, Marc/M-4939-2017; Van Camp, Nadja/AAC-4357-2019; Dollé, Frédéric/R-5756-2017	Van Camp, Nadja/0000-0002-2261-7314; Brouillet, Emmanuel/0000-0001-6322-7403; Van Camp, Nadja/0000-0002-2261-7314; 	MIRCen; IPSEN Innovation	MIRCen; IPSEN Innovation(Ipsen)	The research reported in this manuscript has been funded by MIRCen and IPSEN Innovation (http://www.ipsen.com/fr). The funders had no role in study design, data collection or decision to publish. Their support was requested for data analysis and their advice for preparation and critical evaluation of the manuscript.	Bedard PJ, 1999, MOVEMENT DISORD, V14, P4; Bezard E, 1998, REV NEUROSCIENCE, V9, P71; Bezard E, 1997, NEUROSCI LETT, V234, P47, DOI 10.1016/S0304-3940(97)00663-0; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Blanchet PJ, 1998, MOVEMENT DISORD, V13, P798, DOI 10.1002/mds.870130507; Blanchet PJ, 2004, PARKINSONISM RELAT D, V10, P297, DOI 10.1016/j.parkreldis.2004.02.011; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Calabresi P, 2000, ANN NEUROL, V47, pS60; Castillo PE, 2008, NEURON, V59, P1, DOI 10.1016/j.neuron.2008.06.016; Chabrier PE, 2007, CNS DRUG REV, V13, P317, DOI 10.1111/j.1527-3458.2007.00018.x; Chase Thomas N., 1998, Neurology, V50, pS17; Chase TN, 2000, ANN NEUROL, V47, pS122; Church JS, 2006, BEHAV RES METHODS, V38, P434, DOI 10.3758/BF03192797; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; da Silva-Junior FP, 2005, PARKINSONISM RELAT D, V11, P449, DOI 10.1016/j.parkreldis.2005.05.008; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; HANTRAYE P, 1993, NEUROSCIENCE, V53, P169, DOI 10.1016/0306-4522(93)90295-Q; Hill MP, 2004, J PHARMACOL EXP THER, V310, P386, DOI 10.1124/jpet.104.066191; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Iravani MM, 2003, J NEUROSCI, V23, P9107; Jarraya B, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000130; Kobylecki C, 2001, MOVEMENT DISORD, V26, P2354; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Koprich JB, 2011, MOVEMENT DISORD, V26, P1225, DOI 10.1002/mds.23631; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Rascol O, 2001, CLIN NEUROPHARMACOL, V24, P313, DOI 10.1097/00002826-200111000-00002; Sawada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015298; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; Schneider JS, 1998, MOVEMENT DISORD, V13, P637, DOI 10.1002/mds.870130405; Sgambato-Faure V, 2005, J NEUROPATH EXP NEUR, V64, P936, DOI 10.1097/01.jnen.0000186922.42592.b7; Sgambato-Faure V, 2012, PROG NEUROBIOL, V96, P69, DOI 10.1016/j.pneurobio.2011.10.005; Shin M, 2011, NEUROBIOL AGING, V32, P2100, DOI 10.1016/j.neurobiolaging.2009.11.015; Spinnewyn B, 2011, NEUROPHARMACOLOGY, V60, P692, DOI 10.1016/j.neuropharm.2010.11.019; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tahar AH, 2003, ADV NEUROL, V91, P51; VARASTET M, 1994, NEUROSCIENCE, V63, P47, DOI 10.1016/0306-4522(94)90006-X; Walton A, 2006, NEUROBIOL AGING, V27, P1477, DOI 10.1016/j.neurobiolaging.2005.08.003; Wolf E, 2010, MOVEMENT DISORD, V25, P1357, DOI 10.1002/mds.23034	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52680	10.1371/journal.pone.0052680	http://dx.doi.org/10.1371/journal.pone.0052680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300984	Green Published, gold			2022-12-27	WOS:000313480000012
J	Donega, V; van Velthoven, CTJ; Nijboer, CH; van Bel, F; Kas, MJH; Kavelaars, A; Heijnen, CJ				Donega, Vanessa; van Velthoven, Cindy T. J.; Nijboer, Cora H.; van Bel, Frank; Kas, Martien J. H.; Kavelaars, Annemieke; Heijnen, Cobi J.			Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement	PLOS ONE			English	Article							HYPOXIA-ISCHEMIA; PROGENITOR CELLS; THERAPY; INJURY; ENCEPHALOPATHY; ASPHYXIA; GRAFTS	Mesenchymal stem cell (MSC) administration via the intranasal route could become an effective therapy to treat neonatal hypoxic-ischemic (HI) brain damage. We analyzed long-term effects of intranasal MSC treatment on lesion size, sensorimotor and cognitive behavior, and determined the therapeutic window and dose response relationships. Furthermore, the appearance of MSCs at the lesion site in relation to the therapeutic window was examined. Nine-day-old mice were subjected to unilateral carotid artery occlusion and hypoxia. MSCs were administered intranasally at 3, 10 or 17 days after hypoxia-ischemia (HI). Motor, cognitive and histological outcome was investigated. PKH-26 labeled cells were used to localize MSCs in the brain. We identified 0.5 x 10(6) MSCs as the minimal effective dose with a therapeutic window of at least 10 days but less than 17 days post-HI. A single dose was sufficient for a marked beneficial effect. MSCs reach the lesion site within 24 h when given 3 or 10 days after injury. However, no MSCs were detected in the lesion when administered 17 days following HI. We also show for the first time that intranasal MSC treatment after HI improves cognitive function. Improvement of sensorimotor function and histological outcome was maintained until at least 9 weeks post-HI. The capacity of MSCs to reach the lesion site within 24 h after intranasal administration at 10 days but not at 17 days post-HI indicates a therapeutic window of at least 10 days. Our data strongly indicate that intranasal MSC treatment may become a promising non-invasive therapeutic tool to effectively reduce neonatal encephalopathy.	[Donega, Vanessa; van Velthoven, Cindy T. J.; Nijboer, Cora H.; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [van Bel, Frank] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Kas, Martien J. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	CJHeijnen@mdanderson.org	Donega, Vanessa/M-8058-2014; Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618; van Velthoven, Cindy/0000-0001-5120-4546; Donega, Vanessa/0000-0002-3152-2675	EU-7 Neurobid from the European Union [HEALTH-F2-2009-241778]; Zon-MW Project [116002003]	EU-7 Neurobid from the European Union; Zon-MW Project	This study was supported by EU-7 Neurobid (HEALTH-F2-2009-241778) from the European Union and Zon-MW Project (no 116002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY DM, 1993, LEUKEMIA RES, V17, P873, DOI 10.1016/0145-2126(93)90153-C; Auger CJ, 2006, J NEUROENDOCRINOL, V18, P187, DOI 10.1111/j.1365-2826.2005.01400.x; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64; van Velthoven CTJ, 2010, PEDIATR RES, V68, P419, DOI 10.1203/PDR.0b013e3181f1c289; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2006, CELL TRANSPLANT, V15, P231, DOI 10.3727/000000006783982034	24	125	132	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e51253	10.1371/journal.pone.0051253	http://dx.doi.org/10.1371/journal.pone.0051253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300948	Green Submitted, gold, Green Published			2022-12-27	WOS:000313480000003
J	Lucas, D; Delgado-Garcia, JM; Escudero, B; Albo, C; Aza, A; Acin-Perez, R; Torres, Y; Moreno, P; Enriquez, JA; Samper, E; Blanco, L; Fairen, A; Bernad, A; Gruart, A				Lucas, Daniel; Delgado-Garcia, Jose M.; Escudero, Beatriz; Albo, Carmen; Aza, Ana; Acin-Perez, Rebeca; Torres, Yaima; Moreno, Paz; Antonio Enriquez, Jose; Samper, Enrique; Blanco, Luis; Fairen, Alfonso; Bernad, Antonio; Gruart, Agnes			Increased Learning and Brain Long-Term Potentiation in Aged Mice Lacking DNA Polymerase mu	PLOS ONE			English	Article							RABBIT FOLLOWING STIMULATION; STRAND BREAK REPAIR; SYNAPTIC-TRANSMISSION; POL-MU; HIPPOCAMPAL NEUROGENESIS; LASTING POTENTIATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CA3-CA1 SYNAPSE; TRANSGENIC MICE	A definitive consequence of the aging process is the progressive deterioration of higher cognitive functions. Defects in DNA repair mechanisms mostly result in accelerated aging and reduced brain function. DNA polymerase m is a novel accessory partner for the non-homologous end-joining DNA repair pathway for double-strand breaks, and its deficiency causes reduced DNA repair. Using associative learning and long-term potentiation experiments, we demonstrate that Pol mu(-/-) mice, however, maintain the ability to learn at ages when wild-type mice do not. Expression and biochemical analyses suggest that brain aging is delayed in Pol mu(-/-) mice, being associated with a reduced error-prone DNA oxidative repair activity and a more efficient mitochondrial function. This is the first example in which the genetic ablation of a DNA-repair function results in a substantially better maintenance of learning abilities, together with fewer signs of brain aging, in old mice.	[Lucas, Daniel] Ctr Nacl Biotecnol CSIC, Dept Immunol & Oncol, Madrid, Spain; [Delgado-Garcia, Jose M.; Gruart, Agnes] Univ Pablo Olavide, Div Neurociencias, Seville, Spain; [Escudero, Beatriz; Albo, Carmen; Acin-Perez, Rebeca; Torres, Yaima; Moreno, Paz; Antonio Enriquez, Jose; Samper, Enrique; Bernad, Antonio] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid, Spain; [Escudero, Beatriz; Albo, Carmen; Acin-Perez, Rebeca; Torres, Yaima; Antonio Enriquez, Jose; Samper, Enrique; Bernad, Antonio] Ctr Nacl Invest Cardiovasc, Dev & Cardiac Repair Dept, Madrid, Spain; [Aza, Ana; Blanco, Luis] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Fairen, Alfonso] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alacant, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Pablo de Olavide; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Bernad, A (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid, Spain.	abernad@cnic.es; agrumas@upo.es	Acin-Perez, Rebeca/AAU-4913-2020; Blanco, Luis/I-1848-2015; Lucas, Daniel/ABB-6893-2021; Moreno-Murciano, Paz/D-7871-2018; Bernad, Antonio/P-8573-2017; Delgado-Garcia, Jose M./V-1567-2019; Acin-Perez, Rebeca/H-6160-2015; Enríquez, J.A./M-8468-2016	Acin-Perez, Rebeca/0000-0001-9553-8337; Lucas, Daniel/0000-0002-0147-5425; Acin-Perez, Rebeca/0000-0001-9553-8337; Enríquez, J.A./0000-0002-3671-2961; Bernad, Antonio/0000-0003-0620-9668	Spanish Ministry of Education and Reserach [BFU2008-03390/BMC/MICINN, BFU2008-00899/MICINN, BFU2007-60263/MICINN, PAC08-0261-1581/JCCM, SAF 2008-02099/MICINN, PLE2009-0147]	Spanish Ministry of Education and Reserach(German Research Foundation (DFG))	This work was supported by grants BFU2008-03390/BMC/MICINN (A.G.), BFU2008-00899/MICINN (J.M.D.-G.), BFU2007-60263/MICINN and PAC08-0261-1581/JCCM (A.F.), and SAF 2008-02099/MICINN and PLE2009-0147 (A.B.) from the Spanish Ministry of Education and Reserach. D.L. was a fellow of the Spanish Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Davis BJ, 2008, NUCLEIC ACIDS RES, V36, P3085, DOI 10.1093/nar/gkn164; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Epel E, 2004, ANN NY ACAD SCI, V1032, P208, DOI 10.1196/annals.1314.022; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gozalbo-Lopez B, 2009, MOL CELL BIOL, V29, P1266, DOI 10.1128/MCB.01518-08; Griffiths LM, 2009, MOL CELL BIOL, V29, P794, DOI 10.1128/MCB.01357-08; Gruart A, 2008, NEUROBIOL DIS, V30, P439, DOI 10.1016/j.nbd.2008.03.001; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kim HJ, 2011, EXP DERMATOL, V20, P920, DOI 10.1111/j.1600-0625.2011.01354.x; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389; LUND RD, 1966, SCIENCE, V151, P1397, DOI 10.1126/science.151.3716.1397; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moon FA, 2007, DNA REPAIR AMST, V6, P1709; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Rockwood LD, 2003, MUTAT RES-FUND MOL M, V529, P51, DOI 10.1016/S0027-5107(03)00108-8; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takatsuki K, 2003, J NEUROSCI, V23, P17; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Uchiyama Y, 2009, BIOCHIMIE, V91, P165, DOI 10.1016/j.biochi.2008.07.005; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Yoo EG, 2011, ENDOCRINOLOGY, V152, P3135, DOI 10.1210/en.2010-1122; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	66	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53243	10.1371/journal.pone.0053243	http://dx.doi.org/10.1371/journal.pone.0053243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301049	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000042
J	Choi, Y; Kim, HS; Cho, KW; Lee, KM; Yi, YJ; Eun, SJ; Kim, HJ; Woo, J; Choi, SH; Whangbo, TK; Choi, C; Noh, DY; Moon, WK				Choi, YoonSeok; Kim, Hoe Suk; Cho, Kyoung-Won; Lee, Kyung-Min; Yi, Yoon Jung; Eun, Sung-Jong; Kim, Hyun Jin; Woo, Jisu; Choi, Seung Hong; Whangbo, Taeg-Keun; Choi, ChulSoo; Noh, Dong-Young; Moon, Woo Kyung			Noninvasive Identification of Viable Cell Populations in Docetaxel-Treated Breast Tumors Using Ferritin-Based Magnetic Resonance Imaging	PLOS ONE			English	Article							CANCER STEM-CELLS; IRON-OXIDE NANOPARTICLES; MRI REPORTER; CHEMOTHERAPY; TRACKING; QUANTIFICATION; RESISTANCE; RECEPTOR	Background: Cancer stem cells (CSCs) are highly tumorigenic and are responsible for tumor progression and chemoresistance. Noninvasive imaging methods for the visualization of CSC populations within tumors in vivo will have a considerable impact on the development of new CSC-targeting therapeutics. Methodology/Principal Findings: In this study, human breast cancer stem cells (BCSCs) transduced with dual reporter genes (human ferritin heavy chain [FTH] and enhanced green fluorescence protein [EGFP]) were transplanted into NOD/SCID mice to allow noninvasive tracking of BCSC-derived populations. No changes in the properties of the BCSCs were observed due to ferritin overexpression. Magnetic resonance imaging (MRI) revealed significantly different signal intensities (R-2* values) between BCSCs and FTH-BCSCs in vitro and in vivo. In addition, distinct populations of pixels with high R-2* values were detected in docetaxel-treated FTH-BCSC tumors compared with control tumors, even before the tumor sizes changed. Histological analysis revealed that areas showing high R-2* values in docetaxel-treated FTH-BCSC tumors by MRI contained EGFP+/FTH+ viable cell populations with high percentages of CD44+/CD24- cells. Conclusions/Significance: These findings suggest that ferritin-based MRI, which provides high spatial resolution and tissue contrast, can be used as a reliable method to identify viable cell populations derived from BCSCs after chemotherapy and may serve as a new tool to monitor the efficacy of CSC-targeting therapies in vivo.	[Choi, YoonSeok; Kim, Hoe Suk; Cho, Kyoung-Won; Yi, Yoon Jung; Kim, Hyun Jin; Woo, Jisu; Choi, Seung Hong; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Choi, YoonSeok; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Hoe Suk; Woo, Jisu] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Lee, Kyung-Min; Noh, Dong-Young] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Choi, ChulSoo] Gachon Univ Med Sci, Inst LeeGilYeo Canc & Diabet Ctr, Inchon, South Korea; [Eun, Sung-Jong; Whangbo, Taeg-Keun] Gachon Univ, Dept Comp Sci, Songnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Gachon University; Gachon University	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.	moonwk@snu.ac.kr	Noh, Dong-Young/G-5531-2011; Moon, Woo Kyung/J-2755-2012	Choi, Seung Hong/0000-0002-0412-2270	National Research Foundation of Korea (NRF); Korea government (MEST) [2012-01010846]; Second Stage of Brain Korea 21 program	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Second Stage of Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NO. 2012-01010846) and the Second Stage of Brain Korea 21 program in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406; Bair S, 2009, BLOOD, V113, P1841, DOI 10.1182/blood-2008-09-178517; Choi SH, 2012, NMR BIOMED, V25, P737, DOI 10.1002/nbm.1788; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elliott R.L., 2012, J CANC THER, V03, P278; Flegel T, 2012, J VET INTERN MED; Foster P, 2011, STEM CELLS BIOL REG, P297, DOI 10.1007/978-1-61779-246-5_17; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Gilad AA, 2008, J NUCL MED, V49, P1905, DOI 10.2967/jnumed.108.053520; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Kim HS, 2010, CANCER RES, V70, P7315, DOI 10.1158/0008-5472.CAN-10-0241; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim EK, 2011, BIOMATERIALS, V32, P7941, DOI 10.1016/j.biomaterials.2011.06.077; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; McLaughlin R, 2011, NMR BIOMED, V24, P712, DOI 10.1002/nbm.1739; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Naumova AV, 2010, MOL IMAGING, V9, P201, DOI 10.2310/7290.2010.00020; Penet MF, 2010, FUTURE MED CHEM, V2, P975, DOI 10.4155/FMC.10.25; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Shigdar S, 2012, THER DELIV, V3, P227, DOI 10.4155/TDE.11.148; Snyder EL, 2009, LAB INVEST, V89, P857, DOI 10.1038/labinvest.2009.54; Townson JL, 2009, CANCER RES, V69, P8326, DOI 10.1158/0008-5472.CAN-09-1496; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Xia T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/420364; Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	41	11	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52931	10.1371/journal.pone.0052931	http://dx.doi.org/10.1371/journal.pone.0052931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301003	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900046
J	Ma, ZL; Li, R; Yu, J; He, Y; Li, J				Ma, Zhenling; Li, Rui; Yu, Jing; He, Yong; Li, Juan			Alterations in Regional Homogeneity of Spontaneous Brain Activity in Late-Life Subthreshold Depression	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; VOXEL-BASED MORPHOMETRY; MAJOR DEPRESSION; BIPOLAR DISORDER; PARKINSONS-DISEASE; FRONTAL-LOBE; ABNORMALITIES; FMRI; CORTEX; ASYMMETRY	The early detection of major depression in elderly individuals who are at risk of developing the disease is of prime importance when it comes to the prevention of geriatric depression. We used resting-state functional magnetic resonance imaging (fMRI) to examine changes in regional homogeneity (ReHo) of spontaneous activity in late-life subthreshold depression (StD), and we evaluated the sensitivity/specificity performance of these changes. Nineteen elderly individuals with StD and 18 elderly controls underwent a resting-state fMRI scan. The ReHo approach was employed to examine whether StD was related to alterations in resting-state neural activity, in the form of abnormal regional synchronization. Receiver operating characteristic curve analysis and the Fisher stepwise discriminant analysis were used to evaluate the sensitivity/specificity characteristics of the ReHo index in discriminating between the StD subjects and normal controls. The results demonstrated that, compared to controls, StD subjects display lower ReHo in the right orbitofrontal cortex (OFC), left dorsolateral prefrontal cortex (DLPFC), left postcentral gyrus (PCG), and left middle frontal and inferior temporal gyri, as well as higher ReHo in the bilateral insula and right DLPFC. The left PCG and the right DLPFC, OFC, and posterior insula, together reported a predictive accuracy of 91.9%. These results suggest that the regional activity coherence was changed in the resting brain of StD subjects, and that these alterations may serve as potential markers for the early detection of StD in late-life depression.	[Ma, Zhenling; Li, Rui; Yu, Jing; Li, Juan] Chinese Acad Sci, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing, Peoples R China; [Ma, Zhenling] Peking Union Med Coll, Sch Nursing, Beijing 100021, Peoples R China; [Li, Rui; Li, Juan] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Li, Rui; Li, Juan] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing 100875, Peoples R China; [Yu, Jing] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; School of Nursing - PUMC; Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University; Southwest University - China; Beijing Normal University	Li, J (corresponding author), Chinese Acad Sci, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.	lijuan@psych.ac.cn	He, Yong/Q-5756-2018; Yu, Jing/AAN-1565-2020; He, Yong/C-2161-2009	He, Yong/0000-0002-7039-2850; li, rui/0000-0002-4101-5415	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation; National Natural Science Foundation of China [30770725, 30911120494, 31070916]; National Science & Technology Pillar Program of China [2009BAI77B03]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research Team [Y2CX131003]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX251005]; Shang Shan Funding	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Team(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Shang Shan Funding	This work was supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China Postdoctoral Science Foundation, the National Natural Science Foundation of China (30770725, 30911120494 and 31070916), the National Science & Technology Pillar Program of China (2009BAI77B03), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), the CAS/SAFEA International Partnership Program for Creative Research Team (Y2CX131003), Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Y1CX251005), and Shang Shan Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2009, AM J GERIAT PSYCHIAT, V17, P30, DOI 10.1097/JGP.0b013e31817b60af; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Cuijpers P, 2006, INT J GERIATR PSYCH, V21, P811, DOI 10.1002/gps.1565; Damoiseaux JS, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt106; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; Frodl T, 2009, WORLD J BIOL PSYCHIA, V10, P202, DOI 10.1080/15622970701624603; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kenny ER, 2010, AM J GERIAT PSYCHIAT, V18, P643, DOI 10.1097/JGP.0b013e3181cabd0e; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Maeda F, 2000, BRIT J PSYCHIAT, V177, P169, DOI 10.1192/bjp.177.2.169; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; Morys Joanna M, 2003, Folia Morphol (Warsz), V62, P347; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nitschke JB, 2005, INT REV NEUROBIOL, V67, P73, DOI 10.1016/S0074-7742(05)67003-1; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Taylor WD, 2007, PSYCHOL MED, V37, P1763, DOI 10.1017/S0033291707000128; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Ueda K, 2003, NEUROREPORT, V14, P51, DOI 10.1097/00001756-200301200-00010; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Walther S, 2012, J AFFECT DISORDERS, V136, P124, DOI 10.1016/j.jad.2011.08.020; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wu MJ, 2011, PSYCHIAT RES-NEUROIM, V194, P39, DOI 10.1016/j.pscychresns.2011.04.003; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	55	36	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53148	10.1371/journal.pone.0053148	http://dx.doi.org/10.1371/journal.pone.0053148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301035	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900065
J	Ayyagari, P; Ullrich, F; Malmstrom, TK; Andresen, EM; Schootman, M; Miller, JP; Miller, DK; Wolinsky, FD				Ayyagari, Padmaja; Ullrich, Fred; Malmstrom, Theodore K.; Andresen, Elena M.; Schootman, Mario; Miller, J. Philip; Miller, Douglas K.; Wolinsky, Fredric D.			Self-Rated Health Trajectories in the African American Health Cohort	PLOS ONE			English	Article							OLDER-ADULTS; SUBJECTIVE HEALTH; FUNCTIONAL STATUS; SAS PROCEDURE; INNER-CITY; MORTALITY; AGE; COMMUNITY; PATTERNS; TIME	Background: Self-rated health taps health holistically and dynamically blends prior health histories with current illness burdens and expectations for future health. While consistently found as an independent predictor of functional decline, sentinel health events, physician visits, hospital episodes, and mortality, much less is known about intra-individual changes in self-rated health across the life course, especially for African Americans. Materials/Methods: Data on 998 African American men and women aged 50-64 years old were taken from a probability-based community sample that was first assessed in 2000-2001 and re-assessed 1, 2, 3, 4, 7, and 9 years later. Using an innovative approach for including decedents in the analysis, semi-parametric group-based mixture models were used to identify person-centered group trajectories of self-rated health over time. Multivariable multinomial logistic regression analysis was then used to differentiate the characteristics of AAH participants classified into the different group trajectories. Results: Four self-rated health group trajectories were identified: persistently good health, good but declining health, persistently fair health, and fair but declining health. The main characteristics that differentiated the self-rated health trajectory groups from each other were age, education, smoking, morbidity (angina, congestive heart failure, diabetes, and kidney disease), having been hospitalized in the year prior to baseline, depressive symptoms, mobility limitations, and initial self-rated health. Conclusions: This is the first study to examine self-rated health trajectories separately among African Americans. Four qualitatively distinct self-rated health group trajectories were identified that call into question the accuracy of prior reports that a single, average self-rated health trajectory for African Americans adequately captures their within-group heterogeneity.	[Ayyagari, Padmaja; Ullrich, Fred; Wolinsky, Fredric D.] Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA 52246 USA; [Malmstrom, Theodore K.] St Louis Univ, Dept Neurol & Psychiat, St Louis, MO 63103 USA; [Andresen, Elena M.] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Portland, OR 97201 USA; [Schootman, Mario] Washington Univ, Dept Internal Med, St Louis, MO USA; [Miller, J. Philip] Washington Univ, Dept Biostat, St Louis, MO USA; [Miller, Douglas K.] Indiana Univ, Dept Internal Med, Bloomington, IN USA; [Miller, Douglas K.] Regenstrief Inst Inc, Indianapolis, IN USA; [Wolinsky, Fredric D.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wolinsky, Fredric D.] Univ Iowa, Dept Adult Nursing, Iowa City, IA USA	University of Iowa; Saint Louis University; Oregon Health & Science University; Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Iowa; University of Iowa	Wolinsky, FD (corresponding author), Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA 52246 USA.	fredric-wolinsky@uiowa.edu	Wolinsky, Fredric D/F-9231-2011; Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824; Wolinsky, Fredric/0000-0002-0916-4955; Ullrich, Fred/0000-0003-0726-1708; Miller, J Philip/0000-0003-4568-6846	United States National Institutes of Health (NIH) [R01 AG010436]; NATIONAL INSTITUTE ON AGING [R01AG010436, P30AG028740] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported here was supported by a United States National Institutes of Health (NIH) grant (R01 AG010436) to Dr. Douglas Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2009, PSYCHOSOM MED, V71, P345, DOI 10.1097/PSY.0b013e31819ccd10; Blazer DG, 2008, GERONTOLOGIST, V48, P415, DOI 10.1093/geront/48.4.415; Centers for Disease Control and Prevention, 2006, BEH RISK FACT SURV S; Daponte-Codina A, 2008, SCAND J PUBLIC HEALT, V36, P504, DOI 10.1177/1403494807088454; Diehr P, 2003, ANN INTERN MED, V139, P416, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00007; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FERRARO KF, 1980, J HEALTH SOC BEHAV, V21, P377, DOI 10.2307/2136414; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foraker RE, 2011, AGE AGEING, V40, P706, DOI 10.1093/ageing/afr069; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Han B, 2005, GERONTOLOGIST, V45, P216, DOI 10.1093/geront/45.2.216; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hoeymans N, 1997, AM J PUBLIC HEALTH, V87, P1620, DOI 10.2105/AJPH.87.10.1620; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hubbard RA, 2009, J AM STAT ASSOC, V104, P487; IDLER EL, 1993, J GERONTOL, V48, pS289, DOI 10.1093/geronj/48.6.S289; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kennedy BS, 2001, AM J EPIDEMIOL, V153, P232, DOI 10.1093/aje/153.3.232; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Krause N, 1998, GERONTOLOGIST, V38, P653, DOI 10.1093/geront/38.6.653; Lee HL, 2012, ARCH GERONTOL GERIAT, V54, pE334, DOI 10.1016/j.archger.2011.10.009; Liang J, 2005, J GERONTOL B-PSYCHOL, V60, pS224, DOI 10.1093/geronb/60.4.S224; Liang J, 2007, J GERONTOL B-PSYCHOL, V62, pS340, DOI 10.1093/geronb/62.5.S340; Liang J, 2010, J AGING HEALTH, V22, P3, DOI 10.1177/0898264309348877; MADDOX GL, 1973, J HEALTH SOC BEHAV, V14, P87, DOI 10.2307/2136940; Maddox GL, 1999, RES AGING, V21, P501, DOI 10.1177/0164027599213008; Malmstrom TK, 2007, J AM GERIATR SOC, V55, P1049, DOI 10.1111/j.1532-5415.2007.01204.x; McCullough M. E., 2005, PERSONALITY SOCIAL P, V31, P1; McCullough ME, 2004, HEALTH PSYCHOL, V23, P651, DOI 10.1037/0278-6133.23.6.651; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Miller DK, 2005, J GERONTOL A-BIOL, V60, P207, DOI 10.1093/gerona/60.2.207; Miller TR, 2007, J GERONTOL B-PSYCHOL, V62, pS22, DOI 10.1093/geronb/62.1.S22; Molloy DW, 1996, J AM GERIATR SOC, V44, P660, DOI 10.1111/j.1532-5415.1996.tb01828.x; Pinquart M, 2001, PSYCHOL AGING, V16, P414, DOI 10.1037//0882-7974.16.3.414; Sacker A, 2007, AM J PUBLIC HEALTH, V97, P812, DOI 10.2105/AJPH.2006.092320; Sacker A, 2011, J EPIDEMIOL COMMUN H, V65, P130, DOI 10.1136/jech.2009.091199; Sargent-Cox KA, 2010, HEALTH PSYCHOL, V29, P143, DOI 10.1037/a0017652; Stewart AL, 1992, MEASURING FUNCTIONIN; SULS J, 1991, J APPL SOC PSYCHOL, V21, P1125, DOI 10.1111/j.1559-1816.1991.tb00462.x; Wight RG, 2008, SOC SCI MED, V66, P862, DOI 10.1016/j.socscimed.2007.11.002; Wolinsky FD, 1998, J GERONTOL B-PSYCHOL, V53, pS336, DOI 10.1093/geronb/53B.6.S336; Wolinsky FD, 2008, J AGING HEALTH, V20, P143, DOI 10.1177/0898264307310449; Yao L, 2008, RES AGING, V30, P251, DOI 10.1177/0164027507311155	50	29	29	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53278	10.1371/journal.pone.0053278	http://dx.doi.org/10.1371/journal.pone.0053278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300906	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600079
J	Hummel, E; Guttmann, P; Werner, S; Tarek, B; Schneider, G; Kunz, M; Frangakis, AS; Westermann, B				Hummel, Eric; Guttmann, Peter; Werner, Stephan; Tarek, Basel; Schneider, Gerd; Kunz, Michael; Frangakis, Achilleas S.; Westermann, Benedikt			3D Ultrastructural Organization of Whole Chlamydomonas reinhardtii Cells Studied by Nanoscale Soft X-Ray Tomography	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; ELECTRON TOMOGRAPHY; MICROSCOPE; RECONSTRUCTION; PURIFICATION; PROJECTIONS; VOLVOCALES	The complex architecture of their structural elements and compartments is a hallmark of eukaryotic cells. The creation of high resolution models of whole cells has been limited by the relatively low resolution of conventional light microscopes and the requirement for ultrathin sections in transmission electron microscopy. We used soft x-ray tomography to study the 3D ultrastructural organization of whole cells of the unicellular green alga Chlamydomonas reinhardtii at unprecedented spatial resolution. Intact frozen hydrated cells were imaged using the natural x-ray absorption contrast of the sample without any staining. We applied different fiducial-based and fiducial-less alignment procedures for the 3D reconstructions. The reconstructed 3D volumes of the cells show features down to 30 nm in size. The whole cell tomograms reveal ultrastructural details such as nuclear envelope membranes, thylakoids, basal apparatus, and flagellar microtubule doublets. In addition, the x-ray tomograms provide quantitative data from the cell architecture. Therefore, nanoscale soft x-ray tomography is a new valuable tool for numerous qualitative and quantitative applications in plant cell biology.	[Hummel, Eric; Westermann, Benedikt] Univ Bayreuth, Inst Zellbiol, Bayreuth, Germany; [Guttmann, Peter; Werner, Stephan; Tarek, Basel; Schneider, Gerd] Helmholtz Zent Mat & Energie GmbH, Inst Soft Matter & Funct Mat, Berlin, Germany; [Kunz, Michael; Frangakis, Achilleas S.] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Kunz, Michael; Frangakis, Achilleas S.] Goethe Univ Frankfurt, Inst Biophys, D-60054 Frankfurt, Germany	University of Bayreuth; Goethe University Frankfurt; Goethe University Frankfurt	Hummel, E (corresponding author), Univ Bayreuth, Inst Zellbiol, Bayreuth, Germany.	eric.hummel@uni-bayreuth.de	Westermann, Benedikt/H-7766-2013; Guttmann, Peter/H-9869-2015	Westermann, Benedikt/0000-0002-2991-1604; Guttmann, Peter/0000-0002-0534-238X; Frangakis, Achilleas/0000-0002-8067-6611; Schneider, Gerd/0000-0001-9448-0524	German Research Foundation (DFG); University of Bayreuth	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	The authors thank the Helmholtz center for beam time allocation. This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional founding was required to publish this study.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bui KH, 2011, J SYNCHROTRON RADIAT, V18, P2, DOI 10.1107/S0909049510036812; Cardone G, 2005, J STRUCT BIOL, V151, P117, DOI 10.1016/j.jsb.2005.04.006; Carrascosa JL, 2009, J STRUCT BIOL, V168, P234, DOI 10.1016/j.jsb.2009.07.009; Castano-Diez D, 2010, J STRUCT BIOL, V170, P117, DOI 10.1016/j.jsb.2010.01.014; Colon-Ramos DA, 2003, DEV CELL, V4, P941, DOI 10.1016/S1534-5807(03)00163-1; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; DAVIES DR, 1972, MOL GEN GENET, V115, P334; ETTL H, 1976, PROTOPLASMA, V88, P75, DOI 10.1007/BF01280361; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Geimer S, 1997, CELL MOTIL CYTOSKEL, V37, P72; GILBERT PFC, 1972, PROC R SOC SER B-BIO, V182, P89, DOI 10.1098/rspb.1972.0068; GORMAN DS, 1966, PLANT PHYSIOL, V41, P1643, DOI 10.1104/pp.41.10.1643; Guttmann P, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012064; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Harris EH, 2009, CHLAMYDOMONAS SOURCE, V1; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hummel E, 2007, PLANT BIOLOGY, V9, P489, DOI 10.1055/s-2006-924759; Hummel E, 2010, J EXP BOT, V61, P2603, DOI 10.1093/jxb/erq091; Hurbain I, 2011, BIOL CELL, V103, P405, DOI 10.1042/BC20110015; Chichon FJ, 2012, J STRUCT BIOL, V177, P202, DOI 10.1016/j.jsb.2011.12.001; KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Morita E, 1998, PLANTA, V204, P269, DOI 10.1007/s004250050256; Muller WG, 2012, J STRUCT BIOL, V177, P179, DOI 10.1016/j.jsb.2011.11.025; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; OSAFUNE T, 1975, J ELECTRON MICROSC, V24, P247; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rehbein S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110801; Rehbein S, 2012, OPT EXPRESS, V20, P5830, DOI 10.1364/OE.20.005830; SAGER R, 1954, EXP CELL RES, V7, P584, DOI 10.1016/S0014-4827(54)80107-8; SAGER R, 1955, GENETICS, V40, P476; Schmahl G, 1996, NATURWISSENSCHAFTEN, V83, P61, DOI 10.1007/BF01141872; Schneider G, 2003, ANAL BIOANAL CHEM, V376, P558, DOI 10.1007/s00216-003-2007-x; Schneider G, 2012, J STRUCT BIOL, V177, P212, DOI 10.1016/j.jsb.2011.12.023; Schneider G, 2010, NAT METHODS, V7, P985, DOI 10.1038/NMETH.1533; Uchida M, 2010, YEAST; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Weiss D, 2000, ULTRAMICROSCOPY, V84, P185, DOI 10.1016/S0304-3991(00)00034-6; Zeng XH, 2008, APPL OPTICS, V47, P2376, DOI 10.1364/AO.47.002376	49	23	23	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53293	10.1371/journal.pone.0053293	http://dx.doi.org/10.1371/journal.pone.0053293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300909	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600081
J	Issa, F; Hester, J; Milward, K; Wood, KJ				Issa, Fadi; Hester, Joanna; Milward, Kate; Wood, Kathryn J.			Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model	PLOS ONE			English	Article							IMMUNE-RESPONSE; INTERLEUKIN 22; REJECTION; TREG; IDENTIFICATION; ALLOGRAFTS; EFFECTOR; MAJORITY; EXPRESS	Regulatory T cell (Treg) therapy for immune modulation is a promising therapeutic strategy for the treatment and prevention of autoimmune disease and graft-versus-host disease (GvHD) after bone marrow transplantation. However, Treg are heterogeneous and express a variety of chemokine receptor molecules. The optimal subpopulation of Treg for therapeutic use may vary according to the pathological target. Indeed, clinical trials of Treg for the prevention of GvHD where the skin is a major target of the anti-host response have employed Treg derived from a variety of different sources. We postulated that for the effective treatment of GvHD-related skin pathology, Treg must be able to migrate to skin in order to regulate local alloimmune responses efficiently. To test the hypothesis that different populations of Treg display distinct efficacy in vivo based on their expression of tissue-specific homing molecules, we evaluated the activity of human Treg derived from two disparate sources in a model of human skin transplantation. Treg were derived from adult blood or cord blood and expanded in vitro. While Treg from both sources displayed similar in vitro suppressive efficacy, they exhibited marked differences in the expression of skin homing molecules. Importantly, only adult-derived Treg were able to prevent alloimmune-mediated human skin destruction in vivo, by virtue of their improved migration to skin. The presence of Treg within the skin was sufficient to prevent its alloimmune-mediated destruction. Additionally, Treg expressing the skin homing cutaneous lymphocyte antigen (CLA) were more efficient at preventing skin destruction than their CLA-deficient counterparts. Our findings highlight the importance of the careful selection of an effective subpopulation of Treg for clinical use according to the pathology of interest.	[Issa, Fadi; Hester, Joanna; Milward, Kate; Wood, Kathryn J.] Univ Oxford, Transplantat Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX1 2JD, England	University of Oxford	Wood, KJ (corresponding author), Univ Oxford, Transplantat Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX1 2JD, England.	kathryn.wood@nds.ox.ac.uk	Issa, Fadi/HDM-8760-2022	Issa, Fadi/0000-0002-8279-7732; Milward, Kate/0000-0003-3019-4443; Hester, Joanna/0000-0002-7466-3849	Wellcome Trust; European Union; Medical Research Council UK; Royal College of Surgeons of England; Oxfordshire Health Services Research Committee Charitable Trust; MRC [G0800842] Funding Source: UKRI; Medical Research Council [G0800842] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Surgeons of England; Oxfordshire Health Services Research Committee Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from The Wellcome Trust, the European Union Integrated Projects, Reprogramming the Immune System for Establishment of Tolerance (RISET) and the One Study, Medical Research Council UK, the Royal College of Surgeons of England and the Oxfordshire Health Services Research Committee Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Duhen T, 2012, BLOOD; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; McMurchy AN, 2011, SEMIN IMMUNOL; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048; Oliveira V, 2008, EUR J IMMUNOL, V38, P1677, DOI 10.1002/eji.200737562; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Wood KJ, 2011, IMMUNOL REV, V241, P119, DOI 10.1111/j.1600-065X.2011.01013.x	26	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53331	10.1371/journal.pone.0053331	http://dx.doi.org/10.1371/journal.pone.0053331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300911	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000313872600083
J	Ridley, AW; Magabe, S; Schlipalius, DI; Rafter, MA; Collins, PJ				Ridley, Andrew W.; Magabe, Seymour; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.			Sublethal Exposure to Phosphine Decreases Offspring Production in Strongly Phosphine Resistant Female Red Flour Beetles, Tribolium castaneum (Herbst)	PLOS ONE			English	Article							RHYZOPERTHA-DOMINICA F; DROSOPHILA-MELANOGASTER; STARVATION RESISTANCE; IMMATURE STAGES; COLEOPTERA; GRAIN; TENEBRIONIDAE; REPRODUCTION; RESPIRATION; EVOLUTION	The red flour beetle is a cosmopolitan pest of stored grain and stored grain products. The pest has developed resistance to phosphine, the primary chemical used for its control. The reproductive output of survivors from a phosphine treatment is an important element of resistance development but experimental data are lacking. We exposed mated resistant female beetles to 0.135 mg/L of phosphine for 48 h at 25 degrees C. Following one week of recovery we provided two non-exposed males to half of the phosphine exposed females and to half of the non-exposed control females. Females that had been exposed produced significantly fewer offspring than non-exposed females. Females that remained isolated produced significantly fewer offspring than both exposed females with access to males and non-exposed controls (P < 0.05). Some females were permanently damaged from exposure to phosphine and did not reproduce even when given access to males. We also examined the additional effects of starvation prior to phosphine exposure on offspring production. Non-exposed starved females experienced a small reduction in mean offspring production in the week following starvation, followed by a recovery in the second week. Females that were starved and exposed to phosphine demonstrated a very significant reduction in offspring production in the first week following exposure which remained significantly lower than that of starved non-exposed females (P < 0.05). These results demonstrate a clear sublethal effect of phosphine acting on the female reproductive system and in some individuals this can lead to permanent reproductive damage. Pest population rebound after a fumigation may be slower than expected which may reduce the rate of phosphine resistance development. The results presented strongly suggest that phosphine resistance models should include sublethal effects.	[Ridley, Andrew W.; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.] Agrisci Queensland, Dept Agr Fisheries & Forestry, EcoSci Precinct, Brisbane, Qld, Australia; [Ridley, Andrew W.; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Magabe, Seymour] Perum BULOG, Jakarta, Indonesia; [Magabe, Seymour] La Trobe Univ, Dept Agr Sci, Bundoora, Vic, Australia	Queensland Department of Agriculture & Fisheries; La Trobe University	Ridley, AW (corresponding author), Agrisci Queensland, Dept Agr Fisheries & Forestry, EcoSci Precinct, Brisbane, Qld, Australia.	andrew.ridley@daff.qld.gov.au	Rafter, Michelle/AAD-6045-2019; Rafter, Michelle/GRE-8544-2022; Rafter, Michelle A/D-9790-2011; Schlipalius, David/B-8155-2011	Rafter, Michelle/0000-0002-5180-0062; Rafter, Michelle A/0000-0002-5180-0062; Schlipalius, David/0000-0002-8102-7031	Australian Government's Cooperative Research Centres Program	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	AR, DS, MR and PC would like to acknowledge the support the Australian Government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur FH, 2006, J STORED PROD RES, V42, P226, DOI 10.1016/j.jspr.2005.02.003; Baldal EA, 2006, EVOLUTION, V60, P1435, DOI 10.1111/j.0014-3820.2006.tb01222.x; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bloch MC, 1996, ANN ENTOMOL SOC AM, V89, P892, DOI 10.1093/aesa/89.6.892; BOND EJ, 1969, J STORED PROD RES, V5, P289, DOI 10.1016/0022-474X(69)90002-2; BOND EJ, 1973, J STORED PROD RES, V8, P307, DOI 10.1016/0022-474X(73)90047-7; Campbell JF, 2010, J ECON ENTOMOL, V103, P991, DOI 10.1603/EC09347; Daglish GJ, 2006, J STORED PROD RES, V42, P328, DOI 10.1016/j.jspr.2005.04.003; Emekci M, 2004, J STORED PROD RES, V40, P27, DOI 10.1016/S0022-474X(02)00076-0; Espejo M, 1966, TRIBOLIUM INFORM B, V9, P90; FAO, 1975, FAO PLANT PROTECTION, P105; GenStat 14 Committee, 2011, GENSTAT WINDOWS; Good NE, 1933, J AGRIC RES, V46, P0327; Harshman LG, 1998, EVOLUTION, V52, P1679, DOI [10.2307/2411340, 10.1111/j.1558-5646.1998.tb02247.x]; Hinton HE, 1942, NATURE, V149, P500, DOI 10.1038/149500b0; HOBBS SK, 1989, J STORED PROD RES, V25, P137, DOI 10.1016/0022-474X(89)90035-0; HOWE R. W., 1962, BULL ENTOMOL RES, V53, P301, DOI 10.1017/S0007485300048148; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Kaur R, 2012, J STORED PROD RES, V51, P74, DOI 10.1016/j.jspr.2012.08.002; KHAN MA, 1983, Z ANGEW ENTOMOL, V95, P217; Koura A., 1971, RES B OBIHIRO U, V51, P35; Lilford K., 2009, 18 WORLD IMACS C MOD; Opit GP, 2012, J ECON ENTOMOL, V105, P1107, DOI 10.1603/EC12064; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; PRICE LA, 1988, J STORED PROD RES, V24, P51, DOI 10.1016/0022-474X(88)90008-2; Ridley AW, 2011, MOL ECOL, V20, P1635, DOI 10.1111/j.1365-294X.2011.05049.x; Ridley AW, 2012, J STORED PROD RES, V48, P106, DOI 10.1016/j.jspr.2011.10.005; SAXENA J D, 1980, Indian Journal of Entomology, V42, P796; Shi MR, 2012, J STORED PROD RES, V51, P23, DOI 10.1016/j.jspr.2012.06.003; Simwat G. S., 1975, Bulletin of Grain Technology, V13, P23; TAHER M, 1983, J STORED PROD RES, V19, P43, DOI 10.1016/0022-474X(83)90023-1; Taylor R. W. D., 1986, 1986 British Crop Protection Conference. Pests and diseases. Volume 2. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986., P607; Trauner J, 2007, DEV GENES EVOL, V217, P13, DOI 10.1007/s00427-006-0114-3; WHITE GG, 1982, J STORED PROD RES, V18, P115, DOI 10.1016/0022-474X(82)90010-8; Wijayaratne LKW, 2012, PEST MANAG SCI, V68, P217, DOI 10.1002/ps.2247	35	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53356	10.1371/journal.pone.0053356	http://dx.doi.org/10.1371/journal.pone.0053356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300916	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600087
J	Allen, GE; Brown, SGA; Buckley, NA; O'Leary, MA; Page, CB; Currie, BJ; White, J; Isbister, GK				Allen, George E.; Brown, Simon G. A.; Buckley, Nicholas A.; O'Leary, Margaret A.; Page, Colin B.; Currie, Bart J.; White, Julian; Isbister, Geoffrey K.		Asp Investigators	Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming - Australian Snakebite Project (ASP-14)	PLOS ONE			English	Article							IN-VITRO; VENOM; EFFICACY; TEXTILIS; COAGULOPATHY; ANAPHYLAXIS; DEATHS; BITE	Background: Snakebite is a global health issue and treatment with antivenom continues to be problematic. Brown snakes (genus Pseudonaja) are the most medically important group of Australian snakes and there is controversy over the dose of brown snake antivenom. We aimed to investigate the clinical and laboratory features of definite brown snake (Pseudonaja spp.) envenoming, and determine the dose of antivenom required. Methods and Finding: This was a prospective observational study of definite brown snake envenoming from the Australian Snakebite Project (ASP) based on snake identification or specific enzyme immunoassay for Pseudonaja venom. From January 2004 to January 2012 there were 149 definite brown snake bites [median age 42y (2-81y); 100 males]. Systemic envenoming occurred in 136 (88%) cases. All envenomed patients developed venom induced consumption coagulopathy (VICC), with complete VICC in 109 (80%) and partial VICC in 27 (20%). Systemic symptoms occurred in 61 (45%) and mild neurotoxicity in 2 (1%). Myotoxicity did not occur. Severe envenoming occurred in 51 patients (38%) and was characterised by collapse or hypotension (37), thrombotic microangiopathy (15), major haemorrhage (5), cardiac arrest (7) and death (6). The median peak venom concentration in 118 envenomed patients was 1.6 ng/mL (Range: 0.15-210 ng/mL). The median initial antivenom dose was 2 vials (Range: 1-40) in 128 patients receiving antivenom. There was no difference in INR recovery or clinical outcome between patients receiving one or more than one vial of antivenom. Free venom was not detected in 112/115 patients post-antivenom with only low concentrations (0.4 to 0.9 ng/ml) in three patients. Conclusions: Envenoming by brown snakes causes VICC and over a third of patients had serious complications including major haemorrhage, collapse and microangiopathy. The results of this study support accumulating evidence that giving more than one vial of antivenom is unnecessary in brown snake envenoming.	[Buckley, Nicholas A.; Page, Colin B.; Isbister, Geoffrey K.] Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia; [Allen, George E.] Queen Elizabeth II Jubilee Hosp, Emergency Dept, Brisbane, Qld, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Western Australian Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Brown, Simon G. A.] Univ Western Australia, Perth, WA 6009, Australia; [Buckley, Nicholas A.] Univ New S Wales, Sch Med, Prince Wales Hosp, Med Professorial Unit, Sydney, NSW, Australia; [O'Leary, Margaret A.; Isbister, Geoffrey K.] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia; [O'Leary, Margaret A.; Page, Colin B.; Isbister, Geoffrey K.] Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Newcastle, NSW, Australia; [Page, Colin B.] Princess Alexandra Hosp, Emergency Dept, Brisbane, Qld 4102, Australia; [Currie, Bart J.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Currie, Bart J.] No Terr Clin Sch, Darwin, NT, Australia; [White, Julian] Womens & Childrens Hosp, Dept Toxinol, Adelaide, SA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of New South Wales Sydney; University of Newcastle; Calvary Mater Newcastle Hospital; Charles Darwin University; Menzies School of Health Research; Northern Territory Government; Womens & Childrens Hospital Australia	Isbister, GK (corresponding author), Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia.	geoff.isbister@gmail.com	; Buckley, Nicholas/D-4030-2012	O'Leary, Margaret/0000-0003-2579-2334; Buckley, Nicholas/0000-0002-6326-4711; Brown, Simon/0000-0002-9961-0890	NHMRC Project Grant [ID490305]; NHMRC Clinical Career Development Award [ID605817]; NHMRC Career Development Fellowship Award [ID1023265]	NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported in part by NHMRC Project Grant ID490305. GKI is supported by an NHMRC Clinical Career Development Award ID605817. SGAB is supported by NHMRC Career Development Fellowship Award ID1023265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CM, 2012, TOXICOL LETT, V210, P318, DOI 10.1016/j.toxlet.2012.02.001; Birrell GW, 2006, MOL CELL PROTEOMICS, V5, P379, DOI 10.1074/mcp.M500270-MCP200; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Chaisakul J, 2012, TOXICOL LETT; Currie B. J., 2000, EMERGEN MED, V12, P285; Currie BJ, 2004, MED J AUSTRALIA, V181, P693, DOI 10.5694/j.1326-5377.2004.tb06526.x; Gan M, 2009, MED J AUSTRALIA, V191, P183, DOI 10.5694/j.1326-5377.2009.tb02736.x; Health, 2007, SNAK SPID CLIN MAN G; HENDERSON A, 1993, MED J AUSTRALIA, V158, P709, DOI 10.5694/j.1326-5377.1993.tb121923.x; Isbister GK, 2011, TOXICON, V58, P634, DOI 10.1016/j.toxicon.2011.09.013; Isbister GK, 2008, MED J AUSTRALIA, V188, P473, DOI 10.5694/j.1326-5377.2008.tb01721.x; Isbister GK, 2007, TOXICON, V49, P57, DOI 10.1016/j.toxicon.2006.09.007; Isbister GK, 2010, SEMIN THROMB HEMOST, V36, P444, DOI 10.1055/s-0030-1254053; Isbister GK, 2010, TOXICON, V56, P75, DOI 10.1016/j.toxicon.2010.03.013; Isbister GK, 2010, TOXICOLOGY, V268, P148, DOI 10.1016/j.tox.2009.09.013; JELINEK GA, 1990, MED J AUSTRALIA, V153, P658, DOI 10.5694/j.1326-5377.1990.tb126315.x; JELINEK GA, 1991, MED J AUSTRALIA, V155, P761, DOI 10.5694/j.1326-5377.1991.tb94030.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kulawickrama S, 2010, TOXICON, V55, P1510, DOI 10.1016/j.toxicon.2010.03.003; Kuruppu S, 2008, CRIT REV TOXICOL, V38, P73, DOI 10.1080/10408440701703964; Mirtschin PJ, 2006, ECOTOXICOLOGY, V15, P531, DOI 10.1007/s10646-006-0089-x; O'Leary MA, 2009, TOXICON, V54, P192, DOI 10.1016/j.toxicon.2009.04.004; Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611, DOI 10.1055/s-0037-1613264; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Skinner A, 2005, MOL PHYLOGENET EVOL, V37, P558, DOI 10.1016/j.ympev.2005.06.020; Sprivulis P, 1996, ANAESTH INTENS CARE, V24, P379, DOI 10.1177/0310057X9602400314; Sutherland SK, 1995, MED J AUSTRALIA, V163, P616, DOI 10.5694/j.1326-5377.1995.tb124770.x; TIBBALLS J, 1991, ANAESTH INTENS CARE, V19, P530, DOI 10.1177/0310057X9101900407; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; White J, 2001, CSL ANTIVENOM HDB; White J, 2003, TOXIC PLANTS ANIMALS; Yeung JM, 2004, MED J AUSTRALIA, V181, P703, DOI 10.5694/j.1326-5377.2004.tb06528.x	32	59	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53188	10.1371/journal.pone.0053188	http://dx.doi.org/10.1371/journal.pone.0053188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300888	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500119
J	Campos, JC; Queliconi, BB; Dourado, PMM; Cunha, TF; Zambelli, VO; Bechara, LRG; Kowaltowski, AJ; Brum, PC; Mochly-Rosen, D; Ferreira, JCB				Campos, Juliane C.; Queliconi, Bruno B.; Dourado, Paulo M. M.; Cunha, Telma F.; Zambelli, Vanessa O.; Bechara, Luiz R. G.; Kowaltowski, Alicia J.; Brum, Patricia C.; Mochly-Rosen, Daria; Ferreira, Julio C. B.			Exercise Training Restores Cardiac Protein Quality Control in Heart Failure	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 20S PROTEASOME; MICE; DYSFUNCTION; MITOCHONDRIA; DEGRADATION; PROGRESSION; ACTIVATION; DEHYDROGENASE; INACTIVATION	Exercise training is a well-known coadjuvant in heart failure treatment; however, the molecular mechanisms underlying its beneficial effects remain elusive. Despite the primary cause, heart failure is often preceded by two distinct phenomena: mitochondria dysfunction and cytosolic protein quality control disruption. The objective of the study was to determine the contribution of exercise training in regulating cardiac mitochondria metabolism and cytosolic protein quality control in a post-myocardial infarction-induced heart failure (MI-HF) animal model. Our data demonstrated that isolated cardiac mitochondria from MI-HF rats displayed decreased oxygen consumption, reduced maximum calcium uptake and elevated H2O2 release. These changes were accompanied by exacerbated cardiac oxidative stress and proteasomal insufficiency. Declined proteasomal activity contributes to cardiac protein quality control disruption in our MI-HF model. Using cultured neonatal cardiomyocytes, we showed that either antimycin A or H2O2 resulted in inactivation of proteasomal peptidase activity, accumulation of oxidized proteins and cell death, recapitulating our in vivo model. Of interest, eight weeks of exercise training improved cardiac function, peak oxygen uptake and exercise tolerance in MI-HF rats. Moreover, exercise training restored mitochondrial oxygen consumption, increased Ca2+-induced permeability transition and reduced H2O2 release in MI-HF rats. These changes were followed by reduced oxidative stress and better cardiac protein quality control. Taken together, our findings uncover the potential contribution of mitochondrial dysfunction and cytosolic protein quality control disruption to heart failure and highlight the positive effects of exercise training in re-establishing cardiac mitochondrial physiology and protein quality control, reinforcing the importance of this intervention as a nonpharmacological tool for heart failure therapy.	[Campos, Juliane C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Queliconi, Bruno B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Dourado, Paulo M. M.] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil; [Cunha, Telma F.; Bechara, Luiz R. G.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Zambelli, Vanessa O.] Butantan Inst, Sao Paulo, Brazil; [Mochly-Rosen, Daria; Ferreira, Julio C. B.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Stanford University	Ferreira, JCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	jcesarbf@usp.br	Kowaltowski, Alicia J/H-8698-2012; Ferreira, Julio Cesar Batista/I-3177-2012; Bechara, Luiz R G/K-4095-2012; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/AEU-0494-2022; Zambelli, Vanessa O/C-2716-2013; Cunha, Telma F/I-5222-2016; Campos, Juliane/G-5997-2014; Brum, Patricia C/E-6605-2011	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Campos, Juliane/0000-0003-0075-7209; Brum, Patricia C/0000-0002-4750-6506; Zambelli, Vanessa/0000-0003-0890-9561; Queliconi, Bruno Barros/0000-0001-7361-5573; Mochly-Rosen, Daria/0000-0002-6691-8733; Bechara, Luiz/0000-0002-1642-1008	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP) [2009/18546-4, 2010/00028-4, 2012/05765-2]; Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq) [479407/2010-0]; Instituto Nacional de Ciencia e Tecnologia; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/12349-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011147] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP #2009/18546-4, #2010/00028-4 and #2012/05765-2), Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq, 479407/2010-0), Instituto Nacional de Ciencia e Tecnologia and Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina. JCC held a master's fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2009/12349-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; da Cunha FM, 2011, FREE RADICAL BIO MED, V51, P664, DOI 10.1016/j.freeradbiomed.2011.05.035; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Emter CA, 2005, AM J PHYSIOL-HEART C, V289, pH2030, DOI 10.1152/ajpheart.00526.2005; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Ferrington DA, 2004, FEBS LETT, V578, P217, DOI 10.1016/j.febslet.2004.11.003; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Grune Tilman, 2003, Molecular Aspects of Medicine, V24, P195, DOI 10.1016/S0098-2997(03)00014-1; Guyatt GH, 2004, MT SINAI J MED, V71, P47; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Jonsdottir S, 2006, EUR J HEART FAIL, V8, P97, DOI 10.1016/j.ejheart.2005.05.002; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Maki CG, 1996, CANCER RES, V56, P2649; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Oliveira RSF, 2009, J PHYSIOL-LONDON, V587, P3899, DOI 10.1113/jphysiol.2009.173948; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Powers SK, 2002, CURR OPIN CARDIOL, V17, P495, DOI 10.1097/00001573-200209000-00009; Qi ZT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021140; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141; Shin JH, 2009, NEUROSCI RES; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tsukamoto O, 2006, BIOCHEM BIOPH RES CO, V340, P1125, DOI 10.1016/j.bbrc.2005.12.120; Vallentin A, 2007, J BIOL CHEM, V282, P1650, DOI 10.1074/jbc.M601710200; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041	50	56	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52764	10.1371/journal.pone.0052764	http://dx.doi.org/10.1371/journal.pone.0052764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300764	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100078
J	Korman, TP; Bowie, JU				Korman, Tyler P.; Bowie, James U.			Crystal Structure of Proteus mirabilis Lipase, a Novel Lipase from the Proteus/Psychrophilic Subfamily of Lipase Family I.1	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA LIPASE; OPEN CONFORMATION; TRIACYLGLYCEROL LIPASE; BACTERIAL LIPASES; DISULFIDE BOND; CLASSIFICATION; EXPRESSION; FEATURES; REVEALS; GENE	Bacterial lipases from family I.1 and I.2 catalyze the hydrolysis of triacylglycerol between 25-45 degrees C and are used extensively as biocatalysts. The lipase from Proteus mirabilis belongs to the Proteus/psychrophilic subfamily of lipase family I.1 and is a promising catalyst for biodiesel production because it can tolerate high amounts of water in the reaction. Here we present the crystal structure of the Proteus mirabilis lipase, a member of the Proteus/psychrophilic subfamily of I.1lipases. The structure of the Proteus mirabilis lipase was solved in the absence and presence of a bound phosphonate inhibitor. Unexpectedly, both the apo and inhibitor bound forms of P. mirabilis lipase were found to be in a closed conformation. The structure reveals a unique oxyanion hole and a wide active site that is solvent accessible even in the closed conformation. A distinct mechanism for Ca2+ coordination may explain how these lipases can fold without specific chaperones.	[Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA; [Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	bowie@mbi.ucla.edu			Department of Energy [DE-FC02-02ER63421]	Department of Energy(United States Department of Energy (DOE))	This work was supported by grant number DE-FC02-02ER63421 from the Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alquati C, 2002, EUR J BIOCHEM, V269, P3321, DOI 10.1046/j.1432-1033.2002.03012.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; El Khattabi M, 2003, J MOL CATAL B-ENZYM, V22, P329, DOI 10.1016/S1381-1177(03)00047-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao B, 2009, J BIOTECHNOL, V139, P169, DOI 10.1016/j.jbiotec.2008.10.004; Gao B, 2011, J MOL CATAL B-ENZYM, V68, P286, DOI 10.1016/j.molcatb.2010.12.001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Invernizzi G, 2009, J STRUCT BIOL, V168, P562, DOI 10.1016/j.jsb.2009.07.021; Invernizzi G, 2009, J BIOTECHNOL, V141, P42, DOI 10.1016/j.jbiotec.2009.02.020; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Joshi GK, 2007, RES J BIOTECHNOL, V2, P50; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Krishna SH, 2002, CATAL REV, V44, P499, DOI 10.1081/CR-120015481; Lang D, 1996, J MOL BIOL, V259, P704, DOI 10.1006/jmbi.1996.0352; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HW, 2000, BIOTECHNOL LETT, V22, P1543, DOI 10.1023/A:1005621532280; Liebeton K, 2001, J BACTERIOL, V183, P597, DOI 10.1128/JB.183.2.597-603.2001; Lu Yaping, 2010, Weishengwu Xuebao, V50, P755; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pauwels K, 2006, NAT STRUCT MOL BIOL, V13, P374, DOI 10.1038/nsmb1065; Pauwels K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036999; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Whangsuk W, 2012, MOL BIOTECHNOLOGY; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu T, 2010, BBA-PROTEINS PROTEOM, V1804, P2183, DOI 10.1016/j.bbapap.2010.08.012; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	38	17	19	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52890	10.1371/journal.pone.0052890	http://dx.doi.org/10.1371/journal.pone.0052890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300806	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800159
J	Nyuyki, KD; Beiderbeck, DI; Lukas, M; Neumann, ID; Reber, SO				Nyuyki, Kewir D.; Beiderbeck, Daniela I.; Lukas, Michael; Neumann, Inga D.; Reber, Stefan O.			Chronic Subordinate Colony Housing (CSC) as a Model of Chronic Psychosocial Stress in Male Rats	PLOS ONE			English	Article							CHRONIC SOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; DSS-INDUCED COLITIS; HYPOTHALAMIC VASOPRESSIN; LABORATORY RATS; LIFE EVENTS; ANXIETY; NEUROENDOCRINE; BEHAVIOR	Chronic subordinate colony housing (CSC) is an adequate and reliable mouse model of chronic psychosocial stress, resulting in reduced body weight gain, reduced thymus and increased adrenal weight, long-lasting anxiety-like behaviour, and spontaneous colitis. Furthermore, CSC mice show increased corticotrophin (ACTH) responsiveness to acute heterotypic stressors, suggesting a general mechanism which allows a chronically-stressed organism to adequately respond to a novel threat. Therefore, the aim of the present study was to extend the CSC model to another rodent species, namely male Wistar rats, and to characterize relevant physiological, immunological, and behavioural consequences; placing particular emphasis on changes in hypothalamo-pituitary-adrenal (HPA) axis responsiveness to an acute heterotypic stressor. In line with previous mouse data, exposure of Wistar rats to 19 days of CSC resulted in a decrease in body weight gain and absolute thymus mass, mild colonic barrier defects and intestinal immune activation. Moreover, no changes in stress-coping behaviour or social preference were seen; again in agreement with the mouse paradigm. Most importantly, CSC rats showed an increased plasma corticosterone response to an acute heterotypic stressor (open arm, 5 min) despite displaying similar basal levels and similar basal and stressor-induced plasma ACTH levels. In contrast to CSC mice, anxiety-related behaviour and absolute, as well as relative adrenal weights remained unchanged in CSC rats. In summary, the CSC paradigm could be established as an adequate model of chronic psychosocial stress in male rats. Our data further support the initial hypothesis that adrenal hyper-responsiveness to ACTH during acute heterotypic stressors represents a general adaptation, which enables a chronically-stressed organism to adequately respond to novel challenges.	[Nyuyki, Kewir D.; Beiderbeck, Daniela I.; Lukas, Michael; Neumann, Inga D.; Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany	University of Regensburg	Reber, SO (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany.	stefan.reber@biologie.uni-regensburg.de	Lukas, Michael/AAB-4060-2019	Lukas, Michael/0000-0002-4287-7367	Bayerisches Forchungsstiftung	Bayerisches Forchungsstiftung	This study was supported by the Bayerisches Forchungsstiftung (KDN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; AHMED SH, 1995, PSYCHOPHARMACOLOGY, V117, P116, DOI 10.1007/BF02245106; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Barnum CJ, 2007, J NEUROENDOCRINOL, V19, P632, DOI 10.1111/j.1365-2826.2007.01571.x; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Beiderbeck DI, 2007, EUR J NEUROSCI, V26, P3597, DOI 10.1111/j.1460-9568.2007.05974.x; Beiderbeck DI, 2012, PSYCHONEUROENDOCRINO, V37, P1969, DOI 10.1016/j.psyneuen.2012.04.011; Belda X, 2008, ANN NY ACAD SCI, V1148, P165, DOI 10.1196/annals.1410.038; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Chen J, 2008, ANN NY ACAD SCI, V1148, P349, DOI 10.1196/annals.1410.037; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V32, P777, DOI 10.1016/0091-3057(89)90033-6; DEGOEIJ DCE, 1992, ENDOCRINOLOGY, V131, P847, DOI 10.1210/en.131.2.847; Engler H, 2003, PSYCHONEUROENDOCRINO, V28, P951, DOI 10.1016/S0306-4530(02)00117-8; FLANNELLY K, 1977, ANIM BEHAV, V25, P654, DOI 10.1016/0003-3472(77)90116-6; Gasparotto OC, 2005, PHYSIOL BEHAV, V85, P603, DOI 10.1016/j.physbeh.2005.06.014; Hall FS, 1998, J NEUROSCI METH, V79, P47, DOI 10.1016/S0165-0270(97)00155-6; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hillerer KM, 2011, ENDOCRINOLOGY, V152, P3930, DOI 10.1210/en.2011-1091; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KENDALL MD, 1991, BRAIN BEHAV IMMUN, V5, P9, DOI 10.1016/0889-1591(91)90004-T; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KOOLHAAS JM, 1980, PROG NEUROBIOL, V15, P247, DOI 10.1016/0301-0082(80)90024-6; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Landgraf R, 1999, J NEUROENDOCRINOL, V11, P405; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Nyuyki KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023599; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; POST RM, 1992, AM J PSYCHIAT, V149, P999; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Reber SO, 2008, STRESS, V11, P225, DOI 10.1080/10253890701733351; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Reber SO, 2008, ANN NY ACAD SCI, V1148, P184, DOI 10.1196/annals.1410.003; SACHSER N, 1989, PHYSIOL BEHAV, V46, P137, DOI 10.1016/0031-9384(89)90246-1; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; SCHWARTZMAN RA, 1994, INT ARCH ALLERGY IMM, V105, P347, DOI 10.1159/000236781; Singewald GM, 2009, STRESS, V12, P58, DOI 10.1080/10253890802042082; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Slattery DA, 2012, PSYCHONEUROENDOCRINO, V37, P702, DOI 10.1016/j.psyneuen.2011.09.002; Spiga F, 2009, J ENDOCRINOL, V200, P285, DOI 10.1677/JOE-08-0425; Stefanski V, 2003, J NEUROIMMUNOL, V138, P17, DOI 10.1016/S0165-5728(03)00076-6; Stefanski V, 2001, PHYSIOL BEHAV, V73, P385, DOI 10.1016/S0031-9384(01)00495-4; Stefanski V, 1999, J NEUROIMMUNOL, V94, P144, DOI 10.1016/S0165-5728(98)00242-2; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO, V37, P1676, DOI 10.1016/j.psyneuen.2012.02.015; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; Vicario M, 2012, PSYCHONEUROENDOCRINO, V37, P65, DOI 10.1016/j.psyneuen.2011.05.005; Vicario M, 2010, BRAIN BEHAV IMMUN, V24, P1166, DOI 10.1016/j.bbi.2010.06.002; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Waldherr M, 2010, HORM BEHAV, V57, P222, DOI 10.1016/j.yhbeh.2009.11.006; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015	64	42	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52371	10.1371/journal.pone.0052371	http://dx.doi.org/10.1371/journal.pone.0052371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300653	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800074
J	Shimada, Y; Hirano, M; Nishimura, Y; Tanaka, T				Shimada, Yasuhito; Hirano, Minoru; Nishimura, Yuhei; Tanaka, Toshio			A High-Throughput Fluorescence-Based Assay System for Appetite-Regulating Gene and Drug Screening	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; FOOD-INTAKE; LARVAL ZEBRAFISH; NEUROPEPTIDE-Y; RECEPTOR; FLUOXETINE; BRAIN; SIBUTRAMINE; INSULIN; OBESITY	The increasing number of people suffering from metabolic syndrome and obesity is becoming a serious problem not only in developed countries, but also in developing countries. However, there are few agents currently approved for the treatment of obesity. Those that are available are mainly appetite suppressants and gastrointestinal fat blockers. We have developed a simple and rapid method for the measurement of the feeding volume of Danio rerio (zebrafish). This assay can be used to screen appetite suppressants and enhancers. In this study, zebrafish were fed viable paramecia that were fluorescently-labeled, and feeding volume was measured using a 96-well microplate reader. Gene expression analysis of brain-derived neurotrophic factor (bdnf), knockdown of appetite-regulating genes (neuropeptide Y, preproinsulin, melanocortin 4 receptor, agouti related protein, and cannabinoid receptor 1), and the administration of clinical appetite suppressants (fluoxetine, sibutramine, mazindol, phentermine, and rimonabant) revealed the similarity among mechanisms regulating appetite in zebrafish and mammals. In combination with behavioral analysis, we were able to evaluate adverse effects on locomotor activities from gene knockdown and chemical treatments. In conclusion, we have developed an assay that uses zebrafish, which can be applied to high-throughput screening and target gene discovery for appetite suppressants and enhancers.	[Shimada, Yasuhito; Hirano, Minoru; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Ind Technol Innovat Inst, Dept Om Med, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Nishimura, Yuhei/0000-0003-1901-8799; Hirano, Minoru/0000-0002-4546-3864	KAKENHI from Japan Society for the Promotion of Science [24590318]; New Energy and Industrial Technology Development Organization; Japan Chemical Industry Association; Grants-in-Aid for Scientific Research [24590318] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Chemical Industry Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (Grant-in-Aid for Scientific Research, 24590318) from Japan Society for the Promotion of Science, the New Energy and Industrial Technology Development Organization, and the Japan Chemical Industry Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FAKM, 2001, INT J DEV NEUROSCI, V19, P209, DOI 10.1016/S0736-5748(00)00073-3; Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; Ampatzis K, 2008, J COMP NEUROL, V508, P72, DOI 10.1002/cne.21663; Aronne LJ, 2007, CLIN PHARMACOL THER, V81, P748, DOI 10.1038/sj.clpt.6100163; Benkimoun P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e996; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101; Brotchie JM, 2003, CURR OPIN PHARMACOL, V3, P54, DOI 10.1016/S1471-4892(02)00011-5; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Butler AA, 2003, ANN NY ACAD SCI, V994, P240, DOI 10.1111/j.1749-6632.2003.tb03186.x; Casado A, 2003, NUTR NEUROSCI, V6, P103, DOI 10.1080/1028415031000094264; Clements S, 2002, GEN COMP ENDOCR, V125, P319, DOI 10.1006/gcen.2001.7707; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Currie PJ, 2004, PSYCHOPHARMACOLOGY, V172, P359, DOI 10.1007/s00213-003-1681-x; Dakin CL, 2001, ENDOCRINOLOGY, V142, P4244, DOI 10.1210/en.142.10.4244; DEBONS AF, 1970, AM J PHYSIOL, V219, P938, DOI 10.1152/ajplegacy.1970.219.4.938; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Gadde KM, 2006, CIRCULATION, V114, P974, DOI 10.1161/CIRCULATIONAHA.105.596130; Gerozissis K, 2004, EUR J PHARMACOL, V490, P59, DOI 10.1016/j.ejphar.2004.02.044; Heal DJ, 1998, INT J OBESITY, V22, pS18; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; INUI A, 1991, AM J PHYSIOL, V261, pR588, DOI 10.1152/ajpregu.1991.261.3.R588; Janhunen SK, 2011, OBESITY, V19, P1979, DOI 10.1038/oby.2011.51; Johansson K, 2009, OBES REV, V10, P564, DOI 10.1111/j.1467-789X.2009.00581.x; Kanarek R B, 1988, Curr Concepts Nutr, V16, P1; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Lauzurica N, 2012, J PHYSL BIO IN PRESS, V23; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; Cerda-Reverter JM, 2011, EUR J PHARMACOL, V660, P53, DOI 10.1016/j.ejphar.2010.10.108; Mortensen OV, 2001, J NEUROCHEM, V79, P237, DOI 10.1046/j.1471-4159.2001.00587.x; Myung CS, 2005, ARCH PHARM RES, V28, P716, DOI 10.1007/BF02969363; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Papasani MR, 2006, PHYSIOL GENOMICS, V27, P79, DOI 10.1152/physiolgenomics.00012.2006; Piccinetti CC, 2010, HORM BEHAV, V58, P780, DOI 10.1016/j.yhbeh.2010.07.013; Rico EP, 2011, NEUROTOXICOL TERATOL, V33, P608, DOI 10.1016/j.ntt.2011.07.007; Rosenzweig S, 2010, GRAEF ARCH CLIN EXP, V248, P1423, DOI 10.1007/s00417-010-1377-y; Rowland NE, 1996, NUTRITION, V12, P626, DOI 10.1016/S0899-9007(96)00227-4; SCHANZER MC, 1978, NEUROENDOCRINOLOGY, V25, P329, DOI 10.1159/000122754; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schwartz MW, 1997, J AM DIET ASSOC, V97, P54, DOI 10.1016/S0002-8223(97)00018-7; Shishkina GT, 2012, CELL MOL NEUROBIOL, V32, P787, DOI 10.1007/s10571-012-9828-0; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Tanaka T, 2008, J PHARMACOL SCI, V107, P8, DOI 10.1254/jphs.08R03FM; Usenko CY, 2011, ENVIRON TOXICOL CHEM, V30, P1865, DOI 10.1002/etc.570; VANROSSUM JM, 1969, PSYCHOPHARMACOLOGIA, V14, P248, DOI 10.1007/BF00404223; Varga ZM, 2011, METHOD CELL BIOL, V104, P453, DOI 10.1016/B978-0-12-374814-0.00024-0; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang YH, 2006, TOHOKU J EXP MED, V208, P267, DOI 10.1620/tjem.208.267; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; ZAMBOTTI F, 1976, EUR J PHARMACOL, V36, P405, DOI 10.1016/0014-2999(76)90094-7; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	70	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52549	10.1371/journal.pone.0052549	http://dx.doi.org/10.1371/journal.pone.0052549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300705	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800105
J	Wu, H; Xie, JS; Pan, QR; Wang, BB; Hu, DQ; Hu, X				Wu, Hao; Xie, Jiansheng; Pan, Qiangrong; Wang, Beibei; Hu, Danqing; Hu, Xun			Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance	PLOS ONE			English	Article							ANTI-TUMOR ACTIVITY; CELL-DEATH; TOPOISOMERASE-I; CARCINOMA CELLS; P-GLYCOPROTEIN; BETA-HYDROXYISOVALERYLSHIKONIN; MULTIDRUG-RESISTANCE; ANTITUMOR-ACTIVITY; BREAST-CANCER; APOPTOSIS	Purpose: Cancer drug resistance is a major obstacle for the success of chemotherapy. Since most clinical anticancer drugs could induce drug resistance, it is desired to develop candidate drugs that are highly efficacious but incompetent to induce drug resistance. Numerous previous studies have proven that shikonin and its analogs not only are highly tumoricidal but also can bypass drug-transporter and apoptotic defect mediated drug resistance. The purpose of this study is to investigate if or not shikonin is a weak inducer of cancer drug resistance. Experimental Design: Different cell lines (K562, MCF-7, and a MDR cell line K562/Adr), after repeatedly treated with shikonin for 18 months, were assayed for drug resistance and gene expression profiling. Results: After 18-month treatment, cells only developed a mere 2-fold resistance to shikonin and a marginal resistance to cisplatin and paclitaxel, without cross resistance to shikonin analogs and other anticancer agents. Gene expression profiles demonstrated that cancer cells did strongly respond to shikonin treatment but failed to effectively mobilize drug resistant machineries. Shikonin-induced weak resistance was associated with the up-regulation of beta II-tubulin, which physically interacted with shikonin. Conclusion: Taken together, apart from potent anticancer activity, shikonin and its analogs are weak inducers of cancer drug resistance and can circumvent cancer drug resistance. These merits make shikonin and its analogs potential candidates for cancer therapy with advantages of avoiding induction of drug resistance and bypassing existing drug resistance.	[Wu, Hao; Xie, Jiansheng; Pan, Qiangrong; Wang, Beibei; Hu, Danqing; Hu, Xun] Zhejiang Univ, Sch Med, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn	hu, dq/K-9722-2016		National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by National 863 project (2007AA02Z143), China Natural Sciences Foundation projects (30772544, 81071802) and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to X. Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; AHN BZ, 1995, J MED CHEM, V38, P1044, DOI 10.1021/jm00006a025; Allen JD, 1999, CANCER RES, V59, P4237; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; BEKETICORESKOVIC L, 1995, J NATL CANCER I, V87, P1593, DOI 10.1093/jnci/87.21.1593; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen J, 2011, ONCOGENE; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Floreani M, 2000, BIOCHEM PHARMACOL, V60, P601, DOI 10.1016/S0006-2952(00)00350-6; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo X P, 1991, Zhong Xi Yi Jie He Za Zhi, V11, P598; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Hayashi M, 1977, Nihon Yakurigaku Zasshi, V73, P193; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Hsu PC, 2004, J AGR FOOD CHEM, V52, P6330, DOI 10.1021/jf0495993; HU X, 1995, CHEMOTHERAPY, V41, P296, DOI 10.1159/000239359; Hu X, 2008, CANCER LETT, V259, P127, DOI 10.1016/j.canlet.2007.11.007; Hu X, 2007, AUTOPHAGY, V3, P490, DOI 10.4161/auto.4592; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim SH, 2001, CANCER LETT, V172, P171, DOI 10.1016/S0304-3835(01)00665-6; LAU DHM, 1991, CANCER RES, V51, P5181; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Li L, 2007, LIFE SCI, V80, P741, DOI 10.1016/j.lfs.2006.11.002; Ling CQ, 2005, ANN ONCOL, V16, P109, DOI 10.1093/annonc/mdi019; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Masuda Y, 2003, ONCOGENE, V22, P1012, DOI 10.1038/sj.onc.1206200; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nakaya K, 2003, ANTI-CANCER DRUG, V14, P683, DOI 10.1097/01.cad.0000092781.37568.df; Pan QR, 2006, CANCER CHEMOTH PHARM, V58, P99, DOI 10.1007/s00280-005-0133-1; Pan QR, 2005, BIOCHEM BIOPH RES CO, V335, P406, DOI 10.1016/j.bbrc.2005.07.097; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Plyta ZF, 1998, BIOORG MED CHEM LETT, V8, P3385, DOI 10.1016/S0960-894X(98)00600-3; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; SANKAWA U, 1981, CHEM PHARM BULL, V29, P116; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xu D, 2006, CANCER LETT, V243, P274, DOI 10.1016/j.canlet.2005.11.031; Xuan YY, 2009, CANCER LETT, V274, P233, DOI 10.1016/j.canlet.2008.09.029; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Yeh PY, 2003, BIOCHEM PHARMACOL, V66, P25, DOI 10.1016/S0006-2952(03)00250-8; Yoon Y, 1999, PLANTA MED, V65, P532, DOI 10.1055/s-1999-14010	54	40	42	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52706	10.1371/journal.pone.0052706	http://dx.doi.org/10.1371/journal.pone.0052706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300986	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000014
J	Xu, ZY; Jiang, JF; Xu, C; Wang, Y; Sun, L; Guo, XC; Liu, HQ				Xu, Zhenyu; Jiang, Junfeng; Xu, Chen; Wang, Yue; Sun, Lei; Guo, Xiaocan; Liu, Houqi			MicroRNA-181 Regulates CARM1 and Histone Aginine Methylation to Promote Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; EARLY MOUSE EMBRYO; SELF-RENEWAL; CHROMATIN-STRUCTURE; ENDOTHELIAL-CELLS; RNA INTERFERENCE; PLURIPOTENCY; EXPRESSION; MIR-181; IDENTIFICATION	As a novel epigenetic mechanism, histone H3 methylation at R17 and R26, which is mainly catalyzed by coactivator-associated protein arginine methyltransferase 1 (CARM1), has been reported to modulate the transcription of key pluripotency factors and to regulate pluripotency in mouse embryos and mouse embryonic stem cells (mESCs) in previous studies. However, the role of CARM1 in human embryonic stem cells (hESCs) and the regulatory mechanism that controls CARM1 expression during ESCs differentiation are presently unknown. Here, we demonstrate that CARM1 plays an active role in the resistance to differentiation in hESCs by regulating pluripotency genes in response to BMP4. In a functional screen, we identified the miR-181 family as a regulator of CARM1 that is induced during ESC differentiation and show that endogenous miR-181c represses the expression of CARM1. Depletion of CARM1 or enforced expression of miR-181c inhibits the expression of pluripotency genes and induces differentiation independent of BMP4, whereas overexpression of CARM1 or miR-181c inhibitor elevates Nanog and impedes differentiation. Furthermore, expression of CARM1 rescue constructs inhibits the effect of miR-181c overexpression in promoting differentiation. Taken together, our findings demonstrate the importance of a miR-181c-CARM1 pathway in regulating the differentiation of hESCs.	[Xu, Zhenyu; Jiang, Junfeng; Xu, Chen; Wang, Yue; Sun, Lei; Guo, Xiaocan; Liu, Houqi] Second Mil Med Univ, Res Ctr Dev Biol, Shanghai, Peoples R China	Naval Medical University	Wang, Y (corresponding author), Second Mil Med Univ, Res Ctr Dev Biol, Shanghai, Peoples R China.	wangyuesmmu@gmail.com; houqiliu@126.com	Xu, Chen/AAQ-5514-2020; Wang, Yue/AIC-2138-2022; Zhenyu, Xu/AAW-7042-2020	Xu, Chen/0000-0001-8068-2109; Jiang, Junfeng/0000-0003-2696-2032	National Key Basic Research and Development Project (Beijing, China) [2011CB965101]	National Key Basic Research and Development Project (Beijing, China)	This study was supported by the National Key Basic Research and Development Project (Beijing, China) (No. 2011CB965101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045633; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Selvi BR, 2010, J BIOL CHEM, V285, P7143, DOI 10.1074/jbc.M109.063933; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Wu Z, 2011, J GENET GENOMICS, V38, P13, DOI 10.1016/j.jcg.2010.12.006; Wu ZT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373092; Yamaguchi S, 2011, ATHEROSCLEROSIS, V219, P468, DOI 10.1016/j.atherosclerosis.2011.09.004; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	50	29	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53146	10.1371/journal.pone.0053146	http://dx.doi.org/10.1371/journal.pone.0053146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301034	Green Submitted, gold, Green Published			2022-12-27	WOS:000313480000033
J	Chen, ZG; Zhang, TT; Li, HT; Chen, FH; Zou, XL; Ji, JZ; Chen, H				Chen, Zhuang-Gui; Zhang, Tian-Tuo; Li, Hong-Tao; Chen, Fen-Hua; Zou, Xiao-Ling; Ji, Jing-Zhi; Chen, Hong			Neutralization of TSLP Inhibits Airway Remodeling in a Murine Model of Allergic Asthma Induced by Chronic Exposure to House Dust Mite	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; DENDRITIC CELLS; T-BET; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IFN-GAMMA; INFLAMMATION; BLOCKADE	Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function. However, the initiating factor that links airway inflammation to remodeling is unknown. Thymic stromal lymphopoietin (TSLP), an epithelium-derived cytokine, can strongly activate lung dendritic cells (DCs) through the TSLP-TSLPR and OX40L-OX40 signaling pathways to promote Th2 differentiation. To determine whether TSLP is the underlying trigger of airway remodeling in chronic allergen-induced asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite (HDM) extracts for up to 5 consecutive weeks. We showed that repeated respiratory exposure to HDM caused significant airway eosinophilic inflammation, peribronchial collagen deposition, goblet cell hyperplasia, and airway hyperreactivity (AHR) to methacholine. These effects were accompanied with a salient Th2 response that was characterized by the upregulation of Th2-typed cytokines, such as IL-4 and IL-13, as well as the transcription factor GATA-3. Moreover, the levels of TSLP and transforming growth factor beta 1 (TGF-beta 1) were also increased in the airway. We further demonstrated, using the chronic HDM-induced asthma model, that the inhibition of Th2 responses via neutralization of TSLP with an anti-TSLP mAb reversed airway inflammation, prevented structural alterations, and decreased AHR to methacholine and TGF-beta 1 level. These results suggest that TSLP plays a pivotal role in the initiation and persistence of airway inflammation and remodeling in the context of chronic allergic asthma.	[Chen, Zhuang-Gui; Zhang, Tian-Tuo; Li, Hong-Tao; Zou, Xiao-Ling] Sun Yat Sen Univ, Inst Resp Dis, Affiliated Hosp 3, Dept Pulm Dis, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhuang-Gui; Chen, Fen-Hua; Ji, Jing-Zhi; Chen, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, TT (corresponding author), Sun Yat Sen Univ, Inst Resp Dis, Affiliated Hosp 3, Dept Pulm Dis, Guangzhou 510275, Guangdong, Peoples R China.	zhtituli@163.com			Guangdong Natural Science Foundation [10151008901000008]; Science and Technology Planning Project of Guangdong Province, China [2008B030301040]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	Tian-Tuo Zhang was supported by Guangdong Natural Science Foundation (grant number: 10151008901000008; URL of funder's website: http://gdsf.gdstc.gov.cn/). Zhuang-Gui Chen was supported by Science and Technology Planning Project of Guangdong Province, China (grant number: 2008B030301040; URL of funder's website: http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Chen ZG, 2009, CHINESE MED J-PEKING, V122, P1157, DOI 10.3760/cma.j.issn.0366-6999.2009.10.008; Fahy JV, 2001, AM J RESP CRIT CARE, V164, pS46, DOI 10.1164/ajrccm.164.supplement_2.2106066; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kiwamoto T, 2006, AM J RESP CRIT CARE, V174, P142, DOI 10.1164/rccm.200601-079OC; Kolb M, 2002, AM J RESP CELL MOL, V27, P141, DOI 10.1165/ajrcmb.27.2.4674; Komai M, 2003, BRIT J PHARMACOL, V138, P912, DOI 10.1038/sj.bjp.0705105; Labonte I, 2009, AM J PHYSIOL-LUNG C, V297, pL698, DOI 10.1152/ajplung.00142.2009; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Li Hong-tao, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P497; Li YL, 2010, J ASTHMA, V47, P117, DOI 10.3109/02770900903483816; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pascual RM, 2009, J ALLERGY CLIN IMMUN, V124, P883, DOI 10.1016/j.jaci.2009.09.047; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shi LY, 2008, CLIN IMMUNOL, V129, P202, DOI 10.1016/j.clim.2008.07.015; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	51	76	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51268	10.1371/journal.pone.0051268	http://dx.doi.org/10.1371/journal.pone.0051268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300949	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900007
J	Jin, R; Zhao, PX; Ma, XM; Ma, JM; Wu, YN; Yang, XJ; Zhang, JX; Zhong, RG; Zeng, Y				Jin, Rui; Zhao, Pengxiang; Ma, Xuemei; Ma, Jianmin; Wu, Yanan; Yang, Xinji; Zhang, Jingxue; Zhong, Rugang; Zeng, Yi			Quantification of Epstein-Barr Virus DNA in Patients with Idiopathic Orbital Inflammatory Pseudotumor	PLOS ONE			English	Article							MYOFIBROBLASTIC TUMOR; CHILDREN; PLASMA	Inflammatory pseudotumors (IPT) are soft tissue tumors that include a diverse group of lesions characterized by inflammatory cell infiltration and variable fibrotic responses. Idiopathic orbital inflammatory pseudotumors (IOIP) are IPTs of unknown etiology that develop in the orbit. Due to the lack of well-defined pathogenic mechanisms, diagnosis and treatment of this disease remain a significant challenge. Epstein-Barr virus (EBV) infection, which causes significant lymphocyte infiltration, has been proposed to be involved in IOIP. This study tries to validate the relationship between EBV infection and the development of IOIP. Sixteen IOIP tissue samples were obtained from patients during surgical resection of the lesion. One Graves' ophthalmopathy tissue sample and 20 normal donors' plasma serves as controls. The plasma level of five EBV antibodies, including VCA-IgG, VCA-IgA, VCA-IgM, EA-IgG and EBNA1-IgG were examined. All plasma samples were EB-VCA-IgG positive and EB-VCA-IgM negative, suggesting that all people tested had been infected with EBV but not in the acute infection stage. EBV-DNA was detected in 15/16 (94%) of IOIP tissue samples despite different levels of lymphocyte infiltration and 5/16 plasma samples (31%) were detected EBV DNA positive which is higher than the normal controls (10%). Percent of positive plus suspected positive samples with one or more of the three important risk markers (VCA-IgA, EA-IgG, EBV-DNA) is 50% of the patients (8/16) which is much higher compare with the normal controls (20%). The results further reveal the relationship between IOIP and EBV infection.	[Jin, Rui; Zhao, Pengxiang; Ma, Xuemei; Wu, Yanan; Zhong, Rugang; Zeng, Yi] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Ma, Jianmin; Zhang, Jingxue] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Vis Sci Key Lab, Beijing, Peoples R China; [Yang, Xinji] Chinese Armed Police Gen Hosp, Inst Orbital Dis, Beijing, Peoples R China; [Zeng, Yi] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Beijing University of Technology; Capital Medical University; Chinese Center for Disease Control & Prevention	Ma, XM (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China.	xmma@bjut.edu.cn; leslieziyi@163.com	Zhao, Peng/HDO-7507-2022		Beijing Science Nova Program [2004B051/4CE2004A26]	Beijing Science Nova Program	This work was supported by the Beijing Science Nova Program (2004B051/4CE2004A26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Garcia Jesus, 2004, Ann Hepatol, V3, P34; Arber DA, 1998, SEMIN DIAGN PATHOL, V15, P155; ARBER DA, 1995, HUM PATHOL, V26, P1093, DOI 10.1016/0046-8177(95)90271-6; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Bousnina S, 2004, Rev Pneumol Clin, V60, P55, DOI 10.1016/S0761-8417(04)72085-4; Fan HX, 2004, INT J CANCER, V112, P1036, DOI 10.1002/ijc.20520; Gulley ML, 2008, J MOL DIAGN, V10, P279, DOI 10.2353/jmoldx.2008.080023; Henderson JW, 1994, ORBITAL TUMORS, P317; Ishikawa T, 2004, INT J UROL, V11, P337, DOI 10.1111/j.1442-2042.2004.00790.x; Janik JS, 2003, J PEDIATR SURG, V38, P1491, DOI 10.1016/S0022-3468(03)00501-3; Jin Rui, 2010, INT C BIOM ENG COMP, P432; Karnak I, 2001, J PEDIATR SURG, V36, P908, DOI 10.1053/jpsu.2001.23970; Lin Huai-xue, 1988, CHINESE J PRACTICAL, V6, P46; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lo YMD, 1999, CANCER RES, V59, P1188; Martin C J, 1997, J Am Optom Assoc, V68, P775; MAVES CK, 1989, RADIOLOGY, V173, P381, DOI 10.1148/radiology.173.2.2678252; Mergan F, 2005, J PEDIATR SURG, V40, P1581, DOI 10.1016/j.jpedsurg.2005.06.021; Mertens, 2002, PATHOLOGY GENETICS T, P91; Morotti RA, 2005, PEDIATR DEVEL PATHOL, V8, P224, DOI 10.1007/s10024-004-8088-5; Puyan FO, 2004, EUR J HAEMATOL, V72, P285, DOI 10.1111/j.0902-4441.2003.00208.x; Rehmani Jamshed A, 2004, J Coll Physicians Surg Pak, V14, P53; Sanders BM, 2001, J PEDIATR SURG, V36, P169, DOI 10.1053/jpsu.2001.20045; STARK P, 1992, CHEST, V102, P1884, DOI 10.1378/chest.102.6.1884; Sun Hongxia, 2005, OPHTHALMOLOGY CHINA, V6, P369; Trevenzoli M, 2003, ANN MED INTERNE, V154, P557	26	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50812	10.1371/journal.pone.0050812	http://dx.doi.org/10.1371/journal.pone.0050812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300945	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900004
J	Rengo, G; Pagano, G; Squizzato, A; Moja, L; Femminella, GD; de Lucia, C; Komici, K; Parisi, V; Savarese, G; Ferrara, N; Perrone-Filardi, P; Leosco, D				Rengo, Giuseppe; Pagano, Gennaro; Squizzato, Alessandro; Moja, Lorenzo; Femminella, Grazia Daniela; de Lucia, Claudio; Komici, Klara; Parisi, Valentina; Savarese, Gianluigi; Ferrara, Nicola; Perrone-Filardi, Pasquale; Leosco, Dario			Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COLLEGE-OF-CARDIOLOGY; ASSOCIATION TASK-FORCE; ESC WORKING GROUP; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; FOCUSED UPDATE; THROMBOEMBOLISM	Background: Heart failure (HF) patients show high morbidity and mortality rate with increased risk of malignant arrhythmia and thromboembolism. Anticoagulation reduces embolic event and death rates in HF patients with atrial fibrillation, but if antithrombotic therapy is beneficial in patients with HF in sinus rhythm is still debated. Methodology and Principal Findings: We conducted a systematic review of prospective, randomized controlled trials (RCTs) to assess the efficacy and safety of oral anticoagulant therapies (OATs) compared to antiplatelet treatment in HF patients in sinus rhythm. MEDLINE, Web of Science, CENTRAL and Scopus databases were searched up to May 2012. Four RCTs were identified and a total of 3663 patients were included in the meta-analysis. Patients with both ischemic and non-ischemic HF were included. There was no significant difference in mortality (odds ratio (OR) 1.01, 95% confidence interval (CI) 0.86 to 1.19) between OATs group and antiplatelet drug group. OATs have reduced ischemic stroke risk (OR 0.49, 95% CI 0.32 to 0.74), but have increased major bleeding risk (OR 2.01, 95% CI 1.40 to 2.88) compared to antiplatelet treatment. Conclusion: In HF patients in sinus rhythm OATs do not show a better risk-benefit profile compared to antiplatelet treatment in cardioembolism prevention. Warfarin and aspirin seem to be similar in reducing mortality. Warfarin reduces the incidence of ischemic stroke, but increases major bleedings. Thus, it is possible to speculate that aspirin prescription be indicated in patients with high risk of bleeding, whereas warfarin could be preferred in patients with high thromboembolic risk.	[Rengo, Giuseppe; Ferrara, Nicola] Salvatore Maugeri Fdn, Div Cardiol, IRCCS Sci Inst Telese Terme, Benevento, Italy; [Rengo, Giuseppe; Pagano, Gennaro; Femminella, Grazia Daniela; de Lucia, Claudio; Komici, Klara; Parisi, Valentina; Ferrara, Nicola; Leosco, Dario] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy; [Squizzato, Alessandro] Univ Insubria, Res Ctr Thromboembol Disorders & Antithrombot The, Dept Clin & Expt Med, Varese, Italy; [Moja, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Moja, Lorenzo] IRCCS Galeazzi Orthoped Inst, Milan, Italy; [Savarese, Gianluigi; Perrone-Filardi, Pasquale] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Naples Federico II; University of Insubria; University of Milan; IRCCS Istituto Ortopedico Galeazzi; University of Naples Federico II	Rengo, G (corresponding author), Salvatore Maugeri Fdn, Div Cardiol, IRCCS Sci Inst Telese Terme, Benevento, Italy.	giuseppe.rengo@unina.it; gennaropagano85@hotmail.com	Moja, Pasquale Lorenzo/CAH-0318-2022; Parisi, Valentina/K-7062-2016; komici, klara/O-2329-2018; Ferrara, Nicola/A-2904-2014; Ferrara, Nicola/ABG-2180-2021; Rengo, Giuseppe/K-4963-2016; Squizzato, Alessandro/AAC-3575-2019; Rengo, Giuseppe/AAA-2870-2021; Pagano, Gennaro/K-9797-2013; Perrone Filardi, Pasquale/AAC-7590-2022; De Lucia, Claudio/H-4668-2019; Savarese, Gianluigi/K-6845-2016; Komici, Klara/K-7723-2016	Moja, Pasquale Lorenzo/0000-0001-6680-6507; Ferrara, Nicola/0000-0001-8200-4942; Rengo, Giuseppe/0000-0002-9701-0437; Squizzato, Alessandro/0000-0001-5705-2897; Rengo, Giuseppe/0000-0002-9701-0437; Pagano, Gennaro/0000-0002-6247-8988; De Lucia, Claudio/0000-0002-4346-111X; Savarese, Gianluigi/0000-0001-7732-0887; Leosco, Dario/0000-0002-6543-5721; Komici, Klara/0000-0001-9419-2426; Parisi, Valentina/0000-0003-4614-474X; Femminella, Grazia Daniela/0000-0002-7397-483X				Agarwal S, 2012, ARCH INTERN MED, V172, P623, DOI 10.1001/archinternmed.2012.121; ANDERSON GM, 1950, AM HEART J, V39, P697, DOI 10.1016/0002-8703(50)90129-3; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cokkinos DV, 2006, EUR J HEART FAIL, V8, P428, DOI 10.1016/j.ejheart.2006.02.012; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Freudenberger RS, 2010, THROMB HAEMOSTASIS, V103, P489, DOI 10.1160/TH09-04-0247; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; GRIFFITH GC, 1952, ANN INTERN MED, V37, P867, DOI 10.7326/0003-4819-37-5-867; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; HARVEY WP, 1950, NEW ENGL J MED, V242, P208, DOI 10.1056/NEJM195002092420603; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Isnard R, 2001, EUR J HEART FAIL, V3, P265, DOI 10.1016/S1388-9842(01)00140-4; KANNEL WB, 1983, JAMA-J AM MED ASSOC, V250, P2942, DOI 10.1001/jama.250.21.2942; Lip GYH, 2012, EUR J HEART FAIL, V14, P681, DOI 10.1093/eurjhf/hfs073; Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690; Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pilotto A, 2010, CIRC-HEART FAIL, V3, P14, DOI 10.1161/CIRCHEARTFAILURE.109.865022; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Wann LS, 2011, J AM COLL CARDIOL, V57, P223, DOI 10.1016/j.jacc.2010.10.001; Witt BJ, 2007, J CARD FAIL, V13, P489, DOI 10.1016/j.cardfail.2007.01.009; Witt BJ, 2006, AM HEART J, V152, P102, DOI 10.1016/j.ahj.2005.10.018	35	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52952	10.1371/journal.pone.0052952	http://dx.doi.org/10.1371/journal.pone.0052952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301006	Green Published, gold			2022-12-27	WOS:000313320900049
J	Lee, WY; Sun, LM; Lin, MC; Liang, JA; Chang, SN; Sung, FC; Muo, CH; Kao, CH				Lee, Wen-Yuan; Sun, Li-Min; Lin, Ming-Chia; Liang, Ji-An; Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin; Kao, Chia-Hung			A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study	PLOS ONE			English	Article							ESOPHAGEAL CANCER; BISPHOSPHONATES; DISEASE; TRENDS	Background: Controversy still exists regarding whether alendronate (ALN) use increases the risk of esophageal cancer or breast cancer. Methods: This paper explores the possible association between the use of oral ALN in osteoporosis patients and subsequent cancer risk using the National Health Insurance (NHI) system database of Taiwan with a Cox proportional-hazard regression analysis. The exposure cohort contained 5,624 osteoporosis patients used ALN and randomly frequency-matched by age and gender of 3 osteoporosis patients without any kind of anti-osteoporosis drugs in the same period. Results: For a dose >= 1.0 g/year, the risk of developing overall cancer was significantly higher (hazard ratio: 1.69, 95% confidence ratio: 1.39-2.04) than in osteoporosis patients without any anti-osteoporosis drugs. The risks for developing liver, lung, and prostate cancers and lymphoma were also significantly higher than in the control group. Conclusions: This population-based retrospective cohort study did not find a relationship between ALN use and either esophageal or breast cancer, but unexpectedly discovered that use of ALN with dose >= 1.0 g/year significantly increased risks of overall cancer incidence, as well as liver, lung, and prostate cancers and lymphoma. Further large population-based unbiased studies to enforce our findings are required before any confirmatory conclusion can be made.	[Lee, Wen-Yuan] China Med Univ Hosp, Taipei Branch, Taichung, Taiwan; [Lee, Wen-Yuan; Liang, Ji-An; Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Wen-Yuan; Liang, Ji-An; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Sun, Li-Min] Zuoying Armed Forces Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Lin, Ming-Chia] E DA Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Shih-Ni] China Med Univ, Ph D Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chang, Shih-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Inst Environm Hlth, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; E-Da Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Muo, CH (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	A17776@mail.cmuh.org; d10040@mail.cmuh.org.tw			Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH101-TD-C-111-005];  [DMR-101-061];  [DMR-100-076]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; ; 	The study was supported in part by the study projects (DMR-101-061 and DMR-100-076) in the authors' hospital and the Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH101-TD-B-111-004), and the Taiwan Department of Health Cancer Research Center for Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; [Anonymous], CANC STAT ANN REP; [Anonymous], BROWS AL SOD SID EFF; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Cossentino Mark J, 2003, Semin Gastrointest Dis, V14, P128; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Dreyfuss John Henry, 2010, CA Cancer J Clin, V60, P343, DOI 10.3322/caac.20091; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555; Peter C, 1999, INT J CLIN PRACT, P3; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Ryan JM, 1998, RADIOLOGY, V206, P389, DOI 10.1148/radiology.206.2.9457190; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Vestergaard P, 2011, CALCIFIED TISSUE INT, V88, P255, DOI 10.1007/s00223-011-9463-7; Wang Y, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-34; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	27	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53032	10.1371/journal.pone.0053032	http://dx.doi.org/10.1371/journal.pone.0053032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300854	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600051
J	Ringpis, GEE; Shimizu, S; Arokium, H; Camba-Colon, J; Carroll, MV; Cortado, R; Xie, YM; Kim, PY; Sahakyan, A; Lowe, EL; Narukawa, M; Kandarian, FN; Burke, BP; Symonds, GP; An, DS; Chen, ISY; Kamata, M				Ringpis, Gene-Errol E.; Shimizu, Saki; Arokium, Hubert; Camba-Colon, Joanna; Carroll, Maria V.; Cortado, Ruth; Xie, Yiming; Kim, Patrick Y.; Sahakyan, Anna; Lowe, Emily L.; Narukawa, Munetoshi; Kandarian, Fadi N.; Burke, Bryan P.; Symonds, Geoff P.; An, Dong Sung; Chen, Irvin S. Y.; Kamata, Masakazu			Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem/Progenitor Cells in Humanized BLT Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUPPRESSES HIV-1 INFECTION; GENE-THERAPY; LENTIVIRAL VECTOR; TAR DECOY; MONONUCLEAR PHAGOCYTES; DISEASE PROGRESSION; CCR5; INHIBITION; INTERFERENCE	Down-regulation of the HIV-1 coreceptor CCR5 holds significant potential for long-term protection against HIV-1 in patients. Using the humanized bone marrow/liver/thymus (hu-BLT) mouse model which allows investigation of human hematopoietic stem/progenitor cell (HSPC) transplant and immune system reconstitution as well as HIV-1 infection, we previously demonstrated stable inhibition of CCR5 expression in systemic lymphoid tissues via transplantation of HSPCs genetically modified by lentiviral vector transduction to express short hairpin RNA (shRNA). However, CCR5 down-regulation will not be effective against existing CXCR4-tropic HIV-1 and emergence of resistant viral strains. As such, combination approaches targeting additional steps in the virus lifecycle are required. We screened a panel of previously published shRNAs targeting highly conserved regions and identified a potent shRNA targeting the R-region of the HIV-1 long terminal repeat (LTR). Here, we report that human CD4(+) T-cells derived from transplanted HSPC engineered to co-express shRNAs targeting CCR5 and HIV-1 LTR are resistant to CCR5- and CXCR4-tropic HIV-1-mediated depletion in vivo. Transduction with the combination vector suppressed CXCR4- and CCR5-tropic viral replication in cell lines and peripheral blood mononuclear cells in vitro. No obvious cytotoxicity or interferon response was observed. Transplantation of combination vector-transduced HSPC into hu-BLT mice resulted in efficient engraftment and subsequent stable gene marking and CCR5 down-regulation in human CD4(+) T-cells within peripheral blood and systemic lymphoid tissues, including gut-associated lymphoid tissue, a major site of robust viral replication, for over twelve weeks. CXCR4- and CCR5-tropic HIV-1 infection was effectively inhibited in hu-BLT mouse spleen-derived human CD4(+) T-cells ex vivo. Furthermore, levels of gene-marked CD4(+) T-cells in peripheral blood increased despite systemic infection with either CXCR4- or CCR5-tropic HIV-1 in vivo. These results demonstrate that transplantation of HSPCs engineered with our combination shRNA vector may be a potential therapy against HIV disease.	[Ringpis, Gene-Errol E.; Arokium, Hubert; Xie, Yiming; Kim, Patrick Y.; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ringpis, Gene-Errol E.; Shimizu, Saki; Arokium, Hubert; Xie, Yiming; Kim, Patrick Y.; An, Dong Sung; Chen, Irvin S. Y.; Kamata, Masakazu] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Shimizu, Saki; An, Dong Sung; Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Camba-Colon, Joanna; Carroll, Maria V.; Burke, Bryan P.; Symonds, Geoff P.] Calimmune Inc, Los Angeles, CA USA; [Cortado, Ruth; Sahakyan, Anna; Lowe, Emily L.; Narukawa, Munetoshi; An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Kandarian, Fadi N.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Kandarian, Fadi N.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Sahakyan, Anna/0000-0002-8840-9171; Kamata, Masakazu/0000-0003-0323-3742; Chen, Irvin/0000-0003-1199-2415	California Institute for Regenerative Medicine [DR1-01431]; National Institutes of Health [1RO1HL086409, 3RO1HL086409-03S1, 5T32AI060567]; University of California Los Angeles AIDS Institute/Center for AIDS Research [5P30AI028697]; CIRM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, P30AI028697, T32AI060567] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles AIDS Institute/Center for AIDS Research; CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM grant DR1-01431 to ISYC), the National Institutes of Health (1RO1HL086409 and 3RO1HL086409-03S1 to DSA and 5T32AI060567), and the University of California Los Angeles AIDS Institute/Center for AIDS Research (5P30AI028697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ISYC and DSA have a financial interest in Calimmune, Inc. Calimmune is a subcontractor of the grant from CIRM. GER, ISYC, and MK are co-inventors of a provisional application for patent titled SHRNA VECTORS FOR THE TREATMENT OF HIV, #US 61/647,201 (UCLA Case 2012-623-1). All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Anderson J, 2007, MOL THER, V15, P1182, DOI 10.1038/sj.mt.6300157; Anderson JS, 2009, MOL THER, V17, P2103, DOI 10.1038/mt.2009.187; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Baba M, 2000, AIDS RES HUM RETROV, V16, P935, DOI 10.1089/08892220050058344; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kiem HP, 2012, CELL STEM CELL, V10, P137, DOI 10.1016/j.stem.2011.12.015; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; Klasens BIF, 1999, NUCLEIC ACIDS RES, V27, P446, DOI 10.1093/nar/27.2.446; Koper-Emde D, 2004, BIOL CHEM, V385, P791, DOI 10.1515/BC.2004.103; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Liang M, 2010, J GENE MED, V12, P255, DOI 10.1002/jgm.1440; Mcintyre GJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-55; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Morner A, 1999, J VIROL, V73, P2343; Neff CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020209; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Poon B, 2005, J VIROL, V79, P10210, DOI 10.1128/JVI.79.16.10210-10217.2005; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Symonds GP, 2010, IMMUNOL RES, V48, P84, DOI 10.1007/s12026-010-8169-7; Tamhane Mayur, 2008, AIDS Res Ther, V5, P16, DOI 10.1186/1742-6405-5-16; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; Ter Brake O, 2007, J GENE MED, V9, P743, DOI 10.1002/jgm.1078; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; UNAIDS, 2011, 2011 WORLD AIDS DAY; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	64	48	48	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53492	10.1371/journal.pone.0053492	http://dx.doi.org/10.1371/journal.pone.0053492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300932	gold, Green Published			2022-12-27	WOS:000313872600103
J	Migrenne, S; Moreau, E; Pakarinen, P; Dierich, A; Merlet, J; Habert, R; Racine, C				Migrenne, Stephanie; Moreau, Evelyne; Pakarinen, Pirjo; Dierich, Andree; Merlet, Jorge; Habert, Rene; Racine, Chrystele			Mouse Testis Development and Function Are Differently Regulated by Follicle-Stimulating Hormone Receptors Signaling During Fetal and Prepubertal Life	PLOS ONE			English	Article							LEYDIG-CELL DEVELOPMENT; ANTI-MULLERIAN HORMONE; TRANSCRIPTION FACTORS GATA-4; SERTOLI-CELLS; RAT TESTIS; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; MICE; STEROIDOGENESIS; PROLIFERATION	It is currently admitted that Follicle-Stimulating Hormone (FSH) is physiologically involved in the development and function of fetal/neonatal Sertoli cells in the rat but not the mouse. However, FSH is produced by both species from late fetal life onwards. We thus reinvestigated the role of FSH in mouse testis development at day 0 (birth) 6, 8 and 10 post-partum (dpp) by using mice that lack functional FSH receptors (FSH-R-/-). At birth, the number and proliferative index of Sertoli cells were significantly lower in FSH-R-/- mice than in wild type neonates. Claudin 11 mRNA expression also was significantly reduced in FSH-R-/- testes at 0 and 8 dpp, whereas the mRNA levels of other Sertoli cell markers (Transferrin and Desert hedgehog) were comparable in FSH-R-/- and wild type testes. Conversely, AMH mRNA and protein levels were higher at birth, comparable at 6 dpp and then significantly lower in FSH-R-/- testes at 8-10 dpp in FSH-R-/- mice than in controls. Although the plasma concentration of LH and the number of Leydig cells were similar in FSH-R-/- and control (wild type), testosterone concentration and P450c17 mRNA expression were significantly increased in FSH-R-/- testes at birth. Conversely, at 10 dpp when adult Leydig cells appear, expression of the steroidogenic genes P450scc, P450c17 and StAR was lower in FSH-R-/- testes than in controls. In conclusion, our results show that 1) like in the rat, signaling via FSH- R controls Sertoli cell development and function during late fetal life in the mouse as well; 2) paracrine factors produced by Sertoli cells are involved in the FSH-R-dependent regulation of the functions of fetal Leydig cells in late fetal life; and 3) the role of FSH-R signaling changes during the prepubertal period.	[Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France; [Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] CEA, DSV, iRCM, SCSR,LDG, Fontenay Aux Roses, France; [Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] INSERM, U967, Fontenay Aux Roses, France; [Pakarinen, Pirjo] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Dierich, Andree] CNRS 7104, IGBMC, Illkirch Graffenstaden, France; [Dierich, Andree] INSERM, U964, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Habert, R (corresponding author), Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France.	rene.habert@cea.fr		Racine, Chrystele/0000-0003-0250-5355; Habert, Rene/0000-0002-6045-0324	Universite Paris Diderot; INSERM; CEA; Ministere de l'Education Nationale et de la Recherche; Fondation pour la Recherche Medicale	Universite Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Ministere de l'Education Nationale et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Universite Paris Diderot, INSERM and CEA. Stephanie Migrenne holds PhD studentships from the Ministere de l'Education Nationale et de la Recherche and from the Fondation pour la Recherche Medicale. Jorge Merlet holds a PhD studentship from the Ministere de l'Education Nationale et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Barakat B, 2012, MOL CELL ENDOCRINOL, V359, P66, DOI 10.1016/j.mce.2012.02.018; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Delbes R, 2004, ENDOCRINOLOGY, V145, P3395, DOI 10.1210/en.2003-1479; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; HABERT R, 1982, ACTA ENDOCRINOL-COP, V99, P466, DOI 10.1530/acta.0.0990466; Habert R, 2009, FOLIA HISTOCHEM CYTO, V47, pS67, DOI 10.2478/v10042-009-0056-5; Heikinheimo M, 1997, ENDOCRINOLOGY, V138, P3505, DOI 10.1210/en.138.8.3505; HUHTANIEMI I, 1989, International Journal of Developmental Biology, V33, P117; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; KERR JB, 1988, DEVELOPMENT, V103, P535; KERR JB, 1985, CELL TISSUE RES, V239, P405, DOI 10.1007/BF00218021; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Krishnamurthy H, 2001, BIOL REPROD, V65, P1201, DOI 10.1095/biolreprod65.4.1201; KURODA T, 1990, ENDOCRINOLOGY, V127, P1825, DOI 10.1210/endo-127-4-1825; LECERF L, 1993, ENDOCRINOLOGY, V133, P2313, DOI 10.1210/en.133.5.2313; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; MAGRE S, 1991, J ELECTRON MICR TECH, V19, P172, DOI 10.1002/jemt.1060190205; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Migrenne S, 2003, ENDOCRINOLOGY, V144, P2617, DOI 10.1210/en.2002-0011; Migrenne S, 2001, MOL CELL ENDOCRINOL, V172, P193, DOI 10.1016/S0303-7207(00)00339-7; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; NORTON JN, 1989, ENDOCRINOLOGY, V124, P2711, DOI 10.1210/endo-124-6-2711; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 2011, REPRODUCTION, V141, P37, DOI 10.1530/REP-10-0365; ORTH JM, 1984, ENDOCRINOLOGY, V115, P1248, DOI 10.1210/endo-115-4-1248; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Park SY, 2007, ENDOCRINOLOGY, V148, P3704, DOI 10.1210/en.2006-1731; PICON R, 1981, ACTA ENDOCRINOL-COP, V97, P176, DOI 10.1530/acta.0.0970176; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; RANNIKKI AS, 1995, MOL CELL ENDOCRINOL, V107, P199, DOI 10.1016/0303-7207(94)03444-X; Rouiller-Fabre V, 1998, ENDOCRINOLOGY, V139, P1213, DOI 10.1210/en.139.3.1213; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; SKINNER MK, 1980, J BIOL CHEM, V255, P9523; Svechnikov K, 2008, BEST PRACT RES CL EN, V22, P95, DOI 10.1016/j.beem.2007.09.002; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; TEERDS KJ, 1989, J ENDOCRINOL, V120, P97, DOI 10.1677/joe.0.1200097; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VERGOUWEN RPFA, 1993, J REPROD FERTIL, V99, P479, DOI 10.1530/jrf.0.0990479; WARREN DW, 1973, BIOL REPROD, V8, P560, DOI 10.1093/biolreprod/8.5.560; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202	55	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53257	10.1371/journal.pone.0053257	http://dx.doi.org/10.1371/journal.pone.0053257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300903	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100131
J	Ren, J; Sun, JH; Zhang, YP; Liu, T; Ren, QZ; Li, Y; Guo, AK				Ren, Jing; Sun, Jinghan; Zhang, Yunpeng; Liu, Tong; Ren, Qingzhong; Li, Yan; Guo, Aike			Down-Regulation of Decapping Protein 2 Mediates Chronic Nicotine Exposure-Induced Locomotor Hyperactivity in Drosophila	PLOS ONE			English	Article							MESSENGER-RNA TURNOVER; LONG-TERM CHANGES; ADULT DROSOPHILA; MELANOGASTER; GENE; RECEPTORS; MODEL; BEHAVIOR; PATHWAY; ETHANOL	Long-term tobacco use causes nicotine dependence via the regulation of a wide range of genes and is accompanied by various health problems. Studies in mammalian systems have revealed some key factors involved in the effects of nicotine, including nicotinic acetylcholine receptors (nAChRs), dopamine and other neurotransmitters. Nevertheless, the signaling pathways that link nicotine-induced molecular and behavioral modifications remain elusive. Utilizing a chronic nicotine administration paradigm, we found that adult male fruit flies exhibited locomotor hyperactivity after three consecutive days of nicotine exposure, while nicotine-naive flies did not. Strikingly, this chronic nicotine-induced locomotor hyperactivity (cNILH) was abolished in Decapping Protein 2 or 1 (Dcp2 or Dcp1) -deficient flies, while only Dcp2-deficient flies exhibited higher basal levels of locomotor activity than controls. These results indicate that Dcp2 plays a critical role in the response to chronic nicotine exposure. Moreover, the messenger RNA (mRNA) level of Dcp2 in the fly head was suppressed by chronic nicotine treatment, and up-regulation of Dcp2 expression in the nervous system blocked cNILH. These results indicate that down-regulation of Dcp2 mediates chronic nicotine-exposure-induced locomotor hyperactivity in Drosophila. The decapping proteins play a major role in mRNA degradation; however, their function in the nervous system has rarely been investigated. Our findings reveal a significant role for the mRNA decapping pathway in developing locomotor hyperactivity in response to chronic nicotine exposure and identify Dcp2 as a potential candidate for future research on nicotine dependence.	[Ren, Jing; Liu, Tong; Ren, Qingzhong; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [Sun, Jinghan; Zhang, Yunpeng; Li, Yan; Guo, Aike] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	liyan@ibp.ac.cn; akguo@ion.ac.cn	Ren, Qingzhong/U-6833-2017; Zhang, Yunpeng/AAT-5139-2021	Ren, Qingzhong/0000-0001-9633-1477; Zhang, Yunpeng/0000-0001-6014-0193	973 Program [2011CBA00400]; National Science Foundation of China [30921064, 90820008, 31130027, 31070956, 91132709]; One Hundred Talents Project of the CAS [KSCX2-YW-R-156]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB02040100]	973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Project of the CAS; "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a 973 Program (Grant 2011CBA00400 to A.G.), the National Science Foundation of China (Grants 30921064, 90820008, and 31130027 to A.G., 31070956 and 91132709 to Y.L.), the One Hundred Talents Project of the CAS (KSCX2-YW-R-156 to Y.L.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences, grant No.XDB02040100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JL, 1993, J PHYSIOL-LONDON, V463, P605, DOI 10.1113/jphysiol.1993.sp019613; Asherson P, 2007, BRIT J PSYCHIAT, V190, P4, DOI 10.1192/bjp.bp.106.026484; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barik Jacques, 2009, Handb Exp Pharmacol, P173, DOI 10.1007/978-3-540-69248-5_7; Cavalieri C, 2010, FOOD ADDIT CONTAM A, V27, P473, DOI 10.1080/19440040903479768; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Cohen LS, 2005, MOL CELL BIOL, V25, P8779, DOI 10.1128/MCB.25.20.8779-8791.2005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Dwoskin LP, 1999, PSYCHOPHARMACOLOGY, V145, P442, DOI 10.1007/s002130051079; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Ferrari R, 2002, EUR J NEUROSCI, V15, P1810, DOI 10.1046/j.1460-9568.2001.02009.x; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hillebrand J, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00121; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; Huang WH, 2009, INT J NEUROPSYCHOPH, V12, P537, DOI 10.1017/S1461145708009528; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; KLEIN E, 1992, BIOL PSYCHIAT, V31, P279, DOI 10.1016/0006-3223(92)90051-Z; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Li MD, 2002, MOL NEUROBIOL, V25, P265, DOI 10.1385/MN:25:3:265; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; McCarthy MJ, 2012, PSYCHOPHARMACOLOGY, V221, P143, DOI 10.1007/s00213-011-2559-y; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpot RM, 2012, BEHAV BRAIN RES, V230, P62, DOI 10.1016/j.bbr.2012.01.036; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Sellier MJ, 2011, CHEM SENSES, V36, P323, DOI 10.1093/chemse/bjq133; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trauth JA, 2001, BRAIN RES, V892, P269, DOI 10.1016/S0006-8993(00)03227-3; Trimarchi JR, 1997, J NEUROSCI, V17, P4700; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Wang Ju, 2011, Front Psychiatry, V2, P5, DOI 10.3389/fpsyt.2011.00005; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhu HW, 2005, BIOL PSYCHIAT, V58, P981, DOI 10.1016/j.biopsych.2005.05.026	55	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52521	10.1371/journal.pone.0052521	http://dx.doi.org/10.1371/journal.pone.0052521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300696	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800100
J	Schleifer, D; Rothman, DJ				Schleifer, David; Rothman, David J.			"The Ultimate Decision Is Yours'': Exploring Patients' Attitudes about the Overuse of Medical Interventions	PLOS ONE			English	Article							HEALTH-CARE SERVICES; INSURANCE	Previous research has found that American patients strongly believe that more testing and more treatment lead to better outcomes and, to a lesser extent, that newer treatments are more effective. We conducted five focus groups with privately insured, healthy, middle-aged Americans (n = 43) to explore these apparent preferences. Contrary to previous research, an unexpected distinction emerged. Participants placed enormous value on testing and screening, reacting with hostility to guidelines recommending less of either. However, they were suspicious of overmedication. The wariness of pharmaceuticals and enthusiasm for testing and screening both appear to reflect participants' efforts to take responsibility for their health. But recommendations to test and screen less conflicted with their active, engaged, information-seeking roles. Nonetheless, given patients' concerns about overuse of pharmaceuticals, we maintain that they can learn to understand the connections between over-testing and over-treatment, and can actively choose to do less. We close with suggestions about how treatment guidelines can better communicate these connections to patients. Our findings cannot necessarily be generalized beyond privately-insured, healthy, middle-aged Americans. But because we found that, among these individuals, attitudes towards pharmaceuticals differ from attitudes towards testing and screening, we maintain that future research should also distinguish among and compare attitudes towards different types of medical interventions.	[Schleifer, David; Rothman, David J.] Columbia Univ Coll Phys & Surg, Ctr Med Profess, New York, NY 10032 USA	Columbia University	Schleifer, D (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Med Profess, 630 W 168th St, New York, NY 10032 USA.	david.schleifer@gmail.com		Schleifer, David/0000-0002-7341-6897	Selz Foundation	Selz Foundation	This research was supported by a grant from the Selz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIM Foundation, 2012, CHOOS WIS; [Anonymous], 2011, CHICAGO TRIBUNE; [Anonymous], 2008, US TODAY; Arkes HR, 2012, PSYCHOL SCI, V23, P547, DOI 10.1177/0956797612437428; ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329; Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Barker KK, 2011, SOC SCI MED, V72, P1351, DOI 10.1016/j.socscimed.2011.02.024; Best RK, 2012, AM SOCIOL REV, V77, P780, DOI 10.1177/0003122412458509; Brawley O, 2012, CNN HLTH; BRODY DS, 1980, ANN INTERN MED, V93, P718, DOI 10.7326/0003-4819-93-5-718; Broom A, 2005, QUAL HEALTH RES, V15, P325, DOI 10.1177/1049732304272916; Carman K. L., 2010, HEALTH AFFAIR, V29, P1; Chapman Steve, 2011, CHICAGO TRIBUNE; Chimonas S, 2011, ACAD MED, V86, P293, DOI 10.1097/ACM.0b013e3182087156; Davidson AS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.005; DeNavas-Walt C, 2013, US CENSUS BUREAU CUR; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Epstein S, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, P499; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Gerber AS, 2010, HEALTH AFFAIR, V29, P1882, DOI 10.1377/hlthaff.2010.0185; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Hemo B, 2009, AM J MANAG CARE, V15, P529; Henwood F, 2003, SOCIOL HEALTH ILL, V25, P589, DOI 10.1111/1467-9566.00360; Hood VL, 2012, EUR J INTERN MED, V23, P495, DOI 10.1016/j.ejim.2012.03.006; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Institute of Medicine, 2001, CROSSING QUALITY CHA; James CD, 2011, INT J QUAL HEALTH C, V23, P445, DOI 10.1093/intqhc/mzr029; Kaiser Family Foundation, 2011, KAIS HLTH TRACK POLL; Keyhani S, 2012, MED CARE, V50, P257, DOI 10.1097/MLR.0b013e3182422b0f; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Long Q, 2012, SOC SCI MED, V75, P733, DOI 10.1016/j.socscimed.2012.03.054; McHorney CA, 2011, HEALTH EXPECT, V14, P307, DOI 10.1111/j.1369-7625.2010.00619.x; McIntyre MJ, 2011, AUST HEALTH REV, V35, P211, DOI 10.1071/AH10919; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Parker-Pope T, 2012, NY TIMES, pA21; Parker-Pope T, 2012, NY TIMES, pD5; Parsons T, 1951, SOCIAL SYSTEM, P428; Rabin RC, 2012, NY TIMES, pA10; Rosenbaum L, 2012, BOSTON GLOBE, pA15; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P2027, DOI 10.1001/jama.295.17.2027; Rothman D., 1991, STRANGERS BEDSIDE HI, DOI DOI 10.4324/9781315130286; Schepers J, 2007, INFORM MANAGE-AMSTER, V44, P90, DOI 10.1016/j.im.2006.10.007; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shin SM, 2010, J ADV NURS, V66, P2257, DOI 10.1111/j.1365-2648.2010.05364.x; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tucker C, 2009, ATLANTA J CONSTITUTI; Welch H, 2011, OVERDIAGNOSED MAKING; Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006; Woloshin S, 2012, NY TIMES, pD5; Woolf SH, 2012, JAMA-J AM MED ASSOC, V307, P565, DOI 10.1001/jama.2012.100; YOUNG PL, 2010, HEALTHCARE IMPERATIV	58	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52552	10.1371/journal.pone.0052552	http://dx.doi.org/10.1371/journal.pone.0052552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300706	Green Published, gold			2022-12-27	WOS:000313618800106
J	Wei, PL; Liu, SP; Keller, JJ; Lin, HC				Wei, Po-Li; Liu, Shih-Ping; Keller, Joseph J.; Lin, Herng-Ching			Volume-Outcome Relation for Acute Appendicitis: Evidence from a Nationwide Population-Based Study	PLOS ONE			English	Article							HOSPITAL VOLUME; PERFORATED APPENDICITIS; NEGATIVE APPENDECTOMY; SURGICAL MORTALITY; UNITED-STATES; ASIAN COUNTRY; IMPACT; RATES; RISK; ASSOCIATION	Background: Although procedures like appendectomy have been studied extensively, the relative importance of each surgeon's surgical volume-to-ruptured appendicitis has not been explored. The purpose of this study was to investigate the rate of ruptured appendicitis by surgeon-volume groups as a measure of quality of care for appendicitis by using a nationwide population-based dataset. Methods: We identified 65,339 first-time hospitalizations with a discharge diagnosis of acute appendicitis (International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes 540, 540.0, 540.1 and 540.9) between January 2007 and December 2009. We used "whether or not a patient had a perforated appendicitis'' as the outcome measure. A conditional (fixed-effect) logistic regression model was performed to explore the odds of perforated appendicitis among surgeon case volume groups. Results: Patients treated by low-volume surgeons had significantly higher morbidity rates than those treated by high-volume (28.1% vs. 26.15, p < 0.001) and very-high-volume surgeons (28.1% vs. 21.4%, p < 0.001). After adjusting for surgeon practice location, and teaching status of practice hospital, and patient age, gender, and Charlson Comorbidity Index, and hospital acute appendicitis volume, patients treated by low-volume surgeons had significantly higher rates of perforated appendicitis than those treated by medium-volume surgeons (OR = 1.09, p < 0.001), high-volume surgeons (OR = 1.16, p < 0.001), or very-high-volume surgeons (OR = 1.54, p < 0.001). Conclusion: Our study suggested that surgeon volume is an important factor with regard to the rate of ruptured appendicitis.	[Wei, Po-Li] Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Dept Surg, Sch Med, Coll Med, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Keller, Joseph J.] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Al-Omran M, 2003, CAN J SURG, V46, P263; Andersson RE, 2007, WORLD J SURG, V31, P86, DOI 10.1007/s00268-006-0056-y; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Camp M, 2010, ARCH SURG-CHICAGO, V145, P1139, DOI 10.1001/archsurg.2010.271; Ditillo MF, 2006, ANN SURG, V244, P656, DOI 10.1097/01.sla.0000231726.53487.dd; Fuchs JR, 2002, J SURG RES, V106, P131, DOI 10.1006/jsre.2002.6441; Hale DA, 1997, ANN SURG, V225, P252, DOI 10.1097/00000658-199703000-00003; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Lien WC, 2011, WORLD J SURG, V35, P1636, DOI 10.1007/s00268-011-1132-5; Lien YC, 2007, ANN THORAC SURG, V83, P1837, DOI 10.1016/j.athoracsur.2006.12.008; Lin HC, 2006, ANN SURG ONCOL, V13, P1182, DOI 10.1245/s10434-006-9005-0; Nallamothu BK, 2005, ARCH INTERN MED, V165, P333, DOI 10.1001/archinte.165.3.333; NITECKI S, 1990, SURG GYNECOL OBSTET, V171, P185; Paquette IM, 2011, ANN SURG, V253, P534, DOI 10.1097/SLA.0b013e3182096d68; Pittman-Waller VA, 2000, AM SURGEON, V66, P548; Ponsky TA, 2004, JAMA-J AM MED ASSOC, V292, P1977, DOI 10.1001/jama.292.16.1977; Smink DS, 2005, PEDIATRICS, V115, P920, DOI 10.1542/peds.2004-1363; Welke KF, 2009, ANN THORAC SURG, V87, P216, DOI 10.1016/j.athoracsur.2008.10.032; Wen HC, 2006, ANN THORAC SURG, V81, P835, DOI 10.1016/j.athoracsur.2005.09.031; WILLIAMS GR, 1983, ANN SURG, V197, P495, DOI 10.1097/00000658-198305000-00001; Williams NMA, 1998, ANN ROY COLL SURG, V80, P122	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52539	10.1371/journal.pone.0052539	http://dx.doi.org/10.1371/journal.pone.0052539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300703	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800104
J	Zou, SL; Ren, PP; Nguyen, M; Coselli, JS; Shen, YH; LeMaire, SA				Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.			Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; ENDOTHELIAL PROGENITOR CELLS; FACTOR-BETA; DEPENDENT PATHWAY; STEM-CELLS; IN-VITRO; DIFFERENTIATION; ACTIVATION; PHENOTYPE; DISEASE	Background: Descending thoracic aortic aneurysm and dissection (DTAAD) is characterized by progressive medial degeneration, which may result from excessive tissue destruction and insufficient repair. Resistance to tissue destruction and aortic self-repair are critical in preventing medial degeneration. The signaling pathways that control these processes in DTAAD are poorly understood. Because Notch signaling is a critical pathway for cell survival, proliferation, and tissue repair, we examined its activation in DTAAD. Methods: We studied descending thoracic aortic tissue from patients with sporadic thoracic aortic aneurysm (TAA; n = 14) or chronic thoracic aortic dissection (TAD; n = 16) and from age-matched organ donors (n = 12). Using western blot, real-time RT-PCR, and immunofluorescence staining, we examined aortic tissue samples for the Notch ligands Delta-like 1, Delta-like 4 (DLL1/4), and Jagged1; the Notch receptor 1 (Notch1); the Notch1 intracellular domain (NICD); and Hes1, a downstream target of Notch signaling. Results: Western blots and RT-PCR showed higher levels of the Notch1 protein and mRNA and the NICD and Hes1 proteins in both TAA and TAD tissues than in control tissue. However, immunofluorescence staining showed a complex pattern of Notch signaling in the diseased tissue. The ligand DLL1/4 and Notch1 were significantly decreased and NICD and Hes1 were rarely detected in medial vascular smooth muscle cells (VSMCs) in both TAA and TAD tissues, indicating downregulation of Notch signaling in aortic VSMCs. Interestingly Jagged1, NICD, and Hes1 were highly present in CD34+ stem cells and Stro-1+ stem cells in aortas from TAA and TAD patients. NICD and Hes1 were also detected in most fibroblasts and macrophages that accumulated in the aortic wall of DTAAD patients. Conclusions: Notch signaling exhibits a complex pattern in DTAAD. The Notch pathway is impaired in medial VSMCs but activated in stem cells, fibroblasts, and macrophages.	[Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA; [Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Surg, Houston, TX USA; [Zou, Sili] Second Mil Med Univ, Changhai Hosp, Dept Vasc Surg, Shanghai, Peoples R China	Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute; Naval Medical University	Shen, YH (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA.	hyshen@bcm.edu; slemaire@bcm.edu	shen, ying/HHS-5635-2022	LeMaire, Scott/0000-0002-8736-4266	Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections [NIH P50 HL083794];  [R01 HL085341]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085341, P50HL083794] Funding Source: NIH RePORTER	Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grant R01 HL085341 (to S.A.L.). The Thoracic Aortic Disease Tissue Bank at Baylor College of Medicine was supported in part through the Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections (NIH P50 HL083794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Barbour JR, 2007, J SURG RES, V139, P292, DOI 10.1016/j.jss.2006.09.020; Biros E, 2012, ATHEROSCLEROSIS, V221, P383, DOI 10.1016/j.atherosclerosis.2012.01.004; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Collins MJ, 2008, J CLIN PATHOL, V61, P519, DOI 10.1136/jcp.2006.046250; Dawson J, 2006, ANN NY ACAD SCI, V1085, P327, DOI 10.1196/annals.1383.011; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Kiparissides A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014668; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lawson ND, 2001, DEVELOPMENT, V128, P3675; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Parietti E, 2011, EUR J CARDIO-THORAC, V40, pE6, DOI 10.1016/j.ejcts.2011.02.065; Piggott K, 2011, CIRCULATION, V123, P309, DOI 10.1161/CIRCULATIONAHA.110.936203; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sciacca S., 2012, HEART VESSELS; Shen YH, 2012, ANN THORAC SURG, V93, P1524, DOI 10.1016/j.athoracsur.2012.01.063; Sho E, 2004, ARTERIOSCL THROM VAS, V24, P1916, DOI 10.1161/01.ATV.0000142805.20398.74; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stewart KS, 2011, BLOOD, V117, P719, DOI 10.1182/blood-2010-05-284869; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yamanouchi D, 2010, ARTERIOSCL THROM VAS, V30, P702, DOI 10.1161/ATVBAHA.109.200527; Yang K, 2011, J BIOL CHEM, V286, P13741, DOI 10.1074/jbc.M110.181842	46	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52833	10.1371/journal.pone.0052833	http://dx.doi.org/10.1371/journal.pone.0052833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300792	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800157
J	Aizer, A; Kafri, P; Kalo, A; Shav-Tal, Y				Aizer, Adva; Kafri, Pinhas; Kalo, Alon; Shav-Tal, Yaron			The P Body Protein Dcp1a Is Hyper-phosphorylated during Mitosis	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; DECAPPING ENZYME; PROCESSING BODIES; CYTOPLASMIC FOCI; BINDING-PROTEIN; CELL-CYCLE; GW BODIES; DECAY; STABILITY; TRANSPORT	Processing bodies (PBs) are non-membranous cytoplasmic structures found in all eukaryotes. Many of their components such as the Dcp1 and Dcp2 proteins are highly conserved. Using live-cell imaging we found that PB structures disassembled as cells prepared for cell division, and then began to reassemble during the late stages of cytokinesis. During the cell cycle and as cells passed through S phase, PB numbers increased. However, there was no memory of PB numbers between mother and daughter cells. Examination of hDcp1a and hDcp1b proteins by electrophoresis in mitotic cell extracts showed a pronounced slower migrating band, which was caused by hyper-phosphorylation of the protein. We found that hDcp1a is a phospho-protein during interphase that becomes hyper-phosphorylated in mitotic cells. Using truncations of hDcp1a we localized the region important for hyper-phosphorylation to the center of the protein. Mutational analysis demonstrated the importance of serine 315 in the hyper-phosphorylation process, while other serine residues tested had a minor affect. Live-cell imaging demonstrated that serine mutations in other regions of the protein affected the dynamics of hDcp1a association with the PB structure. Our work demonstrates the control of PB dynamics during the cell cycle via phosphorylation.	[Shav-Tal, Yaron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; Bar Ilan Univ, Inst Nanotechnol, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Shav-Tal, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	Yaron.Shav-Tal@biu.ac.il	Aizer, Adva/AAR-3385-2020	Shav-Tal, Yaron/0000-0002-8017-948X	Israel Science Foundation [250/06]; Alon Fellowship	Israel Science Foundation(Israel Science Foundation); Alon Fellowship	This work was supported by grants to YST by the Israel Science Foundation (grant 250/06) and the Alon Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2008, PRION, V2, P131, DOI 10.4161/pri.2.4.7773; ALTUS MS, 1991, J BIOL CHEM, V266, P21190; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Blumenthal J, 2009, FEBS LETT, V583, P197, DOI 10.1016/j.febslet.2008.12.002; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Izaurralde E, 2009, NAT REV MOL CELL BIO, V10, DOI 10.1038/nrm2697; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LAIRDOFFRINGA IA, 1990, MOL CELL BIOL, V10, P6132, DOI 10.1128/MCB.10.12.6132; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Ross J, 1997, BIOESSAYS, V19, P527, DOI 10.1002/bies.950190612; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; She MP, 2004, NAT STRUCT MOL BIOL, V11, P249, DOI 10.1038/nsmb730; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; TABER R, 1971, J VIROL, V8, P395, DOI 10.1128/JVI.8.4.395-401.1971; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	35	40	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e49783	10.1371/journal.pone.0049783	http://dx.doi.org/10.1371/journal.pone.0049783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300942	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900002
J	Bonito, G; Smith, ME; Nowak, M; Healy, RA; Guevara, G; Cazares, E; Kinoshita, A; Nouhra, ER; Dominguez, LS; Tedersoo, L; Murat, C; Wang, Y; Moreno, BA; Pfister, DH; Nara, K; Zambonelli, A; Trappe, JM; Vilgalys, R				Bonito, Gregory; Smith, Matthew E.; Nowak, Michael; Healy, Rosanne A.; Guevara, Gonzalo; Cazares, Efren; Kinoshita, Akihiko; Nouhra, Eduardo R.; Dominguez, Laura S.; Tedersoo, Leho; Murat, Claude; Wang, Yun; Arroyo Moreno, Baldomero; Pfister, Donald H.; Nara, Kazuhide; Zambonelli, Alessandra; Trappe, James M.; Vilgalys, Rytas			Historical Biogeography and Diversification of Truffles in the Tuberaceae and Their Newly Identified Southern Hemisphere Sister Lineage	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; ECTOMYCORRHIZAL FUNGI; GENUS TUBER; TRUE; DIVERSITY; CLADES; ESTABLISHMENT; ASSOCIATIONS; DISPERSAL; EVOLUTION	Truffles have evolved from epigeous (aboveground) ancestors in nearly every major lineage of fleshy fungi. Because accelerated rates of morphological evolution accompany the transition to the truffle form, closely related epigeous ancestors remain unknown for most truffle lineages. This is the case for the quintessential truffle genus Tuber, which includes species with socio-economic importance and esteemed culinary attributes. Ecologically, Tuber spp. form obligate mycorrhizal symbioses with diverse species of plant hosts including pines, oaks, poplars, orchids, and commercially important trees such as hazelnut and pecan. Unfortunately, limited geographic sampling and inconclusive phylogenetic relationships have obscured our understanding of their origin, biogeography, and diversification. To address this problem, we present a global sampling of Tuberaceae based on DNA sequence data from four loci for phylogenetic inference and molecular dating. Our well-resolved Tuberaceae phylogeny shows high levels of regional and continental endemism. We also identify a previously unknown epigeous member of the Tuberaceae - the South American cup-fungus Nothojafnea thaxteri (E.K. Cash) Gamundi. Phylogenetic resolution was further improved through the inclusion of a previously unrecognized Southern hemisphere sister group of the Tuberaceae. This morphologically diverse assemblage of species includes truffle (e.g. Gymnohydnotrya spp.) and non-truffle forms that are endemic to Australia and South America. Southern hemisphere taxa appear to have diverged more recently than the Northern hemisphere lineages. Our analysis of the Tuberaceae suggests that Tuber evolved from an epigeous ancestor. Molecular dating estimates Tuberaceae divergence in the late Jurassic (similar to 156 million years ago), with subsequent radiations in the Cretaceous and Paleogene. Intra-continental diversification, limited long-distance dispersal, and ecological adaptations help to explain patterns of truffle evolution and biodiversity.	[Bonito, Gregory; Vilgalys, Rytas] Duke Univ, Deparment Biol, Durham, NC 27710 USA; [Healy, Rosanne A.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Cazares, Efren; Trappe, James M.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Nouhra, Eduardo R.; Dominguez, Laura S.] Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Tedersoo, Leho] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Tedersoo, Leho] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Murat, Claude] INRA, Champenoux, France; [Murat, Claude] Nancy Univ, Champenoux, France; [Wang, Yun] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Arroyo Moreno, Baldomero] Univ Cordoba, Dept Plant Biol, Cordoba, Spain; [Pfister, Donald H.] Harvard Univ, Farlow Herbarium, Cambridge, MA 02138 USA; [Nara, Kazuhide] Univ Tokyo, Dept Nat Environm Studies, Grad Sch Frontier Sci, Chiba, Japan; [Zambonelli, Alessandra] Univ Bologna, Dipartimento Sci Agr, Bologna, Italy; [Nowak, Michael] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	Duke University; University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; INRAE; Universite de Lorraine; New Zealand Institute for Plant & Food Research Ltd; Universidad de Cordoba; Harvard University; University of Tokyo; University of Bologna; University of Zurich; State University System of Florida; University of Florida	Bonito, G (corresponding author), Duke Univ, Deparment Biol, Durham, NC 27710 USA.	gregory.bonito@duke.edu	Zambonelli, Alessandra/AAF-3581-2019; Guevara, Gonzalo/CAF-2010-2022; Smith, Matthew E./ABC-3015-2020; Tedersoo, Leho/H-3541-2012; Tedersoo, Leho/ABE-7452-2020; Nara, Kazuhide/H-6246-2016; Guevara, Gonzalo/ABG-4765-2021; Guevara, Gonzalo/C-4674-2015; Nowak, Michael/M-3747-2017; Smith, Matthew E/A-8115-2012; Murat, Claude/AAA-5226-2020	Smith, Matthew E./0000-0002-0878-0932; Nara, Kazuhide/0000-0002-3705-231X; Guevara, Gonzalo/0000-0002-2707-4531; Nowak, Michael/0000-0001-8924-6506; Smith, Matthew E/0000-0002-0878-0932; Murat, Claude/0000-0003-0685-7307; Vilgalys, Rytas/0000-0001-8299-3605	NSF [0641297]; Friends of the Farlow; Harvard University Herbaria; David Rockefeller Center for Latin American Studies at Harvard University; Iowa Science Foundation	NSF(National Science Foundation (NSF)); Friends of the Farlow; Harvard University Herbaria; David Rockefeller Center for Latin American Studies at Harvard University; Iowa Science Foundation	This research was supported through NSF award #0641297, REVSYS: Phylogenetic and Revisionary Systematics of North American Truffles (Tuber). Support was also provided by the Friends of the Farlow, which enabled the senior author to conduct research at the Farlow Herbarium. M.E.S. participated via a postdoctoral fellowship from Harvard University Herbaria. D.H.P. received funding from the David Rockefeller Center for Latin American Studies at Harvard University that supported field work in collaboration with M.E.S. Collections and microscopy were enabled by a grant from the Iowa Science Foundation to R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado P, 2012, MYCOLOGIA, V104, P894, DOI 10.3852/11-254; ALVAREZ IF, 1992, MYCOLOGIA, V84, P926, DOI 10.2307/3760294; [Anonymous], 2014, TRACER V1 6; BEATON G, 1977, T BRIT MYCOL SOC, V69, P243, DOI 10.1016/S0007-1536(77)80044-2; BEATON G, 1986, T BRIT MYCOL SOC, V86, P503, DOI 10.1016/S0007-1536(86)80201-7; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bonito G, 2010, MYCOLOGIA, V102, P1042, DOI 10.3852/09-213; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; BRUNS TD, 1989, NATURE, V339, P140, DOI 10.1038/339140a0; Bulman SR, 2010, MYCOL PROG, V9, P205, DOI 10.1007/s11557-009-0626-0; Castellano MA, 1989, KEY SPORES GENERA HY; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Claridge A., 2005, FUNGAL COMMUNITY ITS, V20050554, P599, DOI [10.1201/9781420027891.ch29, DOI 10.1201/9781420027891.CH29]; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Comandini O, 2006, MYCORRHIZA, V16, P381, DOI 10.1007/s00572-006-0047-8; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frank JL, 2009, BOTANY, V87, P821, DOI 10.1139/B09-044; GAMUNDI I J, 1971, Boletin de la Sociedad Argentina de Botanica, V13, P260; GAMUNDI I J, 1971, Darwiniana (San Isidro), V16, P461; Guevara G, MYCOLOGIA IN PRESS; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Jeandroz S, 2008, J BIOGEOGR, V35, P815, DOI 10.1111/j.1365-2699.2007.01851.x; Kinoshita A, 2011, MYCOLOGIA, V103, P779, DOI 10.3852/10-138; Kutorga Ernestas, 2008, Acta Mycologica, V43, P133, DOI 10.5586/am.2008.016; Laessoe T, 2007, MYCOL RES, V111, P1075, DOI 10.1016/j.mycres.2007.08.004; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Maddison WP, 2019, MESQUITE MODULAR SYS; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Marjanovic Z, 2010, SYDOWIA, V62, P67; Martin MP, 1999, MYCOL RES, V103, P203, DOI 10.1017/S0953756298007035; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Mindell RA, 2007, AM J BOT, V94, P351, DOI 10.3732/ajb.94.3.351; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Moreno G, 2012, MYCOL PROG, V11, P463, DOI 10.1007/s11557-011-0762-1; Newsholme C, 1992, WILLOWS GENUS SALIX; O'Donnell K, 2011, FUNGAL GENET BIOL, V48, P252, DOI 10.1016/j.fgb.2010.09.006; ODonnell K, 1997, MYCOLOGIA, V89, P48, DOI 10.2307/3761172; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Perez F, 2007, MYCORRHIZA, V17, P627, DOI 10.1007/s00572-007-0140-7; Ramirez JL, 2000, INT J PLANT SCI, V161, P521, DOI 10.1086/314260; Rifai MA, 1968, VERH K NED AKAD WET, V57, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; Sims HJ, 1999, REV PALAEOBOT PALYNO, V106, P131, DOI 10.1016/S0034-6667(99)00008-1; Singer R, 1987, MUSHROOMS TRUFFLES B; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Spegazzini, 1887, ANALES SOC CI ARGENT, P10; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Trappe J. M., 2009, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Trappe JM, 2008, ECON BOT, V62, P497, DOI 10.1007/s12231-008-9041-8; TRAPPE JM, 1979, MYCOTAXON, V9, P297; WARCUP JH, 1990, MYCOL RES, V94, P173, DOI 10.1016/S0953-7562(09)80609-6; WARCUP JH, 1990, MYCOL RES, V94, P1065, DOI 10.1016/S0953-7562(09)81334-8; Weden C., 2009, ACTA BOT YUNNANICA, V31, P94; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; YAN Y, 2011, RASP RECONSTRUCT ANC; ZHANG BC, 1989, MYCOL RES, V92, P192, DOI 10.1016/S0953-7562(89)80011-5	68	149	165	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52765	10.1371/journal.pone.0052765	http://dx.doi.org/10.1371/journal.pone.0052765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300990	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000313320900037
J	Bujanda, L; Sarasqueta, C; Cosme, A; Hijona, E; Enriquez-Navascues, JM; Placer, C; Villarreal, E; Herreros-Villanueva, M; Giraldez, MD; Gironella, M; Balaguer, F; Castells, A				Bujanda, Luis; Sarasqueta, Cristina; Cosme, Angel; Hijona, Elizabeth; Enriquez-Navascues, Jose M.; Placer, Carlos; Villarreal, Eloisa; Herreros-Villanueva, Marta; Giraldez, Maria D.; Gironella, Meritxell; Balaguer, Francesc; Castells, Antoni			Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; SERUM TETRANECTIN; GASTRIC-JUICE; BLOOD; PREDICTS; MARKER; CELLS; STAGE; SUPAR	Background: Colorectal cancer (CRC) is the second most common cause of death from cancer in both men and women in the majority of developed countries. Molecular tests of blood could potentially provide this ideal screening tool. Aim: Our objective was to assess the usefulness of serum markers and mRNA expression levels in the diagnosis of CRC. Methods: In a prospective study, we measured mRNA expression levels of 13 markers (carbonic anhydrase, guanylyl cyclase C, plasminogen activator inhibitor, matrix metalloproteinase 7 (MMP7), urokinase-type plasminogen activator receptor (uPAR), urokinase-type plasminogen activator, survivin, tetranectin, vascular endothelial growth factor (VEGF), cytokeratin 20, thymidylate synthase, cyclooxygenase 2 (COX-2), and CD44) and three proteins in serum (alpha 1 antitrypsin, carcinoembryonic antigen (CEA) and activated C3 in 42 patients with CRC and 33 with normal colonoscopy results. Results: Alpha 1-antitrypsin was the serum marker that was most useful for CRC diagnosis (1.79 +/- 0.25 in the CRC group vs 1.27 +/- 0.25 in the control group, P < 0.0005). The area under the ROC curve for alpha 1-antitrypsin was 0.88 (0.79-0.96). The mRNA expression levels of five markers were statistically different between CRC cases and controls: those for which the ROC area was over 75% were MMP7 (0.81) and tetranectin (0.80), COX-2 (0.78), uPAR (0.78) and carbonic anhydrase (0.77). The markers which identified early stage CRC (Stages I and II) were alpha 1-antitrypsin, uPAR, COX-2 and MMP7. Conclusions: Serum alpha 1-antitrypsin and the levels of mRNA expression of MMP7, COX-2 and uPAR have good diagnostic accuracy for CRC, even in the early stages.	[Bujanda, Luis; Cosme, Angel; Hijona, Elizabeth; Herreros-Villanueva, Marta] Univ Basque Country UPV EHU, Ctr Invest Biomed Enfermedades Hepat & Digest CIB, Dept Gastroenterol, Biodonostia Inst,Donostia Hosp, San Sebastian, Spain; [Sarasqueta, Cristina] Donostia Hosp, CIBERESP, Dept Epidemiol, San Sebastian, Spain; [Enriquez-Navascues, Jose M.; Placer, Carlos; Villarreal, Eloisa] Donostia Hosp, Dept Surg, San Sebastian, Spain; [Giraldez, Maria D.; Gironella, Meritxell; Balaguer, Francesc; Castells, Antoni] IDIBAPS, CIBERehd, Clin Hosp, Dept Gastroenterol, Barcelona, Spain	Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bujanda, L (corresponding author), Univ Basque Country UPV EHU, Ctr Invest Biomed Enfermedades Hepat & Digest CIB, Dept Gastroenterol, Biodonostia Inst,Donostia Hosp, San Sebastian, Spain.	medik@telefonica.net	Bujanda, Luis/AAB-2485-2021; BALAGUER, FRANCESC/G-2389-2016; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Giraldez, Maria D/E-7395-2018; , Herreros-Villanueva/M-5702-2016; Enriquez-Navascues, Jose M/AAG-8632-2020	Bujanda, Luis/0000-0002-4353-9968; Castells, Antoni/0000-0001-8431-2033; Giraldez, Maria D/0000-0001-6829-7603; , Herreros-Villanueva/0000-0002-6905-0693; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Gironella, Meritxell/0000-0003-4437-5181; Balaguer, Francesc/0000-0002-0206-0539	Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Centro de Investigacion Biomedica en Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; American Joint Committee on Cancer, 1997, MAN STAG CANC; [Anonymous], 2005, SIT CANC ESP; Arvanitis DL, 2002, HISTOL HISTOPATHOL, V17, P471, DOI 10.14670/HH-17.471; Begum FD, 2009, GYNECOL ONCOL, V113, P221, DOI 10.1016/j.ygyno.2009.01.020; Begum FD, 2004, ANTICANCER RES, V24, P1981; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; BERNACKA K, 1988, CANCER, V62, P1188, DOI 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Bujanda L, 2010, WORLD J GASTROENTERO, V16, P862, DOI 10.3748/wjg.v16.i7.862; Bustin Stephen A., 2006, Molecular Aspects of Medicine, V27, P192, DOI 10.1016/j.mam.2005.12.002; Grabarczyk Ewa, 2007, Med Wieku Rozwoj, V11, P41; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Habermann JK, 2006, GASTROENTEROLOGY, V131, P1020, DOI 10.1053/j.gastro.2006.07.011; Hogdall CK, 2002, APMIS, V110, P630, DOI 10.1034/j.1600-0463.2002.1100906.x; Hsu PI, 2007, CLIN CANCER RES, V13, P876, DOI 10.1158/1078-0432.CCR-06-1404; Hurst NG, 2007, BRIT J CANCER, V97, P971, DOI 10.1038/sj.bjc.6603958; Ishigami S, 2008, J SURG RES, V148, P205, DOI 10.1016/j.jss.2007.08.013; Kapsoritakis A, 2003, INT J COLORECTAL DIS, V18, P418, DOI 10.1007/s00384-003-0495-y; Kobayashi H, 2009, INT J ONCOL, V34, P1147, DOI 10.3892/ijo_00000243; Kobayashi H, 2008, INT J ONCOL, V33, P1257, DOI 10.3892/ijo_00000116; Lee K, 2004, PROTEOMICS, V4, P3343, DOI 10.1002/pmic.200400960; Mollnes TE, 1998, CLIN EXP IMMUNOL, V123, P484; PYKE C, 1991, AM J PATHOL, V138, P1059; Sadahiro S, 2007, ANN SURG ONCOL, V14, P1092, DOI 10.1245/s10434-006-9289-0; Setoyama T, 2006, CLIN CANCER RES, V12, P5972, DOI 10.1158/1078-0432.CCR-06-0637; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; Stephens RW, 2010, JNCI, V91, P869; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188	29	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51810	10.1371/journal.pone.0051810	http://dx.doi.org/10.1371/journal.pone.0051810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300952	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900010
J	Miyazaki, Y				Miyazaki, Yuki			Increasing Visual Search Accuracy by Being Watched	PLOS ONE			English	Article							GAZE-DIRECTION; COOPERATION; STARE; CUES; CONTACT; TIME; EYES	In daily life, huge costs can arise from just one incorrect performance on a visual search task (e. g., a fatal accident due to a driver overlooking a pedestrian). One potential way to prevent such drastic accidents would be for people to modify their decision criterion (e. g., placing a greater priority on accuracy rather than speed) during a visual search. The aim of the present study was to manipulate the criterion by creating an awareness of being watched by another person. During a visual search task, study participants were watched (or not watched) via video cameras and monitors. The results showed that, when they believed they were being watched by another person, they searched more slowly and accurately, as measured by reaction times and hit/miss rates. These findings also were obtained when participants were videotaped and they believed their recorded behavior would be watched by another person in the future. The study primarily demonstrated the role of being watched by another on the modulation of the decision criterion for responding during visual searches.	[Miyazaki, Yuki] Chukyo Univ, Sch Psychol, Nagoya, Aichi, Japan; [Miyazaki, Yuki] Kanagawa Univ, Res Inst Visual Sci, Yokohama, Kanagawa, Japan	Chukyo University; Kanagawa University	Miyazaki, Y (corresponding author), Chukyo Univ, Sch Psychol, Nagoya, Aichi, Japan.	y38zaki@lets.chukyo-u.ac.jp	Miyazaki, Yuki/AAD-3241-2022	Miyazaki, Yuki/0000-0003-4790-4368				Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bourrat P, 2011, EVOL PSYCHOL-US, V9, P193, DOI 10.1177/147470491100900206; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Conty L, 2006, SPATIAL VISION, V19, P529, DOI 10.1163/156856806779194026; Conty L, 2010, COGNITION, V115, P133, DOI 10.1016/j.cognition.2009.12.005; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Doi HK, 2007, PERCEPTION, V36, P773, DOI 10.1068/p5614; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Keller J, 2011, EUR J PERSONALITY, V25, P363, DOI 10.1002/per.797; Li XR, 2010, BEHAV RES METHODS, V42, P212, DOI 10.3758/BRM.42.1.212; Macmillan NA, 2005, DETECTION THEORY USE; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Miyazaki Y, 2012, PERCEPT MOTOR SKILL, V114, P1007, DOI 10.2466/21.07.24.PMS.114.3.1007-1022; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; Palanica A, 2011, J VISION, V11, DOI 10.1167/11.2.19; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; SCHOUTEN JF, 1967, ACTA PSYCHOL, V27, P143, DOI 10.1016/0001-6918(67)90054-6; Senju A, 2005, VIS COGN, V12, P127, DOI 10.1080/13506280444000157; Senju A, 2006, PSYCHON B REV, V13, P223, DOI 10.3758/BF03193834; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Vuilleumier P, 2005, VIS COGN, V12, P85, DOI 10.1080/13506280444000120; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Yokoyama T, 2011, PERCEPTION, V40, P785, DOI 10.1068/p7003	36	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53500	10.1371/journal.pone.0053500	http://dx.doi.org/10.1371/journal.pone.0053500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301079	gold, Green Submitted, Green Published			2022-12-27	WOS:000313320900081
J	Sane, E; Isla, E; Barcena, MA; DeMaster, DJ				Sane, Elisabet; Isla, Enrique; Angeles Barcena, Maria; DeMaster, David J.			A Shift in the Biogenic Silica of Sediment in the Larsen B Continental Shelf, Off the Eastern Antarctic Peninsula, Resulting from Climate Change	PLOS ONE			English	Article							SOUTHERN-OCEAN; WEDDELL SEA; SURFACE SEDIMENTS; WESTERN BRANSFIELD; SPONGE SPICULES; ICE SHELF; COMMUNITIES; ACCUMULATION; ASSEMBLAGES; SAMPLES	In 2002, section B of the Larsen ice shelf, off of the Eastern Antarctic Peninsula, collapsed and created the opportunity to study whether the changes at the sea surface left evidence in the sedimentary record. Biogenic silica is major constituent of Antarctic marine sediment, and its presence in the sediment column is associated with diatom production in the euphotic zone. The abundance of diatom valves and the number of sponge spicules in the biogenic silica was analyzed to determine how the origin of the biogenic silica in the upper layers of the sediment column responded to recent environmental changes. Diatom valves were present only in the upper 2 cm of sediment, which roughly corresponds to the period after the collapse of the ice shelf. In contrast, sponge spicules, a more robust form of biogenic silica, were also found below the upper 2 cm layer of the sediment column. Our results indicate that in this region most of the biogenic silica in the sedimentary record originated from sponge spicules rather than diatoms during the time when the sea surface was covered by the Larsen ice shelf. Since the collapse of the ice shelf, the development of phytoplankton blooms and the consequent influx of diatom debris to the seabed have shifted the biogenic silica record to one dominated by diatom debris, as occurs in most of the Antarctic marine sediment. This shift provides further evidence of the anthropogenic changes to the benthic habitats of the Antarctic and will improve the interpretation of the sedimentary record in Polar Regions where these events occur.	[Sane, Elisabet; Isla, Enrique] Inst Marine Sci ICM CSIC, Dept Marine Geol, Barcelona, Spain; [Angeles Barcena, Maria] Univ Salamanca, Dept Geol & Paleontol, E-37008 Salamanca, Spain; [DeMaster, David J.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Salamanca; University of North Carolina; North Carolina State University	Sane, E (corresponding author), Inst Marine Sci ICM CSIC, Dept Marine Geol, Barcelona, Spain.	sane@icm.csic.es	Barcena, María Angeles/D-5839-2011; sane, elisabet/AAT-4775-2020	Barcena, María Angeles/0000-0001-8261-2286; , elisabet/0000-0001-5719-5468; Isla, Enrique/0000-0003-4959-6936	Spanish Ministry of Science and Innovation, through the project CLIMANT [POL2006-06399]; FPU [AP 2005-5060]	Spanish Ministry of Science and Innovation, through the project CLIMANT(Ministry of Science and Innovation, Spain (MICINN)); FPU(Spanish Government)	This study was supported by the Spanish Ministry of Science and Innovation, through the project CLIMANT (POL2006-06399) and the graduate program fellowship FPU AP 2005-5060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELMANN A, 1991, MAR CHEM, V35, P503, DOI 10.1016/S0304-4203(09)90040-8; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barcena MA, 2002, DEEP-SEA RES PT II, V49, P935, DOI 10.1016/S0967-0645(01)00132-1; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; BARTHEL D, 1991, MAR ECOL PROG SER, V69, P303, DOI 10.3354/meps069303; BARTHEL D, 1992, ANTARCT SCI, V4, P137, DOI 10.1017/S0954102092000221; Bavestrello G, 1996, MAR ECOL-P S Z N I, V17, P41, DOI 10.1111/j.1439-0485.1996.tb00488.x; Brey T, 1997, ANTARCT SCI, V9, P266, DOI 10.1017/S0954102097000357; Buffen A, 2007, MAR MICROPALEONTOL, V62, P7, DOI 10.1016/j.marmicro.2006.07.002; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cortese G, 2007, EARTH PLANET SC LETT, V257, P526, DOI 10.1016/j.epsl.2007.03.021; Crosta X, 2009, DEEP-SEA RES PT I, V56, P1983, DOI 10.1016/j.dsr.2009.06.009; DeMaster DJ, 1996, CONT SHELF RES, V16, P617, DOI 10.1016/0278-4343(95)00048-8; DEMASTER DJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1715, DOI 10.1016/0016-7037(81)90006-5; DeMaster DJ, 2002, DEEP-SEA RES PT II, V49, P3155, DOI 10.1016/S0967-0645(02)00076-0; DeMaster DJ, 2003, ORGANIC CARBON CALCI, DOI [10.1594/PANGAEA.124976, DOI 10.1594/PANGAEA.124976]; Diekmann B, 1999, MAR GEOL, V158, P209, DOI 10.1016/S0025-3227(98)00165-0; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; DUNBAR RB, 1989, MAR GEOL, V85, P155, DOI 10.1016/0025-3227(89)90152-7; GERDES D, 1992, POLAR BIOL, V12, P291; Gerdes D, 2003, POLAR BIOL, V26, P295, DOI 10.1007/s00300-003-0484-1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Isla E, 2004, MAR GEOL, V209, P265, DOI 10.1016/j.margeo.2004.06.003; Bertolin ML, 2009, POLAR BIOL, V32, P1435, DOI 10.1007/s00300-009-0638-x; Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; Post AL, 2007, MAR ECOL PROG SER, V344, P29, DOI 10.3354/meps06966; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; RUTZLER K, 1978, MAR BIOL, V49, P147, DOI 10.1007/BF00387114; Sane E, 2012, CONT SHELF RES, V35, P53, DOI 10.1016/j.csr.2011.12.008; Sane E, 2011, CONT SHELF RES, V31, P1161, DOI 10.1016/j.csr.2011.04.002; Sane E, 2011, J SEA RES, V65, P94, DOI 10.1016/j.seares.2010.07.005; Schluter M, 1998, DEEP-SEA RES PT I, V45, P1085, DOI 10.1016/S0967-0637(98)00006-5; Schrader H.-J., 1978, Utrecht Micropaleontological Bulletins, P129; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tsoy IB, 2009, MAR GEOL, V49, P141; Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Wright SW, 2000, DEEP-SEA RES PT II, V47, P2363, DOI 10.1016/S0967-0645(00)00029-1	43	13	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52632	10.1371/journal.pone.0052632	http://dx.doi.org/10.1371/journal.pone.0052632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300983	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900035
J	Seidel, C; Reinhardt, K				Seidel, Conrad; Reinhardt, Klaus			Bugging Forecast: Unknown, Disliked, Occasionally Intimate. Bed Bugs in Germany Meet Unprepared People	PLOS ONE			English	Article							CIMEX-LECTULARIUS L.; FARMERS PERCEPTIONS; BITES; CIMICIDAE; ANIMALS; DISEASE; FEAR	Bed bugs appear to be feared more than vector insects and other household pests. The reasons for this exaggerated fear are not fully understood. One hypothesis is that the folk knowledge on recognising and controlling bed bugs decreased as bed bugs became rarer in the 1960s and led to irrational perceptions. Here, we examine people's ability to recognise a bed bug and their response what to do in case of an infestation. We found that 13% of a sample of 391 people in four large German cities recognised a bed bug; 15% of all respondents would call a pest controller in case of bed bug infestation. This results in the pessimistic estimate that 97% of all early-stage infestations could go untreated. We discuss additional scenarios. The effectiveness of efforts to educate people about the presence of bed bugs has never been tested, but our sample is useful to guide future studies. We found three sources of information were associated with increased recognition rates of bed bugs: a) previous contacts with bed bugs (60% recognition), b) knowledge from friends or relatives (25%) and school or education courses (15%). By contrast, people who heard of bed bugs from television, print media or the Internet showed reduced recognition rates. We propose that the former factors be tested for educational interventions. In Germany, the bed bug is an estranged creature to many people, a fact that seems to hinder rational approaches to their control.	[Seidel, Conrad; Reinhardt, Klaus] Univ Tubingen, Tubingen, Germany; [Reinhardt, Klaus] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Eberhard Karls University of Tubingen; University of Sheffield	Reinhardt, K (corresponding author), Univ Tubingen, Tubingen, Germany.	k.reinhardt@uni-tuebingen.de						Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; DOGGETT SL, 2008, P 6 INT C URB PESTS, P407; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Harlan HJ, 2008, PUBLIC HLTH SIGNIFIC, P131; King F, 1990, NEW SCI, V1701, P35; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; Majekodunmi A, 2002, J ENV HLTH RES, V1; Malotki E, 1997, BEDBUGS NIGHT DANCE; Nagaraju N, 2002, INT J PEST MANAGE, V48, P333, DOI 10.1080/09670870210153164; Osborne P. J., 1971, BRITANNIA, V2, P156; Palis FG, 1998, CROP PROT, V17, P599, DOI 10.1016/S0261-2194(98)00058-1; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Potter Michael F., 2011, American Entomologist, V57, P14; Prokop P, 2010, ECOL PSYCHOL, V22, P222, DOI 10.1080/10407413.2010.496676; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Reinhardt K, 2010, MED VET ENTOMOL, V24, P46, DOI 10.1111/j.1365-2915.2009.00847.x; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K., 2012, 2012 MCGRAW HILL YB; Reinhardt K, 2008, J MED ENTOMOL, V45, P956, DOI 10.1603/0022-2585(2008)45[956:WKTBBK]2.0.CO;2; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Richards L, 2009, J ENV HLTH RES, V9, P17; Seidel C, 2011, POPULATION ANAL CIME; Soukand R, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14110; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230	26	13	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51083	10.1371/journal.pone.0051083	http://dx.doi.org/10.1371/journal.pone.0051083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300947	gold, Green Submitted, Green Published			2022-12-27	WOS:000313320900006
J	Siika, AM; Yiannoutsos, CT; Wools-Kaloustian, KK; Musick, BS; Mwangi, AW; Diero, LO; Kimaiyo, SN; Tierney, WM; Carter, JE				Siika, Abraham M.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Mwangi, Ann W.; Diero, Lameck O.; Kimaiyo, Sylvester N.; Tierney, William M.; Carter, Jane E.			Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; WESTERN KENYA; WEIGHT-LOSS; SURVIVAL; MORTALITY; EPIDEMIOLOGY; PREVALENCE; EXPERIENCE	Objective: This cohort study utilized data from a large HIV treatment program in western Kenya to describe the impact of active tuberculosis (TB) on clinical outcomes among African patients on antiretroviral therapy (ART). Design: We included all patients initiating ART between March 2004 and November 2007. Clinical (signs and symptoms), radiological (chest radiographs) and laboratory (mycobacterial smears, culture and tissue histology) criteria were used to record the diagnosis of TB disease in the program's electronic medical record system. Methods: We assessed the impact of TB disease on mortality, loss to follow-up (LTFU) and incident AIDS-defining events (ADEs) through Cox models and CD4 cell and weight response to ART by non-linear mixed models. Results: We studied 21,242 patients initiating ART-5,186 (24%) with TB; 62% female; median age 37 years. There were proportionately more men in the active TB (46%) than in the non-TB (35%) group. Adjusting for baseline HIV-disease severity, TB patients were more likely to die (hazard ratio - HR = 1.32, 95% CI 1.18-1.47) or have incident ADEs (HR = 1.31, 95% CI: 1.19-1.45). They had lower median CD4 cell counts (77 versus 109), weight (52.5 versus 55.0 kg) and higher ADE risk at baseline (CD4-adjusted odds ratio = 1.55, 95% CI: 1.31-1.85). ART adherence was similarly good in both groups. Adjusting for gender and baseline CD4 cell count, TB patients experienced virtually identical rise in CD4 counts after ART initiation as those without. However, the overall CD4 count at one year was lower among patients with TB (251 versus 269 cells/mu l). Conclusions: Clinically detected TB disease is associated with greater mortality and morbidity despite salutary response to ART. Data suggest that identifying HIV patients co-infected with TB earlier in the HIV-disease trajectory may not fully address TB-related morbidity and mortality.	[Siika, Abraham M.; Diero, Lameck O.; Kimaiyo, Sylvester N.] Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya; [Siika, Abraham M.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Mwangi, Ann W.; Diero, Lameck O.; Kimaiyo, Sylvester N.; Tierney, William M.; Carter, Jane E.] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.; Musick, Beverly S.; Tierney, William M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Mwangi, Ann W.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Tierney, William M.; Carter, Jane E.] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; United States Agency for International Development (USAID); Indiana University System; Indiana University Bloomington; Brown University; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Siika, AM (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya.	amsiika@africaonline.co.ke			USAID PEPFAR's grant [623-A-00-08-00003-00]; Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative; Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention (CDC); Kenya National AIDS and STI Control Program (NASCOP); National AIDS Control Council (NACC); United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR); National Institutes of Health grant [AI-069911]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911] Funding Source: NIH RePORTER	USAID PEPFAR's grant(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Kenya National AIDS and STI Control Program (NASCOP); National AIDS Control Council (NACC); United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The USAID-AMPATH Partnership clinical care programs are supported by USAID PEPFAR's grant #623-A-00-08-00003-00. The USAID-AMPATH Partnership program has in the past received support from the Prevention of Maternal To Child Transmission (MTCT - Plus) Initiative, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), the Kenya National AIDS and STI Control Program (NASCOP) and National AIDS Control Council (NACC) and is currently funded by the United States Agency for International Development President's Emergency Program For AIDS Relief (USAID - PEPFAR). Dr. Yiannoutsos' and Wools-Kaloustian's research was partially supported by the National Institutes of Health grant AI-069911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimos AW, 1996, AM J EMERG MED, V14, P359, DOI 10.1016/S0735-6757(96)90049-2; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2001, INT J TUBERC LUNG D, V5, P205; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; Division of Leprosy Tuberculosis and Lung disease, 2006, GUID IMPL TB HIV COL; Division of Leprosy Tuberculosis and Lung disease, 2012, ANN REP 2010 GOV KEN; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; FLEMING TR, 1995, J ACQ IMMUN DEF SYND, V10, pS9; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lopez-Gatell H, 2008, AIDS, V22, P1869, DOI 10.1097/QAD.0b013e32830e010c; Makombe SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000620; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Murray EJ, 2012, HLTH POLICY PLAN; National AIDS and STI Control Programme, 2005, GUID ANT DRUG THER K; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Pinheiro J, 2001, MIXED EFFECTS MODELS; PITCHENIK AE, 1985, AM REV RESPIR DIS, V131, P393; R Core Team, 2020, R LANG ENV STAT COMP; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Tierney WM, 2007, STUD HEALTH TECHNOL, V129, P372; UNAIDS, 2010, UNAIDS REP GLOB AIDS; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	41	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53022	10.1371/journal.pone.0053022	http://dx.doi.org/10.1371/journal.pone.0053022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301015	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900053
J	de la Pena, E; Malkia, A; Vara, H; Caires, R; Ballesta, JJ; Belmonte, C; Viana, F				de la Pena, Elvira; Maelkiae, Annika; Vara, Hugo; Caires, Rebeca; Ballesta, Juan J.; Belmonte, Carlos; Viana, Felix			The Influence of Cold Temperature on Cellular Excitability of Hippocampal Networks	PLOS ONE			English	Article							DOMAIN POTASSIUM-CHANNEL; NEUROPROTECTIVE AGENT RILUZOLE; POLYUNSATURATED FATTY-ACIDS; BRAIN TEMPERATURE; K+ CHANNELS; SYNAPTIC-TRANSMISSION; MEMBRANE-PROPERTIES; CAPSAICIN-RECEPTOR; PYRAMIDAL NEURONS; TRPM8 CHANNELS	The hippocampus plays an important role in short term memory, learning and spatial navigation. A characteristic feature of the hippocampal region is its expression of different electrical population rhythms and activities during different brain states. Physiological fluctuations in brain temperature affect the activity patterns in hippocampus, but the underlying cellular mechanisms are poorly understood. In this work, we investigated the thermal modulation of hippocampal activity at the cellular network level. Primary cell cultures of mouse E17 hippocampus displayed robust network activation upon light cooling of the extracellular solution from baseline physiological temperatures. The activity generated was dependent on action potential firing and excitatory glutamatergic synaptic transmission. Involvement of thermosensitive channels from the transient receptor potential (TRP) family in network activation by temperature changes was ruled out, whereas pharmacological and immunochemical experiments strongly pointed towards the involvement of temperature-sensitive two-pore-domain potassium channels (K-2P), TREK/TRAAK family. In hippocampal slices we could show an increase in evoked and spontaneous synaptic activity produced by mild cooling in the physiological range that was prevented by chloroform, a K-2P channel opener. We propose that cold-induced closure of background TREK/TRAAK family channels increases the excitability of some hippocampal neurons, acting as a temperature-sensitive gate of network activation. Our findings in the hippocampus open the possibility that small temperature variations in the brain in vivo, associated with metabolism or blood flow oscillations, act as a switch mechanism of neuronal activity and determination of firing patterns through regulation of thermosensitive background potassium channel activity.	[de la Pena, Elvira; Maelkiae, Annika; Vara, Hugo; Caires, Rebeca; Ballesta, Juan J.; Belmonte, Carlos; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	de la Pena, E (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain.	elvirap@umh.es; felix.viana@umh.es	Viana, Felix/U-8533-2017; Elvira, De la Pena/O-7380-2015; Vara Rivera, Hugo/L-4480-2018	Viana, Felix/0000-0003-1439-949X; Elvira, De la Pena/0000-0001-5961-5067; Vara Rivera, Hugo/0000-0002-7287-815X; Caires, Rebeca/0000-0002-5202-6080	Academy of Finland [107866]; Juan de la Cierva fellowship from the Spanish Ministry of Education and Science; Generalitat Valenciana [GVPRE/2008/205, GVAP/007/10, GRISOLIA/2010/020]; Spanish Ministry of Science and Innovation [SAF2010-14990, BFU2008-04425, CSD2007-00023]	Academy of Finland(Academy of Finland); Juan de la Cierva fellowship from the Spanish Ministry of Education and Science; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	During the course of this work, AM was supported by the Academy of Finland (#107866) and a Juan de la Cierva fellowship from the Spanish Ministry of Education and Science. The work was also supported by funds from the Generalitat Valenciana: GVPRE/2008/205 to AM, GVAP/007/10 to EP and GRISOLIA/2010/020 to RC; the Spanish Ministry of Science and Innovation: projects SAF2010-14990 to FV and BFU2008-04425 and CONSOLIDER-INGENIO 2010 CSD2007-00023 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS R, 1964, AM J PHYSIOL, V206, P641, DOI 10.1152/ajplegacy.1964.206.3.641; Aihara H, 2001, BRAIN RES, V893, P36, DOI 10.1016/S0006-8993(00)03285-6; Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Andersen P, 1995, HIPPOCAMPUS, V5, P491, DOI 10.1002/hipo.450050602; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Cadaveira-Mosquera A, 2011, J NEUROSCI, V31, P1375, DOI 10.1523/JNEUROSCI.2791-10.2011; CAIN DP, 1994, BRAIN RES, V658, P135, DOI 10.1016/S0006-8993(09)90019-1; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Danthi S, 2003, J MEMBRANE BIOL, V195, P147, DOI 10.1007/s00232-003-0616-0; de la Pena E, 2005, J PHYSIOL-LONDON, V567, P415, DOI 10.1113/jphysiol.2005.086546; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; DUNCAN WC, 1995, NEUROPSYCHOPHARMACOL, V12, P17, DOI 10.1016/0893-133X(94)00055-5; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; GAO B, 1992, PSYCHOPHARMACOLOGY, V106, P321, DOI 10.1007/BF02245412; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Guler AD, 2002, J NEUROSCI, V22, P6408; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Karnup S, 2001, J PHYSIOL-LONDON, V532, P713, DOI 10.1111/j.1469-7793.2001.0713e.x; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Leinekugel X, 2003, J PHYSIOL-PARIS, V97, P27, DOI 10.1016/j.jphysparis.2003.10.004; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Liu HY, 2007, J PHARMACOL EXP THER, V323, P39, DOI 10.1124/jpet.107.125245; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MORRIS M, 1990, SLEEP, V13, P1; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OBAL F, 1985, PFLUG ARCH EUR J PHY, V404, P73, DOI 10.1007/BF00581494; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reig R, 2010, J NEUROPHYSIOL, V103, P1253, DOI 10.1152/jn.00890.2009; Salerian AJ, 2008, MED HYPOTHESES, V70, P497, DOI 10.1016/j.mehy.2007.06.032; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takigawa T, 2003, J NEUROPHYSIOL, V89, P2238, DOI 10.1152/jn.00957.2002; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; TANCREDI V, 1992, EPILEPSIA, V33, P228, DOI 10.1111/j.1528-1157.1992.tb02311.x; THOMPSON SM, 1985, J NEUROSCI, V5, P817; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, 2000, NEUROSCIENCE, V98, P9, DOI 10.1016/S0306-4522(00)00109-3; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; WEIGHT FF, 1976, NATURE, V261, P720, DOI 10.1038/261720a0; Wu J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-18; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386	96	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52475	10.1371/journal.pone.0052475	http://dx.doi.org/10.1371/journal.pone.0052475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300680	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600016
J	Essig, S; Skinner, R; von der Weid, NX; Kuehni, CE; Michel, G				Essig, Stefan; Skinner, Roderick; von der Weid, Nicolas X.; Kuehni, Claudia E.; Michel, Gisela			Follow-Up Programs for Childhood Cancer Survivors in Europe: A Questionnaire Survey	PLOS ONE			English	Article							LONG-TERM SURVIVORS; ADULT SURVIVORS; CARE; DIAGNOSIS; OUTCOMES; CHILDREN	Background: For many childhood cancer survivors follow-up care is important long after treatment completion. We aimed to describe the availability and characteristics of long-term follow-up programs (LTFU) across Europe, their content and aims, their problems, and to assess opinions on different models of LTFU. Methodology/Principal Findings: We asked 179 pediatric oncology institutions in 20 European countries to complete an online survey on LTFU available at their institution. Of 110 respondents (62% response), 66% reported having LTFU for pediatric survivors, 38% for adult survivors of childhood cancer. Availability varied widely across European regions, from 9% of institutions in Northern Europe reporting LTFU for adult survivors to 83% of institution on the British Isles reporting LTFU for pediatric survivors. Pediatric and adult LTFU were usually located in pediatric hospitals and run by pediatric oncologists. Content of follow-up included screening for adverse outcomes and health education. Important problems included lack of time, personnel and funding. Most institutions without LTFU reported that they would like to offer a program (86%). Conclusion/Significance: Despite general agreement on the need of follow-up care, there is still a lack of well-organized LTFU for survivors of childhood cancer across Europe.	[Essig, Stefan; Kuehni, Claudia E.; Michel, Gisela] Univ Bern, ISPM, Bern, Switzerland; [Skinner, Roderick] Great N Childrens Hosp, Dept Pediat & Adolescent Hematol Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Skinner, Roderick] Great N Childrens Hosp, Childrens BMT Unit, Newcastle Upon Tyne, Tyne & Wear, England; [von der Weid, Nicolas X.] Univ Childrens Hosp Basel UKBB, Basel, Switzerland	University of Bern; University of Basel	Michel, G (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	michel@ispm.unibe.ch	Michel, Gisela/G-1081-2018	Michel, Gisela/0000-0002-9589-0928; Essig, Stefan/0000-0003-3228-7010; Kuehni, Claudia E./0000-0001-8957-2002	Swiss National Science Foundation [PZ00P3-121682, PZ00P3-141722, 323630-133897]; Cancer Research Switzerland [KFS 02606-06-2010]; Swiss Cancer League [KFS 02631-08-2010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Switzerland; Swiss Cancer League	Funding came from Swiss National Science Foundation (PZ00P3-121682, PZ00P3-141722, 323630-133897) http://www.snf.ch/, Cancer Research Switzerland (KFS 02606-06-2010) http://www.krebsforschung.ch/, and the Swiss Cancer League (KFS 02631-08-2010) http://www.krebsliga.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absolom K, 2009, BRIT J CANCER, V101, P561, DOI 10.1038/sj.bjc.6605213; Aziz NM, 2006, CANCER, V107, P841, DOI 10.1002/cncr.22096; Children's Oncology Group (COG), 2008, LONG TERM FOLL UP GU; Economic and Social Research Council, 2010, EC SOC RES COUNC RES; EISER C, 1994, PSYCHO-ONCOL, V3, P197, DOI 10.1002/pon.2960030306; Eshelman-Kent D, 2011, J CANCER SURVIV, V5, P345, DOI 10.1007/s11764-011-0192-8; Ethics Committee University of Zurich, 2012, CHECKL SELBSTB STUD; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Guilcher GMT, 2009, PEDIATR BLOOD CANCER, V52, P113, DOI 10.1002/pbc.21701; Henderson TO, 2010, J CLIN ONCOL, V28, P878, DOI 10.1200/JCO.2009.25.6107; Hess SL, 2011, ACTA ONCOL, V50, P653, DOI 10.3109/0284186X.2010.550934; Jenney M, 2008, BMJ-BRIT MED J, V336, P732, DOI 10.1136/bmj.39490.692627.80; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Landier W, 2006, PEDIATR BLOOD CANCER, V46, P149, DOI 10.1002/pbc.20612; Michel G, 2009, EUR J CANCER, V45, P1616, DOI 10.1016/j.ejca.2009.02.026; Michel G, 2011, PSYCHO-ONCOLOGY, V20, P1034, DOI 10.1002/pon.1823; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; National Health System (NHS), 2011, MOD CAR ACH BETT OUT; Oeffinger KC, 1998, J CLIN ONCOL, V16, P2864, DOI 10.1200/JCO.1998.16.8.2864; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Rebholz CE, 2011, EUR J CANCER, V47, P221, DOI 10.1016/j.ejca.2010.09.017; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Richards M, 2011, BRIT J CANCER, V105, pS1, DOI 10.1038/bjc.2011.416; Ristovski-Slijepcevic S, 2009, PAED CHILD HEALT-CAN, V14, P375, DOI 10.1093/pch/14.6.375; Scottish Intercollegiate Guidelines Network (SIGN), 2004, LONG TERM FOLL UP SU; SKINNER R, 2005, THERAPY BASED LONG T; Skinner R, 2007, ARCH DIS CHILD, V92, P257, DOI 10.1136/adc.2006.095513; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; Stichting Kinderoncologie Nederland (SKION), 2010, RICHTL FOLL UP KIND; Tabone MD, 2006, ARCH PEDIATRIE, V13, P607, DOI 10.1016/j.arcped.2006.03.035; Tabone MD, 2006, SUIVI LONG TERME ENQ; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; United Nations Statistics Division, 2011, COMP MACR CONT REG G; von der Weid N, 2003, EUR J CANCER, V39, P1150, DOI 10.1016/S0959-8049(02)00874-2; Wallace WHB, 2001, BRIT MED J, V323, P271, DOI 10.1136/bmj.323.7307.271	37	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53201	10.1371/journal.pone.0053201	http://dx.doi.org/10.1371/journal.pone.0053201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300889	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313872600068
J	Kollmorgen, G; Bossenmaier, B; Niederfellner, G; Haring, HU; Lammers, R				Kollmorgen, Gwendlyn; Bossenmaier, Birgit; Niederfellner, Gerhard; Haering, Hans-Ulrich; Lammers, Reiner			Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; FAMILY KINASES; PKC-DELTA; C-SRC; ACTIVATION; EXPRESSION; RECEPTOR; IDENTIFICATION; ADHESION; PALMITOYLATION	Cub domain containing protein 1 (CDCP1) is strongly expressed in tumors derived from lung, colon, ovary, or kidney. It is a membrane protein that is phosphorylated and then bound by Src family kinases. Although expression and phosphorylation of CDCP1 have been investigated in many tumor cell lines, the CDCP1 features responsible for transformation have not been fully evaluated. This is in part due to the lack of an experimental system in which cellular transformation depends on expression of exogenous CDCP1 and Src. Here we use retrovirus mediated co-overexpression of c-Src and CDCP1 to induce focus formation of NIH3T3 cells. Employing different mutants of CDCP1 we show that for a full transformation capacity, the intact amino-and carboxy-termini of CDCP1 are essential. Mutation of any of the core intracellular tyrosine residues (Y734, Y743, or Y762) abolished transformation, and mutation of a palmitoylation motif (C689,690G) strongly reduced it. Src kinase binding to CDCP1 was not required since Src with a defective SH2 domain generated even more CDCP1 dependent foci whereas Src myristoylation was necessary. Taken together, the focus formation assay allowed us to define structural requirements of CDCP1/Src dependent transformation and to characterize the interaction of CDCP1 and Src.	[Kollmorgen, Gwendlyn; Bossenmaier, Birgit; Niederfellner, Gerhard] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Haering, Hans-Ulrich; Lammers, Reiner] Univ Tubingen, Dept Internal Med 4, Tubingen, Germany	Roche Holding; Eberhard Karls University of Tubingen	Lammers, R (corresponding author), Univ Tubingen, Dept Internal Med 4, Tubingen, Germany.	reiner.lammers@med.uni-tuebingen.de	Bossenmaier, Birgit/AAN-7075-2020		Roche Diagnostics	Roche Diagnostics	Roche Diagnostics supported the study by a grant to R. Lammers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Orsulic S, 2000, J CELL SCI, V113, P1793; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Spassov DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019154; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zheng CX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006841	42	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53050	10.1371/journal.pone.0053050	http://dx.doi.org/10.1371/journal.pone.0053050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300860	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872600054
J	Terziyska, N; Alves, CC; Groiss, V; Schneider, K; Farkasova, K; Ogris, M; Wagner, E; Ehrhardt, H; Brentjens, RJ; zur Stadt, U; Horstmann, M; Quintanilla-Martinez, L; Jeremias, I				Terziyska, Nadia; Alves, Catarina Castro; Groiss, Volker; Schneider, Katja; Farkasova, Katarina; Ogris, Manfred; Wagner, Ernst; Ehrhardt, Harald; Brentjens, Renier J.; zur Stadt, Udo; Horstmann, Martin; Quintanilla-Martinez, Leticia; Jeremias, Irmela			In Vivo Imaging Enables High Resolution Preclinical Trials on Patients' Leukemia Cells Growing in Mice	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MOUSE MODELS; STEM-CELL; CANCER; EVOLUTION; XENOGRAFTS; LUCIFERASE; THERAPY; IMPACT	Background: Xenograft mouse models represent helpful tools for preclinical studies on human tumors. For modeling the complexity of the human disease, primary tumor cells are by far superior to established cell lines. As qualified exemplary model, patients' acute lymphoblastic leukemia cells reliably engraft in mice inducing orthotopic disseminated leukemia closely resembling the disease in men. Unfortunately, disease monitoring of acute lymphoblastic leukemia in mice is hampered by lack of a suitable readout parameter. Design and Methods: Patients' acute lymphoblastic leukemia cells were lentivirally transduced to express the membrane-bound form of Gaussia luciferase. In vivo imaging was established in individual patients' leukemias and extensively validated. Results: Bioluminescence in vivo imaging enabled reliable and continuous follow-up of individual mice. Light emission strictly correlated to post mortem quantification of leukemic burden and revealed a logarithmic, time and cell number dependent growth pattern. Imaging conveniently quantified frequencies of leukemia initiating cells in limiting dilution transplantation assays. Upon detecting a single leukemia cell within more than 10,000 bone marrow cells, imaging enabled monitoring minimal residual disease, time to tumor re-growth and relapse. Imaging quantified therapy effects precisely and with low variances, discriminating treatment failure from partial and complete responses. Conclusions: For the first time, we characterized in detail how in vivo imaging reforms preclinical studies on patient-derived tumors upon increasing monitoring resolution. In the future, in vivo imaging will enable performing precise preclinical studies on a broad range of highly demanding clinical challenges, such as treatment failure, resistance in leukemia initiating cells, minimal residual disease and relapse.	[Terziyska, Nadia; Alves, Catarina Castro; Groiss, Volker; Schneider, Katja; Ehrhardt, Harald; Jeremias, Irmela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany; [Farkasova, Katarina; Ogris, Manfred; Wagner, Ernst] Univ Munich, Dept Pharm, Ctr System Based Drug Res, Munich, Germany; [Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [zur Stadt, Udo; Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Res Inst Childrens Canc Ctr, Hamburg Eppendorf, Germany; [zur Stadt, Udo; Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost, Hamburg Eppendorf, Germany; [Quintanilla-Martinez, Leticia] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Quintanilla-Martinez, Leticia] Univ Tubingen Hosp, Ctr Comprehens Canc, Tubingen, Germany; [Jeremias, Irmela] Univ Munich, Dept Oncol, Dr von Haunersches Kinderspital, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Jeremias, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany.	irmela.jeremias@helmholtz-muenchen.de	Wagner, Ernst/A-7435-2012; Ehrhardt, Harald/L-9007-2018; Wagner, Ernst/ABB-5976-2020; Jeremias, Irmela/C-6090-2015; Jeremias, Irmela/Q-5934-2019	Wagner, Ernst/0000-0001-8413-0934; Ehrhardt, Harald/0000-0003-4587-1734; Wagner, Ernst/0000-0001-8413-0934; Jeremias, Irmela/0000-0003-1773-7677; Ogris, Manfred/0000-0002-4576-6961	Deutsche Forschungsgemeinschaft (DFG) [SFB684, TP22]; Deutsche Jose Carreras Leukamie Stiftung [R10/26]; Bettina Brau Stiftung; DFG Cluster of Excellence NIM; Dr. Helmut Legerlotz Stiftung; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie Stiftung; Bettina Brau Stiftung; DFG Cluster of Excellence NIM; Dr. Helmut Legerlotz Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by Deutsche Forschungsgemeinschaft (DFG) (SFB684, TP22; http://www.dfg.de/en/index.jsp), Deutsche Jose Carreras Leukamie Stiftung (R10/26; www.carreras-stiftung.de/), Bettina Brau Stiftung (http://www.bettina-braeu-stiftung.de/) and Dr. Helmut Legerlotz Stiftung (all to IJ) and DFG Cluster of Excellence NIM (to EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett DM, 2011, BLOOD, V118, pE112, DOI 10.1182/blood-2011-04-346528; Bottcher S, 2011, BLOOD REV, V25, P91, DOI 10.1016/j.blre.2011.01.001; Castro A.C., 2012, BLOOD, V119, P4224; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Dy GK, 2008, CANCER-AM CANCER SOC, V113, P1857, DOI 10.1002/cncr.23651; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Ehrhardt H, 2011, BLOOD, V118, P6123, DOI 10.1182/blood-2010-02-269811; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Francia G, 2009, CLIN CANCER RES, V15, P6358, DOI 10.1158/1078-0432.CCR-09-0931; Inoue Y, 2011, MOL IMAGING, V10, P377, DOI 10.2310/7290.2010.00057; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lyons SK, 2005, J PATHOL, V205, P194, DOI 10.1002/path.1697; Macor P, 2008, CURR PHARM DESIGN, V14, P2023, DOI 10.2174/138161208785294591; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; McCormick F, 2011, CURR OPIN GENET DEV, V21, P29, DOI 10.1016/j.gde.2010.12.002; Meyer LH, 2011, CANCER CELL, V19, P206, DOI 10.1016/j.ccr.2010.11.014; Misaghian N, 2009, LEUKEMIA, V23, P25, DOI 10.1038/leu.2008.246; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Schmitz M, 2011, BLOOD, V118, P1854, DOI 10.1182/blood-2010-11-320309; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688	34	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52798	10.1371/journal.pone.0052798	http://dx.doi.org/10.1371/journal.pone.0052798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300782	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600026
J	Ulrich, A; Andersen, KR; Schwartz, TU				Ulrich, Alexander; Andersen, Kasper R.; Schwartz, Thomas U.			Exponential Megapriming PCR (EMP) Cloning-Seamless DNA Insertion into Any Target Plasmid without Sequence Constraints	PLOS ONE			English	Article							IN-VITRO; RESTRICTION-ENDONUCLEASE; ENZYMATIC AMPLIFICATION; RF CLONING; RECOMBINATION; MUTAGENESIS; FIDELITY; CONSTRUCTION; CLEAVAGE	We present a fast, reliable and inexpensive restriction-free cloning method for seamless DNA insertion into any plasmid without sequence limitation. Exponential megapriming PCR (EMP) cloning requires two consecutive PCR steps and can be carried out in one day. We show that EMP cloning has a higher efficiency than restriction-free (RF) cloning, especially for long inserts above 2.5 kb. EMP further enables simultaneous cloning of multiple inserts.	[Ulrich, Alexander; Andersen, Kasper R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ulrich, Alexander] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Massachusetts Institute of Technology (MIT); Free University of Berlin	Schwartz, TU (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Ulrich, Alexander Konstantin Christian/0000-0003-4255-4856	National Institutes of Health [GM077537]; German Academic Exchange Service (DAAD); Lundbeck Foundation; Sapere Aude DFF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Lundbeck Foundation(Lundbeckfonden); Sapere Aude DFF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM077537 to TUS. AU acknowledges a predoctoral fellowship from the German Academic Exchange Service (DAAD). KRA was funded by the Lundbeck Foundation and a Sapere Aude DFF postdoc grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte Arun, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip65; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barik S, 1997, Methods Mol Biol, V67, P173; BAUER JC, 1998, Patent No. 5789166; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Chen R, 2008, MOL BIOTECHNOL, V40, P224, DOI 10.1007/s12033-008-9078-z; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Eckert K A, 1991, PCR Methods Appl, V1, P17; FARMER AA, 2002, Patent No. 6410317; Frey B, 1995, BIOCHEMICA, V2, P34; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hansen LL, 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot4093, DOI 10.1101/PDB.PROT4093]; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HE QS, 1994, BIOTECHNIQUES, V17, P82; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mamedov TG, 2008, COMPUT BIOL CHEM, V32, P452, DOI 10.1016/j.compbiolchem.2008.07.021; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MCPHERSON MJ, 2000, PCR BASICS BACKGROUN; MERTZ JE, 1972, P NATL ACAD SCI USA, V69, P3370, DOI 10.1073/pnas.69.11.3370; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Radstrom Peter, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.top20; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SGARAMEL.V, 1970, P NATL ACAD SCI USA, V67, P1468, DOI 10.1073/pnas.67.3.1468; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	39	54	59	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53360	10.1371/journal.pone.0053360	http://dx.doi.org/10.1371/journal.pone.0053360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300917	Green Published, gold			2022-12-27	WOS:000313872600088
J	Ying, Z; Feng, C; Agrawal, R; Zhuang, YM; Gomez-Pinilla, F				Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando			Dietary Omega-3 Deficiency from Gestation Increases Spinal Cord Vulnerability to Traumatic Brain Injury-Induced Damage	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; MEMBRANE HOMEOSTASIS; PHOSPHOLIPASE A(2); RAT; SUPPLEMENTATION	Although traumatic brain injury (TBI) is often associated with gait deficits, the effects of TBI on spinal cord centers are poorly understood. We seek to determine the influence of TBI on the spinal cord and the potential of dietary omega-3 (n-3) fatty acids to counteract these effects. Male rodents exposed to diets containing adequate or deficient levels of n-3 since gestation received a moderate fluid percussion injury when becoming 14 weeks old. TBI reduced levels of molecular systems important for synaptic plasticity (BDNF, TrkB, and CREB) and plasma membrane homeostasis (4-HNE, iPLA2, syntaxin-3) in the lumbar spinal cord. These effects of TBI were more dramatic in the animals exposed to the n-3 deficient diet. Results emphasize the comprehensive action of TBI across the neuroaxis, and the critical role of dietary n-3 as a means to build resistance against the effects of TBI.	[Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724	NINDS NIH HHS [R01 NS050465, R01 NS056413] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; FITZPATRICK JS, 1994, DEV BRAIN RES, V78, P81, DOI 10.1016/0165-3806(94)90012-4; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706	23	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52998	10.1371/journal.pone.0052998	http://dx.doi.org/10.1371/journal.pone.0052998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300842	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500099
J	Cabezon, R; Ricart, E; Espana, C; Panes, J; Benitez-Ribas, D				Cabezon, Raquel; Ricart, Elena; Espana, Carolina; Panes, Julian; Benitez-Ribas, Daniel			Gram-Negative Enterobacteria Induce Tolerogenic Maturation in Dexamethasone Conditioned Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; UP-REGULATION; IN-VITRO; ACTIVATION; DIFFERENTIATION; GENERATION; IMMATURE; SERUM; HYPORESPONSIVENESS	Dendritic cells have been investigated in clinical trials, predominantly with the aim of stimulating immune responses against tumours or infectious diseases. Thus far, however, no clinical studies have taken advantage of their specific immunosuppressive potential. Tolerogenic DCs may represent a new therapeutic strategy for human immune-based diseases, such as Crohn's disease, where the perturbations of the finely tuned balance between the immune system and the microflora result in disease. In the present report, we describe the generation of tolerogenic DCs from healthy donors and Crohn's disease patients using clinical-grade reagents in combination with dexamethasone as immunosuppressive agent and characterize their response to maturation stimuli. Interestingly, we found out that dexamethasone-conditioned DCs keep their tolerogenic properties to Gram-negative bacteria. Other findings included in this study demonstrate that the combination of dexamethasone with a specific cytokine cocktail yielded clinical-grade DCs with the following characteristics: a semi-mature phenotype, a pronounced shift towards anti-inflammatory versus inflammatory cytokine production and low T-cell stimulatory properties. Importantly, in regard to their clinical application, the tolerogenic phenotype of DCs remained stable after the elimination of dexamethasone and after a second stimulation with LPS or bacteria. All these properties make this cell product suitable to be tested in clinical trials of inflammatory conditions including Crohn's disease.	[Ricart, Elena; Panes, Julian; Benitez-Ribas, Daniel] CIBERehd, Barcelona, Spain; [Ricart, Elena; Panes, Julian; Benitez-Ribas, Daniel] Ctr Esther Koplowitz, Barcelona, Spain; [Cabezon, Raquel; Ricart, Elena; Espana, Carolina; Panes, Julian] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Benitez-Ribas, D (corresponding author), CIBERehd, Barcelona, Spain.	daniel.benitez@ciberehd.org	Cabezón, Raquel/F-4208-2016; Panes, Julian/H-5991-2015	Panes, Julian/0000-0002-4971-6902	Ministerio de Ciencia e Innovacion [SAF 2009-07272]; Ministerio de Sanidad y Politica Social [TRA-097]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); CIBERehd; Instituto de Salud Carlos III; FI fellowship from the Generalitat de Catalunya	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Politica Social(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); CIBERehd; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FI fellowship from the Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grant SAF 2009-07272 from the Ministerio de Ciencia e Innovacion, grant TRA-097 from the Ministerio de Sanidad y Politica Social, and by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd). DB-R is supported by CIBERehd and by the Instituto de Salud Carlos III, RC is funded by a FI fellowship from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744; Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Berger TG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006645; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bros M, 2007, BLOOD, V109, P3820, DOI 10.1182/blood-2006-07-035576; Chamorro S, 2009, J IMMUNOL, V183, P2984, DOI 10.4049/jimmunol.0801155; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; de Vries IJM, 2002, J IMMUNOTHER, V25, P429, DOI 10.1097/00002371-200209000-00007; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Duperrier K, 2000, J IMMUNOL METHODS, V238, P119, DOI 10.1016/S0022-1759(00)00147-2; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Fazekasova H, 2009, TRANSPLANTATION, V87, P1617, DOI 10.1097/TP.0b013e3181a5504c; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Harry RA, 2010, ANN RHEUM DIS, V69, P2042, DOI 10.1136/ard.2009.126383; Jin CJ, 2009, LEUKEMIA RES, V34, P513; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kim Chang H, 2005, Curr Opin Hematol, V12, P298, DOI 10.1097/01.moh.0000166496.18773.e3; Kuwana M, 2001, EUR J IMMUNOL, V31, P2547, DOI 10.1002/1521-4141(200109)31:9<2547::AID-IMMU2547>3.0.CO;2-J; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Lagaraine C, 2008, J LEUKOCYTE BIOL, V84, P1057, DOI 10.1189/jlb.1007716; Larange A, 2012, J LEUKOCYTE BIOL, V91, P105, DOI 10.1189/jlb.1110615; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moreau A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00218; Napoletano C, 2007, J IMMUNOTHER, V30, P567, DOI 10.1097/CJI.0b013e318046f396; Naranjo-Gomez M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-89; Pedersen AE, 2009, IMMUNOLOGY, V127, P354, DOI 10.1111/j.1365-2567.2008.02996.x; Peng JC, 2005, J IMMUNOTHER, V28, P599, DOI 10.1097/01.cji.0000175491.21099.04; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 1999, J IMMUNOL, V162, P6473; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Raich-Regue D, 2012, EUR J IMMUNOL, V42, P771, DOI 10.1002/eji.201141835; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Schreibelt G, 2010, BLOOD, V116, P564, DOI 10.1182/blood-2009-11-251884; Shale M, 2009, GUT, V58, P1291, DOI 10.1136/gut.2006.098475; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N	48	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52456	10.1371/journal.pone.0052456	http://dx.doi.org/10.1371/journal.pone.0052456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300676	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100051
J	Mathot, L; Falk-Sorqvist, E; Moens, L; Allen, M; Sjoblom, T; Nilsson, M				Mathot, Lucy; Falk-Sorqvist, Elin; Moens, Lotte; Allen, Marie; Sjoblom, Tobias; Nilsson, Mats			Automated Genotyping of Biobank Samples by Multiplex Amplification of Insertion/Deletion Polymorphisms	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; DNA FRAGMENTS; ANEUPLOIDY; MARKERS; CANCER; MLGA	The genomic revolution in oncology will entail mutational analyses of vast numbers of patient-matched tumor and normal tissue samples. This has meant an increased risk of patient sample mix up due to manual handling. Therefore, scalable genotyping and sample identification procedures are essential to pathology biobanks. We have developed an efficient alternative to traditional genotyping methods suited for automated analysis. By targeting 53 prevalent deletions and insertions found in human populations with fluorescent multiplex ligation dependent genome amplification, followed by separation in a capillary sequencer, a peak spectrum is obtained that can be automatically analyzed. 24 tumor-normal patient samples were successfully matched using this method. The potential use of the developed assay for forensic applications is discussed.	[Mathot, Lucy; Falk-Sorqvist, Elin; Moens, Lotte; Allen, Marie; Sjoblom, Tobias; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden	Uppsala University; Stockholm University	Nilsson, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	mats.nilsson@scilifelab.se	Mathot, Lucy/AAF-1463-2020		Swedish research council, VINNOVA; Innovative Medicines Initiative Joint Undertaking [115234]; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations)	Swedish research council, VINNOVA(Swedish Research CouncilVinnova); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations)	This work has been supported by grants from the Swedish research council, VINNOVA and the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115234 (OncoTrack), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA (European Federation of Pharmaceutical Industries and Associations) companies in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckleton J, 2005, FORENSIC SCI INT, V152, P115, DOI 10.1016/j.forsciint.2004.07.020; CHAKRABORTY R, 1988, GENETICS, V118, P527; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Fondevila M, 2012, INT J LEGAL MED, V126, P725, DOI 10.1007/s00414-012-0721-7; Friis SL, 2012, FORENSIC SCI INT-GEN, V6, pE72, DOI 10.1016/j.fsigen.2011.08.002; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Isaksson M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm651; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Mathot L, 2011, CHEM COMMUN, V47, P547, DOI 10.1039/c0cc02248a; Nei M., 1987, MOL EVOLUTIONARY GEN; Pereira R, 2009, ELECTROPHORESIS, V30, P3682, DOI 10.1002/elps.200900274; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Stenberg J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni071; Stenberg J, 2009, BIOINFORMATICS, V25, P666, DOI 10.1093/bioinformatics/btp001; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wyatt AW, 2009, MOL VIS, V15, P1445	22	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52750	10.1371/journal.pone.0052750	http://dx.doi.org/10.1371/journal.pone.0052750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300761	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100077
J	Nojima, T; Konno, H; Kodera, N; Seio, K; Taguchi, H; Yoshida, M				Nojima, Tatsuya; Konno, Hiroki; Kodera, Noriyuki; Seio, Kohji; Taguchi, Hideki; Yoshida, Masasuke			Nano-Scale Alignment of Proteins on a Flexible DNA Backbone	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ATOMIC-FORCE MICROSCOPY; NANOSTRUCTURES; VARIANT; FRET	Nano-scale alignment of several proteins with freedom of motion is equivalent to an enormous increase in effective local concentration of proteins and will enable otherwise impossible weak and/or cooperative associations between them or with their ligands. For this purpose, a DNA backbone made of six oligodeoxynucleotide (ODN) chains is designed in which five double-stranded segments are connected by four single-stranded flexible linkers. A desired protein with an introduced cysteine is connected covalently to the 5'-end of azido-ODN by catalyst-free click chemistry. Then, six protein-ODN conjugates are assembled with their complementary nucleotide sequences into a single multi-protein-DNA complex, and six proteins are aligned along the DNA backbone. Flexible alignment of proteins is directly observed by high-speed AFM imaging, and association of proteins with weak interaction is demonstrated by fluorescence resonance energy transfer between aligned proteins.	[Nojima, Tatsuya; Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 603, Japan; [Konno, Hiroki; Kodera, Noriyuki] Kanazawa Univ, Inst Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa, Japan; [Seio, Kohji] Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 227, Japan; [Taguchi, Hideki] Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 227, Japan	Kyoto Sangyo University; Kanazawa University; Tokyo Institute of Technology; Tokyo Institute of Technology	Nojima, T (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan.	nojima.t.aa@m.titech.ac.jp	Kodera, Noriyuki/AAJ-1797-2020; Seio, Kohji/Y-8597-2018; Taguchi, Hideki/B-6946-2009; Nojima, Tatsuya/S-4325-2019; Kodera, Noriyuki/E-6569-2015; Nojima, Tatsuya/E-9741-2017	Seio, Kohji/0000-0001-5258-4763; Taguchi, Hideki/0000-0002-6612-9339; Nojima, Tatsuya/0000-0002-0422-0225; Kodera, Noriyuki/0000-0003-4880-8423; Nojima, Tatsuya/0000-0002-0422-0225	Ministry of Education, Culture, Sports, Science and Technology, Japan [19058004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (No. 19058004 to M. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Erkelenz M, 2011, J AM CHEM SOC, V133, P16111, DOI 10.1021/ja204993s; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Kukolka F, 2004, ORG BIOMOL CHEM, V2, P2203, DOI 10.1039/b406492e; Liu Z, 2005, J MICROSC-OXFORD, V218, P233, DOI 10.1111/j.1365-2818.2005.01482.x; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Muller J, 2008, BIOCHEM BIOPH RES CO, V377, P62, DOI 10.1016/j.bbrc.2008.09.078; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakata E, 2012, ANGEW CHEM INT EDIT, V51, P2421, DOI 10.1002/anie.201108199; Niemeyer CM, 1998, ANGEW CHEM INT EDIT, V37, P2265, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2265::AID-ANIE2265>3.0.CO;2-F; Numajiri K, 2010, J AM CHEM SOC, V132, P9937, DOI 10.1021/ja104702q; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Tepper AWJW, 2010, J AM CHEM SOC, V132, P6550, DOI 10.1021/ja101515y; Vinkenborg JL, 2007, CHEMBIOCHEM, V8, P1119, DOI 10.1002/cbic.200700109; Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/NNANO.2009.50, 10.1038/nnano.2009.50]; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	21	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52534	10.1371/journal.pone.0052534	http://dx.doi.org/10.1371/journal.pone.0052534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300700	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800102
J	Chen, ZH; Zhao, RJ; Li, RH; Guo, CP; Zhang, GJ				Chen, Zhi-Hong; Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun			Bioluminescence Imaging of DNA Synthetic Phase of Cell Cycle in Living Animals	PLOS ONE			English	Article							VITRO MODEL SYSTEM; IN-VIVO; TOPOISOMERASE-I; HOLLOW FIBERS; CANCER; EXPRESSION; RESISTANCE	Bioluminescence reporter proteins have been widely used in the development of tools for monitoring biological events in living cells. Currently, some assays like flow cytometry analysis are available for studying DNA synthetic phase (S-phase) targeted anti-cancer drug activity in vitro; however, techniques for imaging of in vivo models remain limited. Cyclin A2 is known to promote S-phase entry in mammals. Its expression levels are low during G1-phase, but they increase at the onset of S-phase. Cyclin A2 is degraded during prometaphase by ubiquitin-dependent, proteasome-mediated proteolysis. In this study, we have developed a cyclin A2-luciferase (CYCA-Luc) fusion protein targeted for ubiquitin-proteasome dependent degradation, and have evaluated its utility in screening S-phase targeted anti-cancer drugs. Similar to endogenous cyclin A2, CYCA-Luc accumulates during S-phase and is degraded during G2/M-phase. Using Cdc20 siRNA we have demonstrated that Cdc20 can mediate CYCA-Luc degradation. Moreover, using noninvasive bioluminescent imaging, we demonstrated accumulation of CYCA-Luc in response to 10-hydroxycamptothecin (HCPT), an S-phase targeted anti-cancer drug, in human tumor cells in vivo and in vitro. Our results indicate that a CYCA-Luc fusion reporter system can be used to monitor S-phase of cell cycle, and evaluate pharmacological activity of anti-cancer drug HCPT in real time in vitro and in vivo, and is likely to provide an important tool for screening such drugs.	[Chen, Zhi-Hong; Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun] Shantou Univ, Canc Hosp, Coll Med, Breast Ctr, Shantou, Peoples R China; [Chen, Zhi-Hong] Mudanjiang Med Univ, Heilongjiang Prov Key Lab Canc Prevent & Treatmen, Mudanjiang, Peoples R China; [Zhao, Rui-Jun; Li, Rong-Hui; Guo, Cui-Ping; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China	Shantou University; Mudanjiang Medical University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Canc Hosp, Coll Med, Breast Ctr, Shantou, Peoples R China.	guoj_zhang@yahoo.com	Zhang, Guo-Jun/H-3890-2015	Zhang, Guo-Jun/0000-0001-5182-5887	National Basic Research Project of China [2011CB707705]; National Natural Science Foundation of China [30973377, 31271068]	National Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by grants from the National Basic Research Project of China (2011CB707705) and the National Natural Science Foundation of China (30973377 and 31271068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Aziz W, 2004, BIOCHEM PHARMACOL, V68, P11, DOI 10.1016/j.bcp.2004.03.021; Abdel-Aziz W, 2003, CRIT REV ONCOL HEMAT, V48, P19, DOI 10.1016/S1040-8428(03)00096-9; Arrondeau J, 2010, DISCOV MED, V10, P355; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Chiarle R, 2001, BREAST CANCER RES, V3, P91; Cho YS, 2003, CLIN CANCER RES, V9, P1171; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Honda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039249; Kuhling H, 2003, J PATHOL, V199, P424, DOI 10.1002/path.1322; Liao Z, 2008, MOL PHARMACOL, V73, P490, DOI 10.1124/mol.107.041178; Liu WF, 2011, EUR J MED CHEM, V46, P2408, DOI 10.1016/j.ejmech.2011.03.024; Lyons SK, 2006, CANCER RES, V66, P4701, DOI 10.1158/0008-5472.CAN-05-3598; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Wexler EJ, 2000, CLIN CANCER RES, V6, P3361; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang GJ, 2008, NAT PROTOC, V3, P891, DOI 10.1038/nprot.2008.52; Zhang GJ, 2007, NEOPLASIA, V9, P652, DOI 10.1593/neo.07421; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307	30	8	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53291	10.1371/journal.pone.0053291	http://dx.doi.org/10.1371/journal.pone.0053291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301056	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000047
J	Funakoshi-Tago, M; Sumi, K; Kasahara, T; Tago, K				Funakoshi-Tago, Megumi; Sumi, Kazuya; Kasahara, Tadashi; Tago, Kenji			Critical Roles of Myc-ODC Axis in the Cellular Transformation Induced by Myeloproliferative Neoplasm-Associated JAK2 V617F Mutant	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; C-MYC; ORNITHINE-DECARBOXYLASE; POLYCYTHEMIA-VERA; NUDE-MICE; ESSENTIAL THROMBOCYTHEMIA; LEUKEMIA CELLS; CYCLE ARREST; FERM DOMAIN; PROTEIN	The acquired mutation (V617F) of Janus kinase 2 (JAK2) is observed in the majority of patients with myeloproliferative neoplasms (MPNs). In the screening of genes whose expression was induced by JAK2 (V617F), we found the significant induction of c-Myc mRNA expression mediated by STAT5 activation. Interestingly, GSK-3 beta was inactivated in transformed Ba/F3 cells by JAK2 (V617F), and this enhanced the protein expression of c-Myc. The enforced expression of c-Myc accelerated cell proliferation but failed to inhibit apoptotic cell death caused by growth factor deprivation; however, the inhibition of GSK-3 beta completely inhibited the apoptosis of cells expressing c-Myc. Strikingly, c-Myc T58A mutant exhibited higher proliferative activity in a growth-factor-independent manner; however, this mutant failed to induce apoptosis. In addition, knockdown of c-Myc significantly inhibited the proliferation of transformed cells by JAK2 (V617F), suggesting that c-Myc plays an important role in oncogenic activity of JAK2 (V617F). Furthermore, JAK2 (V617F) induced the expression of a target gene of c-Myc, ornithine decarboxylase (ODC), known as the rate-limiting enzyme in polyamine biosynthesis. An ODC inhibitor, difluoromethylornithine (DFMO), prevented the proliferation of transformed cells by JAK2 (V617F). Importantly, administration of DFMO effectively delayed tumor formation in nude mice inoculated with transformed cells by JAK2 (V617F), resulting in prolonged survival; therefore, ODC expression through c-Myc is a critical step for JAK2 (V617F)-induced transformation and DFMO could be used as effective therapy for MPNs.	[Funakoshi-Tago, Megumi; Sumi, Kazuya; Kasahara, Tadashi] Keio Univ, Fac Pharmacol, Dept Biochem, Tokyo, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, Shimotsuke Shi, Japan	Keio University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharmacol, Dept Biochem, Tokyo, Japan.	tago-mg@pha.keio.ac.jp; ktago@jichi.ac.jp			MEXT [21790090]; Takeda Science Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants (21790090) from MEXT and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Auvinen M, 1997, CANCER RES, V57, P3016; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Choi SH, 2000, LEUKEMIA RES, V24, P119, DOI 10.1016/S0145-2126(99)00161-7; Cohen S.S., 1997, GUIDE POLYAMINES; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DESSER H, 1975, CLIN CHIM ACTA, V63, P243, DOI 10.1016/0009-8981(75)90044-3; Fozard J. R, 1980, EUR J PHARMACOL, V65, P79; FOZARD JR, 1980, SCIENCE, V208, P505; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Furuhata A, 2009, BIOCHEM BIOPH RES CO, V383, P411, DOI 10.1016/j.bbrc.2009.04.015; Ho Kevin, 2010, J Assoc Genet Technol, V36, P107; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamishimoto J, 2011, CELL SIGNAL, V23, P849, DOI 10.1016/j.cellsig.2011.01.009; Karlsson H, 1999, MOL CELL ENDOCRINOL, V154, P37, DOI 10.1016/S0303-7207(99)00101-X; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Ravanko K, 2000, CANCER RES, V60, P5244; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Theophile K, 2008, ANN HEMATOL, V87, P263, DOI 10.1007/s00277-007-0424-1; Wallace HM, 2009, ESSAYS BIOCHEM, V46, P1, DOI [10.1042/BSE0460001, 10.1042/bse0460001]; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108	50	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52844	10.1371/journal.pone.0052844	http://dx.doi.org/10.1371/journal.pone.0052844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300995	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000017
J	Monsarrat, S; Benhamou, S; Sarrazin, F; Bessa-Gomes, C; Bouten, W; Duriez, O				Monsarrat, Sophie; Benhamou, Simon; Sarrazin, Francois; Bessa-Gomes, Carmen; Bouten, Willem; Duriez, Olivier			How Predictability of Feeding Patches Affects Home Range and Foraging Habitat Selection in Avian Social Scavengers?	PLOS ONE			English	Article							VULTURES GYPS-FULVUS; FOOD SUPPLEMENTATION; ECOLOGICAL TRAPS; BREEDING SUCCESS; SPACE USE; BEHAVIOR; CONSERVATION; POPULATION; SEX; ALBATROSSES	Feeding stations are commonly used to sustain conservation programs of scavengers but their impact on behaviour is still debated. They increase the temporal and spatial predictability of food resources while scavengers have supposedly evolved to search for unpredictable resources. In the Grands Causses (France), a reintroduced population of Griffon vultures Gyps fulvus can find carcasses at three types of sites: 1. "light feeding stations'', where farmers can drop carcasses at their farm (spatially predictable), 2. "heavy feeding stations'', where carcasses from nearby farms are concentrated (spatially and temporally predictable) and 3. open grasslands, where resources are randomly distributed (unpredictable). The impact of feeding stations on vulture's foraging behaviour was investigated using 28 GPS-tracked vultures. The average home range size was maximal in spring (1272 +/- 752 km(2)) and minimal in winter (473 +/- 237 km(2)) and was highly variable among individuals. Analyses of home range characteristics and feeding habitat selection via compositional analysis showed that feeding stations were always preferred compared to the rest of the habitat where vultures can find unpredictable resources. Feeding stations were particularly used when resources were scarce (summer) or when flight conditions were poor (winter), limiting long-ranging movements. However, when flight conditions were optimal, home ranges also encompassed large areas of grassland where vultures could find unpredictable resources, suggesting that vultures did not lose their natural ability to forage on unpredictable resources, even when feeding stations were available. However during seasons when food abundance and flight conditions were not limited, vultures seemed to favour light over heavy feeding stations, probably because of the reduced intraspecific competition and a pattern closer to the natural dispersion of resources in the landscape. Light feeding stations are interesting tools for managing food resources, but don't prevent vultures to feed at other places with possibly high risk of intoxication (poison).	[Monsarrat, Sophie; Benhamou, Simon; Duriez, Olivier] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, Montpellier, France; [Sarrazin, Francois] UPMC, CNRS, MNHN, UMR 7204, Paris, France; [Bessa-Gomes, Carmen] Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France; [Bouten, Willem] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Amsterdam	Duriez, O (corresponding author), Univ Montpellier 2, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, Montpellier, France.	olivier.duriez@cefe.cnrs.fr	Bouten, Willem/G-4383-2018; Sarrazin, Francois/B-7593-2013; Sarrazin, François/AAB-4227-2019; Duriez, Olivier/R-4772-2016	Bouten, Willem/0000-0002-5250-8872; Sarrazin, Francois/0000-0001-5901-4819; Sarrazin, François/0000-0001-5901-4819; Duriez, Olivier/0000-0003-1868-9750; Monsarrat, Sophie/0000-0002-6220-5306; Bessa Gomes, Carmen/0000-0002-3476-0767	ANR [ANR-07-BLAN-0201]	ANR(French National Research Agency (ANR))	Project funded by ANR grant no ANR-07-BLAN-0201, coordinated by F. Sarrazin and C. Bessa-Gomes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrados C, 2002, CR BIOL, V325, P165, DOI 10.1016/S1631-0691(02)01414-2; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2010, R LANG ENV STAT COMP; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bahat O, 1995, THESIS TEL AVIV U TE; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; BENHAMOU S, 1989, J THEOR BIOL, V139, P379, DOI 10.1016/S0022-5193(89)80216-4; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Blondel J, 2010, MEDITERRANEAN REGION; BlSSzquez M., 2009, VULTURES FEEDING STA, P308; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Bose M, 2012, BIRD STUDY IN PRESS; Bose M, 2007, IBIS, V149, P490, DOI 10.1111/j.1474-919X.2007.00674.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Carrete M, 2005, BIOL CONSERV, V126, P582, DOI 10.1016/j.biocon.2005.06.031; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Cramp S., 1982, HDB BIRDS EUROPE MID; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Dupont H, 2012, J APPL ECOL, V49, P404, DOI 10.1111/j.1365-2664.2012.02111.x; Duriez O, 2012, BIRD STUDY IN PRESS; Fischer AB, 1969, ZOOL JB SYST, V96, P81; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gault A, 2006, THESIS U PARIS 6 PAR, P6; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Goss-Custard John D., 1997, P373; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; Margalida A, 2010, EUR J WILDLIFE RES, V56, P673, DOI 10.1007/s10344-010-0366-0; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Meretsky VJ, 1999, J WILDLIFE MANAGE, V63, P107, DOI 10.2307/3802491; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Mundy P., 1992, VULTURES AFRICA; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Piper S.E., 2004, P341; Piper SE, 1999, BIRD STUDY, V46, P230; Piper SE, 2006, THESSALONIKI, P41; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; R Development Core Team, 2012, R LANG ENV STAT COMP; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Reddy A, 2007, CURR SCI INDIA, V92, P659; Ridoux V, 1997, ECOLOGY; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sarrazin F, 1996, IBIS, V138, P315, DOI 10.1111/j.1474-919X.1996.tb04344.x; SARRAZIN F, 1994, AUK, V111, P853; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Terrasse M., 1994, P479; Terrasse Michel, 2004, P127; Wienecke BC, 2000, DEEP-SEA RES PT II, V47, P2573, DOI 10.1016/S0967-0645(00)00036-9; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Xirouchakis SM, 2009, WILDLIFE BIOL, V15, P37, DOI 10.2981/07-090	64	112	116	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53077	10.1371/journal.pone.0053077	http://dx.doi.org/10.1371/journal.pone.0053077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301024	gold, Green Submitted, Green Published			2022-12-27	WOS:000313480000029
J	Kwan, HT; Chan, DW; Cai, PCH; Mak, CSL; Yung, MMH; Leung, THY; Wong, OGW; Cheung, ANY; Ngan, HYS				Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Wong, Oscar G. W.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.			AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/beta-Catenin Signaling Activity	PLOS ONE			English	Article							PROTEIN-KINASE; BETA-CATENIN; BREAST-CANCER; WNT PATHWAY; MAMMALIAN TARGET; LUNG-CANCER; DISHEVELLED OVEREXPRESSION; ANTIDIABETIC DRUG; DIABETIC-PATIENTS; HUMAN COUNTERPART	Recent evidence has suggested that AMPK activators may be applied as therapeutic drugs in suppressing cancer cell growth. However, the molecular mechanism of their suppressive function in cancer cells is still unclear. Here we show that AMPK activators impair cervical cancer cell growth through the reduction of DVL3, a positive regulator in Wnt/beta-catenin signaling and an oncogenic player in cervical cancer tumorigenesis. By western blot and immunohistochemical analyses, we demonstrated that DVL3 was frequently upregulated and significantly associated with elevated beta-catenin (P = 0.009) and CyclinD1 (P = 0.009) expressions in cervical cancer. Enforced expression of DVL3 elevated beta-catenin and augmented cervical cancer cell growth, verifying that DVL3-mediated Wnt/beta-catenin activation is involved in cervical cancer oncogenesis. On the other aspect, we noted that the cervical cancer cell growth was remarkably suppressed by AMPK activators and such cell growth inhibition was in concomitant with the reduction of DVL3 protein level in dose- and time-dependent manners. Besides, impaired mTOR signaling activity also reduced DVL3 expression. In contrast, co-treatment with Compound C (AMPK inhibitor) could significantly abrogate metformin induced DVL3 reduction. In addition, co-treatment with AM114 or MG132 (proteosomal inhibitors) could partially restore DVL3 expression under the treatment of metformin. Further in vivo ubiquitination assay revealed that metformin could reduce DVL3 by ubiquitin/proteasomal degradation. To our knowledge, this is the first report showing the probable molecular mechanisms of that the AMPK activators suppress cervical cancer cell growth by impairing DVL3 protein synthesis via AMPK/mTOR signaling and/or partially promoting the proteasomal degradation of DVL3.	[Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Obstet, Hong Kong, Hong Kong, Peoples R China; [Kwan, H. T.; Chan, David W.; Cai, Patty C. H.; Mak, Celia S. L.; Yung, Mingo M. H.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wong, Oscar G. W.; Cheung, Annie N. Y.] Univ Hong Kong, LKS Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, DW (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	YUNG, Mingo Ming Ho/AHB-5775-2022; Wong, Gee Wan/C-4661-2009; Chan, David/O-9896-2018; Cheung, Annie Nga Yin/C-4231-2009	YUNG, Mingo Ming Ho/0000-0003-0903-1164; Chan, David/0000-0002-6951-3467; Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by Wong Check She Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Cazzaniga M, 2009, CANCER EPIDEM BIOMAR, V18, P701, DOI 10.1158/1055-9965.EPI-08-0871; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chen H, 2011, J BIOL CHEM, V286, P14870, DOI 10.1074/jbc.M110.211607; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng ZB, 2011, HUM PATHOL, V42, P659, DOI 10.1016/j.humpath.2010.07.021; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Hutchinson DJ, 2008, AM J HEALTH-SYST PH, V65, P2105, DOI 10.2146/ajhp070627; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Miyoshi Y, 1998, CANCER RES, V58, P2524; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pereira-Suarez AL, 2002, TUMOR BIOL, V23, P45, DOI 10.1159/000048688; Perez-Plasencia Carlos, 2008, Int Arch Med, V1, P10, DOI 10.1186/1755-7682-1-10; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Proud CG, 1997, BIOCHEM J, V328, P329; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Shao M, 2009, DEVELOPMENT, V136, P2121, DOI 10.1242/dev.032649; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Szalmas A, 2009, SEMIN CANCER BIOL, V19, P144, DOI 10.1016/j.semcancer.2009.02.011; Takatani T, 2011, MOL CELL ENDOCRINOL, V339, P114, DOI 10.1016/j.mce.2011.04.003; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Uematsu K, 2007, ANTICANCER RES, V27, P4239; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Vazquez-Martin A, 2009, CELL CYCLE, V8, P3679, DOI 10.4161/cc.8.22.9905; Yu SYM, 2009, TUMOR BIOL, V30, P80, DOI 10.1159/000216843; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; ZYLBERBERG B, 1991, PRESSE MED, V20, P1320	60	67	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53597	10.1371/journal.pone.0053597	http://dx.doi.org/10.1371/journal.pone.0053597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301094	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900087
J	Motrich, RD; Castro, GM; Caputto, BL				Motrich, Ruben D.; Castro, Gonzalo M.; Caputto, Beatriz L.			Old Players with a Newly Defined Function: Fra-1 and c-Fos Support Growth of Human Malignant Breast Tumors by Activating Membrane Biogenesis at the Cytoplasm	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; PHOSPHOLIPID-SYNTHESIS; TRANSCRIPTION FACTORS; ANTIGEN 1; EXPRESSION; AP-1; JUN; PHOSPHORYLATION; LOCALIZATION; NUCLEAR	A shared characteristic of tumor cells is their exacerbated growth. Consequently, tumor cells demand high rates of phospholipid synthesis required for membrane biogenesis to support their growth. c-Fos, in addition to its AP-1 transcription factor activity, is the only protein known up to date that is capable of activating lipid synthesis in normal and brain tumor tissue. For this latter activity, c-Fos associates to the endoplasmic reticulum (ER) through its N-terminal domain and activates phospholipid synthesis, an event that requires it Basic Domain (BD) (aa 139-159). Fra-1, another member of the FOS family of proteins, is over-expressed in human breast cancer cells and its BD is highly homologous to that of c-Fos with two conservative substitutions in its basic amino acids. Consequently, herein we examined if Fra-1 and/or c-Fos participate in growth of breast cancer cells by activating phospholipid synthesis as found previously for c-Fos in brain tumors. We found both Fra-1 and c-Fos over-expressed in >95% of human ductal breast carcinoma biopsies examined contrasting with the very low or undetectable levels in normal tissue. Furthermore, both proteins associate to the ER and activate phospholipid synthesis in cultured MCF7 and MDA-MB231 breast cancer cells and in human breast cancer samples. Stripping tumor membranes of Fra-1 and c-Fos prior to assaying their lipid synthesis capacity in vitro results in non-activated lipid synthesis levels that are restored to their initial activated state by addition of Fra-1 and/or c-Fos to the assays. In MDA-MB231 cells primed to proliferate, blocking Fra-1 and c-Fos with neutralizing antibodies blocks lipid-synthesis activation and cells do not proliferate. Taken together, these results disclose the cytoplasmic activity of Fra-1 and c-Fos as potential targets for controlling growth of breast carcinomas by decreasing the rate of membrane biogenesis required for growth.	[Motrich, Ruben D.; Castro, Gonzalo M.; Caputto, Beatriz L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Natl Sci & Tech Res Council,Dept Quim Biol, RA-5000 Cordoba, Argentina	National University of Cordoba	Caputto, BL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Natl Sci & Tech Res Council,Dept Bioquim Clin, Ciudad Univ, RA-5000 Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar		Castro, Gonzalo Manuel/0000-0002-0984-3835; Motrich, Ruben/0000-0002-5772-1285	Agencia Nacional de Promocion Cientifica y Tecnologica; Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica (Ministerio de Ciencia y Technologia) and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Gaggiotti MC, 2009, BIOPOLYMERS, V91, P710, DOI 10.1002/bip.21212; Chiappetta G, 2000, CLIN CANCER RES, V6, P4300; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Debinski W, 2005, MOL CANCER RES, V3, P237; Debinski W, 2011, CANCER BIOL THER, V11, P254, DOI 10.4161/cbt.11.2.13953; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Garbarino-Pico E, 2005, NEUROCHEM INT, V47, P260, DOI 10.1016/j.neuint.2005.04.024; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gil GA, 2012, NEUROCHEM RES, V37, P1364, DOI 10.1007/s11064-012-0763-8; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Logullo AF, 2011, HISTOPATHOLOGY, V58, P617, DOI 10.1111/j.1365-2559.2011.03785.x; Ma K, 2009, CANCER INVEST, V27, P353, DOI 10.1080/07357900802254008; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Nakajima H, 2007, J ANTIBIOT, V60, P682, DOI 10.1038/ja.2007.87; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ramos-Nino ME, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-81; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Silvestre DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009544; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; Song YH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-298; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Young MR, 2002, MOL CELL BIOL, V22, P587, DOI 10.1128/MCB.22.2.587-598.2002; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	49	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53211	10.1371/journal.pone.0053211	http://dx.doi.org/10.1371/journal.pone.0053211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301044	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900068
J	Tort, ABL; Targino, ZH; Amaral, OB				Tort, Adriano B. L.; Targino, Ze H.; Amaral, Olavo B.			Rising Publication Delays Inflate Journal Impact Factors	PLOS ONE			English	Article							CITATION; BEHAVIOR; METRICS; ACCESS	Journal impact factors have become an important criterion to judge the quality of scientific publications over the years, influencing the evaluation of institutions and individual researchers worldwide. However, they are also subject to a number of criticisms. Here we point out that the calculation of a journal's impact factor is mainly based on the date of publication of its articles in print form, despite the fact that most journals now make their articles available online before that date. We analyze 61 neuroscience journals and show that delays between online and print publication of articles increased steadily over the last decade. Importantly, such a practice varies widely among journals, as some of them have no delays, while for others this period is longer than a year. Using a modified impact factor based on online rather than print publication dates, we demonstrate that online-to-print delays can artificially raise a journal's impact factor, and that this inflation is greater for longer publication lags. We also show that correcting the effect of publication delay on impact factors changes journal rankings based on this metric. We thus suggest that indexing of articles in citation databases and calculation of citation metrics should be based on the date of an article's online appearance, rather than on that of its publication in print.	[Tort, Adriano B. L.; Targino, Ze H.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Amaral, Olavo B.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio de Janeiro	Tort, ABL (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	tort@neuro.ufrn.br	Gois, José/AAI-2545-2020; Tort, Adriano/A-9945-2009; Amaral, Olavo/B-2874-2009	Tort, Adriano/0000-0002-9877-7816; Amaral, Olavo/0000-0002-4299-8978				Abbott A, 2010, NATURE, V465, P860, DOI 10.1038/465860a; [Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; Bar-Ilan J, 2005, LIBR INFORM SCI RES, V27, P363, DOI 10.1016/j.lisr.2005.04.011; Bollen J, 2005, INFORM PROCESS MANAG, V41, P1419, DOI 10.1016/j.ipm.2005.03.024; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Craig I, 2006, CITATIONS ONLINEEARL; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Hartshorne JK, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00008; Hemminger BM, 2007, J AM SOC INF SCI TEC, V58, P2205, DOI 10.1002/asi.20686; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Liu ZM, 2005, J DOC, V61, P700, DOI 10.1108/00220410510632040; Marder E, 2010, P NATL ACAD SCI USA, V107, P21233, DOI 10.1073/pnas.1016516107; Mueller PS, 2006, NETH J MED, V64, P39; Schwarz Greg J., 2004, B AM ASTRONOMICAL SO, V36, P1654; Seglen P. O., 1997, BRIT MED J, V314, P497, DOI DOI 10.1136/BMJ.314.7079.497; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540; Yu G, 2005, SCIENTOMETRICS, V64, P235, DOI 10.1007/s11192-005-0249-4; Yue WP, 2007, J MED LIBR ASSOC, V95, P70	21	63	65	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53374	10.1371/journal.pone.0053374	http://dx.doi.org/10.1371/journal.pone.0053374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300920	Green Published, gold			2022-12-27	WOS:000313872600091
J	Bleckley, S; Stone, JW; Schroeder, SJ				Bleckley, Samuel; Stone, Jonathan W.; Schroeder, Susan J.			Crumple: A Method for Complete Enumeration of All Possible Pseudoknot-Free RNA Secondary Structures	PLOS ONE			English	Article							DYNAMIC-PROGRAMMING ALGORITHM; TOBACCO-MOSAIC-VIRUS; STRUCTURE PREDICTION; INCLUDING PSEUDOKNOTS; WEB SERVER; THERMODYNAMIC STABILITIES; TRYPANOSOMA-BRUCEI; PARTITION-FUNCTION; COAT PROTEIN; HELICAL RNA	The diverse landscape of RNA conformational space includes many canyons and crevices that are distant from the lowest minimum free energy valley and remain unexplored by traditional RNA structure prediction methods. A complete description of the entire RNA folding landscape can facilitate identification of biologically important conformations. The Crumple algorithm rapidly enumerates all possible non-pseudoknotted structures for an RNA sequence without consideration of thermodynamics while filtering the output with experimental data. The Crumple algorithm provides an alternative approach to traditional free energy minimization programs for RNA secondary structure prediction. A complete computation of all non-pseudoknotted secondary structures can reveal structures that would not be predicted by methods that sample the RNA folding landscape based on thermodynamic predictions. The free energy minimization approach is often successful but is limited by not considering RNA tertiary and protein interactions and the possibility that kinetics rather than thermodynamics determines the functional RNA fold. Efficient parallel computing and filters based on experimental data make practical the complete enumeration of all non-pseudoknotted structures. Efficient parallel computing for Crumple is implemented in a ring graph approach. Filters for experimental data include constraints from chemical probing of solvent accessibility, enzymatic cleavage of paired or unpaired nucleotides, phylogenetic covariation, and the minimum number and lengths of helices determined from crystallography or cryo-electron microscopy. The minimum number and length of helices has a significant effect on reducing conformational space. Pairing constraints reduce conformational space more than single nucleotide constraints. Examples with Alfalfa Mosaic Virus RNA and Trypanosome brucei guide RNA demonstrate the importance of evaluating all possible structures when pseduoknots, RNA-protein interactions, and metastable structures are important for biological function. Crumple software is freely available at http://adenosine.chem.ou.edu/software.html.	[Bleckley, Samuel; Stone, Jonathan W.; Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	susan.schroeder@ou.edu		Schroeder, Susan/0000-0003-4755-2294	National Science Foundation CAREER Award [0844913]; Div Of Molecular and Cellular Bioscience [0844913] Funding Source: National Science Foundation	National Science Foundation CAREER Award(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation CAREER Award # 0844913, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Bloomfield V, 2000, CHEM ENZYMATIC METHO, P45; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Byun Y, 2009, BIOINFORMATICS, V25, P1435, DOI 10.1093/bioinformatics/btp252; DIJKSTRA EW, 1980, INFORM PROCESS LETT, V11, P1, DOI 10.1016/0020-0190(80)90021-6; Dinan J, 2007, DYNAMIC LOAD BALANCI; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Forum M, 1994, MPI MESS PASS INT ST; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guogas LM, 2004, SCIENCE, V306, P2108, DOI 10.1126/science.1103399; Gupta A, 2012, RNA BIOL, V9, DOI [10.4161/rna.18386, 10.4161/rna.9.2.18386]; HE L, 1991, BIOCHEMISTRY-US, V30, P11124, DOI 10.1021/bi00110a015; Hofacker IL, 2010, RNA, V16, P1308, DOI 10.1261/rna.2093310; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; LARSON SB, 1993, NATURE, V361, P179, DOI 10.1038/361179a0; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003665; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McDowell JA, 1997, BIOCHEMISTRY-US, V36, P8030, DOI 10.1021/bi970122c; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Nguyen MT, 2010, BIOCHEMISTRY-US, V49, P10574, DOI 10.1021/bi101521p; PIPAS JM, 1975, P NATL ACAD SCI USA, V72, P2017, DOI 10.1073/pnas.72.6.2017; QUIGLEY GJ, 1984, NUCLEIC ACIDS RES, V12, P347, DOI 10.1093/nar/12.1Part1.347; Rastegari B, 2007, J COMPUT BIOL, V14, P16, DOI 10.1089/cmb.2006.0108; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Ruan JH, 2004, NUCLEIC ACIDS RES, V32, pW146, DOI 10.1093/nar/gkh444; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Schroeder SJ, 2009, J VIROL, V83, P6326, DOI 10.1128/JVI.00251-09; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52414	10.1371/journal.pone.0052414	http://dx.doi.org/10.1371/journal.pone.0052414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300665	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100047
J	Jang, HB; Kim, YK; del Castillo, CS; Nho, SW; Cha, IS; Park, SB; Ha, MA; Hikima, J; Hong, SJ; Aoki, T; Jung, TS				Jang, Ho Bin; Kim, Young Kyu; del Castillo, Carmelo S.; Nho, Seong Won; Cha, In Seok; Park, Seong Bin; Ha, Mi Ae; Hikima, Jun-ichi; Hong, Sung Jong; Aoki, Takashi; Jung, Tae Sung			RNA-Seq-Based Metatranscriptomic and Microscopic Investigation Reveals Novel Metalloproteases of Neobodo sp as Potential Virulence Factors for Soft Tunic Syndrome in Halocynthia roretzi	PLOS ONE			English	Article							EVOLUTIONARY FAMILIES; GEN.-NOV; SEQUENCE; SURFACE; KINETOPLASTIDS; LEISHMANIA; MORPHOLOGY; ENCYSTMENT; EUGLENOZOA; DIVERSITY	Bodonids and trypanosomatids are derived from a common ancestor with the bodonids being a more primitive lineage. The Neobodonida, one of the three clades of bodonids, can be free-living, commensal or parasitic. Despite the ecological and evolutionary significance of these organisms, however, many of their biological and pathological features are currently unknown. Here, we employed metatranscriptomics using RNA-seq technology combined with field-emission microscopy to reveal the virulence factors of a recently described genus of Neobodonida that is considered to be responsible for ascidian soft tunic syndrome (AsSTS), but whose pathogenesis is unclear. Our microscopic observation of infected tunic tissues suggested putative virulence factors, enabling us to extract novel candidate transcripts; these included cysteine proteases of the families C1 and C2, serine proteases of S51 and S9 families, and metalloproteases grouped into families M1, M3, M8, M14, M16, M17, M24, M41, and M49. Protease activity/inhibition assays and the estimation of expression levels within gene clusters allowed us to identify metalloprotease-like enzymes as potential virulence attributes for AsSTS. Furthermore, a multimarker-based phylogenetic analysis using 1,184 concatenated amino acid sequences clarified the order Neobodo sp. In sum, we herein used metatranscriptomics to elucidate the in situ expression profiles of uncharacterized putative transcripts of Neobodo sp., combined these results with microscopic observation to select candidate genes relevant to pathogenesis, and used empirical screening to define important virulence factors.	[Jang, Ho Bin; Kim, Young Kyu; del Castillo, Carmelo S.; Nho, Seong Won; Cha, In Seok; Park, Seong Bin; Ha, Mi Ae; Hikima, Jun-ichi; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Coll Vet Med, Aquat Biotechnol Ctr, WCU Project, Jinju, South Korea; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo, Japan; [Hong, Sung Jong] Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea	Gyeongsang National University; Waseda University; Chung Ang University; Chung Ang University Hospital	Jung, TS (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Aquat Biotechnol Ctr, WCU Project, Jinju, South Korea.	jungts@gnu.ac.kr	Hikima, Jun-ichi/AAI-6983-2020; Del Castillo, Carmelo/CAH-7345-2022; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946; del Castillo, Carmelo/0000-0001-6786-4004; Jang, Ho Bin/0000-0003-1316-316X	World Class University (WCU) Project [R32-10253]	World Class University (WCU) Project	This work was supported by World Class University (WCU) Project Grant R32-10253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2011, TRENDS PARASITOL, V27, P450, DOI 10.1016/j.pt.2011.06.003; Arner E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-391; Azumi K, 2007, ZOOL SCI, V24, P1231, DOI 10.2108/zsj.24.1231; Azumi K, 2007, FISHERIES SCI, V73, P263, DOI 10.1111/j.1444-2906.2007.01332.x; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BROOKER BE, 1972, PROTOPLASMA, V74, P397, DOI 10.1007/BF01281958; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Cha IS, 2011, DEV COMP IMMUNOL, V35, P809, DOI 10.1016/j.dci.2011.01.011; CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Choi DL, 2006, DIS AQUAT ORGAN, V72, P65, DOI 10.3354/dao072065; Cotrin SS, 2004, ANAL BIOCHEM, V335, P244, DOI 10.1016/j.ab.2004.09.012; Cubillos-Ruiz A, 2006, METAGENOMICS INTEGRA, P1; D'Avila-Levy CM, 2009, J EUKARYOT MICROBIOL, V56, P454, DOI 10.1111/j.1550-7408.2009.00424.x; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; DANSOHKAWA M, 1995, ZOOL SCI, V12, P289, DOI 10.2108/zsj.12.289; de Souza W, 2008, MICRON, V39, P77, DOI 10.1016/j.micron.2006.11.003; Deschamps P, 2011, MOL BIOL EVOL, V28, P53, DOI 10.1093/molbev/msq289; Drummond AJ, 2009, FIGTREE V 1 3 1, V1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elias CGR, 2006, PARASITOLOGY, V132, P37, DOI 10.1017/S0031182005008802; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FUKE M, 1993, ACTA ZOOL-STOCKHOLM, V74, P61, DOI 10.1111/j.1463-6395.1993.tb01221.x; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hirose E, 2009, J FISH DIS, V32, P433, DOI 10.1111/j.1365-2761.2009.01034.x; Hirose E, 2012, DIS AQUAT ORGAN, V97, P227, DOI 10.3354/dao02422; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson AP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-594; Jang HB, 2011, ANAL CHEM, V83, P1717, DOI 10.1021/ac102846q; Jung SJ, 2001, BIOLOGY OF ASCIDIANS, P436; Kitamura SI, 2010, J FISH DIS, V33, P153, DOI 10.1111/j.1365-2761.2009.01103.x; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Kumagai A, 2009, ANN REPORT JAPAN FIS, P3; Kumagai A, 2011, DIS AQUAT ORGAN, V95, P153, DOI 10.3354/dao02372; Kumagai A, 2010, DIS AQUAT ORGAN, V90, P223, DOI 10.3354/dao02228; Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Moran M. A., 2009, MICROBE, V4, P329, DOI DOI 10.1128/microbe.4.329.1; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2000, NUCLEIC ACIDS RES, V28, P323, DOI 10.1093/nar/28.1.323; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Stoeck T, 2005, INT J SYST EVOL MICR, V55, P2623, DOI 10.1099/ijs.0.63769-0; Suenaga H, 2012, ENVIRON MICROBIOL, V14, P13, DOI 10.1111/j.1462-2920.2011.02438.x; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; VANDAELE Y, 1992, BIOL CELL, V76, P87, DOI 10.1016/0248-4900(92)90198-A; Vermelho Alane Beatriz, 2010, Open Parasitology Journal, V4, P5; Vickerman K., 1990, P215; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnecke F, 2009, J BIOTECHNOL, V142, P91, DOI 10.1016/j.jbiotec.2009.03.022; Weatherby K, 2011, PROTIST, V162, P142, DOI 10.1016/j.protis.2010.02.003; Yao CQ, 2010, INFECT IMMUN, V78, P22, DOI 10.1128/IAI.00776-09; Zarlenga DS, 2004, VET PARASITOL, V126, P195, DOI 10.1016/j.vetpar.2004.09.001	73	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52379	10.1371/journal.pone.0052379	http://dx.doi.org/10.1371/journal.pone.0052379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300657	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100046
J	Koutsoudakis, G; Dragun, J; Perez-del-Pulgar, S; Coto-Llerena, M; Mensa, L; Crespo, G; Gonzalez, P; Navasa, M; Forns, X				Koutsoudakis, George; Dragun, Jakub; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Mensa, Laura; Crespo, Gonzalo; Gonzalez, Patricia; Navasa, Miquel; Forns, Xavier			Interplay between Basic Residues of Hepatitis C Virus Glycoprotein E2 with Viral Receptors, Neutralizing Antibodies and Lipoproteins	PLOS ONE			English	Article							B TYPE-I; ENVELOPE PROTEIN; CELL ENTRY; HEPARAN-SULFATE; BINDING-SITES; LOW-DENSITY; INFECTION; DOMAINS; IDENTIFICATION; CONSTRUCTION	Positively-charged amino acids are located at specific positions in the envelope glycoprotein E2 of the hepatitis C virus (HCV): two histidines (H) and four arginines (R) in two conserved WHY and one RGERCDLEDRDR motifs, respectively. Additionally, the E2 hypervariable region 1 (HVR1) is rich in basic amino acids. To investigate the role(s) of these residues in HCV entry, we subjected to comparative infection and sedimentation analysis cell culture-produced (HCVcc, genotype 2a) wild type virus, a panel of alanine single-site mutants and a HVR1-deletion variant. Initially, we analyzed the effects of these mutations on E2-heparan sulfate (HS) interactions. The positive milieu of the HVR1, formulated by its basic amino acids (key residues the conserved H-386 and R-408), and the two highly conserved basic residues H-488 and R-648 contributed to E2-HS interactions. Mutations in these residues did not alter the HCVcc-CD81 entry, but they modified the HCVcc-scavenger receptor class B type I (SR-BI) dependent entry and the neutralization by anti-E2 or patients IgG. Finally, separation by density gradients revealed that mutant viruses abolished partially or completely the infectivity of low density particles, which are believed to be associated with lipoproteins. This study shows that there exists a complex interplay between the basic amino acids located in HVR1 and other conserved E2 motifs with the HS, the SR-BI, and neutralizing antibodies and suggests that HCV-associated lipoproteins are implicated in these interactions.	[Koutsoudakis, George; Dragun, Jakub; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Mensa, Laura; Crespo, Gonzalo; Gonzalez, Patricia; Navasa, Miquel; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Koutsoudakis, G (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	gkoutsou@clinic.ub.es	Mensa, Laura/ABC-3124-2021; Navasa, Miquel/G-7958-2016; Coto Llerena, Mairene/H-4168-2014	Navasa, Miquel/0000-0002-3130-9604; Forns, Xavier/0000-0002-8188-1764; Mensa, Laura/0000-0003-2009-3550; Perez-del-Pulgar, Sofia/0000-0002-9890-300X; Crespo, Gonzalo/0000-0002-1178-4897	Instituto de Salud Carlos III Ministerio de Economia y Competitividad [PI11/01907, PI10/01551]; Fondo Europeo de Desarrollo Regional; Union Europea; Una manera de hacer Europa; EIHCV Marie Curie Research Training Network [MRTN-CT-2006-035599, MRTNCT-2006-035599]; Roche Organ Transplantation Research Foundation (ROTRF) [CI: 442035057]; Ministerio de Economia y Competitividad	Instituto de Salud Carlos III Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Union Europea; Una manera de hacer Europa; EIHCV Marie Curie Research Training Network; Roche Organ Transplantation Research Foundation (ROTRF); Ministerio de Economia y Competitividad(Spanish Government)	XF and MN received support, in part, by grants from Instituto de Salud Carlos III Ministerio de Economia y Competitividad (PI11/01907 and PI10/01551, respectively), cofunded by Fondo Europeo de Desarrollo Regional, Union Europea, Una manera de hacer Europa, and the EIHCV Marie Curie Research Training Network (MRTN-CT-2006-035599). XF also received a grant by the Roche Organ Transplantation Research Foundation (ROTRF, Cover Letter CI: 442035057). The other authors were supported by grants from the following institutions: GK and JD from the EIHCV Marie Curie Research Training Network (MRTNCT-2006-035599), LM from the Ministerio de Economia y Competitividad, and MCL the Roche Organ Transplantation Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; CARDIN AD, 1989, ANN NY ACAD SCI, V556, P186; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Dragun J, 2011, AM J TRANSPLANT, V11, P767, DOI 10.1111/j.1600-6143.2011.03440.x; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Lacek K, 2012, J HEPATOL; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Olenina LV, 2005, J VIRAL HEPATITIS, V12, P584, DOI 10.1111/j.1365-2893.2005.00647.x; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52651	10.1371/journal.pone.0052651	http://dx.doi.org/10.1371/journal.pone.0052651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300734	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100070
J	Meulenberg, CJW; Todorovic, V; Cemazar, M				Meulenberg, Cecil J. W.; Todorovic, Vesna; Cemazar, Maja			Differential Cellular Effects of Electroporation and Electrochemotherapy in Monolayers of Human Microvascular Endothelial Cells	PLOS ONE			English	Article							ACTIN CYTOSKELETON; ELECTRIC PULSES; BLOOD-FLOW; IN-VIVO; TUMORS; TRANSFECTION; BLEOMYCIN; MOLECULES; MECHANISM; MEMBRANE	In vivo electroporation of tumours shows disruption of blood flow and creates a vascular effect with an initial rapid and transient vasoconstriction phase and a much longer lasting phase with changed microvascular endothelium. These changes are not well understood but are presumed to involve the cytoskeleton. The paper presents for the first time differential in vitro effects describing cytoskeleton changes and monolayer integrity changes by both electroporation and electrochemotherapy of monolayers of human microvascular endothelial cells (HMEC-1). After the application of electric field pulses, the morphology of cells, and both the F-actin and Beta-tubulin cytoskeleton proteins were affected. During both electroporation and electrochemotherapy, the initial phase of cellular damage was noticed at 10 min as swollen cells and honeycomb-like actin bundles. The electroporation-induced cellular effects, observed from electric pulses >150 V, were voltage-dependent and within 24 hrs partly recoverable. The electrochemotherapy-induced cellular effects developed at 2 hrs in spindle-like cells, and more densely packed F-actin and Beta-tubulin were observed, which were dependent on the amount of bleomycin and the voltages applied (>50 V). In addition, for electrochemotherapy with electric pulses >150 V cellular changes were not recoverable within 24 hrs. The effects on monolayer integrity were reflected in the enhanced monolayer permeability, with the electrochemotherapy showing an earlier onset and synergy. We conclude that electrochemotherapy as compared to electroporation leads within 24 hrs to a quicker and more pronounced monolayer integrity damage and endothelial cell death, which together provide further insight into the cellular changes of the vascular disruption of electrochemotherapy.	[Meulenberg, Cecil J. W.; Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Todorovic, Vesna; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia	University of Primorska; Institute of Oncology - Slovenia	Meulenberg, CJW (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.	cecil.meulenberg@fvz.upr.si	Cemazar, Maja/K-6182-2013; Todorovic, Vesna/L-7966-2014	Cemazar, Maja/0000-0002-1418-1928; Todorovic, Vesna/0000-0002-9943-1673; Meulenberg, Cecil/0000-0001-8778-3316	Slovenian Research Agency [P3-0003, J3-4259]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (program no. P3-0003, project no. J3-4259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANGERO C, 1989, BIOCHIM BIOPHYS ACTA, V981, P295, DOI 10.1016/0005-2736(89)90040-0; Cemazar M, 2006, CURR PHARM DESIGN, V12, P3817, DOI 10.2174/138161206778559740; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Gehl J, 2000, MELANOMA RES, V10, P585, DOI 10.1097/00008390-200012000-00011; Harkin DG, 1996, CELL MOTIL CYTOSKEL, V35, P345, DOI 10.1002/(SICI)1097-0169(1996)35:4<345::AID-CM6>3.0.CO;2-5; Heller R, 1996, CANCER-AM CANCER SOC, V77, P964, DOI 10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Kotnik T, 2010, J MEMBRANE BIOL, V236, P3, DOI 10.1007/s00232-010-9279-9; Markelc B, 2012, J MEMBRANE BIOL, V245, P545, DOI 10.1007/s00232-012-9435-5; MIR LM, 1995, J IMMUNOTHER, V17, P30, DOI 10.1097/00002371-199501000-00004; OSBORN M, 1984, EXP CELL RES, V150, P408, DOI 10.1016/0014-4827(84)90584-6; Pavlin M, 2002, IEEE T BIO-MED ENG, V49, P605, DOI 10.1109/TBME.2002.1001975; Pehlivanova VN, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-9; Phez E, 2005, BBA-GEN SUBJECTS, V1724, P248, DOI 10.1016/j.bbagen.2005.04.005; Pron G, 1999, BIOCHEM PHARMACOL, V57, P45, DOI 10.1016/S0006-2952(98)00282-2; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Pucihar G, 2007, EUR BIOPHYS J BIOPHY, V36, P173, DOI 10.1007/s00249-006-0115-1; Rosazza C, 2011, MOL THER, V19, P913, DOI 10.1038/mt.2010.303; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Sersa G, 1999, EUR J CANCER, V35, P672, DOI 10.1016/S0959-8049(98)00426-2; Sersa G, 2002, BRIT J CANCER, V87, P1047, DOI 10.1038/sj.bjc.6600606; Snoj M, 2009, TUMORI J, V95, P398; Stacey M, 2011, BIOELECTROCHEMISTRY, V82, P131, DOI 10.1016/j.bioelechem.2011.06.002; Sugar IP, 2003, J PHYS CHEM B, V107, P3862, DOI 10.1021/jp022343k; Susil R, 1998, ELECTRO MAGNETOBIOL, V17, P391, DOI 10.3109/15368379809030739; Towhidi L, 2012, RADIOL ONCOL, V46, P119, DOI 10.2478/v10019-012-0014-2; Valic B, 2003, EUR BIOPHYS J BIOPHY, V32, P519, DOI 10.1007/s00249-003-0296-9; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Xiao DY, 2011, CELL BIOL INT, V35, P99, DOI 10.1042/CBI20100464	33	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52713	10.1371/journal.pone.0052713	http://dx.doi.org/10.1371/journal.pone.0052713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300747	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100074
J	Han, SH; Kim, SU; Kim, CO; Jeong, SJ; Park, JY; Choi, JY; Kim, DY; Ahn, SH; Song, YG; Han, KH; Kim, JM				Han, Sang Hoon; Kim, Seung Up; Kim, Chang Oh; Jeong, Su Jin; Park, Jun Yong; Choi, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Song, Young Goo; Han, Kwang-Hyub; Kim, June Myung			Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan (R)) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; METABOLIC SYNDROME; HEPATOTOXICITY; FIBROSIS; PREVALENCE; THERAPY; INDIVIDUALS; DISEASE; RISK	Background and Aims: Liver stiffness measurement (LSM) using transient elastography (Fibroscan (R)) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection. Methods: We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal. Results: Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (beta = -0.234, P = 0.023 and beta = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and gamma-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023). Conclusion: The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and gamma-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively.	[Han, Sang Hoon; Kim, Seung Up; Kim, Chang Oh; Jeong, Su Jin; Park, Jun Yong; Choi, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Song, Young Goo; Han, Kwang-Hyub; Kim, June Myung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Han, Sang Hoon; Kim, Chang Oh; Jeong, Su Jin; Choi, Jun Yong; Song, Young Goo; Kim, June Myung] Yonsei Univ, Coll Med, AIDS Res Inst, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, JM (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	jmkim@yuhs.ac	Park, Jun Yong/H-7127-2019; Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156; Choi, Jun Yong/0000-0002-2775-3315; Kim, Chang Oh/0000-0002-0773-5443; Han, Sang Hoon/0000-0002-4278-5198; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Jeong, Su Jin/0000-0003-4025-4542; Park, Jun Yong/0000-0001-6324-2224; Kim, Seung Up/0000-0002-9658-8050	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A050021]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Good Health R & D Project, part of the Ministry of Health, Welfare and Family Affairs, Republic of Korea (A050021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Battegay M, 2009, SWISS MED WKLY, V139, P564, DOI smw-12662; Bonfanti P, 2005, AIDS, V19, P1433, DOI 10.1097/01.aids.0000180791.85003.3b; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Cooper CL, 2002, CLIN INFECT DIS, V34, P1259, DOI 10.1086/339867; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim SU, 2010, WORLD J GASTROENTERO, V16, P5173, DOI 10.3748/wjg.v16.i41.5173; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Palella F, 2011, CURR OPIN HIV AIDS; Pineda JA, 2010, J VIRAL HEPATITIS, V17, P714, DOI 10.1111/j.1365-2893.2009.01229.x; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Vecchi VL, 2010, WORLD J GASTROENTERO, V16, P5225, DOI 10.3748/wjg.v16.i41.5225; Vogel M, 2007, CURR OPIN HIV AIDS, V2, P306, DOI 10.1097/COH.0b013e3281ca6fd2; World Health Organization, 2006, INT STAT CLASS DIS R; Worm SW, 2009, CIRCULATION, V119, P805, DOI 10.1161/CIRCULATIONAHA.108.790857; Zucchetto A, 2010, CLIN INFECT DIS, V51, P1099, DOI 10.1086/656629	27	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52720	10.1371/journal.pone.0052720	http://dx.doi.org/10.1371/journal.pone.0052720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300987	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000015
J	Andersen, JT; Petersen, M; Jimenez-Solem, E; Broedbaek, K; Andersen, NL; Torp-Pedersen, C; Keiding, N; Poulsen, HE				Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Andersen, Nadia Lyhne; Torp-Pedersen, Christian; Keiding, Niels; Poulsen, Henrik Enghusen			Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study	PLOS ONE			English	Article							DANISH; MULTICENTER; POPULATION	Background: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associated with an increased risk for miscarriages and major malformations. Methods: We conducted a nationwide cohort study including all women in Denmark with a known conception between 1997 and 2007. The Fertility Database was used to identify all women giving birth and the National Hospital Register was used to identify all women with a record of miscarriage or induced abortion. Prescription data was obtained from the National Prescription Register. The primary outcome was the number of miscarriages and offspring with major congenital malformations among users of clarithromycin compared to non-users. Results: We identified 931 504 pregnancies (705 837 live births, 77 553 miscarriages, and 148 114 induced abortions). 401 women redeemed a prescription of clarithromycin in the first trimester of which 40 (10.0%) experienced a miscarriage and among the live born nine (3.6%) had offspring with malformations. The hazard ratio (HR) of having a miscarriage after exposure to clarithromycin was 1.56 (CI95% 1.14-2.13). There was no increased hazard of having a miscarriage when being exposed to penicillin or erythromycin. There was no increased prevalence (OR = 1.03 (CI95% 0.52-2.00)) of having offspring with malformations after exposure to clarithromycin. Conclusions: We found an increased hazard of miscarriage but no increased prevalance of having offspring with malformations among women redeeming a prescription of clarithromycin in early pregnancy. This is supported by previous studies in animals and humans. However, further research is required to explore the possible effect of treatment indication on the associations found.	[Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Rigshosp, Copenhagen Univ Hosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark; [Andersen, Jon Traerup; Petersen, Morten; Jimenez-Solem, Espen; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark; [Andersen, Nadia Lyhne] Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Torp-Pedersen, Christian; Keiding, Niels; Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Andersen, JT (corresponding author), Rigshosp, Copenhagen Univ Hosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark.	jta@rh.dk	Torp-Pedersen, Christian/E-5931-2013; Jimenez-Solem, Espen/B-4207-2012	Jimenez-Solem, Espen/0000-0002-3777-147X; Andersen, Jon/0000-0003-0169-1328; Poulsen, Henrik Enghusen/0000-0003-4242-9924	Danish Agency for Science, Technology and Innovation; P. Carl Petersen Foundation	Danish Agency for Science, Technology and Innovation; P. Carl Petersen Foundation	The study is supported by grants from the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/), and the P. Carl Petersen Foundation (http://www.pcarlp-fond.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Laboratories, 2010, BIAX PROD INF; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1992, LANCET, V339, P1600, DOI DOI 10.1016/0140-6736(92)91856-4; Bar-Oz B, 2008, EUR J OBSTET GYN R B, V141, P31, DOI 10.1016/j.ejogrb.2008.07.008; Blenstrup LT, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494811399957; Buss L, 2006, ACTA OBSTET GYN SCAN, V85, P467, DOI 10.1080/00016340500494887; Drinkard CR, 2000, PHARMACOEPIDEM DR S, V9, P549, DOI 10.1002/pds.538; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; European Surveillance of Congenital Anomalies, 2005, EUROCAT GUID 1 3 REF; Gaist D, 1997, DAN MED BULL, V44, P445; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P221; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Sorensen H T, 1996, J Med Syst, V20, P57; The Danish National Board of Health, 2004, PROJ VEDR DAT LANDSP; Thorning H, 2004, PROJECT DATA QUALITY; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Witt A, 2003, AM J OBSTET GYNECOL, V188, P816, DOI 10.1067/mob.2003.171	20	114	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53327	10.1371/journal.pone.0053327	http://dx.doi.org/10.1371/journal.pone.0053327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301061	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900075
J	Chang, HM; Shyu, MK; Tseng, GF; Liu, CH; Chang, HS; Lan, CT; Hsu, WM; Liao, WC				Chang, Hung-Ming; Shyu, Ming-Kwang; Tseng, Guo-Fang; Liu, Chiung-Hui; Chang, Hung-Shuo; Lan, Chyn-Tair; Hsu, Wen-Ming; Liao, Wen-Chieh			Neuregulin Facilitates Nerve Regeneration by Speeding Schwann Cell Migration via ErbB2/3-Dependent FAK Pathway	PLOS ONE			English	Article							NEU DIFFERENTIATION FACTOR; PERIPHERAL-NERVE; PROLIFERATION; RECOVERY; PLASTICITY; KINASE; INJURY; ROLES	Background: Adequate migration of Schwann cells (Sc) is crucial for axon-guidance in the regenerative process after peripheral nerve injury (PNI). Considering neuregulin-erbB-FAK signaling is an essential pathway participating in the regulation of Sc migration during development, the present study is aimed to examine whether neuregulin would exert its beneficial effects on adult following PNI and further determine the potential changes of downstream pathway engaged in neuro-regeneration by both in vitro and in vivo approaches. Methodology and Principal Findings: Cultured RSC96 cells treated with neuregulin were processed for erbB2/3 immunofluorescence and FAK immunoblotings. The potential effects of neuregulin on Sc were assessed by cell adherence, spreading, and migration assays. In order to evaluate the functional significance of neuregulin on neuro-regeneration, the in vivo model of PNI was performed by chronic end-to-side neurorrhaphy (ESN). In vitro studies indicated that after neuregulin incubation, erbB2/3 were not only expressed in cell membranes, but also distributed throughout the cytoplasm and nucleus of RSC96 cells. Activation of erbB2/3 was positively correlated with FAK phosphorylation. Neuregulin also increases Sc adherence, spreading, and migration by 127.2+/-5.0%, 336.8+/-3.0%, and 80.0+/-5.7%, respectively. As for in vivo study, neuregulin significantly accelerates the speed of Sc migration and increases Sc expression in the distal stump of injured nerves. Retrograde labeling and compound muscle action potential recordings (CMAP) also showed that neuregulin successfully facilitates nerve regeneration by eliciting noticeably larger CMAP and promoting quick re-innervation of target muscles. Conclusions: As neuregulin successfully improves axo-glial interaction by speeding Sc migration via the erbB2/3-FAK pathway, therapeutic use of neuregulin may thus serve as a promising strategy to facilitate the progress of nerve regeneration after PNI.	[Chang, Hung-Ming] Taipei Med Univ, Sch Med, Dept Anat, Coll Med, Taipei, Taiwan; [Shyu, Ming-Kwang; Chang, Hung-Shuo] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tseng, Guo-Fang] Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan; [Liu, Chiung-Hui] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Lan, Chyn-Tair; Liao, Wen-Chieh] Chung Shan Med Univ, Dept Anat, Fac Med, Taichung, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Pediat Surg, Taipei 100, Taiwan; [Liao, Wen-Chieh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Tzu Chi University; National Taiwan University; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Liao, WC (corresponding author), Chung Shan Med Univ, Dept Anat, Fac Med, Taichung, Taiwan.	khrnangel@gmail.com	Liu, Chiung-Hui/K-2974-2016	Liu, Chiung-Hui/0000-0002-2656-2576; HSU, WEN-MING/0000-0002-5145-9538; Liao, Wen Chieh/0000-0001-7848-2124; SHYU, MING-KWANG/0000-0001-9057-4101	 [NSC 99-2320-B-040-002-MY3];  [NSC 101-2320-B-040-003]	; 	This study is supported by the research grants (NSC 99-2320-B-040-002-MY3 and NSC 101-2320-B-040-003) to Dr. H-M Chang and Dr. W-C Liao from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2011, J NEUROSCI, V31, P5106, DOI 10.1523/JNEUROSCI.5635-10.2011; Chen LE, 1998, NEUROCHEM INT, V33, P341, DOI 10.1016/S0197-0186(98)00037-0; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Corfas G, 2004, J NEUROSCI, V24, P9250, DOI 10.1523/JNEUROSCI.3649-04.2004; Dezawa Mari, 2000, Acta Anatomica Nipponica, V75, P255; Eckert JM, 2009, GLIA, V57, P1501, DOI 10.1002/glia.20866; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fang WK, 2009, AM J CHINESE MED, V37, P945, DOI 10.1142/S0192415X09007363; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gambarotta G, 2004, J BIOL CHEM, V279, P48808, DOI 10.1074/jbc.M408374200; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Ji Y, 2012, J PROTEOME RES; Joung I, 2010, MOL CELLS, V30, P477, DOI 10.1007/s10059-010-0137-5; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Liao WC, 2010, NEUROSCIENCE, V171, P934, DOI 10.1016/j.neuroscience.2010.09.036; Liao WC, 2009, J ANAT, V215, P506, DOI 10.1111/j.1469-7580.2009.01135.x; Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005; Lu MC, 2009, CELL BIOCHEM FUNCT, V27, P186, DOI 10.1002/cbf.1554; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Priestley JV, 2007, BRAIN, V130, P895, DOI 10.1093/brain/awm041; Robinson Michael D, 2002, Phys Med Rehabil Clin N Am, V13, P109, DOI 10.1016/S1047-9651(03)00074-3; Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; Vartanian T, 2000, BIOCHEM BIOPH RES CO, V271, P414, DOI 10.1006/bbrc.2000.2624; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Yildiz M, 2011, EUR ARCH OTO-RHINO-L, V268, P1127, DOI 10.1007/s00405-011-1492-3	37	66	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53444	10.1371/journal.pone.0053444	http://dx.doi.org/10.1371/journal.pone.0053444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301073	gold, Green Submitted, Green Published			2022-12-27	WOS:000313320900078
J	Jankanpaa, HJ; Frenkel, M; Zulfugarov, I; Reichelt, M; Krieger-Liszkay, A; Mishra, Y; Gershenzon, J; Moen, J; Lee, CH; Jansson, S				Jankanpaa, Hanna Johansson; Frenkel, Martin; Zulfugarov, Ismayil; Reichelt, Michael; Krieger-Liszkay, Anja; Mishra, Yogesh; Gershenzon, Jonathan; Moen, Jon; Lee, Choon-Hwan; Jansson, Stefan			Non-Photochemical Quenching Capacity in Arabidopsis thaliana Affects Herbivore Behaviour	PLOS ONE			English	Article							INDUCED RESPONSES; PLUTELLA-XYLOSTELLA; JASMONIC ACID; LIGHT; DEFENSE; STRESS; OVIPOSITION; FLUORESCENT; COMPETITION; FITNESS	Under natural conditions, plants have to cope with numerous stresses, including light-stress and herbivory. This raises intriguing questions regarding possible trade-offs between stress defences and growth. As part of a program designed to address these questions we have compared herbivory defences and damage in wild type Arabidopsis thaliana and two "photoprotection genotypes", npq4 and oePsbS, which respectively lack and overexpress PsbS (a protein that plays a key role in qE-type non-photochemical quenching). In dual-choice feeding experiments both a specialist (Plutella xylostella) and a generalist (Spodoptera littoralis) insect herbivore preferred plants that expressed PsbS most strongly. In contrast, although both herbivores survived equally well on each of the genotypes, for oviposition female P. xylostella adults preferred plants that expressed PsbS least strongly. However, there were no significant differences between the genotypes in levels of the 10 most prominent glucosinolates; key substances in the Arabidopsis anti-herbivore chemical defence arsenal. After transfer from a growth chamber to the field we detected significant differences in the genotypes' metabolomic profiles at all tested time points, using GC-MS, but no consistent "metabolic signature'' for the lack of PsbS. These findings suggest that the observed differences in herbivore preferences were due to differences in the primary metabolism of the plants rather than their contents of typical "defence compounds". A potentially significant factor is that superoxide accumulated most rapidly and to the highest levels under high light conditions in npq4 mutants. This could trigger changes in planta that are sensed by herbivores either directly or indirectly, following its dismutation to H2O2.	[Jankanpaa, Hanna Johansson; Mishra, Yogesh; Jansson, Stefan] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Frenkel, Martin; Moen, Jon] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Zulfugarov, Ismayil; Lee, Choon-Hwan] Pusan Natl Univ, Dept Mol Biol, Pusan, South Korea; [Zulfugarov, Ismayil] Azerbaijan Natl Acad Sci, Inst Bot, Baku, Azerbaijan; [Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany; [Krieger-Liszkay, Anja] CEA, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanisme, Gif Sur Yvette, France	Umea University; Umea University; Pusan National University; Azerbaijan National Academy of Sciences (ANAS); Institute of Botany Azerbaijan National Academy of Sciences; Max Planck Society; CEA; UDICE-French Research Universities; Universite Paris Saclay	Jansson, S (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.		Gershenzon, Jonathan/K-1331-2013; Jansson, Stefan/A-1119-2009; Mishra, Yogesh/AAI-3004-2021; Zulfugarov, Ismayil/I-2314-2014	Gershenzon, Jonathan/0000-0002-1812-1551; Jansson, Stefan/0000-0002-7906-6891; Zulfugarov, Ismayil/0000-0002-9723-3542; Krieger-Liszkay, Anja/0000-0001-7141-4129	The Swedish Research Council (VR); The Max Planck Society; Agence Nationale de la Recherche [ANR-09-BLAN-0005-01]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0071776]	The Swedish Research Council (VR)(Swedish Research Council); The Max Planck Society(Max Planck Society); Agence Nationale de la Recherche(French National Research Agency (ANR)); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Funders are The Swedish Research Council (VR), The Max Planck Society, Agence Nationale de la Recherche (reference ANR-09-BLAN-0005-01), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0071776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Amiard V, 2007, NEW PHYTOL, V173, P722, DOI 10.1111/j.1469-8137.2006.01954.x; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Baldwin IT, 1996, ENTOMOLOGIA EXPT APP, V80, P353; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chen YG, 2008, ENTOMOL EXP APPL, V126, P244, DOI 10.1111/j.1570-7458.2007.00662.x; Cipollini DF, 2002, OECOLOGIA, V131, P514, DOI 10.1007/s00442-002-0909-5; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Frenkel M, 2008, NEW PHYTOL, V180, P545, DOI 10.1111/j.1469-8137.2008.02591.x; Frenkel M, 2007, PHYSIOL PLANTARUM, V129, P455, DOI 10.1111/j.1399-3054.2006.00831.x; Frenkel M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-12; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Gardner SN, 2002, EVOL ECOL RES, V4, P1131; Georgiou CD, 2005, ANAL BIOCHEM, V347, P144, DOI 10.1016/j.ab.2005.09.013; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Gohre V, 2012, MOL PLANT MICROBE IN, V25, P1083, DOI 10.1094/MPMI-11-11-0301; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Heil M, 2001, EUR J PLANT PATHOL, V107, P137, DOI 10.1023/A:1008793009517; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hideg E, 2002, PLANT CELL PHYSIOL, V43, P1154, DOI 10.1093/pcp/pcf145; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jankanpaa HJ, 2012, PLANT CELL ENVIRON, V35, P1824, DOI 10.1111/j.1365-3040.2012.02519.x; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kalai T, 2002, ARKIVOC, P112, DOI 10.3998/ark.5550190.0003.312; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Karpinski S, 2003, CURR OPIN PLANT BIOL, V6, P390, DOI 10.1016/S1369-5266(03)00061-X; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kulheim C, 2005, PHYSIOL PLANTARUM, V125, P202, DOI 10.1111/j.1399-3054.2005.00547.x; Kulheim C, 2002, SCIENCE, V297; Li Q, 2000, J CHEM ECOL, V26, P2401, DOI 10.1023/A:1005535129399; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Lu YB, 2004, ECOL LETT, V7, P337, DOI 10.1111/j.1461-0248.2004.00582.x; Mahalingam R, 2006, PLANT CELL ENVIRON, V29, P1357, DOI 10.1111/j.1365-3040.2006.01516.x; Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mubarakshina MM, 2010, J EXP BOT, V61, P3577, DOI 10.1093/jxb/erq171; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Roach T, 2012, BIOCH BIOPH IN PRESS; Siemens DH, 2002, ECOLOGY, V83, P505, DOI 10.1890/0012-9658(2002)083[0505:CODITC]2.0.CO;2; Spencer JL, 1996, ENTOMOL EXP APPL, V81, P165, DOI 10.1007/BF00192141; STOCKHOFF BA, 1993, PHYSIOL ENTOMOL, V18, P409, DOI 10.1111/j.1365-3032.1993.tb00615.x; van Kleunen M, 2004, BASIC APPL ECOL, V5, P173, DOI 10.1078/1439-1791-00225; Verhage A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00047; Wasternack C, 1998, FETT-LIPID, V100, P139	51	28	28	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53232	10.1371/journal.pone.0053232	http://dx.doi.org/10.1371/journal.pone.0053232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301046	Green Submitted, gold, Green Published			2022-12-27	WOS:000313320900069
J	Ono, M; Tanaka, RJ; Kano, M; Sugiman, T				Ono, Masahiro; Tanaka, Reiko J.; Kano, Manabu; Sugiman, Toshio			Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CANONICAL CORRESPONDENCE-ANALYSIS; ACUTE PROMYELOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BREAST-CANCER; MICROARRAY DATA; CELLS; CLASSIFICATION; TRANSLOCATION	The understanding of pathological processes is based on the comparison between physiological and pathological conditions, and transcriptomic analysis has been extensively applied to various diseases for this purpose. However, the way in which the transcriptomic data of pathological cells relate to the transcriptomes of normal cellular counterparts has not been fully explored, and may provide new and unbiased insights into the mechanisms of these diseases. To achieve this, it is necessary to develop a method to simultaneously analyse components across different levels, namely genes, normal cells, and diseases. Here we propose a multidimensional method that visualises the cross-level relationships between these components at three different levels based on transcriptomic data of physiological and pathological processes, by adapting Canonical Correspondence Analysis, which was developed in ecology and sociology, to microarray data (CCA on Microarray data, CCAM). Using CCAM, we have analysed transcriptomes of haematological disorders and those of normal haematopoietic cell differentiation. First, by analysing leukaemia data, CCAM successfully visualised known relationships between leukaemia subtypes and cellular differentiation, and their characteristic genes, which confirmed the relevance of CCAM. Next, by analysing transcriptomes of myelodysplastic syndromes (MDS), we have shown that CCAM was effective in both generating and testing hypotheses. CCAM showed that among MDS patients, high-risk patients had transcriptomes that were more similar to those of both haematopoietic stem cells (HSC) and megakaryocyte-erythroid progenitors ( MEP) than low-risk patients, and provided a prognostic model. Collectively, CCAM reveals hidden relationships between pathological and physiological processes and gene expression, providing meaningful clinical insights into haematological diseases, and these could not be revealed by other univariate and multivariate methods. Furthermore, CCAM was effective in identifying candidate genes that are correlated with cellular phenotypes of interest. We expect that CCAM will benefit a wide range of medical fields.	[Ono, Masahiro] UCL, Immunobiol Unit, Inst Child Hlth, London, England; [Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Kano, Manabu] Kyoto Univ, Dept Syst Sci, Kyoto, Japan; [Sugiman, Toshio] Kyoto Univ, Grad Sch Human Environm Studies, Dept Human Coexistence, Kyoto, Japan	University of London; University College London; Imperial College London; Kyoto University; Kyoto University	Ono, M (corresponding author), UCL, Immunobiol Unit, Inst Child Hlth, London, England.	m.ono@ucl.ac.uk	Ono, Masahiro/H-2378-2011; Kano, Manabu/AAH-6448-2020	Ono, Masahiro/0000-0002-9284-7326; Kano, Manabu/0000-0002-2325-1043	EPSRC; BBSRC [BB/J013951/1] Funding Source: UKRI; EPSRC [EP/G007446/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J013951/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.O. is a Human Frontier Science Program (HFSP, www.hfsp.org) Long-Term Fellow. R.J.T. is supported by EPSRC (www.epsrc.ac.uk) Career Acceleration Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Burkle A, 2007, BLOOD, V110, P3316, DOI 10.1182/blood-2007-05-089409; Cazzola M, 2011, HAEMATOL-HEMATOL J, V96, P349, DOI 10.3324/haematol.2010.030023; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Cox CV, 2005, STEM CELL REV, V1, P189, DOI 10.1385/SCR:1:3:189; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Faderl S, 2003, CANCER-AM CANCER SOC, V98, P1337, DOI 10.1002/cncr.11664; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; FOURNIER S, 1992, J CLIN INVEST, V89, P1312, DOI 10.1172/JCI115717; Greenacre M, 2008, CORRES ANAL PRACTICE; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61; GRIFFIN JD, 1983, BLOOD, V61, P85; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Hubmann R, 2010, BRIT J HAEMATOL, V148, P868, DOI 10.1111/j.1365-2141.2009.08024.x; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kishino H, 2000, Genome Inform Ser Workshop Genome Inform, V11, P83; Koury M, 2008, WINTROBES CLIN HEMAT; Kuhn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-26; Lanasa MC, 2011, LEUKEMIA LYMPHOMA, V52, P1398, DOI 10.3109/10428194.2011.568076; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; LEBEAU MM, 1983, NEW ENGL J MED, V309, P630, DOI 10.1056/NEJM198309153091103; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; McCune B, 1997, ECOLOGY, V78, P2617; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Nikpour M, 2010, BRIT J HAEMATOL, V149, P844, DOI 10.1111/j.1365-2141.2010.08174.x; Nolte F, 2010, FUTURE ONCOL, V6, P445, DOI [10.2217/fon.09.175, 10.2217/FON.09.175]; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; NUCIFORA G, 1993, BLOOD, V82, P712; Oksanen J, 2011, TECHNICAL REPORT; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Porakishvili N, 2011, BRIT J HAEMATOL, V153, P486, DOI 10.1111/j.1365-2141.2011.08605.x; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Schoch C, 1996, BRIT J HAEMATOL, V94, P493, DOI 10.1046/j.1365-2141.1996.d01-1829.x; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shih AH, 2011, SEMIN ONCOL, V38, P613, DOI 10.1053/j.seminoncol.2011.04.013; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Sugiman T, 1998, ASIAN J SOC PSYCHOL, V1, P51, DOI DOI 10.1111/1467-839X.00005; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Szczepanski T, 2003, BEST PRACT RES CL HA, V16, P561, DOI 10.1053/ybeha.2003.285; Tanaka RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019895; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; Valent P, 2009, LEUKEMIA LYMPHOMA, V50, P341, DOI 10.1080/10428190902756107; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53544	10.1371/journal.pone.0053544	http://dx.doi.org/10.1371/journal.pone.0053544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301083	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900083
J	Rijnkels, M; Freeman-Zadrowski, C; Hernandez, J; Potluri, V; Wang, LG; Li, W; Lemay, DG				Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Hernandez, Joseph; Potluri, Vani; Wang, Liguo; Li, Wei; Lemay, Danielle G.			Epigenetic Modifications Unlock the Milk Protein Gene Loci during Mouse Mammary Gland Development and Differentiation	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; DNA METHYLATION; CHROMATIN-STRUCTURE; TRANSGENIC MICE; HUMAN GENOME; CASEIN GENE; CELL-FATE; TRANSCRIPTION FACTORS; SECRETORY ACTIVATION; REGULATORY ELEMENTS	Background: Unlike other tissues, development and differentiation of the mammary gland occur mostly after birth. The roles of systemic hormones and local growth factors important for this development and functional differentiation are well-studied. In other tissues, it has been shown that chromatin organization plays a key role in transcriptional regulation and underlies epigenetic regulation during development and differentiation. However, the role of chromatin organization in mammary gland development and differentiation is less well-defined. Here, we have studied the changes in chromatin organization at the milk protein gene loci (casein, whey acidic protein, and others) in the mouse mammary gland before and after functional differentiation. Methodology/Principal Findings: Distal regulatory elements within the casein gene cluster and whey acidic protein gene region have an open chromatin organization after pubertal development, while proximal promoters only gain open-chromatin marks during pregnancy in conjunction with the major induction of their expression. In contrast, other milk protein genes, such as alpha-lactalbumin, already have an open chromatin organization in the mature virgin gland. Changes in chromatin organization in the casein gene cluster region that are present after puberty persisted after lactation has ceased, while the changes which occurred during pregnancy at the gene promoters were not maintained. In general, mammary gland expressed genes and their regulatory elements exhibit developmental stage- and tissue-specific chromatin organization. Conclusions/Significance: A progressive gain of epigenetic marks indicative of open/active chromatin on genes marking functional differentiation accompanies the development of the mammary gland. These results support a model in which a chromatin organization is established during pubertal development that is then poised to respond to the systemic hormonal signals of pregnancy and lactation to achieve the full functional capacity of the mammary gland.	[Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Hernandez, Joseph; Potluri, Vani] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat Nutr, Houston, TX 77030 USA; [Wang, Liguo; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Lemay, Danielle G.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; University of California System; University of California Davis	Rijnkels, M (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat Nutr, Houston, TX 77030 USA.	rijnkel@bcm.edu		Lemay, Danielle/0000-0003-3318-0485; Wang, Liguo/0000-0003-2072-4826	National Institute of Health [1R21HD05376, 1R03HD05609]; USDA [6200-51000-048]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA))	This work was supported by grants from National Institute of Health (1R21HD05376, 1R03HD05609) and USDA (6200-51000-048) to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ausuble F. M., 1987, CURRENT PROTOCOLS MO; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Blakely CM, 2006, CANCER RES, V66, P6421, DOI 10.1158/0008-5472.CAN-05-4235; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Buser AC, 2007, MOL ENDOCRINOL, V21, P106, DOI 10.1210/me.2006-0297; Casey TM, 2007, J MAMMARY GLAND BIOL, V12, P293, DOI 10.1007/s10911-007-9055-3; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Ginger MR, 2003, BREAST CANCER RES, V5, P192, DOI 10.1186/bcr603; Ginger MR, 2001, MOL ENDOCRINOL, V15, P1993, DOI 10.1210/me.15.11.1993; Hemberg M, 2012, NUCL ACIDS RES; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON ML, 1983, J BIOL CHEM, V258, P805; Jura J, 2005, BBA-GENE STRUCT EXPR, V1727, P58, DOI 10.1016/j.bbaexp.2004.11.008; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kim K, 2010, INT J BIOCHEM CELL B, V42, P1517, DOI 10.1016/j.biocel.2010.05.009; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Kleinberg D, 2008, J MAMMARY GLAND BIOL, V13, P353, DOI 10.1007/s10911-008-9103-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lee HJ, 2011, STEM CELLS; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; LI BL, 1994, CELL GROWTH DIFFER, V5, P711; LI BL, 1995, MOL CARCINOGEN, V14, P75, DOI 10.1002/mc.2940140203; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; LI S, 1995, MOL CELL BIOL, V15, P2063; LI S, 1994, J BIOL CHEM, V269, P14235; LI S, 1994, MOL ENDOCRINOL, V8, P1328, DOI 10.1210/me.8.10.1328; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Master Stephen R, 2004, Breast Dis, V19, P47; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Medina D, 2001, ANN NY ACAD SCI, V952, P23, DOI 10.1111/j.1749-6632.2001.tb02725.x; Millot B, 2003, BIOCHEM J, V372, P41, DOI 10.1042/BJ20021894; Millot B, 2001, BIOCHEM J, V359, P557, DOI 10.1042/0264-6021:3590557; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Platenburg GJ, 1996, TRANSGENIC RES, V5, P421, DOI 10.1007/BF01980207; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rosen JM, 1998, BIOCHEM SOC SYMP, P101; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vafaizadeh V, 2012, FRONT BIOSCI-LANDMRK, V17, P1232, DOI 10.2741/3983; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagschal A, 2007, COLD SPRING HARB PRO, V2007; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wellberg E, 2010, DEVELOPMENT, V137, P945, DOI 10.1242/dev.041657; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Whitelaw CBA, 2000, ADV EXP MED BIOL, V480, P147; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	88	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53270	10.1371/journal.pone.0053270	http://dx.doi.org/10.1371/journal.pone.0053270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301053	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900072
J	Zhou, DE; Yang, L; Zheng, LT; Ge, WT; Li, D; Zhang, Y; Hu, XD; Gao, ZB; Xu, JH; Huang, YQ; Hu, HG; Zhang, H; Zhang, H; Liu, MM; Yang, HM; Zheng, L; Zheng, S				Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Zhang, Yong; Hu, Xueda; Gao, Zhibo; Xu, Jinghong; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zhang, Hao; Liu, Mingming; Yang, Huanming; Zheng, Lei; Zheng, Shu			Exome Capture Sequencing of Adenoma Reveals Genetic Alterations in Multiple Cellular Pathways at the Early Stage of Colorectal Tumorigenesis	PLOS ONE			English	Article							INACTIVATING MUTATIONS; SOMATIC MUTATIONS; HUMAN BREAST; METHYLATION; FRAMEWORK; CANCERS; HEAD	Most of colorectal adenocarcinomas are believed to arise from adenomas, which are premalignant lesions. Sequencing the whole exome of the adenoma will help identifying molecular biomarkers that can predict the occurrence of adenocarcinoma more precisely and help understanding the molecular pathways underlying the initial stage of colorectal tumorigenesis. We performed the exome capture sequencing of the normal mucosa, adenoma and adenocarcinoma tissues from the same patient and sequenced the identified mutations in additional 73 adenomas and 288 adenocarcinomas. Somatic single nucleotide variations (SNVs) were identified in both the adenoma and adenocarcinoma by comparing with the normal control from the same patient. We identified 12 nonsynonymous somatic SNVs in the adenoma and 42 nonsynonymous somatic SNVs in the adenocarcinoma. Most of these mutations including OR6X1, SLC15A3, KRTHB4, RBFOX1, LAMA3, CDH20, BIRC6, NMBR, GLCCI1, EFR3A, and FTHL17 were newly reported in colorectal adenomas. Functional annotation of these mutated genes showed that multiple cellular pathways including Wnt, cell adhesion and ubiquitin mediated proteolysis pathways were altered genetically in the adenoma and that the genetic alterations in the same pathways persist in the adenocarcinoma. CDH20 and LAMA3 were mutated in the adenoma while NRXN3 and COL4A6 were mutated in the adenocarcinoma from the same patient, suggesting for the first time that genetic alterations in the cell adhesion pathway occur as early as in the adenoma. Thus, the comparison of genomic mutations between adenoma and adenocarcinoma provides us a new insight into the molecular events governing the early step of colorectal tumorigenesis.	[Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zheng, Shu] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Inst Canc, Hangzhou, Zhejiang, Peoples R China; [Zhou, Donger; Yang, Liu; Zheng, Liangtao; Ge, Weiting; Li, Dan; Xu, Jinghong; Huang, Yanqin; Hu, Hanguang; Zhang, Hang; Zheng, Lei; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yong; Hu, Xueda; Gao, Zhibo; Zhang, Hao; Liu, Mingming; Yang, Huanming] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr,Johns Hopkins, Baltimore, MD 21205 USA; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Surg, Sidney Kimmel Comprehens Canc Ctr,Johns Hopkins, Baltimore, MD 21205 USA	Zhejiang University; Beijing Genomics Institute (BGI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zheng, S (corresponding author), China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Inst Canc, Hangzhou, Zhejiang, Peoples R China.	lzheng6@jhmi.edu	wei, jiang/GRX-7907-2022; xu, jing/GRR-8698-2022; yang, liu/GVU-8760-2022; GE, Weiting/AAK-5197-2020	GE, Weiting/0000-0002-4769-0251; Zheng, Liangtao/0000-0001-9795-3198	National Natural Science of China Foundation [30973382]; National High Technology Research and Development Program of China [2006AA02A302, 2012AA02A204, 2012AA02A506]; NIH [K23 CA148964-01]; Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE [R01CA169702, K23CA148964, P30CA006973] Funding Source: NIH RePORTER	National Natural Science of China Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project is supported by the National Natural Science of China Foundation 30973382 and the National High Technology Research and Development Program of China (2006AA02A302,2012AA02A204,2012AA02A506). Lei Zheng is supported by an NIH K23 CA148964-01 and a Johns Hopkins University School of Medicine Clinician Scientist Award. Lei Zheng is an adjunct "Guangji Scholar" at the Second Affiliated Hospital of Zhejiang University School of medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jie He PZ, 2011, CHINESE CANC REGISTR; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lovig T, 2002, SCAND J GASTROENTERO, V37, P1184, DOI 10.1080/003655202760373407; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Olivier Magali, 2004, IARC Sci Publ, P247; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yang G, 1998, J NATL CANCER I, V90, P1661, DOI 10.1093/jnci/90.21.1661	40	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53310	10.1371/journal.pone.0053310	http://dx.doi.org/10.1371/journal.pone.0053310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301059	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900074
J	Zussy, C; Brureau, A; Keller, E; Marchal, S; Blayo, C; Delair, B; Ixart, G; Maurice, T; Givalois, L				Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent			Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-beta Peptide Injection in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SOLUBLE-PROTEIN OLIGOMERS; CENTRAL-NERVOUS-SYSTEM; A-BETA; NEUROTROPHIC FACTOR; IN-VITRO; BETA-PROTEIN/A4 DEPOSITS; INDUCED NEUROTOXICITY; MEMORY DEFICITS; APOPTOTIC DEATH	Alzheimer's disease (AD) is a neurodegenerative pathology associated with aging characterized by the presence of senile plaques and neurofibrillary tangles that finally result in synaptic and neuronal loss. The major component of senile plaques is an amyloid-beta protein (A beta). Recently, we characterized the effects of a single intracerebroventricular (icv) injection of A beta fragment (25-35) oligomers (oA beta(25-35)) for up to 3 weeks in rats and established a clear parallel with numerous relevant signs of AD. To clarify the long- term effects of oA beta(25-35) and its potential role in the pathogenesis of AD, we determined its physiological, behavioral, biochemical and morphological impacts 6 weeks after injection in rats. oA beta(25-35) was still present in the brain after 6 weeks. oA beta(25-35) injection did not affect general activity and temperature rhythms after 6 weeks, but decreased body weight, induced short-and long-term memory impairments, increased corticosterone plasma levels, brain oxidative (lipid peroxidation), mitochondrial (caspase-9 levels) and reticulum stress (caspase-12 levels), astroglial and microglial activation. It provoked cholinergic neuron loss and decreased brain-derived neurotrophic factor levels. It induced cell loss in the hippocampic CA subdivisions and decreased hippocampic neurogenesis. Moreover, oA beta(25-35) injection resulted in increased APP expression, A beta(1-42) generation, and increased Tau phosphorylation. In conclusion, this in vivo study evidenced that the soluble oligomeric forms of short fragments of A beta, endogenously identified in AD patient brains, not only provoked long- lasting pathological alterations comparable to the human disease, but may also directly contribute to the progressive increase in amyloid load and Tau pathology, involved in the AD physiopathology.	[Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] Inserm U710, Mol Mechanisms Neurodegenerat Dementia Lab, Montpellier, France; [Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] Univ Montpellier 2, Montpellier, France; [Zussy, Charleine; Brureau, Anthony; Keller, Emeline; Marchal, Stephane; Blayo, Claire; Delair, Brice; Ixart, Guy; Maurice, Tangui; Givalois, Laurent] EPHE, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Givalois, L (corresponding author), Inserm U710, Mol Mechanisms Neurodegenerat Dementia Lab, Montpellier, France.	lgivalois@univ-montp2.fr	Maurice, Tangui/AAP-2499-2020; MARCHAL, stéphane/M-4324-2017	Maurice, Tangui/0000-0002-4074-6793; MARCHAL, stéphane/0000-0002-1101-7890; Givalois, Laurent/0000-0002-6698-5346	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by annual INSERM funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 2000, J NEUROENDOCRINOL, V12, P486, DOI 10.1046/j.1365-2826.2000.00475.x; Alkam T, 2008, J PHARMACOL EXP THER, V327, P137, DOI 10.1124/jpet.108.141309; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bazan-Peregrino M, 2007, J NEUROSCI RES, V85, P332, DOI 10.1002/jnr.21112; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Chavant F, 2010, J PHARMACOL EXP THER, V332, P505, DOI 10.1124/jpet.109.162164; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cotrufo T, 2003, J NEUROSCI, V23, P3566; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; Delobette S, 1997, EUR J PHARMACOL, V319, P1, DOI 10.1016/S0014-2999(96)00922-3; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Geci C, 2007, J NEUROCHEM, V101, P664, DOI 10.1111/j.1471-4159.2006.04415.x; Givalois L, 2004, MOL CELL NEUROSCI, V27, P280, DOI 10.1016/j.mcn.2004.07.002; Givalois L, 2004, ENDOCRINOLOGY, V145, P4737, DOI 10.1210/en.2004-0616; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Khan A, 2012, MOL CELL BIOCHEM, V369, P55, DOI 10.1007/s11010-012-1368-x; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Korolainen MA, 2005, NEUROBIOL DIS, V20, P858, DOI 10.1016/j.nbd.2005.05.021; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li XK, 2005, NEUROL RES, V27, P218, DOI 10.1179/016164105X35585; Lin F, 2012, ARZNEIMITTELFORSCH, V62, P187, DOI 10.1055/s-0031-1299763; Lin HB, 2009, PSYCHOPHARMACOLOGY, V204, P705, DOI 10.1007/s00213-009-1499-2; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; MASUGI F, 1989, METHOD FIND EXP CLIN, V11, P707; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Maurice T, 1996, BRAIN RES, V731, P249, DOI 10.1016/S0006-8993(96)00710-X; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2004, BRIT J PHARMACOL, V142, P689, DOI 10.1038/sj.bjp.0705835; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 2008, J PERIODONTOL, V79, P1535, DOI 10.1902/jop.2008.080171; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; ROZEMULLER JM, 1989, NEUROSCI LETT, V101, P288, DOI 10.1016/0304-3940(89)90547-8; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sigurdsson EM, 1997, NEUROBIOL AGING, V18, P591, DOI 10.1016/S0197-4580(97)00154-1; STANDAERT DG, 1991, AM J PATHOL, V139, P681; Stepanichev M Yu, 2006, Neurosci Behav Physiol, V36, P101, DOI 10.1007/s11055-005-0167-1; Stepanichev MY, 2004, PHYSIOL BEHAV, V80, P647, DOI 10.1016/j.physbeh.2003.11.003; Stepanichev MY, 2003, BRAIN RES BULL, V61, P197, DOI 10.1016/S0361-9230(03)00118-7; Stepanichev MY, 2003, J NEUROSCI RES, V71, P110, DOI 10.1002/jnr.10469; Sutton ET, 1997, EXP CELL RES, V230, P368, DOI 10.1006/excr.1996.3440; Tekirian TL, 2001, J ALZHEIMERS DIS, V3, P241; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; van de Nes JAP, 1998, ACTA NEUROPATHOL, V96, P129, DOI 10.1007/s004010050872; van de Nes JAP, 2006, ACTA NEUROPATHOL, V111, P126, DOI 10.1007/s00401-005-0018-8; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Villard V, 2009, NEUROPSYCHOPHARMACOL, V34, P1552, DOI 10.1038/npp.2008.212; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Yamada K, 2000, PHARMACOL THERAPEUT, V88, P93, DOI 10.1016/S0163-7258(00)00081-4; Yamaguchi Y, 2001, EUR J PHARMACOL, V412, P265, DOI 10.1016/S0014-2999(01)00730-0; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	87	82	84	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53117	10.1371/journal.pone.0053117	http://dx.doi.org/10.1371/journal.pone.0053117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301030	Green Published, gold			2022-12-27	WOS:000313320900062
J	Mercapide, J; Anzanello, F; Rappa, G; Lorico, A				Mercapide, Javier; Anzanello, Fabio; Rappa, Germana; Lorico, Aurelio			Relationship between Tumor Cell Invasiveness and Polyploidization	PLOS ONE			English	Article							BREAST-CANCER; FUSION; METASTASIS; CONSEQUENCES; ANEUPLOIDY; MIGRATION; MECHANISM	A number of studies have shown that tumor cells fuse with other tumor and non-tumor cells. In the present study on tumor cell lines derived from glioblastoma, breast cancer, and melanoma, we estimated the frequency of fusion between tumor cells by establishing the fraction of cells with whole tumor-genome duplication in each cell line. Together with this, the capacity of the tumor cell lines to spread through a basement membrane scaffold was assessed, in order to test the hypothesis that pericellular proteolysis by enzymatic release in the spaces of intercellular contact could account for differences in the fusogenicity of tumor cells. The difference in invasiveness between the cell lines accounted for their specific amount of cells with tumor-genome duplication, which, depending on the cell line analyzed, ranged from 2% to 25% of the total cells. These results support the hypothesis that cell-to-cell invasion eliciting membrane fusion causes polyploidization in tumor cells.	[Mercapide, Javier; Anzanello, Fabio; Rappa, Germana; Lorico, Aurelio] Roseman Univ Hlth Sci, Canc Res Ctr, Las Vegas, NV USA		Lorico, A (corresponding author), Roseman Univ Hlth Sci, Canc Res Ctr, Las Vegas, NV USA.	alorico@roseman.edu	Lorico, Aurelio/AAG-8095-2021	Lorico, Aurelio/0000-0003-0644-7375	United States National Institutes of Health [R01CA133797]; NATIONAL CANCER INSTITUTE [R01CA133797] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health R01CA133797 (GR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duesberg P, 2000, CANCER GENET CYTOGEN, V119, P83, DOI 10.1016/S0165-4608(99)00236-8; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; FODSTAD O, 1988, CANCER RES, V48, P4382; GOLDENBERG D M, 1968, European Journal of Cancer, V4, P547, DOI 10.1016/0014-2964(68)90011-X; LARIZZA L, 1984, CANCER METAST REV, V3, P193, DOI 10.1007/BF00048385; Mercapide J, 2012, INT J CANCER, V131, P334, DOI 10.1002/ijc.26361; MILLER FR, 1989, CANCER RES, V49, P4316; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35	20	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53364	10.1371/journal.pone.0053364	http://dx.doi.org/10.1371/journal.pone.0053364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300919	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600090
J	Wang, H; Chen, SS; Zhang, J; Rothenbacher, FP; Jiang, TT; Kan, BA; Zhong, ZT; Zhu, J				Wang, Hui; Chen, Shusu; Zhang, Juan; Rothenbacher, Francesca P.; Jiang, Tiantian; Kan, Biao; Zhong, Zengtao; Zhu, Jun			Catalases Promote Resistance of Oxidative Stress in Vibrio Cholerae	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; OXYR; GENE; REGULATOR; COLONIZATION; EXPRESSION; PROTECTION; MUTANT; OXYGEN	Oxidative stress is a major challenge faced by bacteria. Many bacteria control oxidative stress resistance pathways through the transcriptional regulator OxyR. The human pathogen Vibrio cholerae is a Gram-negative bacterium that is the causative agent of cholera. V. cholerae lives in both aquatic environments and human small intestines, two environments in which it encounters reactive oxygen species (ROS). To study how V. cholerae responds to oxidative stress, we constructed an inframe oxyR deletion mutant. We found that this mutant was not only sensitive to H2O2, but also displayed a growth defect when diluted in rich medium. Further study showed that two catalases, KatG and KatB, either when expressed in living cells, present in culture supernatants, or added as purified recombinant proteins, could rescue the oxyR growth defect. Furthermore, although it could colonize infant mouse intestines similar to that of wildtype, the oxyR mutant was defective in zebrafish intestinal colonization. Alternatively, co-infection with wildtype, but not katG-katB deletion mutants, greatly enhanced oxyR mutant colonization. Our study suggests that OxyR in V. cholerae is critical for antioxidant defense and that the organism is capable of scavenging environmental ROS to facilitate population growth.	[Wang, Hui; Chen, Shusu; Zhang, Juan; Jiang, Tiantian; Zhong, Zengtao; Zhu, Jun] Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Rothenbacher, Francesca P.; Zhu, Jun] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kan, Biao] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Nanjing Agricultural University; University of Pennsylvania; Pennsylvania Medicine; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhong, ZT (corresponding author), Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.	mol_microb@njau.edu.cn; junzhu@mail.med.upenn.edu	Zhong, Zengtao/E-2533-2016; Zhu, Jun/A-1324-2007		United States National Institutes of Health/NIAID [R01 (AI072479)]; Natural Sciences Foundation of China [30830008, 30900036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072479] Funding Source: NIH RePORTER	United States National Institutes of Health/NIAID; Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by the United States National Institutes of Health/NIAID R01 (AI072479), an Natural Sciences Foundation of China key project (30830008) (to B. K.), and an Natural Sciences Foundation of China Young Scientist award (30900036) (to H. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaoui A, 2009, TRENDS MOL MED, V15, P571, DOI 10.1016/j.molmed.2009.10.003; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; CROSS CE, 1984, LANCET, V1, P1328; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Faruque SM, 2002, MICROBIOL IMMUNOL, V46, P59, DOI 10.1111/j.1348-0421.2002.tb02659.x; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GRISHAM MB, 1987, AM J PHYSIOL, V253, pG93, DOI 10.1152/ajpgi.1987.253.1.G93; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Helmann JD., 2002, SCI STKE, V2002, pe46; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Lizarraga-Partida ML, 2009, ENVIRON MICROBIOL, V11, P201, DOI 10.1111/j.1462-2920.2008.01753.x; Maciver I, 1996, INFECT IMMUN, V64, P4618, DOI 10.1128/IAI.64.11.4618-4629.1996; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mongkolsuk S, 1998, J BACTERIOL, V180, P3988, DOI 10.1128/JB.180.15.3988-3991.1998; O'Toole R, 2004, MICROB PATHOGENESIS, V37, P41, DOI 10.1016/j.micpath.2004.03.001; Pradel E, 2004, ANNU REV GENET, V38, P347, DOI 10.1146/annurev.genet.38.072902.092528; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Stern AM, 2012, MBIO, V3, DOI 10.1128/mBio.00013-12; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	38	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53383	10.1371/journal.pone.0053383	http://dx.doi.org/10.1371/journal.pone.0053383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300923	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600094
J	Eckert, JJ; Porter, R; Watkins, AJ; Burt, E; Brooks, S; Leese, HJ; Humpherson, PG; Cameron, IT; Fleming, TP				Eckert, Judith J.; Porter, Richard; Watkins, Adam J.; Burt, Elizabeth; Brooks, Suzanne; Leese, Henry J.; Humpherson, Peter G.; Cameron, Iain T.; Fleming, Tom P.			Metabolic Induction and Early Responses of Mouse Blastocyst Developmental Programming following Maternal Low Protein Diet Affecting Life-Long Health	PLOS ONE			English	Article							IN-VITRO CULTURE; FEMALE REPRODUCTIVE-TRACT; SYSTOLIC BLOOD-PRESSURE; MTOR COMPLEX 1; AMINO-ACIDS; LONG-TERM; PREIMPLANTATION EMBRYO; FETAL-GROWTH; EARLY-PREGNANCY; DISEASE	Previously, we have shown that a maternal low protein diet, fed exclusively during the preimplantation period of mouse development (Emb-LPD), is sufficient to induce by the blastocyst stage a compensatory growth phenotype in late gestation and postnatally, correlating with increased risk of adult onset cardiovascular disease and behavioural dysfunction. Here, we examine mechanisms of induction of maternal Emb-LPD programming and early compensatory responses by the embryo. Emb-LPD induced changes in maternal serum metabolites at the time of blastocyst formation (E3.5), notably reduced insulin and increased glucose, together with reduced levels of free amino acids (AAs) including branched chain AAs leucine, isoleucine and valine. Emb-LPD also caused reduction in the branched chain AAs within uterine fluid at the blastocyst stage. These maternal changes coincided with an altered content of blastocyst AAs and reduced mTORC1 signalling within blastocysts evident in reduced phosphorylation of effector S6 ribosomal protein and its ratio to total S6 protein but no change in effector 4E-BP1 phosphorylated and total pools. These changes were accompanied by increased proliferation of blastocyst trophectoderm and total cells and subsequent increased spreading of trophoblast cells in blastocyst outgrowths. We propose that induction of metabolic programming following Emb-LPD is achieved through mTORC1signalling which acts as a sensor for preimplantation embryos to detect maternal nutrient levels via branched chain AAs and/or insulin availability. Moreover, this induction step associates with changes in extra-embryonic trophectoderm behaviour occurring as early compensatory responses leading to later nutrient recovery.	[Eckert, Judith J.; Porter, Richard; Watkins, Adam J.; Burt, Elizabeth; Brooks, Suzanne; Fleming, Tom P.] Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England; [Eckert, Judith J.; Cameron, Iain T.] Univ Southampton, Fac Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Leese, Henry J.] Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Humpherson, Peter G.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Southampton; University of Southampton; University of Hull; University of York - UK; University of York - UK	Fleming, TP (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England.	tpf@soton.ac.uk	Watkins, Adam J/J-4839-2013; Watkins, Adam/AAH-9401-2021	Watkins, Adam J/0000-0002-0842-1251; Watkins, Adam/0000-0002-0842-1251; Burt, Elizabeth/0000-0003-3801-0151	BBSRC [BB/F007450/1, BB/I001840/1]; Biotechnology and Biological Sciences Research Council [BB/I001840/1, BB/F007450/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for BBSRC funding (BB/F007450/1, BB/I001840/1) to TPF and JJE in support of this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Banrezes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029388; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Basatemur E, 2008, PLACENTA, V29, pS135, DOI 10.1016/j.placenta.2008.08.013; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; CHISHOLM JC, 1985, J EMBRYOL EXP MORPH, V86, P311; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Douglas AJ, 2011, PROG NEURO-PSYCHOPH, V35, P1167, DOI 10.1016/j.pnpbp.2010.07.024; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dumoulin JC, 2010, HUM REPROD, V25, P605, DOI 10.1093/humrep/dep456; DUNGLISON GF, 1995, J REPROD FERTIL, V105, P115, DOI 10.1530/jrf.0.1050115; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2007, MOL REPROD DEV, V74, P1149, DOI 10.1002/mrd.20746; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gardner DS, 2004, HYPERTENSION, V43, P1290, DOI 10.1161/01.HYP.0000126991.67203.7b; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; Groebner AE, 2011, REPRODUCTION, V141, P685, DOI 10.1530/REP-10-0533; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hernandez CE, 2010, PHYSIOL BEHAV, V101, P588, DOI 10.1016/j.physbeh.2010.08.020; Heyner S, 1997, Early Pregnancy, V3, P153; Hong J, 2007, THERIOGENOLOGY, V68, P728, DOI 10.1016/j.theriogenology.2007.06.002; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kaye Peter L., 1995, Progress in Growth Factor Research, V6, P1, DOI 10.1016/0955-2235(95)00001-1; Kaye PL, 1999, HUM REPROD, V14, P3052, DOI 10.1093/humrep/14.12.3052; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Koga K, 2008, REPROD SCI, V15, P231, DOI 10.1177/1933719108316391; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LAMB VK, 1994, J REPROD FERTIL, V102, P169, DOI 10.1530/jrf.0.1020169; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Mahsoudi B, 2007, BIOL REPROD, V77, P889, DOI 10.1095/biolreprod.106.057885; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Pampfer S, 2000, J REPROD FERTIL, P129; Partridge RJ, 1996, REPROD FERT DEVELOP, V8, P945, DOI 10.1071/RD9960945; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Petrie L, 2002, BRIT J NUTR, V88, P471, DOI 10.1079/BJN2002695; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Richards T, 2010, BIOL REPROD, V82, P769, DOI 10.1095/biolreprod.109.081646; Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008; Satterfield MC, 2010, BIOL REPROD, V82, P224, DOI 10.1095/biolreprod.109.076729; SCHULTZ GA, 1981, J REPROD FERTIL, V61, P387, DOI 10.1530/jrf.0.0610387; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sinclair KD, 2007, THERIOGENOLOGY, V67, P43, DOI 10.1016/j.theriogenology.2006.09.017; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; SPINDLE A, 1995, THERIOGENOLOGY, V44, P761, DOI 10.1016/0093-691X(95)00275-D; Suzuki C, 2007, ZYGOTE, V15, P317, DOI 10.1017/S0967199407004273; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Thompson JG, 2007, REPROD FERT DEVELOP, V19, P43, DOI 10.1071/RD06129; Torrens C, 2009, EXP PHYSIOL, V94, P1024, DOI 10.1113/expphysiol.2009.047340; Van Winkle LJ, 2006, HUM REPROD UPDATE, V12, P145, DOI 10.1093/humupd/dmi044; VANWINKLE LJ, 1995, BIOL REPROD, V52, P96, DOI 10.1095/biolreprod52.1.96; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Watkins AJ, 2008, SEMIN REPROD MED, V26, P175, DOI 10.1055/s-2008-1042956; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783; Zhao XM, 2000, DEVELOPMENT, V127, P2643	78	81	83	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52791	10.1371/journal.pone.0052791	http://dx.doi.org/10.1371/journal.pone.0052791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300778	Green Published, Green Accepted, gold			2022-12-27	WOS:000312829100083
J	Barbone, D; Cheung, P; Battula, S; Busacca, S; Gray, SG; Longley, DB; Bueno, R; Sugarbaker, DJ; Fennell, DA; Broaddus, VC				Barbone, Dario; Cheung, Priscilla; Battula, Sailaja; Busacca, Sara; Gray, Steven G.; Longley, Daniel B.; Bueno, Raphael; Sugarbaker, David J.; Fennell, Dean A.; Broaddus, V. Courtney			Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; HISTONE DEACETYLASE INHIBITORS; APOPTOTIC RESISTANCE; MELANOMA-CELLS; LUNG-CANCER; PHASE-II; BCL-2; MODULATION; BORTEZOMIB; CONTRIBUTE	When grown in 3D cultures as spheroids, mesothelioma cells acquire a multicellular resistance to apoptosis that resembles that of solid tumors. We have previously found that resistance to the proteasome inhibitor bortezomib in 3D can be explained by a lack of upregulation of Noxa, the pro-apoptotic BH3 sensitizer that acts via displacement of the Bak/Bax-activator BH3-only protein, Bim. We hypothesized that the histone deacetylase inhibitor vorinostat might reverse this block to Noxa upregulation in 3D. Indeed, we found that vorinostat effectively restored upregulation of Noxa protein and message and abolished multicellular resistance to bortezomib in the 3D spheroids. The ability of vorinostat to reverse resistance was ablated by knockdown of Noxa or Bim, confirming the essential role of the Noxa/Bim axis in the response to vorinostat. Addition of vorinostat similarly increased the apoptotic response to bortezomib in another 3D model, the tumor fragment spheroid, which is grown from human mesothelioma ex vivo. In addition to its benefit when used with bortezomib, vorinostat also enhanced the response to cisplatin plus pemetrexed, as shown in both 3D models. Our results using clinically relevant 3D models show that the manipulation of the core apoptotic repertoire may improve the chemosensitivity of mesothelioma. Whereas neither vorinostat nor bortezomib alone has been clinically effective in mesothelioma, vorinostat may undermine chemoresistance to bortezomib and to other therapies thereby providing a rationale for combinatorial strategies.	[Barbone, Dario; Cheung, Priscilla; Battula, Sailaja; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA; [Busacca, Sara; Fennell, Dean A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Gray, Steven G.] St James Hosp, Dept Cardiothorac Surg, Dublin, Ireland; [Longley, Daniel B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Bueno, Raphael; Sugarbaker, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Thorac Surg, Boston, MA 02115 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Leicester; Trinity College Dublin; Queens University Belfast; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA.	dario.barbone@ucsf.edu	Gray, Steven G./I-3081-2019	Gray, Steven G./0000-0002-5850-6392; Cheung, Priscilla/0000-0002-8677-9304	TRDRP fellowship [18FT-0120]; Department of Defense Mesothelioma Program [PR080717]; Simmons Mesothelioma Foundation	TRDRP fellowship; Department of Defense Mesothelioma Program; Simmons Mesothelioma Foundation	This work was supported by a TRDRP fellowship to DB (18FT-0120), a Department of Defense Mesothelioma Program grant to VCB (PR080717) and by the Simmons Mesothelioma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; Facchetti F, 2004, APOPTOSIS, V9, P573, DOI 10.1023/B:APPT.0000038036.31271.50; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hurwitz JL, 2012, EUR J CANCER, V48, P1096, DOI 10.1016/j.ejca.2011.11.009; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; METCALF RA, 1992, CANCER RES, V52, P2610; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Paik PK, 2010, J THORAC ONCOL, V5, P275, DOI 10.1097/JTO.0b013e3181c5e366; Perego P, 2012, BIOCHEM PHARMACOL, V83, P987, DOI 10.1016/j.bcp.2011.11.010; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Scherpereel A, 2011, EUR RESPIR J, V37, P129, DOI 10.1183/09031936.00037310; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Wilson SM, 2008, AM J RESP CELL MOL, V39, P576, DOI 10.1165/rcmb.2007-0460OC; Xargay-Torrent S, 2011, CLIN CANCER RES, V17, P3956, DOI 10.1158/1078-0432.CCR-10-3412; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC	29	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52753	10.1371/journal.pone.0052753	http://dx.doi.org/10.1371/journal.pone.0052753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300762	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800138
J	Feng, Q; Zou, X; Lu, L; Li, Y; Liu, YZ; Zhou, JF; Duan, CM				Feng, Qiang; Zou, Xia; Lu, Ling; Li, Yun; Liu, Yunzhang; Zhou, Jianfeng; Duan, Cunming			The Stress-Response Gene redd1 Regulates Dorsoventral Patterning by Antagonizing Wnt/beta-catenin Activity in Zebrafish	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; HOMEOBOX GENE; IGF BINDING; ORGANIZER FORMATION; MAMMALIAN TARGET; SKELETAL-MUSCLE; AXIS FORMATION; ENERGY STRESS; EXPRESSION	REDD1/redd1 is a stress-response gene that is induced under various stressful conditions such as hypoxia, DNA damage, and energy stress. The increased REDD1 inhibits mTOR signaling and cell growth. Here we report an unexpected role of Redd1 in regulating dorsoventral patterning in zebrafish embryos and the underlying mechanisms. Zebrafish redd1 mRNA is maternally deposited. Although it is ubiquitously detected in many adult tissues, its expression is highly tissue-specific and dynamic during early development. Hypoxia and heat shock strongly induce redd1 expression in zebrafish embryos. Knockdown of Redd1 using two independent morpholinos results in dorsalized embryos and this effect can be rescued by injecting redd1 mRNA. Forced expression of Redd1 ventralizes embryos. Co-expression of Redd1 with Wnt3a or a constitutively active form of beta-catenin suggests that Redd1 alters dorsoventral patterning by antagonizing the Wnt/beta-catenin signaling pathway. These findings have unraveled a novel role of Redd1 in early development by antagonizing Wnt/beta-catenin signaling.	[Feng, Qiang; Zou, Xia; Lu, Ling; Li, Yun; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Ocean University of China; University of Michigan System; University of Michigan	Zhou, JF (corresponding author), Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China.	jfzhou@ouc.edu.cn; cduan@umich.edu			National Science Foundation of China [30972238, 40876064, 30970357, 30928021]; Program for New Century Excellent Talents in University [NCET-10-0723]; Major Science Programs of China [2011CB943800]; US NSF [IOS-1051034]; Direct For Biological Sciences [1051034] Funding Source: National Science Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Major Science Programs of China; US NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation of China (Grant #30972238, #40876064, #30970357 and #30928021), Program for New Century Excellent Talents in University (NCET-10-0723) and Major Science Programs of China (#2011CB943800). C. D. was supported by US NSF Research Grant IOS-1051034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KD, 2010, DEV DYNAM, V239, P2828, DOI 10.1002/dvdy.22419; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai W, 2010, FASEB J, V24, P2020, DOI 10.1096/fj.09-149435; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Erter CE, 2001, DEVELOPMENT, V128, P3571; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Horndasch M, 2006, ONCOGENE, V25, P3397, DOI 10.1038/sj.onc.1209380; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang XL, 2009, AM J PHYSIOL-REG I, V296, pR1348, DOI 10.1152/ajpregu.90969.2008; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhong YB, 2011, J CELL SCI, V124, P1925, DOI 10.1242/jcs.082644	57	23	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52674	10.1371/journal.pone.0052674	http://dx.doi.org/10.1371/journal.pone.0052674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300740	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800125
J	Chahad-Ehlers, S; Gentile, C; Lima, JBP; Peixoto, AA; Bruno, RV				Chahad-Ehlers, Samira; Gentile, Carla; Pereira Lima, Jose Bento; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira			Analysis of cycle Gene Expression in Aedes aegypti Brains by In Situ Hybridization	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; TRANSCRIPTIONAL REPRESSOR; DROSOPHILA; MOSQUITO; NEURONS; INSECT; ORANGE; LIGHT; PATTERNS; TIMELESS	Even though the blood-sucking mosquito Aedes aegypti is one of the most important disease vectors, relatively little is known about the molecular mechanisms underlying processes involved in the temporal pattern of its activity and host seeking behavior. In this study, we analyzed the expression of the cycle (cyc) gene, one of the core components of the circadian clock, in Ae. aegypti brains by in situ hybridization at two different time points in light-dark conditions and compared the results with those obtained using a quantitative PCR assay (qPCR). Within the brain, differential labeling was detected according to distinct areas empirically pre-defined. Six out of seven of these areas showed significantly higher staining at ZT3 (three hours after light-on) compared to ZT11 (one before light-off), which is consistent with the qPCR data. Predominant staining was observed in three of those areas which correspond to positions of the optical and antennal lobes, as well as the region where the neurons controlling activity rhythms are presumably localized.	[Chahad-Ehlers, Samira; Gentile, Carla; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento] Inst Biol Exercito, Lab Entomol, Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira] CNPq, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bruno, RV (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	rafaelav@ioc.fiocruz.br	Bruno, Rafaela/AAQ-7611-2020; Chahad-Ehlers, Samira/H-8024-2015	Chahad-Ehlers, Samira/0000-0003-2321-4389; Bruno, Rafaela/0000-0002-7082-9768	Howard Hughes Medical Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj); Fundacao Oswaldo Cruz (FIOCRUZ)	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by grants from the Howard Hughes Medical Institute, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj), and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2004, GENETICS, V168, P2025, DOI 10.1534/genetics.104.028399; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chang DC, 2003, J BIOL CHEM, V278, P38149, DOI 10.1074/jbc.M306937200; Clements AN., 1999, SENSORY RECEPTION BE; Cortes T, 2010, INSECT MOL BIOL, V19, P123, DOI 10.1111/j.1365-2583.2009.00931.x; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; KASAI M, 1987, PHYSIOL ENTOMOL, V12, P59, DOI 10.1111/j.1365-3032.1987.tb00724.x; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Malpel S, 2002, DEVELOPMENT, V129, P1443; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Meireles ACA, 2006, FEBS LETT, V580, P2, DOI 10.1016/j.febslet.2005.11.031; Meireles-Filho AC, 2006, BMC MOL BIOL, V27, P7; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NYHOF JM, 1989, INT J INSECT MORPHOL, V18, P13, DOI 10.1016/0020-7322(89)90033-0; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sambrook J., 2001, MOL CLONING LAB MANU; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Saunders DS, 2002, INSECT CLOCKS; Schiemenz H, 1957, DTSCH ENTOMOL Z, V4, P64; Shao QM, 2008, CELL TISSUE RES, V331, P435, DOI 10.1007/s00441-007-0534-z; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zucker RM, 2006, CYTOM PART A, V69A, P1143, DOI 10.1002/cyto.a.20343	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52559	10.1371/journal.pone.0052559	http://dx.doi.org/10.1371/journal.pone.0052559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300979	Green Published, gold			2022-12-27	WOS:000313320900031
J	Grietens, KP; Ribera, JM; Soto, V; Tenorio, A; Hoibak, S; Aguirre, AR; Toomer, E; Rodriguez, H; Cuentas, AL; D'Alessandro, U; Gamboa, D; Erhart, A				Grietens, Koen Peeters; Muela Ribera, Joan; Soto, Veronica; Tenorio, Alex; Hoibak, Sarah; Rosas Aguirre, Angel; Toomer, Elizabeth; Rodriguez, Hugo; Llanos Cuentas, Alejandro; D'Alessandro, Umberto; Gamboa, Dionicia; Erhart, Annette			Traditional Nets Interfere with the Uptake of Long-Lasting Insecticidal Nets in the Peruvian Amazon: The Relevance of Net Preference for Achieving High Coverage and Use	PLOS ONE			English	Article							TREATED BED NETS; ANOPHELES-DARLINGI; PLASMODIUM-VIVAX; MOSQUITO NETS; MALARIA; AREA; ACCEPTABILITY; OWNERSHIP; CURTAINS; VECTOR	Background: While coverage of long-lasting insecticide-treated nets (LLIN) has steadily increased, a growing number of studies report gaps between net ownership and use. We conducted a mixed-methods social science study assessing the importance of net preference and use after Olyset (R) LLINs were distributed through a mass campaign in rural communities surrounding Iquitos, the capital city of the Amazonian region of Peru. Methods: The study was conducted in the catchment area of the Paujil and Cahuide Health Centres (San Juan district) between July 2007 and November 2008. During a first qualitative phase, participant observation and in-depth interviews collected information on key determinants for net preference and use. In a second quantitative phase, a survey among recently confirmed malaria patients evaluated the acceptability and use of both LLINs and traditional nets, and a case control study assessed the association between net preference/use and housing structure (open vs. closed houses). Results: A total of 10 communities were selected for the anthropological fieldwork and 228 households participated in the quantitative studies. In the study area, bed nets are considered part of the housing structure and are therefore required to fulfil specific architectural and social functions, such as providing privacy and shelter, which the newly distributed Olyset (R) LLINs ultimately did not. The LLINs' failure to meet these criteria could mainly be attributed to their large mesh size, transparency and perceived ineffectiveness to protect against mosquitoes and other insects, resulting in 63.3% of households not using any of the distributed LLINs. Notably, LLIN usage was significantly lower in houses with no interior or exterior walls (35.2%) than in those with walls (73.8%) (OR = 5.2, 95CI [2.2; 12.3], p<0.001). Conclusion: Net preference can interfere with optimal LLIN use. In order to improve the number of effective days of LLIN protection per dollar spent, appropriate quantitative and qualitative methods for collecting information on net preference should be developed before any LLIN procurement decision is made.	[Grietens, Koen Peeters; D'Alessandro, Umberto; Erhart, Annette] Prince Leopold Inst Trop Med, Antwerp, Belgium; [Grietens, Koen Peeters; Muela Ribera, Joan; Toomer, Elizabeth] PASS Int, Partners Appl Social Sci, Tessenderlo, Belgium; [Soto, Veronica; Rosas Aguirre, Angel; Llanos Cuentas, Alejandro; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Tenorio, Alex; Rosas Aguirre, Angel; Rodriguez, Hugo] Proyecto PAMAFRO, Organismo Andino Salud Convenio Hipolito Unanue, Lima, Peru; [Hoibak, Sarah] MENTOR Initiat, Crawley, England; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Grietens, KP (corresponding author), Prince Leopold Inst Trop Med, Antwerp, Belgium.	kpeeters@itg.be	Aguirre, Angel Rosas/A-5054-2016; D'Alessandro, Umberto/D-3457-2015; Peeters Grietens, Koen/G-7028-2019; Gamboa, Dionicia/CAF-2097-2022; Ribera, JM/B-8181-2009	Aguirre, Angel Rosas/0000-0002-3271-7028; D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Gamboa, Dionicia/0000-0002-1420-7729; Ribera, JM/0000-0003-1042-6024; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; muela ribera, joan/0000-0003-2111-6275	Belgian Cooperation [95502]; National Institute of Health [U19 SI089681]	Belgian Cooperation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study received financial support from the Belgian Cooperation within the Framework Agreement III consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), Antwerp- Belgium, and the ITM Alexander von Humboldt (ITM-AvH), Universidad Peruana Cayetano Heredia in Lima, Peru, Project 95502. DG is also supported by a National Institute of Health grant (U19 SI089681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agypeong I, 1999, J BIOSOC SCI, V31, P79; AIKINS MK, 1994, J TROP MED HYG, V97, P81; Alliance for Malaria Prevention Toolkit 2.0, 2011, ALL MAL PREV TOOLK 2; American Anthropological Association, 2018, AM ANTHR ASS STAT ET; American Anthropological Association, 1998, ANTHR NEWS; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], QUICK FACTS PROC LON; [Anonymous], REF UPD GMAP OBJ TAR; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-298; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Bean J, 2001, INSECTICIDE TR UNPUB; Brieger W, 1994, HLTH ED RES, V11, P133; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Fernando SD, 2008, T R SOC TROP MED HYG, V22, P222; Gamble C, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003755.pub2, 10.1002/14651858.CD001031.pub2]; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Global Fund to Fight Aids Tuberculosis and Malaria, 2011, COUNTR COORD MECH; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Gunasekaran K, 2009, ACTA TROP, V112, P149, DOI 10.1016/j.actatropica.2009.07.013; Harvey SA, 2000, INSECTICIDE IM UNPUB; Harvey SA, 2008, AM J TROP MED HYG, V79, P834, DOI 10.4269/ajtmh.2008.79.834; Helman CG, 2007, CULTURE HLTH ILLNESS; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Koenker H, 2011, PUBLIC HLTH BAYER CR; Llanos-Zavalaga Fernando, 2005, Rev Med Hered, V16, P97; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Oficina General de Epidemiologia DIRESA Loreto, 2008, AN SIT SAL REG LOR A; OGEP, 2006, WEEKL EP B; Organismo Andino de Salud-Convenio Hipolito Unanue, PROYECT PAMA FRO; PAMAFRO, 2011, REP RES; Peeters Grietens K, 2010, MALARIA J, V9, P1; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; R4D, 2012, EXP ACC LLIN GLOB MA; RBM, 2001, FIN REP INS TREAT BE; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Schoeler GB, 2003, J AM MOSQUITO CONTR, V19, P286; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; Teddlie C., 2008, FDN MIXED METHODS RE; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; WHO, 2009, 12 WHOPES WORK GROUP; WHO, 2011, VECT CONTR; WHO, 2011, SYST IMPR VAL MON LL; WHO, 2011, GUIDELINES MONITORIN; WHO, 2011, INC M PIL STUD PROJ; WHOPES, 2011, LONG LAST INS MOSQ N; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	53	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50294	10.1371/journal.pone.0050294	http://dx.doi.org/10.1371/journal.pone.0050294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300943	Green Published, gold			2022-12-27	WOS:000313320900003
J	Guo, Q; Koirala, S; Perkins, EM; McCaffery, JM; Shaw, JM				Guo, Qian; Koirala, Sajjan; Perkins, Edward M.; McCaffery, J. Michael; Shaw, Janet M.			The Mitochondrial Fission Adaptors Caf4 and Mdv1 Are Not Functionally Equivalent	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; WD REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; DNM1P; YEAST; DIVISION; FIS1P; DUPLICATION; RECRUITMENT; MORPHOLOGY	Mitochondrial fission in eukaryotes is mediated by protein complexes that encircle and divide mitochondrial tubules. In budding yeast, fission requires the membrane-anchored protein Fis1 and the dynamin-related GTPase Dnm1. Dnm1 is recruited to mitochondria via interactions with the adaptor proteins Caf4 and Mdv1, which bind directly to Fis1. Unlike Mdv1, a function for Caf4 in mitochondrial membrane scission has not been established. In this study, we demonstrate that Caf4 is a bona fide fission adaptor that assembles at sites of mitochondrial division. We also show that fission complexes may contain Caf4 alone or both Caf4 and Mdv1 without compromising fission function. Although there is a correspondence between Caf4 and Mdv1 expression levels and their contribution to fission, the two adaptor proteins are not equivalent. Rather, our functional and phylogenetic analyses indicate that Caf4 mitochondrial fission activity has diverged from that of Mdv1.	[Guo, Qian; Koirala, Sajjan; Shaw, Janet M.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Perkins, Edward M.; McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	Utah System of Higher Education; University of Utah; Johns Hopkins University	Shaw, JM (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	shaw@biochem.utah.edu	Koirala, Sajjan/AAI-4424-2020	Perkins, Edward/0000-0002-3077-7422	National Institutes of Health [GM53466, GM84970]; NCRR [SRR022588A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053466, R01GM084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1 grants GM53466 and GM84970 to JMS and NCRR SRR022588A to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Maniatis T., 1982, MOL CLONING LAB MANU; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Musso G, 2007, TRENDS GENET, V23, P266, DOI 10.1016/j.tig.2007.03.012; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhang Y, 2012, J BIOL CHEM, V287, P9855, DOI 10.1074/jbc.M111.329359	32	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53523	10.1371/journal.pone.0053523	http://dx.doi.org/10.1371/journal.pone.0053523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300936	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600106
J	Marklein, D; Graab, U; Naumann, I; Yan, TD; Ridzewski, R; Nitzki, F; Rosenberger, A; Dittmann, K; Wienands, J; Wojnowski, L; Fulda, S; Hahn, H				Marklein, Diana; Graab, Ulrike; Naumann, Ivonne; Yan, Tiandong; Ridzewski, Rosalie; Nitzki, Frauke; Rosenberger, Albert; Dittmann, Kai; Wienands, Juergen; Wojnowski, Leszek; Fulda, Simone; Hahn, Heidi			PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells	PLOS ONE			English	Article							TOPOISOMERASE-II INHIBITORS; FLOW-CYTOMETRIC ANALYSIS; CYTOCHROME-C RELEASE; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; INTERGROUP RHABDOMYOSARCOMA; MTOR INHIBITION; PHASE-II; PROTEIN-1 EXPRESSION	We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy of DOX in several sarcoma cell lines and interacts with DOX in the induction of apoptosis. PI103 decreased the expression of MDR1 and MRP1, which resulted in DOX accumulation. However, the enhancement of DOX-induced apoptosis was unrelated to DOX accumulation. Neither did it involve inhibition of mTOR. Instead, the combination treatment of DOX plus PI103 activated Bax, the mitochondrial apoptosis pathway, and caspase 3. Caspase 3 activation was also observed in xenografts of sarcoma cells in nude mice upon combination of DOX with the specific PI3K inhibitor GDC-0941. Although the increase in apoptosis did not further impact on tumor growth when compared to the efficient growth inhibition by GDC-0941 alone, these findings suggest that inhibition of PI3K may improve DOX-induced proapoptotic effects in sarcoma. Taken together with similar recent studies of neuroblastoma- and glioblastoma-derived cells, PI3K inhibition seems to be a more general option to sensitize tumor cells to anthracyclines.	[Marklein, Diana; Ridzewski, Rosalie; Nitzki, Frauke; Hahn, Heidi] Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Graab, Ulrike; Naumann, Ivonne; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany; [Yan, Tiandong; Wojnowski, Leszek] Univ Med Ctr, Dept Pharmacol, Mainz, Germany; [Rosenberger, Albert] Univ Med Ctr, Dept Genet Epidemiol, Gottingen, Germany; [Dittmann, Kai; Wienands, Juergen] Univ Med Ctr, Dept Cellular & Mol Immunol, Gottingen, Germany	University of Gottingen; Goethe University Frankfurt; Johannes Gutenberg University of Mainz; University of Gottingen; University of Gottingen	Hahn, H (corresponding author), Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	hhahn@gwdg.de		Fulda, Simone/0000-0002-0459-6417	DFG [GRK 1034, WO505/3-1]; Deutsche Krebshilfe [109837 (KoSAR)]	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was supported by the DFG GRK 1034 (to H. H.), by the grant 109837 (KoSAR) from the Deutsche Krebshilfe (to H. H. and S. F.) and by the DFG grant WO505/3-1 (to L. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Beck WT, 1999, DRUG RESIST UPDATE, V2, P382, DOI 10.1054/drup.1999.0110; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Bergeron C, 2008, EUR J CANCER, V44, P427, DOI 10.1016/j.ejca.2007.12.007; Biehn SE, 2007, ANN HEMATOL, V86, P211, DOI 10.1007/s00277-006-0220-3; Blay JY, 2011, ANN ONCOL, V22, P280, DOI 10.1093/annonc/mdq307; BONADONNA G, 1970, CANCER RES, V30, P2572; Congdon LM, 2008, BIOCHEM PHARMACOL, V75, P883, DOI 10.1016/j.bcp.2007.10.026; Cortes F, 2003, MUTAGENESIS, V18, P105, DOI 10.1093/mutage/18.2.105; CRIST W, 1995, J CLIN ONCOL, V13, P610, DOI 10.1200/JCO.1995.13.3.610; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; Gatta G, 2003, EUR J CANCER, V39, P2600, DOI 10.1016/j.ejca.2003.09.004; Giantris A, 1998, CRIT REV ONCOL HEMAT, V27, P53, DOI 10.1016/S1040-8428(97)10007-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gortzak E, 2001, EUR J CANCER, V37, P1096, DOI 10.1016/S0959-8049(01)00083-1; GREENE RF, 1983, CANCER RES, V43, P3417; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Han Z, 2007, J EXP CLIN CANC RES, V26, P261; Hideshima T, 2001, CANCER RES, V61, P3071; Kanbe E, 2003, EXP HEMATOL, V31, P300, DOI 10.1016/S0301-472X(03)00003-1; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Liu F, 2010, ONCOL REP, V23, P1469, DOI 10.3892/or_00000786; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; MAURER HM, 1993, CANCER-AM CANCER SOC, V71, P1904, DOI 10.1002/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X; MAURER HM, 1988, CANCER-AM CANCER SOC, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mohr A, 2004, CELL DEATH DIFFER, V11, P1153, DOI 10.1038/sj.cdd.4401480; Murphy KM, 2000, J BIOL CHEM, V275, P17225, DOI 10.1074/jbc.C900590199; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO;2-X; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Rabbani A, 2005, BIOESSAYS, V27, P50, DOI 10.1002/bies.20160; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Simbre Valeriano C, 2005, Paediatr Drugs, V7, P187, DOI 10.2165/00148581-200507030-00005; Stahnke K, 2004, APOPTOSIS, V9, P457, DOI 10.1023/B:APPT.0000031454.62937.fa; STILLER CA, 1994, PAEDIATR PERINAT EP, V8, P107, DOI 10.1111/j.1365-3016.1994.tb00439.x; Takahashi-Hyodo SA, 1999, MUTAT RES-FUND MOL M, V431, P13, DOI 10.1016/S0027-5107(99)00151-7; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; TAN C, 1973, CANCER-AM CANCER SOC, V32, P9, DOI 10.1002/1097-0142(197307)32:1<9::AID-CNCR2820320102>3.0.CO;2-6; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Zhang LL, 2002, CANCER RES, V62, P2034	51	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52898	10.1371/journal.pone.0052898	http://dx.doi.org/10.1371/journal.pone.0052898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300809	Green Published, gold			2022-12-27	WOS:000313872600033
J	Chapman, NM; Yoder, AN; Houtman, JCD				Chapman, Nicole M.; Yoder, Ashley N.; Houtman, Jon C. D.			Non-Catalytic Functions of Pyk2 and Fyn Regulate Late Stage Adhesion in Human T Cells	PLOS ONE			English	Article							TYROSINE KINASE PYK2; ACTIN CYTOSKELETON; ANTIGEN RECEPTOR; ACTIVATION; PHOSPHORYLATION; COMPLEX; NCK; AUTOIMMUNE; INTEGRINS; SYNAPSE	T cell activation drives the protective immune response against pathogens, but is also critical for the development of pathological diseases in humans. Cytoskeletal changes are required for downstream functions in T cells, including proliferation, cytokine production, migration, spreading, and adhesion. Therefore, investigating the molecular mechanism of cytoskeletal changes is crucial for understanding the induction of T cell-driven immune responses and for developing therapies to treat immune disorders related to aberrant T cell activation. In this study, we used a plate-bound adhesion assay that incorporated near-infrared imaging technology to address how TCR signaling drives human T cell adhesion. Interestingly, we observed that T cells have weak adhesion early after TCR activation and that binding to the plate was significantly enhanced 30-60 minutes after receptor activation. This late stage of adhesion was mediated by actin polymerization but was surprisingly not dependent upon Src family kinase activity. By contrast, the non-catalytic functions of the kinases Fyn and Pyk2 were required for late stage human T cell adhesion. These data reveal a novel TCR-induced signaling pathway that controls cellular adhesion independent of the canonical TCR signaling cascade driven by tyrosine kinase activity.	[Chapman, Nicole M.; Houtman, Jon C. D.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Yoder, Ashley N.; Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Houtman, JCD (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854	American Heart Association Pre-doctoral fellowship [11PRE7390070]; National Institutes of Health (NIH) Predoctoral Training Grant in Immunology [T32 AI007485]; American Heart Association undergraduate fellowship [12UFEL12060651]; Scientist Development Grant from the American Heart Association [0830244N]; National Institutes of Health [R01 CA136729]; NATIONAL CANCER INSTITUTE [R01CA136729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	American Heart Association Pre-doctoral fellowship(American Heart Association); National Institutes of Health (NIH) Predoctoral Training Grant in Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association undergraduate fellowship(American Heart Association); Scientist Development Grant from the American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by an American Heart Association Pre-doctoral fellowship (11PRE7390070) and the National Institutes of Health (NIH) Predoctoral Training Grant in Immunology (T32 AI007485) to NMC, an American Heart Association undergraduate fellowship to ANY (12UFEL12060651), and a Scientist Development Grant 0830244N from the American Heart Association and R01 CA136729 from the National Institutes of Health to JCDH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Berg NN, 1997, J IMMUNOL, V159, P1753; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cleland SY, 2011, FEBS LETT, V585, P3710, DOI 10.1016/j.febslet.2011.10.031; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Fukai I, 2000, EUR J IMMUNOL, V30, P3507, DOI 10.1002/1521-4141(2000012)30:12<3507::AID-IMMU3507>3.0.CO;2-O; Gao CL, 2009, BIOCHEM J, V420, P49, DOI 10.1042/BJ20090037; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Keck K, 2009, MOL THER, V17, P538, DOI 10.1038/mt.2008.273; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lasserre R, 2010, FEBS LETT, V584, P4845, DOI 10.1016/j.febslet.2010.09.001; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Pauker MH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002423; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Reicher B, 2010, FEBS LETT, V584, P4858, DOI 10.1016/j.febslet.2010.09.002; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Sancho D, 2002, J IMMUNOL, V169, P292, DOI 10.4049/jimmunol.169.1.292; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen A, 2005, IMMUNOLOGY, V116, P276, DOI 10.1111/j.1365-2567.2005.02222.x; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; St-Pierre J, 2011, CELL SIGNAL, V23, P718, DOI 10.1016/j.cellsig.2010.12.006; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53011	10.1371/journal.pone.0053011	http://dx.doi.org/10.1371/journal.pone.0053011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300847	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100108
J	Han, Y; Huang, H; Xiao, Z; Zhang, W; Cao, YF; Qu, LK; Shou, CC				Han, Yong; Huang, Hao; Xiao, Zhen; Zhang, Wei; Cao, Yanfei; Qu, Like; Shou, Chengchao			Integrated Analysis of Gene Expression Profiles Associated with Response of Platinum/Paclitaxel-Based Treatment in Epithelial Ovarian Cancer	PLOS ONE			English	Article							DNA METHYLATION; AKT INHIBITORS; COLON-CANCER; CELLS; PACLITAXEL; CHEMOTHERAPY; RESISTANCE; SIGNATURES; CISPLATIN; BETA	Purpose: This study aims to explore gene expression signatures and serum biomarkers to predict intrinsic chemoresistance in epithelial ovarian cancer (EOC). Patients and Methods: Gene expression profiling data of 322 high-grade EOC cases between 2009 and 2010 in The Cancer Genome Atlas project (TCGA) were used to develop and validate gene expression signatures that could discriminate different responses to first-line platinum/paclitaxel-based treatments. A gene regulation network was then built to further identify hub genes responsible for differential gene expression between the complete response (CR) group and the progressive disease (PD) group. Further, to find more robust serum biomarkers for clinical application, we integrated our gene signatures and gene signatures reported previously to identify secretory protein-encoding genes by searching the DAVID database. In the end, gene-drug interaction network was constructed by searching Comparative Toxicogenomics Database (CTD) and literature. Results: A 349-gene predictive model and an 18-gene model independent of key clinical features with high accuracy were developed for prediction of chemoresistance in EOC. Among them, ten important hub genes and six critical signaling pathways were identified to have important implications in chemotherapeutic response. Further, ten potential serum biomarkers were identified for predicting chemoresistance in EOC. Finally, we suggested some drugs for individualized treatment. Conclusion: We have developed the predictive models and serum biomarkers for platinum/paclitaxel response and established the new approach to discover potential serum biomarkers from gene expression profiles. The potential drugs that target hub genes are also suggested.	[Han, Yong; Huang, Hao; Cao, Yanfei; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Xiao, Zhen; Zhang, Wei] Wuhan Univ, Renmin Hosp, Dept Gynecol, Wuhan 430072, Hubei, Peoples R China; [Cao, Yanfei] Changzhi Med Coll, Changzhi, Shanxi, Peoples R China	Peking University; Wuhan University; Changzhi Medical College	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	scc@bjcancer.org		Han, Yong/0000-0001-9935-2978	National 973 Program of China [2009CB521805]	National 973 Program of China(National Basic Research Program of China)	This study was funded by the National 973 Program of China (2009CB521805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; [Anonymous], 2011, GENE EXPRESSION PROF; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Davies S, 2011, ONCOL REP, V25, P855, DOI 10.3892/or.2011.1147; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gamarra-Luques CD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-200; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Kim YJ, 2012, ANTICANCER RES, V32, P799; Kim YM, 2002, J BIOL CHEM, V277, P6799, DOI 10.1074/jbc.M109434200; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; L'Esperance S, 2006, INT J ONCOL, V29, P5; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lu ZH, 2006, EXP CELL RES, V312, P1865, DOI 10.1016/j.yexcr.2006.02.017; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Mehnert JM, 2011, MOL CANCER THER, V10, P1509, DOI 10.1158/1535-7163.MCT-10-0944; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Sabatier R, 2011, BRIT J CANCER, V105, P304, DOI 10.1038/bjc.2011.219; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Si HP, 2012, INT J ONCOL, V40, P1291, DOI 10.3892/ijo.2011.1303; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Su JL, 2011, CANCER RES, V71, P6878, DOI 10.1158/0008-5472.CAN-11-0295; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Xu R, 2009, ANTICANCER RES, V29, P261; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang CY, 2011, MOL CANCER THER, V10, P1137, DOI 10.1158/1535-7163.MCT-10-1028	58	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52745	10.1371/journal.pone.0052745	http://dx.doi.org/10.1371/journal.pone.0052745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300757	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100076
J	Ludwig, SKJ; Smits, NGE; van der Veer, G; Bremer, MGEG; Nielen, MWF				Ludwig, Susann K. J.; Smits, Nathalie G. E.; van der Veer, Grishja; Bremer, Maria G. E. G.; Nielen, Michel W. F.			Multiple Protein Biomarker Assessment for Recombinant Bovine Somatotropin (rbST) Abuse in Cattle	PLOS ONE			English	Article							IGF BINDING-PROTEINS; HUMAN GROWTH-HORMONE; GH ABUSE; PROTEOMIC APPROACH; ANTIBODY-FORMATION; COLLAGEN TURNOVER; I CONCENTRATIONS; SERUM; MARKERS; COWS	Biomarker profiling, as a rapid screening approach for detection of hormone abuse, requires well selected candidate biomarkers and a thorough in vivo biomarker evaluation as previously done for detection of growth hormone doping in athletes. The bovine equivalent of growth hormone, called recombinant bovine somatotropin (rbST) is (il)legally administered to enhance milk production in dairy cows. In this study, first a generic sample pre-treatment and 4-plex flow cytometric immunoassay (FCIA) were developed for simultaneous measurement of four candidate biomarkers selected from literature: insulin-like growth factor 1 (IGF-1), its binding protein 2 (IGFBP2), osteocalcin and endogenously produced antibodies against rbST. Next, bovine serum samples from two extensive controlled rbST animal treatment studies were used for in vivo validation and biomarker evaluation. Finally, advanced statistic tools were tested for the assessment of biomarker combination quality aiming to correctly identify rbST-treated animals. The statistical prediction tool k-nearest neighbours using a combination of the biomarkers osteocalcin and endogenously produced antibodies against rbST proved to be very reliable and correctly predicted 95% of the treated samples starting from the second rbST injection until the end of the treatment period and even thereafter. With the same biomarker combination, only 12% of untreated animals appeared false-positive. This reliability meets the requirements of Commission Decision 2002/657/EC for screening methods in veterinary control. From the results of this multidisciplinary study, it is concluded that the osteocalcin - anti-rbST-antibodies combination represent fit-for-purpose biomarkers for screening of rbST abuse in dairy cattle and can be reliably measured in both the developed 4-plex FCIA as well as in a cost-effective 2-plex microsphere-based binding assay. This screening method can be incorporated in routine veterinary monitoring programmes: in the European Union for detection of rbST abuse and in the control of rbST-free dairy farms in the United States of America and other countries.	[Ludwig, Susann K. J.; Smits, Nathalie G. E.; van der Veer, Grishja; Bremer, Maria G. E. G.; Nielen, Michel W. F.] Wageningen UR, RIKILT Inst Food Safety, Wageningen, Netherlands; [Nielen, Michel W. F.] Wageningen Univ, Organ Chem Lab, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ludwig, SKJ (corresponding author), Wageningen UR, RIKILT Inst Food Safety, Wageningen, Netherlands.	susann.ludwig@wur.nl	Ludwig, Susann KJ/I-5844-2014	Ludwig, Susann KJ/0000-0002-7614-0558	Dutch Ministry of Economic Affairs, Agriculture and Innovation [72029.01]	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This project was financially supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (http://www.rijksoverheid.nl/ministeries/eleni project 72029.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, FED REGISTER, V58, P59; [Anonymous], 1999, OFF J EUR COMM, VL 331, P71; ARMSTRONG JD, 1993, DOMEST ANIM ENDOCRIN, V10, P315, DOI 10.1016/0739-7240(93)90035-A; BLUM WF, 1993, GROWTH REGULAT, V3, P100; Boateng J, 2009, PROTEOM CLIN APPL, V3, P912, DOI 10.1002/prca.200800190; Bremer MGEG, 2010, ANALYST, V135, P1147, DOI 10.1039/b925372f; Cacciatore G, 2009, ANAL CHIM ACTA, V637, P351, DOI 10.1016/j.aca.2008.11.027; Castigliego L, 2009, RES VET SCI, V87, P29, DOI 10.1016/j.rvsc.2008.10.012; Castigliego L, 2007, J DAIRY RES, V74, P79, DOI 10.1017/S0022029906002159; Chung L, 2009, GROWTH HORM IGF RES, V19, P383, DOI 10.1016/j.ghir.2009.04.019; Chung LP, 2006, J CLIN ENDOCR METAB, V91, P671, DOI 10.1210/jc.2005-1137; Dall R, 2000, J CLIN ENDOCR METAB, V85, P4193, DOI 10.1210/jc.85.11.4193; Di Luigi L, 2009, EUR J ENDOCRINOL, V160, P753, DOI 10.1530/EJE-08-0884; Dimitriadou E, 2011, E1071 MISC FUNCTIONS; Ding J, 2011, PROTEOMICS, V11, P3565, DOI 10.1002/pmic.201100077; Ding J, 2009, GROWTH HORM IGF RES, V19, P399, DOI 10.1016/j.ghir.2009.04.018; Draisci R, 2007, PROTEOMICS, V7, P3184, DOI 10.1002/pmic.200601039; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EPPARD PJ, 1992, J DAIRY SCI, V75, P2959, DOI 10.3168/jds.S0022-0302(92)78059-X; Erotokritou-Mulligan I, 2010, CLIN ENDOCRINOL, V72, P520, DOI 10.1111/j.1365-2265.2009.03668.x; European Commission, 2002, OFFICIAL J, V221, P8; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; Healy ML, 2005, J CLIN ENDOCR METAB, V90, P641, DOI 10.1210/jc.2004-0386; KERR DE, 1991, CAN J ANIM SCI, V71, P695, DOI 10.4141/cjas91-085; Kicman AT, 1997, CLIN ENDOCRINOL, V47, P43, DOI 10.1046/j.1365-2265.1997.2111036.x; Kniess A, 2003, ANAL BIOANAL CHEM, V376, P696, DOI 10.1007/s00216-003-1926-x; Le Breton MH, 2010, J AGR FOOD CHEM, V58, P729, DOI 10.1021/jf903032q; Le Breton MH, 2009, ANAL CHIM ACTA, V637, P121, DOI 10.1016/j.aca.2008.09.003; Lee AJ, 2000, ANN CLIN BIOCHEM, V37, P432, DOI 10.1258/0004563001899573; Longobardi S, 2000, J CLIN ENDOCR METAB, V85, P1505, DOI 10.1210/jc.85.4.1505; LUCY MC, 1994, BIOL REPROD, V50, P1136, DOI 10.1095/biolreprod50.5.1136; Ludwig SKJ, 2012, FOOD CONTROL, V26, P68, DOI 10.1016/j.foodcont.2011.12.011; MCGUIRE MA, 1992, J ANIM SCI, V70, P2901, DOI 10.2527/1992.7092901x; Mooney MH, 2008, BIOMARKERS, V13, P246, DOI [10.1080/13547500701838593, 10.1080/13547500701838593 ]; Nelson AE, 2011, ENDOCR UPDAT, P139, DOI 10.1007/978-1-4419-7014-5_15; Powrie JK, 2007, GROWTH HORM IGF RES, V17, P220, DOI 10.1016/j.ghir.2007.01.011; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rochereau-Roulet S, 2011, ANAL CHIM ACTA, V700, P189, DOI 10.1016/j.aca.2011.01.035; Sartorio A, 2006, J ENDOCRINOL INVEST, V29, P237, DOI 10.1007/BF03345546; Sato R, 2011, RES VET SCI, V91, P196, DOI 10.1016/j.rvsc.2010.12.007; SHARMA BK, 1994, J DAIRY SCI, V77, P2232, DOI 10.3168/jds.S0022-0302(94)77166-6; Smits NGE, 2012, DRUG TEST ANAL, V4, P362, DOI 10.1002/dta.336; Smits NGE, 2012, ANALYST, DOI [10.1039/c1032an35226e, DOI 10.1039/C1032AN35226E]; Teale P, 2009, BIOANALYSIS, V1, P1103, DOI [10.4155/bio.09.87, 10.4155/BIO.09.87]; Wallace JD, 2000, J CLIN ENDOCR METAB, V85, P124, DOI 10.1210/jc.85.1.124; ZHAO X, 1994, DOMEST ANIM ENDOCRIN, V11, P209, DOI 10.1016/0739-7240(94)90028-0; ZWICKL CM, 1990, J DAIRY SCI, V73, P2888, DOI 10.3168/jds.S0022-0302(90)78976-X	47	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52917	10.1371/journal.pone.0052917	http://dx.doi.org/10.1371/journal.pone.0052917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300820	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100097
J	Ntusi, NBA; Badri, M; Khalfey, H; Whitelaw, A; Oliver, S; Piercy, J; Raine, R; Joubert, I; Dheda, K				Ntusi, Ntobeko B. A.; Badri, Motasim; Khalfey, Hoosain; Whitelaw, Andrew; Oliver, Stephen; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan			ICU-Associated Acinetobacter baumannii Colonisation/Infection in a High HIV-Prevalence Resource-Poor Setting	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; RISK-FACTORS; GLOBAL EPIDEMIOLOGY; RESISTANT; PATHOGENS; HOSPITALS	Background: There are hardly any data about the incidence, risk factors and outcomes of ICU-associated A. baumannii colonisation/infection in HIV-infected and uninfected persons from resource-poor settings like Africa. Methods: We reviewed the case records of patients with A. baumannii colonisation/infection admitted into the adult respiratory and surgical ICUs in Cape Town, South Africa, from January 1 to December 31 2008. In contrast to colonisation, infection was defined as isolation of A. baumannii from any biological site in conjunction with a compatible clinical picture warranting treatment with antibiotics effective against A. baumannii. Results: The incidence of A. baumannii colonisation/infection in 268 patients was 15 per 100 person-years, with an in-ICU mortality of 26.5 per 100 person-years. The average length of stay in ICU was 15 days (range 1-150). A. baumannii was most commonly isolated from the respiratory tract followed by the bloodstream. Independent predictors of mortality included older age (p = 0.02), low CD4 count if HIV-infected (p = 0.038), surgical intervention (p = 0.047), co-morbid Gram-negative sepsis (p = 0.01), high APACHE-II score (p = 0.001), multi-organ dysfunction syndrome (p = 0.012), and a positive blood culture for A. baumannii (p = 0.017). Of 21 A. baumannii colonised/infected HIV-positive persons those with clinical AIDS (CD4<200 cells/mm(3)) had significantly higher in-ICU mortality and were more likely to have a positive blood culture. Conclusion In this resource-poor setting A. baumannii infection in critically ill patients is common and associated with high mortality. HIV co-infected patients with advanced immunosuppression are at higher risk of death.	[Badri, Motasim; Khalfey, Hoosain; Dheda, Keertan] Groote Schuur Hosp, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Khalfey, Hoosain; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan] Groote Schuur Hosp, Dept Crit Care, ZA-7925 Cape Town, South Africa; [Ntusi, Ntobeko B. A.] Groote Schuur Hosp, Cardiac Clin, Dept Med, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Oliver, Stephen] Groote Schuur Hosp, Dept Microbiol, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Oliver, Stephen] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Ntusi, Ntobeko B. A.; Badri, Motasim; Khalfey, Hoosain; Whitelaw, Andrew; Oliver, Stephen; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Ntusi, Ntobeko/AAA-1152-2020; Badri, Motasim/E-1141-2013	Badri, Motasim/0000-0002-5268-6492; Ntusi, Ntobeko A. B./0000-0003-2347-7883; Whitelaw, Andrew/0000-0001-9070-5247	SA MRC (South African Medical Research Council); Discovery Academic Foundation; SA DST (Deptartment of Science and Technology) (SARChI); EU; EDCTP (European-Developing Countries Clinical Trial Partnership)	SA MRC (South African Medical Research Council); Discovery Academic Foundation; SA DST (Deptartment of Science and Technology) (SARChI); EU(European Commission); EDCTP (European-Developing Countries Clinical Trial Partnership)	NN receives funding from the SA MRC (South African Medical Research Council) and the Discovery Academic Foundation. KD is supported by the SA DST (Deptartment of Science and Technology) (SARChI), SA MRC, EU (FP7) and the EDCTP (European-Developing Countries Clinical Trial Partnership). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, J INFECTION, V53, P98, DOI 10.1016/j.jinf.2005.10.021; Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Chen CH, 2003, INFECTION, V31, P331, DOI 10.1007/s15010-003-3223-1; Daniels TL, 2008, INFECT CONT HOSP EP, V29, P1080, DOI 10.1086/591456; Diekema DJ, 2000, INT J ANTIMICROB AG, V13, P257, DOI 10.1016/S0924-8579(99)00131-4; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P117, DOI 10.1111/j.1469-0691.2006.01596.x; Falagas ME, 2006, CRIT CARE, V10, P793; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gounden R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-26; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; Manfredi R, 2001, CHEMOTHERAPY, V47, P19, DOI 10.1159/000048497; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Paul M, 2005, J HOSP INFECT, V60, P256, DOI 10.1016/j.jhin.2005.01.007; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; POTGIETER PD, 1987, CRIT CARE MED, V15, P495, DOI 10.1097/00003246-198705000-00008; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x; Trottier Vincent, 2007, Surg Infect (Larchmt), V8, P437, DOI 10.1089/sur.2006.029; UNAIDS/WHO, 2009, REP GLOB HIV AIDS EP; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Webster CA, 1999, EUR J CLIN MICROBIOL, V18, P595, DOI 10.1007/s100960050354; Zapor MJ, 2005, CURR OPIN INFECT DIS, V18, P395, DOI 10.1097/01.qco.0000182102.50430.2c	25	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52452	10.1371/journal.pone.0052452	http://dx.doi.org/10.1371/journal.pone.0052452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300673	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100050
J	Tollenaere, C; Susi, H; Nokso-Koivisto, J; Koskinen, P; Tack, A; Auvinen, P; Paulin, L; Frilander, MJ; Lehtonen, R; Laine, AL				Tollenaere, Charlotte; Susi, Hanna; Nokso-Koivisto, Jussi; Koskinen, Patrik; Tack, Ayco; Auvinen, Petri; Paulin, Lars; Frilander, Mikko J.; Lehtonen, Rainer; Laine, Anna-Liisa			SNP Design from 454 Sequencing of Podosphaera plantaginis Transcriptome Reveals a Genetically Diverse Pathogen Metapopulation with High Levels of Mixed-Genotype Infection	PLOS ONE			English	Article							POWDERY MILDEW FUNGI; PLANT-PATHOGEN; LOCAL ADAPTATION; EVOLUTION; VIRULENCE; DYNAMICS; ECOLOGY; SCALE; HOST; MICROSATELLITE	Background: Molecular tools may greatly improve our understanding of pathogen evolution and epidemiology but technical constraints have hindered the development of genetic resources for parasites compared to free-living organisms. This study aims at developing molecular tools for Podosphaera plantaginis, an obligate fungal pathogen of Plantago lanceolata. This interaction has been intensively studied in the A land archipelago of Finland with epidemiological data collected from over 4,000 host populations annually since year 2001. Principal Findings: A cDNA library of a pooled sample of fungal conidia was sequenced on the 454 GS-FLX platform. Over 549,411 reads were obtained and annotated into 45,245 contigs. Annotation data was acquired for 65.2% of the assembled sequences. The transcriptome assembly was screened for SNP loci, as well as for functionally important genes (mating-type genes and potential effector proteins). A genotyping assay of 27 SNP loci was designed and tested on 380 infected leaf samples from 80 populations within the A land archipelago. With this panel we identified 85 multilocus genotypes (MLG) with uneven frequencies across the pathogen metapopulation. Approximately half of the sampled populations contain polymorphism. Our genotyping protocol revealed mixed-genotype infection within a single host leaf to be common. Mixed infection has been proposed as one of the main drivers of pathogen evolution, and hence may be an important process in this pathosystem. Significance: The developed SNP panel offers exciting research perspectives for future studies in this well-characterized pathosystem. Also, the transcriptome provides an invaluable novel genomic resource for powdery mildews, which cause significant yield losses on commercially important crops annually. Furthermore, the features that render genetic studies in this system a challenge are shared with the majority of obligate parasitic species, and hence our results provide methodological insights from SNP calling to field sampling protocols for a wide range of biological systems. A	[Tollenaere, Charlotte; Susi, Hanna; Nokso-Koivisto, Jussi; Koskinen, Patrik; Tack, Ayco; Lehtonen, Rainer; Laine, Anna-Liisa] Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland; [Koskinen, Patrik; Auvinen, Petri; Paulin, Lars; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki	Laine, AL (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Laine, Anna-Liisa/B-1398-2016; Tack, Ayco/B-7120-2017; Frilander, Mikko J/B-6660-2009; Tollenaere, Charlotte/ABB-6175-2020	Auvinen, Petri/0000-0002-3947-4778; Laine, Anna-Liisa/0000-0002-0703-5850; Tack, Ayco/0000-0002-3550-1070; Frilander, Mikko J/0000-0002-1732-4808; Tollenaere, Charlotte/0000-0003-2045-2824; Koskinen, Patrik/0000-0003-1485-4990; Lehtonen, Rainer Juhani/0000-0002-8343-0318	Academy of Finland [250444, 136393, 133499]; European Research Council [PATHEVOL 281517]	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This work has been funded by the Academy of Finland (www.aka.fi/; Grant Nos 250444, 136393, 133499) and European Research Council (http://erc.europa.eu/; PATHEVOL 281517) grants to ALL. These funding sourced have covered the salary of ALL, CT, HS and AT as well as all laboratory costs and sampling costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Alizon S, 2008, AM NAT, V172, pE150, DOI 10.1086/590958; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Brewer MT, 2011, FUNGAL GENET BIOL, V48, P704, DOI 10.1016/j.fgb.2011.04.004; Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Giraud T, 2008, PARASITE, V15, P449, DOI 10.1051/parasite/2008153449; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Laine AL, 2008, ECOL LETT, V11, P327, DOI 10.1111/j.1461-0248.2007.01146.x; Linde CC, 2002, PHYTOPATHOLOGY, V92, P946, DOI 10.1094/PHYTO.2002.92.9.946; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mideo N, 2009, TRENDS PARASITOL, V25, P261, DOI 10.1016/j.pt.2009.03.001; Mori Y, 2000, MYCOLOGIA, V92, P74, DOI 10.2307/3761452; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Perez G, 2010, MOL ECOL, V19, P1801, DOI 10.1111/j.1365-294X.2010.04584.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; Salvaudon L, 2008, CURR OPIN PLANT BIOL, V11, P135, DOI 10.1016/j.pbi.2008.02.002; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Shama LNS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-278; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Tokarska M, 2009, HEREDITY, V103, P326, DOI 10.1038/hdy.2009.73; VANBAALEN M, 1995, TRENDS MICROBIOL, V3, P414, DOI 10.1016/S0966-842X(00)88991-X; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Webling R, 2012, FUNGAL GENETICS BIOL; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]	61	46	46	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52492	10.1371/journal.pone.0052492	http://dx.doi.org/10.1371/journal.pone.0052492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300684	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100053
J	Xu, QL; Shi, YL; Dadhwal, P; Liang, FT				Xu, Qilong; Shi, Yanlin; Dadhwal, Poonam; Liang, Fang Ting			RpoS Regulates Essential Virulence Factors Remaining to Be Identified in Borrelia burgdorferi	PLOS ONE			English	Article							SURFACE PROTEIN-C; BINDING-PROTEIN; INFECTIVITY; EXPRESSION; BBK32; OSPC	Background: Since the RpoN-RpoS regulatory network was revealed in the Lyme disease spirochete Borrelia burgdorferi a decade ago, both upstream and downstream of the pathway have been intensively investigated. While significant progress has been made into understanding of how the network is regulated, most notably, discovering a relationship of the network with Rrp2 and BosR, only three crucial virulence factors, including outer surface protein C (OspC) and decorin-binding proteins (Dbps) A and B, are associated with the pathway. Moreover, for more than 10 years no single RpoS-controlled gene has been found to be critical for infection, raising a question about whether additional RpoS-dependent virulence factors remain to be identified. Methodology/Principal Findings: The rpoS gene was deleted in B. burgdorferi; resulting mutants were modified to constitutively express all the known virulence factors, OspC, DbpA and DbpB. This genetic modification was unable to restore the rpoS mutant with infectivity. Conclusions/Significance: The inability to restore the rpoS mutant with infectivity by simultaneously over-expressing all the three virulence factors allows us to conclude RpoS also regulates essential genes that remain to be identified in B. burgdorferi.	[Xu, Qilong; Shi, Yanlin; Dadhwal, Poonam; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Liang, FT (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [RO1 AI077733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by RO1 AI077733 from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Banik S, 2011, INFECT IMMUN, V79, P1208, DOI 10.1128/IAI.01156-10; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Gautam A, 2008, MICROBIOL-SGM, V154, P275, DOI 10.1099/mic.0.2007/011676-0; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Samuels DS, 2009, MOL MICROBIOL, V74, P1295, DOI 10.1111/j.1365-2958.2009.06971.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shi YL, 2006, INFECT IMMUN, V74, P6509, DOI 10.1128/IAI.00740-06; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Xu H, INFECT IMMUN, V78, P2910; Xu H, PLOS PATHOG, V6; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100	30	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53212	10.1371/journal.pone.0053212	http://dx.doi.org/10.1371/journal.pone.0053212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300893	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100128
J	Jiao, S; Hsu, L; Berndt, S; Bezieau, S; Brenner, H; Buchanan, D; Caan, BJ; Campbell, PT; Carlson, CS; Casey, G; Chan, AT; Chang-Claude, J; Chanock, S; Conti, DV; Curtis, KR; Duggan, D; Gallinger, S; Gruber, SB; Harrison, TA; Hayes, RB; Henderson, BE; Hoffmeister, M; Hopper, JL; Hudson, TJ; Hutter, CM; Jackson, RD; Jenkins, MA; Kantor, ED; Kolonel, LN; Kury, S; Le Marchand, L; Lemire, M; Newcomb, PA; Potter, JD; Qu, CH; Rosse, SA; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Ulrich, CM; Zanke, BW; Peters, U				Jiao, Shuo; Hsu, Li; Berndt, Sonja; Bezieau, Stephane; Brenner, Hermann; Buchanan, Daniel; Caan, Bette J.; Campbell, Peter T.; Carlson, Christopher S.; Casey, Graham; Chan, Andrew T.; Chang-Claude, Jenny; Chanock, Stephen; Conti, David V.; Curtis, Keith R.; Duggan, David; Gallinger, Steven; Gruber, Stephen B.; Harrison, Tabitha A.; Hayes, Richard B.; Henderson, Brian E.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Hutter, Carolyn M.; Jackson, Rebecca D.; Jenkins, Mark A.; Kantor, Elizabeth D.; Kolonel, Laurence N.; Kuery, Sebastien; Le Marchand, Loic; Lemire, Mathieu; Newcomb, Polly A.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Schoen, Robert E.; Schumacher, Fred R.; Seminara, Daniela; Slattery, Martha L.; Ulrich, Cornelia M.; Zanke, Brent W.; Peters, Ulrike			Genome-Wide Search for Gene-Gene Interactions in Colorectal Cancer	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; ASSOCIATION SCAN; ENVIRONMENT INTERACTIONS; RANDOM FORESTS; HUMAN-DISEASES; VARIANTS; RISK; METAANALYSIS; EPISTASIS; SEROTONIN	Genome-wide association studies (GWAS) have successfully identified a number of single-nucleotide polymorphisms (SNPs) associated with colorectal cancer (CRC) risk. However, these susceptibility loci known today explain only a small fraction of the genetic risk. Gene-gene interaction (GxG) is considered to be one source of the missing heritability. To address this, we performed a genome-wide search for pair-wise GxG associated with CRC risk using 8,380 cases and 10,558 controls in the discovery phase and 2,527 cases and 2,658 controls in the replication phase. We developed a simple, but powerful method for testing interaction, which we term the Average Risk Due to Interaction (ARDI). With this method, we conducted a genome-wide search to identify SNPs showing evidence for GxG with previously identified CRC susceptibility loci from 14 independent regions. We also conducted a genome-wide search for GxG using the marginal association screening and examining interaction among SNPs that pass the screening threshold (p < 10(-4)). For the known locus rs10795668 (10p14), we found an interacting SNP rs367615 (5q21) with replication p = 0.01 and combined p = 4.19x10(-8). Among the top marginal SNPs after LD pruning (n = 163), we identified an interaction between rs1571218 (20p12.3) and rs10879357 (12q21.1) (nominal combined p = 2.51x10(-6); Bonferroni adjusted p = 0.03). Our study represents the first comprehensive search for GxG in CRC, and our results may provide new insight into the genetic etiology of CRC.	[Jiao, Shuo; Hsu, Li; Carlson, Christopher S.; Curtis, Keith R.; Harrison, Tabitha A.; Hutter, Carolyn M.; Kantor, Elizabeth D.; Newcomb, Polly A.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Ulrich, Cornelia M.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Berndt, Sonja; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bezieau, Stephane; Kuery, Sebastien] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Bezieau, Stephane; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Buchanan, Daniel] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Caan, Bette J.] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; [Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Carlson, Christopher S.; Newcomb, Polly A.; Potter, John D.; Ulrich, Cornelia M.; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Casey, Graham; Conti, David V.; Gruber, Stephen B.; Henderson, Brian E.; Schumacher, Fred R.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Gallinger, Steven] Toronto Gen Hosp, Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Hayes, Richard B.] NYU, Sch Med, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Ulrich, Cornelia M.] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Zanke, Brent W.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); QIMR Berghofer Medical Research Institute; Kaiser Permanente; American Cancer Society; University of Washington; University of Washington Seattle; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; New York University; University of Melbourne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University System of Ohio; Ohio State University; Cancer Research Center of Hawaii; University of Hawaii System; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Ottawa; Ottawa Hospital Research Institute	Jiao, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	sjiao@fhcrc.org	KÜRY, Sébastien/G-5971-2015; Brenner, Hermann/B-4627-2017; Gallinger, Steven/E-4575-2013; Chan, Andrew T/P-8293-2014; Brenner, Hermann/ABE-6383-2020; Schumacher, Fredrick/R-6043-2019; Jenkins, Mark/P-7803-2015; Berndt, Sonja I/J-8423-2016; Hoffmeister, Michael/B-5745-2012; Bézieau, stéphane/G-5621-2015; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022	KÜRY, Sébastien/0000-0001-5497-0465; Brenner, Hermann/0000-0002-6129-1572; Chan, Andrew T/0000-0001-7284-6767; Brenner, Hermann/0000-0002-6129-1572; Schumacher, Fredrick/0000-0002-3073-7463; Jenkins, Mark/0000-0002-8964-6160; Hoffmeister, Michael/0000-0002-8307-3197; Bézieau, stéphane/0000-0003-0095-1319; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Potter, John/0000-0001-5439-1500; Kantor, Elizabeth/0000-0002-9124-5323; Buchanan, Daniel/0000-0003-2225-6675; Caan, Bette/0000-0002-5803-310X; Harrison, Tabitha/0000-0002-4173-7530	Hospital Clinical Research Program (PHRC); Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health [U01 CA074783, U01 CA122839]; Ontario Research Fund [GL2]; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; National Cancer Institute [R01 CA60987]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Australasian Colorectal Cancer Family Registry [U01 CA097735]; Seattle Colorectal Cancer Family Registry [U01 CA074794]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [R01 CA48998, U01 CA137088, R01 CA059045]; National Institutes of Health [P01 CA 055075, R01 137178, P50 CA 127003, P01 CA 087969, CA42182, R01 CA076366]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; Intramural Research Program of the National Cancer Institute; National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI] [Z01 CP 010200]; National Cancer Institute; Gene Environment Association Studies, GENEVA Coordinating Center [U01 HG004446]; NIH GEI [U01 HG 004438]; National Institutes of Health from the National Cancer Institute and Office of Dietary Supplements [K05 CA154337]; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, 268200764316C];  [R37 CA54281];  [P01 CA033619];  [R01 CA63464]; NATIONAL CANCER INSTITUTE [R01CA060987, U01CA097735, R37CA054281, U01CA137088, P01CA033619, K05CA154337, R01CA059045, K22CA095011, R01CA048998, P50CA127003, U19CA148107, P01CA055075, U01CA074794, R01CA076366, R01CA042182, R01CA063464, P30CA015704, P01CA087969, U01CA122839, U01CA074783, Z01CP010200] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014358] Funding Source: NIH RePORTER	Hospital Clinical Research Program (PHRC); Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australasian Colorectal Cancer Family Registry; Seattle Colorectal Cancer Family Registry; Ontario Registry for Studies of Familial Colorectal Cancer; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI]; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gene Environment Association Studies, GENEVA Coordinating Center; NIH GEI; National Institutes of Health from the National Cancer Institute and Office of Dietary Supplements; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ASTERISK was funded by a Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). ARCTIC is partly supported by the National Cancer Institute, National Institutes of Health through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section below. ARCTIC is also supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. TJH and BWZ are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Economic Development and Innovation. COLO2&3 is supported by the National Cancer Institute (R01 CA60987). CCFR is supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011 and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. This genome wide scan was supported by the National Cancer Institute, National Institutes of Health by U01 CA122839. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government or the CFR. The following Colon CFR centers contributed data to this manuscript and were supported by the following sources: Australasian Colorectal Cancer Family Registry (U01 CA097735), Seattle Colorectal Cancer Family Registry (U01 CA074794) and Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783). DACHS was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS was supported by the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (R01 CA48998 to MLS). GECCO is supported by National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088). Funding for the genome-wide scan of DALS, PLCO, and WHI was provided by the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (R01 CA059045). HPFS, NHS, PHS: The National Institutes of Health supported HPFS (P01 CA 055075, R01 137178, P50 CA 127003), NHS (R01 137178, P50 CA 127003, P01 CA 087969), and PHS (CA42182). MEC is supported by R37 CA54281, P01 CA033619, and R01 CA63464. PLCO was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer scan, supported by the Intramural Research Program of the National Cancer Institute. The datasets used in this analysis were accessed with appropriate approval through the dbGaP online resource (http://www.cgems.cancer.gov/data_acess.html) through dbGaP accession number 000207v.1p1.c1.; (National Cancer Institute (2009) Cancer Genetic Markers of Susceptibility (CGEMS) data website, http://cgems.cancer.gov/data_access.html; Yeager et al. 2007). Control samples were also genotyped as part of the GWAS of Lung Cancer and Smoking (Landi et al. 2009). Funding for this work was provided through the National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI] (Z01 CP 010200). The human subjects participating in the GWAS are derived from the Prostate, Lung, Colon and Ovarian Screening Trial and the study is supported by intramural resources of the National Cancer Institute. Assistance with genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies, GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01 HG 004438). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000093. PMH was supported by the National Institutes of Health (R01 CA076366 to PAN). VITAL was supported, in part, by the National Institutes of Health (K05 CA154337) from the National Cancer Institute and Office of Dietary Supplements. WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, and 268200764316C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee S, 2010, CGEN R PACKAGE ANAL; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; CATTANEO MG, 1993, CANCER RES, V53, P5566; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Gogele M, 2012, AM J EPIDEMIOL, V175, P739, DOI 10.1093/aje/kwr385; Hambek M, ANTICANCER RES, V26, P1091; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hsu L, 2012, GENET EPIDEMIOL, V36, P183, DOI 10.1002/gepi.21610; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lignitto L, 2011, NAT CELL BIOL, V13, P412, DOI 10.1038/ncb2209; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Prentice RL, 2011, J NATL CANCER I, V103, P1209, DOI 10.1093/jnci/djr279; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Siddiqui EJ, 2006, BJU INT, V97, P634, DOI 10.1111/j.1464-410X.2006.06056.x; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tao S, 2012, HUM GENET, V131, P1225, DOI 10.1007/s00439-012-1148-4; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; VanderWeele TJ, 2011, ANN HUM GENET, V75, P146, DOI 10.1111/j.1469-1809.2010.00600.x; VanderWeele TJ, 2010, GENET EPIDEMIOL, V34, P327, DOI 10.1002/gepi.20484; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	64	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52535	10.1371/journal.pone.0052535	http://dx.doi.org/10.1371/journal.pone.0052535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300701	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800103
J	Lindner, R; Friedel, CC				Lindner, Robert; Friedel, Caroline C.			A Comprehensive Evaluation of Alignment Algorithms in the Context of RNA-Seq	PLOS ONE			English	Article							SPLICE JUNCTIONS; READ ALIGNMENT; TOOL; ULTRAFAST	Transcriptome sequencing (RNA-Seq) overcomes limitations of previously used RNA quantification methods and provides one experimental framework for both high-throughput characterization and quantification of transcripts at the nucleotide level. The first step and a major challenge in the analysis of such experiments is the mapping of sequencing reads to a transcriptomic origin including the identification of splicing events. In recent years, a large number of such mapping algorithms have been developed, all of which have in common that they require algorithms for aligning a vast number of reads to genomic or transcriptomic sequences. Although the FM-index based aligner Bowtie has become a de facto standard within mapping pipelines, a much larger number of possible alignment algorithms have been developed also including other variants of FM-index based aligners. Accordingly, developers and users of RNA-seq mapping pipelines have the choice among a large number of available alignment algorithms. To provide guidance in the choice of alignment algorithms for these purposes, we evaluated the performance of 14 widely used alignment programs from three different algorithmic classes: algorithms using either hashing of the reference transcriptome, hashing of reads, or a compressed FM-index representation of the genome. Here, special emphasis was placed on both precision and recall and the performance for different read lengths and numbers of mismatches and indels in a read. Our results clearly showed the significant reduction in memory footprint and runtime provided by FM-index based aligners at a precision and recall comparable to the best hash table based aligners. Furthermore, the recently developed Bowtie 2 alignment algorithm shows a remarkable tolerance to both sequencing errors and indels, thus, essentially making hash-based aligners obsolete.	[Lindner, Robert] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Friedel, Caroline C.] Univ Munich, Inst Informat, D-80539 Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich	Friedel, CC (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	caroline.friedel@lmu.de	Friedel, Caroline/AAG-5017-2019	Friedel, Caroline/0000-0003-3569-4877	DFG [FR2938/1-1]	DFG(German Research Foundation (DFG))	The study was partially supported by DFG (www.dfg.de/) grant FR2938/1-1 to CCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bonfert T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S9; Burrows M, 1994, BLOCK SORTING LOSSLE; Chen LY, 2011, NUCL ACIDS RES; Clement NL, 2010, BIOINFORMATICS, V26, P38, DOI 10.1093/bioinformatics/btp614; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	21	48	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52403	10.1371/journal.pone.0052403	http://dx.doi.org/10.1371/journal.pone.0052403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300661	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800080
J	Palagi, E; Cordoni, G				Palagi, Elisabetta; Cordoni, Giada			The Right Time to Happen: Play Developmental Divergence in the Two Pan Species	PLOS ONE			English	Article							SOCIAL PLAY; CHIMPANZEES; BONOBOS; PANISCUS; EVOLUTION; SEX	Bonobos, compared to chimpanzees, are highly motivated to play as adults. Therefore, it is interesting to compare the two species at earlier developmental stages to determine how and when these differences arise. We measured and compared some play parameters between the two species including frequency, number of partners (solitary, dyadic, and polyadic play), session length, and escalation into overt aggression. Since solitary play has a role in developing cognitive and physical skills, it is not surprising that chimpanzees and bonobos share similar developmental trajectories in the motivation to engage in this activity. The striking divergence in play developmental pathways emerged for social play. Infants of the two species showed comparable social play levels, which began to diverge during the juvenile period, a 'timing hotspot' for play development. Compared to chimpanzees, social play sessions in juvenile bonobos escalated less frequently into overt aggression, lasted longer, and frequently involved more than two partners concurrently (polyadic play). In this view, play fighting in juvenile bonobos seems to maintain a cooperative mood, whereas in juvenile chimpanzees it acquires more competitive elements. The retention of juvenile traits into adulthood typical of bonobos can be due to a developmental delay in social inhibition. Our findings show that the divergence of play ontogenetic pathways between the two Pan species and the relative emergence of play neotenic traits in bonobos can be detected before individuals reach sexual maturity. The high play motivation showed by adult bonobos compared to chimpanzees is probably the result of a long developmental process, rooted in the delicate transitional phase, which leads subjects from infancy to juvenility.	[Palagi, Elisabetta; Cordoni, Giada] Univ Pisa, Museo Storia Nat & Terr, Pisa, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Cordoni, Giada/ABE-2242-2020	Cordoni, Giada/0000-0001-7093-0025				Brosnan SF, 2010, CURR BIOL, V20, pR98, DOI 10.1016/j.cub.2009.12.009; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; COPPINGER R, 1987, ETHOLOGY, V75, P89; Cordoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027344; De Waal, 1989, PEACEMAKING PRIMATES; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Doran Diane M., 1994, P93; ENOMOTO T, 1990, PRIMATES, V31, P469, DOI 10.1007/BF02382531; Fagen R. M., 2011, OXFORD HDB DEV PLAY, P83; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Fry D., 2005, NATURE PLAY GREAT AP, P54; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gosso Yumi, 2005, NATURE PLAY GREAT AP, P213; Gruber T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00128; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; HAYAKI H, 1985, Primates, V26, P343, DOI 10.1007/BF02382452; Kahlenberg SM, 2010, CURR BIOL, V20, pR1067, DOI 10.1016/j.cub.2010.11.024; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; MARTIN P, 1985, ADV STUD BEHAV, V15, P59, DOI 10.1016/S0065-3454(08)60487-8; McKinney ML, 1998, BIOSCIENCE, V48, P109, DOI 10.2307/1313136; MOREY DF, 1994, AM SCI, V82, P336; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Palagi E, 2008, ANIM BEHAV, V75, P887, DOI 10.1016/j.anbehav.2007.07.016; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2007, ISSUES PSYCHOL MOTIV, P157; Palagi E, HDB SOLITUDE PSYCHOL; Palagi E, 2007, AM J PHYS ANTHROPOL, V134, P219, DOI 10.1002/ajpa.20657; PAQUETTE D, 1994, AGGRESSIVE BEHAV, V20, P49, DOI 10.1002/1098-2337(1994)20:1<49::AID-AB2480200107>3.0.CO;2-C; PARKER ST, 1999, ORIGINS INTELLIGENCE; Pellegrini AD., 2009, ROLE PLAY HUMAN DEV, DOI [10.1093/acprof:oso/9780195367324.001.0001, DOI 10.1093/ACPROF:OSO/9780195367324.001.0001]; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Power T. G., 2000, PLAY EXPLORATION CHI; Ramsey Jacklyn K., 2005, P89; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Smith P. K., 2010, CHILDREN AND PLAY; Tratz E., 1954, Saugetierkundliche Mitteilungen, V2, P97; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5; Wrangham R., 1996, DEMONIC MALES; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089	43	38	38	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52767	10.1371/journal.pone.0052767	http://dx.doi.org/10.1371/journal.pone.0052767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300765	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800140
J	Roy, JS; O'Connor, D; Green, DM				Roy, Jean-Sebastien; O'Connor, David; Green, David M.			Oscillation of an Anuran Hybrid Zone: Morphological Evidence Spanning 50 Years	PLOS ONE			English	Article							TOADS BUFO-AMERICANUS; ALLOZYME VARIATION; GENETIC-STRUCTURE; PRESERVATION; MORPHOMETRICS; MAINTENANCE; MOVEMENT; MODELS	Background: The hybrid zone between the primarily forest-dwelling American toad, Anaxyrus americanus, and the prairie-adapted Canadian toad, A. hemiophrys, in southeastern Manitoba is known to have shifted its position during the past 50 years. Hybrid zones are areas of interbreeding between species and their movement across a landscape should reflect their underlying dynamics and environmental change. However, empirical demonstrations of hybrid zone movements over long periods of time are rare. This hybrid zone is dominated by individuals of intermediate morphology and genetic composition. We sought to determine if it had continued to move and if that movement was associated with shifts in habitat, as predicted. Methodology/Principle Findings: We used variation in the toads' most diagnostic morphological feature, the separation between their interorbital cranial crests, to determine the geographic position of the hybrid zone center at four times between 1960 and 2009 using maximum likelihood methods. The hybrid zone center moved west by 38 km over 19 years and then east again by 10 km over the succeeding 29 years. The position of the hybrid zone did not track either the direction or the magnitude of movement of the forest-prairie habitat transition over the same time period. Conclusions/Significance: This is the first reported evidence of oscillation in the position of a hybrid zone. The back and forth movement indicates that neither species maintains a selective advantage over the other in the long term. However, the movement of the hybrid zone was not bounded by the breadth of the habitat transition. Its oscillation suggests that the hybrid zone is better described as being elastically tethered to the habitat transition.	[Roy, Jean-Sebastien; O'Connor, David; Green, David M.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	McGill University	Green, DM (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	david.m.green@mcgill.ca			NSERC Canada Discovery Grant	NSERC Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by an NSERC Canada Discovery Grant to DMG. (http://www.nserc-crsng.gc.ca/Index_eng.asp.) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 1998, ANAL 1 3 APPL ANAL H; BERT TM, 1995, EVOLUTION, V49, P276, DOI 10.1111/j.1558-5646.1995.tb02240.x; Blum MJ, 2002, EVOLUTION, V56, P1992, DOI 10.1111/j.0014-3820.2002.tb00125.x; Bronson CL, 2003, EVOLUTION, V57, P630; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Buggs RJA, 2006, CURR BIOL, V16, P996, DOI 10.1016/j.cub.2006.03.093; Charpentier MJE, 2012, MOL ECOL, V21, P715, DOI 10.1111/j.1365-294X.2011.05302.x; Cook FR, 1983, NATL MUS CANADA PUBL, V3, P1; Dasmahapatra KK, 2002, EVOLUTION, V56, P741, DOI 10.1111/j.0014-3820.2002.tb01385.x; Endler J.A., 1977, Monographs in Population Biology, pi; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Good TP, 2000, EVOLUTION, V54, P1774; Goodisman MAD, 1998, EVOLUTION, V52, P1423, DOI 10.1111/j.1558-5646.1998.tb02024.x; GREEN DM, 1983, HERPETOLOGICA, V39, P28; Green DM, 1997, HERPETOLOGICA, V53, P218; Harrison RG, 1993, HYBRID ZONES EVOLUTI; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HENRICH T W, 1968, Herpetologica, V24, P1; Krosby M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014164; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; LEE JC, 1982, SYST ZOOL, V31, P266, DOI 10.2307/2413232; Lee JH, 2012, ICHTHYOL RES, V59, P49, DOI 10.1007/s10228-011-0255-x; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; McLachlan G. J., 1992, DISCRIMINANT ANAL ST, DOI DOI 10.1002/0471725293; Melo MT, 2010, ZOOLOGIA-CURITIBA, V27, P892, DOI 10.1590/S1984-46702010000600009; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOORE WS, 1977, Q REV BIOL, V52, P263, DOI 10.1086/409995; MOORE WS, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P196; Phillips BL, 2004, EVOLUTION, V58, P1536; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Reudink MW, 2007, AUK, V124, P463, DOI 10.1642/0004-8038(2007)124[463:SADOTH]2.0.CO;2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; Toews DPL, 2011, J AVIAN BIOL, V42, P434, DOI 10.1111/j.1600-048X.2011.05360.x; Vervust B, 2009, AMPHIBIA-REPTILIA, V30, P321, DOI 10.1163/156853809788795209; Weisstein EW, 2009, GNOMONIC PROJECTION; Wilcox CD, 2002, UTHSCSA IMAGETOOL WI	41	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52819	10.1371/journal.pone.0052819	http://dx.doi.org/10.1371/journal.pone.0052819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300785	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800152
J	Sano, H; Kunwar, PS; Renault, AD; Barbosa, V; Clark, IBN; Ishihara, S; Sugimura, K; Lehmann, R				Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Clark, Ivan B. N.; Ishihara, Shuji; Sugimura, Kaoru; Lehmann, Ruth			The Drosophila Actin Regulator ENABLED Regulates Cell Shape and Orientation during Gonad Morphogenesis	PLOS ONE			English	Article							ENA/VASP PROTEINS; TYROSINE KINASE; AXON GUIDANCE; E-CADHERIN; FIBROBLAST MOTILITY; EMBRYONIC GONAD; GENE-EXPRESSION; ROBO RECEPTORS; BARBED END; FAT-BODY	Organs develop distinctive morphologies to fulfill their unique functions. We used Drosophila embryonic gonads as a model to study how two different cell lineages, primordial germ cells (PGCs) and somatic gonadal precursors (SGPs), combine to form one organ. We developed a membrane GFP marker to image SGP behaviors live. These studies show that a combination of SGP cell shape changes and inward movement of anterior and posterior SGPs leads to the compaction of the spherical gonad. This process is disrupted in mutants of the actin regulator, enabled (ena). We show that Ena coordinates these cell shape changes and the inward movement of the SGPs, and Ena affects the intracellular localization of DE-cadherin (DE-cad). Mathematical simulation based on these observations suggests that changes in DE-cad localization can generate the forces needed to compact an elongated structure into a sphere. We propose that Ena regulates force balance in the SGPs by sequestering DE-cad, leading to the morphogenetic movement required for gonad compaction.	[Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Lehmann, Ruth] NYU Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, HHMI, New York, NY 10016 USA; [Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Lehmann, Ruth] NYU Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, Dev Genet Program, New York, NY 10016 USA; [Clark, Ivan B. N.] Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland; [Ishihara, Shuji] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Ishihara, Shuji] PRESTO JST, Saitama, Japan; [Sugimura, Kaoru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Sugimura, Kaoru] RIKEN Brain Sci Inst, Saitama, Japan	Howard Hughes Medical Institute; New York University; New York University; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; RIKEN	Sano, H (corresponding author), Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 830, Japan.	sano_hiroko@kurume-u.ac.jp		Renault, Andrew/0000-0003-4313-9726; Sugimura, Kaoru/0000-0002-3076-7347; Lehmann, Ruth/0000-0002-8454-5651; Sano, Hiroko/0000-0001-9834-647X	JSPS; MEXT; PRESTO from JSPS; NHI [HD3407064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900, R37HD041900] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from JSPS; NHI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Program for Researchers to Promote Creative and Independent Research from JSPS (H. S.), a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (H. S. and K. S.), PRESTO from JSPS (S. I.), and a NHI grant HD3407064 (R. L.). R. L. is an HHMI investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 1998, DEVELOPMENT, V125, P655; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Clark IBN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-52; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kirby RJ, 2001, CURR BIOL, V11, P1044, DOI 10.1016/S0960-9822(01)00319-0; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Moore LA, 1998, DEVELOPMENT, V125, P837; Moore LA, 1998, DEVELOPMENT, V125, P667; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Riechmann V, 1998, DEVELOPMENT, V125, P713; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Sonnenblick BP, 1941, P NATL ACAD SCI USA, V27, P484, DOI 10.1073/pnas.27.10.484; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tucker PK, 2011, DIS MODEL MECH, V4, P126, DOI 10.1242/dmm.005694; Van Doren M, 1998, CURR BIOL, V8, P243; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; ZHAO DB, 1988, EMBO J, V7, P1115, DOI 10.1002/j.1460-2075.1988.tb02920.x	57	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52649	10.1371/journal.pone.0052649	http://dx.doi.org/10.1371/journal.pone.0052649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300733	Green Published, gold			2022-12-27	WOS:000313618800120
J	Setati, ME; Jacobson, D; Andong, UC; Bauer, F				Setati, Mathabatha Evodia; Jacobson, Daniel; Andong, Ursula-Claire; Bauer, Florian			The Vineyard Yeast Microbiome, a Mixed Model Microbial Map	PLOS ONE			English	Article							ASCOMYCETOUS YEAST; GRAPE; IDENTIFICATION; POPULATIONS; DIVERSITY; ECOLOGY; FUNGUS; SOIL	Vineyards harbour a wide variety of microorganisms that play a pivotal role in pre- and post-harvest grape quality and will contribute significantly to the final aromatic properties of wine. The aim of the current study was to investigate the spatial distribution of microbial communities within and between individual vineyard management units. For the first time in such a study, we applied the Theory of Sampling (TOS) to sample gapes from adjacent and well established commercial vineyards within the same terroir unit and from several sampling points within each individual vineyard. Cultivation-based and molecular data sets were generated to capture the spatial heterogeneity in microbial populations within and between vineyards and analysed with novel mixed-model networks, which combine sample correlations and microbial community distribution probabilities. The data demonstrate that farming systems have a significant impact on fungal diversity but more importantly that there is significant species heterogeneity between samples in the same vineyard. Cultivation-based methods confirmed that while the same oxidative yeast species dominated in all vineyards, the least treated vineyard displayed significantly higher species richness, including many yeasts with biocontrol potential. The cultivatable yeast population was not fully representative of the more complex populations seen with molecular methods, and only the molecular data allowed discrimination amongst farming practices with multivariate and network analysis methods. Importantly, yeast species distribution is subject to significant intra-vineyard spatial fluctuations and the frequently reported heterogeneity of tank samples of grapes harvested from single vineyards at the same stage of ripeness might therefore, at least in part, be due to the differing microbiota in different sections of the vineyard.	[Setati, Mathabatha Evodia; Jacobson, Daniel; Andong, Ursula-Claire; Bauer, Florian] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University	Setati, ME (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa.	setati@sun.ac.za	Bauer, Florian/A-1078-2013	Bauer, Florian/0000-0001-5764-4542; Jacobson, Daniel/0000-0002-9822-8251; Setati, Mathabatha/0000-0002-5450-009X	Stellenbosch University (Subcom- B fund); WineTech; National Research Foundation (THRIP programme)	Stellenbosch University (Subcom- B fund); WineTech; National Research Foundation (THRIP programme)	This work was supported by Stellenbosch University (Subcom- B fund), WineTech and the National Research Foundation (THRIP programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, STAT DAT AN SOFTW SY; Barata A, 2008, J APPL MICROBIOL, V104, P1182, DOI 10.1111/j.1365-2672.2007.03631.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barata A, 2008, FEMS YEAST RES, V8, P1008, DOI 10.1111/j.1567-1364.2008.00399.x; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Barata A, 2012, INT J FOOD MICROBIOL, V154, P152, DOI 10.1016/j.ijfoodmicro.2011.12.029; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Combina M, 2005, J APPL MICROBIOL, V98, P1055, DOI 10.1111/j.1365-2672.2005.02540.x; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; Demeter, 2010, DEM PROD STAND US DE; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Esbensen K.H., 2004, CHEMOMETR INTELL LAB, V74, P236; Esbensen KH, 2010, PROCESS ANAL TECHNOL; Esbensen KH, 2007, CHEMOMETR INTELL LAB, V88, P41, DOI 10.1016/j.chemolab.2006.09.011; Esbensen KH, 2012, TRAC-TREND ANAL CHEM, V32, P154, DOI 10.1016/j.trac.2011.09.008; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Gerhards D, 2011, 9 INT S OEN BORD, P263; Gy P.M., 1998, SAMPLING ANAL PURPOS; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoffman S, 2003, CURRENT PROTOCOLS MO; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Infruitec-Nietvoorbij Agricultural Research Council, 2010, INT PROD WIN GUID FA; Lamine C, 2011, J RURAL STUD, V27, P209, DOI 10.1016/j.jrurstud.2011.02.001; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Nisiotou AA, 2008, INT J SYST EVOL MICR, V58, P1263, DOI 10.1099/ijs.0.65649-0; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Paz Z, 2007, J APPL MICROBIOL, V103, P2570, DOI 10.1111/j.1365-2672.2007.03512.x; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pitard F.F., 1993, PIERRE GYS SAMPLING, Vsecond; Prakitchaiwattana CJ, 2004, FEMS YEAST RES, V4, P865, DOI 10.1016/j.femsyr.2004.05.004; Probst B, 2008, BIOL FERT SOILS, V44, P443, DOI 10.1007/s00374-007-0225-7; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Reeve JR, 2010, BIORESOURCE TECHNOL, V101, P5658, DOI 10.1016/j.biortech.2010.01.144; Reeve JR, 2005, AM J ENOL VITICULT, V56, P367; REGUEIRO LA, 1993, AM J ENOL VITICULT, V44, P405; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; Sabate J, 2002, MICROBIOL RES, V157, P267, DOI 10.1078/0944-5013-00163; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Schwartz A., 1993, South African Journal for Enology and Viticulture, V14, P16; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slabbert E, 2010, S AFR J SCI, V106, P52, DOI 10.4102/sajs.v106i7/8.329; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Sztejnberg A, 2004, CROP PROT, V23, P1125, DOI 10.1016/j.cropro.2004.04.004; Tofalo R, 2011, ANN MICROBIOL, V61, P57, DOI 10.1007/s13213-010-0102-8	46	119	120	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52609	10.1371/journal.pone.0052609	http://dx.doi.org/10.1371/journal.pone.0052609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300721	Green Published, gold			2022-12-27	WOS:000313618800112
J	Brown, TM; Allen, AE; al-Enezi, J; Wynne, J; Schlangen, L; Hommes, V; Lucas, RJ				Brown, Timothy M.; Allen, Annette E.; al-Enezi, Jazi; Wynne, Jonathan; Schlangen, Luc; Hommes, Vanja; Lucas, Robert J.			The Melanopic Sensitivity Function Accounts for Melanopsin-Driven Responses in Mice under Diverse Lighting Conditions	PLOS ONE			English	Article							ACTION SPECTRUM; GANGLION-CELLS; IN-VIVO; BISTABILITY; PHOTORECEPTORS; HUMANS; VISION; RETINA; SYSTEM; SLEEP	In addition to rods and cones, photoreception in mammals extends to a third retinal cell type expressing the photopigment melanopsin. The influences of this novel opsin are widespread, ranging from pupillary and circadian responses to brightness perception, yet established approaches to quantifying the biological effects of light do not adequately account for melanopsin sensitivity. We have recently proposed a novel metric, the melanopic sensitivity function (V-Z lambda), to address this deficiency. Here, we further validate this new measure with a variety of tests based on potential barriers to its applicability identified in the literature or relating to obvious practical benefits. Using electrophysiogical approaches and pupillometry, initially in rodless+coneless mice, our data demonstrate that under a very wide range of different conditions (including switching between stimuli with highly divergent spectral content) the V-Z lambda function provides an accurate prediction of the sensitivity of melanopsin-dependent responses. We further show that V-Z lambda provides the best available description of the spectral sensitivity of at least one aspect of the visual response in mice with functional rods and cones: tonic firing activity in the lateral geniculate nuclei. Together, these data establish V-Z lambda as an important new approach for light measurement with widespread practical utility.	[Brown, Timothy M.; Allen, Annette E.; al-Enezi, Jazi; Wynne, Jonathan; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Schlangen, Luc] Philips Lighting, Eindhoven, Netherlands; [Hommes, Vanja] Philips Consumer Lifestyle, Drachten, Netherlands	University of Manchester; Philips; Philips	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Robert.lucas@manchester.ac.uk		Brown, Timothy/0000-0002-5625-4750; Alenezi, Jazi/0000-0002-0275-5437; Lucas, Robert/0000-0002-1088-8029; Schlangen, Luc/0000-0002-8424-7240; Allen, Annette/0000-0003-0214-7076	European Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council (UK); Philips Lighting (the Netherlands); The Cultural Office of the State of Kuwait; BBSRC [BB/I017836/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017836/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Philips Lighting (the Netherlands)(Netherlands Government); The Cultural Office of the State of Kuwait; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council, Wellcome Trust, Biotechnology and Biological Sciences Research Council (UK), Philips Lighting (the Netherlands) and The Cultural Office of the State of Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi Y, 2006, ENERG BUILDINGS, V38, P588, DOI 10.1016/j.enbuild.2005.09.005; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Berman S. M., 1990, Lighting Research and Technology, V22, P37; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brown TM, 2012, CURR BIOL, V22, P1134, DOI 10.1016/j.cub.2012.04.039; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Cooper HM, 2008, J BIOL RHYTHM, V23, P392, DOI 10.1177/0748730408323064; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HARRINGTON RE, 1954, J OPT SOC AM, V44, P113, DOI 10.1364/JOSA.44.000113; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; MINKE B, 1978, BIOL CYBERN, V30, P33, DOI 10.1007/BF00365481; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Rahman SA, 2008, ENDOCRINOLOGY, V149, P6125, DOI 10.1210/en.2007-1742; Rollag MD, 2008, J BIOL RHYTHM, V23, P396, DOI 10.1177/0748730408323067; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shichida Y, 2012, BIOCHEMISTRY; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; STABELL U, 1981, J OPT SOC AM, V71, P841, DOI 10.1364/JOSA.71.000841; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Vienot F, 2009, J MOD OPTIC, V56, P1433, DOI 10.1080/09500340903151278	34	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53583	10.1371/journal.pone.0053583	http://dx.doi.org/10.1371/journal.pone.0053583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301090	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000069
J	Kovacs, AT; Eckhardt, TH; van Kranenburg, R; Kuipers, OP				Kovacs, Akos T.; Eckhardt, Tom H.; van Kranenburg, Richard; Kuipers, Oscar P.			Functional Analysis of the ComK Protein of Bacillus coagulans	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; NATURAL GENETIC-TRANSFORMATION; SUBTILIS K-STATE; BIOFILM FORMATION; GENOME SEQUENCE; BINDING-SITE; DNA UPTAKE; EXPRESSION; ACTIVATION; ACID	The genes for DNA uptake and recombination in Bacilli are commonly regulated by the transcriptional factor ComK. We have identified a ComK homologue in Bacillus coagulans, an industrial relevant organism that is recalcitrant for transformation. Introduction of B. coagulans comK gene under its own promoter region into Bacillus subtilis comK strain results in low transcriptional induction of the late competence gene comGA, but lacking bistable expression. The promoter regions of B. coagulans comK and the comGA genes are recognized in B. subtilis and expression from these promoters is activated by B. subtilis ComK. Purified ComK protein of B. coagulans showed DNA-binding ability in gel retardation assays with B. subtilis- and B. coagulans-derived probes. These experiments suggest that the function of B. coagulans ComK is similar to that of ComK of B. subtilis. When its own comK is overexpressed in B. coagulans the comGA gene expression increases 40-fold, while the expression of another late competence gene, comC is not elevated and no reproducible DNA-uptake could be observed under these conditions. Our results demonstrate that B. coagulans ComK can recognize several B. subtilis comK-responsive elements, and vice versa, but indicate that the activation of the transcription of complete sets of genes coding for a putative DNA uptake apparatus in B. coagulans might differ from that of B. subtilis.	[Kovacs, Akos T.; Eckhardt, Tom H.; Kuipers, Oscar P.] Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [van Kranenburg, Richard] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Groningen, Netherlands	University of Groningen; Wageningen University & Research	Kuipers, OP (corresponding author), Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Kovács, Ákos T/A-9433-2015	Kuipers, Oscar/0000-0001-5596-7735; Kovács, Ákos T/0000-0002-4465-1636; van Kranenburg, Richard/0000-0001-5856-1546	SenterNovem [IS044081]	SenterNovem	Part of this work was financially supported by a SenterNovem subsidy IS044081. This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; ALBANO M, 1987, J BACTERIOL, V169, P3110, DOI 10.1128/jb.169.7.3110-3117.1987; Ashikaga S, 2000, J BACTERIOL, V182, P2411, DOI 10.1128/JB.182.9.2411-2415.2000; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Blomqvist T, 2006, APPL ENVIRON MICROB, V72, P6751, DOI 10.1128/AEM.01156-06; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Doron SI, 2008, J CLIN GASTROENTEROL, V42, pS58, DOI 10.1097/MCG.0b013e3181618ab7; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; GASSON MJ, 1983, J BACTERIOL, V154, P1; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P5046, DOI 10.1128/AEM.00660-10; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kovacs AT, 2010, APPL ENVIRON MICROB, V76, P4085, DOI 10.1128/AEM.03060-09; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mellegard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024304; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009724; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Oomes SJCM, 2007, INT J FOOD MICROBIOL, V120, P85, DOI 10.1016/j.ijfoodmicro.2007.06.013; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Rhee M, 2011, STANDARDS GENOMIC SC, V5; Rhee MS, 2007, PLASMID, V58, P13, DOI 10.1016/j.plasmid.2006.11.006; Sambrook J., 2001, MOL CLONING LAB MANU; Smits WK, 2007, MOL MICROBIOL, V64, P368, DOI 10.1111/j.1365-2958.2007.05662.x; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Su F, 2011, J BACTERIOL, V193, P6398, DOI 10.1128/JB.06157-11; Su F, 2011, J BACTERIOL, V193, P4563, DOI 10.1128/JB.05378-11; Susanna KA, 2006, MICROBIOL-SGM, V152, P473, DOI 10.1099/mic.0.28357-0; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; Susanna KA, 2007, J BACTERIOL, V189, P4718, DOI 10.1128/JB.00281-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; Turgay K, 1998, EMBO J, V17, P6730; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; VENEMA G, 1965, J BACTERIOL, V89, P1250, DOI 10.1128/JB.89.5.1250-1255.1965; Wang QZ, 2011, P NATL ACAD SCI USA, V108, P18920, DOI 10.1073/pnas.1111085108; Woodbury RL, 2006, RES MICROBIOL, V157, P851, DOI 10.1016/j.resmic.2006.07.002; Wydau S, 2006, FEMS MICROBIOL LETT, V257, P32, DOI 10.1111/j.1574-6968.2006.00141.x	63	6	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53471	10.1371/journal.pone.0053471	http://dx.doi.org/10.1371/journal.pone.0053471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301076	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000060
J	Smail-Faugeron, V; Chabouis, HF; Durieux, P; Attal, JP; Muller-Bolla, M; Courson, F				Smail-Faugeron, Violaine; Chabouis, Helene Fron; Durieux, Pierre; Attal, Jean-Pierre; Muller-Bolla, Michele; Courson, Frederic			Development of a Core Set of Outcomes for Randomized Controlled Trials with Multiple Outcomes - Example of Pulp Treatments of Primary Teeth for Extensive Decay in Children	PLOS ONE			English	Article							CLINICAL-TRIALS; REPORTING BIAS; END-POINTS; SUCCESS	Objectives: Evidence-based comparisons of interventions can be challenging because of the diversity of outcomes in randomized controlled trials (RCTs). We aimed to describe outcomes in RCTs assessing pulp treatments for primary teeth and to develop a core set of component outcomes to be part of composite outcome defining the failure of a pulp treatment. Methods: We systematically reviewed articles of RCTs comparing pulp treatments for primary molars published up to February 2012. We abstracted all outcomes assessed in each trial, then used a small-group consensus process to group similar outcomes, which were reduced to a composite outcome of failure of a pulp treatment by a 3-round Delphi process involving expert authors and dentists. Results: We included 47 reports of RCTs in the review, for 83 reported outcomes (median 11 outcomes per RCT). These outcomes were grouped into 24 overarching outcome categories. We contacted 210 experts for the Delphi process and 25% to 30% participated. The process identified the following 5 component outcomes as part of a composite outcome of failure of a pulp treatment: soft-tissue pathology, pain, pathologic mobility, pathologic radiolucency and pathologic root resorption. Conclusions: RCTs of pulp treatments for primary teeth investigate diverse outcomes. Our consensus process, involving clinicians but no patient, allowed for compiling a core set of component outcomes to define the composite outcome failure of a pulp treatment for primary teeth.	[Smail-Faugeron, Violaine; Courson, Frederic] Bretonneau Hosp, AP HP, Serv Odontol, Paris, France; [Smail-Faugeron, Violaine; Chabouis, Helene Fron; Attal, Jean-Pierre; Muller-Bolla, Michele; Courson, Frederic] Univ Paris Descartes Sorbonne Paris Cite, Fac Chirurg Dent, Unite Rech Biomat Innovants & Interface EA4462, Montrouge, France; [Chabouis, Helene Fron; Attal, Jean-Pierre] Hop Charles Foix, AP HP, Serv Odontol, Ivry, France; [Chabouis, Helene Fron] Univ Paris 13 Sorbonne Paris Cite, Ecole Doctorale Galilee, Villetaneuse, France; [Durieux, Pierre] Ctr Rech Cordeliers, Equipe 20, Inst Natl Sante & Rech Med, UMR S 872, Paris, France; [Durieux, Pierre] Univ Paris Descartes Sorbonne Paris Cite, Fac Med, Paris, France; [Durieux, Pierre] Hop Europe Georges Pompidou, AP HP, Dept Informat Hosp, Paris, France; [Muller-Bolla, Michele] Univ Nice Sophia Antipolis, Serv Odontol, Fac Chirurg Dent, Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur	Smail-Faugeron, V (corresponding author), Bretonneau Hosp, AP HP, Serv Odontol, Paris, France.	viosmail@orange.fr		Smail-Faugeron, Violaine/0000-0002-3197-6650				[Anonymous], 2009, GUID PULP THER PRIM, P212; BARDECKI MJ, 1984, TECHNOL FORECAST SOC, V25, P281, DOI 10.1016/0040-1625(84)90006-4; Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Beretta R, 1996, Nurse Res, V3, P79, DOI 10.7748/nr.3.4.79.s8; Carr A, 2011, INT J ORAL MAX IMPL, V26, P85; Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES), 1999, NAT HLTH NUTR EX SUR; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Dalkey NC, 1969, DELPHI METHOD EXPT S; Dwan K, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-52; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Faggion CM, 2010, J DENT, V38, P443, DOI 10.1016/j.jdent.2010.03.003; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Furukawa TA, 2007, JAMA-J AM MED ASSOC, V297, P468, DOI 10.1001/jama.297.5.468-b; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Glenny AM, 2003, EUR J ORAL SCI, V111, P85, DOI 10.1034/j.1600-0722.2003.00013.x; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Lee YL, 2009, COMP MINERAL TRIOXID; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Nadin G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003220; Needleman I, 2012, J CLIN PERIODONTOL, V39, P122, DOI 10.1111/j.1600-051X.2011.01836.x; Offen W, 2007, DRUG INF J, V41, P31, DOI 10.1177/009286150704100105; Papaspyridakos P, 2012, J DENT RES, V91, P242, DOI 10.1177/0022034511431252; Richards D, 2005, EVID BASED DENT, V6, P1; Sackman H, 1975, DELPHI CRITIQUE EXPE; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Tendal B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4829; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Williamson P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000041; Williamson P, 2012, J HEALTH SERV RES PO, V17, P1, DOI 10.1258/jhsrp.2011.011131; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	33	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e51908	10.1371/journal.pone.0051908	http://dx.doi.org/10.1371/journal.pone.0051908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300955	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000005
J	Hosur, V; Cox, ML; Burzenski, LM; Riding, RL; Alley, L; Lyons, BL; Kavirayani, A; Martin, KA; Cox, GA; Johnson, KR; Shultz, LD				Hosur, Vishnu; Cox, Melissa L.; Burzenski, Lisa M.; Riding, Rebecca L.; Alley, Lynn; Lyons, Bonnie L.; Kavirayani, Anoop; Martin, Kimberly A.; Cox, Gregory A.; Johnson, Kenneth R.; Shultz, Leonard D.			Retrotransposon Insertion in the T-cell Acute Lymphocytic Leukemia 1 (Tal1) Gene Is Associated with Severe Renal Disease and Patchy Alopecia in Hairpatches (Hpt) Mice	PLOS ONE			English	Article							SCL GENE; CRITICAL REGULATOR; STEM-CELLS; MOUSE; ABSENCE; HEMATOPOIESIS; LOCUS; EXPRESSION; SCL/TAL-1; SEQUENCES	"Hairpatches" (Hpt) is a naturally occurring, autosomal semi-dominant mouse mutation. Hpt/Hpt homozygotes die in utero, while Hpt/+ heterozygotes exhibit progressive renal failure accompanied by patchy alopecia. This mutation is a model for the rare human disorder "glomerulonephritis with sparse hair and telangiectases" (OMIM 137940). Fine mapping localized the Hpt locus to a 6.7 Mb region of Chromosome 4 containing 62 known genes. Quantitative real time PCR revealed differential expression for only one gene in the interval, T-cell acute lymphocytic leukemia 1 (Tal1), which was highly upregulated in the kidney and skin of Hpt/+ mice. Southern blot analysis of Hpt mutant DNA indicated a new EcoRI site in the Tal1 gene. High throughput sequencing identified an endogenous retroviral class II intracisternal A particle insertion in Tal1 intron 4. Our data suggests that the IAP insertion in Tal1 underlies the histopathological changes in the kidney by three weeks of age, and that glomerulosclerosis is a consequence of an initial developmental defect, progressing in severity over time. The Hairpatches mouse model allows an investigation into the effects of Tal1, a transcription factor characterized by complex regulation patterns, and its effects on renal disease.	[Hosur, Vishnu; Cox, Melissa L.; Burzenski, Lisa M.; Riding, Rebecca L.; Alley, Lynn; Lyons, Bonnie L.; Kavirayani, Anoop; Martin, Kimberly A.; Cox, Gregory A.; Johnson, Kenneth R.; Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Shultz, LD (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	lenny.shultz@jax.org		Kavirayani, Anoop/0000-0003-3874-3101	NIH [HLO77642, CA034196, AR054170, DK057199]; Jackson Laboratory; JDRF; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057199] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jackson Laboratory; JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grants HLO77642, CA034196, AR054170, and DK057199. MC was supported by a fellowship funded by The Jackson Laboratory. VH was supported by a fellowship from the JDRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Barton LM, 1999, INT J BIOCHEM CELL B, V31, P1193, DOI 10.1016/S1357-2725(99)00082-5; Basu SK, 2011, EMBO J, V30, P3714, DOI 10.1038/emboj.2011.250; BEGLEY CG, 1994, GENE, V138, P93, DOI 10.1016/0378-1119(94)90787-0; Bloor AJC, 2002, J HEMATOTH STEM CELL, V11, P195, DOI 10.1089/152581602753658402; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Dekel B, 2004, KIDNEY INT, V65, P1162, DOI 10.1111/j.1523-1755.2004.00489.x; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Fishbane S, 2009, CURR OPIN NEPHROL HY, V18, P112, DOI 10.1097/MNH.0b013e328324b672; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Horie K, 2007, GENETICS, V176, P815, DOI 10.1534/genetics.107.071647; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SHULTZ LD, 1991, LAB INVEST, V65, P588; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yang M, 2011, ADV CHRONIC KIDNEY D, V18, P400, DOI 10.1053/j.ackd.2011.10.001; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	30	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53426	10.1371/journal.pone.0053426	http://dx.doi.org/10.1371/journal.pone.0053426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301070	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900077
J	Yu, B; Sun, HB; Ma, HW; Peng, M; Kong, FX; Meng, FX; Liu, N; Guo, QY				Yu, Bing; Sun, Hongbin; Ma, Hongwei; Peng, Miao; Kong, Fanxing; Meng, Fanxing; Liu, Na; Guo, Qiyong			Aberrant Whole-Brain Functional Connectivity and Intelligence Structure in Children with Primary Nocturnal Enuresis	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MOTOR CORTEX; CORTICAL HUBS; MRI; DISCONNECTIVITY; SINGLE; MEMORY	Aim: To assess the potential relationship between intelligence structure abnormalities and whole-brain functional connectivity in children with primary nocturnal enuresis (PNE) with resting-state functional magnetic resonance imaging (fMRI) to provide insights into the association between these two seemingly unrelated conditions. Methods: Intelligence testing and fMRI data were obtained from 133 right-handed children, including 67 PNE children (M/F, 39:28; age, 10.5 +/- 1.2 y) and 66 age-matched healthy controls (M/F, 37:29; age, 10.1 +/- 1.1 y). All intelligence tests were performed using the China-Wechsler Intelligence Scale for Children (C-WISC). Each subject's full intelligence quotient (FIQ), verbal IQ (VIQ), performance IQ (PIQ), and memory/caution (M/C) factor was measured and recorded. Resting state fMRI scans were performed on a 3.0-T MR scanner and post-processed using REST software. Comparisons of z-score correlation coefficients between distinct cerebral regions were used to identify altered functional connectivity in PNE children. Results: The PNE group had normal FIQ, VIQ, and PIQ values, indicating no significant variation from the control group. However, the M/C factor was significantly lower in the PNE group. Compared to the control group, PNE children exhibited overall lower levels of functional connectivity that were most apparent in the cerebello-thalamo-frontal pathway. The M/C factor significantly correlated with z-scores representing connectivity between Cerebellum_Crus1_L and Frontal_Mid_R. Conclusion: PNE children exhibit intelligence structure imbalance and attention deficits. Our findings suggest that cerebello-thalamo-frontal circuit abnormalities are likely to be involved in the onset and progression of attention impairment in PNE children.	[Yu, Bing; Kong, Fanxing; Meng, Fanxing; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China; [Sun, Hongbin] China Med Univ, Hosp 4, Dept Radiol, Shenyang, Peoples R China; [Ma, Hongwei] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Peoples R China; [Peng, Miao] China Med Univ, Shengjing Hosp, Psychol Outpatient Serv, Shenyang, Peoples R China; [Liu, Na] Peoples Hosp Liaoning Prov, Dept Radiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China.	guoqy@vip.sina.com		Yu, Bing/0000-0003-0237-7824; Sun, Hongbin/0000-0002-5571-5658	National Natural Science Foundation of China [30571985, 30370520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30571985, and 30370520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baeyens D, 2005, ACTA PAEDIATR, V94, P1619, DOI 10.1080/08035250510041240; Baeyens D, 2005, EUR J PEDIATR, V164, P665, DOI 10.1007/s00431-005-1712-1; Baeyens D, 2006, J UROLOGY, V176, P744, DOI 10.1016/S0022-5347(06)00295-3; Beckel JM, 2009, HDB EXP PHARM, P149; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dai Xiao-Mei, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P607; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Gong YX, 1993, MANUAL CHINESE REVIS; Jan JE, 2009, J PINEAL RES, V46, P1, DOI 10.1111/j.1600-079X.2008.00628.x; Jissendi P, 2008, J NEURORADIOLOGY, V35, P42, DOI 10.1016/j.neurad.2007.11.001; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Lei D, 2011, HUM BRAIN MAPP; Lei D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031023; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Muller D, 2001, J UROLOGY, V166, P2432, DOI 10.1016/S0022-5347(05)65609-1; ORNITZ EM, 1992, PSYCHOPHYSIOLOGY, V29, P437, DOI 10.1111/j.1469-8986.1992.tb01717.x; Peltier SJ, 2005, BRAIN RES, V1057, P10, DOI 10.1016/j.brainres.2005.06.078; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Sheridan MA, 2007, J AM ACAD CHILD PSY, V46, P1357, DOI 10.1097/chi.0b013e31812eecf7; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yu B, 2012, EUR J RADIOL; Yu B, 2011, J PAEDIATR CHILD H, V47, P429, DOI 10.1111/j.1440-1754.2010.02000.x	32	18	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51924	10.1371/journal.pone.0051924	http://dx.doi.org/10.1371/journal.pone.0051924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300958	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900014
J	Kristof, A; Husti, Z; Koncz, I; Kohajda, Z; Szel, T; Juhasz, V; Biliczki, P; Jost, N; Baczko, I; Papp, JG; Varro, A; Virag, L				Kristof, Attila; Husti, Zoltan; Koncz, Istvan; Kohajda, Zsofia; Szel, Tamas; Juhasz, Viktor; Biliczki, Peter; Jost, Norbert; Baczko, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo			Diclofenac Prolongs Repolarization in Ventricular Muscle with Impaired Repolarization Reserve	PLOS ONE			English	Article							TORSADES-DE-POINTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IN-VIVO; CARDIOVASCULAR SAFETY; PHARMACOLOGICAL BLOCK; CARDIAC-HYPERTROPHY; INHIBITION; DOG; KS; PHARMACOKINETICS	Background: The aim of the present work was to characterize the electrophysiological effects of the non-steroidal antiinflammatory drug diclofenac and to study the possible proarrhythmic potency of the drug in ventricular muscle. Methods: Ion currents were recorded using voltage clamp technique in canine single ventricular cells and action potentials were obtained from canine ventricular preparations using microelectrodes. The proarrhythmic potency of the drug was investigated in an anaesthetized rabbit proarrhythmia model. Results: Action potentials were slightly lengthened in ventricular muscle but were shortened in Purkinje fibers by diclofenac (20 mu M). The maximum upstroke velocity was decreased in both preparations. Larger repolarization prolongation was observed when repolarization reserve was impaired by previous BaCl2 application. Diclofenac (3 mg/kg) did not prolong while dofetilide (25 mu g/kg) significantly lengthened the QT(c) interval in anaesthetized rabbits. The addition of diclofenac following reduction of repolarization reserve by dofetilide further prolonged QTc. Diclofenac alone did not induce Torsades de Pointes ventricular tachycardia (TdP) while TdP incidence following dofetilide was 20%. However, the combination of diclofenac and dofetilide significantly increased TdP incidence (62%). In single ventricular cells diclofenac (30 mM) decreased the amplitude of rapid (I-Kr) and slow (I-Ks) delayed rectifier currents thereby attenuating repolarization reserve. L-type calcium current (I-Ca) was slightly diminished, but the transient outward (I-to) and inward rectifier (I-K1) potassium currents were not influenced. Conclusions: Diclofenac at therapeutic concentrations and even at high dose does not prolong repolarization markedly and does not increase the risk of arrhythmia in normal heart. However, high dose diclofenac treatment may lengthen repolarization and enhance proarrhythmic risk in hearts with reduced repolarization reserve.	[Husti, Zoltan; Koncz, Istvan; Szel, Tamas; Juhasz, Viktor; Biliczki, Peter; Baczko, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Kristof, Attila; Kohajda, Zsofia; Jost, Norbert; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Hungarian Academy of Sciences	Varro, A (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary.	varro.andras@med.u-szeged.hu	Varro, Andras/M-2647-2016; Baczko, István/I-7752-2019	Baczko, István/0000-0002-9588-0797; Husti, Zoltan/0000-0002-3956-8213	Hungarian Scientific Research Fund [OTKA CNK-77855, K-82079, NK-104331]; Hungarian National Office for Research and Technology, Anyos Jedlik Programme [TECH_08_A1_CARDIO08]; Hungarian National Development Agency; European Regional Fund [TAMOP-4.2.2./B-10/1-2010-0012, TAMOP-4.2.1/B-09/1/KONV-2010-0005]; HU-RO Cross-Border Cooperation Programmes [HURO/0802/011_AF-HURO_CARDIOPOL]; Hungarian Academy of Sciences; Janos Bolyai Research Scholarship	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office for Research and Technology, Anyos Jedlik Programme; Hungarian National Development Agency; European Regional Fund; HU-RO Cross-Border Cooperation Programmes; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Janos Bolyai Research Scholarship(Hungarian Academy of Sciences)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA CNK-77855, K-82079 and NK-104331); the Hungarian National Office for Research and Technology, Anyos Jedlik Programme (TECH_08_A1_CARDIO08), and the Hungarian National Development Agency, and co-financed by the European Regional Fund (TAMOP-4.2.2./B-10/1-2010-0012, TAMOP-4.2.1/B-09/1/KONV-2010-0005); the HU-RO Cross-Border Cooperation Programmes (HURO/0802/011_AF-HURO_CARDIOPOL); the Hungarian Academy of Sciences and the Janos Bolyai Research Scholarship (I. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jenoobi Fahad I, 2010, Sci Pharm, V78, P465, DOI 10.3797/scipharm.1003-10; Batey AJ, 2002, BRIT J PHARMACOL, V135, P1003, DOI 10.1038/sj.bjp.0704550; BIRD HA, 1986, AGENTS ACTIONS, V18, P447, DOI 10.1007/BF01965010; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bort R, 1999, BIOCHEM PHARMACOL, V58, P787, DOI 10.1016/S0006-2952(99)00167-7; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; CARLSSON L, 1990, J CARDIOVASC PHARM, V16, P276, DOI 10.1097/00005344-199008000-00014; Christ T, 2005, N-S ARCH PHARMACOL, V371, P393, DOI 10.1007/s00210-005-1063-5; CORABOEUF E, 1979, AM J PHYSIOL, V236, pH561, DOI 10.1152/ajpheart.1979.236.4.H561; Corrado D, 2007, CARDIOL CLIN, V25, P391, DOI 10.1016/j.ccl.2007.07.008; DUNCAN JJ, 1988, AM J SPORT MED, V16, P656, DOI 10.1177/036354658801600618; Farkas Andras, 2004, Journal of Pharmacological and Toxicological Methods, V50, P175, DOI 10.1016/j.vascn.2004.05.002; Fei XW, 2006, BIOCHEM BIOPH RES CO, V346, P1275, DOI 10.1016/j.bbrc.2006.06.034; Fosbol EL, 2010, EXPERT OPIN DRUG SAF, V9, P893, DOI 10.1517/14740338.2010.501331; Gillon D, 2006, HERALD SCOTLAND 0922; Girennavar B, 2007, J FOOD SCI, V72, pC417, DOI 10.1111/j.1750-3841.2007.00483.x; Hart G, 2003, EXP PHYSIOL, V88, P639, DOI 10.1113/eph8802619; Hidaka M, 2008, BIOSCI BIOTECH BIOCH, V72, P406, DOI 10.1271/bbb.70511; Huang WF, 2006, CLIN THER, V28, P1827, DOI 10.1016/j.clinthera.2006.11.009; Huang WF, 2006, DRUG SAFETY, V29, P261, DOI 10.2165/00002018-200629030-00009; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Lawrence Chris L., 2005, Journal of Pharmacological and Toxicological Methods, V52, P46, DOI 10.1016/j.vascn.2005.04.011; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Lengyel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018751; LIN JH, 1987, CLIN PHARMACOKINET, V12, P402, DOI 10.2165/00003088-198712060-00002; Liu LY, 2005, NEUROPHARMACOLOGY, V48, P918, DOI 10.1016/j.neuropharm.2004.12.020; Lu Y, 2004, DRUG CHEM TOXICOL, V27, P269, DOI 10.1081/DCT-120037748; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Niemi M, 2001, CLIN PHARMACOL THER, V69, P194, DOI 10.1067/mcp.2001.114229; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; SCHEIDEL B, 1993, ARZNEIMITTEL-FORSCH, V43-2, P1211; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Varkevisser R, 2012, HEART RHYTHM, V9, P1718, DOI 10.1016/j.hrthm.2012.05.016; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Virag L, 2009, BRIT J PHARMACOL, V156, P1076, DOI 10.1111/j.1476-5381.2009.00116.x; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; vonMoltke LL, 1996, J CLIN PSYCHOPHARM, V16, P104, DOI 10.1097/00004714-199604000-00002; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Yarishkin OV, 2009, KOREAN J PHYSIOL PHA, V13, P437, DOI 10.4196/kjpp.2009.13.6.437	45	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53255	10.1371/journal.pone.0053255	http://dx.doi.org/10.1371/journal.pone.0053255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300901	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600076
J	Chen, XS; Yin, YP; Shen, C; Liu, GG; Zhu, ZJ; Wei, WH; Wang, HC; Huang, SJ; Li, J; Tucker, JD; Mabey, DC; Peeling, RW				Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Liu, Guo-Gu; Zhu, Zheng-Jun; Wei, Wan-Hui; Wang, Hong-Chun; Huang, Shui-Jie; Li, Jing; Tucker, Joseph D.; Mabey, David C.; Peeling, Rosanna W.			Rapid Syphilis Testing Uptake for Female Sex Workers at Sex Venues in Southern China: Implications for Expanding Syphilis Screening	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PARTNER NOTIFICATION; RISK; PREVALENCE; HIV	Background: Accessibility of syphilis testing services is critical in syphilis control programs for female sex workers (FSWs), but few FSWs attend public STI clinics or other testing sites. Introduction of free rapid syphilis testing (RST) into outreach programs for FSWs will help improve test uptake. Methods: Commercial sex venues were identified in two cities in South China. In cooperation with health advocacy organizations, health outreach teams from local public health or medical facilities approached all types of sex venues in study areas to offer free RST. Acceptability and uptake of RST among FSWs were evaluated. Results: A total of 2812 FSWs were offered RST and 2670 (95.0%) accepted syphilis testing. 182 (6.8%) FSWs had a positive RST result among whom 136 (74.7%) were willing to attend an STD clinic for confirmatory testing and treatment. More than half (89, 66.4%) of those with syphilis were not willing to notify their sex partners. Multivariate logistic analysis showed that syphilis test uptake was associated with residing in Jiangmen (AOR, 1.78; 95% CI, 1.15-2.77), older age (AOR, 2.11, 95% CI, 1.17-3.79 for age of 31 years or above), and not working at a service venue (AOR, 1.60; 95% CI, 1.10-2.34). Conclusions: RST at sex venues is well accepted by FSWs when it is integrated into ongoing outreach services. Such programs provide excellent opportunities for expanding syphilis screening efforts among specific subgroups of FSW who are difficult to reach through clinic-based programs.	[Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Wei, Wan-Hui; Wang, Hong-Chun; Li, Jing] Natl Ctr Sexually Translated Dis STD Control, Nanjing, Jiangsu, Peoples R China; [Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Wei, Wan-Hui; Wang, Hong-Chun; Li, Jing] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Shen, Crystal] Mayo Clin & Mayo Grad Sch Med, Rochester, NY USA; [Liu, Guo-Gu] Hlth Bur Liuzhou City, Liuzhou, Peoples R China; [Zhu, Zheng-Jun; Huang, Shui-Jie] Jiangmen Ctr STD Control, Jiangmen, Peoples R China; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Mabey, David C.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London WC1, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine	Chen, XS (corresponding author), Natl Ctr Sexually Translated Dis STD Control, Nanjing, Jiangsu, Peoples R China.	chenxs@ncstdlc.org		Tucker, Joseph/0000-0003-2804-1181; Mabey, David/0000-0002-0031-8276	Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases through the Bill and Melinda Gates Foundation) [A70577]; UNC Fogarty AIDS International Research and Training Program [NIH FIC D43 TW01039]; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER [D43TW001039, K01TW008200] Funding Source: NIH RePORTER	Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases through the Bill and Melinda Gates Foundation); UNC Fogarty AIDS International Research and Training Program; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a grant to principal investigator XS Chen from the Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases A70577 through a grant from the Bill and Melinda Gates Foundation), the UNC Fogarty AIDS International Research and Training Program (NIH FIC D43 TW01039), and the UNC Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-19; Campos PE, 2006, SEX TRANSM INFECT, V82, pV22, DOI 10.1136/sti.2006.023325; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Chang H, 2010, NIH FOG INT CLIN SCH; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Chen XS, 2012, SEX TRANSM DIS, V39, P1; China Ministry of Health, 2010, CHIN 2010 UNGASS COU; China's Action Plan to Prevent and Control HIV/AIDS, 2010, CHIN ACT PLAN PREV C, P2011; Gupte S, 2011, SEX TRANSM DIS, V38, P499, DOI 10.1097/OLQ.0b013e318205e45d; Han ZG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-148; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; Sabido M, 2009, EMERG INFECT DIS, V15, P647, DOI 10.3201/eid1504.081293; Sano P, 2004, SEX TRANSM DIS, V31, P713, DOI 10.1097/01.olq.0000145848.79694.7b; Tucker J, 2010, SOC SCI MED, V70, P121, DOI 10.1016/j.socscimed.2009.10.010; Tucker JD, 2011, JAIDS-J ACQ IMM DEF, V57, pE106, DOI 10.1097/QAI.0b013e31821d3694; Wang AL, 2012, SEX TRANSM INFECT, V88, P386, DOI 10.1136/sextrans-2011-050275; Wang Y, 2011, AIDS BEHAV, V15, P702, DOI 10.1007/s10461-010-9703-2; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Weeks MR, 2010, AIDS EDUC PREV, V22, P252, DOI 10.1521/aeap.2010.22.3.252; Yin YP, 2012, CLIN J INFECT	27	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52579	10.1371/journal.pone.0052579	http://dx.doi.org/10.1371/journal.pone.0052579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300709	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100064
J	Gallardo, JE				Gallardo, Jose E.			A Multilevel Probabilistic Beam Search Algorithm for the Shortest Common Supersequence Problem	PLOS ONE			English	Article							OLIGONUCLEOTIDE MICROARRAYS; COMPLEXITY; SUBSEQUENCE	The shortest common supersequence problem is a classical problem with many applications in different fields such as planning, Artificial Intelligence and especially in Bioinformatics. Due to its NP-hardness, we can not expect to efficiently solve this problem using conventional exact techniques. This paper presents a heuristic to tackle this problem based on the use at different levels of a probabilistic variant of a classical heuristic known as Beam Search. The proposed algorithm is empirically analysed and compared to current approaches in the literature. Experiments show that it provides better quality solutions in a reasonable time for medium and large instances of the problem. For very large instances, our heuristic also provides better solutions, but required execution times may increase considerably.	Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain	Universidad de Malaga	Gallardo, JE (corresponding author), Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain.	pepeg@lcc.uma.es			Spanish Ministerio de Ciencia e Innovacion [TIN2011-28627-C04-01]; Junta de Andalucia [TIC-6083]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This work is partially supported by Spanish Ministerio de Ciencia e Innovacion under project ANYSELF (TIN2011-28627-C04-01), and by Junta de Andalucia under project DNEMESIS (TIC-6083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back Thomas, 1997, HDB EVOLUTIONARY COM, V1st; Baker J.E., P INT C GEN ALG THEI, P101; Barr A, 1981, HDB ARTIFICIAL INTEL; Blum C, 2007, LECT NOTES COMPUT SC, V4446, P36; Branke J., 1996, Proceedings of the Second Nordic Workshop on Genetic Algorithms and Their Applications (2NWGA), P105; Branke J, 1998, OR SPEKTRUM, V20, P39, DOI 10.1007/BF01545528; Cotta C, 2005, LECT NOTES COMPUT SC, V3562, P84; Cotta C, 2005, LECT NOTES COMPUT SC, V3512, P50; FOULSER DE, 1992, ARTIF INTELL, V57, P143, DOI 10.1016/0004-3702(92)90016-Q; Fraser C.B., 1995, THESIS U GLASGOW GLA; Gallardo JE, 2007, IEEE T SYST MAN CY B, V37, P77, DOI 10.1109/TSMCB.2006.883266; Hallet MT, 1998, THESIS U VICTORIA VI; Jeong Seop Sim, 2003, Journal of Discrete Algorithms, V1, P111, DOI 10.1016/S1570-8667(03)00011-X; JIANG T, 1995, SIAM J COMPUT, V24, P1122, DOI 10.1137/S009753979223842X; Kasif S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf105; Kubalik J, 2010, P 12 ANN C GEN EV CO, P249; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; MAIER D, 1978, J ACM, V25, P322, DOI 10.1145/322063.322075; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Michel R, 1999, NEW IDEAS OPTIMIZATI, P51; MIDDENDORF M, 1994, THEOR COMPUT SCI, V125, P205, DOI 10.1016/0304-3975(92)00074-2; Mousavi SR, 2012, ENG APPL ARTIF INTEL, V25, P457, DOI 10.1016/j.engappai.2011.08.006; Neri F, 2012, STUD COMPUT INTELL, V379, P1, DOI 10.1007/978-3-642-23247-3; Ning K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni147; Ning K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S12; Pietrzak K, 2003, J COMPUT SYST SCI, V67, P757, DOI 10.1016/S0022-0000(03)00078-3; Rahmann S, 2003, BIOINFORMATICS, V19, pII156, DOI 10.1093/bioinformatics/btg1073; TIMKOVSKII VG, 1989, CYBERNETICS+, V25, P565, DOI 10.1007/BF01075212; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winston P. H., 1984, ARTIFICIAL INTELLIGE	31	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52427	10.1371/journal.pone.0052427	http://dx.doi.org/10.1371/journal.pone.0052427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300667	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100048
J	Hardoim, CCP; Esteves, AIS; Pires, FR; Goncalves, JMS; Cox, CJ; Xavier, JR; Costa, R				Hardoim, Cristiane C. P.; Esteves, Ana I. S.; Pires, Francisco R.; Goncalves, Jorge M. S.; Cox, Cymon J.; Xavier, Joana R.; Costa, Rodrigo			Phylogenetically and Spatially Close Marine Sponges Harbour Divergent Bacterial Communities	PLOS ONE			English	Article							VERTICAL TRANSMISSION; MICROBIAL COMMUNITY; SP-NOV; HOST-SPECIFICITY; RIBOSOMAL-RNA; DNA TAXONOMY; FERROUS IRON; DIVERSITY; SYMBIONTS; AMPLIFICATION	Recent studies have unravelled the diversity of sponge-associated bacteria that may play essential roles in sponge health and metabolism. Nevertheless, our understanding of this microbiota remains limited to a few host species found in restricted geographical localities, and the extent to which the sponge host determines the composition of its own microbiome remains a matter of debate. We address bacterial abundance and diversity of two temperate marine sponges belonging to the Irciniidae family - Sarcotragus spinosulus and Ircinia variabilis - in the Northeast Atlantic. Epifluorescence microscopy revealed that S. spinosulus hosted significantly more prokaryotic cells than I. variabilis and that prokaryotic abundance in both species was about 4 orders of magnitude higher than in seawater. Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) profiles of S. spinosulus and I. variabilis differed markedly from each other - with higher number of ribotypes observed in S. spinosulus - and from those of seawater. Four PCR-DGGE bands, two specific to S. spinosulus, one specific to I. variabilis, and one present in both sponge species, affiliated with an uncultured sponge-specific phylogenetic cluster in the order Acidimicrobiales (Actinobacteria). Two PCR-DGGE bands present exclusively in S. spinosulus fingerprints affiliated with one sponge-specific phylogenetic cluster in the phylum Chloroflexi and with sponge-derived sequences in the order Chromatiales (Gammaproteobacteria), respectively. One Alphaproteobacteria band specific to S. spinosulus was placed in an uncultured sponge-specific phylogenetic cluster with a close relationship to the genus Rhodovulum. Our results confirm the hypothesized host-specific composition of bacterial communities between phylogenetically and spatially close sponge species in the Irciniidae family, with S. spinosulus displaying higher bacterial community diversity and distinctiveness than I. variabilis. These findings suggest a pivotal host-driven effect on the shape of the marine sponge microbiome, bearing implications to our current understanding of the distribution of microbial genetic resources in the marine realm.	[Hardoim, Cristiane C. P.; Esteves, Ana I. S.; Costa, Rodrigo] Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal; [Pires, Francisco R.; Xavier, Joana R.] Univ Acores, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, Dept Biol, Ponta Delgada, Acores, Portugal; [Goncalves, Jorge M. S.] Univ Algarve, Fisheries Biodivers & Conservat Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal; [Xavier, Joana R.] Ctr Adv Studies Blanes, Girona, Spain	Universidade do Algarve; Universidade dos Acores; Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Costa, R (corresponding author), Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal.	rscosta@ualg.pt	da Silva Costa, Rodrigo/N-7274-2013; Cox, Cymon/D-1303-2012; Hardoim, Cristiane C.P./D-4544-2015; Gonçalves, Jorge MS/G-5206-2011; Xavier, Joana/J-8387-2012	da Silva Costa, Rodrigo/0000-0002-5932-4101; Cox, Cymon/0000-0002-4927-979X; Hardoim, Cristiane C.P./0000-0003-4650-0177; Gonçalves, Jorge MS/0000-0001-7704-8190; Xavier, Joana/0000-0003-1386-4492; Esteves, Ana/0000-0002-9614-0635	Portuguese Foundation for Science and Technology (FCT) [PTDC/MAR/101431/2008]; FCT [SFRH/BD/60873/2009, SFRH/BPD/62946/2009]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financed by the Portuguese Foundation for Science and Technology (FCT - http://www.fct.pt) through the research project PTDC/MAR/101431/2008. CCPH has a PhD fellowship granted by FCT (Grant No. SFRH/BD/60873/2009). JRX's research is funded by a FCT postdoctoral fellowship (grant no. SFRH/BPD/62946/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Cardenas P, 2009, ZOOTAXA, P1; Cichewicz RH, 2004, ORG LETT, V6, P1951, DOI 10.1021/ol049503q; Clark DA, 1996, MICROBIOL-UK, V142, P785, DOI 10.1099/00221287-142-4-785; Clum A, 2009, STAND GENOMIC SCI, V1, P38, DOI 10.4056/sigs.1463; COOK SDC, 2002, SYSTEMA PORIFERA GUI, P1022, DOI DOI 10.1007/978-1-4615-0747-5_99; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Davis-Belmar CS, 2009, ADV MATER RES-SWITZ, V71-73, P271, DOI 10.4028/www.scientific.net/AMR.71-73.271; De Rosa S, 2003, BIOMOL ENG, V20, P311, DOI 10.1016/S1389-0344(03)00038-8; Emura C, 2006, TETRAHEDRON, V62, P5682, DOI 10.1016/j.tet.2006.03.087; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1563, DOI 10.1017/S0025315407058195; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Friedrich AB, 1999, MAR BIOL, V134, P461, DOI 10.1007/s002270050562; Garrity, 2006, BERGEYS MANUAL SYS C, V2, P161; Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; Hardoim CCP, 2012, BRAZ J MICR IN PRESS; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HIRAISHI A, 1995, INT J SYST BACTERIOL, V45, P319, DOI 10.1099/00207713-45-2-319; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imhoff JF, 2005, BERGEYS MANUAL SYS C, V2, P205; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; Liu YH, 2006, NAT PROD REP, V23, P630, DOI 10.1039/b604586c; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MCLACHLAN J, 1964, CAN J MICROBIOL, V10, P769, DOI 10.1139/m64-098; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mitova M, 2003, Z NATURFORSCH C, V58, P740; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P4133, DOI 10.1128/AEM.00454-08; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Orhan I, 2010, MAR DRUGS, V8, P47, DOI 10.3390/md8010047; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Proctor LM, 1997, AQUAT MICROB ECOL, V12, P105, DOI 10.3354/ame012105; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RADEMAKER JLW, 2004, MOL MICROBIAL ECOLOG, P1397; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Siegl A, 2010, ENV MICROBIOL REP, V2, P507, DOI 10.1111/j.1758-2229.2009.00057.x; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Srinivas TNR, 2007, INT J SYST EVOL MICR, V57, P228, DOI 10.1099/ijs.0.64470-0; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Usher KM, 2006, EUR J PHYCOL, V41, P179, DOI 10.1080/09670260600631352; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; VICENTE VP, 1990, CORAL REEFS, V8, P199, DOI 10.1007/BF00265011; Watjen W, 2009, J PHARM PHARMACOL, V61, P919, DOI 10.1211/jpp/61.07.0011; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xu SH, 2008, STEROIDS, V73, P568, DOI 10.1016/j.steroids.2008.01.009; Yang JK, 2011, AQUAT MICROB ECOL, V62, P231, DOI 10.3354/ame01473; [No title captured]	89	34	35	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53029	10.1371/journal.pone.0053029	http://dx.doi.org/10.1371/journal.pone.0053029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300853	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100110
J	Kawabe, T; Kawabe, K; Sapru, HN				Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.			Effect of Barodenervation on Cardiovascular Responses Elicited from the Hypothalamic Arcuate Nucleus of the Rat	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE RAT; MEDULLARY PRESSOR AREA; OBESE ZUCKER RATS; PARAVENTRICULAR NUCLEUS; SPINAL-CORD; CONTAINING NEURONS; ARTERIAL-PRESSURE; NEUROPEPTIDE-Y; BLOOD-PRESSURE; GLUTAMATE	We have previously reported that chemical stimulation of the hypothalamic arcuate nucleus (ARCN) in the rat elicited increases as well as decreases in blood pressure (BP) and sympathetic nerve activity (SNA). The type of response elicited from the ARCN (i.e., increase or decrease in BP and SNA) depended on the level of baroreceptor activity which, in turn, was determined by baseline BP in rats with intact baroreceptors. Based on this information, it was hypothesized that baroreceptor unloading may play a role in the type of response elicited from the ARCN. Therefore, the effect of barodenervation on the ARCN-induced cardiovascular and sympathetic responses and the neurotransmitters in the hypothalamic paraventricular nucleus (PVN) mediating the excitatory responses elicited from the ARCN were investigated in urethane-anesthetized adult male Wistar rats. Bilateral barodenervation converted decreases in mean arterial pressure (MAP) and greater splanchnic nerve activity (GSNA) elicited by chemical stimulation of the ARCN with microinjections of Nmethyl-D-aspartic acid to increases in MAP and GSNA and exaggerated the increases in heart rate (HR). Combined microinjections of NBQX and D-AP7 (ionotropic glutamate receptor antagonists) into the PVN in barodenervated rats converted increases in MAP and GSNA elicited by the ARCN stimulation to decreases in MAP and GSNA and attenuated increases in HR. Microinjections of SHU9119 (a melanocortin 3/4 receptor antagonist) into the PVN in barodenervated rats attenuated increases in MAP, GSNA and HR elicited by the ARCN stimulation. ARCN neurons projecting to the PVN were immunoreactive for proopiomelanocortin, alpha-melanocyte stimulating hormone (alpha-MSH) and adrenocorticotropic hormone (ACTH). It was concluded that increases in MAP and GSNA and exaggeration of tachycardia elicited by the ARCN stimulation in barodenervated rats may be mediated via release of alpha-MSH and/or ACTH and glutamate from the ARCN neurons projecting to the PVN.	[Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sapru, HN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	sapru@umdnj.edu			National Institutes of Health [HL024347, HL076248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076248, R01HL024347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this research was provided by National Institutes of Health grants HL024347 and HL076248 awarded to HNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO G, 1988, BRAIN RES, V453, P191, DOI 10.1016/0006-8993(88)90158-8; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; Dampney RAL, 2003, ACTA PHYSIOL SCAND, V177, P209, DOI 10.1046/j.1365-201X.2003.01070.x; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Dun SL, 2006, PEPTIDES, V27, P1949, DOI 10.1016/j.peptides.2005.10.027; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; GONZALEZ ER, 1983, HYPERTENSION, V5, P346, DOI 10.1161/01.HYP.5.3.346; Grassi G, 2000, HYPERTENSION, V36, P538, DOI 10.1161/01.HYP.36.4.538; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Herman JP, 2000, J COMP NEUROL, V422, P352; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huber DA, 2010, J PHYSIOL-LONDON, V588, P1515, DOI 10.1113/jphysiol.2009.186387; Hwang LL, 2004, NEUROPEPTIDES, V38, P69, DOI 10.1016/j.npep.2004.02.001; IBATA Y, 1985, BRAIN RES, V341, P233, DOI 10.1016/0006-8993(85)91062-5; Kasamatsu K, 2004, AM J PHYSIOL-REG I, V287, pR715, DOI 10.1152/ajpregu.00642.2003; Kawabe T, 2008, NEUROSCIENCE, V153, P605, DOI 10.1016/j.neuroscience.2008.02.076; Kawabe T, 2006, BRAIN RES, V1102, P117, DOI 10.1016/j.brainres.2006.05.002; Kawabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045180; Kawabe T, 2009, BRAIN RES, V1248, P115, DOI 10.1016/j.brainres.2008.10.059; Kiss J, 2005, EUR J NEUROSCI, V21, P2111, DOI 10.1111/j.1460-9568.2005.04012.x; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Li SG, 1997, J AUTONOM NERV SYST, V62, P147, DOI 10.1016/S0165-1838(96)00119-1; Liu J, 2007, ENDOCRINOLOGY, V148, P5531, DOI 10.1210/en.2007-0745; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Nakamura T, 2009, HYPERTENSION, V54, P1369, DOI 10.1161/HYPERTENSIONAHA.109.140715; OSBORN JW, 1990, AM J PHYSIOL, V259, pR1172, DOI 10.1152/ajpregu.1990.259.6.R1172; Ovesjo ML, 2001, J NEUROENDOCRINOL, V13, P505, DOI 10.1046/j.1365-2826.2001.00662.x; Palkovits M, 2008, ANN NY ACAD SCI, V1148, P57, DOI 10.1196/annals.1410.062; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pilowsky PM, 2002, J HYPERTENS, V20, P1675, DOI 10.1097/00004872-200209000-00002; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Pyner S, 1999, NEUROSCIENCE, V88, P949, DOI 10.1016/S0306-4522(98)00255-3; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sapru HN, 2002, CLIN EXP PHARMACOL P, V29, P491, DOI 10.1046/j.1440-1681.2002.03661.x; SAPRU HN, 1976, AM J PHYSIOL, V230, P664, DOI 10.1152/ajplegacy.1976.230.3.664; SAPRU HN, 1979, AM J PHYSIOL, V236, pH174, DOI 10.1152/ajpheart.1979.236.1.H174; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Steiner F A, 1970, Prog Brain Res, V32, P102, DOI 10.1016/S0079-6123(08)61525-3; STEINER FA, 1969, BRAIN RES, V12, P74, DOI 10.1016/0006-8993(69)90056-0; SUNDARAM K, 1991, BRAIN RES, V544, P33, DOI 10.1016/0006-8993(91)90882-V; Tabara Y, 2008, HYPERTENS RES, V31, P1219, DOI 10.1291/hypres.31.1219; VANDENPOL AN, 1991, J NEUROSCI, V11, P2087; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; Yang Z, 1998, J PHYSIOL-LONDON, V513, P521, DOI 10.1111/j.1469-7793.1998.521bb.x; Yang Z, 2002, EXP PHYSIOL, V87, P663, DOI 10.1113/eph8702439; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001; ZIEGLGANSBERGER W, 1973, EXP BRAIN RES, V17, P35	53	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53111	10.1371/journal.pone.0053111	http://dx.doi.org/10.1371/journal.pone.0053111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300873	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100120
J	Kuo, SH; Tang, GM; Ma, KR; Babij, R; Cortes, E; Vonsattel, JPG; Faust, PL; Sulzer, D; Louis, ED				Kuo, Sheng-Han; Tang, Guomei; Ma, Karen; Babij, Rachel; Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.; Sulzer, David; Louis, Elan D.			Macroautophagy Abnormality in Essential Tremor	PLOS ONE			English	Article							AUTOPHAGY INDUCTION; MUTANT HUNTINGTIN; PURKINJE-CELLS; DISEASE; NEURODEGENERATION; PATHOLOGY; ACCUMULATION; PARKINSONS; CLEARANCE; ATAXIN-3	Macroautophagy is a cellular mechanism for the clearance of protein aggregates and damaged organelles. Impaired macroautophagy has been observed in neurodegenerative disorders. We investigated the macroautophagy pathway in essential tremor (ET) cases compared to age-matched controls. We analyzed microtubule-associated protein light chain 3-II (LC3-II), S6K, phosphorylated S6K, beclin-1, and mitochondrial membrane proteins levels by Western blot in the postmortem cerebellum of 10 ET cases and 11 controls. We also performed immunohistochemistry in 12 ET cases and 13 controls to quantify LC3 clustering in Purkinje cells (PCs). LC3-II protein levels were significantly lower in ET cases vs. controls on Western blot (0.84 +/- 0.14 vs. 1.00 +/- 0.14, p = 0.02), and LC3-II clustering in PCs by immunohistochemistry was significantly lower in ET cases vs. controls (2.03 +/- 3.45 vs. 8.80 +/- 9.81, p = 0.03). In ET cases, disease duration was inversely correlated with LC3-II protein level (r = -0.64, p = 0.046). We found that mitochondrial membrane proteins were accumulated in ET (TIM23: 1.36 +/- 0.11 in ET cases vs. 1.00 +/- 0.08 in controls, p = 0.02; TOMM20: 1.63 +/- 0.87 in ET cases vs. 1.00 +/- 0.14 in controls, p = 0.03). Beclin-1, which is involved in macroautophagy, was strikingly deficient in ET (0.42 +/- 0.13 vs. 1.00 +/- 0.35, p<0.001). Decreased macroautophagy was observed in the ET cerebellum, and this could be due to a decrease in beclin-1 levels, which subsequently lead to mitochondrial accumulation as a result of autophagic failure. This provides a possible means by which perturbed macroautophagy could contribute to PC pathology in ET.	[Kuo, Sheng-Han; Tang, Guomei; Sulzer, David; Louis, Elan D.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA; [Ma, Karen; Babij, Rachel; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, GH Sergievsky Ctr, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] New York Presbyterian Hosp, New York, NY USA; [Louis, Elan D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Louis, ED (corresponding author), Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA.	EDL2@columbia.edu		Kuo, Sheng-Han/0000-0002-9412-931X	National Institutes of Health (Bethesda, MD) [R01 NS42859]; Udall Center for Parkinson's Disease Research (Columbia University); Parkinson's Disease Foundation; JPB Foundation; American Academy of Neurology Clinical Research Training Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042859] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Center for Parkinson's Disease Research (Columbia University); Parkinson's Disease Foundation; JPB Foundation; American Academy of Neurology Clinical Research Training Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 NS42859 from the National Institutes of Health (Bethesda, MD), Udall Center for Parkinson's Disease Research (Columbia University), Parkinson's Disease Foundation, JPB Foundation, and American Academy of Neurology Clinical Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373; Erickson-Davis CR, 2010, J NEUROPATH EXP NEUR, V69, P262, DOI 10.1097/NEN.0b013e3181d1ad04; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Higashi S, 2011, J NEUROPATH EXP NEUR, V70, P264, DOI 10.1097/NEN.0b013e318211c86a; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuo SH, 2011, J NEUROL NEUROSUR PS, V82, P1038, DOI 10.1136/jnnp.2010.213330; Kuo SH, 2011, ACTA NEUROPATHOL, V121, P287, DOI 10.1007/s00401-010-0776-9; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Louis ED, 2006, NEUROLOGY, V66, P1756, DOI 10.1212/01.wnl.0000218162.80315.b9; Louis ED, 2005, MOVEMENT DISORD, V20, P1361, DOI 10.1002/mds.20583; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Louis ED, 2009, ARCH NEUROL-CHICAGO, V66, P1202, DOI 10.1001/archneurol.2009.217; Louis ED, 2009, NEUROSCI LETT, V450, P287, DOI 10.1016/j.neulet.2008.11.043; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Sosunov AA, 2008, EPILEPSIA, V49, P53, DOI 10.1111/j.1528-1167.2008.01493.x; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	40	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53040	10.1371/journal.pone.0053040	http://dx.doi.org/10.1371/journal.pone.0053040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300858	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100112
J	Nepelska, M; Cultrone, A; Beguet-Crespel, F; Le Roux, K; Dore, J; Arulampalam, V; Blottiere, HM				Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Arulampalam, Vermulugesan; Blottiere, Herve M.			Butyrate Produced by Commensal Bacteria Potentiates Phorbol Esters Induced AP-1 Response in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; HISTONE DEACETYLASE INHIBITORS; COLON-CANCER-CELLS; CHAIN FATTY-ACIDS; BILE-ACIDS; SODIUM-BUTYRATE; GENE-EXPRESSION; COLORECTAL-CANCER; IN-VITRO; JUN	The human intestine is a balanced ecosystem well suited for bacterial survival, colonization and growth, which has evolved to be beneficial both for the host and the commensal bacteria. Here, we investigated the effect of bacterial metabolites produced by commensal bacteria on AP-1 signaling pathway, which has a plethora of effects on host physiology. Using intestinal epithelial cell lines, HT-29 and Caco-2, stably transfected with AP-1-dependent luciferase reporter gene, we tested the effect of culture supernatant from 49 commensal strains. We observed that several bacteria were able to activate the AP-1 pathway and this was correlated to the amount of short chain fatty acids (SCFAs) produced. Besides being a major source of energy for epithelial cells, SCFAs have been shown to regulate several signaling pathways in these cells. We show that propionate and butyrate are potent activators of the AP-1 pathway, butyrate being the more efficient of the two. We also observed a strong synergistic activation of AP-1 pathway when using butyrate with PMA, a PKC activator. Moreover, butyrate enhanced the PMA-induced expression of c-fos and ERK1/2 phosphorylation, but not p38 and JNK. In conclusion, we showed that SCFAs especially butyrate regulate the AP-1 signaling pathway, a feature that may contribute to the physiological impact of the gut microbiota on the host. Our results provide support for the involvement of butyrate in modulating the action of PKC in colon cancer cells.	[Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Blottiere, Herve M.] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Blottiere, Herve M.] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Arulampalam, Vermulugesan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet	Blottiere, HM (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020	BLOTTIERE, Hervé M/0000-0002-8390-0607; 	European Community's Seventh Framework Programme (FP7), MetaHIT [HEALTH-F4-2007-201052]; European Marie-Curie Initial Training Network Cross-Talk [215553]	European Community's Seventh Framework Programme (FP7), MetaHIT; European Marie-Curie Initial Training Network Cross-Talk	This work was financed by grants from the European Community's Seventh Framework Programme (FP7/2007-2013), MetaHIT, grant agreement HEALTH-F4-2007-201052. M.N. has been supported by the European Marie-Curie Initial Training Network Cross-Talk (grant agreement # 215553). J.D., V. A., and H. B. are partners of the European Marie-Curie Initial Training Network Cross-Talk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1980, NATURE, V283, P781, DOI 10.1038/283781a0; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Blottiere HM, 2003, P NUTR SOC, V62, P101, DOI 10.1079/PNS2002215; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHAUHAN D, 1994, BLOOD, V84, P2243; Chen-Deutsch XW, 2009, LEUKEMIA RES, V33, P1372, DOI 10.1016/j.leukres.2009.03.003; Chessel D., 2004, R NEWS, V4, P5; CUMMINGS JH, 1984, P NUTR SOC, V43, P35, DOI 10.1079/PNS19840025; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; FITZER CJ, 1987, CARCINOGENESIS, V8, P217, DOI 10.1093/carcin/8.2.217; Gaschott T, 2001, BIOCHEM BIOPH RES CO, V283, P80, DOI 10.1006/bbrc.2001.4756; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; KIM YS, 1980, CANCER-AM CANCER SOC, V45, P1185, DOI 10.1002/1097-0142(19800315)45:5+<1185::AID-CNCR2820451324>3.0.CO;2-W; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; Le Blay G, 1999, BRIT J NUTR, V82, P419, DOI 10.1017/S000711459900166X; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Maier S, 2009, J CELL PHYSIOL, V218, P638, DOI 10.1002/jcp.21642; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; MOROTOMI M, 1990, CANCER RES, V50, P3595; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rickard KL, 1999, CARCINOGENESIS, V20, P977, DOI 10.1093/carcin/20.6.977; Rivero JA, 1998, BIOCHEM BIOPH RES CO, V248, P664, DOI 10.1006/bbrc.1998.9041; Saunders N, 1999, CANCER RES, V59, P399; Siavoshian S, 2000, GUT, V46, P507, DOI 10.1136/gut.46.4.507; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; WEISBURGER JH, 1983, ENVIRON HEALTH PERSP, V50, P101, DOI 10.2307/3429539; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Young DA, 2005, FEBS J, V272, P1912, DOI 10.1111/j.1742-4658.2005.04622.x	58	53	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52869	10.1371/journal.pone.0052869	http://dx.doi.org/10.1371/journal.pone.0052869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300800	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100087
J	Zhang, YP; Liu, XH; Gao, SH; Wang, JM; Gu, YS; Zhang, JY; Zhou, X; Li, QX				Zhang, Yun-Ping; Liu, Xiao-Hong; Gao, Su-Hong; Wang, Jia-Mei; Gu, Yue-Shan; Zhang, Jiu-Yue; Zhou, Xia; Li, Qing-Xia			Risk Factors for Preterm Birth in Five Maternal and Child Health Hospitals in Beijing	PLOS ONE			English	Article							PRENATAL-CARE; PREGNANCY; EPIDEMIOLOGY; ASSOCIATION	Background: Preterm birth, the birth of an infant prior to 37 completed weeks of gestation, is the leading cause of perinatal morbidity and mortality. Preterm infants are at greater risk of respiratory, gastrointestinal and neurological diseases. Despite significant research in developed countries, little is known about the causes of preterm birth in many developing countries, especially China. This study investigates the association between sciodemographic data, obstetric risk factor, and preterm birth in five Maternal and Child Health hospitals in Beijing, China. Methods and Findings: A case-control study was conducted on 1391 women with preterm birth (case group) and 1391 women with term delivery (control group), who were interviewed within 48 hours of delivery. Sixteen potential factors were investigated and statistical analysis was performed by univariate analysis and logistic regression analysis. Univariate analysis showed that 14 of the 16 factors were associated with preterm birth. Inter-pregnancy interval and inherited diseases were not risk factors. Logistic regression analysis showed that obesity (odds ratio (OR) = 3.030, 95% confidence interval (CI) 1.166-7.869), stressful life events (OR = 5.535, 95% CI 2.315-13.231), sexual activity (OR = 1.674, 95% CI 1.279-2.191), placenta previa (OR 13.577, 95% CI 2.563-71.912), gestational diabetes mellitus (OR = 3.441, 95% CI1.694-6.991), hypertensive disorder complicating pregnancy (OR = 6.034, 95% CI = 3.401-10.704), history of preterm birth (OR = 20.888, 95% CI 2.519-173.218) and reproductive abnormalities (OR = 3.049, 95% CI 1.010-9.206) were independent risk factors. Women who lived in towns and cities (OR = 0.603, 95% CI 0.430-0.846), had a balanced diet (OR = 0.533, 95% CI 0.421-0.675) and had a record of prenatal care (OR = 0.261, 95% CI 0.134-0.510) were less likely to have preterm birth. Conclusions: Obesity, stressful life events, sexual activity, placenta previa, gestational diabetes mellitus, hypertensive disorder complicating pregnancy, history of preterm birth and reproductive abnormalities are independent risk factors to preterm birth. Identification of remedial factors may inform local health and education policy.	[Zhang, Yun-Ping; Liu, Xiao-Hong; Gao, Su-Hong; Wang, Jia-Mei] Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Gu, Yue-Shan] Maternal & Child Hlth Hosp, Dept Breast Surg, Beijing, Peoples R China; [Zhang, Jiu-Yue] Maternal & Child Hlth Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Zhou, Xia] Maternal & Child Hlth Hosp, Dept Pediat, Beijing, Peoples R China; [Li, Qing-Xia] Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China		Zhang, YP (corresponding author), Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China.	ypzhang7090@yahoo.com.cn			United Nations International Children's Emergency Fund [YH601-11]; Beijing Municipal Science and Technology Commission [Z090507017709014]	United Nations International Children's Emergency Fund; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by a grant from United Nations International Children's Emergency Fund (#YH601-11) and by the grant from Beijing Municipal Science and Technology Commission (#Z090507017709014). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; Behrman RE, 2007, PRETERM BIRTH CAUSES; Buekens P, 2001, PAEDIATR PERINAT EP, V15, P159, DOI 10.1046/j.1365-3016.2001.00015.x; Conway D, 2011, AM J OBSTET GYNECOL, V204, pS55; Culhane J F, 2001, Matern Child Health J, V5, P127, DOI 10.1023/A:1011305300690; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; DeFranco EA, 2007, AM J OBSTET GYNECOL, V197; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gou Wenli, 2004, OBSTET GYNECOLOGY VE, P97; Hedderson MM, 2003, OBSTET GYNECOL, V102, P850, DOI 10.1016/S0029-7844(03)00661-6; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Hogan V K, 2001, Matern Child Health J, V5, P67, DOI 10.1023/A:1011360813893; Lumley J, 2003, BJOG-INT J OBSTET GY, V110, P3, DOI 10.1016/S1470-0328(03)00011-9; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Orvos H, 2002, EUR J OBSTET GYN R B, V100, P171, DOI 10.1016/S0301-2115(01)00471-7; Pan BJ, 2002, STRAIT PREV MED, V8, P1; Peng XS, 2002, CHIN J DIS CONTROL P, V6, P348; Pu J, 2005, J PRACTICAL OBSTET G, V11, P650; Rasmussen ALY, 2009, WEIGHT GAIN PREGNANC; Sayle AE, 2001, OBSTET GYNECOL, V97, P283, DOI 10.1016/S0029-7844(00)01147-9; Vintzileos AM, 2002, AM J OBSTET GYNECOL, V187, P1254, DOI 10.1067/mob.2002.127140; Wadhwa PD, 1996, PSYCHOSOM MED, V58, P432, DOI 10.1097/00006842-199609000-00006; Whitehead N, 2002, AM J EPIDEMIOL, V155, P117, DOI 10.1093/aje/155.2.117; Yao RY, 2007, CHIN J SCH HLTH, V28, P440; Zheng WY, 2006, PRETERM PRETERM INFA; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	26	29	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52780	10.1371/journal.pone.0052780	http://dx.doi.org/10.1371/journal.pone.0052780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300774	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100081
J	Kanitz, E; Otten, W; Tuchscherer, M; Grabner, M; Brussow, KP; Rehfeldt, C; Metges, CC				Kanitz, Ellen; Otten, Winfried; Tuchscherer, Margret; Graebner, Maria; Bruessow, Klaus-Peter; Rehfeldt, Charlotte; Metges, Cornelia C.			High and Low Protein: Carbohydrate Dietary Ratios during Gestation Alter Maternal-Fetal Cortisol Regulation in Pigs	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; MESSENGER-RNA EXPRESSION; TYPE-2 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; PLACENTAL METABOLISM; RIBONUCLEIC-ACID; PLASMA-CORTISOL; BIRTH-WEIGHT; PREGNANCY	Imbalanced maternal nutrition during gestation can cause alterations of the hypothalamic-pituitary-adrenal (HPA) system in offspring. The present study investigated the effects of maternal low-and high-protein diets during gestation in pigs on the maternal-fetal HPA regulation and expression of the glucocorticoid receptor (GR), mineralocorticoid receptor (MR), 11 beta-hydroxysteroid dehydrogenase 1 and 2 (11 beta-HSD1 and 11 beta-HSD2) and c-fos mRNAs in the placenta and fetal brain. Twenty-seven German Landrace sows were fed diets with high (HP, 30%), low (LP, 6.5%) or adequate (AP, 12.1%) protein levels made isoenergetic by varying the carbohydrate levels. On gestational day 94, fetuses were recovered under general anesthesia for the collection of blood, brain and placenta samples. The LP diet in sows increased salivary cortisol levels during gestation compared to the HP and AP sows and caused an increase of placental GR and c-fos mRNA expression. However, the diurnal rhythm of plasma cortisol was disturbed in both LP and HP sows. Total plasma cortisol concentrations in the umbilical cord vessels were elevated in fetuses from HP sows, whereas corticosteroid-binding globulin levels were decreased in LP fetuses. In the hypothalamus, LP fetuses displayed an enhanced mRNA expression of 11b-HSD1 and a reduced expression of c-fos. Additionally, the 11b-HSD2 mRNA expression was decreased in both LP and HP fetuses. The present results suggest that both low and high protein: carbohydrate dietary ratios during gestation may alter the expression of genes encoding key determinants of glucocorticoid hormone action in the fetus with potential long-lasting consequences for stress adaptation and health.	[Kanitz, Ellen; Otten, Winfried; Tuchscherer, Margret; Graebner, Maria] Leibniz Inst Farm Anim Biol, Res Unit Behav Physiol, Dummerstorf, Germany; [Bruessow, Klaus-Peter] Leibniz Inst Farm Anim Biol, Res Unit Reprod Biol, Dummerstorf, Germany; [Rehfeldt, Charlotte] Leibniz Inst Farm Anim Biol, Res Unit Muscle Biol & Growth, Dummerstorf, Germany; [Metges, Cornelia C.] Leibniz Inst Farm Anim Biol, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Kanitz, E (corresponding author), Leibniz Inst Farm Anim Biol, Res Unit Behav Physiol, Dummerstorf, Germany.	ekanitz@fbn-dummerstorf.de	Otten, Winfried/V-8376-2019	Otten, Winfried/0000-0002-5613-5356	German Research Foundation, Bonn [PAK 24: OT 137/3-1, ME 1420/8-1]	German Research Foundation, Bonn(German Research Foundation (DFG))	The study was supported by grants from the German Research Foundation, Bonn (PAK 24: OT 137/3-1; ME 1420/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Belda X, 2005, PHARMACOL BIOCHEM BE, V81, P41, DOI 10.1016/j.pbb.2005.02.009; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; BRIGHT GM, 1995, J CLIN ENDOCR METAB, V80, P770, DOI 10.1210/jc.80.3.770; BURTON PJ, 1994, J ENDOCRINOL, V143, P505, DOI 10.1677/joe.0.1430505; Clarke KA, 2002, J ENDOCRINOL, V172, P527, DOI 10.1677/joe.0.1720527; Daenzer M, 2002, J NUTR, V132, P142, DOI 10.1093/jn/132.2.142; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Felix B, 1999, STEREOTAXIC ATLAS PI; Galler JR, 1993, TXB PEDIAT NUTR, P173; Galler JR, 1997, NUTR PEDIAT 2, P196; GfE, 2006, EMPFEHLUNGEN ENERGIE; Gnanalingham MG, 2007, REPRODUCTION, V134, P615, DOI 10.1530/REP-06-0369; GOLD PW, 1986, NEW ENGL J MED, V314, P1335, DOI 10.1056/NEJM198605223142102; GOMEZSANCHEZ EP, 1992, AM J PHYSIOL, V263, pE1125; GOMEZSANCHEZ EP, 1986, ENDOCRINOLOGY, V118, P819, DOI 10.1210/endo-118-2-819; Heo J, 2005, J ANIM SCI, V83, P208; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herrick K, 2003, J CLIN ENDOCR METAB, V88, P3554, DOI 10.1210/jc.2003-030287; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Jacobson L, 1997, ENDOCRINOLOGY, V138, P1048, DOI 10.1210/en.138.3.1048; Kanitz E, 2002, BIOL NEONATE, V81, P203, DOI 10.1159/000051535; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Kattesh HG, 1997, BIOL NEONATE, V72, P192, DOI 10.1159/000244484; Klemcke HG, 2003, BIOL REPROD, V69, P1945, DOI 10.1095/biolreprod.103.018150; KLEMCKE HG, 1995, BIOL REPROD, V53, P1293, DOI 10.1095/biolreprod53.6.1293; Klemcke HG, 2000, LIFE SCI, V66, P1045, DOI 10.1016/S0024-3205(99)00669-4; Klemcke HG, 1996, BIOL REPROD, V55, P217, DOI 10.1095/biolreprod55.1.217; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lesage J, 2006, STRESS, V9, P183, DOI 10.1080/10253890601056192; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lohrke B, 2005, J MOL ENDOCRINOL, V35, P531, DOI 10.1677/jme.1.01852; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; Metzler-Zebeli BU, 2012, BRIT J NUTR, V108, P2176, DOI 10.1017/S0007114512000414; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Phillips DI, 1998, J CLIN ENDOCR METAB, V83, P747; POND WG, 1992, GROWTH DEVELOP AGING, V56, P115; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; SAS S., 2009, STAT US GUID VERS 9; SCHOKNECHT PA, 1994, THERIOGENOLOGY, V42, P217, DOI 10.1016/0093-691X(94)90265-8; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 1995, J STEROID BIOCHEM, V55, P447, DOI 10.1016/0960-0760(95)00193-X; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; Stimson RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008779; Sun K, 2002, BIOL REPROD, V67, P1450, DOI 10.1095/biolreprod.102.005892; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Umemoto S, 1997, NEUROSCIENCE, V80, P763, DOI 10.1016/S0306-4522(97)00050-X; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; WALKER CD, 1990, ENDOCRINOLOGY, V127, P832, DOI 10.1210/endo-127-2-832; Wan SL, 2005, NEUROSCI LETT, V382, P96, DOI 10.1016/j.neulet.2005.02.066; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854	68	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52748	10.1371/journal.pone.0052748	http://dx.doi.org/10.1371/journal.pone.0052748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300759	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800137
J	Tucker, JM; Schwartz, MK; Truex, RL; Pilgrim, KL; Allendorf, FW				Tucker, Jody M.; Schwartz, Michael K.; Truex, Richard L.; Pilgrim, Kristine L.; Allendorf, Fred W.			Historical and Contemporary DNA Indicate Fisher Decline and Isolation Occurred Prior to the European Settlement of California	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MARTES-PENNANTI; GENETIC DIVERSITY; MICROSATELLITE ANALYSIS; ANCIENT DNA; RANGE; CONSERVATION; LOCI; CONTRACTION; BOTTLENECKS	Establishing if species contractions were the result of natural phenomena or human induced landscape changes is essential for managing natural populations. Fishers (Martes pennanti) in California occur in two geographically and genetically isolated populations in the northwestern mountains and southern Sierra Nevada. Their isolation is hypothesized to have resulted from a decline in abundance and distribution associated with European settlement in the 1800s. However, there is little evidence to establish that fisher occupied the area between the two extant populations at that time. We analyzed 10 microsatelliteloci from 275 contemporary and 21 historical fisher samples (1880-1920) to evaluate the demographic history of fisher in California. We did not find any evidence of a recent (post-European) bottleneck in the northwestern population. In the southern Sierra Nevada, genetic subdivision within the population strongly influenced bottleneck tests. After accounting for genetic subdivision, we found a bottleneck signal only in the northern and central portions of the southern Sierra Nevada, indicating that the southernmost tip of these mountains may have acted as a refugium for fisher during the anthropogenic changes of the late 19th and early 20th centuries. Using a coalescent-based Bayesian analysis, we detected a 90% decline in effective population size and dated the time of decline to over a thousand years ago. We hypothesize that fisher distribution in California contracted to the two current population areas pre-European settlement, and that portions of the southern Sierra Nevada subsequently experienced another more recent bottleneck post-European settlement.	[Tucker, Jody M.] US Forest Serv, USDA, Sequoia Natl Forest, Porterville, CA 93257 USA; [Tucker, Jody M.; Schwartz, Michael K.; Pilgrim, Kristine L.] ARS, USDA, Rocky Mt Res Stn, Missoula, MT USA; [Tucker, Jody M.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Truex, Richard L.] US Forest Serv, USDA, Rocky Mt Reg, Golden, CO USA; [Allendorf, Fred W.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Tucker, JM (corresponding author), US Forest Serv, USDA, Sequoia Natl Forest, Porterville, CA 93257 USA.	jtucker@fs.fed.us	Schwartz, Michael K/C-3184-2014	Schwartz, Michael K/0000-0003-3521-3367	U.S. Forest Service Pacific Southwest Region; Rocky Mountain Research Station; University of Montana	U.S. Forest Service Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service); Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); University of Montana	This work was funded by the U.S. Forest Service Pacific Southwest Region, Rocky Mountain Research Station and the University of Montana. Additional funding was provided by the National Fish and Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHIE JW, 1985, EVOLUTION, V39, P623, DOI 10.1111/j.1558-5646.1985.tb00399.x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; Aubry K, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P201; Aubry KB, 2003, BIOL CONSERV, V114, P79, DOI 10.1016/S0006-3207(03)00003-X; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Beaumont MA, 1999, GENETICS, V153, P2013; Beck, 1992, CALIFORNIA SPOTTED O, P225, DOI DOI 10.3996/012012-JFWM-002.S8);; Beesley D., 1996, SIERRA NEVADA ECOSYS, VII, P3; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Broquet T, 2010, CONSERV BIOL, V24, P1596, DOI 10.1111/j.1523-1739.2010.01556.x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Buskirk Steven W., 1994, P283; Callas R.L., 2008, TRANSLOCATION PLAN R, P80; Carr D, 2007, J WILDLIFE MANAGE, V71, P1853, DOI 10.2193/2006-274; Carr D, 2007, OIKOS, V116, P629, DOI 10.1111/j.2007.0030-1299.15568.x; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; Cornuet JM, 1996, GENETICS, V144, P2001; Dallas JF, 1998, MOL ECOL, V7, P1248; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Davis FW, 2007, ECOL APPL, V17, P2195, DOI 10.1890/06-1484.1; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Duffy AJ, 1998, ANIM GENET, V29, P63; Eckert AJ, 2008, MOL ECOL, V17, P1983, DOI 10.1111/j.1365-294X.2008.03722.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Fleischer RC, 2000, AUK, V117, P1051, DOI 10.1642/0004-8038(2000)117[1051:IOTEHE]2.0.CO;2; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Garroway CJ, 2011, MOL ECOL, V20, P3978, DOI 10.1111/j.1365-294X.2011.05243.x; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gaston KJ, 1998, OIKOS, V81, P38, DOI 10.2307/3546465; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Graham Russell W., 1994, P26; Greenwald DN, 2000, PETITION LIST UNPUB; Grinnell J., 1937, FUR BEARING MAMMALS; Hapeman P, 2011, J HERED, V102, P251, DOI 10.1093/jhered/esr001; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hull JM, 2010, MOL PHYLOGENET EVOL, V56, P212, DOI 10.1016/j.ympev.2010.02.027; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Jordan MJ, 2007, MOL ECOL NOTES, V7, P797, DOI 10.1111/j.1471-8286.2007.01708.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Kyle CJ, 2001, MOL ECOL, V10, P2341, DOI 10.1046/j.1365-294X.2001.01351.x; Kyle CJ, 2001, MOL ECOL, V10, P337, DOI 10.1046/j.1365-294x.2001.01222.x; Kyle CJ, 2000, CAN J ZOOL, V78, P1150, DOI 10.1139/cjz-78-7-1150; Lamb HH, 1965, PALAEOGEOGR PALAEOCL, V1, P13, DOI DOI 10.1016/0031-0182(65)90004-0; Leblois R, 2006, MOL ECOL, V15, P3601, DOI 10.1111/j.1365-294X.2006.03046.x; Lewis JC, 2004, FEASIBILITY ASSESSME; Loader C, 2007, LOCFIT LOCAL REGRESS; Lofroth E.C., 2010, CONSERVATION FISHERS, VI; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; Mock KE, 2004, CONSERV GENET, V5, P631, DOI 10.1007/s10592-004-1849-x; Moser S., 2009, CEC5002008071 CAL CL; Newton I, 1997, ECOGRAPHY, V20, P137, DOI 10.1111/j.1600-0587.1997.tb00356.x; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; Powell R.A., 2005, EVALUATING DEMOGRAPH; Purcell KL, 2009, FOREST ECOL MANAG, V258, P2696, DOI 10.1016/j.foreco.2009.09.041; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez JP, 2002, ECOL APPL, V12, P238; Ross JD, 2006, CONSERV GENET, V7, P735, DOI 10.1007/s10592-005-9110-9; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz MK, 2007, J MAMMAL, V88, P921, DOI 10.1644/06-MAMM-A-217R1.1; Schwartz MK, 2007, J WILDLIFE MANAGE, V71, P2170, DOI 10.2193/2007-026; Sierra Pacific Industries United States Fish and Wildlife Service, 2007, CAND CONS AGR ASS FI; SLATKIN M, 1995, GENETICS, V139, P457; Smith BJ, 2007, J STAT SOFTW, V21, P1; Smulders MJM, 2003, CONSERV GENET, V4, P441, DOI 10.1023/A:1024767114707; Spencer W, 2008, BASE LINE EVAL UNPUB; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Storz JF, 2002, EVOLUTION, V56, P154; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; United States Fish and Wildlife Service, 2004, FED REGISTER, V69, P18770; USFWS NMFS, 1996, FED REGISTER, V61, P4722; Vinkey RS, 2006, J MAMMAL, V87, P265, DOI 10.1644/05-MAMM-A-151R1.1; WADE MJ, 1980, GENET RES, V36, P1, DOI 10.1017/S0016672300019613; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir RD, 2010, J WILDLIFE MANAGE, V74, P405, DOI 10.2193/2008-579; Williams RN, 2000, J MAMMAL, V81, P895, DOI 10.1644/1545-1542(2000)081<0895:AOGVAS>2.3.CO;2; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wisely SM, 2004, J MAMMAL, V85, P640, DOI 10.1644/BEL-011; Wisely SM, 2004, CONSERV GENET, V5, P105, DOI 10.1023/B:COGE.0000014061.04963.da; Yang DS, 2009, MOL ECOL, V18, P5115, DOI 10.1111/j.1365-294X.2009.04399.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zielinski WJ, 2005, J BIOGEOGR, V32, P1385, DOI 10.1111/j.1365-2699.2005.01234.x; Zielinski WJ, 2004, J MAMMAL, V85, P649, DOI 10.1644/BOS-126; Zielinski WJ, 2004, J WILDLIFE MANAGE, V68, P475, DOI 10.2193/0022-541X(2004)068[0475:RHSBFI]2.0.CO;2; Zielinski WJ, 1999, J MAMMAL, V80, P961, DOI 10.2307/1383266; Zielinski WJ, 1995, CALIF FISH GAME, V81, P104; Zielinski WJ, 2012, J FISH WILD IN PRESS	115	24	24	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52803	10.1371/journal.pone.0052803	http://dx.doi.org/10.1371/journal.pone.0052803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300783	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800150
J	Donofrio, G; Franceschi, V; Lovero, A; Capocefalo, A; Camero, M; Losurdo, M; Cavirani, S; Marinaro, M; Grandolfo, E; Buonavoglia, C; Tempesta, M				Donofrio, Gaetano; Franceschi, Valentina; Lovero, Angela; Capocefalo, Antonio; Camero, Michele; Losurdo, Michele; Cavirani, Sandro; Marinaro, Mariarosaria; Grandolfo, Erika; Buonavoglia, Canio; Tempesta, Maria			Clinical Protection of Goats against CpHV-1 Induced Genital Disease with a BoHV-4-Based Vector Expressing CpHV-1 gD	PLOS ONE			English	Article							CAPRINE HERPESVIRUS-1 INFECTION; BOVINE HERPESVIRUS-1; GLYCOPROTEIN-D; CIDOFOVIR; VACCINE; BOVINE-HERPESVIRUS-4; IMMUNIZATION; VIRUS; CELLS; PCR	Caprine herpesvirus type 1 (CpHV-1) is an alphaherpesvirus causing genital disease leading to abortion in adult pregnant goats and a systemic disease with high morbility and mortality in kids. Further, Caprine herpesvirus 1 infection represents a valuable large animal model for human herpesvirus induced genital disease, exploitable for pathogenic studies, new vaccines and antiviral molecules testing. Here, the bovine herpesvirus 4 (BoHV-4) based vector derived from an apathogenic isolate of BoHV-4 and expressing the immunodominant CpHV-1 glycoprotein D (BoHV-4-A-gD(cp)gD(106 Delta)TK) was constructed and its ability to protect goats against CpHV-1 induced genital disease evaluated. The subcutaneous route of recombinant BoHV-4 administration was first tested in vivo/ex vivo by in vivo image analysis and in vitro by goat skin primary cultures preparation and transduction. Next, an exploratory immunization and safety study in goats was performed with two recombinant BoHV4, BoHV-4-A-gD(cp)gD(106)Delta TK or BoHV-4-CMV-IgK-gE2gD-TM. In both cases no clinical signs were evident but a good titer of serum neutralizing antibodies was produced in all inoculated animals. When a challenge experiment was performed in a new group of animals using a highly pathogenic dose of CpHV-1, all the vaccinated goats with BoHV-4-AgD(cp)gD(106)Delta TK were protected toward CpHV-1 induced genital disease respect to the unvaccinated control which showed typical vaginal lesions with a high grade of clinical score as well as a long lasting viral shedding. In summary, the data acquired in the present study validate BoHV-4-based vector as a safe and effective viral vector for goat vaccination against CpHV-1 induced genital disease and pave the way for further applications.	[Donofrio, Gaetano; Franceschi, Valentina; Capocefalo, Antonio; Cavirani, Sandro; Grandolfo, Erika] Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy; [Lovero, Angela; Camero, Michele; Losurdo, Michele; Buonavoglia, Canio; Tempesta, Maria] Univ Bari, Dept Vet Publ Hlth, Valenzano, Italy; [Marinaro, Mariarosaria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	University of Parma; Universita degli Studi di Bari Aldo Moro; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Donofrio, G (corresponding author), Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	Capocefalo, Antonio/O-3027-2017; tempesta, maria/AAE-5332-2021; franceschi, valentina/AAR-5566-2020	Capocefalo, Antonio/0000-0002-4215-4265; Cavirani, Sandro/0000-0002-1014-2307; franceschi, valentina/0000-0003-3945-2285; Donofrio, Gaetano/0000-0002-8984-0377; Camero, Michele/0000-0003-0026-8325; TEMPESTA, MARIA/0000-0003-4300-8822	Ministry of Education, University and Research (PRIN) [2008WCSTJM]	Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Ministry of Education, University and Research (PRIN 2008, project 2008WCSTJM "Activity of antiviral drugs and vaccines against herpesvirus infection in goats: an animal model for the study of genital herpesvirus infection in man''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonavoglia C, 1996, COMP IMMUNOL MICROB, V19, P275, DOI 10.1016/0147-9571(96)00014-8; Camero M, 2007, VACCINE, V25, P1658, DOI 10.1016/j.vaccine.2006.11.002; Camero M, 2010, ANTIVIR THER, V15, P785, DOI 10.3851/IMP1611; Capocefalo A, 2010, J VIROL METHODS, V169, P420, DOI 10.1016/j.jviromet.2010.08.002; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Donofrio G, 2008, VACCINE, V26, P6031, DOI 10.1016/j.vaccine.2008.09.023; Donofrio G, 2002, J VIROL METHODS, V101, P49, DOI 10.1016/S0166-0934(01)00419-0; Donofrio G, 2007, REPRODUCTION, V134, P183, DOI 10.1530/REP-07-0065; Donofrio G, 2006, CLIN VACCINE IMMUNOL, V13, P1246, DOI 10.1128/CVI.00200-06; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Donofrio G, 2011, VACCINE, V29, P867, DOI 10.1016/j.vaccine.2010.11.048; Donofrio G, 2009, CLIN VACCINE IMMUNOL, V16, P1675, DOI 10.1128/CVI.00224-09; Donofrio G, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-65; Donofrio G, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-68; Elia G, 2008, J VIROL METHODS, V148, P155, DOI 10.1016/j.jviromet.2007.10.021; ENGELS M, 1987, J GEN VIROL, V68, P2019, DOI 10.1099/0022-1317-68-7-2019; Gillet L, 2009, VET RES, V40, DOI 10.1051/vetres/2009034; GREWAL AS, 1986, AUST VET J, V63, P79, DOI 10.1111/j.1751-0813.1986.tb02935.x; Keuser V, 2002, VET RES COMMUN, V26, P221, DOI 10.1023/A:1015205705149; Keuser W, 2006, VIRUS RES, V115, P112, DOI 10.1016/j.virusres.2005.07.009; Manoj S, 2003, VIROLOGY, V313, P296, DOI 10.1016/S0042-6822(03)00325-8; Marinaro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034913; McGeoch DJ, 2005, J GEN VIROL, V86, P307, DOI 10.1099/vir.0.80588-0; OSORIO FA, 1983, AM J VET RES, V44, P975; Redaelli M, 2012, NEURO-ONCOLOGY, V14, P288, DOI 10.1093/neuonc/nor219; Redaelli M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-298; Reddy PS, 2000, VET IMMUNOL IMMUNOP, V76, P257, DOI 10.1016/S0165-2427(00)00217-8; Singh M, 2011, IN VITRO CELL DEV-AN, V47, P83, DOI 10.1007/s11626-010-9373-4; Six A, 2001, ARCH VIROL, V146, P1325, DOI 10.1007/s007050170094; TARIGAN S, 1987, AUST VET J, V64, P321, DOI 10.1111/j.1751-0813.1987.tb07345.x; Tempesta M, 2008, ANTIMICROB AGENTS CH, V52, P4064, DOI 10.1128/AAC.00725-08; Tempesta M, 2007, VACCINE, V25, P7927, DOI 10.1016/j.vaccine.2007.09.004; Tempesta M, 1999, J CLIN MICROBIOL, V37, P1598, DOI 10.1128/JCM.37.5.1598-1599.1999; Tempesta M, 2000, J VET MED B, V47, P197, DOI 10.1046/j.1439-0450.2000.00334.x; Tempesta M, 2004, COMP IMMUNOL MICROB, V27, P25, DOI 10.1016/S0147-9571(03)00012-2; Tempesta M, 1999, COMP IMMUNOL MICROB, V22, P137, DOI 10.1016/S0147-9571(98)00029-0; Tempesta M, 2001, VACCINE, V19, P3860, DOI 10.1016/S0264-410X(01)00136-0; Tempesta M, 2007, ANTIVIR THER, V12, P977; Tempesta M, 2007, ANTIVIR RES, V74, P138, DOI 10.1016/j.antiviral.2006.11.001; Thiry J, 2006, VET MICROBIOL, V113, P303, DOI 10.1016/j.vetmic.2005.11.001; Thiry Julien, 2007, BMC Vet Res, V3, P33, DOI 10.1186/1746-6148-3-33; Uzal FA, 2004, J VET DIAGN INVEST, V16, P478, DOI 10.1177/104063870401600523; VANDERLUGT JJ, 1993, J S AFR VET ASSOC, V64, P169	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52758	10.1371/journal.pone.0052758	http://dx.doi.org/10.1371/journal.pone.0052758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300989	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000016
J	Liu, XJ; Wang, MS; Chen, HL; Guo, YL; Ma, FG; Shi, F; Bi, YL; Li, Y				Liu, Xiaojie; Wang, Mingshan; Chen, Huailong; Guo, Yunliang; Ma, Fuguo; Shi, Fei; Bi, Yanlin; Li, Ying			Hypothermia Protects the Brain from Transient Global Ischemia/Reperfusion by Attenuating Endoplasmic Reticulum Response-Induced Apoptosis through CHOP	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; NEURONAL CELL-DEATH; THERAPEUTIC HYPOTHERMIA; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; STRESS; EXPRESSION; STROKE; INJURY; GRP78	Endoplasmic reticulum (ER) stress has been implicated in the pathology of cerebral ischemia. Apoptotic cell death occurs during prolonged period of stress or when the adaptive response fails. Hypothermia blocked the TNF or Fas-mediated extrinsic apoptosis pathway and the mitochondria pathway of apoptosis, however, whether hypothermia can block endoplasmic reticulum mediated apoptosis is never known. This study aimed to elucidate whether hypothermia attenuates brain cerebral ischemia/reperfusion (I/R) damage by suppressing ER stress-induced apoptosis. A 15 min global cerebral ischemia rat model was used in this study. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) positive cells in hippocampus CA1 were assessed after reperfusion of the brain. The expressions of C/EBP-homolo gous protein (CHOP) and glucose-regulated protein 78 (GRP78) in ischemic hippocampus CA1 were measured at 6, 12, 24 and 48 h after reperfusion. The results showed that hypothermia significantly attenuated brain I/R injury, as shown by reduction in cell apoptosis, CHOP expression, and increase in GRP78 expression. These results suggest that hypothermia could protect brain from I/R injury by suppressing ER stress-induced apoptosis.	[Liu, Xiaojie; Wang, Mingshan; Chen, Huailong; Guo, Yunliang; Ma, Fuguo; Shi, Fei; Bi, Yanlin; Li, Ying] Qingdao Municipal Hosp, Dept Anesthesiol, Qingdao, Shandong, Peoples R China	Qingdao Municipal Hospital	Wang, MS (corresponding author), Qingdao Municipal Hosp, Dept Anesthesiol, Qingdao, Shandong, Peoples R China.	slwangmingshan@163.com			Qingdao Municipal Science and Technology Bureau [11-2-3-2-5-nsh]; Shandong Provincial Health Department [2001CAICKAF]	Qingdao Municipal Science and Technology Bureau; Shandong Provincial Health Department	This work was supported by Qingdao Municipal Science and Technology Bureau 11-2-3-2-5-nsh Shandong Provincial Health Department 2001CAICKAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS MJ, 1995, ANN INTERN MED, V122, P622, DOI 10.7326/0003-4819-122-8-199504150-00013; Aoki M, 2001, MOL BRAIN RES, V95, P117, DOI 10.1016/S0169-328X(01)00255-8; Bossenmeyer-Pourie C, 2000, PEDIATR RES, V47, P385, DOI 10.1203/00006450-200003000-00017; Campos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044191; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jiang YF, 2012, NEUROSCI LETT, V516, P182, DOI 10.1016/j.neulet.2012.03.074; Kawahara K, 2001, FEBS LETT, V506, P135, DOI 10.1016/S0014-5793(01)02898-8; Khar A, 2003, FREE RADICAL BIO MED, V35, P949, DOI 10.1016/S0891-5849(03)00469-6; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Kohno K, 1997, NEUROSCI LETT, V224, P17, DOI 10.1016/S0304-3940(97)13459-0; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Liu L, 2008, J NEUROCHEM, V106, P541, DOI 10.1111/j.1471-4159.2008.05411.x; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao H, 2004, STROKE, V35, P572, DOI 10.1161/01.STR.0000110787.42083.58; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	36	36	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53431	10.1371/journal.pone.0053431	http://dx.doi.org/10.1371/journal.pone.0053431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301071	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000057
J	Wu, T; Zhang, ZH; Yuan, ZQ; Lo, LJ; Chen, J; Wang, YZ; Peng, JR				Wu, Ting; Zhang, Zhenhai; Yuan, Zhangqin; Lo, Li Jan; Chen, Jun; Wang, Yizhen; Peng, Jinrong			Distinctive Genes Determine Different Intramuscular Fat and Muscle Fiber Ratios of the longissimus dorsi Muscles in Jinhua and Landrace Pigs	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; ACID-BINDING PROTEINS; SKELETAL-MUSCLE; MEAT QUALITY; MICROARRAY ANALYSIS; LIPID-METABOLISM; CARCASS CHARACTERISTICS; LIPOPROTEIN-LIPASE; SUBCUTANEOUS ADIPOCYTES	Meat quality is determined by properties such as carcass color, tenderness and drip loss. These properties are closely associated with meat composition, which includes the types of muscle fiber and content of intramuscular fat (IMF). Muscle fibers are the main contributors to meat mass, while IMF not only contributes to the sensory properties but also to the plethora of physical, chemical and technological properties of meat. However, little is known about the molecular mechanisms that determine meat composition in different pig breeds. In this report we show that Jinhua pigs, a Chinese breed, contains much higher levels of IMF than do Landrace pigs, a Danish breed. We analyzed global gene expression profiles in the longissimus dorsi muscles in Jinhua and Landrace breeds at the ages of 30, 90 and 150 days. Cross-comparison analysis revealed that genes that regulate fatty acid biosynthesis (e.g., fatty acid synthase and stearoyl-CoA desaturase) are expressed at higher levels in Jinhua pigs whereas those that regulate myogenesis (e.g., myogenic factor 6 and forkhead box O1) are expressed at higher levels in Landrace pigs. Among those genes which are highly expressed in Jinhua pigs at 90 days (d90), we identified a novel gene porcine FLJ36031 (pFLJ), which functions as a positive regulator of fat deposition in cultured intramuscular adipocytes. In summary, our data showed that the up-regulation of fatty acid biosynthesis regulatory genes such as pFLJ and myogenesis inhibitory genes such as myostatin in the longissimus dorsi muscles of Jinhua pigs could explain why this local breed produces meat with high levels of IMF.	[Wu, Ting; Yuan, Zhangqin; Lo, Li Jan; Wang, Yizhen; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhenhai] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn; pengjr@zju.edu.cn	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525; Peng, Jinrong/0000-0002-0793-4848; wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2009ZX08009-144B]; Fundamental Research Funds for the Central Universities	Special Fund for Cultivation and Breeding of New Transgenic Organism; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported financially by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grant No. 2009ZX08009-144B) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Bai QF, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-8; Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Bayer S, 2011, APPL MICROBIOL BIOT, V89, P91, DOI 10.1007/s00253-010-2831-9; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; CAMERON ND, 1990, MEAT SCI, V27, P227, DOI 10.1016/0309-1740(90)90053-9; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Cassano M, 2011, DEVELOPMENT, V138, P4523, DOI 10.1242/dev.070706; Cesar ASM, 2010, GENET MOL RES, V9, P727, DOI 10.4238/vol9-2gmr733; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen HB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-64; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Costabile G, 2011, J ENDOCRINOL INVEST, V34, pE110, DOI [10.3275/7276, 10.1007/BF03347469]; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; Dai FW, 2009, S AFR J ANIM SCI, V39, P267; Ding ST, 2000, J ANIM SCI, V78, P2127; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Edwards LN, 2010, MEAT SCI, V86, P938, DOI 10.1016/j.meatsci.2010.07.020; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evock-Clover CM, 2002, COMP BIOCHEM PHYS A, V133, P345, DOI 10.1016/S1095-6433(02)00113-7; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fortin A, 2005, MEAT SCI, V69, P297, DOI 10.1016/j.meatsci.2004.07.011; GarciaMacias JA, 1996, ANIM SCI, V63, P487, DOI 10.1017/S1357729800015381; Gardan D, 2007, COMP BIOCHEM PHYS B, V148, P14, DOI 10.1016/j.cbpb.2007.03.017; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gardner KL, 2006, J CELL PHYSIOL, V206, P196, DOI 10.1002/jcp.20449; Geyer CB, 2009, DEV BIOL, V330, P142, DOI 10.1016/j.ydbio.2009.03.020; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI 10.1002/jcp.22241; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Grizard J, 1999, EAAP PUBLIC, P177; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Guo W, 2008, ASIAN AUSTRAL J ANIM, V21, P11, DOI 10.5713/ajas.2008.60256; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Inuzuka H, 1999, BBA-GENE STRUCT EXPR, V1447, P199, DOI 10.1016/S0167-4781(99)00161-X; Ishimoto K, 2011, YAKUGAKU ZASSHI, V131, P1189, DOI 10.1248/yakushi.131.1189; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Jiang YZ, 2011, ANIMAL, V5, P1485, DOI 10.1017/S1751731111000425; Jiang YH, 2010, RES VET SCI, V89, P133, DOI 10.1016/j.rvsc.2010.01.009; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kallio P, 2009, INT J OBESITY, V33, P80, DOI 10.1038/ijo.2008.196; Kaphalia BS, 2001, J BIOCHEM MOL TOXIC, V15, P165, DOI 10.1002/jbt.14; Kaphalia BS, 1997, CHEM RES TOXICOL, V10, P211, DOI 10.1021/tx960079e; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Latorre MA, 2003, ANIM SCI, V77, P33, DOI 10.1017/S1357729800053625; Latorre MA, 2003, MEAT SCI, V65, P1369, DOI 10.1016/S0309-1740(03)00059-7; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Li ZC, 2010, MOL REPROD DEV, V77, P76, DOI 10.1002/mrd.21111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez IP, 2005, MOL CELL BIOCHEM, V275, P109, DOI 10.1007/s11010-005-1082-z; Ma J, 2007, J DIABETES COMPLICAT, V21, P28, DOI 10.1016/j.jdiacomp.2006.03.002; Matsakas A, 2009, HISTOL HISTOPATHOL, V24, P611, DOI 10.14670/HH-24.611; Miao ZG, 2009, ANIMAL, V3, P468, DOI 10.1017/S1751731108003613; Miyagawa S, 2010, XENOTRANSPLANTATION, V17, P61, DOI 10.1111/j.1399-3089.2009.00565.x; Mostyn A, 2007, P NUTR SOC, V66, p57A; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Newcom DW, 2004, J ANIM SCI, V82, P2264; Pannier L, 2010, MEAT SCI, V85, P515, DOI 10.1016/j.meatsci.2010.02.025; Pas MFWT, 2000, J ANIM SCI, V78, P69; Patruno M, 2008, DIFFERENTIATION, V76, P168, DOI 10.1111/j.1432-0436.2007.00189.x; Paturi G, 2010, FOOD RES INT, V43, P856, DOI 10.1016/j.foodres.2009.12.003; Pulawa LK, 2007, DIABETES, V56, pA340; Raj S, 2010, MEAT SCI, V86, P324, DOI 10.1016/j.meatsci.2010.04.037; Reiter SS, 2007, COMP BIOCHEM PHYS D, V2, P200, DOI 10.1016/j.cbd.2007.04.008; Rosell CM, 1996, J AGR FOOD CHEM, V44, P3453, DOI 10.1021/jf9601022; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Serlachius M, 2004, EXP CELL RES, V296, P256, DOI 10.1016/j.yexcr.2004.02.016; Serre C, 2010, J INVEST DERMATOL, V130, pS76; Shan T, 2009, ANIM GENET, V40, P863, DOI 10.1111/j.1365-2052.2009.01927.x; Shan TZ, 2006, J ANIM FEED SCI, V15, P621, DOI 10.22358/jafs/66931/2006; Shan TZ, 2009, J CELL BIOCHEM, V107, P984, DOI 10.1002/jcb.22203; Shen WJ, 2008, DIABETES, V57, pA390; Siders JL, 2001, AM J HUM GENET, V69, P639; Soeno Y, 1998, ZOOL SCI, V15, P217, DOI 10.2108/zsj.15.217; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Symonds ME, 2004, P NUTR SOC, V63, P397, DOI 10.1079/PNS2004366; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Van den Maagdenberg K, 2007, J ANIM SCI, V85, P952, DOI 10.2527/jas.2006-563; Verner J, 2007, J ANIM BREED GENET, V124, P81, DOI 10.1111/j.1439-0388.2007.00639.x; Wang D, 2009, POULTRY SCI, V88, P2285, DOI 10.3382/ps.2009-00190; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Wei L, 2010, J INVEST DERMATOL, V130, pS132; WOOD JD, 1987, ANIM PROD, V44, P488; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; Yang HJ, 2010, AMINO ACIDS, V38, P1333, DOI 10.1007/s00726-009-0342-8; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zhao SH, 2005, GENOMICS, V86, P618, DOI 10.1016/j.ygeno.2005.08.001; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	95	66	70	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53181	10.1371/journal.pone.0053181	http://dx.doi.org/10.1371/journal.pone.0053181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301040	gold, Green Submitted, Green Published			2022-12-27	WOS:000313480000037
J	Chen, ZZ; Lessey, E; Berginski, ME; Cao, L; Li, J; Trepat, X; Itano, M; Gomez, SM; Kapustina, M; Huang, C; Burridge, K; Truskey, G; Jacobson, K				Chen, Zaozao; Lessey, Elizabeth; Berginski, Matthew E.; Cao, Li; Li, Jonathan; Trepat, Xavier; Itano, Michelle; Gomez, Shawn M.; Kapustina, Maryna; Huang, Cai; Burridge, Keith; Truskey, George; Jacobson, Ken			Gleevec, an Abl Family Inhibitor, Produces a Profound Change in Cell Shape and Migration	PLOS ONE			English	Article							TYROSINE KINASE; EXTRACELLULAR-MATRIX; NEONATAL LETHALITY; MICE DEFICIENT; GROWTH-FACTOR; ADHESION; ACTIN; RAT; LAMELLIPODIA; PAXILLIN	The issue of how contractility and adhesion are related to cell shape and migration pattern remains largely unresolved. In this paper we report that Gleevec (Imatinib), an Abl family kinase inhibitor, produces a profound change in the shape and migration of rat bladder tumor cells (NBTII) plated on collagen-coated substrates. Cells treated with Gleevec adopt a highly spread D-shape and migrate more rapidly with greater persistence. Accompanying this more spread state is an increase in integrin-mediated adhesion coupled with increases in the size and number of discrete adhesions. In addition, both total internal reflection fluorescence microscopy (TIRFM) and interference reflection microscopy (IRM) revealed a band of small punctate adhesions with rapid turnover near the cell leading margin. These changes led to an increase in global cell-substrate adhesion strength, as assessed by laminar flow experiments. Gleevec-treated cells have greater RhoA activity which, via myosin activation, led to an increase in the magnitude of total traction force applied to the substrate. These chemical and physical alterations upon Gleevec treatment produce the dramatic change in morphology and migration that is observed.	[Chen, Zaozao; Lessey, Elizabeth; Itano, Michelle; Kapustina, Maryna; Burridge, Keith; Jacobson, Ken] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Chen, Zaozao; Itano, Michelle; Kapustina, Maryna; Burridge, Keith; Jacobson, Ken] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Chen, Zaozao; Jacobson, Ken] Univ N Carolina, Sch Med, Program Mol & Cellular Biophys, Chapel Hill, NC USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Cao, Li; Li, Jonathan; Truskey, George] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Trepat, Xavier] Univ Barcelona, Inst Bioengn Catalonia, Barcelona, Spain; [Trepat, Xavier] Ciber Enfermedades Respiratorias, Barcelona, Spain; [Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Huang, Cai] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA; [Gomez, Shawn M.] Univ N Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Kentucky; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jacobson, K (corresponding author), Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	frap@med.unc.edu	Truskey, George/AAB-7793-2021; Chen, Zaozao/AAS-6111-2021; Truskey, George A/B-2215-2012; Kapustina, Maryna/B-8929-2014; , UNC Flow Cytometry Core/AGU-9839-2022; Itano, Michelle/AAU-4367-2020; Trepat, Xavier/I-3912-2015	Truskey, George/0000-0002-6885-4489; Truskey, George A/0000-0002-6885-4489; Itano, Michelle/0000-0001-6853-1228; Trepat, Xavier/0000-0002-7621-5214; Gomez, Shawn/0000-0002-8251-4552	National Institutes of Health Cell Migration Consortium National Institutes of Health [GM 64346]; National Institutes of Health [GM029860]; Chinese government fellowship (China Scholarship Council (CSC)); National Institutes of Health Cell Migration Consortium [NIH GM 64346]; Molecular and Cellular Biophysics Program [NIH T32GM008570]; IVB Training Program [NIH T32HL069768]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, T32GM008570, U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese government fellowship (China Scholarship Council (CSC)); National Institutes of Health Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular and Cellular Biophysics Program; IVB Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Cell Migration Consortium National Institutes of Health GM 64346 (KJ) and National Institutes of Health GM029860 (KB). ZC was supported by Chinese government fellowship (China Scholarship Council (CSC)), the National Institutes of Health Cell Migration Consortium (NIH GM 64346), and Molecular and Cellular Biophysics Program (NIH T32GM008570). EL was supported by the IVB Training Program (NIH T32HL069768). URL of funder's website: NIH: http://grants.nih.gov/grants/guide/ CSC: http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Bellone G, 2004, CANCER BIOL THER, V3, P385, DOI 10.4161/cbt.3.4.727; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chan BP, 2004, BIOTECHNOL PROGR, V20, P566, DOI 10.1021/bp034215z; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hubbard SR, 2002, CURR OPIN STRUC BIOL, V12, P735, DOI 10.1016/S0959-440X(02)00383-4; IZZARD CS, 1976, J CELL SCI, V21, P129; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Krieger SM, 2004, MOL CELL BIOL; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1997, J CELL SCI, V110, P2833; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MEININGER CJ, 1992, BLOOD, V79, P958; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanz-Moreno V, 2009, CELL CYCLE, V8, P1484, DOI 10.4161/cc.8.10.8490; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Schweizer A, 1999, J BIOL CHEM, V274, P20450, DOI 10.1074/jbc.274.29.20450; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; TOYOSHIMA K, 1971, JNCI-J NATL CANCER I, V47, P979; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H; TUCKER GC, 1991, J CELL SCI, V100, P371; TUCKER GC, 1990, CANCER RES, V50, P129; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VALLES AM, 1990, P NATL ACAD SCI USA, V87, P1124, DOI 10.1073/pnas.87.3.1124; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	60	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52233	10.1371/journal.pone.0052233	http://dx.doi.org/10.1371/journal.pone.0052233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300967	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900022
J	Kadnikov, VV; Mardanov, AV; Podosokorskaya, OA; Gavrilov, SN; Kublanov, IV; Beletsky, AV; Bonch-Osmolovskaya, EA; Ravin, NV				Kadnikov, Vitaly V.; Mardanov, Andrey V.; Podosokorskaya, Olga A.; Gavrilov, Sergey N.; Kublanov, Ilya V.; Beletsky, Alexey V.; Bonch-Osmolovskaya, Elizaveta A.; Ravin, Nikolai V.			Genomic Analysis of Melioribacter roseus, Facultatively Anaerobic Organotrophic Bacterium Representing a Novel Deep Lineage within Bacteriodetes/Chlorobi Group	PLOS ONE			English	Article							CELLULOSE-BINDING DOMAIN; ALTERNATIVE COMPLEX-III; RHODOBACTER-CAPSULATUS; RHODOTHERMUS-MARINUS; NITROGEN-FIXATION; RIBOSOMAL-RNA; CYTOCHROME-C; PHYLOGENY; PHOTOSYNTHESIS; CLASSIFICATION	Melioribacter roseus is a moderately thermophilic facultatively anaerobic organotrophic bacterium representing a novel deep branch within Bacteriodetes/Chlorobi group. To better understand the metabolic capabilities and possible ecological functions of M. roseus and get insights into the evolutionary history of this bacterial lineage, we sequenced the genome of the type strain P3M-2(T). A total of 2838 open reading frames was predicted from its 3.30 Mb genome. The whole proteome analysis supported phylum-level classification of M. roseus since most of the predicted proteins had closest matches in Bacteriodetes, Proteobacteria, Chlorobi, Firmicutes and deeply-branching bacterium Caldithrix abyssi, rather than in one particular phylum. Consistent with the ability of the bacterium to grow on complex carbohydrates, the genome analysis revealed more than one hundred glycoside hydrolases, glycoside transferases, polysaccharide lyases and carbohydrate esterases. The reconstructed central metabolism revealed pathways enabling the fermentation of complex organic substrates, as well as their complete oxidation through aerobic and anaerobic respiration. Genes encoding the photosynthetic and nitrogen-fixation machinery of green sulfur bacteria, as well as key enzymes of autotrophic carbon fixation pathways, were not identified. The M. roseus genome supports its affiliation to a novel phylum Ignavibateriae, representing the first step on the evolutionary pathway from heterotrophic ancestors of Bacteriodetes/Chlorobi group towards anaerobic photoautotrophic Chlorobi.	[Kadnikov, Vitaly V.; Mardanov, Andrey V.; Beletsky, Alexey V.; Ravin, Nikolai V.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Podosokorskaya, Olga A.; Gavrilov, Sergey N.; Kublanov, Ilya V.; Bonch-Osmolovskaya, Elizaveta A.] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Ravin, NV (corresponding author), Russian Acad Sci, Ctr Bioengn, Moscow, Russia.	nravin@biengi.ac.ru	Kadnikov, Vitaly V/E-2359-2014; Beletsky, Alexey/AAA-5366-2019; Mardanov, Andrey/S-2294-2016; Kadnikov, Vitaly/AAB-5305-2019; Kublanov, Ilya V/D-2976-2013; Podosokorskaya, Olga/ADN-6642-2022; Ravin, Nikolai V/C-5907-2014	Kadnikov, Vitaly V/0000-0002-3022-9784; Beletsky, Alexey/0000-0002-7611-2354; Mardanov, Andrey/0000-0002-8245-8757; Kadnikov, Vitaly/0000-0002-3022-9784; Kublanov, Ilya V/0000-0002-6845-8873; Ravin, Nikolai/0000-0002-1456-1832	Ministry of Education and Sciences of Russia [11.519.11.2029]; Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences	Ministry of Education and Sciences of Russia; Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences	This work was performed using the scientific equipment of Core Research Facility of Centre 'Bioengineering' RAS and supported by Ministry of Education and Sciences of Russia (contract 11.519.11.2029). The work of V.V.K., A.V.M. and N.V.R. was supported by the Program "The origin and evolution of biosphere'' of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Alexander B, 2002, ARCH MICROBIOL, V178, P131, DOI 10.1007/s00203-002-0432-4; BARRETT EL, 1987, MICROBIOL REV, V51, P192, DOI 10.1128/MMBR.51.2.192-205.1987; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Brun E, 2000, BIOCHEMISTRY-US, V39, P2445, DOI 10.1021/bi992079u; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; BUCHANAN BB, 1990, PHOTOSYNTH RES, V24, P47, DOI 10.1007/BF00032643; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Crotti LB, 1998, J BASIC MICROB, V38, P181; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; Garrity G.M., 2001, BERGEYS MANUAL SYSTE, P601; Gilkes NR, 1999, GENETICS BIOCH ECOLO, P24; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gruber TM, 1998, FEMS MICROBIOL LETT, V162, P53, DOI 10.1016/S0378-1097(98)00102-5; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Huxley L, 2011, BBA-BIOENERGETICS, V1807, P85, DOI 10.1016/j.bbabio.2010.08.005; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Jeong HS, 2000, J BACTERIOL, V182, P1208, DOI 10.1128/JB.182.5.1208-1214.2000; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Krieg NR., 2010, BERGEYS MANUAL SYSTE, P25, DOI [10.1007/978-0-387-68572-4_3, DOI 10.1007/978-0-387-68572-4]; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Liu Z, 2012, ISME J IN PRESS; Liu ZF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00185; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Nold SC, 1996, APPL ENVIRON MICROB, V62, P4598, DOI 10.1128/AEM.62.12.4598-4607.1996; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PASTER BJ, 1994, J BACTERIOL, V176, P725, DOI 10.1128/jb.176.3.725-732.1994; Pereira MM, 2007, FEBS LETT, V581, P4831, DOI 10.1016/j.febslet.2007.09.008; Perevalova AA, 2008, APPL ENVIRON MICROB, V74, P7620, DOI 10.1128/AEM.00972-08; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Podosokorskaya O, 2013, ENV MICROBI IN PRESS; Refojo PN, 2010, BBA-BIOENERGETICS, V1797, P1869, DOI 10.1016/j.bbabio.2010.04.012; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stelter M, 2008, BIOCHEMISTRY-US, V47, P11953, DOI 10.1021/bi800999g; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Swem LR, 2001, J MOL BIOL, V309, P121, DOI 10.1006/jmbi.2001.4652; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; WAHLUND TM, 1993, J BACTERIOL, V175, P474, DOI 10.1128/JB.175.2.474-478.1993; Wilson DB, 2009, CELLULOSE, V16, P723, DOI 10.1007/s10570-009-9326-9; WILSON DB, 1992, CRIT REV BIOTECHNOL, V12, P45, DOI 10.3109/07388559209069187; WINTERHALTER C, 1995, MOL MICROBIOL, V15, P431, DOI 10.1111/j.1365-2958.1995.tb02257.x; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l	69	47	52	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53047	10.1371/journal.pone.0053047	http://dx.doi.org/10.1371/journal.pone.0053047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301019	Green Submitted, gold, Green Published			2022-12-27	WOS:000313320900055
J	Lee, YC; Tzeng, WF; Chiou, TJ; Chu, ST				Lee, Ying Chu; Tzeng, Woan-Fang; Chiou, Tzeon-Jye; Chu, Sin Tak			MicroRNA-138 Suppresses Neutrophil Gelatinase-Associated Lipocalin Expression and Inhibits Tumorigenicity	PLOS ONE			English	Article							NGAL; CANCER; PROTEIN	The expression of neutrophil gelatinase-associated lipocalin (NGAL) is up-regulated in some cancers; therefore NGAL has potential as a tumor biomarker. Although the regulation mechanism for this is unknown, one study has shown that it is likely to involve a microRNA (miRNA). Here, we investigate the relation between miRNA expression and NGAL expression, and the role of NGAL in tumorigenesis. Using miRNA target-detecting software, we analyze the mRNA sequence of NGAL and identify a target site for microRNA-138 (miR-138) in nucleotides 25-53 of the 3' UTR. We then analyze NGAL and miR-138 expression in three cancer cell lines originating from breast, endometrial and pancreatic carcinomas (the MCF-7, RL95-2 and AsPC-1 cell lines), respectively, using quantitative (real-time) PCR and western blot analysis. Metastasis is a critical event in cancer progression, in which malignant cell proliferation, migration and invasion increase. To determine whether miR-138-regulated NGAL expression is associated with metastasis, the proliferation and migration of the cell line are examined after miR-138 transfection. Using nude mice, we examine both the tumorigenicity of these cell lines and of miR-138-transfected cancer cells in vivo, as well as the effect of treating tumors with an antibody against NGAL. Our results show that these cancer cell lines down-regulate NGAL when miR-138 is highly expressed. Ectopic transfection of miR-138 suppresses NGAL expression and cell migration in RL95-2 and AsPC-1 cells, demonstrating that miR-138-regulated NGAL expression is associated with cell migration. Additionally, injection of the NGAL antibody diminishes NGAL-mediated tumorigenesis in nude mice, and miR-138 transfection of cancer cells reduces tumor formation. As the cell proliferation data showed that the tumor size should be regulated by NGAL-related cell growth. Taken together, our results indicate that NGAL may be a good target for cancer therapy and suggest that miR-138 acts as a tumor suppressor and may prevent metastasis.	[Lee, Ying Chu; Chu, Sin Tak] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Tzeng, Woan-Fang] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Dept Med, Div Transfus Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chu, Sin Tak] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Fu Jen Catholic University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Chu, ST (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	stc316@gate.sinica.edu.tw			National Science Council of Taiwan [NSC 98-2314-B-075-022-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council of Taiwan (grant number NSC 98-2314-B-075-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin HH, 2007, TOXICOLOGY, V234, P203, DOI 10.1016/j.tox.2007.02.017; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Rodriguez Luis G., 2004, V294, P23; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	21	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52979	10.1371/journal.pone.0052979	http://dx.doi.org/10.1371/journal.pone.0052979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300839	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600043
J	Tian, JX; Du, QZ; Chang, MQ; Zhang, DQ				Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang			Allelic Variation in PtGA20Ox Associates with Growth and Wood Properties in Populus spp	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; GIBBERELLIN BIOSYNTHESIS; NATURAL-POPULATIONS; CANDIDATE GENES; COMPLEX TRAITS; MESSENGER-RNA; GENETICS; POLYMORPHISMS; METABOLISM	Populus tomentosa is an economically important tree crop that produces wood for lumber, pulp, paper, and biofuels. Wood quality traits are likely to be strongly affected by the plant hormone gibberellic acid (GA), which regulates growth. GA20Ox encodes one of the major regulatory enzymes of GA biosynthesis and may therefore play a large role in growth and wood quality. Here, linkage disequilibrium (LD) studies were used to identify significant associations between single nucleotide polymorphisms (SNPs) within PtGA20Ox and growth and wood-quality traits of P. tomentosa. We isolated a full-length GA20Ox cDNA from Populus tomentosa by reverse transcription (RT)-PCR; this 1401 bp cDNA clone had an open reading frame of 1158 bp and encoded a protein of 385 amino acids. PtGA20Ox transcripts were maximally expressed in the mature xylem of vascular tissues, suggesting that PtGA20Ox is highly expressed and specifically associated with secondary xylem formation. Resequencing the PtGA20Ox locus of 36 individuals identified 55 SNPs, and the frequency of SNPs was 1/31 bp. The 29 most common SNPs (frequency >0.1) were genotyped in an association population (426 individuals) that was also phenotyped for key growth and wood quality traits. LD did not extend over the entire gene (r(2)<0.1, within 500 bp), demonstrating that a candidate-gene-based LD approach may the best way to understand the molecular basis underlying quantitative variation in this species. SNP-and haplotype-based association analyses indicated that four SNPs (false discovery rate Q<0.05) and 14 haplotypes (P<0.05) were significantly associated with growth and wood properties. The phenotypic variance explained by each SNP ranged from 3.44% to 14.47%. The SNP markers identified in this study can be applied to breeding programs for the improvement of growth and wood-property traits by marker-assisted selection.	[Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China; [Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn			State Key Basic Research Program of China [2012CB114506]; Projects of the National Natural Science Foundation of China [31170622, 30872042]	State Key Basic Research Program of China(National Basic Research Program of China); Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Program of China (No. 2012CB114506) and as the Projects of the National Natural Science Foundation of China (Nos. 31170622, 30872042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, INT J PLANT GENOMICS, V2008, P1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Daykin A, 1997, PLANTA, V203, P526, DOI 10.1007/s004250050222; Deng Wei, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P1095; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fang XT, 2010, GENES GENOM, V32, P29, DOI 10.1007/s13258-010-0762-6; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HEDRICK PW, 1987, GENETICS, V117, P331; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang Z., 1992, J BEIJING FOR U, V14, P26, DOI DOI 10.13332/J.1000-1522.1992.S3.00; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Ismail M, 2012, J MOL EVOL, V74, P257, DOI 10.1007/s00239-012-9504-5; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Koshkin AA, 1998, TETRAHEDRON LETT, V39, P4381, DOI 10.1016/S0040-4039(98)00706-0; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; LEWONTIN RC, 1964, GENETICS, V49, P49; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Niki T, 2001, PLANT PHYSIOL, V126, P965, DOI 10.1104/pp.126.3.965; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pritchard JK, 2000, GENETICS, V155, P945; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Ridoutt BG, 1996, PHYSIOL PLANTARUM, V96, P559, DOI 10.1111/j.1399-3054.1996.tb00227.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sari-Gorla M, 1999, THEOR APPL GENET, V99, P289, DOI 10.1007/s001220051234; SAUTER M, 1992, PLANTA, V188, P362, DOI 10.1007/BF00192803; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sexton TR, 2010, AUST FORESTRY, V73, P254, DOI 10.1080/00049158.2010.10676336; Shao YF, 2011, THEOR APPL GENET, V122, P1005, DOI 10.1007/s00122-010-1505-4; Shen HuiJuan, 1996, Scientia Silvae Sinicae, V32, P165; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Sokal R. R, 1981, BIOMETRY; Southerton SG, 2010, AUST FORESTRY, V73, P259, DOI 10.1080/00049158.2010.10676337; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Weir BS., 1996, GENETIC DATA ANAL; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7; Zhang DeQiang, 2005, Forestry Studies in China, V7, P1, DOI 10.1007/s11632-005-0024-x	70	37	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53116	10.1371/journal.pone.0053116	http://dx.doi.org/10.1371/journal.pone.0053116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300875	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600061
J	Ho, CSJ; Rydstrom, A; Manimekalai, MSS; Svanborg, C; Gruber, G				Ho, James C. S.; Rydstrom, Anna; Manimekalai, Malathy Sony Subramanian; Svanborg, Catharina; Grueber, Gerhard			Low Resolution Solution Structure of HAMLET and the Importance of Its Alpha-Domains in Tumoricidal Activity	PLOS ONE			English	Article							APOPTOSIS-LIKE MECHANISM; KILLS TUMOR-CELLS; OLEIC-ACID; MOONLIGHTING PROTEINS; APO-BOVINE; LACTALBUMIN; LETHAL; COMPLEX; HOLOGRAPHY; CONVERSION	HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) is the first member in a new family of protein-lipid complexes with broad tumoricidal activity. Elucidating the molecular structure and the domains crucial for HAMLET formation is fundamental for understanding its tumoricidal function. Here we present the low-resolution solution structure of the complex of oleic acid bound HAMLET, derived from small angle X-ray scattering data. HAMLET shows a two-domain conformation with a large globular domain and an extended part of about 2.22 nm in length and 1.29 nm width. The structure has been superimposed into the related crystallographic structure of human alpha-lactalbumin, revealing that the major part of alpha-lactalbumin accommodates well in the shape of HAMLET. However, the C-terminal residues from L105 to L123 of the crystal structure of the human alpha-lactalbumin do not fit well into the HAMLET structure, resulting in an extended conformation in HAMLET, proposed to be required to form the tumoricidal active HAMLET complex with oleic acid. Consistent with this low resolution structure, we identified biologically active peptide epitopes in the globular as well as the extended domains of HAMLET. Peptides covering the alpha1 and alpha2 domains of the protein triggered rapid ion fluxes in the presence of sodium oleate and were internalized by tumor cells, causing rapid and sustained changes in cell morphology. The alpha peptide-oleate bound forms also triggered tumor cell death with comparable efficiency as HAMLET. In addition, shorter peptides corresponding to those domains are biologically active. These findings provide novel insights into the structural prerequisites for the dramatic effects of HAMLET on tumor cells.	[Ho, James C. S.; Rydstrom, Anna; Svanborg, Catharina] Lund Univ, Dept Microbiol Immunol & Glycobiol MIG, Inst Lab Med, Lund, Sweden; [Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Lund University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Svanborg, C (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol MIG, Inst Lab Med, Lund, Sweden.	catharina.svanborg@med.lu.se; ggrueber@ntu.edu.sg	Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Rydstrom, Anna/0000-0002-3404-7195	Sharon D. Lund foundation grant; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Ministry of Education (MOE), Singapore (AcRF) [Tier 1, RG 45/10]	Sharon D. Lund foundation grant; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Ministry of Education (MOE), Singapore (AcRF)	This research was supported by the Sharon D. Lund foundation grant and the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society to C. Svanborg and by the Ministry of Education (MOE), Singapore (AcRF, Tier 1; RG 45/10) to G. Gruber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA KR, 1989, J MOL BIOL, V208, P99, DOI 10.1016/0022-2836(89)90091-0; Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; ALEXANDRESCU AT, 1992, EUR J BIOCHEM, V210, P699, DOI 10.1111/j.1432-1033.1992.tb17471.x; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BREW K, 1967, J BIOL CHEM, V242, P3747; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; BRODBECK U, 1966, J BIOL CHEM, V241, P762; CAMPBELL J, 1964, BIOCHEM J, V93, P183, DOI 10.1042/bj0930183; Chrysina ED, 2000, J BIOL CHEM, V275, P37021, DOI 10.1074/jbc.M004752200; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Dymkowska D, 2006, BBA-MOL CELL RES, V1763, P152, DOI 10.1016/j.bbamcr.2005.12.009; Dymkowska D, 2004, TOXICOL MECH METHOD, V14, P73, DOI 10.1080/15376520490257518; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; FITZGERALD LA, 1984, J CELL SCI, V67, P1; Guinier A, 1955, SMALL ANGLE SCTTERIN; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; Harata K, 1999, J MOL BIOL, V287, P347, DOI 10.1006/jmbi.1999.2598; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KOGA K, 1985, BIOCHEMISTRY-US, V24, P7257, DOI 10.1021/bi00346a035; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Pettersson J, 2006, BIOCHEM BIOPH RES CO, V345, P260, DOI 10.1016/j.bbrc.2006.04.081; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schnars U., 2005, DIGITAL HOLOGRAPHY D; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Svensson M, 2002, ADV EXP MED BIOL, V503, P125; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Trulsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017179; Wijesinha-Bettoni R, 2001, J MOL BIOL, V307, P885, DOI 10.1006/jmbi.2001.4530; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Wu LC, 1997, P NATL ACAD SCI USA, V94, P14314, DOI 10.1073/pnas.94.26.14314; Yu FR, 2008, J PHARM PHARMACOL, V60, P253, DOI 10.1211/jpp.60.2.0015; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003	52	22	23	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53051	10.1371/journal.pone.0053051	http://dx.doi.org/10.1371/journal.pone.0053051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300861	Green Published, gold			2022-12-27	WOS:000312829100114
J	Krakstad, C; Birkeland, E; Seidel, D; Kusonmano, K; Petersen, K; Mjos, S; Hoivik, EA; Wik, E; Halle, MK; Oyan, AM; Kalland, KH; Werner, HMJ; Trovik, J; Salvesen, H				Krakstad, Camilla; Birkeland, Even; Seidel, Danila; Kusonmano, Kanthida; Petersen, Kjell; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Oyan, Anne M.; Kalland, Karl-Henning; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga			High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated	PLOS ONE			English	Article							LUNG ADENOCARCINOMA; COLORECTAL CANCERS; SOMATIC MUTATIONS; CARCINOMA; BRAF; INHIBITION; PTEN; VEMURAFENIB; ACTIVATION; GENOME	Background: Despite being the most common pelvic gynecologic malignancy in industrialized countries, no targeted therapies are available for patients with metastatic endometrial carcinoma. In order to improve treatment, underlying molecular characteristics of primary and metastatic disease must be explored. Methodology/Principal Findings: We utilized the mass spectrometric-based mutation detection technology OncoMap to define the types and frequency of point somatic mutations in endometrial cancer. 67 primary tumors, 15 metastases corresponding to 7 of the included primary tumors and 11 endometrial cancer cell lines were screened for point mutations in 28 known oncogenes. We found that 27 (40.3%) of 67 primary tumors harbored one or more mutations with no increase in metastatic lesions. FGFR2, KRAS and PIK3CA were consistently the most frequently mutated genes in primary tumors, metastatic lesions and cell lines. Conclusions/Significance: Our results emphasize the potential for targeting FGFR2, KRAS and PIK3CA mutations in endometrial cancer for development of novel therapeutic strategies.	[Krakstad, Camilla; Birkeland, Even; Kusonmano, Kanthida; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga] Univ Bergen, Dept Clin Med, Bergen, Norway; [Krakstad, Camilla; Birkeland, Even; Kusonmano, Kanthida; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Seidel, Danila] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Seidel, Danila] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Seidel, Danila] Univ Cologne, Lab Translat Canc Genom, Ctr Integrated Oncol Koln Bonn, D-50931 Cologne, Germany; [Kusonmano, Kanthida; Petersen, Kjell] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Oyan, Anne M.; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Oyan, Anne M.; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Cologne; Max Planck Society; University of Cologne; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Krakstad, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	camilla.krakstad@med.uib.no	salvesen, Helga B/C-1187-2017; Kalland, Karl-Henning/B-9445-2017; Krakstad, Camilla/AAB-5138-2020; Kusonmano, Kanthida/AAQ-2802-2020; Seidel, Danila/Y-6795-2018; Werner, henrica/ABG-1235-2021; Halle, Mari K/AAT-4856-2020; Wik, E./AAA-9105-2020	salvesen, Helga B/0000-0002-4438-8831; Kalland, Karl-Henning/0000-0003-4486-2334; Krakstad, Camilla/0000-0002-0174-8139; Seidel, Danila/0000-0003-4388-3117; Werner, henrica/0000-0001-5186-8369; Halle, Mari K/0000-0002-2660-8271	Western Norway Regional Health Authority [911351, 911624]; Norwegian Research Council [193373, 205404]; Norwegian Cancer Society [628837]	Western Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	The Western Norway Regional Health Authority (grant number: 911351 and 911624), Norwegian Research Council (grant number: 193373 and 205404), and The Norwegian Cancer Society (grant number: 628837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Birkeland E, 2012, BR J CANC; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Fujimoto T, 2009, GYNECOL ONCOL, V112, P342, DOI 10.1016/j.ygyno.2008.10.019; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; Mutter GL, 1999, J CLIN PATHOL-MOL PA, V52, P257, DOI 10.1136/mp.52.5.257; Peterson LM, 2012, INT J GYNECOL PATHOL, V31, P195, DOI 10.1097/PGP.0b013e318231fc51; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2005, INT J CANCER, V115, P930, DOI 10.1002/ijc.20702; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Semczuk A, 1998, J CANCER RES CLIN, V124, P695, DOI 10.1007/s004320050234; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532	35	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52795	10.1371/journal.pone.0052795	http://dx.doi.org/10.1371/journal.pone.0052795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300780	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100084
J	Gongora-Castillo, E; Childs, KL; Fedewa, G; Hamilton, JP; Liscombe, DK; Magallanes-Lundback, M; Mandadi, KK; Nims, E; Runguphan, W; Vaillancourt, B; Varbanova-Herde, M; DellaPenna, D; McKnight, TD; O'Connor, S; Buell, CR				Gongora-Castillo, Elsa; Childs, Kevin L.; Fedewa, Greg; Hamilton, John P.; Liscombe, David K.; Magallanes-Lundback, Maria; Mandadi, Kranthi K.; Nims, Ezekiel; Runguphan, Weerawat; Vaillancourt, Brieanne; Varbanova-Herde, Marina; DellaPenna, Dean; McKnight, Thomas D.; O'Connor, Sarah; Buell, C. Robin			Development of Transcriptomic Resources for Interrogating the Biosynthesis of Monoterpene Indole Alkaloids in Medicinal Plant Species	PLOS ONE			English	Article							GENOME; HYDROXYLATION	The natural diversity of plant metabolism has long been a source for human medicines. One group of plant-derived compounds, the monoterpene indole alkaloids (MIAs), includes well-documented therapeutic agents used in the treatment of cancer (vinblastine, vincristine, camptothecin), hypertension (reserpine, ajmalicine), malaria (quinine), and as analgesics (7-hydroxymitragynine). Our understanding of the biochemical pathways that synthesize these commercially relevant compounds is incomplete due in part to a lack of molecular, genetic, and genomic resources for the identification of the genes involved in these specialized metabolic pathways. To address these limitations, we generated large-scale transcriptome sequence and expression profiles for three species of Asterids that produce medicinally important MIAs: Camptotheca acuminata, Catharanthus roseus, and Rauvolfia serpentina. Using next generation sequencing technology, we sampled the transcriptomes of these species across a diverse set of developmental tissues, and in the case of C. roseus, in cultured cells and roots following elicitor treatment. Through an iterative assembly process, we generated robust transcriptome assemblies for all three species with a substantial number of the assembled transcripts being full or near-full length. The majority of transcripts had a related sequence in either UniRef100, the Arabidopsis thaliana predicted proteome, or the Pfam protein domain database; however, we also identified transcripts that lacked similarity with entries in either database and thereby lack a known function. Representation of known genes within the MIA biosynthetic pathway was robust. As a diverse set of tissues and treatments were surveyed, expression abundances of transcripts in the three species could be estimated to reveal transcripts associated with development and response to elicitor treatment. Together, these transcriptomes and expression abundance matrices provide a rich resource for understanding plant specialized metabolism, and promotes realization of innovative production systems for plant-derived pharmaceuticals.	[Gongora-Castillo, Elsa; Childs, Kevin L.; Hamilton, John P.; Vaillancourt, Brieanne; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Fedewa, Greg; Magallanes-Lundback, Maria; Varbanova-Herde, Marina; DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Liscombe, David K.; Nims, Ezekiel; Runguphan, Weerawat] MIT, Dept Chem, Cambridge, MA 02139 USA; [Mandadi, Kranthi K.; McKnight, Thomas D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [O'Connor, Sarah] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [O'Connor, Sarah] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	Michigan State University; Michigan State University; Massachusetts Institute of Technology (MIT); Texas A&M University System; Texas A&M University College Station; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Mandadi, Kranthi/I-4033-2019; Hamilton, John P/G-1379-2016; O'Connor, Sarah Ellen/X-2893-2019; Góngora-Castillo, Elsa B/R-8854-2016; Runguphan, Weerawat/GSM-9179-2022; Childs, Kevin/C-9513-2014; O'Connor, Sarah/O-5850-2016	Mandadi, Kranthi/0000-0003-2986-4016; Hamilton, John P/0000-0002-8682-5526; Góngora-Castillo, Elsa B/0000-0001-6327-6993; Fedewa, Greg/0000-0002-3448-3819; Vaillancourt, Brieanne/0000-0002-6795-5173; Runguphan, Weerawat/0000-0001-5707-3516; Childs, Kevin/0000-0002-3680-062X; O'Connor, Sarah/0000-0003-0356-6213; Buell, C Robin/0000-0002-6727-4677	National Institute of General Medical Sciences [1RC2GM092521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0654] Funding Source: researchfish; BBSRC [BBS/E/J/000C0654] Funding Source: UKRI	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for medicinal plant transcriptome work was provided by a grant to CRB, DD, TDM, and SO from the National Institute of General Medical Sciences (1RC2GM092521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARORA RB, 1956, J PHARMACOL EXP THER, V117, P62; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENSCH KG, 1969, SCIENCE, V165, P495, DOI 10.1126/science.165.3892.495; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; CORDELL GA, 1974, LLOYDIA, V37, P219; GEORGE P, 1965, JNCI-J NATL CANCER I, V35, P355; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kinghorn AD, 2011, J NAT PROD, V74, P1539, DOI 10.1021/np200391c; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; LopezMeyer M, 1997, PLANT J, V11, P1167, DOI 10.1046/j.1365-313X.1997.11061167.x; Lorence A, 2004, PHYTOCHEMISTRY, V65, P2735, DOI 10.1016/j.phytochem.2004.09.001; Mccoy E, 2006, J AM CHEM SOC, V128, P14276, DOI 10.1021/ja066787w; MCFARLANE J, 1975, BIOCHEM BIOPH RES CO, V66, P1263, DOI 10.1016/0006-291X(75)90495-7; MEEHAN TD, 1973, BIOCHEM BIOPH RES CO, V53, P1043, DOI 10.1016/0006-291X(73)90570-6; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; R Core Team, 2021, R LANGUAGE ENV STAT; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shamon SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007655.pub2; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szabo LF, 2008, MOLECULES, V13, P1875, DOI 10.3390/molecules13081875; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vazquez-Flota FA, 1998, PHYTOCHEMISTRY, V49, P395, DOI 10.1016/S0031-9422(98)00176-9; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	107	109	3	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52506	10.1371/journal.pone.0052506	http://dx.doi.org/10.1371/journal.pone.0052506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300689	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800096
J	Ni, ZH; Tao, K; Chen, G; Chen, QG; Tang, JM; Luo, XM; Yin, PH; Tang, JH; Wang, XBA				Ni, Zhenhua; Tao, Kun; Chen, Guo; Chen, Qingge; Tang, Jianmin; Luo, Xuming; Yin, Peihao; Tang, Jihong; Wang, Xiongbiao			CLPTM1L Is Overexpressed in Lung Cancer and Associated with Apoptosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TERT-CLPTM1L LOCUS; SUSCEPTIBILITY; VARIANTS; EXPRESSION; CELLS; GENE	CLPTM1L is believed to be associated with lung cancer. However, there is little information regarding its expression and function. Here using immunohistochemistry, we found that CLPTM1L expression was markedly increased in lung cancer tissues relative to normal tissues, especially in lung adenocarcinoma. CLPTM1L expression was not found to be associated with stages, smoking status, lymph node metastasis, or T lymphocyte infiltration but with differentiation stage. We found CLPTM1L to be enriched in the mitochondrial compared with plasma membrane protein extracts. CLPTM1L-EGFP transfection showed that the molecule product was expressed in cytoplasm and indicated the mitochondrial localization stained with mitochondrial marker MitoTracker. CLPTM1L transferred lung cancer cell line 95-D showed no growth inhibition or cell apoptosis, but it did show inhibited sensitivity to cis-diamminedichloroplatinum(II) (cisplatin, CDDP). Knockdown of CLPTM1L by RNAi did not interfere with cell proliferation but it did increase cell sensitivity to CDDP and activation of caspase-9 and caspase-3/7. These data indicate CLPTM1L is a mitochondria protein and that it may be associated with anti-apoptotic mechanism which affects drug-resistance in turn.	[Ni, Zhenhua; Chen, Guo; Chen, Qingge; Tang, Jianmin; Luo, Xuming; Yin, Peihao; Tang, Jihong; Wang, Xiongbiao] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China; [Tao, Kun] Shanghai Changning Cent Hosp, Dept Pathol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, XBA (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China.	xiongbiao6@yahoo.com			Shanghai Science and Technology Committee [09JC1412900, 10411969100]; Shanghai Educational Committee [10YZ54]; Shanghai Putuo District Science and Technology Committee; Innovation Program of Shanghai Municipal Education commission [13ZZ096]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Educational Committee; Shanghai Putuo District Science and Technology Committee; Innovation Program of Shanghai Municipal Education commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the Shanghai Science and Technology Committee (No. 09JC1412900, No. 10411969100), the Shanghai Educational Committee (No. 10YZ54), the Shanghai Putuo District Science and Technology Committee (2010), and the Innovation Program of Shanghai Municipal Education commission (13ZZ096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2005, ONCOL REP, V14, P601; Batra J, 2011, AM J EPIDEMIOL, V174, P1391, DOI 10.1093/aje/kwr271; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kratz CP, 2011, J MED GENET, V48, P473, DOI 10.1136/jmedgenet-2011-100001; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Ribatti D, 2011, ADV EXP MED BIOL, V716, P270, DOI 10.1007/978-1-4419-9533-9_14; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Wang SM, 2012, MOL CARCINOGEN, V51, pE118, DOI 10.1002/mc.21872; Wauters E, 2011, EUR RESPIR J, V38, P924, DOI 10.1183/09031936.00187110; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	25	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52598	10.1371/journal.pone.0052598	http://dx.doi.org/10.1371/journal.pone.0052598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300716	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800109
J	Gutig, R; Gollisch, T; Sompolinsky, H; Meister, M				Guetig, Robert; Gollisch, Tim; Sompolinsky, Haim; Meister, Markus			Computing Complex Visual Features with Retinal Spike Times	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; STRIATE CORTEX; FEEDFORWARD INHIBITION; SOMATOSENSORY CORTEX; RECEPTIVE-FIELDS; AUDITORY-CORTEX; NEURAL-NETWORKS; EYE-MOVEMENTS; INFORMATION	Neurons in sensory systems can represent information not only by their firing rate, but also by the precise timing of individual spikes. For example, certain retinal ganglion cells, first identified in the salamander, encode the spatial structure of a new image by their first-spike latencies. Here we explore how this temporal code can be used by downstream neural circuits for computing complex features of the image that are not available from the signals of individual ganglion cells. To this end, we feed the experimentally observed spike trains from a population of retinal ganglion cells to an integrate-and-fire model of post-synaptic integration. The synaptic weights of this integration are tuned according to the recently introduced tempotron learning rule. We find that this model neuron can perform complex visual detection tasks in a single synaptic stage that would require multiple stages for neurons operating instead on neural spike counts. Furthermore, the model computes rapidly, using only a single spike per afferent, and can signal its decision in turn by just a single spike. Extending these analyses to large ensembles of simulated retinal signals, we show that the model can detect the orientation of a visual pattern independent of its phase, an operation thought to be one of the primitives in early visual processing. We analyze how these computations work and compare the performance of this model to other schemes for reading out spike-timing information. These results demonstrate that the retina formats spatial information into temporal spike sequences in a way that favors computation in the time domain. Moreover, complex image analysis can be achieved already by a simple integrate-and-fire model neuron, emphasizing the power and plausibility of rapid neural computing with spike times.	[Guetig, Robert] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Guetig, Robert; Sompolinsky, Haim] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Guetig, Robert; Sompolinsky, Haim] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, Gottingen, Germany; [Sompolinsky, Haim; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Max Planck Society; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Gottingen; Harvard University; Harvard University	Gutig, R (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	guetig@em.mpg.de; meister@caltech.edu	889, CRC/L-1607-2018; Sompolinsky, Haim/ABB-8398-2021	889, CRC/0000-0002-6678-3138; Gollisch, Tim/0000-0003-3998-533X; Meister, Markus/0000-0003-2136-6506	Minerva Foundation; German Research Foundation; Max Planck Society; German Research Foundation [SFB 889]; International Human Frontier Science Program Organization; Israel Science Foundation; Israeli Ministry of Defense; Gatsby Charitable Foundation; National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER	Minerva Foundation; German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Defense; Gatsby Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Minerva Foundation and the German Research Foundation (RG); the Max Planck Society, the German Research Foundation SFB 889, and the International Human Frontier Science Program Organization (TG); the Israel Science Foundation, the Israeli Ministry of Defense, and the Gatsby Charitable Foundation (HS); and the National Institutes of Health (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; BARNDEN JA, 1993, IEEE T NEURAL NETWOR, V4, P844, DOI 10.1109/72.248461; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; BRAINARD DH, 1989, COLOR RES APPL, V14, P23, DOI 10.1002/col.5080140107; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Carandini M, 2006, J PHYSIOL-LONDON, V577, P463, DOI 10.1113/jphysiol.2006.118976; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; CARR CE, 1990, J NEUROSCI, V10, P3227; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1976, J PHYSIOL-LONDON, V255, P299, DOI 10.1113/jphysiol.1976.sp011281; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Delorme A, 2003, J COMPUT NEUROSCI, V15, P357, DOI 10.1023/A:1027420012134; Delorme A, 2001, NEURAL NETWORKS, V14, P795, DOI 10.1016/S0893-6080(01)00049-1; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; FREUND TF, 1989, J COMP NEUROL, V289, P315, DOI 10.1002/cne.902890211; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Gollisch T, 2008, BIOL CYBERN, V99, P263, DOI 10.1007/s00422-008-0252-y; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2006, J NEUROPHYSIOL, V96, P2845, DOI 10.1152/jn.01131.2005; Gutig R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000141; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Hromadka T, 2009, CURR OPIN NEUROBIOL, V19, P430, DOI 10.1016/j.conb.2009.07.009; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; KAPLAN E, 1984, EXP BRAIN RES, V55, P111; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NODA H, 1975, BRAIN RES, V84, P515, DOI 10.1016/0006-8993(75)90769-6; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Sawtell NB, 2006, J NEUROSCI, V26, P8221, DOI 10.1523/JNEUROSCI.1508-06.2006; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Segev R, 2007, J NEUROPHYSIOL, V98, P1380, DOI 10.1152/jn.00395.2007; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000286; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; STONE J, 1974, J NEUROPHYSIOL, V37, P722, DOI 10.1152/jn.1974.37.4.722; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 2000, BRAIN RES, V886, P33, DOI 10.1016/S0006-8993(00)02751-7; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	79	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53063	10.1371/journal.pone.0053063	http://dx.doi.org/10.1371/journal.pone.0053063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301021	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000313320900057
J	Martinez-Palacian, A; del Castillo, G; Suarez-Causado, A; Garcia-Alvaro, M; de la Morena-Frutos, D; Fernandez, M; Roncero, C; Fabregat, I; Herrera, B; Sanchez, A				Martinez-Palacian, Adoracion; del Castillo, Gaelle; Suarez-Causado, Amileth; Garcia-Alvaro, Maria; de la Morena-Frutos, Diego; Fernandez, Margarita; Roncero, Cesareo; Fabregat, Isabel; Herrera, Blanca; Sanchez, Aranzazu			Mouse Hepatic Oval Cells Require Met-Dependent PI3K to Impair TGF-beta-Induced Oxidative Stress and Apoptosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FETAL-RAT HEPATOCYTES; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; UP-REGULATION; EXPRESSION; PROLIFERATION; ACTIVATION	We have previously shown that oval cells harboring a genetically inactivated Met tyrosine kinase (Met(-/-) oval cells) are more sensitive to TGF-beta-induced apoptosis than cells expressing a functional Met (Met(flx/flx)), demonstrating that the HGF/Met axis plays a pivotal role in oval cell survival. Here, we have examined the mechanism behind this effect and have found that TGF-beta-induced a mitochondria-dependent apoptotic cell death in Met(flx/flx) and Met(-/-) oval cells, associated with a marked increase in levels of the BH3-only proteins Bim and Bmf. Bmf plays a key role during TGF-beta-mediated apoptosis since knocking down of BMF significantly diminished the apoptotic response in Met(-/-) oval cells. TGF-beta also induced oxidative stress accompanied by NADPH oxidase 4 (Nox4) mRNA up-regulation and decreased protein levels of antioxidant enzymes. Antioxidants inhibit both TGF-beta-induced caspase 3 activity and Bmf up-regulation, revealing an oxidative stress-dependent Bmf regulation by TGF-beta. Notably, oxidative stress-related events were strongly amplified in Met(-/-) oval cells, emphasizing the critical role of Met in promoting survival. Pharmacological inhibition of PI3K did impair HGF- driven protection from TGF-beta-induced apoptosis and increased sensitivity of Met(flx/flx) oval cells to TGF-beta by enhancing oxidative stress, reaching apoptotic indices similar to those obtained in Met(-/-) oval cells. Interestingly, both PI3K inhibition and/ or knockdown itself resulted in caspase-3 activation and loss of viability in Met(flx/flx) oval cells, whereas no effect was observed in Met(-/-) oval cells. Altogether, results presented here provide solid evidences that both paracrine and autocrine HGF/Met signaling requires PI3K to promote mouse hepatic oval cell survival against TGF-beta-induced oxidative stress and apoptosis.	[Martinez-Palacian, Adoracion; del Castillo, Gaelle; Suarez-Causado, Amileth; Garcia-Alvaro, Maria; de la Morena-Frutos, Diego; Fernandez, Margarita; Roncero, Cesareo; Herrera, Blanca; Sanchez, Aranzazu] Univ Complutense, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain; [Fabregat, Isabel] Univ Barcelona, Inst Invest Biomed Bellvitge, Oncol Mol Lab, Barcelona, Spain; [Fabregat, Isabel] Univ Barcelona, Inst Invest Biomed Bellvitge, Dept Ciencies Fisiol 2, Barcelona, Spain	Complutense University of Madrid; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sanchez, A (corresponding author), Univ Complutense, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain.	munozas@farm.ucm.es	Herrera, Blanca/K-1803-2014; Sánchez, Aránzazu/H-7810-2015; Roncero, Cesáreo/H-9039-2015; Fernández, Margarita/H-9077-2015; Fabregat, Isabel/H-7038-2015	Herrera, Blanca/0000-0002-2415-2055; Sánchez, Aránzazu/0000-0001-9145-6633; Roncero, Cesáreo/0000-0001-7608-8553; Fernández, Margarita/0000-0001-7207-2028; Fabregat, Isabel/0000-0003-0136-8440	Ministry of Education and Science [SAF2006-12025]; Alban scholarship program; Ministry of Education and Science (Spain) [SAF2006-12025]; Ministry of Science and Innovation (Spain) [SAF2009-12477]; CAM-UCM [920359]; BSCH-UCM [920359];  [S2010/BMD-2402]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alban scholarship program; Ministry of Education and Science (Spain)(Spanish Government); Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM-UCM; BSCH-UCM; 	AMP was recipient of a research-training contract (grant SAF2006-12025) from the Ministry of Education and Science. GC was recipient of a research-training contract from the Ministry of Education and Science. ASC was recipient of an Alban scholarship program and then a research assistant contract (grant SAF2009-12477). MGA is recipient of a research assistant contract (grant S2010/BMD-2402). This work has been supported by grants SAF2006-12025 from Ministry of Education and Science (Spain), SAF2009-12477 from Ministry of Science and Innovation (Spain), and 920359 (CAM-UCM, BSCH-UCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Del Castillo G, 2008, J CELL PHYSIOL, V215, P846, DOI 10.1002/jcp.21370; del Castillo G, 2008, AM J PATHOL, V172, P1238, DOI 10.2353/ajpath.2008.070793; del Castillo G, 2006, EXP CELL RES, V312, P2860, DOI 10.1016/j.yexcr.2006.05.017; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Freathy C, 2000, HEPATOLOGY, V32, P750, DOI 10.1053/jhep.2000.18329; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Grotegut S, 2010, INT J ONCOL, V36, P1261, DOI 10.3892/ijo_00000610; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Herrera B, 2001, FEBS LETT, V499, P225, DOI 10.1016/S0014-5793(01)02554-6; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hu ZX, 2010, EUR J PHARMACOL, V645, P23, DOI 10.1016/j.ejphar.2010.07.011; HU ZY, 1993, AM J PATHOL, V142, P1823; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kannan R, 2004, FREE RADICAL BIO MED, V37, P166, DOI 10.1016/j.freeradbiomed.2004.04.011; Kato H, 2007, HEPATO-GASTROENTEROL, V54, P821; KAYANOKI Y, 1994, J BIOL CHEM, V269, P15488; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Li H, 2006, AM J NEPHROL, V26, P519, DOI 10.1159/000097368; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; Martinez-Palacian A, 2012, CELL SIGNAL, V24, P505, DOI 10.1016/j.cellsig.2011.09.031; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; NAKAMURA T, 1985, BIOCHEM BIOPH RES CO, V133, P1042, DOI 10.1016/0006-291X(85)91241-0; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nguyen LN, 2007, HEPATOLOGY, V45, P31, DOI 10.1002/hep.21466; Niimura M, 2006, NEUROSCI LETT, V407, P136, DOI 10.1016/j.neulet.2006.08.060; OBERHAMMER F, 1991, CANCER RES, V51, P2478; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Okano J, 2003, BIOCHEM BIOPH RES CO, V309, P298, DOI 10.1016/j.bbrc.2003.04.002; Park DY, 1999, J KOREAN MED SCI, V14, P531, DOI 10.3346/jkms.1999.14.5.531; Park HJ, 2002, HEPATOLOGY, V35, P1360, DOI 10.1053/jhep.2002.33205; Preisegger KH, 1999, LAB INVEST, V79, P103; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; SANCHEZ A, 1995, J CELL PHYSIOL, V165, P398, DOI 10.1002/jcp.1041650221; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsuboi S, 1999, J BIOCHEM-TOKYO, V126, P815, DOI 10.1093/oxfordjournals.jbchem.a022521; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Valdes-Arzate A, 2009, FREE RADICAL BIO MED, V47, P424, DOI 10.1016/j.freeradbiomed.2009.05.014; Webster CRL, 2001, HEPATOLOGY, V33, P608, DOI 10.1053/jhep.2001.22756; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yamamoto K, 2001, HYPERTENSION, V37, P1341, DOI 10.1161/01.HYP.37.5.1341; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yao P, 2004, J HEPATOL, V40, P391, DOI 10.1016/j.jhep.2003.11.001; Yu XJ, 2010, MOL BIOL REP, V37, P2423, DOI 10.1007/s11033-009-9753-6; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	70	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53108	10.1371/journal.pone.0053108	http://dx.doi.org/10.1371/journal.pone.0053108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301029	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000313320900061
J	Nelson, BT; Ding, XS; Boney-Montoya, J; Gerard, RD; Kliewer, SA; Andrews, MT				Nelson, Bethany T.; Ding, Xunshan; Boney-Montoya, Jamie; Gerard, Robert D.; Kliewer, Steven A.; Andrews, Matthew T.			Metabolic Hormone FGF21 Is Induced in Ground Squirrels during Hibernation but Its Overexpression Is Not Sufficient to Cause Torpor	PLOS ONE			English	Article							PANCREATIC TRIACYLGLYCEROL LIPASE; PDK4 GENE-EXPRESSION; BETA-KLOTHO; SKELETAL-MUSCLE; PPAR-ALPHA; INDUCTION; BRAIN; TRANSCRIPTION; PGC-1-ALPHA; FGF-21	Hibernation is a natural adaptation that allows certain mammals to survive physiological extremes that are lethal to humans. Near freezing body temperatures, heart rates of 3-10 beats per minute, absence of food consumption, and depressed metabolism are characteristic of hibernation torpor bouts that are periodically interrupted by brief interbout arousals (IBAs). The molecular basis of torpor induction is unknown, however starved mice overexpressing the metabolic hormone fibroblast growth factor 21 (FGF21) promote fat utilization, reduce body temperature, and readily enter torpor-all hallmarks of mammalian hibernation. In this study we cloned FGF21 from the naturally hibernating thirteen-lined ground squirrel (Ictidomys tridecemlineatus) and found that levels of FGF21 mRNA in liver and FGF21 protein in serum are elevated during hibernation torpor bouts and significantly elevated during IBAs compared to summer active animals. The effects of artificially elevating circulating FGF21 concentrations 50 to 100-fold via adenoviral-mediated overexpression were examined at three different times of the year. This is the first time that a transgenic approach has been used in a natural hibernator to examine mechanistic aspects of hibernation. Surgically implanted transmitters measured various metrics of the hibernation phenotype over a 7-day period including changes in motor activity, heart rate and core body temperature. In April fed-state animals, FGF21 overexpression decreased blood insulin and free fatty acid concentrations, effects similar to those seen in obese mice. However, elevated FGF21 concentrations did not cause torpor in these fed-state animals nor did they cause torpor or affect metabolic parameters in fasted-state animals in March/April, August or October. We conclude that FGF21 is strongly regulated during torpor and IBA but that its overexpression is not sufficient to cause torpor in naturally hibernating ground squirrels.	[Nelson, Bethany T.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Ding, Xunshan; Boney-Montoya, Jamie; Gerard, Robert D.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Duluth; University of Texas System; University of Texas Southwestern Medical Center Dallas	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu			National Institutes of Health (NIH) [5RC2HL101625, 1RL1GM084436]; Robert A. Welch Foundation [I-1558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084436] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants 5RC2HL101625 to MTA, 1RL1GM084436 to SAK, and Robert A. Welch Foundation Grant I-1558 to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bauer VW, 2001, AM J PHYSIOL-REG I, V281, pR1186, DOI 10.1152/ajpregu.2001.281.4.R1186; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Geiser F, 1998, AM J PHYSIOL-REG I, V275, pR1627, DOI 10.1152/ajpregu.1998.275.5.R1627; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gerard RD, 1995, ADENOVIRUS VECTORS D, P285; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lyman C.P., 1982, HIBERNATION TORPOR M; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Ornitz DM, 2001, GENOME BIOL, V2; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Squire TL, 2003, PHYSIOL GENOMICS, V16, P131, DOI 10.1152/physiolgenomics.00168.2002; Squire TL, 2003, PHYSIOL GENOMICS, V16, P119, DOI 10.1152/physiolgenomics.00167.2002; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tsintzas K, 2006, J PHYSIOL-LONDON, V575, P291, DOI 10.1113/jphysiol.2006.109892; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374; Vybiral S, 1997, COMP BIOCHEM PHYS A, V118, P1125, DOI 10.1016/S0300-9629(97)00239-9; WANG LCH, 1988, CRYOBIOLOGY, V25, P355, DOI 10.1016/0011-2240(88)90043-0; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53574	10.1371/journal.pone.0053574	http://dx.doi.org/10.1371/journal.pone.0053574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301087	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900084
J	Ramos-Moreno, T; Lendinez, JG; Pino-Barrio, MJ; del Arco, A; Martinez-Serrano, A				Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; del Arco, Araceli; Martinez-Serrano, Alberto			Clonal Human Fetal Ventral Mesencephalic Dopaminergic Neuron Precursors for Cell Therapy Research	PLOS ONE			English	Article							STEM-CELLS; PARKINSONS-DISEASE; LONG-TERM; IN-VITRO; PROGENITOR CELLS; RAT MODEL; TRANSPLANTATION; GENERATION; DIFFERENTIATE; BEHAVIOR	A major challenge for further development of drug screening procedures, cell replacement therapies and developmental studies is the identification of expandable human stem cells able to generate the cell types needed. We have previously reported the generation of an immortalized polyclonal neural stem cell (NSC) line derived from the human fetal ventral mesencephalon (hVM1). This line has been biochemically, genetically, immunocytochemically and electrophysiologically characterized to document its usefulness as a model system for the generation of A9 dopaminergic neurons (DAn). Long-term in vivo transplantation studies in parkinsonian rats showed that the grafts do not mature evenly. We reasoned that diverse clones in the hVM1 line might have different abilities to differentiate. In the present study, we have analyzed 9 hVM1 clones selected on the basis of their TH generation potential and, based on the number of v-myc copies, v-myc down-regulation after in vitro differentiation, in vivo cell cycle exit, TH+ neuron generation and expression of a neuronal mature marker (hNSE), we selected two clones for further in vivo PD cell replacement studies. The conclusion is that homogeneity and clonality of characterized NSCs allow transplantation of cells with controlled properties, which should help in the design of long-term in vivo experiments.	[Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Dept Mol Biol UAM, Madrid, Spain; [Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Ctr Mol Biol Severo Ochoa UAM CSIC, Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Fac Ciencias Ambientales & Bioquim, CRIB, Area Bioquim, Toledo, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Castilla-La Mancha	Ramos-Moreno, T (corresponding author), Univ Autonoma Madrid, Dept Mol Biol UAM, Nicolas Cabrera 1,Campus Cantoblanco, Madrid, Spain.	tramos@cbm.uam.es	Martínez-Serrano, Alberto/J-8146-2014; del Arco, Araceli/R-5653-2019	Martinez Serrano, Alberto/0000-0003-3927-6699; del Arco, Araceli/0000-0002-6839-542X; Ramos-Moreno, Tania/0000-0001-5269-6351	Spanish Ministry of Economy and Competitiveness [PLE2009-0101, SAF2010-17167]; Comunidad Autonoma Madrid [S2011-BMD-2336]; Instituto Salud Carlos III (RETICS TerCel) [RD06/0010/0009]; European Union (Excell) [NMP4-SL-2008-214706]; Foundation Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad Autonoma Madrid(Comunidad de Madrid); Instituto Salud Carlos III (RETICS TerCel)(Instituto de Salud Carlos III); European Union (Excell); Foundation Ramon Areces	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (formerly Science and Innovation; PLE2009-0101, SAF2010-17167), Comunidad Autonoma Madrid (S2011-BMD-2336), Instituto Salud Carlos III (RETICS TerCel, RD06/0010/0009) and European Union (Excell, NMP4-SL-2008-214706). This work was also supported by an institutional grant from Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Baizabal JM, 2012, STEM CELLS DEV, V21, P1047, DOI 10.1089/scd.2011.0241; Blakemore C, 2012, NEURON, V75, P948, DOI 10.1016/j.neuron.2012.09.001; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; Cacci E, 2007, EXP CELL RES, V313, P588, DOI 10.1016/j.yexcr.2006.11.001; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Courtois ET, 2010, J BIOL CHEM, V285, P9881, DOI 10.1074/jbc.M109.054312; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gaillard A, 2011, TRENDS NEUROSCI, V34, P124, DOI 10.1016/j.tins.2011.01.003; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hebsgaard JB, 2009, GLIA, V57, P1648, DOI 10.1002/glia.20877; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Lepski G, 2011, MOL CELL NEUROSCI, V47, P36, DOI 10.1016/j.mcn.2011.02.011; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Martinez-Serrano A, 2011, VITAM HORM, V87, P175, DOI 10.1016/B978-0-12-386015-6.00029-9; Martinez-Serrano A, 2010, FUTUR NEUROL, V5, P161, DOI 10.2217/FNL.10.6; Miljan EA, 2009, STEM CELLS DEV, V18, P307, DOI 10.1089/scd.2008.0078; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Politis M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-1; Ramos-Moreno T, 2012, BEHAV BRAIN RES, V232, P225, DOI 10.1016/j.bbr.2012.04.020; Ribeiro D, 2013, NEUROBIOL DIS, V49, P118, DOI 10.1016/j.nbd.2012.08.006; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Sanchez-Pernaute R, 2001, J NEUROSCI RES, V65, P284, DOI 10.1002/jnr.1152; Seiz EG, 2012, EXP CELL RES, V318, P2446, DOI 10.1016/j.yexcr.2012.07.018; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Wakeman DR, 2011, MT SINAI J MED, V78, P126, DOI 10.1002/msj.20233; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yan J, 2001, J NEUROCHEM, V76, P307, DOI 10.1046/j.1471-4159.2001.00073.x	36	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52714	10.1371/journal.pone.0052714	http://dx.doi.org/10.1371/journal.pone.0052714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300748	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600023
J	Sharpe, SC; Koester, JA; Loebl, M; Cockshutt, AM; Campbell, DA; Irwin, AJ; Finkel, ZV				Sharpe, Susan C.; Koester, Julie A.; Loebl, Martina; Cockshutt, Amanda M.; Campbell, Douglas A.; Irwin, Andrew J.; Finkel, Zoe V.			Influence of Cell Size and DNA Content on Growth Rate and Photosystem II Function in Cryptic Species of Ditylum brightwellii	PLOS ONE			English	Article							MARINE DIATOMS; METABOLIC-RATE; GENOME SIZE; SEXUAL REPRODUCTION; LIGHT-ABSORPTION; GENE-EXPRESSION; NUCLEAR VOLUME; LIFE-CYCLE; PHYTOPLANKTON; ALLOMETRY	DNA content and cell volume have both been hypothesized as controls on metabolic rate and other physiological traits. We use cultures of two cryptic species of Ditylum brightwellii (West) Grunow with an approximately two-fold difference in genome size and a small and large culture of each clone obtained by isolating small and large cells to compare the physiological consequences of size changes due to differences in DNA content and reduction in cell size following many generations of asexual reproduction. We quantified the growth rate, the functional absorption cross-section of photosystem II (PSII), susceptibility of PSII to photoinactivation, PSII repair capacity, and PSII reaction center proteins D1 (PsbA) and D2 (PsbD) for each culture at a range of irradiances. The species with the smaller genome has a higher growth rate and, when acclimated to growth-limiting irradiance, has higher PSII repair rate capacity, PSII functional optical absorption cross-section, and PsbA per unit protein, relative to the species with the larger genome. By contrast, cell division rates vary little within clonal cultures of the same species despite significant differences in average cell volume. Given the similarity in cell division rates within species, larger cells within species have a higher demand for biosynthetic reductant. As a consequence, larger cells within species have higher numbers of PSII per unit protein (PsbA), since PSII photochemically generates the reductant to support biosynthesis. These results suggest that DNA content, as opposed to cell volume, has a key role in setting the differences in maximum growth rate across diatom species of different size while PSII content and related photophysiological traits are influenced by both growth rate and cell size.	[Koester, Julie A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Loebl, Martina] Univ Bremen, Ctr Marine Environm Sci MARUM, Bremen Int Grad Sch Marine Sci GLOMAR, D-28359 Bremen, Germany; [Koester, Julie A.; Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada	University of Washington; University of Washington Seattle; University of Bremen; Mount Allison University	Finkel, ZV (corresponding author), Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada.	zfinkel@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe/B-9626-2008	Campbell, Douglas A./0000-0001-8996-5463; Koester, Julie A/0000-0003-2014-0310; Irwin, Andrew/0000-0001-7784-2319; Finkel, Zoe/0000-0003-4212-3917	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery; Undergraduate Student Research Awards (Canada) (USRA) program; MtA's RTM Allan Summer Research Fellowship; NBIF; IRAP; CFI	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Undergraduate Student Research Awards (Canada) (USRA) program; MtA's RTM Allan Summer Research Fellowship; NBIF; IRAP; CFI(Canada Foundation for Innovation)	Funding was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (ZF, DC, AI) and Undergraduate Student Research Awards (Canada) (USRA) program (SC), MtA's RTM Allan Summer Research Fellowship (SC), NBIF (ZF), IRAP (ZF, AC), and CFI (ZF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUSTI S, 1991, CAN J FISH AQUAT SCI, V48, P763, DOI 10.1139/f91-091; Agutter PS, 2011, J EXP BIOL, V214, P1055, DOI 10.1242/jeb.054502; Amato A, 2005, J PHYCOL, V41, P542, DOI 10.1111/j.1529-8817.2005.00080.x; Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; BANSE K, 1976, J PHYCOL, V12, P135; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; Brown J. H., 1995, MACROECOLOGY; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Connolly JA, 2008, J PHYCOL, V44, P124, DOI 10.1111/j.1529-8817.2007.00452.x; COSTELLO J C, 1981, Journal of Plankton Research, V3, P415, DOI 10.1093/plankt/3.3.415; Cyr H, 2004, ECOLOGY, V85, P1802, DOI 10.1890/03-0695; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DUYSENS LNM, 1956, BIOCHIM BIOPHYS ACTA, V19, P1; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Finkel ZV, 2004, MAR ECOL PROG SER, V273, P269, DOI 10.3354/meps273269; Francis D, 2008, ANN BOT-LONDON, V101, P747, DOI 10.1093/aob/mcn038; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Glazier DS, 2008, P ROY SOC B-BIOL SCI, V275, P1405, DOI 10.1098/rspb.2008.0118; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRIS M, 1971, EXP CELL RES, V66, P329, DOI 10.1016/0014-4827(71)90685-9; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; HEMMINGSEN AM, 1960, REP STENO MEM HOSP, V9, P15; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; KARENTZ D, 1991, J PHYCOL, V27, P326, DOI 10.1111/j.0022-3646.1991.00326.x; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; KIDD AD, 1992, GENOME, V35, P126, DOI 10.1139/g92-021; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KOCIOLEK J P, 1989, Diatom Research, V4, P47; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; LAWS EA, 1975, ECOLOGY, V56, P419, DOI 10.2307/1934972; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 2002, MAR ECOL PROG SER, V242, P95, DOI 10.3354/meps242095; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; MacDonald JD, 1869, MAG NAT HIST, V4, P1; Mei ZP, 2011, MAR ECOL PROG SER, V434, P29, DOI 10.3354/meps09149; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mulo P, 2003, FUNCT PLANT BIOL, V30, P1097, DOI 10.1071/FP03149; Nurse P., 1985, P185; Paasche E, 1973, NORW J BOT, V20, P151; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Pfitzer E, 1869, SITZUNGSBER NIEDERRH, V26, P86; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Raven JA, 2005, VIE MILIEU, V55, P209; RAVEN JA, 1991, J PHOTOCH PHOTOBIO B, V9, P239, DOI 10.1016/1011-1344(91)80158-E; Round F. E., 1990, DIATOMS BIOL MORPHOL; Rynearson TA, 2000, LIMNOL OCEANOGR, V45, P1329, DOI 10.4319/lo.2000.45.6.1329; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; SCHLESINGER DA, 1981, CAN J FISH AQUAT SCI, V38, P1052, DOI 10.1139/f81-145; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TAGUCHI S, 1976, J PHYCOL, V12, P185, DOI 10.1111/j.1529-8817.1976.tb00499.x; TANG EPY, 1995, J PLANKTON RES, V17, P303, DOI 10.1093/plankt/17.2.303; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Ukeles R., 1973, HDB PHYCOLOGICAL MET, P233; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; von Dassow P, 2008, J PHYCOL, V44, P335, DOI 10.1111/j.1529-8817.2008.00476.x; von Stosch HA, 1964, HELGOL WISS MEERESUN, V11, P1; WERNER D, 1971, ARCH MIKROBIOL, V80, P115, DOI 10.1007/BF00411877; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; White CR, 2010, NATURE, V464, P691, DOI 10.1038/464691a; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772	85	10	10	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52916	10.1371/journal.pone.0052916	http://dx.doi.org/10.1371/journal.pone.0052916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300819	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600037
J	Wang, Q; Huang, JS; Ma, KS; Li, TJ; Chen, M; Wang, SG; Bie, P; He, ZP				Wang, Qi; Huang, Jiansheng; Ma, Kuansheng; Li, Tingjun; Chen, Ming; Wang, Shugang; Bie, Ping; He, Zhenping			Evaluation of Ghost Cell Survival in the Area of Radiofrequency Ablation	PLOS ONE			English	Article							RADIO-FREQUENCY ABLATION; HEPATIC-TUMORS; HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; IN-VIVO; DESTRUCTION; EXPERIENCE	Background and Aim: Researchers have demonstrated dead cells in radiofrequency ablation (RFA) lesions that have morphological similarities to viable tumor cells and are thus referred to as ghost cells. However, studies on how long ghost cells persist have not been systematically performed. Methods: A tumor model was established by implanting VX2 tumor tissue into the livers of 48 New Zealand rabbits. Two weeks later, these tumors were eliminated with RFA. The lesions were resected at 0 weeks, 1 week, 2 weeks, 4 weeks, 8 weeks, or 12 weeks after treatment, and samples were stained either with hematoxylin and eosin (HE) or nicotinamide adenine dinucleotide (NADH). The presence of the cells and the morphological changes that they underwent were examined by light microscopy. Results: Four weeks after RFA, there were no obvious morphological changes observed in HE-stained ghost cells, and NADH staining revealed no viable cells. Eight weeks after RFA, the cell structure became indistinct. Twelve weeks after RFA, ghost cells were no longer present. Conclusions: The morphological characteristics of ghost cells are maintained for at least 4 weeks, during which time HE staining cannot be used to differentiate ghost cells from residual tumor cells. NADH staining for cell viability is necessary to differentiate residual tumor cells from ghost cells. This evidence adds to our understanding of the mechanisms of RFA when used on solid tumors.	[Wang, Qi; Huang, Jiansheng; Ma, Kuansheng; Li, Tingjun; Chen, Ming; Wang, Shugang; Bie, Ping; He, Zhenping] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Ma, KS (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China.	makuansheng@vip.sina.com			Natural Science Foundation from Chongqing City in China (CSTC) [2008BB5028]	Natural Science Foundation from Chongqing City in China (CSTC)	This study was supported by a grant from the Natural Science Foundation from Chongqing City in China (CSTC, 2008BB5028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 1984, CANCER, V53, P1397; Dobbins C, 2008, J SURG RES, V148, P251, DOI 10.1016/j.jss.2007.09.008; Glantzounis GK, 2004, BRIT J SURG, V91, P1330, DOI 10.1002/bjs.4694; Gnant MFX, 1999, SURGERY, V126, P890, DOI 10.1067/msy.2099.100668; Hennings L, 2009, INT J HYPERTHER, V25, P355, DOI 10.1080/02656730902964357; Isbert C, 2001, SURG ENDOSC, V15, P1320, DOI 10.1007/s00464-001-0006-6; Kim SK, 2004, KOREAN J RADIOL, V5, P240, DOI 10.3348/kjr.2004.5.4.240; Kotoh K, 2005, LIVER INT, V25, P1217, DOI 10.1111/j.1478-3231.2005.01167.x; Llovet JM, 2001, HEPATOLOGY, V33, P1124, DOI 10.1053/jhep.2001.24233; Mazzaglia PJ, 2007, SURGERY, V142, P10, DOI 10.1016/j.surg.2007.01.036; Miao Y, 2000, EUR RADIOL, V10, P188, DOI 10.1007/s003300050031; Mostafa EM, 2008, J VASC INTERV RADIOL, V19, P1740, DOI 10.1016/j.jvir.2008.08.028; Mutsaerts ELAR, 2003, EUR J SURG ONCOL, V29, P731, DOI 10.1016/S0748-7983(03)00146-X; Ng KK, 2006, BRIT J SURG, V93, P440, DOI 10.1002/bjs.5267; Nikfarjam M, 2005, J SURG RES, V127, P208, DOI 10.1016/j.jss.2005.02.009; Raman JD, 2008, J UROLOGY, V179, P2142, DOI 10.1016/j.juro.2008.01.119; Rhim H, 2008, J GASTROEN HEPATOL, V23, P1492, DOI 10.1111/j.1440-1746.2008.05550.x; Sato K, 2008, J GASTROEN HEPATOL, V23, P1105, DOI 10.1111/j.1440-1746.2008.05328.x; Shen P, 2007, J GASTROINTEST SURG, V11, P603, DOI 10.1007/s11605-006-0046-2; Ypsilantis P, 2008, J SURG RES, V150, P60, DOI 10.1016/j.jss.2007.09.019	20	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53158	10.1371/journal.pone.0053158	http://dx.doi.org/10.1371/journal.pone.0053158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300883	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600065
J	Bodelon, C; Pfeiffer, RM; Bollati, V; Debbache, J; Calista, D; Ghiorzo, P; Fargnoli, MC; Bianchi-Scarra, G; Peris, K; Hoxha, M; Hutchinson, A; Burdette, L; Burke, L; Fang, SY; Tucker, MA; Goldstein, AM; Lee, JE; Wei, QY; Savage, SA; Yang, XHR; Amos, C; Landi, MT				Bodelon, Clara; Pfeiffer, Ruth M.; Bollati, Valentina; Debbache, Julien; Calista, Donato; Ghiorzo, Paola; Fargnoli, Maria Concetta; Bianchi-Scarra, Giovanna; Peris, Ketty; Hoxha, Mirjam; Hutchinson, Amy; Burdette, Laurie; Burke, Laura; Fang, Shenying; Tucker, Margaret A.; Goldstein, Alisa M.; Lee, Jeffrey E.; Wei, Qingyi; Savage, Sharon A.; Yang, Xiaohong R.; Amos, Christopher; Landi, Maria Teresa			On the Interplay of Telomeres, Nevi and the Risk of Melanoma	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; GENOME-WIDE ASSOCIATION; MEDITERRANEAN POPULATION; FAMILIAL MELANOMA; DYSPLASTIC NEVUS; DNA-REPAIR; SUSCEPTIBILITY; MC1R; VARIANTS; DISEASE	The relationship between telomeres, nevi and melanoma is complex. Shorter telomeres have been found to be associated with many cancers and with number of nevi, a known risk factor for melanoma. However, shorter telomeres have also been found to decrease melanoma risk. We performed a systematic analysis of telomere-related genes and tagSNPs within these genes, in relation to the risk of melanoma, dysplastic nevi, and nevus count combining data from four studies conducted in Italy. In addition, we examined whether telomere length measured in peripheral blood leukocytes is related to the risk of melanoma, dysplastic nevi, number of nevi, or telomere-related SNPs. A total of 796 cases and 770 controls were genotyped for 517 SNPs in 39 telomere-related genes genotyped with a custom-made array. Replication of the top SNPs was conducted in two American populations consisting of 488 subjects from 53 melanoma-prone families and 1,086 cases and 1,024 controls from a case-control study. We estimated odds ratios for associations with SNPs and combined SNP P-values to compute gene region-specific, functional group-specific, and overall P-value using an adaptive rank-truncated product algorithm. In the Mediterranean population, we found suggestive evidence that RECQL4, a gene involved in genome stability, RTEL1, a gene regulating telomere elongation, and TERF2, a gene implicated in the protection of telomeres, were associated with melanoma, the presence of dysplastic nevi and number of nevi, respectively. However, these associations were not found in the American samples, suggesting variable melanoma susceptibility for these genes across populations or chance findings in our discovery sample. Larger studies across different populations are necessary to clarify these associations.	[Bodelon, Clara; Pfeiffer, Ruth M.; Debbache, Julien; Hutchinson, Amy; Burdette, Laurie; Burke, Laura; Tucker, Margaret A.; Goldstein, Alisa M.; Savage, Sharon A.; Yang, Xiaohong R.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bollati, Valentina; Hoxha, Mirjam] Univ Milan, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Bollati, Valentina; Hoxha, Mirjam] IRCCS Osped Maggiore Policlin, Fdn Ca Granda, Milan, Italy; [Debbache, Julien] Univ Zurich, Div Cell & Dev Biol, Zurich, Switzerland; [Calista, Donato] Osped Gen Provinciale M Bufalini, Dept Dermatol, Cesena, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] IRCCS AOU San Martino IST, Lab Genet Rare Hereditary Canc, Genoa, Italy; [Fargnoli, Maria Concetta; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy; [Fang, Shenying; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Amos, Christopher] Dartmouth Coll, Ctr Genom Med, Dept Community & Family Med, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Zurich; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of L'Aquila; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Landi, MT (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Tucker, Margaret A/B-4297-2015; Calista, Donato/AAM-1567-2020; Scarrà, Giovanna Bianchi/G-8933-2014; Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015; Ghiorzo, Paola/CAG-0673-2022	Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Ghiorzo, Paola/0000-0002-3651-8173; Peris, Ketty/0000-0002-5237-0463; Bollati, Valentina/0000-0002-0370-9598; Fargnoli, Maria Concetta/0000-0002-7249-2556; Fang, Shenying/0000-0002-0604-793X	United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH [CA 5558 - 01A2, 2P50CA093459]; Marit Peterson Fund for Melanoma Research; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marit Peterson Fund for Melanoma Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Intramural Research Program of United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics and by the RO1 Grant (CA 5558 - 01A2) from the NIH to M. T. Landi. The MD Anderson Cancer Center study was supported by the NIH grant 2P50CA093459 (SF, JEL, QW, CA), and the Marit Peterson Fund for Melanoma Research (SF, JEL). Telomere length quantification was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) (MFAG 10361) To V. Bollati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Fargnoli MC, 2006, J NATL CANCER I, V98, P144, DOI 10.1093/jnci/djj025; Ghiorzo P, 2012, EXPT DERMAT IN PRESS; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Landi MT, 2001, BRIT J CANCER, V85, P1304, DOI 10.1054/bjoc.2001.2029; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Mirabello L, 2011, INT J MOL EPIDEMIOL, V2, P19; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Simon T, 2010, AM J MED GENET A, V152A, P1575, DOI 10.1002/ajmg.a.33427; Tucker MA, 2002, CANCER, V94, P3192, DOI 10.1002/cncr.10605; Tucker MA, 2003, ONCOGENE, V22, P3042, DOI 10.1038/sj.onc.1206444; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Wheeler W., 2011, INT J CANC; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	30	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52466	10.1371/journal.pone.0052466	http://dx.doi.org/10.1371/journal.pone.0052466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300679	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100052
J	Kobayashi, Y; Okada, Y; Itakura, G; Iwai, H; Nishimura, S; Yasuda, A; Nori, S; Hikishima, K; Konomi, T; Fujiyoshi, K; Tsuji, O; Toyama, Y; Yamanaka, S; Nakamura, M; Okano, H				Kobayashi, Yoshiomi; Okada, Yohei; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Yasuda, Akimasa; Nori, Satoshi; Hikishima, Keigo; Konomi, Tsunehiko; Fujiyoshi, Kanehiro; Tsuji, Osahiko; Toyama, Yoshiaki; Yamanaka, Shinya; Nakamura, Masaya; Okano, Hideyuki			Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; EXPRESSION PROFILE; GENE-EXPRESSION; GROWTH-FACTOR; FETAL-BRAIN; MOUSE MODEL; TRANSPLANTATION; PLURIPOTENCY; GENERATION; FIBERS	Murine and human iPSC-NS/PCs (induced pluripotent stem cell-derived neural stem/progenitor cells) promote functional recovery following transplantation into the injured spinal cord in rodents. However, for clinical applicability, it is critical to obtain proof of the concept regarding the efficacy of grafted human iPSC-NS/PCs (hiPSC-NS/PCs) for the repair of spinal cord injury (SCI) in a non-human primate model. This study used a pre-evaluated "safe" hiPSC-NS/PC clone and an adult common marmoset (Callithrix jacchus) model of contusive SCI. SCI was induced at the fifth cervical level (C5), followed by transplantation of hiPSC-NS/PCs at 9 days after injury. Behavioral analyses were performed from the time of the initial injury until 12 weeks after SCI. Grafted hiPSC-NS/PCs survived and differentiated into all three neural lineages. Furthermore, transplantation of hiPSC-NS/PCs enhanced axonal sparing/regrowth and angiogenesis, and prevented the demyelination after SCI compared with that in vehicle control animals. Notably, no tumor formation occurred for at least 12 weeks after transplantation. Quantitative RT-PCR showed that mRNA expression levels of human neurotrophic factors were significantly higher in cultured hiPSC-NS/PCs than in human dermal fibroblasts (hDFs). Finally, behavioral tests showed that hiPSC-NS/PCs promoted functional recovery after SCI in the common marmoset. Taken together, these results indicate that pre-evaluated safe hiPSC-NS/PCs are a potential source of cells for the treatment of SCI in the clinic.	[Kobayashi, Yoshiomi; Okada, Yohei; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Yasuda, Akimasa; Nori, Satoshi; Konomi, Tsunehiko; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Kobayashi, Yoshiomi; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Hikishima, Keigo; Konomi, Tsunehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kanagawa, Japan; [Fujiyoshi, Kanehiro] Natl Hosp Org, Murayama Med Ctr, Dept Orthoped Surg, Tokyo, Japan; [Tsuji, Osahiko] Saitama Social Insurance Hosp, Dept Orthoped Surg, Saitama, Japan; [Yamanaka, Shinya] Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Keio University; Keio University	Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan.	masa@a8.keio.jp; hidokano@a2.keio.jp	Nakamura, Masaya/K-4111-2013; Kobayashi, Yoshiomi/W-5573-2019; Konomi, Tsunehiko/ABB-1765-2020; Okano, Hideyuki/I-7584-2019; Toyama, Yoshiaki/K-5743-2013; Hikishima, Keigo/L-1202-2013; Tsuji, Osahiko/AHB-2622-2022; Hikishima, Keigo/AAP-9586-2020; Okada, Yohei/L-1662-2013; Nori, Satoshi/K-3260-2019; Konomi, Tsunehiko/AAY-6082-2020	Konomi, Tsunehiko/0000-0001-6704-7573; Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297; Iwai, Hiroki/0000-0002-5722-8706	Japan Society for the Promotion of Science (SPS); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Project for Realization of Regenerative Medicine; MEXT; Japan Science and Technology-California Institute for Regenerative Medicine; Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program); Keio University; JSPS; Keio Gijuku Academic Development Funds; Ministry of Education, Science, Sports and Culture of Japan	Japan Society for the Promotion of Science (SPS); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology-California Institute for Regenerative Medicine; Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development Funds; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (SPS) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Project for Realization of Regenerative Medicine; and Support for Core Institutes for iPS Cell Research from the MEXT; Japan Science and Technology-California Institute for Regenerative Medicine collaborative program; "Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program); the Kanrinmaru project from Keio University; Research Fellowships for Young Scientists from JSPS; Keio Gijuku Academic Development Funds; by a Grant-in-Aid for the Global COE program from MEXT to Keio University; and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Net-work) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Fujiyoshi K, 2011, 41 ANN M NEUR 2011 W; Fujiyoshi K, 2009, 39 ANN M NEUR 2009 C; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kitamura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027706; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Krenz NR, 1998, NEUROSCIENCE, V85, P443, DOI 10.1016/S0306-4522(97)00622-2; Krenz NR, 1999, J NEUROSCI, V19, P7405, DOI 10.1523/JNEUROSCI.19-17-07405.1999; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Ohta K, 1999, SPINAL CORD, V37, P580, DOI 10.1038/sj.sc.3100881; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Okano H, 2012, CIRCULATION IN PRESS; Okano Hideyuki, 2002, Keio Journal of Medicine, V51, P115; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rhee Y-H, 2011, J CLIN INVEST, P1; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Scivoletto G, 2009, BRAIN RES BULL, V78, P43, DOI 10.1016/j.brainresbull.2008.06.002; Shang AJ, 2011, BRAIN RES, V1391, P102, DOI 10.1016/j.brainres.2011.03.019; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sundberg M, 2010, STEM CELL RES, V5, P91, DOI 10.1016/j.scr.2010.04.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Van Middendorp JJ, 2011, LANCET; Wang W., 2011, P IEEE GLOBECOM, P1, DOI DOI 10.1080/01431161.2010.489073; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Yamane J, 2010, J NEUROSCI RES, V88, P1394, DOI 10.1002/jnr.22322; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	71	186	194	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52787	10.1371/journal.pone.0052787	http://dx.doi.org/10.1371/journal.pone.0052787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300777	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100082
J	Olausson, P; Gerdle, B; Ghafouri, N; Larsson, B; Ghafouri, B				Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar			Identification of Proteins from Interstitium of Trapezius Muscle in Women with Chronic Myalgia Using Microdialysis in Combination with Proteomics	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; 2-DIMENSIONAL GEL-ELECTROPHORESIS; CEREBROSPINAL-FLUID PROTEOME; VASTUS LATERALIS MUSCLE; SKELETAL-MUSCLE; HIGH-RESOLUTION; LARGE MOLECULES; WORK; PAIN; FIBROMYALGIA	Background: Microdialysis (MD) of the trapezius muscle has been an attractive technique to investigating small molecules and metabolites in chronic musculoskeletal pain in human. Large biomolecules such as proteins also cross the dialysis membrane of the catheters. In this study we have applied in vivo MD in combination with two dimensional gel electrophoresis (2-DE) and mass spectrometry to identify proteins in the extracellular fluid of the trapezius muscle. Materials and Methods: Dialysate from women with chronic trapezius myalgia (TM; n = 37), women with chronic wide spread pain (CWP; n = 18) and healthy controls (CON; n = 22) was collected from the trapezius muscle using a catheter with a cut-off point of 100 kDa. Proteins were separated by two-dimensional gel electrophoresis and visualized by silver staining. Detected proteins were identified by nano liquid chromatography in combination with tandem mass spectrometry. Results: Ninety-seven protein spots were identified from the interstitial fluid of the trapezius muscle; 48 proteins in TM and 30 proteins in CWP had concentrations at least two-fold higher or lower than in CON. The identified proteins pertain to several functional classes, e. g., proteins involved in inflammatory responses. Several of the identified proteins are known to be involved in processes of pain such as: creatine kinase, nerve growth factor, carbonic anhydrase, myoglobin, fatty acid binding protein and actin aortic smooth muscle. Conclusions: In this study, by using in vivo microdialysis in combination with proteomics a large number of proteins in muscle interstitium have been identified. Several of the identified proteins were at least two-fold higher or lower in chronic pain patients. The applied techniques open up for the possibility of investigating protein changes associated with nociceptive processes of chronic myalgia.	[Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar] Cty Council, Pain & Rehabil Ctr, Linkoping, Sweden; [Ghafouri, Nazdar] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Ghafouri, Bijar] Cty Council, Ctr Occupat & Environm Med, Linkoping, Sweden	Linkoping University; Umea University; Linkoping University	Ghafouri, B (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden.	bijar.ghafouri@liu.se	Ghafouri, Bijar/H-8257-2014	Gerdle, Bjorn/0000-0002-4316-1264; Olausson, Patrik/0000-0002-3689-788X	Swedish Research Council [K2011-69X-21874-01-6]; Swedish Council for Working Life and Social Research [2010-0913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Swedish Research Council (K2011-69X-21874-01-6) and the Swedish Council for Working Life and Social Research 2010-0913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afinowi R, 2009, J NEUROSCI METH, V181, P95, DOI 10.1016/j.jneumeth.2009.02.021; Bailey DM, 2001, AVIAT SPACE ENVIR MD, V72, P513; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Bernard BP, 1997, MUSCULOSCELETAL DISO; Blanco I, 2004, J RHEUMATOL, V31, P2082; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Darde VM, 2010, J PROTEOME RES, V9, P4420, DOI 10.1021/pr1002017; Ferrero S, 2008, EXPERT REV PROTEOMIC, V5, P705, DOI 10.1586/14789450.5.5.705; Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Fulle S, 2000, FREE RADICAL BIO MED, V29, P1252, DOI 10.1016/S0891-5849(00)00419-6; Gerdle B, 2012, POTENTIAL MUSCLE BIO; Gerdle B, 2008, PAIN, V139, P578, DOI 10.1016/j.pain.2008.06.012; Gerdle B, 2008, EUR J PAIN, V12, P82, DOI 10.1016/j.ejpain.2007.03.009; Gerdle B, 2010, J REHABIL MED, V42, P679, DOI 10.2340/16501977-0581; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Ghafouri B, 2007, ANAL BIOCHEM, V371, P121, DOI 10.1016/j.ab.2007.07.002; Ghafouri B, 2010, SCAND J CLIN LAB INV, V70, P478, DOI 10.3109/00365513.2010.511257; Ghafouri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027257; Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; HAGBERG M, 1982, INT ARCH OCC ENV HEA, V50, P377, DOI 10.1007/BF00377834; Hermens H., 1997, SENIAM STATE ART SEN; Hody S, 2011, MED SCI SPORT EXER, V43, P2281, DOI 10.1249/MSS.0b013e318222edf3; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Hung PH, 2011, MOL BIOSYST, V7, P1990, DOI 10.1039/c1mb05055a; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kunz S, 2005, NEUROSCI LETT, V381, P289, DOI 10.1016/j.neulet.2005.02.022; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Larsson B, 2005, J MUSCULOSKELET PAIN, V13, P5, DOI 10.1300/J094v13n04_03; Larsson B, 2008, PAIN, V140, P479, DOI 10.1016/j.pain.2008.10.001; Liu XD, 2006, PROTEOMICS, V6, P1019, DOI 10.1002/pmic.200500247; Marchi A, 2009, CLIN DRUG INVEST, V29, P41, DOI 10.2165/0044011-200929001-00006; Mense S, 2009, EXP BRAIN RES, V196, P89, DOI 10.1007/s00221-008-1674-4; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; Niederberger E, 2008, ANESTHESIOLOGY, V108, P314, DOI 10.1097/01.anes.0000299838.13368.6e; Oki G, 2012, PAIN, V153, P532, DOI 10.1016/j.pain.2011.11.008; Olausson P, 2012, SCANDINAVIAN J CLIN, V0, P1; Packer NH, 1998, ELECTROPHORESIS, V19, P981, DOI 10.1002/elps.1150190613; Paulo JA, 2011, ELECTROPHORESIS, V32, P1939, DOI 10.1002/elps.201100203; Robinson PA, 2003, AM J PHYSIOL-CELL PH, V284, pC681, DOI 10.1152/ajpcell.00370.2002; Rosendal L, 2005, PAIN, V119, P201, DOI 10.1016/j.pain.2005.09.026; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; Ruiz-Romero C, 2010, OSTEOARTHR CARTILAGE, V18, P500, DOI 10.1016/j.joca.2009.11.012; Schumechel DE, 2012, NEUROTOXICOLOGY; Seeber B, 2010, FERTIL STERIL, V93, P2137, DOI 10.1016/j.fertnstert.2008.12.121; Sluiter JK, 2001, SCAND J WORK ENV HEA, V27, P1; Sorichter S, 1998, BRIT J SPORT MED, V32, P121, DOI 10.1136/bjsm.32.2.121; SWAIN M, 1995, ELECTROPHORESIS, V16, P948, DOI 10.1002/elps.11501601159; Takeda S, 2011, NEUROSCIENCE, V186, P110, DOI 10.1016/j.neuroscience.2011.04.035; Tumblin A, 2010, HAEMATOL-HEMATOL J, V95, P1467, DOI 10.3324/haematol.2009.018044; Waling K, 2002, SPINE, V27, P789, DOI 10.1097/00007632-200204150-00002; Wilson R, 2009, MATRIX BIOL, V28, P121, DOI 10.1016/j.matbio.2009.01.004; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P171, DOI 10.1007/s00418-002-0427-x; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhu Y, 2011, J ORTHOP RES, V29, P1896, DOI 10.1002/jor.21466	67	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52560	10.1371/journal.pone.0052560	http://dx.doi.org/10.1371/journal.pone.0052560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300707	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100063
J	Reimann, K; Krishnamoorthy, G; Wangemann, P				Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine			NOS Inhibition Enhances Myogenic Tone by Increasing Rho-Kinase Mediated Ca2+ Sensitivity in the Male but Not the Female Gerbil Spiral Modiolar Artery	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; COCHLEAR BLOOD-FLOW; NITRIC-OXIDE; GENDER-DIFFERENCES; CARDIOVASCULAR MEDICINE; MYOSIN PHOSPHATASE; CEREBRAL-ARTERY; K+ CHANNELS; GUINEA-PIGS	Cochlear blood flow regulation is important to prevent hearing loss caused by ischemia and oxidative stress. Cochlear blood supply is provided by the spiral modiolar artery (SMA). The myogenic tone of the SMA is enhanced by the nitric oxide synthase (NOS) blocker L-N-G-Nitro-Arginine (LNNA) in males, but not in females. Here, we investigated whether this gender difference is based on differences in the cytosolic Ca2+ concentration and/or the Ca2+ sensitivity of the myofilaments. Vascular diameter, myogenic tone, cytosolic Ca2+, and Ca2+ sensitivity were evaluated in pressurized SMA segments isolated from male and female gerbils using laser-scanning microscopy and microfluorometry. The gender difference of the LNNA-induced tone was compared, in the same vessel segments, to tone induced by 150 mM K+ and endothelin-1, neither of which showed an apparent gender-difference. Interestingly, LNNA-induced tone in male SMAs was observed in protocols that included changes in intramural pressure, but not when the intramural pressure was held constant. LNNA in male SMAs did not increase the global Ca2+ concentration in smooth muscle cells but increased the Ca2+ sensitivity. This increase in the Ca2+ sensitivity was abolished in the presence of the guanylyl cyclase inhibitor ODQ or by extrinsic application of either the nitric oxide (NO)-donor DEA-NONOate or the cGMP analog 8-pCPT-cGMP. The rho-kinase blocker Y27632 decreased the basal Ca2+ sensitivity and abolished the LNNA-induced increase in Ca2+ sensitivity in male SMAs. Neither LNNA nor Y27632 changed the Ca2+ sensitivity in female SMAs. The data suggest that the gender difference in LNNA-induced tone is based on a gender difference in the regulation of rho-kinase mediated Ca2+ sensitivity. Rho-kinase and NO thus emerge as critical factors in the regulation of cochlear blood flow. The larger role of NO-dependent mechanisms in male SMAs predicts greater restrictions on cochlear blood flow under conditions of impaired endothelial cell function.	[Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Reimann, Katrin] Univ Tubingen, Univ Klin Hals Nasen & Ohrenheilkunde, Tubingen, Germany	Kansas State University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wangemann, P (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013	Natarajan, Gayathri/0000-0001-7654-5013; Krishnamoorthy, Gayathri/0000-0002-2208-3244	Kansas State University;  [NIH-R01-DC04280];  [NIH-P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004280] Funding Source: NIH RePORTER	Kansas State University; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH-R01-DC04280 (to PW). The Confocal Microscopy Core Facility was supported by Kansas State University and NIH-P20-RR017686 (to PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain FA, 2009, CIRC J, V73, P1774, DOI 10.1253/circj.CJ-09-0588; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Boettcher FA, 2002, J ACOUST SOC AM, V112, P2948, DOI 10.1121/1.1513364; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BROWN JN, 1994, AM J PHYSIOL, V266, pH458, DOI 10.1152/ajpheart.1994.266.2.H458; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chrissobolis S, 2004, STROKE, V35, P2200, DOI 10.1161/01.STR.0000136951.85586.c8; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; de Wit C, 1998, HYPERTENSION, V31, P787, DOI 10.1161/01.HYP.31.3.787; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; HAYASHI T, 1992, P NATL ACAD SCI USA, V89, P11259, DOI 10.1073/pnas.89.23.11259; Hiroki J, 2005, BIOCHEM BIOPH RES CO, V326, P154, DOI 10.1016/j.bbrc.2004.11.011; Iwasaki S, 1998, ACTA OTO-LARYNGOL, V118, P666; JOHNSTONE B M, 1965, Acta Otolaryngol, V60, P113, DOI 10.3109/00016486509126994; Knot HJ, 1999, AM J PHYSIOL-HEART C, V276, pH961, DOI 10.1152/ajpheart.1999.276.3.H961; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Mandala M, 2007, NITRIC OXIDE-BIOL CH, V16, P104, DOI 10.1016/j.niox.2006.06.007; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; McDonald L J, 1995, Adv Pharmacol, V34, P263; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; QUIRK WS, 1989, HEARING RES, V41, P53, DOI 10.1016/0378-5955(89)90178-0; Reimann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025659; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scherer EQ, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-10; Scherer EQ, 2002, STROKE, V33, P2965, DOI 10.1161/01.STR.0000043673.22993.FD; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Si JQ, 2002, HEARING RES, V171, P167, DOI 10.1016/S0378-5955(02)00497-5; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Thompson J, 2003, CLIN EXP PHARMACOL P, V30, P1, DOI 10.1046/j.1440-1681.2003.03790.x; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Wangemann P, 1998, HEARING RES, V118, P90, DOI 10.1016/S0378-5955(98)00017-3; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wei JY, 1998, J MOL NEUROSCI, V10, P53, DOI 10.1007/BF02737085; Wellman GC, 1996, CIRC RES, V79, P1024, DOI 10.1161/01.RES.79.5.1024; WING KG, 1953, J COMP PHYSIOL PSYCH, V46, P352, DOI 10.1037/h0058043; Wirth A, 2010, BBA-MOL BASIS DIS, V1802, P1276, DOI 10.1016/j.bbadis.2010.05.002; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976	45	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53655	10.1371/journal.pone.0053655	http://dx.doi.org/10.1371/journal.pone.0053655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301097	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000073
J	Vervoort, SJ; Lourenco, AR; van Boxtel, R; Coffer, PJ				Vervoort, Stephin J.; Lourenco, Ana Rita; van Boxtel, Ruben; Coffer, Paul J.			SOX4 Mediates TGF-beta-Induced Expression of Mesenchymal Markers during Mammary Cell Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; CADHERIN; METASTASIS; DIFFERENTIATION; PROGRESSION; PROTEIN; ACTIVATION; SYNTENIN; PATHWAYS	The epithelial to mensenchymal transition program regulates various aspects of embryonic development and tissue homeostasis, but aberrant activation of this pathway in cancer contributes to tumor progression and metastasis. TGF-beta potently induces an epithelial to mensenchymal transition in cancers of epithelial origin by inducing transcriptional changes mediated by several key transcription factors. Here, we identify the developmental transcription factor SOX4 as a transcriptional target of TGF-beta in immortalized human mammary epithelial cells. SOX4 expression and activity are rapidly induced in the early stages of the TGF-beta-induced epithelial to mensenchymal transition. We demonstrate that conditional activation of Sox4 is sufficient to induce the expression of N-cadherin and additional mesenchymal markers including vimentin and fibronectin, but fails to induce complete EMT as no changes are observed in the expression of E-cadherin and beta-catenin. Moreover, shRNA-mediated knockdown of SOX4 significantly delays TGF-beta-induced mRNA and protein expression of mesenchymal markers. Taken together, these data suggest that TGF-beta-mediated increased expression of SOX4 is required for the induction of a mesenchymal phenotype during EMT in human mammary epithelial cells.	[Vervoort, Stephin J.; Lourenco, Ana Rita; van Boxtel, Ruben; Coffer, Paul J.] Univ Med Ctr, Dept Cell Biol, Utrecht, Netherlands; [Vervoort, Stephin J.; Coffer, Paul J.] Univ Med Ctr, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Coffer, PJ (corresponding author), Univ Med Ctr, Dept Cell Biol, Utrecht, Netherlands.	P.J.Coffer@umcutrecht.nl	Vervoort, Stephin/AAP-7854-2020; Coffer, Paul/AAF-7970-2020	van Boxtel, Ruben/0000-0003-1285-2836	"Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship [SFRH/BD/75747/2011]; "Center for Translational Molecular Medicine" CTMM grant	"Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship; "Center for Translational Molecular Medicine" CTMM grant	Ana Rita Lourenco is the recipient of a "Fundacao para a Ciencia e a Tecnologia" (FCT) fellowship (SFRH/BD/75747/2011) - http://www.fct.pt/index.phtml.en. Ruben van Boxtel is supported by a "Center for Translational Molecular Medicine" CTMM grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Broos S, 2011, NUCLEIC ACIDS RES, V39, pW74, DOI 10.1093/nar/gkr355; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kuwahara M, 2012, NATURE IMMUNOLOGY; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu ZD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r180; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Su Y, 2012, ONCOGENE, V31, P4484, DOI 10.1038/onc.2011.574; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Vervoort SJ, 2012, ONCOGENE IN PRESS; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	43	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53238	10.1371/journal.pone.0053238	http://dx.doi.org/10.1371/journal.pone.0053238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301048	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000041
J	Beilstein, F; Bouchoux, J; Rousset, M; Demignot, S				Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie			Proteomic Analysis of Lipid Droplets from Caco-2/TC7 Enterocytes Identifies Novel Modulators of Lipid Secretion	PLOS ONE			English	Article							VIRUS CORE PROTEIN; SEX STEROID ACTION; INTESTINAL LIPOPROTEIN OVERPRODUCTION; POSTPRANDIAL TRIGLYCERIDE-METABOLISM; DIFFERENTIATION-RELATED PROTEIN; SUBNORMAL TESTOSTERONE LEVELS; ACYL-COA SYNTHETASE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-2; GASTROINTESTINAL-TRACT; INDUCED-STEATOSIS	In enterocytes, the dynamic accumulation and depletion of triacylglycerol (TAG) in lipid droplets (LD) during fat absorption suggests that cytosolic LD-associated TAG contribute to TAG-rich lipoprotein (TRL) production. To get insight into the mechanisms controlling the storage/secretion balance of TAG, we used as a tool hepatitis C virus core protein, which localizes onto LDs, and thus may modify their protein coat and decrease TRL secretion. We compared the proteome of LD fractions isolated from Caco-2/TC7 enterocytes expressing or not hepatitis C virus core protein by a differential proteomic approach (isobaric tag for relative and absolute quantitation (iTRAQ) labeling coupled with liquid chromatography and tandem mass spectrometry). We identified 42 proteins, 21 being involved in lipid metabolism. Perilipin-2/ADRP, which is suggested to stabilize long term-stored TAG, was enriched in LD fractions isolated from Caco-2/TC7 expressing core protein while perilipin-3/TIP47, which is involved in LD synthesis from newly synthesized TAG, was decreased. Endoplasmic reticulum-associated proteins were strongly decreased, suggesting reduced interactions between LD and endoplasmic reticulum, where TRL assembly occurs. For the first time, we show that 17 beta-hydroxysteroid dehydrogenase 2 (DHB2), which catalyzes the conversion of 17-keto to 17 beta-hydroxysteroids and which was the most highly enriched protein in core expressing cells, is localized to LD and interferes with TAG secretion, probably through its capacity to inactivate testosterone. Overall, we identified potential new players of lipid droplet dynamics, which may be involved in the balance between lipid storage and secretion, and may be altered in enterocytes in pathological conditions such as insulin resistance, type II diabetes and obesity.	[Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] Univ Paris 06, UMR S 872, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] INSERM, U872, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Demignot, Sylvie] Ecole Prat Hautes Etud, Lab Pharmacol Cellulaire & Mol, Paris, France; [Beilstein, Frauke; Bouchoux, Julien; Rousset, Monique; Demignot, Sylvie] Univ Paris 05, UMR S 872, Paris, France; [Rousset, Monique; Demignot, Sylvie] Inst Cardiometab & Nutr ICAN, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Demignot, S (corresponding author), Univ Paris 06, UMR S 872, Paris, France.	sylvie.demignot@crc.jussieu.fr		Demignot, Sylvie/0000-0001-7149-1992; Beilstein, Frauke/0000-0001-9809-7151	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France); ANRS; INSERM (Institut National de la Sante et de la Recherche Medicale)	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France)(ANRS); ANRS(ANRSFrench National Research Agency (ANR)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	FB and JB were the recipients of an ANRS (Agence Nationale de Recherches sur le Sida et les hepatites, Paris, France) fellowship. This work was supported by ANRS and INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Agledahl I, 2008, SCAND J CLIN LAB INV, V68, P641, DOI 10.1080/00365510801999068; Agledahl I, 2008, ASIAN J ANDROL, V10, P542, DOI 10.1111/j.1745-7262.2008.00387.x; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bellocq D, 2010, STEROIDS, V75, P665, DOI 10.1016/j.steroids.2010.04.003; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; CHANTRET I, 1994, J CELL SCI, V107, P213; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; English MA, 2000, BRIT J CANCER, V83, P550, DOI 10.1054/bjoc.2000.1324; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Gassler N, 2003, HUM PATHOL, V34, P1048, DOI 10.1053/S0046-8177(03)00431-3; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Horiguchi Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P121, DOI 10.1016/j.abb.2008.08.020; Kaminsky LS, 2003, DRUG METAB DISPOS, V31, P1520, DOI 10.1124/dmd.31.12.1520; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Negro F, 2010, DIGEST DIS, V28, P294, DOI 10.1159/000282105; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Pfaffl MW, 2003, J STEROID BIOCHEM, V84, P159, DOI 10.1016/S0960-0760(03)00025-6; Poutanen M, 2012, J ENDOCRINOL, V212, P1, DOI 10.1530/JOE-11-0414; Ramalho F, 2003, ANTIVIR RES, V60, P125, DOI 10.1016/j.antiviral.2003.08.007; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Sano T, 2001, CLIN SCI, V101, P485, DOI 10.1042/CS20010052; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Uchida A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00026; Vidal R, 2005, J LIPID RES, V46, P258, DOI 10.1194/jlr.M400209-JLR200; Walther Tobias C, 2009, Biochim Biophys Acta, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang XW, 2012, AM J PHYSIOL-ENDOC M, V302, pE740, DOI 10.1152/ajpendo.00533.2011; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; WU L, 1993, J BIOL CHEM, V268, P12964; Xu CS, 2009, DRUG METAB DISPOS, V37, P1539, DOI 10.1124/dmd.109.026989; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	69	37	37	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53017	10.1371/journal.pone.0053017	http://dx.doi.org/10.1371/journal.pone.0053017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301014	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900052
J	Kumar, N; Saini, D; Froelicher, V				Kumar, Nikhil; Saini, Divya; Froelicher, Victor			A Gender-Based Analysis of High School Athletes Using Computerized Electrocardiogram Measurements	PLOS ONE			English	Article								Background: The addition of the ECG to the preparticipation examination (PPE) of high school athletes has been a topic for debate. Defining the difference between the high school male and female ECG is crucial to help initiate its implementation in the High School PPE. Establishing the different parameters set for the male and female ECG would help to reduce false positives. We examined the effect of gender on the high school athlete ECG by obtaining and analyzing ECG measurements of high school athletes from Henry M. Gunn High School. Methods: In 2011 and 2012, computerized Electrocardiograms were recorded and analyzed on 181 athletes (52.5% male; mean age 16.1+/-1.1 years) who participated in 17 different sports. ECG statistics included intervals and durations in all 3 axes (X, Y, Z) to calculate 12 lead voltage sums, QRS Amplitude, QT interval, QRS Duration, and the sum of the R wave in V5 and the S Wave in V2 (RS Sum). Results: By computer analysis, we demonstrated that male athletes had significantly greater QRS duration, Q-wave duration, and T wave amplitude. (P<0.05). By contrast, female athletes had a significantly greater QTc interval. (P<0.05). Conclusion: The differences in ECG measurements in high school athletes are strongly associated with gender. However, body size does not correlate with the aforementioned ECG measurements. Our tables of the gender-specific parameters can help facilitate the development of a more large scale and in-depth ECG analysis for screening high school athletes in the future.	[Kumar, Nikhil; Saini, Divya] Henry M Gunn High Sch, Palo Alto, CA USA; [Froelicher, Victor] Palo Alto Vet Affairs Med Ctr, Palo Alto, CA USA; [Froelicher, Victor] Stanford Univ, Palo Alto, CA 94304 USA	Stanford University	Kumar, N (corresponding author), Henry M Gunn High Sch, Palo Alto, CA USA.	nikhilkumar1@gmail.com		Froelicher, Victor/0000-0001-8831-4853				Arnold RH, 2003, HEART, V89, P293, DOI 10.1136/heart.89.3.293; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Gomez JE, 1999, ARCH PEDIAT ADOL MED, V153, P723, DOI 10.1001/archpedi.153.7.723; Mandic S, 2010, PHYSICIAN SPORTSMED, V38, P0091; Maron BJ, 2010, ANN INTERN MED, V152, P324, DOI 10.7326/0003-4819-152-5-201003020-00012; OTTERSTAD JE, 1991, J HUM HYPERTENS, V5, P101; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455	7	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53365	10.1371/journal.pone.0053365	http://dx.doi.org/10.1371/journal.pone.0053365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301064	Green Submitted, gold, Green Published			2022-12-27	WOS:000313320900076
J	Phillips, AT; Stauft, CB; Aboellail, TA; Toth, AM; Jarvis, DL; Powers, AM; Olson, KE				Phillips, Aaron T.; Stauft, Charles B.; Aboellail, Tawfik A.; Toth, Ann M.; Jarvis, Donald L.; Powers, Ann M.; Olson, Ken E.			Bioluminescent Imaging and Histopathologic Characterization of WEEV Neuroinvasion in Outbred CD-1 Mice	PLOS ONE			English	Article							EQUINE-ENCEPHALITIS-VIRUS; HEPARAN-SULFATE BINDING; ST-LOUIS ENCEPHALITIS; WESTERN-EQUINE; SINDBIS-VIRUS; ENCEPHALOMYELITIS VIRUS; ALPHAVIRUS REPLICATION; CHIKUNGUNYA VIRUS; INFECTION; EXPRESSION	Western equine encephalitis virus (WEEV; Alphavirus) is a mosquito-borne virus that can cause severe encephalitis in humans and equids. Previous studies have shown that intranasal infection of outbred CD-1 mice with the WEEV McMillan (McM) strain result in high mortality within 4 days of infection. Here in vivo and ex vivo bioluminescence (BLM) imaging was applied on mice intranasally infected with a recombinant McM virus expressing firefly luciferase (FLUC) to track viral neuroinvasion by FLUC detection and determine any correlation between BLM and viral titer. Immunological markers of disease (MCP-1 and IP-10) were measured and compared to wild type virus infection. Histopathology was guided by corresponding BLM images, and showed that neuroinvasion occurred primarily through cranial nerves, mainly in the olfactory tract. Olfactory bulb neurons were initially infected with subsequent spread of the infection into different regions of the brain. WEEV distribution was confirmed by immunohistochemistry as having marked neuronal infection but very few infected glial cells. Axons displayed infection patterns consistent with viral dissemination along the neuronal axis. The trigeminal nerve served as an additional route of neuroinvasion showing significant FLUC expression within the brainstem. The recombinant virus WEEV. McM. FLUC had attenuated replication kinetics and induced a weaker immunological response than WEEV. McM but produced comparable pathologies. Immunohistochemistry staining for FLUC and WEEV antigen showed that transgene expression was present in all areas of the CNS where virus was observed. BLM provides a quantifiable measure of alphaviral neural disease progression and a method for evaluating antiviral strategies.	[Phillips, Aaron T.; Stauft, Charles B.; Aboellail, Tawfik A.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Toth, Ann M.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Powers, Ann M.] Ctr Dis Control, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Colorado State University; University of Wyoming	Phillips, AT (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	aaron.phillips@colostate.edu	Aboellail, Tawfik/AAB-8990-2019	Aboellail, Tawfik/0000-0003-0989-5333; Jarvis, Donald/0000-0002-8104-7155; Stauft, Charles/0000-0001-5633-2950	National Institutes of Health (NIH) [R01 AI46435]; RMRCE [AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI046435] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RMRCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health (NIH) (R01 AI46435) and the RMRCE (AI065357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Caley IJ, 1997, J VIROL, V71, P3031, DOI 10.1128/JVI.71.4.3031-3038.1997; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Del Piero F, 2001, VET PATHOL, V38, P451, DOI 10.1354/vp.38-4-451; FINLEY KH, 1955, NEUROLOGY, V5, P223; Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x; Foy BD, 2008, ADV EXP MED BIOL, V627, P19, DOI 10.1007/978-0-387-78225-6_2; Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57; Griffin DE, 2004, ARCH VIROL, P21; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; HARDY JL, 1987, AM J TROP MED HYG, V37, pS18, DOI 10.4269/ajtmh.1987.37.18S; HIGGS S, 1995, INSECT MOL BIOL, V4, P97, DOI 10.1111/j.1365-2583.1995.tb00013.x; HIGGS S, 1993, PARASITOL TODAY, V9, P444, DOI 10.1016/0169-4758(93)90098-Z; HOPKINS TA, 1967, J AM CHEM SOC, V89, P7148, DOI 10.1021/ja01002a076; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Julander JG, 2007, VIROLOGY, V360, P454, DOI 10.1016/j.virol.2006.10.031; Karabatsos N, 1985, AM J TROPICAL MED HY; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Logue CH, 2010, ANTIVIR RES, V87, P195, DOI 10.1016/j.antiviral.2010.04.013; Logue CH, 2009, J GEN VIROL, V90, P1848, DOI 10.1099/vir.0.008656-0; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Meyer KF, 1931, SCIENCE, V74, P227, DOI 10.1126/science.74.1913.227; Nagata LP, 2006, J GEN VIROL, V87, P2353, DOI 10.1099/vir.0.81815-0; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Patterson M, 2011, VACCINE, V29, P9345, DOI 10.1016/j.vaccine.2011.09.130; Powers AM, 1996, P NATL ACAD SCI USA, V93, P4187, DOI 10.1073/pnas.93.9.4187; RaymsKeller A, 1995, INSECT MOL BIOL, V4, P245, DOI 10.1111/j.1365-2583.1995.tb00030.x; Reed DS, 2005, J INFECT DIS, V192, P1173, DOI 10.1086/444397; REISEN WK, 1995, J MED ENTOMOL, V32, P267, DOI 10.1093/jmedent/32.3.267; Roy CJ, 2009, VIROL J, V6, P13; Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06; Ryman KD, 2007, J GEN VIROL, V88, P518, DOI 10.1099/vir.0.82359-0; Ryzhikov A B, 1991, Biomed Sci, V2, P607; Ryzhikov AB, 1995, ARCH VIROL, V140, P2243, DOI 10.1007/BF01323243; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Steele K., 2007, MED ASPECTS BIOL WAR; Toth AM, 2011, PROTEIN EXPRES PURIF, V80, P274, DOI 10.1016/j.pep.2011.08.002; Vanlandingham DL, 2005, AM J TROP MED HYG, V73, P309; Vogel P, 1996, ARCH PATHOL LAB MED, V120, P164; WOODMAN DR, 1975, INFECT IMMUN, V12, P1006, DOI 10.1128/IAI.12.5.1006-1011.1975; Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Ziegler SA, 2011, VECTOR-BORNE ZOONOT, V11, P1471, DOI 10.1089/vbz.2011.0648	53	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53462	10.1371/journal.pone.0053462	http://dx.doi.org/10.1371/journal.pone.0053462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301074	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900079
J	Cai, WB; Zhang, Y; Cheng, R; Wang, Z; Fang, SH; Xu, ZM; Yang, X; Yang, ZH; Ma, JX; Shao, CK; Gao, GQ				Cai, Wei-Bin; Zhang, Yang; Cheng, Rui; Wang, Zheng; Fang, Shu-Huan; Xu, Zu-Min; Yang, Xia; Yang, Zhong-Han; Ma, Jian-Xing; Shao, Chun-Kui; Gao, Guo-Quan			Dual Inhibition of Plasminogen Kringle 5 on Angiogenesis and Chemotaxis Suppresses Tumor Metastasis by Targeting HIF-1 alpha Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; EPITHELIUM-DERIVED FACTOR; CXC CHEMOKINE RECEPTOR-4; FACTOR-I HIF-1; RETINAL NEOVASCULARIZATION; SIGNALING PATHWAY; GENE-EXPRESSION; CANCER CELLS; PROGRESSION	We had demonstrated that plasminogen kringle 5 (K5), a potent angiogenic inhibitor, inhibited retinal neovascularization and hepatocellular carcinoma growth by anti-angiogenesis. The current study investigated the effects and the underlying mechanisms of K5 on both tumor growth and spontaneous pulmonary metastasis in Lewis lung carcinoma (LLC) implanted mouse model. Similarly, K5 could decrease expression of VEGF in LLC cells and grafted tissues and suppress tumor angiogenesis and growth. K5 had no direct effect on proliferation and apoptosis of LLC. However, K5 could significantly inhibit SDF-1 alpha-induced chemotaxis movement of LLC cells and resulted in a great reduction of surface metastatic nodules and micrometastases in the lungs of LLC tumor-bearing mice. K5 also decreased expression of chemokine (C-X-C motif) receptor 4 (CXCR4) in LLC cells and grafted tissues. Furthermore, K5 down-regulated SDF-1 alpha expression in metastatic lung tissues of LLC-bearing mice. Therefore, K5 may suppress tumor pulmonary metastasis through inhibiting SDF-1 alpha-CXCR4 chemotaxis movement and down-regulation of VEGF. Moreover, the role of hypoxia inducible factor-1 alpha (HIF-1 alpha), a crucial transcriptional factor for both VEGF and CXCR4 expression, was evaluated. The siRNA of HIF-1 alpha attenuated expression of VEGF and CXCR4 and inhibited LLC migration. K5 decreased HIF-1 alpha protein level and impaired nuclear HIF-1 alpha accumulation. These results showed for the first time that K5 inhibits LLC growth and metastasis via the dual effects of anti-angiogenesis and suppression of tumor cell motility by targeting the pivotal molecule, HIF-1 alpha.	[Cai, Wei-Bin; Zhang, Yang; Cheng, Rui; Wang, Zheng; Fang, Shu-Huan; Xu, Zu-Min; Yang, Xia; Yang, Zhong-Han; Gao, Guo-Quan] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Shu-Huan] Guangzhou Univ Chinese Med, DME Ctr, Clin Pharmacol Inst, Guangzhou, Guangdong, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Key Lab Funct Mol Marine Microorganisms, Dept Educ Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Shao, Chun-Kui] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, China Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University; Sun Yat Sen University	Shao, CK (corresponding author), Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	chunkuishao2011@163.com; gaogq@mail.sysu.edu.cn			National Nature Science Foundation of China [30700120, 30971208, 30973449, 81070746, 81071893, 81172163, 81272515, 81272338, 81272553]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102-053]; Program for Doctoral Station in University [20070558215, 108104, 20100171110049]; Guandong natural science foundation [10151008901000007, S2012020010898, 10251008901000009]; Fundamental Research Funds for the Central Universities of China [09YKPY73, 10YKPY28]; Changjiang Scholars and Innovative Research Team in University [PCSIRT 0947]; Guangzhou Science and Technology Project [2011J4100106, 2011Y1-00017-8]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University; Guandong natural science foundation; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangzhou Science and Technology Project	This work was supported by National Nature Science Foundation of China (30700120, 30971208, 30973449, 81070746, 81071893, 81172163, 81272515, 81272338 and 81272553), National Key Sci-Tech Special Project of China (2009ZX09103-642 and 2013ZX09102-053), Program for Doctoral Station in University (20070558215, 108104, 20100171110049), Guandong natural science foundation (10151008901000007, S2012020010898 and Key Project 10251008901000009), Fundamental Research Funds for the Central Universities of China (Youth Program 09YKPY73, 10YKPY28), Changjiang Scholars and Innovative Research Team in University (985 project PCSIRT 0947), and Guangzhou Science and Technology Project (2011J4100106, 2011Y1-00017-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cai WB, 2005, J CELL BIOCHEM, V96, P1254, DOI 10.1002/jcb.20601; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Cheng ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023752; Chilov D, 1999, J CELL SCI, V112, P1203; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Jiang WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037132; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Reddy K, 2008, INT J CANCER, V123, P831, DOI 10.1002/ijc.23582; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Weidner N, 1991, NEW ENGL J MED, V32, P1, DOI DOI 10.1056/NEJM19910103; Yang X, 2010, J CELL MOL MED, V14, P2519, DOI 10.1111/j.1582-4934.2009.01004.x; Yang Y, 2006, CANCER BIOL THER, V5, P399; Zhang D, 2001, DIABETOLOGIA, V44, P757, DOI 10.1007/s001250051685; Zhang SX, 2004, DIABETOLOGIA, V47, P124, DOI 10.1007/s00125-003-1276-4; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; Zhu BH, 2007, MOL CANCER THER, V6, P3297, DOI 10.1158/1535-7163.MCT-06-0798; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	47	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53152	10.1371/journal.pone.0053152	http://dx.doi.org/10.1371/journal.pone.0053152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300882	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600063
J	Carey, JC; Fulweiler, RW				Carey, Joanna C.; Fulweiler, Robinson W.			The Terrestrial Silica Pump	PLOS ONE			English	Article							BIOGENIC SILICA; CARBON; CYCLE; BIOGEOCHEMISTRY; VEGETATION	Silicon (Si) cycling controls atmospheric CO2 concentrations and thus, the global climate, through three well-recognized means: chemical weathering of mineral silicates, occlusion of carbon (C) to soil phytoliths, and the oceanic biological Si pump. In the latter, oceanic diatoms directly sequester 25.8 Gton C yr(-1), accounting for 43% of the total oceanic net primary production (NPP). However, another important link between C and Si cycling remains largely ignored, specifically the role of Si in terrestrial NPP. Here we show that 55% of terrestrial NPP (33 Gton C yr(-1)) is due to active Si-accumulating vegetation, on par with the amount of C sequestered annually via marine diatoms. Our results suggest that similar to oceanic diatoms, the biological Si cycle of land plants also controls atmospheric CO2 levels. In addition, we provide the first estimates of Si fixed in terrestrial vegetation by major global biome type, highlighting the ecosystems of most dynamic Si fixation. Projected global land use change will convert forests to agricultural lands, increasing the fixation of Si by land plants, and the magnitude of the terrestrial Si pump.	[Carey, Joanna C.; Fulweiler, Robinson W.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Fulweiler, Robinson W.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University; Boston University	Carey, JC (corresponding author), Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA.	jocarey@bu.edu	Fulweiler, Robinson W./A-3806-2010	Fulweiler, Robinson W./0000-0003-0871-4246	STAR Fellowship [FP917238]; U.S. Environmental Protection Agency (EPA); Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration; Department of Earth Sciences at Boston University	STAR Fellowship; U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Department of Earth Sciences at Boston University	This research was partially developed under STAR Fellowship Assistance Agreement no. FP917238 awarded by the U.S. Environmental Protection Agency (EPA) to J.C. Carey. It has not been formally reviewed by EPA. The views expressed in this paper are solely those of J.C. Carey and R. W. Fulweiler, and EPA does not endorse any products or commercial services mentioned in this publication. In addition, this research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration to J.C. Carey. The authors would also like to thank the Department of Earth Sciences at Boston University for partial funding support of J.C Carey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMIRAAL W, 1990, BIOGEOCHEMISTRY, V9, P175, DOI 10.1007/BF00692170; Amos GL, 1952, SILICA TIMBERS; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Carey JC, 2013, BIOGEOCHEMISTRY, V113, P525, DOI 10.1007/s10533-012-9784-2; Carey JC, 2012, BIOGEOCHEMISTRY, V111, P125, DOI 10.1007/s10533-011-9671-2; Clymans W, 2011, BIOGEOSCIENCE DISCUS, V8, P4391; CONLEY DJ, 1993, MAR ECOL PROG SER, V101, P179, DOI 10.3354/meps101179; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Cornelis J.-T., 2010, BIOGEOSCI DISCUSS, V7, P5873, DOI DOI 10.5194/BGD-7-5873-2010; Danielsson A, 2008, J MARINE SYST, V73, P263, DOI 10.1016/j.jmarsys.2007.10.015; Derry LA, 2005, NATURE, V433, P728, DOI 10.1038/nature03299; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Epstein E, 2009, ANN APPL BIOL, V155, P155, DOI 10.1111/j.1744-7348.2009.00343.x; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Fulweiler RW, 2005, BIOGEOCHEMISTRY, V74, P115, DOI 10.1007/s10533-004-2947-z; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Hou LJ, 2010, J ENVIRON SCI, V22, P374, DOI 10.1016/S1001-0742(09)60118-2; Houghton R. A., 1990, EARTH TRANSFORMED HU; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Ittekkot V, 2000, BIOSCIENCE, V50, P776, DOI 10.1641/0006-3568(2000)050[0776:HAAMBA]2.0.CO;2; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Koeppen RC, 1978, SOME ANATOMICAL CHAR, P15; Laruelle GG, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003267; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Ma J.F, 2001, SILICON AGR, V8, P17, DOI 10.1016/S0928-3420(01)80006-9; OFFICER CB, 1980, MAR ECOL PROG SER, V3, P83, DOI 10.3354/meps003083; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sferratore A, 2006, ENVIRON SCI TECHNOL, V40, P6630, DOI 10.1021/es060710q; Street-Perrott FA, 2008, EARTH SURF PROC LAND, V33, P1436, DOI 10.1002/esp.1712; Struyf E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1128; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Turner RE, 1998, P NATL ACAD SCI USA, V95, P13048, DOI 10.1073/pnas.95.22.13048; Vandevenne F, 2012, FRONT ECOL ENVIRON, V10, P243, DOI 10.1890/110046	35	88	89	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52932	10.1371/journal.pone.0052932	http://dx.doi.org/10.1371/journal.pone.0052932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300825	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600038
J	Cherry, JD; Liu, B; Frost, JL; Lemere, CA; Williams, JP; Olschowka, JA; O'Banion, MK				Cherry, Jonathan D.; Liu, Bin; Frost, Jeffrey L.; Lemere, Cynthia A.; Williams, Jacqueline P.; Olschowka, John A.; O'Banion, M. Kerry			Galactic Cosmic Radiation Leads to Cognitive Impairment and Increased A beta Plaque Accumulation in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							HIPPOCAMPAL IL-1-BETA OVEREXPRESSION; AMYLOID-BETA; DEPOSITION; CLEARANCE; EXPOSURE; DEFICITS; DAMAGE; NEUROINFLAMMATION; INFLAMMATION; NEUROGENESIS	Galactic Cosmic Radiation consisting of high-energy, high-charged (HZE) particles poses a significant threat to future astronauts in deep space. Aside from cancer, concerns have been raised about late degenerative risks, including effects on the brain. In this study we examined the effects of Fe-56 particle irradiation in an APP/PS1 mouse model of Alzheimer's disease (AD). We demonstrated 6 months after exposure to 10 and 100 cGy Fe-56 radiation at 1 GeV/mu, that APP/PS1 mice show decreased cognitive abilities measured by contextual fear conditioning and novel object recognition tests. Furthermore, in male mice we saw acceleration of A beta plaque pathology using Congo red and 6E10 staining, which was further confirmed by ELISA measures of A beta isoforms. Increases were not due to higher levels of amyloid precursor protein (APP) or increased cleavage as measured by levels of the beta C-terminal fragment of APP. Additionally, we saw no change in microglial activation levels judging by CD68 and Iba-1 immunoreactivities in and around A beta plaques or insulin degrading enzyme, which has been shown to degrade A beta. However, immunohistochemical analysis of ICAM-1 showed evidence of endothelial activation after 100 cGy irradiation in male mice, suggesting possible alterations in A beta trafficking through the blood brain barrier as a possible cause of plaque increase. Overall, our results show for the first time that HZE particle radiation can increase A beta plaque pathology in an APP/PS1 mouse model of AD.	[Cherry, Jonathan D.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Liu, Bin; Frost, Jeffrey L.; Lemere, Cynthia A.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA; [Williams, Jacqueline P.] Univ Rochester, Sch Med & Dent, Dept Radiat Oncol, Rochester, NY USA; [Olschowka, John A.; O'Banion, M. Kerry] Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Rochester; University of Rochester	O'Banion, MK (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA.	Kerry_Obanion@urmc.rochester.edu	Cherry, Jonathan/D-5394-2015	O'Banion, M. Kerry/0000-0003-1246-3363	NASA Space Radiobiology Research Program [NNX08BA09G]; University of Rochester Behavioral Science Facility Core [P30 ES01247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NASA Space Radiobiology Research Program; University of Rochester Behavioral Science Facility Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NASA Space Radiobiology Research Program, Grant NNX08BA09G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; The authors thank Peter Guida, Adam Rusek, and their teams at Brookhaven National Laboratories for support during mouse irradiations. Jack Walter, Mallory Olschowka, and Lee Trojanczyk assisted with irradiations, animal management, contextual fear conditioning, and tissue collection and processing. We thank Katherine Bachmann in the University of Rochester Behavioral Science Facility Core (supported in part by P30 ES01247) for running the novel object recognition test.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chakrabarty P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-16; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; Clark RE, 2000, J NEUROSCI, V20, P8853; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Encinas JM, 2008, EXP NEUROL, V210, P274, DOI 10.1016/j.expneurol.2007.10.021; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hein AM, 2012, J NEUROIMMUNE PHARM, V7, P145, DOI 10.1007/s11481-011-9294-3; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kahn MS, 2012, BEHAV BRAIN RES, V229, P176, DOI 10.1016/j.bbr.2012.01.010; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Kyrkanides S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-112; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mizumatsu S, 2003, CANCER RES, V63, P4021; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Nelson Gregory A, 2003, Gravit Space Biol Bull, V16, P29; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rydberg B, 1996, RADIAT RES, V145, P200, DOI 10.2307/3579175; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Villasana L, 2010, HIPPOCAMPUS, V20, P19, DOI 10.1002/hipo.20659; Vlkolinsky R, 2010, RADIAT RES, V173, P342, DOI 10.1667/RR1825.1; Vlkolinsky R, 2008, RADIAT RES, V169, P523, DOI 10.1667/RR1228.1; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	51	133	138	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53275	10.1371/journal.pone.0053275	http://dx.doi.org/10.1371/journal.pone.0053275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300905	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600078
J	Yoshikawa, N; Shimizu, N; Maruyama, T; Sano, M; Matsuhashi, T; Fukuda, K; Kataoka, M; Satoh, T; Ojima, H; Sawai, T; Morimoto, C; Kuribara, A; Hosono, O; Tanaka, H				Yoshikawa, Noritada; Shimizu, Noriaki; Maruyama, Takako; Sano, Motoaki; Matsuhashi, Tomohiro; Fukuda, Keiichi; Kataoka, Masaharu; Satoh, Toru; Ojima, Hidenori; Sawai, Takashi; Morimoto, Chikao; Kuribara, Akiko; Hosono, Osamu; Tanaka, Hirotoshi			Cardiomyocyte-Specific Overexpression of HEXIM1 Prevents Right Ventricular Hypertrophy in Hypoxia-Induced Pulmonary Hypertension in Mice	PLOS ONE			English	Article							CARDIAC LINEAGE PROTEIN-1; SMOOTH-MUSCLE-CELLS; ELONGATION-FACTOR-B; ENDOTHELIAL GROWTH-FACTOR; ARTERIAL-HYPERTENSION; GLUCOCORTICOID-RECEPTOR; PRESSURE-OVERLOAD; GENE-EXPRESSION; DOWN-REGULATION; P-TEFB	Right ventricular hypertrophy (RVH) and right ventricular (RV) contractile dysfunction are major determinants of prognosis in pulmonary arterial hypertension (PAH) and PAH remains a severe disease. Recently, direct interruption of left ventricular hypertrophy has been suggested to decrease the risk of left-sided heart failure. Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is a negative regulator of positive transcription elongation factor b (P-TEFb), which activates RNA polymerase II (RNAPII)-dependent transcription and whose activation is strongly associated with left ventricular hypertrophy. We hypothesized that during the progression of PAH, increased P-TEFb activity might also play a role in RVH, and that HEXIM1 might have a preventive role against such process. We revealed that, in the mouse heart, HEXIM1 is highly expressed in the early postnatal period and its expression is gradually decreased, and that prostaglandin I-2, a therapeutic drug for PAH, increases HEXIM1 levels in cardiomyocytes. These results suggest that HEXIM1 might possess negative effect on cardiomyocyte growth and take part in cardiomyocyte regulation in RV. Using adenovirus-mediated gene delivery to cultured rat cardiomyocytes, we revealed that overexpression of HEXIM1 prevents endothelin-1-induced phosphorylation of RNAPII, cardiomyocyte hypertrophy, and mRNA expression of hypertrophic genes, whereas a HEXIM1 mutant lacking central basic region, which diminishes P-TEFb-suppressing activity, could not. Moreover, we created cardiomyocyte-specific HEXIM1 transgenic mice and revealed that HEXIM1 ameliorates RVH and prevents RV dilatation in hypoxia-induced PAH model. Taken together, these findings indicate that cardiomyocyte-specific overexpression of HEXIM1 inhibits progression to RVH under chronic hypoxia, most possibly via inhibition of P-TEFb-mediated enlargement of cardiomyocytes. We conclude that P-TEFb/HEXIM1-dependent transcriptional regulation may play a pathophysiological role in RVH and be a novel therapeutic target for mitigating RVH in PAH.	[Yoshikawa, Noritada; Shimizu, Noriaki; Maruyama, Takako; Kuribara, Akiko; Hosono, Osamu; Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, Dept Rheumatol & Allergy, IMSUT Hosp, Tokyo, Japan; [Sano, Motoaki; Matsuhashi, Tomohiro; Fukuda, Keiichi; Kataoka, Masaharu] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kataoka, Masaharu; Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Mitaka, Tokyo 181, Japan; [Ojima, Hidenori] Natl Canc Ctr, Res Inst, Div Pathol, Tokyo 104, Japan; [Sawai, Takashi] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate, Japan; [Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders, Tokyo, Japan; [Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Tokyo, Japan	University of Tokyo; Keio University; Kyorin University; National Cancer Center - Japan; Iwate Medical University; Juntendo University; Juntendo University	Tanaka, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Rheumatol & Allergy, IMSUT Hosp, Tokyo, Japan.	hirotnk@ims.u-tokyo.ac.jp	Fukuda, Keiichi/L-3777-2013; Sano, Motoaki/L-3405-2013	Yoshikawa, Noritada/0000-0002-7530-0791	Ministry of Health, Labour, and Welfare [24390236, 22790693, 23791050, 24930026]; Takeda Science Foundation; Suzuken Memorial Foundation; Actelion Academia Prize (Actelion Pharmaceuticals); Actelion Pharmaceuticals; Grants-in-Aid for Scientific Research [22390200, 23791050, 24390236] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Actelion Academia Prize (Actelion Pharmaceuticals); Actelion Pharmaceuticals; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (B) to HT (24390236), for Young Scientists (B) to NY (22790693) and NS (23791050), and for Encouragement of Scientists to TM (24930026), grants from the Ministry of Health, Labour, and Welfare to HT, grants from Takeda Science Foundation and Suzuken Memorial Foundation to NS, and grant from Actelion Academia Prize (Actelion Pharmaceuticals) to NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With respect to funding from Actelion Pharmaceuticals, the authors do not have any other relevant declarations such as employment, consultancy, patents, products in development or marketed products, and their funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Endo J, 2007, CIRCULATION, V116, P1176, DOI 10.1161/CIRCULATIONAHA.106.650903; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Espinoza-Derout J, 2009, CIRC RES, V104, P1347, DOI 10.1161/CIRCRESAHA.108.191726; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; FILEP JG, 1995, CIRCULATION, V92, P2969, DOI 10.1161/01.CIR.92.10.2969; Gardin JM, 2004, JAMA-J AM MED ASSOC, V292, P2396, DOI 10.1001/jama.292.19.2396; GRAINGER DJ, 1992, BIOCHEM J, V283, P403, DOI 10.1042/bj2830403; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Huang F, 2004, MECH DEVELOP, V121, P559, DOI 10.1016/j.mod.2004.04.012; Huang FC, 2002, GENE, V292, P245, DOI 10.1016/S0378-1119(02)00596-6; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Mascareno E, 2012, J BIOL CHEM, V287, P13084, DOI 10.1074/jbc.M111.288944; Mascareno E, 2009, J CELL MOL MED, V13, P2744, DOI 10.1111/j.1582-4934.2008.00404.x; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Ogba N, 2010, ONCOGENE, V29, P3639, DOI 10.1038/onc.2010.110; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Park AM, 2010, HYPERTENSION, V56, P1145, DOI 10.1161/HYPERTENSIONAHA.110.160515; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ritchie RH, 2004, AM J PHYSIOL-HEART C, V287, pH1179, DOI 10.1152/ajpheart.00725.2003; Roeleveld RJ, 2004, CHEST, V125, P572, DOI 10.1378/chest.125.2.572; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shimizu N, 2008, MOL ENDOCRINOL, V22, P2609, DOI 10.1210/me.2008-0101; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Turano M, 2006, J CELL PHYSIOL, V206, P603, DOI 10.1002/jcp.20502; UNVERFERTH DV, 1986, AM J CARDIOL, V57, P816, DOI 10.1016/0002-9149(86)90620-X; Uzuki M, 2001, CLIN SCI, V100, P577, DOI 10.1042/CS20000242; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wilkins MR, 2005, AM J RESP CRIT CARE, V171, P1292, DOI 10.1164/rccm.200410-1411OC; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yokoyama C, 2002, CIRCULATION, V106, P2397, DOI 10.1161/01.CIR.0000034733.93020.BC; Yoshikawa N, 2008, BIOCHEM BIOPH RES CO, V371, P44, DOI 10.1016/j.bbrc.2008.03.155; Yoshikawa N, 2009, AM J PHYSIOL-ENDOC M, V296, pE1363, DOI 10.1152/ajpendo.90767.2008	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52522	10.1371/journal.pone.0052522	http://dx.doi.org/10.1371/journal.pone.0052522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300697	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600018
J	Biswal, BK; Beyrouthy, MJ; Hever-Jardine, MP; Armstrong, D; Tomlinson, CR; Christensen, BC; Marsit, CJ; Spinella, MJ				Biswal, Bijesh K.; Beyrouthy, Maroun J.; Hever-Jardine, Mary P.; Armstrong, David; Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.			Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation	PLOS ONE			English	Article							GERM-CELL TUMORS; STEM-CELLS; DOWN-REGULATION; METHYLATION; DNMT3B; GENES; CISPLATIN; DIFFERENTIATION; LINKING; COMPLEX	Human embryonal carcinoma (EC) cells are the stem cells of nonseminoma testicular germ cells tumors (TGCTs) and share remarkable similarities to human embryonic stem (ES) cells. In prior work we found that EC cells are hypersensitive to low nanomolar doses of 5-aza deoxycytidine (5-aza) and that this hypersensitivity partially depended on unusually high levels of the DNA methyltransferase, DNMT3B. We show here that low-dose 5-aza treatment results in DNA damage and induction of p53 in NT2/D1 cells. In addition, low-dose 5-aza results in global and gene specific promoter DNA hypomethylation. Low-dose 5-aza induces a p53 transcriptional signature distinct from that induced with cisplatin in NT2/D1 cells and also uniquely downregulates genes associated with pluripotency including NANOG, SOX2, GDF3 and Myc target genes. Changes in the p53 and pluripotency signatures with 5-aza were to a large extent dependent on high levels of DNMT3B. In contrast to the majority of p53 target genes upregulated by 5-aza that did not show DNA hypomethylation, several other genes induced with 5-aza had corresponding decreases in promoter methylation. These genes include RIN1, SOX15, GPER, and TLR4 and are novel candidate tumors suppressors in TGCTs. Our studies suggest that the hypersensitivity of NT2/D1 cells to low-dose 5-aza is multifactorial and involves the combined activation of p53 targets, repression of pluripotency genes, and activation of genes repressed by DNA methylation. Low-dose 5-aza therapy may be a general strategy to treat those tumors that are sustained by cells with embryonic stem-like properties. GEO number for the microarray data: GSE42647.	[Biswal, Bijesh K.; Beyrouthy, Maroun J.; Hever-Jardine, Mary P.; Armstrong, David; Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Hanover, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Spinella, MJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	michael.spinella@dartmouth.edu	Tomlinson, Craig/F-1319-2017; Spinella, Michael/B-7210-2014	Biswal, Bijesh Kumar/0000-0002-5609-7660; Tomlinson, Craig/0000-0003-0923-1449; Marsit, Carmen/0000-0003-4566-150X	United States Department of Defense Investigator-Initiated Research Award [PR093629]; Prouty developmental award from the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	United States Department of Defense Investigator-Initiated Research Award(United States Department of Defense); Prouty developmental award from the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Department of Defense Investigator-Initiated Research Award PR093629 (MJS) and a Prouty developmental award from the Norris Cotton Cancer Center (MJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Baylin SB, 2005, COLD SH Q B, V70, P427, DOI 10.1101/sqb.2005.70.010; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Efstathiou Eleni, 2006, J Natl Compr Canc Netw, V4, P1059; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Giuliano CJ, 2005, BBA-GENE STRUCT EXPR, V1731, P48, DOI 10.1016/j.bbaexp.2005.08.006; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kashiwagi K, 2011, NUCLEIC ACIDS RES, V39, P874, DOI 10.1093/nar/gkq870; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Koychev D, 2011, INT J ANDROL, V34, pE266, DOI 10.1111/j.1365-2605.2011.01145.x; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Maslov AY, 2012, ONCOGENE, DOI [10.1038/onc.2012.9, DOI 10.1038/0NC.2012.9]; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okamoto K, 2012, INT J UROL, V19, P504, DOI 10.1111/j.1442-2042.2012.02986.x; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	56	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53003	10.1371/journal.pone.0053003	http://dx.doi.org/10.1371/journal.pone.0053003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300844	Green Submitted, gold, Green Published			2022-12-27	WOS:000312829100106
J	Chen, DF; Li, Y; Zhou, ZY; Xing, YG; Zhong, Y; Zou, XN; Tian, W; Zhang, C				Chen, Dafu; Li, Yang; Zhou, Zhiyu; Xing, Yonggang; Zhong, Yu; Zou, Xuenong; Tian, Wei; Zhang, Chi			Synergistic Inhibition of Wnt Pathway by HIF-1 alpha and Osteoblast-Specific Transcription Factor Osterix (Osx) in Osteoblasts	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; RECEPTOR-RELATED PROTEIN-5; GROWTH-FACTOR VEGF; BONE-FORMATION; SKELETAL DEVELOPMENT; DIFFERENTIATION; ANGIOGENESIS; CHONDROCYTES; HEDGEHOG; PROLIFERATION	Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation. Inhibition of Wnt pathway by Osx highlights the potential for feedback control mechanisms involved in bone formation. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of hypoxia. HIF-1 alpha has been reported to couple angiogenesis to osteogenesis. Our recent study has demonstrated that Osx and HIF-1 alpha cooperatively regulate VEGF expression in osteoblasts. Effects of hypoxia/HIF-1 alpha on osteoblast proliferation and related mechanisms are not well understood. In this study, osteoblast growth under hypoxia was examined. We observed that osteoblast growth was inhibited under hypoxia. To explore possible mechanisms for hypoxia/HIF-1 alpha to inhibit osteoblast proliferation, we tested the effect of hypoxia/HIF-1 alpha on Wnt pathway. Quantitative RT-PCR results revealed that Wnt target genes such as cyclin D1 and c-Myc were downregulated under hypoxia while HIF-1 alpha was upregulated. Treatment of desferrioxamine, a HIF-1 alpha activator, led to further downregulation of expressions of cyclin D1 and c-Myc in osteoblasts. On the contrary, the inhibition of HIF-1 alpha by siRNA in osteoblasts led to the expression increase of cyclin D1 and c-Myc. These data suggest that HIF-1 alpha inhibits Wnt pathway in osteoblasts. To examine the effect of HIF-1 alpha on Wnt pathway, HIF-1 alpha was cotransfected with beta-catenin along with Topflash reporter in transient transfection assay. Our results showed that HIF-1 alpha inhibited beta-catenin-induced Topflash reporter activity. Interestingly, a synergistic interplay was observed between Osx and HIF-1 alpha in the inhibition of beta-catenin-induced Topflash expression. Our findings indicate that Osx and HIF-1 alpha cooperatively inhibit Wnt pathway. This study revealed additional new information of the cooperation between HIF-1 alpha and Osx in osteoblasts.	[Chen, Dafu; Xing, Yonggang; Tian, Wei] Beijing JiShuiTan Hosp, Lab Bone Tissue Engn, Beijing Res Inst Traumatol & Orthopaed, Beijing, Peoples R China; [Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, Dallas, TX 75390 USA; [Li, Yang; Zhong, Yu; Zou, Xuenong] Sun Yat Sen Univ, Dept Spine, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University	Tian, W (corresponding author), Beijing JiShuiTan Hosp, Lab Bone Tissue Engn, Beijing Res Inst Traumatol & Orthopaed, Beijing, Peoples R China.	tianweijst@yahoo.com.cn; Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012; ZHOU, ZHIYU/AAU-5036-2021	ZHOU, ZHIYU/0000-0002-8101-2083	Arthritis Foundation; National Basic Research Program of China (973 Program) [2012CB619105]; National Natural Science Foundation of China [81171682]	Arthritis Foundation; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Bone Research Laboratory is supported by a Research Grant from the Arthritis Foundation (http://www.arthritis.org). This work is also supported by the National Basic Research Program of China (973 Program, No. 2012CB619105) and is in part supported by the National Natural Science Foundation of China (Grant Number 81171682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Chen DF, 2012, BIOCHEM BIOPH RES CO, V424, P176, DOI 10.1016/j.bbrc.2012.06.104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maxwell PH, 2002, CLIN MED, V2, P356, DOI 10.7861/clinmedicine.2-4-356; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; Ratcliffe PJ, 2000, NAT MED, V6, P1315, DOI 10.1038/82113; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	32	38	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52948	10.1371/journal.pone.0052948	http://dx.doi.org/10.1371/journal.pone.0052948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300831	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100103
J	Hassenklover, T; Pallesen, LP; Schild, D; Manzini, I				Hassenkloever, Thomas; Pallesen, Lars P.; Schild, Detlev; Manzini, Ivan			Amino Acid- vs. Peptide-Odorants: Responses of Individual Olfactory Receptor Neurons in an Aquatic Species	PLOS ONE			English	Article							XENOPUS-LAEVIS TADPOLES; MULTIDRUG-RESISTANCE TRANSPORTERS; CHANNEL CATFISH; N-ACETYLASPARTYLGLUTAMATE; ICTALURUS-PUNCTATUS; FEEDING-BEHAVIOR; FISH OLFACTION; DISSOLVED FREE; RAINBOW-TROUT; STREAM WATER	Amino acids are widely used waterborne olfactory stimuli proposed to serve as cues in the search for food. In natural waters the main source of amino acids is the decomposition of proteins. But this process also produces a variety of small peptides as intermediate cleavage products. In the present study we tested whether amino acids actually are the natural and adequate stimuli for the olfactory receptors they bind to. Alternatively, these olfactory receptors could be peptide receptors which also bind amino acids though at lower affinity. Employing calcium imaging in acute slices of the main olfactory epithelium of the fully aquatic larvae of Xenopus laevis we show that amino acids, and not peptides, are more effective waterborne odorants.	[Hassenkloever, Thomas; Pallesen, Lars P.; Schild, Detlev; Manzini, Ivan] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany; [Hassenkloever, Thomas; Schild, Detlev; Manzini, Ivan] Univ Gottingen, Cluster Excellence Nanoscale Microscopy & Mol Phy, Gottingen, Germany	University of Gottingen; University of Gottingen	Manzini, I (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany.	imanzin@gwdg.de	Manzini, Ivan/V-4545-2019; Manzini, Ivan/F-8927-2015	Manzini, Ivan/0000-0002-3575-9637; Manzini, Ivan/0000-0002-3575-9637; Hassenklover, Thomas/0000-0002-9895-1263	DFG Schwerpunktprogramm [1392]; Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB)	DFG Schwerpunktprogramm(German Research Foundation (DFG)); Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB)	This work was supported by DFG Schwerpunktprogramm 1392 (http://cms.uni-konstanz.de/spp) to IM, and Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB, http://www.cmpb.de) to IM and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Bischofberger J, 1996, J NEUROPHYSIOL, V76, P2089, DOI 10.1152/jn.1996.76.3.2089; Braubach OR, 2009, BEHAV BRAIN RES, V198, P190, DOI 10.1016/j.bbr.2008.10.044; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; CARR WES, 1986, J CHEM ECOL, V12, P989, DOI 10.1007/BF01638992; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; COFFIN RB, 1989, LIMNOL OCEANOGR, V34, P531, DOI 10.4319/lo.1989.34.3.0531; Delay RJ, 2002, CHEM SENSES, V27, P673, DOI 10.1093/chemse/27.8.673; Dittmar T., 2009, PRACTICAL GUIDELINES, P67; Doolin RE, 2005, CHEM SENSES, V30, P105, DOI 10.1093/chemse/bji005; Doolin RE, 2005, CHEM SENSES, V30, P127, DOI 10.1093/chemse/bji008; DUCHAMPVIRET P, 1989, J NEUROPHYSIOL, V61, P1085, DOI 10.1152/jn.1989.61.5.1085; DUCHAMPVIRET P, 1990, BRAIN RES, V517, P256, DOI 10.1016/0006-8993(90)91035-F; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Hansen A, 2003, J NEUROSCI, V23, P9328; HARA TJ, 1994, REV FISH BIOL FISHER, V4, P1, DOI 10.1007/BF00043259; HARA TJ, 1977, COMP BIOCHEM PHYS A, V56, P559, DOI 10.1016/0300-9629(77)90285-7; HARA TJ, 1992, FISH CHEMORECEPTION, P150; Hassenklover T, 2008, GLIA, V56, P1614, DOI 10.1002/glia.20714; Hubbard PC, 2011, J COMP PHYSIOL A, V197, P839, DOI 10.1007/s00359-011-0646-5; Ishizawa S, 2010, FISHERIES SCI, V76, P669, DOI 10.1007/s12562-010-0246-2; Janecka A, 2004, CURR TOP MED CHEM, V4, P1, DOI 10.2174/1568026043451618; JORGENSEN NOG, 1986, FRESHWATER BIOL, V16, P255, DOI 10.1111/j.1365-2427.1986.tb00969.x; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; KANG JS, 1991, J GEN PHYSIOL, V98, P699, DOI 10.1085/jgp.98.4.699; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEE C, 1977, LIMNOL OCEANOGR, V22, P502, DOI 10.4319/lo.1977.22.3.0502; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Manzini I, 2002, J NEUROSCI METH, V121, P159, DOI 10.1016/S0165-0270(02)00248-0; Manzini I, 2002, J PHYSIOL-LONDON, V545, P475, DOI 10.1113/jphysiol.2002.031914; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; Mezler M, 2001, J EXP BIOL, V204, P2987; Michel WC, 2003, J EXP BIOL, V206, P1697, DOI 10.1242/jeb.00339; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Mobley AS, 2008, ANAT REC, V291, P763, DOI 10.1002/ar.20704; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Nikonov AA, 2007, J NEUROPHYSIOL, V98, P1909, DOI 10.1152/jn.00548.2007; Pantoja S, 1999, MAR CHEM, V63, P273, DOI 10.1016/S0304-4203(98)00067-X; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Schmachtenberg O, 2004, EUR J NEUROSCI, V20, P3378, DOI 10.1111/j.1460-9568.2004.03825.x; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; SORENSEN PW, 1998, PHYSL FISHES, P251; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; TRANVIK LJ, 1995, BIOGEOCHEMISTRY, V30, P77; Valentincic T, 2000, J EXP BIOL, V203, P3307; Valentincic T, 1997, CHEM SENSES, V22, P375, DOI 10.1093/chemse/22.4.375; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x	59	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53097	10.1371/journal.pone.0053097	http://dx.doi.org/10.1371/journal.pone.0053097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300867	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100118
J	Wang, F; Shi, Y; Lu, L; Liu, L; Cai, YL; Zheng, HR; Liu, X; Yan, F; Zou, C; Sun, CY; Shi, J; Lu, SK; Chen, Y				Wang, Feng; Shi, Yu; Lu, Lin; Liu, Li; Cai, Youli; Zheng, Hairong; Liu, Xin; Yan, Fei; Zou, Chao; Sun, Chengyu; Shi, Jie; Lu, Shukun; Chen, Yun			Targeted Delivery of GDNF through the Blood-Brain Barrier by MRI-Guided Focused Ultrasound	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; P-SELECTIN; RAT-BRAIN; DRUG; MICROBUBBLES; DISRUPTION; ADDICTION; MOUSE	Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), are promising therapeutic agents for neurodegenerative diseases. However, the application of GDNF to treat these diseases effectively is limited because the blood-brain barrier (BBB) prevents the local delivery of macromolecular therapeutic agents from entering the central nervous system (CNS). Focused ultrasound combined with microbubbles (MBs) using appropriate parameters has been previously demonstrated to be able to open the BBB locally and noninvasively. This study investigated the targeted delivery of GDNF MBs through the BBB by magnetic resonance imaging (MRI)-guided focused ultrasound. Evans Blue extravasation and histological examination were used to determine the optimum focused ultrasound parameters. Enzyme-linked immunosorbent assay was performed to verify the effects of GDNF bound on MBs using a biotin-avidin bridging chemistry method to promote GDNF delivery into the brain. The results showed that GDNF can be delivered locally and noninvasively into the CNS through the BBB using MRI-guided focused ultrasound combined with MBs under optimum parameters. MBs that bind GDNF combined with MRI-guided focused ultrasound may be an effective way of delivering neurotrophic factors directly into the CNS. The method described herein provides a potential means of treating patients with CNS diseases.	[Wang, Feng; Shi, Yu; Liu, Li; Cai, Youli; Lu, Shukun; Chen, Yun] Peking Univ, Dept Ultrasound, Shenzhen Hosp, Biomed Res Inst,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Lu, Lin; Sun, Chengyu; Shi, Jie] Peking Univ, Natl Inst Drug Dependence, Shenzhen, Peoples R China; [Zheng, Hairong; Liu, Xin; Yan, Fei; Zou, Chao] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wang, Feng] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China; [Liu, Xin; Zou, Chao] Shenzhen Key Lab MRI, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Xinxiang Medical University	Chen, Y (corresponding author), Peking Univ, Dept Ultrasound, Shenzhen Hosp, Biomed Res Inst,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China.	cyun126@126.com	SHI, JIE/GXG-3394-2022		National Natural Science Foundation [30970833, 81101048, U1204810]; National 973 basic research program [2011CB707903]; National Postdoctoral Science Foundation [2011M501111]; Shenzhen Basic Research Program [JC201005280495A]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 basic research program(National Basic Research Program of China); National Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shenzhen Basic Research Program	This work was supported by grants from the National Natural Science Foundation (No. 30970833), National 973 basic research program (No. 2011CB707903), the National Natural Science Foundation (No. 81101048 and No. U1204810), National Postdoctoral Science Foundation (No. 2011M501111), and Shenzhen Basic Research Program (No. JC201005280495A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carnicella S, 2009, PHARMACOL THERAPEUT, V122, P9, DOI 10.1016/j.pharmthera.2008.12.001; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; Deng CX, 2010, THER DELIV, V1, P819, DOI 10.4155/TDE.10.66; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Garbayo E, 2007, INT J PHARMACEUT, V344, P9, DOI 10.1016/j.ijpharm.2007.04.003; Gearhart DA, 2006, J NEUROSCI METH, V150, P159, DOI 10.1016/j.jneumeth.2005.06.009; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kaufmann BA, 2007, EUR HEART J, V28, P2011, DOI 10.1093/eurheartj/ehm176; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Mcdannold N, 2008, ULTRASOUND MED BIOL, V34, P930, DOI 10.1016/j.ultrasmedbio.2007.11.009; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nevalainen N, 2010, NEUROSCIENCE, V171, P1357, DOI 10.1016/j.neuroscience.2010.10.010; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takalkar AM, 2004, J CONTROL RELEASE, V96, P473, DOI 10.1016/j.jconrel.2004.03.002; Tempany CMC, 2003, RADIOLOGY, V226, P897, DOI 10.1148/radiol.2271020395; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang F, 2009, J ULTRAS MED, V28, P1501, DOI 10.7863/jum.2009.28.11.1501; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038	30	41	48	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52925	10.1371/journal.pone.0052925	http://dx.doi.org/10.1371/journal.pone.0052925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300823	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100100
J	Zhang, N; Pan, XM; Ge, M				Zhang, Nan; Pan, Xian-Ming; Ge, Meng			Without Salt, the 'Thermophilic' Protein Mth10b Is Just Mesophilic	PLOS ONE			English	Article							DNA-BINDING PROTEIN; CRYSTAL-STRUCTURE; METHANOPYRUS-KANDLERI; ION-PAIRS; HYPERTHERMOPHILIC ARCHAEON; GUANIDINE-HYDROCHLORIDE; THERMOTOGA-MARITIMA; THERMOSTABILITY; STABILITY; ENZYMES	Most proteins from thermophiles or hyperthermophiles are intrinsically thermostable. However, though Methanobacterium thermoautotrophicum Delta H is a thermophilic archaeon with an optimal growth temperature of 65 degrees C, Mth10b, an atypical member the Sac10b protein family from M. thermoautotrophicum DH, seems not intrinsically thermostable. In this work, to clarify the molecular mechanism of Mth10b remaining stable under its physiological conditions, the thermodynamic properties of Mth10b were studied through equilibrium unfolding experiments performed at pH 7.0 monitored by circular dichroism (CD) spectra in detail. Our work demonstrated that Mth10b is not intrinsically thermostable and that due to the masking effect upon the large numbers of destabilizing electrostatic repulsions resulting from the extremely uneven distribution of charged residues over the surface of Mth10b, salt can contribute to the thermostability of Mth10b greatly. Considering that the intracellular salt concentration is high to 0.7 M, we concluded that salt is the key extrinsic factor to Mth10b remaining stable under its physiological conditions. In other word, without salt, 'thermophilic' protein Mth10b is just a mesophilic one.	[Zhang, Nan; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ge, Meng] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Pan, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn; gemeng@big.ac.cn			Natural Science Foundation of China [30870475]; Ministry of Science and Technology of China [2009CB918801]; China Postdoctoral Science Foundation [201104166, 20100470567]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants 30870475 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm), 2009CB918801 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), and 201104166 and 20100470567 from the China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Ermler U, 1997, STRUCTURE, V5, P635, DOI 10.1016/S0969-2126(97)00219-0; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Freire E, 1995, METHOD ENZYMOL, V259, P144; Gaseidnes S, 2003, PROTEIN ENG, V16, P841, DOI 10.1093/protein/gzg105; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Ge M, 2009, EXTREMOPHILES, V13, P481, DOI 10.1007/s00792-009-0233-7; Ge M, 2009, EXTREMOPHILES, V13, P131, DOI 10.1007/s00792-008-0204-4; Goihberg E, 2007, PROTEINS, V66, P196, DOI 10.1002/prot.21170; Grabarse W, 1999, STRUCTURE, V7, P1257, DOI 10.1016/S0969-2126(00)80059-3; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Liu YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034986; Liu YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019977; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pace C N, 1986, Methods Enzymol, V131, P266; Privalov PL, 1979, ADV PROCHEM SIOPHYS, V210, P455; Rahman RNZA, 1998, BIOCHEM BIOPH RES CO, V248, P920, DOI 10.1006/bbrc.1998.8933; Ramos A, 1997, APPL ENVIRON MICROB, V63, P4020, DOI 10.1128/AEM.63.10.4020-4025.1997; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Shima S, 1998, ARCH MICROBIOL, V170, P469, DOI 10.1007/s002030050669; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Suvd D, 2001, J BIOCHEM, V129, P461, DOI 10.1093/oxfordjournals.jbchem.a002878; SUZUKI Y, 1989, P JPN ACAD B-PHYS, V65, P146, DOI 10.2183/pjab.65.146; SUZUKI Y, 1987, APPL MICROBIOL BIOT, V26, P546, DOI 10.1007/BF00253030; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Wilquet V, 1998, EUR J BIOCHEM, V255, P628, DOI 10.1046/j.1432-1327.1998.2550628.x; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250	51	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53125	10.1371/journal.pone.0053125	http://dx.doi.org/10.1371/journal.pone.0053125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300880	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100124
J	Baczyk, D; Kibschull, M; Mellstrom, B; Levytska, K; Rivas, M; Drewlo, S; Lye, SJ; Naranjo, JR; Kingdom, JCP				Baczyk, Dora; Kibschull, Mark; Mellstrom, Britt; Levytska, Khrystyna; Rivas, Marcos; Drewlo, Sascha; Lye, Stephen J.; Naranjo, Jose R.; Kingdom, John C. P.			DREAM Mediated Regulation of GCM1 in the Human Placental Trophoblast	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSOR; PROTEIN; CELLS; CALSENILIN; SYNCYTIN; TERM; DIFFERENTIATION; APOPTOSIS; INTERACTS	The trophoblast transcription factor glial cell missing-1 (GCM1) regulates differentiation of placental cytotrophoblasts into the syncytiotrophoblast layer in contact with maternal blood. Reduced placental expression of GCM1 and abnormal syncytiotrophoblast structure are features of hypertensive disorder of pregnancy - preeclampsia. In-silico techniques identified the calcium-regulated transcriptional repressor - DREAM (Downstream Regulatory Element Antagonist Modulator) - as a candidate for GCM1 gene expression. Our objective was to determine if DREAM represses GCM1 regulated syncytiotrophoblast formation. EMSA and ChIP assays revealed a direct interaction between DREAM and the GCM1 promoter. siRNA-mediated DREAM silencing in cell culture and placental explant models significantly up-regulated GCM1 expression and reduced cytotrophoblast proliferation. DREAM calcium dependency was verified using ionomycin. Furthermore, the increased DREAM protein expression in preeclamptic placental villi was predominantly nuclear, coinciding with an overall increase in sumolylated DREAM and correlating inversely with GCM1 levels. In conclusion, our data reveal a calcium-regulated pathway whereby GCM1-directed villous trophoblast differentiation is repressed by DREAM. This pathway may be relevant to disease prevention via calcium-supplementation.	[Baczyk, Dora; Kibschull, Mark; Levytska, Khrystyna; Drewlo, Sascha; Lye, Stephen J.; Kingdom, John C. P.] Univ Toronto, Mt Sinai Hosp, Res Ctr Womens & Infants Hlth, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mellstrom, Britt; Rivas, Marcos; Naranjo, Jose R.] CSIC, Natl Biotechnol Ctr, Dept Mol & Cellular Biol, Madrid, Spain; [Lye, Stephen J.; Kingdom, John C. P.] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Baczyk, D (corresponding author), Univ Toronto, Mt Sinai Hosp, Res Ctr Womens & Infants Hlth, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	baczyk@lunenfeld.ca	Drewlo, Sascha/AAS-9890-2020; NARANJO, Jose R/K-1950-2014; Kingdom, John/A-3247-2013; Kingdom, John/AAF-2145-2020; Lye, Stephen J/E-7269-2013	NARANJO, Jose R/0000-0002-0270-3469; Lye, Stephen J/0000-0002-3305-4406	Canadian Institute of Health Research [64302]; Department of Obstetrics Gynecology; Rose Torno Chair at MSH; Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health; Molly Towell Perinatal Research Foundation Fellowship; Spanish Science Agency-DGICYT [SAF2010-21784, SAF2008-03469]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Obstetrics Gynecology; Rose Torno Chair at MSH; Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health(Canadian Institutes of Health Research (CIHR)); Molly Towell Perinatal Research Foundation Fellowship; Spanish Science Agency-DGICYT	This research is supported by Canadian Institute of Health Research (Grant no. 64302) to JK, Department of Obstetrics & Gynecology and Rose Torno Chair at MSH as well as by the Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health & Molly Towell Perinatal Research Foundation Fellowship to SD, and Spanish Science Agency-DGICYT (grants SAF2010-21784; SAF2008-03469) to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Baczyk D, 2004, PLACENTA, V25, P553, DOI 10.1016/j.placenta.2003.12.004; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baczyk D, 2011, CELL CALCIUM, V49, P350, DOI 10.1016/j.ceca.2010.12.003; Benirschke K., 2005, PATHOLOGY HUMAN PLAC; Bieche I, 1999, CANCER RES, V59, P2759; Burton GJ, 2009, TAIWAN J OBSTET GYNE, V48, P28, DOI 10.1016/S1028-4559(09)60032-2; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cali T., 2012, J BIOL CHEM; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Ellery PM, 2009, PLACENTA, V30, P329, DOI 10.1016/j.placenta.2009.01.002; Fitzgerald B, 2011, PLACENTA, V32, P339, DOI 10.1016/j.placenta.2011.01.018; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Huppertz B, 2010, PLACENTA, V31, pS75, DOI 10.1016/j.placenta.2009.12.001; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Matsuda M, 2006, ENDOCRINOLOGY, V147, P4608, DOI 10.1210/en.2006-0254; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Moreau R, 2002, BIOL REPROD, V67, P1473, DOI 10.1095/biolreprod.102.005397; Palczewska M, 2011, BBA-MOL CELL RES, V1813, P1050, DOI 10.1016/j.bbamcr.2010.11.001; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rivas M, 2011, ANTIOXID REDOX SIGNA; Robson SC, 2002, AM J OBSTET GYNECOL, V187, P1349, DOI 10.1067/mob.2002.126866; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; SIMPSON RA, 1992, PLACENTA, V13, P501, DOI 10.1016/0143-4004(92)90055-X; Walker MG, 2012, PLACENTA; Wu LJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-3; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	43	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e51837	10.1371/journal.pone.0051837	http://dx.doi.org/10.1371/journal.pone.0051837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300953	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000004
J	Hahn, C; Lim, HK; Won, WY; Ahn, KJ; Jung, WS; Lee, CU				Hahn, Changtae; Lim, Hyun-Kook; Won, Wang Yeon; Ahn, Kook Jin; Jung, Won-Sang; Lee, Chang Uk			Apathy and White Matter Integrity in Alzheimer's Disease: A Whole Brain Analysis with Tract-Based Spatial Statistics	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; PARKINSONS-DISEASE; DEPRESSION; DEMENTIA; ADOLESCENTS; INVENTORY; DIAGNOSIS; REGION; ROBUST	The aim of this study was to investigate the microstructural alterations of white matter (WM) in Alzheimer's disease (AD) patients with apathy and to observe the relationships with the severity of apathy. Sixty drug-naive subjects took part in this study (30 apathetic and 30 nonapathetic subjects with AD). The loss of integrity in WM was compared in AD patients with and without apathy through measurement of fractional anisotropy (FA) using by tract-based spatial statistics (TBSS). In addition, we explored the correlation pattern between FA values and the severity of apathy in AD patients with apathy. The apathy group had significantly reduced FA values (p(corrected)<0.05) in the genu of the corpus callosum compared to the nonapathy group. The severity of apathy was negatively correlated with FA values of the left anterior and posterior cingulum, right superior longitudinal fasciculus, splenium, body and genu of the corpus callosum and bilateral uncinate fasciculusin the apathy group (p(corrected)<0.05). This study was the first to explore FA values in whole brain WM in AD patients with apathy. The findings of these microstructural alterations of WM may be the key to the understanding of underlying neurobiological mechanism and clinical significances of apathy in AD.	[Hahn, Changtae; Lee, Chang Uk] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Lim, Hyun-Kook] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Psychiat, Suwon, South Korea; [Won, Wang Yeon] Catholic Univ Korea, Coll Med, St Paul Hosp, Dept Psychiat, Seoul, South Korea; [Ahn, Kook Jin] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea; [Jung, Won-Sang] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Suwon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, CU (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea.	jihan@catholic.ac.kr			Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ007186]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2042339]	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next Generation BioGreen 21 Program (no. PJ007186), Rural Development Administration, Republic of Korea. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2042339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2007, DEMENT GERIATR COGN, V24, P91, DOI 10.1159/000103914; Benoit M, 2011, J NEUROL SCI, V310, P58, DOI 10.1016/j.jns.2011.07.006; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Castellon SA, 1998, J NEUROPSYCH CLIN N, V10, P320, DOI 10.1176/jnp.10.3.320; Chilovi BV, 2009, DEMENT GERIATR COGN, V27, P390, DOI 10.1159/000210045; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Frye RE, 2010, DEV MED CHILD NEUROL, V52, P760, DOI 10.1111/j.1469-8749.2010.03633.x; Fuh JL, 2005, J NEUROL NEUROSUR PS, V76, P1337, DOI 10.1136/jnnp.2004.056408; Guimaraes HC, 2008, ARQ NEURO-PSIQUIAT, V66, P436, DOI 10.1590/S0004-282X2008000300035; Hoare J, 2010, J NEUROPSYCH CLIN N, V22, P313, DOI 10.1176/appi.neuropsych.22.3.313; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kang SY, 2008, NEUROLOGY, V70, P2386, DOI 10.1212/01.wnl.0000314686.94007.d0; Karlsgodt KH, 2010, J NEUROSCI, V30, P8197, DOI 10.1523/JNEUROSCI.0359-10.2010; Kim JW, 2011, AM J GERIAT PSYCHIAT, V19, P644, DOI 10.1097/JGP.0b013e31820dcc73; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Likitjaroen Y, 2012, EUR ARCH PSY CLIN N, V262, P341, DOI 10.1007/s00406-011-0234-2; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez M.F., 2010, BRAIN BEHAV INTRO BE; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naik M, 2010, ACTA RADIOL, V51, P662, DOI 10.3109/02841851003709870; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ota M, 2012, INT J GERIATR PSYCH, V27, P722, DOI 10.1002/gps.2779; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Palmqvist S, 2011, DEMENT GERIATR COGN, V32, P417, DOI 10.1159/000335778; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Reuter-Lorenz PA, 2002, IS CL CO NE, P341; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Robert PH, 2010, CNS NEUROSCI THER, V16, P263, DOI 10.1111/j.1755-5949.2009.00132.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Starkstein SE, 2009, J NEUROPSYCH CLIN N, V21, P259, DOI 10.1176/appi.neuropsych.21.3.259; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Torrente F, 2011, J ATTEN DISORD, V15, P545, DOI 10.1177/1087054709359887; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	55	55	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53493	10.1371/journal.pone.0053493	http://dx.doi.org/10.1371/journal.pone.0053493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301077	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000061
J	Bosker, WM; Karschner, EL; Lee, D; Goodwin, RS; Hirvonen, J; Innis, RB; Theunissen, EL; Kuypers, KPC; Huestis, MA; Ramaekers, JG				Bosker, Wendy M.; Karschner, Erin L.; Lee, Dayong; Goodwin, Robert S.; Hirvonen, Jussi; Innis, Robert B.; Theunissen, Eef L.; Kuypers, Kim P. C.; Huestis, Marilyn A.; Ramaekers, Johannes G.			Psychomotor Function in Chronic Daily Cannabis Smokers during Sustained Abstinence	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; SIMULTANEOUS QUANTIFICATION; DRIVING PERFORMANCE; MASS-SPECTROMETRY; MOTOR CONTROL; ORAL FLUID; USERS; DELTA-9-TETRAHYDROCANNABINOL; MIRTAZAPINE; SLEEP	Background: The present study assessed psychomotor function in chronic, daily cannabis smokers during 3 weeks continuously monitored abstinence on a secure research unit. We hypothesized that psychomotor performance would improve during abstinence of chronic, daily cannabis smokers. Methodology/Principal Findings: Performance on the critical tracking (CTT) and divided attention (DAT) tasks was assessed in 19 male chronic, daily cannabis smokers at baseline and after 8, 14-16 and 21-23 days of continuously monitored abstinence. Psychomotor performance was compared to a control group of non-intoxicated occasional drug users. Critical frequency (lambda(c)) of the CTT and tracking error and control losses of the DAT were the primary outcome measures. Results showed that chronic cannabis smokers' performance on the CTT (p<0.001) and the DAT (p<0.001) was impaired during baseline relative to the comparison group. Psychomotor performance in the chronic cannabis smokers improved over 3 weeks of abstinence, but did not recover to equivalent control group performance. Conclusions/Significance: Sustained cannabis abstinence moderately improved critical tracking and divided attention performance in chronic, daily cannabis smokers, but impairment was still observable compared to controls after 3 weeks of abstinence. Between group differences, however, need to be interpreted with caution as chronic smokers and controls were not matched for education, social economic status, life style and race.	[Bosker, Wendy M.; Theunissen, Eef L.; Kuypers, Kim P. C.; Ramaekers, Johannes G.] Maastricht Univ, Dept Neuropsychol, Maastricht, Netherlands; [Bosker, Wendy M.; Theunissen, Eef L.; Kuypers, Kim P. C.; Ramaekers, Johannes G.] Maastricht Univ, Dept Psychopharmacol, Maastricht, Netherlands; [Karschner, Erin L.; Lee, Dayong; Goodwin, Robert S.; Huestis, Marilyn A.] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Hirvonen, Jussi; Innis, Robert B.] NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA	Maastricht University; Maastricht University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ramaekers, JG (corresponding author), Maastricht Univ, Dept Neuropsychol, Maastricht, Netherlands.	j.ramaekers@maastrichtuniversity.nl	Kuypers, Kim/L-1206-2019; Hirvonen, Jussi/AAC-1864-2020; Hirvonen, Jussi/H-2521-2012	Kuypers, Kim/0000-0001-7634-3809; Lee, Dayong/0000-0003-0725-8760	Intramural Programs of the NIMH [Z01-MH-002852-04]; NIDA [Z01-DA000413-13]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002852, Z01MH002852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000413, ZIADA000413] Funding Source: NIH RePORTER	Intramural Programs of the NIMH; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Programs of the NIMH (project no. Z01-MH-002852-04) and the NIDA (project no. Z01-DA000413-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battisti RA, 2010, PSYCHOPHARMACOLOGY, V209, P319, DOI 10.1007/s00213-010-1800-4; Bosker WM, 2010, PSYCHOPHARMACOLOGY, V209, P69, DOI 10.1007/s00213-009-1767-1; de Fonseca FR, 1998, NEUROBIOL DIS, V5, P483, DOI 10.1006/nbdi.1998.0217; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2010, ISR STAT COMPTR REP; Giuffrida A, 2000, PROSTAG OTH LIPID M, V61, P63, DOI 10.1016/S0090-6980(00)00055-1; Hirvonen J, 2011, MOL PSYCHIAT; Hunault CC, 2009, PSYCHOPHARMACOLOGY, V204, P85, DOI 10.1007/s00213-008-1440-0; Jex HR., 1966; Karschner EL, 2009, ADDICTION, V104, P2041, DOI 10.1111/j.1360-0443.2009.02705.x; Karschner EL, 2009, J ANAL TOXICOL, V33, P469, DOI 10.1093/jat/33.8.469; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V192, P111, DOI 10.1007/s00213-006-0679-6; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; Lowe RH, 2007, J CHROMATOGR A, V1163, P318, DOI 10.1016/j.chroma.2007.06.069; Milman G, 2010, J CHROMATOGR A, V1217, P1513, DOI 10.1016/j.chroma.2009.12.053; MOSKOWITZ H, 1973, J SAFETY RES, V5, P185; Pillay SS, 2008, EXP CLIN PSYCHOPHARM, V16, P22, DOI 10.1037/1064-1297.16.1.22; Pope H G Jr, 2001, Curr Psychiatry Rep, V3, P507, DOI 10.1007/s11920-001-0045-7; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Ramaekers JG, 2006, DRUG ALCOHOL DEPEN, V85, P114, DOI 10.1016/j.drugalcdep.2006.03.015; Ramaekers JG, 2009, J PSYCHOPHARMACOL, V23, P266, DOI 10.1177/0269881108092393; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; Ramaekers JG, 1998, HUM PSYCHOPHARM CLIN, V13, pS87, DOI 10.1002/(SICI)1099-1077(1998110)13:2+<S87::AID-HUP53>3.3.CO;2-#; Ramaekers JG, 2010, PSYCHOPHARMACOLOGY B; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Ramaekers JG, 2011, PSYCHOPHARMACOLOGY, V215, P321, DOI 10.1007/s00213-010-2149-4; SAMHSA, 2010, NSDUH SER H, VI; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; Wingen M, 2005, J CLIN PSYCHIAT, V66, P436, DOI 10.4088/JCP.v66n0405	33	59	59	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53127	10.1371/journal.pone.0053127	http://dx.doi.org/10.1371/journal.pone.0053127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301031	Green Published, gold			2022-12-27	WOS:000313320900063
J	Schuldt, BM; Guhr, A; Lenz, M; Kobold, S; MacArthur, BD; Schuppert, A; Loser, P; Muller, FJ				Schuldt, Bernhard M.; Guhr, Anke; Lenz, Michael; Kobold, Sabine; MacArthur, Ben D.; Schuppert, Andreas; Loeser, Peter; Mueller, Franz-Josef			Power-Laws and the Use of Pluripotent Stem Cell Lines	PLOS ONE			English	Article							DERIVATION; GENERATION; ADVANTAGE; EMBRYOS; POLICY; STATE; CALL	It is widely accepted that the (now reversed) Bush administration's decision to restrict federal funding for human embryonic stem cell (hESC) research to a few "eligible" hESC lines is responsible for the sustained preferential use of a small subset of hESC lines (principally the H1 and H9 lines) in basic and preclinical research. Yet, international hESC usage patterns, in both permissive and restrictive political environments, do not correlate with a specific type of stem cell policy. Here we conducted a descriptive analysis of hESC line usage and compared the ability of policy-driven processes and collaborative processes inherent to biomedical research to recapitulate global hESC usage patterns. We find that current global hESC usage can be modelled as a cumulative advantage process, independent of restrictive or permissive policy influence, suggesting a primarily innovation-driven (rather than policy-driven) mechanism underlying human pluripotent stem cell usage in preclinical research.	[Schuldt, Bernhard M.; Lenz, Michael; Schuppert, Andreas] Rhein Westfal TH Aachen, Graduiertenschule Aachen Inst Adv Study Computat, D-52062 Aachen, Germany; [Guhr, Anke; Kobold, Sabine; Loeser, Peter] Robert Koch Inst, Berlin, Germany; [MacArthur, Ben D.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton, Hants, England; [MacArthur, Ben D.] Univ Southampton, Sch Math, Southampton, Hants, England; [MacArthur, Ben D.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany	RWTH Aachen University; Robert Koch Institute; University of Southampton; University of Southampton; University of Southampton	Loser, P (corresponding author), Robert Koch Inst, Berlin, Germany.	loeserp@rki.de; fj.mueller@zip-kiel.de	Lenz, Michael/J-4401-2016; Müller, Franz-Josef/E-3336-2010	Lenz, Michael/0000-0002-6319-6480; Müller, Franz-Josef/0000-0001-9478-8430; MacArthur, Ben/0000-0002-5396-9750; Schuppert, Andreas/0000-0003-3783-6605	Bayer Technologies Services; Else Kroner Fresenius Stiftung	Bayer Technologies Services; Else Kroner Fresenius Stiftung	The authors would like to formally state that the work leading to the manuscript has been funded in part by Bayer Technologies Services by providing salary to Bernhard Schuldt and Andreas Schuppert. Also, the work has been funded in part by a fellowship to Franz-Josef Muller by the Else Kroner Fresenius Stiftung. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials and there are no commercial or other interests (such as patents, products in development, consultancy etc.) tied to the manuscript. The funding sources had no influence on or took part in the interpretation of the scientific data presented or conclusions drawn.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aldhous P, 2005, NATURE, V434, P694, DOI 10.1038/434694a; [Anonymous], 2009, GER REC FDA CLEAR BE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Fletcher J, 2006, TLS-TIMES LIT SUPPL, P8; Fraga AM, 2011, CELL TRANSPLANT, V20, P431, DOI 10.3727/096368910X522261; GENTLEMAN RCV, 2005, BIOINFORMATICS COMPU, V19; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Holden C, 2009, SCIENCE, V323, P1552, DOI 10.1126/science.323.5921.1552a; Isasi RM, 2009, STEM CELL RES, V3, P96, DOI 10.1016/j.scr.2009.05.003; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Levine AD, 2011, NAT BIOTECHNOL, V29, P1079, DOI 10.1038/nbt.2029; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; McCormick JB, 2009, CELL STEM CELL, V4, P107, DOI 10.1016/j.stem.2009.01.002; Miller G, 2010, SCIENCE, V330, P1742, DOI 10.1126/science.330.6012.1742; Morris SA, 2005, 10 INT C INT SOC SCI; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; O'Rourke PP, 2008, CELL STEM CELL, V2, P307, DOI 10.1016/j.stem.2008.03.018; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel R, 2011, J STEM CELL RES THER, V1, P107, DOI DOI 10.4172/2157-7633.1000107; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Peura TT, 2007, THERIOGENOLOGY, V67, P32, DOI 10.1016/j.theriogenology.2006.09.031; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Russo E, 2005, PLOS BIOL, V3, P1167, DOI 10.1371/journal.pbio.0030234; Schlaeger TM, 2007, DRUG DISCOV TODAY, V12, P269, DOI 10.1016/j.drudis.2007.02.011; Scott CT, 2011, CELL, V145, P820, DOI 10.1016/j.cell.2011.05.032; Scott CT, 2010, NAT METHODS, V7, P866, DOI 10.1038/nmeth1110-866; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Scott CT, 2009, NATURE, V460, P33, DOI 10.1038/460033b; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon C, 2005, FERTIL STERIL, V83, P246, DOI 10.1016/j.fertnstert.2004.09.004; SIMON HA, 1955, BIOMETRIKA, V42, P425; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Venables WN., 2002, MODERN APPL STAT S 4; Vogel G, 2001, SCIENCE, V293, P1242, DOI 10.1126/science.293.5533.1242; Vogel G, 2008, SCIENCE, V322, P1766, DOI 10.1126/science.322.5909.1766; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	57	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52068	10.1371/journal.pone.0052068	http://dx.doi.org/10.1371/journal.pone.0052068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300961	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900017
J	Clark, CM; Flynn, DFB; Butterfield, BJ; Reich, PB				Clark, Christopher M.; Flynn, Dan F. B.; Butterfield, Bradley J.; Reich, Peter B.			Testing the Link between Functional Diversity and Ecosystem Functioning in a Minnesota Grassland Experiment	PLOS ONE			English	Article							COMMUNITY ASSEMBLY RULES; PLANT DIVERSITY; SPECIES RICHNESS; UNIFIED APPROACH; TRAIT DIVERSITY; MULTIPLE TRAITS; BIODIVERSITY; INDEXES; PRODUCTIVITY; DISSIMILARITY	The functional diversity of a community can influence ecosystem functioning and reflects assembly processes. The large number of disparate metrics used to quantify functional diversity reflects the range of attributes underlying this concept, generally summarized as functional richness, functional evenness, and functional divergence. However, in practice, we know very little about which attributes drive which ecosystem functions, due to a lack of field-based tests. Here we test the association between eight leading functional diversity metrics (Rao's Q, FD, FDis, FEve, FDiv, convex hull volume, and species and functional group richness) that emphasize different attributes of functional diversity, plus 11 extensions of these existing metrics that incorporate heterogeneous species abundances and trait variation. We assess the relationships among these metrics and compare their performances for predicting three key ecosystem functions (above-and belowground biomass and light capture) within a long-term grassland biodiversity experiment. Many metrics were highly correlated, although unique information was captured in FEve, FDiv, and dendrogram-based measures (FD) that were adjusted by abundance. FD adjusted by abundance outperformed all other metrics in predicting both above-and belowground biomass, although several others also performed well (e. g. Rao's Q, FDis, FDiv). More generally, trait-based richness metrics and hybrid metrics incorporating multiple diversity attributes outperformed evenness metrics and single-attribute metrics, results that were not changed when combinations of metrics were explored. For light capture, species richness alone was the best predictor, suggesting that traits for canopy architecture would be necessary to improve predictions. Our study provides a comprehensive test linking different attributes of functional diversity with ecosystem function for a grassland system.	[Clark, Christopher M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Clark, Christopher M.] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Flynn, Dan F. B.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Butterfield, Bradley J.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Butterfield, Bradley J.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Columbia University; Northern Arizona University; Northern Arizona University; University of Minnesota System; University of Minnesota Twin Cities	Clark, CM (corresponding author), US EPA, Global Change Res Program, Off Res & Dev, Washington, DC 20460 USA.	clark.christopher@epa.gov	Flynn, Dan/AAT-7028-2020; Flynn, Dan/A-4200-2008	Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Reich, Peter/0000-0003-4424-662X	U.S. Department of Energy; National Institute for Climate Change Research; NSF; Direct For Biological Sciences [1242531] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute for Climate Change Research; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding from U.S. Department of Energy, National Institute for Climate Change Research; and the NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Burnham KaDA, 2002, MODEL SELECTION MULT; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lin BB, 2011, J APPL ECOL, V48, P609, DOI 10.1111/j.1365-2664.2010.01944.x; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Petchey O.L., 2009, BIODIVERSITY ECOSYST, P49; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; USDA National Plant Data Team, 2012, PLANTS DAT; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	54	62	63	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52821	10.1371/journal.pone.0052821	http://dx.doi.org/10.1371/journal.pone.0052821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300787	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000313872600027
J	Guenther, S; Aschenbrenner, K; Stamm, I; Bethe, A; Semmler, T; Stubbe, A; Stubbe, M; Batsajkhan, N; Glupczynski, Y; Wieler, LH; Ewers, C				Guenther, Sebastian; Aschenbrenner, Katja; Stamm, Ivonne; Bethe, Astrid; Semmler, Torsten; Stubbe, Annegret; Stubbe, Michael; Batsajkhan, Nyamsuren; Glupczynski, Youri; Wieler, Lothar H.; Ewers, Christa			Comparable High Rates of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in Birds of Prey from Germany and Mongolia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; CTX-M; COMPANION ANIMALS; FECAL SAMPLES; BACTERIA; ENTEROBACTERIACEAE; EMERGENCE; LIVESTOCK; STRAINS; GENES	Frequent contact with human waste and liquid manure from intensive livestock breeding, and the increased loads of antibiotic-resistant bacteria that result, are believed to be responsible for the high carriage rates of ESBL-producing E. coli found in birds of prey (raptors) in Central Europe. To test this hypothesis against the influence of avian migration, we initiated a comparative analysis of faecal samples from wild birds found in Saxony-Anhalt in Germany and the Gobi-Desert in Mongolia, regions of dissimilar human and livestock population characteristics and agricultural practices. We sampled a total of 281 wild birds, mostly raptors with primarily north-to-south migration routes. We determined antimicrobial resistance, focusing on ESBL production, and unravelled the phylogenetic and clonal relatedness of identified ESBL-producing E. coli isolates using multi-locus sequence typing (MLST) and macrorestriction analyses. Surprisingly, the overall carriage rates (approximately 5%) and the proportion of ESBL-producers among E. coli (Germany: 13.8%, Mongolia: 10.8%) were similar in both regions. Whereas bla(CTX-M-1) predominated among German isolates (100%), bla(CTX-M-9) was the most prevalent in Mongolian isolates (75%). We identified sequence types (STs) that are well known in human and veterinary clinical ESBL-producing E. coli (ST12, ST117, ST167, ST648) and observed clonal relatedness between a Mongolian avian ESBL-E. coli (ST167) and a clinical isolate of the same ST that originated in a hospitalised patient in Europe. Our data suggest the influence of avian migratory species in the transmission of ESBL-producing E. coli and challenge the prevailing assumption that reducing human influence alone invariably leads to lower rates of antimicrobial resistance.	[Guenther, Sebastian; Aschenbrenner, Katja; Bethe, Astrid; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Stamm, Ivonne] Vet Med Labor GmbH, Ludwigsburg, Germany; [Stubbe, Annegret; Stubbe, Michael] Univ Halle Wittenberg, Inst Biol, Dept Zool, D-06108 Halle, Germany; [Batsajkhan, Nyamsuren] Natl Univ Mongolia, Dept Zool, Ulaanbaatar, Mongolia; [Glupczynski, Youri] Catholic Univ Louvain, CHU Mont Godinne, Natl Reference Lab Antimicrobial Resistance Gram, Yvoir, Belgium; [Ewers, Christa] Univ Giessen, Fac Vet, Inst Hyg & Infect Dis Anim, D-35390 Giessen, Germany	Free University of Berlin; Vet Med Labor GmbH; Martin Luther University Halle Wittenberg; National University of Mongolia; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Justus Liebig University Giessen	Guenther, S (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	guenther.sebastian@fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Ewers, Christa/AAL-9186-2020; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Ewers, Christa/0000-0001-6167-1340; Wieler, Lothar H./0000-0003-4365-3717; Guenther, Sebastian/0000-0003-0173-7314	Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo) [01KI1012A]; German Research Foundation (DFG); Indo-German Research Training Group [GRK1673]	Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Indo-German Research Training Group	This work was supported by the Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo, Grant no. 01KI1012A) and the German Research Foundation (DFG) funded Indo-German Research Training Group (Grant GRK1673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Berthold P, 2001, OXFORD ORNITHOLOGICA; Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Bloom DE, 2011, SCIENCE, V333, P562, DOI 10.1126/science.1209290; Bonnedahl J., 2011, ANTIBIOTIC RESISTANC; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; Grimm V, 2004, J CLIN MICROBIOL, V42, P3766, DOI 10.1128/JCM.42.8.3766-3774.2004; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; Hernandez J, 2010, ENV MICROBIOL REP, V2, P329, DOI 10.1111/j.1758-2229.2010.00142.x; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Maguire AJ, 2001, ANTIMICROB AGENTS CH, V45, P1022, DOI 10.1128/AAC.45.4.1022-1029.2001; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Naseer U, 2009, APMIS, V117, P526, DOI 10.1111/j.1600-0463.2009.02465.x; Nelson M, 2008, DIS AQUAT ORGAN, V81, P53, DOI 10.3354/dao01937; Nemoy LL, 2005, J CLIN MICROBIOL, V43, P1776, DOI 10.1128/JCM.43.4.1776-1781.2005; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Park YJ, 2007, J ANTIMICROB CHEMOTH, V60, P868, DOI 10.1093/jac/dkm266; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pinto L, 2010, APPL ENVIRON MICROB, V76, P4118, DOI 10.1128/AEM.02761-09; Radhouani H, 2010, J ANTIMICROB CHEMOTH, V65, P171, DOI 10.1093/jac/dkp403; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Steinfeld H., 2010, LIVESTOCK CHANGING L; Stubbe M., 2010, Erforschung Biologischer Ressourcen der Mongolei, V11, P23; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Williams NJ, 2011, J APPL MICROBIOL, V110, P962, DOI 10.1111/j.1365-2672.2011.04952.x; Wint W., 2007, GRIDDED LIVESTOCK WO; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	49	93	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53039	10.1371/journal.pone.0053039	http://dx.doi.org/10.1371/journal.pone.0053039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300857	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600053
J	Komine, Y; Takao, K; Miyakawa, T; Yamamori, T				Komine, Yuriko; Takao, Keizo; Miyakawa, Tsuyoshi; Yamamori, Tetsuo			Behavioral Abnormalities Observed in Zfhx2-Deficient Mice	PLOS ONE			English	Article							KNOCKOUT MICE; FACTOR ATBF1; TESTS; SCHIZOPHRENIA; HYPERACTIVITY; DISORDERS; ANXIETY; BRAIN; MODEL	Zfhx2 (also known as zfh-5) encodes a transcription factor containing three homeobox domains and 18 Zn-finger motifs. We have reported that Zfhx2 mRNA is expressed mainly in differentiating neurons in the mouse brain and its expression level is negatively regulated by the antisense transcripts of Zfhx2. Although the expression profile of Zfhx2 suggests that ZFHX2 might have a role in a particular step of neuronal differentiation, the specific function of the gene has not been determined. We generated a Zfhx2-deficient mouse line and performed a comprehensive battery of behavioral tests to elucidate the function of ZFHX2. Homozygous Zfhx2-deficient mice showed several behavioral abnormalities, namely, hyperactivity, enhanced depression-like behaviors, and an aberrantly altered anxiety-like phenotype. These behavioral phenotypes suggest that ZFHX2 might play roles in controlling emotional aspects through the function of monoaminergic neurons where ZFHX2 is expressed. Moreover, considering their phenotypes, the Zfhx2-deficient mice may provide a novel model of human psychiatric disorders.	[Komine, Yuriko; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Genet Engn & Funct Genom Grp, Frontier Technol Ctr, Grad Sch Med, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Fujita Health University; Japan Science & Technology Agency (JST)	Yamamori, T (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Miyakawa, Tsuyoshi/A-7741-2008; Yamamori, Tetsuo/N-6536-2015; Takao, Keizo/B-9527-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Yamamori, Tetsuo/0000-0001-5016-0078; Takao, Keizo/0000-0002-4734-3583; KOMINE, Yuriko/0000-0002-0097-8813	Ministry of Education, Culture, Sports, Science and Technology of Japan [170245, 22123009]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) (170245 to TY and YK), a Grant-in-Aid for Scientific Research on Innovative Areas (Neocortical Organization) (22123009 to TY), a Grant-in-Aid for Exploratory Research and Integrative Brain Research (IBR-shien), and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Komine Y, 2006, MOL CELL NEUROSCI, V31, P273, DOI 10.1016/j.mcn.2005.09.017; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Takao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009460; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	21	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53114	10.1371/journal.pone.0053114	http://dx.doi.org/10.1371/journal.pone.0053114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300874	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600060
J	Reineke, EL; York, B; Stashi, E; Chen, X; Tsimelzon, A; Xu, JM; Newgard, CB; Taffet, GE; Taegtmeyer, H; Entman, ML; O'Malley, BW				Reineke, Erin L.; York, Brian; Stashi, Erin; Chen, Xian; Tsimelzon, Anna; Xu, Jianming; Newgard, Christopher B.; Taffet, George E.; Taegtmeyer, Heinrich; Entman, Mark L.; O'Malley, Bert W.			SRC-2 Coactivator Deficiency Decreases Functional Reserve in Response to Pressure Overload of Mouse Heart	PLOS ONE			English	Article							FETAL GENE PROGRAM; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; DILATED CARDIOMYOPATHY; INSULIN-RESISTANCE; ENERGY-METABOLISM; SKELETAL-MUSCLES; IN-VIVO; EXPRESSION; SIGNATURE	A major component of the cardiac stress response is the simultaneous activation of several gene regulatory networks. Interestingly, the transcriptional regulator steroid receptor coactivator-2, SRC-2 is often decreased during cardiac failure in humans. We postulated that SRC-2 suppression plays a mechanistic role in the stress response and that SRC-2 activity is an important regulator of the adult heart gene expression profile. Genome-wide microarray analysis, confirmed with targeted gene expression analyses revealed that genetic ablation of SRC-2 activates the "fetal gene program'' in adult mice as manifested by shifts in expression of a) metabolic and b) sarcomeric genes, as well as associated modulating transcription factors. While these gene expression changes were not accompanied by changes in left ventricular weight or cardiac function, imposition of transverse aortic constriction (TAC) predisposed SRC-2 knockout (KO) mice to stress-induced cardiac dysfunction. In addition, SRC-2 KO mice lacked the normal ventricular hypertrophic response as indicated through heart weight, left ventricular wall thickness, and blunted molecular signaling known to activate hypertrophy. Our results indicate that SRC-2 is involved in maintenance of the steady-state adult heart transcriptional profile, with its ablation inducing transcriptional changes that mimic a stressed heart. These results further suggest that SRC-2 deletion interferes with the timing and integration needed to respond efficiently to stress through disruption of metabolic and sarcomeric gene expression and hypertrophic signaling, the three key stress responsive pathways.	[Reineke, Erin L.; York, Brian; Stashi, Erin; Chen, Xian; Xu, Jianming; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tsimelzon, Anna] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Newgard, Christopher B.] Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Taegtmeyer, Heinrich] Univ Texas Med Sch Houston, Dept Internal Med, Div Cardiol, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Duke University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.tmc.edu			Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U19 DK62434-08]; National Institute of Child Health and Human Development (NICHD) [HD08818-37]; Curtis & Doris K. Hankamer Foundation; Medallion Foundation; National Institutes of Health (NIH) [R01 HL-089792, 5 T32 HD07165]; NHLBI [R01 HL061483];  [CA125123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD007857, P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089792, R01HL022512, R01HL061483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Curtis & Doris K. Hankamer Foundation; Medallion Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) U19 DK62434-08, National Institute of Child Health and Human Development (NICHD) HD08818-37 to B. W. O'Malley, and in part to M. L. Entman (the Curtis & Doris K. Hankamer Foundation, the Medallion Foundation, and National Institutes of Health (NIH) R01 HL-089792), H. Taegtmeyer (NHLBI R01 HL061483), and A. Tsimelzon (CA125123). Erin Reineke is supported by NIH Training Grant 5 T32 HD07165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Duteil D, 2010, CELL METAB, V12, P496, DOI 10.1016/j.cmet.2010.09.016; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2011, ANN REV PHARM TOXICO; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pandya K, 2011, CIRC RES, V109, P609, DOI 10.1161/CIRCRESAHA.111.252619; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53395	10.1371/journal.pone.0053395	http://dx.doi.org/10.1371/journal.pone.0053395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300926	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600097
J	Wilson, JR; Kay, MC; Colgate, J; Qi, R; Lenihan, HS				Wilson, Jono R.; Kay, Matthew C.; Colgate, John; Qi, Roy; Lenihan, Hunter S.			Small-Scale Spatial Variation in Population Dynamics and Fishermen Response in a Coastal Marine Fishery	PLOS ONE			English	Article							LIFE-HISTORY; MANAGEMENT; CALIFORNIA; PATTERNS; REPRODUCTION; ROCKFISH; HABITAT; GROWTH	A major challenge for small-scale fisheries management is high spatial variability in the demography and life history characteristics of target species. Implementation of local management actions that can reduce overfishing and maximize yields requires quantifying ecological heterogeneity at small spatial scales and is therefore limited by available resources and data. Collaborative fisheries research (CFR) is an effective means to collect essential fishery information at local scales, and to develop the social, technical, and logistical framework for fisheries management innovation. We used a CFR approach with fishing partners to collect and analyze geographically precise demographic information for grass rockfish (Sebastes rastrelliger), a sedentary, nearshore species harvested in the live fish fishery on the West Coast of the USA. Data were used to estimate geographically distinct growth rates, ages, mortality, and length frequency distributions in two environmental subregions of the Santa Barbara Channel, CA, USA. Results indicated the existence of two subpopulations; one located in the relatively cold, high productivity western Channel, and another in the relatively warm, low productivity eastern Channel. We parameterized yield per recruit models, the results of which suggested nearly twice as much yield per recruit in the high productivity subregion relative to the low productivity subregion. The spatial distribution of fishing in the two environmental subregions demonstrated a similar pattern to the yield per recruit outputs with greater landings, effort, and catch per unit effort in the high productivity subregion relative to the low productivity subregion. Understanding how spatial variability in stock dynamics translates to variability in fishery yield and distribution of effort is important to developing management plans that maximize fishing opportunities and conservation benefits at local scales.	[Wilson, Jono R.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Kay, Matthew C.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Colgate, John] Commercial Fishermen Santa Barbara, Santa Barbara, CA USA; [Qi, Roy] Univ Calif Santa Barbara, Coll Creat Studies, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wilson, JR (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	jonowilson@bren.ucsb.edu			California Ocean Protection Council/California Coastal Conservancy research award [07-021]; California Sea Grant award [NA10OAR4170060]; Coastal Environmental Quality Initiative Fellowship	California Ocean Protection Council/California Coastal Conservancy research award; California Sea Grant award; Coastal Environmental Quality Initiative Fellowship	Funding for this work was provided by the California Ocean Protection Council/California Coastal Conservancy research award 07-021 to MCK, JRW and HSL, California Sea Grant award (# NA10OAR4170060) to HSL, JRW, and MCK and Coastal Environmental Quality Initiative Fellowship to JRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Berkes F., 2001, MANAGING SMALL SCALE; Beverton R.J., 1957, FISHERY INVESTIGAT 2, VXIX; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; Buonaccorsi VP, 2004, MAR BIOL, V145, P779, DOI 10.1007/s00227-004-1362-2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cailliet GML, 1986, FISHES FIELD LAB MAN; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Caselle JE, 2010, B MAR SCI, V86, P355; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Choat J. Howard, 2002, P57; Davis NA, 2008, MAR POLICY, V32, P867, DOI 10.1016/j.marpol.2008.01.001; Fujita RM, 2010, B MAR SCI, V86, P251; Gunderson DR, 2008, FISHERIES, V33, P172, DOI 10.1577/1548-8446-33.4.172; GUNDERSON DR, 1977, FISH B-NOAA, V75, P369; Hamilton SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024580; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hanan Doyle A., 2012, Open Fish Science Journal, V5, P30; Harms S, 1998, J GEOPHYS RES-OCEANS, V103, P3041, DOI 10.1029/97JC02393; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hill B. J., 1990, LEGAL SIZE THEIR USE, P9; HOENIG JM, 1983, FISH B US, V82, P898, DOI DOI 10.1890/04-0594; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Jentoft S, 1998, MAR POLICY, V22, P423, DOI 10.1016/S0308-597X(97)00040-7; Kay MC, 2012, ECOL APPL, V22, P322, DOI 10.1890/11-0155.1; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; LOVE MS, 1981, FISH B-NOAA, V79, P533; Miller D., 1972, CALIFORNIA DEP FISH; Phipps K, 2010, P MAN DAT POOR FISH; Prince J, 2010, B MAR SCI, V86, P197; Prince Jeremy, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P187; Punt A.E., 2005, USING INFORM DATA RI; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Stephenson RL, 1999, FISH RES, V43, P247, DOI 10.1016/S0165-7836(99)00076-4; Stewart J, 2008, FISHERIES MANAG ECOL, V15, P291, DOI 10.1111/j.1365-2400.2008.00614.x; WESTRHEIM SJ, 1975, J FISH RES BOARD CAN, V32, P2399, DOI 10.1139/f75-277; White JW, 2008, ECOLOGY, V89, P1323, DOI 10.1890/07-0840.1; YOSHIYAMA RM, 1986, ENVIRON BIOL FISH, V17, P23, DOI 10.1007/BF00000398; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	14	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52837	10.1371/journal.pone.0052837	http://dx.doi.org/10.1371/journal.pone.0052837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300793	Green Published, gold			2022-12-27	WOS:000313872600028
J	Bogdanowicz, W; Piksa, K; Tereba, A				Bogdanowicz, Wieslaw; Piksa, Krzysztof; Tereba, Anna			Hybridization Hotspots at Bat Swarming Sites	PLOS ONE			English	Article							SPECIES MYOTIS-MYOTIS; POPULATION-STRUCTURE; CRYPTIC DIVERSITY; GENETIC-STRUCTURE; GENUS MYOTIS; VESPERTILIONIDAE; CHIROPTERA; ALCATHOE; HYBRIDS; INTROGRESSION	During late summer and early autumn in temperate zones of the Northern Hemisphere, thousands of bats gather at caves, mainly for the purpose of mating. We demonstrated that this swarming behavior most probably leads not only to breeding among bats of the same species but also interbreeding between different species. Using 14 nuclear microsatellites and three different methods (the Bayesian assignment approaches of STRUCTURE and NEWHYBRIDS and a principal coordinate analysis of pairwise genetic distances), we analyzed 375 individuals belonging to three species of whiskered bats (genus Myotis) at swarming sites across their sympatric range in southern Poland. The overall hybridization rate varied from 3.2 to 7.2%. At the species level, depending on the method used, these values ranged from 2.1-4.6% in M. mystacinus and 3.0-3.7% in M. brandtii to 6.5-30.4% in M. alcathoe. Hybrids occurred in about half of the caves we studied. In all three species, the sex ratio of hybrids was biased towards males but the observed differences did not differ statistically from those noted at the population level. In our opinion, factors leading to the formation of these admixed individuals and their relatively high frequency are: i) swarming behaviour at swarming sites, where high numbers of bats belonging to several species meet; ii) male-biased sex ratio during the swarming period; iii) the fact that all these bats are generally polygynous. The highly different population sizes of different species at swarming sites may also play some role. Swarming sites may represent unique hybrid hotspots, which, as there are at least 2,000 caves in the Polish Carpathians alone, may occur on a massive scale not previously observed for any group of mammal species in the wild. Evidently, these sites should be treated as focal points for the conservation of biodiversity and evolutionary processes.	[Bogdanowicz, Wieslaw; Tereba, Anna] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Piksa, Krzysztof] Cracow Pedag Univ, Inst Biol, Krakow, Poland	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Pedagogical University of Cracow	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland.	wieslawb@miiz.waw.pl		Piksa, Krzysztof/0000-0001-5057-895X; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education in Poland [N N304 081 435]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	Funding was provided by the Ministry of Science and Higher Education in Poland (Grant No. N N304 081 435). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLEN I., 2010, FAUNA FLORA, V108, P8; Anderson EC, 2002, GENETICS, V160, P1217; Artyushin IV, 2009, ZOOTAXA, P40; Bachanek J, 2010, ACTA CHIROPTEROL, V12, P439, DOI 10.3161/150811010X538007; Bashta AT, 2011, FOLIA ZOOL, V60, P1; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P279, DOI 10.3161/150811012X661611; Bogdanowicz W, 2012, J MAMMAL, V93, P799, DOI 10.1644/11-MAMM-A-180.3; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Castella V, 2000, MOL ECOL, V9, P1000, DOI 10.1046/j.1365-294x.2000.00939-6.x; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davies N, 1996, TRENDS ECOL EVOL, V11, P508, DOI 10.1016/0169-5347(96)88900-2; Dietz C., 2007, FLEDERMAUSE EUROPAS; Dietz C, 2004, ILLUSTRATED IDENTI 2; Fenton MB, 2012, P NATL ACAD SCI USA, V109, P6794, DOI 10.1073/pnas.1204793109; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HOOD G, 2005, POPTOOLS VERSION 2 6; Hosken DJ, 1998, J ZOOL, V245, P261, DOI 10.1111/j.1469-7998.1998.tb00100.x; HUFF DR, 1993, THEOR APPL GENET, V86, P927, DOI 10.1007/BF00211043; Hulva P, 2010, MOL ECOL, V19, P5417, DOI 10.1111/j.1365-294X.2010.04899.x; Hutson AM, 2008, MYOTIS MYSTACINUS IU; Hutson AM, 2008, MYOTIS BRANDTII ICUN; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Jan CMI, 2010, ACTA CHIROPTEROL, V12, P471, DOI 10.3161/150811010X538043; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lucan RK, 2009, ACTA CHIROPTEROL, V11, P61, DOI 10.3161/150811009X465695; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Niermann N, 2007, ACTA CHIROPTEROL, V9, P361; Papadatou E, 2008, J MAMMAL, V89, P503, DOI 10.1644/07-MAMM-A-163R1.1; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R., 2007, GENALEX 6 1 APPENDIX; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard JK, 2000, GENETICS, V155, P945; Racey P. A., 2000, REPROD BIOL BATS, P314; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Shriver MD, 1997, AM J HUM GENET, V60, P957; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Sztencel-Jablonka A, 2012, CAN J ZOOL, V90, P1251, DOI 10.1139/Z2012-092; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Dyke F., 2008, CONSERVATION BIOL FD; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; von Helversen O, 2001, NATURWISSENSCHAFTEN, V88, P217, DOI 10.1007/s001140100225; WATT EM, 1995, MOL ECOL, V4, P261, DOI 10.1111/j.1365-294X.1995.tb00217.x; Webb N. J., 1995, Australian Mammalogy, V18, P19	62	26	26	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53334	10.1371/journal.pone.0053334	http://dx.doi.org/10.1371/journal.pone.0053334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300912	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500139
J	Li, GQ; Wang, KY; Li, DH; Wang, N; Liu, DH				Li, GangQiang; Wang, Kevin Yueju; Li, DaHui; Wang, Nan; Liu, DeHu			Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein	PLOS ONE			English	Article							FIBRINOLYTIC ENZYME; PLASMINOGEN-ACTIVATOR; LUMBROKINASE; PROTEASES	A lumbrokinase gene encoding a blood-clot dissolving protein was cloned from earthworm (Eisenia fetida) by RT-PCR amplification. The gene designated as CST1 (GenBank No. AY840996) was sequence analyzed. The cDNA consists of 888 bp with an open reading frame of 729 bp, which encodes 242 amino acid residues. Multiple sequence alignments revealed that CST1 shares similarities and conserved amino acids with other reported lumbrokinases. The amino acid sequence of CST1 exhibits structural features similar to those found in other serine proteases, including human tissue-type (tPA), urokinase (uPA), and vampire bat (DSPA alpha 1) plasminogen activators. CST1 has a conserved catalytic triad, found in the active sites of protease enzymes, which are important residues involved in polypeptide catalysis. CST1 was expressed as inclusion bodies in Escherichia coli BL21(DE3). The molecular mass of recombinant CST1 (rCST) was 25 kDa as estimated by SDS-PAGE, and further confirmed by Western Blot analysis. His-tagged rCST1 was purified and renatured using nickel-chelating resin with a recovery rate of 50% and a purity of 95%. The purified, renatured rCST1 showed fibrinolytic activity evaluated by both a fibrin plate and a blood clot lysis assay. rCST1 degraded fibrin on the fibrin plate. A significant percentage (65.7%) of blood clot lysis was observed when blood clot was treated with 80 mg/mL of rCST1 in vitro. The antithrombotic activity of rCST1 was 912 units/mg calculated by comparison with the activity of a lumbrokinase standard. These findings indicate that rCST1 has potential as a potent blood-clot treatment. Therefore, the expression and purification of a single lumbrokinase represents an important improvement in the use of lumbrokinases.	[Li, GangQiang; Wang, Nan; Liu, DeHu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Wang, Kevin Yueju] NE State Univ, Dept Nat Sci, Broken Arrow, OK USA; [Li, DaHui] Peking Univ, Pharmaceut Sch, Beijing 100871, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Peking University	Liu, DH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	liudehu2006@126.com			National High-tech Research & Development Program of China (863 Program) [2007AA02Z111]; National Technology for the 11th Five-year Plan of China [2006BAD31B01-04]; National Biotechnology Development Plan [2008ZX08005-004, 2009ZX08005-004B]; Researcher Foundation of the Chinese Academy of Agricultural Sciences	National High-tech Research & Development Program of China (863 Program); National Technology for the 11th Five-year Plan of China; National Biotechnology Development Plan; Researcher Foundation of the Chinese Academy of Agricultural Sciences	This work was supported by the National High-tech Research & Development Program of China (863 Program: 2007AA02Z111), National Technology for the 11th Five-year Plan of China (2006BAD31B01-04), National Biotechnology Development Plan (2008ZX08005-004), (2009ZX08005-004B) and the Researcher Foundation of the Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode W, 1997, CURR OPIN STRUC BIOL, V7, P865, DOI 10.1016/S0959-440X(97)80159-5; Cooper E., 2009, FOCUS, P1; Cooper EL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164152; Cooper EL, 2010, DRUG DISCOV TODAY, V15, P966, DOI 10.1016/j.drudis.2010.09.004; Cooper EL, 2004, ADV EXP MED BIOL, V546, P359; Dafer Rima M, 2007, Expert Rev Neurother, V7, P333, DOI 10.1586/14737175.7.4.333; DEOGNY L, 1975, CLIN CHIM ACTA, V60, P85, DOI 10.1016/0009-8981(75)90183-7; Dong GQ, 2004, ACTA BIOCH BIOPH SIN, V36, P303, DOI 10.1093/abbs/36.4.303; Gao Y, 1999, J CAP U MED SCI, V20, P264; Ge T, 2005, PROTEIN EXPRES PURIF, V42, P20, DOI 10.1016/j.pep.2005.04.005; Hraenjak T, 1998, COMP BIOCH PHYSL B, V119, P825; Hu RL, 2004, PROTEIN EXPRES PURIF, V37, P83, DOI 10.1016/j.pep.2004.05.018; Hu Y, 2005, PROTEIN EXPRES PURIF, V43, P18, DOI 10.1016/j.pep.2005.05.003; Ji HR, 2008, EUR J PHARMACOL, V590, P281, DOI 10.1016/j.ejphar.2008.05.037; Jin LR, 2000, CLIN HEMORHEOL MICRO, V23, P213; Kim YS, 1998, ARCH PHARM RES, V21, P374, DOI 10.1007/BF02974629; Labat-Robert J, 2012, PATHOL BIOL, V60, P66, DOI 10.1016/j.patbio.2011.11.010; Li DH, 2008, WORLD J MICROB BIOT, V24, P613, DOI 10.1007/s11274-007-9515-3; Li Yu-hua, 2006, Yaoxue Xuebao, V41, P939; MIHARA H, 1983, THROMB HAEMOSTASIS, V50, P258; MIHARA H, 1991, JPN J PHYSIOL, V41, P461, DOI 10.2170/jjphysiol.41.461; Pan R., 2010, APPL ENV SOIL SCI, DOI [10.1155/2010/294258, DOI 10.1155/2010/294258]; Prasad S, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-14; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; SUMI H, 1993, COMP BIOCHEM PHYS B, V106, P763, DOI 10.1016/0305-0491(93)90160-7; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Wang F, 2005, J MOL BIOL, V348, P671, DOI 10.1016/j.jmb.2005.02.055; Wei ZR, 2008, PROTEIN EXPRES PURIF, V57, P27, DOI 10.1016/j.pep.2007.09.001; Wu JX, 2007, INT J BIOL MACROMOL, V40, P399, DOI 10.1016/j.ijbiomac.2006.10.001; Xu JM, 2000, CHIN J NEW DRUGS CLI, V5, P406; Xu ZR, 2010, PROTEIN EXPRES PURIF, V69, P198, DOI 10.1016/j.pep.2009.08.013; Zhao J, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/97654	32	14	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53110	10.1371/journal.pone.0053110	http://dx.doi.org/10.1371/journal.pone.0053110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300872	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100119
J	Liu, J; Wei, XL; Huang, WH; Chen, CF; Bai, JW; Zhang, GJ				Liu, Jing; Wei, Xiao-Long; Huang, Wen-He; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun			Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas	PLOS ONE			English	Article							CANCER; P27; PHOSPHORYLATION; LOCALIZATION; UBIQUITINATION; MODULATION; IMPACT	Background: S-phase kinase protein 2 (Skp2), an oncogenic protein, is a key regulator in different cellular and molecular processes, through ubiquitin-proteasome degradation pathway. Increased levels of Skp2 are observed in various types of cancer and associated with poor prognosis. However, in human breast carcinomas, the underlying mechanism and prognostic significance of cytoplasmic Skp2 is still undefined. Methods: To investigate the role of cytoplasmic Skp2 expression in human breast carcinomas, we immnohistochemically assessed cytoplasmic Skp2, p-Akt1, and p27 expression in 251 patients with invasive ductal carcinomas of the breast. Association of cytoplasmic Skp2 expression with p-Akt1 and p27 was analyzed as well as correspondence with other clinicopathological parameters. Disease-free survival and overall survival were determined based on the Kaplan-Meier method and Cox regression models. Results: Cytoplasmic of Skp2 was detected in 165 out of 251 (65.7%) patients. Cytoplasmic Skp2 expression was associated with larger tumor size, more advanced histological grade, and positive HER2 expression. Increased cytoplasmic Skp2 expression correlated with p-Akt1 expression, with 54.2% (51/94) of low p-Akt1-expressing breast carcinomas, but 72.6% (114/157) of high p-Akt1-expressing breast carcinomas exhibiting cytoplasmic Skp2 expression. Elevated cytoplasmic Skp2 expression with low p-Akt1 expression was associated with poor disease-free and overall survival (DFS and OS), and Cox regression models demonstrated that cytoplasmic Skp2 expression was an independent prognostic marker for invasive breast carcinomas. Conclusion: Cytoplasmic Skp2 expression is associated with aggressive prognostic factors, such as larger tumor size, and advanced histological grade of the breast cancers. Results demonstrate that combined cytoplasmic Skp2 and p-Akt1 expression may be prognostic for patients with invasive breast carcinomas, and cytoplasmic Skp2 may serve as a potential therapeutic target.	[Liu, Jing; Wei, Xiao-Long; Huang, Wen-He; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Affiliated Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China; [Liu, Jing; Wei, Xiao-Long; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China.	guoj_zhang@yahoo.com	Chen, Chunfa/V-7357-2019; Zhang, Guo-Jun/H-3890-2015; Bai, Jingwen/AAG-3794-2019	Chen, Chunfa/0000-0002-1128-485X; Zhang, Guo-Jun/0000-0001-5182-5887; bai, jingwen/0000-0002-2107-2746	State Key Development Program for Basic Research of China [2011CB707705]; National Natural Science Foundation of China [30973377]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by State Key Development Program for Basic Research of China (No. 2011CB707705, http://www.973.gov.cn/Default_3.aspx), and by National Natural Science Foundation of China (No. 30973377, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2012, APPL IMMUNOHISTO M M, V20, P47, DOI 10.1097/PAI.0b013e318219a19f; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chander H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022456; Chen GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017578; Ganiatsas S, 2001, ONCOGENE, V20, P3641, DOI 10.1038/sj.onc.1204501; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Genestie C, 1998, ANTICANCER RES, V18, P571; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu SG, 2011, MOL CANCER RES, V9, P390, DOI 10.1158/1541-7786.MCR-10-0359; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Masuda T, 2002, CANCER RES, V62, P3819; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Traub F, 2006, BREAST CANCER RES TR, V99, P185, DOI 10.1007/s10549-006-9202-3; Yang G, 2002, CLIN CANCER RES, V8, P3419; Zheng WQ, 2005, STEROIDS, V70, P770, DOI 10.1016/j.steroids.2005.04.012	23	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52675	10.1371/journal.pone.0052675	http://dx.doi.org/10.1371/journal.pone.0052675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300741	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100072
J	Schlegel, P; Havenhand, JN; Gillings, MR; Williamson, JE				Schlegel, Peter; Havenhand, Jon N.; Gillings, Michael R.; Williamson, Jane E.			Individual Variability in Reproductive Success Determines Winners and Losers under Ocean Acidification: A Case Study with Sea Urchins	PLOS ONE			English	Article							INFLUENCE FERTILIZATION SUCCESS; SPAWNING MARINE-INVERTEBRATES; NEAR-FUTURE LEVELS; CLIMATE-CHANGE; STRONGYLOCENTROTUS-FRANCISCANUS; INTRACELLULAR-PH; SPERM LIMITATION; GAMETE TRAITS; SEXUAL SELECTION; INTERNAL PH	Background: Climate change will lead to intense selection on many organisms, particularly during susceptible early life stages. To date, most studies on the likely biotic effects of climate change have focused on the mean responses of pooled groups of animals. Consequently, the extent to which inter-individual variation mediates different selection responses has not been tested. Investigating this variation is important, since some individuals may be preadapted to future climate scenarios. Methodology/Principal Findings: We examined the effect of CO2-induced pH changes ("ocean acidification'') in sperm swimming behaviour on the fertilization success of the Australasian sea urchin Heliocidaris erythrogramma, focusing on the responses of separate individuals and pairs. Acidification significantly decreased the proportion of motile sperm but had no effect on sperm swimming speed. Subsequent fertilization experiments showed strong inter-individual variation in responses to ocean acidification, ranging from a 44% decrease to a 14% increase in fertilization success. This was partly explained by the significant relationship between decreases in percent sperm motility and fertilization success at Delta pH = 0.3, but not at Delta pH = 0.5. Conclusions and Significance: The effects of ocean acidification on reproductive success varied markedly between individuals. Our results suggest that some individuals will exhibit enhanced fertilization success in acidified oceans, supporting the concept of 'winners' and 'losers' of climate change at an individual level. If these differences are heritable it is likely that ocean acidification will lead to selection against susceptible phenotypes as well as to rapid fixation of alleles that allow reproduction under more acidic conditions. This selection may ameliorate the biotic effects of climate change if taxa have sufficient extant genetic variation upon which selection can act.	[Schlegel, Peter; Gillings, Michael R.; Williamson, Jane E.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Havenhand, Jon N.] Univ Gothenburg, Dept Biol & Environm Sci, Tjarno Marine Biol Lab, Stromstad, Sweden	Macquarie University; University of Gothenburg	Schlegel, P (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	peter.schlegel@mq.edu.au	Havenhand, Jon N/F-5435-2013; Gillings, Michael/AAF-5772-2020; Gillings, Michael R/C-6553-2008; Williamson, Jane E/G-9871-2011	Havenhand, Jon N/0000-0003-0253-3428; Gillings, Michael/0000-0002-4043-4351; Gillings, Michael R/0000-0002-4043-4351; Williamson, Jane E/0000-0003-3627-4508; Havenhand, Jonathan/0000-0001-6721-7763	Australian Research Council; Linnaeus-grant from the Swedish Research Council VR-Review; Linnaeus-grant Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Australian Research Council(Australian Research Council); Linnaeus-grant from the Swedish Research Council VR-Review(Swedish Research Council); Linnaeus-grant Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	This work was funded by the Australian Research Council and a Linnaeus-grant from the Swedish Research Councils VR-Review and Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(www.cemeb.gu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Chan KYK, 2011, J EXP BIOL, V214, P3857, DOI 10.1242/jeb.054809; CHRISTEN R, 1983, EXP CELL RES, V149, P289, DOI 10.1016/0014-4827(83)90400-7; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Doo SS, 2012, ICES J MAR SCI, V69, P460, DOI 10.1093/icesjms/fsr123; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Evans JP, 2005, EVOLUTION, V59, P106; Frankham R, 2005, HEREDITY, V95, P183, DOI 10.1038/sj.hdy.6800706; Glantz MH, 1995, STUD ENVIRON SCI, V65, P41, DOI 10.1016/S0166-1116(06)80193-7; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; LEE HC, 1983, DEV BIOL, V95, P31, DOI 10.1016/0012-1606(83)90004-0; Levitan DR, 2008, EVOLUTION, V62, P1305, DOI 10.1111/j.1558-5646.2008.00378.x; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; LEVITAN DR, 1995, J EXP MAR BIOL ECOL, V190, P221, DOI 10.1016/0022-0981(95)00039-T; Levitan DR, 1996, NATURE, V382, P153, DOI 10.1038/382153a0; LEWIS E, 1998, ORNLCDIAC105 US DOE; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Styan CA, 1998, AM NAT, V152, P290, DOI 10.1086/286168; Styan CA, 2005, MAR BIOL, V147, P235, DOI 10.1007/s00227-005-1554-4; Styan CA, 2000, MAR BIOL, V137, P943, DOI 10.1007/s002270000401; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; VOGEL H, 1982, MATH BIOSCI, V58, P189, DOI 10.1016/0025-5564(82)90073-6; Wright JT, 2005, MAR ECOL PROG SER, V298, P143, DOI 10.3354/meps298143; Wright JT, 2001, ECOLOGY, V82, P2200, DOI 10.1890/0012-9658(2001)082[2200:EOVRAP]2.0.CO;2	59	69	70	3	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53118	10.1371/journal.pone.0053118	http://dx.doi.org/10.1371/journal.pone.0053118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300876	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100121
J	Xu, X; Fu, WW; Wu, WY				Xu, Xin; Fu, Wen-Wen; Wu, Wen-Yu			Serum 25-Hydroxyvitamin D Deficiency in Chinese Patients with Vitiligo: A Case-Control Study	PLOS ONE			English	Article							VITAMIN-D; RISK	Background: Low vitamin D levels have been noted in patients with a variety of autoimmune diseases. A recent study showed that low vitamin D levels may be associated with vitiligo. Objectives: To assess 25-hydroxyvitamin D (25(OH)D) status in Chinese patients with vitiligo in comparison of normal controls and explore possible affecting factors. Methods: We performed a case-control study including 171 patients, 50 controls in 25(OH)D lowest months and 30 patients, 20 controls in 25(OH)D highest months. Demographic and clinical variables of patients were analyzed to determine the correlation with 25(OH) D levels. Results: 25(OH)D mean value of patients was highest in September and October, lowest in March. None of the patients and normal controls had 'sufficient' 25(OH)D (> = 75 nmol/L). No significant difference was found in either 25(OH)D mean values or insufficiency/deficiency ratio between patients and controls in 25(OH)D highest and lowest periods. Female patients were at a higher risk of 25(OH)D deficiency than male patients(P = 0.019). For non-segmental type, patients with 25(OH)D deficiency were more likely to have autoimmune thyroid disease than those with insufficiency (P = 0.016). Sex (P = 0.035), thyroid conditions (p = 0.034), testing month (p = 0.049) were independent factors affecting 25(OH)D level in multivariate analysis. Conclusion: Chinese population lack 25(OH)D universally. 25(OH)D level shows no correlation with onset of vitiligo in Chinese. However deficient 25(OH)D level may be linked to autoimmune disorders in patients.	[Xu, Xin; Fu, Wen-Wen; Wu, Wen-Yu] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China	Fudan University	Wu, WY (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.	wuwydr@gmail.com			Shanghai Medical College of Fudan University	Shanghai Medical College of Fudan University	The funder of the article was Shanghai Medical College of Fudan University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutillas-Marco E, 2010, LUPUS, V19, P810, DOI 10.1177/0961203309360807; Cutolo M, 2007, ARTHRITIS RHEUM, V56, P1719, DOI 10.1002/art.22569; De Souza HN, 2008, ARQ BRAS ENDOCRINOL, V52, P684, DOI 10.1590/S0004-27302008000400015; Ersoy-Evans S, 2010, J AM ACAD DERMATOL, V62, P942, DOI 10.1016/j.jaad.2010.02.009; Gallagher JC, 2010, J CLIN ENDOCR METAB, V95, P2630, DOI 10.1210/jc.2010-0918; Gannage-Yared MH, 2009, EUR J ENDOCRINOL, V160, P965, DOI 10.1530/EJE-08-0952; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Orgaz-Molina J, 2012, J AM ACAD DERMATOL; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Silverberg JI, 2010, J AM ACAD DERMATOL, V62, P937, DOI 10.1016/j.jaad.2009.11.024; Word AP, 2012, BRIT J DERMATOL, V166, P372, DOI 10.1111/j.1365-2133.2011.10667.x	11	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52778	10.1371/journal.pone.0052778	http://dx.doi.org/10.1371/journal.pone.0052778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300773	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100080
J	Bergmann, HC; Rijpkema, M; Fernandez, G; Kessels, RPC				Bergmann, Heiko C.; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.			The Effects of Valence and Arousal on Associative Working Memory and Long-Term Memory	PLOS ONE			English	Article							ATTENTION-GRABBING POWER; AUTOMATIC VIGILANCE; EMOTIONAL AROUSAL; NEGATIVE WORDS; PERCEPTION; ACTIVATION; ENHANCEMENT; SPECIFICITY; RETENTION; DECISION	Background: Emotion can either facilitate or impair memory, depending on what, when and how memory is tested and whether the paradigm at hand is administered as a working memory (WM) or a long-term memory (LTM) task. Whereas emotionally arousing single stimuli are more likely to be remembered, memory for the relationship between two or more component parts (i.e., relational memory) appears to be worse in the presence of emotional stimuli, at least in some relational memory tasks. The current study investigated the effects of both valence (neutral vs. positive vs. negative) and arousal (low vs. high) in an inter-item WM binding and LTM task. Methodology/Principal Findings: A five-pair delayed-match-to-sample (WM) task was administered. In each trial, study pairs consisted of one neutral picture and a second picture of which the emotional qualities (valence and arousal levels) were manipulated. These pairs had to be remembered across a delay interval of 10 seconds. This was followed by a probe phase in which five pairs were tested. After completion of this task, an unexpected single item LTM task as well as an LTM task for the pairs was assessed. As expected, emotional arousal impaired WM processing. This was reflected in lower accuracy for pairs consisting of high-arousal pictures compared to pairs with low-arousal pictures. A similar effect was found for the associative LTM task. However, the arousal effect was modulated by affective valence for the WM but not the LTM task; pairs with low-arousal negative pictures were not processed as well in the WM task. No significant differences were found for the single-item LTM task. Conclusions/Significance: The present study provides additional evidence that processes during initial perception/encoding and post-encoding processes, the time interval between study and test and the interaction between valence and arousal might modulate the effects of "emotion" on associative memory.	[Bergmann, Heiko C.; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bergmann, HC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	h.bergmann@donders.ru.nl	Fernandez, Guillen/B-3771-2009; Rijpkema, Mark/D-1974-2010; Kessels, Roy P.C./D-1902-2010	Fernandez, Guillen/0000-0002-5522-0604; Rijpkema, Mark/0000-0002-8495-4703; Kessels, Roy P.C./0000-0001-9500-9793	Netherlands Organisation for Scientific Research (NWO) [452-08-005]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a VIDI innovational grant from the Netherlands Organisation for Scientific Research (NWO, no. 452-08-005), awarded to RPCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; BARGH JA, 1992, J PERS SOC PSYCHOL, V62, P893, DOI 10.1037/0022-3514.62.6.893; Bergmann HC, 2012, NEUROIMAGE, V63, P989, DOI 10.1016/j.neuroimage.2012.03.047; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CONTINI L, 1992, PERCEPT MOTOR SKILL, V75, P427, DOI 10.2466/PMS.75.5.427-431; D'Argembeau A, 2004, EMOTION, V4, P173, DOI 10.1037/1528-3542.4.2.173; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Ecker UKH, 2007, BRAIN RES, V1185, P221, DOI 10.1016/j.brainres.2007.09.047; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; Guillet R, 2009, MEM COGNITION, V37, P866, DOI 10.3758/MC.37.6.866; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Horstmann G, 2006, PSYCHON B REV, V13, P1067, DOI 10.3758/BF03213927; Huijbers M.J, 2011, J AGING RES; Jacobs WJ, 1998, PSYCHOL PUBLIC POL L, V4, P1110; Jang Y, 2009, J EXP PSYCHOL GEN, V138, P291, DOI 10.1037/a0015525; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2005, PSYCHOL AGING, V20, P241, DOI 10.1037/0882-7974.20.2.241; Kensinger EA, 2007, J GERONTOL B-PSYCHOL, V62, pP208, DOI 10.1093/geronb/62.4.P208; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Kensinger EA, 2007, J MEM LANG, V56, P575, DOI 10.1016/j.jml.2006.05.004; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kindt M, 1999, J PSYCHOPATHOL BEHAV, V21, P207, DOI 10.1023/A:1022873331067; Kohler T, 2005, Z KLIN PSYCH PSYCHIA, V53, P205; Kohler T, 2002, Z KLIN PSYCHOL PSYCH, V50, P328; Lang PJ, 2008, INT AFFECTIVE PICTUR; Levine LJ, 2009, COGNITION EMOTION, V23, P833, DOI 10.1080/02699930902738863; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; MacKay DG, 2005, PSYCHOL SCI, V16, P25, DOI 10.1111/j.0956-7976.2005.00776.x; Madan CR, 2012, J MEM LANG, V66, P695, DOI 10.1016/j.jml.2012.04.001; Mather M, 2006, J COGNITIVE NEUROSCI, V18, P614, DOI 10.1162/jocn.2006.18.4.614; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Mather M, 2007, PERSPECT PSYCHOL SCI, V2, P33, DOI 10.1111/j.1745-6916.2007.00028.x; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Mitchell KJ, 2006, NEUROREPORT, V17, P1543, DOI 10.1097/01.wnr.0000234743.50442.e5; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Murray BD, 2012, MEM COGNITION, V40, P1056, DOI 10.3758/s13421-012-0215-3; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pierce BH, 2011, EMOTION, V11, P139, DOI 10.1037/a0021287; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Schmidt SR, 2002, J EXP PSYCHOL LEARN, V28, P353, DOI 10.1037//0278-7393.28.2.353; Stanny CJ, 2000, AM J PSYCHOL, V113, P359, DOI 10.2307/1423364; STEBLAY NM, 1992, LAW HUMAN BEHAV, V16, P413, DOI 10.1007/BF02352267; Tabert MH, 2001, NEUROPSYCHOLOGIA, V39, P556, DOI 10.1016/S0028-3932(00)00157-3; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Zimmer H.D., 2012, HDB BINDING MEMORY P, P3, DOI [DOI 10.1093/ACPROF:OSO/9780198529675.003.0001, 10.1093/acprof:oso/9780198529675.003.0001]; Zimmerman CA, 2010, J MEM LANG, V62, P240, DOI 10.1016/j.jml.2009.11.004	60	14	15	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52616	10.1371/journal.pone.0052616	http://dx.doi.org/10.1371/journal.pone.0052616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300724	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800114
J	Heyes, DJ; Khara, B; Sakuma, M; Hardman, SJO; O'Cualain, R; Rigby, SEJ; Scrutton, NS				Heyes, Derren J.; Khara, Basile; Sakuma, Michiyo; Hardman, Samantha J. O.; O'Cualain, Ronan; Rigby, Stephen E. J.; Scrutton, Nigel S.			Ultrafast Red Light Activation of Synechocystis Phytochrome Cph1 Triggers Major Structural Change to Form the Pfr Signalling-Competent State	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; MIDINFRARED SPECTROSCOPY; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PROTEIN MOTIONS; DRIVEN ENZYME; GROUND-STATE; SOLVENT	Phytochromes are dimeric photoreceptors that regulate a range of responses in plants and microorganisms through interconversion of red light-absorbing (Pr) and far-red light-absorbing (Pfr) states. Photoconversion between these states is initiated by light-driven isomerization of a bilin cofactor, which triggers protein structural change. The extent of this change, and how light-driven structural changes in the N-terminal photosensory region are transmitted to the C-terminal regulatory domain to initiate the signalling cascade, is unknown. We have used pulsed electron-electron double resonance (PELDOR) spectroscopy to identify multiple structural transitions in a phytochrome from Synechocystis sp. PCC6803 (Cph1) by measuring distances between nitroxide labels introduced into the protein. We show that monomers in the Cph1 dimer are aligned in a parallel 'head-to-head' arrangement and that photoconversion between the Pr and Pfr forms involves conformational change in both the N- and C-terminal domains of the protein. Cryo-trapping and kinetic measurements were used to probe the extent and temporal properties of protein motions for individual steps during photoconversion of Cph1. Formation of the primary photoproduct Lumi-R is not affected by changes in solvent viscosity and dielectric constant. Lumi-R formation occurs at cryogenic temperatures, consistent with their being no major structural reorganization of Cph1 during primary photoproduct formation. All remaining steps in the formation of the Pfr state are affected by solvent viscosity and dielectric constant and occur only at elevated temperatures, implying involvement of a series of long-range solvent-coupled conformational changes in Cph1. We show that signalling is achieved through ultrafast photoisomerization where localized structural change in the GAF domain is transmitted and amplified to cause larger-scale and slower conformational change in the PHY and histidine kinase domains. This hierarchy of timescales and extent of structural change orientates the histidine kinase domain to elicit the desired light-activated biological response.	[Heyes, Derren J.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; Univ Manchester, Fac Life Sci, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk		Hardman, Samantha/0000-0002-8310-4758; Heyes, Derren/0000-0002-7453-1571; O'Cualain, Ronan/0000-0002-4767-6142	Engineering and Physical Sciences Research Council; Royal Society; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish; EPSRC [EP/J020192/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (Established Career Fellowship to NSS) and the Royal Society (Wolfson Merit Award to NSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Frauenfelder H, 2002, BIOPHYS CHEM, V98, P35, DOI 10.1016/S0301-4622(02)00083-2; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Schweiger A, 2001, PRINCIPLES PULSE ELE, P444; SCHWEIGER A, 2001, PRINCIPLES PULSE ELE, P183; Schweiger A, 2001, PRINCIPLES PULSE ELE, P420; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	46	15	15	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52418	10.1371/journal.pone.0052418	http://dx.doi.org/10.1371/journal.pone.0052418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300666	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800084
J	Qu, F; Wu, CS; Hou, JF; Jin, Y; Zhang, JL				Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan			Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; QUANTITATIVE-ANALYSIS; INDUCED APOPTOSIS; IN-VITRO; KAPPA-B; CELLS; TRIPTERYGIUM; INJURY; RATS; MICE	Background: Hypersensitivity diseases are associated with many severe human illnesses, including leprosy and tuberculosis. Emerging evidence suggests that the pathogenesis and pathological mechanisms of treating these diseases may be attributable to sphingolipid metabolism. Methods: High performance liquid chromatography-tandem mass spectrometry was employed to target and measure 43 core sphingolipids in the plasma, kidneys, livers and spleens of BALB/c mice from four experimental groups: control, delayed-type hypersensitivity (DTH) model, DTH+triptolide, and control+triptolide. Orthogonal partial least squares discriminant analysis (OPLS-DA) was used to identify potential biomarkers associated with variance between groups. Relationships between the identified biomarkers and disease markers were evaluated by Spearman correlation. Results: As a treatment to hypersensitivity disease, triptolide significantly inhibit the ear swelling and recover the reduction of splenic index caused by DTH. The sphingolipidomic result revealed marked alterations in sphingolipid levels between groups that were associated with the effects of the disease and triptolide treatment. Based on this data, 23 potential biomarkers were identified by OPLS-DA, and seven of these biomarkers correlated markedly with the disease markers (p<0.05) by Spearman correlation. Conclusions: These data indicate that differences in sphingolipid levels in plasma and tissues are related to DTH and treatment with triptolide. Restoration of proper sphingolipid levels may attribute to the therapeutic effect of triptolide treatment. Furthermore, these findings demonstrate that targeted sphingolipidomic analysis followed by multivariate analysis presents a novel strategy for the identification of biomarkers in biological samples.	[Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan] Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100021, Peoples R China; [Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhang, JL (corresponding author), Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100021, Peoples R China.	zhjl@imm.ac.cn	Qu, Feng/L-6355-2013; Wu, Caisheng/AAT-2701-2021	Qu, Feng/0000-0002-3812-0732; 	Ministry of Science and Technology of People's Republic of China [2012ZX09301002-006]; Natural Science Foundation of China [81273484]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by Ministry of Science and Technology of People's Republic of China (2012ZX09301002-006) and the Natural Science Foundation of China (No. 81273484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2011, BRIT J CLIN PHARMACO, V71, P701, DOI 10.1111/j.1365-2125.2010.03764.x; Aoyagi Y, 2008, BIOORG MED CHEM LETT, V18, P2459, DOI 10.1016/j.bmcl.2008.02.039; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bucci M, 2011, NAT CHEM BIOL, V7, P577; [Committee BC Services USDoHaH Administration FaD Research CfDEa Medicine CfV], 2001, GUID IND BIOAN METH; Dan H, 2008, J BIOCHEM MOL TOXIC, V22, P422, DOI 10.1002/jbt.20261; de Grauw JC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3427; Dyatlovitskaya EV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P347, DOI 10.1134/S0006297906040018; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Ge HL, 2011, ANGIOLOGY, V62, P265, DOI 10.1177/0003319710385337; GU WZ, 1995, INT J IMMUNOPHARMACO, V17, P351; Hawthorne KM, 2011, SEMIN OPHTHALMOL, V26, P246, DOI 10.3109/08820538.2011.588659; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Jia W., 2009, MED METABONOMICS; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lalazar G, 2006, MINI-REV MED CHEM, V6, P1249, DOI 10.2174/138955706778742722; Leuenroth SJ, 2008, J AM SOC NEPHROL, V19, P1659, DOI 10.1681/ASN.2008030259; Liang M, 2008, CANCER LETT, V270, P337, DOI 10.1016/j.canlet.2008.05.025; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Liou JT, 2008, EUR J PHARMACOL, V589, P288, DOI 10.1016/j.ejphar.2008.04.056; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Mouritsen OG, 2011, PHYS CHEM CHEM PHYS; Napolitano G, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3141pe34; Organization TWH, 2009, HDB GOOD LAB PRACT; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Steenholdt C, 2012, J CROHNS COLITIS, V6, P108, DOI 10.1016/j.crohns.2011.08.001; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tao R, 2011, EXP MOL PATHOL, V90, P137, DOI 10.1016/j.yexmp.2010.12.001; Tao X, 2008, ARTHRITIS RHEUM-US, V58, P1774, DOI 10.1002/art.23513; Ullrich SE, 1999, TOXICOL SCI, V52, P61, DOI 10.1093/toxsci/52.1.61; van Eden W, 2009, J NEUROIMMUNOL, V217, P10, DOI 10.1016/j.jneuroim.2009.09.008; Wang T, 2009, PHARMACOL REP, V61, P697, DOI 10.1016/S1734-1140(09)70122-7; Wang ZP, 2009, INT J TOXICOL, V28, P177, DOI 10.1177/1091581809337418; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; Yang F, 2011, EXP TOXICOL PATHOL; Yang F, 2011, J HUAZHONG U SCI-MED, V31, P335, DOI 10.1007/s11596-011-0377-4; Ye XC, 2010, TOXICOL LETT, V192, P212, DOI 10.1016/j.toxlet.2009.10.028; Yu C, 2011, FITOTERAPIA, V82, P709, DOI 10.1016/j.fitote.2011.02.011; Zeng R, 2011, J HUAZHONG U SCI-MED, V31, P446, DOI 10.1007/s11596-011-0471-7; Zhang GT, 2009, J ETHNOPHARMACOL, V125, P41, DOI 10.1016/j.jep.2009.06.020; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	47	23	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52454	10.1371/journal.pone.0052454	http://dx.doi.org/10.1371/journal.pone.0052454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300675	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800090
J	Song, AAL; Abdullah, JO; Abdullah, MP; Shafee, N; Othman, R; Tan, EF; Noor, NM; Raha, AR				Song, Adelene Ai-Lian; Abdullah, Janna Ong; Abdullah, Mohd Puad; Shafee, Norazizah; Othman, Roohaida; Tan, Ee-Fun; Noor, Normah Mohd; Raha, Abdul Rahim			Overexpressing 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGR) in the Lactococcal Mevalonate Pathway for Heterologous Plant Sesquiterpene Production	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COA REDUCTASE; ESSENTIAL OIL; EXPRESSION; SYNTHASE; GENES; BIOSYNTHESIS; ESSENTIALITY; CLONING	Isoprenoids are a large and diverse group of metabolites with interesting properties such as flavour, fragrance and therapeutic properties. They are produced via two pathways, the mevalonate pathway or the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway. While plants are the richest source of isoprenoids, they are not the most efficient producers. Escherichia coli and yeasts have been extensively studied as heterologous hosts for plant isoprenoids production. In the current study, we describe the usage of the food grade Lactococcus lactis as a potential heterologous host for the production of sesquiterpenes from a local herbaceous Malaysian plant, Persicaria minor (synonym Polygonum minus). A sesquiterpene synthase gene from P. minor was successfully cloned and expressed in L. lactis. The expressed protein was identified to be a beta-sesquiphellandrene synthase as it was demonstrated to be functional in producing beta-sesquiphellandrene at 85.4% of the total sesquiterpenes produced based on in vitro enzymatic assays. The recombinant L. lactis strain developed in this study was also capable of producing beta-sesquiphellandrene in vivo without exogenous substrates supplementation. In addition, overexpression of the strain's endogenous 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMGR), an established rate-limiting enzyme in the eukaryotic mevalonate pathway, increased the production level of beta-sesquiphellandrene by 1.25-1.60 fold. The highest amount achieved was 33 nM at 2 h post-induction.	[Song, Adelene Ai-Lian; Abdullah, Mohd Puad; Raha, Abdul Rahim] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia; [Abdullah, Janna Ong; Shafee, Norazizah] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia; [Raha, Abdul Rahim] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor Darul, Malaysia; [Othman, Roohaida; Noor, Normah Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor Darul, Malaysia; [Tan, Ee-Fun] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Raha, AR (corresponding author), Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia.	raha@biotech.upm.edu.my	Noor, Normah Mohd/X-1754-2019; BIOTECH, JANNA ONG BINTI ABDULLAH //AAF-9573-2020	BIOTECH, JANNA ONG BINTI ABDULLAH //0000-0002-8280-5923	The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI) [07-05-MGI-GMB 004]	The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI)	This work was supported by "The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI) (07-05-MGI-GMB 004)" and National Science Fellowship, MOSTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha K, 2010, J APPL MICROBIOL, V109, P1632, DOI 10.1111/j.1365-2672.2010.04789.x; Baharum SN, 2010, MOLECULES, V15, P7006, DOI 10.3390/molecules15107006; Balibar CJ, 2009, J BACTERIOL, V191, P851, DOI 10.1128/JB.01357-08; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; de Vos WM, 2004, TRENDS BIOTECHNOL, V22, P72, DOI 10.1016/j.tibtech.2003.11.011; Deligeorgopoulou A, 2003, BIOCHEMISTRY-US, V42, P7741, DOI 10.1021/bi034410m; DENYER CV, 1994, J NAT PROD, V57, P658, DOI 10.1021/np50107a017; El-Baroty G. S., 2010, Advances in Food Sciences, V32, P142; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Hernandez I, 2007, APPL ENVIRON MICROB, V73, P1544, DOI 10.1128/AEM.01870-06; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KH, 2011, J FOOD SCI, V76, pH226, DOI 10.1111/j.1750-3841.2011.02427.x; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; Ohto C, 2009, APPL MICROBIOL BIOT, V82, P837, DOI 10.1007/s00253-008-1807-5; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Song AAL, 2012, INT J MOL SCI, V13, P1582, DOI 10.3390/ijms13021582; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1	35	25	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52444	10.1371/journal.pone.0052444	http://dx.doi.org/10.1371/journal.pone.0052444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300671	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800087
J	Wang, XY; Jensen-Taubman, SM; Keefe, KM; Yang, DL; Linnoila, RI				Wang, Xiao-Yang; Jensen-Taubman, Sandra M.; Keefe, Kathleen M.; Yang, Danlei; Linnoila, R. Ilona			Achaete-Scute Complex Homolog-1 Promotes DNA Repair in the Lung Carcinogenesis through Matrix Metalloproteinase-7 and O(6)-Methylguanine-DNA Methyltransferase	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; NEUROENDOCRINE DIFFERENTIATION; HISTONE H2AX; CANCER; GENE; CELL; TUMORIGENESIS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; HYPERMETHYLATION; PROLIFERATION	Lung cancer is the leading cause of cancer-related deaths in the world. Achaete-scute complex homolog-1 (Ascl1) is a member of the basic helix-loop-helix (bHLH) transcription factor family that has multiple functions in the normal and neoplastic lung such as the regulation of neuroendocrine differentiation, prevention of apoptosis and promotion of tumor-initiating cells. We now show that Ascl1 directly regulates matrix metalloproteinase-7 (MMP-7) and O(6)-methylguanine-DNA methyltransferase (MGMT). Loss- and gain-of-function experiments in human bronchial epithelial and lung carcinoma cell lines revealed that Ascl1, MMP-7 and MGMT are able to protect cells from the tobacco-specific nitrosamine NNK-induced DNA damage and the alkylating agent cisplatin-induced apoptosis. We also examined the role of Ascl1 in NNK-induced lung tumorigenesis in vivo. Using transgenic mice which constitutively expressed human Ascl1 in airway lining cells, we found that there was a delay in lung tumorigenesis. We conclude that Ascl1 potentially enhances DNA repair through activation of MMP-7 and MGMT which may impact lung carcinogenesis and chemoresistance. The study has uncovered a novel and unexpected function of Ascl1 which will contribute to better understanding of lung carcinogenesis and the broad implications of transcription factors in tobacco-related carcinogenesis.	[Wang, Xiao-Yang; Jensen-Taubman, Sandra M.; Keefe, Kathleen M.; Yang, Danlei; Linnoila, R. Ilona] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XY (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	xiaoyangwang@gmail.com; linnoila@mail.nih.gov			Intramural Research Program of the National Cancer Institute at National Institutes of Health	Intramural Research Program of the National Cancer Institute at National Institutes of Health	This study was supported by the Intramural Research Program of the National Cancer Institute at National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan G, 2006, INT J ONCOL, V29, P745; Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; BELINSKY SA, 1992, CANCER RES, V52, P3164; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Biswas T, 1999, ONCOGENE, V18, P525, DOI 10.1038/sj.onc.1202320; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Brown PJ, 2008, CANCER LETT, V260, P48, DOI 10.1016/j.canlet.2007.10.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Demelash A, 2012, MOL BIOL CELL, V23, P2856, DOI 10.1091/mbc.E10-12-1010; Esteller M, 1999, CANCER RES, V59, P793; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Hang B, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/709521; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen-Taubman S, 2010, TOXICOL SCI, V117, P238, DOI 10.1093/toxsci/kfq177; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Kondo N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/543531; LINNOILA RI, 1988, AM J CLIN PATHOL, V90, P641, DOI 10.1093/ajcp/90.6.641; Linnoila RI, 2000, CANCER RES, V60, P4005; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu LL, 1999, CARCINOGENESIS, V20, P279, DOI 10.1093/carcin/20.2.279; Miki M, 2012, LUNG CANCER, V75, P58, DOI 10.1016/j.lungcan.2011.05.019; Mitsiades N, 2001, CANCER RES, V61, P577; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pulling LC, 2003, CANCER RES, V63, P4842; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakumi K, 1997, CANCER RES, V57, P2415; Shopland DR, 1995, ENVIRON HEALTH PERSP, V103, P131, DOI 10.2307/3432300; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Verbeek B, 2008, BRIT MED BULL, V85, P17, DOI 10.1093/bmb/ldm036; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2007, LAB INVEST, V87, P527, DOI 10.1038/labinvest.3700552; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675	38	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52832	10.1371/journal.pone.0052832	http://dx.doi.org/10.1371/journal.pone.0052832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300791	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800156
J	Acosta, SA; Tajiri, N; Shinozuka, K; Ishikawa, H; Grimmig, B; Diamond, D; Sanberg, PR; Bickford, PC; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Grimmig, Bethany; Diamond, David; Sanberg, Paul R.; Bickford, Paula C.; Kaneko, Yuji; Borlongan, Cesar V.			Long-Term Upregulation of Inflammation and Suppression of Cell Proliferation in the Brain of Adult Rats Exposed to Traumatic Brain Injury Using the Controlled Cortical Impact Model	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER; ALZHEIMERS-DISEASE; HEAD-INJURY; MICE; NEUROGENESIS; HIPPOCAMPUS; DEPRESSION; DEFICITS; ATROPHY	The long-term consequences of traumatic brain injury (TBI), specifically the detrimental effects of inflammation on the neurogenic niches, are not very well understood. In the present in vivo study, we examined the prolonged pathological outcomes of experimental TBI in different parts of the rat brain with special emphasis on inflammation and neurogenesis. Sixty days after moderate controlled cortical impact injury, adult Sprague-Dawley male rats were euthanized and brain tissues harvested. Antibodies against the activated microglial marker, OX6, the cell cycle-regulating protein marker, Ki67, and the immature neuronal marker, doublecortin, DCX, were used to estimate microglial activation, cell proliferation, and neuronal differentiation, respectively, in the subventricular zone (SVZ), subgranular zone (SGZ), striatum, thalamus, and cerebral peduncle. Stereology-based analyses revealed significant exacerbation of OX6-positive activated microglial cells in the striatum, thalamus, and cerebral peduncle. In parallel, significant decrements in Ki67-positive proliferating cells in SVZ and SGZ, but only trends of reduced DCX-positive immature neuronal cells in SVZ and SGZ were detected relative to sham control group. These results indicate a progressive deterioration of the TBI brain over time characterized by elevated inflammation and suppressed neurogenesis. Therapeutic intervention at the chronic stage of TBI may confer abrogation of these deleterious cell death processes.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Grimmig, Bethany; Sanberg, Paul R.; Bickford, Paula C.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Grimmig, Bethany; Bickford, Paula C.] James A Haley Vet Affairs Hosp, Tampa, FL USA; [Diamond, David] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Bickford, Paula C/J-5970-2012; Borlongan, Cesar/I-5696-2012; Kaneko, Yuji/J-6447-2012; Tajiri, Naoki/K-1230-2012	Bickford, Paula C/0000-0001-9657-7725; Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X; Shinozuka, Kazutaka/0000-0002-6435-4460; Sanberg, Paul/0000-0001-9130-4592; Ishikawa, Hiroto/0000-0003-0760-7203	Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida and Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; SanBio Inc.; KMPHC; NeuralStem Inc.; National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida and Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Foundation; SanBio Inc.; KMPHC; NeuralStem Inc.; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. CVB is funded by the National Institutes of Health 1R01NS071956-01A1, James and Esther King Biomedical Research Foundation 1KG01-33966, SanBio Inc., KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, Department of Defense W81XWH-11-1-0634, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., KMPHC and NeuralStem Inc. CVB is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bye N, 2010, INJURY S1, V41, pS42; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Jia X, 2012, J TRAUMA ACUTE CARE; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu CY, 2008, NEUROSURGERY, V63, pN12, DOI 10.1227/01.NEU.0000339457.01711.3B; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mannix RC, 2012, INT J ALZHEIMERS DIS, V2012; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	51	142	144	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53376	10.1371/journal.pone.0053376	http://dx.doi.org/10.1371/journal.pone.0053376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301065	Green Submitted, gold, Green Published			2022-12-27	WOS:000313480000052
J	Bock, J; Mochmann, LH; Schlee, C; Farhadi-Sartangi, N; Gollner, S; Muller-Tidow, C; Baldus, CD				Bock, Juliane; Mochmann, Liliana H.; Schlee, Cornelia; Farhadi-Sartangi, Nasrin; Goellner, Stefanie; Mueller-Tidow, Carsten; Baldus, Claudia D.			ERG Transcriptional Networks in Primary Acute Leukemia Cells Implicate a Role for ERG in Deregulated Kinase Signaling	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER; LYMPHOBLASTIC-LEUKEMIA; NORMAL KARYOTYPE; SCREEN REVEALS; PHASE I/II; EXPRESSION; GENE; PREDICTS; TARGET	High expression of the E26 transforming sequence related gene ( ERG) is associated with poor prognosis in a subgroup of leukemia patients with acute myeloid (AML) and acute T-lymphoblastic leukemia (T-ALL). In a previous study we proposed that ERG overexpression may deregulate several signaling cascades in acute leukemia. Herein, we further expand those studies by identifying a consensus of biological targets in primary blasts of newly diagnosed acute leukemia patients. Our findings of chromatin immunoprecipitation-on-chip of primary samples revealed 48 significantly enriched single genes including DAAM1 and NUMB. Significantly enriched signaling pathways included WNT/beta-catenin, p53, and PI3K/AKT with ERG overexpression inducing dephosphorylation of AKT(Ser473) relative to non ERG expressing K562 cells. Cell based ERG overexpression studies also revealed drug resistance to multi-kinase inhibitor, BAY 43-9006 (Sorafenib) and to the tyrosine kinase inhibitor TKI258. Thus in primary leukemic cells, ERG may contribute to the dysregulation of kinase signaling, which results in resistance to kinase inhibitors.	[Bock, Juliane; Mochmann, Liliana H.; Schlee, Cornelia; Farhadi-Sartangi, Nasrin; Baldus, Claudia D.] Univ Hosp Berlin, Charite, Dept Hematol & Oncol, Berlin, Germany; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol Oncol & Pneumol, D-48149 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster	Baldus, CD (corresponding author), Univ Hosp Berlin, Charite, Dept Hematol & Oncol, Campus Benjamin Franklin, Berlin, Germany.	claudia.baldus@charite.de	Müller-Tidow, Carsten CMT/B-5257-2014; Göllner, Stefanie/AAX-3901-2020; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by research funding from the Deutsche Krebshilfe to CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Ciarlo M, 2012, INT J CANCER, V131, P582, DOI 10.1002/ijc.26402; Eid MA, 2010, INT J LAB HEMATOL, V32, P197, DOI 10.1111/j.1751-553X.2009.01168.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fortson WS, 2011, INT J ONCOL, V39, P111, DOI 10.3892/ijo.2011.1014; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hart AH, 2000, ONCOGENE, V19, P6400, DOI 10.1038/sj.onc.1204040; Hoemme C, 2008, BLOOD, V111, P2887, DOI 10.1182/blood-2007-03-079921; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim KB, 2011, CLIN CANCER RES, V17, P7451, DOI 10.1158/1078-0432.CCR-11-1747; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong XT, 1997, BLOOD, V90, P1192; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Metzeler KH, 2009, J CLIN ONCOL, V27, P5031, DOI 10.1200/JCO.2008.20.5328; Mochmann LH, 2011, ONCOGENE, V30, P2044, DOI 10.1038/onc.2010.582; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Pereira JKN, 2012, LEUKEMIA RES, V36, P1300, DOI 10.1016/j.leukres.2012.06.010; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsuzuki S, 2012, BLOOD, V117, P7079; Vu C, 2010, CLIN CANCER RES, V16, P5374, DOI 10.1158/1078-0432.CCR-10-0480; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhu XP, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-17; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	39	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52872	10.1371/journal.pone.0052872	http://dx.doi.org/10.1371/journal.pone.0052872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300998	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000019
J	Gao, N; Zou, D; Qiao, HL				Gao, Na; Zou, Dan; Qiao, Hai-Ling			Concentration-Dependent Inhibitory Effect of Baicalin on the Plasma Protein Binding and Metabolism of Chlorzoxazone, a CYP2E1 Probe Substrate, in Rats In Vitro and In Vivo	PLOS ONE			English	Article							PHARMACOKINETICS; LIVER; 6-HYDROXYCHLORZOXAZONE; CYTOCHROME-P-450; EXPRESSION; INDUCTION; INJURY; RADIX	Some of the components found in herbs may be inhibitors or inducers of cytochrome P450 enzymes, which may therefore result in undesired herb- drug interactions. As a component extracted from Radix Scutellariae, the direct effect of baicalin on cytochrome P450 has not been investigated sufficiently. In this study, we investigated concentration-dependent inhibitory effect of baicalin on the plasma protein binding and metabolism of chlorzoxazone (CZN), a model CYP2E1 probe substrate, in rats in vitro and in vivo. Animal experiment was a randomized, three-period crossover design. Significant changes in pharmacokinetic parameters of CZN such as C-max, t(1/2) and V-d were observed after treatment with baicalin in vivo (P < 0.05). C-max decreased by 25% and 33%, whereas t(1/2) increased by 34% and 53%, V-d increased by 37% and 50% in 225 mg/kg and 450 mg/kg baicalin-treated rats, respectively. The AUC and CL of CZN were not affected (P > 0.05). Correlation analysis showed that the changes in CZN concentrations and baicalin concentrations were in good correlation (r > 0.99). In vitro experiments, baicalin decreased the formation of 6-OH-chlorzoxazone in a concentration-dependent manner and exhibited a competitive inhibition in rat liver microsomes, with a Ki value of 145.8 mu M. The values of C-max/Ki were 20 and 39 after treatment with baicalin (225 and 450 mg/kg), respectively. Protein binding experiments in vivo showed that the plasma free-fraction (fu) of CZN increased 2.6-fold immediately after baicalin treatment (450 mg/kg) and in vitro showed that baicalin (125-2500 mg/L) increased the unbound CZN from 1.63% to 3.58%. The results indicate that pharmacokinetic changes in CZN are induced by inhibitory effect of baicalin on the plasma protein binding of CZN and CYP2E1 activity.	[Gao, Na; Qiao, Hai-Ling] Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou, Peoples R China; [Zou, Dan] Henan Med Coll Staff & Workers, Dept Histol & Embryol, Zhengzhou, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou, Peoples R China.	qiaohl@zzu.edu.cn			National Natural Science Foundation of China [81041113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81041113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek HW, 2006, J PHARM SCI-US, V95, P2452, DOI 10.1002/jps.20698; Chittur SV, 1997, J CHROMATOGR B, V693, P479, DOI 10.1016/S0378-4347(97)00024-8; Christensen H, 2006, J PHARM SCI-US, V95, P2778, DOI 10.1002/jps.20733; Fan L, 2009, EUR J CLIN PHARMACOL, V65, P403, DOI 10.1007/s00228-008-0594-3; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Hou Yan-ning, 2000, Yaoxue Xuebao, V35, P890; Jang SI, 2003, IMMUNOPHARM IMMUNOT, V25, P585, DOI 10.1081/IPH-120026443; Lai MY, 2003, J PHARM PHARMACOL, V55, P205, DOI 10.1211/002235702522; Lai MY, 2004, PLANTA MED, V70, P132, DOI 10.1055/s-2004-815489; Lee KS, 2011, J APPL TOXI IN PRESS; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li J, 2012, MED CHEM, V8, P208, DOI 10.2174/157340612800493692; Li Y, 2010, EUR J PHARMACOL, V640, P46, DOI 10.1016/j.ejphar.2010.05.017; Lininger SW, 2000, NATURAL PHARM; McGuffin M., 1997, AM HERBAL PRODUCTS A; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Shaik IH, 2011, J PHARM SCI-US, V100, P5281, DOI 10.1002/jps.22708; Srinivas NR, 2010, XENOBIOTICA, V40, P357, DOI 10.3109/00498251003663724; Tang YH, 2006, BIOMED CHROMATOGR, V20, P1116, DOI 10.1002/bmc.655; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023; Zeng MF, 2010, FITOTERAPIA, V81, P490, DOI 10.1016/j.fitote.2010.01.004	22	20	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53038	10.1371/journal.pone.0053038	http://dx.doi.org/10.1371/journal.pone.0053038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301016	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900054
J	Vacchi-Suzzi, C; Hahne, F; Scheubel, P; Marcellin, M; Dubost, V; Westphal, M; Boeglen, C; Buchmann-Moller, S; Cheung, MS; Cordier, A; De Benedetto, C; Deurinck, M; Frei, M; Moulin, P; Oakeley, E; Grenet, O; Grevot, A; Stull, R; Theil, D; Moggs, JG; Marrer, E; Couttet, P				Vacchi-Suzzi, Caterina; Hahne, Florian; Scheubel, Philippe; Marcellin, Magali; Dubost, Valerie; Westphal, Magdalena; Boeglen, Catherine; Buechmann-Moller, Stine; Cheung, Ming Sin; Cordier, Andre; De Benedetto, Christopher; Deurinck, Mark; Frei, Moritz; Moulin, Pierre; Oakeley, Edward; Grenet, Olivier; Grevot, Armelle; Stull, Robert; Theil, Diethilde; Moggs, Jonathan G.; Marrer, Estelle; Couttet, Philippe			Heart Structure-Specific Transcriptomic Atlas Reveals Conserved microRNA-mRNA Interactions	PLOS ONE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; RAT-LIVER; PROLIFERATION; ACTIVATION; BIOMARKERS; MOUSE; HYPERTROPHY	MicroRNAs are short non-coding RNAs that regulate gene expression at the post-transcriptional level and play key roles in heart development and cardiovascular diseases. Here, we have characterized the expression and distribution of microRNAs across eight cardiac structures (left and right ventricles, apex, papillary muscle, septum, left and right atrium and valves) in rat, Beagle dog and cynomolgus monkey using microRNA sequencing. Conserved microRNA signatures enriched in specific heart structures across these species were identified for cardiac valve (miR-let-7c, miR-125b, miR-127, miR-199a-3p, miR-204, miR-320, miR-99b, miR-328 and miR-744) and myocardium (miR-1, miR-133b, miR-133a, miR-208b, miR-30e, miR-499-5p, miR-30e*). The relative abundance of myocardium-enriched (miR-1) and valve-enriched (miR-125b-5p and miR-204) microRNAs was confirmed using in situ hybridization. MicroRNA-mRNA interactions potentially relevant for cardiac functions were explored using anti-correlation expression analysis and microRNA target prediction algorithms. Interactions between miR-1/Timp3, miR-125b/Rbm24, miR-204/Tgfbr2 and miR-208b/Csnk2a2 were identified and experimentally investigated in human pulmonary smooth muscle cells and luciferase reporter assays. In conclusion, we have generated a high-resolution heart structure-specific mRNA/microRNA expression atlas for three mammalian species that provides a novel resource for investigating novel microRNA regulatory circuits involved in cardiac molecular physiopathology.	[Vacchi-Suzzi, Caterina; Hahne, Florian; Scheubel, Philippe; Marcellin, Magali; Dubost, Valerie; Westphal, Magdalena; Boeglen, Catherine; Buechmann-Moller, Stine; Cheung, Ming Sin; Cordier, Andre; Deurinck, Mark; Frei, Moritz; Moulin, Pierre; Oakeley, Edward; Grenet, Olivier; Grevot, Armelle; Theil, Diethilde; Moggs, Jonathan G.; Marrer, Estelle; Couttet, Philippe] Novartis Inst Biomed Res, Basel, Switzerland; [De Benedetto, Christopher; Stull, Robert] Novartis Inst Biomed Res, E Hanover, NJ USA	Novartis; Novartis	Couttet, P (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	philippe.couttet@novartis.com	Couttet, Philippe/AAH-5489-2019	Couttet, Philippe/0000-0002-5255-6647				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukushima Tamio, 2007, Journal of Toxicological Sciences, V32, P401, DOI 10.2131/jts.32.401; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lema C, 2010, TOXICOL LETT, V198, P100, DOI 10.1016/j.toxlet.2010.06.019; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; Van Hummelen P, 2010, MUTAT RES-REV MUTAT, V705, P165, DOI 10.1016/j.mrrev.2010.04.007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang RR, 2011, INTERNAL MED, V50, P1789, DOI 10.2169/internalmedicine.50.5129; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	67	57	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52442	10.1371/journal.pone.0052442	http://dx.doi.org/10.1371/journal.pone.0052442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300973	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900025
J	Vorsino, AE; King, CB; Haines, WP; Rubinoff, D				Vorsino, Adam E.; King, Cynthia B.; Haines, William P.; Rubinoff, Daniel			Modeling the Habitat Retreat of the Rediscovered Endemic Hawaiian Moth Omiodes continuatalis Wallengren (Lepidoptera: Crambidae)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOLOGICAL-CONTROL; LEAFROLLER MOTH; THRESHOLD CRITERIA; ECOLOGICAL NICHES; PRESENCE-ABSENCE; CLIMATE MODELS; DISTRIBUTIONS; IMPACTS; RARE	Survey data over the last 100 years indicate that populations of the endemic Hawaiian leafroller moth, Omiodes continuatalis (Wallengren) (Lepidoptera: Crambidae), have declined, and the species is extirpated from large portions of its original range. Declines have been attributed largely to the invasion of non-native parasitoid species into Hawaiian ecosystems. To quantify changes in O. continuatalis distribution, we applied the maximum entropy modeling approach using MAXENT. The model referenced historical (1892-1967) and current (2004-2008) survey data, to create predictive habitat suitability maps which illustrate the probability of occurrence of O. continuatalis based on historical data as contrasted with recent survey results. Probability of occurrence is predicted based on the association of biotic (vegetation) and abiotic (proxy of precipitation, proxy of temperature, elevation) environmental factors with 141 recent and historic survey locations, 38 of which O. continuatalis were collected from. Models built from the historical and recent surveys suggest habitat suitable for O. continuatalis has changed significantly over time, decreasing both in quantity and quality. We reference these data to examine the potential effects of non-native parasitoids as a factor in changing habitat suitability and range contraction for O. continuatalis. Synthesis and applications: Our results suggest that the range of O. continuatalis, an endemic Hawaiian species of conservation concern, has shrunk as its environment has degraded. Although few range shifts have been previously demonstrated in insects, such contractions caused by pressure from introduced species may be important factors in insect extinctions.	[Vorsino, Adam E.; King, Cynthia B.; Haines, William P.; Rubinoff, Daniel] Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu	Vorsino, Adam/H-3435-2013		USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award) [2004-34135-14998]; USDA-NIFA Agreement [58-5320-9-430]; Hatch projects [HAW00942-H, HAW00956-H]; University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant) [DGE02-32016]; NSF Graduate Research Fellowship Program	USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award); USDA-NIFA Agreement; Hatch projects(United States Department of Agriculture (USDA)); University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant); NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	This research was funded by a USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award #2004-34135-14998), as well as USDA-NIFA Agreement No. 58-5320-9-430, and Hatch projects HAW00942-H and HAW00956-H, administered by the College of Tropical Agriculture and Human Resources. Additional funding was provided by the University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant #DGE02-32016), and the NSF Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bartel RA, 2009, ECOGRAPHY, V32, P888, DOI 10.1111/j.1600-0587.2009.05797.x; Benson J, 2003, BIOL CONTROL, V28, P197, DOI 10.1016/S1049-9644(03)00058-6; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Chu PS, 2010, J CLIMATE, V23, P4881, DOI 10.1175/2010JCLI3484.1; CLOUT MN, 1995, IBIS, V137, pS181, DOI 10.1111/j.1474-919X.1995.tb08440.x; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 10; Follett Peter A., 2000, American Entomologist, V46, P82; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; Gagne W.C., 1985, P105; Gagne W. C, 1982, P 3 C EUR LEP CAMBR; Gagne W. C., 1982, P 4 C NAT SCI HAW VO, P63; Gagne WC, 1981, ISLAND ECOSYSTEMS BI; Gagne WC, 1980, P 3 HAW VOLC NAT PAR, P115; Giambelluca TW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034377; Haines William P., 2004, Bishop Museum Occasional Papers, V79, P45; HAWKINS BA, 1993, SCIENCE, V262, P1429, DOI 10.1126/science.262.5138.1429; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howarth F.G., 1985, P149; HOWARTH F G, 1983, Proceedings of the Hawaiian Entomological Society, V24, P239; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Irving DB, 2011, CLIM RES, V49, P169, DOI 10.3354/cr01028; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Johnson MT, 2005, OECOLOGIA, V142, P529, DOI 10.1007/s00442-004-1754-5; King C, 2008, PAC SCI, V62, P147, DOI 10.2984/1534-6188(2008)62[147:FROFBI]2.0.CO;2; King C, 2009, J LEPID SOC, V63, P11; King Cynthia B. A., 2008, Proceedings of the Hawaiian Entomological Society, V40, P11; King CBA, 2010, J APPL ECOL, V47, P299, DOI 10.1111/j.1365-2664.2010.01780.x; Krushelnycky Paul D., 2005, Proceedings of the Hawaiian Entomological Society, V37, P1; Krushelnycky PD, 2012, ANTWEB ANTS HAWAII; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; LEVINS RICHARD, 1968; Lippitt CD, 2008, ECOL MODEL, V210, P339, DOI 10.1016/j.ecolmodel.2007.08.005; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Menuz DR, 2011, THESIS; Messing RH, 2006, FRONT ECOL ENVIRON, V4, P132, DOI 10.1890/1540-9295(2006)004[0132:BCOISS]2.0.CO;2; [National Oceanic and Atmospheric Institute (NOAA) National Ocean Services (NOS)], 2007, 10 M DIG EL MOD HAW; NISHIDA G. M., 2002, HAWAIIAN TERRESTRIAL; Oboyski PT, 2004, J INSECT CONSERV, V8, P229, DOI 10.1023/B:JICO.0000045821.71118.54; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peck RW, 2008, BIOL INVASIONS, V10, P1441, DOI 10.1007/s10530-008-9218-1; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; REIMER NJ, 1994, WESTV STUD, P11; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; ROLLINS M.G., 2007, DEV LANDFIRE FIRE RE; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Rubinoff D, 2002, FREMONTIA, V30, P62; Samways M.J., 2005, INSECT DIVERSITY CON; Schultz CB, 1999, OECOLOGIA, V119, P231, DOI 10.1007/s004420050781; Speight MR, 1999, ECOLOGY INSECTS CONC; Timm OE, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014923; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Zimmerman E.C., 1958, INSECTS HAWAII LEPID	77	6	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51885	10.1371/journal.pone.0051885	http://dx.doi.org/10.1371/journal.pone.0051885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300954	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900011
J	Nasu, M; Takata, N; Danjo, T; Sakaguchi, H; Kadoshima, T; Futaki, S; Sekiguchi, K; Eiraku, M; Sasai, Y				Nasu, Makoto; Takata, Nozomu; Danjo, Teruko; Sakaguchi, Hideya; Kadoshima, Taisuke; Futaki, Sugiko; Sekiguchi, Kiyotoshi; Eiraku, Mototsugu; Sasai, Yoshiki			Robust Formation and Maintenance of Continuous Stratified Cortical Neuroepithelium by Laminin-Containing Matrix in Mouse ES Cell Culture	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIRECTED DIFFERENTIATION; CAJAL-RETZIUS; RADIAL GLIA; NEURONS; GENES; PAX6; SPECIFICATION; EXPRESSION; GENERATION	In the mammalian cortex, the dorsal telencephalon exhibits a characteristic stratified structure. We previously reported that three-dimensional (3D) culture of mouse ES cells (mESCs) can efficiently generate cortical neuroepithelium (NE) and layer-specific cortical neurons. However, the cortical NE generated in this mESC culture was structurally unstable and broke into small neural rosettes by culture day 7, suggesting that some factors for reinforcing the structural integrity were missing. Here we report substantial supporting effects of the extracellular matrix (ECM) protein laminin on the continuous formation of properly polarized cortical NE in floating aggregate culture of mESCs. The addition of purified laminin and entactin (a laminin-associated protein), even at low concentrations, stabilized the formation of continuous cortical NE as well as the maintenance of basement membrane and prevented rosette formation. Treatment with the neutralizing beta 1-integrin antibody impaired the continuous NE formation. The stabilized cortical NE exhibited typical interkinetic nuclear migration of cortical progenitors, as seen in the embryonic cortex. The laminin-treated cortical NE maintained a continuous structure even on culture days 12 and 15, and contained ventricular, basal-progenitor, cortical-plate and Cajal-Retzius cell layers. The cortical NE in this culture was flanked by cortical hem-like tissue. Furthermore, when Shh was added, ventral telencephalic structures such as lateral ganglionic eminence-like tissue formed in the region adjacent to the cortical NE. Thus, our results indicate that laminin-entactin ECM promotes the formation of structurally stable telencephalic tissues in 3D ESC culture, and supports the morphogenetic recapitulation of cortical development.	[Nasu, Makoto; Takata, Nozomu; Danjo, Teruko; Sakaguchi, Hideya; Kadoshima, Taisuke; Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Kadoshima, Taisuke; Eiraku, Mototsugu; Sasai, Yoshiki] RIKEN, Dimens Tissue Anal Unit 4, Ctr Dev Biol, Kobe, Hyogo, Japan; [Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 565, Japan	RIKEN; RIKEN; Osaka University	Sasai, Y (corresponding author), RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan.	yoshikisasai@cdb.riken.jp	Takata, Nozomu/AAI-9801-2020; Nasu, Makoto/ABB-9555-2021	Nasu, Makoto/0000-0003-1361-7598; Eiraku, Mototsugu/0000-0002-9433-9085; Takata, Nozomu/0000-0003-0171-6994	MEXT; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [24680037] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from MEXT (YS, ME, KS), and the Leading Project for Realization of Regenerative Medicine (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; CHAMSON A, 1989, ARCH DERMATOL RES, V281, P267, DOI 10.1007/BF00431061; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021; FLEISCHMAJER R, 1993, J HISTOCHEM CYTOCHEM, V41, P1359, DOI 10.1177/41.9.7689083; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; OJAKIAN GK, 1994, J CELL SCI, V107, P561; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	46	59	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53024	10.1371/journal.pone.0053024	http://dx.doi.org/10.1371/journal.pone.0053024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300850	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600048
J	Renner, SC; Baur, S; Possler, A; Winkler, J; Kalko, EKV; Bates, PJJ; Mello, MAR				Renner, Swen C.; Baur, Sofia; Possler, Astrid; Winkler, Julia; Kalko, Elisabeth K. V.; Bates, Paul J. J.; Mello, Marco A. R.			Food Preferences of Winter Bird Communities in Different Forest Types	PLOS ONE			English	Article							HABITAT QUALITY; FORAGING BEHAVIOR; BREEDING HABITAT; WEIGHT CYCLE; LIDAR; RISK; TEMPERATURE; PREDATION; ABUNDANCE; FITNESS	Food availability for forest birds is a function of habitat type, forest management regime, and season. In winter, it is also impacted by variations in the weather. In the current study we assessed the food preferences of wild bird populations in two types of forest (spruce and beech) during the months of November 2010 to April 2011 in the Schwabische Alb Biodiversity Exploratory, south-western Germany. Our aim was to investigate whether local bird communities preferred fat-rich, carbohydrate-rich or wild fruits and to determine how forest structure, seasonality and local weather conditions affected food preferences. We found higher bird activity in beech forests for the eleven resident species. We observed a clear preference for fat-rich food for all birds in both forest types. Snow cover affected activity at food stations but did not affect food preferences. Periods of extreme low temperatures increased activity.	[Renner, Swen C.; Baur, Sofia; Possler, Astrid; Winkler, Julia; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Bates, Paul J. J.] Harrison Inst, Sevenoaks, Kent, England; [Mello, Marco A. R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol, Belo Horizonte, MG, Brazil	Ulm University; Universidade Federal de Minas Gerais	Renner, SC (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	swen.renner@uni-ulm.de	Bates, Paul/HDO-0192-2022; Mello, Marco A. R./B-1095-2008	Mello, Marco A. R./0000-0002-9098-9427; /0000-0002-6893-4219	DFG Priority Program [1374]	DFG Priority Program(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; [Anonymous], 2010, R LANG ENV STAT COMP; Antczak M, 2010, ORNIS FENNICA, V87, P99; Barboza PS, 2009, INTEGRATIVE WILDLIFE, P209; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brotons L, 1997, ARDEA, V85, P249; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Diggs NE, 2011, CONDOR, V113, P646, DOI 10.1525/cond.2011.090201; Doligez B, 2008, ECOLOGY, V89, P1436, DOI 10.1890/07-0113.1; ELGAR MA, 1986, BEHAV ECOL SOCIOBIOL, V19, P433, DOI 10.1007/BF00300546; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Glutz von Blotzheim U. N., 1988, HDB VOGEL MITTELEURO, V11; Glutz von Blotzheim U. N., 1997, HDB VOGEL MITTELEURO, V14, P2; Glutz von Blotzheim U. N., 1993, HDB VOGEL MITTELEURO, V13/I; Glutz Von Blotzheim U.N., 1980, HDB VOGEL MITTELEURO, V9; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; GRODZINSKI W, 1970, OIKOS, V21, P52, DOI 10.2307/3543838; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; HAFTORN S, 1992, ORNIS SCAND, V23, P435, DOI 10.2307/3676674; Hewson CM, 2011, FOREST ECOL MANAG, V261, P1224, DOI 10.1016/j.foreco.2011.01.001; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; Hinsley SA, 1999, J AVIAN BIOL, V30, P271, DOI 10.2307/3677353; Hinsley SA, 2002, FUNCT ECOL, V16, P851, DOI 10.1046/j.1365-2435.2002.00697.x; Holzinger J., 1997, VOGEL BADEN WURTTEMB; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Kohler A, 2010, FUNCT ECOL, V24, P1241, DOI 10.1111/j.1365-2435.2010.01728.x; Lahti K, 1998, ECOLOGY, V79, P2904, DOI 10.1890/0012-9658(1998)079[2904:TAFDIW]2.0.CO;2; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; LEHIKOINEN E, 1987, ORNIS SCAND, V18, P216, DOI 10.2307/3676769; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; LWF Bayern, 2004, VOG STAATSW WAS STEC; MACCARONE AD, 1987, WILSON BULL, V99, P94; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Muller J, 2009, BASIC APPL ECOL, V10, P671, DOI 10.1016/j.baae.2009.03.004; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Nakamura M, 2001, ECOL RES, V16, P301, DOI 10.1046/j.1440-1703.2001.00397.x; Nikolov SC, 2009, FOREST ECOL MANAG, V257, P580, DOI 10.1016/j.foreco.2008.09.030; Nutrition values, 2012, NAHRW ERN; Renner SC, 2006, BIODIVERS CONSERV, V15, P1545, DOI 10.1007/s10531-005-2930-6; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; ROGERS CM, 1990, ORNIS SCAND, V21, P105, DOI 10.2307/3676805; Sjoberg K, 2000, ECOLOGY, V81, P329, DOI 10.2307/177430; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; Turcotte Y, 2005, ECOGRAPHY, V28, P129, DOI 10.1111/j.0906-7590.2005.04047.x; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Wells K, 2011, BASIC APPL ECOL, V12, P97, DOI 10.1016/j.baae.2011.01.002	52	20	23	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53121	10.1371/journal.pone.0053121	http://dx.doi.org/10.1371/journal.pone.0053121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300878	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600062
J	Sawiak, SJ; Wood, NI; Carpenter, TA; Morton, AJ				Sawiak, Stephen J.; Wood, Nigel I.; Carpenter, T. Adrian; Morton, A. Jennifer			Huntington's Disease Mouse Models Online: High-Resolution MRI Images with Stereotaxic Templates for Computational Neuroanatomy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EXPANDED CAG REPEAT; MUTANT HUNTINGTIN; TRANSGENIC MOUSE; MATTER ATROPHY; EARLY MOTOR; MICE; LENGTH; MUTATION; BRAIN	Magnetic resonance imaging (MRI) has proved to be an ideal modality for non-destructive and highly detailed assessment of structural morphology in biological tissues. Here we used MRI to make a dataset of ex vivo brains from two different rodent models of Huntington's disease (HD), the R6/2 line and the YAC 128 mouse. We are making the whole dataset (399 transgenic HD and wildtype (WT) brains, from mice aged 9-80 weeks) publicly available. These data will be useful, not only to investigators interested in the study of HD, but also to researchers of computational neuroanatomy who may not have access to such large datasets from mouse models. Here we demonstrate a number of uses of such data, for example to produce maps of grey and white matter and cortical thickness. As an example of how the library might provide insights in mouse models of HD, we calculated whole brain grey matter volumes across different age groups with different numbers of cytosine-adenine-guanine (CAG) repeats in a fragment of the gene responsible for HD in humans. (The R6/2 dataset was obtained from an allelic series of R6/2 mice carrying a range of CAG repeat lengths between 109 and 464.) This analysis revealed different trajectories for each fragment length. In particular there was a gradient of decreasing pathology with longer CAG repeat lengths, reflecting our previous findings with behavioural and histological studies. There will be no constraints placed on the use of the datasets included here. The original data will be easily and permanently accessible via the University of Cambridge data repository (http://www.dspace.cam.ac.uk/handle/1810/243361).	[Sawiak, Stephen J.; Carpenter, T. Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Sawiak, Stephen J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Wood, Nigel I.; Morton, A. Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge; University of Cambridge; University of Cambridge	Sawiak, SJ (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England.	sjs80@wbic.cam.ac.uk	Sawiak, Stephen J/I-8944-2012; Morton, Jenny/AAT-8642-2020	Sawiak, Stephen J/0000-0003-4210-9816; Morton, Jenny/0000-0003-0181-6346	CHDI, Inc.	CHDI, Inc.	This study was supported by a grant from CHDI, Inc. to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Carroll JB, 2011, NEUROBIOL DIS, V43, P257, DOI 10.1016/j.nbd.2011.03.018; Carter RJ, 1999, J NEUROSCI, V19, P3248; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Glynn D, 2007, NEUROBIOL DIS, V25, P483, DOI 10.1016/j.nbd.2006.10.011; Gomez-Anson B, 2009, PARKINSONISM RELAT D, V15, P213, DOI 10.1016/j.parkreldis.2008.05.010; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hobbs NZ, 2010, J NEUROL NEUROSUR PS, V81, P756, DOI 10.1136/jnnp.2009.190702; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Jech R, 2007, MOVEMENT DISORD, V22, P1783, DOI 10.1002/mds.21620; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kielar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032636; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; OLIVA D, 1993, ARCH NEUROL-CHICAGO, V50, P17, DOI 10.1001/archneur.1993.00540010013010; Paxinos G, 2004, MOUSE BRAIN STEREOTA, V1; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Shan ZYY, 2006, LECT NOTES COMPUT SC, V4191, P332; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tang B, 2011, NEUROBIOL DIS, V42, P459, DOI 10.1016/j.nbd.2011.02.008; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1	41	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53361	10.1371/journal.pone.0053361	http://dx.doi.org/10.1371/journal.pone.0053361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300918	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600089
J	Yasuda, T; Loenneke, JP; Thiebaud, RS; Abe, T				Yasuda, Tomohiro; Loenneke, Jeremy P.; Thiebaud, Robert S.; Abe, Takashi			Effects of Blood Flow Restricted Low-Intensity Concentric or Eccentric Training on Muscle Size and Strength	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; HORMONAL RESPONSES; CONTRACTIONS; EXERCISE; ACTIVATION; HYDRATION; HYPERTROPHY; GLUCOSE	We investigated the acute and chronic effects of low-intensity concentric or eccentric resistance training with blood flow restriction (BFR) on muscle size and strength. Ten young men performed 30% of concentric one repetition maximal dumbbell curl exercise (four sets, total 75 reps) 3 days/week for 6 weeks. One arm was randomly chosen for concentric BFR (CON-BFR) exercise only and the other arm performed eccentric BFR (ECC-BFR) exercise only at the same exercise load. During the exercise session, iEMG for biceps brachii muscles increased progressively during CON-BFR, which was greater (p<0.05) than that of the ECC-BFR. Immediately after the exercise, muscle thickness (MTH) of the elbow flexors acutely increased (p<0.01) with both CON-BFR and ECC-BFR, but was greater with CON-BFR (11.7%) (p<0.01) than ECC-BFR (3.9%) at 10-cm above the elbow joint. Following 6-weeks of training, MRI-measured muscle cross-sectional area (CSA) at 10-cm position and mid-upper arm (12.0% and 10.6%, respectively) as well as muscle volume (12.5%) of the elbow flexors were increased (p<0.01) with CON-BFR. Increases in muscle CSA and volume were lower in ECC-BFR (5.1%, 0.8% and 2.9%, respectively) than in the CON-BFR and only muscle CSA at 10-cm position increased significantly (p<0.05) after the training. Maximal voluntary isometric strength of elbow flexors was increased (p<0.05) in CON-BFR (8.6%), but not in ECC (3.8%). These results suggest that CON-BFR training leads to pronounced acute changes in muscle size, an index of muscle cell swelling, the response to which may be an important factor for promoting muscle hypertrophy with BFR resistance training.	[Yasuda, Tomohiro] Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan; [Loenneke, Jeremy P.; Thiebaud, Robert S.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA; [Abe, Takashi] Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, Oxford, MS USA	University of Tokyo; University of Oklahoma System; University of Oklahoma - Norman; University of Mississippi	Yasuda, T (corresponding author), Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan.	yasuda-tomohiro@umin.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology [23700713]	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by Grant-in-aid (#23700713 to TY) from the Japan Ministry of Education, Culture, Sports, Science, and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 2005, INT J KAATSU TRAIN R, V1, P6, DOI [DOI 10.3806/IJKTR.1.6, 10.3806/ijktr.1.6]; Abe T, 2012, CLIN PHYSIOL FUNCT I, V32, P247, DOI 10.1111/j.1475-097X.2012.01126.x; Berneis K, 1999, AM J PHYSIOL-ENDOC M, V276, pE188, DOI 10.1152/ajpendo.1999.276.1.E188; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J.E., 1988, STAT POWER ANAL BEHA; DALTON PA, 1991, EUR J APPL PHYSIOL O, V63, P412, DOI 10.1007/BF00868071; Durand RJ, 2003, MED SCI SPORT EXER, V35, P937, DOI 10.1249/01.MSS.0000069522.38141.0B; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farthing JP, 2003, EUR J APPL PHYSIOL, V89, P578, DOI 10.1007/s00421-003-0842-2; Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Grant ACG, 2000, BBA-GEN SUBJECTS, V1475, P39, DOI 10.1016/S0304-4165(00)00045-3; Gundermann DM, 2012, J APPL PHYSIOL, V112, P1520, DOI 10.1152/japplphysiol.01267.2011; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173, DOI 10.1152/jappl.1996.81.5.2173; Karabulut M, 2010, EUR J APPL PHYSIOL, V108, P147, DOI 10.1007/s00421-009-1204-5; Keller U, 2003, EUR J CLIN NUTR, V57, pS69, DOI 10.1038/sj.ejcn.1601904; Kraemer RR, 2006, EUR J APPL PHYSIOL, V96, P551, DOI 10.1007/s00421-005-0094-4; Loenneke JP, 2012, MED HYPOTHESES, V78, P151, DOI 10.1016/j.mehy.2011.10.014; Loenneke JP, 2010, INT J SPORTS MED, V31, P1, DOI 10.1055/s-0029-1239499; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P2903, DOI 10.1007/s00421-011-2266-8; Manini TM, 2011, ACTA PHYSIOL, V201, P255, DOI 10.1111/j.1748-1716.2010.02172.x; Manini TM, 2009, EXERC SPORT SCI REV, V37, P78, DOI 10.1097/JES.0b013e31819c2e5c; Millar ID, 1997, BIOCHEM BIOPH RES CO, V230, P351, DOI 10.1006/bbrc.1996.5959; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179, DOI 10.1152/jappl.1986.60.4.1179; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Ogawa M., 2012, J PHYS ED SPORTS MAN, V3, P14; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Seger JY, 1988, EUR J APPL PHYSL OCC, V79, P49; Takarada Y, 2000, J APPL PHYSIOL, V88, P2097, DOI 10.1152/jappl.2000.88.6.2097; Umbel JD, 2009, EUR J APPL PHYSIOL, V107, P687, DOI 10.1007/s00421-009-1175-6; Yasuda T, 2012, SCAND J MED IN PRESS; Yasuda T, 2011, EUR J APPL PHYSIOL, V111, P2525, DOI 10.1007/s00421-011-1873-8; Yasuda T, 2010, METABOLISM, V59, P1510, DOI 10.1016/j.metabol.2010.01.016; Yasuda T, 2010, CLIN PHYSIOL FUNCT I, V30, P338, DOI 10.1111/j.1475-097X.2010.00949.x; Yasuda T, 2008, J SPORT SCI MED, V7, P467; Yasuda T, 2009, J SPORT SCI, V27, P479, DOI 10.1080/02640410802626567	38	110	112	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52843	10.1371/journal.pone.0052843	http://dx.doi.org/10.1371/journal.pone.0052843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300795	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600029
J	Castellino, FJ; Liang, Z; Davis, PK; Balsara, RD; Musunuru, H; Donahue, DL; Smith, DL; Sandoval-Cooper, MJ; Ploplis, VA; Walsh, M				Castellino, Francis J.; Liang, Zhong; Davis, Patrick K.; Balsara, Rashna D.; Musunuru, Harsha; Donahue, Deborah L.; Smith, Denise L.; Sandoval-Cooper, Mayra J.; Ploplis, Victoria A.; Walsh, Mark			Abnormal Whole Blood Thrombi in Humans with Inherited Platelet Receptor Defects	PLOS ONE			English	Article							GLYCOPROTEIN-IB-ALPHA; BERNARD-SOULIER-SYNDROME; CARDIOPULMONARY BYPASS; DINUCLEOTIDE DELETION; POLYMORPHISM; AGGREGATION; ACTIVATION; COLLAGEN; DOMAIN; THROMBELASTOGRAPHY	To delineate the critical features of platelets required for formation and stability of thrombi, thromboelastography and platelet aggregation measurements were employed on whole blood of normal patients and of those with Bernard-Soulier Syndrome (BSS) and Glanzmann's Thrombasthenia (GT). We found that separation of platelet activation, as assessed by platelet aggregation, from that needed to form viscoelastic stable whole blood thrombi, occurred. In normal human blood, ristocetin and collagen aggregated platelets, but did not induce strong viscoelastic thrombi. However, ADP, arachidonic acid, thrombin, and protease-activated-receptor-1 and -4 agonists, stimulated both processes. During this study, we identified the genetic basis of a very rare double heterozygous GP1b deficiency in a BSS patient, along with a new homozygous GP1b inactivating mutation in another BSS patient. In BSS whole blood, ADP responsiveness, as measured by thrombus strength, was diminished, while ADP-induced platelet aggregation was normal. Further, the platelets of 3 additional GT patients showed very weak whole blood platelet aggregation toward the above agonists and provided whole blood thrombi of very low viscoelastic strength. These results indicate that measurements of platelet counts and platelet aggregability do not necessarily correlate with generation of stable thrombi, a potentially significant feature in patient clinical outcomes.	[Castellino, Francis J.; Liang, Zhong; Davis, Patrick K.; Balsara, Rashna D.; Musunuru, Harsha; Donahue, Deborah L.; Smith, Denise L.; Sandoval-Cooper, Mayra J.; Ploplis, Victoria A.; Walsh, Mark] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Walsh, Mark] Mem Hosp S Bend, Dept Emergency Med, South Bend, IN USA	University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Walsh, Mark/0000-0002-5795-1144	Memorial Hospital of South Bend	Memorial Hospital of South Bend	This work was supported by a grant from Memorial Hospital of South Bend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfsharKharghan V, 1997, BLOOD, V90, P2634, DOI 10.1182/blood.V90.7.2634.2634_2634_2643; Ballotta A, 2007, J THORAC CARDIOV SUR, V134, P132, DOI 10.1016/j.jtcvs.2007.01.055; Basani RB, 1999, METH MOLEC MED, V31, P313, DOI 10.1385/1-59259-248-1:313; Basani RB, 1996, BLOOD, V88, P167; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Bunescu A, 2002, CLIN SCI, V102, P279, DOI 10.1042/CS20010118; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cammerer U, 2003, ANESTH ANALG, V96, P51, DOI 10.1097/00000539-200301000-00011; CARR ME, 1986, BIOCHEM J, V239, P513, DOI 10.1042/bj2390513; Castellino FJ, 2011, BLOOD, V117, P283, DOI 10.1182/blood-2010-07-299057; Cheng H, 2009, AM J PHYSIOL-HEART C, V297, pH2128, DOI 10.1152/ajpheart.00107.2009; Davis PK, 2012, NEUROCRIT CARE; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Ezumi Y, 2000, BIOCHEM BIOPH RES CO, V277, P27, DOI 10.1006/bbrc.2000.3624; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; JENKINS CSP, 1976, J CLIN INVEST, V57, P112, DOI 10.1172/JCI108251; Johansson PI, 2012, CURR OPIN ANESTHESIO, V25, P235, DOI 10.1097/ACO.0b013e32834fab76; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kaski S, 1996, IMMUNOGENETICS, V44, P170, DOI 10.1007/s002510050108; Kenny D, 1997, BLOOD, V90, P2626, DOI 10.1182/blood.V90.7.2626.2626_2626_2633; Kenny D, 1998, BLOOD, V92, P175, DOI 10.1182/blood.V92.1.175.413a36_175_183; KUIJPERS RWAM, 1992, J CLIN INVEST, V89, P381, DOI 10.1172/JCI115596; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Maquelin KN, 1998, J THORAC CARDIOV SUR, V115, P1160, DOI 10.1016/S0022-5223(98)70416-7; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Preisman S, 2010, EUR J CARDIO-THORAC, V37, P1367, DOI 10.1016/j.ejcts.2009.12.044; RINDER CS, 1994, J THORAC CARDIOV SUR, V107, P280; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; SUGIYAMA T, 1987, BLOOD, V69, P1712; Walsh Mark, 2011, J Extra Corpor Technol, V43, P162; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wolberg AS, 2005, BRIT J HAEMATOL, V131, P645, DOI 10.1111/j.1365-2141.2005.05820.x; Wolberg AS, 2003, BLOOD, V101, P3008, DOI 10.1182/blood-2002-08-2527	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52878	10.1371/journal.pone.0052878	http://dx.doi.org/10.1371/journal.pone.0052878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300803	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500076
J	Gawthorne, JA; Reddick, LE; Akpunarlieva, SN; Beckham, KSH; Christie, JM; Alto, NM; Gabrielsen, M; Roe, AJ				Gawthorne, Jayde A.; Reddick, L. Evan; Akpunarlieva, Snezhana N.; Beckham, Katherine S. H.; Christie, John M.; Alto, Neal M.; Gabrielsen, Mads; Roe, Andrew J.			Express Your LOV: An Engineered Flavoprotein as a Reporter for Protein Expression and Purification	PLOS ONE			English	Article							INNER MEMBRANE-PROTEINS; ESCHERICHIA-COLI; CRYSTALLIZATION; OVEREXPRESSION; OPTIMIZATION; ILOV; GFP	In this work, we describe the utility of Light, Oxygen, or Voltage-sensing (LOV) flavoprotein domains from plant phototropins as a reporter for protein expression and function. Specifically, we used iLOV, an enhanced and more photostable variant of LOV. A pET-based plasmid for protein expression was constructed, encoding a C terminal iLOV-octahistidine (His8)-tag and a HRV 3C protease cleavage recognition site. Ten different proteins, with various sub-cellular locations, were cloned into the plasmid, creating iLOV-His8 tag fusions. To test protein expression and how iLOV could be used as a reporter, the proteins were expressed in three different cell lines, in four different culture media, at two different temperatures. To establish whether the presence of the iLOV tag could have an impact on the functionality, one of the proteins, EspG, was over-expressed and purified. EspG is an "effector" protein normally produced by enterohemorrhagic E. coli strains and "injected" into host cells via the T3SS. We tested functionality of EspG-iLOV fusion by performing functional studies of EspG in mammalian host cells. When EspG-iLOV was microinjected into the host cell, the Golgi apparatus was completely disrupted as had previously been observed for EspG.	[Gabrielsen, Mads] Beatson Inst, Glasgow, Lanark, Scotland; [Christie, John M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gawthorne, Jayde A.; Akpunarlieva, Snezhana N.; Beckham, Katherine S. H.; Roe, Andrew J.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Reddick, L. Evan; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Mol Microbiol, Dallas, TX 75390 USA	Beatson Institute; University of Glasgow; University of Glasgow; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gabrielsen, M (corresponding author), Beatson Inst, Glasgow, Lanark, Scotland.	mgabr@chem.gla.ac.uk; Andrew.Roe@Glasgow.ac.uk		Beckham, Kate/0000-0002-4929-6119; Gabrielsen, Mads/0000-0002-9848-2276; Christie, John/0000-0002-9976-0055; roe, andrew/0000-0003-3698-6134	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G011389/1, BB/H023518/1]; Biotechnology and Biological Sciences Research Council [BB/G011389/1, BB/H023518/1] Funding Source: researchfish; BBSRC [BB/H023518/1, BB/G011389/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to AJR and MG (BB/G011389/1) and a BBSRC Tools and Development Fund (BB/H023518/1) to AJR and JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Dortay H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018900; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Gabrielsen M, 2011, MOL MEMBR BIOL, V28, P445, DOI 10.3109/09687688.2011.628954; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; McLuskey K, 2008, MOL MEMBR BIOL, V25, P599, DOI 10.1080/09687680802510289; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Reddick LE, 2012, JOVE-J VIS EXP, DOI 10.3791/3650; Selyunin Andrey S, 2011, Small GTPases, V2, P217; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vizcaino-Caston I, 2012, BIOTECHNOL LETT, V34, P175, DOI 10.1007/s10529-011-0767-5	22	22	22	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52962	10.1371/journal.pone.0052962	http://dx.doi.org/10.1371/journal.pone.0052962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300834	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000312829100105
J	Pan, QC; Ali, F; Yang, XH; Li, JS; Yan, JB				Pan, Qingchun; Ali, Farhan; Yang, Xiaohong; Li, Jiansheng; Yan, Jianbing			Exploring the Genetic Characteristics of Two Recombinant Inbred Line Populations via High-Density SNP Markers in Maize	PLOS ONE			English	Article							SEGREGATION DISTORTION; CONFIDENCE-INTERVALS; MOLECULAR MARKERS; LOCI; DIVERSITY; QTL; MAP	Understanding genetic characteristics can reveal the genetic diversity in maize and be used to explore evolutionary mechanisms and gene cloning. A high-density linkage map was constructed to determine recombination rates (RRs), segregation distortion regions (SDRs), and recombinant blocks (RBs) in two recombinant inbred line populations (RILs) (B73/By804 and Zong3/87-1) generated by the single seed descent method. Population B73/By804 containing 174 lines were genotyped with 198 simple sequence repeats (SSRs) markers while population Zong3/87-1 comprised of 175 lines, were genotyped with 210 SSR markers along with 1536 single nucleotide polymorphism (SNP) markers for each population, spanning 1526.7 cM and 1996.2 cM in the B73/By804 and Zong3/87-1 populations, respectively. The total variance of the RR in the whole genome was nearly 100 fold, and the maximum average was 10.43-11.50 cM/Mb while the minimum was 0.08-0.10 cM/Mb in the two populations. The average number of RB was 44 and 37 in the Zong3/87-1 and B73/By804 populations, respectively, whereas 28 SDRs were observed in both populations. We investigated 11 traits in Zong3/87-1 and 10 traits in B73/By804. Quantitative trait locus (QTLs) mapping of SNP+SSR with SNP and SSR marker sets were compared to showed the impact of different density markers on QTL mapping and resolution. The confidence interval of QTL Pa19 (FatB gene controlling palmitic acid content) was reduced from 3.5 Mb to 1.72 Mb, and the QTL Oil6 (DGAT1-2 gene controlling oil concentration) was significantly reduced from 10.8 Mb to 1.62 Mb. Thus, the use of high-density markers considerably improved QTL mapping resolution. The genetic information resulting from this study will support forthcoming efforts to understand recombination events, SDRs, and variations among different germplasm. Furthermore, this study will facilitate gene cloning and understanding of the fundamental sources of total variation and RR in maize, which is the most widely cultivated cereal crop.	[Ali, Farhan; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Pan, Qingchun; Yang, Xiaohong; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Ali, Farhan] Cereal Crops Res Inst CCRI Nowshera, Kyber Pukhtunkhwa, Pakistan	Huazhong Agricultural University; China Agricultural University	Yan, JB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yjianbing@mail.hzau.edu.cn	Ali, Farhan/AAA-6193-2019	Ali, Farhan/0000-0003-4519-7903	National Hi-Tech Research and Development Program of China [2012AA10A307]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Hi-Tech Research and Development Program of China (2012AA10A307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2006, GENOME RES, V16, P115, DOI [10.1101/gr.4249906, 10.1101/gr4249906]; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Bennewitz J, 2002, GENETICS, V160, P1673; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Davis GL, 1999, GENETICS, V152, P1137; Esch E, 2007, GENETICS, V177, P1851, DOI 10.1534/genetics.107.080622; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HENDERSON CR, 1984, J DAIRY SCI, V67, P1581, DOI 10.3168/jds.S0022-0302(84)81480-0; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lawrence CJ, 2007, PLANT CELL, V19, P2091, DOI 10.1105/tpc.107.053660; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024699; Li Lin, 2009, Scientia Agricultura Sinica, V42, P2262; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Liu XianJun, 2011, Journal of Agricultural Science (Toronto), V3, P172; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Visscher PM, 1996, GENETICS, V143, P1013; Wang G, 2012, GENET MOL RES, V11, P693, DOI 10.4238/2012.March.19.3; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yan Jian-Bing, 2003, Acta Genetica Sinica, V30, P913; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Zak M, 2007, GENETICS, V176, P1845, DOI 10.1534/genetics.106.068031; Zhang H, 2011, THEOR APPL GENET, V124, P459; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	44	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52777	10.1371/journal.pone.0052777	http://dx.doi.org/10.1371/journal.pone.0052777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300772	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100079
J	Chandiramani, M; Seed, PT; Orsi, NM; Ekbote, UV; Bennett, PR; Shennan, AH; Tribe, RM				Chandiramani, Manju; Seed, Paul T.; Orsi, Nicolas M.; Ekbote, Uma V.; Bennett, Phillip R.; Shennan, Andrew H.; Tribe, Rachel M.			Limited Relationship between Cervico-Vaginal Fluid Cytokine Profiles and Cervical Shortening in Women at High Risk of Spontaneous Preterm Birth	PLOS ONE			English	Article							SONOGRAPHIC SHORT CERVIX; HISTOLOGIC CHORIOAMNIONITIS; INTRAAMNIOTIC INFECTION; PREMATURE LABOR; CERCLAGE; PROGESTERONE; PREGNANCY; DELIVERY; PATIENT; FETAL	Objective: To determine the relationship between high vaginal pro-inflammatory cytokines and cervical shortening in women at high risk of spontaneous preterm labor and to assess the influence of cervical cerclage and vaginal progesterone on this relationship. Methods: This prospective longitudinal observational study assessed 112 women with at least one previous preterm delivery between 16 and 34 weeks' gestation. Transvaginal cervical length was measured and cervico-vaginal fluid sampled every two weeks until 28 weeks. If the cervix shortened (, 25 mm) before 24 weeks' gestation, women (cases) were randomly assigned to cerclage or progesterone and sampled weekly. Cytokine concentrations were measured in a subset of cervico-vaginal fluid samples (n = 477 from 78 women) by 11-plex fluid-phase immunoassay. Results: All 11 inflammatory cytokines investigated were detected in cervico-vaginal fluid from women at high risk of preterm birth, irrespective of later cervical shortening. At less than 24 weeks' gestation and prior to intervention, women destined to develop a short cervix (n = 36) exhibited higher cervico-vaginal concentrations than controls (n = 42) of granulocyte-macrophage colony-stimulating factor [(GM-CSF) 16.2 fold increase, confidence interval (CI) 1.8-147; p = 0.01] and monocyte chemotactic protein-1 [(MCP-1) 4.8, CI 1.0-23.0; p = 0.05]. Other cytokines were similar between cases and controls. Progesterone treatment did not suppress cytokine concentrations. Interleukin (IL)-6, IL-8, granulocyte colony-stimulating factor (G-CSF), interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha concentrations were higher following randomization to cerclage versus progesterone (p, 0.05). Cerclage, but not progesterone treatment, was followed by a significant increase in cervical length [mean 11.4 mm, CI 5.0-17.7; p<0.001]. Conclusions: Although GM-CSF and MCP-1 cervico-vaginal fluid concentrations were raised, the majority of cervico-vaginal cytokines did not increase in association with cervical shortening. Progesterone treatment showed no significant anti-inflammation action on cytokine concentrations. Cerclage insertion was associated with an increase in the majority of inflammatory markers and cervical length.	[Chandiramani, Manju; Seed, Paul T.; Shennan, Andrew H.; Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Chandiramani, Manju; Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Orsi, Nicolas M.; Ekbote, Uma V.] St James Univ Hosp, Inst Mol Med, Gynaeimmunol & Oncol Grp, YCR & Liz Dawn Pathol & Translat Sci Ctr, Leeds, W Yorkshire, England	University of London; King's College London; Imperial College London; Saint James's University Hospital; University of Leeds	Chandiramani, M (corresponding author), Kings Coll London, Div Womens Hlth, London WC2R 2LS, England.	m.chandiramani@imperial.ac.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Orsi, Nicolas/0000-0003-0890-0399; Tribe, Rachel/0000-0003-3675-9978; Bennett, Phillip/0000-0002-6253-4919; Shennan, Andrew/0000-0001-5273-3132	Action Medical Research [SP4113]; National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's; St Thomas' NHS Foundation Trust; King's College London	Action Medical Research; National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London	Research was supported by a grant from Action Medical Research (SP4113) and the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Berghella V, 2003, CLIN OBSTET GYNECOL, V46, P947, DOI 10.1097/00003081-200312000-00026; Berghella V, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.019; Curry AE, 2008, J REPROD IMMUNOL, V77, P152, DOI 10.1016/j.jri.2007.06.051; Dodd JM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub2; Elovitz MA, 2008, J MATERN-FETAL NEO M, V21, P223, DOI 10.1080/14767050801923680; Esplin MS, 2005, J MATERN-FETAL NEO M, V17, P365, DOI 10.1080/14767050500141329; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; GOMEZ R, 1995, CLIN PERINATOL, V22, P281; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; GREIG PC, 1993, AM J OBSTET GYNECOL, V169, P1035, DOI 10.1016/0002-9378(93)90050-S; Hassan S, 2006, J PERINAT MED, V34, P13, DOI 10.1515/JPM.2006.002; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; HILLIER SL, 1993, OBSTET GYNECOL, V81, P941; Kalan AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.013; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kindt TJ, 2007, KUBY IMMUNOLOGY, P302; MACNAUGHTON MC, 1993, BRIT J OBSTET GYNAEC, V100, P516; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; March of Dimes, 2011, MARCH OF DIMES WELCO; March of Dimes, 2009, WHITE PAPER ON PRETE; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Menon R, 2008, AM J OBSTET GYNECOL, V198; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Rafael TJ, 2011, AM J PERINAT, V28, P389, DOI 10.1055/s-0031-1272967; Romero R, 2006, AM J OBSTET GYNECOL, V194, P1, DOI 10.1016/j.ajog.2005.12.002; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; ROMERO R, 2004, PRETERM BIRTH, P28; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Ryckman KK, 2009, J REPROD IMMUNOL, V79, P174, DOI 10.1016/j.jri.2008.11.003; Sakai M, 2006, AM J OBSTET GYNECOL, V194, P14, DOI 10.1016/j.ajog.2005.06.014; Simcox R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.03.010; Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P560, DOI 10.1067/S0002-9378(03)00518-0; Simhan HN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.038; To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Yoon BH, 1998, AM J OBSTET GYNECOL, V179, P1254, DOI 10.1016/S0002-9378(98)70142-5	39	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52412	10.1371/journal.pone.0052412	http://dx.doi.org/10.1371/journal.pone.0052412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300664	Green Published, gold			2022-12-27	WOS:000313618800083
J	Dobrovolska, O; Shumilina, E; Gladyshev, VN; Dikiy, A				Dobrovolska, Olena; Shumilina, Elena; Gladyshev, Vadim N.; Dikiy, Alexander			Structural Analysis of Glutaredoxin Domain of Mus musculus Thioredoxin Glutathione Reductase	PLOS ONE			English	Article							CATALYTIC MECHANISM; TARGETING SEQUENCES; ESCHERICHIA-COLI; CDNA CLONING; RAT-LIVER; SELENOCYSTEINE; SELENOPROTEIN; PURIFICATION; EXPRESSION; PROTEINS	Thioredoxin glutathione reductase (TGR) is a member of the mammalian thioredoxin reductase family that has a monothiol glutaredoxin (Grx) domain attached to the thioredoxin reductase module. Here, we report a structure of the Grx domain of mouse TGR, determined through high resolution NMR spectroscopy to the final backbone RMSD value of 0.48 +/- 0.10 angstrom. The structure represents a sandwich-like molecule composed of a four stranded beta-sheet flanked by five alpha-helixes, with the CxxS active motif located on the catalytic loop. We structurally characterized the glutathione-binding site in the protein and describe sequence and structural relationships of the domain with glutaredoxins. The structure illuminates a key functional center that evolved in mammalian TGRs to act in thiol-disulfide reactions. Our study allows us to hypothesize that Cys105 might be functionally relevant for TGR catalysis. In addition, the data suggest that the N-terminus of Grx acts as a possible regulatory signal also protecting the protein active site from unwanted interactions in cellular cytosol.	[Dobrovolska, Olena; Shumilina, Elena; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	Norwegian University of Science & Technology (NTNU); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; Shumilina, Elena/AFJ-4014-2022; Shumilina, Elena/AAF-4604-2022	Shumilina, Elena/0000-0002-6798-2374; Shumilina, Elena/0000-0002-6798-2374; Gladyshev, Vadim/0000-0002-0372-7016; Dobrovolska, Olena/0000-0002-0881-4960	NT Faculty, NTNU; United States National Institutes of Health [GM065204]; BioStruct; Norwegian national graduate school in Structural biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	NT Faculty, NTNU; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioStruct; Norwegian national graduate school in Structural biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AD acknowledges the support from NT Faculty, NTNU. ES acknowledges the NT Faculty, NTNU, for financial support through a post-doctoral fellowship. OD acknowledges the NT Faculty, NTNU, for financial support through PhD fellowship. This work was also supported by United States National Institutes of Health GM065204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge support from BioStruct, the Norwegian national graduate school in Structural biology.	Aachmann FL, 2010, J BIOL CHEM, V285, P33315, DOI 10.1074/jbc.M110.132308; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; Aslund F, 1996, J BIOL CHEM, V271, P6736, DOI 10.1074/jbc.271.12.6736; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gasdaska PY, 1999, FEBS LETT, V442, P105, DOI 10.1016/S0014-5793(98)01638-X; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Ge Y, 2009, INT J BIOCHEM CELL B, V41, P900, DOI 10.1016/j.biocel.2008.08.032; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Goncharuk SA, 2011, ACTA NATURAE, V3, P77, DOI 10.32607/20758251-2011-3-3-77-84; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang HH, 2011, BIOCHEMISTRY-US, V50, P5870, DOI 10.1021/bi200107n; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krueger-Koplin RD, 2004, J BIOMOL NMR, V28, P43, DOI 10.1023/B:JNMR.0000012875.80898.8f; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Miranda-Vizuete A, 1999, BBA-GENE STRUCT EXPR, V1447, P113, DOI 10.1016/S0167-4781(99)00129-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Shumilina E, 2012, BIOMOL NMR ASSIGN, V6, P103, DOI 10.1007/s12104-011-9335-0; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Sutovsky P, 1997, MOL REPROD DEV, V47, P79, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;79::AID-MRD11&gt;3.0.CO;2-V; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Watabe S, 1999, EUR J BIOCHEM, V264, P74, DOI 10.1046/j.1432-1327.1999.00578.x; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52914	10.1371/journal.pone.0052914	http://dx.doi.org/10.1371/journal.pone.0052914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300818	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800161
J	Ibison, F; Olotu, A; Muema, DM; Mwacharo, J; Ohuma, E; Kimani, D; Marsh, K; Bejon, P; Ndungu, FM				Ibison, Frances; Olotu, Ally; Muema, Daniel M.; Mwacharo, Jedida; Ohuma, Eric; Kimani, Domtila; Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.			Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; CLINICAL MALARIA; MICE; TRANSMISSION; INFECTION; CHABAUDI; PERSISTENCE; MECHANISMS; PROTECTION; PATTERNS	Background: Although antibodies are critical for immunity to malaria, their functional attributes that determine protection remain unclear. We tested for associations between antibody avidities to Plasmodium falciparum (Pf) antigens and age, asymptomatic parasitaemia, malaria exposure index (a distance weighted local malaria prevalence) and immunity to febrile malaria during 10-months of prospective follow up. Methods: Cross-sectional antibody levels and avidities to Apical Membrane Antigen 1 (AMA1), Merozoite Surface Protein 142 (MSP1) and Merozoite Surface Protein 3 (MSP3) were measured by Enzyme Linked Immunosorbent Assay in 275 children, who had experienced at least one episode of clinical malaria by the time of this study, as determined by active weekly surveillance. Results: Antibody levels to AMA1, MSP1 and MSP3 increased with age. Anti-AMA1 and MSP1 antibody avidities were (respectively) positively and negatively associated with age, while anti-MSP3 antibody avidities did not change. Antibody levels to all three antigens were elevated in the presence of asymptomatic parasitaemia, but their associated avidities were not. Unlike antibody levels, antibody avidities to the three-merozoite antigens did not increase with exposure to Pf malaria. There were no consistent prospective associations between antibody avidities and malaria episodes. Conclusion: We found no evidence that antibody avidities to Pf-merozoite antigens are associated with either exposure or immunity to malaria.	[Ibison, Frances; Olotu, Ally; Muema, Daniel M.; Mwacharo, Jedida; Ohuma, Eric; Kimani, Domtila; Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Ibison, Frances] Univ Birmingham, Sch Med, Birmingham, W Midlands, England; [Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of Birmingham; University of Oxford	Ndungu, FM (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.	FNdungu@kemri-wellcome.org	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030	Wellcome Trust [B9RTIR0]; European and Developing Countries Clinical Trials Partnership (EDCTP); MRC Medical Research Council (UK); MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European and Developing Countries Clinical Trials Partnership (EDCTP); MRC Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (grant number B9RTIR0). FMN is a post-doctoral fellow under the Malaria Vectored Vaccines Consortium (MVVC), funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). PB is funded by the MRC Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Ferreira MU, 1996, AM J TROP MED HYG, V55, P315, DOI 10.4269/ajtmh.1996.55.315; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736; Leoratti FMS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-186; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; Moormann AM, 2009, PARASITE IMMUNOL, V31, P547, DOI 10.1111/j.1365-3024.2009.01137.x; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; O'Meara WP, 2009, TROP MED INT HEALTH, V14, P29, DOI 10.1111/j.1365-3156.2008.02194.x; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; STEVENSON MM, 1989, EXP MOL PATHOL, V51, P80, DOI 10.1016/0014-4800(89)90009-9; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Tutterrow Yeung Lo, 2012, PLoS One, V7, pe40049, DOI 10.1371/journal.pone.0040049; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; WEISS L, 1989, AM J TROP MED HYG, V41, P144, DOI 10.4269/ajtmh.1989.41.144; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52939	10.1371/journal.pone.0052939	http://dx.doi.org/10.1371/journal.pone.0052939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300828	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800162
J	Meng, ZF; Xin, RL; Zhong, P; Zhang, CY; Abubakar, YF; Li, JY; Liu, W; Zhang, XY; Xu, JQ				Meng, Zhefeng; Xin, Ruolei; Zhong, Ping; Zhang, Chiyu; Abubakar, Yassir F.; Li, Jingyun; Liu, Wei; Zhang, Xiaoyan; Xu, Jianqing			A New Migration Map of HIV-1 CRF07_BC in China: Analysis of Sequences from 12 Provinces over a Decade	PLOS ONE			English	Article							INJECTION-DRUG USERS; HEPATITIS-C VIRUS; CIRCULATING RECOMBINANT; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; INFECTION; SUBTYPES; STRAINS; HISTORY; RATES	Background: As one of prevalence HIV-1 strains in IDUs in Asia, the origination and full transmission map of CRF07_BC is of great interested and remains unclear. In the study, we collected 769 CRF07_BC derived sequences (including 45 sequences generated in our laboratory) from 12 provinces in China for reconstructing transmission map. Meanwhile, ample historic epidemic evidences were also reviewed to assist sequences analysis. Methodology/Principal Findings: In the study, we collected 769 CRF07_BC derived sequences and identified 138 independent sequences from 12 provinces in China for subsequent phylogeographic tree analysis, Bayes Factor test and the estimation of state tMRCA. The analyses demonstrated that CRF07_BC was originated in 1993 in IDU in Yunnan province and then initially spread to Guangxi (eastern neighbor to Yunnan) in 1994, to Xinjiang (northwest) in 1995 and to Sichuan (northern neighbor to Yunnan) in 1996. The subsequent transmissions occurred from Yunnan to Liaoning (northeast) in 1997 and to Jiangsu in 1998. Interestingly, after the early introduction of CRF07_BC into Guangxi, Xinjiang and Sichuan, these three regions served as secondary epicenters for further spreading into Gansu, Ningxia, Qinghai, Beijing and Hunan during 1999-2001. These analyzed results are in accordance with early epidemic investigations. Conclusions/Significance: Our data not just reconstructed the migration map of CRF07_BC, but also firstly revealed the active roles of these secondary epicenters in the dynamic migration of CRF07_BC in China.	[Meng, Zhefeng; Abubakar, Yassir F.; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Meng, Zhefeng; Abubakar, Yassir F.; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xin, Ruolei] Beijing Ctr Dis Control & Prevent, Dept AIDS STD, Beijing, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS STD, Shanghai, Peoples R China; [Zhang, Chiyu] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Jingyun] Acad Mil Med Sci, Inst Microbiol Epidemiol, Beijing, Peoples R China; [Liu, Wei] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhang, XY (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhang_xycn2002@yahoo.com.cn; jianqingxu2008@gmail.com		Zhang, Chiyu/0000-0001-8735-9857; meng, zhefeng/0000-0001-9396-0673	NSFC [30901257]; National Grand Program on Key Infectious Disease Control [2008ZX10001-004, 2012ZX10001-006, 2012ZX10001-008]; China Ministry of Health; China Ministry of Science and Technology	NSFC(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease Control; China Ministry of Health; China Ministry of Science and Technology(Ministry of Science and Technology, China)	The researches were supported by NSFC Grant 30901257 and National Grand Program on Key Infectious Disease Control (Grant# 2008ZX10001-004, 2012ZX10001-006 and 2012ZX10001-008), China Ministry of Health & China Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Chen J, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P74; Chen X, 2000, J CHINA AIDS STD PRE, V6, P141; Chu Tian-xin, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P281; Department of Control Minister of Health China, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P7; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jia C, 2003, JIANGSU HLTH CARE, V5, P6; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin YT, 2007, J INFECT DIS, V195, P1283, DOI 10.1086/513437; Liu J, 2011, PLOS ONE, V8; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; Liu W, 2003, PRAC PREV MED, V10, P644; Liu W, 2001, GUANGXI YU FANG ZHI, V7, P257; Ma F, 2004, MED ANIM PREV CONT, V20, P250; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2011, CHINESE MED J-PEKING, V124, P304, DOI 10.3760/cma.j.issn.0366-6999.2011.02.028; Meng ZF, 2007, AIDS RES HUM RETROV, V23, P1049, DOI 10.1089/aid.2007.0058; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; National HIV Sentinel Surveillance Collaborative Group, 2000, J CHINA AIDS STD PRE, V4, P242; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Qin G, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P39; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shao Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P109; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sun X, 1999, J CHIN AIDS STD PREV, V5, P97; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Wolf H, 1996, CHINESE J VIROL, V12, P9; Wu H, 2000, CHIN J MICROBIOL IMM, V20, P462; Xin Ruo-lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P876; Xing S, 2002, J CHINA AIDS STD PRE, V8, P21; Yan YanSheng (et al. ), 2000, Chinese Journal of Zoonoses, V16, P91; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang G, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P15; Zhang T, 2001, J CHINA AIDS STD PRE, V7, P28	50	32	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52373	10.1371/journal.pone.0052373	http://dx.doi.org/10.1371/journal.pone.0052373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300654	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800075
J	Riedel, SS; Mottok, A; Brede, C; Bauerlein, CA; Garrote, ALJ; Ritz, M; Mattenheimer, K; Rosenwald, A; Einsele, H; Bogen, B; Beilhack, A				Riedel, Simone S.; Mottok, Anja; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Ritz, Miriam; Mattenheimer, Katharina; Rosenwald, Andreas; Einsele, Hermann; Bogen, Bjarne; Beilhack, Andreas			Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma	PLOS ONE			English	Article							T-CELLS; MELPHALAN; MARROW; GROWTH; MICE; PLASMACYTOMA; CHEMOKINES; CLEARANCE; MIGRATION; PROTEINS	Background: Multiple myeloma (MM) is a B-cell malignancy, where malignant plasma cells clonally expand in the bone marrow of older people, causing significant morbidity and mortality. Typical clinical symptoms include increased serum calcium levels, renal insufficiency, anemia, and bone lesions. With standard therapies, MM remains incurable; therefore, the development of new drugs or immune cell-based therapies is desirable. To advance the goal of finding a more effective treatment for MM, we aimed to develop a reliable preclinical MM mouse model applying sensitive and reproducible methods for monitoring of tumor growth and metastasis in response to therapy. Material and Methods: A mouse model was created by intravenously injecting bone marrow-homing mouse myeloma cells (MOPC-315.BM) that expressed luciferase into BALB/c wild type mice. The luciferase in the myeloma cells allowed in vivo tracking before and after melphalan treatment with bioluminescence imaging (BLI). Homing of MOPC-315.BM luciferase+ myeloma cells to specific tissues was examined by flow cytometry. Idiotype-specific myeloma protein serum levels were measured by ELISA. In vivo measurements were validated with histopathology. Results: Strong bone marrow tropism and subsequent dissemination of MOPC-315.BM luciferase+ cells in vivo closely mimicked the human disease. In vivo BLI and later histopathological analysis revealed that 12 days of melphalan treatment slowed tumor progression and reduced MM dissemination compared to untreated controls. MOPC-315.BM luciferase+ cells expressed CXCR4 and high levels of CD44 and alpha 4 beta 1 in vitro which could explain the strong bone marrow tropism. The results showed that MOPC-315.BM cells dynamically regulated homing receptor expression and depended on interactions with surrounding cells. Conclusions: This study described a novel MM mouse model that facilitated convenient, reliable, and sensitive tracking of myeloma cells with whole body BLI in living animals. This model is highly suitable for monitoring the effects of different treatment regimens.	[Riedel, Simone S.; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Ritz, Miriam; Mattenheimer, Katharina; Einsele, Hermann; Beilhack, Andreas] Wurzburg Univ Clin, Dept Med 2, Wurzburg, Germany; [Riedel, Simone S.; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Beilhack, Andreas] GK Immunomodulat, Grad Sch Life Sci, Wurzburg, Germany; [Mottok, Anja; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Beilhack, Andreas] Univ Wurzburg, Interdisciplinary Ctr Clin Res IZKF, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Oslo; University of Oslo; National Hospital Norway; University of Wurzburg	Bogen, B (corresponding author), Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway.	bjarne.bogen@medisin.uio.no; beilhack_a@medizin.uni-wuerzburg.de	Mottok, Anja/AAO-1801-2021	Mottok, Anja/0000-0003-3125-0494	German Research Foundation (DFG) [CRU 216 TP4]; Multiple Myeloma Research Foundation; Interdisciplinary Center for Clinical Research at Wurzburg University; Norwegian Cancer Society; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Multiple Myeloma Research Foundation; Interdisciplinary Center for Clinical Research at Wurzburg University; Norwegian Cancer Society(Norwegian Cancer Society); University of Wuerzburg	This work was supported by grants to AB from the German Research Foundation (DFG CRU 216 TP4)(www.dfg.de), the Multiple Myeloma Research Foundation (www.themmrf.org) and the Interdisciplinary Center for Clinical Research (IZKF) at Wurzburg University (www.izkf.uni-wuerzburg.de). BB is supported by grants from the Norwegian Cancer Society (www.kreftforeningen.no) and Multiple Myeloma Research Foundation (www.themmrf.org). This publication was funded by the German Research Foundation (DFG) (www.dfg.de) and the University of Wuerzburg in the funding programme Open Access Publishing (http://openaccess.uni-wuerzburg.de/open_access_zeitschriften). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Chesi M., 2012, BLOOD; Deleu S, 2009, LEUKEMIA, V23, P1894, DOI 10.1038/leu.2009.121; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Fowler JA, 2009, DIS MODEL MECH, V2, P604, DOI 10.1242/dmm.003160; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; HOOGSTRATEN B, 1967, BLOOD-J HEMATOL, V30, P74, DOI 10.1182/blood.V30.1.74.74; Howlander N, 2012, SEER CANCER STATISTI; Jodal HC, 2011, SCAND J IMMUNOL, V73, P388; Jovasevic VM, 2004, J IMMUNOL, V172, P1449, DOI 10.4049/jimmunol.172.3.1449; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kueh, 2008, WHO CLASSIFICATION T; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Laubach JP, 2010, MED ONCOL, V27, P1, DOI 10.1007/s12032-010-9442-2; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; MILLAR JL, 1978, BRIT J CANCER, V38, P137, DOI 10.1038/bjc.1978.173; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; Mokyr MB, 2006, CANCER IMMUNOL IMMUN, V55, P459, DOI 10.1007/s00262-005-0029-2; MORELL A, 1973, CLIN EXP IMMUNOL, V13, P521; OGAWA M, 1971, CANCER RES, V31, P2116; Okada T, 1999, CLIN EXP METASTAS, V17, P623, DOI 10.1023/A:1006715504719; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Parmo-Cabanas M, 2004, EXP CELL RES, V294, P571, DOI 10.1016/j.yexcr.2003.12.003; Pellegrino A, 2004, CANCER LETT, V207, P221, DOI 10.1016/j.canlet.2003.10.036; Poeschinger T, 2013, MOL IMAGING BIOL, V15, P28, DOI 10.1007/s11307-012-0559-x; RIFAI A, 1983, J IMMUNOL, V130, P1826; ROHRER JW, 1979, J IMMUNOL, V123, P1083; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; Sahota SS, 1997, BLOOD, V89, P219, DOI 10.1182/blood.V89.1.219.219_219_226; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; VALERIOTE F, 1981, JNCI-J NATL CANCER I, V66, P1083, DOI 10.1093/jnci/66.6.1083; van Driel M, 1998, LEUKEMIA, V12, P1821, DOI 10.1038/sj.leu.2401179; Van Riet I, 1998, MED ONCOL, V15, P154, DOI 10.1007/BF02821934; Vanderkerken Karin, 2005, V113, P191, DOI 10.1385/1-59259-916-8:191; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52398	10.1371/journal.pone.0052398	http://dx.doi.org/10.1371/journal.pone.0052398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300660	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800079
J	Tsai, WY; Hsieh, SC; Lai, CY; Lin, HE; Nerurkar, VR; Wang, WK				Tsai, Wen-Yang; Hsieh, Szu-Chia; Lai, Chih-Yun; Lin, Hong-En; Nerurkar, Vivek R.; Wang, Wei-Kung			C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; TRUNCATED DENGUE-2; PRECURSOR MEMBRANE; PARTIAL PROTECTION; GLYCOPROTEINS; EPITOPES; IMMUNOGENICITY; PREMEMBRANE	Background: The envelope (E) protein of dengue virus (DENV) is the major immunogen for dengue vaccine development. At the C-erminus are two alpha-helices (EH1 and EH2) and two transmembrane domains (ET1 and ET2). After synthesis, E protein forms a heterodimer with the precursor membrane (prM) protein, which has been shown as a chaperone for E protein and could prevent premature fusion of E protein during maturation. Recent reports of enhancement of DENV infectivity by anti-prM monoclonal antibodies (mAbs) suggest the presence of prM protein in dengue vaccine is potentially harmful. A better understanding of prM-E interaction and its effect on recognition of E and prM proteins by different antibodies would provide important information for future design of safe and effective subunit dengue vaccines. Methodology/Principal Findings: In this study, we examined a series of C-terminal truncation constructs of DENV4 prME, E and prM. In the absence of E protein, prM protein expressed poorly. In the presence of E protein, the expression of prM protein increased in a dose-dependent manner. Radioimmunoprecipitation, sucrose gradient sedimentation and pulse-chase experiments revealed ET1 and EH2 were involved in prM-E interaction and EH2 in maintaining the stability of prM protein. Dot blot assay revealed E protein affected the recognition of prM protein by an anti-prM mAb; truncation of EH2 or EH1 affected the recognition of E protein by several anti-E mAbs, which was further verified by capture ELISA. The E protein ectodomain alone can be recognized well by all anti-E mAbs tested. Conclusions/Significance: A C-terminal domain (EH2) of DENV E protein can affect the expression and stability of its chaperone prM protein. These findings not only add to our understanding of the interaction between prM and E proteins, but also suggest the ectodomain of E protein alone could be a potential subunit immunogen without inducing anti-prM response.	[Tsai, Wen-Yang; Hsieh, Szu-Chia; Lai, Chih-Yun; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Hsieh, Szu-Chia; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA; [Lin, Hong-En] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10764, Taiwan	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Taiwan University	Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	wangwk@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine; National Institute of General Medical Sciences, National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Cooperative Research Agreement by International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine and Award Number P20GM103516 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 1999, J IMMUNOL, V163, P6756; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bonafe N, 2009, VACCINE, V27, P213, DOI 10.1016/j.vaccine.2008.10.046; BRAY M, 1991, VIROLOGY, V185, P505, DOI 10.1016/0042-6822(91)90809-P; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DELENDA C, 1994, J GEN VIROL, V75, P1569, DOI 10.1099/0022-1317-75-7-1569; Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; Hu HP, 2007, VIROLOGY, V368, P376, DOI 10.1016/j.virol.2007.06.026; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175; Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WHO, 2009, DENG HEM FEV DIAGN T; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990	48	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52600	10.1371/journal.pone.0052600	http://dx.doi.org/10.1371/journal.pone.0052600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300717	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800110
J	Doppler, H; Liou, GY; Storz, P				Doeppler, Heike; Liou, Geou-Yarh; Storz, Peter			Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity	PLOS ONE			English	Article							NF-KAPPA-B; MULTIPLE-MYELOMA; ACTIVATION; APOPTOSIS; PATHWAY; PROTEIN; ALPHA; IAPS; UBIQUITINATION; DEGRADATION	Background: Increased levels of NF-kappa B are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-kappa B activation pathways have been implicated. Methodology/Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NF-kappa B activity in PDAC cell lines. Increased activity of the p52/RelB NF-kappa B complex is mediated through stabilization and activation of NF-kappa B-inducing kinase (NIK). We identify proteasomal downregulation of TNF receptor-associated factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines. Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells. Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer. Our data indicates that the TRAF2/NIK/NF-kappa B2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.	[Doeppler, Heike; Liou, Geou-Yarh; Storz, Peter] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			AACR [08-20-25-STOR]; National Institutes of Health [CA135102, CA140182, P50CA102701]; Pancreatic Cancer Action Network (PanCAN); Patty Boshell Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA102701, R21CA135102, R01CA140182] Funding Source: NIH RePORTER	AACR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network (PanCAN); Patty Boshell Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the AACR (08-20-25-STOR), the National Institutes of Health grants CA135102, CA140182 and P50CA102701 (Mayo Clinic SPORE in Pancreatic Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues in the Storz laboratory for helpful discussions and Jenni Bachhofer for help with the manuscript. We also thank the Pancreatic Cancer Action Network (PanCAN) and the Patty Boshell Pancreatic Cancer Foundation for their support.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Chandler NM, 2004, J SURG RES, V118, P9, DOI 10.1016/S0022-4804(03)00354-8; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	27	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53676	10.1371/journal.pone.0053676	http://dx.doi.org/10.1371/journal.pone.0053676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301098	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000074
J	Chen, BJ; Jiao, YQ; Zhang, P; Sun, AY; Pitt, GS; Deoliveira, D; Drago, N; Ye, T; Liu, C; Chao, NJ				Chen, Benny J.; Jiao, Yiqun; Zhang, Ping; Sun, Albert Y.; Pitt, Geoffrey S.; Deoliveira, Divino; Drago, Nicholas; Ye, Tong; Liu, Chen; Chao, Nelson J.			Long-Term In Vivo Imaging of Multiple Organs at the Single Cell Level	PLOS ONE			English	Article							BONE-MARROW; TRANSPLANTATION; MOTILITY	Two-photon microscopy has enabled the study of individual cell behavior in live animals. Many organs and tissues cannot be studied, especially longitudinally, because they are located too deep, behind bony structures or too close to the lung and heart. Here we report a novel mouse model that allows long-term single cell imaging of many organs. A wide variety of live tissues were successfully engrafted in the pinna of the mouse ear. Many of these engrafted tissues maintained the normal tissue histology. Using the heart and thymus as models, we further demonstrated that the engrafted tissues functioned as would be expected. Combining two-photon microscopy with fluorescent tracers, we successfully visualized the engrafted tissues at the single cell level in live mice over several months. Four dimensional (three-dimensional (3D) plus time) information of individual cells was obtained from this imaging. This model makes long-term high resolution 4D imaging of multiple organs possible.	[Chen, Benny J.; Jiao, Yiqun; Zhang, Ping; Sun, Albert Y.; Pitt, Geoffrey S.; Deoliveira, Divino; Drago, Nicholas; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Chao, Nelson J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Chen, Benny J.; Chao, Nelson J.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Ye, Tong] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Duke University; Duke University; Duke University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Chen, BJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	chen0032@mc.duke.edu	Ye, Tong/A-8251-2010; Pitt, Geoffrey/L-4927-2019; Ye, Tong/ABG-8560-2021	Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969; Pitt, Geoffrey/0000-0003-2246-0289	NIH [U19AI067798, R33-AI080525, P01-CA047741]; NATIONAL CANCER INSTITUTE [P01CA047741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101, R01HL071165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, R33AI080525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partly supported by NIH grants U19AI067798, R33-AI080525, and P01-CA047741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhakta NR, 2005, SEMIN IMMUNOL, V17, P411, DOI 10.1016/j.smim.2005.09.004; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2002, TRANSPLANTATION, V73, P115, DOI 10.1097/00007890-200201150-00022; Chen BJ, 2002, BLOOD, V99, P364, DOI 10.1182/blood.V99.1.364; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; FULMER RI, 1963, AM J ANAT, V113, P273, DOI 10.1002/aja.1001130206; Hajdu SI, 2002, ANN CLIN LAB SCI, V32, P309; Markees TG, 1997, TRANSPLANTATION, V64, P329, DOI 10.1097/00007890-199707270-00026; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Zhang JF, 2012, BLOOD, V119, P6344, DOI 10.1182/blood-2011-03-342055	16	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52087	10.1371/journal.pone.0052087	http://dx.doi.org/10.1371/journal.pone.0052087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300962	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900018
J	Mangner, N; Linke, A; Oberbach, A; Kullnick, Y; Gielen, S; Sandri, M; Hoellriegel, R; Matsumoto, Y; Schuler, G; Adams, V				Mangner, Norman; Linke, Axel; Oberbach, Andreas; Kullnick, Yvonne; Gielen, Stephan; Sandri, Marcus; Hoellriegel, Robert; Matsumoto, Yasuharu; Schuler, Gerhard; Adams, Volker			Exercise Training Prevents TNF-alpha Induced Loss of Force in the Diaphragm of Mice	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ANTIINFLAMMATORY CYTOKINES; PHYSICAL-EXERCISE; CREATINE-KINASE; EXPRESSION; DYSFUNCTION; PROTEINS; CONTRACTILITY	Rationale: Inflammatory cytokines like tumor necrosis factor alpha (TNF-alpha) are elevated in congestive heart failure and are known to induce the production of reactive oxygen species as well as to deteriorate respiratory muscle function. Objectives: Given the antioxidative effects of exercise training, the aim of the present study was to investigate if exercise training is capable of preventing a TNF-alpha induced loss of diaphragmatic force in mice and, if so, to elucidate the potential underlying mechanisms. Methods: Prior to intraperitoneal injection of TNF-alpha or saline, C57Bl6 mice were assigned to four weeks of exercise training or sedentary behavior. Diaphragmatic force and power generation were determined in vitro. Expression/activity of radical scavenger enzymes, enzymes producing reactive oxygen species and marker of oxidative stress were measured in the diaphragm. Main Results: In sedentary animals, TNF-alpha reduced specific force development by 42% concomitant with a 2.6-fold increase in the amount of carbonylated alpha-actin and creatine kinase. Furthermore, TNF-alpha led to an increased NAD(P) H oxidase activity in both sedentary and exercised mice whereas xanthine oxidase activity and intramitochondrial ROS production was only enhanced in sedentary animals by TNF-alpha. Exercise training prevented the TNF-alpha induced force reduction and led to an enhanced mRNA expression and activity of glutathione peroxidase. Carbonylation of proteins, in particular of alpha-actin and creatine kinase, was diminished by exercise training. Conclusion: TNF-alpha reduces the force development in the diaphragm of mice. This effect is almost abolished by exercise training. This may be a result of reduced carbonylation of proteins due to the antioxidative properties of exercise training.	[Mangner, Norman; Linke, Axel; Sandri, Marcus; Hoellriegel, Robert; Schuler, Gerhard; Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany; [Oberbach, Andreas; Kullnick, Yvonne] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany; [Gielen, Stephan] Univ Halle Wittenberg, Univ Hosp, D-06108 Halle, Germany; [Matsumoto, Yasuharu] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan	Heart Center Leipzig GMBH; Leipzig University; Leipzig University; Martin Luther University Halle Wittenberg; Tohoku University	Mangner, N (corresponding author), Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany.	norman.mangner@med.uni-leipzig.de	Mangner, Norman/AAN-4673-2020	Mangner, Norman/0000-0003-0793-7923				Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; Adams V, 2008, EUR J CARDIOV PREV R, V15, P293, DOI 10.1097/HJR.0b013e3282f3ec43; Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Alloatti G, 2000, AM J PHYSIOL-REG I, V279, pR2156, DOI 10.1152/ajpregu.2000.279.6.R2156; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Barreiro E, 2005, AM J RESP CELL MOL, V33, P636, DOI 10.1165/rcmb.2005-0114OC; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Eikermann M, 2006, INTENS CARE MED, V32, P251, DOI 10.1007/s00134-005-0029-x; Filippatos GS, 2005, CURR OPIN CLIN NUTR, V8, P249, DOI 10.1097/01.mco.0000165002.08955.5b; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; HATCH MD, 1978, ANAL BIOCHEM, V85, P271, DOI 10.1016/0003-2697(78)90299-3; Hollriegel R., 2012, INT J CARDIOL; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; KOTTKE M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P215, DOI 10.1016/0005-2736(91)90287-I; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Li X, 2000, CIRCULATION, V102, P1690, DOI 10.1161/01.CIR.102.14.1690; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5; MANCINI DM, 1992, CIRCULATION, V86, P909, DOI 10.1161/01.CIR.86.3.909; Matsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224; Meyer FJ, 2001, CIRCULATION, V103, P2153; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Powell SR, 2012, PROG MOL BIOL TRANSL, V109, P295, DOI 10.1016/B978-0-12-397863-9.00009-2; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Smart Neil A, 2011, Congest Heart Fail, V17, P110, DOI 10.1111/j.1751-7133.2011.00217.x; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Supinski GS, 2009, AM J PHYSIOL-LUNG C, V296, pL994, DOI 10.1152/ajplung.90404.2008; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Wilcox P, 1996, AM J RESP CRIT CARE, V153, P1611, DOI 10.1164/ajrccm.153.5.8630610; WILCOX PG, 1994, AM J RESP CRIT CARE, V150, P1368, DOI 10.1164/ajrccm.150.5.7952566; Yan LJ, 2011, J CHROMATOGR B, V879, P1308, DOI 10.1016/j.jchromb.2010.08.004; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007; Zheng JZ, 2010, J NEUROCHEM, V115, P1556, DOI 10.1111/j.1471-4159.2010.07062.x	51	33	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52274	10.1371/journal.pone.0052274	http://dx.doi.org/10.1371/journal.pone.0052274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300968	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900023
J	Zhou, F; Xue, M; Qin, D; Zhu, XF; Wang, C; Zhu, JZ; Hao, TT; Cheng, L; Chen, XY; Bai, ZQ; Feng, NH; Gao, SJ; Lu, C				Zhou, Feng; Xue, Min; Qin, Di; Zhu, Xiaofei; Wang, Cong; Zhu, Jianzhong; Hao, Tingting; Cheng, Lin; Chen, Xiuying; Bai, Zhiqiang; Feng, Ninghan; Gao, Shou-Jiang; Lu, Chun			HIV-1 Tat Promotes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3 beta Signaling Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYTIC CYCLE REPLICATION; GROWTH-FACTOR; PROTEIN; ACTIVATION; AIDS; INDUCTION; RECEPTOR; CELLS; VGPCR	Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is etiologically associated with KS, the most common AIDS-related malignancy. KS is characterized by vast angiogenesis and hyperproliferative spindle cells. We have previously reported that HIV-1 Tat can trigger KSHV reactivation and accelerate Kaposin A-induced tumorigenesis. Here, we explored Tat promotion of KSHV vIL-6-induced angiogenesis and tumorigenesis. Tat promotes vIL-6-induced cell proliferation, cellular transformation, vascular tube formation and VEGF production in culture. Tat enhances vIL-6-induced angiogenesis and tumorigenesis of fibroblasts and human endothelial cells in a chicken chorioallantoic membrane (CAM) model. In an allograft model, Tat promotes vIL-6-induced tumorigenesis and expression of CD31, CD34, SMA, VEGF, b-FGF, and cyclin D1. Mechanistic studies indicated Tat activates PI3K and AKT, and inactivates PTEN and GSK-3 beta in vIL-6 expressing cells. LY294002, a specific inhibitor of PI3K, effectively impaired Tat's promotion of vIL-6-induced tumorigenesis. Together, these results provide the first evidence that Tat might contribute to KS pathogenesis by synergizing with vIL-6, and identify PI3K/AKT pathway as a potential therapeutic target in AIDS-related KS patients.	[Zhou, Feng; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng; Xue, Min; Qin, Di; Zhu, Xiaofei; Hao, Tingting; Cheng, Lin; Chen, Xiuying; Bai, Zhiqiang; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhou, Feng] Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China; [Xue, Min] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China; [Wang, Cong] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jianzhong] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Gao, Shou-Jiang] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Xuzhou Medical University; Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; University of Southern California	Lu, C (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	clu@njmu.edu.cn	Gao, Shou-Jiang/B-8641-2012; Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021	Lu, Chun/0000-0002-6078-9352; Gao, Shou-Jiang/0000-0001-6194-1742	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [30972619, 81171552, 30900064, 31270199]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032, 09KJB310007]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Natural Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC201178]; China Postdoctoral Science Foundation [2012M511304]; NATIONAL CANCER INSTITUTE [R01CA132637, R01CA124332] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803), National Natural Science Foundation of China grants 30972619 and 81171552 to C.L., 30900064 to D.Q., and 31270199 to Z.B.), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to C.L. and grant 09KJB310007 to D.Q.), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to D.Q.), Natural Science Foundation of Jiangsu Province (BK2010577 to N.F.), Jiangsu Province's Outstanding Medical Academic Leader Program (RC201178 to N.F.), and China Postdoctoral Science Foundation (2012M511304 to Z.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam N, 2009, J VIROL, V83, P5117, DOI 10.1128/JVI.01601-08; Agwale SM, 2002, P NATL ACAD SCI USA, V99, P10037, DOI 10.1073/pnas.152313899; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aranda E, 2009, BIOL RES, V42, P377, DOI [/S0716-97602009000300012, 10.4067/S0716-97602009000300012]; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Boykins RA, 1999, J IMMUNOL, V163, P15; Burger R, 1998, BLOOD, V91, P1858, DOI 10.1182/blood.V91.6.1858.1858_1858_1863; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cantaluppi V, 2001, AIDS RES HUM RETROV, V17, P965, DOI 10.1089/088922201750290087; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Geras-Raaka E, 1998, J EXP MED, V188, P405, DOI 10.1084/jem.188.2.405; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Guo HG, 2004, J VIROL, V78, P9336, DOI 10.1128/JVI.78.17.9336-9342.2004; Harrington W, 1997, LANCET, V349, P774; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2007, CELL CYCLE, V6, P438, DOI 10.4161/cc.6.4.3843; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Pati S, 2003, J VIROL, V77, P5759, DOI 10.1128/JVI.77.10.5759-5773.2003; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Rusnati Marco, 2002, Angiogenesis, V5, P141, DOI 10.1023/A:1023892223074; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Wan XY, 1999, J VIROL, V73, P8268, DOI 10.1128/JVI.73.10.8268-8278.1999; Wood NH, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-14; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055; Ziegelbauer JM, 2011, BBA-GENE REGUL MECH, V1809, P623, DOI 10.1016/j.bbagrm.2011.05.003	46	68	75	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53145	10.1371/journal.pone.0053145	http://dx.doi.org/10.1371/journal.pone.0053145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301033	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900064
J	Steiner, WW; Steiner, EM				Steiner, Walter W.; Steiner, Estelle M.			Fission Yeast Hotspot Sequence Motifs Are Also Active in Budding Yeast	PLOS ONE			English	Article							RECOMBINATION HOT-SPOT; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; GENE; HUMANS; BREAKS	In most organisms, including humans, meiotic recombination occurs preferentially at a limited number of sites in the genome known as hotspots. There has been substantial progress recently in elucidating the factors determining the location of meiotic recombination hotspots, and it is becoming clear that simple sequence motifs play a significant role. In S. pombe, there are at least five unique sequence motifs that have been shown to produce hotspots of recombination, and it is likely that there are more. In S. cerevisiae, simple sequence motifs have also been shown to produce hotspots or show significant correlations with hotspots. Some of the hotspot motifs in both yeasts are known or suspected to bind transcription factors (TFs), which are required for the activity of those hotspots. Here we show that four of the five hotspot motifs identified in S. pombe also create hotspots in the distantly related budding yeast S. cerevisiae. For one of these hotspots, M26 (also called CRE), we identify TFs, Cst6 and Sko1, that activate and inhibit the hotspot, respectively. In addition, two of the hotspot motifs show significant correlations with naturally occurring hotspots. The conservation of these hotspots between the distantly related fission and budding yeasts suggests that these sequence motifs, and others yet to be discovered, may function widely as hotspots in many diverse organisms.	[Steiner, Walter W.] Niagara Univ, Dept Biol, Lewiston, NY 14109 USA; [Steiner, Estelle M.] Niagara Cty Community Coll, Div Sci & Technol, Sanborn, NY USA	State University of New York (SUNY) System; SUNY Community College	Steiner, WW (corresponding author), Niagara Univ, Dept Biol, Lewiston, NY 14109 USA.	wsteiner@niagara.edu			National Institutes of Health [R15GM078065-01A1]; Niagara University Academic Center for Integrated Sciences (ACIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM078065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Niagara University Academic Center for Integrated Sciences (ACIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health, R15GM078065-01A1, to WWS and the Niagara University Academic Center for Integrated Sciences (ACIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de Castro E, 2012, EMBO J, V31, P124, DOI 10.1038/emboj.2011.350; Fox ME, 2000, GENETICS, V156, P59; Garcia-Gimeno MA, 2000, MOL CELL BIOL, V20, P4340, DOI 10.1128/MCB.20.12.4340-4349.2000; GEDVILAITE A, 1994, CURR GENET, V25, P475, DOI 10.1007/BF00351665; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GUTZ H, 1971, GENETICS, V69, P331; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; JUDD SR, 1988, GENETICS, V118, P401; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Loprieno N, 1974, HDB GENETICS, P395; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NEHLIN JO, 1992, NUCLEIC ACIDS RES, V20, P5271, DOI 10.1093/nar/20.20.5271; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; Sipiczki M, 2000, GENOME BIOL, V1, P10111011; STAPLETON A, 1991, GENETICS, V127, P39; Steiner WW, 2011, GENETICS, V187, P385, DOI 10.1534/genetics.110.124636; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; TRECO D, 1985, MOL CELL BIOL, V5, P2029, DOI 10.1128/MCB.5.8.2029; Wahls WP, 2011, GENETICS, V189, P685, DOI 10.1534/genetics.111.134130; Wahls WP, 2010, TRENDS GENET, V26, P202, DOI 10.1016/j.tig.2010.02.003; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53090	10.1371/journal.pone.0053090	http://dx.doi.org/10.1371/journal.pone.0053090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300865	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600055
J	Wang, S; Wei, W; Zheng, YD; Hou, JL; Dou, YX; Zhang, SH; Luo, XN; Cai, XP				Wang, Shuai; Wei, Wei; Zheng, Yadong; Hou, Junling; Dou, Yongxi; Zhang, Shaohua; Luo, Xuenong; Cai, Xuepeng			The Role of Insulin C-Peptide in the Coevolution Analyses of the Insulin Signaling Pathway: A Hint for Its Functions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EVOLUTIONARY ANALYSIS; PROTEIN-INTERACTION; HUMAN PROINSULIN; DIABETIC-RATS; TUBULAR CELLS; PREDICTION; RECEPTOR; INCREASES; RESIDUES	As the linker between the A chain and B chain of proinsulin, C-peptide displays high variability in length and amino acid composition, and has been considered as an inert byproduct of insulin synthesis and processing for many years. Recent studies have suggested that C-peptide can act as a bioactive hormone, exerting various biological effects on the pathophysiology and treatment of diabetes. In this study, we analyzed the coevolution of insulin molecules among vertebrates, aiming at exploring the evolutionary characteristics of insulin molecule, especially the C-peptide. We also calculated the correlations of evolutionary rates between the insulin and the insulin receptor (IR) sequences as well as the domain-domain pairs of the ligand and receptor by the mirrortree method. The results revealed distinctive features of C-peptide in insulin intramolecular coevolution and correlated residue substitutions, which partly supported the idea that C-peptide can act as a bioactive hormone, with significant sequence features, as well as a linker assisting the formation of mature insulin during synthesis. Interestingly, the evolution of C-peptide exerted the highest correlation with that of the insulin receptor and its ligand binding domain (LBD), implying a potential relationship with the insulin signaling pathway.	[Wang, Shuai; Wei, Wei; Zheng, Yadong; Hou, Junling; Dou, Yongxi; Zhang, Shaohua; Luo, Xuenong; Cai, Xuepeng] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Zoonoses CAAS, Key Lab Vet Parasitol Gansu Prov,Lanzhou Vet Res, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Luo, XN (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Zoonoses CAAS, Key Lab Vet Parasitol Gansu Prov,Lanzhou Vet Res, Lanzhou, Gansu, Peoples R China.	xuenongluo@yahoo.com.cn; wslanzhou@126.com	YD, Zh/HGA-5541-2022; Sánchez-Margalet, Victor/AAB-9986-2021; Wang, Shuai/ABE-4447-2022; WEI, Wei/AAK-9139-2021	YD, Zh/0000-0001-6795-9978; Sánchez-Margalet, Victor/0000-0001-8638-8680; Wang, Shuai/0000-0001-7028-8503; WEI, Wei/0000-0002-6478-5973	"863" High Technology Project [2006AA10A207]; National Key Project of Scientific and Technical Supporting program [2007BAD40B03]; Ministry of Science and Technology, China	"863" High Technology Project(National High Technology Research and Development Program of China); National Key Project of Scientific and Technical Supporting program; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was supported by "863" High Technology Project (NO. 2006AA10A207) and a National Key Project of Scientific and Technical Supporting program (No. 2007BAD40B03), the Ministry of Science and Technology, China, funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; BENNER SA, 1994, J MOL BIOL, V235, P926, DOI 10.1006/jmbi.1994.1049; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; Chen LM, 2002, J BIOCHEM, V131, P855, DOI 10.1093/oxfordjournals.jbchem.a003175; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dou TH, 2006, FRONT BIOSCI-LANDMRK, V11, P380, DOI 10.2741/1805; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Felsenstein, 2002, SCIENCES; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Grunberger G, 2001, DIABETOLOGIA, V44, P1247, DOI 10.1007/s001250100632; Hills CE, 2008, EXP DIABETES RES, DOI 10.1155/2008/635158; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; Johansson J, 2002, BIOCHEM BIOPH RES CO, V295, P1035, DOI 10.1016/S0006-291X(02)00721-0; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kitamura T, 2001, BIOCHEM J, V355, P123, DOI 10.1042/0264-6021:3550123; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lindahl E, 2007, CELL MOL LIFE SCI, V64, P479, DOI 10.1007/s00018-007-6467-6; Livingstone CD, 1996, METHOD ENZYMOL, V266, P497; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Maestroni A, 2005, EUR J ENDOCRINOL, V152, P135, DOI 10.1530/eje.1.01823; Min CY, 2004, EUR J BIOCHEM, V271, P1737, DOI 10.1111/j.1432-1033.2004.04079.x; Munte CE, 2005, FEBS J, V272, P4284, DOI 10.1111/j.1742-4658.2005.04843.x; Nordquist L, 2009, AM J PHYSIOL-RENAL, V297, pF1265, DOI 10.1152/ajprenal.00228.2009; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Samnegard B, 2005, NEPHROL DIAL TRANSPL, V20, P532, DOI 10.1093/ndt/gfh683; Shafqat J, 2002, CELL MOL LIFE SCI, V59, P1185, DOI 10.1007/s00018-002-8496-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Stevens MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE497, DOI 10.1152/ajpendo.00048.2004; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; VINGRON M, 1989, COMPUT APPL BIOSCI, V5, P115; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200	52	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52847	10.1371/journal.pone.0052847	http://dx.doi.org/10.1371/journal.pone.0052847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300796	Green Submitted, gold, Green Published			2022-12-27	WOS:000312829100086
J	Collu, F; Ceccarelli, M; Ruggerone, P				Collu, Francesca; Ceccarelli, Matteo; Ruggerone, Paolo			Exploring Binding Properties of Agonists Interacting with a delta-Opioid Receptor	PLOS ONE			English	Article							CONFORMATIONALLY SAMPLED PHARMACOPHORE; PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS; N-DESMETHYLCLOZAPINE; SIMULATIONS REVEAL; CRYSTAL-STRUCTURE; LIGAND-BINDING; COMPLEX; RHODOPSIN; HYDRATION	Ligand-receptor interactions are at the basis of the mediation of our physiological responses to a large variety of ligands, such as hormones, neurotransmitters and environmental stimulants, and their tuning represents the goal of a large variety of therapies. Several molecular details of these interactions are still largely unknown. In an effort to shed some light on this important issue, we performed a computational study on the interaction of two related compounds differing by a single methyl group (clozapine and desmethylclozapine) with a delta-opioid receptor. According to experiments, desmethylclozapine is more active than clozapine, providing a system well suited for a comparative study. We investigated stable configurations of the two drugs inside the receptor by simulating their escape routes by molecular dynamics simulations. Our results point out that the action of the compounds might be related to the spatial and temporal distribution of the affinity sites they visit during their permanency. Moreover, no particularly pronounced structural perturbations of the receptor were detected during the simulations, reinforcing the idea of a strong dynamical character of the interaction process, with an important role played by the solvent in addition.	[Collu, Francesca] Univ Cagliari, CNR IOM SLACS, Monserrato, Italy; [Collu, Francesca; Ceccarelli, Matteo; Ruggerone, Paolo] Univ Cagliari, Dipartimento Fis, Monserrato, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Cagliari; University of Cagliari	Ruggerone, P (corresponding author), Univ Cagliari, Dipartimento Fis, Monserrato, Italy.	paolo.ruggerone@dsf.unica.it	Ceccarelli, Matteo/C-8557-2018; Ruggerone, Paolo/AAN-6032-2021	Ceccarelli, Matteo/0000-0003-4272-902X; Ruggerone, Paolo/0000-0003-0825-0824	COSMOLAB; Cybersar	COSMOLAB; Cybersar	The authors have read the journal's policy and have the following conflicts. Funding for this study was received from COSMOLAB and Cybersar. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Alkorta I, 1996, PROTEIN ENG, V9, P573, DOI 10.1093/protein/9.7.573; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Aparasu R, 1999, J PAIN SYMPTOM MANAG, V18, P280, DOI 10.1016/S0885-3924(99)00085-8; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baron Riccardo, 2006, Trends in Physical Chemistry, V11, P87; Baron R, 2009, J CHEM THEORY COMPUT, V5, P3150, DOI 10.1021/ct900373z; Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Bernard D, 2005, J MED CHEM, V48, P7773, DOI 10.1021/jm050785p; Bernard D, 2003, J AM CHEM SOC, V125, P3101, DOI 10.1021/ja027644m; Biarnes X, 2011, J COMPUT AID MOL DES, V25, P395, DOI 10.1007/s10822-011-9415-3; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chakrabarti S, 1998, MOL PHARMACOL, V54, P949, DOI 10.1124/mol.54.6.949; Chang CE, 2005, J CHEM THEORY COMPUT, V1, P1017, DOI 10.1021/ct0500904; Chaturvedi K, 2000, BIOPOLYMERS, V55, P334, DOI 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dolenc J, 2011, J COMPUT AID MOL DES, V25, P709, DOI 10.1007/s10822-011-9453-x; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Ensing B, 2006, ACCOUNTS CHEM RES, V39, P73, DOI 10.1021/ar040198i; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; FILLERS JP, 1982, ACTA CRYSTALLOGR B, V38, P1750, DOI 10.1107/S0567740882007109; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010; Hajjar E, 2010, J MOL MODEL, V16, P1701, DOI 10.1007/s00894-010-0698-4; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; HUBER T, 1994, J COMPUT AID MOL DES, V8, P695, DOI 10.1007/BF00124016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Iannuzzi M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238302; Jardon-Valadez E, 2010, BIOPHYS J, V99, P2200, DOI 10.1016/j.bpj.2010.06.067; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kane BE, 2006, AAPS J, V8, pE126, DOI 10.1208/aapsj080115; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lameh J, 2007, PHARMACOL THERAPEUT, V115, P223, DOI 10.1016/j.pharmthera.2007.05.004; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LIPKOWSKI AW, 1986, J MED CHEM, V29, P1222, DOI 10.1021/jm00157a018; Mancini I, 1998, SUPPORT CARE CANCER, V6, P356, DOI 10.1007/s005200050177; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marchi M, 1998, J CHEM PHYS, V109, P5194, DOI 10.1063/1.477136; Masetti M, 2009, J PHYS CHEM B, V113, P4807, DOI 10.1021/jp803936q; Mendoza MC, 2009, CLIN NEUROPHARMACOL, V32, P154, DOI 10.1097/WNF.0b013e31818d46f5; Meng F, 2000, J BIOL CHEM, V275, P21939, DOI 10.1074/jbc.M002864200; Mezei M, 2006, J COMPUT AID MOL DES, V20, P97, DOI 10.1007/s10822-006-9039-1; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Nguyen PH, 2012, PHYS CHEM CHEM PHYS, V14, P877, DOI 10.1039/c1cp21779h; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Olianas MC, 2009, EUR J PHARMACOL, V607, P96, DOI 10.1016/j.ejphar.2009.02.025; Onali P, 2007, NEUROPSYCHOPHARMACOL, V32, P773, DOI 10.1038/sj.npp.1301152; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pizzitutti F, 2007, J PHYS CHEM B, V111, P7584, DOI 10.1021/jp0717185; Pogozheva ID, 2005, AAPS J, V7; Procacci P, 1997, J COMPUT CHEM, V18, P1848, DOI 10.1002/(SICI)1096-987X(19971130)18:15<1848::AID-JCC2>3.0.CO;2-O; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Provasi D, 2010, BIOPHYS J, V98, P2347, DOI 10.1016/j.bpj.2010.01.047; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Quock RM, 1999, PHARMACOL REV, V51, P503; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith A, 2003, LIFE SCI, V73; Sterpone F, 2001, J MOL BIOL, V311, P409, DOI 10.1006/jmbi.2001.4860; STRAATSMA TP, 2004, NWCHEM COMPUTATIONAL; Sugihara M, 2011, J PHYS CHEM B, V115, P6172, DOI 10.1021/jp1101785; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Vargiu AV, 2008, NUCLEIC ACIDS RES, V36, P5910, DOI 10.1093/nar/gkn561; Venken T, 2011, PROTEINS, V79, P3221, DOI 10.1002/prot.23158; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	98	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52633	10.1371/journal.pone.0052633	http://dx.doi.org/10.1371/journal.pone.0052633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300729	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800117
J	Seiler, S; Schmidt, H; Lechner, A; Benke, T; Sanin, G; Ransmayr, G; Lehner, R; Dal-Bianco, P; Santer, P; Linortner, P; Eggers, C; Haider, B; Uranues, M; Marksteiner, J; Leblhuber, F; Kapeller, P; Bancher, C; Schmidt, R				Seiler, Stephan; Schmidt, Helena; Lechner, Anita; Benke, Thomas; Sanin, Guenter; Ransmayr, Gerhard; Lehner, Riccarda; Dal-Bianco, Peter; Santer, Peter; Linortner, Patricia; Eggers, Christian; Haider, Bernhard; Uranues, Margarete; Marksteiner, Josef; Leblhuber, Friedrich; Kapeller, Peter; Bancher, Christian; Schmidt, Reinhold		PRODEM Study Grp	Driving Cessation and Dementia: Results of the Prospective Registry on Dementia in Austria (PRODEM)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER DRIVERS; PATHOLOGICAL DIAGNOSIS; PERFORMANCE; RISK; PREDICTORS; CONSORTIUM; GUIDELINES; CRASHES; ABILITY	Objective: To assess the influence of cognitive, functional and behavioral factors, co-morbidities as well as caregiver characteristics on driving cessation in dementia patients. Methods: The study cohort consists of those 240 dementia cases of the ongoing prospective registry on dementia in Austria (PRODEM) who were former or current car-drivers (mean age 74.2 (+/- 8.8) years, 39.6% females, 80.8% Alzheimer's disease). Reasons for driving cessation were assessed with the patients' caregivers. Standardized questionnaires were used to evaluate patient-and caregiver characteristics. Cognitive functioning was determined by Mini-Mental State Examination (MMSE), the CERAD neuropsychological test battery and Clinical Dementia Rating (CDR), activities of daily living (ADL) by the Disability Assessment for Dementia, behavior by the Neuropsychiatric Inventory (NPI) and caregiver burden by the Zarit burden scale. Results: Among subjects who had ceased driving, 136 (93.8%) did so because of "Unacceptable risk'' according to caregiver's judgment. Car accidents and revocation of the driving license were responsible in 8 (5.5%) and 1(0.7%) participant, respectively. Female gender (OR 5.057; 95% CI 1.803-14.180; p = 0.002), constructional abilities (OR 0.611; 95% CI 0.445-0.839; p = 0.002) and impairment in Activities of Daily Living (OR 0.941; 95% CI 0.911-0.973; p<0.001) were the only significant and independent associates of driving cessation. In multivariate analysis none of the currently proposed screening tools for assessment of fitness to drive in elderly subjects including the MMSE and CDR were significantly associated with driving cessation. Conclusion: The risk-estimate of caregivers, but not car accidents or revocation of the driving license determines if dementia patients cease driving. Female gender and increasing impairment in constructional abilities and ADL raise the probability for driving cessation. If any of these factors also relates to undesired traffic situations needs to be determined before recommendations for their inclusion into practice parameters for the assessment of driving abilities in the elderly can be derived from our data.	[Seiler, Stephan; Schmidt, Helena; Lechner, Anita; Linortner, Patricia; Schmidt, Reinhold] Med Univ Graz, Div Neurogeriatr, Dept Neurol, Graz, Austria; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Graz, Austria; [Benke, Thomas; Sanin, Guenter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Ransmayr, Gerhard; Lehner, Riccarda] Gen Hosp Linz, Dept Neurol, Linz, Austria; [Dal-Bianco, Peter; Santer, Peter] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Eggers, Christian; Haider, Bernhard] Konventhosp Barmherzigen Bruder Linz, Dept Neurol, Linz, Austria; [Uranues, Margarete] Landesnervenklin Sigmund Freud Graz, Dept Geriatr Psychiat, Graz, Austria; [Marksteiner, Josef] Reg Hosp Hall Tirol, Dept Psychiat & Psychotherapy, Hall In Tirol, Austria; [Leblhuber, Friedrich] Nervenklin Wagner Jauregg Linz, Dept Neurol & Geriatr Psychiat, Linz, Austria; [Kapeller, Peter] Reg Hosp Villach, Dept Neurol & Psychosomat Med, Villach, Austria; [Bancher, Christian] Reg Hosp Horn, Dept Neurol, Horn, Austria	Medical University of Graz; Medical University of Graz; Medical University of Innsbruck; Kepler University Hospital; Medical University of Vienna; Konventhospital Der Barmherzigen Bruder; Kepler University Hospital	Schmidt, R (corresponding author), Med Univ Graz, Div Neurogeriatr, Dept Neurol, Graz, Austria.	reinhold.schmidt@medunigraz.at	Schmidt, Reinhold/E-1137-2014; bancher, christian/AAX-8974-2020	Delazer, Margarete/0000-0001-6482-4445; Sen, Abhijit/0000-0001-9560-4226; Berger-Sieczkowski, Evelyn/0000-0001-7570-0499	Austrian Alzheimer Society; Jubilaumsfonds of the Austrian National Bank [13240]	Austrian Alzheimer Society; Jubilaumsfonds of the Austrian National Bank	The research presented in this paper was supported by the Austrian Alzheimer Society (http://alzheimer.mcw-portal.com) and the Jubilaumsfonds of the Austrian National Bank, grant 13240 (http://www.oenb.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2003, ALZ DIS ASSOC DIS, V17, P68, DOI 10.1097/00002093-200304000-00003; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auracher-Jaeger B, 2006, LEITLINIEN FUER GESU; Berry C, 2011, OLDER DRIVERS BEHAV; Brown LB, 2004, J GERIATR PSYCH NEUR, V17, P232, DOI 10.1177/0891988704269825; Canadian Medical Association, 2000, DET MED FITN DRIV GU, P56; Carr DB, 2000, J AM GERIATR SOC, V48, P18, DOI 10.1111/j.1532-5415.2000.tb03023.x; Chipman ML, 1998, ACCIDENT ANAL PREV, V30, P299, DOI 10.1016/S0001-4575(97)00107-3; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; De Raedt R, 2000, AGE AGEING, V29, P517, DOI 10.1093/ageing/29.6.517; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Foley DJ, 2000, J AM GERIATR SOC, V48, P928, DOI 10.1111/j.1532-5415.2000.tb06889.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frittelli C, 2009, INT J GERIATR PSYCH, V24, P232, DOI 10.1002/gps.2095; Fuller R, 2005, ACCIDENT ANAL PREV, V37, P461, DOI 10.1016/j.aap.2004.11.003; Gallo JJ, 1999, J AM GERIATR SOC, V47, P335, DOI 10.1111/j.1532-5415.1999.tb02998.x; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Grabowski DC, 2004, JAMA-J AM MED ASSOC, V291, P2840, DOI 10.1001/jama.291.23.2840; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; Herrmann N, 2006, CAN MED ASSOC J, V175, P591, DOI 10.1503/cmaj.051707; Langford J, 2004, ACCIDENT ANAL PREV, V36, P993, DOI 10.1016/j.aap.2003.11.003; Lincoln NB, 2010, INT J GERIATR PSYCH, V25, P489, DOI 10.1002/gps.2367; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKENNA FP, 1991, ACCIDENT ANAL PREV, V23, P45, DOI 10.1016/0001-4575(91)90034-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Memory Clinic NPZ, 2005, CONSTR EST REG ALZH; Mitchell CGB, 2008, TRAFFIC INJ PREV, V9, P360, DOI 10.1080/15389580801895160; Molnar LJ, 2005, PUBLIC POLICY AGING, V15, P13; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; ONeill D., 2004, TRANSPORTATION AGING, V27, P56; Patterson C, 2001, T CAN J NEUROL SC S1, V28, P3; Redberg RF, 2009, J AM COLL CARDIOL, V54, P1364, DOI 10.1016/j.jacc.2009.08.005; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; Siren A, 2012, ACCIDENT ANAL PREV, V45, P634, DOI 10.1016/j.aap.2011.09.032; Stapleton T, 2012, AUST OCCUP THER J, V59, P63, DOI 10.1111/j.1440-1630.2011.00980.x; Talbot A, 2005, AGE AGEING, V34, P363, DOI 10.1093/ageing/afi090; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	48	73	73	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52710	10.1371/journal.pone.0052710	http://dx.doi.org/10.1371/journal.pone.0052710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300746	Green Published, gold			2022-12-27	WOS:000313618800128
J	Xiong, JJ; Che, XX; Li, XQ; Yu, H; Gong, Z; Li, WD				Xiong, Jianjun; Che, Xiangxin; Li, Xueqin; Yu, Huan; Gong, Zhen; Li, Weidong			Cloning and Characterization of the Human USP22 Gene Promoter	PLOS ONE			English	Article							CELL-CYCLE; SP1 PHOSPHORYLATION; CANCER-CELLS; TRANSCRIPTION; EXPRESSION; DEATH; OVEREXPRESSION	Ubiquitin-specific processing enzyme 22 (USP22) plays a direct role in regulating cell cycle, and its overexpression has been reported to be involved in tumor progression. However, little is known about the regulation of USP22 transcription. In this study, we cloned and characterized the human USP22 promoter. Using 5' RACE (rapid amplification of cDNA ends) analysis, the transcriptional initiation site was identified. Promoter deletion analysis showed that the sequence between -210 and -7 contains the basal promoter for USP22 in human fibroblast and tumor cells. Surprisingly, mutations in a putative Sp1 binding site immediately upstream of the USP22 transcriptional start site (-13 to -7) resulted in a significant induction of promoter activity. Further study revealed that Sp1 binds to this site in human normal fibroblast cells, and treatment with the Sp1 inhibitor mithramycin A led to a marked increase in USP22 transcript levels. Forced expression of exogenous Sp1 repressed the USP22 promoter activity in HeLa cells. In contrast, knockdown of Sp1 enhanced USP22 promoter activity and mRNA levels. These data suggest that Sp1 is a crucial regulator of USP22 transcription.	[Xiong, Jianjun; Che, Xiangxin; Li, Xueqin; Yu, Huan; Gong, Zhen] Jiujiang Univ, Coll Basic Med Sci, Jiujiang, Peoples R China; [Xiong, Jianjun; Che, Xiangxin; Li, Weidong] Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China	Jiujiang University	Li, WD (corresponding author), Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China.	lwd62518@yahoo.com.cn			National Natural Sciences Foundation of China [31000581]; Natural Science Foundation of Jiangxi, China [2010GQY0199]; Jiangxi Provincial Department of Education, China [GJJ11619];  [2010BSA14000]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province); Jiangxi Provincial Department of Education, China; 	This work was supported by the National Natural Sciences Foundation of China (31000581); Natural Science Foundation of Jiangxi, China (2010GQY0199); Jiangxi Science and Technology Support Programmer, China (2010BSA14000); and Science Programmer of Jiangxi Provincial Department of Education, China (GJJ11619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Guo LL, 2010, J NEUROSCI RES, V88, P3233, DOI 10.1002/jnr.22486; Hsu TI, 2011, ONCOGENE, V568, P1; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Li F, 2012, GENE, V503, P200, DOI 10.1016/j.gene.2012.04.088; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Vij N, 2006, AM J RESP CELL MOL, V34, P754, DOI 10.1165/rcmb.2005-0442OC; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	28	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52716	10.1371/journal.pone.0052716	http://dx.doi.org/10.1371/journal.pone.0052716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300749	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800129
J	Blaber, SP; Hill, CJ; Webster, RA; Say, JM; Brown, LJ; Wang, SC; Vesey, G; Herbert, BR				Blaber, Sinead P.; Hill, Cameron J.; Webster, Rebecca A.; Say, Jana M.; Brown, Louise J.; Wang, Shih-Chang; Vesey, Graham; Herbert, Benjamin Ross			Effect of Labeling with Iron Oxide Particles or Nanodiamonds on the Functionality of Adipose-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; MAGNETIC-RESONANCE; IN-VITRO; RAT MODEL; PROLIFERATION; TRACKING; ISCHEMIA; DELIVERY; INHIBIT; BINDING	Stem cells are increasingly the focus of translational research as well as having emerging roles in human cellular therapy. To support these uses there is a need for improved methods for in vivo cell localization and tracking. In this study, we examined the effects of cell labeling on the in vitro functionality of human adipose-derived mesenchymal stem cells. Our results provide a basis for future in vivo studies investigating implanted cell fate and longevity. In particular, we investigated the effects of two different particles: micron-sized (similar to 0.9 mu m) fluorescently labeled ( Dragon Green) superparamagnetic iron oxide particles (M-SPIO particles); and, carboxylated nanodiamonds of similar to 0.25 mu m in size. The effects of labeling on the functionality of adipose-derived MSCs were assessed by in vitro morphology, osteogenic and adipogenic differentiation potential, CD marker expression, cytokine secretion profiling and quantitative proteomics of the intra-cellular proteome. The differentiation and CD marker assays for stem-like functionality were not altered upon label incorporation and no secreted or intra-cellular protein changes indicative of stress or toxicity were detected. These in vitro results indicate that the M-SPIO particles and nanodiamonds investigated in this study are biocompatible with MSCs and therefore would be suitable labels for cell localization and tracking in vivo.	[Blaber, Sinead P.; Hill, Cameron J.; Webster, Rebecca A.; Say, Jana M.; Brown, Louise J.; Herbert, Benjamin Ross] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW, Australia; [Blaber, Sinead P.; Webster, Rebecca A.; Vesey, Graham; Herbert, Benjamin Ross] Regeneus Ltd, Gordon, NSW, Australia; [Say, Jana M.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW, Australia; [Wang, Shih-Chang] Univ Sydney, Westmead Hosp, Dept Radiol, Westmead, NSW 2145, Australia	Macquarie University; Macquarie University; University of Sydney	Herbert, BR (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW, Australia.	Benjamin.Herbert@mq.edu.au		herbert, ben/0000-0003-4697-8197; Brown, Louise/0000-0001-8592-2431	Macquarie University; MQ Research Excellence Scholarship; MQ Research Excellence International Scholarship	Macquarie University; MQ Research Excellence Scholarship; MQ Research Excellence International Scholarship	Regeneus Ltd paid for some of the consumables used in the experiments detailed in this manuscript. Macquarie University post-graduate research funding also contributed to purchasing consumables used in the experiments detailed in this manuscript. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SPB is supported by a MQ Research Excellence Scholarship and JMS is supported by an MQ Research Excellence International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; DAVIES G, 1976, PROC R SOC LON SER-A, V348, P285, DOI 10.1098/rspa.1976.0039; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DYER HB, 1965, J CHEM PHYS, V42, P1898, DOI 10.1063/1.1696224; Fang CY, 2011, SMALL, V7, P3363, DOI 10.1002/smll.201101233; Grillon F, 2012, STEM CELLS TRANSLATI; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Guthi JS, 2010, MOL PHARMACEUT, V7, P32, DOI 10.1021/mp9001393; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kalish R, 1997, DIAM RELAT MATER, V6, P516, DOI 10.1016/S0925-9635(96)00657-7; Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381; Kinnaird T, 2005, CIRC RES, V97, pE51; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lee JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355102; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Nohroudi K, 2010, CELL TRANSPLANT, V19, P431, DOI 10.3727/096368909X484699; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Rand SC, 1994, DIAMOND LASERS, P235; Say Jana M, 2011, Biophys Rev, V3, P171, DOI 10.1007/s12551-011-0056-5; Schrand AM, 2009, CRIT REV SOLID STATE, V34, P18, DOI 10.1080/10408430902831987; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Stroh A, 2009, MOL IMAGING, V8, P166, DOI 10.2310/7290.2009.00017; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Vaijayanthimala V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425103; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Zaitsev A.M., 2001, OPTICAL PROPERTIES D, DOI 10.1007/978-3-662-04548-0; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	44	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52997	10.1371/journal.pone.0052997	http://dx.doi.org/10.1371/journal.pone.0052997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301012	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000024
J	Chevallier, A; Mialot, A; Petit, JM; Fernandez-Salguero, P; Barouki, R; Coumoul, X; Beraneck, M				Chevallier, Aline; Mialot, Antoine; Petit, Jean-Maurice; Fernandez-Salguero, Pedro; Barouki, Robert; Coumoul, Xavier; Beraneck, Mathieu			Oculomotor Deficits in Aryl Hydrocarbon Receptor Null Mouse	PLOS ONE			English	Article							INFANTILE NYSTAGMUS SYNDROME; NUCLEAR TRANSLOCATOR; DIOXIN NEUROTOXICITY; CORTICAL-NEURONS; EYE-MOVEMENTS; MICE LACKING; AH RECEPTOR; BRAIN-STEM; RAT-BRAIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	The Aryl hydrocarbon Receptor or AhR, a ligand-activated transcription factor, is known to mediate the toxic and carcinogenic effects of various environmental pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). Recent studies in Caenorhabditis elegans and Drosophila melanogaster show that the orthologs of the AhR are expressed exclusively in certain types of neurons and are implicated in the development and the homeostasis of the central nervous system. While physiological roles of the AhR were demonstrated in the mammalian heart, liver and gametogenesis, its ontogenic expression and putative neural functions remain elusive. Here, we report that the constitutive absence of the AhR in adult mice (AhR-/-) leads to abnormal eye movements in the form of a spontaneous pendular horizontal nystagmus. To determine if the nystagmus is of vestibular, visual, or cerebellar origin, gaze stabilizing reflexes, namely vestibulo-ocular and optokinetic reflexes (VOR and OKR), were investigated. The OKR is less effective in the AhR-/- mice suggesting a deficit in the visuo-motor circuitry, while the VOR is mildly affected. Furthermore, the AhR is expressedin the retinal ganglion cells during the development, however electroretinograms revealed no impairment of retinal cell function. The structure of the cerebellum of the AhR-/- mice is normal which is compatible with the preserved VOR adaptation, a plastic process dependent on cerebellar integrity. Finally, intoxication with TCDD of control adults did not lead to any abnormality of the oculomotor control. These results demonstrate that the absence of the AhR leads to acquired central nervous system deficits in the adults. Given the many common features between both AhR mouse and human infantile nystagmus syndromes, the AhR-/- mice might give insights into the developmental mechanisms which lead to congenital eye disorders.	[Chevallier, Aline; Barouki, Robert; Coumoul, Xavier] Ctr Univ St Peres, INSERM, UMR S 747, Paris, France; [Mialot, Antoine; Beraneck, Mathieu] Ctr Univ St Peres, UMR 8194, CNRS, Ctr Etud Sensori Motricite, Paris, France; [Barouki, Robert] Hop Necker Enfants Malad, AP HP, Paris, France; [Fernandez-Salguero, Pedro] Univ Extramadura, Extramadura, Spain; [Chevallier, Aline; Mialot, Antoine; Petit, Jean-Maurice; Barouki, Robert; Coumoul, Xavier; Beraneck, Mathieu] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Coumoul, X (corresponding author), Ctr Univ St Peres, INSERM, UMR S 747, Paris, France.	xavier.coumoul@parisdescartes.fr; mathieu.beraneck@parisdescartes.fr	Fernandez-Salguero, Pedro M./J-8437-2014; Chevallier, Aline/O-5939-2014; COUMOUL, Xavier/AAR-3649-2020	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; COUMOUL, Xavier/0000-0003-2928-9648; Beraneck, Mathieu/0000-0003-2722-0532	CNES (Centre National d'Etudes Spatiales); CNRS (Centre National de Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale); MESR (Ministere de l'enseignement superieur et de la recherche); Universite Paris Descartes	CNES (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales); CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); MESR (Ministere de l'enseignement superieur et de la recherche)(Ministry of Research, France); Universite Paris Descartes	This work was funded by the CNES (Centre National d'Etudes Spatiales); CNRS (Centre National de Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale); the MESR (Ministere de l'enseignement superieur et de la recherche; Bourse doctorale, Aline Chevallier); the Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi RV, 2002, BRIT J OPHTHALMOL, V86, P1152, DOI 10.1136/bjo.86.10.1152; Akahoshi Eiichi, 2006, Environ Health, V5, P24, DOI 10.1186/1476-069X-5-24; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Buttner U, 1988, Rev Oculomot Res, V2, P3; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Emmons RB, 1999, DEVELOPMENT, V126, P3937; Fernandez M, 2010, J NEUROCHEM, V115, P897, DOI 10.1111/j.1471-4159.2010.06974.x; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gohlke JM, 2009, REPROD TOXICOL, V28, P321, DOI 10.1016/j.reprotox.2009.05.067; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Huang MYY, 2011, ANN NY ACAD SCI, V1233, P285, DOI 10.1111/j.1749-6632.2011.06150.x; Huang X, 2004, DEVELOPMENT, V131, P819, DOI 10.1242/dev.00959; Hufner Katharina, 2011, Front Neurol, V2, P60, DOI 10.3389/fneur.2011.00060; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x; Lin CH, 2009, J NEUROCHEM, V111, P777, DOI 10.1111/j.1471-4159.2009.06364.x; McLean RJ, 2009, EXPERT OPIN PHARMACO, V10, P1805, DOI 10.1517/14656560902978446; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; Petersen SL, 2000, J COMP NEUROL, V427, P428, DOI 10.1002/1096-9861(20001120)427:3<428::AID-CNE9>3.0.CO;2-P; Sanchez-Martin FJ, 2011, J NEUROCHEM, V118, P153, DOI 10.1111/j.1471-4159.2011.07291.x; Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P1139, DOI 10.1289/ehp.0800485; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; Strupp M, 2011, DTSCH ARZTEBL INT, V108, P197, DOI 10.3238/arztebl.2011.0197; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Traber GL, 2012, INVEST OPHTH VIS SCI, V53, P5737, DOI 10.1167/iovs.12-10137; van Alphen B, 2010, INVEST OPHTH VIS SCI, V51, P623, DOI 10.1167/iovs.09-4072; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; Williamson MA, 2005, TOXICOL SCI, V83, P340, DOI 10.1093/toxsci.kfi031	38	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53520	10.1371/journal.pone.0053520	http://dx.doi.org/10.1371/journal.pone.0053520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301081	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000062
J	Sieber, MW; Jaenisch, N; Brehm, M; Guenther, M; Linnartz-Gerlach, B; Neumann, H; Witte, OW; Frahm, C				Sieber, Matthias W.; Jaenisch, Nadine; Brehm, Martin; Guenther, Madlen; Linnartz-Gerlach, Bettina; Neumann, Harald; Witte, Otto W.; Frahm, Christiane			Attenuated Inflammatory Response in Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Knock-Out Mice following Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; RESIDENT MICROGLIA; POSTISCHEMIC BRAIN; DENDRITIC CELLS; IMMUNE-SYSTEM; CUTTING EDGE; MACROPHAGES; DAMAGE; PATHOPHYSIOLOGY; ACTIVATION	Background: Triggering receptor expressed on myeloid cells-2 (TREM2) is a microglial surface receptor involved in phagocytosis. Clearance of apoptotic debris after stroke represents an important mechanism to re-attain tissue homeostasis and thereby ensure functional recovery. The role of TREM2 following stroke is currently unclear. Methods and Results: As an experimental stroke model, the middle cerebral artery of mice was occluded for 30 minutes with a range of reperfusion times (duration of reperfusion: 6 h/12 h/24 h/2 d/7 d/28 d). Quantitative PCR (qPCR) revealed a greatly increased transcription of TREM2 after stroke. We subsequently analyzed the expression of pro-inflammatory cytokines, chemokines and their receptors in TREM2-knockout (TREM2-KO) mice via qPCR. Microglial activation (CD68, Iba1) and CD3-positive T-cell invasion were analyzed via qPCR and immunohistochemistry. Functional consequences of TREM2 knockout were assessed by infarct volumetry. The acute inflammatory response (12 h reperfusion) was very similar between TREM2-KO mice and their littermate controls. However, in the sub-acute phase (7 d reperfusion) following stroke, TREM2-KO mice showed a decreased transcription of pro-inflammatory cytokines TNF alpha, IL-1 alpha and IL-1 beta, associated with a reduced microglial activity (CD68, Iba1). Furthermore, TREM2-KO mice showed a reduced transcription of chemokines CCL2 (MCP1), CCL3 (MIP1 alpha) and the chemokine receptor CX3CR1, followed by a diminished invasion of CD3-positive T-cells. No effect on the lesion size was observed. Conclusions: Although we initially expected an exaggerated pro-inflammatory response following ablation of TREM2, our data support a contradictory scenario that the sub-acute inflammatory reaction after stroke is attenuated in TREM2-KO mice. We therefore conclude that TREM2 appears to sustain a distinct inflammatory response after stroke.	[Sieber, Matthias W.; Jaenisch, Nadine; Brehm, Martin; Guenther, Madlen; Witte, Otto W.; Frahm, Christiane] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany; [Linnartz-Gerlach, Bettina; Neumann, Harald] Univ Hosp Bonn, Inst Reconstruct Neurobiol, Neural Regenerat Grp, Bonn, Germany	Friedrich Schiller University of Jena; University of Bonn	Frahm, C (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Witte, Otto/P-4127-2018; Linnartz-Gerlach, Bettina/B-9428-2011; Neumann, Harald/A-9718-2010	Witte, Otto/0000-0003-2101-4105; Linnartz-Gerlach, Bettina/0000-0003-4485-684X; Neumann, Harald/0000-0002-5071-5202	European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES) [LSHB-CT-2006-018936]; Jena centre for systems biology of ageing - Jenage [BMBF 0315581]; Deutsche Forschungsgemeinschaft [KFO177, SFB704, FOR1336]; Hertie-Foundation	European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES); Jena centre for systems biology of ageing - Jenage; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie-Foundation	This project was supported by the European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES [LSHB-CT-2006-018936]) and is part of the research program of the Jena centre for systems biology of ageing - Jenage (BMBF 0315581). The Neural Regeneration Group at the University Bonn LIFE & BRAIN Center is supported by the Hertie-Foundation and the Deutsche Forschungsgemeinschaft (KFO177, SFB704, FOR1336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Barnum CJ, 2011, EXP NEUROL, V229, P198, DOI 10.1016/j.expneurol.2011.02.016; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Charles JF, 2008, INFECT IMMUN, V76, P2439, DOI 10.1128/IAI.00115-08; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Fisher Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010830; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim SW, 2007, J NEUROSCI RES, V85, P1252, DOI 10.1002/jnr.21236; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Linnartz B, 2010, INT J ALZHEIMERS DIS, V2010; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang X, 2004, ACTA NEUROCHIR SUPPL, V89, P49; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005	37	96	106	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52982	10.1371/journal.pone.0052982	http://dx.doi.org/10.1371/journal.pone.0052982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301011	Green Submitted, gold, Green Published			2022-12-27	WOS:000313480000023
J	Midtbo, LK; Ibrahim, MM; Myrmel, LS; Aune, UL; Alvheim, AR; Liland, NS; Torstensen, BE; Rosenlund, G; Liaset, B; Brattelid, T; Kristiansen, K; Madsen, L				Midtbo, Lisa Kolden; Ibrahim, Mohammad Madani; Myrmel, Lene Secher; Aune, Ulrike Liisberg; Alvheim, Anita Royneberg; Liland, Nina S.; Torstensen, Bente E.; Rosenlund, Grethe; Liaset, Bjorn; Brattelid, Trond; Kristiansen, Karsten; Madsen, Lise			Intake of Farmed Atlantic Salmon Fed Soybean Oil Increases Insulin Resistance and Hepatic Lipid Accumulation in Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PERSISTENT ORGANIC POLLUTANTS; ADIPOSE-TISSUE INFLAMMATION; FISH-OIL; VEGETABLE-OIL; INDUCED OBESITY; SALAR L.; METABOLISM; STEATOSIS; RECEPTOR	Background: To ensure sustainable aquaculture, fish derived raw materials are replaced by vegetable ingredients. Fatty acid composition and contaminant status of farmed Atlantic salmon (Salmo salar L.) are affected by the use of plant ingredients and a spillover effect on consumers is thus expected. Here we aimed to compare the effects of intake of Atlantic salmon fed fish oil (FO) with intake of Atlantic salmon fed a high proportion of vegetable oils (VOs) on development of insulin resistance and obesity in mice. Methodology/principal findings: Atlantic salmon were fed diets where FO was partly (80%) replaced with three different VOs; rapeseed oil (RO), olive oil (OO) or soy bean oil (SO). Fillets from Atlantic salmon were subsequently used to prepare Western diets (WD) for a mouse feeding trial. Partial replacement of FO with VOs reduced the levels of polychlorinated biphenyls (PCB) and dichloro-diphenyl-tricloroethanes (DDT) with more than 50% in salmon fillets, in WDs containing the fillets, and in white adipose tissue from mice consuming the WDs. Replacement with VOs, SO in particular, lowered the n-3 polyunsaturated fatty acid (PUFA) content and increased n-6 PUFA levels in the salmon fillets, in the prepared WDs, and in red blood cells collected from mice consuming the WDs. Replacing FO with VO did not influence obesity development in the mice, but replacement of FO with RO improved glucose tolerance. Compared with WD-FO fed mice, feeding mice WD-SO containing lower PCB and DDT levels but high levels of linoleic acid (LA), exaggerated insulin resistance and increased accumulation of fat in the liver. Conclusion/Significance: Replacement of FO with VOs in aqua feed for farmed salmon had markedly different spillover effects on metabolism in mice. Our results suggest that the content of LA in VOs may be a matter of concern that warrants further investigation.	[Midtbo, Lisa Kolden; Myrmel, Lene Secher; Aune, Ulrike Liisberg; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Midtbo, Lisa Kolden; Ibrahim, Mohammad Madani; Myrmel, Lene Secher; Aune, Ulrike Liisberg; Alvheim, Anita Royneberg; Liland, Nina S.; Torstensen, Bente E.; Liaset, Bjorn; Brattelid, Trond; Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Ibrahim, Mohammad Madani] Univ Bergen, Inst Biomed, Bergen, Norway	University of Copenhagen; University of Bergen	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	kk@bio.ku.dk; lise.madsen@nifes.no	Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012; Liland, Nina Sylvia/AAC-8701-2020	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Liaset, Bjorn/0000-0002-8652-7801; Liland, Nina Sylvia/0000-0002-1310-0620	Research Council of Norway [199626]; Skretting Aquaculture Research Centre (ARC)	Research Council of Norway(Research Council of Norway); Skretting Aquaculture Research Centre (ARC)	This study was funded by the Research Council of Norway, project 199626. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.; Grete Rosenlund is funded by Skretting Aquaculture Research Centre (ARC). Skretting ARC's role was to produce the salmon for the feeding trial with a fatty acid composition tailored according to the study design. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abeywardena Mahinda Y., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P232; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Airaksinen R, 2011, DIABETES CARE, V34, P1972, DOI 10.2337/dc10-2303; Alvheim AR, 2012, BR J NUTR, P1; Alvheim AR, 2012, OBESITY SILVER SPRIN, V10, P1984; Arslan G, 2002, LIPIDS, V37, P935, DOI 10.1007/s11745-006-0983-2; Berntssen MHG, 2010, CHEMOSPHERE, V78, P637, DOI 10.1016/j.chemosphere.2009.12.021; Berntssen MHG, 2005, AQUACULT NUTR, V11, P219, DOI 10.1111/j.1365-2095.2005.00345.x; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Javadi M, 2004, BRIT J NUTR, V92, P391, DOI 10.1079/BJN20041217; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kajikawa S, 2009, PROSTAG LEUKOTR ESS, V80, P229, DOI 10.1016/j.plefa.2009.02.004; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Liland NS, 2013, AQUACULT NUTR, V19, P289, DOI 10.1111/j.1365-2095.2012.00958.x; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Mori T, 2007, J NUTR, V137, P2629, DOI 10.1093/jn/137.12.2629; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Perez-Echarri N, 2008, EUR J NUTR, V47, P380, DOI 10.1007/s00394-008-0738-3; Perez-Martinez P, 2010, BBA-MOL CELL BIOL L, V1801, P362, DOI 10.1016/j.bbalip.2009.09.010; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28; Samane S, 2009, METABOLISM, V58, P909, DOI 10.1016/j.metabol.2009.02.013; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Seierstad SL, 2005, EUR J CLIN INVEST, V35, P52, DOI 10.1111/j.1365-2362.2005.01443.x; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Tacon A. G. J., 2006, USE FISHERY RESOURCE; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tanaka N, 2010, BIOCHEM PHARMACOL, V80, P1601, DOI 10.1016/j.bcp.2010.07.031; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; Torstensen BE, 2005, J AGR FOOD CHEM, V53, P10166, DOI 10.1021/jf051308i; Torstensen BE, 2011, BRIT J NUTR, V106, P633, DOI 10.1017/S0007114511000729; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Ukropec J, 2003, LIPIDS, V38, P1023, DOI 10.1007/s11745-006-1156-z; Ukropec J, 2010, DIABETOLOGIA, V53, P899, DOI 10.1007/s00125-010-1683-2; Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001	47	32	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53094	10.1371/journal.pone.0053094	http://dx.doi.org/10.1371/journal.pone.0053094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301026	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900059
J	Cao, W; Ribeiro, RD; Liu, DA; Saintigny, P; Xia, RH; Xue, YW; Lin, RX; Mao, L; Ren, HN				Cao, Wei; Ribeiro, Rachel de Oliveira; Liu, Diane; Saintigny, Pierre; Xia, Ronghui; Xue, Yuwen; Lin, Ruxian; Mao, Li; Ren, Hening			EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POLYCOMB GROUP GENE; ZESTE HOMOLOG 2; AGGRESSIVE BREAST-CANCER; GROUP PROTEINS BMI1; DNA METHYLATION; PROSTATE-CANCER; CLINICAL-IMPLICATIONS; INCREASED EXPRESSION; HISTONE DEACETYLASE; DOWN-REGULATION	Background: Epigenetic silencing is a common mechanism to inactivate tumor suppressor genes during carcinogenesis. Enhancer of Zeste 2 (EZH2) is the histone methyltransferase subunit in polycomb repressive complex 2 which mediates transcriptional repression through histone methylation. EZH2 overexpression has been linked to aggressive phenotypes of certain cancers. However, the mechanism that EZH2 played in promoting malignancy in non-small cell lung cancer (NSCLC) remains unclear. In addition, the correlation of EZH2 overexpression and the prognosis of NSCLC patients in non-Asian cohort need to be determined. Methodology/Principal Findings: Up-regulation of EZH2 was found in NSCLC cells compared with normal human bronchial epithelial cells by western blot assay. Upon EZH2 knockdown using small interfering RNA (siRNA), the proliferation, anchorage-independent growth and invasion of NSCLC cells were remarkably suppressed with profound induction of G1 arrest. Furthermore, the expression of cyclin D1 was notably reduced whereas p15(INK4B), p21(Waf1/Cip1) and p27(Kip1) were increased in NSCLC cells after EZH2-siRNA delivery. To determine whether EZH2 expression contributes to disease progression in patients with NSCLC, Taqman quantitative real-time RT-PCR was used to measure the expression of EZH2 in paired tumor and normal samples. Univariate analysis revealed that patients with NSCLC whose tumors had a higher EZH2 expression had significantly inferior overall, disease-specific, and disease-free survivals compared to those whose tumors expressed lower EZH2 (P = 0.005, P = 0.001 and P = 0.003, respectively). In multivariate analysis, EZH2 expression was an independent predictor of disease-free survival (hazard ratio = 0.450, 95% CI: 0.270 to 0.750, P = 0.002). Conclusions/Significance: Our results demonstrate that EZH2 overexpression is critical for NSCLC progression. EZH2 mRNA levels may serve as a prognostic predictor for patients with NSCLC.	[Cao, Wei; Xia, Ronghui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Maxillofacial Head & Neck Oncol,Hosp 9, Shanghai 200030, Peoples R China; [Cao, Wei; Xia, Ronghui; Lin, Ruxian; Mao, Li; Ren, Hening] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Ribeiro, Rachel de Oliveira; Saintigny, Pierre; Xue, Yuwen; Mao, Li; Ren, Hening] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center	Ren, HN (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	Hren@umaryland.edu	Cao, Wei/ABE-1035-2021; Mao, Li/C-7570-2011	Cao, Wei/0000-0003-2184-9380; Mao, Li/0000-0001-7263-3358; Saintigny, Pierre/0000-0002-8090-9323	NIH [R01 CA126818, R01 CA136635]; National Natural Science Foundation of China [81202130]; NATIONAL CANCER INSTITUTE [R01CA126818, P30CA016672, R01CA136635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by NIH grants R01 CA126818 and R01 CA136635. WC is supported in part by the National Natural Science Foundation of China (Grant No. 81202130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Custodio AB, 2009, J THORAC ONCOL, V4, P891, DOI 10.1097/JTO.0b013e3181a4b8fb; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Cao W, 2011, CANCER PREV RES, V4, P1816, DOI 10.1158/1940-6207.CAPR-11-0130; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Choi JH, 2010, APMIS, V118, P196, DOI 10.1111/j.1600-0463.2009.02579.x; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Hinz S, 2009, J UROLOGY, V182, P2920, DOI 10.1016/j.juro.2009.08.014; Huqun, 2012, CANCER-AM CANCER SOC, V118, P1599, DOI 10.1002/cncr.26441; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kikuchi J, 2010, CANCER-AM CANCER SOC, V116, P3015, DOI 10.1002/cncr.25128; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Mao L, 2001, LUNG CANCER, V34, pS27, DOI 10.1016/S0169-5002(01)00341-5; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mok Tony, 2009, Discov Med, V8, P227; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Toll AD, 2010, HUM PATHOL, V41, P1205, DOI 10.1016/j.humpath.2010.03.004; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang J, 2007, CANCER RES, V67, P10647, DOI 10.1158/0008-5472.CAN-07-1337; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; Zhang J, 2006, CANCER RES, V66, P18, DOI 10.1158/0008-5472.CAN-04-3905	47	56	61	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52984	10.1371/journal.pone.0052984	http://dx.doi.org/10.1371/journal.pone.0052984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300840	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600044
J	Emde, S; Rueckert, S; Palm, HW; Klimpel, S				Emde, Sebastian; Rueckert, Sonja; Palm, Harry W.; Klimpel, Sven			Invasive Ponto-Caspian Amphipods and Fish Increase the Distribution Range of the Acanthocephalan Pomphorhynchus tereticollis in the River Rhine	PLOS ONE			English	Article							NEOGOBIUS-MELANOSTOMUS PALLAS; GOBY APOLLONIA-MELANOSTOMA; ROUND GOBY; MACROINVERTEBRATE COMMUNITY; METAZOAN PARASITES; GREAT-LAKES; LAEVIS; PREDATION; GOBIIDAE; HOST	Non-indigenous species that become invasive are one of the main drivers of biodiversity loss worldwide. In various freshwater systems in Europe, populations of native amphipods and fish are progressively displaced by highly adaptive non-indigenous species that can perform explosive range extensions. A total of 40 Ponto-Caspian round gobies Neogobius melanostomus from the Rhine River near Dusseldorf, North Rhine-Westphalia, Germany, were examined for metazoan parasites and feeding ecology. Three metazoan parasite species were found: two Nematoda and one Acanthocephala. The two Nematoda, Raphidascaris acus and Paracuaria adunca, had a low prevalence of 2.5%. The Acanthocephala, Pomphorhynchus tereticollis, was the predominant parasite species, reaching a level of 90.0% prevalence in the larval stage, correlated with fish size. In addition, four invasive amphipod species, Corophium curvispinum (435 specimens), Dikerogammarus villosus (5,454), Echinogammarus trichiatus (2,695) and Orchestia cavimana (1,448) were trapped at the sampling site. Only D. villosus was infected with P. tereticollis at a prevalence of 0.04%. The invasive goby N. melanostomus mainly preys on these non-indigenous amphipods, and may have replaced native amphipods in the transmission of P. tereticollis into the vertebrate paratenic host. This study gives insight into a potential parasite-host system that consists mainly of invasive species, such as the Ponto-Caspian fish and amphipods in the Rhine. We discuss prospective distribution and migration pathways of non-indigenous vertebrate (round goby) and invertebrates (amphipods) under special consideration of parasite dispersal.	[Emde, Sebastian; Klimpel, Sven] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, SGN, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Rueckert, Sonja] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Palm, Harry W.] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Edinburgh Napier University; University of Rostock	Klimpel, S (corresponding author), Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, SGN, Inst Ecol Evolut & Divers, Frankfurt, Germany.	sven.klimpel@senckenberg.de	Rueckert, Sonja/E-4695-2011		Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council DFG [PA 664/4-2, 6-1]	Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council DFG(German Research Foundation (DFG))	The present study was financially supported by the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts as well as the German Research Council DFG PA 664/4-2 and 6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin OM, 2003, SYST PARASITOL, V54, P229, DOI 10.1023/A:1022654921523; Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; [Anonymous], 2000, NEMATODE PARASITES V; [Anonymous], 1994, PARASITIC NEMATODES; Baldauf SA, 2007, INT J PARASITOL, V37, P61, DOI 10.1016/j.ijpara.2006.09.003; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Bernauer Dietmar, 2006, Aquatic Invasions, V1, P55, DOI 10.3391/ai.2006.1.2.2; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Bombarova M, 2007, GENETICA, V131, P141, DOI 10.1007/s10709-006-9124-3; Busch Markus Wilhelm, 2012, P329; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Dezfuli BS, 2011, PARASITE IMMUNOL, V33, P116, DOI 10.1111/j.1365-3024.2010.01266.x; DICK JTA, 1995, BEHAV ECOL SOCIOBIOL, V37, P393, DOI 10.1007/s002650050206; Dunn AM, 1998, ECOGRAPHY, V21, P593, DOI 10.1111/j.1600-0587.1998.tb00551.x; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Eggers Thomas Ols, 2004, Lauterbornia, V50, P1; Emde S, 2010, THESIS HEINRICH HEIN; Francova K, 2011, J APPL ICHTHYOL, V27, P879, DOI 10.1111/j.1439-0426.2010.01582.x; Freyhof J, 2003, BERICHTE IGB, V17, P51; Galil Bella S., 2007, V193, P59; Go Nan YJ, 1969, MEMOIRES MUSEUM NA A, V57; Gollasch Stephan, 2006, Aquatic Invasions, V1, P245, DOI 10.3391/ai.2006.1.4.8; HINE PM, 1974, J FISH BIOL, V6, P521, DOI 10.1111/j.1095-8649.1974.tb04569.x; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson CJ, 1997, CAN J FISH AQUAT SCI, V54, P815, DOI 10.1139/cjfas-54-4-815; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kopp K, 2007, OIKOS, V116, P295, DOI [10.1111/j.2006.0030-1299.15290.x, 10.1111/j.0030-1299.2007.15290.x]; Kvach Y, 2008, J GREAT LAKES RES, V34, P23, DOI 10.3394/0380-1330(2008)34[23:MPOIRA]2.0.CO;2; Kvach Yuriy, 2005, Acta Ichthyologica et Piscatoria, V35, P103; Kvach Y, 2007, PARASITOL RES, V100, P767, DOI 10.1007/s00436-006-0311-z; Kvach Y, 2011, PARASITOL RES, V109, P769, DOI 10.1007/s00436-011-2321-8; Lederer AM, 2008, J GREAT LAKES RES, V34, P690, DOI 10.3394/0380-1330-34.4.690; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Machkevsky V.K., 1990, EKOL MORYA, V36, P69; MacNeil C, 2003, FRESHWATER BIOL, V48, P2085, DOI 10.1046/j.1365-2427.2003.01145.x; Molnar K, 2006, J APPL ICHTHYOL, V22, P395, DOI 10.1111/j.1439-0426.2006.00742.x; Muhlegger JM, 2008, THESIS U WIEN; Nachev M, 2010, IMPACT INVASIVE GOBI, V2010; Ondrackova M, 2005, J APPL ICHTHYOL, V21, P345, DOI 10.1111/j.1439-0426.2005.00682.x; Palm HW, 2008, ZOOMORPHOLOGY, V127, P249, DOI 10.1007/s00435-008-0068-2; Panov Vadim E., 2009, Integrated Environmental Assessment and Management, V5, P110, DOI 10.1897/IEAM_2008-034.1; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Paterson RA, 2011, J ANIM ECOL, V80, P990, DOI 10.1111/j.1365-2656.2011.01834.x; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Perrot-Minnot MJ, 2004, INT J PARASITOL, V34, P45, DOI 10.1016/j.ijpara.2003.10.005; Pinkas L., 1971, CALIF DEP FISH GAME, V152, P1, DOI DOI 10.1201/B18714-2; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pronin NM, 1997, FOLIA PARASIT, V44, P1; QUIGLEY MA, 1989, HYDROBIOLOGIA, V171, P255, DOI 10.1007/BF00008147; Rakauskas Vytautas, 2008, Acta Zoologica Lituanica, V18, P180, DOI 10.2478/v10043-008-0030-z; Riemann F., 1988, P293; Sapota MR, 2006, NOBANIS INVASIVE ALI; Scholl F, 2007, MAKROZOOBENTHOS RHEI; Spakulova M, 2011, HELMINTHOLOGIA, V48, P268, DOI 10.2478/s11687-011-0038-y; Staas S, 2009, FISCHE RHEINS ANGELF; STOREY AW, 1991, HYDROBIOLOGIA, V211, P111, DOI 10.1007/BF00037367; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Thomas F, 2002, BEHAV ECOL SOCIOBIOL, V51, P296, DOI [10.1007/s00265-001-0442-2, 10.1007/S00265-001-0442-2]; Thunken T, 2010, HYDROBIOLOGIA, V654, P137, DOI 10.1007/s10750-010-0377-6; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; van der Velde G, 2007, AQUAT INVASIONS, V2, P261, DOI 10.3391/ai.2007.2.3.11	67	39	40	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53218	10.1371/journal.pone.0053218	http://dx.doi.org/10.1371/journal.pone.0053218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300895	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600072
J	Maletzki, C; Stier, S; Gruenert, U; Gock, M; Ostwald, C; Prall, F; Linnebacher, M				Maletzki, Claudia; Stier, Saskia; Gruenert, Ulrike; Gock, Michael; Ostwald, Christiane; Prall, Friedrich; Linnebacher, Michael			Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; CANCER XENOGRAFTS; MOLECULAR-BIOLOGY; BRAF MUTATION; MODEL; PROLIFERATION; HETEROGENEITY; IMPACT; TUMORS	Background: Colorectal cancer (CRC) represents a morphologic and molecular heterogenic disease. This heterogeneity substantially impairs drug effectiveness and prognosis. The subtype of mismatch repair deficient (MMR-D) CRCs, accounting for about 15% of all cases, shows particular differential responses up to resistance towards currently approved cytostatic drugs. Pre-clinical in vitro models representing molecular features of MMR-D tumors are thus mandatory for identifying biomarkers that finally help to predict responses towards new cytostatic drugs. Here, we describe the successful establishment and characterization of three patient-derived MMR-D cell lines (HROC24, HROC87, and HROC113) along with their corresponding xenografts. Methodology: MMR-D cell lines (HROC24, HROC87, and HROC113) were established from a total of ten clinicopathological well-defined MMR-D cases (120 CRC cases in total). Cells were comprehensively characterized by phenotype, morphology, growth kinetics, invasiveness, and molecular profile. Additionally, response to clinically relevant chemotherapeutics was examined in vitro and in vivo. Principal Findings: Two MMR-D lines showing CIMP-H derived from sporadic CRC (HROC24: K-ras(wt), B-raf(mut), HROC87: K-ras(wt), B-raf(mut)), whereas the HROC113 cell line (K-ras(mut), B-raf(wt)) was HNPCC-associated. A diploid DNA-status could be verified by flow cytometry and SNP Array analysis. All cell lines were characterized as epithelial (EpCAM(+)) tumor cells, showing surface tumor marker expression (CEACAM(+)). MHC-class II was inducible by Interferon-gamma stimulation. Growth kinetics as well as invasive potential was quite heterogeneous between individual lines. Besides, MMR-D cell lines exhibited distinct responsiveness towards chemotherapeutics, even when comparing in vitro and in vivo sensitivity. Conclusions: These newly established and well-characterized, low-passage MMR-D cell lines provide a useful tool for future investigations on the biological characteristics of MMR-D CRCs, both of sporadic and hereditary origin. Additionally, matched patient-derived immune cells allow for comparative genetic studies.	[Maletzki, Claudia; Stier, Saskia; Gruenert, Ulrike; Linnebacher, Michael] Univ Rostock, Div Mol Oncol & Immunotherapy, D-18055 Rostock, Germany; [Gock, Michael] Univ Rostock, Dept Gen Thorac Vasc & Transplantat Surg, D-18055 Rostock, Germany; [Ostwald, Christiane; Prall, Friedrich] Univ Rostock, Inst Pathol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Linnebacher, M (corresponding author), Univ Rostock, Div Mol Oncol & Immunotherapy, D-18055 Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402	Else-Kroner Fresenius Stiftung [2006/A29]; Deutsche Krebshilfe [108919]	Else-Kroner Fresenius Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was substantially supported by grant number 2006/A29 from the Else-Kroner Fresenius Stiftung to ML and by grant number 108919 from the Deutsche Krebshilfe (http://www.northgermantumorbank-crc.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JM, 2011, VIRCHOWS ARCH, V459, P55, DOI 10.1007/s00428-011-1080-3; Baguley BC, 1999, ONCOL RES, V11, P115; Bass A, 2011, J CLIN ONCOL, V29, P2728, DOI 10.1200/JCO.2011.36.1816; Bocsi J, 1999, J CANCER RES CLIN, V125, P9, DOI 10.1007/s004320050236; Castellanos E, 2011, CURR ONCOL REP, V13, P195, DOI 10.1007/s11912-011-0164-1; Correale P, 2012, INT J CANCER, V130, P1577, DOI 10.1002/ijc.26181; DANES BS, 1988, SCAND J GASTROENTERO, V23, P840, DOI 10.3109/00365528809090770; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; El-Osta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025806; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Gagos S, 1996, CANCER GENET CYTOGEN, V90, P157, DOI 10.1016/S0165-4608(96)00049-0; Harrison S, 2011, SURG-J R COLL SURG E, V9, P200, DOI 10.1016/j.surge.2011.01.011; Hector S, 2012, GUT, V61, P725, DOI 10.1136/gutjnl-2011-300433; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hewitt RE, 2000, J PATHOL, V192, P446; Jaster R, 2005, J CELL MOL MED, V9, P670, DOI 10.1111/j.1582-4934.2005.tb00497.x; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kang GH, 2011, ARCH PATHOL LAB MED, V135, P698, DOI 10.1043/2010-0523-RA.1; Kim ST, 2010, CANCER CHEMOTH PHARM, V66, P659, DOI 10.1007/s00280-009-1206-3; KIRKLAND SC, 1986, BRIT J CANCER, V53, P779, DOI 10.1038/bjc.1986.132; Klier U, 2010, LANGENBECK ARCH SURG, V395, P365, DOI 10.1007/s00423-010-0598-1; Ku JL, 2010, CARCINOGENESIS, V31, P1003, DOI 10.1093/carcin/bgq043; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Madajewicz S, 2012, INVEST NEW DRUG, V30, P772, DOI 10.1007/s10637-010-9598-9; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; POUPON MF, 1993, J NATL CANCER I, V85, P2023, DOI 10.1093/jnci/85.24.2023; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Saif MW, 2011, ANTICANCER RES, V31, P2971; Swanton C, 2009, BRIT J CANCER, V100, P1517, DOI 10.1038/sj.bjc.6605031; Tognon M, 1996, CANCER GENET CYTOGEN, V90, P17, DOI 10.1016/0165-4608(96)00067-2; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227	37	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52485	10.1371/journal.pone.0052485	http://dx.doi.org/10.1371/journal.pone.0052485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300683	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600017
J	Nassour, M; Idoux-Gillet, Y; Selmi, A; Come, C; Faraldo, MLM; Deugnier, MA; Savagner, P				Nassour, Mayssa; Idoux-Gillet, Ysia; Selmi, Abdelkader; Come, Christophe; Faraldo, Maria-Luisa M.; Deugnier, Marie-Ange; Savagner, Pierre			Slug Controls Stem/Progenitor Cell Growth Dynamics during Mammary Gland Morphogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMAD-INTERACTING PROTEIN-1; CANCER STEM-CELLS; BREAST-CANCER; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NEURAL CREST; SELF-RENEWAL; SNAIL; CARCINOMA	Background: Morphogenesis results from the coordination of distinct cell signaling pathways controlling migration, differentiation, apoptosis, and proliferation, along stem/progenitor cell dynamics. To decipher this puzzle, we focused on epithelial-mesenchymal transition (EMT) "master genes''. EMT has emerged as a unifying concept, involving cell-cell adhesion, migration and apoptotic pathways. EMT also appears to mingle with stemness. However, very little is known on the physiological role and relevance of EMT master-genes. We addressed this question during mammary morphogenesis. Recently, a link between Slug/Snai2 and stemness has been described in mammary epithelial cells, but EMT master genes actual localization, role and targets during mammary gland morphogenesis are not known and we focused on this basic question. Methodology/Principal Findings: Using a Slug-lacZ transgenic model and immunolocalization, we located Slug in a distinct subpopulation covering about 10-20% basal cap and duct cells, mostly cycling cells, coexpressed with basal markers P-cadherin, CK5 and CD49f. During puberty, Slug-deficient mammary epithelium exhibited a delayed development after transplantation, contained less cycling cells, and overexpressed CK8/18, ER, GATA3 and BMI1 genes, linked to luminal lineage. Other EMT master genes were overexpressed, suggesting compensation mechanisms. Gain/loss-of-function in vitro experiments confirmed Slug control of mammary epithelial cell luminal differentiation and proliferation. In addition, they showed that Slug enhances specifically clonal mammosphere emergence and growth, cell motility, and represses apoptosis. Strikingly, Slug-deprived mammary epithelial cells lost their potential to generate secondary clonal mammospheres. Conclusions/Significance: We conclude that Slug pathway controls the growth dynamics of a subpopulation of cycling progenitor basal cells during mammary morphogenesis. Overall, our data better define a key mechanism coordinating cell lineage dynamics and morphogenesis, and provide physiological relevance to broadening EMT pathways.	[Nassour, Mayssa; Idoux-Gillet, Ysia; Selmi, Abdelkader; Come, Christophe; Savagner, Pierre] Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, Ctr Reg Lutte Canc Val dAurelle Paul Lamarque,U89, F-34059 Montpellier, France; [Faraldo, Maria-Luisa M.; Deugnier, Marie-Ange] Inst Curie, CNRS, UMR144, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Savagner, P (corresponding author), Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, Ctr Reg Lutte Canc Val dAurelle Paul Lamarque,U89, F-34059 Montpellier, France.	psavagner@unicancer.montpellier.fr	Deugnier, Marie-Ange/M-7556-2018; Savagner, Pierre/AAD-9357-2020; Martin-Faraldo, Maria-Luisa/M-5811-2018; Côme, Christophe/E-8395-2016; Deugnier, Marie-Ange/AAF-5877-2021	Côme, Christophe/0000-0001-5229-4440; Deugnier, Marie-Ange/0000-0002-2199-1099; Faraldo, Marisa/0000-0001-9497-1171; Savagner, Pierre/0000-0002-8287-2229; Selmi, Abdelkader/0000-0001-5760-0507; Idoux-Gillet, Ysia/0000-0002-0436-1968	Fondation de France; Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon); Ligue Regionale contre le Cancer; ARC (Association pour la Recherche sur le Cancer); Ligue Regionale contre le Cancer (Languedoc-Roussillon)	Fondation de France(Fondation de France); Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon); Ligue Regionale contre le Cancer(Ligue nationale contre le cancer); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale contre le Cancer (Languedoc-Roussillon)	Financial support was provided by the Fondation de France, the Ligue Regionale contre le Cancer (Languedoc-Roussillon) and Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon). In addition, the authors gratefully acknowledge support from the Ligue Regionale contre le Cancer for C. Come and Y. Idoux-Gillet and ARC (Association pour la Recherche sur le Cancer) for M. Nassour and V. Arnoux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DEOME KB, 1959, CANCER RES, V19, P515; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MAYOR R, 1995, DEVELOPMENT, V121, P767; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Perez-Losada J, 2010, CELL CYCLE, V9, P2706; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Romano LA, 1999, DEV BIOL, V212, P243, DOI 10.1006/dbio.1999.9339; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shi J, 2011, DEVELOPMENT; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Sun Y, 2010, BLOOD, V115, P1709, DOI 10.1182/blood-2009-07-232934; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, COLD SPRING HARBOR P, V3; Wegwitz F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012103; YOUNG LJT, 1984, CANCER RES, V44, P4333	42	73	76	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53498	10.1371/journal.pone.0053498	http://dx.doi.org/10.1371/journal.pone.0053498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300933	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100133
J	Jiang, N; Yang, YP; Janbon, G; Pan, J; Zhu, XD				Jiang, Nan; Yang, Yaping; Janbon, Guilhem; Pan, Jiao; Zhu, Xudong			Identification and Functional Demonstration of miRNAs in the Fungus Cryptococcus neoformans	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; RNA INTERFERENCE; MICRORNAS; GENE; LACCASE; BIOGENESIS; MECHANISMS; EXPRESSION; VIRULENCE; PATHWAYS	microRNAs (miRNAs), endogenous posttranscriptional repressors by base-pairing of their cognate mRNAs in plants and animals, have mostly been thought lost in the kingdom of fungi. Here, we report the identification of miRNAs from the fungus Cryptococcus neoformans. With bioinformatics and Northern blotting approaches, we found that these miRNAs and their hairpin precursors were present in this fungus. The size of miR1 and miR2 is 22 nt and 18 nt, respectively. The precursors are about similar to 70 nt in length that is close to mammalian pre-miRNAs. Characteristic features of miRNAs are also found in miR1/2. We demonstrated that the identified miRNAs, miR1 and miR2, caused transgene silencing via the canonical RNAi pathway. Bioinformantics analysis helps to reveal a number of identical sequences of the miR1/2 in transposable elements (TEs) and pseudogenes, prompting us to think that fungal miRNAs might be involved in the regulation of the activity of transposons and the expression of pseudogenes. This study identified functional miRNAs in C. neoformans, and sheds light on the diversity and evolutionary origin of eukaryotic miRNAs.	[Jiang, Nan; Yang, Yaping; Pan, Jiao; Zhu, Xudong] Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China; [Jiang, Nan] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Janbon, Guilhem] Inst Pasteur, Dept Mol Mycol, Paris, France	Nankai University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zhu, XD (corresponding author), Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China.	Xudong82@nankai.edu.cn	yang, yaping/AAQ-8228-2020; Janbon, Guilhem/AAW-7398-2021; Janbon, Guilhem/AAL-6607-2021; JIANG, NAN/AHB-1945-2022	Janbon, Guilhem/0000-0002-4788-1154; 	Natural Science Foundation of China (NSFC) [30770043]; National Basic Research Program ("973'' Program) [2007CB707801]; National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI47087]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI047087] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program ("973'' Program)(National Basic Research Program of China); National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported, in part, by Natural Science Foundation of China (NSFC Grant #30770043), and a National Basic Research Program ("973'' Program #2007CB707801). The authors also acknowledge use of the C. neoformans Genome Project, Stanford Genome Technology Center (http://www-sequence.standford.edu), funded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health under cooperative agreement AI47087. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benfey PN, 2003, SCIENCE, V425, P244; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Drivinya Antra, 2004, Nihon Ishinkin Gakkai Zasshi, V45, P1, DOI 10.3314/jjmm.45.1; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Janbon G, 2010, FUNGAL GENET BIOL, V47, P1070, DOI 10.1016/j.fgb.2010.10.005; Jiang N, 2009, APPL ENVIRON MICROB, V75, P6777, DOI 10.1128/AEM.00708-09; Jiang N, 2009, FEMS MICROBIOL LETT, V296, P84, DOI 10.1111/j.1574-6968.2009.01619.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Liu H, 2002, GENETICS, V160, P463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Swami M, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2834; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wickes B.L., 1994, MOL BIOL PATHOGENIC, P309; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Yu SW, 2010, PLANT MOL BIOL REP, V28, P502, DOI 10.1007/s11105-009-0175-3; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004; Zhu XD, 2003, MOL MICROBIOL, V50, P1271, DOI 10.1046/j.1365-2958.2003.03752.x	44	52	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52734	10.1371/journal.pone.0052734	http://dx.doi.org/10.1371/journal.pone.0052734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300755	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800135
J	Ritz, T; Enlow, MB; Schulz, SM; Kitts, R; Staudenmayer, J; Wright, RJ				Ritz, Thomas; Enlow, Michelle Bosquet; Schulz, Stefan M.; Kitts, Robert; Staudenmayer, John; Wright, Rosalind J.			Respiratory Sinus Arrhythmia as an Index of Vagal Activity during Stress in Infants: Respiratory Influences and Their Control	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PULMONARY GAS-EXCHANGE; PERIOD VARIABILITY; PRETERM INFANTS; STILL-FACE; REACTIVITY; ATTENTION; RESPONSES; STABILITY; ADOLESCENTS	Respiratory sinus arrhythmia (RSA) is related to cardiac vagal outflow and the respiratory pattern. Prior infant studies have not systematically examined respiration rate and tidal volume influences on infant RSA or the extent to which infants' breathing is too fast to extract a valid RSA. We therefore monitored cardiac activity, respiration, and physical activity in 23 six-month old infants during a standardized laboratory stressor protocol. On average, 12.6% (range 0-58.2%) of analyzed breaths were too short for RSA extraction. Higher respiration rate was associated with lower RSA amplitude in most infants, and lower tidal volume was associated with lower RSA amplitude in some infants. RSA amplitude corrected for respiration rate and tidal volume influences showed theoretically expected strong reductions during stress, whereas performance of uncorrected RSA was less consistent. We conclude that stress-induced changes of peak-valley RSA and effects of variations in breathing patterns on RSA can be determined for a representative percentage of infant breaths. As expected, breathing substantially affects infant RSA and needs to be considered in studies of infant psychophysiology.	[Ritz, Thomas] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Enlow, Michelle Bosquet; Kitts, Robert] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Enlow, Michelle Bosquet; Kitts, Robert] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schulz, Stefan M.] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany; [Schulz, Stefan M.] Univ Wurzburg, CHFC, D-97070 Wurzburg, Germany; [Staudenmayer, John] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Wright, Rosalind J.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Dept Med,Med Sch, Boston, MA 02115 USA; [Wright, Rosalind J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Southern Methodist University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wurzburg; University of Wurzburg; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ritz, T (corresponding author), So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA.	tritz@smu.edu; michelle.bosquet@childrens.harvard.edu	Ghiami, Zeinab/G-5492-2016; Schulz, Stefan M/E-8737-2010	Schulz, Stefan M/0000-0003-0550-2440; Bosquet Enlow, Michelle/0000-0003-2598-3894	BMBF [01EO1004, R01 HL080674]; Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital;  [R01 HL089761];  [K08MH074588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089761, R01HL080674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH074588] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	During preparation of this manuscript, the authors were supported by R01 HL089761 (TR), K08MH074588 (MBE), BMBF project 01EO1004 (SMS), R01 HL080674 (RJW), and the Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital (MBE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkon A, 2006, DEV PSYCHOBIOL, V48, P197, DOI 10.1002/dev.20129; Balding DJ, 2004, APPL LONGITUDINAL AN; BALDZER K, 1989, PEDIATR RES, V26, P188, DOI 10.1203/00006450-198909000-00004; Bar-Haim Y, 2000, DEV PSYCHOBIOL, V37, P44, DOI 10.1002/1098-2302(200007)37:1<44::AID-DEV6>3.0.CO;2-7; Bazhenova OV, 2007, INT J PSYCHOPHYSIOL, V63, P64, DOI 10.1016/j.ijpsycho.2006.08.008; Bazhenova OV, 2001, CHILD DEV, V72, P1314, DOI 10.1111/1467-8624.00350; Beauchaine TP, 2001, J ABNORM PSYCHOL, V110, P610, DOI 10.1037//0021-843X.110.4.610; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; BIGGER JT, 1993, J AM COLL CARDIOL, V21, P729, DOI 10.1016/0735-1097(93)90106-B; Brown TE, 2003, J APPL PHYSIOL, V75, P2310; Carroll JL, 2003, J APPL PHYSIOL, V94, P375, DOI 10.1152/japplphysiol.00809.2002; Castro Mario, 2009, Proc Am Thorac Soc, V6, P1, DOI 10.1513/pats.200810-116CB; Chen CL, 2004, J APPL PHYSIOL, V96, P2226, DOI 10.1152/japplphysiol.01037.2003; Cyranowski JM, 2011, PSYCHOSOM MED, V73, P336, DOI 10.1097/PSY.0b013e318213925d; De Geus EJC, 2007, PSYCHOSOM MED, V69, P356, DOI 10.1097/PSY.0b013e318049cc2d; DITTO B, 1990, PSYCHOSOM MED, V52, P610, DOI 10.1097/00006842-199011000-00002; Dubreuil E, 2003, PSYCHOPHYSIOLOGY, V40, P849, DOI 10.1111/1469-8986.00103; DYKES FD, 1986, PEDIATR RES, V20, P301, DOI 10.1203/00006450-198604000-00005; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961, DOI 10.1152/jappl.1983.54.4.961; Eckberg DL, 2009, J APPL PHYSIOL, V106, P1740, DOI 10.1152/japplphysiol.91107.2008; El-Sheikh M, 2005, DEV PSYCHOBIOL, V46, P66, DOI 10.1002/dev.20036; Enlow MB, 2009, PSYCHOSOM MED, V71, P607, DOI 10.1097/PSY.0b013e3181ad1c8b; FOX NA, 1983, PSYCHOPHYSIOLOGY, V20, P481, DOI 10.1111/j.1469-8986.1983.tb03000.x; Gerlach AL, 2006, PSYCHOSOM MED, V68, P331, DOI 10.1097/01.psy.0000203284.53066.4b; Giardino ND, 2003, AM J PHYSIOL-HEART C, V284, pH1585, DOI 10.1152/ajpheart.00893.2002; GIDDENS DP, 1985, J THEOR BIOL, V113, P759, DOI 10.1016/S0022-5193(85)80192-2; Gorman J M, 2000, Am Heart J, V140, P77, DOI 10.1067/mhj.2000.109981; Grossman P, 2004, AM J PHYSIOL-HEART C, V287, pH728, DOI 10.1152/ajpheart.00825.2003; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P702, DOI 10.1111/j.1469-8986.1990.tb03198.x; GROSSMAN P, 1991, PSYCHOPHYSIOLOGY, V28, P201, DOI 10.1111/j.1469-8986.1991.tb00412.x; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Haley DW, 2003, CHILD DEV, V74, P1534, DOI 10.1111/1467-8624.00621; HARPER RM, 1978, SLEEP, V1, P33, DOI 10.1093/sleep/1.1.33; Hayano J, 1996, CIRCULATION, V94, P842, DOI 10.1161/01.CIR.94.4.842; Hill-Soderlund AL, 2008, DEV PSYCHOBIOL, V50, P361, DOI 10.1002/dev.20302; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Holditch-Davis Diane, 2004, J Perinatol, V24, P631, DOI 10.1038/sj.jp.7211150; INUI K, 1993, J NEUROPHYSIOL, V70, P2205, DOI 10.1152/jn.1993.70.6.2205; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Karemaker JM, 2009, J APPL PHYSIOL, V106, P1742, DOI 10.1152/japplphysiol.91107.2008a; KITNEY R I, 1984, Automedica (London), V5, P289; KOIZUMI K, 1981, J AUTONOM NERV SYST, V3, P483, DOI 10.1016/0165-1838(81)90082-5; Longin E, 2005, EARLY HUM DEV, V81, P663, DOI 10.1016/j.earlhumdev.2005.03.015; LOPES OU, 1976, NATURE, V264, P454, DOI 10.1038/264454a0; Lucini D, 2005, HYPERTENSION, V46, P1201, DOI 10.1161/01.HYP.0000185147.32385.4b; Marsh P, 2008, PSYCHOPHYSIOLOGY, V45, P100, DOI 10.1111/j.1469-8986.2007.00603.x; Moore GA, 2004, DEV PSYCHOL, V40, P1068, DOI 10.1037/0012-1649.40.6.1068; Moore GA, 2009, J CHILD PSYCHOL PSYC, V50, P1392, DOI 10.1111/j.1469-7610.2009.02171.x; Oberlander TF, 2010, ALCOHOL CLIN EXP RES, V34, P681, DOI 10.1111/j.1530-0277.2009.01137.x; Overbeek TJM, 2012, BIOL PSYCHOL, V91, P128, DOI 10.1016/j.biopsycho.2012.05.011; Patzak A, 1996, AM J PHYSIOL-REG I, V271, pR1025, DOI 10.1152/ajpregu.1996.271.4.R1025; PEREYRA PM, 1992, J NEUROL SCI, V110, P107, DOI 10.1016/0022-510X(92)90016-E; Porges SW, 1999, PSYCHOPHYSIOLOGY, V36, P14, DOI 10.1017/S004857729997035X; PORGES SW, 1991, ANN NY ACAD SCI, V618, P57, DOI 10.1111/j.1749-6632.1991.tb27237.x; RICHARDS JE, 1994, PSYCHOPHYSIOLOGY, V31, P235, DOI 10.1111/j.1469-8986.1994.tb02212.x; RICHARDS JE, 1991, PSYCHOPHYSIOLOGY, V28, P43, DOI 10.1111/j.1469-8986.1991.tb03385.x; RICHARDS JE, 1989, PSYCHOPHYSIOLOGY, V26, P422, DOI 10.1111/j.1469-8986.1989.tb01944.x; Ritz T, 2005, PSYCHOPHYSIOLOGY, V42, P568, DOI 10.1111/j.1469-8986.2005.00312.x; Ritz T, 2002, PSYCHOPHYSIOLOGY, V39, P546, DOI 10.1017/S0048577202010715; Ritz T, 2001, PSYCHOPHYSIOLOGY, V38, P858, DOI 10.1017/S0048577201000701; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Ritz T, 2009, BIOL PSYCHOL, V80, P158, DOI 10.1016/j.biopsycho.2008.08.003; ROTHER M, 1989, EARLY HUM DEV, V20, P1, DOI 10.1016/0378-3782(89)90068-6; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; Schulz SM, 2009, BEHAV RES METHODS, V41, P1121, DOI 10.3758/BRM.41.4.1121; SLEIGHT P, 1978, CLIN SCI MOL MED, V55, pS381, DOI 10.1042/cs055381s; SNIDMAN N, 1995, PSYCHOPHYSIOLOGY, V32, P199, DOI 10.1111/j.1469-8986.1995.tb02949.x; SPYER KM, 1988, ANN NY ACAD SCI, V533, P350, DOI 10.1111/j.1749-6632.1988.tb37263.x; Steptoe A, 1996, J Cardiovasc Risk, V3, P83, DOI 10.1097/00043798-199602000-00012; STEVENSON M, 1978, DEV PSYCHOBIOL, V11, P393, DOI 10.1002/dev.420110503; THOMPSON CR, 1993, EARLY HUM DEV, V31, P217, DOI 10.1016/0378-3782(93)90197-3; Weinberg MK, 1996, CHILD DEV, V67, P905, DOI 10.2307/1131869; Wilhelm FH, 2004, TECH PAPERS ISA, V449, P317; WITTE H, 1988, PFLUG ARCH EUR J PHY, V412, P442, DOI 10.1007/BF01907565; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2010, BIOL PSYCHOL, V84, P46, DOI 10.1016/j.biopsycho.2010.01.007; Yeragani VK, 2002, BIOL PSYCHIAT, V52, P418, DOI 10.1016/S0006-3223(02)01394-X	81	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52729	10.1371/journal.pone.0052729	http://dx.doi.org/10.1371/journal.pone.0052729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300753	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800133
J	Agim, ZS; Esendal, M; Briollais, L; Uyan, O; Meschian, M; Martinez, LAM; Ding, YM; Basak, AN; Ozcelik, H				Agim, Zeynep Sena; Esendal, Melda; Briollais, Laurent; Uyan, Ozgun; Meschian, Mehran; Martinez, Luis Antonio Mendoza; Ding, Yongmei; Basak, A. Nazli; Ozcelik, Hilmi			Discovery, Validation and Characterization of Erbb4 and Nrg1 Haplotypes Using Data from Three Genome-Wide Association Studies of Schizophrenia	PLOS ONE			English	Article							NEUREGULIN 1; BIPOLAR DISORDER; GENE; SUSCEPTIBILITY; METAANALYSIS; INVOLVEMENT; PHENOTYPES; GENOTYPES; SUPPORT	Schizophrenia is one of the most common and complex neuropsychiatric disorders, which is contributed both by genetic and environmental exposures. Recently, it is shown that NRG1-mediated ErbB4 signalling regulates many important cellular and molecular processes such as cellular growth, differentiation and death, particularly in myelin-producing cells, glia and neurons. Recent association studies have revealed genomic regions of NRG1 and ERBB4, which are significantly associated with risk of developing schizophrenia; however, inconsistencies exist in terms of validation of findings between distinct populations. In this study, we aim to validate the previously identified regions and to discover novel haplotypes of NRG1 and ERBB4 using logistic regression models and Haploview analyses in three independent datasets from GWAS conducted on European subjects, namely, CATIE, GAIN and nonGAIN. We identified a significant 6-kb block in ERBB4 between chromosome locations 212,156,823 and 212,162,848 in CATIE and GAIN datasets (p = 0.0206 and 0.0095, respectively). In NRG1, a significant 25-kb block, between 32,291,552 and 32,317,192, was associated with risk of schizophrenia in all CATIE, GAIN, and nonGAIN datasets (p = 0.0005, 0.0589, and 0.0143, respectively). Fine mapping and FastSNP analysis of genetic variation located within significantly associated regions proved the presence of binding sites for several transcription factors such as SRY, SOX5, CEPB, and ETS1. In this study, we have discovered and validated haplotypes of ERBB4 and NRG1 in three independent European populations. These findings suggest that these haplotypes play an important role in the development of schizophrenia by affecting transcription factor binding affinity.	[Agim, Zeynep Sena; Uyan, Ozgun; Basak, A. Nazli] Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey; [Esendal, Melda; Meschian, Mehran; Martinez, Luis Antonio Mendoza; Ding, Yongmei; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Briollais, Laurent] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada	Bogazici University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Ozcelik, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ozcelik@lunenfeld.ca	Agim, Zeynep Sena/L-8142-2019; Briollais, Laurent/A-2941-2013	Agim, Zeynep Sena/0000-0002-8699-9884; 	Suna and Inan Kirac Foundation; Scientific and Technological Research Council of Turkey [SBAG 109S075]; Bogazici University Research Funds [BAP 6055]; National Institute of Mental Health (NIMH) [N01MH900001, MH074027]; Genomics Research Branch at NIMH; Genetic Association Information Network (GAIN); NIMH Schizophrenia Genetics Initiative [U01s: MH46276, MH46289, MH46318]; MGS Part 1 (MGS1) [R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879]; MGS Part 2 (MGS2) [R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879];  [MGS U01s: MH79469];  [MH79470]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046276, U01MH079469, U01MH046289, Z01MH900001, R01MH067257, R01MH060879, R01MH059571, U01MH079470, R01MH059588, R01MH074027] Funding Source: NIH RePORTER	Suna and Inan Kirac Foundation; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bogazici University Research Funds(Bogazici University); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Genomics Research Branch at NIMH; Genetic Association Information Network (GAIN); NIMH Schizophrenia Genetics Initiative; MGS Part 1 (MGS1); MGS Part 2 (MGS2); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Suna and Inan Kirac Foundation, by The Scientific and Technological Research Council of Turkey (SBAG 109S075) and by Bogazici University Research Funds (BAP 6055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The principal investigators of the CATIE trial, Jeffrey A. Lieberman, T. Scott Stroup, and Joseph P. McEvoy, received the funding from the National Institute of Mental Health (NIMH; N01MH900001) along with MH074027 (PI P. F. Sullivan). Funding support for the companion studies, Genome-Wide Association Study of Schizophrenia (GAIN) and Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN), was provided by Genomics Research Branch at NIMH (see below), and the genotyping and analysis of samples was provided through the Genetic Association Information Network (GAIN) and under the MGS U01s: MH79469 and MH79470. Assistance with data cleaning was provided by the National Center for Biotechnology Information. Samples and associated phenotype data for the MGS GWAS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH46276 (C. R. Cloninger), MH46289 (C. Kaufmann), and MH46318 (M. T. Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (N. G. Buccola), MH59588 (B. J. Mowry), MH59571 (P. V. Gejman), MH59565 (Robert Freedman), MH59587 (F. Amin), MH60870 (W. F. Byerley), MH59566 (D. W. Black), MH59586 (J. M. Silverman), MH61675 (D. F. Levinson), and MH60879 (C. R. Cloninger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gong YG, 2009, SCHIZOPHR RES, V111, P109, DOI 10.1016/j.schres.2009.03.017; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lachman HM, 2006, AM J MED GENET B, V141B, P102, DOI 10.1002/ajmg.b.30242; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lu CL, 2010, NEUROSCI LETT, V481, P120, DOI 10.1016/j.neulet.2010.06.067; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Thomson PA, 2007, MOL PSYCHIATR, V12, P94, DOI 10.1038/sj.mp.4001889; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Walker RM, 2010, NEUROSCI LETT, V478, P9, DOI 10.1016/j.neulet.2010.04.056; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	28	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53042	10.1371/journal.pone.0053042	http://dx.doi.org/10.1371/journal.pone.0053042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301017	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000026
J	Chtarto, A; Bockstael, O; Gebara, E; Vermoesen, K; Melas, C; Pythoud, C; Levivier, M; De Witte, O; Luthi-Carter, R; Clinkers, R; Tenenbaum, L				Chtarto, Abdelwahed; Bockstael, Olivier; Gebara, Elias; Vermoesen, Katia; Melas, Catherine; Pythoud, Catherine; Levivier, Marc; De Witte, Olivier; Luthi-Carter, Ruth; Clinkers, Ralph; Tenenbaum, Liliane			An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-kappa B Activation for Disease-Inducible Gene Transfer	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; VIRAL VECTOR SEROTYPE-1; CENTRAL-NERVOUS-SYSTEM; TRANSGENE EXPRESSION; IN-VIVO; STATUS EPILEPTICUS; MAMMALIAN-CELLS; KAINIC ACID; DOPAMINERGIC-NEURONS	Stimulation of resident cells by NF-kappa B activating cytokines is a central element of inflammatory and degenerative disorders of the central nervous system (CNS). This disease-mediated NF-kappa B activation could be used to drive transgene expression selectively in affected cells, using adeno-associated virus (AAV)-mediated gene transfer. We have constructed a series of AAV vectors expressing GFP under the control of different promoters including NF-kappa B -responsive elements. As an initial screen, the vectors were tested in vitro in HEK-293T cells treated with TNF-alpha. The best profile of GFP induction was obtained with a promoter containing two blocks of four NF-kappa B -responsive sequences from the human JCV neurotropic polyoma virus promoter, fused to a new tight minimal CMV promoter, optimally distant from each other. A therapeutical gene, glial cell line-derived neurotrophic factor (GDNF) cDNA under the control of serotype 1-encapsidated NF-kappa B -responsive AAV vector (AAV-NF) was protective in senescent cultures of mouse cortical neurons. AAV-NF was then evaluated in vivo in the kainic acid (KA)-induced status epilepticus rat model for temporal lobe epilepsy, a major neurological disorder with a central pathophysiological role for NF-kappa B activation. We demonstrate that AAV-NF, injected in the hippocampus, responded to disease induction by mediating GFP expression, preferentially in CA1 and CA3 neurons and astrocytes, specifically in regions where inflammatory markers were also induced. Altogether, these data demonstrate the feasibility to use disease-activated transcription factor-responsive elements in order to drive transgene expression specifically in affected cells in inflammatory CNS disorders using AAV-mediated gene transfer.	[Chtarto, Abdelwahed; Bockstael, Olivier; Melas, Catherine; De Witte, Olivier] ULB, Lab Expt Neurosurg, Brussels, Belgium; [Chtarto, Abdelwahed; Bockstael, Olivier; Melas, Catherine] ULB, IRIBHM, Fac Med, Brussels, Belgium; [Gebara, Elias; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain & Mind Inst, CH-1015 Lausanne, Switzerland; [Vermoesen, Katia; Clinkers, Ralph] Vrije Univ Brussel, Fac Med & Pharm, Ctr Neurosci C4F, Dept Pharmaceut Chem & Drug Anal, Brussels, Belgium; [Pythoud, Catherine; Levivier, Marc; Tenenbaum, Liliane] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Ecole Polytechnique Federale de Lausanne; Vrije Universiteit Brussel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chtarto, A (corresponding author), ULB, Lab Expt Neurosurg, Brussels, Belgium.	achtarto@ulb.ac.be	Tenenbaum, Liliane/O-5917-2016; Tenenbaum, Liliane/AAW-5685-2021	Tenenbaum, Liliane/0000-0003-4619-9660; Tenenbaum, Liliane/0000-0003-4619-9660; Gebara, Elias/0000-0003-4389-6604	FNRS- Televie [7.4.593.08 F]; "Credit aux chercheurs'' from the Belgian National Research Foundation [1.5.093.08]; Fonds National de la Recherche Scientifique Medicale [7.4.536.09 F]; "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC; Swiss National Research Foundation (FNS) [FN31003A-127177]; Agency for Innovation by Science and Technology (IWT Vlaanderen); Research Foundation Flanders (FWO Vlaanderen).	FNRS- Televie(Fonds de la Recherche Scientifique - FNRS); "Credit aux chercheurs'' from the Belgian National Research Foundation; Fonds National de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC; Swiss National Research Foundation (FNS)(Swiss National Science Foundation (SNSF)); Agency for Innovation by Science and Technology (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO Vlaanderen).(FWO)	This work was supported by FNRS- Televie: grant number: 7.4.593.08 F. "Credit aux chercheurs'' from the Belgian National Research Foundation: grant number: 1.5.093.08, "Fonds National de la Recherche Scientifique Medicale'' grant number 7.4.536.09 F. "Region Bruxelles-Capitale'' (SOIB) grant REGAVEC 2007-10, Swiss National Research Foundation (FNS) grant number: FN31003A-127177, Agency for Innovation by Science and Technology (IWT Vlaanderen), and Research Foundation Flanders (FWO Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2007, ANN RHEUM DIS, V66, P1143, DOI 10.1136/ard.2006.064519; Afione SA, 1996, J VIROL, V70, P3235, DOI 10.1128/JVI.70.5.3235-3241.1996; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Bockstael O, 2012, HUM GENE THER, V23, P742, DOI 10.1089/hum.2011.216; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Channavajhala PL, 2005, BIOCHEM BIOPH RES CO, V334, P1214, DOI 10.1016/j.bbrc.2005.07.009; Chtarto A, 2003, GENE THER, V10, P84, DOI 10.1038/sj.gt.3301838; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; EGGERMONT J, 1993, EMBO J, V12, P2539, DOI 10.1002/j.1460-2075.1993.tb05909.x; Emborg ME, 2009, NEUROBIOL DIS, V36, P303, DOI 10.1016/j.nbd.2009.07.022; Fluri DA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-75; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gemma C, 2002, J NEUROSCI, V22, P6114; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Haberman RP, 2002, MOL THER, V6, P495, DOI 10.1006/mthe.2002.0701; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Jakobsson J, 2004, EUR J NEUROSCI, V19, P761, DOI 10.1111/j.0953-816X.2003.03147.x; Jankowsky JL, 2000, LEARN MEMORY, V7, P400, DOI 10.1101/lm.32600; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lock M, 2010, HUM GENE THER, V21, P1273, DOI 10.1089/hum.2009.223; LOTHMAN EW, 1990, EPILEPSY RES, V6, P110, DOI 10.1016/0920-1211(90)90085-A; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Lubin FD, 2005, NEUROSCIENCE, V133, P969, DOI 10.1016/j.neuroscience.2005.03.028; Majores M, 2004, EPILEPSY RES, V60, P173, DOI 10.1016/j.eplepsyres.2004.07.002; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Melas C, 2008, HUM GENE THER; Oprica M, 2003, J CELL MOL MED, V7, P127, DOI 10.1111/j.1582-4934.2003.tb00211.x; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Phillips MI, 2002, HYPERTENSION, V39, P651, DOI 10.1161/hy0202.103472; RANGANATHAN PN, 1993, NUCLEIC ACIDS RES, V21, P1959, DOI 10.1093/nar/21.8.1959; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; Rong YQ, 1996, J NEUROCHEM, V67, P662; Sheppard PW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-276; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Van der Perren A, 2011, GENE THER, V18, P517, DOI 10.1038/gt.2010.179; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Vermoesen K, 2012, EPILEPSIA, V53, P870, DOI 10.1111/j.1528-1167.2012.03436.x; Vermoesen K, 2010, EPILEPSY RES, V90, P164, DOI 10.1016/j.eplepsyres.2010.04.001; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, EXP NEUROL; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	72	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53156	10.1371/journal.pone.0053156	http://dx.doi.org/10.1371/journal.pone.0053156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301037	Green Published, gold			2022-12-27	WOS:000313480000035
J	Erdoes, G; Balmer, ML; Slack, E; Kocsis, I; Lehmann, LE; Eberle, B; Stuber, F; Book, M				Erdoes, Gabor; Balmer, Maria L.; Slack, Emma; Kocsis, Istvan; Lehmann, Lutz E.; Eberle, Balthasar; Stueber, Frank; Book, Malte			CD62L (L-Selectin) Shedding for Assessment of Perioperative Immune Sensitivity in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass	PLOS ONE			English	Article							OPEN-HEART-SURGERY; LEUKOCYTE ADHESION MOLECULE-1; INFLAMMATORY RESPONSE; CORONARY REVASCULARIZATION; NOSOCOMIAL INFECTIONS; MONOCYTE ACTIVATION; EXPRESSION; NEUTROPHILS; COMPLEMENT; INTERLEUKIN-8	Objective: To investigate the suitability of blood granulocyte and monocyte sensitivity, as measured by the quantity of different agonists required to induce CD62L shedding, for assessment of perioperative immune changes in patients undergoing cardiac surgery with cardiopulmonary bypass. Methods: Patients scheduled for aortocoronary bypass grafting or for valve surgery were included in this prospective observational study. Blood samples were drawn before anesthesia induction, directly after surgery and 48 hours after anesthesia induction. We determined the concentration of two different inflammatory stimuli - lipoteichoic acid (LTA) and tumor necrosis factor alpha (TNF) - required to induce shedding of 50% of surface CD62L from blood granulocytes and monocytes. In parallel monocyte surface human leukocyte antigen (HLA)-DR, and plasma interleukin (IL)-8, soluble (s)CD62L, soluble (s)Toll-like receptor (TLR)-2 and ADAM17 quantification were used to illustrate perioperative immunomodulation. Results: 25 patients were enrolled. Blood granulocytes and monocytes showed decreased sensitivity to the TLR 2/6 agonist Staphylococcus aureus LTA immediately after surgery (p = 0.001 and p = 0.004 respectively). In contrast, granulocytes (p = 0.01), but not monocytes (p = 0.057) displayed a decreased postoperative sensitivity to TNF. We confirmed the presence of a systemic inflammatory response and a decreased immune sensitivity in the post-surgical period by measuring significant increases in the perioperative plasma concentration of IL-8 (p <= 0.001) and sTLR (p = 0.004), and decreases in monocyte HLA-DR (p<0.001), plasma sCD62L (p<0.001). In contrast, ADAM17 plasma levels did not show significant differences over the observation period (p = 0.401). Conclusions: Monitoring granulocyte and monocyte sensitivity using the "CD62L shedding assay'' in the perioperative period in cardiac surgical patients treated with the use of cardiopulmonary bypass reveals common changes in sensitivity to TLR2/6 ligands and to TNF stimulus. Further long-term follow-up studies will address the predictive value of these observations for clinical purposes.	[Erdoes, Gabor; Lehmann, Lutz E.; Eberle, Balthasar; Stueber, Frank; Book, Malte] Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Balmer, Maria L.; Slack, Emma] Univ Bern, Dept Clin Res, Maurice E Muller Labs, Bern, Switzerland; [Slack, Emma] Swiss Fed Inst Technol, Dept Microbiol, Zurich, Switzerland; [Kocsis, Istvan] Semmelweis Univ, Dept Anesthesiol & Intens Care, H-1085 Budapest, Hungary	University of Bern; University Hospital of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Semmelweis University	Erdoes, G (corresponding author), Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Balmer, Maria Luisa/AAB-8993-2021; Slack, Emma/AAD-5837-2019; Balmer, Maria L/A-8546-2013; Erdoes, Gabor/J-5742-2014; Kocsis, István/O-2025-2017; Slack, Emma/B-1612-2016	Balmer, Maria Luisa/0000-0003-0356-6352; Slack, Emma/0000-0002-2473-1145; Erdoes, Gabor/0000-0002-6742-1016; Slack, Emma/0000-0002-2473-1145				Argyris M, 2006, EUR J CARDIO-THORAC, V29, P456, DOI 10.1016/j.ejcts.2005.12.035; Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8; Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blume ED, 1997, CIRCULATION, V96, P352; Day RB, 2012, CELL MOL LIFE SCI, V69, P1415, DOI 10.1007/s00018-011-0870-8; Diegeler A, 2000, CIRCULATION, V102, P95; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Falagas ME, 2006, J THORAC CARDIOV SUR, V132, P481, DOI 10.1016/j.jtcvs.2006.05.019; Finn A, 1977, PERFUSION, V13, P322; GIBBON J H Jr, 1954, Minn Med, V37, P171; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; Gu YJ, 1998, ANN THORAC SURG, V65, P420, DOI 10.1016/S0003-4975(97)01127-2; Hambsch J, 2002, ANESTHESIOLOGY, V96, P1078, DOI 10.1097/00000542-200205000-00009; Hamers LAC, 2011, EUR J CARDIO-THORAC, V40, P372, DOI 10.1016/j.ejcts.2010.11.063; Hazama Shiro, 2004, Ann Thorac Cardiovasc Surg, V10, P90; Ilton MK, 1999, J THORAC CARDIOV SUR, V118, P930, DOI 10.1016/S0022-5223(99)70064-4; KAWAMURA T, 1993, CAN J ANAESTH, V40, P1016, DOI 10.1007/BF03009470; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Mazzone A, 2003, PERFUSION-UK, V18, P3, DOI 10.1191/0267659103pf622oa; MORISSET R, 1977, CAN MED ASSOC J, V116, P279; Pavelkova M, 2006, PHYSIOL RES, V55, P165, DOI 10.33549/physiolres.930662; PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Raja Shahzad G, 2005, Asian Cardiovasc Thorac Ann, V13, P382; Ryan T, 1997, CRIT CARE MED, V25, P2009, DOI 10.1097/00003246-199712000-00018; SCHUTT C, 1988, IMMUNOL LETT, V19, P321, DOI 10.1016/0165-2478(88)90162-9; SPERTINI O, 1991, LEUKEMIA, V5, P300; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Videm V, 2004, SCAND J IMMUNOL, V59, P25, DOI 10.1111/j.0300-9475.2004.01351.x; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845; Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043; Wehlin L, 2005, SCAND CARDIOVASC J, V39, P78, DOI 10.1080/14017430410004623; Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3; Zhao L C, 2001, Dev Immunol, V8, P267, DOI 10.1155/2001/91831	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53045	10.1371/journal.pone.0053045	http://dx.doi.org/10.1371/journal.pone.0053045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301018	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000027
J	Tuerkcan, S; Richly, MU; Alexandrou, A; Masson, JB				Tuerkcan, Silvan; Richly, Maximilian U.; Alexandrou, Antigoni; Masson, Jean-Baptiste			Probing Membrane Protein Interactions with Their Lipid Raft Environment Using Single-Molecule Tracking and Bayesian Inference Analysis	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; EPSILON-TOXIN; CLOSTRIDIUM-PERFRINGENS; TRANSIENT CONFINEMENT; OXIDE NANOPARTICLES; CHOLESTEROL; DIFFUSION; MICRODOMAINS; RECEPTOR	The statistical properties of membrane protein random walks reveal information on the interactions between the proteins and their environments. These interactions can be included in an overdamped Langevin equation framework where they are injected in either or both the friction field and the potential field. Using a Bayesian inference scheme, both the friction and potential fields acting on the epsilon-toxin receptor in its lipid raft have been measured. Two types of events were used to probe these interactions. First, active events, the removal of cholesterol and sphingolipid molecules, were used to measure the time evolution of confining potentials and diffusion fields. Second, passive rare events, de-confinement of the receptors from one raft and transition to an adjacent one, were used to measure hopping energies. Lipid interactions with the epsilon-toxin receptor are found to be an essential source of confinement. epsilon-toxin receptor confinement is due to both the friction and potential field induced by cholesterol and sphingolipids. Finally, the statistics of hopping energies reveal sub-structures of potentials in the rafts, characterized by small hopping energies, and the difference of solubilization energy between the inner and outer raft area, characterized by higher hopping energies.	[Tuerkcan, Silvan; Richly, Maximilian U.; Alexandrou, Antigoni] Ecole Polytech, CNRS, INSERM U696, Lab Opt & Biosci, F-91128 Palaiseau, France; [Tuerkcan, Silvan; Masson, Jean-Baptiste] Inst Pasteur, Paris, France; [Tuerkcan, Silvan; Masson, Jean-Baptiste] CNRS, URA 2171, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Alexandrou, A (corresponding author), Ecole Polytech, CNRS, INSERM U696, Lab Opt & Biosci, F-91128 Palaiseau, France.	antigoni.alexandrou@polytechnique.edu; jbmasson@pasteur.fr		masson, jean-baptiste/0000-0002-5484-9056; Alexandrou, Antigoni/0000-0003-3727-6863	Delegation Generale pour l'Armement (DGA); Centre de competences en Nanosciences C'Nano Ile-de-France; Fondation de France; ANR Piribio; Bayer Science and Education Foundation	Delegation Generale pour l'Armement (DGA); Centre de competences en Nanosciences C'Nano Ile-de-France; Fondation de France(Fondation de France); ANR Piribio(French National Research Agency (ANR)); Bayer Science and Education Foundation	This work was supported by the Delegation Generale pour l'Armement (DGA), Centre de competences en Nanosciences C'Nano Ile-de-France, Fondation de France, ANR Piribio, Bayer Science and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2010, BIOPHYS J, V99, P834, DOI 10.1016/j.bpj.2010.04.072; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Beaurepaire E, 2004, NANO LETT, V4, P2079, DOI 10.1021/nl049105g; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Casanova D, 2007, J AM CHEM SOC, V129, P12592, DOI 10.1021/ja0731975; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cover TM., 2006, WILEY SERIES TELECOM; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Giaume D, 2008, LANGMUIR, V24, P11018, DOI 10.1021/la8015468; GOINS B, 1986, BIOPHYS J, V49, P849, DOI 10.1016/S0006-3495(86)83714-6; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Richly MU, 2012, HYDRODYNAMIC F UNPUB; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Turkcan S, 2012, BIOPHYS J, V102, P2299, DOI 10.1016/j.bpj.2012.03.072; Turkcan S, 2012, BIOPHYS J, V102, P2288, DOI 10.1016/j.bpj.2012.01.063; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Voisinne G, 2010, BIOPHYS J, V98, P596, DOI 10.1016/j.bpj.2009.10.051; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	46	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53073	10.1371/journal.pone.0053073	http://dx.doi.org/10.1371/journal.pone.0053073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301023	gold, Green Published			2022-12-27	WOS:000313480000028
J	Xu, XH; Wang, F; Chen, H; Sun, W; Zhang, XS				Xu, Xiao Hui; Wang, Fang; Chen, Hao; Sun, Wei; Zhang, Xian Sheng			Transcript Profile Analyses of Maize Silks Reveal Effective Activation of Genes Involved in Microtubule-Based Movement, Ubiquitin-Dependent Protein Degradation, and Transport in the Pollination Process	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; VITRO STYLAR MATRIX; ZEA-MAYS-L; PISTIL INTERACTIONS; ARABIDOPSIS POLLEN; IN-VITRO; SELF-INCOMPATIBILITY; RECEPTOR KINASES; REPRODUCTIVE DEVELOPMENT; EXPRESSION PROFILES	Pollination is the first crucial step of sexual reproduction in flowering plants, and it requires communication and coordination between the pollen and the stigma. Maize (Zea mays) is a model monocot with extraordinarily long silks, and a fully sequenced genome, but little is known about the mechanism of its pollen-stigma interactions. In this study, the dynamic gene expression of silks at four different stages before and after pollination was analyzed. The expression profiles of immature silks (IMS), mature silks (MS), and silks at 20 minutes and 3 hours after pollination (20MAP and 3HAP, respectively) were compared. In total, we identified 6,337 differentially expressed genes in silks (SDEG) at the four stages. Among them, the expression of 172 genes were induced upon pollination, most of which participated in RNA binding, processing and transcription, signal transduction, and lipid metabolism processes. Genes in the SDEG dataset could be divided into 12 time-course clusters according to their expression patterns. Gene Ontology (GO) enrichment analysis revealed that many genes involved in microtubule-based movement, ubiquitin-mediated protein degradation, and transport were predominantly expressed at specific stages, indicating that they might play important roles in the pollination process of maize. These results add to current knowledge about the pollination process of grasses and provide a foundation for future studies on key genes involved in the pollen-silk interaction in maize.	[Xu, Xiao Hui; Wang, Fang; Chen, Hao; Sun, Wei; Zhang, Xian Sheng] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Zhang, XS (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	zhangxs@sdau.edu.cn	zhang, xian/GYA-0290-2022	Xu, Xiaohui/0000-0002-3823-0122	Major Research Plan from the Ministry of Science and Technology of China [2013CB945100]	Major Research Plan from the Ministry of Science and Technology of China	This work is supported by the Major Research Plan from the Ministry of Science and Technology of China (no. 2013CB945100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2010, PLANT PHYSIOL, V154, P1347, DOI 10.1104/pp.110.162172; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Boavida LC, 2011, PLANT PHYSIOL, V155, P2066, DOI 10.1104/pp.110.169813; Chae K, 2007, J BIOL CHEM, V282, P33845, DOI 10.1074/jbc.M703997200; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Dobritsa AA, 2009, SEX PLANT REPROD, V22, P167, DOI 10.1007/s00497-009-0101-8; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; DUPUIS I, 1990, PLANT SCI, V70, P11, DOI 10.1016/0168-9452(90)90026-K; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; Foster J, 2008, SEX PLANT REPROD, V21, P143, DOI 10.1007/s00497-008-0074-z; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Hennig L, 2004, PLANT PHYSIOL, V135, P1765, DOI 10.1104/pp.104.043182; HESLOPHARRISON Y, 1984, ACTA BOT NEERL, V33, P81, DOI 10.1111/j.1438-8677.1984.tb01774.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HISCOCK SJ, 1994, PLANTA, V193, P377, DOI 10.1007/BF00201816; Hiscock SJ, 2002, SEX PLANT REPROD, V15, P65, DOI 10.1007/s00497-002-0143-7; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; HULSKAMP M, 1995, PLANT J, V8, P703, DOI 10.1046/j.1365-313X.1995.08050703.x; Johnson MA, 2003, TRENDS PLANT SCI, V8, P97, DOI 10.1016/S1360-1385(03)00009-8; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kiesselbach T.A., 1999, STRUCTURE REPROD COR; Kim HU, 2002, PLANT MOL BIOL, V50, P1, DOI 10.1023/A:1016077014583; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Krichevsky A, 2007, DEV BIOL, V303, P405, DOI 10.1016/j.ydbio.2006.12.003; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; LAVITHIS M, 1995, SEX PLANT REPROD, V8, P289, DOI 10.1007/BF00229386; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lord EM, 2003, J EXP BOT, V54, P47, DOI 10.1093/jxb/54.380.47; Ma J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r181; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Makkena S, 2012, J EXP BOT, V63, P5545, DOI 10.1093/jxb/ers209; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; MUSCHIETTI J, 1994, PLANT J, V6, P321, DOI 10.1046/j.1365-313X.1994.06030321.x; Otsu CT, 2004, J EXP BOT, V55, P1643, DOI 10.1093/jxb/erh195; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Quiapim AC, 2009, PLANT PHYSIOL, V149, P1211, DOI 10.1104/pp.108.131573; Renak D, 2012, SEX PLANT REPROD, V25, P39, DOI 10.1007/s00497-011-0178-8; RUBINSTEIN AL, 1995, P NATL ACAD SCI USA, V92, P3086, DOI 10.1073/pnas.92.8.3086; Sakai N, 2004, INT J BIOCHEM CELL B, V36, P776, DOI 10.1016/S1357-2725(03)00263-2; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Samuel MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011338; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Steinebrunner I, 2003, PLANT PHYSIOL, V131, P1638, DOI 10.1104/pp.102.014308; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Sutovsky P, 2001, J CELL SCI, V114, P1665; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Tan XY, 2010, PLANT CELL PHYSIOL, V51, P635, DOI 10.1093/pcp/pcq029; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tung CW, 2005, PLANT PHYSIOL, V138, P977, DOI 10.1104/pp.105.060558; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Wolters-Arts M, 2002, PLANT CELL ENVIRON, V25, P513, DOI 10.1046/j.1365-3040.2002.00827.x; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; Xu XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-294; Zhang XR, 1998, PLANT MOL BIOL REP, V16, P301, DOI 10.1023/A:1007540610933; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; Zinkl GM, 2000, ANN BOT-LONDON, V85, P15, DOI 10.1006/anbo.1999.1066	91	12	12	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53545	10.1371/journal.pone.0053545	http://dx.doi.org/10.1371/journal.pone.0053545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301084	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000064
J	Netto-Ferreira, AL; Birindelli, JLO; de Sousa, LM; Mariguela, TC; Oliveira, C				Netto-Ferreira, Andre Luiz; Olivan Birindelli, Jose Luis; de Sousa, Leandro Melo; Mariguela, Tatiane Casagrande; Oliveira, Claudio			A New Miniature Characid (Ostariophysi: Characiformes: Characidae), with Phylogenetic Position Inferred from Morphological and Molecular Data	PLOS ONE			English	Article							TELEOSTEI CHARACIFORMES; FISHES TELEOSTEI; RESOLUTION	Erythrocharax altipinnis is described from the Serra do Cachimbo, Para, Brazil. The new taxon is distinguished from all of the Characidae genera by having the pelvic bones firmly attached through the isquiatic processes; a nearly triangular hiatus in the musculature covering the anterior chamber of the swim bladder between the first and second pleural ribs (pseudotympanum); the pedunculate, notably expanded and distally compressed teeth in both jaws; circumorbital series represented by antorbital and four infraorbital bones with laterosensory canals not enclosed; a single tooth row in the premaxillary with the teeth perfectly aligned and similar in shape and cusp number; the first three branched dorsal-fin rays distinctly elongate in males; a bright red adipose and caudal fins in life; a conspicuous dark midlateral stripe extending from the opercle to the tip of the median caudal-fin rays; and by the absence of a humeral spot. The phylogenetic position of the new taxon is discussed using morphological and molecular datasets, with conflicting results of both approaches discussed. Additionally, a summarized discussion on the current problems in the Characidae taxonomy is presented and the principal biases in the morphological dataset are also discussed.	[Netto-Ferreira, Andre Luiz; Olivan Birindelli, Jose Luis] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [de Sousa, Leandro Melo] Fed Univ Para, Fac Ciencias Biol, Zool Lab, Altamira, Para, Brazil; [Mariguela, Tatiane Casagrande; Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Para; Universidade de Sao Paulo; Universidade Estadual Paulista	Netto-Ferreira, AL (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	alnferreira@gmail.com	Fapesp, Biota/F-8655-2017; Birindelli, José L.O./AAS-7096-2020; Netto-Ferreira, André/F-7018-2015; de Sousa, Leandro Melo/I-6108-2012; Birindelli, Jose LO/F-4991-2015; Oliveira, Claudio/D-7713-2012	Fapesp, Biota/0000-0002-9887-8449; Birindelli, José L.O./0000-0001-9646-9636; Netto-Ferreira, André/0000-0002-3096-0411; de Sousa, Leandro Melo/0000-0002-0793-9737; Oliveira, Claudio/0000-0002-7010-8880	FAPESP [2010/19088-7, 2010/51250-9, 2010/17999-2, 2010/17009-2]; CNPQ [303854/2009-0]; South American Characiformes Inventory (FAPESP) [2011/50282-7]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); South American Characiformes Inventory (FAPESP)	Authors are financially supported by FAPESP (ALN-F - 2010/19088-7; JLB - 2010/51250-9; TCM - 2010/17999-2; CO - 2010/17009-2), and CNPQ (CO 303854/2009-0). The present contribution was also supported by the South American Characiformes Inventory (FAPESP 2011/50282-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Carvalho MR, 2011, ZOOTAXA, P2946; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Eschmeyer W. N., 2012, SPECIES FAMILY SUBFA; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Langeani F, 2010, NEOTROP ICHTHYOL, V8, P727, DOI 10.1590/S1679-62252010000400004; Lima F. C. T., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Malabarba LR, 1999, P BIOL SOC WASH, V112, P410; Malabarba LR, 2012, ZOOTAXA, P47; Malabarba Luiz R., 1998, P193; Malabarba LR, 2012, COPEIA, P243, DOI 10.1643/CI-11-143; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2011, ZOOTAXA, P1; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mariguela TC, 2012, MOL PHYLOGE IN PRESS; Mattox GMT, 2012, ZOOL J LINN SOC-LOND, V165, P809, DOI 10.1111/j.1096-3642.2012.00830.x; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Orti G, 1996, MOL BIOL EVOL, V13, P556, DOI 10.1093/oxfordjournals.molbev.a025616; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Tagliacollo VA, 2012, MOL PHYLOGENET EVOL, V64, P297, DOI 10.1016/j.ympev.2012.04.007; TAYLOR W R, 1985, Cybium, V9, P107; Weiss FE, 2012, J SYST PALAEONTOL, V10, P73, DOI 10.1080/14772019.2011.565082; WEITZMAN SH, 1988, P BIOL SOC WASH, V101, P444	28	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52098	10.1371/journal.pone.0052098	http://dx.doi.org/10.1371/journal.pone.0052098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300963	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900019
J	Thibodeau, PH; Boroditsky, L				Thibodeau, Paul H.; Boroditsky, Lera			Natural Language Metaphors Covertly Influence Reasoning	PLOS ONE			English	Article							COGNITION; NEED	Metaphors pervade discussions of social issues like climate change, the economy, and crime. We ask how natural language metaphors shape the way people reason about such social issues. In previous work, we showed that describing crime metaphorically as a beast or a virus, led people to generate different solutions to a city's crime problem. In the current series of studies, instead of asking people to generate a solution on their own, we provided them with a selection of possible solutions and asked them to choose the best ones. We found that metaphors influenced people's reasoning even when they had a set of options available to compare and select among. These findings suggest that metaphors can influence not just what solution comes to mind first, but also which solution people think is best, even when given the opportunity to explicitly compare alternatives. Further, we tested whether participants were aware of the metaphor. We found that very few participants thought the metaphor played an important part in their decision. Further, participants who had no explicit memory of the metaphor were just as much affected by the metaphor as participants who were able to remember the metaphorical frame. These findings suggest that metaphors can act covertly in reasoning. Finally, we examined the role of political affiliation on reasoning about crime. The results confirm our previous findings that Republicans are more likely to generate enforcement and punishment solutions for dealing with crime, and are less swayed by metaphor than are Democrats or Independents.	[Thibodeau, Paul H.; Boroditsky, Lera] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Thibodeau, Paul H.] Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA	Stanford University; Trinity University	Thibodeau, PH (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	pthibode@trinity.edu	Thibodeau, Paul/AAY-7259-2021		Stanford Graduate Fellowship; NSF grant; McDonnell Scholar award; Intelligence Advanced Research Projects Activity (IARPA) via the Department of Defense US Army Research Laboratory [W911NF-12-C-0022]; Division Of Behavioral and Cognitive Sci [1058119] Funding Source: National Science Foundation	Stanford Graduate Fellowship(Stanford University); NSF grant(National Science Foundation (NSF)); McDonnell Scholar award; Intelligence Advanced Research Projects Activity (IARPA) via the Department of Defense US Army Research Laboratory; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a Stanford Graduate Fellowship to the first author and an NSF grant and a McDonnell Scholar award to the second author. This work was also supported by the Intelligence Advanced Research Projects Activity (IARPA) via the Department of Defense US Army Research Laboratory - contract number W911NF-12-C-0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; [Anonymous], 1995, FRAME REFLECTION RES; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Carpini MXD, 2000, PS, V33, P635, DOI 10.2307/420870; Converse P., 1964, IDEOLOGY DISCONTENT, P206; Hardisty DJ, 2010, PSYCHOL SCI, V21, P86, DOI 10.1177/0956797609355572; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Krugman P, 2010, NY TIMES; Lakoff George, 2002, MORAL POLITICS LIBER; Schon D. A., 1979, METAPHOR THOUGHT, P137; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782	14	128	128	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52961	10.1371/journal.pone.0052961	http://dx.doi.org/10.1371/journal.pone.0052961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301009	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900051
J	Bernal, A; Fernandez, M; Perez, LM; Martin, NS; Galvez, BG				Bernal, Aurora; Fernandez, Maria; Perez, Laura M.; San Martin, Nuria; Galvez, Beatriz G.			Method for Obtaining Committed Adult Mesenchymal Precursors from Skin and Lung Tissue	PLOS ONE			English	Article							STEM-CELLS; ADIPOSE-TISSUE; MULTIPOTENT; BONE; DIFFERENTIATION; IDENTIFICATION; POPULATION; MOUSE; BLOOD; MICE	Aims: The present study reports an easy and efficient method for obtaining adult mesenchymal precursors from different adult mouse tissues. Materials and Methods: We describe the isolation and expansion of mesenchymal precursors from skin and lung by a non-enzymatic method. Skin and lung mesenchymal precursors isolated by a modified explant technique were characterized in vitro by defined morphology and by a specific gene expression profile and surface markers. Results and Conclusions: Our results show that these precursors express stem cell and mesenchymal surface markers as well as epithelial markers. However, they are negative for markers of endothelium, cardiac and skeletal muscle or adipose tissue, indicating that they have initiated commitment to the tissues from which were isolated. These precursors can migrate without any stimulus and in response to stimuli as SDF1, MCP1 and TNF alpha and can be differentiated into epithelial lineages. Based on the properties of these precursors from adult tissues, we propose their use as tools for regenerative biomedicine.	[Bernal, Aurora; Fernandez, Maria; Perez, Laura M.; San Martin, Nuria; Galvez, Beatriz G.] CNIC, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Galvez, BG (corresponding author), CNIC, Madrid, Spain.	bgonzalez@cnic.es	Gálvez, Beatriz G./H-1644-2015; Pérez, Laura M./E-7818-2016; Bernal, Aurora/AAG-1926-2019	Gálvez, Beatriz G./0000-0002-8082-9323; Pérez, Laura M./0000-0003-0649-7778; Bernal, Aurora/0000-0002-5741-7865	Spanish Ministry of Science and Innovation [SAF 2010-15239]; "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation [RYC2009-04669]; Spanish Ministry of Economy and Competition; Pro-CNIC Foundation; FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competition(Spanish Government); Pro-CNIC Foundation; FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry	This study was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2010-15239) to BGG. BGG acknowledges support from the "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation (RYC2009-04669). The CNIC (Centro Nacional de Investigaciones Cardiovasculares) is supported by the Spanish Ministry of Economy and Competition and the Pro-CNIC Foundation. LMP and AB are supported by FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barrandon Y, 2012, SEMIN CELL DEV BIOL; Bernal A, 2012, CELL DEATH DIFFER, V19, P345, DOI 10.1038/cdd.2011.110; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2010, HUM GENE THER, V21, P1057, DOI 10.1089/hum.2010.136; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carmeliet P, 1997, AM J PHYSIOL-HEART C, V273, pH2091, DOI 10.1152/ajpheart.1997.273.5.H2091; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hegab AE, 2010, STEM CELLS DEV, V19, P523, DOI 10.1089/scd.2009.0287; Hunt DPJ, 2009, CURR OPIN BIOTECH, V20, P522, DOI 10.1016/j.copbio.2009.10.004; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Minasi MG, 2002, DEVELOPMENT, V129, P2773; NAKAHARA H, 1991, EXP CELL RES, V195, P492, DOI 10.1016/0014-4827(91)90401-F; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sellheyer K, 2010, J AM ACAD DERMATOL, V63, P93, DOI 10.1016/j.jaad.2009.07.013; Snippert HJ, 2010, SCIENCE; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	41	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53215	10.1371/journal.pone.0053215	http://dx.doi.org/10.1371/journal.pone.0053215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300894	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600071
J	Bhattacharjee, RB; Bag, J				Bhattacharjee, Rumpa Biswas; Bag, Jnanankur			Depletion of Nuclear Poly(A) Binding Protein PABPN1 Produces a Compensatory Response by Cytoplasmic PABP4 and PABP5 in Cultured Human Cells	PLOS ONE			English	Article							POLY(A)-BINDING PROTEIN; MESSENGER-RNA; TAIL LENGTH; APOPTOSIS; P53; PHOSPHORYLATION; TRANSCRIPTION; ACETYLATION; POLYMERASE; CLEAVAGE	Background: In vertebrates, poly(A) binding protein (PABP) is known to exist in five different isoforms. PABPs are primarily cytosolic with the exception of the nuclear PABP (PABPN1), which is located in the nucleus. Within the nucleus, PABPN1 is believed to bind to the poly(A) tail of nascent mRNA and along with cleavage and polyadenylation specificity factor (CPSF) define the length of the newly synthesized poly(A) tail. Methodology/Principal Findings: The cellular role of PABP1 has been extensively studied over the years; however, the function of other PABPs remains poorly defined. In order to understand the role of PABPN1 in cellular mRNA metabolism and it's interrelation with other PABPs, we depleted PABPN1 using RNAi in HeLa and HEK293 cells. Our results show that PABPN1 depletion did not have any effect on the poly(A) tail length, nuclear export of mRNA, mRNA translation, and transcription. Rather, PABPN1 depletion resulted in a compensatory response as observed by increased level of PABP5 and nuclear accumulation of PABP4. In addition, PABP4 was associated with the poly(A) tract of pre-mRNA and CPSF in PABPN1 depleted cells. Nevertheless, PABPN1 depletion significantly affected cell survival as evidenced by an increase in apoptosis markers: phosphorylated p53 and PUMA and as judged by the expression of ER stress marker GRP78. Conclusion: Our results suggest that although function of PABPN1 may be compensated by nuclear translocation of PABP4 and perhaps by increase in the cytoplasmic abundance of PABP5, these were not sufficient to prevent apoptosis of cells. Thus PABPN1 may have a novel anti apoptotic role in mammalian cells.	[Bhattacharjee, Rumpa Biswas; Bag, Jnanankur] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Bag, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jbag@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study has been funded by The Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bhattacharjee RB, 2012, CELL BIOL INT, V36, P697, DOI 10.1042/CBI20110348; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Burgess H, 2004, J CELL SCI, V124, P3344; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lemay JF, 2010, MOL CELL, V37, P447, DOI 10.1016/j.molcel.2010.01.029; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Salles FJ, 1999, METH MOL B, V118, P441; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V409, P171, DOI 10.1016/j.bbrc.2011.04.094; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V408, P375, DOI 10.1016/j.bbrc.2011.04.003	37	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53036	10.1371/journal.pone.0053036	http://dx.doi.org/10.1371/journal.pone.0053036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300856	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600052
J	Fuchs, JE; Huber, RG; Von Grafenstein, S; Wallnoefer, HG; Spitzer, GM; Fuchs, D; Liedl, KR				Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Fuchs, Dietmar; Liedl, Klaus R.			Dynamic Regulation of Phenylalanine Hydroxylase by Simulated Redox Manipulation	PLOS ONE			English	Article							RESOLUTION CRYSTAL-STRUCTURES; CATALYTIC DOMAIN; SERUM PHENYLALANINE; MOLECULAR MOTIONS; OXIDATIVE STRESS; STRUCTURAL BASIS; ACTIVATION; TETRAHYDROBIOPTERIN; PHENYLKETONURIA; ACID	Recent clinical studies revealed increased phenylalanine levels and phenylalanine to tyrosine ratios in patients suffering from infection, inflammation and general immune activity. These data implicated down-regulation of activity of phenylalanine hydroxylase by oxidative stress upon in vivo immune activation. Though the structural damage of oxidative stress is expected to be comparably small, a structural rationale for this experimental finding was lacking. Hence, we investigated the impact of side chain oxidation at two vicinal cysteine residues on local conformational flexibility in the protein by comparative molecular dynamics simulations. Analysis of backbone dynamics revealed a highly flexible loop region (Tyr138-loop) in proximity to the active center of phenylalanine hydroxylase. We observed elevated loop dynamics in connection with a loop movement towards the active site in the oxidized state, thereby partially blocking access for the substrate phenylalanine. These findings were confirmed by extensive replica exchange molecular dynamics simulations and serve as a first structural explanation for decreased enzyme turnover in situations of oxidative stress.	[Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; [Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Liedl, Klaus R.] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Medical University of Innsbruck	Liedl, KR (corresponding author), Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria.	Klaus.Liedl@uibk.ac.at	Liedl, Klaus/ABB-4725-2021; Fuchs, Dietmar/AAL-8011-2021; Huber, Roland G/AAG-6353-2019; Liedl, Klaus R/F-3099-2015	Liedl, Klaus/0000-0002-0985-2299; Fuchs, Dietmar/0000-0003-1627-9563; Huber, Roland G/0000-0001-5093-5988; Liedl, Klaus R/0000-0002-0985-2299	Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase" [P23051]; DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck; Austrian Science Fund (FWF) [P 23051] Funding Source: researchfish	Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase"(Austrian Science Fund (FWF)); DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research of the manuscript was supported by funding of the Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase" (P23051). Julian E. Fuchs is a recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABITA JP, 1976, J BIOL CHEM, V251, P5310; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; Andersen OA, 2001, J MOL BIOL, V314, P279, DOI 10.1006/jmbi.2001.5061; [Anonymous], 2008, AMBER 10; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Cerreto M, 2011, BBA-MOL BASIS DIS, V1812, P1435, DOI 10.1016/j.bbadis.2011.07.012; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Eisensmith RC, 1996, PEDIATRICS, V97, P512; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 2003, PEDIATRICS, V112, P1557; Erlandsen H, 2002, J MOL BIOL, V320, P645, DOI 10.1016/S0022-2836(02)00496-5; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Folling A., 1934, Z PHYSL CHEM, V227, P169; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fuchs J E, 2011, PTERIDINES, V22, P31; Fuchs JE, 2012, PTERIDINES, V23, P57; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAUFMAN S, 1975, NEW ENGL J MED, V293, P785, DOI 10.1056/NEJM197510162931601; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kirchmair J, 2008, J MED CHEM, V51, P7021, DOI 10.1021/jm8005977; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; KOIZUMI S, 1987, BIOCHEMISTRY-US, V26, P6461, DOI 10.1021/bi00394a025; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Miranda FF, 2004, PROTEIN SCI, V13, P1219, DOI 10.1110/ps.03595904; Miranda FF, 2002, J BIOL CHEM, V277, P40937, DOI 10.1074/jbc.M112197200; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Murr C, 1999, INCREASED NEOPTERIN; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Neurauter G, 2008, CANCER LETT, V272, P141, DOI 10.1016/j.canlet.2008.07.002; Olsson E, 2011, EUR J INORG CHEM, P2720, DOI 10.1002/ejic.201001218; Olsson E, 2011, CHEM-EUR J, V17, P3746, DOI 10.1002/chem.201002910; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; Ribas GS, 2011, CELL MOL NEUROBIOL, V31, P653, DOI 10.1007/s10571-011-9693-2; Ronau JA, 2012, CRYSTALLOGR IN PRESS; ROSENBLATT D, 1968, NATURE, V218, P677, DOI 10.1038/218677a0; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; SHIMAN R, 1982, J BIOL CHEM, V257, P1213; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Sura GR, 2006, BIOCHEMISTRY-US, V45, P9632, DOI 10.1021/bi060754b; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Teigen K, 2003, J BIOMOL STRUCT DYN, V20, P733, DOI 10.1080/07391102.2003.10506889; Teigen K, 2007, CURR MED CHEM, V14, P455, DOI 10.2174/092986707779941023; Van Gool AR, 2004, ANTI-CANCER DRUG, V15, P587, DOI 10.1097/01.cad.0000132230.51759.8d; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	73	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53005	10.1371/journal.pone.0053005	http://dx.doi.org/10.1371/journal.pone.0053005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300845	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600046
J	Ji, GY; Zhang, YP; Yang, QH; Cheng, SB; Hao, J; Zhao, XH; Jiang, ZQ				Ji, Guiyuan; Zhang, Yupei; Yang, Qinhe; Cheng, Shaobin; Hao, Jing; Zhao, Xihong; Jiang, Zhuoqin			Genistein Suppresses LPS-Induced Inflammatory Response through Inhibiting NF-kappa B following AMP Kinase Activation in RAW 264.7 Macrophages	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; PROSTATE-CANCER CELLS; PROTEIN-KINASE; INSULIN-RESISTANCE; SIGNALING PATHWAY; SOY ISOFLAVONES; METABOLISM; APOPTOSIS; STRESS; PLASMA	Genistein, the major isoflavone in soybean, was recently reported to exert beneficial effects in metabolic disorders and inflammatory diseases. In the present study, we investigated the effects and mechanisms of a dietary concentration of genistein on the inflammatory response in lipopolysaccharide (LPS)-treated RAW 264.7 macrophages. Our results demonstrated that genistein effectively inhibited the LPS-induced overproduction of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6), as well as LPS-induced nuclear factor kappa B (NF-kappa B) activation. In addition, the data also showed that genistein prevented LPS-induced decrease in adenosine monophosphate-activated protein kinase (AMPK) phosphorylation. These effects were obviously attenuated by an AMPK inhibitor. Taken together, our results suggest that the dietary concentration of genistein is able to attenuate inflammatory responses via inhibition of NF-kappa B activation following AMPK stimulation. The data provide direct evidence for the potential application of low concentrations of genistein in the prevention and treatment of inflammatory diseases.	[Ji, Guiyuan] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ji, Guiyuan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhang, Yupei; Yang, Qinhe; Cheng, Shaobin] Jinan Univ, Dept Tradit Chinese Med, Coll Med, Guangzhou, Guangdong, Peoples R China; [Hao, Jing] Guangxi Bot Garden Med Plant, Nanning, Peoples R China; [Zhao, Xihong] Wuhan Inst Technol, Key Lab Green Chem Proc, Minist Educ, Sch Chem Engn & Pharm, Wuhan, Peoples R China; [Ji, Guiyuan; Jiang, Zhuoqin] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Jinan University; Wuhan Institute of Technology; Sun Yat Sen University	Jiang, ZQ (corresponding author), Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	jiangzhq@mail.sysu.edu.cn			Guangdong Natural Science Foundation [10151008901000063]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The study was supported by Guangdong Natural Science Foundation (10151008901000063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu PVA, 2012, J NUTR, V142, P724, DOI 10.3945/jn.111.152322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cederroth CR, 2008, DIABETES, V57, P1176, DOI 10.2337/db07-0630; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Choi C, 2003, BIOSCI BIOTECH BIOCH, V67, P1916, DOI 10.1271/bbb.67.1916; Dalmas E, 2012, ADIPOSE TISSUE BIOL, P167; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Hsu MH, 2011, J PHARMACOL EXP THER, V337, P125, DOI 10.1124/jpet.110.175851; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Ji G, 2011, INT IMMUNOPHARMACOLO; Kang JL, 2001, AM J RESP CRIT CARE, V164, P2206, DOI 10.1164/ajrccm.164.12.2104017; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; King RA, 1998, AM J CLIN NUTR, V67, P867, DOI 10.1093/ajcn/67.5.867; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lahti Aleksi, 2006, BMC Pharmacology, V6, P5, DOI 10.1186/1471-2210-6-5; Li YW, 2002, CLIN CANCER RES, V8, P2369; Misra P, 2008, AMP ACTIVATED PROTEI; Park CE, 2010, J MED FOOD, V13, P815, DOI 10.1089/jmf.2009.1359; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, P1; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sheu F, 2001, J AGR FOOD CHEM, V49, P1767, DOI 10.1021/jf001198+; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Squadrito F, 2002, ATHEROSCLEROSIS, V163, P339, DOI 10.1016/S0021-9150(02)00013-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu X, 1995, BIOAVAILABILITY SOYB, P2307; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	40	99	104	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53101	10.1371/journal.pone.0053101	http://dx.doi.org/10.1371/journal.pone.0053101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300870	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600058
J	Oyanagi, J; Ogawa, T; Sato, H; Higashi, S; Miyazaki, K				Oyanagi, Jun; Ogawa, Takashi; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru			Epithelial-Mesenchymal Transition Stimulates Human Cancer Cells to Extend Microtubule-based Invasive Protrusions and Suppresses Cell Growth in Collagen Gel	PLOS ONE			English	Article							TGF-BETA; E-CADHERIN; K-RAS; PROTEIN; EXPRESSION; TAU; INVADOPODIA; PLASTICITY; TGF-BETA-1; PODOSOMES	Epithelial-mesenchymal transition (EMT) is a crucial event in tumor invasion and metastasis. However, most of past EMT studies have been conducted in the conventional two-dimensional (2D) monolayer culture. Therefore, it remains unclear what invasive phenotypes are acquired by EMT-induced cancer cells. To address this point, we attempted to characterize EMT cells in more physiological, three-dimensional (3D) collagen gel culture. EMT was induced by treating three human carcinoma cell lines (A549, Panc-1 and MKN-1) with TGF-beta. The TGF-beta treatment stimulated these cells to overexpress the invasion markers laminin gamma 2 and MT1-MMP in 2D culture, in addition to the induction of well-known morphological change and EMT marker expression. EMT induction enhanced cell motility and adhesiveness to fibronectin and collagen in 2D culture. Although EMT cells showed comparable cell growth to control cells in 2D culture, their growth rates were extremely suppressed in soft agar and collagen gel cultures. Most characteristically, EMT-induced cancer cells commonly and markedly extended invasive protrusions in collagen gel. These protrusions were mainly supported by microtubules rather than actin cytoskeleton. Snail-introduced, stable EMT cells showed similar protrusions in 3D conditions without TGF-beta. Moreover, these protrusions were suppressed by colchicine or inhibitors of heat shock protein 90 (HSP-90) and protein phosphatase 2A. However, MMP inhibitors did not suppress the protrusion formation. These data suggest that EMT enhances tumor cell infiltration into interstitial stroma by extending microtubule-based protrusions and suppressing cell growth. The elevated cell adhesion to fibronectin and collagen and high cell motility also seem important for the tumor invasion.	[Oyanagi, Jun; Ogawa, Takashi; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan; [Oyanagi, Jun; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Universi, Div Cell Biol, Kihara Inst Biol Res, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University	Miyazaki, K (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23112517, 23300351]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (23112517 and 23300351) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/english/e-grants/index.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; ANZANO MA, 1983, P NATL ACAD SCI-BIOL, V80, P6264, DOI 10.1073/pnas.80.20.6264; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bakin AV, 2002, J CELL SCI, V115, P3193; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; HOWE PH, 1993, J BIOL CHEM, V268, P21448; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; ITO M, 1992, JPN J CANCER RES, V83, P86, DOI 10.1111/j.1349-7006.1992.tb02356.x; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kikuchi K, 2008, CANCER SCI, V99, P2252, DOI 10.1111/j.1349-7006.2008.00927.x; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matrone MA, 2010, ONCOGENE, V29, P3217, DOI 10.1038/onc.2010.68; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsubota Y, 2010, INT J CANCER, V127, P2031, DOI 10.1002/ijc.25231; VALVERIUS EM, 1989, CANCER RES, V49, P6269; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Whipple RA, 2007, EXP CELL RES, V313, P1326, DOI 10.1016/j.yexcr.2007.02.001; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279	48	51	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53209	10.1371/journal.pone.0053209	http://dx.doi.org/10.1371/journal.pone.0053209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300891	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600069
J	Clark, KB; Noisakran, S; Onlamoon, N; Hsiao, HM; Roback, J; Villinger, F; Ansari, AA; Perng, GC				Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Roback, John; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen			Multiploid CD61+Cells Are the Pre-Dominant Cell Lineage Infected during Acute Dengue Virus Infection in Bone Marrow	PLOS ONE			English	Article							IN-VITRO; MONONUCLEAR PHAGOCYTES; HUMAN MEGAKARYOCYTES; HEMORRHAGIC-FEVER; GUINEA-PIGS; BLOOD; EXPRESSION; PLATELETS; DIFFERENTIATION; THROMBOPOIETIN	Depression of the peripheral blood platelet count during acute infection is a hallmark of dengue. This thrombocytopenia has been attributed, in part, to an insufficient level of platelet production by megakaryocytes that reside in the bone marrow (BM). Interestingly, it was observed that dengue patients experience BM suppression at the onset of fever. However, few studies focus on the interaction between dengue virus (DENV) and megakaryocytes and how this interaction can lead to a reduction in platelets. In the studies reported herein, BM cells from normal healthy rhesus monkeys (RM) and humans were utilized to identify the cell lineage(s) that were capable of supporting virus infection and replication. A number of techniques were employed in efforts to address this issue. These included the use of viral RNA quantification, nonstructural protein and infectivity assays, phenotypic studies utilizing immunohistochemical staining, anti-differentiation DEAB treatment, and electron microscopy. Cumulative results from these studies revealed that cells in the BM were indeed highly permissive for DENV infection, with human BM having higher levels of viral production compared to RM. DENV-like particles were predominantly observed in multi-nucleated cells that expressed CD61+. These data suggest that megakaryocytes are likely the predominant cell type infected by DENV in BM, which provides one explanation for the thrombocytopenia and the dysfunctional platelets characteristic of dengue virus infection.	[Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Onlamoon, Nattawat] Mahidol Univ, Off Res & Dev, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Roback, John] Emory Univ, Ctr Emory Bone Marrow Transplant Ctr, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Perng, Guey Chuen] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	Emory University; Emory University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Emory University; Emory University; National Cheng Kung University	Perng, GC (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	gperng@emory.edu	Noisakran, Sansanee/H-5186-2011; Onlamoon, Nattawat/AAR-8390-2020; Clark, Kristina/G-2821-2016	Noisakran, Sansanee/0000-0002-9336-3331; Clark, Kristina/0000-0002-8829-9793; Onlamoon, Nattawat/0000-0002-8784-3005; Perng, Oscar/0000-0001-7510-4486	U19 Pilot Project Funds [U19 AI057266, RFA-AI-02-042]; National Institutes of Health/SERCEB; Emory URC grants; HHMI Grad-into-Med program fund; NCRR [DRR000165]; National Science Council [NSC99-2321-B006-008]; Center of Infectious Disease and Signaling Research, NCKU, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	U19 Pilot Project Funds; National Institutes of Health/SERCEB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory URC grants; HHMI Grad-into-Med program fund; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Council(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, NCKU, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported in part by the U19 Pilot Project Funds U19 AI057266 (RFA-AI-02-042), National Institutes of Health/SERCEB, Emory URC grants, HHMI Grad-into-Med program fund, the NCRR p51 support to the Yerkes National Primate Research Center DRR000165, and the National Science Council (NSC99-2321-B006-008) with the Center of Infectious Disease and Signaling Research, NCKU, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P46, DOI 10.1111/j.1574-695X.2008.00399.x; BESSMAN JD, 1984, AM J HEMATOL, V16, P161, DOI 10.1002/ajh.2830160208; BIERMAN HR, 1965, ANN INTERN MED, V62, P867, DOI 10.7326/0003-4819-62-5-867; Boukour S, 2006, J THROMB HAEMOST, V4, P426, DOI 10.1111/j.1538-7836.2006.01749.x; Butthep P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P246; CARBALLAL G, 1977, J INFECT DIS, V135, P367, DOI 10.1093/infdis/135.3.367; CARBALLAL G, 1981, J INFECT DIS, V143, P7, DOI 10.1093/infdis/143.1.7; CASSEL DL, 1993, MOL IMMUNOL, V30, P451, DOI 10.1016/0161-5890(93)90113-P; DALTON AJ, 1961, J NATL CANCER I, V27, P747; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Gubler DJ, 1997, DENGUE DENGUE HEMORR; HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hathirat P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P80; Institute of Laboratory Animal Research CoLS National Research Council, 1996, GUID CAR US LAB AN; JACOBS MG, 1991, BRIT MED J, V302, P828, DOI 10.1136/bmj.302.6780.828; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Kho L K, 1972, Paediatr Indones, V12, P31; Kim JA, 2002, STEM CELLS, V20, P402, DOI 10.1634/stemcells.20-5-402; LARRAMENDY ML, 1994, BRIT J HAEMATOL, V86, P203, DOI 10.1111/j.1365-2141.1994.tb03279.x; LEVINE RF, 1980, BRIT J HAEMATOL, V45, P487, DOI 10.1111/j.1365-2141.1980.tb07168.x; MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23; Marianneau P, 1998, CLIN DIAGN VIROL, V10, P113, DOI 10.1016/S0928-0197(98)00031-2; Mosquera JA, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-26; Murgue B, 1997, J INFECT DIS, V175, P1497, DOI 10.1086/516486; NAKAO S, 1989, BLOOD, V74, P1235; NANAKORN S, 1966, B WORLD HEALTH ORGAN, V35, P54; NELSON ER, 1964, JAMA-J AM MED ASSOC, V190, P99; Noisakran S, 2012, EXP HEMATOL, V40, P250, DOI 10.1016/j.exphem.2011.11.011; Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253; Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990; Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67; Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503; RUSSELL PK, 1967, J IMMUNOL, V99, P285; STENBERG PE, 1989, BLOOD CELLS, V15, P23; Tsai JJ, 2012, THER ADV HEMATOL, V3, P59, DOI 10.1177/2040620711417660; Tsai JJ, 2011, J INNATE IMMUN, V3, P530, DOI 10.1159/000322904; WONG KF, 1991, AM J HEMATOL, V38, P339, DOI 10.1002/ajh.2830380420; Wu ZH, 1996, THROMB HAEMOSTASIS, V75, P661; ZUCKERFRANKLIN D, 1989, P NATL ACAD SCI USA, V86, P5595, DOI 10.1073/pnas.86.14.5595	42	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52902	10.1371/journal.pone.0052902	http://dx.doi.org/10.1371/journal.pone.0052902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300812	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100093
J	Tang, XM; Han, FT; Zhao, K; Xu, Y; Wu, X; Wang, JB; Jiang, LX; Shi, W				Tang, Xueming; Han, Fangting; Zhao, Kai; Xu, Yan; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi; Shi, Wei			A 90-Day Dietary Toxicity Study of Genetically Modified Rice T1C-1 Expressing Cry1C Protein in Sprague Dawley Rats	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; SAFETY; PLANTS; RESISTANCE; BORER; GENE; MOTH; CORN	In a 90-day study, Sprague Dawley rats were fed transgenic T1C-1 rice expressing Cry1C protein and were compared with rats fed non-transgenic parental rice Minghui 63 and rats fed a basal diet. No adverse effects on animal behavior or weight gain were observed during the study. Blood samples were collected and analyzed, and standard hematological and biochemical parameters were compared. A few of these parameters were found to be significantly different, but were within the normal reference intervals for rats of this breed and age, and were thus not considered to be treatment-related. Following sacrifice, a large number of organs were weighed, and macroscopic and histopathological examinations were performed with no changes reported. The aim of this study was to use a known animal model to determine the safety of the genetically modified (GM) rice T1C-1. The results showed no adverse or toxic effects due to T1C-1 rice when tested in this 90-day study.	[Tang, Xueming; Zhao, Kai; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Tang, Xueming; Zhao, Kai; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi] Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China; [Han, Fangting; Xu, Yan; Shi, Wei] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences; Shanghai Normal University	Zhao, K (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China.	kzhao118@163.com		wang, jinbin/0000-0001-7080-4264	Shanghai Agricultural Science Committee Key Foundation of China [6-4 (2009), 1-8 (2011)]; Shanghai Agricultural Science Key Research Foundation [1-8 (2011)]; Public Research Platform Foundation of SSTC [10DZ2294103]; National Science & Technology Support Programme [2010BAK69B18]; Shanghai Academy of Agricultural Sciences [2012 (9)]	Shanghai Agricultural Science Committee Key Foundation of China; Shanghai Agricultural Science Key Research Foundation; Public Research Platform Foundation of SSTC; National Science & Technology Support Programme; Shanghai Academy of Agricultural Sciences	This work was financially supported by Shanghai Agricultural Science Committee Key Foundation of China, grant no. 6-4 (2009) & 1-8 (2011), Shanghai Agricultural Science Key Research Foundation, grant no. 1-8 (2011), The Public Research Platform Foundation of SSTC, grant no. 10DZ2294103, the National Science & Technology Support Programme, grant no. 2010BAK69B18, and the Shanghai Academy of Agricultural Sciences, grant no. 2012 (9). The authors also thank Experimental Animal Centre of Fudan University and Shanghai Agrobiological Gene Center, especially Dr. Weiwei Qiao, Dr. Xianzhe Zhao, and Dr. Guolan Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Brake DG, 2004, J AGR FOOD CHEM, V52, P2097, DOI 10.1021/jf0347362; Cao J, 1999, MOL BREEDING, V5, P131, DOI 10.1023/A:1009619924620; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Cheng XY, 1998, P NATL ACAD SCI USA, V95, P2767, DOI 10.1073/pnas.95.6.2767; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; FAO, 1996, 61 FAO UN; FAO/WHO, 2000, SAF ASP GEN MOD FOOD; Gatehouse AMR, 1997, MOL BREEDING, V3, P49, DOI 10.1023/A:1009600321838; Guo Xing, 2010, Journal of Agricultural Biotechnology, V18, P346; High SM, 2004, TRENDS PLANT SCI, V9, P286, DOI 10.1016/j.tplants.2004.04.002; HOFTE H, 1989, MICROBIOL REV, V53, P242; *ILSI, 1996, SAF ASS NOV FOOD GUI; James C., 2004, GLOBAL STATUS COMMER; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; MONETTE R, 1994, J INSECT PHYSIOL, V40, P273, DOI 10.1016/0022-1910(94)90067-1; Oecd, 1993, SAFETY EVALUATION FO; OECD, 1996, FOOD SAF EV; *OECD, 1997, OECD WORKSH TOX NUTR; Papst C, 2005, AGRON J, V97, P219; Poulsen M, 2007, FOOD CHEM TOXICOL, V45, P364, DOI 10.1016/j.fct.2006.09.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SCHARDEIN JL, 1968, PATHOL VET, V5, P238, DOI 10.1177/030098586800500305; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Wang ZH, 2002, J SCI FOOD AGR, V82, P738, DOI 10.1002/jsfa.1105; WHO, 1995, WHO WORKSH; WHO, 1991, STRAT ASS SAF FOODS; Xue JL, 2005, LETT APPL MICROBIOL, V40, P460, DOI 10.1111/j.1472-765X.2005.01712.x; Yuan YF, 2011, J SCI FOOD AGR, V91, P2066, DOI 10.1002/jsfa.4421; 宋立江, 2003, [卫生毒理学杂志, Journal of Health Toxicology], V17, P193	33	14	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52507	10.1371/journal.pone.0052507	http://dx.doi.org/10.1371/journal.pone.0052507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300690	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100057
J	Urushihara, H; Taketsuna, M; Liu, Y; Oda, E; Nakamura, M; Nishiuma, S; Maeda, R				Urushihara, Hisashi; Taketsuna, Masanori; Liu, Ying; Oda, Eisei; Nakamura, Masaki; Nishiuma, Shinichi; Maeda, Rei			Increased Risk of Acute Pancreatitis in Patients with Type 2 Diabetes: An Observational Study Using a Japanese Hospital Database	PLOS ONE			English	Article							POPULATION-BASED COHORT; ANTIDIABETIC DRUGS; EXENATIDE; EPIDEMIOLOGY; ASSOCIATION; SITAGLIPTIN; MANAGEMENT; GLYBURIDE; THERAPIES; MELLITUS	Background: Increased risks of acute pancreatitis in patients with type 2 diabetes mellitus have been reported recently in several countries. We aimed to estimate the risks of acute pancreatitis in Japanese patients with diabetes mellitus. Methods/Findings: We examined a large-scale hospital administrative database consisting of one million patients in 16 secondary medical care hospitals, from 2003 to 2010. The incidence rates of acute pancreatitis were estimated with cohort design; the odds ratios associated with diabetes mellitus and other comorbid risk factors were estimated with separate case-control analyses. In cohort analysis, the incidence of acute pancreatitis was higher in 14,707 diabetic patients than in 186,032 non-diabetic patients (4.75 vs. 1.65 per 1,000 patient-years) and increased in male patients and as age advanced. The adjusted odds ratio of acute pancreatitis in patients with diabetes mellitus was 1.86 (P<0.001) compared with non-diabetic patients in case-control analysis from 1,372 cases and 5,469 matched controls, which is consistent with the ones reported in previous studies. Alcoholism and gallstones were associated with a large increase in the risk of acute pancreatitis (adjusted odds ratio 13.40 and 14.29, respectively, P<0.001), although dyslipidemia was associated with significant risk reduction (adjusted odds ratio 0.62, P<0.001). Conclusions: This observational study ascertained the elevated incidence rates and risk of acute pancreatitis in Japanese patients with diabetes. The risk estimates in Japanese patients with diabetes were in agreement with the ones reported in previous studies, and the elevated risk of acute pancreatitis in patients with diabetes would be generalized in different locations/populations.	[Urushihara, Hisashi] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan; [Taketsuna, Masanori] Eli Lilly Japan KK, Asia Pacific Stat Sci, Kobe, Hyogo, Japan; [Liu, Ying; Nishiuma, Shinichi; Maeda, Rei] Eli Lilly Japan KK, Global Patient Safety Japan, Kobe, Hyogo, Japan; [Oda, Eisei] Med TOUKEI Corp, Shinjuku Ku, Tokyo, Japan; [Nakamura, Masaki] Med Data Vis Co Ltd, Business Dev Dept, Chiyoda Ku, Tokyo, Japan	Kyoto University; Eli Lilly; Eli Lilly	Urushihara, H (corresponding author), Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan.	urushihara.hisashi.2s@kyoto-u.ac.jp		Urushihara, Hisashi/0000-0001-6913-9930	Pfizer Health Research Foundation [10-8-043]; Eli Lilly Japan	Pfizer Health Research Foundation; Eli Lilly Japan(Eli Lilly)	This study was sponsored by Eli Lilly Japan. HU was supported by the 2011 research grant of Pfizer Health Research Foundation (10-8-043) (http://www.pfizer-zaidan.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2010, ANN PHARMACOTHER, V44, P904, DOI 10.1345/aph.1M676; [Anonymous], 2010, 2010 GUID AC PANCR; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Blomgren KB, 2002, DIABETES CARE, V25, P298, DOI 10.2337/diacare.25.2.298; Dore DD, 2011, DIABETES OBES METAB, V13, P559, DOI 10.1111/j.1463-1326.2011.01376.x; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Eland IA, 2000, SCAND J GASTROENTERO, V35, P1110; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; Floyd A, 2002, SCAND J GASTROENTERO, V37, P1461, DOI 10.1080/003655202762671369; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; Hashikata Hirokuni, 2011, Environmental Health and Preventive Medicine, V16, P313, DOI 10.1007/s12199-010-0201-y; JENSEN E, 1988, EUR J CLIN INVEST, V18, P226, DOI 10.1111/j.1365-2362.1988.tb01250.x; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kingsnorth A, 2006, BMJ-BRIT MED J, V332, P1072, DOI 10.1136/bmj.332.7549.1072; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; Lee Phillip H, 2011, Ann Pharmacother, V45, pe22, DOI 10.1345/aph.1P714; MOREAU JA, 1988, MAYO CLIN PROC, V63, P466, DOI 10.1016/S0025-6196(12)65644-4; Murata A, 2011, PANCREAS, V40, P1018, DOI 10.1097/MPA.0b013e31821bd233; National Statistics Center Statistics Bureau, PORT SIT OFF STAT JA; Nitsche CJ, 2010, BEST PRACT RES CL GA, V24, P143, DOI 10.1016/j.bpg.2010.02.002; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Seino Y, 1995, MED FRONTLINE, V50, P639; Sekimoto M, 2006, J HEPATO-BILIARY-PAN, V13, P10, DOI 10.1007/s00534-005-1047-3; Spranger J, 2011, GASTROENTEROLOGY, V141, P20, DOI 10.1053/j.gastro.2011.05.019; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	31	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53224	10.1371/journal.pone.0053224	http://dx.doi.org/10.1371/journal.pone.0053224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300896	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100129
J	Chou, MF; Prisic, S; Lubner, JM; Church, GM; Husson, RN; Schwartz, D				Chou, Michael F.; Prisic, Sladjana; Lubner, Joshua M.; Church, George M.; Husson, Robert N.; Schwartz, Daniel			Using Bacteria to Determine Protein Kinase Specificity and Predict Target Substrates	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; CASEIN KINASE; MASS-SPECTROMETRY; IN-VITRO; PHOSPHORYLATED INVITRO; ESCHERICHIA-COLI; MOTIFS; IDENTIFICATION; CHANNEL; PHOSPHOPROTEOME	The identification of protein kinase targets remains a significant bottleneck for our understanding of signal transduction in normal and diseased cellular states. Kinases recognize their substrates in part through sequence motifs on substrate proteins, which, to date, have most effectively been elucidated using combinatorial peptide library approaches. Here, we present and demonstrate the ProPeL method for easy and accurate discovery of kinase specificity motifs through the use of native bacterial proteomes that serve as in vivo libraries for thousands of simultaneous phosphorylation reactions. Using recombinant kinases expressed in E. coli followed by mass spectrometry, the approach accurately recapitulated the well-established motif preferences of human basophilic (Protein Kinase A) and acidophilic (Casein Kinase II) kinases. These motifs, derived for PKA and CK II using only bacterial sequence data, were then further validated by utilizing them in conjunction with the scan-x software program to computationally predict known human phosphorylation sites with high confidence.	[Chou, Michael F.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Prisic, Sladjana; Husson, Robert N.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Lubner, Joshua M.; Schwartz, Daniel] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Connecticut	Schwartz, D (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	daniel.schwartz@uconn.edu	Husson, Robert/Y-7288-2019	Lubner, Joshua/0000-0003-1506-0949; Prisic, Sladjana/0000-0003-3137-4358; church, george/0000-0001-6232-9969	University of Connecticut Research Foundation; Genomes to Life grant from US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI051707, R01AI059702, R01AI099204] Funding Source: NIH RePORTER	University of Connecticut Research Foundation; Genomes to Life grant from US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by grants from the University of Connecticut Research Foundation (http://uconn.edu/)(DS) and the Genomes to Life grant from US Department of Energy (http://genomicscience.energy.gov/)(GMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Chambers SP, 2004, PROTEIN EXPRES PURIF, V36, P40, DOI 10.1016/j.pep.2004.03.003; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Kettenbach AN, 2012, CHEM BIOL, V19, P608, DOI 10.1016/j.chembiol.2012.04.011; Knight JDR, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-5; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; O'Donnell M RM, 2011, FASEB J; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saad FA, 2005, BIOCHEM BIOPH RES CO, V333, P443, DOI 10.1016/j.bbrc.2005.05.124; Sarno S, 1996, J BIOL CHEM, V271, P10595, DOI 10.1074/jbc.271.18.10595; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SUGIMOTO K, 1992, BIOSCI BIOTECH BIOCH, V56, P1174, DOI 10.1271/bbb.56.1174; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	49	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52747	10.1371/journal.pone.0052747	http://dx.doi.org/10.1371/journal.pone.0052747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300758	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800136
J	Kim, J; Gao, L; Tan, K				Kim, Jongkwang; Gao, Long; Tan, Kai			Multi-Analyte Network Markers for Tumor Prognosis	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DNA METHYLATION; GLIOBLASTOMA; CLASSIFICATION; GLIOMAS; HYPERMETHYLATION; EPIGENETICS; INTERACTOME; MODULARITY	Deregulation of gene expression, a hallmark of cancer, is caused by both genetic and epigenetic mechanisms. The rapid accumulation of epigenome maps of various cancers suggests a new avenue of research, namely integrating epigenomic data with other types of omic data for cancer diagnosis, prognosis, and biomarker discovery. We introduce the MAPIT algorithm (Multi Analyte Pathway Inference Tool), to enable principled integration of epigenomic, transcriptomic, and protein interactome data. As a proof-of-principle, we apply MAPIT to glioblastoma multiforme (GBM), the most common and aggressive form of brain tumor. Few predictive markers were reported for the prognosis of GBM patients. By integrating mRNA transcriptome, promoter DNA methylome and protein-protein physical interactome, we find ten expression-and three methylation-based network markers, involving 118 genes. When tested on additional GBM patient samples, the prognostic accuracy of the multi-analyte network markers (73.5%) is 9.7% and 8.6% higher than previous prognostic signatures built on gene expression or DNA methylation alone. Our results highlight the critical role of two novel pathways in the prognosis of GBM patients, small GTPase-mediated protein trafficking and ubiquitination-dependent protein degradation. A better understanding of these two pathways could lead to personalized therapies for subgroups of GBM patients. Our study demonstrates that integrating epigenomic, transcriptomic, and interactomic data can improve the accuracy network-based prognosis markers and lead to novel mechanistic understanding of cancer.	[Kim, Jongkwang; Tan, Kai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Gao, Long; Tan, Kai] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Tan, K (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	kai-tan@uiowa.edu		Kim, Jong K./0000-0001-9290-0820; Tan, Kai/0000-0002-9104-5567; Gao, Long/0000-0002-2631-6914	American Brain Tumor Association Discovery grant; National Institutes of Health [HG006130, HL110349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110349] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006130] Funding Source: NIH RePORTER	American Brain Tumor Association Discovery grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an American Brain Tumor Association Discovery grant and the National Institutes of Health grants HG006130 and HL110349 (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Buonerba C., 2010, CRIT REV ONCOL HEMAT; Castaldi PJ, 2011, BRIEF BIOINFORM, V12, P189, DOI 10.1093/bib/bbq073; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Guillaud M, 2008, CANCER RES, V68, P3099, DOI 10.1158/0008-5472.CAN-07-2113; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; IARC, 2007, WHO CLASSIFICATION T; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-521; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu HQ, 2005, BIOINFORMATICS, V21, P3377, DOI 10.1093/bioinformatics/bti544; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Nutt CL, 2003, CANCER RES, V63, P1602; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unterkircher T, 2011, CLIN CANCER RES, V17, P4019, DOI 10.1158/1078-0432.CCR-11-0075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen Z, 2012, J AM MED INFORM ASS; Wu WKK, 2010, CANCER LETT, V293, P15, DOI 10.1016/j.canlet.2009.12.002; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52973	10.1371/journal.pone.0052973	http://dx.doi.org/10.1371/journal.pone.0052973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300836	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800164
J	Peralta Quesada, PC; Schausberger, P				Peralta Quesada, Paulo C.; Schausberger, Peter			Prenatal Chemosensory Learning by the Predatory Mite Neoseiulus californicus	PLOS ONE			English	Article							BEHAVIOR; MEMORY; EXPOSURE; PREY; CANNIBALISM; PREFERENCES; EXPERIENCE; LARVAE; ACARI	Background: Prenatal or embryonic learning, behavioral change following experience made prior to birth, may have significant consequences for postnatal foraging behavior in a wide variety of animals, including mammals, birds, fish, amphibians, and molluscs. However, prenatal learning has not been previously shown in arthropods such as insects, spiders and mites. Methodology/Principal Findings: We examined prenatal chemosensory learning in the plant-inhabiting predatory mite Neoseiulus californicus. We exposed these predators in the embryonic stage to two flavors (vanillin or anisaldehyde) or no flavor (neutral) by feeding their mothers on spider mite prey enriched with these flavors or not enriched with any flavor (neutral). After the predators reached the protonymphal stage, we assessed their prey choice through residence and feeding preferences in experiments, in which they were offered spider mites matching the maternal diet (neutral, vanillin or anisaldehyde spider mites) and non-matching spider mites. Predator protonymphs preferentially resided in the vicinity of spider mites matching the maternal diet irrespective of the type of maternal diet and choice situation. Across treatments, the protonymphs preferentially fed on spider mites matching the maternal diet. Prey and predator sizes did not differ among neutral, vanillin and anisaldehyde treatments, excluding the hypothesis that size-assortative predation influenced the outcome of the experiments. Conclusions/Significance: Our study reports the first example of prenatal learning in arthropods.	[Peralta Quesada, Paulo C.; Schausberger, Peter] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Vienna, Austria.	peter.schausberger@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198				Becques A, 2010, CHEM SENSES, V35, P41, DOI 10.1093/chemse/bjp080; Bertin A, 2010, ETHOLOGY, V116, P1027, DOI 10.1111/j.1439-0310.2010.01820.x; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Brodsgaard H.F., 1990, Bulletin SROP, V13, P36; Castagnoli Marisa, 2003, Redia, V86, P153; CAUBET Y, 1992, Q J EXP PSYCHOL-B, V44B, P165; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Croft BA, 1999, EXP APPL ACAROL, V23, P599, DOI 10.1023/A:1006236310613; Darmaillacq AS, 2008, ANIM BEHAV, V76, P131, DOI 10.1016/j.anbehav.2008.02.006; Davis CP, 2010, BEHAV BRAIN RES, V212, P27, DOI 10.1016/j.bbr.2010.03.022; Desage M, 1996, J CHROMATOGR B, V678, P205, DOI 10.1016/0378-4347(95)00527-7; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Ferrari MCO, 2010, BEHAV ECOL SOCIOBIOL, V64, P549, DOI 10.1007/s00265-009-0870-y; Gandolfi M, 2003, P ROY SOC B-BIOL SCI, V270, P2623, DOI 10.1098/rspb.2003.2541; Gottlieb G., 1971, DEV SPECIES IDENTIFI; Gruest N, 2004, DEV PSYCHOBIOL, V44, P189, DOI 10.1002/dev.20004; Harshaw C, 2011, DEV PSYCHOBIOL, V53, P291, DOI 10.1002/dev.20521; Helle W, 1985, SPIDER MITES BIOL B, V1B; Hepper PG, 1996, ACTA PAEDIATR, V85, P16, DOI 10.1111/j.1651-2227.1996.tb14272.x; HEPPER PG, 1992, Q J EXP PSYCHOL-B, V44B, P179; Hoy MA, 2011, AGRICULTURAL ACAROLOGY: INTRODUCTION TO INTEGRATED MITE MANAGEMENT, P1, DOI 10.1201/b10909; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Minelli A, 2006, DEV GENES EVOL, V216, P373, DOI 10.1007/s00427-006-0075-6; Oostindjer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025318; Oostindjer M, 2009, CHEM SENSES, V34, P775, DOI 10.1093/chemse/bjp063; Palma AD, 2001, EXP APPL ACAROL, V25, P525, DOI 10.1023/A:1014741808835; Pearse JM, 2008, ANIMAL LEARNING COGN; PEDERSEN PE, 1982, DEV PSYCHOBIOL, V15, P349, DOI 10.1002/dev.420150407; Rahmani H, 2009, BEHAV ECOL, V20, P946, DOI 10.1093/beheco/arp081; Ray WS, 1932, CHILD DEV, V3, P175, DOI 10.2307/1125392; Sabelis M.W., 1985, P141; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2008, J ANIM ECOL, V77, P1109, DOI 10.1111/j.1365-2656.2008.01440.x; Schausberger P, 1999, ENVIRON ENTOMOL, V28, P322, DOI 10.1093/ee/28.2.322; Schausberger P, 2010, BEHAVIOUR, V147, P883, DOI 10.1163/000579510X495799; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Shimoda T, 2005, J CHEM ECOL, V31, P2019, DOI 10.1007/s10886-005-6075-6; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; SPELT DK, 1948, J EXP PSYCHOL, V38, P338, DOI 10.1037/h0059632; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Walter DE, 2009, MANUAL ACAROLOGY, P83; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Walzer A, 2007, BIOL CONTROL, V41, P42, DOI 10.1016/j.biocontrol.2006.11.012; Wells DL, 2006, ANIM BEHAV, V72, P681, DOI 10.1016/j.anbehav.2005.12.008; YASTREBTSOV A, 1992, International Journal of Acarology, V18, P121; Zhukovskaya NA, 2009, CHEM NAT COMPD+, V45, P148, DOI 10.1007/s10600-009-9264-7	51	21	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e53229	10.1371/journal.pone.0053229	http://dx.doi.org/10.1371/journal.pone.0053229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300897	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800167
J	Hardikar, S; Onstad, L; Blount, PL; Odze, RD; Reid, BJ; Vaughan, TL				Hardikar, Sheetal; Onstad, Lynn; Blount, Patricia L.; Odze, Robert D.; Reid, Brian J.; Vaughan, Thomas L.			The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: A Prospective Study of Barrett's Esophagus	PLOS ONE			English	Article							BODY-MASS INDEX; GASTROESOPHAGEAL-REFLUX DISEASE; SQUAMOUS-CELL CARCINOMA; HIGH-GRADE DYSPLASIA; GASTRIC CARDIA; CANCER-RISK; CIGARETTE-SMOKING; HELICOBACTER-PYLORI; ABDOMINAL OBESITY; INTESTINAL METAPLASIA	Background: Esophageal adenocarcinoma (EA) incidence in many developed countries has increased dramatically over four decades, while survival remains poor. Persons with Barrett's esophagus (BE), who experience substantially elevated EA risk, are typically followed in surveillance involving periodic endoscopy with biopsies, although few progress to EA. No medical, surgical or lifestyle interventions have been proven to safely lower EA risk. Design: We investigated whether smoking, obesity or alcohol could predict progression to EA in a prospective cohort of 411 BE patients. Data were collected during personal interview. Adjusted hazard ratios (HR) were estimated using Cox regression. Results: 39% had body mass index (BMI) over 30 and 64% had smoked cigarettes. Main analyses focused on those with at least 5 months of follow-up (33,635 person-months), in whom 45 developed EA. Risk increased by 3% per year of age (trend p-value 0.02), with approximate doubling of risk among males. EA risk increased with smoking pack-years (trend p-value 0.04) and duration (p-value 0.05). Compared to never-smokers, the HR for those in the highest pack-year tertile was 2.29 (95%CI 1.04-5.07). No association was found with alcohol or BMI, whereas a suggestion of increased risk was observed in those with higher waist-hip ratio, especially among males. Conclusion: EA risk significantly increased with increasing age and cigarette exposure. Abdominal obesity, but not BMI, was associated with a modest increased risk. Continued follow-up of this and other cohorts is needed to precisely define these relationships so as to inform risk stratification and preventive interventions.	[Hardikar, Sheetal; Onstad, Lynn; Blount, Patricia L.; Reid, Brian J.; Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hardikar, Sheetal; Vaughan, Thomas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Blount, Patricia L.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA USA; [Odze, Robert D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Odze, Robert D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle	Vaughan, TL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	tvaughan@u.washington.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	United States National Institutes of Health [P01CA091955, K05CA124911]; NATIONAL CANCER INSTITUTE [K05CA124911, P01CA091955] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported through the United States National Institutes of Health grants P01CA091955 and K05CA124911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2008, EUR J CANCER, V44, P465, DOI 10.1016/j.ejca.2007.12.009; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Chow WH, 1998, CANCER RES, V58, P588; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Coleman HG, 2012, GASTROENTEROLOGY, V142, P233, DOI 10.1053/j.gastro.2011.10.034; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Cook MB, 2012, GASTROENTEROLOGY, V142, P744, DOI 10.1053/j.gastro.2011.12.049; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2008, CANCER EPIDEM BIOMAR, V17, P352, DOI 10.1158/1055-9965.EPI-07-0748; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; de Jonge PJF, 2010, GUT, V59, P1030, DOI 10.1136/gut.2009.176701; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Dong LM, 2008, NUTR CANCER, V60, P39, DOI 10.1080/01635580701586762; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Ertan A, 2000, DIGEST DIS SCI, V45, P1670, DOI 10.1023/A:1005545918399; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; Fouad YM, 2009, WORLD J GASTROENTERO, V15, P3511, DOI 10.3748/wjg.15.3511; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Freedman ND, 2011, GUT, V60, P1029, DOI 10.1136/gut.2010.233866; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Jung KW, 2011, AM J GASTROENTEROL, V106, P1447, DOI 10.1038/ajg.2011.130; Kendall BJ, 2008, GUT, V57, P448, DOI 10.1136/gut.2007.131243; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Kubo A, 2009, CANCER CAUSE CONTROL, V20, P303, DOI 10.1007/s10552-008-9244-4; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Loffeld RJLF, 2005, NETH J MED, V63, P344; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; Oh DS, 2010, WORLD J GASTROENTERO, V16, P3762, DOI 10.3748/wjg.v16.i30.3762; Orlando RC, 2005, MED CLIN N AM, V89, P219, DOI 10.1016/j.mcna.2004.08.006; Pandeya N, 2009, GASTROENTEROLOGY, V136, P1215, DOI 10.1053/j.gastro.2008.12.052; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Sikkema M, 2011, AM J GASTROENTEROL, V106, P1231, DOI 10.1038/ajg.2011.153; Smit CF, 2001, ANN OTO RHINOL LARYN, V110, P190, DOI 10.1177/000348940111000216; Smith KJ, 2009, CLIN GASTROENTEROL H, V7, P840, DOI 10.1016/j.cgh.2009.04.018; Solaymani-Dodaran M, 2005, AM J GASTROENTEROL, V100, P2616, DOI 10.1111/j.1572-0241.2005.00340.x; Steevens J, 2011, CANCER EPIDEM BIOMAR, V20, P345, DOI 10.1158/1055-9965.EPI-10-0636; Steffen A, 2009, CANCER EPIDEM BIOMAR, V18, P2079, DOI 10.1158/1055-9965.EPI-09-0265; Thompson OM, 2010, OBESITY, V18, P2204, DOI 10.1038/oby.2009.508; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; Vaughan TL, 2002, CANCER EPIDEM BIOMAR, V11, P745; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Vogt S, 2006, TOXICOLOGY, V222, P71, DOI 10.1016/j.tox.2006.01.025; Weston AP, 2004, AM J GASTROENTEROL, V99, P1657, DOI 10.1111/j.1572-0241.2004.30426.x; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121	64	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52192	10.1371/journal.pone.0052192	http://dx.doi.org/10.1371/journal.pone.0052192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300966	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000006
J	Frank, MC; Tenenbaum, JB; Gibson, E				Frank, Michael C.; Tenenbaum, Joshua B.; Gibson, Edward			Learning and Long-Term Retention of Large-Scale Artificial Languages	PLOS ONE			English	Article							8-MONTH-OLD INFANTS; WORD SEGMENTATION; STATISTICAL SEGMENTATION; NATURAL-LANGUAGE; MEMORY; SPEECH; ACQUISITION; VOCABULARY; DISCOVERY; CHILDREN	Recovering discrete words from continuous speech is one of the first challenges facing language learners. Infants and adults can make use of the statistical structure of utterances to learn the forms of words from unsegmented input, suggesting that this ability may be useful for bootstrapping language-specific cues to segmentation. It is unknown, however, whether performance shown in small-scale laboratory demonstrations of "statistical learning'' can scale up to allow learning of the lexicons of natural languages, which are orders of magnitude larger. Artificial language experiments with adults can be used to test whether the mechanisms of statistical learning are in principle scalable to larger lexicons. We report data from a large-scale learning experiment that demonstrates that adults can learn words from unsegmented input in much larger languages than previously documented and that they retain the words they learn for years. These results suggest that statistical word segmentation could be scalable to the challenges of lexical acquisition in natural language learning.	[Frank, Michael C.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Tenenbaum, Joshua B.; Gibson, Edward] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT)	Frank, MC (corresponding author), Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA.	mcfrank@stanford.edu		Frank, Michael/0000-0002-7551-4378	Jacob Javits Graduate Fellowship; NSF DDRIG [0746251]	Jacob Javits Graduate Fellowship; NSF DDRIG	This work was supported by a Jacob Javits Graduate Fellowship to the first author and NSF DDRIG #0746251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; BAHRICK HP, 1993, PSYCHOL SCI, V4, P316, DOI 10.1111/j.1467-9280.1993.tb00571.x; Barr D., J MEMORY LA IN PRESS; Bates E, 1996, SCIENCE, V274, P1849, DOI 10.1126/science.274.5294.1849; Bloom P., 2002, CHILDREN LEARN MEANI, DOI DOI 10.1207/S15327809JLS1402_7; Brent MR, 1999, TRENDS COGN SCI, V3, P294, DOI 10.1016/S1364-6613(99)01350-9; Brent MR, 1999, MACH LEARN, V34, P71, DOI 10.1023/A:1007541817488; Carey S., 1978, LINGUISTIC THEORY PS; Dutoit T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1393, DOI 10.1109/ICSLP.1996.607874; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Frank MC, 2010, P ANN M COGN SCI SOC; Frank MC, 2010, COGNITION, V117, P107, DOI 10.1016/j.cognition.2010.07.005; French RM, 2011, PSYCHOL REV, V118, P614, DOI 10.1037/a0025255; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Goldwater S, 2009, COGNITION, V112, P21, DOI 10.1016/j.cognition.2009.03.008; Hart B., 1995, MEANINGFUL DIFFERENC; Hay J, 2011, INFANCY; Hay JF, 2011, COGNITIVE PSYCHOL, V63, P93, DOI 10.1016/j.cogpsych.2011.06.002; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Jusczyk PW, 1997, SCIENCE, V277, P1984, DOI 10.1126/science.277.5334.1984; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kurumada C, ZIPFIAN FRE IN PRESS; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mintz TH, 2002, COGNITIVE SCI, V26, P393, DOI 10.1207/s15516709cog2604_1; Mirman D, 2008, COGNITION, V108, P271, DOI 10.1016/j.cognition.2008.02.003; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Perruchet P, 1998, J MEMORY LANGUAGE, V39; Pinker Steven, 1994, LANGUAGE INSTINCT; Roy BC, 2009, P 30 ANN C COGN SCI; Saffran JR, 2003, CURR DIR PSYCHOL SCI, V12, P110, DOI 10.1111/1467-8721.01243; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Snow C, 1978, CHILD DEV, P1114; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Yang CD, 2004, TRENDS COGN SCI, V8, P451, DOI 10.1016/j.tics.2004.08.006; Yang C, 2008, J LINGUIST, V44, P205, DOI 10.1017/S0022226707004999; Zellig S, 1951, METHODS STRUCTURAL L; Zipf, 1965, HUMAN BEHAV PRINCIPL	48	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52500	10.1371/journal.pone.0052500	http://dx.doi.org/10.1371/journal.pone.0052500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300975	Green Published, gold			2022-12-27	WOS:000313320900027
J	Lam, NT; Currie, PD; Lieschke, GJ; Rosenthal, NA; Kaye, DM				Lam, Nicholas T.; Currie, Peter D.; Lieschke, Graham J.; Rosenthal, Nadia A.; Kaye, David M.			Nerve Growth Factor Stimulates Cardiac Regeneration via Cardiomyocyte Proliferation in Experimental Heart Failure	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ZEBRAFISH; ACTIVATION; EXPRESSION; GSK3-BETA; RECEPTOR; REPAIR; END	Although the adult heart likely retains some regenerative capacity, heart failure (HF) typically remains a progressive disorder. We hypothesise that alterations in the local environment contribute to the failure of regeneration in HF. Previously we showed that nerve growth factor (NGF) is deficient in the failing heart and here we hypothesise that diminished NGF limits the cardiac regenerative response in HF. The capacity of NGF to augment cardiac regeneration was tested in a zebrafish model of HF. Cardiac injury with a HF phenotype was induced in zebrafish larvae at 72 hours post fertilization (hpf) by exposure to aristolochic acid (AA, 2.5 mu M, 72-75 hpf). By 168 hpf, AA induced HF and death in 37.5% and 20.8% of larvae respectively (p<0.001). NGF mRNA expression was reduced by 42% (p<0.05). The addition of NGF (50 ng/ml) after exposure to AA reduced the incidence of HF by 50% (p<0.01) and death by 65% (p<0.01). Mechanistically, AA mediated HF was characterised by reduced cardiomyocyte proliferation as reflected by a 6.4 fold decrease in BrdU+ cardiomyocytes (p<0.01) together with features of apoptosis and loss of cardiomyocytes. Following AA exposure, NGF increased the abundance of BrdU+ cardiomyocytes in the heart by 4.8 fold (p<0.05), and this was accompanied by a concomitant significant increase in cardiomyocyte numbers. The proliferative effect of NGF on cardiomyocytes was not associated with an anti-apoptotic effect. Taken together the study suggests that NGF stimulates a regenerative response in the failing zebrafish heart, mediated by stimulation of cardiomyocyte proliferation.	[Lam, Nicholas T.; Kaye, David M.] Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Lam, Nicholas T.; Kaye, David M.] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Lam, Nicholas T.; Currie, Peter D.; Lieschke, Graham J.; Rosenthal, Nadia A.] Monash Univ, ARMI, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Australian Regenerative Medicine Institute; Monash University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Rosenthal, Nadia/H-4012-2013; Kaye, David/AAF-1202-2021	Lieschke, Graham/0000-0003-0325-798X; Currie, Peter/0000-0001-8874-8862; Lam, Nicholas/0000-0002-9446-7378; Kaye, David/0000-0003-4058-0372	NHMRC of Australia; National Health and Medical Research Council of Australia; Victorian Government; Australian Regenerative Medicine Institute (ARMI); State Government of Victoria; Australian Government	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Australian Regenerative Medicine Institute (ARMI); State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	The project was supported by the NHMRC of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tanneale Marshall and Ouda Khammy for technical assistance; Stephen Cody, Judy Callaghan and Iska Carmichael from Monash Micro Imaging for confocal microscope training and imaging advice. We also thank Geoffrey Burns (Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School) for Tg(cmlc2:DsRed2-nuc) zebrafish and technical advice. DMK is supported by a Program Grant from the National Health and Medical Research Council of Australia and Baker IDI receives Infrastructure support from the Victorian Government. NTL was supported by an Australian Regenerative Medicine Institute (ARMI) post-graduate scholarship. ARMI is supported by grants from the State Government of Victoria and the Australian Government.	Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhat RV, 2002, J ALZHEIMERS DIS, V4, P291, DOI 10.3233/JAD-2002-4404; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Goold RG, 2003, J NEUROCHEM, V87, P935, DOI 10.1046/j.1471-4159.2003.02062.x; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Woulfe KC, 2010, CIRC RES, V106, P1635, DOI 10.1161/CIRCRESAHA.109.211482; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	33	22	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53210	10.1371/journal.pone.0053210	http://dx.doi.org/10.1371/journal.pone.0053210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300892	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600070
J	Noguchi, C; Araki, Y; Miki, D; Shimizu, N				Noguchi, Chiemi; Araki, Yoshio; Miki, Daisuke; Shimizu, Noriaki			Fusion of the Dhfr/Mtx and IR/MAR Gene Amplification Methods Produces a Rapid and Efficient Method for Stable Recombinant Protein Production	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; EXTRACHROMOSOMAL DOUBLE MINUTES; REPLICATION INITIATION REGION; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; DNA-DAMAGE; EXPRESSION; LINES; METHOTREXATE; STABILITY	Amplification of the dihydrofolate reductase gene (Dhfr) by methotrexate (Mtx) exposure is commonly used for recombinant protein expression in Chinese hamster ovary (CHO) cells. However, this method is both time-and labor-intensive, and the high-producing cells that are generated are frequently unstable in culture. Another gene amplification method is based on using a plasmid bearing a mammalian replication initiation region (IR) and a matrix attachment region (MAR), which result in the spontaneous initiation of gene amplification in transfected cells. The IR/MAR and Dhfr/Mtx methods of gene amplification are based on entirely different principles. In this study, we combine these two methods to yield a novel method, termed the IR/MAR-Dhfr fusion method, which was used to express three proteins, the Fc receptor, GFP, and recombinant antibody. The fusion method resulted in a dramatic increase in expression of all three proteins in two CHO sub-lines, DXB-11, and DG44. The IR/MAR-Dhfr fusion amplified the genes rapidly and efficiently, and produced larger amounts of antibody than the Dhfr/Mtx or IR/MAR methods alone. While the amplified structure produced by the Dhfr/Mtx method was highly unstable, and the antibody production rate rapidly decreased with the culture time of the cells, the IR/MAR-Dhfr fusion method resulted in stable amplification and generated clonal cells that produced large amounts of antibody protein over a long period of time. In summary, the novel IR/MAR-Dhfr fusion method enables isolation of stable cells that produce larger amounts of a target recombinant protein more rapidly and easily than either the Dhfr/Mtx or IR/MAR methods alone.	[Noguchi, Chiemi; Araki, Yoshio; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan; [Miki, Daisuke] Tosoh Co, Ayase, Kanagawa, Japan	Hiroshima University; Tosoh Corporation	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Science and Technology; Japan Society for the Promotion of Science [23380203]	Japan Science and Technology(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Practical Application Research from Japan Science and Technology to NS, and a Grant-in-Aid for Scientific Research (B) [grant number 23380203] from the Japan Society for the Promotion of Science to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Asaoka Y, 2012, PROTEIN EXPRES PURIF, V82, P155, DOI 10.1016/j.pep.2011.12.006; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; HAKALA MT, 1957, SCIENCE, V126, P255, DOI 10.1126/science.126.3267.255; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Jun SC, 2005, APPL MICROBIOL BIOT, V69, P162, DOI 10.1007/s00253-005-1972-8; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kim M., 2011, BIOTECHNOL BIOENG; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; LORICO A, 1988, CANCER RES, V48, P2036; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; Omasa T, 2002, J BIOSCI BIOENG, V94, P600, DOI 10.1016/S1389-1723(02)80201-8; PALLAVICINI MG, 1990, MOL CELL BIOL, V10, P401, DOI 10.1128/MCB.10.1.401; Savelyeva L, 2001, CANCER LETT, V167, P115, DOI 10.1016/S0304-3835(01)00472-4; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	35	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52990	10.1371/journal.pone.0052990	http://dx.doi.org/10.1371/journal.pone.0052990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300841	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600045
J	Pombert, JF; James, ER; Janouskovec, J; Keeling, PJ				Pombert, Jean-Francois; James, Erick R.; Janouskovec, Jan; Keeling, Patrick J.			Evidence for Transitional Stages in the Evolution of Euglenid Group II Introns and Twintrons in the Monomorphina aenigmatica Plastid Genome	PLOS ONE			English	Article							PHOTOSYNTHETIC EUGLENOIDS; CHLOROPLAST GENOME; SEQUENCE; GENE; RNA; GENERATION; ALIGNMENT; ORIGIN; TOOL	Background: Photosynthetic euglenids acquired their plastid by secondary endosymbiosis of a prasinophyte-like green alga. But unlike its prasinophyte counterparts, the plastid genome of the euglenid Euglena gracilis is riddled with introns that interrupt almost every protein-encoding gene. The atypical group II introns and twintrons (introns-within-introns) found in the E. gracilis plastid have been hypothesized to have been acquired late in the evolution of euglenids, implying that massive numbers of introns may be lacking in other taxa. This late emergence was recently corroborated by the plastid genome sequences of the two basal euglenids, Eutreptiella gymnastica and Eutreptia viridis, which were found to contain fewer introns. Methodology/Principal Findings: To gain further insights into the proliferation of introns in euglenid plastids, we have characterized the complete plastid genome sequence of Monomorphina aenigmatica, a freshwater species occupying an intermediate phylogenetic position between early and late branching euglenids. The M. aenigmatica UTEX 1284 plastid genome (74,746 bp, 70.6% A+ T, 87 genes) contains 53 intron insertion sites, of which 41 were found to be shared with other euglenids including 12 of the 15 twintron insertion sites reported in E. gracilis. Conclusions: The pattern of insertion sites suggests an ongoing but uneven process of intron gain in the lineage, with perhaps a minimum of two bursts of rapid intron proliferation. We also identified several sites that represent intermediates in the process of twintron evolution, where the external intron is in place, but not the internal one, offering a glimpse into how these convoluted molecular contraptions originate.	[Pombert, Jean-Francois; James, Erick R.; Janouskovec, Jan; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Pombert, JF (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jpombert@mail.ubc.ca; pkeeling@mail.ubc.ca	Janouškovec, Jan/ABA-2568-2021; James, Erick R/D-4725-2012	Janouškovec, Jan/0000-0001-6547-749X; Pombert, Jean-Francois/0000-0002-3449-8375; Keeling, Patrick/0000-0002-7644-0745	Natural History and Engineering Research Council of Canada [227301]	Natural History and Engineering Research Council of Canada	This work was supported by a grant from the Natural History and Engineering Research Council of Canada to PJK (227301). PJK is a Fellow of the Canadian Institute for Advanced Research (CIFAR). The authors gratefully acknowledge the Compute Canada/CLUMEQ consortium for access to their computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; COPERTINO DW, 1993, TRENDS BIOCHEM SCI, V18, P467, DOI 10.1016/0968-0004(93)90008-B; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Doetsch NA, 1998, MOL BIOL EVOL, V15, P76, DOI 10.1093/oxfordjournals.molbev.a025850; Doetsch NA, 2001, MOL GEN GENET, V264, P682, DOI 10.1007/s004380000355; DRAGER RG, 1993, NUCLEIC ACIDS RES, V21, P2389, DOI 10.1093/nar/21.10.2389; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hrda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033746; JENKINS KP, 1995, RNA, V1, P624; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim JI, 2010, J PHYCOL, V46, P1278, DOI 10.1111/j.1529-8817.2010.00910.x; Krajcovic J, 2002, CELL OR EX, V4, P185; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leander BS, 2007, BIOESSAYS, V29, P987, DOI 10.1002/bies.20645; Leander BS, 2004, TRENDS MICROBIOL, V12, P251, DOI 10.1016/j.tim.2004.04.001; Leander BS, 2001, EUR J PROTISTOL, V37, P337, DOI 10.1078/0932-4739-00842; Linton EW, 2010, PROTIST, V161, P603, DOI 10.1016/j.protis.2010.02.002; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIER UG, 1995, MOL GEN GENET, V246, P128, DOI 10.1007/BF00290141; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Nudelman MA, 2006, J PHYCOL, V42, P194, DOI 10.1111/j.1529-8817.2006.00170.x; Scamborova P, 2004, MOL CELL BIOL, V24, P1855, DOI 10.1128/MCB.24.5.1855-1869.2004; Sheveleva EV, 2002, NUCLEIC ACIDS RES, V30, P1247, DOI 10.1093/nar/30.5.1247; Thompson MD, 1995, NUCLEIC ACIDS RES, V23, P4745, DOI 10.1093/nar/23.23.4745; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Wiegert KE, 2012, PROTIST, V163, P832, DOI 10.1016/j.protis.2012.01.002; Zhang LQ, 1995, RNA, V1, P1079	37	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53433	10.1371/journal.pone.0053433	http://dx.doi.org/10.1371/journal.pone.0053433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300929	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600100
J	Santoro, M; Mattiucci, S; Nascetti, G; Kinsella, JM; Di Prisco, F; Troisi, S; D'Alessio, N; Veneziano, V; Aznar, FJ				Santoro, Mario; Mattiucci, Simonetta; Nascetti, Giuseppe; Kinsella, John M.; Di Prisco, Francesca; Troisi, Sabatino; D'Alessio, Nicola; Veneziano, Vincenzo; Aznar, Francisco J.			Helminth Communities of Owls (Strigiformes) Indicate Strong Biological and Ecological Differences from Birds of Prey (Accipitriformes and Falconiformes) in Southern Italy	PLOS ONE			English	Article							PARASITIC HELMINTHS; DIGESTIVE-TRACT; DIET; RAPTORS; ACANTHOCEPHALA; RICHNESS; PATTERN; EAGLE; FAUNA; AVES	We compared the helminth communities of 5 owl species from Calabria (Italy) and evaluated the effect of phylogenetic and ecological factors on community structure. Two host taxonomic scales were considered, i.e., owl species, and owls vs. birds of prey. The latter scale was dealt with by comparing the data here obtained with that of birds of prey from the same locality and with those published previously on owls and birds of prey from Galicia (Spain). A total of 19 helminth taxa were found in owls from Calabria. Statistical comparison showed only marginal differences between scops owls (Otus scops) and little owls (Athene noctua) and tawny owls (Strix aluco). It would indicate that all owl species are exposed to a common pool of 'owl generalist' helminth taxa, with quantitative differences being determined by differences in diet within a range of prey relatively narrow. In contrast, birds of prey from the same region exhibited strong differences because they feed on different and wider spectra of prey. In Calabria, owls can be separated as a whole from birds of prey with regard to the structure of their helminth communities while in Galicia helminths of owls represent a subset of those of birds of prey. This difference is related to the occurrence in Calabria, but not Galicia, of a pool of 'owl specialist' species. The wide geographical occurrence of these taxa suggest that local conditions may determine fundamental differences in the composition of local communities. Finally, in both Calabria and Galicia, helminth communities from owls were species-poor compared to those from sympatric birds of prey. However, birds of prey appear to share a greater pool of specific helmith taxa derived from cospeciation processes, and a greater potential exchange of parasites between them than with owls because of phylogenetic closeness.	[Santoro, Mario; Mattiucci, Simonetta] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Sect Parasitol, Rome, Italy; [Santoro, Mario; Nascetti, Giuseppe] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Kinsella, John M.] Helm W Lab, Missoula, MT USA; [Di Prisco, Francesca; D'Alessio, Nicola] Ist Zooprofilatt Sperimentale Mezzogiorno, Sect Avellino, Avellino, Italy; [Troisi, Sabatino] Ist Gest Fauna Onlus, Naples, Italy; [Veneziano, Vincenzo] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy; [Aznar, Francisco J.] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Aznar, Francisco J.] Univ Valencia, Dept Zool, Valencia, Spain	Sapienza University Rome; Tuscia University; IZS del Mezzogiorno; University of Naples Federico II; University of Valencia; University of Valencia	Santoro, M (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Sect Parasitol, Rome, Italy.	marisant@libero.it	Aznar, Francisco Javier/S-3427-2018; Santoro, Mario/K-3251-2019; Mattiucci, Simonetta/K-5285-2018; Veneziano, Vincenzo/ABC-5774-2020; Nascetti, Giuseppe/AAA-6396-2020	Aznar, Francisco Javier/0000-0002-1316-1175; Nascetti, Giuseppe/0000-0002-1159-8103; VENEZIANO, Vincenzo/0000-0003-2496-4034	Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy [IZSME 06/10 RC]	Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy	This work was supported by Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy (project IZSME 06/10 RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivizatos H, 2005, BELG J ZOOL, V135, P109; [Anonymous], 2000, NEMATODE PARASITES V; Arcidiacono G, 2007, STUDI TRENT SCI NAT, V83, P243; Borgsteede FHM, 2003, ACTA PARASITOL, V48, P200; BOSAKOWSKI T, 1992, CAN J ZOOL, V70, P984, DOI 10.1139/z92-140; Bose M, 2001, J RAPTOR RES, V35, P240; BUSH AO, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P197; Capizzi D, 2000, ITAL J ZOOL, V67, P73, DOI 10.1080/11250000009356298; Cecere Francesco, 2000, Hystrix, V11, P47; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Combes Claude., 2001, PARASITISM ECOLOGY E; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Cui QH, 2008, POL J ECOL, V56, P173; De Muro P, 1934, CROCE ROSSA ITALIANA, V9, P486; Dimitrova ZM, 2005, SYST PARASITOL, V62, P117, DOI 10.1007/s11230-005-5486-7; Dubois G., 1938, MEMOIRES SOC SCI NAT, V6, P1; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; EWALD JA, 1991, J PARASITOL, V77, P485, DOI 10.2307/3283141; EWALD JA, 1993, J PARASITOL, V79, P952, DOI 10.2307/3283737; Fedynich AM, 1996, CAN J ZOOL, V74, P1253, DOI 10.1139/z96-139; FEDYNICH AM, 1994, CAN J ZOOL, V72, P496, DOI 10.1139/z94-067; Ferrer D, 2004, VET J, V167, P181, DOI 10.1016/S1090-0233(03)00103-5; Ferrer D, 2004, VET REC, V154, P17, DOI 10.1136/vr.154.1.17; FURMAGA STEFAN, 1957, ACTA PARASITOL POLONICA, V5, P215; Gibson DI, 2002, KEYS TREMATODA, V1; Illescas Gomez M.P., 1993, Research and Reviews in Parasitology, V53, P129; JAKSIC FM, 1982, OECOLOGIA, V52, P171, DOI 10.1007/BF00363832; JAKSIC FM, 1982, AM MIDL NAT, V107, P151, DOI 10.2307/2425196; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; KENNEDY CR, 1986, PARASITOLOGY, V93, P205, DOI 10.1017/S0031182000049945; Khalil LF, 1994, KEYS CESTODE PARASIT; KINSELLA JM, 1995, J RAPTOR RES, V29, P117; Kinsella JM, 1998, J HELMINTHOL SOC W, V65, P65; Kinsella JM, 1996, J HELMINTHOL SOC W, V63, P262; Kinsella JM, 2001, COMP PARASITOL, V68, P130; Kinsella JM, 2007, ACTA PARASITOL, V52, P151, DOI 10.2478/s11686-007-0021-4; Krone O, 2000, J WILDLIFE DIS, V36, P559, DOI 10.7589/0090-3558-36.3.559; Krone O., 2002, P105, DOI 10.1002/9780470752319.ch7; Krone O., 2000, P101; Krone O, 2007, RAPTOR RES MANAGEMEN, P318; Kuris AM, 2007, INT J PARASITOL, V37, P539, DOI 10.1016/j.ijpara.2006.12.003; KUTZER E, 1982, Angewandte Parasitologie, V23, P190; Lacina David, 2000, P65; LOTZ JM, 1991, PARASITOLOGY, V103, P127, DOI 10.1017/S0031182000059370; Marchesi L, 2005, IBIS, V147, P176, DOI 10.1111/j.1474-919x.2004.00388.x; Morand S, 2000, DEV AN VET, V32, P63; Mutafchiev Y, 2010, SYST PARASITOL, V76, P191, DOI 10.1007/s11230-010-9243-1; Noeckler K., 2007, FAOWHOOIE GUIDELINES, P69; Perera A, 2013, J HELMINTHOL, V87, P189, DOI 10.1017/S0022149X12000181; PETERSON RT, 1983, FIELD GUIDE BIRDS BR; Pojmanska T., 2008, Keys to the Trematoda, Volume 3, P233, DOI 10.1079/9780851995885.0233; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Poulin R, 2011, J HELMINTHOL, V85, P228, DOI 10.1017/S0022149X10000696; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R., 2007, EVOL ECOL, V2; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Reiczigel J., 2005, QUANTITATIVE PARASIT; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; San Martin OJ, 2009, LUNDIANA, V10, P19; Sanmartin ML, 2004, PARASITOL RES, V92, P255, DOI 10.1007/s00436-003-1042-z; Santoro M, 2013, J HELMINTHOL, V87, P277, DOI 10.1017/S0022149X12000338; Santoro M, 2011, J PARASITOL, V97, P364, DOI 10.1645/GE-2602.1; Santoro M, 2012, J PARASITOL, V98, P22, DOI 10.1645/GE-2924.1; Santoro M, 2010, VET J, V186, P119, DOI 10.1016/j.tvjl.2009.07.001; Sitko Jilji, 2001, Acta Societatis Zoologicae Bohemicae, V65, P45; Snow D, 1998, COMPLETE BIRDS W PAL	67	17	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53375	10.1371/journal.pone.0053375	http://dx.doi.org/10.1371/journal.pone.0053375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300921	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872600092
J	Sun, YR; Fukamachi, T; Saito, H; Kobayashi, H				Sun, Yirong; Fukamachi, Toshihiko; Saito, Hiromi; Kobayashi, Hiroshi			Respiration and the F(1)Fo-ATPase Enhance Survival under Acidic Conditions in Escherichia coli	PLOS ONE			English	Article							PROTON-TRANSLOCATING ATPASE; PARTIAL PURIFICATION; AGMATINE ANTIPORTER; MOTIVE FORCE; CAD OPERON; RESISTANCE; PH; EXPRESSION; INCREASES; SYNTHASE	Besides amino acid decarboxylation, the ADP biosynthetic pathway was reported to enhance survival under extremely acidic conditions in Escherichia coli (Sun et al., J. Bacteriol. 193: 3072-3077, 2011). E. coli has two pathways for ATP synthesis from ADP: glycolysis and oxidative phosphorylation. We found in this study that the deletion of the F(1)Fo-ATPase, which catalyzes the synthesis of ATP from ADP and inorganic phosphate using the electro-chemical gradient of protons generated by respiration in E. coli, decreased the survival at pH 2.5. A mutant deficient in hemA encoding the glutamyl tRNA reductase, which synthesizes glutamate 1-semialdehyde also showed the decreased survival of E. coli at pH 2.5. Glutamate 1-semialdehyde is a precursor of heme synthesis that is an essential component of the respiratory chain. The ATP content decreased rapidly at pH 2.5 in these mutants as compared with that of their parent strain. The internal pH was lowered by the deletion of these genes at pH 2.5. These results suggest that respiration and the F(1)Fo-ATPase are still working at pH 2.5 to enhance the survival under such extremely acidic conditions.	[Sun, Yirong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Fukamachi, Toshihiko] Interscience Co Ltd, Tokyo, Japan; [Saito, Hiromi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba, Japan; [Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chiba University	Sun, YR (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	sunyr1206@163.com						AVISSAR YJ, 1989, J BACTERIOL, V171, P2919, DOI 10.1128/jb.171.6.2919-2924.1989; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugelavicius A, 2006, BIOLOGIJA, V2, P89; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gensure RH, 2006, BIOCHEM J, V398, P485, DOI 10.1042/BJ20051620; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hirata S, 2008, IMMUNOL LETT, V115, P105, DOI 10.1016/j.imlet.2007.10.006; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; KINOSHITA N, 1984, J BACTERIOL, V160, P1074, DOI 10.1128/JB.160.3.1074-1077.1984; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KOBAYASHI H, 1972, J BIOCHEM, V71, P387; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; LASKO DR, 1993, BIOTECHNOL BIOENG, V42, P30, DOI 10.1002/bit.260420105; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LEYER GJ, 1995, APPL ENVIRON MICROB, V61, P3752, DOI 10.1128/AEM.61.10.3752-3755.1995; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; MENG SY, 1992, J BACTERIOL, V174, P2659, DOI 10.1128/jb.174.8.2659-2669.1992; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Sato M, 2000, APPL ENVIRON MICROB, V66, P943, DOI 10.1128/AEM.66.3.943-947.2000; Sun L, 2005, LETT APPL MICROBIOL, V40, P397, DOI 10.1111/j.1472-765X.2005.01714.x; Sun Y, 2012, J APPL MICROBIOL, V112, P775, DOI 10.1111/j.1365-2672.2012.05246.x; Sun YR, 2011, J BACTERIOL, V193, P3072, DOI 10.1128/JB.00091-11; SUZUKI T, 1988, J BIOL CHEM, V263, P11840; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Vazquez-Juarez RC, 2008, INFECT IMMUN, V76, P5072, DOI 10.1128/IAI.00677-08; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Vothknecht UC, 1996, P NATL ACAD SCI USA, V93, P9287, DOI 10.1073/pnas.93.17.9287	39	8	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52577	10.1371/journal.pone.0052577	http://dx.doi.org/10.1371/journal.pone.0052577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300708	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500036
J	Hayes, M; Pyon, YS; Li, J				Hayes, Matthew; Pyon, Yoon Soo; Li, Jing			A Model-Based Clustering Method for Genomic Structural Variant Prediction and Genotyping Using Paired-End Sequencing Data	PLOS ONE			English	Article							COPY NUMBER; POPULATION-SCALE; COMBINATORIAL ALGORITHMS; POLYMORPHISM; TECHNOLOGY; DISCOVERY; MAP	Structural variation (SV) has been reported to be associated with numerous diseases such as cancer. With the advent of next generation sequencing (NGS) technologies, various types of SV can be potentially identified. We propose a model based clustering approach utilizing a set of features defined for each type of SV events. Our method, termed SVMiner, not only provides a probability score for each candidate, but also predicts the heterozygosity of genomic deletions. Extensive experiments on genome-wide deep sequencing data have demonstrated that SVMiner is robust against the variability of a single cluster feature, and it significantly outperforms several commonly used SV detection programs. SVMiner can be downloaded from http://cbc.case.edu/svminer/.	[Hayes, Matthew; Pyon, Yoon Soo; Li, Jing] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA	Case Western Reserve University	Li, J (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	jingli@case.edu		Li, Jing/0000-0003-1160-6959	National Institutes of Health/NLM GAANN fellowship [LM008991]; NATIONAL LIBRARY OF MEDICINE [R01LM008991] Funding Source: NIH RePORTER	National Institutes of Health/NLM GAANN fellowship; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work supported by National Institutes of Health/NLM (LM008991) GAANN fellowship to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koboldt DC, 2012, METHODS MOL BIOL, V838, P369, DOI 10.1007/978-1-61779-507-7_18; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	29	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52881	10.1371/journal.pone.0052881	http://dx.doi.org/10.1371/journal.pone.0052881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300804	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100090
J	Masuda, S; Iwasaki, S; Tomaru, U; Sato, J; Kawakami, A; Ichijo, K; Sogo, S; Baba, T; Katsumata, K; Kasahara, M; Ishizu, A				Masuda, Sakiko; Iwasaki, Sari; Tomaru, Utano; Sato, Juri; Kawakami, Ai; Ichijo, Kana; Sogo, Sayuri; Baba, Tomohisa; Katsumata, Kazuaki; Kasahara, Masanori; Ishizu, Akihiro			Mechanism of Fc gamma Receptor-Mediated Trogocytosis-Based False-Positive Results in Flow Cytometry	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; T-CELLS; ANTIGEN PRESENTATION; TARGET-CELLS; MONOCYTES; LYMPHOCYTES; ANTIBODIES; COMPLEXES; EXCHANGE	The whole blood erythrocyte lysis method is the most common protocol of sample preparation for flow cytometry (FCM). Although this method has many virtues, our recent study has demonstrated false-positive results when surface markers of monocytes were examined by this method due to the phenomenon called Fc gamma receptor (Fc gamma R)-mediated trogocytosis. In the present study, similar Fc gamma R-mediated trogocytosis-based false-positive results have been demonstrated when granulocytes were focused on instead of monocytes. These findings indicated that not only monocytes but also granulocytes, the largest population with Fc gamma R expression in peripheral blood, could perform Fc gamma R-mediated trogocytosis. Since the capacity of Fc gamma R-mediated trogocytosis was different among blood samples, identification of factors that could regulate the occurrence of Fc gamma R-mediated trogocytosis should be important for the quality control of FCM. Our studies have suggested that such factors are present in the serum. In order to identify the serum factors, we employed the in vitro model of Fc gamma R-mediated trogocytosis using granulocytes. Investigation with this model determined the serum factors as heat-labile molecules with molecular weight of more than 100 kDa. Complements in the classical pathway were initially assumed as candidates; however, the C1 inhibitor did not yield an obvious influence on Fc gamma R-mediated trogocytosis. On the other hand, although immunoglobulin ought to be resistant to heat inactivation, the inhibitor of human anti-mouse antibodies (HAMA) effectively blocked Fc gamma R-mediated trogocytosis. Moreover, the inhibition rates were significantly higher in HAMA(high) serum than HAMA(low) serum. The collective findings suggested the involvement of heterophilic antibodies such as HAMA in the mechanism of false-positive results in FCM due to Fc gamma R-mediated trogocytosis.	[Iwasaki, Sari; Katsumata, Kazuaki; Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Masuda, Sakiko; Kawakami, Ai] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Iwasaki, Sari; Tomaru, Utano; Baba, Tomohisa; Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Sato, Juri; Ichijo, Kana; Sogo, Sayuri] Hokkaido Univ, Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Ishizu, A (corresponding author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan.	aishizu@med.hokudai.ac.jp	Katsumata, Kazuaki/J-8277-2019; Kasahara, Masanori/G-7651-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan; Hokkaido University, Faculty of Health Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkaido University, Faculty of Health Sciences	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the grant from Hokkaido University, Faculty of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Horner H, 2007, J IMMUNOL, V179, P337, DOI 10.4049/jimmunol.179.1.337; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Iwasaki S, 2011, CYTOM PART A, V79A, P46, DOI 10.1002/cyto.a.20984; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Li YL, 2007, J IMMUNOL, V179, P4263, DOI 10.4049/jimmunol.179.6.4263; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; Xu H, 2006, J IMMUNOL, V176, P750, DOI 10.4049/jimmunol.176.2.750	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52918	10.1371/journal.pone.0052918	http://dx.doi.org/10.1371/journal.pone.0052918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300821	Green Published, gold			2022-12-27	WOS:000312829100098
J	DeSantis, LRG; Schubert, BW; Scott, JR; Ungar, PS				DeSantis, Larisa R. G.; Schubert, Blaine W.; Scott, Jessica R.; Ungar, Peter S.			Implications of Diet for the Extinction of Saber-Toothed Cats and American Lions	PLOS ONE			English	Article							RANCHO-LA-BREA; MICROWEAR TEXTURE ANALYSIS; SCANNING-ELECTRON-MICROSCOPY; DENTAL MICROWEAR; LARGE CARNIVORES; FEEDING-BEHAVIOR; SMILODON-FATALIS; PREDATORY BEHAVIOR; KILLING BEHAVIOR; LATE PLEISTOCENE	The saber-toothed cat, Smilodon fatalis, and American lion, Panthera atrox, were among the largest terrestrial carnivores that lived during the Pleistocene, going extinct along with other megafauna,12,000 years ago. Previous work suggests that times were difficult at La Brea (California) during the late Pleistocene, as nearly all carnivores have greater incidences of tooth breakage (used to infer greater carcass utilization) compared to today. As Dental Microwear Texture Analysis (DMTA) can differentiate between levels of bone consumption in extant carnivores, we use DMTA to clarify the dietary niches of extinct carnivorans from La Brea. Specifically, we test the hypothesis that times were tough at La Brea with carnivorous taxa utilizing more of the carcasses. Our results show no evidence of bone crushing by P. atrox, with DMTA attributes most similar to the extant cheetah, Acinonyx jubatus, which actively avoids bone. In contrast, S. fatalis has DMTA attributes most similar to the African lion Panthera leo, implying that S. fatalis did not avoid bone to the extent previously suggested by SEM microwear data. DMTA characters most indicative of bone consumption (i.e., complexity and textural fill volume) suggest that carcass utilization by the extinct carnivorans was not necessarily more complete during the Pleistocene at La Brea; thus, times may not have been "tougher" than the present. Additionally, minor to no significant differences in DMTA attributes from older (similar to 30-35 Ka) to younger (similar to 11.5 Ka) deposits offer little evidence that declining prey resources were a primary cause of extinction for these large cats.	[DeSantis, Larisa R. G.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Schubert, Blaine W.] E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Johnson City, TN 37614 USA; [Schubert, Blaine W.] E Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA; [Scott, Jessica R.] Univ Arkansas, Dept Sociol & Anthropol, Little Rock, AR 72204 USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Vanderbilt University; East Tennessee State University; East Tennessee State University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		DeSantis, Larisa/0000-0003-1159-9154	Vanderbilt University; East Tennessee State University; University of Arkansas	Vanderbilt University; East Tennessee State University; University of Arkansas	Funding was provided by Vanderbilt University, East Tennessee State University, and the University of Arkansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyonge W, 1996, J MAMMAL, V77, P1059, DOI 10.2307/1382786; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Behrensmeyer Anna K., 1992, P15; Binder WJ, 2010, J VERTEBR PALEONTOL, V30, P255, DOI 10.1080/02724630903413016; Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; Christiansen P, 2009, J VERTEBR PALEONTOL, V29, P934, DOI 10.1671/039.029.0314; Dunn OJ, 1964, AM SOC QUAL, V6, P241; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; Freeman PW, 2006, PAPERS NATURAL RESOU, V12; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Galbany J, 2005, SCANNING, V27, P23; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Harris, 2001, RANCHO BREA RECORD P; HAYNES G, 1982, ARCTIC, V35, P266; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Martin PS, 1984, QUATERNARY EXTINCTIO; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen JA, 2012, P NATL ACAD SCI USA, V109, P4191, DOI 10.1073/pnas.1113788109; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam JC., 1932, FELIDAE RANCHO BREA; Milhacher MC, 2012, PALAEONTOL ELECTRON, V15, P1; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Mondini M, 2008, QUATERN INT, V180, P52, DOI 10.1016/j.quaint.2007.08.013; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nigra John O., 1947, BULL SO CALIFORNIA ACAD SCI, V46, P26; O'Keefe F, 2008, J VERTEBR PALEONTOL, V28, p122A; O'Keefe RF, 2009, CONTRIB SCI, V518, P1; Plavcan JM, 2008, AM J PHYS ANTHROPOL, V136, P65, DOI 10.1002/ajpa.20779; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; PROTHERO DR, 2009, CINCINNATI MUSEUM CT, V3, P291; Schaller G. B., 1972, SERENGETI LION STUDY; Schmitt E, 2011, THESIS E TENNESSEE S; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shaw CA, 1985, CONTRIBUTIONS SCI, V359, P1; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Therrien F, 2005, J ZOOL, V267, P249, DOI 10.1017/S0952836905007430; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; Ungar PS, 2008, DENTAL MICROWEAR TEX, V53, P389; Van Valkenburgh B, 2009, BIOL LETTERS, V5, P563, DOI 10.1098/rsbl.2009.0261; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; VanValkenburgh B, 1996, J MAMMAL, V77, P240, DOI 10.2307/1382725; Watts HE, 2009, P ROY SOC B-BIOL SCI, V276, P2291, DOI 10.1098/rspb.2009.0268; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2004, ALCHERINGA, V28, P291, DOI 10.1080/03115510408619286	57	57	58	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52453	10.1371/journal.pone.0052453	http://dx.doi.org/10.1371/journal.pone.0052453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300674	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800089
J	Karimian, G; Buist-Homan, M; Mikus, B; Henning, RH; Faber, KN; Moshage, H				Karimian, Golnar; Buist-Homan, Manon; Mikus, Bojana; Henning, Robert H.; Faber, Klaas Nico; Moshage, Han			Angiotensin II Protects Primary Rat Hepatocytes against Bile Salt-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEPATIC STELLATE CELLS; ACID-INDUCED APOPTOSIS; LIVER FIBROSIS; ER STRESS; INDUCED HEPATOTOXICITY; TRIGGERS APOPTOSIS; RECEPTOR BLOCKER; OXIDATIVE STRESS; CHOP GADD153	Angiotensin II (AT-II) is a pro-fibrotic compound that acts via membrane-bound receptors (AT-1R/AT-2R) and thereby activates hepatic stellate cells (HSCs). AT-II receptor blockers (ARBs) are thus important candidates in the treatment of liver fibrosis. However, multiple case reports suggest that AT-1R blockers may induce hepatocyte injury. Therefore, we investigated the effect of AT-II and its receptor blockers on cytokine-, oxidative stress-and bile salt-induced cell death in hepatocytes. Primary rat hepatocytes were exposed to TNF-alpha/Actinomycin D, the ROS-generating agent menadione or the bile salts: glycochenodeoxycholic acid (GCDCA) and tauro-lithocholic acid-3 sulfate (TLCS), to induce apoptosis. AT-II (100 nmol/L) was added 10 minutes prior to the cell death-inducing agent. AT-1R antagonists (Sartans) and the AT-2R antagonist PD123319 were used at 1 mu mol/L. Apoptosis (caspase-3 activity, acridine orange staining) and necrosis (Sytox green staining) were quantified. Expression of CHOP (marker for ER stress) and AT-II receptor mRNAs were quantified by Q-PCR. AT-II dose-dependently reduced GCDCA-induced apoptosis of hepatocytes (-50%, p<0.05) without inducing necrosis. In addition, AT-II reduced TLCS-induced apoptosis of hepatocytes (-50%, p<0.05). However, AT-II did not suppress TNF/Act-D and menadione-induced apoptosis. Only the AT-1R antagonists abolished the protective effect of AT-II against GCDCA-induced apoptosis. AT-II increased phosphorylation of ERK and a significant reversal of the protective effect of AT-II was observed when signaling kinases, including ERK, were inhibited. Moreover, AT-II prevented the GCDCA-induced expression of CHOP (the marker of the ER-mediated apoptosis). Conclusion: Angiotensin II protects hepatocytes from bile salt-induced apoptosis through a combined activation of PI3-kinase, MAPKs, PKC pathways and inhibition of bile salt-induced ER stress. Our results suggest a mechanism for the observed hepatocyte-toxicity of Sartans (angiotensin receptor blockers, ARBs) in some patients with chronic liver injury.	[Karimian, Golnar; Buist-Homan, Manon; Mikus, Bojana; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands	University of Groningen; University of Groningen	Karimian, G (corresponding author), Univ Groningen, Sect Hepatobiliairy Surg & Liver Transplantat, Surg Res Lab, Dept Surg,Univ Med Ctr Groningen, Groningen, Netherlands.	g.karimian01@umcg.nl	Henning, Robert H/AAY-5222-2020	Henning, Robert/0000-0002-5135-4621; Moshage, Han/0000-0002-4764-0246	University of Groningen	University of Groningen	This research was funded by the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, DIGEST DIS SCI, V56, P564, DOI 10.1007/s10620-010-1507-8; Andrade RJ, 1998, ANN PHARMACOTHER, V32, P1371, DOI 10.1345/aph.18087a; Andrade RJ, 2002, EUR J GASTROEN HEPAT, V14, P887, DOI 10.1097/00042737-200208000-00014; ASBERT M, 1992, J HEPATOL, V15, P179, DOI 10.1016/0168-8278(92)90033-L; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; Basile G, 2003, J CLIN GASTROENTEROL, V36, P273, DOI 10.1097/00004836-200303000-00017; Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Beltran AE, 2009, J HYPERTENS, V27, P142, DOI 10.1097/HJH.0b013e328317a730; Bernstein H, 1999, TOXICOL LETT, V108, P37, DOI 10.1016/S0378-4274(99)00113-7; Bosch X, 1997, JAMA-J AM MED ASSOC, V278, P1572, DOI 10.1001/jama.278.19.1572; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; El-Demerdash E, 2008, CLIN EXP PHARMACOL P, V35, P159, DOI 10.1111/j.1440-1681.2007.04797.x; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Guo Jeff J, 2005, Res Social Adm Pharm, V1, P460, DOI 10.1016/j.sapharm.2005.06.005; Hariraj R, 2000, BRIT MED J, V321, P547, DOI 10.1136/bmj.321.7260.547; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hsieh YC, 2003, SHOCK, V19, P582, DOI 10.1097/01.shk.0000065705.84144.ed; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Ikura Y, 2005, HEPATOL RES, V32, P107, DOI 10.1016/j.hepres.2005.01.017; Jao HC, 2001, SHOCK, V15, P130, DOI 10.1097/00024382-200115020-00009; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Kiykim A, 2003, AM J GASTROENTEROL, V98, P507; Lee W, 2005, APOPTOSIS, V10, P407, DOI 10.1007/s10495-005-0814-6; Leung PS, 2004, CURR PROTEIN PEPT SC, V5, P267, DOI 10.2174/1389203043379693; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; MORRIS BJ, 1979, ENDOCRINOLOGY, V105, P796, DOI 10.1210/endo-105-3-796; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; Nygaard Birte, 1996, Blood Pressure, V5, P190, DOI 10.3109/08037059609062128; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Perez MJ, 2011, BRIT J PHARMACOL, V162, P1686, DOI 10.1111/j.1476-5381.2010.01174.x; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rene JM, 2001, MED CLIN-BARCELONA, V117, P637, DOI 10.1016/S0025-7753(01)72204-X; Roma MG, 2011, CLIN SCI, V121, P523, DOI 10.1042/CS20110184; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Tabak F, 2002, J CLIN GASTROENTEROL, V34, P585, DOI 10.1097/00004836-200205000-00022; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tsuchiya S, 2006, TOXICOL LETT, V166, P140, DOI 10.1016/j.toxlet.2006.06.006; Vallejo I, 2000, MED CLIN-BARCELONA, V115, P719, DOI 10.1016/S0025-7753(00)71672-1; Warner FJ, 2007, CLIN SCI, V113, P109, DOI 10.1042/CS20070026; Weng YI, 2003, ALCOHOL, V29, P83, DOI 10.1016/S0741-8329(02)00325-7; Weng YI, 2002, BBA-MOL CELL RES, V1589, P285, DOI 10.1016/S0167-4889(02)00189-1; Weng YI, 2008, ALCOHOL, V42, P397, DOI 10.1016/j.alcohol.2008.02.004; Woudenberg-Vrenken TE, 2010, LIVER INT, V30, P1511, DOI 10.1111/j.1478-3231.2010.02325.x; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshiji H, 2003, HEPATOL RES, V27, P51, DOI 10.1016/S1386-6346(03)00160-8; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017	65	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52647	10.1371/journal.pone.0052647	http://dx.doi.org/10.1371/journal.pone.0052647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300732	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800119
J	Mannara, F; Valente, T; Saura, J; Graus, F; Saiz, A; Moreno, B				Mannara, Francesco; Valente, Tony; Saura, Josep; Graus, Francesc; Saiz, Albert; Moreno, Beatriz			Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IMMUNOGLOBULIN-DEFICIENT RATS; T-CELLS; PROTEOLIPID PROTEIN; FINE SPECIFICITY; BASIC-PROTEIN; MICE; INDUCTION; EXPRESSION	Experimental autoimmune encephalomyelitis (EAE) is the most relevant animal model to study demyelinating diseases such as multiple sclerosis. EAE can be induced by active (active EAE) or passive (at-EAE) transfer of activated T cells in several species and strains of rodents. However, histological features of at-EAE model in C57BL/6 are poorly described. The aim of this study was to characterize the neuroinflammatory and neurodegenerative responses of at-EAE in C57BL/6 mice by histological techniques and compare them with that observed in the active EAE model. To develop the at-EAE, splenocytes from active EAE female mice were harvested and cultured in presence of MOG35-55 and IL-12, and then injected intraperitoneally in recipient female C57BL6/J mice. In both models, the development of EAE was similar except for starting before the onset of symptoms and presenting a higher EAE cumulative score in the at-EAE model. Spinal cord histological examination revealed an increased glial activation as well as more extensive demyelinating areas in the at-EAE than in the active EAE model. Although inflammatory infiltrates composed by macrophages and T lymphocytes were found in the spinal cord and brain of both models, B lymphocytes were significantly increased in the at-EAE model. The co-localization of these B cells with IgG and their predominant distribution in areas of demyelination would suggest that IgG-secreting B cells are involved in the neurodegenerative processes associated with at-EAE.	[Mannara, Francesco; Valente, Tony; Graus, Francesc; Saiz, Albert; Moreno, Beatriz] Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain; [Mannara, Francesco; Valente, Tony; Graus, Francesc; Saiz, Albert; Moreno, Beatriz] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Mannara, Francesco; Valente, Tony; Saura, Josep] Univ Barcelona, Biochem & Mol Biol Unit, Sch Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Valente, T (corresponding author), Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain.	valente@clinic.ub.es	Graus, Francesc/K-9904-2018; Saiz, Albert/K-8236-2014; Valente, Tony/M-3097-2014; Saura, Josep/I-4428-2012	Saiz, Albert/0000-0002-5793-8791; Valente, Tony/0000-0002-2697-8184; Graus, Francesc/0000-0002-8924-8322; Saura, Josep/0000-0002-5601-4466	Fundacio La Marato de TV3 [101610]	Fundacio La Marato de TV3	This work was supported by a grant from Fundacio La Marato de TV3 (101610). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Amor S, 1996, J IMMUNOL, V156, P3000; AMOR S, 1994, J IMMUNOL, V153, P4349; Batoulis H, 2011, APMIS, V119, P819, DOI 10.1111/j.1600-0463.2011.02794.x; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; LASSMANN H, 1988, ACTA NEUROPATHOL, V75, P566, DOI 10.1007/BF00686201; LININGTON C, 1988, AM J PATHOL, V130, P443; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; TUOHY VK, 1992, J NEUROIMMUNOL, V39, P67, DOI 10.1016/0165-5728(92)90175-K; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WEINBERG AD, 1993, J NEUROIMMUNOL, V48, P105, DOI 10.1016/0165-5728(93)90064-6; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; WILLENBORG DO, 1983, J NEUROIMMUNOL, V5, P99, DOI 10.1016/0165-5728(83)90001-2; WILLENBORG DO, 1986, J NEUROIMMUNOL, V11, P93, DOI 10.1016/0165-5728(86)90111-6; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52361	10.1371/journal.pone.0052361	http://dx.doi.org/10.1371/journal.pone.0052361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300649	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800070
J	Soubannier, V; Rippstein, P; Kaufman, BA; Shoubridge, EA; McBride, HM				Soubannier, Vincent; Rippstein, Peter; Kaufman, Brett A.; Shoubridge, Eric A.; McBride, Heidi M.			Reconstitution of Mitochondria Derived Vesicle Formation Demonstrates Selective Enrichment of Oxidized Cargo	PLOS ONE			English	Article							VESICULAR TRANSPORT; PROTEIN; PARKIN; MITOPHAGY; FUSION; TRANSLOCATION; DEGRADATION; PROTEASOME; MITOFUSIN; MEMBRANE	The mechanisms that ensure the removal of damaged mitochondrial proteins and lipids are critical for the health of the cell, and errors in these pathways are implicated in numerous degenerative diseases. We recently uncovered a new pathway for the selective removal of proteins mediated by mitochondrial derived vesicular carriers (MDVs) that transit to the lysosome. However, it was not determined whether these vesicles were selectively enriched for oxidized, or damaged proteins, and the extent to which the complexes of the electron transport chain and the mtDNA-containing nucloids may have been incorporated. In this study, we have developed a cell-free mitochondrial budding reaction in vitro in order to better dissect the pathway. Our data confirm that MDVs are stimulated upon various forms of mitochondrial stress, and the vesicles incorporated quantitative amounts of cargo, whose identity depended upon the nature of the stress. Under the conditions examined, MDVs did not incorporate complexes I and V, nor were any nucleoids present, demonstrating the specificity of cargo incorporation. Stress-induced MDVs are selectively enriched for oxidized proteins, suggesting that conformational changes induced by oxidation may initiate their incorporation into the vesicles. Ultrastructural analyses of MDVs isolated on sucrose flotation gradients revealed the formation of both single and double membranes vesicles of unique densities and uniform diameter. This work provides a framework for a reductionist approach towards a detailed examination of the mechanisms of MDV formation and cargo incorporation, and supports the emerging concept that MDVs are critical contributors to mitochondrial quality control.	[Soubannier, Vincent; Shoubridge, Eric A.; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rippstein, Peter] Univ Ottawa, Inst Heart, Lipoproteins & Atherosclerosis Grp, Ottawa, ON, Canada; [Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	McGill University; University of Ottawa; University of Ottawa Heart Institute; University of Pennsylvania	McBride, HM (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	heidi.mcbride@mcgill.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280	Heart and Stroke Foundation of Ontario [5769]; Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar	This study was supported by the Heart and Stroke Foundation of Ontario, Grant-In-Aid 5769; The Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; ARGAN C, 1983, J BIOL CHEM, V258, P6667; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Cai Q, 2012, CURR BIOL; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Joselin AP, 2012, HUM MOL GENET; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; McBride HM, 1996, J CELL BIOL, V134, P307, DOI 10.1083/jcb.134.2.307; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	37	198	200	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52830	10.1371/journal.pone.0052830	http://dx.doi.org/10.1371/journal.pone.0052830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300790	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800155
J	Cui, HY; Gao, HB; Cui, XL; Zhao, Y; Shi, XM; Li, QL; Yan, S; Gao, M; Wang, M; Liu, CJ; Wang, YF				Cui, Hongyu; Gao, Hongbo; Cui, Xianlan; Zhao, Yan; Shi, Xingming; Li, Qiaoling; Yan, Shuai; Gao, Ming; Wang, Mei; Liu, Changjun; Wang, Yunfeng			Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (AI) Virus H5 Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored AI Vaccine	PLOS ONE			English	Article							INFECTIOUS BURSAL DISEASE; BACTERIAL ARTIFICIAL CHROMOSOME; NEWCASTLE-DISEASE; RECOMBINANT HERPESVIRUS; MATERNAL ANTIBODIES; SEQUENCE-ANALYSIS; GLYCOPROTEIN-B; FOWLPOX VIRUS; IBDV VP2; HA GENE	Background: Herpesvirus of turkey (HVT) as a vector to express the haemagglutinin (HA) of avian influenza virus (AIV) H5 was developed and its protection against lethal Marek's disease virus (MDV) and highly pathogenic AIV (HPAIV) challenges was evaluated previously. It is well-known that avirulemt MDV type 1 vaccines are more effective than HVT in prevention of lethal MDV infection. To further increase protective efficacy against HPAIV and lethal MDV, a recombinant MDV type 1 strain 814 was developed to express HA gene of HPAIV H5N1. Methodology/Principal Findings: A recombinant MDV-1 strain 814 expressing HA gene of HPAIV H5N1 virus A/goose/Guangdong/3/96 at the US2 site (rMDV-HA) was developed under the control of a human CMV immediate-early promoter. The HA expression in the rMDV-HA was tested by immunofluorescence and Western blot analyses, and in vitro and in vivo growth properties of rMDV-HA were also analyzed. Furthermore, we evaluated and compared the protective immunity of rMDV-HA and previously constructed rHVT-HA against HPAIV and lethal MDV. Vaccination of chickens with rMDV-HA induced 80% protection against HPAIV, which was better than the protection rate by rHVT-HA (66.7%). In the animal study with MDV challenge, chickens immunized with rMDV-HA were completely protected against virulent MDV strain J-1 whereas rHVT-HA only induced 80% protection with the same challenge dose. Conclusions/Significance: The rMDV-HA vaccine was more effective than rHVT-HA vaccine for protection against lethal MDV and HPAIV challenges. Therefore, avirulent MDV type 1 vaccine is a better vector than HVT for development of a recombinant live virus vaccine against virulent MDV and HPAIV in poultry.	[Cui, Hongyu; Gao, Hongbo; Zhao, Yan; Shi, Xingming; Li, Qiaoling; Yan, Shuai; Gao, Ming; Wang, Mei; Liu, Changjun; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Cui, Xianlan] Hlth Anim Lab, Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Gao, Hongbo/AHE-9262-2022; Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China [SKLVBP201212]; Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard [0302012009]	State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China; Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard	The study was supported by a grant from the State Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (SKLVBP201212) and the Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard (0302012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; Bublot M, 2007, J COMP PATHOL, V137, pS81, DOI 10.1016/j.jcpa.2007.04.017; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2009, REV SCI TECH OIE, V28, P245, DOI 10.20506/rst.28.1.1861; Capua I, 2000, VET REC, V147, P751; Chen HL, 2009, SCI CHINA SER C, V52, P419, DOI 10.1007/s11427-009-0068-6; Cui HY, 2009, J VIROL METHODS, V156, P66, DOI 10.1016/j.jviromet.2008.10.021; Cui Hongyu, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P569, DOI 10.1016/S1872-2075(08)60028-X; Cui SJ, 2008, J VET DIAGN INVEST, V20, P567, DOI 10.1177/104063870802000505; DARTEIL R, 1995, VIROLOGY, V211, P481, DOI 10.1006/viro.1995.1430; Gao HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022549; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Heckert RA, 1996, AVIAN DIS, V40, P770, DOI 10.2307/1592296; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Lee LF, 2008, VACCINE, V26, P1887, DOI 10.1016/j.vaccine.2008.01.046; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Liu Ai-ling, 2009, Chinese Journal of Virology, V25, P368; Liu ChaoNan, 2006, Scientia Agricultura Sinica, V39, P412; Liu JX, 2011, J VIROL, V85, P10989, DOI 10.1128/JVI.05420-11; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; MORGAN RW, 1993, AVIAN DIS, V37, P1032, DOI 10.2307/1591910; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Oveissi S, 2010, COMP IMMUNOL MICROB, V33, P491, DOI 10.1016/j.cimid.2009.08.004; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pavlova SP, 2009, VACCINE, V27, P5085, DOI 10.1016/j.vaccine.2009.06.048; Prandini F, 2008, ZOOTECNICA INT, P40; Reddy SK, 1996, VACCINE, V14, P469, DOI 10.1016/0264-410X(95)00242-S; ROSS LJN, 1993, J GEN VIROL, V74, P371, DOI 10.1099/0022-1317-74-3-371; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Schat K.A, 2008, DIS POULTRY, P452; Schroer D, 2009, AVIAN DIS, V53, P190, DOI 10.1637/8416-072308-Reg.1; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shi Wei-song, 2008, Chinese Journal of Virology, V24, P117; Spatz SJ, 2007, VIRUS GENES, V35, P753, DOI 10.1007/s11262-007-0157-1; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TARNOWSKI BI, 1991, BIOTECH HISTOCHEM, V66, P296, DOI 10.3109/10520299109109990; Tong K, 1984, ACTA VET ZOOTECHNICA, V15, P109; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; Tsukamoto K, 2002, J VIROL, V76, P5637, DOI 10.1128/JVI.76.11.5637-5645.2002; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WITTER RL, 1991, AVIAN DIS, V35, P877, DOI 10.2307/1591624; WITTER RL, 1987, AVIAN DIS, V31, P752, DOI 10.2307/1591027; Xia CY, 2000, CHINESE J VET SCI TE, V30, P24; Yun Shui-li, 2009, Chinese Journal of Virology, V25, P430; ZELNIK V, 1995, J GEN VIROL, V76, P2903, DOI 10.1099/0022-1317-76-11-2903; Zhou XM, 2010, VACCINE, V28, P3990, DOI 10.1016/j.vaccine.2010.03.021	51	26	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53340	10.1371/journal.pone.0053340	http://dx.doi.org/10.1371/journal.pone.0053340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301062	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000050
J	Dokter, AM; Shamoun-Baranes, J; Kemp, MU; Tijm, S; Holleman, I				Dokter, Adriaan M.; Shamoun-Baranes, Judy; Kemp, Michael U.; Tijm, Sander; Holleman, Iwan			High Altitude Bird Migration at Temperate Latitudes: A Synoptic Perspective on Wind Assistance	PLOS ONE			English	Article							NOCTURNAL PASSERINE MIGRATION; FLIGHT ALTITUDES; RADAR; AUTUMN; MIGRANTS; WEATHER; EUROPE; MODELS	At temperate latitudes the synoptic patterns of bird migration are strongly structured by the presence of cyclones and anticyclones, both in the horizontal and altitudinal dimensions. In certain synoptic conditions, birds may efficiently cross regions with opposing surface wind by choosing a higher flight altitude with more favourable wind. We observed migratory passerines at mid-latitudes that selected high altitude wind optima on particular nights, leading to the formation of structured migration layers at varying altitude up to 3 km. Using long-term vertical profiling of bird migration by C-band Doppler radar in the Netherlands, we find that such migration layers occur nearly exclusively during spring migration in the presence of a high-pressure system. A conceptual analytic framework providing insight into the synoptic patterns of wind assistance for migrants that includes the altitudinal dimension has so far been lacking. We present a simple model for a baroclinic atmosphere that relates vertical profiles of wind assistance to the pressure and temperature patterns occurring at temperate latitudes. We show how the magnitude and direction of the large scale horizontal temperature gradient affects the relative gain in wind assistance that migrants obtain through ascending. Temperature gradients typical for northerly high-pressure systems in spring are shown to cause high altitude wind optima in the easterly sectors of anticyclones, thereby explaining the frequent observations of high altitude migration in these synoptic conditions. Given the recurring synoptic arrangements of pressure systems across temperate continents, the opportunities for exploiting high altitude wind will differ between flyways, for example between easterly and westerly oceanic coasts.	[Dokter, Adriaan M.; Shamoun-Baranes, Judy; Kemp, Michael U.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Dokter, Adriaan M.; Tijm, Sander; Holleman, Iwan] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Holleman, Iwan] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Royal Netherlands Meteorological Institute; Radboud University Nijmegen	Dokter, AM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	a.m.dokter@uva.nl	Holleman, Iwan/D-6229-2013; Shamoun-Baranes, Judy/Q-1311-2019; Dokter, Adriaan/AAA-9244-2021; Shamoun-Baranes, Judy/C-6921-2013	Shamoun-Baranes, Judy/0000-0002-1652-7646; Shamoun-Baranes, Judy/0000-0002-1652-7646				ABLE KP, 1970, BIRD BANDING, V41, P282, DOI 10.2307/4511688; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Baas P, 2009, J APPL METEOROL CLIM, V48, P1627, DOI 10.1175/2009JAMC1965.1; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; BRUDERER B, 1995, IBIS, V137, P44, DOI 10.1111/j.1474-919X.1995.tb03218.x; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; BRUDERER B, 1995, ISR J ZOOL, V76, P1106; BRUDERER B, 1971, ORNITHOL BEOB, V68, P89; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Dokter AM, 2011, J R SOC INTERFACE, V8, P30, DOI 10.1098/rsif.2010.0116; Erni B, 2002, ARDEA, V90, P155; GAUTHREAUX SA, 1991, AM ZOOL, V31, P187; Gauthreaux Sidney A. Jr, 2005, P182; Green M, 2002, J THEOR BIOL, V218, P485, DOI 10.1006/jtbi.2002.3094; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Holton J., 2004, INTRO DYNAMIC METEOR; Karlsson H, 2011, IBIS, V153, P485, DOI 10.1111/j.1474-919X.2011.01130.x; Karlsson H, 2010, BEHAV ECOL SOCIOBIOL, V64, P2021, DOI 10.1007/s00265-010-1015-z; Kemp MU, 2012, J THEOR BIOL, V308, P56, DOI 10.1016/j.jtbi.2012.05.026; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Klaassen M, 2000, J AVIAN BIOL, V31, P47, DOI 10.1034/j.1600-048X.2000.310107.x; KNMI, 2011, EUR WEATH CHARTS ARC; KNMI, 2011, CLIM MONTHL DESCR KN; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Liechti F, 2000, AUK, V117, P205, DOI 10.1642/0004-8038(2000)117[0205:PMFABP]2.0.CO;2; PIERSMA T, 1990, ARDEA, V78, P315; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Richardson W.J., 1990, P78; RICHARDSON WJ, 1976, IBIS, V118, P309, DOI 10.1111/j.1474-919X.1976.tb02023.x; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Schmaljohann H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1609, DOI 10.1007/s00265-009-0758-x; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Unden P., 2002, TECHNICAL REPORT; Van Belle J, 2007, J APPL ECOL, V44, P864, DOI 10.1111/j.1365-2664.2007.01322.x; Zehnder S, 2001, J AVIAN BIOL, V32, P239, DOI 10.1111/j.0908-8857.2001.320306.x	36	50	51	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52300	10.1371/journal.pone.0052300	http://dx.doi.org/10.1371/journal.pone.0052300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300969	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000007
J	Fowler, ML; Li, A				Fowler, Michelle L.; Li, Andrea			Effects of Texture Component Orientation on Orientation Flow Visibility for 3-D Shape Perception	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE; SURFACE ORIENTATION; IDEAL OBSERVERS; SIMPLE CELLS; SELECTIVITY; SUPPRESSION; MECHANISMS; NEURONS; DISCRIMINATION; LIMITATIONS	In images of textured 3-D surfaces, orientation flows created by the texture components parallel to the surface slant play a critical role in conveying the surface slant and shape. This study examines the visibility of these orientation flows in complex patterns. Specifically, we examine the effect of orientation of neighboring texture components on orientation flow visibility. Complex plaids consisting of gratings equally spaced in orientation were mapped onto planar and curved surfaces. The visibility of the component that creates the orientation flows was quantified by measuring its contrast threshold (CT) while varying the combination of neighboring components present in the pattern. CTs were consistently lowest only when components closest in orientation to that of the orientation flows were subtracted from the pattern. This finding suggests that a previously reported frequency-selective cross-orientation suppression mechanism involved with the perception of 3-D shape from texture is affected by proximity in orientation of concurrent texture components.	[Fowler, Michelle L.] CUNY, Grad Ctr, Neuropsychol Doctoral Subprogram, New York, NY USA; [Li, Andrea] Queens Coll, Dept Psychol, Flushing, NY 11367 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Li, A (corresponding author), Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	andrea.li@qc.cuny.edu			National Institutes of Health (NIH) [R15 EY018951]; NIH [R01 EY 13312]; City University of New York PSC- CUNY Research Award Program [PSC-63642-00-41]; NATIONAL EYE INSTITUTE [R15EY018951, R01EY013312] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York PSC- CUNY Research Award Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) R15 EY018951 to AL, NIH R01 EY 13312 to Q. Zaidi, and a grant from the City University of New York PSC- CUNY Research Award Program (PSC-63642-00-41) to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2002, J VISION, V2, P66, DOI 10.1167/2.1.5; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Bajcsy R., 1976, COMPUT GRAPHICS IMAG, V5, P52, DOI DOI 10.1016/S0146-664X(76)80005-6; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; CUMMING BG, 1993, VISION RES, V33, P827, DOI 10.1016/0042-6989(93)90201-7; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Delahunt PB, 2008, J VISION, V8, DOI 10.1167/8.3.5; FIELD DJ, 2004, J VIS, V4, pA283; GEISLER WS, 1991, J NEUROPHYSIOL, V66, P334, DOI 10.1152/jn.1991.66.1.334; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; KNILL DC, 1992, J OPT SOC AM A, V9, P1449, DOI 10.1364/JOSAA.9.001449; Knill DC, 1998, VISION RES, V38, P2635, DOI 10.1016/S0042-6989(97)00415-X; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2003, VISION RES, V43, P2741, DOI 10.1016/j.visres.2003.07.001; Li A, 2001, J OPT SOC AM A, V18, P2430, DOI 10.1364/JOSAA.18.002430; Li A, 2001, VISION RES, V41, P1519, DOI 10.1016/S0042-6989(01)00021-9; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Li A, 2008, VISION RES, V48, P244, DOI 10.1016/j.visres.2007.11.009; Li A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008333; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Roeber U, 2008, J VIS, V8, p[1, 15]; SAKAI K, 1995, J OPT SOC AM A, V12, P1208, DOI 10.1364/JOSAA.12.001208; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; THOMAS JP, 1979, J OPT SOC AM, V69, P652, DOI 10.1364/JOSA.69.000652; TODD JT, 1987, J EXP PSYCHOL HUMAN, V13, P242, DOI 10.1037/0096-1523.13.2.242; TURNER MR, 1991, BIOL CYBERN, V65, P215, DOI 10.1007/BF00206219; Zaidi Q, 2002, VISION RES, V42, P815, DOI 10.1016/S0042-6989(01)00233-4; Zaidi Q, 2006, VISUAL NEUROSCI, V23, P323, DOI 10.1017/S0952523806233170	41	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53556	10.1371/journal.pone.0053556	http://dx.doi.org/10.1371/journal.pone.0053556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301085	Green Published, gold			2022-12-27	WOS:000313480000065
J	Langer, N; Pedroni, A; Jancke, L				Langer, Nicolas; Pedroni, Andreas; Jaencke, Lutz			The Problem of Thresholding in Small-World Network Analysis	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; COMPLEX BRAIN NETWORKS; MULTI CHANNEL EEG; FUNCTIONAL CONNECTIVITY; ANATOMICAL NETWORKS; PERMUTATION TESTS; CORTICAL NETWORKS; WHOLE-BRAIN; EFFICIENCY	Graph theory deterministically models networks as sets of vertices, which are linked by connections. Such mathematical representation of networks, called graphs are increasingly used in neuroscience to model functional brain networks. It was shown that many forms of structural and functional brain networks have small-world characteristics, thus, constitute networks of dense local and highly effective distal information processing. Motivated by a previous small-world connectivity analysis of resting EEG-data we explored implications of a commonly used analysis approach. This common course of analysis is to compare small-world characteristics between two groups using classical inferential statistics. This however, becomes problematic when using measures of inter-subject correlations, as it is the case in commonly used brain imaging methods such as structural and diffusion tensor imaging with the exception of fibre tracking. Since for each voxel, or region there is only one data point, a measure of connectivity can only be computed for a group. To empirically determine an adequate small-world network threshold and to generate the necessary distribution of measures for classical inferential statistics, samples are generated by thresholding the networks on the group level over a range of thresholds. We believe that there are mainly two problems with this approach. First, the number of thresholded networks is arbitrary. Second, the obtained thresholded networks are not independent samples. Both issues become problematic when using commonly applied parametric statistical tests. Here, we demonstrate potential consequences of the number of thresholds and non-independency of samples in two examples (using artificial data and EEG data). Consequently alternative approaches are presented, which overcome these methodological issues.	[Langer, Nicolas; Jaencke, Lutz] Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland; [Langer, Nicolas] Childrens Hosp, Dept Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA; [Langer, Nicolas] Harvard Univ, Sch Med, Boston, MA USA; [Pedroni, Andreas] Univ Basel, Dept Psychol, Div Social & Affect Neurosci, Basel, Switzerland; [Pedroni, Andreas] Univ Basel, Dept Psychol, Ctr Econ Psychol, Basel, Switzerland; [Jaencke, Lutz] Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland	University of Zurich; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basel; University of Basel	Langer, N (corresponding author), Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland.	nicolas.langer@childrens.harvard.edu	Jäncke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0003-2110-9067				Berger VW, 2000, STAT MED, V19, P1319, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1319::AID-SIM490>3.0.CO;2-0; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; Court JH, 2003, SECTION1 GENERAL OVE; Edgington E. S., 1995, RANDOMIZATION TESTS; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Fisher R.A., 1935, THE DESIGN OF EXPERI; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; Jancke L, 2011, J NEUROPSYCHOL, V5, P178, DOI 10.1111/j.1748-6653.2011.02004.x; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Langer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009208; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Manly BFJ, 1997, RANDOMIZATION BOOTST; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Opsahl T, 2009, STRUCTURE AND EVOLUT; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Pitman EJG, 1938, BIOMETRIKA, V29, P322, DOI 10.1093/biomet/29.3-4.322; PITMAN EJG, 1937, ROYAL STAT SOC S, V4, P119; Richiardi J, 2011, PROC IEEE WORKSHOP O; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O., 2010, NETWORKS BRAIN; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; von Bastian CC, 2012, CORTEX IN PRESS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	44	74	76	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53199	10.1371/journal.pone.0053199	http://dx.doi.org/10.1371/journal.pone.0053199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301043	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000313480000039
J	Soylemez, E; de Boer, MP; Sae-Ueng, U; Evilevitch, A; Stewart, TA; Nyman, M				Soylemez, Emrecan; de Boer, Maarten P.; Sae-Ueng, Udom; Evilevitch, Alex; Stewart, Tom A.; Nyman, May			Photocatalytic Degradation of Bacteriophages Evidenced by Atomic Force Microscopy	PLOS ONE			English	Article							WATER; INACTIVATION; COLIFORM; VIRUSES	Methods to supply fresh water are becoming increasingly critical as the world population continues to grow. Small-diameter hazardous microbes such as viruses (20-100 nm diameter) can be filtered by size exclusion, but in this approach the filters are fouled. Thus, in our research, we are investigating an approach in which filters will be reusable. When exposed to ultraviolet (UV) illumination, titanate materials photocatalytically evolve (OH)-O-center dot and O2(center dot-) radicals, which attack biological materials. In the proposed approach, titanate nanosheets are deposited on a substrate. Viruses adsorb on these nanosheets and degrade when exposed to UV light. Using atomic force microscopy (AFM), we image adsorbed viruses and demonstrate that they are removed by UV illumination in the presence of the nanosheets, but not in their absence.	[Soylemez, Emrecan; de Boer, Maarten P.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Sae-Ueng, Udom; Evilevitch, Alex] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Stewart, Tom A.; Nyman, May] Sandia Natl Labs, Albuquerque, NM 87185 USA	Carnegie Mellon University; Carnegie Mellon University; United States Department of Energy (DOE); Sandia National Laboratories	de Boer, MP (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	mpdebo@andrew.cmu.edu	Soylemez, Emrecan/ABA-7415-2020; Soylemez, Emrecan/M-5564-2016; Evilevitch, Alex/P-3103-2014; de Boer, Maarten P/C-1525-2013	Soylemez, Emrecan/0000-0003-4827-2606; Soylemez, Emrecan/0000-0003-4827-2606; Evilevitch, Alex/0000-0002-0245-9574; de Boer, Maarten P/0000-0003-1574-9324	Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories; United States Department of Energy [DEAC04-94AL85000]	Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed-Martin Company, for the United States Department of Energy under Contract No. DEAC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Development of the titanate photocatalysts used in the study, as well as their adhesion to substrates, was supported by the Laboratory Directed Research and Development (LDRD) program at Sandia National Laboratories. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed-Martin Company, for the United States Department of Energy under Contract No. DEAC04-94AL85000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Synthesis and application of the catalytic materials is the subject of a provisional patent application assigned serial number 61/577,349.	[Anonymous], 2006, INT WORKSH NAN WADC; BRADLEY SM, 1992, INORG CHEM, V31, P1181, DOI 10.1021/ic00033a012; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Casey WH, 2006, CHEM REV, V106, P1, DOI 10.1021/cr040095d; Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005; Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039; Cik G, 2006, CHEMOSPHERE, V63, P1419, DOI 10.1016/j.chemosphere.2005.10.017; Coleman HM, 2005, CHEM ENG J, V113, P55, DOI 10.1016/j.cej.2005.07.015; Dubrovin EV, 2008, LANGMUIR, V24, P13068, DOI 10.1021/la8022612; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Evilevitch A, 2011, J MOL BIOL, V405, P18, DOI 10.1016/j.jmb.2010.10.039; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI [10.1016/s1389-5567(00)00002-2, DOI 10.1016/S1389-5567(00)00002-2]; Garcia R, 1999, PHYS REV B, V60, P4961, DOI 10.1103/PhysRevB.60.4961; Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x; GREY IE, 1987, J SOLID STATE CHEM, V66, P7, DOI 10.1016/0022-4596(87)90215-5; Herrmann JM, 2000, CR ACAD SCI II C, V3, P417, DOI 10.1016/S1387-1609(00)01137-3; Hillie T, 2007, NAT NANOTECHNOL, V2, P663, DOI 10.1038/nnano.2007.350; Kuznetsov YG, 2011, BACTERIOPHAGE, V1, P164; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Liga MV, 2011, WATER RES, V45, P535, DOI 10.1016/j.watres.2010.09.012; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; Ostendorf F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/30/305705; Pan JH, 2010, J MATER CHEM, V20, P4512, DOI 10.1039/b925523k; Silhavy T.J., 1984, EXPT GENE FUSIONS; Skorb EV, 2011, PHOTOCH PHOTOBIO SCI, V10, P1974, DOI 10.1039/c1pp05195d; Stewart TA, 2011, APPL CATAL B-ENVIRON, V105, P69, DOI 10.1016/j.apcatb.2011.03.036; Stewart TA, 2009, ENVIRON SCI TECHNOL, V43, P5416, DOI 10.1021/es803683t; Sun DD, 2003, WATER RES, V37, P3452, DOI 10.1016/S0043-1354(03)00228-8; VESENKA J, 1993, BIOPHYS J, V65, P992, DOI 10.1016/S0006-3495(93)81171-8; WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M; Woan K, 2009, ADV MATER, V21, P2233, DOI 10.1002/adma.200802738; Wong MS, 2009, J CHEM TECHNOL BIOT, V84, P158, DOI 10.1002/jctb.2002	33	6	6	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53601	10.1371/journal.pone.0053601	http://dx.doi.org/10.1371/journal.pone.0053601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301095	Green Submitted, Green Published, gold			2022-12-27	WOS:000313480000071
J	Stegen, C; Yakova, Y; Henaff, D; Nadjar, J; Duron, J; Lippe, R				Stegen, Camille; Yakova, Yordanka; Henaff, Daniel; Nadjar, Julien; Duron, Johanne; Lippe, Roger			Analysis of Virion-Incorporated Host Proteins Required for Herpes Simplex Virus Type 1 Infection through a RNA Interference Screen	PLOS ONE			English	Article							CELLULAR-PROTEINS; GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; INHIBITION; TRANSPORT; GLYCOPROTEINS; REPLICATION; ADENOVIRUS; PARTICLES	Viruses are strictly dependent on cells to propagate and many incorporate host proteins in their viral particles, but the significance of this incorporation is poorly understood. Recently, we performed the first comprehensive characterization of the mature herpes simplex virus type 1 (HSV-1) in which up to 49 distinct cellular proteins were identified by mass spectrometry. In the present study, we sought to identify if these cellular factors are relevant for the HSV-1 life cycle. To this end, we performed a small interfering RNA functional screen and found that 15 of these host proteins altered HSV-1 proliferation in cell culture, without any significant effect on cell viability. Moreover, the siRNA used had no negative consequences for Adenovirus type 5 propagation (with one exception) indicating that the modulation was specific for HSV-1 and not merely due to unhealthy cells. The positive host proteins include several Rab GTPases and other intracellular transport components as well as proteins involved in signal transduction, gene regulation and immunity. Remarkably, in most cases when virions were depleted for one of the above proteins, they replicated more poorly in subsequent infections in wild type cells. This highlights for the first time that both the cellular and virion-associated pools of many of these proteins actively contribute to viral propagation. Altogether, these findings underscore the power and biological relevance of combining proteomics and RNA interference to identify novel host-pathogen interactions.	[Stegen, Camille; Yakova, Yordanka; Henaff, Daniel; Nadjar, Julien; Duron, Johanne; Lippe, Roger] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal	Lippe, R (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada.	roger.lippe@umontreal.ca		Lippe, Roger/0000-0001-5066-3070	Canadian Institutes of Health Research [MOP 82921]; Canada Frederick Banting and Charles Best studentship from the CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Frederick Banting and Charles Best studentship from the CIHR	This work was funded by a grant from the Canadian Institutes of Health Research (MOP 82921). YY was supported by a Canada Frederick Banting and Charles Best studentship from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1989, J VIROL, V63, P2260, DOI 10.1128/JVI.63.5.2260-2269.1989; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Bhuyan PK, 2004, J VIROL, V78, P10276, DOI 10.1128/JVI.78.19.10276-10281.2004; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; CHEUNG P, 1991, J VIROL, V65, P1893, DOI 10.1128/JVI.65.4.1893-1904.1991; Clement C, 2008, MOL VIS, V14, P1209; Clemente R, 2010, J VIROL, V84, P3562, DOI 10.1128/JVI.02274-09; Dasgupta A, 2001, J GEN VIROL, V82, P1561, DOI 10.1099/0022-1317-82-7-1561; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Dry I, 2008, J VIROL, V82, P5390, DOI 10.1128/JVI.00094-08; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Dziuba N, 2012, AIDS RES HUM RETROV, V28, P1329, DOI 10.1089/aid.2011.0358; Eckstein A, 2010, ANTIVIR RES, V88, P86, DOI 10.1016/j.antiviral.2010.08.002; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; HAY J, 1977, J ANTIMICROB CHEMOTH, V3, P63, DOI 10.1093/jac/3.suppl_A.63; Indran SV, 2011, J VIROL, V85, P5213, DOI 10.1128/JVI.02605-10; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Karasneh GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025252; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; Krauss O, 2002, J GEN VIROL, V83, P2347, DOI 10.1099/0022-1317-83-10-2347; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lam Q, 1996, EMBO J, V15, P2575, DOI 10.1002/j.1460-2075.1996.tb00615.x; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Lippe R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00181; LODISH HF, 1980, CELL, V19, P161, DOI 10.1016/0092-8674(80)90397-9; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Loret S, 2012, J GEN VIROL, V93, P624, DOI 10.1099/vir.0.039776-0; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; Maric M, 2011, J VIROL, V85, P9667, DOI 10.1128/JVI.05314-11; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Sarma N, 2008, J VIROL, V82, P6600, DOI 10.1128/JVI.00137-08; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; WEINHEIMER SP, 1992, J VIROL, V66, P258, DOI 10.1128/JVI.66.1.258-269.1992; Wu ZT, 2009, J VIROL, V83, P6652, DOI 10.1128/JVI.00260-09; Zenner HL, 2011, J VIROL, V85, P8012, DOI 10.1128/JVI.00500-11; Zhang CW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-242; Zhang YQ, 2008, CLIN EXP DERMATOL, V33, P56, DOI 10.1111/j.1365-2230.2007.02543.x; Zhe R, 2008, ARCH VIROL, V153, P1401, DOI 10.1007/s00705-008-0110-1; Zhou Q, 2012, VIRUS RES; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	62	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53276	10.1371/journal.pone.0053276	http://dx.doi.org/10.1371/journal.pone.0053276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301054	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000045
J	Theodoropoulou, S; Brodowska, K; Kayama, M; Morizane, Y; Miller, JW; Gragoudas, ES; Vavvas, DG				Theodoropoulou, Sofia; Brodowska, Katarzyna; Kayama, Maki; Morizane, Yuki; Miller, Joan W.; Gragoudas, Evangelos S.; Vavvas, Demetrios G.			Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; SKELETAL-MUSCLE; ENERGY STATUS; TUMOR-GROWTH; PHOSPHORYLATION SITES; SIGNALING PATHWAY; MAMMALIAN TARGET; CDK INHIBITORS; BREAST-CANCER	5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR), an analog of AMP is widely used as an activator of AMP-kinase (AMPK), a protein that regulates the responses of the cell to energy change. Recently, we showed that AICAR-induced AMPK activation inhibits the growth of retinoblastoma cells in vitro by decreasing cyclins and by inducing apoptosis and S-phase arrest. In this study, we investigated the effects of AMPK activator AICAR on the growth of retinoblastoma in vivo. Intraperitoneal injection of AICAR resulted in 48% growth inhibition of Y79 retinoblastoma cell tumors in mice. Tumors isolated from mice treated with AICAR had decreased expression of Ki67 and increased apoptotic cells (TUNEL positive) compared with the control. In addition, AICAR treatment suppressed significantly tumor vessel density and macrophage infiltration. We also showed that AICAR administration resulted in AMPK activation and mTOR pathway inhibition. Paradoxically observed down-regulation of p21, which indicates that p21 may have a novel function of an oncogene in retinoblastoma tumor. Our results indicate that AICAR treatment inhibited the growth of retinoblastoma tumor in vivo via AMPK/mTORC1 pathway and by apoptogenic, anti-proliferative, anti-angiogenesis mechanism. AICAR is a promising novel non-chemotherapeutic drug that may be effective as an adjuvant in treating Retinoblastoma.	[Theodoropoulou, Sofia; Brodowska, Katarzyna; Kayama, Maki; Morizane, Yuki; Miller, Joan W.; Gragoudas, Evangelos S.; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Retina Serv,Angiogenesis Lab, Dept Ophthalmol,Massachusetts Eye & Ear Infirmary, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Vavvas, DG (corresponding author), Harvard Univ, Sch Med, Retina Serv,Angiogenesis Lab, Dept Ophthalmol,Massachusetts Eye & Ear Infirmary, Boston, MA 02115 USA.	vavvas@meei.harvard.edu		Theodoropoulou, Sofia/0000-0003-3038-5354; Vavvas, Demetrios/0000-0002-8622-6478; Miller, Joan/0000-0003-2046-3996	National Eye Institute grant [EY014104]; Research to Prevent Blindness Unrestricted Institutional Award; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER	National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Institutional Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grant EY014104 (MEEI Core Grant) and Research to Prevent Blindness Unrestricted Institutional Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Eye Institute grant EY014104 (MEEI Core Grant) and Research to Prevent Blindness Unrestricted Institutional Award.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Apte RS, 2007, OPHTHAL RES, V39, P188, DOI 10.1159/000103578; Baumann P, 2007, EXP CELL RES, V313, P3592, DOI 10.1016/j.yexcr.2007.06.020; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Fadden P, 1997, J BIOL CHEM, V272, P10240; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Gingras AC, 2001, PROG MOLEC, V27, P143; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HEALY E, 1995, BRIT J DERMATOL, V133, P737, DOI 10.1111/j.1365-2133.1995.tb02748.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jia RB, 2007, OPHTHAL RES, V39, P108, DOI 10.1159/000099247; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp B., 2003, AMP ACTIVATED PROTEI; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Miyano-Kurosaki N, 2006, BIOL PHARM BULL, V29, P2197, DOI 10.1248/bpb.29.2197; Nakanishi C, 2004, ONCOLOGY-BASEL, V67, P476, DOI 10.1159/000082933; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishimura S, 2001, J CLIN ONCOL, V19, P4182, DOI 10.1200/JCO.2001.19.21.4182; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Petti C, 2012, MELANOMA RES, V22, P341, DOI 10.1097/CMR.0b013e3283544929; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; ROARTY JD, 1988, OPHTHALMOLOGY, V95, P1583; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P282, DOI 10.1001/archophthalmol.2008.626; Shields CL, 2003, J PEDIAT OPHTH STRAB, V40, P6; Shields CL, 2002, ARCH OPHTHALMOL-CHIC, V120, P460; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Tsuji T, 1998, BIOCHEM BIOPH RES CO, V242, P317, DOI 10.1006/bbrc.1997.7958; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	66	31	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52852	10.1371/journal.pone.0052852	http://dx.doi.org/10.1371/journal.pone.0052852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300996	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000018
J	Wanisch, K; Kovac, S; Schorge, S				Wanisch, Klaus; Kovac, Stjepana; Schorge, Stephanie			Tackling Obstacles for Gene Therapy Targeting Neurons: Disrupting Perineural Nets with Hyaluronidase Improves Transduction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RAT-BRAIN; VECTOR; GLYCOSAMINOGLYCANS; EXPRESSION; ADULT; MICROENVIRONMENT; GLYCOPROTEINS; POLYCATIONS; INTEGRATION	Gene therapy has been proposed for many diseases in the nervous system. In most cases for successful treatment, therapeutic vectors must be able to transduce mature neurons. However, both in vivo, and in vitro, where preliminary characterisation of viral particles takes place, transduction of neurons is typically inefficient. One possible explanation is that the extracellular matrix (ECM), forming dense perineural nets (PNNs) around neurons, physically blocks access to the cell surface. We asked whether co-administration of lentiviral vectors with an enzyme that disrupts the ECM could improve transduction efficiency. Using hyaluronidase, an enzyme which degrades hyaluronic acid, a high molecular weight molecule of the ECM with mainly a scaffolding function, we show that in vitro in mixed primary cortical cultures, and also in vivo in rat cortex, hyaluronidase co-administration increased the percentage of transduced mature, NeuN-positive neurons. Moreover, hyaluronidase was effective at doses that showed no toxicity in vitro based on propidium iodide staining of treated cultures. Our data suggest that limited efficacy of neuronal transduction is partly due to PNNs surrounding neurons, and further that co-applying hyaluronidase may benefit applications where efficient transduction of neurons in vitro or in vivo is required.	[Wanisch, Klaus; Kovac, Stjepana; Schorge, Stephanie] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Kovac, Stjepana] Univ Munster, Dept Neurol, Munster, Germany	University of London; University College London; University of Munster	Wanisch, K (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	klaus.wanisch@gmx.de; s.schorge@ucl.ac.uk	Schorge, Stephanie/C-8515-2009	Schorge, Stephanie/0000-0003-1541-5148	Wellcome Trust [086882/Z/08/Z]; Medical Research Council UK; stipend from the Deutsche Forschungsgemeinschaft [KO-3878/1-1]; Worshipful Company of Pewterers UK; Fellowship from the Royal Society [UF090203]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); stipend from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Worshipful Company of Pewterers UK; Fellowship from the Royal Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KW is funded by the Wellcome Trust (086882/Z/08/Z) and by the Medical Research Council UK. SK was supported by a stipend from the Deutsche Forschungsgemeinschaft (KO-3878/1-1). SS is funded by a fellowship by the Worshipful Company of Pewterers UK, and by a Fellowship from the Royal Society (UF090203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo-Adesida E, 2005, HUM GENE THER, V16, P741, DOI 10.1089/hum.2005.16.741; Batra RK, 1997, J BIOL CHEM, V272, P11736, DOI 10.1074/jbc.272.18.11736; BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P45, DOI 10.1016/0736-5748(92)90006-L; BRAUER K, 1982, J HIRNFORSCH, V23, P701; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Favre D, 2000, GENE THER, V7, P1417, DOI 10.1038/sj.gt.3301256; Forster E, 2001, DEVELOPMENT, V128, P3029; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Ganesh S, 2009, CANCER GENE THER, V16, P383, DOI 10.1038/cgt.2008.90; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; John N, 2006, MOL CELL NEUROSCI, V31, P774, DOI 10.1016/j.mcn.2006.01.011; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Lander C, 1998, J NEUROSCI, V18, P174; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Liehl B, 2007, GENE THER, V14, P1330, DOI 10.1038/sj.gt.3302988; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; MANNING JS, 1971, APPL MICROBIOL, V22, P1162, DOI 10.1128/AEM.22.6.1162-1163.1971; MARGOLIS RK, 1975, BIOCHEMISTRY-US, V14, P4797, DOI 10.1021/bi00693a004; MARGOLIS RU, 1974, BIOCHEMISTRY-US, V13, P2849, DOI 10.1021/bi00711a011; Meyer K, 1934, J BIOL CHEM, V107, P629; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neeves KB, 2007, BRAIN RES, V1180, P121, DOI 10.1016/j.brainres.2007.08.050; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Srinivasan C, 2009, J CONTROL RELEASE, V136, P62, DOI 10.1016/j.jconrel.2009.01.022; Sykova E, 1997, ADV NEUROL, V73, P121; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; VERNA JM, 1989, INT J DEV NEUROSCI, V7, P389, DOI 10.1016/0736-5748(89)90060-9; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; White E, 2011, HUM GENE THER; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yang P, 2010, ACTA PHARMACOL SIN, V31, P531, DOI 10.1038/aps.2010.35; Zhao Y, 2008, HUM GENE THER, V19, P475, DOI 10.1089/hum.2007.119; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53269	10.1371/journal.pone.0053269	http://dx.doi.org/10.1371/journal.pone.0053269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301052	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000044
J	Bienhold, C; Ristova, PP; Wenzhofer, F; Dittmar, T; Boetius, A				Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Dittmar, Thorsten; Boetius, Antje			How Deep-Sea Wood Falls Sustain Chemosynthetic Life	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; MOSBY MUD VOLCANO; COMPLEX BACTERIAL COMMUNITIES; DISSOLVED ORGANIC-CARBON; COLD-SEEP COMMUNITIES; HYDROTHERMAL-VENT; IN-SITU; SULFATE REDUCTION; WHALE-FALL; GEN. NOV.	Large organic food falls to the deep sea - such as whale carcasses and wood logs - are known to serve as stepping stones for the dispersal of highly adapted chemosynthetic organisms inhabiting hot vents and cold seeps. Here we investigated the biogeochemical and microbiological processes leading to the development of sulfidic niches by deploying wood colonization experiments at a depth of 1690 m in the Eastern Mediterranean for one year. Wood-boring bivalves of the genus Xylophaga played a key role in the degradation of the wood logs, facilitating the development of anoxic zones and anaerobic microbial processes such as sulfate reduction. Fauna and bacteria associated with the wood included types reported from other deep-sea habitats including chemosynthetic ecosystems, confirming the potential role of large organic food falls as biodiversity hot spots and stepping stones for vent and seep communities. Specific bacterial communities developed on and around the wood falls within one year and were distinct from freshly submerged wood and background sediments. These included sulfate-reducing and cellulolytic bacterial taxa, which are likely to play an important role in the utilization of wood by chemosynthetic life and other deep-sea animals.	[Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Boetius, Antje] Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Bienhold, Christina; Ristova, Petra Pop; Wenzhoefer, Frank; Boetius, Antje] Max Planck Inst Marine Microbiol, Bremen, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Max Planck Res Grp Marine Geochem, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Max Planck Society	Bienhold, C (corresponding author), Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.	cbienhol@mpi-bremen.de	Boetius, Antje/D-5459-2013; Dittmar, Thorsten/L-7796-2013	Boetius, Antje/0000-0003-2117-4176; Dittmar, Thorsten/0000-0002-3462-0107; Bienhold, Christina/0000-0003-2269-9468	EU [GOCE-CT-2005-511234, 226354]	EU(European Commission)	This work contributed to the GDRE DIWOOD of CNRS and MPG, to the ESF EUROCORES EURODEEP project CHEMECO and the CoML project CHESS, as well as to the EU 6th FP HERMES (GOCE-CT-2005-511234) and the 7th FP HERMIONE (grant agreement no. 226354). Additional funds came from the DFG and the Max Planck Society to A. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Ballard RD, 2001, AM J ARCHAEOL, V105, P607, DOI 10.2307/507409; Becker PT, 2009, CAH BIOL MAR, V50, P343; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boggemann M, 2012, MAR BIODIVERS, V42, P47, DOI 10.1007/s12526-011-0091-2; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Borchert H, 2008, BAYRISCHE LANDESANST, V65, P51; Borda E, 2012, ZOOL SCR, V41, P307, DOI 10.1111/j.1463-6409.2012.00529.x; BORSHEIM KY, 1990, APPL ENVIRON MICROB, V56, P352; Bowman J., 2006, PROKARYOTES, P677, DOI DOI 10.1007/0-387-30747-8_26; BURDIGE DJ, 1992, GEOPHYS RES LETT, V19, P1851, DOI 10.1029/92GL02159; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Carere CR, 2008, INT J MOL SCI, V9, P1342, DOI 10.3390/ijms9071342; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Dupont J, 2009, MYCOL RES, V113, P1351, DOI 10.1016/j.mycres.2009.08.015; Dupre S, 2007, DEEP-SEA RES PT I, V54, P1146, DOI 10.1016/j.dsr.2007.03.007; Fagervold SK, 2012, FEMS MICROBIOL ECOL; Fang JS, 2006, FEMS MICROBIOL ECOL, V57, P429, DOI 10.1111/j.1574-6941.2006.00126.x; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; Felden J, BIOGEOCHEMICAL UNPUB; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Foucher JP, 2009, OCEANOGRAPHY, V22, P92, DOI 10.5670/oceanog.2009.11; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gebruk AV, 2003, SARSIA, V88, P394, DOI 10.1080/00364820310003190; GIBBS PE, 1987, NEW ZEAL J ZOOL, V14, P135, DOI 10.1080/03014223.1987.10422691; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; GLUD RN, 1994, DEEP-SEA RES PT I, V41, P1767; Goffredi SK, 2010, ENVIRON MICROBIOL, V12, P344, DOI 10.1111/j.1462-2920.2009.02072.x; Gontharet S, 2007, DEEP-SEA RES PT II, V54, P1292, DOI 10.1016/j.dsr2.2007.04.007; GOODAY A, 1984, SARSIA, V69, P45, DOI 10.1080/00364827.1984.10420588; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Hall POJ, 2007, LIMNOL OCEANOGR, V52, P19, DOI 10.4319/lo.2007.52.1.0019; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Johansen JE, 1999, INT J SYST BACTERIOL, V49, P1231, DOI 10.1099/00207713-49-3-1231; JOHNSON KS, 1986, SCIENCE, V231, P1139, DOI 10.1126/science.231.4742.1139; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kretschmar EI, 2008, INT BIODETER BIODEGR, V61, P69, DOI 10.1016/j.ibiod.2007.07.004; Kudenov Jerry D., 1995, P207; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Levin LA, 2009, DEEP-SEA RES PT II, V56, P449, DOI 10.1016/j.dsr2.2008.05.032; Lichtschlag A, 2010, LIMNOL OCEANOGR, V55, P931, DOI 10.4319/lo.2009.55.2.0931; Loncke L, 2004, MAR PETROL GEOL, V21, P669, DOI 10.1016/j.marpetgeo.2004.02.004; Lorion J, 2012, CAH BIOL MAR, V53, P77; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Macavoy SE, 2008, J SHELLFISH RES, V27, P153, DOI 10.2983/0730-8000(2008)27[153:CPIBHI]2.0.CO;2; Madigan M.T., 2006, BROCK BIOL MICROORGA; MEYERREIL LA, 1983, MAR BIOL, V77, P247, DOI 10.1007/BF00395813; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; Palacios C, 2006, CAH BIOL MAR, V47, P415; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; REICHENBACH H, 2006, PROKARYOTES HDB BIOL, P00549, DOI DOI 10.1007/0-387-30747-8_20; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; RICE ME, 1985, P BIOL SOC WASH, V98, P54; RICE ME, 1969, AM ZOOL, V9, P803; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Rouse G. W., 2001, POLYCHAETES; Ruehland C, 2010, ENVIRON MICROBIOL, V12, P2312, DOI 10.1111/j.1462-2920.2010.02256.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Southward EC, 2008, J SHELLFISH RES, V27, P139, DOI 10.2983/0730-8000(2008)27[139:TMOBSI]2.0.CO;2; Stubbins A, 2012, LIMNOL OCEANOGR-METH, V10, P347, DOI 10.4319/lom.2012.10.347; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Tyler PA, 2007, MAR ECOL PROG SER, V343, P151, DOI 10.3354/meps06832; Ward ME, 2003, CAN J ZOOL, V81, P582, DOI 10.1139/Z03-034; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Wenzhofer F, 2000, MAR CHEM, V69, P43, DOI 10.1016/S0304-4203(99)00091-2; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; [No title captured]	110	96	99	2	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53590	10.1371/journal.pone.0053590	http://dx.doi.org/10.1371/journal.pone.0053590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301092	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900086
J	Shield, KD; Gmel, G; Kehoe-Chan, T; Dawson, DA; Grant, BF; Rehm, J				Shield, Kevin D.; Gmel, Gerrit; Kehoe-Chan, Tara; Dawson, Deborah A.; Grant, Bridget F.; Rehm, Juergen			Mortality and Potential Years of Life Lost Attributable to Alcohol Consumption by Race and Sex in the United States in 2005	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; GLOBAL BURDEN; RISK; HEALTH; DEATH; INJURY; DISPARITIES; CALCULATE; DRINKING; ACCURACY	Background: Alcohol has been linked to health disparities between races in the US; however, race-specific alcohol-attributable mortality has never been estimated. The objective of this article is to estimate premature mortality attributable to alcohol in the US in 2005, differentiated by race, age and sex for people 15 to 64 years of age. Methods and Findings: Mortality attributable to alcohol was estimated based on alcohol-attributable fractions using indicators of exposure from the National Epidemiologic Survey on Alcohol and Related Conditions and risk relations from the Comparative Risk Assessment study. Consumption data were corrected for undercoverage (the observed underreporting of alcohol consumption when using survey as compared to sales data) using adult per capita consumption from WHO databases. Mortality data by cause of death were obtained from the US Department of Health and Human Services. For people 15 to 64 years of age in the US in 2005, alcohol was responsible for 55,974 deaths (46,461 for men; 9,513 for women) representing 9.0% of all deaths, and 1,288,700 PYLL (1,087,280 for men; 201,420 for women) representing 10.7% of all PYLL. Per 100,000 people, this represents 29 deaths (29 for White; 40 for Black; 82 for Native Americans; 6 for Asian/Pacific Islander) and 670 PYLL (673 for White; 808 for Black; 1,808 for Native American; 158 for Asian/Pacific Islander). Sensitivity analyses showed a lower but still substantial burden without adjusting for undercoverage. Conclusions: The burden of mortality attributable to alcohol in the US is unequal among people of different races and between men and women. Racial differences in alcohol consumption and the resulting harms explain in part the observed disparities in the premature mortality burden between races, suggesting the need for interventions for specific subgroups of the population such as Native Americans.	[Shield, Kevin D.; Gmel, Gerrit; Kehoe-Chan, Tara; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Shield, Kevin D.; Rehm, Juergen] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Kehoe-Chan, Tara] Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Saxony, Germany; [Rehm, Juergen] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Dawson, Deborah A.; Grant, Bridget F.] NIAAA, Lab Epidemiol & Biometry, NIH, Bethesda, MD USA; [Dawson, Deborah A.] Kelly Govt Serv, Bethesda, MD USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; Technische Universitat Dresden; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Shield, KD (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	Kevin.shield@utoronto.ca	Shield, Kevin/AAR-8220-2020; Rehm, Jürgen/K-2147-2012	Rehm, Jürgen/0000-0001-5665-0385; Shield, Kevin/0000-0003-1871-8849	National Institute for Alcohol Abuse and Alcoholism (NIAAA) [HHSN267200700041C]; Ontario Ministry of Health and Long-Term Care; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000449] Funding Source: NIH RePORTER	National Institute for Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Financial support for this study was provided to Jurgen Rehm by the National Institute for Alcohol Abuse and Alcoholism (NIAAA) with contract # HHSN267200700041C to conduct the study titled "Alcohol- and Drug-attributable Burden of Disease and Injury in the US". In addition, Jurgen Rehm received a salary and infrastructure support from the Ontario Ministry of Health and Long-Term Care. Kevin Shield had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen G Cecilie, 2012, Tidsskr Nor Laegeforen, V132, P147, DOI 10.4045/tidsskr.11.0427; Arias E., 2010, NATL VITAL STAT REP, V58; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Centers for Disease Control, 2012, INT CLASS DIS 10 REV; Chartier K, 2010, ALCOHOL RES HEALTH, V33, P152; Cunningham M, 2006, HOMELESSNESS COUNTS; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Ezzati M, 2004, COMP QUANTIFICATION; Flegal KM, 2006, AM J PUBLIC HEALTH, V96, P398, DOI 10.2105/AJPH.2005.079731; Gmel G, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-5; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2003, SOURCE ACCURACY STAT; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; Hollingworth W, 2006, J STUD ALCOHOL, V67, P300, DOI 10.15288/jsa.2006.67.300; James G, 1955, PUBLIC HEALTH REP, V70, P39; Kehoe T, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-6; Korn E. L., 1999, ANAL HLTH SURVEYS; Laslett A.-M., 2010, RANGE MAGNITUDE ALCO; Mackenbach JP, 2003, LANCET, V362, P1409, DOI 10.1016/S0140-6736(03)14639-9; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MIDANIK L, 1982, BRIT J ADDICT, V77, P357; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nashelsky MB, 2003, AM J FOREN MED PATH, V24, P313, DOI 10.1097/01.paf.0000097857.50734.c3; Organization WH, 2009, GLOB HLTH RISKS MORT; OTTEN MW, 1990, JAMA-J AM MED ASSOC, V263, P845, DOI 10.1001/jama.263.6.845; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rehm J., 2012, ALCOHOL CONSUMPTION; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Samokhvalov AV, 2012, ALCOHOL SCI POLICY P; Shield KD, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-9; Shield KD, 2012, INT J PUBLIC HEALTH, V57, P391, DOI 10.1007/s00038-011-0247-7; Shield KD, 2012, INT J METH PSYCH RES, V21, P17, DOI 10.1002/mpr.1345; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; StataCorp, 2007, STAT STAT SOFTW REL; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Taylor B, 2007, ALCOHOL GENDER CULTU; Taylor BJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-265; US Department of Health and Human Services, 2011, NAT EP SURV ALC REL; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2011, GLOB INF SYST ALC HL; World Health Organization, 2011, GLOB STAT REP ALC HL; Zatonski WA, 2011, ANN AGR ENV MED, V18, P194	52	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51923	10.1371/journal.pone.0051923	http://dx.doi.org/10.1371/journal.pone.0051923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300957	Green Published, gold, Green Submitted			2022-12-27	WOS:000313320900013
J	Slater, M; Rovira, A; Southern, R; Swapp, D; Zhang, JJ; Campbell, C; Levine, M				Slater, Mel; Rovira, Aitor; Southern, Richard; Swapp, David; Zhang, Jian J.; Campbell, Claire; Levine, Mark			Bystander Responses to a Violent Incident in an Immersive Virtual Environment	PLOS ONE			English	Article							SOCIAL GROUP MEMBERSHIP; SELF-CATEGORIZATION; GROUP-SIZE; INTERVENTION; OBEDIENCE; IDENTITY; BEHAVIOR; REALITY; PLACE; RACE	Under what conditions will a bystander intervene to try to stop a violent attack by one person on another? It is generally believed that the greater the size of the crowd of bystanders, the less the chance that any of them will intervene. A complementary model is that social identity is critical as an explanatory variable. For example, when the bystander shares common social identity with the victim the probability of intervention is enhanced, other things being equal. However, it is generally not possible to study such hypotheses experimentally for practical and ethical reasons. Here we show that an experiment that depicts a violent incident at life-size in immersive virtual reality lends support to the social identity explanation. 40 male supporters of Arsenal Football Club in England were recruited for a two-factor between-groups experiment: the victim was either an Arsenal supporter or not (in-group/out-group), and looked towards the participant for help or not during the confrontation. The response variables were the numbers of verbal and physical interventions by the participant during the violent argument. The number of physical interventions had a significantly greater mean in the in-group condition compared to the out-group. The more that participants perceived that the Victim was looking to them for help the greater the number of interventions in the in-group but not in the out-group. These results are supported by standard statistical analysis of variance, with more detailed findings obtained by a symbolic regression procedure based on genetic programming. Verbal interventions made during their experience, and analysis of post-experiment interview data suggest that in-group members were more prone to confrontational intervention compared to the out-group who were more prone to make statements to try to diffuse the situation.	[Slater, Mel] Passeig Lluis Co, ICREA, Barcelona, Spain; [Slater, Mel; Rovira, Aitor] Fac Psicol, Dept Personalitat Avaluacio & Tractaments Psicol, Event Lab, Barcelona, Spain; [Slater, Mel; Rovira, Aitor; Swapp, David] UCL, Dept Comp Sci, London, England; [Southern, Richard; Zhang, Jian J.] Bournemouth Univ, Media Sch, Natl Ctr Comp Animat, Poole BH12 5BB, Dorset, England; [Campbell, Claire] Univ Lancaster, Dept Psychol, Fylde Coll, Lancaster LA1 4YF, England; [Campbell, Claire; Levine, Mark] Edge Hill Univ, Dept Psychol, Ormskirk, England; [Levine, Mark] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England	ICREA; University of London; University College London; Bournemouth University; Lancaster University; Edge Hill University; University of Exeter	Slater, M (corresponding author), Passeig Lluis Co, ICREA, Barcelona, Spain.	melslater@ub.edu	Slater, Mel/M-5210-2014	Slater, Mel/0000-0002-6223-0050; Swapp, David/0000-0002-9335-8663; Southern, Richard/0000-0002-1933-3951; Levine, Mark/0000-0001-5696-6021	UK EPSRC project "Visual and Behavioural Fidelity of Virtual Humans with Applications to Bystander Intervention in Violent Emergencies" [EP/F032420/1, EP/F030215/1, EP/F030355/1]; European Senior Research Grant TRAVERSE [227985]; EPSRC [EP/F030215/1, EP/F032420/1, EP/F030355/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F030355/1, EP/F030215/1, EP/F032420/1] Funding Source: researchfish; ICREA Funding Source: Custom	UK EPSRC project "Visual and Behavioural Fidelity of Virtual Humans with Applications to Bystander Intervention in Violent Emergencies"; European Senior Research Grant TRAVERSE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ICREA(ICREA)	This work was funded by the UK EPSRC project "Visual and Behavioural Fidelity of Virtual Humans with Applications to Bystander Intervention in Violent Emergencies" (EP/F032420/1; EP/F030215/1; EP/F030355/1). http://www.epsrc.ac.uk. European Senior Research Grant TRAVERSE grant number 227985. http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Banyard VL, 2008, VIOLENCE VICTIMS, V23, P83, DOI 10.1891/0886-6708.23.1.83; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; BOROFSKY GL, 1971, J EXP SOC PSYCHOL, V7, P313, DOI 10.1016/0022-1031(71)90031-X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cheetham M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.029.2009; Cherry F., 1995, STUBBORN PARTICULARS; CRUZNEIRA C, 1992, COMMUN ACM, V35, P64, DOI 10.1145/129888.129892; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Fischer P, 2006, EUR J SOC PSYCHOL, V36, P267, DOI 10.1002/ejsp.297; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Frankenhuis W. E., 2010, J EVOLUTIONARY PSYCH, V8, P75, DOI DOI 10.1556/JEP.8.2010.1.6; Gillath O, 2008, MEDIA PSYCHOL, V11, P259, DOI 10.1080/15213260801906489; Gillies M, 2010, PRESENCE-VIRTUAL AUG, V19, P95, DOI 10.1162/pres.19.2.95; Hall E.T., 1966, LEONARDO, VVolume 609, DOI DOI 10.2307/1572461; HARARI H, 1985, J SOC PSYCHOL, V125, P653, DOI 10.1080/00224545.1985.9712039; Haslam SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001426; Hesse-Biber S., 1991, QUALITATIVE SOCIOLOG, V14, P289, DOI DOI 10.1007/BF00989642; Koza JR, 1992, GENETIC PROGRAMMING; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; LATANE B, 1969, J EXP SOC PSYCHOL, V5, P189, DOI 10.1016/0022-1031(69)90046-8; LATANE B, 1981, PSYCHOL BULL, V89, P308, DOI 10.1037/0033-2909.89.2.308; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Levine M, 2004, J SOC PSYCHOL, V144, P229, DOI 10.3200/SOCP.144.3.229-245; Levine M, 2002, J APPL SOC PSYCHOL, V32, P1452, DOI 10.1111/j.1559-1816.2002.tb01446.x; Levine M, 2008, J PERS SOC PSYCHOL, V95, P1429, DOI 10.1037/a0012634; Llobera J, 2010, ACM T APPL PERCEPT, V8, DOI 10.1145/1857893.1857896; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Reicher SD, 2012, PERSPECT PSYCHOL SCI, V7, P315, DOI 10.1177/1745691612448482; Rovira A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.059.2009; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SCHWARTZ SH, 1976, J PERS SOC PSYCHOL, V34, P1188, DOI 10.1037/0022-3514.34.6.1188; SCHWARTZ SH, 1980, J PERS SOC PSYCHOL, V39, P418, DOI 10.1037/0022-3514.39.3.418; SHOTLAND RL, 1976, J PERS SOC PSYCHOL, V34, P990, DOI 10.1037/0022-3514.34.5.990; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Tecchia F, 2010, PRESENCE-VIRTUAL AUG, V19, P302, DOI 10.1162/PRES_a_00002; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Wilcox Laurie M., 2006, TAP, V3, P412, DOI [10.1145/1190036.1190041, DOI 10.1145/1190036.1190041]; Zimbardo P. G., 2007, LUCIFER EFFECT UNDER	41	92	93	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52766	10.1371/journal.pone.0052766	http://dx.doi.org/10.1371/journal.pone.0052766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300991	Green Published, gold, Green Accepted			2022-12-27	WOS:000313320900038
J	Chen, HY; Sun, B; Zhao, YJ; Song, X; Fan, WW; Zhou, KK; Zhou, LF; Mao, Y; Lu, DR				Chen, Hongyan; Sun, Bing; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Zhou, Keke; Zhou, Liangfu; Mao, Ying; Lu, Daru			Fine Mapping of a Region of Chromosome 11q23.3 Reveals Independent Locus Associated with Risk of Glioma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CHINESE POPULATION; VARIANTS; SUSCEPTIBILITY; LL5-BETA; VESICLE; IDENTIFICATION; HAPLOTYPES; FILAMIN; COMMON	Background: A single nucleotide polymorphism (SNP) at locus 11q23.3 (rs498872) in the near 5'-UTR of the PHLDB1 gene was recently implicated as a risk factor for gliomas in a genome-wide association study, and this involvement was confirmed in three additional studies. Methodology/Principal Findings: To identify possible causal variants in the region, the authors genotyped 15 tagging SNPs in the 200 kb genomic region at 11q23.3 locus in a Chinese Han population-based case-control study with 983 cases and 1024 controls. We found evidence for an association between two independent loci (both the PHLDB1 and the ACRN1 genes) and a predisposition for gliomas. Among the multiple significant SNPs in the PHLDB1 gene region, the rs17749 SNP was the most significant [P = 1.31x10(-6) in a recessive genetic model]. Additionally, two novel SNPs (rs2236661 and rs494560) that were independent of rs17749 were significantly associated with glioma risk in a recessive genetic model [P = 1.31x10(-5) and P = 3.32x10(-5), respectively]. The second novel locus was within the ARCN1 gene, and it was associated with a significantly reduced risk for glioma. Conclusions/Significance: Our data strongly support PHLDB1 as a susceptibility gene for glioma, also shedding light on a new potentially candidate gene, ARCN1.	[Chen, Hongyan; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Lu, Daru] Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China; [Chen, Hongyan; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Lu, Daru] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Sun, Bing; Zhou, Keke; Zhou, Liangfu; Mao, Ying] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Mao, Y (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China.	maoyinghs@hotmail.com; drlu@fudan.edu.cn	Frank, Viki/GXZ-9902-2022	Mao, Ying/0000-0001-8055-115X	Shanghai Science and Technology Research Program [09JC1402200]; Natural Science Foundation of China [81001114]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry); Doctoral Fund of Ministry of Education of China	Shanghai Science and Technology Research Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was partially supported by Shanghai Science and Technology Research Program (09JC1402200), Natural Science Foundation of China (81001114), the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry) and the Doctoral Fund of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Kateb H, 2007, DIABETES, V56, P2161, DOI 10.2337/db07-0376; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Katoh M, 2003, INT J ONCOL, V23, P1477; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YH, 2008, HUM MUTAT, V29, P381, DOI 10.1002/humu.20645; Liu YH, 2007, CARCINOGENESIS, V28, P1906, DOI 10.1093/carcin/bgm073; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; National Bureau of Statistics of China, 2009, CHIN HLTH STAT YB, P254; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donnell MJ, 1997, GENET ENG NEWS, V17, P39; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schoemaker MJ, 2010, AM J EPIDEMIOL, V171, P1165, DOI 10.1093/aje/kwq075; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xu XJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000956; XUE QC, 1990, CLIN NEUROL NEUROSUR, V92, P27, DOI 10.1016/0303-8467(90)90004-O; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhou KK, 2009, INT J CANCER, V124, P2948, DOI 10.1002/ijc.24307; Zhou QOL, 2010, J BIOL CHEM, V285, P27581, DOI 10.1074/jbc.M110.146886	35	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52864	10.1371/journal.pone.0052864	http://dx.doi.org/10.1371/journal.pone.0052864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300798	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600031
J	Zhang, XL; Qiao, H; Zhao, YL; Wang, X; Sun, HM; Liu, A; Xu, LD; Sun, DL; Jin, Y; Yu, Y; Meng, XN; Bai, J; Chen, F; Fu, SB				Zhang, Xuelong; Qiao, Hong; Zhao, Yanling; Wang, Xi; Sun, Haiming; Liu, An; Xu, Lidan; Sun, Donglin; Jin, Yan; Yu, Yang; Meng, Xiangning; Bai, Jing; Chen, Feng; Fu, Songbin			Association of Single Nucleotide Polymorphisms in TCF2 with Type 2 Diabetes Susceptibility in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER RISK; COMMON VARIANTS; YOUNG GENES; HNF1-BETA; CLASSIFICATION; NEPHROGENESIS; PARTNERS; DISEASE; LINKAGE	Hepatocyte nuclear factor 1 beta (HNF1 beta), a transcription factor encoded by the transcription factor 2 gene (TCF2), plays a critical role in pancreatic cell formation and glucose homeostasis. It has been suggested that single nucleotide polymorphisms (SNPs) of TCF2 are associated with susceptibility to type 2 diabetes (T2D). However, published results are inconsistent and inclusive. To further investigate the role of these common variants, we examined the association of TCF2 polymorphisms with the risk of T2D in a Han population in northeastern China. We genotyped five SNPs in 624 T2D patients and 630 healthy controls by using a SNaPshot method, and evaluated the T2D risk conferred by individual SNPs and haplotypes. In the single-locus analysis, we found that rs752010, rs4430796 and rs7501939 showed allelic differences between T2D patients and healthy controls, with an OR of 1.26 (95% CI 1.08-1.51, P=0.003), an OR of 1.23 (95% CI 1.06-1.55, P=0.001) and an OR of 1.28 (95% CI 1.10-1.61, P=0.001), respectively. Genotype association analysis of each locus also revealed that the homozygous carriers of the at-risk allele had a significant increased T2D risk compared to homozygous carriers of the other allele (OR 1.78, 95% CI 1.20-2.64 for rs752010; OR 1.82, 95% CI 1.24-2.67 for rs4430796; OR 1.95, 95% CI 1.31-2.90 for rs7501939), even after Bonferroni correction for multiple comparisons. Besides, the haplotype-based analysis demonstrated that AGT in block rs752010-rs4430796-rs7501939 was associated with about 30% increase in T2D risk (OR 1.31, 95% CI 1.09-1.57, P=0.01). Our findings suggested that TCF2 variants may be involved in T2D risk in a Han population of northeastern China. Larger studies with ethnically diverse populations are warranted to confirm the results reported in this investigation.	[Zhang, Xuelong; Zhao, Yanling; Sun, Haiming; Liu, An; Xu, Lidan; Sun, Donglin; Jin, Yan; Yu, Yang; Meng, Xiangning; Bai, Jing; Chen, Feng; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Qiao, Hong] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Peoples R China; [Wang, Xi] Harbin Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Harbin, Peoples R China; [Fu, Songbin] Harbin Med Univ, Heilongjiang Higher Educ Inst, Key Lab Med Genet, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Fu, SB (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn			National Basic Research Program of China [2010CB534901]; National Natural Science Foundation of China [81172742]; Ministry of Education of China [NCET-08-0671, NCET-10-0149]; Public Health Department of Heilongjiang Province of China [2010-183]; post-doctoral foundation of Heilongjiang Province of China [LRB 09-293]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Public Health Department of Heilongjiang Province of China; post-doctoral foundation of Heilongjiang Province of China	This work was funded by the National Basic Research Program of China (2010CB534901), the National Natural Science Foundation of China (81172742), the New Century Support Program for the Excellent Scholar, Ministry of Education of China (NCET-08-0671 and NCET-10-0149), the Public Health Department of Heilongjiang Province (No. 2010-183) of China, and the post-doctoral foundation of Heilongjiang Province (LRB 09-293) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Edghill EL, 2008, NEPHROL DIAL TRANSPL, V23, P627, DOI 10.1093/ndt/gfm603; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Fischer E, 2008, KIDNEY INT, V74, P145, DOI 10.1038/ki.2008.250; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Holmkvist J, 2008, DIABETES, V57, P1738, DOI 10.2337/db06-1464; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wang CR, 2009, DIABETES, V58, P1023, DOI 10.2337/db08-1064; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	28	6	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52938	10.1371/journal.pone.0052938	http://dx.doi.org/10.1371/journal.pone.0052938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300827	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600039
J	Drannik, AG; Nag, K; Yao, XD; Henrick, BM; Ball, TB; Plummer, FA; Wachihi, C; Kimani, J; Rosenthal, KL				Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Ball, T. Blake; Plummer, Francis A.; Wachihi, Charles; Kimani, Joshua; Rosenthal, Kenneth L.			Anti-HIV-1 Activity of Elafin Depends on Its Nuclear Localization and Altered Innate Immune Activation in Female Genital Epithelial Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKOCYTE PROTEASE INHIBITOR; NF-KAPPA-B; HERPES-SIMPLEX-VIRUS; TRAPPIN-2 PRE-ELAFIN; HIV-INFECTION; SEX-WORKERS; PROTEINASE-INHIBITOR; REPRODUCTIVE-TRACT; PSEUDOMONAS-AERUGINOSA	Elafin (E) and its precursor trappin-2 (Tr) are alarm antiproteases with antimicrobial and immunomodulatory activities. Tr and E (Tr/E) have been associated with HIV-1 resistance. We recently showed that Tr/E reduced IL-8 secretion and NF-kappa B activation in response to a mimic of viral dsRNA and contributed to anti-HIV activity of cervicovaginal lavage fluid (CVL) of HIV-resistant (HIV-R) commercial sex workers (CSWs). Additionally, Tr, and more so E, were found to inhibit attachment/entry and transcytosis of HIV-1 in human endometrial HEC-1A cells, acting through virus or cells. Given their immunomodulatory activity, we hypothesized that Tr/E could exert anti-HIV-1 activity at multiple levels. Here, using tagged and untagged Tr/E proteins, we comparatively evaluated their protease inhibitory, anti-HIV-1, and immunomodulatory activities, and cellular distribution. E appeared to function as an autocrine/paracrine factor in HEC-1A cells, and anti-HIV-1 activity of E depended on its unmodified N-terminus and altered cellular innate activation, but not its antiprotease activity. Specifically, exogenously added N-terminus-unmodified E was able to enter the nucleus and to reduce viral attachment/entry and transcytosis, preferentially affecting R5-HIV-1(ADA), but not X4-HIV-1(IIIB). Further, anti-HIV-1 activity of E was associated with significantly decreased HIV-1-triggered IL-8 release, attenuated NF-kappa B/p65 nuclear translocation, and significantly modulated mRNA expression of innate sensors TLR3 and RIG-I in HEC-1A cells. Most importantly, we found that elevated Tr/E in CVLs of HIV-R CSWs were associated with lower mRNA levels of TLRs 2, 3, 4 and RIG-I in the genital ECs from this cohort, suggesting a link between Tr/E, HIV-1 resistance and modulated innate viral recognition in the female genital mucosa. Collectively, our data indicate that unmodified N-terminus is critical for intranuclear localization and anti-HIV-1 activity of E. We also propose that E-mediated altered cellular innate activation most likely contributes to the HIV-R phenotype of these subjects.	[Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Rosenthal, Kenneth L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake; Plummer, Francis A.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Wachihi, Charles; Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	McMaster University; University of Manitoba; Public Health Agency of Canada; University of Nairobi	Rosenthal, KL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	Henrick, Bethany/P-7388-2016	Henrick, Bethany/0000-0003-1883-6749	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), Collaboration for AIDS Vaccine Development (CAVD); Bill and Melinda Gates Foundation; Ontario HIV Treatment Network (OHTN); OHTN	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), Collaboration for AIDS Vaccine Development (CAVD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ontario HIV Treatment Network (OHTN); OHTN	This research was supported by a grant as part of the Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD) funded by the Bill and Melinda Gates Foundation to K. L. R. A. G. D. was supported, in part, by a Studentship Award from the Ontario HIV Treatment Network (OHTN) and K. L. R. by a Career Scientist Award from the OHTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bellemare A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-253; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Broliden K, 2009, J INTERN MED, V265, P5, DOI 10.1111/j.1365-2796.2008.02053.x; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Carreno MP, 2002, CYTOKINE, V20, P289, DOI 10.1006/cyto.2002.2009; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035866; Drannik AG, 2012, J VIROL, V86, P4599, DOI 10.1128/JVI.06561-11; Drannik AG, 2011, BIOCHEM SOC T, V39, P1427, DOI 10.1042/BST0391427; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Fantuzzi L, 2008, BLOOD, V111, P3355, DOI 10.1182/blood-2007-08-104901; Flach CF, 2006, INFLAMM BOWEL DIS, V12, P837, DOI 10.1097/01.mib.0000232469.23574.11; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hayashi T, 2010, MICROBES INFECT, V12, P937, DOI 10.1016/j.micinf.2010.06.003; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Hiemstra PS, 2004, CURR PHARM DESIGN, V10, P2891, DOI 10.2174/1381612043383566; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Jain S, 2011, MUCOSAL IMMUNOL, V4, P539, DOI 10.1038/mi.2011.21; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002; MANN DM, 1994, J BIOL CHEM, V269, P23661; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nikolic DS, 2010, J INVEST DERMATOL, V130, P352, DOI 10.1038/jid.2009.227; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; Sanghavi SK, 2005, J IMMUNOL, V175, P5314, DOI 10.4049/jimmunol.175.8.5314; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; SCHALKWIJK J, 1990, BRIT J DERMATOL, V122, P631, DOI 10.1111/j.1365-2133.1990.tb07285.x; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zani ML, 2011, BIOCHEM SOC T, V39, P1441, DOI 10.1042/BST0391441; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176	73	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52738	10.1371/journal.pone.0052738	http://dx.doi.org/10.1371/journal.pone.0052738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300756	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100075
J	Henriquez, DR; Bodaleo, FJ; Montenegro-Venegas, C; Gonzalez-Billault, C				Henriquez, Daniel R.; Bodaleo, Felipe J.; Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian			The Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B) Is Responsible for Tiam1 Binding and Rac1 Activation in Neuronal Cells	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ACTIN STRESS FIBERS; AXON FORMATION; RHO-GTPASES; HIPPOCAMPAL-NEURONS; HEAVY-CHAIN; GROWTH; IDENTIFICATION; INVASION; POLARITY	Microtubule-associated protein 1B (MAP1B) is a neuronal protein involved in the stabilization of microtubules both in the axon and somatodendritic compartments. Acute, genetic inactivation of MAP1B leads to delayed axonal outgrowth, most likely due to changes in the post-translational modification of tubulin subunits, which enhances microtubule polymerization. Furthermore, MAP1B deficiency is accompanied by abnormal actin microfilament polymerization and dramatic changes in the activity of small GTPases controlling the actin cytoskeleton. In this work, we showed that MAP1B interacts with a guanine exchange factor, termed Tiam1, which specifically activates Rac1. These proteins co-segregated in neurons, and interact in both heterologous expression systems and primary neurons. We dissected the molecular domains involved in the MAP1B-Tiam1 interaction, and demonstrated that pleckstrin homology (PH) domains in Tiam1 are responsible for MAP1B binding. Interestingly, only the light chain 1 (LC1) of MAP1B was able to interact with Tiam1. Moreover, it was able to increase the activity of the small GTPase, Rac1. These results suggest that the interaction between Tiam1 and MAP1B, is produced by the binding of LC1 with PH domains in Tiam1. The formation of such a complex impacts on the activation levels of Rac1 confirming a novel function of MAP1B related with the control of small GTPases. These results also support the idea of cross-talk between cytoskeleton compartments inside neuronal cells.	[Henriquez, Daniel R.; Bodaleo, Felipe J.; Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam CENEDYN, Dept Biol, Santiago, Chile	Universidad de Chile	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam CENEDYN, Dept Biol, Santiago, Chile.	chrgonza@uchile.cl	Gonzalez-Billault, Christian/P-2393-2019		FONDECYT grant [1095089]	FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a FONDECYT grant (1095089) to CG-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Cueille N, 2007, BRAIN RES BULL, V71, P610, DOI 10.1016/j.brainresbull.2006.12.003; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DiTella MC, 1996, J CELL SCI, V109, P467; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evers EE, 2000, METHOD ENZYMOL, V325, P403; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gonzalez-Billault C, 2012, CYTOSKELETON HOBOKEN; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1993, PHILOS T ROY SOC B, V340, P267, DOI 10.1098/rstb.1993.0067; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; HAMMARBACK JA, 1991, NEURON, V7, P129, DOI 10.1016/0896-6273(91)90081-A; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mei X, 2000, J NEUROSCI RES, V62, P56, DOI 10.1002/1097-4547(20001001)62:1<56::AID-JNR6>3.0.CO;2-#; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Shepherd TR, 2011, BIOCHEMISTRY-US, V50, P1296, DOI 10.1021/bi1013613; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Takefuji M, 2007, BIOCHEM BIOPH RES CO, V355, P788, DOI 10.1016/j.bbrc.2007.02.028; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; TAKEMURA R, 1992, J CELL SCI, V103, P953; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Togel M, 1998, FEBS LETT, V423, P254, DOI 10.1016/S0014-5793(98)00104-5; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; ZAUNER W, 1992, EUR J CELL BIOL, V57, P66	53	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53123	10.1371/journal.pone.0053123	http://dx.doi.org/10.1371/journal.pone.0053123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300879	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100123
J	Luni, C; Marth, JD; Doyle, FJ				Luni, Camilla; Marth, Jamey D.; Doyle, Francis J., III			Computational Modeling of Glucose Transport in Pancreatic beta-Cells Identifies Metabolic Thresholds and Therapeutic Targets in Diabetes	PLOS ONE			English	Article							INSULIN-SECRETION; EXPRESSION; GLUT2; GLYCOSYLATION; RATS; ISOFORM; PATHWAY; 1-ALPHA; GENE	Pancreatic beta-cell dysfunction is a diagnostic criterion of Type 2 diabetes and includes defects in glucose transport and insulin secretion. In healthy individuals, beta-cells maintain plasma glucose concentrations within a narrow range in concert with insulin action among multiple tissues. Postprandial elevations in blood glucose facilitate glucose uptake into beta-cells by diffusion through glucose transporters residing at the plasma membrane. Glucose transport is essential for glycolysis and glucose-stimulated insulin secretion. In human Type 2 diabetes and in the mouse model of obesity-associated diabetes, a marked deficiency of beta-cell glucose transporters and glucose uptake occurs with the loss of glucose-stimulated insulin secretion. Recent studies have shown that the preservation of glucose transport in beta-cells maintains normal insulin secretion and blocks the development of obesity-associated diabetes. To further elucidate the underlying mechanisms, we have constructed a computational model of human beta-cell glucose transport in health and in Type 2 diabetes, and present a systems analysis based on experimental results from human and animal studies. Our findings identify a metabolic threshold or "tipping point" whereby diminished glucose transport across the plasma membrane of beta-cells limits intracellular glucose-6-phosphate production by glucokinase. This metabolic threshold is crossed in Type 2 diabetes and results in beta-cell dysfunction including the loss of glucose stimulated insulin secretion. Our model further discriminates among molecular control points in this pathway wherein maximal therapeutic intervention is achieved.	[Luni, Camilla; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Luni, Camilla; Doyle, Francis J., III] Sansum Diabet Res Inst, Santa Barbara, CA USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; William Sansum Diabetes Center; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Doyle, FJ (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	frank.doyle@icb.ucsb.edu	Luni, Camilla/ABC-6306-2020	Luni, Camilla/0000-0002-1211-9629	Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; US National Institutes of Health (NIH) grant [DK048247, GM100192]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100192] Funding Source: NIH RePORTER	Institute for Collaborative Biotechnologies from the US Army Research Office; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the US Army Research Office (CL, FJD), and by US National Institutes of Health (NIH) grant DK048247 and GM100192 (JDM). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO T, 1991, J BIOL CHEM, V266, P24632; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Cha JY, 2000, J BIOL CHEM, V275, P18358, DOI 10.1074/jbc.M909536199; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; FERRER J, 1995, DIABETES, V44, P1369, DOI 10.2337/diabetes.44.12.1369; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; ORCI L, 1990, J CLIN INVEST, V86, P1615, DOI 10.1172/JCI114883; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; PERMUTT MA, 1989, P NATL ACAD SCI USA, V86, P8688, DOI 10.1073/pnas.86.22.8688; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; THORENS B, 1993, J CELL BIOL, V123, P1687, DOI 10.1083/jcb.123.6.1687; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Velho G, 1997, DIABETES METAB, V23, P7; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	26	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53130	10.1371/journal.pone.0053130	http://dx.doi.org/10.1371/journal.pone.0053130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300881	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100125
J	Anangi, R; Koshy, S; Huq, R; Beeton, C; Chuang, WJ; King, GF				Anangi, Raveendra; Koshy, Shyny; Huq, Redwan; Beeton, Christine; Chuang, Woei-Jer; King, Glenn F.			Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers	PLOS ONE			English	Article							MEMORY T-CELLS; GATED K+ CHANNELS; THERAPEUTIC TARGET; POTASSIUM CHANNELS; KV1.3 CHANNEL; PEPTIDE INHIBITOR; TOXINS; VENOM; PURIFICATION; LYMPHOCYTES	The K(v)1.3 voltage-gated potassium channel regulates membrane potential and calcium signaling in human effector memory T cells that are key mediators of autoimmune diseases such as multiple sclerosis, type 1 diabetes, and rheumatoid arthritis. Thus, subtype-specific K(v)1.3 blockers have potential for treatment of autoimmune diseases. Several K(v)1.3 channel blockers have been characterized from scorpion venom, all of which have an alpha/beta scaffold stabilized by 3-4 intramolecular disulfide bridges. Chemical synthesis is commonly used for producing these disulfide-rich peptides but this approach is time consuming and not cost effective for production of mutants, fusion proteins, fluorescently tagged toxins, or isotopically labelled peptides for NMR studies. Recombinant production of K(v)1.3 blockers in the cytoplasm of E. coli generally necessitates oxidative refolding of the peptides in order to form their native disulfide architecture. An alternative approach that avoids the need for refolding is expression of peptides in the periplasm of E. coli but this often produces low yields. Thus, we developed an efficient Pichia pastoris expression system for production of K(v)1.3 blockers using margatoxin (MgTx) and agitoxin-2 (AgTx2) as prototypic examples. The Pichia system enabled these toxins to be obtained in high yield (12-18 mg/L). NMR experiments revealed that the recombinant toxins adopt their native fold without the need for refolding, and electrophysiological recordings demonstrated that they are almost equipotent with the native toxins in blocking K(V)1.3 (IC50 values of 201 +/- 39 pM and 97 +/- 3 pM for recombinant AgTx2 and MgTx, respectively). Furthermore, both recombinant toxins inhibited T-lymphocyte proliferation. A MgTx mutant in which the key pharmacophore residue K28 was mutated to alanine was ineffective at blocking K(V)1.3 and it failed to inhibit T-lymphocyte proliferation. Thus, the approach described here provides an efficient method of producing toxin mutants with a view to engineering K(v)1.3 blockers with therapeutic potential.	[Anangi, Raveendra; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Koshy, Shyny; Huq, Redwan; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	University of Queensland; Baylor College of Medicine; National Cheng Kung University	Anangi, R (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	r.anangi@imb.uq.edu.au; glenn.king@imb.uq.edu.au	King, Glenn F/J-5059-2012	King, Glenn F/0000-0002-2308-2200; Beeton, Christine/0000-0002-2500-5874	Taiwan National Science Council [NSC-101-2325-B-006-006]; National Institute of Health (NIH), USA [NINDS NS073712]; Australian National Health and Medical Research Council [APP1012338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Institute of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant (NSC-101-2325-B-006-006) from the Taiwan National Science Council, and in part by grants from the National Institute of Health (NIH) (NINDS NS073712), USA, and the Australian National Health and Medical Research Council (APP1012338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anangi R, 2007, TOXIN REV, V26, P169, DOI 10.1080/15569540701209815; Anangi R, 2010, TOXICON, V56, P1388, DOI 10.1016/j.toxicon.2010.08.004; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chen CY, 2006, PROTEINS, V62, P279, DOI 10.1002/prot.20742; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Giangiacomo KM, 2004, TOXICON, V43, P877, DOI 10.1016/j.toxicon.2003.11.029; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Maggio F, 2002, TOXICON, V40, P1355, DOI 10.1016/S0041-0101(02)00154-X; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Meng E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021608; Mobli M, 2010, TOXICON, V56, P849, DOI 10.1016/j.toxicon.2010.06.018; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Nikouee A, 2012, J PHYS CHEM B, V116, P5132, DOI 10.1021/jp2102463; Pereira LE, 2007, EXP BIOL MED, V232, P1338, DOI 10.3181/0705-RM-148; Possani LD, 1999, PERSPECT DRUG DISCOV, V16, P15; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shah K, 2003, CELL IMMUNOL, V221, P100, DOI 10.1016/S0008-8749(03)00063-7; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Turkov M, 1997, PROTEIN EXPRES PURIF, V10, P123, DOI 10.1006/prep.1997.0724; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wuthrich K, 1986, NMR PROTEINS NUCL AC	50	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52965	10.1371/journal.pone.0052965	http://dx.doi.org/10.1371/journal.pone.0052965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300835	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800163
J	Chen, CG; Diao, DK; Guo, L; Shi, M; Gao, J; Hu, MR; Yu, M; Qian, L; Guo, N				Chen, Changguo; Diao, Dekun; Guo, Liang; Shi, Ming; Gao, Jie; Hu, Meiru; Yu, Ming; Qian, Lu; Guo, Ning			All-Trans-Retinoic Acid Modulates ICAM-1 N-Glycan Composition by Influencing GnT-III Levels and Inhibits Cell Adhesion and Trans-Endothelial Migration	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN HEPATOCARCINOMA CELLS; BREAST-CANCER CELLS; INTERCELLULAR-ADHESION; ACETYLGLUCOSAMINYLTRANSFERASE-III; MOLECULE-1 ICAM-1; DOWN-REGULATION; EXPRESSION; GLYCOSYLATION; METASTASIS	Changes in the expression of glycosyltransferases directly influence the oligosaccharide structures and conformations of cell surface glycoproteins and consequently cellular phenotype transitions and biological behaviors. In the present study, we show that all-trans-retinoic acid (ATRA) modulates the N-glycan composition of intercellular adhesion molecule-1 (ICAM-1) by manipulating the expression of two N-acetylglucosaminyltransferases, GnT-III and GnT-V, via the ERK signaling pathway. Exposure of various cells to ATRA caused a remarkable gel mobility down-shift of ICAM-1. Treatment with PNGase F confirmed that the reduction of the ICAM-1 molecular mass is attributed to the decreased complexity of N-glycans. We noticed that the expression of the mRNA encoding GnT-III, which stops branching, was significantly enhanced following ATRA exposure. In contrast, the level of the mRNA encoding GnT-V, which promotes branching, was reduced following ATRA exposure. Silencing of GnT-III prevented the molecular mass shift of ICAM-1. Moreover, ATRA induction greatly inhibited the adhesion of SW480 and U937 cells to the HUVEC monolayer, whereas knock-down of GnT-III expression effectively restored cell adhesion function. Treatment with ATRA also dramatically reduced the trans-endothelial migration of U937 cells. These data indicate that the alteration of ICAM-1 N-glycan composition by ATRA-induced GnT-III activities hindered cell adhesion and cell migration functions simultaneously, pinpointing a unique regulatory role of specific glycosyltransferases in the biological behaviors of tumor cells and a novel function of ATRA in the modulation of ICAM-1 N-glycan composition.	[Chen, Changguo; Guo, Liang; Shi, Ming; Hu, Meiru; Yu, Ming; Qian, Lu; Guo, Ning] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China; [Chen, Changguo] Navy Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Diao, Dekun] Henan Univ, Sch Med, Lab Cellular & Mol Immunol, Kaifeng, Peoples R China; [Gao, Jie] Shandong Acad Med Sci, Inst Basic Med, Jinan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Sixth Medical Center of Chinese PLA General Hospital; Henan University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Qian, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China.	qianlubj@sohu.com; ningguo@nic.bmi.ac.cn		, Liang/0000-0002-8748-5770	National Basic Research Program of China (973 Program) [2010CB911904]; National Natural Science Foundation of China [30972690, 31271440, 81272232, 30800582]; Beijing National Natural Science Foundation [5103042]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing National Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by the National Basic Research Program of China (973 Program, 2010CB911904), the National Natural Science Foundation of China (No. 30972690, 31271440, 81272232 and 30800582) and Beijing National Natural Science Foundation (No. 5103042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyak MA, 2001, J BIOL CHEM, V276, P33582, DOI 10.1074/jbc.M105318200; AOUDJIT F, 1995, CELL GROWTH DIFFER, V6, P515; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Baj G, 1999, J BIOL REG HOMEOS AG, V13, P115; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carvalho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027892; Chang YJ, 2002, J BIOL CHEM, V277, P7118, DOI 10.1074/jbc.M109924200; Donadio AC, 2002, CLIN EXP METASTAS, V19, P437, DOI 10.1023/A:1016329802327; Geyer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1853, DOI 10.1016/j.bbapap.2006.10.007; Gille J, 1997, J CLIN INVEST, V99, P492, DOI 10.1172/JCI119184; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Guo HB, 2000, J CELL BIOCHEM, V79, P370, DOI 10.1002/1097-4644(20001201)79:3<370::AID-JCB30>3.0.CO;2-Z; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; ISHIBASHI K, 1989, CLIN CHIM ACTA, V185, P325, DOI 10.1016/0009-8981(89)90223-4; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Klaassen I, 2001, INT J CANCER, V92, P661, DOI 10.1002/1097-0215(20010601)92:5<661::AID-IJC1251>3.0.CO;2-O; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Maeda K, 2002, ONCOL REP, V9, P511; Maruo Y, 2002, INT J CANCER, V100, P486, DOI 10.1002/ijc.10514; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Salomon B, 1998, J IMMUNOL, V161, P5138; Santin AD, 1998, AM J OBSTET GYNECOL, V179, P1020, DOI 10.1016/S0002-9378(98)70209-1; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Soprano KJ, 2002, J NUTR, V132, p3809S, DOI 10.1093/jn/132.12.3809S; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Streb JW, PLOS ONE, V6, P4; TAKAHASHI M, 1995, CARDIOVASC RES, V29, P670; Tempia-Caliera AA, 2002, J SURG ONCOL, V79, P93, DOI 10.1002/jso.10053; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Urano F, 2000, J CELL SCI, V113, P3697; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Xu YY, 2010, J CELL BIOCHEM, V109, P468, DOI 10.1002/jcb.22423; Yamamoto H, 2000, CANCER RES, V60, P134; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	53	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52975	10.1371/journal.pone.0052975	http://dx.doi.org/10.1371/journal.pone.0052975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300837	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800165
J	Grompone, G; Martorell, P; Llopis, S; Gonzalez, N; Genoves, S; Mulet, AP; Fernandez-Calero, T; Tiscornia, I; Bollati-Fogolin, M; Chambaud, I; Foligne, B; Montserrat, A; Ramon, D				Grompone, Gianfranco; Martorell, Patricia; Llopis, Silvia; Gonzalez, Nuria; Genoves, Salvador; Paula Mulet, Ana; Fernandez-Calero, Tamara; Tiscornia, Ines; Bollati-Fogolin, Mariela; Chambaud, Isabelle; Foligne, Benoit; Montserrat, Agustin; Ramon, Daniel			Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; FREE-RADICALS; LONGEVITY; MODEL; INHIBITION; DISEASE; CONSUMPTION; ACIDOPHILUS; MODULATION; DISCOVERY	Numerous studies have shown that resistance to oxidative stress is crucial to stay healthy and to reduce the adverse effects of aging. Accordingly, nutritional interventions using antioxidant food-grade compounds or food products are currently an interesting option to help improve health and quality of life in the elderly. Live lactic acid bacteria (LAB) administered in food, such as probiotics, may be good antioxidant candidates. Nevertheless, information about LAB-induced oxidative stress protection is scarce. To identify and characterize new potential antioxidant probiotic strains, we have developed a new functional screening method using the nematode Caenorhabditis elegans as host. C. elegans were fed on different LAB strains (78 in total) and nematode viability was assessed after oxidative stress (3 mM and 5 mM H2O2). One strain, identified as Lactobacillus rhamnosus CNCM I-3690, protected worms by increasing their viability by 30% and, also, increased average worm lifespan by 20%. Moreover, transcriptomic analysis of C. elegans fed with this strain showed that increased lifespan is correlated with differential expression of the DAF-16/insulin-like pathway, which is highly conserved in humans. This strain also had a clear anti-inflammatory profile when co-cultured with HT-29 cells, stimulated by pro-inflammatory cytokines, and co-culture systems with HT-29 cells and DC in the presence of LPS. Finally, this Lactobacillus strain reduced inflammation in a murine model of colitis. This work suggests that C. elegans is a fast, predictive and convenient screening tool to identify new potential antioxidant probiotic strains for subsequent use in humans.	[Grompone, Gianfranco; Chambaud, Isabelle] Danone Res, Gut Microbiol & Probiot Platform, Palaiseau, France; [Martorell, Patricia; Llopis, Silvia; Gonzalez, Nuria; Genoves, Salvador; Ramon, Daniel] Biopolis SL, Dept Food Biotechnol, Valencia, Spain; [Fernandez-Calero, Tamara] Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay; [Tiscornia, Ines; Bollati-Fogolin, Mariela] Inst Pasteur Montevideo, Cell Biol Unit, Montevideo, Uruguay; [Foligne, Benoit] Univ Lille Nord France, CNRS UMR 8204, Ctr Infect & Immun Lille, INSERM,U1019,IPL, Lille, France; [Montserrat, Agustin] Danone Res Spain, Barcelona, Spain	Danone Nutricia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Danone Nutricia	Grompone, G (corresponding author), Danone Res, Gut Microbiol & Probiot Platform, Palaiseau, France.	gianfranco.grompone@danone.com	Mulet, Ana/AAW-5713-2021; Martorell, Patricia/ABC-8717-2021; Foligne, Benoit/B-2754-2014	Foligne, Benoit/0000-0001-9263-9706; Bollati-Fogolin, Mariela/0000-0001-6829-3135	ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY)	ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY)	Funders of this work were: ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY): PE_ALI_1_1702 and Danone Research. ANII had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Danone Research had no role in study design, data collection and analysis, but checked the manuscript before publication.	Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; Amrit Francis R G, 2010, Curr Aging Sci, V3, P166; Ashrafi Kaveh, 2007, WormBook, P1; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Butalla AC, 2012, NUTR CANCER, V64, P331, DOI 10.1080/01635581.2012.650779; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Ellinger S, 2011, PHYTOMEDICINE, V18, P903, DOI 10.1016/j.phymed.2011.06.006; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Fasseas MK, 2013, APPL MICROBIOL BIOT, V97, P2109, DOI 10.1007/s00253-012-4357-9; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano-Santini R, 2011, CELL MOL LIFE SCI, V68, P1917, DOI 10.1007/s00018-011-0670-1; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Han W, 2006, INFLAMM BOWEL DIS, V12, P1044, DOI 10.1097/01.mib.0000235101.09231.9e; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kim SO, 2006, CELL MICROBIOL, V8, P1958, DOI 10.1111/j.1462-5822.2006.00763.x; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LeBlanc JG, 2011, J BIOTECHNOL, V151, P287, DOI 10.1016/j.jbiotec.2010.11.008; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lin MY, 1999, J AGR FOOD CHEM, V47, P3661, DOI 10.1021/jf981235l; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Lin MY, 2000, DIGEST DIS SCI, V45, P1617, DOI 10.1023/A:1005577330695; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Pravda J, 2005, WORLD J GASTROENTERO, V11, P2371, DOI 10.3748/wjg.v11.i16.2371; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Richmond J, 2000, ATLA-ALTERN LAB ANIM, V28, P761, DOI 10.1177/026119290002800608; Richmond Jon, 2002, ILAR J, V43 Suppl, pS63; Rijkers GT, 2010, J NUTR, V140, p671S, DOI 10.3945/jn.109.113779; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Salminen A, 2008, CELL MOL LIFE SCI, V65, P1049, DOI 10.1007/s00018-008-7461-3; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Sanz Alberto, 2008, Curr Aging Sci, V1, P10; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; Sun J, 2010, LETT APPL MICROBIOL, V50, P264, DOI 10.1111/j.1472-765X.2009.02786.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Tomas-Barberan FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wang CY, 2011, J FOOD PROTECT, V74, P86, DOI 10.4315/0362-028X.JFP-10-155; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367; Zhou YM, 2011, BIOSCI BIOTECH BIOCH, V75, P1746, DOI 10.1271/bbb.110290	65	102	105	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52493	10.1371/journal.pone.0052493	http://dx.doi.org/10.1371/journal.pone.0052493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300685	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800095
J	Kronish, IM; Carson, AP; Davidson, KW; Muntner, P; Safford, MM				Kronish, Ian M.; Carson, April P.; Davidson, Karina W.; Muntner, Paul; Safford, Monika M.			Depressive Symptoms and Cardiovascular Health by the American Heart Association's Definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study	PLOS ONE			English	Article							DIABETES-MELLITUS; CARDIAC RISK; DISEASE; HYPERTENSION; EVENTS; CARE; PREVALENCE; BEHAVIORS; MORTALITY; ADHERENCE	Background: Depressive symptoms are associated with increased incident and recurrent cardiovascular events. In 2010, the American Heart Association published the Life's Simple 7, a metric for assessing cardiovascular health as measured by 4 health behaviors (smoking, physical activity, body mass index, diet) and 3 biological measures (cholesterol, blood pressure, glucose). The association between depressive symptoms and the Life's Simple 7 has not yet been explored. Methods: Data from 20,093 participants >= 45 years of age who enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between 2003 and 2007 and who had complete data available on Life's Simple 7 components were used for these analyses. The prevalence of ideal, intermediate, and poor health on each Life's Simple 7 component and total Life's Simple 7 scores were compared between participants with and without depressive symptoms. Depressive symptoms were measured using the 4-item Centers for Epidemiologic Studies of Depression scale. Results: Participants with depressive symptoms were more likely to have poor levels on each of the Life's Simple 7 components other than cholesterol [ adjusted prevalence ratios (95% CI): smoking 1.41 (1.29-1.55); physical activity 1.38 (1.31-1.46); body mass index 1.09 (1.04-1.15); diet 1.08 (1.06-1.10); blood pressure 1.11 (1.02-1.21); glucose 1.24 (1.09-1.41)]. There was a graded association between increasing depressive symptoms and lower total Life's Simple 7 score. Conclusion: Depressive symptoms are associated with worse cardiovascular health on the overall Life's Simple 7 and on individual components representing both health behaviors and biological factors.	[Kronish, Ian M.; Davidson, Karina W.] Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA; [Carson, April P.; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kronish, IM (corresponding author), Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA.	ik2293@columbia.edu	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kronish, Ian/0000-0003-0945-2380; Carson, April/0000-0002-7970-6756	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01 NS041588]; National Heart, Lung, and Blood Institute [K23 HL098359, R01 HL080477, HL088117, HL084034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, K24HL084034, K23HL098359, P01HL088117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. Dr. Kronish was supported by grant K23 HL098359 from the National Heart, Lung, and Blood Institute. Drs. Safford and Muntner were supported by R01 HL080477 from the National Heart, Lung, and Blood Institute. Dr. Davidson was supported by HL088117 and HL084034 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Behrens T, 2004, METHOD INFORM MED, V43, P505; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038; Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Feighner JP, 1995, J CLIN PSYCHIAT, V56, P574; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Glymour MM, 2010, NEUROLOGY, V75, P2063, DOI 10.1212/WNL.0b013e318200d70e; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; Huffman JC, 2011, CIRC-CARDIOVASC QUAL, V4, P198, DOI 10.1161/CIRCOUTCOMES.110.959379; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Katon W, 2010, CONTEMP CLIN TRIALS, V31, P312, DOI 10.1016/j.cct.2010.03.009; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Pan A, 2011, STROKE; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014; Rush AJ, 2003, BIOL PSYCHIAT, V53, P743, DOI 10.1016/S0006-3223(03)00088-X; Rutledge T, 2002, PSYCHOSOM MED, V64, P758, DOI 10.1097/01.PSY.0000031578.42041.1C; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Tedders SH, 2011, J AFFECT DISORD; Thorndike AN, 2008, ARCH INTERN MED, V168, P186, DOI 10.1001/archinternmed.2007.60; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	40	66	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52771	10.1371/journal.pone.0052771	http://dx.doi.org/10.1371/journal.pone.0052771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300767	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800142
J	Osthus, IBO; Sgura, A; Berardinelli, F; Alsnes, IV; Bronstad, E; Rehn, T; Stobakk, PK; Hatle, H; Wisloff, U; Nauman, J				Osthus, Ida Beate O.; Sgura, Antonella; Berardinelli, Francesco; Alsnes, Ingvild Vatten; Bronstad, Eivind; Rehn, Tommy; Stobakk, Per Kristian; Hatle, Havard; Wisloff, Ulrik; Nauman, Javaid			Telomere Length and Long-Term Endurance Exercise: Does Exercise Training Affect Biological Age? A Pilot Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTHY; MORTALITY; WOMEN; ASSOCIATION; RISK; DIET	Background: Telomeres are potential markers of mitotic cellular age and are associated with physical ageing process. Longterm endurance training and higher aerobic exercise capacity (VO2max) are associated with improved survival, and dynamic effects of exercise are evident with ageing. However, the association of telomere length with exercise training and VO2max has so far been inconsistent. Our aim was to assess whether muscle telomere length is associated with endurance exercise training and VO2max in younger and older people. Methods: Twenty men; 10 young (22-27 years) and 10 old (66-77 years), were studied in this cross-sectional study. Five out of 10 young adults and 5 out of 10 older were endurance athletes, while other halves were exercising at a medium level of activity. Mean telomere length was measured as telomere/single copy gene-ratio (T/S-ratio) using quantitative real time polymerase chain reaction. VO2max was measured directly running on a treadmill. Results: Older endurance trained athletes had longer telomere length compared with older people with medium activity levels (T/S ratio 1.12 +/- 0.1 vs. 0.92 +/- 0.2, p = 0.04). Telomere length of young endurance trained athletes was not different than young non-athletes (1.47 +/- 0.2 vs. 1.33 +/- 0.1, p = 0.12). Overall, there was a positive association between T/S ratio and VO2max (r = 0.70, p = 0.001). Among endurance trained athletes, we found a strong correlation between VO2max and T/S ratio (r = 0.78, p = 0.02). However, corresponding association among non-athlete participants was relatively weak (r = 0.58, p = 0.09). Conclusion: Our data suggest that VO2max is positively associated with telomere length, and we found that long-term endurance exercise training may provide a protective effect on muscle telomere length in older people.	[Osthus, Ida Beate O.; Alsnes, Ingvild Vatten; Bronstad, Eivind; Rehn, Tommy; Stobakk, Per Kristian; Hatle, Havard; Wisloff, Ulrik; Nauman, Javaid] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Sgura, Antonella; Berardinelli, Francesco] Univ Rome Roma Tre, Dept Biol, Rome, Italy; [Bronstad, Eivind] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Bronstad, Eivind; Rehn, Tommy] Norwegian Univ Sci & Technol, Ctr Sports & Phys Act Res, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Roma Tre University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Nauman, J (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	javaid.nauman@ntnu.no	Nauman, Javaid/AAF-2284-2019; Sgura, Antonella/H-3274-2019; Berardinelli, Francesco/AAP-2355-2021; Wisloff, Ulrik/K-2899-2012	Nauman, Javaid/0000-0003-1347-2448; Berardinelli, Francesco/0000-0002-3094-4139; Wisloff, Ulrik/0000-0002-7211-3587; Alsnes, Ingvild Vatten/0000-0002-2136-6664	K.G. Jebsen Foundation; Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim	K.G. Jebsen Foundation; Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim	The present study was supported by grants from the K.G. Jebsen Foundation, the Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2012, DIABETIC MED, V29, pe377, DOI 10.1111/j.1464-5491.2012.03737.x; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bronstad E, 2012, EUR RESPIR J, V40, P1130, DOI 10.1183/09031936.00193411; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Grimsmo J, 2011, SCAND J MED SCI SPOR, V21, pE351, DOI 10.1111/j.1600-0838.2011.01307.x; Grimsmo J, 2010, EUR J CARDIOV PREV R, V17, P100, DOI 10.1097/HJR.0b013e32833226be; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kadi F, 2010, SCAND J MED SCI SPOR, V20, P39, DOI 10.1111/j.1600-0838.2009.00966.x; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Ludlow Andrew T, 2011, J Aging Res, V2011, P790378, DOI 10.4061/2011/790378; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Lund TC, 2007, MUSCLE NERVE, V36, P387, DOI 10.1002/mus.20824; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ponsot E, 2008, MUSCLE NERVE, V37, P467, DOI 10.1002/mus.20964; Rae DE, 2010, EUR J APPL PHYSIOL, V109, P323, DOI 10.1007/s00421-010-1353-6; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Shin YA, 2008, MECH AGEING DEV, V129, P254, DOI 10.1016/j.mad.2008.01.001; Walters SJ, 2009, PHARM STAT, V8, P163, DOI 10.1002/pst.334; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Woo J, 2008, ARCH INTERN MED, V168, P2163, DOI 10.1001/archinte.168.19.2163; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	32	81	83	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52769	10.1371/journal.pone.0052769	http://dx.doi.org/10.1371/journal.pone.0052769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300766	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800141
J	Papareddy, P; Kalle, M; Sorensen, OE; Lundqvist, K; Morgelin, M; Malmsten, M; Schmidtchen, A				Papareddy, Praveen; Kalle, Martina; Sorensen, Ole E.; Lundqvist, Katarina; Morgelin, Matthias; Malmsten, Martin; Schmidtchen, Artur			Tissue Factor Pathway Inhibitor 2 Is Found in Skin and Its C-Terminal Region Encodes for Antibacterial Activity	PLOS ONE			English	Article							SERINE PROTEINASE-INHIBITORS; ANTIMICROBIAL PEPTIDES; PROTEASE INHIBITORS; IMMUNE-RESPONSES; EXPRESSION; MECHANISM; BACTERIA; BILAYERS; KININOGEN; MELITTIN	Background: Tissue factor pathway inhibitor 2 (TFPI-2) is a matrix-associated serine protease inhibitor with an enigmatic function in vivo. Here, we describe that TFPI-2 is present in fibrin of wounds and also expressed in skin, where it is up-regulated upon wounding. Methodology and Principal Findings: Neutrophil elastase cleaved TFPI-2, and a C-terminal fragment was found to bind to bacteria. Similarly, a prototypic peptide representing this C-terminal part, EDC34, bound to bacteria and bacterial lipopolysaccharide, and induced bacterial permeabilization. The peptide also induced leakage in artificial liposomes, and displayed a random coil conformation upon interactions with liposomes as well as lipopolysaccharide. EDC34 was antibacterial against both Gram-negative and Gram-positive bacteria in physiological buffer conditions. Conclusions/Significance: The results demonstrate that the C-terminus of TFPI-2 encodes for antimicrobial activity, and may be released during wounding.	[Papareddy, Praveen; Kalle, Martina; Lundqvist, Katarina; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Sorensen, Ole E.; Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden	Lund University; Lund University; Uppsala University	Papareddy, P (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	praveen.papareddy@med.lu.se	Schmidtchen, Artur/F-9507-2015	Sorensen, Ole E./0000-0001-8681-6921; Papareddy, Praveen/0000-0002-3872-478X	Swedish Research Council [2009-3378, 2009-3009]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; The Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; The Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 2009-3378 and 2009-3009), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, and Kock Foundations, XImmune AB, and The Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Hisaka T, 2004, THROMB HAEMOSTASIS, V91, P569, DOI 10.1160/TH03-06-0358; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Iino M, 1998, ARTERIOSCL THROM VAS, V18, P40, DOI 10.1161/01.ATV.18.1.40; Kong DS, 2004, BIOCHEM BIOPH RES CO, V324, P1179, DOI 10.1016/j.bbrc.2004.09.179; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V317, P311, DOI 10.1006/abbi.1995.1168; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V319, P55, DOI 10.1006/abbi.1995.1266; RAO CN, 1995, J INVEST DERMATOL, V104, P379, DOI 10.1111/1523-1747.ep12665851; Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tossi A, 2000, BIOPOLYMERS, V55, P4; Udagawa K, 1998, PLACENTA, V19, P217, DOI 10.1016/S0143-4004(98)90011-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52772	10.1371/journal.pone.0052772	http://dx.doi.org/10.1371/journal.pone.0052772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300768	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800143
J	Timmers, I; Jansma, BM; Rubio-Gozalbo, ME				Timmers, Inge; Jansma, Bernadette M.; Rubio-Gozalbo, M. Estela			From Mind to Mouth: Event Related Potentials of Sentence Production in Classic Galactosemia	PLOS ONE			English	Article							LEXICAL ACCESS; ELECTROPHYSIOLOGICAL EVIDENCE; SYNTACTIC STRUCTURE; BRAIN POTENTIALS; VERBAL DYSPRAXIA; TIME-COURSE; LANGUAGE; CHILDREN; SPEECH; COMPREHENSION	Patients with classic galactosemia, an inborn error of metabolism, have speech and language production impairments. Past research primarily focused on speech (motor) problems, but these cannot solely explain the language impairments. Which specific deficits contribute to the impairments in language production is not yet known. Deficits in semantic and syntactic planning are plausible and require further investigation. In the present study, we examined syntactic encoding while patients and matched controls overtly described scenes of moving objects using either separate words (minimal syntactic planning) or sentences (sentence-level syntactic planning). The design of the paradigm also allowed tapping into local noun phrase- and more global sentence-level syntactic planning. Simultaneously, we recorded event-related potentials (ERPs). The patients needed more time to prepare and finish the utterances and made more errors. The patient ERPs had a very similar morphology to that of healthy controls, indicating overall comparable neural processing. Most importantly, the ERPs diverged from those of controls in several functionally informative time windows, ranging from very early (90-150 ms post scene onset) to relatively late (1820-2020 ms post scene onset). These time windows can be associated with different linguistic encoding stages. The ERP results form the first neuroscientific evidence for language production impairments in patients with galactosemia in lexical and syntactic planning stages, i.e., prior to the linguistic output phase. These findings hence shed new light on the language impairments in this disease.	[Timmers, Inge; Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Timmers, Inge; Jansma, Bernadette M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Jansma, Bernadette M.] Maastricht Univ, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Lab Genet Metab Dis, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Rubio-Gozalbo, ME (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	estela.rubio@mumc.nl	Rubio-Gozalbo, M Estela/H-1833-2011	Timmers, Inge/0000-0001-7162-6623; Jansma, Bernadette M./0000-0002-2925-0244	Maastricht University Incentive; Galactosemia Research Fund	Maastricht University Incentive; Galactosemia Research Fund	This work was supported by a Maastricht University Incentive to B. M. Jansma in the context of supporting "Woman in higher positions in science" and a Galactosemia Research Fund grant to M. E. Rubio-Gozalbo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Allum PH, 2009, J EXP PSYCHOL LEARN, V35, P1240, DOI 10.1037/a0016367; Antshel KM, 2004, NEUROPSYCHOLOGY, V18, P658, DOI 10.1037/0894-4105.18.4.658; Berry GT, 2011, J INHERIT METAB DIS, V34, P345, DOI 10.1007/s10545-010-9260-x; Bles M, 2007, BRAIN RES, V1150, P143, DOI 10.1016/j.brainres.2007.02.071; Bock J.K., 1994, HDB PSYCHOLINGUISTIC, P945; BOCK JK, 1982, PSYCHOL REV, V89, P1, DOI 10.1037/0033-295X.89.1.1; Bock K., 1995, SPEECH LANGUAGE COMM, V2nd ed., P181, DOI DOI 10.1016/B978-012497770-9/50008-X; Coles M.G.H., 1995, OX PSYCH S, P1; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doyle CM, 2010, J INHERIT METAB DIS, V33, P603, DOI 10.1007/s10545-010-9154-y; Dubroff JG, 2008, J INHERIT METAB DIS, V31, P533, DOI 10.1007/s10545-008-0806-0; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Indefrey P, 2004, BRAIN LANG, V89, P312, DOI 10.1016/S0093-934X(03)00352-3; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jansma Bernadette M., 2004, MULTIDISCIPLINARY AP, P361, DOI DOI 10.1515/9783110894028; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KAUFMAN FR, 1995, EUR J PEDIATR, V154, pS2, DOI 10.1007/BF02143794; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kutas M, 2003, MIND, BRAIN, AND LANGUAGE: MULTIDISCIPLINARY PERSPECTIVES, P171; Lebea PJ, 2005, MED HYPOTHESES, V65, P1051, DOI 10.1016/j.mehy.2005.06.025; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luck S.J., 2005, INTRO EVENT RELATED; Makeig S., 2009, OXFORD HDB EVENT REL; Marek A, 2007, APHASIOLOGY, V21, P1147, DOI 10.1080/02687030600646577; Mercier M, 2009, EUR J NEUROSCI, V29, P424, DOI 10.1111/j.1460-9568.2008.06583.x; Meyer A. S., 2004, INTERFACE LANGUAGE V, P191; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Meyers J. E., 1995, REY COMPLEX FIGURE T; Mortensen L, 2008, Q J EXP PSYCHOL, V61, P1217, DOI 10.1080/17470210701467912; NELSON CD, 1991, PEDIATRICS, V88, P346; NELSON MD, 1992, RADIOLOGY, V184, P255, DOI 10.1148/radiology.184.1.1319076; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Potter NL, 2008, J INHERIT METAB DIS, V31, P524, DOI 10.1007/s10545-008-0877-y; Potter NL, 2011, J INHERIT METAB DIS, V34, P377, DOI 10.1007/s10545-010-9213-4; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rabovsky M, 2011, J COGNITIVE NEUROSCI; Rahman RA, 2008, PSYCHON B REV, V15, P1055, DOI 10.3758/PBR.15.6.1055; Robertson A, 2000, GENET MED, V2, P142, DOI 10.1097/00125817-200003000-00005; Rogalski E, 2011, J NEUROSCI, V31, P3344, DOI 10.1523/JNEUROSCI.5544-10.2011; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schadewaldt P, 2010, PEDIATRICS, V125, pE374, DOI 10.1542/peds.2008-3325; Schmitt BM, 2000, J COGNITIVE NEUROSCI, P48; SCHWEITZER S, 1993, EUR J PEDIATR, V152, P36, DOI 10.1007/BF02072514; Shield JPH, 2000, ARCH DIS CHILD, V83, P248, DOI 10.1136/adc.83.3.248; Shriberg LD, 2010, J SPEECH LANGUAGE HE; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; van Haasen PP, 1986, WISC R WESCHLER INTE; vanTurennout M, 1997, J EXP PSYCHOL LEARN, V23, P787, DOI 10.1037/0278-7393.23.4.787; Vos PG, 1988, BOURDON VOS TEST BOU; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619; WAISBREN SE, 1983, J PEDIATR-US, V102, P75, DOI 10.1016/S0022-3476(83)80292-3; Waisbren SE, 2012, J INHERIT METAB DIS, V35, P279, DOI 10.1007/s10545-011-9372-y; Webb AL, 2003, PEDIATR RES, V53, P396, DOI 10.1203/01.PDR.0000049666.19532.1B; Widhalm K, 2002, NUTR RES, V22, P257, DOI 10.1016/S0271-5317(01)00401-8	69	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52826	10.1371/journal.pone.0052826	http://dx.doi.org/10.1371/journal.pone.0052826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300788	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800153
J	Zhou, QC; Sheng, GH				Zhou, Quancheng; Sheng, Guihua			Pyrolytic and Kinetic Characteristics of the Thermal Decomposition of Perilla frutescens Polysaccharide	PLOS ONE			English	Article							TG-FTIR; CAKE	The thermal decomposition of Perilla frutescens polysaccharide was examined by thermogravimetry, differential thermogravimetry, and differential thermal analysis. The results showed that the mass loss of the substance proceeded in three steps. The first stage can be attributed to the expulsion of the water from ambient temperature to 182 degrees C. The second stage corresponded to devolatilization from 182 degrees C to 439 degrees C. The residue slowly degraded in the third stage. The weight loss in air is faster than that in nitrogen, because the oxygen in air accelerated the pyrolytic reaction speed reaction. The heating rate significantly affected the pyrolysis of the sample. Similar activation energies of the degradation process (210-211 kJ mol(-1)) were obtained by the FWO, KAS, and Popescu techniques. According to Popescu mechanism functions, the possible kinetic model was estimated to be Avrami-Erofeev 20 g(alpha) = [-ln(1-alpha)](4).	[Zhou, Quancheng] Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Peoples R China; [Sheng, Guihua] Shandong Univ Technol, Sch Life Sci, Zibo, Peoples R China	Shandong University of Technology; Shandong University of Technology	Zhou, QC (corresponding author), Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Peoples R China.	zhouquancheng@126.com		Sheng, Guihua/0000-0003-3933-7930				Adriana V.M., 2011, BIOMA BIOEN, V35, P1121; Beis SH, 2002, RENEW ENERG, V26, P21, DOI 10.1016/S0960-1481(01)00109-4; Brebu M, 2011, CELL CHEM TECHNOL, V45, P43; Cabrales L, 2010, J THERM ANAL CALORIM, V102, P485, DOI 10.1007/s10973-010-0911-9; Feng XB, 2011, J MICROBIOL METH, V84, P359, DOI 10.1016/j.mimet.2010.12.012; Hirose S, 2002, J THERM ANAL CALORIM, V70, P853, DOI 10.1023/A:1022212421525; Karaosmanoglu F, 2001, ENERG SOURCE, V23, P377; KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045; Lerdkanchanaporn S, 1998, THERMOCHIM ACTA, V324, P25, DOI 10.1016/S0040-6031(98)00520-6; Li DM, 2011, BIOMASS BIOENERG, V35, P1765, DOI 10.1016/j.biombioe.2011.01.011; Li DM, 2010, CHEM ENG RES DES, V88, P647, DOI 10.1016/j.cherd.2009.10.011; Liang J, 2008, THERMOSETTING RESIN, V23, P11; Liu Q, 2008, J ANAL APPL PYROL, V82, P170, DOI 10.1016/j.jaap.2008.03.007; Liu Y., 2008, J CHANGSHA U TECH NA, V5, P1; Lopez FA, 2008, J THERM ANAL CALORIM, V91, P633, DOI 10.1007/s10973-007-8321-3; Orfao JJM, 1999, FUEL, V78, P349, DOI 10.1016/S0016-2361(98)00156-2; OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881; Pappa A, 2003, J ANAL APPL PYROL, V67, P221, DOI 10.1016/S0165-2370(02)00063-3; Park HY, 2010, FOOD CHEM, V119, P724, DOI 10.1016/j.foodchem.2009.07.020; Peiretti PG, 2011, LIVEST SCI, V138, P118, DOI 10.1016/j.livsci.2010.12.007; [彭云云 PENG Yunyun], 2009, [化工进展, Chemical Industry and Engineering Progress], V28, P1478; Popescu C, 1996, THERMOCHIM ACTA, V285, P309, DOI 10.1016/0040-6031(96)02916-4; Putun AE, 2002, ENERGY, V27, P703, DOI 10.1016/S0360-5442(02)00015-4; Putun E, 2006, BIORESOURCE TECHNOL, V97, P701, DOI 10.1016/j.biortech.2005.04.005; Rao TR, 1998, ENERGY, V23, P973, DOI 10.1016/S0360-5442(98)00037-1; Rychly J, 2002, POLYM DEGRAD STABIL, V78, P357, DOI 10.1016/S0141-3910(02)00187-8; Sensoz S, 2008, BIORESOURCE TECHNOL, V99, P5492, DOI 10.1016/j.biortech.2007.10.046; She ZG, 2003, CHINESE J ORG CHEM, V23, P1149; Shen DK, 2010, J ANAL APPL PYROL, V87, P199, DOI 10.1016/j.jaap.2009.12.001; Wang X., 2009, FOOD SCI, V44, P44; Xiujuan Guo, 2011, Recent Researches in Energy & Environment. 6th IASME - WSEAS International Conference on Energy and Environment (EE '11), P137; Ye NH, 2010, PLOS ONE, P126; Zhao G, 2010, NEUROCHEM INT, V56, P168, DOI 10.1016/j.neuint.2009.09.015; Zhou QC, 2012, ADV MAT RES, V518-523, P3904; Zhu JF, 2011, J ANHUI AGR SCI, V39, P266	35	2	3	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52597	10.1371/journal.pone.0052597	http://dx.doi.org/10.1371/journal.pone.0052597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300715	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800108
J	Chu, Y; Liu, CY; Wu, YC; Hsieh, MJ; Chen, TP; Chao, YK; Wu, CY; Yuan, HC; Ko, PJ; Liu, YH; Liu, HP				Chu, Yen; Liu, Chien-Ying; Wu, Yi-Cheng; Hsieh, Ming-Ju; Chen, Tzu-Ping; Chao, Ying-Kai; Wu, Ching-Yang; Yuan, Hsu-Chia; Ko, Po-Jen; Liu, Yun-Hen; Liu, Hui-Ping			Comparison of Hemodynamic and Inflammatory Changes between Transoral and Transthoracic Thoracoscopic Surgery	PLOS ONE			English	Article							SAFETY VALVE TECHNIQUE; SURGICAL LUNG-BIOPSY; TRANSESOPHAGEAL MEDIASTINOSCOPY; SUBMUCOSAL ENDOSCOPY; THORACIC-SURGERY; FEASIBILITY; MODEL; CHOLECYSTECTOMY; CARDIOPULMONARY; PERITONEOSCOPY	Background: Natural orifice transluminal endoscopy has been developed for abdominal surgical procedures. The aim of this study was to compare the surgical outcome between a novel transoral approach and a standard transthoracic approach for the thoracic cavity in a canine model. Methods: Twenty-eight dogs were assigned to transoral (n = 14) or standard thoracoscopy ( n = 14). Each group underwent thoracic exploration, pre-determined surgical lung biopsy, and pericardial window creation. Blood draws were obtained before surgery and at postoperative days 1, 3, 7, and 14. Operative time, complications, laboratory parameters, hemodynamic parameters, and inflammatory parameters were compared between the two procedures. The animals were monitored for two weeks and necropsy were performed for surgical outcome evaluation. Results: The thoracic procedures were successfully performed in all of the dogs, with the exception of one animal in the transoral group. There were no serious acute or delayed complications related to surgery. There was no difference between the two surgical groups for each of the hemodynamic parameters that were evaluated. Regarding the immunological impact of the surgeries, transoral thoracoscopy was associated with significant elevations in interleukin 6 and c-reactive protein levels on postoperative days 1 and 3, respectively, when compared with the standard thoracoscopy. All dogs recovered well, without signs of mediastinitis or thoracic infection. Necropsy revealed absence of infection, no injury to vital organs, and confirmed the success of the novel procedure. Conclusions: This study suggests that both techniques were comparable with respect to procedure success rate, hemodynamic impact, and inflammatory changes. Furthermore, there was no difference in the incidence of postoperative discomfort between groups.	[Chu, Yen; Wu, Yi-Cheng; Hsieh, Ming-Ju; Chen, Tzu-Ping; Chao, Ying-Kai; Wu, Ching-Yang; Ko, Po-Jen; Liu, Yun-Hen; Liu, Hui-Ping] Chang Gung Univ, Chang Gung Mem Hosp, Dept Thorac Surg, Tao Yuan, Taiwan; [Liu, Chien-Ying] Chang Gung Univ, Chang Gung Mem Hosp, Dept Thorac Med, Tao Yuan, Taiwan; [Yuan, Hsu-Chia] Chang Gung Univ, Chang Gung Mem Hosp, Lab Anim Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Liu, YH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Thorac Surg, Tao Yuan, Taiwan.	foreverairmail@gmail.com; zebraairmail@gmail.com	Hsieh, Ming-Ju/AAY-2569-2021; Chao, YinKai/ABE-7827-2020	Hsieh, Ming-Ju/0000-0003-2450-4257; Chao, Yin Kai/0000-0001-8649-8783; Chu, Yen/0000-0002-7712-8331	Chang-Gung Memorial Hospital (Taiwan) [CMRPG-391912, CMRPG-28028, CMRPG-3A0371]; National Science Council of Taiwan [NSC 100-2314-B-182A-052]	Chang-Gung Memorial Hospital (Taiwan)(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Chang-Gung Memorial Hospital (CMRPG-391912 for YHL, and CMRPG-28028 and CMRPG-3A0371 for CYL, Taiwan) and by the National Science Council of Taiwan (NSC 100-2314-B-182A-052 for CYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz A, 2011, EUR UROL, V59, P1019, DOI 10.1016/j.eururo.2011.03.021; Chukwumah C, 2010, CURR PROB SURG, V47, P630, DOI 10.1067/j.cpsurg.2010.04.002; Coomber RS, 2012, WORLD J GASTRO ENDOS, V4, P65, DOI 10.4253/wjge.v4.i3.65; Dallemagne B, 2009, BRIT J SURG, V96, P1162, DOI 10.1002/bjs.6704; De Palma GD, 2010, MINERVA CHIR, V65, P11; Fritscher-Ravens A, 2010, ENDOSCOPY, V42, P468, DOI 10.1055/s-0029-1244019; Hazey JW, 2008, SURG ENDOSC, V22, P16, DOI 10.1007/s00464-007-9548-6; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Ko PJ, 2012, J SURG RES, V175, P207, DOI 10.1016/j.jss.2011.03.016; Lehmann KS, 2010, ANN SURG, V252, P263, DOI 10.1097/SLA.0b013e3181e6240f; Lima E, 2007, SURG ENDOSC, V21, P854, DOI 10.1007/s00464-007-9366-x; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Liu YH, 2012, SURG INNOV, V19, P162, DOI 10.1177/1553350611421915; Liu YH, 2011, SURG ENDOSC, V25, P3912, DOI 10.1007/s00464-011-1819-6; Liu YH, 2011, SURG ENDOSC, V25, P1652, DOI 10.1007/s00464-010-1401-7; Palanivelu C, 2008, SURG ENDOSC, V22, P1343, DOI 10.1007/s00464-008-9811-5; Romeo C, 2002, J PEDIATR SURG, V37, P741, DOI 10.1053/jpsu.2002.32268; Sumiyama K, 2008, GASTROINTEST ENDOSC, V67, P497, DOI 10.1016/j.gie.2007.08.040; Sumiyama K, 2007, GASTROINTEST ENDOSC, V65, P679, DOI 10.1016/j.gie.2006.10.017; Suzuki K, 2010, GASTROINTEST ENDOSC, V72, P1241, DOI 10.1016/j.gie.2010.08.038; von Delius S, 2010, ENDOSCOPY, V42, P405, DOI 10.1055/s-0029-1243948; Wichmann MW, 2005, ARCH SURG-CHICAGO, V140, P692, DOI 10.1001/archsurg.140.7.692	22	73	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e50338	10.1371/journal.pone.0050338	http://dx.doi.org/10.1371/journal.pone.0050338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300944	Green Published, gold, Green Submitted			2022-12-27	WOS:000313480000001
J	Lisi, L; Camardese, G; Treglia, M; Tringali, G; Carrozza, C; Janiri, L; Dello Russo, C; Navarra, P				Lisi, Lucia; Camardese, Giovanni; Treglia, Mariangela; Tringali, Giuseppe; Carrozza, Cinzia; Janiri, Luigi; Dello Russo, Cinzia; Navarra, Pierluigi			Monocytes from Depressed Patients Display an Altered Pattern of Response to Endotoxin Challenge	PLOS ONE			English	Article							MAJOR DEPRESSION; GENE-EXPRESSION; SEROTONIN TRANSPORTER; IN-VITRO; PROSTAGLANDINS; LYMPHOCYTES; CYTOKINES	It is now well established that major depression is accompanied and characterized by altered responses of the immune-inflammatory system. In this study we investigated the pro-inflammatory activation of monocytes isolated from depressed patients as a parameter not influenced by such confounds as the time of day, the nutritional and exercise status or the age and gender of patients. Monocytes from depressed patients and from healthy controls were isolated in vitro; after 24-h incubation under basal conditions, cells were exposed for 24-h to 100 ng/ml of endotoxin (bacterial lipopolysaccharide, LPS). We found that monocytes from drug-free depressed patients and controls release the same amounts of prostaglandin E2 (PGE2) under basal conditions, whereas monocytes from patients are dramatically less reactive to LPS (8.62-fold increase vs previous 24 hrs) compared to healthy controls (123.3-fold increase vs previous 24 hrs). Such blunted prostanoid production was paralleled by a reduction in COX-2 gene expression, whereas other pro-inflammatory mediators, namely interleukin-1 beta (IL-1 beta) and -6 (IL-6) showed a trend to increased gene expression. The above changes were not associated to increased levels of circulating glucocorticoids. After 8 months of antidepressive drug treatment, the increase in PGE2 production after the endotoxin challenge was partially restored, whereas the increase in IL-1 beta and -6 levels observed at baseline was completely abolished. In conclusion, our findings show that the reactivity of monocytes from depressed patients might be considered as a marker of the immune-inflammatory disorders associated to depression, although the lack of paired healthy controls at follow-up does not allow to conclude that monocyte reactivity to endotoxin is also a marker of treatment outcome.	[Lisi, Lucia; Tringali, Giuseppe; Dello Russo, Cinzia; Navarra, Pierluigi] Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, I-00168 Rome, Italy; [Camardese, Giovanni; Treglia, Mariangela; Janiri, Luigi] Univ Cattolica Sacro Cuore, Sch Med, Inst Psychiat & Psychol, I-00168 Rome, Italy; [Carrozza, Cinzia] Univ Cattolica Sacro Cuore, Sch Med, Inst Biochem & Clin Biochem, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Navarra, P (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, I-00168 Rome, Italy.	pnavarra@rm.unicatt.it	Navarra, Pierluigi/AAL-4307-2020; Dello Russo, Cinzia/K-5283-2018; Camardese, Giovanni/AAC-1840-2022; Lisi, Lucia/AAL-1063-2020; Stevens, David/F-4683-2015	Dello Russo, Cinzia/0000-0002-2538-3832; Camardese, Giovanni/0000-0002-8139-9230; NAVARRA, Pierluigi/0000-0002-4424-650X; Lisi, Lucia/0000-0003-1397-2426; JANIRI, LUIGI/0000-0002-1633-9418				CALABRESE JR, 1986, PSYCHIAT RES, V17, P41, DOI 10.1016/0165-1781(86)90040-5; Dean B, 2011, INT J NEUROPSYCHOPH, V14, P997, DOI 10.1017/S1461145710001410; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Fazzino F, 2008, J NEUROIMMUNOL, V196, P173, DOI 10.1016/j.jneuroim.2008.03.012; Galli M, 2006, INT J MOL MED, V18, P141; Gonda X, 2008, ANN GEN PSYCHIATR, V13, P7; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Bonfiglio JJ, 2011, NEUROENDOCRINOLOGY, V94, P12, DOI 10.1159/000328226; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Krause Daniela L., 2012, Inflammopharmacology, V20, P169, DOI 10.1007/s10787-011-0112-6; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lima L, 2002, CELL MOL NEUROBIOL, V22, P797, DOI 10.1023/A:1021869310702; LINNOILA M, 1983, ARCH GEN PSYCHIAT, V40, P405; Lok A, 2012, PSYCHONEUROENDOCRINO, V37, P892, DOI 10.1016/j.psyneuen.2011.10.005; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; OHISHI K, 1988, BIOL PSYCHIAT, V23, P326, DOI 10.1016/0006-3223(88)90283-1; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SEHGAL PB, 1992, RES IMMUNOL, V143, P724, DOI 10.1016/0923-2494(92)80011-9; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029	25	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52585	10.1371/journal.pone.0052585	http://dx.doi.org/10.1371/journal.pone.0052585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300980	gold, Green Published, Green Submitted			2022-12-27	WOS:000313480000011
J	Haberling, IS; Badzakova-Trajkov, G; Corballis, MC				Haeberling, Isabelle S.; Badzakova-Trajkov, Gjurgjica; Corballis, Michael C.			Asymmetries of the Arcuate Fasciculus in Monozygotic Twins: Genetic and Nongenetic Influences	PLOS ONE			English	Article							HUMAN BRAIN; LANGUAGE LATERALIZATION; HEMISPHERIC DOMINANCE; SEX-DIFFERENCES; FUNCTIONAL MR; DIFFUSION; FMRI; TRACTOGRAPHY; DTI; HANDEDNESS	We assessed cerebral asymmetry for language in 35 monozygotic twin pairs. Using DTI, we reconstructed the arcuate fasciculus in each twin. Among the male twins, right-handed pairs showed greater left-sided asymmetry of connectivity in the arcuate fasciculus than did those with discordant handedness, and within the discordant group the right-handers had greater left-sided volume asymmetry of the arcuate fasciculus than did their left-handed co-twins. There were no such effects in the female twins. Cerebral asymmetry for language showed more consistent results, with the more left-cerebrally dominant twins also showing more leftward asymmetry of high anisotropic fibers in the arcuate fasciculus, a result applying equally to female as to male twins. Reversals of arcuate fasciculus asymmetry were restricted to pairs discordant for language dominance, with the left-cerebrally dominant twins showing leftward and the right-cerebrally dominant twins rightward asymmetry of anisotropic diffusion in the arcuate fasciculus. Because monozygotic twin pairs share the same genotype, our results indicate a strong nongenetic component in arcuate fasciculus asymmetry, particularly in those discordant for cerebral asymmetry.	[Haeberling, Isabelle S.] Univ Auckland, Res Ctr Cognit Neurosci, Auckland 1, New Zealand; Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Auckland; University of Auckland	Haberling, IS (corresponding author), Univ Auckland, Res Ctr Cognit Neurosci, Auckland 1, New Zealand.	i.haberling@auckland.ac.nz		Corballis, Michael/0000-0002-3126-6114	Marsden Fund [UOA-0710]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a grant to M.C.C. from the Marsden Fund (UOA-0710) administered by The Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock JE, 2003, NEUROIMAGE, V18, P423, DOI 10.1016/S1053-8119(02)00013-7; Annett M, 2002, HANDEDNESS BRAIN ASY; Annett M, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P73, DOI 10.1017/CBO9780511576744.006; Badzakova-Trajkov G, 2010, NEUROPSYCHOLOGIA, V48, P3086, DOI 10.1016/j.neuropsychologia.2010.06.020; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bernal B, 2010, MAGN RESON IMAGING, V28, P217, DOI 10.1016/j.mri.2009.07.008; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Chang EF, 2011, J NEUROSURG, V114, P893, DOI 10.3171/2010.11.JNS10888; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P3197, DOI 10.1016/j.neuropsychologia.2008.07.017; Ellmore TM, 2010, NEUROIMAGE, V49, P2033, DOI 10.1016/j.neuroimage.2009.10.055; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hagmann P, 2006, HUM BRAIN MAPP, V27, P828, DOI 10.1002/hbm.20224; Halwani GF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00156; Herve PY, 2006, NEUROIMAGE, V29, P1066, DOI 10.1016/j.neuroimage.2005.08.031; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jansen A, 2006, NEUROIMAGE, V33, P204, DOI 10.1016/j.neuroimage.2006.06.019; Jansen A, 2004, HUM BRAIN MAPP, V23, P168, DOI 10.1002/hbm.20055; Kaplan E, 2010, NEUROIMAGE, V52, P436, DOI 10.1016/j.neuroimage.2010.04.247; Knecht S, 2002, NAT NEUROSCI, V5, P695, DOI 10.1038/nn868; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luders E, 2010, PROG BRAIN RES, V186, P3, DOI 10.1016/B978-0-444-53630-3.00001-4; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McManus I.C., 2002, RIGHT HAND LEFT HAND; MCMANUS IC, 1980, NEUROPSYCHOLOGIA, V18, P347, DOI 10.1016/0028-3932(80)90130-X; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; Papoutsi M, 2011, NEUROIMAGE, V58, P656, DOI 10.1016/j.neuroimage.2011.06.036; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Powell JL, 2012, NEUROSCIENCE; Propper RE, 2010, BRAIN COGNITION, V73, P85, DOI 10.1016/j.bandc.2010.03.004; Pujol J, 2002, NEUROIMAGE, V17, P670, DOI 10.1106/nimg.2002.1203; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Sicotte N L, 1999, Laterality, V4, P265, DOI 10.1080/135765099396980; Sommer IEC, 2002, BRAIN, V125, P2710, DOI 10.1093/brain/awf284; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Takao H, 2011, HUM BRAIN MAPP, V32, P1762, DOI 10.1002/hbm.21145; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Woermann FG, 2003, NEUROLOGY, V61, P699, DOI 10.1212/01.WNL.0000078815.03224.57; Yang MJ, 2006, HUM REPROD, V21, P2175, DOI 10.1093/humrep/del133; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yetkin FZ, 1998, AM J NEURORADIOL, V19, P1095	58	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52315	10.1371/journal.pone.0052315	http://dx.doi.org/10.1371/journal.pone.0052315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300971	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900024
J	Party, V; Hanot, C; Busser, DS; Rochat, D; Renou, M				Party, Virginie; Hanot, Christophe; Buesser, Daniela Schmidt; Rochat, Didier; Renou, Michel			Changes in Odor Background Affect the Locomotory Response to Pheromone in Moths	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; HOST-PLANT VOLATILES; SEX-PHEROMONE; EMISSION; WALKING; DISTRACTION; ATTRACTION; MORPHOLOGY; PHYSIOLOGY; LOCATION	Many animals rely on chemical cues to recognize and locate a resource, and they must extract the relevant information from a complex and changing odor environment. For example, in moths, finding a mate is mediated by a sex pheromone, which is detected in a rich environment of volatile plant compounds. Here, we investigated the effects of a volatile plant background on the walking response of male Spodoptera littoralis to the female pheromone. Males were stimulated by combining pheromone with one of three plant compounds, and their walking paths were recorded with a locomotion compensator and analyzed. We found that the addition of certain volatile plant compounds disturbed the orientation toward the sex pheromone. The effect on locomotion was correlated with the capacity of the plant compound to antagonize pheromone detection by olfactory receptor neurons, suggesting a masking effect of the background over the pheromone signal. Moths were more sensitive to changes in background compared to a constant background, suggesting that a background odor also acts as a distracting stimulus. Our experiments show that the effects of odorant background on insect responses to chemical signals are complex and cannot be explained by a single mechanism.	[Party, Virginie; Hanot, Christophe; Buesser, Daniela Schmidt; Rochat, Didier; Renou, Michel] INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Party, V (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France.	vparty@live.fr	RENOU, Michel/AAT-7340-2021	RENOU, Michel/0000-0001-6172-0210				Barrozo RB, 2004, CHEM SENSES, V29, P319, DOI 10.1093/chemse/bjh035; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Berti S, 2008, PSYCHOPHYSIOLOGY, V45, P608, DOI 10.1111/j.1469-8986.2008.00660.x; Blejec A, 2005, NEUROCOMPUTING, V65, P557, DOI 10.1016/j.neucom.2004.10.103; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Byers JA, 2004, NATURWISSENSCHAFTEN, V91, P215, DOI 10.1007/s00114-004-0520-1; Chan AAYH, 2010, ANIM BEHAV, V80, P1075, DOI 10.1016/j.anbehav.2010.09.025; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kolosova N, 2001, PLANT CELL, V13, P2333, DOI 10.1105/tpc.13.10.2333; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Light Douglas M., 1993, Chemoecology, V4, P145, DOI 10.1007/BF01256549; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; MarionPoll F, 1995, J NEUROSCI METH, V63, P197, DOI 10.1016/0165-0270(95)00110-7; Minoli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034141; MOORHOUSE JE, 1990, ANIM BEHAV, V39, P613, DOI 10.1016/S0003-3472(05)80372-0; MOORHOUSE JE, 1987, EXP BIOL, V46, P193; NEIL SJ, 1986, ETHOLOGY, V73, P225; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Parmentier FBR, 2008, COGNITION, V106, P408, DOI 10.1016/j.cognition.2007.03.008; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Raguso Robert A., 1999, Plant Species Biology, V14, P95, DOI 10.1046/j.1442-1984.1999.00014.x; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Rouyar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026443; Sakuma M, 2002, COMPUT ELECTRON AGR, V35, P243, DOI 10.1016/S0168-1699(02)00021-2; Schmidt-Busser D, 2009, J COMP PHYSIOL A, V195, P853, DOI 10.1007/s00359-009-0464-1; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Svensson GP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5901; Svensson GP, 2004, OIKOS, V104, P91, DOI 10.1111/j.0030-1299.2004.12517.x; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thorpe CM, 2002, BEHAV PROCESS, V58, P79; Willis MA, 2011, J EXP BIOL, V214, P4121, DOI 10.1242/jeb.036954	45	24	28	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52897	10.1371/journal.pone.0052897	http://dx.doi.org/10.1371/journal.pone.0052897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301000	Green Published, gold			2022-12-27	WOS:000313320900043
J	Soga, M; Koike, S				Soga, Masashi; Koike, Shinsuke			Large Forest Patches Promote Breeding Success of a Terrestrial Mammal in Urban Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; RACCOON DOG; DECIDUOUS FORESTS; BIODIVERSITY; CONNECTIVITY; JAPAN; AREA	Despite a marked increase in the focus toward biodiversity conservation in fragmented landscapes, studies that confirm species breeding success are scarce and limited. In this paper, we asked whether local (area of forest patches) and landscape (amount of suitable habitat surrounding of focal patches) factors affect the breeding success of raccoon dogs (Nyctereutes procyonoides) in Tokyo, Central Japan. The breeding success of raccoon dogs is easy to judge as adults travel with pups during the breeding season. We selected 21 forest patches (3.3-797.8 ha) as study sites. In each forest patch, we used infrared-triggered cameras for a total of 60 camera days per site. We inspected each photo to determine whether it was of an adult or a pup. Although we found adult raccoon dogs in all 21 forest patches, pups were found only in 13 patches. To estimate probability of occurrence and detection for raccoon in 21 forest fragments, we used single season site occupancy models in PRESENCE program. Model selection based on AIC and model averaging showed that the occupancy probability of pups was positively affected by patch area. This result suggests that large forests improve breeding success of raccoon dogs. A major reason for the low habitat value of small, isolated patches may be the low availability of food sources and the high risk of being killed on the roads in such areas. Understanding the effects of local and landscape parameters on species breeding success may help us to devise and implement effective long-term conservation and management plans.	[Soga, Masashi; Koike, Shinsuke] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan	Tokyo University of Agriculture & Technology	Soga, M (corresponding author), Tokyo Univ Agr & Technol, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	soga06154053@yahoo.co.jp	Koike, Shinsuke/C-4619-2013	Koike, Shinsuke/0000-0002-2926-8196	Tokyu Foundation for Better Environment [2012-13];  [22651086]	Tokyu Foundation for Better Environment; 	This study was funded by Grant-in-Aid for Challenging Exploratory Research (22651086) and the Tokyu Foundation for Better Environment (no. 2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Davies KF, 1998, J ANIM ECOL, V67, P460, DOI 10.1046/j.1365-2656.1998.00210.x; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HARASHINA K, 1999, J JAPANESE I LANDSCA, V62, P569; Hines J., 2006, PRESENCE2 SOFTWARE E; Hirasawa Mizuho, 2006, Mammal Study, V31, P9, DOI 10.3106/1348-6160(2006)31[9:SFHOTR]2.0.CO;2; Kauhala K, 1998, ECOGRAPHY, V21, P457, DOI 10.1111/j.1600-0587.1998.tb00436.x; Koike S, 2008, J FOREST RES-JPN, V13, P215, DOI 10.1007/s10310-008-0069-5; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Kurki S, 2000, ECOLOGY, V81, P1985, DOI 10.1890/0012-9658(2000)081[1985:LFAFCE]2.0.CO;2; Kurosawa R, 2003, CONSERV BIOL, V17, P695, DOI 10.1046/j.1523-1739.2003.01118.x; LOMOLINO MV, 1990, OIKOS, V57, P297, DOI 10.2307/3565957; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Marzluff JM, 2000, WILDLIFE SOC B, V28, P1132; Morrison M.L., 1998, WILDLIFE HABITAT REL; Mortelliti A, 2011, J APPL ECOL, V48, P153, DOI 10.1111/j.1365-2664.2010.01918.x; Newmark WD, 2011, P NATL ACAD SCI USA, V108, P11488, DOI 10.1073/pnas.1104955108; OHDACHI S. D., 2009, WILD MAMMALS JAPAN; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Saeki M, 2004, BIOL CONSERV, V118, P559, DOI 10.1016/j.biocon.2003.10.004; Soga M, J INSECT CO IN PRESS; Sonoda Y, 2002, ENV SYST RES, V30, P101; Sonoda Youichi, 2008, Ecology and Civil Engineering, V11, P41, DOI 10.3825/ece.11.41; Takatsuki S, 2008, MAMMALOGY JAPAN	28	13	14	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51802	10.1371/journal.pone.0051802	http://dx.doi.org/10.1371/journal.pone.0051802			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300951	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900009
J	Liu, Y; Whelan, RJ; Pattnaik, BR; Ludwig, K; Subudhi, E; Rowland, H; Claussen, N; Zucker, N; Uppal, S; Kushner, DM; Felder, M; Patankar, MS; Kapur, A				Liu, Yang; Whelan, Rebecca J.; Pattnaik, Bikash R.; Ludwig, Kai; Subudhi, Enkateswar; Rowland, Helen; Claussen, Nick; Zucker, Noah; Uppal, Shitanshu; Kushner, David M.; Felder, Mildred; Patankar, Manish S.; Kapur, Arvinder			Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53	PLOS ONE			English	Article							PHASE-III TRIAL; DOXORUBICIN PLUS CISPLATIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; MOUSE SKIN; CARCINOMA; PACLITAXEL; GROWTH; FILGRASTIM; INHIBITION	Novel strategies are necessary to improve chemotherapy response in advanced and recurrent endometrial cancer. Here, we demonstrate that terpenoids present in the Steam Distilled Extract of Ginger (SDGE) are potent inhibitors of proliferation of endometrial cancer cells. SDGE, isolated from six different batches of ginger rhizomes, consistently inhibited proliferation of the endometrial cancer cell lines Ishikawa and ECC-1 at IC50 of 1.25 mu g/ml. SDGE also enhanced the anti-proliferative effect of radiation and cisplatin. Decreased proliferation of Ishikawa and ECC-1 cells was a direct result of SDGE-induced apoptosis as demonstrated by FITC-Annexin V staining and expression of cleaved caspase 3. GC/MS analysis identified a total of 22 different terpenoid compounds in SDGE, with the isomers neral and geranial constituting 30-40%. Citral, a mixture of neral and geranial inhibited the proliferation of Ishikawa and ECC-1 cells at an IC50 10 mu M (2.3 mu g/ml). Phenolic compounds such as gingerol and shogaol were not detected in SDGE and 6-gingerol was a weaker inhibitor of the proliferation of the endometrial cancer cells. SDGE was more effective in inducing cancer cell death than citral, suggesting that other terpenes present in SDGE were also contributing to endometrial cancer cell death. SDGE treatment resulted in a rapid and strong increase in intracellular calcium and a 20-40% decrease in the mitochondrial membrane potential. Ser-15 of p53 was phosphorylated after 15 min treatment of the cancer cells with SDGE. This increase in p53 was associated with 90% decrease in Bcl2 whereas no effect was observed on Bax. Inhibitor of p53, pifithrin-alpha, attenuated the anti-cancer effects of SDGE and apoptosis was also not observed in the p53(neg) SKOV-3 cells. Our studies demonstrate that terpenoids from SDGE mediate apoptosis by activating p53 and should be therefore be investigated as agents for the treatment of endometrial cancer.	[Liu, Yang] Shandong Univ, Dept Obstet & Gynecol, Qi Lu Hosp, Jinan, Peoples R China; [Liu, Yang; Ludwig, Kai; Rowland, Helen; Claussen, Nick; Zucker, Noah; Uppal, Shitanshu; Kushner, David M.; Felder, Mildred; Patankar, Manish S.; Kapur, Arvinder] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Whelan, Rebecca J.] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA; [Pattnaik, Bikash R.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Subudhi, Enkateswar] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Orissa, India	Shandong University; University of Wisconsin System; University of Wisconsin Madison; Oberlin College; University of Wisconsin System; University of Wisconsin Madison; Siksha 'O' Anusandhan University	Patankar, MS (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.	patankar@wisc.edu; akaur@wisc.edu	Uppal, Shitanshu/D-9374-2015; Whelan, Rebecca/J-7861-2019; Subudhi, Enketeswara/B-6206-2016	Uppal, Shitanshu/0000-0002-8329-6948; Whelan, Rebecca/0000-0002-9293-1528; Subudhi, Enketeswara/0000-0003-0571-6940; Ludwig, Kai/0000-0001-9867-9346; Pattnaik, Bikash/0000-0002-5385-358X	Department of Obstetrics and Gynecology; Wisconsin Ovarian Cancer Alliance; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation); University of Wisconsin Comprehensive Cancer Centers; National Institutes of Health [CA14520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Department of Obstetrics and Gynecology; Wisconsin Ovarian Cancer Alliance; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation); University of Wisconsin Comprehensive Cancer Centers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was provided by grants from the Department of Obstetrics and Gynecology to AK and MSP, a charitable donation from Jean McKenzie and research grants from the Wisconsin Ovarian Cancer Alliance to MSP and the Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation) to BRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply grateful to Dagna Sheerar and Karen Erslund (University of Wisconsin-Madison Paul P. Carbone Comprehensive Cancer Center, Flow Cytometry Facility) for their advice and help with the flow cytometry assays, to Rob McClain (Department of Chemistry) for his help with the GC-MS analysis, Dr. Randy Kimple and Molly Smith for their assistance with the irradiation of cells, and Jennifer Gubbels (Augustana College, Sioux Falls, ND) for critical reading of the manuscript. We also acknowledge the support provided by the University of Wisconsin Comprehensive Cancer Centers Flow Cytometry facility which is supported by a core grant (CA14520) from the National Institutes of Health.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Brown AC, 2009, PHYTOTHER RES, V23, P640, DOI 10.1002/ptr.2677; Chen CY, 2008, J NAT PROD, V71, P137, DOI 10.1021/np070279y; Choudhury D, 2010, FOOD CHEM TOXICOL, V48, P2872, DOI 10.1016/j.fct.2010.07.020; COHEN CJ, 1984, OBSTET GYNECOL, V63, P719; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Fleming GF, 2004, ANN ONCOL, V15, P1173, DOI 10.1093/annonc/mdh316; Gallion HH, 2003, J CLIN ONCOL, V21, P3808, DOI 10.1200/JCO.2003.10.083; Gehrig PA, 2010, GYNECOL ONCOL, V116, P187, DOI 10.1016/j.ygyno.2009.10.041; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Homesley HD, 2009, GYNECOL ONCOL, V112, P543, DOI 10.1016/j.ygyno.2008.11.014; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang HC, 2011, BIOSCI BIOTECH BIOCH, V75, P1067, DOI 10.1271/bbb.100851; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Ju SA, 2012, INT J CANCER, V130, P2618, DOI 10.1002/ijc.26316; Katiyar SK, 1996, CANCER RES, V56, P1023; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krell J, 2012, LANCET ONCOL, V13, P235, DOI 10.1016/S1470-2045(12)70097-9; Lee C, 2011, FOOD CHEM TOXICOL, V49, P1261, DOI 10.1016/j.fct.2011.03.005; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; LUNA RMD, 1995, NATURE, V378, P203; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Pan MH, 2008, MOL NUTR FOOD RES, V52, P527, DOI 10.1002/mnfr.200700157; Park EJ, 2002, CANCER METAST REV, V21, P231, DOI 10.1023/A:1021254725842; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Rhode Jennifer, 2007, BMC Complement Altern Med, V7, P44, DOI 10.1186/1472-6882-7-44; Riyazi A, 2007, PLANTA MED, V73, P355, DOI 10.1055/s-2007-967171; SATYASWAROOP PG, 1991, CANCER RES, V51, P5661; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spinner DM, 2000, METH MOLEC MED, V39, P175; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; Weng CJ, 2010, MOL NUTR FOOD RES, V54, P1618, DOI 10.1002/mnfr.201000108; Wohlmuth H, 2006, J AGR FOOD CHEM, V54, P1414, DOI 10.1021/jf0521799; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang SY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/936030	48	64	68	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53178	10.1371/journal.pone.0053178	http://dx.doi.org/10.1371/journal.pone.0053178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300887	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600067
J	McGlade, D; McClenahan, C; Pierscionek, B				McGlade, Donal; McClenahan, Carol; Pierscionek, Barbara			Attitudes Underlying Corneal Donation in a Group of Trainee Allied Health Professionals	PLOS ONE			English	Article							EXPECTANCY-VALUE MUDDLE; PLANNED BEHAVIOR; ORGAN DONATION; ENTERTAINMENT-EDUCATION; EXTENDED THEORY; SMOKING STATUS; DONOR; CARE; DETERMINANTS; PSYCHOLOGY	Background: The focus of this study was to investigate factors that may influence personal willingness to register consent to donate corneal tissue upon death using the theory of planned behaviour in a relatively ethnically homogenous group of trainee allied health professionals. The attainment of this knowledge will be of paramount importance in relation to potential interventions that are designed to change donation-related behaviour. Methods: A questionnaire-based study was undertaken with 92 pre-registration nurses (mean age 24.0 years (standard deviation 65.6 years); female: male = 89: 3) enrolled at a University in Northern Ireland. Intention to register consent to donate corneal tissue upon death was assessed using both direct and belief-based measures found in the theory of planned behaviour. Descriptive statistics were used to assess demographic information, with correlation and regression analyses being used to identify factors influencing intentions. Results: The majority of participants were religious (94.6%, n = 87) and mostly Protestant (58.7%, n = 54) or Catholic (35.9%, n = 33). Generally speaking, the theory of planned behaviour accounted for 84% of the variance in intention to register consent. In relation to the constructs found in the theory of planned behaviour, attitude was found to be the strongest predictor of intention to register consent, with subjective norm being the second strongest predictor. Perceived behavioural control did not significantly predict intention to register consent. Conclusions: The theory of planned behaviour has allowed an understanding of the factors that influence the personal intentions of a group of future allied health professionals from the same ethnic group to register consent to donate their corneal tissue.	[McGlade, Donal] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [McClenahan, Carol] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland; [Pierscionek, Barbara] Kingston Univ London, Fac Sci Engn & Comp, Kingston Upon Thames, Surrey, England	Ulster University; Ulster University; Kingston University	Pierscionek, B (corresponding author), Kingston Univ London, Fac Sci Engn & Comp, Kingston Upon Thames, Surrey, England.	b.pierscionek@kingston.ac.uk	Pierscionek, Barbara/AAK-5760-2021					Abramson S, 2000, CLIN J SPORT MED, V10, P40, DOI 10.1097/00042752-200001000-00008; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akgun HS, 2003, TRANSPLANT P, V35, P1273, DOI 10.1016/S0041-1345(03)00437-8; AMMERMAN AS, 1993, PREV MED, V22, P96, DOI 10.1006/pmed.1993.1007; Anker AE, 2009, PROG TRANSPLANT, V19, P343; Armitage CJ, 2001, J APPL SOC PSYCHOL, V31, P1431, DOI 10.1111/j.1559-1816.2001.tb02681.x; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bae HS, 2008, HEALTH COMMUN, V23, P87, DOI 10.1080/10410230701808038; Bae HS, 2008, J HEALTH COMMUN, V13, P20, DOI 10.1080/10810730701806953; Ben Natan M, 2010, INT NURS REV, V57, P388, DOI 10.1111/j.1466-7657.2010.00807.x; Bener A, 2008, EXP CLIN TRANSPLANT, V6, P249; Blanchard CM, 2009, APPETITE, V52, P15, DOI 10.1016/j.appet.2008.07.001; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Bresnahan M, 2007, HEALTH COMMUN, V21, P201, DOI 10.1080/10410230701307436; CRONEN VE, 1975, SPEECH MONOGR, V42, P143; Ertin H, 2010, NURS ETHICS, V17, P705, DOI 10.1177/0969733010378933; EVANS MG, 1991, AM PSYCHOL, V46, P6, DOI 10.1037/0003-066X.46.1.6; Fishbein M., 2010, PREDICTING CHANGING, P449; Floden Anne, 2009, Intensive Crit Care Nurs, V25, P306, DOI 10.1016/j.iccn.2009.06.002; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Francis JJ, 2004, MEASUREMENT ISSUES T; French DP, 2003, BRIT J HEALTH PSYCH, V8, P37, DOI 10.1348/135910703762879192; Garde PP, 1994, J TRANSPLANT COORDIN, V4, P48; Giles M, 2004, HEALTH EDUC RES, V19, P380, DOI 10.1093/her/cyg063; Godin G, 2008, PROG TRANSPLANT, V18, P109, DOI 10.7182/prtr.18.2.p288715285l34314; Heyes A, 2005, J HEALTH ECON, V24, P561, DOI 10.1016/j.jhealeco.2004.09.002; Huchting K, 2008, ADDICT BEHAV, V33, P538, DOI 10.1016/j.addbeh.2007.11.002; Hyde MK, 2010, BRIT J HEALTH PSYCH, V15, P435, DOI 10.1348/135910709X468232; Hyde MK, 2009, HEALTH EDUC RES, V24, P1080, DOI 10.1093/her/cyp028; Hyde MK, 2009, BRIT J HEALTH PSYCH, V14, P423, DOI 10.1348/135910708X339542; Hyde MK, 2009, J APPL SOC PSYCHOL, V39, P880, DOI 10.1111/j.1559-1816.2009.00464.x; Kawahara K, 2000, J Epidemiol, V10, P157; Kawakami M, 1997, INTERNAL MED, V36, P162, DOI 10.2169/internalmedicine.36.162; Marks WH, 2006, AM J TRANSPLANT, V6, P1101, DOI 10.1111/j.1600-6143.2006.01269.x; McGlade D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000055; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; MICHIE S, 2008, J APPL PSYCHOL, V57, P660, DOI DOI 10.1111/J.1464-0597.2008.00341.X; Nardini S, 1998, EUR RESPIR J, V12, P1450, DOI 10.1183/09031936.98.12061450; Newton JD, 2012, PSYCHOL HEALTH, V27, P588, DOI 10.1080/08870446.2011.611244; NHSBT, 2009, TRANSPL ACT UK 2008; NHSBT, 2011, TRANSPL ACT UK 2010; Nursing and Midwifery Council, 2008, STAT AN REG 1 APR 20; Ozdag N, 2001, EDTNA ERCA J, V27, P201; Park HS, 2007, HUM COMMUN RES, V33, P194, DOI 10.1111/j.1468-2958.2007.00296.x; Pipe A, 2009, PATIENT EDUC COUNS, V74, P118, DOI 10.1016/j.pec.2008.07.042; Zambudio AR, 2009, PROG TRANSPLANT, V19, P371; SCHWARTZ B, 1967, AM J SOCIOL, V73, P1, DOI 10.1086/224432; Siegel J.T., 2010, UNDERSTANDING ORGAN, P313; Skowronski JJ, 1997, BASIC APPL SOC PSYCH, V19, P427; Smith M, 2004, ORGAN DONATION SERVI; Spencer EH, 2006, AM J CLIN NUTR, V84, P655, DOI 10.1093/ajcn/84.3.655; Wight C, 1998, TRANSPLANT P, V30, P2253, DOI 10.1016/S0041-1345(98)00609-5	52	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53538	10.1371/journal.pone.0053538	http://dx.doi.org/10.1371/journal.pone.0053538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300937	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000313872600107
J	Jego, S; Salvert, D; Renouard, L; Mori, M; Goutagny, R; Luppi, PH; Fort, P				Jego, Sonia; Salvert, Denise; Renouard, Leslie; Mori, Masatomo; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice			Tuberal Hypothalamic Neurons Secreting the Satiety Molecule Nesfatin-1 Are Critically Involved in Paradoxical (REM) Sleep Homeostasis	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; C-FOS EXPRESSION; OREXIN NEURONS; GABAERGIC NEURONS; MCH NEURONS; LOCUS-COERULEUS; DEPRIVATION; EXCITABILITY; ACTIVATION; RECEPTOR	The recently discovered Nesfatin-1 plays a role in appetite regulation as a satiety factor through hypothalamic leptin-independent mechanisms. Nesfatin-1 is co-expressed with Melanin-Concentrating Hormone (MCH) in neurons from the tuberal hypothalamic area (THA) which are recruited during sleep states, especially paradoxical sleep (PS). To help decipher the contribution of this contingent of THA neurons to sleep regulatory mechanisms, we thus investigated in rats whether the co-factor Nesfatin-1 is also endowed with sleep-modulating properties. Here, we found that the disruption of the brain Nesfatin-1 signaling achieved by icv administration of Nesfatin-1 antiserum or antisense against the nucleobindin2 (NUCB2) prohormone suppressed PS with little, if any alteration of slow wave sleep (SWS). Further, the infusion of Nesfatin-1 antiserum after a selective PS deprivation, designed for elevating PS needs, severely prevented the ensuing expected PS recovery. Strengthening these pharmacological data, we finally demonstrated by using c-Fos as an index of neuronal activation that the recruitment of Nesfatin-1-immunoreactive neurons within THA is positively correlated to PS but not to SWS amounts experienced by rats prior to sacrifice. In conclusion, this work supports a functional contribution of the Nesfatin-1 signaling, operated by THA neurons, to PS regulatory mechanisms. We propose that these neurons, likely releasing MCH as a synergistic factor, constitute an appropriate lever by which the hypothalamus may integrate endogenous signals to adapt the ultradian rhythm and maintenance of PS in a manner dictated by homeostatic needs. This could be done through the inhibition of downstream targets comprised primarily of the local hypothalamic wake-active orexin-and histamine-containing neurons.	[Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] CNRS, UMR5292, Sleep Waking Neuronal Networks, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Lyon Neurosci Res Ctr CRNL, INSERM, U1028, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Univ Lyon, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Univ Lyon 1, F-69365 Lyon, France; [Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Gunma University	Fort, P (corresponding author), CNRS, UMR5292, Sleep Waking Neuronal Networks, Lyon, France.	patrice.fort@univ-lyon1.fr	Luppi, Pierre-Hervé/C-4333-2014; goutagny, romain/C-1461-2018; FORT, Patrice/G-6851-2017	Luppi, Pierre-Hervé/0000-0002-0503-423X; goutagny, romain/0000-0002-1268-533X; FORT, Patrice/0000-0003-1211-8631	CNRS; INSERM; Universite Claude Bernard - Lyon I	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Claude Bernard - Lyon I	This work was supported by CNRS, INSERM and Universite Claude Bernard - Lyon I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2009, J PHYSIOL-LONDON, V587, P33, DOI 10.1113/jphysiol.2008.164400; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Antal-Zimanyi I, 2009, J MOL NEUROSCI, V39, P86, DOI 10.1007/s12031-009-9207-6; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Cahill L, 2000, NEUROBIOL LEARN MEM, V74, P259, DOI 10.1006/nlme.1999.3950; Chen X, 2012, REGUL PEPTIDES, V177, P21, DOI 10.1016/j.regpep.2012.04.003; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Fujihara H, 2003, MOL BRAIN RES, V119, P152, DOI 10.1016/j.molbrainres.2003.09.005; Garcia-Fuster MJ, 2012, EUR NEUROPSYCHOPHARM, V22, P607, DOI 10.1016/j.euroneuro.2011.12.001; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Goebel M, 2011, PEPTIDES, V32, P36, DOI 10.1016/j.peptides.2010.09.027; Gokcek-Sarac C, 2012, BEHAV BRAIN RES, V235, P326, DOI 10.1016/j.bbr.2012.08.005; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Palasz A, 2012, NEUROPEPTIDES, V46, P105, DOI 10.1016/j.npep.2011.12.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Price CJ, 2008, J NEUROENDOCRINOL, V20, P245, DOI 10.1111/j.1365-2826.2007.01641.x; Price CJ, 2008, BRAIN RES, V1230, P99, DOI 10.1016/j.brainres.2008.06.084; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Satoh S, 2006, BEHAV BRAIN RES, V170, P277, DOI 10.1016/j.bbr.2006.03.010; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; SHIROMANI PJ, 1995, J NEUROSCI, V15, P3500; SIM LJ, 1995, BRAIN RES BULL, V36, P399, DOI 10.1016/0361-9230(94)00220-U; Stengel A, 2011, ENDOCRINOLOGY, V152, P4033, DOI 10.1210/en.2011-1500; Stengel A, 2010, REGUL PEPTIDES, V163, P18, DOI 10.1016/j.regpep.2010.05.002; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Torterolo Pablo, 2011, Front Neurol, V2, P14, DOI 10.3389/fneur.2011.00014; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Verret L, 2006, J COMP NEUR IN PRESS; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	68	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52525	10.1371/journal.pone.0052525	http://dx.doi.org/10.1371/journal.pone.0052525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300698	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100060
J	Ju, JM; Qi, ZC; Cai, XT; Cao, P; Huang, Y; Wang, SZ; Liu, N; Chen, YJ				Ju, Jianming; Qi, Zhichao; Cai, Xueting; Cao, Peng; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun			The Apoptotic Effects of Toosendanin Are Partially Mediated by Activation of Deoxycytidine Kinase in HL-60 Cells	PLOS ONE			English	Article							CHINESE TRADITIONAL MEDICINE; HUMAN CANCER-CELLS; HUMAN-LYMPHOCYTES; NUCLEOSIDE ANALOGS; DNA-SYNTHESIS; PHOSPHORYLATION; INHIBITION; CYTOTOXICITY; IRRADIATION; BINDING	Triterpenoid toosendanin (TSN) exhibits potent cytotoxic activity through inducing apoptosis in a variety of cancer cell lines. However, the target and mechanism of the apoptotic effects by TSN remain unknown. In this study, we captured a specific binding protein of TSN in HL-60 cells by serial affinity chromatography and further identified it as deoxycytidine kinase (dCK). Combination of direct activation of dCK and inhibition of TSN-induced apoptosis by a dCK inhibitor confirmed that dCK is a target for TSN partially responsible for the apoptosis in HL-60 cells. Moreover, the activation of dCK by TSN was a result of conformational change, rather than auto-phosphorylation. Our results further imply that, in addition to the dATP increase by dCK activation in tumor cells, dCK may also involve in the apoptotic regulation.	[Ju, Jianming; Qi, Zhichao; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Ju, Jianming; Qi, Zhichao; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China; [Ju, Jianming; Cai, Xueting; Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Dept Pharmaceut Anal & Metabol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Nanjing University of Chinese Medicine	Liu, N (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	liunan0428@yahoo.com.cn; yjchen@cpu.edu.cn	Wang, Shuzhen/L-2895-2016; Chen, Yijun/H-3209-2019	Wang, Shuzhen/0000-0003-3869-2463; Chen, Yijun/0000-0002-4920-152X; , Peng/0000-0002-2044-3074	Ministry of Education of China; State Administration of Foreign Export Affairs of China [111-2-07]; National Natural Science Foundation of China [81001378, 81102467]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMKF201208]	Ministry of Education of China(Ministry of Education, China); State Administration of Foreign Export Affairs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Natural Medicines, China Pharmaceutical University	This work was supported by the grants from the "111'' Project from the Ministry of Education of China and the State Administration of Foreign Export Affairs of China (No. 111-2-07), the National Natural Science Foundation of China (No. 81001378 and No. 81102467) and the Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. SKLNMKF201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bierau J, 2006, CANCER CHEMOTH PHARM, V57, P105, DOI 10.1007/s00280-005-0005-8; Carpinella MC, 2003, J AGR FOOD CHEM, V51, P369, DOI 10.1021/jf025811w; Chung C.-C., 1975, ACTA CHIM SINICA, V33, P35; Csapo Z, 2003, BIOCHEM PHARMACOL, V65, P2031, DOI 10.1016/S0006-2952(03)00182-5; Csapo Z, 2001, BIOCHEM PHARMACOL, V61, P191, DOI 10.1016/S0006-2952(00)00534-7; Guo Y, 2012, J AGR FOOD CHEM, V60, P7016, DOI 10.1021/jf301734h; He YJ, 2010, PLANTA MED, V76, P1447, DOI 10.1055/s-0029-1240902; Ju JM, 2012, TOXICOL IN VITRO; Keszler G, 2005, ARCH BIOCHEM BIOPHYS, V436, P69, DOI 10.1016/j.abb.2005.01.009; Keszler G, 2004, NUCLEOS NUCLEOT NUCL, V23, P1335, DOI 10.1081/NCN-200027586; Keszler G, 2004, BIOCHEM PHARMACOL, V67, P947, DOI 10.1016/j.bcp.2003.10.019; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; LI PZ, 1982, CHIN TRADIT HERB DRU, V13, P28; Liu Qian, 2010, Journal of China Pharmaceutical University, V41, P451; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Paintsil E, 2011, ANTIMICROB AGENTS CH, V55, P895, DOI 10.1128/AAC.01303-10; PLAGEMANN PGW, 1978, CANCER RES, V38, P978; Raynal NJM, 2011, LEUKEMIA RES, V35, P110, DOI 10.1016/j.leukres.2010.04.014; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Sabini E, 2007, NUCLEIC ACIDS RES, V35, P186, DOI 10.1093/nar/gkl1038; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; Sasvari-Szekely M, 1998, BIOCHEM PHARMACOL, V56, P1175, DOI 10.1016/S0006-2952(98)00108-7; Sato S, 2011, CHEM BIOL, V18, P131, DOI 10.1016/j.chembiol.2010.10.017; Shi YL, 2007, PROG NEUROBIOL, V82, P1, DOI 10.1016/j.pneurobio.2007.02.002; Shu G.X., 1980, ACTA CHIM SINICA, V38, P196; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Smal C, 2010, NUCLEOS NUCLEOT NUCL, V29, P404, DOI 10.1080/15257771003741216; Spasokoukotskaja T, 1999, EUR J CANCER, V35, P1862, DOI 10.1016/S0959-8049(99)00223-3; Tang MZ, 2004, TOXICOLOGY, V201, P31, DOI 10.1016/j.tox.2004.03.023; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; Van den Neste E, 2003, BIOCHEM PHARMACOL, V65, P573, DOI 10.1016/S0006-2952(02)01559-9; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamamoto K, 2006, ANAL BIOCHEM, V352, P15, DOI 10.1016/j.ab.2006.02.008; Yu JCH, 2004, NEUROSIGNALS, V13, P248, DOI 10.1159/000079339; Yu XC, 2010, J BIOMOL SCREEN, V15, P72, DOI 10.1177/1087057109353604; Zhang B, 2005, INVEST NEW DRUG, V23, P547, DOI 10.1007/s10637-005-0909-5; Zhang J, 2008, ANAL CHIM ACTA, V622, P182, DOI 10.1016/j.aca.2008.05.046; Zhou JY, 2003, FEBS LETT, V555, P375, DOI 10.1016/S0014-5793(03)01291-2; ZOU J, 1985, Journal of Traditional Chinese Medicine, V5, P29	41	14	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52536	10.1371/journal.pone.0052536	http://dx.doi.org/10.1371/journal.pone.0052536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300702	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100061
J	Le Calvez-Kelm, F; Oliver, J; Damiola, F; Forey, N; Robinot, N; Durand, G; Voegele, C; Vallee, MP; Byrnes, G; Hopper, JL; Southey, MC; Andrulis, IL; John, EM; Tavtigian, SV; Lesueur, F				Le Calvez-Kelm, Florence; Oliver, Javier; Damiola, Francesca; Forey, Nathalie; Robinot, Nivonirina; Durand, Geoffroy; Voegele, Catherine; Vallee, Maxime P.; Byrnes, Graham; Hopper, John L.; Southey, Melissa C.; Andrulis, Irene L.; John, Esther M.; Tavtigian, Sean V.; Lesueur, Fabienne		Breast Canc Family Registry	RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; OVARIAN-CANCER; GERMLINE MUTATIONS; MISSENSE SUBSTITUTIONS; PENETRANCE ANALYSIS; BRCA1 CARRIERS; GENE; RISK; PALB2; RECOMBINATION	Background: Although inherited breast cancer has been associated with germline mutations in genes that are functionally involved in the DNA homologous recombination repair (HRR) pathway, including BRCA1, BRCA2, TP53, ATM, BRIP1, CHEK2 and PALB2, about 70% of breast cancer heritability remains unexplained. Because of their critical functions in maintaining genome integrity and already well-established associations with breast cancer susceptibility, it is likely that additional genes involved in the HRR pathway harbor sequence variants associated with increased risk of breast cancer. RAD51 plays a central biological function in DNA repair and despite the fact that rare, likely dysfunctional variants in three of its five paralogs, RAD51C, RAD51D, and XRCC2, have been associated with breast and/or ovarian cancer risk, no population-based case-control mutation screening data are available for the RAD51 gene. We thus postulated that RAD51 could harbor rare germline mutations that confer increased risk of breast cancer. Methodology/Principal Findings: We screened the coding exons and proximal splice junction regions of the gene for germline sequence variation in 1,330 early-onset breast cancer cases and 1,123 controls from the Breast Cancer Family Registry, using the same population-based sampling and analytical strategy that we developed for assessment of rare sequence variants in ATM and CHEK2. In total, 12 distinct very rare or private variants were characterized in RAD51, with 10 cases (0.75%) and 9 controls (0.80%) carrying such a variant. Variants were either likely neutral missense substitutions (3), silent substitutions (4) or non-coding substitutions (5) that were predicted to have little effect on efficiency of the splicing machinery. Conclusion: Altogether, our data suggest that RAD51 tolerates so little dysfunctional sequence variation that rare variants in the gene contribute little, if anything, to breast cancer susceptibility.	[Le Calvez-Kelm, Florence; Oliver, Javier; Damiola, Francesca; Forey, Nathalie; Robinot, Nivonirina; Durand, Geoffroy; Voegele, Catherine; Vallee, Maxime P.; Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Hopper, John L.] EGA Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.; Breast Canc Family Registry] Stanford Canc Inst, Stanford, CA USA; [Tavtigian, Sean V.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of Melbourne; University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Lesueur, F (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	lesueurf@iarc.fr	Andrulis, Irene L./E-7267-2013; oliver, javier/A-5338-2009; Lesueur, Fabienne/R-2178-2017	oliver, javier/0000-0002-8073-4711; Lesueur, Fabienne/0000-0001-7404-4549; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Damiola, Francesca/0000-0002-0238-1252; Vallee, Maxime/0000-0002-3616-9508; Ranoroarivony Robiniot, Nivonirina/0000-0002-2532-1455; Southey, Melissa/0000-0002-6313-9005; Byrnes, Graham/0000-0003-3893-7539	National Cancer Institute (NCI), National Institutes of Health (NIH) [R01 CA121245]; NIH [RFA-CA-06-503]; Cancer Care Ontario [U01 CA69467]; Cancer Prevention Institute of California [U01 CA69417]; University of Melbourne [U01 CA69638]; NATIONAL CANCER INSTITUTE [U01CA069467, R01CA121245, U01CA069417, U01CA069638] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Care Ontario; Cancer Prevention Institute of California; University of Melbourne(University of Melbourne); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH) grant R01 CA121245. The Breast Cancer Family Registry (BCFR) was supported by the NIH under RFA-CA-06-503 and through cooperative agreements with members of the BCFR and Principal Investigators, including Cancer Care Ontario (U01 CA69467), the Cancer Prevention Institute of California (U01 CA69417) and the University of Melbourne (U01 CA69638). The content of this manuscript does not necessarily reflect the views or policies of the NCI or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the BCFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; He XF, 2011, BREAST CANCER RES TR, V129, P649, DOI 10.1007/s10549-011-1537-8; Ishida T, 2007, BIOL PHARM BULL, V30, P1374, DOI 10.1248/bpb.30.1374; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Kadouri L, 2004, BRIT J CANCER, V90, P2002, DOI 10.1038/sj.bjc.6601837; Kato M, 2000, J HUM GENET, V45, P133, DOI 10.1007/s100380050199; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lose F, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1415; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nguyen-Dumont T, 2009, HUM MUTAT, V30, P884, DOI 10.1002/humu.20949; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Park JY, 2008, NUCLEIC ACIDS RES, V36, P3226, DOI 10.1093/nar/gkn171; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rapakko K, 2006, CANCER LETT, V236, P142, DOI 10.1016/j.canlet.2005.05.032; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Voegele C, 2007, BIOINFORMATICS, V23, P2504, DOI 10.1093/bioinformatics/btm365; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang ZW, 2010, BREAST CANCER RES TR, V124, P765, DOI 10.1007/s10549-010-0885-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yu KD, 2011, BREAST CANCER RES TR, V128, P297, DOI 10.1007/s10549-011-1402-9; Yu KD, 2011, BREAST CANCER RES TR, V126, P365, DOI 10.1007/s10549-010-0937-5; Zheng YL, 2010, BREAST CANCER RES TR, V124, P857, DOI 10.1007/s10549-010-1095-5	57	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52374	10.1371/journal.pone.0052374	http://dx.doi.org/10.1371/journal.pone.0052374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300655	gold, Green Published			2022-12-27	WOS:000312829100045
J	Wall, JS; Kennel, SJ; Williams, A; Richey, T; Stuckey, A; Huang, Y; Macy, S; Donnell, R; Barbour, R; Seubert, P; Schenk, D				Wall, Jonathan S.; Kennel, Stephen J.; Williams, Angela; Richey, Tina; Stuckey, Alan; Huang, Ying; Macy, Sallie; Donnell, Robert; Barbour, Robin; Seubert, Peter; Schenk, Dale			AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils	PLOS ONE			English	Article							P-COMPONENT SCINTIGRAPHY; RENAL-DISEASE; LIGHT-CHAINS; BETA; TRANSTHYRETIN; MECHANISMS; EPRODISATE; DIAGNOSIS; PATHOLOGY; SYSTEM	The monoclonal antibody 2A4 binds an epitope derived from a cleavage site of serum amyloid protein A (sAA) containing a -Glu-Asp- amino acid pairing. In addition to its reactivity with sAA amyloid deposits, the antibody was also found to bind amyloid fibrils composed of immunoglobulin light chains. The antibody binds to synthetic fibrils and human light chain (AL) amyloid extracts with high affinity even in the presence of soluble light chain proteins. Immunohistochemistry with biotinylated 2A4 demonstrated positive reaction with AL kappa and AL lambda human amyloid deposits in various organs. Surface plasmon resonance analyses using synthetic AL fibrils as a substrate revealed that 2A4 bound with a K-D of similar to 10 nM. Binding was inhibited in the presence of the -Glu-Asp- containing immunogen peptide. Radiolabeled 2A4 specifically localized with human AL amyloid extracts implanted in mice (amyloidomas) as evidenced by single photon emission (SPECT) imaging. Furthermore, co-localization of the radiolabeled mAb with amyloid was shown in biodistribution and micro-autoradiography studies. Treatment with 2A4 expedited regression of AL kappa amyloidomas in mice, likely mediated by the action of macrophages and neutrophils, relative to animals that received a control antibody. These data indicate that the 2A4 mAb might be of interest for potential imaging and immunotherapy in patients with AL amyloidosis.	[Wall, Jonathan S.; Kennel, Stephen J.; Williams, Angela; Richey, Tina; Huang, Ying; Macy, Sallie] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA; [Wall, Jonathan S.; Kennel, Stephen J.; Stuckey, Alan] Univ Tennessee, Dept Radiol, Grad Sch Med, Knoxville, TN 37996 USA; [Donnell, Robert] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Barbour, Robin; Seubert, Peter; Schenk, Dale] Neotope Biosci, San Francisco, CA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Wall, JS (corresponding author), Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA.	jwall@utmck.edu		Donnell, Robert L./0000-0002-6778-954X; Wall, Jonathan/0000-0002-5516-8578	Elan Pharmaceuticals, South San Francisco, USA	Elan Pharmaceuticals, South San Francisco, USA	This work was supported by a collaborative research grant from Elan Pharmaceuticals, South San Francisco, USA ("funders''). The funders had no role in data collection and analysis associated with this manuscript. The decision to publish (and where) as well as certain aspects of the experimental design, were made jointly by JSW, SJK, PS, and DS.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benson MD, 2006, MUSCLE NERVE, V33, P609, DOI 10.1002/mus.20503; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Chee CE, 2010, CL LYMPH MYELOM LEUK, V10, P177, DOI 10.3816/CLML.2010.n.027; Davis DP, 1999, J IMMUNOL, V163, P3842; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Guz G, 2009, CURR OPIN INFECT DIS, V22, P309, DOI 10.1097/QCO.0b013e328329d15e; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hachulla E, 1996, AM J MED, V101, P77, DOI 10.1016/S0002-9343(94)00054-9; Hachulla E, 2002, JOINT BONE SPINE, V69, P538, DOI 10.1016/S1297-319X(02)00449-9; Haupt C, 2011, J MOL BIOL, V408, P529, DOI 10.1016/j.jmb.2011.02.032; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hazenberg BPC, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.043; Hazenberg BPC, 2004, NETH J MED, V62, P121; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Hrncic R, 1988, DISSOLUTION HUMAN AM, P166; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Koivuniemi R, 2008, AMYLOID, V15, P262, DOI 10.1080/13506120802524676; Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724; Kurosawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1012, DOI 10.1016/j.bbrc.2005.09.142; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Mekinian A, 2010, AM J MED, V123, P864, DOI 10.1016/j.amjmed.2010.03.022; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Nakamura T, 2011, CLIN EXP RHEUMATOL, V29, P850; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2005, AMYLOID AMYLOIDOSIS, P482; Phipps JE, 2010, EXP HEMATOL, V38, P1006, DOI 10.1016/j.exphem.2010.07.001; Pinney JH, 2012, ANN CLIN BIOCHEM, V49, P229, DOI 10.1258/acb.2011.011225; Pokkuluri PR, 1999, AMYLOID, V6, P165, DOI 10.3109/13506129909007322; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roy I, 2004, BIOTECHNOL APPL BIOC, V39, P165, DOI 10.1042/BA20030133; Rule AD, 2007, NAT CLIN PRACT NEPHR, V3, P592, DOI 10.1038/ncpneph0615; Rumjon A, 2012, INT J NEPHROL RENOV, V5, P37, DOI 10.2147/IJNRD.S19165; SAILE R, 1993, EUR J NUCL MED, V20, P130; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Stangou AJ, 2004, CURR OPIN NEUROL, V17, P615, DOI 10.1097/00019052-200410000-00012; Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2006, J NUCL MED, V47, P2016; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00032; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Zago W, 2012, J NEUROSCI, V32, P2696, DOI 10.1523/JNEUROSCI.1676-11.2012	48	56	59	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52686	10.1371/journal.pone.0052686	http://dx.doi.org/10.1371/journal.pone.0052686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300743	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800126
J	Li, ZM; Huang, JJ; Xia, Y; Sun, J; Huang, Y; Wang, Y; Zhu, YJ; Li, YJ; Zhao, W; Wei, WX; Lin, TY; Huang, HQ; Jiang, WQ				Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi			Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; ABSOLUTE MONOCYTE; RESPONSE CRITERIA; PROGNOSTIC-FACTOR; SURVIVAL; LYMPHOPENIA; EXPRESSION; COUNT; TUMOR; CHEMOTHERAPY	Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic significance of the immunologically relevant lymphocyte-to-monocyte ratio (LMR), in diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Methodology/Principal Findings: We analyzed retrospective data from 438 newly diagnosed DLBCL patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. We randomly selected 200 patients (training set) to generate a cutoff value for LMR by receiver operating characteristic (ROC) curve analysis. LMR was then analyzed in a testing set (n = 238) and in all patients (n = 438) for validation. The LMR cutoff value for survival analysis determined by ROC curve in the training set was 2.6. Patients with low LMR tended to have more adverse clinical characteristics. Low LMR at diagnosis was associated with worse survival in DLBCL, and could also identify high-risk patients in the low-risk IPI category. Multivariate analysis identified LMR as an independent prognostic factor of survival in the testing set and in all patients. Conclusions/Significance: Baseline LMR, a surrogate biomarker of the immune microenvironment, is an effective prognostic factor in DLBCL patients treated with R-CHOP therapy. Future prospective studies are required to confirm our findings.	[Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Ctr Canc, Dept Clin Trial Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022; Wu, William K.K./A-3277-2009	Wu, William K.K./0000-0002-5662-5240; Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (NO. 81071950), Fundamental Research Funds for the Central Universities (NO. 10ykpy36), National-Eleventh Five Technology Major Project (NO. 2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Ansell SM, 2001, J CLIN ONCOL, V19, P720, DOI 10.1200/JCO.2001.19.3.720; Bari A, 2010, ANN ONCOL, V21, P1486, DOI 10.1093/annonc/mdp531; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Borg C, 2004, CANCER-AM CANCER SOC, V101, P2675, DOI 10.1002/cncr.20688; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Huang JJ, 2011, ANN ONCOL, V22, P149, DOI 10.1093/annonc/mdq314; Huang JJ, 2011, HUM PATHOL, V42, P1459, DOI 10.1016/j.humpath.2010.12.014; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Kim YR, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-34; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Pileri SA, 2011, SEMIN DIAGN PATHOL, V28, P113, DOI 10.1053/j.semdp.2011.02.001; Porrata LF, 2007, LEUKEMIA, V21, P2554, DOI 10.1038/sj.leu.2404819; Porrata LF, 2004, CLIN EXP MED, V4, P78, DOI 10.1007/s10238-004-0041-4; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vegso G, 2011, PATHOL ONCOL RES, V17, P443, DOI 10.1007/s12253-010-9329-8; Wada N, 2012, HISTOPATHOLOGY, V60, P924, DOI 10.1111/j.1365-2559.2011.04161.x; Wada N, 2012, HISTOPATHOLOGY, V60, P313, DOI 10.1111/j.1365-2559.2011.04096.x; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Wilcox RA, 2009, BLOOD, V114, P2936, DOI 10.1182/blood-2009-05-220111	35	221	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41658	10.1371/journal.pone.0041658	http://dx.doi.org/10.1371/journal.pone.0041658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	23300886	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700134
J	Li, ZF; Yang, YQ; Xie, DF; Zhu, LF; Zhang, ZG; Lin, WX				Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong			Identification of Autotoxic Compounds in Fibrous Roots of Rehmannia (Rehmannia glutinosa Libosch.)	PLOS ONE			English	Article							SEEDLING GROWTH; POPULATIONS; GERMINATION; PATHOGENS; EXTRACTS	Rehmannia is a medicinal plant in China. Autotoxicity has been reported to be one of the major problems hindering the consecutive monoculture of Rehmannia. However, potential autotoxins produced by the fibrous roots are less known. In this study, the autotoxicity of these fibrous roots was investigated. Four groups of autotoxic compounds from the aqueous extracts of the fibrous roots were isolated and characterized. The ethyl acetate extracts of these water-soluble compounds were further analyzed and separated into five fractions. Among them, the most autotoxic fraction (Fr 3) was subjected to GC/MS analysis, resulting in 32 identified compounds. Based on literature, nine compounds were selected for testing their autotoxic effects on radicle growth. Seven out of the nine compounds were phenolic, which significantly reduced radicle growth in a concentration-dependent manner. The other two were aliphatic compounds that showed a moderate inhibition effect at three concentrations. Concentration of these compounds in soil samples was determined by HPLC. Furthermore, the autotoxic compounds were also found in the top soil of the commercially cultivated Rehmannia fields. It appears that a close link exists between the autotoxic effects on the seedlings and the compounds extracted from fibrous roots of Rehmannia.	[Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong] Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University	Li, ZF (corresponding author), Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China.	wenxiong181@163.com			National Natural Science Foundation of China [30772729]; Provincial Natural Science Foundation of Fujian, China [2008J0051]; key discipline program of Fujian Province, China [20020F012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); key discipline program of Fujian Province, China	This work was supported by The National Natural Science Foundation of China (No. 30772729), Provincial Natural Science Foundation of Fujian, China (No. 2008J0051), and the key discipline program of Fujian Province, China (grant No. 20020F012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogatek R, 2006, BIOL PLANTARUM, V50, P156, DOI 10.1007/s10535-005-0094-6; Canals RM, 2005, J THEOR BIOL, V235, P402, DOI 10.1016/j.jtbi.2005.01.020; Chon SU, 2005, J AGRON CROP SCI, V191, P75, DOI 10.1111/j.1439-037X.2004.00138.x; Chon SU, 2004, AGRON J, V96, P1673, DOI 10.2134/agronj2004.1673; Chou CH, 1976, J CHEM ECOL, V2, P353, DOI 10.1007/BF00988282; Cui YY, 2000, PLANT CELL TISS ORG, V62, P219, DOI 10.1023/A:1006412321864; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Gao WW, 2006, CHINA J CHINESE MAT, V31, P1665; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Kalinova J, 2007, J AGR FOOD CHEM, V55, P6453, DOI 10.1021/jf070795u; Kong CH, 1999, J CHEM ECOL, V25, P2347, DOI 10.1023/A:1020882109682; Li Jing, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1679; Lin WX, 2000, ALLELOPATHY J, V7, P215; Liu HY, 2006, J N CHINA AGR, V21, P131; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Wilson S, 2004, SCI HORTIC-AMSTERDAM, V102, P221, DOI 10.1016/j.scienta.2004.01.001; Wu HW, 2007, PLANT SOIL, V296, P85, DOI 10.1007/s11104-007-9292-7; [解红娥 XIE Hong'e], 2007, [山西农业科学, Journal of Shanxi Agricultural Sciences], V35, P59; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zhang ZC, 2008, ARCH VIROL, V153, P595, DOI 10.1007/s00705-007-0002-9; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhao YJ, 2005, ALLELOPATHY J, V15, P67	24	93	116	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28806	10.1371/journal.pone.0028806	http://dx.doi.org/10.1371/journal.pone.0028806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235251	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400012
J	Zhu, JY; Yang, P; Zhang, Z; Wu, GX; Yang, B				Zhu, Jia-Ying; Yang, Pu; Zhang, Zhong; Wu, Guo-Xing; Yang, Bin			Transcriptomic Immune Response of Tenebrio molitor Pupae to Parasitization by Scleroderma guani	PLOS ONE			English	Article							GENE-EXPRESSION; HELIOTHIS-VIRESCENS; INNATE IMMUNITY; PIERIS-RAPAE; RECOGNITION PROTEINS; MOLECULAR-CLONING; TRICHOPLUSIA-NI; STORAGE PROTEIN; ENZYME-ACTIVITY; VENOM PROTEINS	Background: Host and parasitoid interaction is one of the most fascinating relationships of insects, which is currently receiving an increasing interest. Understanding the mechanisms evolved by the parasitoids to evade or suppress the host immune system is important for dissecting this interaction, while it was still poorly known. In order to gain insight into the immune response of Tenebrio molitor to parasitization by Scleroderma guani, the transcriptome of T. molitor pupae was sequenced with focus on immune-related gene, and the non-parasitized and parasitized T. molitor pupae were analyzed by digital gene expression (DGE) analysis with special emphasis on parasitoid-induced immune-related genes using Illumina sequencing. Methodology/Principal Findings: In a single run, 264,698 raw reads were obtained. De novo assembly generated 71,514 unigenes with mean length of 424 bp. Of those unigenes, 37,373 (52.26%) showed similarity to the known proteins in the NCBI nr database. Via analysis of the transcriptome data in depth, 430 unigenes related to immunity were identified. DGE analysis revealed that parasitization by S. guani had considerable impacts on the transcriptome profile of T. molitor pupae, as indicated by the significant up-or down-regulation of 3,431 parasitism-responsive transcripts. The expression of a total of 74 unigenes involved in immune response of T. molitor was significantly altered after parasitization. Conclusions/Significance: obtained T. molitor transcriptome, in addition to establishing a fundamental resource for further research on functional genomics, has allowed the discovery of a large group of immune genes that might provide a meaningful framework to better understand the immune response in this species and other beetles. The DGE profiling data provides comprehensive T. molitor immune gene expression information at the transcriptional level following parasitization, and sheds valuable light on the molecular understanding of the host-parasitoid interaction.	[Zhu, Jia-Ying; Yang, Bin] SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Yang, Pu] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China; [Zhang, Zhong] Taishan Med Univ, Dept Pathogen Biol, Tai An, Shandong, Peoples R China; [Wu, Guo-Xing] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Shandong First Medical University & Shandong Academy of Medical Sciences; Yunnan Agricultural University	Zhu, JY (corresponding author), SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	jyzhu001@gmail.com	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	Key Project of Chinese Ministry of Education [211171]; Applied Basic Research Programs of Yunnan Province [2010CD063]; National Natural Science Foundation of China [31260449]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Applied Basic Research Programs of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of Chinese Ministry of Education (211171), Applied Basic Research Programs of Yunnan Province (2010CD063), and National Natural Science Foundation of China (31260449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Asgari S, 2004, J INSECT PHYSIOL, V50, P687, DOI 10.1016/j.jinsphys.2004.05.003; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benassi V, 2000, ARCH INSECT BIOCHEM, V43, P64, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;64::AID-ARCH2&gt;3.0.CO;2-I; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chen Jun, 2000, Chinese Journal of Biological Control, V16, P166; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Coudron TA, 1997, COMP BIOCHEM PHYS B, V116, P197, DOI 10.1016/S0305-0491(96)00217-9; COUDRON TA, 1994, ARCH INSECT BIOCHEM, V26, P97, DOI 10.1002/arch.940260204; Coustau C, 1996, INSECT MOL BIOL, V5, P167, DOI 10.1111/j.1365-2583.1996.tb00050.x; Dong K, 1996, ARCH INSECT BIOCHEM, V32, P237, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;237::AID-ARCH7&gt;3.0.CO;2-V; Doucet D, 2008, ARCH INSECT BIOCHEM, V67, P188, DOI 10.1002/arch.20227; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hughes Austin L, 2012, Immunogenetics, V64, P549, DOI 10.1007/s00251-012-0610-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KUNKEL JG, 1990, ARCH INSECT BIOCHEM, V13, P117, DOI 10.1002/arch.940130111; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Ourth DD, 2005, BIOCHEM BIOPH RES CO, V335, P1085, DOI 10.1016/j.bbrc.2005.07.189; Pal S, 2009, FLY, V3, P121, DOI 10.4161/fly.8827; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pick C, 2009, FEBS J, V276, P1930, DOI 10.1111/j.1742-4658.2009.06918.x; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qin X, 1982, SCI SILVAE SINICAE, V18, P209; Quicke D. L. J., 1997, PARASITIC WASPS; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmidt O, 2006, ARCH INSECT BIOCHEM, V61, P107, DOI 10.1002/arch.20110; Schmidt O, 1989, Subcell Biochem, V15, P91; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takeda T, 2006, PESTIC BIOCHEM PHYS, V86, P15, DOI 10.1016/j.pestbp.2005.11.012; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang L, 1980, SCI SILVAE SINICAE, V16, P41; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275; Zhu JY, 2009, INSECT SCI, V16, P227, DOI 10.1111/j.1744-7917.2009.01252.x; Zhu JY, 2009, J ZHEJIANG UNIV-SC B, V10, P445, DOI 10.1631/jzus.B0820314; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	90	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54411	10.1371/journal.pone.0054411	http://dx.doi.org/10.1371/journal.pone.0054411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23301042	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400162
J	Zhu, JF; Zhang, LF; Li, WF; Han, SY; Yang, WH; Qi, LW				Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Han, Suying; Yang, Wenhua; Qi, Liwang			Reference Gene Selection for Quantitative Real-time PCR Normalization in Caragana intermedia under Different Abiotic Stress Conditions	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; TRANSCRIPTION FACTOR; INTERNAL CONTROL; EXPRESSION NORMALIZATION; VALIDATION; ARABIDOPSIS; IDENTIFICATION; DROUGHT; RICE	Quantitative real-time reverse transcription polymerase chain reaction (qPCR), a sensitive technique for gene expression analysis, depends on the stability of the reference genes used for data normalization. Caragana intermedia, a native desert shrub with strong drought-resistance, sand-fixing capacity and high forage value that is widespread in the desert land of west and northwest China, has not been investigated regarding the identification of reference genes suitable for the normalization of qPCR data. In this study, 10 candidate reference genes were analyzed in C. intermedia subjected to different abiotic (osmotic, salt, cold and heat) stresses, in two distinct plant organs (roots and leaves). The expression stability of these genes was assessed using geNorm, NormFinder and BestKeeper algorithms. The best-ranked reference genes differed across the different sets of samples, but UNK2, PP2A and SAND were the most stable across all tested samples. UNK2 and SAND would be appropriate for normalizing gene expression data for salt-treated roots, whereas the combination of UNK2, SAND and EF-1 alpha would be appropriate for salt-treated leaves. UNK1, UNK2 and PP2A would be appropriate for PEG-treated (osmotic) roots, whereas the combination of TIP41 and PP2A was the most suitable for PEG-treated leaves. SAND, PP2A and TIP41 exhibited the most stable expression in heat-treated leaves. In cold-treated leaves, SAND and EF-1 alpha were the most stably expressed. To further validate the suitability of the reference genes identified in this study, the expression levels of DREB1 and DREB2 (homologs of AtDREB1 and AtDREB2) were studied in parallel. This study is the first systematic analysis for the selection of superior reference genes for qPCR in C. intermedia under different abiotic stress conditions, and will benefit future studies on gene expression in C. intermedia and other species of the leguminous genus Caragana.	[Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Yang, Wenhua; Qi, Liwang] Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China; [Han, Suying] Chinese Acad Forestry, Res Inst Forest Ecol & Protect, Key Lab, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Qi, LW (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China.	lwqi@caf.ac.cn	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	National Basic Research Program of China [2009CB119106]; National High Technology Research and Development Program of China [2011AA100203]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2009CB119106) and the National High Technology Research and Development Program of China (2011AA100203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo WH, 2010, AGROFOREST SYST, V80, P423, DOI 10.1007/s10457-010-9337-4; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	44	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53196	10.1371/journal.pone.0053196	http://dx.doi.org/10.1371/journal.pone.0053196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301042	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900067
J	Yang, WH; He, KL; Zhang, J; Guo, SY				Yang, Wenhui; He, Kanglai; Zhang, Jie; Guo, Shuyuan			pH-Controlled Bacillus thuringiensis Cry1Ac Protoxin Loading and Release from Polyelectrolyte Microcapsules	PLOS ONE			English	Article							CALCIUM-CARBONATE PARTICLES; LOW-MOLECULAR-WEIGHT; DELTA-ENDOTOXIN; SPODOPTERA-EXIGUA; INSECTICIDAL ACTIVITY; MULTILAYER FILMS; DOMAIN III; TOXICITY; ENCAPSULATION; FORMULATIONS	Crystal proteins synthesized by Bacillus thuringiensis (Bt) have been used as biopesticides because of their toxicity to the insect larval hosts. To protect the proteins from environmental stress to extend their activity, we have developed a new microcapsule formulation. Poly (acrylic acid) (PAH) and poly (styrene sulfonate) (PSS) were fabricated through layer-by-layer self-assembly based on a CaCO3 core. Cry1Ac protoxins were loaded into microcapsules through layer-by-layer self-assembly at low pH, and the encapsulated product was stored in water at 4 degrees C. Scanning electron microscopy (SEM) was used to observe the morphology of the capsules. To confirm the successful encapsulation, the loading results were observed with a confocal laser scattering microscope (CLSM), using fluorescein-labeled Cry1Ac protoxin (FITC-Cry1Ac). The protoxins were released from the capsule under the alkaline condition corresponding to the midgut of certain insects, a condition which seldom exists elsewhere in the environment. The following bioassay experiment demonstrated that the microcapsules with Cry1Ac protoxins displayed approximately equivalent insecticidal activity to the Asian corn borer compared with free Cry1Ac protoxins, and empty capsules proved to have no effect on insects. Further result also indicated that the formulation could keep stable under the condition of heat and desiccation. These results suggest that this formulation provides a promising methodology that protects protoxins from the environment and releases them specifically in the target insects' midgut, which has shown potential as biopesticide in the field.	[Yang, Wenhui; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, WH (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn	Yang, Wan/K-7592-2013	Yang, Wan/0000-0002-7555-9728	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Natural Science Foundation of China [31171911]; National High Technology Research and Development Program of China (863 Program) [2011AA10A203]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the grants from the Major State Basic Research Development Program of China (973 Program; No. 2009CB118902), the Natural Science Foundation of China (No. 31171911), and the National High Technology Research and Development Program of China (863 Program; No. 2011AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov A, 2003, MACROMOL RAPID COMM, V24, P274, DOI 10.1002/marc.200390041; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Cote JC, 2001, PHYTOPROTECTION, V82, P73, DOI 10.7202/706218ar; de Maagd RA, 2000, APPL ENVIRON MICROB, V66, P1559, DOI 10.1128/AEM.66.4.1559-1563.2000; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891; Donath E, 2002, CHEM-EUR J, V8, P5481, DOI 10.1002/1521-3765(20021202)8:23<5481::AID-CHEM5481>3.0.CO;2-8; Gao CY, 2002, ANGEW CHEM INT EDIT, V41, P3789, DOI 10.1002/1521-3773(20021018)41:20<3789::AID-ANIE3789>3.0.CO;2-D; Garcia-Gutierrez K, 2011, BIOPROC BIOSYST ENG, V34, P701, DOI 10.1007/s00449-011-0519-x; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850, DOI 10.1093/jee/64.4.850; IGNOFFO CM, 1992, FLA ENTOMOL, V75, P516, DOI 10.2307/3496133; Jada A, 2003, COLLOID SURFACE A, V219, P7, DOI 10.1016/S0927-7757(03)00010-4; Jada A, 2000, J MATER SCI LETT, V19, P2077, DOI 10.1023/A:1026737701570; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Lamprecht A, 2000, EUR J PHARM BIOPHARM, V49, P1, DOI 10.1016/S0939-6411(99)00063-6; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Myasnik M, 2001, CURR MICROBIOL, V43, P140, DOI 10.1007/s002840010276; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Regev A, 1996, APPL ENVIRON MICROB, V62, P3581, DOI 10.1128/AEM.62.10.3581-3586.1996; Sopena F, 2009, CIENC INVESTIG AGRAR, V36, P27; Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U; Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P219, DOI 10.1603/0022-0493-93.2.219; Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.3.CO;2-P; Tong WJ, 2006, J PHYS CHEM B, V110, P12905, DOI 10.1021/jp055258w; Tong WJ, 2005, J PHYS CHEM B, V109, P13159, DOI 10.1021/jp0511092; Wei W, 2008, ADV MATER, V20, P2292, DOI 10.1002/adma.200702663; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004	35	152	155	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45233	10.1371/journal.pone.0045233	http://dx.doi.org/10.1371/journal.pone.0045233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024810	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100068
J	Kim, J; Kim, G; An, S; Kwon, YK; Yoon, S				Kim, Jinkyu; Kim, Gunn; An, Sungbae; Kwon, Young-Kyun; Yoon, Sungroh			Entropy-Based Analysis and Bioinformatics-Inspired Integration of Global Economic Information Transfer	PLOS ONE			English	Article							FALSE DISCOVERY RATE; TIME-SERIES; STOCK-MARKET; NETWORK; MODEL; COINTEGRATION; RETURNS; GENES; FLOW	The assessment of information transfer in the global economic network helps to understand the current environment and the outlook of an economy. Most approaches on global networks extract information transfer based mainly on a single variable. This paper establishes an entirely new bioinformatics-inspired approach to integrating information transfer derived from multiple variables and develops an international economic network accordingly. In the proposed methodology, we first construct the transfer entropies (TEs) between various intra- and inter-country pairs of economic time series variables, test their significances, and then use a weighted sum approach to aggregate information captured in each TE. Through a simulation study, the new method is shown to deliver better information integration compared to existing integration methods in that it can be applied even when intra-country variables are correlated. Empirical investigation with the real world data reveals that Western countries are more influential in the global economic network and that Japan has become less influential following the Asian currency crisis.	[Kim, Jinkyu; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Kim, Gunn] Sejong Univ, Dept Phys, Seoul, South Korea; [An, Sungbae] Singapore Management Univ, Sch Econ, Singapore, Singapore; [Kwon, Young-Kyun] Kyung Hee Univ, Dept Phys, Seoul, South Korea; [Kwon, Young-Kyun] Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea	Seoul National University (SNU); Sejong University; Singapore Management University; Kyung Hee University; Kyung Hee University	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@snu.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0009963, 2012R1A2A4A01008475]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant No. 2011-0009963 to SY and Grant No. 2012R1A2A4A01008475 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MACR DAT EM DEV MARK; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard O., 1989, LECT MACROECONOMICS; Box G., 1970, TIME SERIES ANAL; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CARLSTEIN E, 1986, ANN STAT, V14, P1171, DOI 10.1214/aos/1176350057; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Dees S, 2007, J APPL ECONOMET, V22, P1, DOI 10.1002/jae.932; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freeman C, 1987, TECHNOLOGY POLICY EC; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Granger CWJ, 2004, AM ECON REV, V94, P421, DOI 10.1257/0002828041464669; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Kim K, 2004, PHYSICA A, V344, P272, DOI 10.1016/j.physa.2004.06.131; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Matia K, 2003, EUROPHYS LETT, V61, P422, DOI 10.1209/epl/i2003-00194-y; McCauley JL, 2003, PHYSICA A, V329, P178, DOI 10.1016/S0378-4371(03)00589-2; Park JB, 2007, PHYSICA A, V379, P179, DOI 10.1016/j.physa.2006.12.042; Peter FJ, 2011, THESIS EBERHARD KARL; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Silva AC, 2004, PHYSICA A, V344, P227, DOI 10.1016/j.physa.2004.06.122; Stanley HE, 2001, PHYSICA A, V299, P1, DOI 10.1016/S0378-4371(01)00351-X; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thurow L., 1993, HEAD HEAD COMING EC; Vincente R, 2011, J COMPUT NEUROSCI, V30, P45; Vogel E. F., 1979, JAPAN NUMBER ONE LES; Yang JS, 2006, PHYSICA A, V363, P377, DOI 10.1016/j.physa.2005.12.039; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	37	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51986	10.1371/journal.pone.0051986	http://dx.doi.org/10.1371/journal.pone.0051986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23922872	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900015
J	Kim, JE; Ryu, HJ; Kang, TC				Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon			Status Epilepticus Induces Vasogenic Edema via Tumor Necrosis Factor-alpha/Endothelin-1-Mediated Two Different Pathways	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RAT PIRIFORM CORTEX; NADPH-OXIDASE; FACTOR-ALPHA; KAINIC ACID; NITRIC-OXIDE; RECEPTOR; PERMEABILITY; ENDOTHELIN; SEIZURE	Status epilepticus (SE) induces vasogenic edema in the piriform cortex with disruptions of the blood-brain barrier (BBB). However, the mechanisms of vasogenic edema formation following SE are still unknown. Here we investigated the endothelin B (ETB) receptor-mediated pathway of SE-induced vasogenic edema. Following SE, the release of tumor necrosis factor-alpha (TNF-alpha) stimulated endothelin-1 (ET-1) release and expression in neurons and endothelial cells. In addition, TNF-a-induced ET-1 increased BBB permeability via ETB receptor-mediated endothelial nitric oxide synthase (eNOS) activation in endothelial cells. ETB receptor activation also increased intracellular reactive oxygen species by NADPH oxidase production in astrocytes. These findings suggest that SE results in BBB dysfunctions via endothelial-astroglial interactions through the TNF-alpha-ET-1-eNOS/ NADPH oxidase pathway, and that these ETB receptor-mediated interactions may be an effective therapeutic strategy for vasogenic edema in various neurological diseases.	[Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea; [Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Inst Epilepsy Res, Chunchon, Kangwon Do, South Korea	Hallym University; Hallym University	Kang, TC (corresponding author), Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea.	tckang@hallym.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A111313]; National Research Foundation of Korea [2012R1A2A1A01001775]; Korean government	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by grants from the Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (Grant number A111313) and the National Research Foundation of Korea (MEST No. 2012R1A2A1A01001775), funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BD, 1989, J INVEST DERMATOL, V93, P280, DOI 10.1111/1523-1747.ep12277592; BEDI KS, 1991, J COMP NEUROL, V311, P425, DOI 10.1002/cne.903110311; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Davenport AP, 2004, J CARDIOVASC PHARM, V44, pS276, DOI 10.1097/01.fjc.0000166284.08657.64; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; Kim JE, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-6; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kleeberg J, 2004, AM J PHYSIOL-HEART C, V286, pH1339, DOI 10.1152/ajpheart.00227.2003; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; NITSCH C, 1985, J NEUROL SCI, V67, P67, DOI 10.1016/0022-510X(85)90023-1; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Sheen SH, 2011, BRAIN RES, V1369, P173, DOI 10.1016/j.brainres.2010.10.080; Skopal J, 1998, J CARDIOVASC PHARM, V31, pS370, DOI 10.1097/00005344-199800001-00104; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tack I, 1997, AM J PHYSIOL-RENAL, V272, pF31, DOI 10.1152/ajprenal.1997.272.1.F31; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	47	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74458	10.1371/journal.pone.0074458	http://dx.doi.org/10.1371/journal.pone.0074458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	23922872	Green Submitted, gold, Green Published			2022-12-27	WOS:000324481600131
